Citrus Sinensis ID: 038294
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 799 | 2.2.26 [Sep-21-2011] | |||||||
| Q39202 | 832 | G-type lectin S-receptor- | yes | no | 0.946 | 0.908 | 0.442 | 0.0 | |
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.946 | 0.866 | 0.327 | 5e-99 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.884 | 0.852 | 0.334 | 1e-94 | |
| P17801 | 817 | Putative receptor protein | N/A | no | 0.916 | 0.895 | 0.332 | 1e-90 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.852 | 0.854 | 0.332 | 3e-83 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.931 | 0.898 | 0.300 | 6e-81 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.917 | 0.863 | 0.276 | 3e-72 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.399 | 0.388 | 0.430 | 4e-71 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.829 | 0.760 | 0.303 | 1e-70 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.887 | 0.837 | 0.296 | 2e-66 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 638 bits (1646), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 353/798 (44%), Positives = 490/798 (61%), Gaps = 42/798 (5%)
Query: 25 TINLGSSLSSTSS---NSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHAN 81
++ +G SL+++ S +SSW SPS DFAFGFR++ N D F L+IWF+KI ++TIVWHA
Sbjct: 31 SVPVGESLTASESQQISSSWRSPSGDFAFGFRKIQPN-DGFTLSIWFDKISDKTIVWHAQ 89
Query: 82 GDNP----APRGSTLELTATG-LLLKDPGGKTIWDGKPDKKVSDAAMLDTGNFVLRASG- 135
N P GS + LTA G L++ DP G+ +W VS D GNFVL G
Sbjct: 90 AVNTTTGLVPNGSKVTLTADGGLVIADPRGQELWRALSGGSVSRGRFTDDGNFVLFRDGS 149
Query: 136 -NNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFSN-GSLKLISVA 193
++ + W SF+NPTDT+LP Q +++ L SR TET+F KGRF LR + G+L+L S+
Sbjct: 150 EDSDEVLWSSFENPTDTLLPNQNIEVGRNLSSRRTETSFKKGRFSLRLEDDGNLQLHSLN 209
Query: 194 WPSRFQ---YKSYYTSNTGSANSTGSGHQLVFNESADVYIV-KDNGQIVQLPQWAKLSPR 249
+ + Y YY SNT N+ G QLVFN+S ++Y++ ++N + V + S
Sbjct: 210 AETASESDIYSQYYESNTNDPNN--PGIQLVFNQSGEIYVLQRNNSRFVVKDRDPDFSIA 267
Query: 250 VDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCL 309
Y G L PK + D++C + +G+ CG+N+ C
Sbjct: 268 APFYIST-----GFLLSTIIPKEARRIVGGCLLGLCRDNMCSP-DDALGNMACGYNNICS 321
Query: 310 L-QNGRPFCDCPPGYVLADPNNRFRGCKPNF-WQGCGPDDGSRNAQ-ELYEIREFNNVDW 366
L N RP C+CP +VL DP+N + C P+F Q C P++ + N+ LYE +W
Sbjct: 322 LGNNKRPKCECPERFVLKDPSNEYGDCLPDFEMQTCRPENQTANSDVNLYEFITLEKTNW 381
Query: 367 PFGDYERLEPYNQTECEISCLHDCLCAVAIYDGNR---CWKKKLPLSNGWLRDTGFSKVL 423
PFGDYE Y++ C+ SCL DCLCA I+ NR CWKKK PLS+G G S
Sbjct: 382 PFGDYESYANYDEERCKASCLSDCLCAAVIFGTNRDLKCWKKKFPLSHGERSPRGDSDTF 441
Query: 424 FKVRKGNFPGYSDNSGSKKERGPLFLLGAFLLGGSIF------CNAFLLLAILIFLKWRR 477
KVR + K+ L + + LLG S F C+ +K +
Sbjct: 442 IKVRNRSIADVPVTGNRAKKLDWLIIACSVLLGTSAFVIFDTSCSYRKTKKSKNMMKNQA 501
Query: 478 RKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGK--AIA 535
R ++ +E NLR F+Y EL EAT F EELGRG+FGIVYKG L+ A G +A
Sbjct: 502 RDIGRTTATTTANELNLRVFTYGELAEATRDFTEELGRGAFGIVYKGYLEVAGGSEVTVA 561
Query: 536 VKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 595
VKKLDRL + E+EFK+EV IG+ HHKNLV+L+GFC+E ++++VYEF+ GTLAN +F
Sbjct: 562 VKKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLF 621
Query: 596 AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655
P+P W R I++ IARG++YLHEEC+ IIHCDIKPQNILLD Y++ +ISDFGL+KL
Sbjct: 622 RRPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKL 681
Query: 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG 715
LL +Q+ T T IRGT+GYVAPEWF+N+P+++KVDVYS+GVMLLEI+CC+++V++ E
Sbjct: 682 LLMNQTYTLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDL----ED 737
Query: 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
IL +WAYDC+ +GRL+ L + D AM D +++++ IA+WCI+E+ RP M+ V Q
Sbjct: 738 NVILINWAYDCFRQGRLEDLTEDDSEAMNDMETVERYVKIAIWCIQEEHGMRPNMRNVTQ 797
Query: 776 MLEGLLEVPNPPCPSSFS 793
MLEG+++V +PP PS +S
Sbjct: 798 MLEGVIQVFDPPNPSPYS 815
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 362 bits (930), Expect = 5e-99, Method: Compositional matrix adjust.
Identities = 271/828 (32%), Positives = 406/828 (49%), Gaps = 72/828 (8%)
Query: 11 LLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNK 70
CF L+ L+ I LGS L ++ N +W+S + FA GF + +D FLL+IWF +
Sbjct: 16 FFCFFLVS-LATEPHIGLGSKLKASEPNRAWVSANGTFAIGFTRFKP-TDRFLLSIWFAQ 73
Query: 71 IP-ERTIVWHANGDNPAPRGSTLELTATGLLLKDPGGKTIW-DGKPDKKVSDAAMLDTGN 128
+P + TIVW N ++P + + LEL ATG L+ +W + V A M ++GN
Sbjct: 74 LPGDPTIVWSPNRNSPVTKEAVLELEATGNLVLSDQNTVVWTSNTSNHGVESAVMSESGN 133
Query: 129 FVLRASGNNSD-YAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFSNGSL 187
F+L + + WQSF P+DT+LP Q L + L S + + ++ + SL
Sbjct: 134 FLLLGTEVTAGPTIWQSFSQPSDTLLPNQPLTVSLELTSNPSPSRHGHYSLKMLQQHTSL 193
Query: 188 KL-----ISVAWPSRFQY------KSYYTSNTGSANSTGSGHQLVFNESA--DVYIVKD- 233
L I++ + + Y + T + TGS ++V+ ES+ VY+ K+
Sbjct: 194 SLGLTYNINLDPHANYSYWSGPDISNVTGDVTAVLDDTGS-FKIVYGESSIGAVYVYKNP 252
Query: 234 --------NGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTL 285
N + L + L R+ L+ +G L Y + + + W P
Sbjct: 253 VDDNRNYNNSSNLGLTKNPVLR-------RLVLENNGNLRLYRWDNDMNGSSQWVPEWAA 305
Query: 286 PDDICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCP--PGYVLADPNNRFRGCKPN--FWQ 341
+ C +G CG N C L + DC PG V + C N Q
Sbjct: 306 VSNPCDI------AGICG-NGVCNLDRTKKNADCLCLPGSVKLPDQENAKLCSDNSSLVQ 358
Query: 342 GCGPDDGSRNAQELYEIREFNNVDWPFGDYERLEPY----NQTECEISCLHDCLCAVAIY 397
C + + N ++I ++ F + +E N +C CL DC C ++Y
Sbjct: 359 EC---ESNINRNGSFKISTVQETNYYFSERSVIENISDISNVRKCGEMCLSDCKCVASVY 415
Query: 398 ----DGNRCWKKKLPLSNGWLRDTGFSKVLFKVRKGNFPGYSDNSGSKKERGPLFLLGAF 453
+ CW K L+ G RD G S + K R + N+ K R L
Sbjct: 416 GLDDEKPYCWILK-SLNFGGFRDPG-STLFVKTRANESYPSNSNNNDSKSRKSHGLRQKV 473
Query: 454 LLGGSIFCNAFLLLAILIFLKW----RRRKYENNVQDSSTSETNLRFFSYNELKEATGGF 509
L+ I +L+A+L L + R+R + ++S + F+Y +L+ T F
Sbjct: 474 LVI-PIVVGMLVLVALLGMLLYYNLDRKRTLKRAAKNSLILCDSPVSFTYRDLQNCTNNF 532
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+ LG G FG VYKG + A +AVK+LDR EREF +EV+ IG HH NLV+L
Sbjct: 533 SQLLGSGGFGTVYKGTV--AGETLVAVKRLDRALSHGEREFITEVNTIGSMHHMNLVRLC 590
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP----DWNLRVRISLEIARGLVYLHEECNV 625
G+C E +RLLVYE+M NG+L IF+ + DW R I++ A+G+ Y HE+C
Sbjct: 591 GYCSEDSHRLLVYEYMINGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRN 650
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
IIHCDIKP+NILLD+ F K+SDFGL+K++ + S TMIRGTRGY+APEW N P++
Sbjct: 651 RIIHCDIKPENILLDDNFCPKVSDFGLAKMMGREHSHVVTMIRGTRGYLAPEWVSNRPIT 710
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
K DVYS+G++LLEI+ RR+++M + E WAY G VD +A+
Sbjct: 711 VKADVYSYGMLLLEIVGGRRNLDMSYDAED-FFYPGWAYKELTNGTSLKAVDKRLQGVAE 769
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL-EVPNPPCPSSF 792
+ K L +A WCI+++ S RP+M V+++LEG E+ PP P +
Sbjct: 770 EEEVVKALKVAFWCIQDEVSMRPSMGEVVKLLEGTSDEINLPPMPQTI 817
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 1e-94, Method: Compositional matrix adjust.
Identities = 271/811 (33%), Positives = 411/811 (50%), Gaps = 104/811 (12%)
Query: 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWF-NKIPERTIVWHANG 82
+TI LGS + ++ SN +W SP+ F+ F + + + FL A+ F +P +W A
Sbjct: 25 STIPLGSVIYASGSNQNWPSPNSTFSVSFVP-SPSPNSFLAAVSFAGSVP----IWSAGT 79
Query: 83 DNPAPRGSTLELTATGLLLKDPGGKTIWDGKPDK-KVSDAAMLDTGNFVLRASGNNSDYA 141
+ RGS T+ L L + G T+WD K D+ V+ ++ DTG F+L N S
Sbjct: 80 VDS--RGSLRLHTSGSLRLTNGSGTTVWDSKTDRLGVTSGSIEDTGEFILL--NNRSVPV 135
Query: 142 WQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFSNGSLKLISVAWPSRFQYK 201
W SF NPTDTI+ +Q +L S L F+L S G+L L W + Y
Sbjct: 136 WSSFDNPTDTIVQSQNFTAGKILRSGLYS-------FQLERS-GNLTL---RWNTSAIYW 184
Query: 202 SYYTSNTGSANSTGSGHQLVFNESADVYIVKDN----GQIVQLPQWAKLSPRVDHYFR-V 256
++ S +S S +L + V I + N +IV + + FR +
Sbjct: 185 NH--GLNSSFSSNLSSPRLSLQTNGVVSIFESNLLGGAEIVYSGDYGD-----SNTFRFL 237
Query: 257 TLDFDGVLAEYAHPKNSS--TNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCLLQNGR 314
LD DG L Y+ +S N W D C + G CG C +
Sbjct: 238 KLDDDGNLRIYSSASRNSGPVNAHWSAV-----DQC------LVYGYCGNFGICSYNDTN 286
Query: 315 PFCDCPP-GYVLADPNNRFRGCKPNF-WQGCGPDDGSRNAQELYEIREFNNVDWPFGDYE 372
P C CP + D N+R +GCK C G+ +L R F D P + E
Sbjct: 287 PICSCPSRNFDFVDVNDRRKGCKRKVELSDC---SGNTTMLDLVHTRLFTYEDDP--NSE 341
Query: 373 RLEPYNQTECEISCLHD--CLCAVAIYDGN-RCWKKK------------LPLSNGWLRDT 417
+ C +CL CL +V++ DG+ CW+K +P S +++
Sbjct: 342 SFFA-GSSPCRANCLSSVLCLASVSMSDGSGNCWQKHPGSFFTGYQWPSVP-STSYVKVC 399
Query: 418 G--FSKVLFKVRKGNFPGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLAILIFLKW 475
G + L + KG D++ SK L+++ ++ G + L+A+ I L W
Sbjct: 400 GPVVANTLERATKG------DDNNSKVH---LWIVAVAVIAGLLG-----LVAVEIGLWW 445
Query: 476 RRRKYENNVQDSSTSETNLRF-------FSYNELKEATGGFKEELGRGSFGIVYKGVLKS 528
+ S+ T L + F+Y EL+ T FKE+LG G FG VY+GVL +
Sbjct: 446 CCCRKNPRFGTLSSHYTLLEYASGAPVQFTYKELQRCTKSFKEKLGAGGFGTVYRGVLTN 505
Query: 529 ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588
+ +AVK+L+ + Q E++F+ EV+ I THH NLV+L+GFC + +RLLVYEFM NG
Sbjct: 506 RT--VVAVKQLEGIEQG-EKQFRMEVATISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNG 562
Query: 589 TLANLIFAIPKPD---WNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645
+L N +F W R I+L A+G+ YLHEEC I+HCDIKP+NIL+D+ F+A
Sbjct: 563 SLDNFLFTTDSAKFLTWEYRFNIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAA 622
Query: 646 KISDFGLSKLLLSDQSRTH-TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCR 704
K+SDFGL+KLL +R + + +RGTRGY+APEW N P+++K DVYS+G++LLE++ +
Sbjct: 623 KVSDFGLAKLLNPKDNRYNMSSVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGK 682
Query: 705 RSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS--DEPAMADRSRLQKWLMIAMWCIRE 762
R+ ++ E+ + WAY+ + +G ++D+ E D ++ + + + WCI+E
Sbjct: 683 RNFDVS-EKTNHKKFSIWAYEEFEKGNTKAILDTRLSEDQTVDMEQVMRMVKTSFWCIQE 741
Query: 763 DPSKRPTMKVVLQMLEGLLEVPNPPCPSSFS 793
P +RPTM V+QMLEG+ E+ NP CP + S
Sbjct: 742 QPLQRPTMGKVVQMLEGITEIKNPLCPKTIS 772
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P17801|KPRO_MAIZE Putative receptor protein kinase ZmPK1 OS=Zea mays GN=PK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 334 bits (857), Expect = 1e-90, Method: Compositional matrix adjust.
Identities = 281/844 (33%), Positives = 403/844 (47%), Gaps = 112/844 (13%)
Query: 6 LPCLILLCFPLLQFLSAATT---INLGSSLSSTSSNSSWLSPSE-DFAFGFRQLNNNSDL 61
L +L F + F AA++ + LGSSL S SS L S+ F+ GF ++ ++
Sbjct: 9 LSTACILSFFIALFPRAASSRDILPLGSSLVVESYESSTLQSSDGTFSSGFYEVYTHA-- 66
Query: 62 FLLAIWFNKIP-----ERTIVWHANGDNPA-PRGSTLELTATG-LLLKDPGGKTIW--DG 112
F ++W++K +TIVW AN D P R S L L G ++L D G +W DG
Sbjct: 67 FTFSVWYSKTEAAAANNKTIVWSANPDRPVHARRSALTLQKDGNMVLTDYDGAAVWRADG 126
Query: 113 KPDKKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETN 172
V A +LDTGN V+ SG N+ WQSF +PTDT LPTQ++ + L+ T +
Sbjct: 127 NNFTGVQRARLLDTGNLVIEDSGGNT--VWQSFDSPTDTFLPTQLITAATRLVP--TTQS 182
Query: 173 FSKGRFELRFSNGSL--------KLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNE 224
S G + RFS+ S+ ++ + WP Q + Y NST +L
Sbjct: 183 RSPGNYIFRFSDLSVLSLIYHVPQVSDIYWPDPDQ--NLYQDGRNQYNST----RLGMLT 236
Query: 225 SADVYIVKD--NGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPT 282
+ V D +GQ + + + P V R+TLD DG L Y+ + +
Sbjct: 237 DSGVLASSDFADGQALVA---SDVGPGVKR--RLTLDPDGNLRLYSMNDSDGSWSVSMVA 291
Query: 283 RTLPDDICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQG 342
T P +I G CG N C + P C CPPGY +P N GC
Sbjct: 292 MTQPCNI---------HGLCGPNGICHY-SPTPTCSCPPGYATRNPGNWTEGCMAIVNTT 341
Query: 343 CGPDDGSRNAQELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYD--GN 400
C R + N D+ D + L + C C+ DC C Y
Sbjct: 342 C-----DRYDKRSMRFVRLPNTDFWGSDQQHLLSVSLRTCRDICISDCTCKGFQYQEGTG 396
Query: 401 RCWKK-------------------KLP----LSNGWL-RDTGFSKV--------LFKVRK 428
C+ K KLP +SN + R F V + K +
Sbjct: 397 SCYPKAYLFSGRTYPTSDVRTIYLKLPTGVSVSNALIPRSDVFDSVPRRLDCDRMNKSIR 456
Query: 429 GNFPGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLAILIFLKWRRRKYE--NNVQD 486
FP G + + F F+ + +F+ A LK R E + +
Sbjct: 457 EPFPDVHKTGGGESK---WFYFYGFIAAFFVVEVSFISFAWFFVLKRELRPSELWASEKG 513
Query: 487 SSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER 546
+N R +SY EL +AT FK ELGRG G VYKGVL+ + +AVKKL+ + Q +
Sbjct: 514 YKAMTSNFRRYSYRELVKATRKFKVELGRGESGTVYKGVLED--DRHVAVKKLENVRQGK 571
Query: 547 EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWN 603
E F++E+S IGR +H NLV++ GFC E +RLLV E++ NG+LAN++F+ DW
Sbjct: 572 E-VFQAELSVIGRINHMNLVRIWGFCSEGSHRLLVSEYVENGSLANILFSEGGNILLDWE 630
Query: 604 LRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL---LSDQ 660
R I+L +A+GL YLH EC +IHCD+KP+NILLD F KI+DFGL KLL S Q
Sbjct: 631 GRFNIALGVAKGLAYLHHECLEWVIHCDVKPENILLDQAFEPKITDFGLVKLLNRGGSTQ 690
Query: 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEM-----EVEEEG 715
+ +H +RGT GY+APEW + P++AKVDVYS+GV+LLE++ R E+ EV
Sbjct: 691 NVSH--VRGTLGYIAPEWVSSLPITAKVDVYSYGVVLLELLTGTRVSELVGGTDEVHSML 748
Query: 716 RAILTDWAYDCYAEGR--LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVV 773
R ++ + E + +D +DS + + + + +A+ C+ ED SKRPTM+
Sbjct: 749 RKLVRMLSAKLEGEEQSWIDGYLDSKLNRPVNYVQARTLIKLAVSCLEEDRSKRPTMEHA 808
Query: 774 LQML 777
+Q L
Sbjct: 809 VQTL 812
|
Probable receptor. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (794), Expect = 3e-83, Method: Compositional matrix adjust.
Identities = 257/772 (33%), Positives = 372/772 (48%), Gaps = 91/772 (11%)
Query: 38 NSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPA--PRGSTLELT 95
N + LS F GF N S + L I + +P T VW AN P P STLELT
Sbjct: 30 NQTILSFKAIFRLGFFSTTNGSSNWYLGISYASMPTPTHVWVANRIRPVSDPDSSTLELT 89
Query: 96 ATG-LLLKDPGGKTIWDGKPDKKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILP 154
+TG L++ + +W + +D +TGN +L ++ WQSF NPTDT LP
Sbjct: 90 STGYLIVSNLRDGVVWQTDNKQPGTDFRFSETGNLIL--INDDGSPVWQSFDNPTDTWLP 147
Query: 155 TQILDLDSVLISRLTETNFSKGRFELRFSNGSLKLISVAWPSRFQYKSYYTSNT---GSA 211
+ + + S + + S G + LR S PS +++ Y T +
Sbjct: 148 GMNVTGLTAMTSWRSLFDPSPGFYSLRLS-----------PSFNEFQLVYKGTTPYWSTG 196
Query: 212 NSTGSGHQLVFNESADVYIVKDNGQIVQLPQWA--KLSPRVD-----HYFRVTLDFDGVL 264
N TG V E YI + + P + + P +D R + +G L
Sbjct: 197 NWTGEAFVGV-PEMTIPYIYRFHFVNPYTPTASFWYIVPPLDSVSEPRLTRFMVGANGQL 255
Query: 265 AEYA-HPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGY 323
+Y P+ S N W P+D CR ++N CG +C + +P C C G+
Sbjct: 256 KQYTWDPQTQSWNMFWLQ----PEDPCR-VYN-----LCGQLGFCSSELLKP-CACIRGF 304
Query: 324 VLADPNNRFRGCKPNFWQGCGPDDG-----SRNAQELYEIREFNNVDWPFGDYERLEPYN 378
P N ++ GC ++G S + + ++R +V RL+ +
Sbjct: 305 ---RPRNDAAWRSDDYSDGCRRENGDSGEKSDTFEAVGDLRYDGDVK-----MSRLQ-VS 355
Query: 379 QTECEISCLHDCLCAVAIYDGNRCWKKKLPLSNGWLRDTGFSKVLFKVRKGNFPGYSDNS 438
++ C +CL + C V Y + + K+L + P NS
Sbjct: 356 KSSCAKTCLGNSSC-VGFYHKEK---------------SNLCKILLES-----PNNLKNS 394
Query: 439 GSKKERGPLFLLGAFLLGGSIFCNAFLLLAILIFLKWRRRKYENNVQDSST-SETNLRFF 497
+ + L GSI F LL LI LK R++ + QD + NL+ F
Sbjct: 395 KGNISKSIIILCSVV---GSISVLGFTLLVPLILLKRSRKRKKTRKQDEDGFAVLNLKVF 451
Query: 498 SYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAI 557
S+ EL+ AT GF +++G G FG V+KG L +S +AVK+L+R E EF++EV I
Sbjct: 452 SFKELQSATNGFSDKVGHGGFGAVFKGTLPGSS-TFVAVKRLERPGSG-ESEFRAEVCTI 509
Query: 558 GRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKP-DWNLRVRISLEIARG 615
G H NLV+L GFC E L+RLLVY++M G+L++ L PK W R RI+L A+G
Sbjct: 510 GNIQHVNLVRLRGFCSENLHRLLVYDYMPQGSLSSYLSRTSPKLLSWETRFRIALGTAKG 569
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
+ YLHE C IIHCDIKP+NILLD+ ++AK+SDFGL+KLL D SR +RGT GYVA
Sbjct: 570 IAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLATMRGTWGYVA 629
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEIICCRRSV--------EMEVEEEGRAILTDWAYDCY 727
PEW P++ K DVYSFG+ LLE+I RR+V E E E E + WA
Sbjct: 630 PEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPE-KWFFPPWAAREI 688
Query: 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779
+G +D +VDS + + + +A+WCI+++ RP M V++MLEG
Sbjct: 689 IQGNVDSVVDSRLNGEYNTEEVTRMATVAIWCIQDNEEIRPAMGTVVKMLEG 740
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 302 bits (774), Expect = 6e-81, Method: Compositional matrix adjust.
Identities = 250/832 (30%), Positives = 392/832 (47%), Gaps = 88/832 (10%)
Query: 4 LALPCLILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFL 63
L L +CF F+ ++ ++ S + S + + +S + GF + ++S+ F
Sbjct: 5 LTLTSFFFICF----FIHGSSAVDTISGDFTLSGDQTIVSSDGTYEMGFFKPGSSSN-FY 59
Query: 64 LAIWFNKIPERTIVWHANGDNPAP--RGSTLELTATGLLLKDPGGKT-IWDGKPDKKVS- 119
+ +W+ ++ + TI+W AN D S +++ L+L D +T +W + S
Sbjct: 60 IGMWYKQLSQ-TILWVANRDKAVSDKNSSVFKISNGNLILLDGNYQTPVWSTGLNSTSSV 118
Query: 120 ---DAAMLDTGNFVLRASGNN--SDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFS 174
+A + D GN VLR G++ ++ WQSF +P DT LP + LD T++
Sbjct: 119 SALEAVLQDDGNLVLRTGGSSLSANVLWQSFDHPGDTWLPGVKIRLDKRTGKSQRLTSWK 178
Query: 175 KGRFELRFSNGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDN 234
+ S L S+ YK + GS SG +N + ++
Sbjct: 179 S------LEDPSPGLFSLELDESTAYKILWN---GSNEYWSSGP---WNPQSRIFDSVPE 226
Query: 235 GQIVQLPQWAKLSPRVDHYF-----------RVTLDFDGVLAEYAHPKNSSTNQSWFPTR 283
++ + ++ S D YF R +D G + ++ + N++W
Sbjct: 227 MRLNYIYNFSFFSNTTDSYFTYSIYNQLNVSRFVMDVSGQIKQFTWLEG---NKAWNLFW 283
Query: 284 TLPDDICRRLFNEIGS-GTCGFNSYCLLQNGRPFCDCPPGYVLA-----DPNNRFRGCKP 337
+ P C+ ++ GS G C S PFC CP G+ D + GC
Sbjct: 284 SQPRQQCQ-VYRYCGSFGICSDKS-------EPFCRCPQGFRPMSQKDWDLKDYSAGCVR 335
Query: 338 NFWQGCGPDDGSRNAQELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIY 397
C D + + + D + E L + + C +C DC C Y
Sbjct: 336 KTELQCSRGD----INQFFRLPNMKLAD----NSEVLTRTSLSICASACQGDCSCKAYAY 387
Query: 398 D--GNRC--WKKKLPLSNGWLRDTGFSKVLFKVR--KGNFPGYSDNSGSKKERGPLFLLG 451
D ++C W K + L+ L D +F +R + P SG +G +F
Sbjct: 388 DEGSSKCLVWSKDV-LNLQQLEDENSEGNIFYLRLAASDVPNVG-ASGKSNNKGLIF--- 442
Query: 452 AFLLGGSIFCNAFLLLAILIFLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKE 511
G++ + +++ +L+ + R + L FSY EL+ AT F +
Sbjct: 443 -----GAVLGSLGVIVLVLLVVILILRYRRRKRMRGEKGDGTLSAFSYRELQNATKNFSD 497
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
+LG G FG V+KG L +S IAVK+L+ ++Q E++F++EV IG H NLV+L GF
Sbjct: 498 KLGGGGFGSVFKGALPDSSD--IAVKRLEGISQG-EKQFRTEVVTIGTIQHVNLVRLRGF 554
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRVRISLEIARGLVYLHEECNVP 626
C E +LLVY++M NG+L + +F + W LR +I+L ARGL YLH+EC
Sbjct: 555 CSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVLGWKLRFQIALGTARGLAYLHDECRDC 614
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IIHCDIKP+NILLD+ F K++DFGL+KL+ D SR T +RGTRGY+APEW ++A
Sbjct: 615 IIHCDIKPENILLDSQFCPKVADFGLAKLVGRDFSRVLTTMRGTRGYLAPEWISGVAITA 674
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD-EPAMAD 745
K DVYS+G+ML E++ RR+ E E+ R + A +G + LVD E D
Sbjct: 675 KADVYSYGMMLFELVSGRRNTEQSENEKVRFFPSWAATILTKDGDIRSLVDPRLEGDAVD 734
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSFSIAVT 797
+ + +A WCI+++ S RP M V+Q+LEG+LEV PP P S V
Sbjct: 735 IEEVTRACKVACWCIQDEESHRPAMSQVVQILEGVLEVNPPPFPRSIQALVV 786
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (699), Expect = 3e-72, Method: Compositional matrix adjust.
Identities = 236/853 (27%), Positives = 382/853 (44%), Gaps = 120/853 (14%)
Query: 10 ILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFN 69
+ L F L + AA TI G SL ++ +SP + F GF +++ FL IW+
Sbjct: 13 LFLYFFLYESSMAANTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFL-GIWYG 71
Query: 70 KIPERTIVWHANGDNP-APRGSTLELTATG-LLLKDPGGKTIWDGKPDKKVSD-----AA 122
I ++ +VW AN P + + L ++ G L+L D T+W + ++ +
Sbjct: 72 NIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRVVS 131
Query: 123 MLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLD------SVLISRLTETNFSKG 176
+ DTGNFVL + + W+SF +PTDT LP + ++ +S +ET+ S G
Sbjct: 132 IHDTGNFVLSETDTDRP-IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSPG 190
Query: 177 RFELRFSNGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVF-------------N 223
+ L I V W + + + + SA TG + + +
Sbjct: 191 NYSLGVDPSGAPEI-VLWEGN-KTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPD 248
Query: 224 ESADVYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTR 283
E+ VY + P V F+V ++G E + + T + W +
Sbjct: 249 ETGSVYFT-----------YVPSDPSVLLRFKVL--YNGTEEEL---RWNETLKKWTKFQ 292
Query: 284 TLPDDICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGC 343
+ PD C + +N CG C ++ C C GY N RGC+ C
Sbjct: 293 SEPDSECDQ-YNR-----CGKFGICDMKGSNGICSCIHGYEQVSVGNWSRGCRRRTPLKC 346
Query: 344 GPDDGSRNAQELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLC-AVAIYDGNRC 402
+ S E ++ D+ ++ ++P +C CL +C C A ++ G C
Sbjct: 347 -ERNISVGEDEFLTLKSVKLPDFEIPEHNLVDP---EDCRERCLRNCSCNAYSLVGGIGC 402
Query: 403 WKKKLPLSNGWLRDTGFSKVLFKVRKGNFPGYSDNSGSKKERGPLFLLGAFLLGGSIFCN 462
L + + G S + ++ +D+ + + + ++ A L+G
Sbjct: 403 MIWNQDLVDLQQFEAGGSSLHIRL--------ADSEVGENRKTKIAVIVAVLVG------ 448
Query: 463 AFLLLAILIFLKWRRRKYEN-----------------------------------NVQDS 487
+L+ I L WR ++ ++ ++
Sbjct: 449 -VILIGIFALLLWRFKRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGK 507
Query: 488 STSETNLRFFSYNELKEATGGF--KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE 545
+ + + L FS N + AT F + ELGRG FG VYKGVL+ G+ IAVK+L + +
Sbjct: 508 AVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLED--GREIAVKRLSGKSGQ 565
Query: 546 REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DW 602
EFK+E+ I + H+NLV+LLG C E ++LVYE+M N +L +F K DW
Sbjct: 566 GVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDW 625
Query: 603 NLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662
LR I IARGL+YLH + + IIH D+K N+LLD + KISDFG++++ +Q+
Sbjct: 626 KLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNE 685
Query: 663 THTM-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD 721
+T+ + GT GY++PE+ S K DVYSFGV+LLEI+ +R+ + E G L
Sbjct: 686 ANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGS--LIG 743
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE--- 778
+A+ Y GR + LVD + + + +AM C+++ ++RP M VL MLE
Sbjct: 744 YAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDT 803
Query: 779 GLLEVPNPPCPSS 791
L P P +S
Sbjct: 804 ATLAAPRQPTFTS 816
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 270 bits (690), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 146/339 (43%), Positives = 208/339 (61%), Gaps = 20/339 (5%)
Query: 470 LIFLKWRRRKYENNV----QDSSTSETNLR-------FFSYNELKEATGGFKEELGRGSF 518
LIF+ +R K + + Q+SS + L F+Y +L+ AT F +LG+G F
Sbjct: 445 LIFVAFRIHKRKKMILEAPQESSEEDNFLENLSGMPIRFAYKDLQSATNNFSVKLGQGGF 504
Query: 519 GIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578
G VY+G L G +AVKKL+ + Q + +EF++EVS IG HH +LV+L GFC E +R
Sbjct: 505 GSVYEGTL--PDGSRLAVKKLEGIGQGK-KEFRAEVSIIGSIHHLHLVRLRGFCAEGAHR 561
Query: 579 LLVYEFMGNGTLANLIFAIPKPD----WNLRVRISLEIARGLVYLHEECNVPIIHCDIKP 634
LL YEF+ G+L IF D W+ R I+L A+GL YLHE+C+ I+HCDIKP
Sbjct: 562 LLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKP 621
Query: 635 QNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFG 694
+NILLD+ F+AK+SDFGL+KL+ +QS T +RGTRGY+APEW N +S K DVYS+G
Sbjct: 622 ENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRGYLAPEWITNYAISEKSDVYSYG 681
Query: 695 VMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM-ADRSRLQKWL 753
++LLE+I R++ + E + +A+ EG+L +VD + R+Q+ +
Sbjct: 682 MVLLELIGGRKNYDPSETSE-KCHFPSFAFKKMEEGKLMDIVDGKMKNVDVTDERVQRAM 740
Query: 754 MIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSF 792
A+WCI+ED RP+M V+QMLEG+ V PP S+
Sbjct: 741 KTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSSTM 779
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 268 bits (685), Expect = 1e-70, Method: Compositional matrix adjust.
Identities = 236/778 (30%), Positives = 344/778 (44%), Gaps = 115/778 (14%)
Query: 75 TIVWHANGDNPAPRGSTLELTATGLLLKDPGGKTI--WDGKP-DKKVSDAAMLDTGNFVL 131
+ +W +N D+P T+ LT G+ + + G I W V + D GN +L
Sbjct: 84 STIWSSNRDSPVSSSGTMNLTPQGISVIEDGKSQIPVWSTPVLASPVKSLRLTDAGNLLL 143
Query: 132 RASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKG--RFELRFSNGSLKL 189
N S W+SF PTD+I+ Q L L L ++ ++FS G +F + S+G ++
Sbjct: 144 LDHLNVS--LWESFDFPTDSIVLGQRLKLGMFLSGSVSRSDFSTGDYKFLVGESDGLMQW 201
Query: 190 ISVA-WPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSP 248
W R ++ SN T + ++ + ++ NG +V + L P
Sbjct: 202 RGQNYWKLRMHIRANVDSNFPVEYLTVT--------TSGLALMARNGTVVVV--RVALPP 251
Query: 249 RVDHYFRVT-LDFDG--VLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFN 305
D FRV +D G +++ ++ KN T S P D C+ F CG
Sbjct: 252 SSD--FRVAKMDSSGKFIVSRFSG-KNLVTEFSG------PMDSCQIPF------VCGKL 296
Query: 306 SYCLLQNG--RPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQELYEIREFNN 363
C L N C CP + + +G C P S + E R +
Sbjct: 297 GLCNLDNASENQSCSCPDEMRM----DAGKGV-------CVPVSQSLSLPVSCEARNISY 345
Query: 364 VDWPFG----DYERLEPYNQ----TECEISCLHDCLCAVAIYDGNR--CWKKKLPLSNGW 413
++ G +P C C +C C Y+ C+ K +
Sbjct: 346 LELGLGVSYFSTHFTDPVEHGLPLLACHDICSKNCSCLGVFYENTSRSCYLVKDSFGSLS 405
Query: 414 LRDT--------GFSKVLFKVRKGNFPGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFL 465
L G+ K+ + PG ++ GS L LL C+ F
Sbjct: 406 LVKNSPENHDLIGYVKLSIRKTNAQPPGNNNRGGSSFPVIALVLLP---------CSGFF 456
Query: 466 LLAILIFLKWRR---RKY----ENNVQDSSTSETN----------LRFFSYNELKEATGG 508
LL L L WRR +Y E V + E+ + F + EL++AT
Sbjct: 457 LLIALGLLWWRRCAVMRYSSIREKQVTRPGSFESGDLGSFHIPGLPQKFEFEELEQATEN 516
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
FK ++G G FG VYKG L + IAVKK+ +EF +E++ IG H NLV+L
Sbjct: 517 FKMQIGSGGFGSVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEIAIIGNIRHTNLVKL 574
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNVP 626
GFC LLVYE+M +G+L +F+ P +W R I+L ARGL YLH C+
Sbjct: 575 RGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTARGLAYLHSGCDQK 634
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IIHCD+KP+NILL ++F KISDFGLSKLL ++S T +RGTRGY+APEW NA +S
Sbjct: 635 IIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYLAPEWITNAAISE 694
Query: 687 KVDVYSFGVMLLEII-----CCRRSVEMEVEEE-------------GRAILTDWAYDCYA 728
K DVYS+G++LLE++ C RS V E+ G +A D +
Sbjct: 695 KADVYSYGMVLLELVSGRKNCSFRSRSNSVTEDNNQNHSSTTTTSTGLVYFPLYALDMHE 754
Query: 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
+GR L D +K + IA+ C+ E+P+ RPTM V+ M EG + + NP
Sbjct: 755 QGRYMELADPRLEGRVTSQEAEKLVRIALCCVHEEPALRPTMAAVVGMFEGSIPLGNP 812
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 244/822 (29%), Positives = 375/822 (45%), Gaps = 113/822 (13%)
Query: 34 STSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNP-APRGSTL 92
+ SSN + +SPS+ F GF +++S +L IW+ IP RT VW AN DNP + TL
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYL-GIWYKIIPIRTYVWVANRDNPLSSSNGTL 95
Query: 93 ELTATGLLLKDPGGKTIWD----GKPDKKVSDAAMLDTGNFVLRASGNN--SDYAWQSFK 146
+++ L++ D + +W G + A +LD GNFVLR S NN S + WQSF
Sbjct: 96 KISDNNLVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQSFD 155
Query: 147 NPTDTILPTQILDLDS-------VLISRLTETNFSKGRFELRFSNGSLKLISVAWPSRFQ 199
PTDT+L + D+ +L S T + S G F S KL + +P +
Sbjct: 156 FPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDF-------STKLRTSGFPEFYI 208
Query: 200 YKS---YYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSPRVDHYFRV 256
Y Y S N S + + D ++N Q+V ++ + + Y +
Sbjct: 209 YNKESITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVV----YSYRVNKTNIYSIL 264
Query: 257 TLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCLLQNGRPF 316
+L G+L + + QSW P D+C + E CG YC N P
Sbjct: 265 SLSSTGLLQRLTWMEAA---QSWKQLWYSPKDLCDN-YKE-----CGNYGYCD-ANTSPI 314
Query: 317 CDCPPGYVLADPNNRFR----GCKPNFWQGCGPDDG--SRNAQELYEIREFNNVDWPFGD 370
C+C G+ + R GC C DG L + E +VD G
Sbjct: 315 CNCIKGFEPMNEQAALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTE-TSVDKGIG- 372
Query: 371 YERLEPYNQTECEISCLHDCLC-AVAIYDGNRCWKKKLPLSNGWLRDTGFSKVLFKVRKG 429
ECE CL C C A A D + NG +S LF +R
Sbjct: 373 --------LKECEERCLKGCNCTAFANTD----------IRNGGSGCVIWSGGLFDIR-- 412
Query: 430 NFPGYSDNSGSKKERGPL---FLLGAFLLGGSIFCNAFLLLAILIFLKWRRRKYEN---- 482
N+ + + G L + ++G SI + LLL+ +IF W+R++ +
Sbjct: 413 NYAKGGQDLYVRVAAGDLEDKRIKSKKIIGSSIGVSILLLLSFIIFHFWKRKQKRSITIQ 472
Query: 483 -------NVQDS-----------STSETN------LRFFSYNELKEATGGFKEE--LGRG 516
QDS TS+ N L + L AT F + LG+G
Sbjct: 473 TPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNFSTDNKLGQG 532
Query: 517 SFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL 576
FGIVYKG+L GK IAVK+L +++ + EF +EV I + H NLV+LLG C +
Sbjct: 533 GFGIVYKGML--LDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLLGCCVDKG 590
Query: 577 NRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIK 633
++L+YE++ N +L + +F + +W R I IARGL+YLH++ IIH D+K
Sbjct: 591 EKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCRIIHRDLK 650
Query: 634 PQNILLDNYFSAKISDFGLSKLLLSDQSRTHT-MIRGTRGYVAPEWFKNAPVSAKVDVYS 692
N+LLD + KISDFG++++ +++ +T + GT GY++PE+ + S K DV+S
Sbjct: 651 ASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFSMKSDVFS 710
Query: 693 FGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR-LDVLVDSDEPAMADR---SR 748
FGV+LLEII +R+ +L + + + EG+ L+++ + A++
Sbjct: 711 FGVLLLEIISGKRNKGFYNSNRDLNLL-GFVWRHWKEGKELEIVDPINIDALSSEFPTHE 769
Query: 749 LQKWLMIAMWCIREDPSKRPTMKVVLQML-EGLLEVPNPPCP 789
+ + + I + C++E RP M V+ ML +P P P
Sbjct: 770 ILRCIQIGLLCVQERAEDRPVMSSVMVMLGSETTAIPQPKRP 811
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 799 | ||||||
| 224138692 | 776 | predicted protein [Populus trichocarpa] | 0.952 | 0.980 | 0.656 | 0.0 | |
| 255583185 | 787 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.959 | 0.974 | 0.576 | 0.0 | |
| 357482147 | 800 | Kinase-like protein [Medicago truncatula | 0.939 | 0.938 | 0.539 | 0.0 | |
| 356540555 | 802 | PREDICTED: G-type lectin S-receptor-like | 0.973 | 0.970 | 0.533 | 0.0 | |
| 357482135 | 803 | Kinase-like protein [Medicago truncatula | 0.967 | 0.962 | 0.523 | 0.0 | |
| 224099309 | 801 | predicted protein [Populus trichocarpa] | 0.959 | 0.957 | 0.534 | 0.0 | |
| 356495581 | 801 | PREDICTED: G-type lectin S-receptor-like | 0.976 | 0.973 | 0.525 | 0.0 | |
| 356495583 | 809 | PREDICTED: G-type lectin S-receptor-like | 0.971 | 0.959 | 0.521 | 0.0 | |
| 224103119 | 799 | predicted protein [Populus trichocarpa] | 0.973 | 0.973 | 0.519 | 0.0 | |
| 359487487 | 808 | PREDICTED: G-type lectin S-receptor-like | 0.958 | 0.948 | 0.519 | 0.0 |
| >gi|224138692|ref|XP_002326666.1| predicted protein [Populus trichocarpa] gi|222833988|gb|EEE72465.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1030 bits (2662), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 507/772 (65%), Positives = 614/772 (79%), Gaps = 11/772 (1%)
Query: 31 SLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGS 90
S S T++ ++WLSPS DFAFGFRQL N S+LFLLAIWF+ IP RTIVWH+NG+NP PRGS
Sbjct: 7 SSSLTTNGNTWLSPSGDFAFGFRQLGN-SNLFLLAIWFDIIPARTIVWHSNGNNPLPRGS 65
Query: 91 TLELTATGLLLKDPGGKTIWDGKPDKKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTD 150
+ELT++ L+L +P G IW P V AAMLDTGNFVL+ + ++S Y W++FKNPTD
Sbjct: 66 KVELTSSNLVLTNPKGLIIWQANPATPVISAAMLDTGNFVLKGN-DSSTYIWETFKNPTD 124
Query: 151 TILPTQILDLDSVLISRLTETNFSKGRFELRFSNGSLKLISVAWPSRFQYKSYYTSNTGS 210
TILPTQ LDL S L SRLTETN+SKGRFEL FSNGSL+L +AWPS FQY YY+SNT +
Sbjct: 125 TILPTQTLDLGSKLFSRLTETNYSKGRFELNFSNGSLELNPIAWPSEFQYDHYYSSNTYN 184
Query: 211 ANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHP 270
A+ SG++LVFNESA+VYIVK NG+I Q P W +++ D+Y+R TL FDGV +Y+ P
Sbjct: 185 ADPYESGYRLVFNESANVYIVKLNGEIAQFPDWNRINYTGDNYYRATLGFDGVFTQYSLP 244
Query: 271 KNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCLLQ-NGRPFCDCPPGYVLADPN 329
KNS+TNQ W+P +++P D+C +FN+IGSG CGFNSYC +Q N +P CDCPPGYV DPN
Sbjct: 245 KNSTTNQGWWPVQSIPLDMCTAIFNDIGSGPCGFNSYCSIQENRKPTCDCPPGYVFLDPN 304
Query: 330 NRFRGCKPNFWQGCGPDDGSRNAQELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHD 389
NR GCKP F QGCG DDG + +ELYEIR+F+NV+WP DYERL PYNQT+CE SCL+D
Sbjct: 305 NRLGGCKPTFPQGCGLDDGRGDPEELYEIRQFDNVNWPLNDYERLSPYNQTQCEKSCLYD 364
Query: 390 CLCAVAIYDGNRCWKKKLPLSNGWLRDTGFSKVLFKVRKGNFPGYSDNSGSKKERGPLFL 449
C CAVAI+DG +CWKK+LPLSNG TGFSK LFKVRK P N GS KE+ P+ L
Sbjct: 365 CSCAVAIFDGRQCWKKRLPLSNGRYMRTGFSKTLFKVRKEVPPSGYCNVGSDKEK-PV-L 422
Query: 450 LGAFLLGGSIFCNAFLLLA-ILIFLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGG 508
LGA LLG S F N LL+ LI + R RK + DSS + LR F+Y EL+EAT G
Sbjct: 423 LGA-LLGSSAFLNVILLVVTFLILFRRRERKVKKAGPDSSIYFSTLRSFTYKELEEATDG 481
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F EELGRGSFGIVYKG ++S+SG AIAVKKLD+LAQEREREF++EVSAIG THHKNLV+L
Sbjct: 482 FMEELGRGSFGIVYKGFMRSSSGNAIAVKKLDKLAQEREREFRTEVSAIGETHHKNLVRL 541
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
LG+CDE +RLL+YEFM NGTLAN +F +P+PDW+ RV+I+L +ARGL+YLH EC PII
Sbjct: 542 LGYCDEGSHRLLIYEFMSNGTLANFLFTLPRPDWHQRVKIALGVARGLLYLHGECEFPII 601
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
HCDIKPQNILLD+ FSA+ISDFGL+KLLLS+Q+RT TMIRGTRGYVAPEWFKN PV+AKV
Sbjct: 602 HCDIKPQNILLDDSFSARISDFGLAKLLLSNQTRTRTMIRGTRGYVAPEWFKNVPVTAKV 661
Query: 689 DVYSFGVMLLEIICCRRSVEMEVE--EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746
DVYSFGV+LLEIICCRRSV M++E EE RAILTDWAYDCY GR+ LVD+D+ AM D+
Sbjct: 662 DVYSFGVLLLEIICCRRSVVMDLEEGEEERAILTDWAYDCYIGGRIYHLVDNDKVAMDDK 721
Query: 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSFSIAVTG 798
RL+KW+ ++MWCI+E+PSKRPTMK+VL+MLEG L+V PP S F ++ +G
Sbjct: 722 ERLKKWVEVSMWCIQEEPSKRPTMKMVLEMLEGFLDV--PPLQSPFPLSSSG 771
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255583185|ref|XP_002532358.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223527945|gb|EEF30031.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 887 bits (2293), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/786 (57%), Positives = 576/786 (73%), Gaps = 19/786 (2%)
Query: 9 LILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWF 68
LI+L LL LSA I L SSL + +++ SW SPS DFAFGF +L N ++LFLLAIWF
Sbjct: 6 LIVLILFLLPPLSAQQNITLSSSLVANNNSPSWTSPSGDFAFGFHKLVN-TNLFLLAIWF 64
Query: 69 NKIPERTIVWHANGDNPAPRGSTLELTATGLLLKDPGGKTIWDGKPDKKVSDAAMLDTGN 128
+KIP++TIVW ANGD PA +GS LE++ GLLL DPGG+ IW+ + VS AAMLDTGN
Sbjct: 65 DKIPDKTIVWDANGDKPAQQGSKLEVSVNGLLLTDPGGQLIWE-QQTATVSYAAMLDTGN 123
Query: 129 FVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFSNGSLK 188
FVL NNSDY W+SFKNPTDTILP+Q L+ + L SRL ETN+S+GRF+L F NG L+
Sbjct: 124 FVL--VDNNSDYLWESFKNPTDTILPSQALEPGTFLFSRLAETNYSRGRFQLYFLNGDLQ 181
Query: 189 LISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLP-QWAKLS 247
L V WP++ QY +Y++S T S++S+ SG+QLVFN+S D+Y+VK +G V+LP Q +
Sbjct: 182 LSPVGWPTKVQYGAYFSSGTSSSDSSVSGYQLVFNQS-DIYMVKTDGVTVRLPWQQQDTA 240
Query: 248 PRV-DHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNS 306
P + +Y+R TLD++GVL +Y PK S +++SW + +P DIC +FN IGSG CG+NS
Sbjct: 241 PSLAGNYYRATLDYNGVLTQYVCPKGSGSDRSWSIVQYIPQDICSAIFNGIGSGACGYNS 300
Query: 307 YCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQELYEIREFNNVDW 366
C NGRP C CP GY D NN F GCKP+F GCG D S N ++LYE RE V+W
Sbjct: 301 ICTEVNGRPNCACPLGYSFIDQNNLFGGCKPDFPLGCGVADASENMEDLYEFRELQYVNW 360
Query: 367 PFGDYERLEPYNQTECEISCLHDCLCAVAIYDGNRCWKKKLPLSNGWLRDTGFSKVLFKV 426
P GDYERL PY+ EC+ SCL DC+CA AIY + CWKK++PL+NG L + G S L KV
Sbjct: 361 PLGDYERLSPYSVEECKTSCLQDCMCAAAIYGSSICWKKRIPLANGRL-EKGNSLALIKV 419
Query: 427 RKGN---FPGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLAI--LIFLKWRRRKYE 481
RKG PG + K+++ LF G+ LG S+ NAF L + ++FLK R K
Sbjct: 420 RKGAPLAQPGLTCIKKKKQDKTILF--GS--LGTSLVLNAFFLFTVPLILFLKLNR-KSN 474
Query: 482 NNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR 541
+Q S+ ETNL FSY EL+EAT FKE++GRGS IVYKG+LK + IAVKKLD+
Sbjct: 475 KVLQLSTLLETNLHMFSYKELEEATDNFKEQVGRGSSAIVYKGILKCSPNNVIAVKKLDK 534
Query: 542 LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD 601
L+QE E+EF++E+ IG+T HKNLV+LLGFC+E +RLLVY+FM GTLAN + IPKP+
Sbjct: 535 LSQEAEKEFRTEMKVIGKTCHKNLVRLLGFCEEGSHRLLVYQFMTRGTLANFLLGIPKPE 594
Query: 602 WNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661
WN+R +I LEIARGL+YLHEEC PIIHCDIKP+NILLD YF+AKISDFGLSKLLLS+QS
Sbjct: 595 WNIRAQIVLEIARGLLYLHEECEAPIIHCDIKPENILLDEYFTAKISDFGLSKLLLSNQS 654
Query: 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD 721
RT T+IRGTRGYVAPEWF+N V+AKVDVYSFGV+LLEIICC+++V ++E+E ILT+
Sbjct: 655 RTMTLIRGTRGYVAPEWFRNVAVTAKVDVYSFGVVLLEIICCKKNVS-KLEDEKDGILTE 713
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
W YDC E RLD +++ DE A+AD+ RL W+ +A+WC +EDPS RP+MK VLQMLEG
Sbjct: 714 WVYDCLQEERLDAVIEFDEEAVADKERLNSWVRMAIWCTQEDPSTRPSMKTVLQMLEGFT 773
Query: 782 EVPNPP 787
E+P+ P
Sbjct: 774 EIPSLP 779
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482147|ref|XP_003611359.1| Kinase-like protein [Medicago truncatula] gi|355512694|gb|AES94317.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 848 bits (2191), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 421/781 (53%), Positives = 559/781 (71%), Gaps = 30/781 (3%)
Query: 30 SSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDN----- 84
SS ST++ +SWLSPS +FAFGF+QL ++LF+LAIW+NKIPE+TIVW A N
Sbjct: 28 SSTLSTTNKNSWLSPSGEFAFGFQQLGTATNLFMLAIWYNKIPEKTIVWSAKNTNNNNLV 87
Query: 85 PAPRGSTLELTATGLLLKDPGGKTIWDGKPDKKVSDAAMLDTGNFVLRASGNNSDYAWQS 144
AP GS ++LT+ GL L G++IW +P+ VS M DTGNFVL NS W+S
Sbjct: 88 QAPTGSQVQLTSGGLTLTTQQGESIWTAQPNTAVSYGIMHDTGNFVL--VNKNSSIVWES 145
Query: 145 FKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRF--SNGSLKLISVAWPSRFQYKS 202
FK PTDT+LP Q L+L + SR +ETN++ GRF+L F + +L L +AWP++ +YK
Sbjct: 146 FKFPTDTLLPNQSLELGGNITSRFSETNYTSGRFQLYFRDDDHNLMLSPLAWPTQLRYKF 205
Query: 203 YYTSNTGSANSTGSGHQLVFNESADVYI-VKDNGQIVQLPQWAK-----LSPRVDHYFRV 256
YY + ++ S+ LVF+ES D+Y+ NG +PQ + L P++ +Y+R
Sbjct: 206 YYRIDVNNSASSS----LVFDESGDIYVETNKNGTTRIIPQGTQWKNLDLDPKL-YYYRA 260
Query: 257 TLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCLLQNGRPF 316
TLD+ GVL +Y+HP+++ Q W R +PD+IC +FNE+GSGTCG+NSYC ++N RP
Sbjct: 261 TLDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAIFNEMGSGTCGYNSYCSMENQRPT 320
Query: 317 CDCPPGYVLADPNNRFRGCKPNFWQGCGPDDG---SRNAQELYEIREFNNVDWPFGDYER 373
C CP GY L DP+N+F GC+ NF GCG ++G + +ELYE +VDWP DYE+
Sbjct: 321 CKCPYGYSLIDPSNQFGGCQLNFTLGCGDNNGEGLNVKPEELYEFTVLRDVDWPLSDYEK 380
Query: 374 LEPYNQTECEISCLHDCLCAVAIYDGNRCWKKKLPLSNGWLRDTGFSKVLFKVRKGNFPG 433
++PY+Q +C+ SCLHDC+CAVA+++ N CWKK+LP++NG + +G VL K R F
Sbjct: 381 MQPYSQQDCQQSCLHDCMCAVAVFNNNTCWKKRLPIANGRAQ-SGGQLVLVKTRVSPFGP 439
Query: 434 YSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLAILIFLKWRRRKYENNVQDSSTSETN 493
S KK+ +L L+ ++F N+ LL A++ + ++ VQ ++ ETN
Sbjct: 440 SSTTHDLKKDDRVKPILQGLLISSTVF-NSILLAAVVFMTLLKPKRV---VQAATLVETN 495
Query: 494 LRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQEREREFKS 552
L FSY+ LKEAT GF EELGRGSFGIVYKG LK+ S +AVK+LDRL ++RE+EFK+
Sbjct: 496 LCSFSYDALKEATWGFSEELGRGSFGIVYKGELKAGSTCNVVAVKRLDRLVEDREKEFKT 555
Query: 553 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEI 612
E+ AIG+T HKNLV+L+GFCDE L+R+LVYEFM NG+LAN++F KP WN RV +L I
Sbjct: 556 ELRAIGKTCHKNLVRLVGFCDEGLHRMLVYEFMSNGSLANILFGETKPIWNQRVGFALGI 615
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
ARGLVYLHEEC+ PIIHCDIKPQNIL+D YF+AKISDFGL+KLLL+DQSRT+TM+RGTRG
Sbjct: 616 ARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKISDFGLAKLLLADQSRTNTMVRGTRG 675
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE-MEVEEEGRAILTDWAYDCYAEGR 731
YVAPEWFKN PV+AKVDVYSFG MLLEI+CCR+SV ME EE +AILTDWA DCY EGR
Sbjct: 676 YVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSVVLMESGEEEKAILTDWACDCYMEGR 735
Query: 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSS 791
+D LV++D+ A+ D RL+KW+ IA+WCI+E P RPTM++V+QMLE +++VP+PP P S
Sbjct: 736 IDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEMRPTMRMVMQMLEDVVKVPDPPSPFS 795
Query: 792 F 792
F
Sbjct: 796 F 796
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540555|ref|XP_003538753.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 846 bits (2185), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/809 (53%), Positives = 572/809 (70%), Gaps = 31/809 (3%)
Query: 4 LALPCLILL-CFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLF 62
+A P L + L + I L S+LS T+ N +WLSPS +FAFGFRQLN+ ++LF
Sbjct: 1 MASPTLFFIFSLVFLHVMFVLGNITLSSTLS-TNDNDAWLSPSGEFAFGFRQLNS-TNLF 58
Query: 63 LLAIWFNKIPERTIVWHANGDNP---APRGSTLELTATGLLLKDPGGKTIWDGKPDKKVS 119
++AIW++KIP +TIVW+A + AP GS ++LT GL L P G++IW +P +S
Sbjct: 59 VVAIWYDKIPAKTIVWNAKANETLATAPAGSQVQLTLEGLTLTSPKGESIWKAQPSVPLS 118
Query: 120 DAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFE 179
AMLDTGNFVL NS + W+SFKNPTDT+LP Q L+LD L SRL +TN++ GRF+
Sbjct: 119 YGAMLDTGNFVL--VNKNSTFEWESFKNPTDTLLPNQFLELDGKLTSRLQDTNYTTGRFQ 176
Query: 180 LRFSNGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIV- 238
L F NG L L +AWP++ +Y+ YY +++ S +LVF+E ++Y+ + NG +
Sbjct: 177 LYFQNGVLLLSPLAWPTQLRYRYYY-----RIDASHSASRLVFDELGNIYVERVNGTRIR 231
Query: 239 -QLPQW--AKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFN 295
Q P W + L P+ ++Y+R TL+F+GV +YAHP+ ++ Q W R +P +IC +FN
Sbjct: 232 PQGPTWGNSSLDPK-EYYYRATLEFNGVFTQYAHPRTNNAYQGWTIMRYVPGNICTAIFN 290
Query: 296 EIGSGTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQEL 355
E GSG+CG+NSYC ++N RP C CP GY + DP+N F GC+PNF CG D ++ +EL
Sbjct: 291 EYGSGSCGYNSYCSMENDRPTCKCPYGYSMVDPSNEFGGCQPNFTLACGVDVKAQ-PEEL 349
Query: 356 YEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYDGNRCWKKKLPLSNG--- 412
YE+ EF + ++P GDYE+ +PY+Q EC SCLHDC+CA+A+ GN CW K+LPLSNG
Sbjct: 350 YEMHEFRDFNFPLGDYEKKQPYSQQECRQSCLHDCICAMAVLGGNTCWMKRLPLSNGRVI 409
Query: 413 WLRDTGFSKVLFKVRKGNF-PGYSDN----SGSKKERGPLFLLGAFLLGGSIFCN-AFLL 466
+ D F + +VR+ + PG ++ + SKKE G +L L+G +F + + LL
Sbjct: 410 HVNDQHFVYIKTRVRRDFYDPGANEELPPGADSKKEDGAKPILLGSLIGSLVFISISMLL 469
Query: 467 LAILIFLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVL 526
A+ F+ + + S ETNL F+Y L++AT GF EE+GRGSFGIVYKG L
Sbjct: 470 CAVSWFILLKPKLTRLVPAIPSLLETNLHSFTYETLEKATRGFCEEIGRGSFGIVYKGQL 529
Query: 527 KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586
++AS IAVK+LDRLAQERE+EF++E+SAIG+T HKNLV+L+GFCDE +NRLLVYEFM
Sbjct: 530 EAASCNVIAVKRLDRLAQEREKEFRAELSAIGKTCHKNLVRLIGFCDEGINRLLVYEFMS 589
Query: 587 NGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645
NGTLA+++F K P WN RV ++L IARGL+YLHEEC+ IIHCDIKPQNIL+D +F+A
Sbjct: 590 NGTLADILFGQSKAPIWNTRVGLALGIARGLLYLHEECDSAIIHCDIKPQNILIDEHFNA 649
Query: 646 KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR 705
KISDFGL+KLLL DQ+RT+TMIRGTRGYVAPEWFKN V+ KVDVYSFGVMLLEIICCRR
Sbjct: 650 KISDFGLAKLLLFDQTRTNTMIRGTRGYVAPEWFKNIAVTVKVDVYSFGVMLLEIICCRR 709
Query: 706 SV-EMEVEEEGRAILTDWAYDCYAEGR-LDVLVDSDEPAMADRSRLQKWLMIAMWCIRED 763
+V ME EEE + ILTDWAYDCY EGR +D LV++DE A++D RL+KW+ IA WCI E+
Sbjct: 710 NVLTMEAEEEEKVILTDWAYDCYIEGRNIDALVENDEEALSDNGRLEKWIKIAFWCINEN 769
Query: 764 PSKRPTMKVVLQMLEGLLEVPNPPCPSSF 792
P RPTM +V+ MLEG +EVPNPP P S
Sbjct: 770 PEVRPTMGMVMLMLEGFVEVPNPPPPFSM 798
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357482135|ref|XP_003611353.1| Kinase-like protein [Medicago truncatula] gi|355512688|gb|AES94311.1| Kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 840 bits (2169), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/808 (52%), Positives = 569/808 (70%), Gaps = 35/808 (4%)
Query: 9 LILLCFPLLQFLSAATTINLGSSLSSTSSNSS-WLSPSEDFAFGFRQLNNNSDLFLLAIW 67
L ++ LQ + A ++ S LS+T++N++ WLSPS +FAFGFR N ++ F+LAIW
Sbjct: 7 LYIIAILFLQLILAFGNVSPSSRLSTTNNNNNPWLSPSGEFAFGFR--NTTTNFFMLAIW 64
Query: 68 FNKIPERTIVWHANGDNP------APRGSTLELTATGLLLKDPGGKTIWDGKPDKKVSDA 121
+N I ++TIVW A N AP GS ++LT+ GL L +P ++IW +P+ VS
Sbjct: 65 YNNIHDQTIVWSAKDMNNSNNLVLAPTGSQVQLTSGGLTLTNPQNESIWTAQPNDIVSYG 124
Query: 122 AMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELR 181
MLD GNFVL N S W+SFK PTDT+LP Q L+L + L SR +ETNF+ GRF+L
Sbjct: 125 TMLDNGNFVL--VNNKSAIVWESFKFPTDTLLPNQSLELGATLTSRFSETNFTSGRFQLY 182
Query: 182 FSNG--SLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYI-VKDNGQIV 238
F++ +L L +AWP++F+Y YY N+ + LVF+ES D+Y+ NG
Sbjct: 183 FNDDDHNLMLSPLAWPTQFRYNFYYRI---EVNNNSASSSLVFDESGDIYVETNKNGTTR 239
Query: 239 QLPQWAK-----LSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRL 293
PQ + L P++ +Y+R LD+ GVL +Y+HP+++ Q W R +PD+IC +
Sbjct: 240 IKPQGTQWKNLDLDPKL-YYYRAILDYYGVLTQYSHPRDTKAKQGWTIMRYVPDNICIAI 298
Query: 294 FNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDG---SR 350
FNE+GSGTCG+NSYC ++N RP C CP GY L DP+N+F GC+ NF GCG D+G +
Sbjct: 299 FNEMGSGTCGYNSYCSMENQRPTCKCPYGYSLIDPSNQFGGCQLNFTLGCGADNGEGLNV 358
Query: 351 NAQELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYDGNRCWKKKLPLS 410
++LYE NV+WP DYER++PY+Q +C+ SCLHDC+C+V ++ CWKK+ PL+
Sbjct: 359 KPEDLYEFTVLTNVNWPLSDYERMQPYSQHDCQQSCLHDCMCSVVVFSNQNCWKKRSPLA 418
Query: 411 NGWLRDTGFSKVLFKVRKGNFP--GYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLA 468
NG ++G + VL K R G S ++ KK+ +L L+G ++F N+ LL A
Sbjct: 419 NG-REESGGNLVLIKTRVSPLGKIGASPSTNLKKDNQVNPILRGLLIGSAVF-NSILLAA 476
Query: 469 ILIFLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKS 528
+++ + ++ V ++ ETNL FSY+ LKEAT GF EELGRGSFGIV+KG LK+
Sbjct: 477 VVLVTLLKPKRV---VVGTTLLETNLCSFSYDALKEATWGFIEELGRGSFGIVFKGELKA 533
Query: 529 A-SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587
A S +AVK+LDRLAQ+RE+EFK+E+ AIG+T HKNLV+L+G+CDE ++R+LVYEFM N
Sbjct: 534 ATSCNVVAVKRLDRLAQDREKEFKTELRAIGKTCHKNLVKLIGYCDEGMHRMLVYEFMNN 593
Query: 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKI 647
G+LAN++F KP WN R+ +L IARGLVYLHEEC+ PIIHCDIKPQNIL+D YF+AKI
Sbjct: 594 GSLANILFGQTKPTWNQRIGFALGIARGLVYLHEECDTPIIHCDIKPQNILIDEYFTAKI 653
Query: 648 SDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSV 707
SDFGL+KLLL+DQSRT TMIRGTRGYVAPEWFKN PV+AKVDVYSFG MLLEI+CCR+SV
Sbjct: 654 SDFGLAKLLLADQSRTKTMIRGTRGYVAPEWFKNVPVTAKVDVYSFGAMLLEIVCCRKSV 713
Query: 708 E-MEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSK 766
ME EE +AILTDWA DCY EGR+D LV++D+ A+ D RL+KW+ IA+WCI+E P
Sbjct: 714 VLMESGEEEKAILTDWACDCYMEGRIDALVENDQEALDDIDRLEKWIKIAIWCIQEHPEM 773
Query: 767 RPTMKVVLQMLEGLLEVPNPPCPSSFSI 794
RPTM++V+QMLEG+++VPNPP P SFS+
Sbjct: 774 RPTMRMVMQMLEGVVQVPNPPSPFSFSL 801
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099309|ref|XP_002334494.1| predicted protein [Populus trichocarpa] gi|222872794|gb|EEF09925.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 822 bits (2122), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/793 (53%), Positives = 551/793 (69%), Gaps = 26/793 (3%)
Query: 4 LALPCL-----ILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNN 58
+A P L +L+ P I +G+SLS TS N+SWLSPS DFAFGF L N
Sbjct: 1 MAFPILHLSFSLLIMLPPFAVSQTGGNITVGASLS-TSENTSWLSPSGDFAFGFHPLYGN 59
Query: 59 SDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT-GLLLKDPGGKTIWDGKPD-K 116
LFLLAIW++KIPE+TIVW+ANGD PAP GS LTA G+ L DP G+ +W +
Sbjct: 60 KYLFLLAIWYDKIPEKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIG 119
Query: 117 KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKG 176
V+ AM D GNFVL+ SD W+SFKNP DT+LP+Q+LD L SR +E NFS G
Sbjct: 120 VVAYGAMTDKGNFVLQ--DRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSENNFSMG 177
Query: 177 RFELRFSN-GSLKLISVAWPSRFQYKSYYTSNT-GSANSTGSGHQLVFNESADVYIVKDN 234
RF+L+ ++ G+L+L ++ PS + + YY S T G +S+ G+Q+VFNES +YI+++N
Sbjct: 178 RFQLKLTDDGNLELATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILREN 237
Query: 235 GQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLF 294
QI L Q S D Y R TL+FDG+ +Y HPK S+ N+ W P + PD+IC+ F
Sbjct: 238 DQIFSLTQRVTASTG-DFYRRATLNFDGLFTQYYHPKASTGNERWTPIWSQPDNICQASF 296
Query: 295 NEIGSGTCGFNSYCLLQNGR-PFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQ 353
GSGTCGFNS C L + R P C+CP GY L DP++++ C+PN+ Q C D+ + +
Sbjct: 297 VSSGSGTCGFNSVCRLNSDRRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVE 355
Query: 354 ELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIY-DGNRCWKKKLPLSNG 412
+LY+ E N DWP DY L+P+ + +C SCL+DC+CAVAI+ G+ CWKKKLPLSNG
Sbjct: 356 DLYDFEELTNTDWPTSDYALLKPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNG 415
Query: 413 WLRDTGFSKVLFKVRKGNF----PGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLA 468
++ K L KVR+ N P + +N KK+R L L+G+ LG S+F N L+ A
Sbjct: 416 RVQTNLDGKALLKVRRSNVNPRSPYFPNN---KKDRDGLILVGSVFLGCSVFVNFLLVCA 472
Query: 469 ILI--FLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVL 526
I + F +RRR +D + ETNLR F+Y EL EAT GFKEELGRG+FG+VYKGV+
Sbjct: 473 IFMCFFFIYRRRTKRIPQKDGAV-ETNLRCFTYQELAEATEGFKEELGRGAFGVVYKGVV 531
Query: 527 KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586
S +AVKKL+ +A++R REFK+EV+ IG+THHKNLV+LLGFC+E RLLVYEFM
Sbjct: 532 HIGSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMS 591
Query: 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAK 646
NG+L++ IF KP W +R++I+ +ARGL+YLHEEC+ IIHCDIKPQNILLD Y++A+
Sbjct: 592 NGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEECSNQIIHCDIKPQNILLDEYYNAR 651
Query: 647 ISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706
ISDFGL+KLLL DQS+THT IRGT+GYVAPEWF+N PV+ KVDVYS+GV+LLEIICCRR+
Sbjct: 652 ISDFGLAKLLLLDQSQTHTAIRGTKGYVAPEWFRNLPVTVKVDVYSYGVLLLEIICCRRN 711
Query: 707 VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSK 766
V+ + E +AILTDWAYDCY EG LD LV SD A+ D +L+++LMIA WCI+EDPS
Sbjct: 712 VDSKATIEEQAILTDWAYDCYREGTLDALVGSDTGALDDIEKLERFLMIAFWCIQEDPSL 771
Query: 767 RPTMKVVLQMLEG 779
RPTM+ V QMLEG
Sbjct: 772 RPTMRKVTQMLEG 784
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495581|ref|XP_003516653.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 818 bits (2114), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/805 (52%), Positives = 554/805 (68%), Gaps = 25/805 (3%)
Query: 4 LALPCLILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNN-NSDLF 62
+A+ ++ L+ +NL S LS T N +W SPS +FAFGFRQL+N + LF
Sbjct: 1 MAVLTFLIRTLVFLRVSLVFANVNLDSRLS-TDGNDAWRSPSGEFAFGFRQLSNFGTKLF 59
Query: 63 LLAIWFNKIPERTIVWHANGD---NPAPRGSTLELTATGLLLKDPGGKTIWDGKPDKKVS 119
++AIW++KIP++T+VW A + AP GS +++T GL L P G +IW KP+ VS
Sbjct: 60 MVAIWYDKIPDKTVVWSAKTEYKLATAPTGSHVQITKEGLSLTSPEGDSIWRAKPEATVS 119
Query: 120 DAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLD--SVLISRLTETNFSKGR 177
+ AML+ GNFVL G+ + WQSF NPTDT+LP Q L L VL SR T+TN++ GR
Sbjct: 120 EGAMLNNGNFVLLNGGSEYENMWQSFDNPTDTLLPNQSLQLGLGGVLTSRFTDTNYTTGR 179
Query: 178 FELRFSNGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQI 237
F+L F + ++ L +A+PS+ +Y YY + + S G+ +LVF++S ++Y+ G
Sbjct: 180 FQLYFQDFNVMLSPLAFPSQLRYNPYYHAINDA--SVGNASRLVFDKSGEIYVETTGGTR 237
Query: 238 VQ-LPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNE 296
+ LPQ +Y+R TLDF GV YAHP+N+S W +PD+IC +FN+
Sbjct: 238 NRILPQVDNTLDTEVNYYRATLDFSGVFTLYAHPRNTSGQPRWRIMNYVPDNICDAIFND 297
Query: 297 IGSGTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQELY 356
GSG+CG+NSYC ++N RP C+CP GY L DP+N GC+PNF CG D + +ELY
Sbjct: 298 YGSGSCGYNSYCSMENDRPTCNCPYGYSLVDPSNESGGCQPNFTLACGAD-VQQPPEELY 356
Query: 357 EIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYDGNRCWKKKLPLSNGW--- 413
E+ N ++P GDYE++EPY+Q EC+ +CLHDC+CAVAI + + CW K+LPL NG
Sbjct: 357 EMHVAKNFNFPLGDYEKVEPYSQQECQQACLHDCMCAVAILEVDTCWMKRLPLGNGRQLP 416
Query: 414 LRDTGFSKVLFKVRKGNFPGYSDNS-----GSKKE-RGPLFLLGAFLLGGSIFCNAFLLL 467
+RD F + ++ +PG ++ SKKE R +LG+ + S+ N+ LL
Sbjct: 417 IRDQHFVYIKTRLSPDFYPGLANRELPAAPDSKKENRAKSIILGSLI--ASLVVNSILLA 474
Query: 468 AILIFLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLK 527
A+ +F + K + +Q S+ ETNL FS+ LKEAT F +ELGRGS GIVYKG L+
Sbjct: 475 AVALFF-LLKPKLKKVIQASALLETNLHSFSFEALKEATEDFCKELGRGSCGIVYKGKLE 533
Query: 528 SA-SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586
+A S IAVK+LDRLAQERE+EF++E+SAIG+T HKNLV+L+GFCD+ +NRLLVYEFM
Sbjct: 534 TADSCNVIAVKRLDRLAQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGINRLLVYEFMS 593
Query: 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAK 646
NGTLA+++F KP WNLRV L IARGLVYLHEEC+ IIHCDIKPQNIL+D +F+AK
Sbjct: 594 NGTLADILFGHSKPIWNLRVGFVLGIARGLVYLHEECDSAIIHCDIKPQNILIDEHFNAK 653
Query: 647 ISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706
ISDFGL+KLLL DQSRT+TMIRGTRGYVAPEWFKN V+ KVDVYSFGVMLLE ICCRRS
Sbjct: 654 ISDFGLAKLLLFDQSRTNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGVMLLENICCRRS 713
Query: 707 V-EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPS 765
V ME EEE +AILTDWAYDC EGRL LV++D A++D RLQ+W+ IA+WCI+EDP
Sbjct: 714 VMTMEPEEEEKAILTDWAYDCCVEGRLHALVENDREALSDIGRLQRWVKIAIWCIQEDPE 773
Query: 766 KRPTMKVVLQMLEGLLEVPNPPCPS 790
RPTM V QMLEGL+EV NPP P+
Sbjct: 774 MRPTMGKVNQMLEGLVEVANPPSPN 798
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495583|ref|XP_003516654.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 806 bits (2082), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/811 (52%), Positives = 555/811 (68%), Gaps = 35/811 (4%)
Query: 1 MDSLALPCLILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNN-S 59
M +L L LI+ + A + L S L T ++ +WLSPS +FAFGFRQLN+N +
Sbjct: 1 MAALNLNLLIVTLIYIHHVSLAFAKVTLNSPLF-TDTDDAWLSPSGEFAFGFRQLNDNDT 59
Query: 60 DLFLLAIWFNKIPE-RTIVWHANGDNP---APRGSTLELTATGLLLKDPGGKTIWDGKPD 115
LF++AIW+N IP+ +T+VW A DN AP GS L++T GL L +P G IW
Sbjct: 60 KLFMVAIWYNMIPDDQTVVWSARKDNKLATAPAGSKLQITQEGLSLTNPKGDFIWTASSK 119
Query: 116 KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSK 175
VS+ AMLD+GNFVL +S WQSF++PTDT+LP Q L L +L SRLT+TN++
Sbjct: 120 DFVSEGAMLDSGNFVLL--NGSSANVWQSFEHPTDTLLPNQSLQLGGMLTSRLTDTNYTT 177
Query: 176 GRFELRFSNGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNG 235
GRF+L F G+L L +AWPS+ +YKSY +++G+ +L+FN S D+Y+ NG
Sbjct: 178 GRFQLYFDGGNLLLSPLAWPSQLRYKSYPV-----IDASGNASRLLFNISGDIYVETTNG 232
Query: 236 QIVQLPQWAK----------LSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTL 285
+Q PQ K L+P ++ ++R TLD GV +YAHP+N++ Q W R +
Sbjct: 233 NRIQ-PQGQKWVSNSSSSLDLNPEMN-FYRATLDPSGVFTQYAHPRNNTARQGWIIMRYV 290
Query: 286 PDDICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGP 345
PDDIC +F+ GSG+CG+NSYC ++N RP C+C GY L DP+N+F GC+PNF CG
Sbjct: 291 PDDICNIIFDRFGSGSCGYNSYCDMENERPTCNCLDGYSLVDPSNQFGGCQPNFTLACGA 350
Query: 346 DDGSRNAQELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYDGNRCWKK 405
D + ++LY + + + ++P DYE+++PY Q EC CLHDC+CAVAI+ + CW K
Sbjct: 351 DVQAP-PEQLYHMLQSSRYNFPEADYEKIQPYTQQECLQFCLHDCMCAVAIFGLDTCWMK 409
Query: 406 KLPLSNGWLRDTGFSK-VLFKVRKGN--FPGYSDN----SGSKKERGPLFLLGAFLLGGS 458
+LPLSNG + D V K+R +PG ++ + S KE G +L L+G
Sbjct: 410 RLPLSNGRVTDVNDHHFVYIKIRNSRDFYPGVNEELPPGADSNKEDGAKPILMGSLIGSL 469
Query: 459 IFCNAFLLLAILIFLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSF 518
+ L L+ L + K V +S ETNL FSY LKEAT GF EELGRGS
Sbjct: 470 VVNGILLATVALLVLLKPKLKVAVPVAAASLLETNLHSFSYEALKEATWGFSEELGRGSC 529
Query: 519 GIVYKGVLKSA-SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 577
GIVYKG L++ S IAVK+LDRLAQERE+EF++E+SAIG+T HKNLV+L+GFCD+ +N
Sbjct: 530 GIVYKGKLEAEDSCNVIAVKRLDRLAQEREKEFRTELSAIGKTSHKNLVRLIGFCDQGIN 589
Query: 578 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNI 637
RLLVYEFM NGTLA+++F KP+WN RV +L IARGLVYLHEEC+ PIIHCDIKPQNI
Sbjct: 590 RLLVYEFMSNGTLADILFGHSKPNWNTRVGFALGIARGLVYLHEECDTPIIHCDIKPQNI 649
Query: 638 LLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVML 697
L+D +F+ KISDFGL+KLLLSDQSRT+TMIRGTRGYVAPEWFKN V+ KVDVYSFG+ML
Sbjct: 650 LIDEHFNTKISDFGLAKLLLSDQSRTNTMIRGTRGYVAPEWFKNVAVTVKVDVYSFGIML 709
Query: 698 LEIICCRRSVEMEVE-EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIA 756
LEIICCRRSV ME EE +A+L DWA DCY EGR+D LV+++E A++D+ RLQKW+ IA
Sbjct: 710 LEIICCRRSVVMEEPGEEEKAVLADWACDCYMEGRIDALVENEEEALSDKERLQKWIKIA 769
Query: 757 MWCIREDPSKRPTMKVVLQMLEGLLEVPNPP 787
+WCI E+P RPT+ +V+QMLEG ++V NPP
Sbjct: 770 IWCIHENPEMRPTIGMVVQMLEGFVQVSNPP 800
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103119|ref|XP_002334088.1| predicted protein [Populus trichocarpa] gi|222839594|gb|EEE77931.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/806 (51%), Positives = 556/806 (68%), Gaps = 28/806 (3%)
Query: 4 LALPCL-----ILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNN 58
+A P L +L+ P I +G+SLS TS N+SWLSPS DFAFGF QL N
Sbjct: 1 MAFPILHLSFSLLIMLPPFAVSQTGGNITVGASLS-TSDNTSWLSPSGDFAFGFYQLYGN 59
Query: 59 SDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTAT-GLLLKDPGGKTIWDGKPD-K 116
DLFLLAIW++KIP++TIVW+ANGD PAP GS LTA G+ L DP G+ +W +
Sbjct: 60 KDLFLLAIWYDKIPDKTIVWYANGDKPAPTGSKAVLTANRGISLTDPQGRELWRSETIIG 119
Query: 117 KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKG 176
V+ AM DTGNFVLR SD W+SFKNP DT+LP+Q+LD L SR +ETNFS G
Sbjct: 120 DVAYGAMTDTGNFVLR--DRVSDKLWESFKNPADTLLPSQVLDRGMTLSSRQSETNFSMG 177
Query: 177 RFELRF-SNGSLKLISVAWPSRFQYKSYYTSNT-GSANSTGSGHQLVFNESADVYIVKDN 234
RF+L+ +G+L L ++ PS + + YY S T G +S+ G+Q+VFNES +YI++ N
Sbjct: 178 RFQLKLRDDGNLVLATINLPSDYTNEPYYKSGTDGGLDSSSPGYQVVFNESGYLYILRKN 237
Query: 235 GQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLF 294
QI L Q S D Y R TL+FDGV +Y HPK S+ N+ W P + PD+IC+
Sbjct: 238 DQIFSLTQRVTASTG-DFYHRATLNFDGVFTQYYHPKASTGNERWTPIWSQPDNICQASS 296
Query: 295 NEIGSGTCGFNSYCLLQ-NGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQ 353
GSGTCGFNS C L +GRP C+CP GY L DP++++ C+PN+ Q C D+ + +
Sbjct: 297 VSAGSGTCGFNSVCRLNSDGRPICECPGGYSLLDPSDQYGSCRPNYTQSCEEDEVA-PVE 355
Query: 354 ELYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIY-DGNRCWKKKLPLSNG 412
+LY+ E N DWP DY L+P+ + +C SCL+DC+CAVAI+ G+ CWKKKLPLSNG
Sbjct: 356 DLYDFEELTNTDWPTSDYALLQPFTEEKCRQSCLNDCMCAVAIFRSGDMCWKKKLPLSNG 415
Query: 413 WLRDTGFSKVLFKVRKGNF----PGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLA 468
++ +K L KVR+ N P + +N KK+R L L+G+ LG S+F N L+ A
Sbjct: 416 RVQTIVDAKALLKVRRSNVNPRSPYFPNN---KKDRDGLILVGSVFLGCSVFVNFLLVCA 472
Query: 469 ILI--FLKWRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVL 526
I + F +RRR +D + ETNLR F+Y EL EAT GFKEELGRG+FG+VY+GV+
Sbjct: 473 ICMGFFFIYRRRTKRIPQKDGAV-ETNLRCFTYQELAEATEGFKEELGRGAFGVVYRGVV 531
Query: 527 KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586
S +AVKKL+ +A++R REFK+EV+ IG+THHKNLV+LLGFC+E RLLVYEFM
Sbjct: 532 HIGSSIVVAVKKLNNVAEDRVREFKTEVNVIGQTHHKNLVRLLGFCEEGDQRLLVYEFMS 591
Query: 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAK 646
NG+L++ IF KP W +R++I+ +ARGL+YLHE+ IIHCDIKPQNILLD +A+
Sbjct: 592 NGSLSSFIFQDAKPGWKIRIQIAFGVARGLLYLHEDSQ--IIHCDIKPQNILLDESLNAR 649
Query: 647 ISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706
ISDFGL+KLL +DQ++T T IRGT+GYVAPEWFKN PV+ KVD YSFG++LLE++CCR++
Sbjct: 650 ISDFGLAKLLKTDQTKTTTAIRGTKGYVAPEWFKNLPVTTKVDTYSFGILLLELVCCRKN 709
Query: 707 VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSK 766
E+ +E + +L DWA DC EG+L++LV+ DE AM D R+++++M+A+WCI+EDPS
Sbjct: 710 FEINAMQEHQIVLADWACDCLKEGKLNLLVEEDEEAMEDMKRVERFVMVAIWCIQEDPSL 769
Query: 767 RPTMKVVLQMLEGLLEVPNPPCPSSF 792
RP MK V+QMLEG ++V PP PSSF
Sbjct: 770 RPGMKKVVQMLEGGVQVSVPPDPSSF 795
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487487|ref|XP_002269067.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RLK1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 781 bits (2018), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/783 (51%), Positives = 538/783 (68%), Gaps = 17/783 (2%)
Query: 19 FLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVW 78
F A I LGSSL ++ ++SSW SPS +FAFGF QL N +LFLLAIWF+KIPE+T+ W
Sbjct: 24 FSQANPEIRLGSSLIASDNSSSWRSPSGEFAFGFHQLGNQ-NLFLLAIWFDKIPEKTLAW 82
Query: 79 HANGDNPAPRGSTLELTATG-LLLKDPGGKTIWDGKPD-KKVSDAAMLDTGNFVLRASGN 136
+ANGDNPAP GS +ELT+ G L+L DP G IW + V+ A MLD GNF L
Sbjct: 83 YANGDNPAPEGSKVELTSDGQLILNDPKGDEIWRPQTTLNGVTHAYMLDAGNFALVNGDQ 142
Query: 137 NSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRF-SNGSLKLISVAWP 195
NS + W+SFKNP DT+LPTQ+L++ + SR E+N+SKGRF+LR +G+L L +
Sbjct: 143 NSTHVWESFKNPVDTVLPTQVLEIGGTVSSRQAESNYSKGRFQLRLLPDGNLVLNTFDLQ 202
Query: 196 SRFQYKSYYTSNT-GSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSPRVDHYF 254
+ Y +YY S T +AN + SG +++F+E +Y+V +G V L + S +Y+
Sbjct: 203 TNTAYDAYYWSKTYDAANRSNSGERVIFDELGHLYVVLQSGDNVTLKSGSAESTG-GYYY 261
Query: 255 RVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSYCLL-QNG 313
R TLDFDGV Y PK S N SW P +P DIC + ++G G+CGFNSYC+ +G
Sbjct: 262 RATLDFDGVFRIYTRPKLQS-NGSWVPFWYVPKDICSEIGGDLGGGSCGFNSYCVPDSSG 320
Query: 314 RPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQELYEIREFNNVDWPF-GDYE 372
RP C+C PG+ ADP+N+ GCK N Q C + G N ++LY+ RE +N+ WP ++E
Sbjct: 321 RPACECLPGFFPADPHNKLNGCKHNLTQKC--EAGGSNMEDLYQKREVSNLFWPSSANFE 378
Query: 373 RLEPYNQTECEISCLHDCLCAVAIYDGNRCWKKKLPLSNGWLRDTGFSKVLFKVRK---- 428
+ E ++ C SCL+DC C VA++ C KKK+PLSNG + + K L KV +
Sbjct: 379 KKESLSEDLCWTSCLYDCNCVVAVHKEGTCRKKKMPLSNGRVDWSTRGKTLVKVPRYDAF 438
Query: 429 -GNFPGYSDNSGSKKERGPLFLLGAFLLGGSIFCNAFLLLAILIFLKWRRRKYENNVQDS 487
G P KKE+G L+G+ LLG S+F N L+ AI + + +K + S
Sbjct: 439 SGETPFRDPIREKKKEQGTFILVGSILLGSSVFLNFLLVAAISLVRSYPSQKRRELTRAS 498
Query: 488 STSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSAS-GKAIAVKKLDRLAQER 546
S ETN+R F+Y ELK+A GF+EELGRG+FG VYKGVL S+S G +AVKKLD+L QE
Sbjct: 499 SILETNIRSFTYEELKQAADGFREELGRGAFGTVYKGVLSSSSSGTQVAVKKLDKLVQEG 558
Query: 547 EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV 606
EREFK+EV I THHKNLV+L+GFCDE ++LLVYEFM NGTLA+ +F PDW +R
Sbjct: 559 EREFKTEVRTIAMTHHKNLVRLIGFCDEGPHKLLVYEFMCNGTLASFLFGSSAPDWKIRT 618
Query: 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666
+++ +ARGL+YLHEEC+ IIHCDIKPQN+LLD+ F+A+ISDFGL+KLL+SDQ+RT T
Sbjct: 619 QMAFGVARGLMYLHEECSTQIIHCDIKPQNVLLDDSFTARISDFGLAKLLMSDQTRTLTA 678
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC 726
IRGT+GYVAPEWF++ P++AKVDVYS+GVMLLEII CR+ ++ + E E AILTDWAYDC
Sbjct: 679 IRGTKGYVAPEWFRSKPITAKVDVYSYGVMLLEIISCRKCIDFQTENEEEAILTDWAYDC 738
Query: 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
Y RLD LV++D+ A D RL+K +M+A+WCI+EDPS RP+M+ V QMLEG++EVP P
Sbjct: 739 YRGHRLDKLVENDDDARNDMRRLEKLVMVAIWCIQEDPSLRPSMRNVTQMLEGVVEVPMP 798
Query: 787 PCP 789
PCP
Sbjct: 799 PCP 801
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 799 | ||||||
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.374 | 0.360 | 0.445 | 3.4e-95 | |
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.640 | 0.618 | 0.342 | 1.2e-81 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.364 | 0.354 | 0.456 | 1.8e-76 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.375 | 0.353 | 0.399 | 1.3e-72 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.375 | 0.383 | 0.380 | 2.1e-68 | |
| TAIR|locus:2197649 | 821 | AT1G61360 [Arabidopsis thalian | 0.381 | 0.371 | 0.361 | 8e-66 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.260 | 0.238 | 0.490 | 9.5e-66 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.583 | 0.579 | 0.317 | 1.9e-65 | |
| TAIR|locus:2197714 | 792 | AT1G61440 [Arabidopsis thalian | 0.389 | 0.392 | 0.380 | 3.4e-65 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.591 | 0.584 | 0.307 | 2.9e-63 |
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 718 (257.8 bits), Expect = 3.4e-95, Sum P(3) = 3.4e-95
Identities = 138/310 (44%), Positives = 208/310 (67%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSA 556
F+Y EL+ T FKE+LG G FG VY+GVL + + +AVK+L+ + Q E++F+ EV+
Sbjct: 474 FTYKELQRCTKSFKEKLGAGGFGTVYRGVLTNRT--VVAVKQLEGIEQG-EKQFRMEVAT 530
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD---WNLRVRISLEIA 613
I THH NLV+L+GFC + +RLLVYEFM NG+L N +F W R I+L A
Sbjct: 531 ISSTHHLNLVRLIGFCSQGRHRLLVYEFMRNGSLDNFLFTTDSAKFLTWEYRFNIALGTA 590
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-TMIRGTRG 672
+G+ YLHEEC I+HCDIKP+NIL+D+ F+AK+SDFGL+KLL +R + + +RGTRG
Sbjct: 591 KGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSSVRGTRG 650
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732
Y+APEW N P+++K DVYS+G++LLE++ +R+ ++ E+ + WAY+ + +G
Sbjct: 651 YLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVS-EKTNHKKFSIWAYEEFEKGNT 709
Query: 733 DVLVDS--DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPS 790
++D+ E D ++ + + + WCI+E P +RPTM V+QMLEG+ E+ NP CP
Sbjct: 710 KAILDTRLSEDQTVDMEQVMRMVKTSFWCIQEQPLQRPTMGKVVQMLEGITEIKNPLCPK 769
Query: 791 SFS-IAVTGS 799
+ S ++ +G+
Sbjct: 770 TISEVSFSGN 779
|
|
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 702 (252.2 bits), Expect = 1.2e-81, Sum P(2) = 1.2e-81
Identities = 191/558 (34%), Positives = 280/558 (50%)
Query: 255 RVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGS-GTCGFNSYCLLQNG 313
R +D G + ++ + N++W + P C+ ++ GS G C S
Sbjct: 258 RFVMDVSGQIKQFTWLEG---NKAWNLFWSQPRQQCQ-VYRYCGSFGICSDKS------- 306
Query: 314 RPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNAQELYEIREFNNV-DWPFGDY- 371
PFC CP G+ P ++ ++ GC + ++ +I +F + + D
Sbjct: 307 EPFCRCPQGF---RPMSQKDWDLKDYSAGCVRKTELQCSRG--DINQFFRLPNMKLADNS 361
Query: 372 ERLEPYNQTECEISCLHDCLCAVAIYD--GNRC--WKKKLPLSNGWLRDTGFSKVLFKVR 427
E L + + C +C DC C YD ++C W K + L+ L D +F +R
Sbjct: 362 EVLTRTSLSICASACQGDCSCKAYAYDEGSSKCLVWSKDV-LNLQQLEDENSEGNIFYLR 420
Query: 428 --KGNFPGYSDNSGSKKERXXXXXXXXXXXXXSIFCNXXXXXXXXXXXKWRRRKYENNVQ 485
+ P SG + + ++RRRK +
Sbjct: 421 LAASDVPNVGA-SGKSNNKGLIFGAVLGSLGVIVLV----LLVVILILRYRRRKRMRGEK 475
Query: 486 DSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE 545
T L FSY EL+ AT F ++LG G FG V+KG L +S IAVK+L+ ++Q
Sbjct: 476 GDGT----LSAFSYRELQNATKNFSDKLGGGGFGSVFKGALPDSSD--IAVKRLEGISQG 529
Query: 546 REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD---- 601
E++F++EV IG H NLV+L GFC E +LLVY++M NG+L + +F +
Sbjct: 530 -EKQFRTEVVTIGTIQHVNLVRLRGFCSEGSKKLLVYDYMPNGSLDSHLFLNQVEEKIVL 588
Query: 602 -WNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660
W LR +I+L ARGL YLH+EC IIHCDIKP+NILLD+ F K++DFGL+KL+ D
Sbjct: 589 GWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKLVGRDF 648
Query: 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT 720
SR T +RGTRGY+APEW ++AK DVYS+G+ML E++ RR+ E E+ R
Sbjct: 649 SRVLTTMRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEKVR-FFP 707
Query: 721 DWAYDCYA-EGRLDVLVDSD-EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
WA +G + LVD E D + + +A WCI+++ S RP M V+Q+LE
Sbjct: 708 SWAATILTKDGDIRSLVDPRLEGDAVDIEEVTRACKVACWCIQDEESHRPAMSQVVQILE 767
Query: 779 GLLEVPNPPCPSSFSIAV 796
G+LEV PP P S V
Sbjct: 768 GVLEVNPPPFPRSIQALV 785
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 1.8e-76, Sum P(2) = 1.8e-76
Identities = 137/300 (45%), Positives = 193/300 (64%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSA 556
F+Y +L+ AT F +LG+G FG VY+G L G +AVKKL+ + Q + +EF++EVS
Sbjct: 483 FAYKDLQSATNNFSVKLGQGGFGSVYEGTLPD--GSRLAVKKLEGIGQGK-KEFRAEVSI 539
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD----WNLRVRISLEI 612
IG HH +LV+L GFC E +RLL YEF+ G+L IF D W+ R I+L
Sbjct: 540 IGSIHHLHLVRLRGFCAEGAHRLLAYEFLSKGSLERWIFRKKDGDVLLDWDTRFNIALGT 599
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
A+GL YLHE+C+ I+HCDIKP+NILLD+ F+AK+SDFGL+KL+ +QS T +RGTRG
Sbjct: 600 AKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTTMRGTRG 659
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732
Y+APEW N +S K DVYS+G++LLE+I R++ + E + +A+ EG+L
Sbjct: 660 YLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSE-KCHFPSFAFKKMEEGKL 718
Query: 733 DVLVDSDEPAM-ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSS 791
+VD + R+Q+ + A+WCI+ED RP+M V+QMLEG+ V PP S+
Sbjct: 719 MDIVDGKMKNVDVTDERVQRAMKTALWCIQEDMQTRPSMSKVVQMLEGVFPVVQPPSSST 778
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 534 (193.0 bits), Expect = 1.3e-72, Sum P(3) = 1.3e-72
Identities = 125/313 (39%), Positives = 181/313 (57%)
Query: 484 VQDSSTSETNLRFFSYNELKEATGGF-KE-ELGRGSFGIVYKGVLKSASGKAIAVKKLDR 541
++ + + + L FS N + AT F KE ELGRG FG VYKGVL+ G+ IAVK+L
Sbjct: 504 IEGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLED--GREIAVKRLSG 561
Query: 542 LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP- 600
+ + EFK+E+ I + H+NLV+LLG C E ++LVYE+M N +L +F K
Sbjct: 562 KSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQA 621
Query: 601 --DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658
DW LR I IARGL+YLH + + IIH D+K N+LLD + KISDFG++++
Sbjct: 622 LIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGG 681
Query: 659 DQSRTHTM-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA 717
+Q+ +T+ + GT GY++PE+ S K DVYSFGV+LLEI+ +R+ + E G
Sbjct: 682 NQNEANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHGSL 741
Query: 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
I +A+ Y GR + LVD + + + +AM C+++ ++RP M VL ML
Sbjct: 742 I--GYAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLML 799
Query: 778 EG---LLEVPNPP 787
E L P P
Sbjct: 800 ESDTATLAAPRQP 812
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 525 (189.9 bits), Expect = 2.1e-68, Sum P(3) = 2.1e-68
Identities = 118/310 (38%), Positives = 185/310 (59%)
Query: 491 ETNLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERER 548
+ L F + + EAT GF +LG+G FG VYKG L A G+ +AVK+L R +++
Sbjct: 447 DLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTL--ACGQEVAVKRLSRTSRQGVE 504
Query: 549 EFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLR 605
EFK+E+ I + H+NLV++LG+C + R+L+YE+ N +L + IF + DW R
Sbjct: 505 EFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKR 564
Query: 606 VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665
V I IARG++YLHE+ + IIH D+K N+LLD+ +AKISDFGL++ L D++ +T
Sbjct: 565 VEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANT 624
Query: 666 M-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY 724
+ GT GY++PE+ + S K DV+SFGV++LEI+ RR+ EE + L A+
Sbjct: 625 TRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFR-NEEHKLNLLGHAW 683
Query: 725 DCYAEGRLDVLVDSD-EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783
+ E + ++D + D S + + + I + C+++DP RP M VV+ ML + +
Sbjct: 684 RQFLEDKAYEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLL 743
Query: 784 PNPPCPSSFS 793
+P P F+
Sbjct: 744 LDPRQPGFFN 753
|
|
| TAIR|locus:2197649 AT1G61360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 496 (179.7 bits), Expect = 8.0e-66, Sum P(3) = 8.0e-66
Identities = 115/318 (36%), Positives = 182/318 (57%)
Query: 480 YENNVQDSSTSETNLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVK 537
+++++Q S L FF ++L+ AT F +LG+G FG VYKG L+ GK IAVK
Sbjct: 471 WKSDLQSQDVS--GLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQD--GKEIAVK 526
Query: 538 KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI 597
+L + + EF +E+ I + H+NL++LLG C + +LLVYE+M N +L IF +
Sbjct: 527 RLTSSSVQGTEEFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDL 586
Query: 598 PKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
K DW R I IARGL+YLH + + ++H D+K NILLD + KISDFGL++
Sbjct: 587 KKKLEIDWATRFNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLAR 646
Query: 655 LLLSDQSRTHT-MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE 713
L +Q + T + GT GY++PE+ S K D+YSFGV++LEII + +
Sbjct: 647 LFHGNQHQDSTGSVVGTLGYMSPEYAWTGTFSEKSDIYSFGVLMLEIITGKEISSFSYGK 706
Query: 714 EGRAILTDWAYDCYAE-GRLDVL-VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771
+ + +L+ +A+D ++E G +++L D D+ + + + I + C++ RP +K
Sbjct: 707 DNKNLLS-YAWDSWSENGGVNLLDQDLDDSDSVNSVEAGRCVHIGLLCVQHQAIDRPNIK 765
Query: 772 VVLQMLEGLLEVPNPPCP 789
V+ ML ++P P P
Sbjct: 766 QVMSMLTSTTDLPKPTQP 783
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 9.5e-66, Sum P(3) = 9.5e-66
Identities = 104/212 (49%), Positives = 140/212 (66%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSA 556
F + EL++AT FK ++G G FG VYKG L + IAVKK+ +EF +E++
Sbjct: 505 FEFEELEQATENFKMQIGSGGFGSVYKGTLPDET--LIAVKKITNHGLHGRQEFCTEIAI 562
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIAR 614
IG H NLV+L GFC LLVYE+M +G+L +F+ P +W R I+L AR
Sbjct: 563 IGNIRHTNLVKLRGFCARGRQLLLVYEYMNHGSLEKTLFSGNGPVLEWQERFDIALGTAR 622
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
GL YLH C+ IIHCD+KP+NILL ++F KISDFGLSKLL ++S T +RGTRGY+
Sbjct: 623 GLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTTMRGTRGYL 682
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706
APEW NA +S K DVYS+G++LLE++ R++
Sbjct: 683 APEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 554 (200.1 bits), Expect = 1.9e-65, Sum P(2) = 1.9e-65
Identities = 163/514 (31%), Positives = 252/514 (49%)
Query: 300 GTCGFNSYCLLQNGRPF-CDCPPGYVLADPNNRFRGCKPNFWQGCGP-----DDGSRNAQ 353
G CG C++ P C C G+V P++ + N+ GC G+ +
Sbjct: 286 GVCGPFGLCIVSV--PLKCKCLKGFV---PHSTEEWKRGNWTGGCARLTELHCQGNSTGK 340
Query: 354 ELYEIREFNNVDWP-FGDYERLEPYNQTECEISCLHDCLC-AVAIYDGNRC--WKKKLPL 409
++ NV P F +YE + EC SCLH+C C A A G C W + L
Sbjct: 341 DVNIFHPVTNVKLPDFYEYE--SSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQNLMD 398
Query: 410 SNGWLRDTGFSKVLFKVRKGNFPGYSDNSGSKKERXXXXXXXXXXXXXSIFCNXXXXXXX 469
+ ++ + ++L +R +S+ G+K+ + S+F
Sbjct: 399 A---VQFSAGGEIL-SIRLA----HSELGGNKRNKIIVASTVSL----SLFVILTSAAFG 446
Query: 470 XXXXKWRRRKYENNV---QDSSTSET-NLRFFSYNELKEATGGFK--EELGRGSFGIVYK 523
+ + + Y D + E L FF N ++ AT F +LG+G FG VYK
Sbjct: 447 FWRYRVKHKAYTLKDAWRNDLKSKEVPGLEFFEMNTIQTATNNFSLSNKLGQGGFGSVYK 506
Query: 524 GVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583
G L+ GK IAVK+L + + + EF +E+ I + H+NLV++LG C E +LL+YE
Sbjct: 507 GKLQD--GKEIAVKQLSSSSGQGKEEFMNEIVLISKLQHRNLVRVLGCCIEGEEKLLIYE 564
Query: 584 FMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD 640
FM N +L +F K DW R I IARGL+YLH + + +IH D+K NILLD
Sbjct: 565 FMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIARGLLYLHRDSRLKVIHRDLKVSNILLD 624
Query: 641 NYFSAKISDFGLSKLLLSDQSRTHTM-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
+ KISDFGL+++ Q + T + GT GY++PE+ S K D+YSFGV+LLE
Sbjct: 625 EKMNPKISDFGLARMYEGTQCQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLE 684
Query: 700 IICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR-LQ--KWLMIA 756
II + EEG+ +L +A++ + E + L+D D +AD R L+ + + I
Sbjct: 685 IIIGEKISRFSYGEEGKTLLA-YAWESWGETKGIDLLDQD---LADSCRPLEVGRCVQIG 740
Query: 757 MWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPS 790
+ C++ P+ RP +L ML ++P+P P+
Sbjct: 741 LLCVQHQPADRPNTLELLAMLTTTSDLPSPKQPT 774
|
|
| TAIR|locus:2197714 AT1G61440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 522 (188.8 bits), Expect = 3.4e-65, Sum P(3) = 3.4e-65
Identities = 127/334 (38%), Positives = 186/334 (55%)
Query: 475 WRRR-KYENNVQDSSTSET--NLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSA 529
WR R K+ + ++ S+ L FF N ++ AT F +LG G FG VYKG L+
Sbjct: 441 WRNRVKHHDAWRNDLQSQDVPGLEFFEMNTIQTATSNFSLSNKLGHGGFGSVYKGKLQD- 499
Query: 530 SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589
G+ IAVK+L +++ ++EF +E+ I + H+NLV++LG C E +LL+YEFM N +
Sbjct: 500 -GREIAVKRLSSSSEQGKQEFMNEIVLISKLQHRNLVRVLGCCVEGKEKLLIYEFMKNKS 558
Query: 590 LANLIFAIPKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAK 646
L +F K DW R I I RGL+YLH + + +IH D+K NILLD + K
Sbjct: 559 LDTFVFGSRKRLELDWPKRFDIIQGIVRGLLYLHRDSRLRVIHRDLKVSNILLDEKMNPK 618
Query: 647 ISDFGLSKLLLSDQSRTHTM-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR 705
ISDFGL++L Q + T + GT GY++PE+ S K D+YSFGV+LLEII +
Sbjct: 619 ISDFGLARLFQGSQYQDKTRRVVGTLGYMSPEYAWTGVFSEKSDIYSFGVLLLEIISGEK 678
Query: 706 SVEMEVEEEGRAILTDWAYDCYAEGR----LD-VLVDSDEPAMADRSRLQKWLMIAMWCI 760
EEG+A+L + ++C+ E R LD L DS PA R + I + C+
Sbjct: 679 ISRFSYGEEGKALLA-YVWECWCETRGVNLLDQALDDSSHPAEVGRC-----VQIGLLCV 732
Query: 761 REDPSKRPTMKVVLQMLEGLLEVPNPPCPSSFSI 794
+ P+ RP +L ML ++P P P+ F++
Sbjct: 733 QHQPADRPNTLELLSMLTTTSDLPLPKQPT-FAV 765
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 535 (193.4 bits), Expect = 2.9e-63, Sum P(2) = 2.9e-63
Identities = 158/513 (30%), Positives = 243/513 (47%)
Query: 300 GTCGFNSYCLLQNGRPFCDCPPGYVLADPNNRFRGCKPNFWQGCGPD-----DGSRNAQE 354
G CG C++ + P C C G+V RG N+ GC G+ N +
Sbjct: 286 GFCGPFGICVM-SVPPKCKCFKGFVPKSIEEWKRG---NWTDGCVRHTELHCQGNTNGKT 341
Query: 355 LYEIREFNNVDWPFGDYERLEPYNQTE-CEISCLHDCLC-AVAIYDGNRCWKKKLPLSNG 412
+ N+ P D+ + E C CLH+C C A A +G C L +
Sbjct: 342 VNGFYHVANIKPP--DFYEFASFVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQDLMDA 399
Query: 413 WLRDTGFSKVLFKVRKGNFPGYSDNSGSKKERXXXXXXXXXXX----XXSIFCNXXXXXX 468
G ++L +R + S+ G+K+ + + FC
Sbjct: 400 VQFSAG-GEIL-SIRLAS----SELGGNKRNKIIVASIVSLSLFVILAFAAFCFLRYKVK 453
Query: 469 XXXXXKWRR----RKYENNVQDSSTSETNLRFFSYNELKEATGGFK--EELGRGSFGIVY 522
K + + N+++ S L+FF N ++ AT F +LG+G FG VY
Sbjct: 454 HTVSAKISKIASKEAWNNDLEPQDVS--GLKFFEMNTIQTATDNFSLSNKLGQGGFGSVY 511
Query: 523 KGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582
KG L+ GK IAVK+L + + + EF +E+ I + HKNLV++LG C E RLLVY
Sbjct: 512 KGKLQD--GKEIAVKRLSSSSGQGKEEFMNEIVLISKLQHKNLVRILGCCIEGEERLLVY 569
Query: 583 EFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639
EF+ N +L +F K DW R I IARGL YLH + + +IH D+K NILL
Sbjct: 570 EFLLNKSLDTFLFDSRKRLEIDWPKRFNIIEGIARGLHYLHRDSCLRVIHRDLKVSNILL 629
Query: 640 DNYFSAKISDFGLSKLLLSDQSRTHTM-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLL 698
D + KISDFGL+++ + + +T + GT GY+APE+ S K D+YSFGV+LL
Sbjct: 630 DEKMNPKISDFGLARMYQGTEYQDNTRRVAGTLGYMAPEYAWTGMFSEKSDIYSFGVILL 689
Query: 699 EIICCRRSVEMEVEEEGRAILTDWAYDCYAE-GRLDVLVDSDEPAMADRSRLQKWLMIAM 757
EII + +G+ +L +A++ + E G +D+L D D +++ + I +
Sbjct: 690 EIITGEKISRFSYGRQGKTLLA-YAWESWCESGGIDLL-DKDVADSCHPLEVERCVQIGL 747
Query: 758 WCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPS 790
C++ P+ RP +L ML ++ +P P+
Sbjct: 748 LCVQHQPADRPNTMELLSMLTTTSDLTSPKQPT 780
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q39202 | RLK1_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.4423 | 0.9461 | 0.9086 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_1505000001 | hypothetical protein (801 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 799 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-51 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-50 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-43 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-42 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-40 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-39 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-34 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 5e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-26 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 7e-24 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-23 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-22 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-22 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-21 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 1e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-21 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-21 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-19 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-19 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-19 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-19 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-19 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 9e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-18 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-18 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-18 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 3e-18 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-17 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-17 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 3e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 7e-17 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-17 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 8e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-16 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-16 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 8e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 8e-16 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-15 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 7e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-14 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-14 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-14 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-14 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-13 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-13 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 8e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-12 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-12 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-12 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-11 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-11 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 7e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-11 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 4e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-09 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 9e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 8e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 2e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 5e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 7e-53
Identities = 73/192 (38%), Positives = 106/192 (55%), Gaps = 9/192 (4%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
LG G FG VY K +GK +A+K + + + E E+ + + +H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPIIHC 630
++ + LV E+ G+L +L+ + +RI L+I GL YLH IIH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 631 DIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WFKNAPVSAKV 688
D+KP+NILLD+ K++DFGLSKLL SD+S T I GT Y+APE S K
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT-IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 689 DVYSFGVMLLEI 700
D++S GV+L E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 91/270 (33%), Positives = 138/270 (51%), Gaps = 19/270 (7%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLV 566
+LG GSFG VYK K +GK +AVK L + ++ ++++ + E+ + R H N+V
Sbjct: 3 LLRKLGSGSFGTVYKAKHKG-TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+L+ ++ + LV E+ G L + + + +I+L+I RGL YLH
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN---G 118
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW-FKNAPVS 685
IIH D+KP+NILLD KI+DFGL+K LL S T GT Y+APE
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT-FVGTPWYMAPEVLLGGNGYG 177
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
KVDV+S GV+L E++ + E + ++ L ++ DEP +
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLI---------RRILGPPLEFDEPKWSS 228
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
S K L+ C+ +DPSKRPT + +LQ
Sbjct: 229 GSEEAKDLIK--KCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-50
Identities = 73/273 (26%), Positives = 125/273 (45%), Gaps = 29/273 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 567
E+LG GSFG VY K +GK +A+K + + +++RE E+ + + H N+V+
Sbjct: 3 ILEKLGEGSFGKVYLARDKK-TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
L ++ LV E+ G L +L+ + + +I L YLH + I
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---I 118
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D+KP+NILLD K++DFGL++ L + T + GT Y+APE
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTTFV-GTPEYMAPEVLLGKGYGKA 176
Query: 688 VDVYSFGVMLLEIICCRR--SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
VD++S GV+L E++ + + ++ E + I E ++
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKP-----------KPPFPPPEWDISP 225
Query: 746 RSR--LQKWLMIAMWCIREDPSKRPTMKVVLQM 776
++ ++K + +DP KR T + LQ
Sbjct: 226 EAKDLIRK-------LLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 5e-43
Identities = 88/281 (31%), Positives = 132/281 (46%), Gaps = 37/281 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
++LG G+FG VYKG LK +AVK L A E ER EF E S + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPN 62
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+V+LLG C + +V E+M G L + L K ++++L+IA+G+ YL
Sbjct: 63 IVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES-- 120
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTM--IRGTRGYVAPEW 678
+H D+ +N L+ KISDFGLS+ + D + R I+ ++APE
Sbjct: 121 -KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK----WMAPES 175
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736
K+ ++K DV+SFGV+L EI M EE + + D Y RL
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-----VLELLEDGY---RLPRPE 227
Query: 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
+ + + + LM + C DP RPT +++ L
Sbjct: 228 NCPDE-LYE-------LM--LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 5e-42
Identities = 92/280 (32%), Positives = 131/280 (46%), Gaps = 36/280 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
++LG G+FG VYKG LK GK +AVK L A E++ EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+V+LLG C E +V E+M G L + L PK + + +L+IARG+ YL +
Sbjct: 63 VVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK- 121
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV---APEWFK 680
IH D+ +N L+ KISDFGLS+ L D RG + + APE K
Sbjct: 122 --NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY---YRKRGGKLPIRWMAPESLK 176
Query: 681 NAPVSAKVDVYSFGVMLLEII-CCRRS-VEMEVEEEGRAILTDWAYDCYAEG-RLDVLVD 737
++K DV+SFGV+L EI + M EE + G RL
Sbjct: 177 EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE---------VLEYLKNGYRLP-QPP 226
Query: 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
+ P + D + + C EDP RPT ++++L
Sbjct: 227 NCPPELYD---------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 86/284 (30%), Positives = 128/284 (45%), Gaps = 43/284 (15%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
++LG G+FG VYKG LK +AVK L A E++ EF E + + H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTL-----ANLIFAIPKPDWNLRVRISLEIARGLVYL 619
+V+LLG C E ++V E+M G L N + D + +L+IARG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSD---LLSFALQIARGMEYL 119
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV---AP 676
+ IH D+ +N L+ KISDFGLS+ L D + ++G + + AP
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIRWMAP 173
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII-CCRRS-VEMEVEEEGRAILTDWAYDCYAEG-RLD 733
E K ++K DV+SFGV+L EI M E + +G RL
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE---------VLEYLKKGYRLP 224
Query: 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
+ P + + + C EDP RPT ++++L
Sbjct: 225 -KPPNCPPELYK---------LMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKK--LDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E LGRGSFG VY + K +G+ +AVK L ++E + E+ + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 569 LGFC-DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
G DE N L ++ E++ G+L++L+ K + + + +I GL YLH
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG--- 121
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM-IRGTRGYVAPEWFKNAPVS 685
I+H DIK NIL+D+ K++DFG +K L ++ T +RGT ++APE +
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181
Query: 686 AKVDVYSFGVMLLEIIC 702
D++S G ++E+
Sbjct: 182 RAADIWSLGCTVIEMAT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (354), Expect = 3e-37
Identities = 88/294 (29%), Positives = 128/294 (43%), Gaps = 58/294 (19%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 567
++LG G+FG VYKG LK GK AVK L A E ER +F E + + H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 568 LLGFCDEALNRLLVYEFMGNGTL------ANLIFAIPKPD---WNLRVRISLEIARGLVY 618
LLG C E LV E+M G L + +F P+ + +++IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM-----IRGTRGY 673
L +H D+ +N L+ KISDFGLS+ + D IR +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173
Query: 674 VAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGR 731
+APE K+ ++K DV+SFGV+L EI + + EE
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------------------ 215
Query: 732 LDVLVDSDEPAMADRSRLQK-------WLMIAMWCIREDPSKRPTMKVVLQMLE 778
VL + RL K + + C + DP RPT +++ LE
Sbjct: 216 --VL-----EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 62/191 (32%), Positives = 104/191 (54%), Gaps = 7/191 (3%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
E++G+G FG VYK K +GK +A+K + ++E++ + +E+ + + H N+V+
Sbjct: 5 LEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPII 628
G + +V EF G+L +L+ + + ++ + E+ +GL YLH II
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GII 120
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
H DIK NILL + K+ DFGLS L ++R +TM+ GT ++APE P K
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMV-GTPYWMAPEVINGKPYDYKA 178
Query: 689 DVYSFGVMLLE 699
D++S G+ +E
Sbjct: 179 DIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 79/272 (29%), Positives = 133/272 (48%), Gaps = 29/272 (10%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQLLG 570
LG+GS G+VYK K +GK A+KK+ E R + E+ + +V+ G
Sbjct: 8 VLGQGSSGVVYKVRHK-PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYG 66
Query: 571 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHEECNVPI 627
F E + V E+M G+LA+L+ + K V I+ +I +GL YLH + + I
Sbjct: 67 AFYKEGEISI-VLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLHTKRH--I 121
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH DIKP N+L+++ KI+DFG+SK+L + + +T + GT Y++PE + S
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYA 180
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747
D++S G+ LLE G+ + E + + D P++
Sbjct: 181 ADIWSLGLTLLECA------------LGKFPFLPPGQPSFFE-LMQAICDGPPPSLPAEE 227
Query: 748 RLQKWL-MIAMWCIREDPSKRPTMKVVLQMLE 778
++ I+ C+++DP KRP+ ++L+
Sbjct: 228 FSPEFRDFISA-CLQKDPKKRPS---AAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 48/281 (17%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E++G G+ G VYK A+GK +A+KK+ RL ++ + +E+ + H N+V
Sbjct: 23 NLEKIGEGASGEVYKAT-DRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 569 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------VRISLEIARGLVYL 619
+ L +V E+M G+L ++I N + E+ +GL YL
Sbjct: 81 YDSYLVGDEL--WVVMEYMDGGSLTDII------TQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
H + +IH DIK NILL S K++DFG + L ++S+ ++++ GT ++APE
Sbjct: 133 H---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVI 188
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEME---VEEEG-RAILTDWAYDCYAEGRLDVL 735
K KVD++S G+M +E+ E E + E RA+ +
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMA------EGEPPYLREPPLRALFL--------------I 228
Query: 736 VDSDEPAMADRSRLQKWLM-IAMWCIREDPSKRPTMKVVLQ 775
P + + + C+ +DP KRP+ + +LQ
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 28/283 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGR-THHKN 564
+LG GSFG VY + K +A+K L + + F E+ + H N
Sbjct: 4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHE 621
+V+L F + + LV E++ G+L +L+ I + + + I +I L YLH
Sbjct: 60 IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 622 ECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTH-----TMIRGTRGYVA 675
+ IIH DIKP+NILLD + K+ DFGL+KLL S + + GT GY+A
Sbjct: 120 KG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 676 PEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732
PE A S+ D++S G+ L E++ E E + +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236
Query: 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
L S+ ++ + + + +DP R + L
Sbjct: 237 SPLSPSNPELISKAAS-----DLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-29
Identities = 74/274 (27%), Positives = 125/274 (45%), Gaps = 33/274 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+G+G FG V G + G+ +AVK L + + F +E S + H NLVQL
Sbjct: 10 LGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQL 65
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI--SLEIARGLVYLHEECNVP 626
LG + +V E+M G+L + + + + L ++ +L++ G+ YL EE N
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL-EEKN-- 122
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
+H D+ +N+L+ AK+SDFGL+K + S+ + + APE + S
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKFST 178
Query: 687 KVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
K DV+SFG++L EI R + +++ + + + EG +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEA-PEGCPPEVYK------- 230
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
+M W + DP+KRPT K + + L
Sbjct: 231 --------VMKDCWEL--DPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 81/283 (28%), Positives = 134/283 (47%), Gaps = 48/283 (16%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREF-KSEVSAIGRTHHKNLVQ 567
+++G+GSFG VY V + + GK +K++D E+ERE +EV + + +H N+++
Sbjct: 5 IKQIGKGSFGKVYL-VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK 63
Query: 568 LLGFCD--EALNRLL-VYEFMGNGTLANLI-----FAIPKPD---WNLRVRISLEIARGL 616
+ + E +L V E+ G L+ I P P+ + V++ L L
Sbjct: 64 ---YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL----AL 116
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
YLH I+H DIKPQNI L + K+ DFG+SK+L S T++ GT Y++P
Sbjct: 117 KYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSP 172
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE-GRAILTDWAYDCYAEGRLDVL 735
E +N P + K D++S G +L E+ + E E E IL
Sbjct: 173 ELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK--------------- 217
Query: 736 VDSDEPAMADR--SRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
P + + S L+ + +++DP +RP++ +LQ
Sbjct: 218 --GQYPPIPSQYSSELRN---LVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 72/197 (36%), Positives = 105/197 (53%), Gaps = 16/197 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
LG+GSFG V V K +GK A+K L ++ + +E E +E + + R +H +V+L
Sbjct: 1 LGKGSFGKVLL-VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 570 -GFCDEALNRL-LVYEFMGNGTLANLIFAIPK-PDWNLRVR-ISLEIARGLVYLHEECNV 625
F E +L LV E+ G L + + + + R R + EI L YLH
Sbjct: 60 YAFQTE--EKLYLVLEYAPGGELFSHLSKEGRFSEE--RARFYAAEIVLALEYLHSL--- 112
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+KP+NILLD K++DFGL+K L S+ SRT+T GT Y+APE
Sbjct: 113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYG 171
Query: 686 AKVDVYSFGVMLLEIIC 702
VD +S GV+L E++
Sbjct: 172 KAVDWWSLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 56/198 (28%), Positives = 105/198 (53%), Gaps = 7/198 (3%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
+ +GRG+FG+VYKG L +G +A+K++ ++ +E + E+ + H N+V
Sbjct: 4 LGDLIGRGAFGVVYKG-LNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIV 62
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+ +G + + + ++ E+ NG+L +I +L ++ +GL YLHE+
Sbjct: 63 KYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---G 119
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
+IH DIK NIL K++DFG++ L+D S+ + GT ++APE + + S
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 687 KVDVYSFGVMLLEIICCR 704
D++S G ++E++
Sbjct: 179 ASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 64/226 (28%), Positives = 94/226 (41%), Gaps = 41/226 (18%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQE-------REREFKSEVSAIGR 559
F + +G GSF V K + K A+K LD +L +E E+E + R
Sbjct: 5 FGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKE------VLTR 57
Query: 560 -THHKNLVQLLG-FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 617
H +++L F DE N V E+ NG L I D + EI L
Sbjct: 58 LNGHPGIIKLYYTFQDEE-NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR--------- 668
YLH + IIH D+KP+NILLD KI+DFG +K+L + S
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 669 ----------GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCR 704
GT YV+PE P D+++ G ++ +++ +
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQERERE-FKSEVSAIGRTHHKNLVQL 568
E +G+GSFG V K V + + GK + K++D E+E++ SEV+ + H N+V+
Sbjct: 6 ETIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVR- 63
Query: 569 LGFCDEALNR-----LLVYEFMGNGTLANLIFAIPKPDWNLRV------RISLEIARGLV 617
+ D ++R +V E+ G LA LI K + RI ++ L
Sbjct: 64 --YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKE--RKYIEEEFIWRILTQLLLALY 119
Query: 618 YLH--EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
H + ++H D+KP NI LD + K+ DFGL+K+L D S T + GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMS 178
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEI 700
PE + K D++S G ++ E+
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 81/281 (28%), Positives = 119/281 (42%), Gaps = 45/281 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +ELG G FG+V+ G + AI K+ R E +F E + + H NLVQL
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAI---KMIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNV 625
G C + +V E+M NG L N + +W L + ++ + YL
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM--CSDVCEAMEYLESNG-- 120
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR---GYVAPEWFKNA 682
IH D+ +N L+ K+SDFGL++ +L DQ +T +GT+ + PE F +
Sbjct: 121 -FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYS 176
Query: 683 PVSAKVDVYSFGVMLLEIICC------RRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736
S+K DV+SFGV++ E+ R S VE RL
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY------------RL---- 220
Query: 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
P +A +M + W E P RP K +L L
Sbjct: 221 --YRPKLAPTEVYT--IMYSCW--HEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 4e-26
Identities = 75/274 (27%), Positives = 126/274 (45%), Gaps = 31/274 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+E+G G FG+V+ G AI K R E +F E + + H LVQL
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAI---KTIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPI 627
G C E LV+EFM +G L++ + A K + + L++ G+ YL +
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH D+ +N L+ K+SDFG+++ +L DQ + T + + +PE F + S+K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD----EPAM 743
DV+SFGV++ EV EG+ Y+ + + +++ +P +
Sbjct: 182 SDVWSFGVLM-----------WEVFSEGKT-----PYENRSNSEVVETINAGFRLYKPRL 225
Query: 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
A +S + + C +E P RP+ ++L L
Sbjct: 226 ASQSVYE----LMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 32/273 (11%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQERER-EFKSEVSAIGRTHHKNLVQ 567
++G+GSFG+V+K V K+ + A+K++D RER E E + + +++
Sbjct: 5 LNKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 568 LL-GFCDEA-LNRLLVYEFMGNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEE 622
F D+ LN +V E+ NG L L+ P P+ + R ++I GL +LH +
Sbjct: 64 YYESFLDKGKLN--IVMEYAENGDLHKLLKMQRGRPLPE-DQVWRFFIQILLGLAHLHSK 120
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I+H DIK N+ LD Y + KI D G++K LLSD + I GT Y++PE ++
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAK-LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742
P + K DV++ GV+L E CC + +G IL G +
Sbjct: 177 PYNEKSDVWALGVVLYE--CCTGKHPFDANNQGALILK------IIRGVFPPVSQMYSQQ 228
Query: 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+A C+ +D +RP +L+
Sbjct: 229 LAQLIDQ---------CLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
E +G+GSFG VYK + K + + +A+K +D E E E + E+ + + + +
Sbjct: 7 ECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
G + ++ E+ G G+ +L+ + + I E+ GL YLHEE IH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-ILREVLLGLEYLHEE---GKIH 121
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIK NILL K++DFG+S L S S+ +T + GT ++APE K + K D
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKAD 180
Query: 690 VYSFGVMLLEII 701
++S G+ +E+
Sbjct: 181 IWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 79/277 (28%), Positives = 125/277 (45%), Gaps = 46/277 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREFK-SEVSAIGRTHHKNLVQLLG 570
LG+GS+G VYK V + + + A+K++D ++ERE +E+ + +H N++
Sbjct: 8 LGKGSYGSVYK-VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNII---S 63
Query: 571 FCDEAL--NRL-LVYEFMGNGTLANLIFAIPKPD--------WNLRVRISLEIARGLVYL 619
+ + L N+L +V E+ G L+ I K W RI +++ RGL L
Sbjct: 64 YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQAL 119
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
HE+ I+H D+K NILL KI D G+SK+L + ++T GT Y+APE +
Sbjct: 120 HEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
K P S K D++S G +L E+ E R++ + R V
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA------PPFEARSM---------QDLRYKVQRGKY 218
Query: 740 EPAMADRSR-LQKWLMIAMWCIREDPSKRPTMKVVLQ 775
P S+ LQ ++ P RP +L
Sbjct: 219 PPIPPIYSQDLQN---FIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 29/210 (13%)
Query: 512 ELGRGSFGIVYKGVLKSAS----GKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 566
ELG+GSFG+VY+G+ K +A+K ++ A RER EF +E S + + ++V
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFA----------IPKPDWNLRVRISLEIARGL 616
+LLG L+V E M G L + + + + P ++++ EIA G+
Sbjct: 73 RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL-SDQSRTHTMIRGTRG--- 672
YL + +H D+ +N ++ + KI DFG+++ + +D R +G +G
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYR-----KGGKGLLP 184
Query: 673 --YVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
++APE K+ + K DV+SFGV+L E+
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 70/195 (35%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 511 EELGRGSFGIVYKGVLKSASGK--AIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQ 567
+ELG G+FG V KGV SGK +AVK L ++EF E S + + H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEECNVP 626
L+G C + +LV E G L + + P +L+ ++ ++A G+ YL E +
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQVAMGMAYL-ESKH-- 115
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLL--SDQSRTHTMIRGTRGYVAPEWFKNAPV 684
+H D+ +N+LL N AKISDFG+S+ L SD R T R + APE
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 685 SAKVDVYSFGVMLLE 699
S+K DV+S+GV L E
Sbjct: 176 SSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 61/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG- 570
ELG G+FG VYK K A A K + ++E +F E+ + H N+V L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 571 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPII 628
F + L L+ EF G L +++ + + ++R + ++ L +LH +I
Sbjct: 71 YFYENKLWILI--EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVI 125
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP-----EWFKNAP 683
H D+K NILL K++DFG+S S + T I GT ++AP E FK+ P
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNP 184
Query: 684 VSAKVDVYSFGVMLLEI 700
K D++S G+ L+E+
Sbjct: 185 YDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 21/210 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE----------FKSEVSAIGRT 560
E +G+G++G VY L +G+ +AVK+++ A R +SE+ +
Sbjct: 7 ELIGKGTYGRVYLA-LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 561 HHKNLVQLLGFCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 619
H N+VQ LGF + L ++ E++ G++ + + + + L + ++ GL YL
Sbjct: 66 DHLNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYL 124
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL--LSDQSRTHTMIRGTRGYVAPE 677
H + I+H D+K N+L+D KISDFG+SK + D + +M +G+ ++APE
Sbjct: 125 H---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM-QGSVFWMAPE 180
Query: 678 WFKNAP--VSAKVDVYSFGVMLLEIICCRR 705
+ SAKVD++S G ++LE+ RR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 47/278 (16%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E +G G FG V +G +G+ +AVK K D AQ F E + + + HHKNLV+L
Sbjct: 12 EIIGEGEFGAVLQG---EYTGQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRL 64
Query: 569 LG-FCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRVRISLEIARGLVYLHEE 622
LG L +V E M G L N + + ++ SL++A G+ YL +
Sbjct: 65 LGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQL---LQFSLDVAEGMEYLESK 119
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
++H D+ +NIL+ AK+SDFGL+++ S + + APE K+
Sbjct: 120 ---KLVHRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHK 172
Query: 683 PVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740
S+K DV+S+GV+L E+ R+ +M ++E + + + DV V
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV---- 228
Query: 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
LM + W +P KRP+ + + LE
Sbjct: 229 ------------LMTSCW--ETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-23
Identities = 77/268 (28%), Positives = 123/268 (45%), Gaps = 30/268 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+LG G FG V++G+ K+ AI + K D L ++++F+ EV A+ R HK+L+ L
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL--KQQDFQKEVQALKRLRHKHLISLFA 69
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHEECNVP 626
C ++ E M G+L L F L V ++ ++A G+ YL EE N
Sbjct: 70 VCSVGEPVYIITELMEKGSL--LAFLRSPEGQVLPVASLIDMACQVAEGMAYL-EEQN-- 124
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IH D+ +NIL+ K++DFGL++L+ D + + + APE + S
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK-WTAPEAASHGTFST 183
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG-RLDVLVDSDEPAMAD 745
K DV+SFG++L E+ +V G YD G R+ P A
Sbjct: 184 KSDVWSFGILLYEMF-----TYGQVPYPGM--NNHEVYDQITAGYRM--------PCPAK 228
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVV 773
+ +M+ W +P RP+ K +
Sbjct: 229 CPQEIYKIMLECWAA--EPEDRPSFKAL 254
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-23
Identities = 64/193 (33%), Positives = 97/193 (50%), Gaps = 7/193 (3%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
K +LG G +G VY+GV K +AVK L E E EF E + + H NLVQLL
Sbjct: 11 KHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 68
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWN--LRVRISLEIARGLVYLHEECNVPI 627
G C ++ EFM G L + + + + N + + ++ +I+ + YL ++
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH D+ +N L+ K++DFGLS+L+ D H + + APE S K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 688 VDVYSFGVMLLEI 700
DV++FGV+L EI
Sbjct: 186 SDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+G G+FG VY V +G+ +AVK ++ + +E E+ + H NLV+ G
Sbjct: 8 IGGGTFGKVYTAV-NLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 571 FCDEALNRLLVYEFM---GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
++R VY FM GTL L+ D ++ +L++ GL YLH I
Sbjct: 67 V---EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GI 120
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG---YVAPEWFKNAPV 684
+H DIKP NI LD+ K+ DFG + L ++ + ++ G Y+APE
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 685 SAK---VDVYSFGVMLLEIICCRR 705
D++S G ++LE+ +R
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-23
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 33/218 (15%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
F EELG G+FG VYKG L + + ++A+K L A+ + + EF+ E + H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHP 68
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------------VR 607
N+V LLG C + +++E++ +G L L+ P D +
Sbjct: 69 NIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-----QSR 662
I+++IA G+ YL +H D+ +N L+ + KISDFGLS+ + S QS+
Sbjct: 129 IAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSK 185
Query: 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
+ +R ++ PE + + D++SFGV+L EI
Sbjct: 186 SLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 7e-23
Identities = 65/232 (28%), Positives = 117/232 (50%), Gaps = 24/232 (10%)
Query: 509 FKEELGRGSFGIVYKG---VLKSASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
F ++LG G FG V L +G+ +AVK L+ +E+ R +F+ E+ + H+N
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 565 LVQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE 621
+V+ G C++ R L+ E++ +G+L + L + + + S +I +G+ YL
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG----YVAPE 677
+ IH D+ +NIL+++ KISDFGL+K+L + + + ++ + APE
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDKDYYYVKEPGESPIFWYAPE 182
Query: 678 WFKNAPVSAKVDVYSFGVMLLEIIC-CRRS-------VEMEVEEEGRAILTD 721
+ + S+ DV+SFGV L E+ S + M +G+ I+T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 75/276 (27%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNLVQL 568
ELG G+ G+V K VL +GK +AVK + RL E K E+ + + + +V
Sbjct: 8 ELGAGNSGVVSK-VLHRPTGKIMAVKTI-RLEIN-EAIQKQILRELDILHKCNSPYIVGF 64
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHEECNVP 626
G + + E+M G+L ++ + R+ +I++ + +GL YLHE+
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHEKHK-- 121
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IIH D+KP NIL+++ K+ DFG+S L++ ++T GT Y+APE + S
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSV 178
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL---VDSDEPAM 743
K D++S G+ L+E+ R + +G ++L V+ P +
Sbjct: 179 KSDIWSLGLSLIELATGRFPY--------------PPENDPPDGIFELLQYIVNEPPPRL 224
Query: 744 -ADR--SRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
+ + Q ++ + C+ +DP +RP+ K +L+
Sbjct: 225 PSGKFSPDFQDFVNL---CLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 1e-22
Identities = 82/283 (28%), Positives = 139/283 (49%), Gaps = 41/283 (14%)
Query: 513 LGRGSFGIVYKGVLKSASGK--AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQLL 569
+G G FG V++G+LK K A+A+K L E++R +F SE S +G+ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 570 GFCDEALNRLLVYEFMGNGTLANLI------FAIPKPDWNLRVRISLEIARGLVYLHEEC 623
G + +++ E+M NG L + F+ + LR IA G+ YL
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-----GIAAGMKYL---S 124
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG--YVAPEWFKN 681
++ +H D+ +NIL+++ K+SDFGLS++L D T+T G + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 682 APVSAKVDVYSFGVMLLEIICC--RRSVEMEVEEEGRAILTDWAYDCYAEG-RLDVLVDS 738
++ DV+SFG+++ E++ R +M E +AI +G RL +D
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---------NDGFRLPAPMDC 235
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
P+ + LQ W +D ++RP ++ +L+ LL
Sbjct: 236 --PSAVYQLMLQCWQ--------QDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 2e-22
Identities = 79/292 (27%), Positives = 136/292 (46%), Gaps = 56/292 (19%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 567
+ +G G FG V +G LK K I A+K L + +++R +F +E S +G+ H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-----------VRISLEIARGL 616
L G ++ +++ E+M NG+L D LR V + IA G+
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL----------DKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM-----IRGTR 671
YL E V H D+ +NIL+++ K+SDFGLS+ L ++ T IR T
Sbjct: 120 KYLSEMNYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT- 175
Query: 672 GYVAPEWFKNAPVSAKVDVYSFGVMLLEIICC--RRSVEMEVEEEGRAILTDWAYDCYAE 729
APE ++ DV+SFG+++ E++ R +M ++ +A+ +
Sbjct: 176 ---APEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY------- 225
Query: 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
RL P D LM + C ++D ++RPT ++ L+ ++
Sbjct: 226 -RL--------PPPMDCPSALYQLM--LDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-21
Identities = 86/333 (25%), Positives = 157/333 (47%), Gaps = 32/333 (9%)
Query: 463 AFLLLAI----LIFLKWRRRKYENNV-QDSSTSETNLRFFSYNELKEAT-----GGFKEE 512
AFL+LA+ +F++ R V + T E L+FF K T KEE
Sbjct: 638 AFLVLALVAFGFVFIRGRNNLELKRVENEDGTWE--LQFFDSKVSKSITINDILSSLKEE 695
Query: 513 --LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+ RG G YKG +G VK+++ + SE++ +G+ H N+V+L+G
Sbjct: 696 NVISRGKKGASYKGKSI-KNGMQFVVKEINDVNSIPS----SEIADMGKLQHPNIVKLIG 750
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHC 630
C L++E++ L+ ++ + W R +I++ IA+ L +LH C+ ++
Sbjct: 751 LCRSEKGAYLIHEYIEGKNLSEVLRNL---SWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690
++ P+ I++D + L LL +D + YVAPE + ++ K D+
Sbjct: 808 NLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS-----SAYVAPETRETKDITEKSDI 861
Query: 691 YSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS--DEPAMADRSR 748
Y FG++L+E++ + + E G + +WA CY++ LD+ +D +++
Sbjct: 862 YGFGLILIELLTGKSPADAEFGVHGS--IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNE 919
Query: 749 LQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
+ + + +A+ C DP+ RP VL+ LE
Sbjct: 920 IVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 65/209 (31%), Positives = 111/209 (53%), Gaps = 27/209 (12%)
Query: 512 ELGRGSFGIVYKGV----LKSASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 566
ELG+GSFG+VY+G +K + +AVK ++ A RER EF +E S + ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGL 616
+LLG + L+V E M +G L + + ++ P P ++++ EIA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG---- 672
YL+ + +H D+ +N ++ + F+ KI DFG+++ D T +G +G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 673 -YVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
++APE K+ + D++SFGV+L EI
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-21
Identities = 39/111 (35%), Positives = 51/111 (45%), Gaps = 11/111 (9%)
Query: 73 ERTIVWHANGDNP-APRGSTLELTATG-LLLKDPGGKTIWDGKPDKKVSD--AAMLDTGN 128
+T+VW AN NP TL L + G L+L D G+ +W K S A + D GN
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDDGN 60
Query: 129 FVLRASGNNSDYAWQSFKNPTDTILPTQILDL-----DSVLISRLTETNFS 174
VL + WQSF +PTDT+LP Q L S + T+ S
Sbjct: 61 LVLYDNSGK--VLWQSFDHPTDTLLPGQKDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 70/207 (33%), Positives = 113/207 (54%), Gaps = 26/207 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKK--LDRLAQEREREFKSEVSAIGRT-------HHK 563
+G GSFG VY G + ++SG+ +AVK+ L ++ + +S + A+ R H+
Sbjct: 8 IGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 564 NLVQLLGFCDEALNRLLVY-EFMGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYL 619
N+VQ LG + L ++ E++ G++A L+ A + VR +I +GL YL
Sbjct: 67 NIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYL 122
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL----LSDQSRTH-TMIRGTRGYV 674
H N IIH DIK NIL+DN KISDFG+SK L LS ++ ++G+ ++
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEII 701
APE K + K D++S G +++E++
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEML 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 62/204 (30%), Positives = 106/204 (51%), Gaps = 30/204 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+LG GS+G VYK + K +G+ +A+K + +E +E E+S + + +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKE-TGQVVAIKVV--PVEEDLQEIIKEISILKQCDSPYIVKY 63
Query: 569 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIA-------RGL 616
G F + L +V E+ G G++++++ +L EIA +GL
Sbjct: 64 YGSYFKNTDL--WIVMEYCGAGSVSDIMKIT---------NKTLTEEEIAAILYQTLKGL 112
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
YLH + IH DIK NILL+ AK++DFG+S L ++ +T+I GT ++AP
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI-GTPFWMAP 168
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEI 700
E + + K D++S G+ +E+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 81/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL-----DRLAQEREREFKSEVSAIGRTHHKNL 565
E LG GSFG VY+G L G AVK++ + QE ++ + E++ + + H N+
Sbjct: 6 ELLGSGSFGSVYEG-LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNI 64
Query: 566 VQLLGFC--DEALNRLLVYEFMGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYLH 620
VQ LG ++ L L E + G+LA L+ + P+P L R +I GL YLH
Sbjct: 65 VQYLGTEREEDNLYIFL--ELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLH 119
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF- 679
+ +H DIK NIL+D K++DFG++K ++ S + +G+ ++APE
Sbjct: 120 ---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE-FSFAKSF-KGSPYWMAPEVIA 174
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
+ D++S G +LE+ + + EG A + + GR L
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWS---QLEGVAAV-------FKIGRSKEL---- 220
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
P + D + I C++ DPS RPT +L+
Sbjct: 221 -PPIPDHLSDEAKDFILK-CLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-21
Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 10/192 (5%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG- 570
++G GS GIV KS +G+ +AVKK+D Q+R +EV + H N+V++
Sbjct: 26 KIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84
Query: 571 -FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
+ L +V EF+ G L +++ + + + L + + L +LH + +IH
Sbjct: 85 YLVGDEL--WVVMEFLEGGALTDIVTHT-RMNEEQIATVCLAVLKALSFLHAQ---GVIH 138
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIK +ILL + K+SDFG + + R +++ GT ++APE P +VD
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVD 197
Query: 690 VYSFGVMLLEII 701
++S G+M++E++
Sbjct: 198 IWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 33/217 (15%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERERE-FKSEVSAIGRTHHK 563
K ELG G+FG V+ G + +AVK L A R+ F+ E + H+
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHE 68
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR---------------VRI 608
N+V+ G C E ++V+E+M +G L + + PD ++I
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS-HGPDAAFLKSPDSPMGELTLSQLLQI 127
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRT--HT 665
+++IA G+VYL + +H D+ +N L+ KI DFG+S+ + + D R HT
Sbjct: 128 AVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHT 184
Query: 666 M--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
M IR ++ PE + + DV+SFGV+L EI
Sbjct: 185 MLPIR----WMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 68/222 (30%), Positives = 105/222 (47%), Gaps = 22/222 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 567
LG+G FG V A+GK A KKLD+ +R ++ K E A+ +
Sbjct: 1 LGKGGFGEVC-ACQVKATGKMYACKKLDK---KRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL-RVRI-SLEIARGLVYLHEECN 624
L + E + L LV M G L I+ + +P + R + +I GL +LH+
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR-- 114
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
I++ D+KP+N+LLD++ + +ISD GL+ + L + GT GY+APE +
Sbjct: 115 -RIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRA-GTPGYMAPEVLQGEVY 171
Query: 685 SAKVDVYSFGVMLLEIICCR-----RSVEMEVEEEGRAILTD 721
VD ++ G L E+I R R ++E EE R L
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM 213
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 74/218 (33%), Positives = 109/218 (50%), Gaps = 28/218 (12%)
Query: 502 LKEATGGF--KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR 559
L + TG F E +G G++G VYK K G+ +A+K +D + ++ E E K E + + +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKT-GQLVAIKIMD-IIEDEEEEIKEEYNILRK 58
Query: 560 -THHKNLVQLLGF--------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----V 606
++H N+ G D+ L LV E G G++ +L+ + K L+
Sbjct: 59 YSNHPNIATFYGAFIKKNPPGNDDQL--WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA 116
Query: 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666
I E RGL YLHE +IH DIK QNILL K+ DFG+S L S R +T
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF 173
Query: 667 IRGTRGYVAPEWF---KNAPVS--AKVDVYSFGVMLLE 699
I GT ++APE + S A+ DV+S G+ +E
Sbjct: 174 I-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 81/306 (26%), Positives = 135/306 (44%), Gaps = 70/306 (22%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--------EVSAIGR-TH 561
++LG G+FG VY K +G+ +A+KK+ +++F S EV ++ +
Sbjct: 5 KQLGDGTFGSVYLARNKE-TGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNE 56
Query: 562 HKNLVQLLGFCDEAL---NRL-LVYEFMGNGTLANLIFA-IPKPDWNLRVR-ISLEIARG 615
H N+V+L E + L V+E+M G L L+ KP +R I +I +G
Sbjct: 57 HPNIVKLK----EVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
L ++H H D+KP+N+L+ KI+DFGL++ + S +T TR Y A
Sbjct: 112 LAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS--RPPYTDYVSTRWYRA 166
Query: 676 PEWF-KNAPVSAKVDVYSFGVMLLEIICCR-----RSVEMEVEE---------------- 713
PE ++ S+ VD+++ G ++ E+ R S E+++
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS---EIDQLYKICSVLGTPTKQDW 223
Query: 714 -EGRAILTDWAY--DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTM 770
EG + + + +A L L+ + P D L+ +R DP KRPT
Sbjct: 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAID-------LI--KDMLRWDPKKRPTA 274
Query: 771 KVVLQM 776
LQ
Sbjct: 275 SQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 5e-21
Identities = 61/199 (30%), Positives = 102/199 (51%), Gaps = 20/199 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
E++G+G+FG VYKGVLK +AVK L + +R+F E + + H N+V+L+
Sbjct: 1 EKIGKGNFGDVYKGVLK--GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHEECNV 625
G C + +V E + G+L + K L V+ +SL+ A G+ YL +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTF---LRKKKNRLTVKKLLQMSLDAAAGMEYLESKN-- 113
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR----GYVAPEWFKN 681
IH D+ +N L+ KISDFG+S+ ++ +T+ G + + APE
Sbjct: 114 -CIHRDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNY 169
Query: 682 APVSAKVDVYSFGVMLLEI 700
+++ DV+S+G++L E
Sbjct: 170 GRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL------DRLAQEREREFKSEVSAIGRTHHKNLV 566
+G G+ GIV+K + +G+ +A+KK+ + + RE K A+ H +V
Sbjct: 8 IGEGAHGIVFKAKDR-ETGETVALKKVALRRLEGGIPNQALREIK----ALQACQHPYVV 62
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNV 625
+LL +LV E+M L+ ++ +P +V+ + +G+ Y+H
Sbjct: 63 KLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN--- 118
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP-V 684
I+H D+KP N+L+ KI+DFGL++L ++ R ++ TR Y APE A
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178
Query: 685 SAKVDVYSFGVMLLEII 701
VD+++ G + E++
Sbjct: 179 DPGVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.5 bits (231), Expect = 1e-20
Identities = 67/199 (33%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNL 565
E+LG G++G+VYK K +G+ +A+KK+ RL E E S E+S + H N+
Sbjct: 4 LEKLGEGTYGVVYKARDK-KTGEIVALKKI-RLDNEEE-GIPSTALREISLLKELKHPNI 60
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECN 624
V+LL LV+E+ L + P P NL I ++ RGL Y H
Sbjct: 61 VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR- 118
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAP 683
I+H D+KPQNIL++ K++DFGL++ TH ++ T Y APE +
Sbjct: 119 --ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSK 174
Query: 684 V-SAKVDVYSFGVMLLEII 701
S VD++S G + E+I
Sbjct: 175 HYSTAVDIWSVGCIFAEMI 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 27/209 (12%)
Query: 512 ELGRGSFGIVY----KGVLKSASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 566
ELG+GSFG+VY KGV+K +A+K ++ A RER EF +E S + + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PK---------PDWNLRVRISLEIARGL 616
+LLG + L++ E M G L + + ++ P+ P ++++ EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG---- 672
YL+ +H D+ +N ++ F+ KI DFG+++ D T +G +G
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 673 -YVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
+++PE K+ + DV+SFGV+L EI
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 2e-20
Identities = 59/193 (30%), Positives = 96/193 (49%), Gaps = 7/193 (3%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +ELG G FG+V G + AI K+ + E EF E + + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAI---KMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEECNVPI 627
G C + +V E+M NG L N + K + + + ++ G+ YL +
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QF 121
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH D+ +N L+D+ K+SDFGLS+ +L D+ + + + PE + S+K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 688 VDVYSFGVMLLEI 700
DV++FGV++ E+
Sbjct: 182 SDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 25/210 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+GRG+FGIV+ + A K + +K++ +++ ++ ++E + H N+++
Sbjct: 8 VGRGAFGIVHL-CRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 571 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE-------IARGLVYLHE 621
D+AL ++V E+ GTLA I R L+ + L+ LH
Sbjct: 67 NFLEDKAL--MIVMEYAPGGTLAEYI--------QKRCNSLLDEDTILHFFVQILLALHH 116
Query: 622 ECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
I+H D+K QNILLD + KI DFG+SK+L S +S+ +T++ GT Y++PE +
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYTVV-GTPCYISPELCE 174
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRSVEME 710
P + K D+++ G +L E+ +R+ E
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 8/195 (4%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+LG G FG V++G+ + + +AVK L + ++F +E + + H L+QL
Sbjct: 10 LLRKLGAGQFGEVWEGLWNNTT--PVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQL 66
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL--RVRISLEIARGLVYLHEECNVP 626
C +V E M G+L + L + ++ ++A G+ YL E N
Sbjct: 67 YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYL-EAQN-- 123
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IH D+ +N+L+ K++DFGL++++ D + + APE S
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 687 KVDVYSFGVMLLEII 701
K DV+SFG++L EI+
Sbjct: 184 KSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 68/208 (32%), Positives = 108/208 (51%), Gaps = 27/208 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKA----IAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQ 567
LG G+FG VY+G+ + G A +AVK L ++ E +F E + + +H+N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 568 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPD--WNLRVR----ISLEIARGLVYLH 620
L+G E L R ++ E M G L + L P+P+ +L ++ + ++A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 621 EECNVPIIHCDIKPQNILLDNYFS---AKISDFGLSKLLLSDQSRTHTMIRGTRG----- 672
E IH DI +N LL AKI+DFG+++ D R +G R
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
++ PE F + ++K DV+SFGV+L EI
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 5e-20
Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 20/203 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL-----DRLAQERE-REFKSEVSAIGRTHHKN 564
E LG+G++G VY G+ + G+ IAVK++ + LA E+E + + EV + H N
Sbjct: 6 EVLGKGAYGTVYCGL--TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEE 622
+VQ LG C + + EF+ G++++++ F P P+ + + +I G+ YLH
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFG-PLPEPVFC-KYTKQILDGVAYLHNN 121
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLS-KLLLSDQSRTHTMI----RGTRGYVAPE 677
C ++H DIK N++L K+ DFG + +L TH+ + GT ++APE
Sbjct: 122 C---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178
Query: 678 WFKNAPVSAKVDVYSFGVMLLEI 700
+ K D++S G + E+
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 64/206 (31%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 514 GRGSFGIVYKGVLKSASGKAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQL-L 569
G+G+FG V V K + K A+K K + + R +E + +H LV L
Sbjct: 9 GKGAFGKVCI-VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWY 67
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL---------RVRISL-EIARGLVYL 619
F DE N LV + + G L ++L +V+ + EI L YL
Sbjct: 68 SFQDEE-NMYLVVDLLLGGDLR----------YHLSQKVKFSEEQVKFWICEIVLALEYL 116
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
H + IIH DIKP NILLD I+DF ++ ++ + T + GT GY+APE
Sbjct: 117 HSK---GIIHRDIKPDNILLDEQGHVHITDFNIAT-KVTPDTLTTSTS-GTPGYMAPEVL 171
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRR 705
S VD +S GV E + +R
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 59/195 (30%), Positives = 99/195 (50%), Gaps = 11/195 (5%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +ELG G FG+V+ G K + +A+K ++ A E +F E + + H LVQL
Sbjct: 8 FMKELGSGQFGVVHLG--KWRAQIKVAIKAINEGAMS-EEDFIEEAKVMMKLSHPKLVQL 64
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
G C + +V EFM NG L N + D + + + ++ G+ YL
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERN--- 119
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
IH D+ +N L+ + K+SDFG+++ +L D+ + + + + PE F + S
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS 179
Query: 686 AKVDVYSFGVMLLEI 700
+K DV+SFGV++ E+
Sbjct: 180 SKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLL 569
LG G+ G V K LK +G A+K + + +++ E+ +V+
Sbjct: 7 SRLGEGAGGSVTKCRLK-NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYY 65
Query: 570 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIA----RGLVYLHEEC 623
G F DE+ + + + E+ G+L ++ + K + ++ +IA +GL YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR- 124
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
IIH DIKP NILL K+ DFG+S L++ + T T GT Y+APE + P
Sbjct: 125 --KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKP 179
Query: 684 VSAKVDVYSFGVMLLEI 700
S DV+S G+ LLE+
Sbjct: 180 YSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 16/198 (8%)
Query: 511 EELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNL 565
++G G++G+VYK + +G+ +A+KK+ + E+ + +H N+
Sbjct: 5 GKIGEGTYGVVYKA--RDKLTGEIVAIKKIKL--RFESEGIPKTALREIKLLKELNHPNI 60
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECN 624
++LL + LV+EFM + L LI + ++ ++ +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH-- 117
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
I+H D+KP+N+L++ K++DFGL++ S R +T TR Y APE
Sbjct: 118 -GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKG 175
Query: 685 -SAKVDVYSFGVMLLEII 701
S VD++S G + E++
Sbjct: 176 YSTPVDIWSVGCIFAELL 193
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-19
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 6/190 (3%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
++G GS GIV +KS SGK +AVKK+D Q+R +EV + H+N+V++
Sbjct: 27 KIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNS 85
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCD 631
+V EF+ G L +++ + + + L + + L LH + +IH D
Sbjct: 86 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQ---GVIHRD 141
Query: 632 IKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVY 691
IK +ILL + K+SDFG + + R +++ GT ++APE P +VD++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVDIW 200
Query: 692 SFGVMLLEII 701
S G+M++E++
Sbjct: 201 SLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-19
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 26/197 (13%)
Query: 530 SGKAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQLL--GFCDEALNRLLVYEF 584
+G +A+K L A E E + F+ E + R +H N+V LL G L V+E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEY 60
Query: 585 MGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL-- 639
+ TL ++ A+P + R+ L++ L H N I+H D+KPQNI++
Sbjct: 61 VPGRTLREVLAADGALPAGE---TGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQ 114
Query: 640 -DNYFSAKISDFGLSKLL-------LSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVY 691
AK+ DFG+ LL ++ +RT ++ GT Y APE + PV+ D+Y
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYCAPEQLRGEPVTPNSDLY 173
Query: 692 SFGVMLLEIICCRRSVE 708
++G++ LE + +R V+
Sbjct: 174 AWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 73/268 (27%), Positives = 133/268 (49%), Gaps = 28/268 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
E +G+GSFG V+KG+ + + + +A+K +D E E E + E++ + + + +
Sbjct: 10 ERIGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
G + ++ E++G G+ +L+ A P ++ + + EI +GL YLH E IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-EILKGLDYLHSEKK---IH 124
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIK N+LL K++DFG++ L Q + +T + GT ++APE + + +K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDSKAD 183
Query: 690 VYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA--MADRS 747
++S G+ +E+ +G +D R+ L+ + P + S
Sbjct: 184 IWSLGITAIEL------------AKGEPPNSD-----MHPMRVLFLIPKNNPPTLTGEFS 226
Query: 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ K + A C+ +DPS RPT K +L+
Sbjct: 227 KPFKEFIDA--CLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 46/280 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLV 566
E +G G+ +VY + + + +A+K++D L + + E + EV A+ + +H N+V
Sbjct: 5 LIEVIGVGATAVVYAAICL-PNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVV 62
Query: 567 QLLGFCDEALNRLL--VYEFMGNGTLANLI-FAIPKP--DWNLRVRISLEIARGLVYLHE 621
+ + + L V ++ G+L +++ + P+ D + + E+ +GL YLH
Sbjct: 63 KY--YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTMIRGTRGYVAPEW 678
IH DIK NILL S KI+DFG+S L + GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 679 FKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV- 736
+ K D++SFG+ +E+ G A + + + VL+
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELA------------TGAAPYSKYP-------PMKVLML 218
Query: 737 --DSDEPAM---ADRSRLQKWL--MIAMWCIREDPSKRPT 769
+D P++ AD + K MI++ C+++DPSKRPT
Sbjct: 219 TLQNDPPSLETGADYKKYSKSFRKMISL-CLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 72/270 (26%), Positives = 131/270 (48%), Gaps = 27/270 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLV 566
++E LG G+ G VYK + + +AVK LD + E +++ SE+ + + ++
Sbjct: 5 YQEILGHGNGGTVYK-AYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYII 62
Query: 567 QLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
G F E NR+ + EFM G+L ++ IP+ + RI++ + +GL YL +
Sbjct: 63 GFYGAFFVE--NRISICTEFMDGGSL-DVYRKIPEH---VLGRIAVAVVKGLTYL---WS 113
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
+ I+H D+KP N+L++ K+ DFG+S L++ ++T+ GT Y+APE
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV---GTNAYMAPERISGEQY 170
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
DV+S G+ +E+ R + +G + L +VD D P +
Sbjct: 171 GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQL---------LQCIVDEDPPVLP 221
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
+K++ C+R+ P +RP + ++
Sbjct: 222 VGQFSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
++G GS GIV K +GK +AVKK+D Q+R +EV + HH+N+V +
Sbjct: 29 KIGEGSTGIVCIATEKH-TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCD 631
+V EF+ G L +++ + + + L + R L YLH N +IH D
Sbjct: 88 YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-ATVCLSVLRALSYLH---NQGVIHRD 143
Query: 632 IKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVY 691
IK +ILL + K+SDFG + + + +++ GT ++APE P +VD++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVDIW 202
Query: 692 SFGVMLLEII 701
S G+M++E+I
Sbjct: 203 SLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 71/266 (26%), Positives = 126/266 (47%), Gaps = 24/266 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
E +G+GSFG VYKG+ + + + +A+K +D E E E + E++ + + + +
Sbjct: 10 ERIGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
G + ++ E++G G+ +L+ P + + I EI +GL YLH E IH
Sbjct: 69 GSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI-ATILREILKGLDYLHSERK---IH 124
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIK N+LL K++DFG++ L Q + +T + GT ++APE K + K D
Sbjct: 125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKAD 183
Query: 690 VYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749
++S G+ +E+ +G +D R+ L+ + P +
Sbjct: 184 IWSLGITAIEL------------AKGEPPNSD-----LHPMRVLFLIPKNSPPTLEGQYS 226
Query: 750 QKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + C+ +DP RPT K +L+
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 64/196 (32%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+ +LG G FG V+ G + +AVK L E F E + + H LVQL
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTT--KVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLY 67
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEECNV 625
C E +V E+M G+L L F LR V ++ +IA G+ YL E N
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSL--LDFLKSGEGKKLRLPQLVDMAAQIAEGMAYL-ESRNY 124
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
IH D+ +NIL+ KI+DFGL++L+ D+ + + APE +
Sbjct: 125 --IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT 182
Query: 686 AKVDVYSFGVMLLEII 701
K DV+SFG++L EI+
Sbjct: 183 IKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 70/266 (26%), Positives = 128/266 (48%), Gaps = 24/266 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
E++G+GSFG V+KG+ + + K +A+K +D E E E + E++ + + + +
Sbjct: 10 EKIGKGSFGEVFKGI-DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
G + ++ E++G G+ +L+ P + + I EI +GL YLH E IH
Sbjct: 69 GSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQI-ATILREILKGLDYLHSEKK---IH 124
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIK N+LL + K++DFG++ L Q + +T + GT ++APE K + +K D
Sbjct: 125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKAD 183
Query: 690 VYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749
++S G+ +E+ + E +L L+ + P + +
Sbjct: 184 IWSLGITAIELA---KGEPPHSELHPMKVL--------------FLIPKNNPPTLEGNYS 226
Query: 750 QKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ C+ ++PS RPT K +L+
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 21/205 (10%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 566
+E +G G FG V +G LK + I A+K L E++R +F SE S +G+ H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLI------FAIPKPDWNLRVRISLEIARGLVYLH 620
L G ++ +++ EFM NG L + + F + + LR IA G+ YL
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR-----GIAAGMKYLS 123
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTR---GYVAP 676
E + +H D+ +NIL+++ K+SDFGLS+ L D S T+T G + + AP
Sbjct: 124 E---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII 701
E ++ DV+S+G+++ E++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 66/193 (34%), Positives = 99/193 (51%), Gaps = 19/193 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+G+G FG V G + G +AVK K D AQ F +E S + + H NLVQLLG
Sbjct: 14 IGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLG 66
Query: 571 FCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNVPI 627
E L +V E+M G+L + + + + + ++ SL++ + YL E N
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EAN-NF 123
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D+ +N+L+ AK+SDFGL+K S Q ++ T APE + S K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 179
Query: 688 VDVYSFGVMLLEI 700
DV+SFG++L EI
Sbjct: 180 SDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 59/201 (29%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 569
+ +G++G V+ K ++G A+K + + R+ + E + + +V+L
Sbjct: 1 ISKGAYGRVFL-AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY 59
Query: 570 -GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
F + N LV E++ G LA+L+ + D ++ EI L YLH + II
Sbjct: 60 YSFQGKK-NLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLH---SNGII 115
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM-------IRGTRGYVAPEWFKN 681
H D+KP NIL+D+ K++DFGLSK+ L + I GT Y+APE
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 682 APVSAKVDVYSFGVMLLEIIC 702
S VD +S G +L E +
Sbjct: 176 QGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 38/275 (13%)
Query: 513 LGRGSFG--IVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLVQL 568
LG+G+FG +Y+ ++ + K+++ RL+++ R+ +E+ + H N++
Sbjct: 8 LGKGAFGEATLYR---RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64
Query: 569 LG-FCDEALNRLLV-YEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYLHEECN 624
F D+ N LL+ E+ GTL + I + + + +I + Y+H+
Sbjct: 65 YNHFMDD--NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA-- 120
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
I+H DIK NI L K+ DFG+SK+L S+ S T++ GT Y++PE +
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD--SDEPA 742
+ K D+++ G +L E++ +R+ + A L+++V
Sbjct: 179 NFKSDIWALGCVLYELLTLKRTFD-------------------ATNPLNLVVKIVQGNYT 219
Query: 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
+ + + +++DP KRPT VL
Sbjct: 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 61/194 (31%), Positives = 94/194 (48%), Gaps = 11/194 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 572
LG+G++GIVY S + IA+K++ + E++ H+N+VQ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVR-IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 573 DEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
E + E + G+L+ L+ + K + + + +I GL YLH+ I+H
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 630 CDIKPQNILLDNYFSA-KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP--VSA 686
DIK N+L++ Y KISDFG SK L T T GT Y+APE P A
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF-TGTLQYMAPEVIDKGPRGYGA 190
Query: 687 KVDVYSFGVMLLEI 700
D++S G ++E+
Sbjct: 191 PADIWSLGCTIVEM 204
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 41/224 (18%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-REFKSEVS 555
F+ +LK+ E+GRG+FG V K +L SG +AVK++ E+E + ++
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLD 54
Query: 556 AIGRTHH-KNLVQLLG---------FC----DEALNRL--LVYEFMGNGTLANLIFAIPK 599
+ R+ +V+ G C D +L++ VYE + + I
Sbjct: 55 VVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYE-VLKSVIPEEILG--- 110
Query: 600 PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
+I++ + L YL EE IIH D+KP NILLD + K+ DFG+S L+
Sbjct: 111 -------KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161
Query: 660 QSRTHTMIRGTRGYVAPEW---FKNAPVSAKVDVYSFGVMLLEI 700
++T G R Y+APE + DV+S G+ L E+
Sbjct: 162 IAKTRDA--GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 8e-19
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 509 FKEELGRGSFGIVYK---GVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 565
F ++LG+G+FG V L+ +G+ +AVKKL E R+F+ E+ + H N+
Sbjct: 8 FIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNI 67
Query: 566 VQLLGFCDEA--LNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
V+ G C A N LV E++ G+L + L + D + + +I +G+ YL +
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK 127
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG--YVAPEWFK 680
+H D+ +NIL+++ KI DFGL+K+L D+ G + APE
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184
Query: 681 NAPVSAKVDVYSFGVMLLEI 700
+ S DV+SFGV+L E+
Sbjct: 185 ESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 565
F + LG GSFG V K SGK A+K L + + ++ +E + H L
Sbjct: 5 FIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR--------G 615
V L G + N LV E++ G L + LR R +AR
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSH----------LRKSGRFPEPVARFYAAQVVLA 113
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
L YLH ++ I++ D+KP+N+LLD+ KI+DFG +K + + RT+T+ GT Y+A
Sbjct: 114 LEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLC-GTPEYLA 166
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEIIC 702
PE + VD ++ G+++ E++
Sbjct: 167 PEIILSKGYGKAVDWWALGILIYEMLA 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 17/221 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 569
LG+G FG V ++ A+GK A KKL++ ++ + ++ E + + H + +V L
Sbjct: 1 LGKGGFGEVSACQMR-ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNV 625
+ LV M G L I+ + P + +I GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+KP+N+LLDN + +ISD GL+ L QS+T GT G++APE +
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-GTPGFMAPELLQGEEYD 175
Query: 686 AKVDVYSFGVMLLEIICCR-----RSVEMEVEEEGRAILTD 721
VD ++ GV L E+I R R ++E +E + IL D
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND 216
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 1e-18
Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 19/201 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
+G+G FG VY G L + G+ I AVK L+R+ E E F E + H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 570 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHEEC 623
G C E L+V +M +G L N I N V+ L++A+G+ YL +
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS---DQSRTHTMIRGTRGYVAPEWFK 680
+H D+ +N +LD F+ K++DFGL++ + HT + ++A E +
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 681 NAPVSAKVDVYSFGVMLLEII 701
+ K DV+SFGV+L E++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 66/264 (25%), Positives = 125/264 (47%), Gaps = 31/264 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-REFKSEVSAIGRTHH---KNLV 566
E +GRG++G VY+G +G+ +A+K ++ + + + + EV+ + + N+
Sbjct: 7 ELIGRGAYGAVYRGK-HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+ G + ++ E+ G++ L+ A P + + V I E+ L Y+H+ V
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV-IIREVLVALKYIHK---VG 121
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV-S 685
+IH DIK NIL+ N + K+ DFG++ LL + S+ T + GT ++APE
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKYYD 180
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
K D++S G+ + E+ + + RA+ ++ S P + D
Sbjct: 181 TKADIWSLGITIYEMA--TGNPPYSDVDAFRAM--------------MLIPKSKPPRLED 224
Query: 746 R--SRLQKWLMIAMWCIREDPSKR 767
S+L + + A C+ E+P +R
Sbjct: 225 NGYSKLLREFVAA--CLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 24/214 (11%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKA---IAVKKL-DRLAQEREREFKSEVSA 556
LKE + LG G+FG VYKGV K +A+K L + + + +E E
Sbjct: 3 ILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV 62
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI----SLEI 612
+ H ++V+LLG C + L+ + M L L+ + N+ + ++I
Sbjct: 63 MASVDHPHVVRLLGICLSS-QVQLITQLM---PLGCLLDYVRNHKDNIGSQYLLNWCVQI 118
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-----TMI 667
A+G+ YL E ++H D+ +N+L+ KI+DFGL+KLL D+ H I
Sbjct: 119 AKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175
Query: 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+ ++A E + + K DV+S+GV + E++
Sbjct: 176 K----WMALESILHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 38/275 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ELG+G++G VYK VL +G +A+K++ RL + E +F + + H +
Sbjct: 5 VLDELGKGNYGSVYK-VLHRPTGVTMAMKEI-RLELD-ESKFNQIIMELDILHKAVSPYI 61
Query: 569 LGFCDEALNRLLVY---EFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEE 622
+ F VY E+M G+L L A ++ RI+ + +GL +L EE
Sbjct: 62 VDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE 121
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK-- 680
N IIH D+KP N+L++ K+ DFG+S L++ ++T+ G + Y+APE K
Sbjct: 122 HN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSG 176
Query: 681 ----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE--GRLDV 734
N + + DV+S G+ +LE+ R E YA +L
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET---------------YANIFAQLSA 221
Query: 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT 769
+VD D P + +A C+ + P++RPT
Sbjct: 222 IVDGDPPTLPSGYSDDAQDFVAK-CLNKIPNRRPT 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 3e-18
Identities = 37/115 (32%), Positives = 54/115 (46%), Gaps = 8/115 (6%)
Query: 36 SSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELT 95
SS + +S + F GF L +D L I + RT+VW AN DNP TL L
Sbjct: 5 SSGQTLVSGNSLFELGFFTLIMQNDYNL--ILYKSSS-RTVVWVANRDNPVSDSCTLTLQ 61
Query: 96 ATG-LLLKDPGGKTIW--DGKPDKKVSDAAMLDTGNFVLRASGNNSDYAWQSFKN 147
+ G L+L D G+ +W + +LD GN V+ ++ ++ WQSF
Sbjct: 62 SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIY--DSDGNFLWQSFDY 114
|
Length = 114 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 46/288 (15%)
Query: 506 TGGFKEE--LGRGSFGIVYKGVLKSASGKAIAVKKLDRL----AQEREREFKSEVSAIGR 559
G FK E +G+G F +VYK + G+ +A+KK+ A+ R+ K E+ + +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICL-LDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQ 58
Query: 560 THHKNLVQLL-GFCDEALNRL-LVYEFMGNGTLANLI--FA-----IPKPD-WNLRVRIS 609
H N+++ L F + N L +V E G L+ +I F IP+ W V
Sbjct: 59 LDHPNVIKYLASFIEN--NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFV--- 113
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669
++ L ++H + I+H DIKP N+ + K+ D GL + S + H+++ G
Sbjct: 114 -QLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-G 168
Query: 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE 729
T Y++PE + K D++S G +L E+ + + + L Y +
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-----KMNL----YSLCKK 219
Query: 730 GRLDVLVDSDE--PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
++ + P AD + +++ CI DP KRP + VLQ
Sbjct: 220 ------IEKCDYPPLPADHYSEELRDLVSR-CINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 4e-18
Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAI--AVKKL--DRLAQEREREFKSEVSAIGRTHHKNLV 566
++LG GSFG+V +G ++ GK I AVK L D+L + +F E + + H+NL+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLI 59
Query: 567 QLLGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHEEC 623
+L G L ++V E G+L + + + + +++IA G+ YL +
Sbjct: 60 RLYGVVLTHPL--MMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK- 116
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSK-LLLSDQSRTHTMIRGTR-GYVAPEWFKN 681
IH D+ +NILL + KI DFGL + L ++ + APE +
Sbjct: 117 --RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 682 APVSAKVDVYSFGVMLLEI 700
S DV+ FGV L E+
Sbjct: 175 RTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 71/219 (32%), Positives = 111/219 (50%), Gaps = 30/219 (13%)
Query: 502 LKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR 559
L++ G F+ E +G G++G VYKG +G+ A+K +D + ++ E E K E++ + +
Sbjct: 11 LRDPAGIFELVEVVGNGTYGQVYKG-RHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLKK 68
Query: 560 -THHKNLVQLLGFC--------DEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRV 606
+HH+N+ G D+ L LV EF G G++ +L+ K DW
Sbjct: 69 YSHHRNIATYYGAFIKKSPPGHDDQL--WLVMEFCGAGSVTDLVKNTKGNALKEDW--IA 124
Query: 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666
I EI RGL +LH +IH DIK QN+LL K+ DFG+S L R +T
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 181
Query: 667 IRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEI 700
I GT ++APE +A + D++S G+ +E+
Sbjct: 182 I-GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 5e-18
Identities = 84/286 (29%), Positives = 139/286 (48%), Gaps = 47/286 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGK--AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQLL 569
+G G FG V G LK + +A+K L E++R +F SE S +G+ H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-----EIARGLVYLHEECN 624
G ++ ++V E+M NG+L + K D V I L IA G+ YL +
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL---RKHDGQFTV-IQLVGMLRGIASGMKYL---SD 124
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG------YVAPEW 678
+ +H D+ +NIL+++ K+SDFGLS++L D +T TRG + APE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYT----TRGGKIPIRWTAPEA 180
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICC--RRSVEMEVEEEGRAILTDWAYDCYAEG-RLDVL 735
++ DV+S+G+++ E++ R EM ++ +AI EG RL
Sbjct: 181 IAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI---------EEGYRL--- 228
Query: 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
PA D LM+ W ++D ++RP + ++ +L+ L+
Sbjct: 229 -----PAPMDCPAALHQLMLDCW--QKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 25/205 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
E+G G++G VYK + +G+ +A+KK+ R+ E RE + + + H
Sbjct: 5 AEIGEGAYGTVYKARDLN-TGRFVALKKV-RVPLSEEGIPLSTLREI-ALLKQLESFEHP 61
Query: 564 NLVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARG 615
N+V+LL C D L LV+E + + LA + PKP ++ + ++ RG
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLRG 119
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
+ +LH I+H D+KPQNIL+ + KI+DFGL+++ + + T ++ T Y A
Sbjct: 120 VDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVV--TLWYRA 174
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEI 700
PE + + VD++S G + E+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 8e-18
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 11/196 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKS---EVSAIGRTHHKNLVQ 567
LG+G+FG VY +G+ +AVK++ D + E ++E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYLCY-DVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G + + E+M G++ + + A + + + +I G+ YLH I
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MI 125
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM--IRGTRGYVAPEWFKNAPVS 685
+H DIK NIL D+ + K+ DFG SK L + S M + GT +++PE
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 686 AKVDVYSFGVMLLEII 701
K DV+S G ++E++
Sbjct: 186 RKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 8e-18
Identities = 73/219 (33%), Positives = 110/219 (50%), Gaps = 30/219 (13%)
Query: 502 LKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR 559
L++ G F+ E +G G++G VYKG +G+ A+K +D E E E K E++ + +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKG-RHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKK 58
Query: 560 -THHKNLVQLLGF--------CDEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRV 606
+HH+N+ G D+ L LV EF G G++ +LI K +W
Sbjct: 59 YSHHRNIATYYGAFIKKNPPGMDDQL--WLVMEFCGAGSVTDLIKNTKGNTLKEEW--IA 114
Query: 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666
I EI RGL +LH+ +IH DIK QN+LL K+ DFG+S L R +T
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF 171
Query: 667 IRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEI 700
I GT ++APE +A K D++S G+ +E+
Sbjct: 172 I-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 21/201 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
+G G++G+V K K A+G+ +A+KK E + + K EV + + H+N+V
Sbjct: 7 GVVGEGAYGVVLKCRNK-ATGEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIV 63
Query: 567 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPK---PDWNLRVR-ISLEIARGLVYLHE 621
L RL LV+E++ TL L+ A P PD VR ++ + + Y H
Sbjct: 64 NLKEAFRRK-GRLYLVFEYVER-TLLELLEASPGGLPPD---AVRSYIWQLLQAIAYCHS 118
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF-K 680
IIH DIKP+NIL+ K+ DFG ++ L + + T TR Y APE
Sbjct: 119 H---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG 175
Query: 681 NAPVSAKVDVYSFGVMLLEII 701
+ VDV++ G ++ E++
Sbjct: 176 DTNYGKPVDVWAIGCIMAELL 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 1e-17
Identities = 56/194 (28%), Positives = 101/194 (52%), Gaps = 12/194 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E++G+G+ G VY + A+G+ +A+K+++ Q ++ +E+ + H N+V L
Sbjct: 25 EKIGQGASGTVYTAI-DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLD 83
Query: 571 ---FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
DE +V E++ G+L +++ + + + E + L +LH +
Sbjct: 84 SYLVGDELW---VVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QV 136
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH DIK NILL S K++DFG + +QS+ TM+ GT ++APE K
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195
Query: 688 VDVYSFGVMLLEII 701
VD++S G+M +E++
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 62/197 (31%), Positives = 104/197 (52%), Gaps = 16/197 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQLL 569
+G G++GIVY+ + SG+ +A+KK+ R+ ER+ S E++ + H N+V+L
Sbjct: 15 IGEGTYGIVYRA-RDTTSGEIVALKKV-RMDNERDGIPISSLREITLLLNLRHPNIVELK 72
Query: 570 GFC--DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVP 626
+ LV E+ LA+L+ +P P +V+ + L++ RGL YLHE
Sbjct: 73 EVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF--- 128
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
IIH D+K N+LL + KI+DFGL++ L + T ++ T Y APE
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--TLWYRAPELLLGCTTY 186
Query: 686 AK-VDVYSFGVMLLEII 701
+D+++ G +L E++
Sbjct: 187 TTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 13/195 (6%)
Query: 512 ELGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQER--EREFKSEVSAIGRTHHKNLVQL 568
ELG G+FG V KG+ K K +AVK L + + E E + + + + +V++
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEECNVP 626
+G C EA + +LV E G L N K + N+ + +++ G+ YL EE N
Sbjct: 62 IGIC-EAESWMLVMELAELGPL-NKFLQKNKHVTEKNI-TELVHQVSMGMKYL-EETN-- 115
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS--RTHTMIRGTRGYVAPEWFKNAPV 684
+H D+ +N+LL AKISDFGLSK L +D++ + T + + APE
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 685 SAKVDVYSFGVMLLE 699
S+K DV+SFGV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 68/226 (30%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVL---KSASGKAIAVKKL-DRLAQEREREFKSEVSA 556
EL + F EELG +FG +YKG L + +A+K L D ++ EF+ E S
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------- 605
+ HH N+V LLG + +++E++ G L LI P D
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 606 ------VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
+ I+++IA G+ YL +H D+ +NIL+ KISD GLS+ + S
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177
Query: 660 -----QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
Q ++ IR ++ PE S+ D++SFGV+L EI
Sbjct: 178 DYYRVQPKSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 84/298 (28%), Positives = 133/298 (44%), Gaps = 54/298 (18%)
Query: 513 LGRGSFGIV----YKGVLKSASGKAIAVKKLDRLAQERE-REFKSEVS---AIGRTHHKN 564
LG G+FG V G+ +AVK L A E++ + SE+ IG+ HKN
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--HKN 77
Query: 565 LVQLLGFCDEALNRLLVYEFM--GN-----------GTLANLIFAIPKPDWNLR----VR 607
++ LLG C + +V E+ GN G A+ P P+ L V
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP-PEETLTQKDLVS 136
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTHTM 666
+ ++ARG+ +L + IH D+ +N+L+ KI+DFGL++ + D R T
Sbjct: 137 FAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAY 724
R ++APE + + + DV+SFGV+L EI S + VEE +
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---------LF 244
Query: 725 DCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
EG R+ ++P Q+ + C E PS+RPT K +++ L+ +L
Sbjct: 245 KLLKEGYRM------EKPQNCT----QELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKNLVQ 567
++G G++G VYK K +G+ +A+KK+ R+ E+E E+ + + H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKK-TGELVALKKI-RMENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 568 LLGFCDEAL--NRLLVYEFMG---NGTLAN--LIFAIPKPDWNLRVRISLEIARGLVYLH 620
L + +V+E+M G L + + F ++ ++ GL YLH
Sbjct: 63 LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES----QIK-CYMKQLLEGLQYLH 117
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT--MIRGTRGYVAPEW 678
+ I+H DIK NIL++N K++DFGL++ S +T +I T Y PE
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI--TLWYRPPEL 172
Query: 679 FKNAPV-SAKVDVYSFGVMLLEII 701
A +VD++S G +L E+
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELF 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-17
Identities = 40/116 (34%), Positives = 54/116 (46%), Gaps = 7/116 (6%)
Query: 36 SSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELT 95
SS + +S F GF +L S + L I + RT+VW AN DNP+ TL L
Sbjct: 5 SSGQTLVSSGSLFELGFFKLIMQSRDYNL-ILYKGSS-RTVVWVANRDNPSGSSCTLTLQ 62
Query: 96 ATG-LLLKDPGGKTIW--DGKPDKKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNP 148
+ G L++ D G +W + +LD GN VL S N + WQSF P
Sbjct: 63 SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSDGN--FLWQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 73/217 (33%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREF----KSEVSAIGRTHHKNLV 566
LG+GSFG V LK + + AVK K D + Q+ + E K ++ G+ H L
Sbjct: 3 LGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFLT 59
Query: 567 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
QL C + +RL V E++ G L I + D + EI GL +LHE
Sbjct: 60 QLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER--- 115
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+K N+LLD+ KI+DFG+ K + T T GT Y+APE P
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFC-GTPDYIAPEILSYQPYG 174
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEE-GRAILTD 721
VD ++ GV+L E++ + E + E+E ++IL D
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED 211
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 21/198 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E LG+G+FG V+KG LK + A+ K D L QE + +F SE + + H N+V+L+G
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLH-EECNV 625
C + +V E + G L F K D L+ V+ +L+ A G+ YL + C
Sbjct: 60 VCTQRQPIYIVMELVPGGDF--LSFLRKKKD-ELKTKQLVKFALDAAAGMAYLESKNC-- 114
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKL----LLSDQSRTHTMIRGTRGYVAPEWFKN 681
IH D+ +N L+ KISDFG+S+ + S I+ T APE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWT----APEALNY 168
Query: 682 APVSAKVDVYSFGVMLLE 699
S++ DV+S+G++L E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 3e-17
Identities = 76/219 (34%), Positives = 114/219 (52%), Gaps = 20/219 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQERERE---FKSEVSAIGRTHHKNLVQ 567
LG+GSFG V LK SG+ AVK K D + Q+ + E + + ++ R +H L Q
Sbjct: 3 LGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 568 LLGFCDEALNRLL-VYEFMGNGTLANLIFAIPKPDW--NLRVRI-SLEIARGLVYLHEEC 623
L C + +RL V EF+ G +L+F I K R R + EI L++LH++
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEITSALMFLHDK- 115
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
II+ D+K N+LLD+ K++DFG+ K + + T T GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC-GTPDYIAPEILQEML 172
Query: 684 VSAKVDVYSFGVMLLEIICCRRSVEMEVEEE-GRAILTD 721
VD ++ GV+L E++C E E E++ AIL D
Sbjct: 173 YGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 73/282 (25%), Positives = 127/282 (45%), Gaps = 27/282 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLVQL 568
+G GS+G+V K K +G+ +A+KK L E ++ K E+ + + H+NLV L
Sbjct: 9 VGEGSYGMVMKCKHKE-TGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
+ LV+EF+ + L +L D + + +I RG+ + H + II
Sbjct: 66 IEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH---SHNII 122
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK- 687
H DIKP+NIL+ K+ DFG ++ L + +T TR Y APE +
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYTDYVATRWYRAPELLVGDTKYGRA 181
Query: 688 VDVYSFGVMLLEIICCRRSV--EMEVEEEGRAI-----LTDWAYDCYAEGRLDV---LVD 737
VD+++ G ++ E++ + ++++ I L + + + L L +
Sbjct: 182 VDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241
Query: 738 SDEPAMADRSRLQKW----LMIAMWCIREDPSKRPTMKVVLQ 775
E ++ R K L +A C+R DP RP+ +L
Sbjct: 242 VKEIEPLEK-RFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 75/292 (25%), Positives = 122/292 (41%), Gaps = 64/292 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLV 566
+ +G G++G VYK A+G+ +A+K KL+ + + E+S + H N+V
Sbjct: 7 LIQRIGSGTYGDVYKARDI-ATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIV 63
Query: 567 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECN 624
G ++L +V E+ G G+L ++ P L++ + E +GL YLHE
Sbjct: 64 AYFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE--- 119
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF---KN 681
IH DIK NILL K++DFG+S L + ++ + I GT ++APE +
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERK 178
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG---RLDV---- 734
K D+++ G+ +E AE D+
Sbjct: 179 GGYDGKCDIWALGITAIE---------------------------LAELQPPMFDLHPMR 211
Query: 735 ------LVDSDEPAMADRSRLQKW-----LMIAMWCIREDPSKRPTMKVVLQ 775
+ P + D+ KW I C+ +DP KRPT +LQ
Sbjct: 212 ALFLISKSNFPPPKLKDKE---KWSPVFHDFIKK-CLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 6e-17
Identities = 66/197 (33%), Positives = 99/197 (50%), Gaps = 17/197 (8%)
Query: 512 ELGRGSFGIVYKGVLKSASGK---AIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
ELG G+FG V KGV K + AI V K + R+ E E + + + +V++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRM 60
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDW----NLRVRISLEIARGLVYLHEECN 624
+G C EA +LV E G L F K D N+ V + +++ G+ YL E N
Sbjct: 61 IGVC-EAEALMLVMEMASGGPLNK--FLSGKKDEITVSNV-VELMHQVSMGMKYL-EGKN 115
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS--RTHTMIRGTRGYVAPEWFKNA 682
+H D+ +N+LL N AKISDFGLSK L +D S + + + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 683 PVSAKVDVYSFGVMLLE 699
S++ DV+S+G+ + E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 7e-17
Identities = 53/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E++G+G+ G VY + A+G+ +A+K+++ Q ++ +E+ + + N+V L
Sbjct: 25 EKIGQGASGTVYTA-IDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHC 630
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALDFLHSN---QVIHR 139
Query: 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690
DIK NILL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 691 YSFGVMLLEII 701
+S G+M +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-17
Identities = 63/206 (30%), Positives = 102/206 (49%), Gaps = 22/206 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKA--IAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
LG G FG V +G L G +AVK KLD EF SE + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 569 LGFCDEALNR------LLVYEFMGNGTLANLIFA-----IPK--PDWNLRVRISLEIARG 615
+G C EA + +++ FM +G L + + +P+ P L ++ ++IA G
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTL-LKFMVDIALG 125
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTHTMIRGTRGYV 674
+ YL N IH D+ +N +L + ++DFGLSK + S D R + + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEI 700
A E + ++K DV++FGV + EI
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 8e-17
Identities = 78/301 (25%), Positives = 136/301 (45%), Gaps = 56/301 (18%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA-IAVKKL-DRLAQEREREFKSEVSAIGRT-HHKNL 565
F++ +G G+FG V K +K + A+K++ + +++ R+F E+ + + HH N+
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLI-----------FAIPKPDWNLR-----VRIS 609
+ LLG C+ L E+ +G L + + FAI + + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669
++ARG+ YL ++ IH D+ +NIL+ + AKI+DFGLS+ + TM R
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRL 185
Query: 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII-------CCRRSVEMEVEEEGRAILTDW 722
++A E + + DV+S+GV+L EI+ C E+
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------------- 232
Query: 723 AYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
Y+ +G RL+ ++ D+ LM W RE P +RP+ +L L +L
Sbjct: 233 -YEKLPQGYRLEKPLNCDDEVYD--------LMRQCW--REKPYERPSFAQILVSLNRML 281
Query: 782 E 782
E
Sbjct: 282 E 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 8e-17
Identities = 52/202 (25%), Positives = 100/202 (49%), Gaps = 14/202 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQERER---EFKSEVSAIGRTHHKN 564
++LG G+F Y +G +AVK++ + E+E + E+ + R +H +
Sbjct: 6 QQLGTGAFSSCY-QARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
++++LG E + L E+M G++++L+ + + + ++ RGL YLHE
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 625 VPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLSDQSRT---HTMIRGTRGYVAPEWFK 680
IIH D+K N+L+D+ +I+DFG + L + + + GT ++APE +
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181
Query: 681 NAPVSAKVDVYSFGVMLLEIIC 702
DV+S G +++E+
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMAT 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 9e-17
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 22/218 (10%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLD-RLAQEREREFK 551
F + L+E T LGRG FG V+ K + VK L + + EF+
Sbjct: 2 FPRSNLQEIT-----TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR 56
Query: 552 SEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL------- 604
E+ + HKN+V+LLG C EA ++ E+ G L + A D L
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLST 116
Query: 605 --RVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662
+V + +IA G+ +L N +H D+ +N L+ + K+S LSK + + +
Sbjct: 117 KQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYY 173
Query: 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
++APE + S K DV+SFGV++ E+
Sbjct: 174 KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 41/210 (19%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-----------H 561
LG G++ +VYK K +G+ +A+KK+ + E K I T
Sbjct: 8 LGEGTYAVVYKARDKE-TGRIVAIKKI------KLGERKEAKDGINFTALREIKLLQELK 60
Query: 562 HKNLVQLLG-FC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR------ISLEIA 613
H N++ LL F +N LV+EFM L +I D ++ + L
Sbjct: 61 HPNIIGLLDVFGHKSNIN--LVFEFME-TDLEKVI-----KDKSIVLTPADIKSYMLMTL 112
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRG 672
RGL YLH I+H D+KP N+L+ + K++DFGL++ S + TH ++ TR
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRW 167
Query: 673 YVAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
Y APE A VD++S G + E++
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 64/200 (32%), Positives = 111/200 (55%), Gaps = 18/200 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKNLVQ 567
E++G G++G+VYKG K +G+ +A+KK+ RL E E E+S + H N+V
Sbjct: 6 EKIGEGTYGVVYKGRNKK-TGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDW--NLRVRISL-EIARGLVYLHEEC 623
L + +RL L++EF+ + L + ++PK + V+ L +I +G+++ H
Sbjct: 64 LQDVLMQE-SRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR- 120
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFKNA 682
++H D+KPQN+L+DN K++DFGL++ + + TH ++ T Y APE +
Sbjct: 121 --RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV--TLWYRAPEVLLGS 176
Query: 683 P-VSAKVDVYSFGVMLLEII 701
P S VD++S G + E+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMA 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 30/207 (14%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHH-KNLV 566
EELGRG++G+V K + +G +AVK++ A +E K ++ R+ V
Sbjct: 7 EELGRGAYGVVDK-MRHVPTGTIMAVKRIR--ATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 567 QLLG---------FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 617
G C E ++ L +F L IP+ + +I++ I + L
Sbjct: 64 TFYGALFREGDVWICMEVMDTSL-DKFYKKVYDKGL--TIPED---ILGKIAVSIVKALE 117
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
YLH + +V IH D+KP N+L++ K+ DFG+S L+ ++ T+ G + Y+APE
Sbjct: 118 YLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK--TIDAGCKPYMAPE 173
Query: 678 WF----KNAPVSAKVDVYSFGVMLLEI 700
K DV+S G+ ++E+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 82/291 (28%), Positives = 132/291 (45%), Gaps = 50/291 (17%)
Query: 513 LGRGSFGIVYKGVLKSASGKA-----IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLV 566
LG G+FG VY+G G +AVK L + A ++E+ EF E + +H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFA-----IPKPDWNLR--VRISLEIARGLVYL 619
+LLG C + ++ E M G L + + P L+ + I L++A+G VYL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 620 HEECNVPIIHCDIKPQNILL-----DNYFSAKISDFGLSK-LLLSDQSRTHTMIRGTR-- 671
+ + IH D+ +N L+ D KI DFGL++ + SD R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----KEGEGLL 175
Query: 672 --GYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCY-- 727
++APE + + + DV+SFGV++ EI + + ++ L + +
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEI--------LTLGQQPYPALNNQEVLQHVT 227
Query: 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
A GRL +P Q LM W +DPS+RPT + ++L+
Sbjct: 228 AGGRL------QKPENCPDKIYQ--LMTNCW--AQDPSERPTFDRIQEILQ 268
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-16
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 509 FKEELGRGSFGIVY----KGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 564
K ELG G+FG V+ +L +AVK L ++ ++F+ E + H++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL----------------RVRI 608
+V+ G C E L+V+E+M +G L N PD + + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-----SRT 663
+ +IA G+VYL ++ +H D+ +N L+ KI DFG+S+ + S RT
Sbjct: 128 ASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 184
Query: 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
IR ++ PE + + D++SFGV+L EI
Sbjct: 185 MLPIR----WMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 4e-16
Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNL 565
LG+GSFG K +L G AI + K D + Q+ + E + V A+ L
Sbjct: 8 LGKGSFG---KVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP-FL 63
Query: 566 VQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
QL C + ++RL V E++ G L I + K V + EIA GL +LH +
Sbjct: 64 TQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK-- 120
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
II+ D+K N++LD KI+DFG+ K + T T GT Y+APE P
Sbjct: 121 -GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC-GTPDYIAPEIIAYQPY 178
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD ++FGV+L E++ + + E E+E
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 4e-16
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
++G GS GIV K SG+ +AVK +D Q+R +EV + H+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKS 86
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCD 631
++ EF+ G L +++ + + + + + L YLH + +IH D
Sbjct: 87 YLVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-ATVCESVLQALCYLHSQ---GVIHRD 142
Query: 632 IKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVY 691
IK +ILL K+SDFG + D + +++ GT ++APE P +VD++
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIW 201
Query: 692 SFGVMLLEII 701
S G+M++E++
Sbjct: 202 SLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 5e-16
Identities = 61/197 (30%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQER-EREFKSEVSAIGRTHHKNLVQLL 569
LG+G FG V V +GK A KKLD RL ++ E+ E + + + +V L
Sbjct: 1 LGKGGFGEVC-AVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNVPI 627
+ + LV M G L I+ + + + + S +I G+++LH + I
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDI 116
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
++ D+KP+N+LLD+ + ++SD GL+ L +T T GT GY+APE K P S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVEL--KDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 688 VDVYSFGVMLLEIICCR 704
VD ++ G + E++ R
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 5e-16
Identities = 53/191 (27%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E++G+G+ G VY + A+G+ +A+++++ Q ++ +E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTA-MDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHC 630
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVIHR 140
Query: 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690
DIK NILL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 691 YSFGVMLLEII 701
+S G+M +E+I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 61/195 (31%), Positives = 94/195 (48%), Gaps = 11/195 (5%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
ELG G+FG VYK K A A K +D ++E ++ E+ + H N+V+LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLA-AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEECNVPIIHC 630
N ++ EF G + ++ + +P ++R+ + L YLHE IIH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHR 127
Query: 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF-----KNAPVS 685
D+K NIL K++DFG+S R + I GT ++APE K+ P
Sbjct: 128 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYD 186
Query: 686 AKVDVYSFGVMLLEI 700
K DV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 8e-16
Identities = 51/191 (26%), Positives = 99/191 (51%), Gaps = 6/191 (3%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E++G+G+ G V+ + A+G+ +A+K+++ Q ++ +E+ + + N+V L
Sbjct: 25 EKIGQGASGTVFTAI-DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHC 630
+V E++ G+L +++ + + + E + L +LH +IH
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHAN---QVIHR 139
Query: 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690
DIK N+LL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 691 YSFGVMLLEII 701
+S G+M +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 8e-16
Identities = 75/294 (25%), Positives = 115/294 (39%), Gaps = 54/294 (18%)
Query: 511 EELGRGSFGIVYKGVLKSASGKA-IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQL 568
+E+G G FG V G KA + VK+L A E+ F EV +H N++Q
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRVRISLEIARGLVYLHEEC 623
LG C E++ LLV EF G L N + ++ R++ E+A GL++LH+
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW----- 678
IH D+ +N L S KI D+GL+ +Q I V W
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLA----LEQYPEDYYITKDCHAVPLRWLAPEL 173
Query: 679 -------FKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE-G 730
+ K +++S GV + E L A Y +
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWE-------------------LFTAADQPYPDLS 214
Query: 731 RLDVL--VDSDEPAMADRSRLQ-----KWLMIAMWCIREDPSKRPTMKVVLQML 777
VL V ++ + +L +W + +C DP RPT + V ++L
Sbjct: 215 DEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 8e-16
Identities = 76/285 (26%), Positives = 124/285 (43%), Gaps = 53/285 (18%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREF-KSEVSAIGRTHHKNLV 566
F +G+GS+G V V GK +KKL+ R A RER+ + E + + H N+V
Sbjct: 4 FVRVVGKGSYGEV-SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV 62
Query: 567 Q--------------LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEI 612
++GFC+ + E G N + +W ++I
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVV-----EW------FVQI 111
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
A L YLHE+ I+H D+K QN+ L K+ D G++++L + T+I GT
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPY 167
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCY--AEG 730
Y++PE F N P + K DV++ G + E+ + + + D Y EG
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK----------DMNSLVYRIIEG 217
Query: 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+L + P + + L+ M R P KRP++K +L+
Sbjct: 218 KLPPMPKDYSPELGE-------LIATMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 74/303 (24%), Positives = 133/303 (43%), Gaps = 57/303 (18%)
Query: 513 LGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERE-REFKSEVSAIGRTHHKNLVQ 567
LG G FG V K G+A +AVK L A E R+ SE + + + +H ++++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 568 LLGFCDEALNRLLVYEFMGNGTL----------------------ANLIFAIPKPDWNLR 605
L G C + LL+ E+ G+L ++ + + +
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 606 VRISL--EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663
IS +I+RG+ YL E + ++H D+ +N+L+ KISDFGLS+ + + S
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS-- 182
Query: 664 HTMIRGTRG-----YVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718
++ ++G ++A E + + + DV+SFGV+L EI+
Sbjct: 183 --YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV----------------T 224
Query: 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
L Y A RL L+ + + ++ + + C +++P KRPT + + LE
Sbjct: 225 LGGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE 284
Query: 779 GLL 781
++
Sbjct: 285 KMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-15
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 17/197 (8%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
++LG G FG V+ G +A+K L + + E F +E + + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNG--HTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYA 68
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI------SLEIARGLVYLHEECN 624
+ ++ E+M NG+L + + K +++ I + +IA G+ ++ E N
Sbjct: 69 VVTQE-PIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFI-ERKN 122
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
IH D++ NIL+ KI+DFGL++L+ ++ + + APE
Sbjct: 123 Y--IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 180
Query: 685 SAKVDVYSFGVMLLEII 701
+ K DV+SFG++L EI+
Sbjct: 181 TIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 73/281 (25%), Positives = 120/281 (42%), Gaps = 47/281 (16%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
++LG G FG V+ G + A+ K ++ E F E + + H LVQL
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKKLRHDKLVQLYA 68
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEECNVP 626
E +V E+M G+L L F L+ V ++ ++A G+ Y+ E N
Sbjct: 69 VVSEE-PIYIVTEYMSKGSL--LDFLKDGEGRALKLPNLVDMAAQVAAGMAYI-ERMNY- 123
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IH D++ NIL+ + KI+DFGL++L+ ++ + + APE +
Sbjct: 124 -IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 687 KVDVYSFGVMLLEIIC---------CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737
K DV+SFG++L E++ R V +VE R DC
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE---RGYRMPCPQDC----------- 228
Query: 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
++ + LM+ W ++DP +RPT + + LE
Sbjct: 229 --PISLHE-------LMLQCW--KKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 60/210 (28%), Positives = 104/210 (49%), Gaps = 25/210 (11%)
Query: 511 EELGRGSFGIVYKGVL--KSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
+++G GSFG K +L GK +K+++ +++ + E + EV+ + H N+V
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKP-----DWNLRVRISLEIARGLVY 618
Q +E N +V ++ G L I A + P DW ++I L +
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDW------FVQICLALKH 116
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
+H+ I+H DIK QNI L + K+ DFG++++L S T I GT Y++PE
Sbjct: 117 VHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEI 172
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRSVE 708
+N P + K D+++ G +L E+ + + E
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 74/294 (25%), Positives = 131/294 (44%), Gaps = 45/294 (15%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEV-SAIGRT----HHKNLV 566
ELG G+ G+V K VL SG +A +KL L E K + + I R H N
Sbjct: 8 ELGAGNGGVVTK-VLHRPSGLIMA-RKLIHL------EIKPAIRNQIIRELKVLHECNSP 59
Query: 567 QLLGF-----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
++GF D ++ + E M G+L ++ + N+ +IS+ + RGL YL E
Sbjct: 60 YIVGFYGAFYSDGEISICM--EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE 117
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ I+H D+KP NIL+++ K+ DFG+S L+ + + GTR Y++PE +
Sbjct: 118 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQG 172
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSV-------------EMEVEEEGRAILTDWAYDCYA 728
+ + D++S G+ L+E+ R + E E + +
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD 232
Query: 729 EGR-------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
R LD +V+ P + + ++ C++++P +R +K + +
Sbjct: 233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTK 286
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/198 (30%), Positives = 106/198 (53%), Gaps = 15/198 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 567
E++G G++G+VYK K +G+ +A+KK+ RL E E + E+S + +H N+V+
Sbjct: 6 EKIGEGTYGVVYKARNKL-TGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVK 63
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS--LEIARGLVYLHEECNV 625
LL LV+EF+ + L + A P L + S ++ +GL + H
Sbjct: 64 LLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH--- 119
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
++H D+KPQN+L++ + K++DFGL++ + ++ TH ++ T Y APE
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILLGCKY 177
Query: 685 -SAKVDVYSFGVMLLEII 701
S VD++S G + E++
Sbjct: 178 YSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 75/300 (25%), Positives = 131/300 (43%), Gaps = 54/300 (18%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQEREREFKSEVSAIGRTHHKN 564
K ELG G+FG V+ + S +AVK L ++F+ E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV-----------------R 607
+V+ G C + ++V+E+M +G L + A PD + V
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA-HGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK-LLLSDQSRT--H 664
I+ +IA G+VYL + +H D+ +N L+ KI DFG+S+ + +D R H
Sbjct: 128 IASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH 184
Query: 665 TM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW 722
TM IR ++ PE + + DV+SFGV+L EI + ++
Sbjct: 185 TMLPIR----WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS-------NTE 233
Query: 723 AYDCYAEGRLDVLVDSDEPAMADRSRL--QKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780
+C +GR+ +R R+ ++ I + C + +P +R +K + ++L L
Sbjct: 234 VIECITQGRV-----------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 23/202 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
E++G G++G+VYK K +G+ +A+KK+ RL E E RE +S + +H
Sbjct: 5 EKIGEGTYGVVYKARDK-LTGEIVALKKI-RLETEDEGVPSTAIRE----ISLLKELNHP 58
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYLHE 621
N+V+LL LV+EF+ + L + + P + + ++ +G+ Y H
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFK 680
++H D+KPQN+L+D + K++DFGL++ + ++ TH ++ T Y APE
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV--TLWYRAPEILL 172
Query: 681 NAP-VSAKVDVYSFGVMLLEII 701
+ S VD++S G + E++
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMV 194
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 27/209 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD-------RLAQEREREFKSEVSAIG----R 559
E LG G+FG VYK K+ +A+K+++ + +ER++ VS + +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 560 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD--------WNLRVRISLE 611
H N+V+ E +V + + L ++ + WN+ V++ L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL- 124
Query: 612 IARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR 671
L YLH+E I+H D+ P NI+L I+DFGL+K T + GT
Sbjct: 125 ---ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTI 177
Query: 672 GYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
Y PE KN P K DV++FG +L ++
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-15
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 16/201 (7%)
Query: 511 EELGRGSFG--IVYK-GVLKSASGKAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLV 566
LG G FG +Y +G+ +AVK L R Q+ +K E++ + +H+N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 567 QLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEE 622
+ G C E + L+ E++ G+L + + PK NL + + +I G+ YLH +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG--YVAPEWFK 680
IH D+ +N+LLDN KI DFGL+K + G + A E K
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 681 NAPVSAKVDVYSFGVMLLEII 701
S DV+SFGV L E++
Sbjct: 184 ENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 4e-15
Identities = 62/201 (30%), Positives = 111/201 (55%), Gaps = 20/201 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 567
E++G G++G+VYK + + + IA+KK+ RL QE E + E+S + H N+V+
Sbjct: 8 EKIGEGTYGVVYKARDR-VTNETIALKKI-RLEQEDEGVPSTAIREISLLKEMQHGNIVR 65
Query: 568 L--LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYLHEEC 623
L + ++ L LV+E++ + L + + P N R+ + +I RG+ Y H
Sbjct: 66 LQDVVHSEKRL--YLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH- 121
Query: 624 NVPIIHCDIKPQNILLDNYFSA-KISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFKN 681
++H D+KPQN+L+D +A K++DFGL++ + ++ TH ++ T Y APE
Sbjct: 122 --RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV--TLWYRAPEILLG 177
Query: 682 A-PVSAKVDVYSFGVMLLEII 701
+ S VD++S G + E++
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 5e-15
Identities = 59/179 (32%), Positives = 84/179 (46%), Gaps = 32/179 (17%)
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL----LLSDQSRTHTMIRGTR 671
L+ +H + +IH DIK NILL + K+ DFG SK+ + D RT GT
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC---GTP 209
Query: 672 GYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEME-VEEEGRAILTDWAYDCYAEG 730
YVAPE ++ P S K D++S GV+L E++ +R + E +EE L G
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA---------G 260
Query: 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM------LEGLLEV 783
R D L S P M + I + DP +RP+ +L M + GLLE+
Sbjct: 261 RYDPLPPSISPEMQE---------IVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEI 310
|
Length = 496 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 13/195 (6%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLL 569
LG G FG V +KS + A+K + + ++ SE + +H +V+L
Sbjct: 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY 59
Query: 570 -GFCDEALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEECNVPI 627
F D+ +L+ E+ G L ++ ++ R I+ + YLH N I
Sbjct: 60 RTFKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLH---NRGI 114
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
I+ D+KP+N+LLD+ K+ DFG +K L S Q +T T GT YVAPE N
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFC-GTPEYVAPEIILNKGYDFS 172
Query: 688 VDVYSFGVMLLEIIC 702
VD +S G++L E++
Sbjct: 173 VDYWSLGILLYELLT 187
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 6e-15
Identities = 73/295 (24%), Positives = 127/295 (43%), Gaps = 47/295 (15%)
Query: 509 FKEELGRGSFGIVY----KGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 564
K ELG G+FG V+ + +AVK L + ++F E + H++
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNL--------------RVRISL 610
+V+ G C E ++V+E+M +G L + A PD L + I+
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA-HGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 611 EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRT--HTM- 666
+IA G+VYL + +H D+ +N L+ KI DFG+S+ + S D R HTM
Sbjct: 128 QIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 667 -IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD 725
IR ++ PE + + DV+S GV+L EI + ++ + +
Sbjct: 185 PIR----WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS-------NNEVIE 233
Query: 726 CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780
C +GR+ R+ ++ + + C + +P R +K + +L+ L
Sbjct: 234 CITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 53/248 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----------------IAVKKLDRLAQERER-EFK 551
KE+LG G FG V+ L A G A +AVK L + R +F
Sbjct: 9 LKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 552 SEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI--------FA----IPK 599
E+ + R + N+++LLG C ++ E+M NG L + F IP
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 600 PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
+ ++++IA G+ YL ++ +H D+ +N L+ N+++ KI+DFG+S+ L S
Sbjct: 126 VSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSG 182
Query: 660 -----QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI-ICCRRSVEMEVEE 713
Q R IR ++A E + DV++FGV L E+ C+ E
Sbjct: 183 DYYRIQGRAVLPIR----WMAWESILLGKFTTASDVWAFGVTLWEMFTLCK--------E 230
Query: 714 EGRAILTD 721
+ ++L+D
Sbjct: 231 QPYSLLSD 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 7e-15
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 7/209 (3%)
Query: 509 FKEELGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQEREREFKS-EVSAIGRTHHKNLV 566
F LG+GSFG V K AI + K D + Q+ + E E + + +
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFL 63
Query: 567 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
L C + ++RL V E++ G L I + + V + EIA GL +LH +
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK--- 120
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+K N++LD+ KI+DFG+ K + D T T GT Y+APE P
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC-GTPDYIAPEIIAYQPYG 179
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD ++FGV+L E++ + E E E+E
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 13/195 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
E +GRG+FG V+ G L+ A +AVK + L + + +F E + + H N+V+L+
Sbjct: 1 ERIGRGNFGEVFSGRLR-ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPII 628
G C + +V E + G + P+ +++ A G+ YL + I
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR----GYVAPEWFKNAPV 684
H D+ +N L+ KISDFG+S+ ++ + G + + APE
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173
Query: 685 SAKVDVYSFGVMLLE 699
S++ DV+SFG++L E
Sbjct: 174 SSESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 67/200 (33%), Positives = 97/200 (48%), Gaps = 23/200 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 567
LG+G FG V ++ A+GK A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECN 624
L + E + L LV M G L I+ + P D V + EI GL LH E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE-- 121
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPEWFKN 681
I++ D+KP+NILLD+Y +ISD GL+ + IR GT GY+APE KN
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAV-----EIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 682 APVSAKVDVYSFGVMLLEII 701
+ D + G ++ E+I
Sbjct: 176 ERYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 16/197 (8%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
++LG G FG V+ G +++ A+ K ++ + F E + + H LV+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ---AFLEEANLMKTLQHDKLVRLYA 68
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI------SLEIARGLVYLHEECN 624
+ ++ E+M G+L + + K D +V + S +IA G+ Y+ +
Sbjct: 69 VVTKEEPIYIITEYMAKGSLLDFL----KSDEGGKVLLPKLIDFSAQIAEGMAYIERK-- 122
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
IH D++ N+L+ KI+DFGL++++ ++ + + APE
Sbjct: 123 -NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 181
Query: 685 SAKVDVYSFGVMLLEII 701
+ K DV+SFG++L EI+
Sbjct: 182 TIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 1e-14
Identities = 54/221 (24%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 512 ELGRGSFGIVYK----GVLKSASGKAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLV 566
++G+G+FG V++ G+L +AVK L + + + + +F+ E + + H N+V
Sbjct: 12 DIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLI--------------------FAIPKPDWN--L 604
+LLG C L++E+M G L + + +
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 605 RVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS-KLLLSDQSRT 663
++ I+ ++A G+ YL E +H D+ +N L+ KI+DFGLS + +D +
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 664 HTM----IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
IR ++ PE + + DV+++GV+L EI
Sbjct: 189 SENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-14
Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 39/211 (18%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSA---------IGRTHHK 563
+G G++G+V V K +G+ +A+KK+ F + A + H+
Sbjct: 8 IGSGAYGVVCSAVDKR-TGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHE 59
Query: 564 NLVQLLG-FCDEALNRL----LVYEFMGNGT-LANLIFAIPKPDWNLRVR-ISLEIARGL 616
N++ LL + +V E M T L +I + P+P + ++ +I RGL
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELM--ETDLHKVIKS-PQPLTDDHIQYFLYQILRGL 116
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG--TRGYV 674
YLH N +IH D+KP NIL+++ KI DFGL++ + D+ + TR Y
Sbjct: 117 KYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 675 APE----WFKNAPVSAKVDVYSFGVMLLEII 701
APE + + +D++S G + E++
Sbjct: 174 APELLLSSSR---YTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 7/210 (3%)
Query: 508 GFKEELGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQEREREFKS-EVSAIGRTHHKNL 565
F LG+GSFG V K AI + K D + Q+ + E E +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPF 62
Query: 566 VQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
+ L C + ++RL V E++ G L I + K V + EI+ GL +LH
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR-- 120
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
II+ D+K N++LD+ KI+DFG+ K + D T T GT Y+APE P
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC-GTPDYIAPEIIAYQPY 178
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD +++GV+L E++ + + E E+E
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 72/274 (26%), Positives = 123/274 (44%), Gaps = 39/274 (14%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL-----DRLAQEREREFKSEVSAIGRT-HHKNLV 566
+G G+ G VYK V+ +G+ A+K + D + ++ RE I R +H N+V
Sbjct: 82 IGSGAGGTVYK-VIHRPTGRLYALKVIYGNHEDTVRRQICREI-----EILRDVNHPNVV 135
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+ D ++ EFM G+L A D ++ +I G+ YLH
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDGGSLEGTHIA----DEQFLADVARQILSGIAYLHRR---H 188
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
I+H DIKP N+L+++ + KI+DFG+S++L ++ + GT Y++PE
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHG 247
Query: 687 KV-----DVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
D++S GV +LE R V +G DWA L + +P
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGR--FPFGVGRQG-----DWA-------SLMCAICMSQP 293
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
A + +++ C++ +P+KR + +LQ
Sbjct: 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 500 NELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR 559
NE+ E G ELG G+FG VYK K +G A K ++ ++E ++ E+ +
Sbjct: 11 NEVWEIIG----ELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYMVEIEILAT 65
Query: 560 THHKNLVQLLG--FCDEALNRLLVYEFMGNG----TLANLIFAIPKPDWNLRVRISLEIA 613
+H +V+LLG + D L ++ EF G + L + +P + R LE
Sbjct: 66 CNHPYIVKLLGAFYWDGKLW--IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLE-- 121
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
L YLH ++ IIH D+K N+LL K++DFG+S + R + I GT +
Sbjct: 122 -ALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYW 176
Query: 674 VAP-----EWFKNAPVSAKVDVYSFGVMLLEI 700
+AP E K+ P K D++S G+ L+E+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+G GSFG +Y KS S + +K++D +E+E K EV + + H N+V
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEAS-KKEVILLAKMKHPNIVTFF 65
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIF----AIPKPDWNLR--VRISLEIARGLVYLHEEC 623
E +V E+ G L I + D L V+ISL GL ++H+
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL----GLKHIHDR- 120
Query: 624 NVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I+H DIK QNI L N AK+ DFG+++ L +T + GT Y++PE +N
Sbjct: 121 --KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEICQNR 177
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVE 708
P + K D++S G +L E+ + E
Sbjct: 178 PYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK-AIAVKKLDRLAQERE-REFKSEVSAIGRT-HHKNL 565
F++ +G G+FG V + ++K K A+K L A E + R+F E+ + + HH N+
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-------PDWNLR------------V 606
+ LLG C+ NR +Y + NL+ + K P + +
Sbjct: 66 INLLGACE---NRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666
+ + ++A G+ YL E+ IH D+ +N+L+ ++KI+DFGLS+ + TM
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTM 177
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
R ++A E + + K DV+SFGV+L EI+
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-14
Identities = 62/198 (31%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 567
LG+G FG V ++ A+GK A K+L++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKRLEK---KRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECN 624
L + E + L LV M G L I+ + P + + + EI GL LH E
Sbjct: 64 NLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-- 121
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLS-KLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
++ D+KP+NILLD+Y +ISD GL+ K+ + R GT GY+APE N
Sbjct: 122 -NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRV---GTVGYMAPEVLNNQR 177
Query: 684 VSAKVDVYSFGVMLLEII 701
+ D + G ++ E+I
Sbjct: 178 YTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 15/196 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQ 567
+ + +G+FG VY K ++G A+K K D +A+ + K+E + + V
Sbjct: 2 KPISKGAFGSVYLAK-KRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNV 625
L + ++ + L LV E++ G A+LI + P+ + I+ E+ G+ LH+
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA-EVVLGVEDLHQR--- 116
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
IIH DIKP+N+L+D K++DFGLS+ L ++ GT Y+APE
Sbjct: 117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDD 171
Query: 686 AKVDVYSFGVMLLEII 701
D +S G ++ E +
Sbjct: 172 KMSDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 17/197 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 567
LG+G FG V ++ A+GK A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECN 624
L + E + L LV M G L I+ + + + V + EI GL LH+E
Sbjct: 64 SLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE-- 121
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
I++ D+KP+NILLD++ +ISD GL+ + Q+ + GT GY+APE KN
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVKNERY 178
Query: 685 SAKVDVYSFGVMLLEII 701
+ D ++ G +L E+I
Sbjct: 179 TFSPDWWALGCLLYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 513 LGRGSFGIVYKGVLKS--ASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
LG+G FG V + LKS S + +AVK K D + EF E + + H N+++L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 569 LGFC--DEALNRL----LVYEFMGNGTLANLIFA--IPKPDWNLR----VRISLEIARGL 616
+G A RL ++ FM +G L + I + + L VR ++IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTHTMIRGTRGYVA 675
YL + IH D+ +N +L+ + ++DFGLSK + S D R + ++A
Sbjct: 127 EYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEII 701
E + + DV++FGV + EI+
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 64/206 (31%), Positives = 106/206 (51%), Gaps = 34/206 (16%)
Query: 513 LGRGSFGIVY--KGVLKSASGKAIAVKKL--------DRLAQEREREFKSEVSAIGRTHH 562
LG+GSFG V+ + + +G+ A+K L DR+ + ER+ +EV +H
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------NH 57
Query: 563 KNLVQL-LGFCDEALNRLLVYEFMGNGTL-----ANLIFAIPKPDWNLRVRISL-EIARG 615
+V+L F E L+ +F+ G L ++F + D V+ L E+A
Sbjct: 58 PFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFT--EED----VKFYLAELALA 110
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
L +LH ++ II+ D+KP+NILLD K++DFGLSK + + + ++ GT Y+A
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMA 166
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEII 701
PE + D +SFGV++ E++
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 83/291 (28%), Positives = 136/291 (46%), Gaps = 45/291 (15%)
Query: 509 FKEELGRGSFGIVYK----GVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTH-- 561
F + LG G+FG V + G+ KS + +AVK L A ERE SE+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIM--SHLG 96
Query: 562 -HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRVRISLEIARG 615
H+N+V LLG C L++ E+ G L N F K + +L + S ++A+G
Sbjct: 97 NHENIVNLLGACTIGGPILVITEYCCYGDLLN--FLRRKRESFLTLEDL-LSFSYQVAKG 153
Query: 616 LVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG-TR-- 671
+ +L + C IH D+ +N+LL + KI DFGL++ +++D ++ +++G R
Sbjct: 154 MAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND---SNYVVKGNARLP 206
Query: 672 -GYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730
++APE N + + DV+S+G++L EI + + Y EG
Sbjct: 207 VKWMAPESIFNCVYTFESDVWSYGILLWEIF------SLGSNPYPGMPVDSKFYKLIKEG 260
Query: 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
+P A + I C DP KRPT K ++Q++ L
Sbjct: 261 -----YRMAQPEHAP----AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQL 302
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 77/296 (26%), Positives = 137/296 (46%), Gaps = 34/296 (11%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEV-SAIGR 559
ELK+ ELG G+ G+V+K V SG +A +KL L E + ++++ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK-VSHKPSGLIMA-RKLIHL--EIKPAIRNQIIRELQV 56
Query: 560 THHKNLVQLLGF-----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 614
H N ++GF D ++ + E M G+L ++ + + ++S+ + +
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 114
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
GL YL E+ I+H D+KP NIL+++ K+ DFG+S L+ + + GTR Y+
Sbjct: 115 GLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYM 169
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734
+PE + S + D++S G+ L+E+ R + +E + + C EG
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELM-----FGCPVEG---- 220
Query: 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPS 790
D E + R R + + P RP M + ++L+ ++ P P PS
Sbjct: 221 --DPAESETSPRPRPPGRPLSSY-----GPDSRPPM-AIFELLDYIVNEPPPKLPS 268
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 67/230 (29%), Positives = 103/230 (44%), Gaps = 40/230 (17%)
Query: 509 FKEELGRGSFGIVY------------KGVLKSASGKA---IAVKKLDRLAQERER-EFKS 552
F E+LG G FG V+ K ++ + A +AVK L A + R +F
Sbjct: 9 FVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLK 68
Query: 553 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLA-----------NLIFAIPKPD 601
EV + R N+ +LLG C ++ E+M NG L L
Sbjct: 69 EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128
Query: 602 WNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-- 659
++ + ++ +IA G+ YL E N +H D+ +N L+ ++ KI+DFG+S+ L S
Sbjct: 129 FSTLLYMATQIASGMRYL-ESLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDY 185
Query: 660 ---QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRR 705
Q R IR ++A E + K DV++FGV L EI+ CR
Sbjct: 186 YRVQGRAPLPIR----WMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 57/193 (29%), Positives = 93/193 (48%), Gaps = 13/193 (6%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
+LG+G FG V+ G + AI K ++ E F E + + H+ LVQL
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYAV 69
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEECNVPI 627
E +V E+M G+L L F + LR V ++ +IA G+ Y+ E N
Sbjct: 70 VSEE-PIYIVTEYMSKGSL--LDFLKGEMGKYLRLPQLVDMAAQIASGMAYV-ERMNY-- 123
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D++ NIL+ K++DFGL++L+ ++ + + APE + K
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 688 VDVYSFGVMLLEI 700
DV+SFG++L E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 19/196 (9%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
+LG G+ G V K V +G +A K + A+ R K + + H ++ F
Sbjct: 12 DLGAGNGGSVSK-VKHIPTGTVMAKKVVHIGAKSSVR--KQILRELQIMHECRSPYIVSF 68
Query: 572 CDEALNR---LLVYEFMGNGTLANLIFAIPKPDWNLRV----RISLEIARGLVYLHEECN 624
LN + EFM G+L I K + V +I++ + GL YL+
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLD----RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR 124
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
I+H DIKP NIL+++ K+ DFG+S L++ + T GT Y++PE +
Sbjct: 125 --IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV---GTSTYMSPERIQGGKY 179
Query: 685 SAKVDVYSFGVMLLEI 700
+ K DV+S G+ ++E+
Sbjct: 180 TVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 27/207 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRT-HHK 563
E +G G++G+V + + SGK +A+KK+ LA+ RE K I R H
Sbjct: 11 ENIGSGAYGVVCSAI-DTRSGKKVAIKKIPHAFDVPTLAKRTLRELK-----ILRHFKHD 64
Query: 564 NLVQLLGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVY 618
N++ + + + +V + M + L ++I + +P +R L ++ RGL Y
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHS-DQPLTEEHIRYFLYQLLRGLKY 122
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS---DQSRTHTMIRGTRGYVA 675
+H +IH D+KP N+L++ +I DFG+++ L S + T TR Y A
Sbjct: 123 IHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 676 PEWFKNAP-VSAKVDVYSFGVMLLEII 701
PE + P + +D++S G + E++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 62/197 (31%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLV 566
E LG GSFG V K +G+ A+K L + L ++ + E S + H +V
Sbjct: 23 GETLGTGSFGRVRIAKHK-GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIV 81
Query: 567 QLL-GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
++ F DE NR+ + EF+ G L + + ++ E+ YLH +
Sbjct: 82 NMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KD 138
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
II+ D+KP+N+LLDN K++DFG +K + RT T+ GT Y+APE ++
Sbjct: 139 --IIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PDRTFTLC-GTPEYLAPEVIQSKGH 192
Query: 685 SAKVDVYSFGVMLLEII 701
VD ++ GV+L E I
Sbjct: 193 GKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG+G+FG V V + A+GK A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 570 GFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHEE 622
+ + +RL V E+ G L +F+ R R EI L YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALGYLHS- 113
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
C+ +++ D+K +N++LD KI+DFGL K +SD + T GT Y+APE ++
Sbjct: 114 CD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 170
Query: 683 PVSAKVDVYSFGVMLLEIICCR 704
VD + GV++ E++C R
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 65/211 (30%), Positives = 94/211 (44%), Gaps = 30/211 (14%)
Query: 511 EELGRGSFGIVYKGVLKSASGKA-IAVKKLDRLAQERE-REFKSEVSAIGRTHHKNLVQL 568
+E+G G FG V G + S A + VK+L A +E +F E H NL+Q
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPK-----PDWNLRVRISLEIARGLVYLHEEC 623
LG C E LLV EF G L + + K PD R++ EIA GL++LH+
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKL-------LLSDQSRTHTMIRGTRGYVAP 676
IH D+ +N LL + KI D+GLS + DQ +R ++AP
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ--LWVPLR----WIAP 171
Query: 677 EWFKN-------APVSAKVDVYSFGVMLLEI 700
E + + +V+S GV + E+
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 29/206 (14%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 567
LGRG+FG VY + +G+ +AVK++ D +QE +E + E+ + H +VQ
Sbjct: 10 LGRGAFGEVYL-CYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 568 LLGFC--DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
G C D +L ++ E+M G++ + + A N+ R + +I +G+ YLH
Sbjct: 69 YYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM- 126
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM---------IRGTRGYVA 675
I+H DIK NIL D+ + K+ DFG SK R T+ + GT +++
Sbjct: 127 --IVHRDIKGANILRDSAGNVKLGDFGASK-------RIQTICMSGTGIKSVTGTPYWMS 177
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEII 701
PE K DV+S ++E++
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 20/212 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGK-AI-AVKKLDRLAQEREREFKSE---VSAIGRTHHKNLVQ 567
LGRG FG V K AI A+KK D +A++ E H LV
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLI----FAIPKPDWNLRVRISLEIARGLVYLHEE 622
L C + + + V E+ G L I F+ P+ V + + GL YLHE
Sbjct: 67 LFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA-----VFYAACVVLGLQYLHEN 120
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I++ D+K N+LLD KI+DFGL K + RT T GT ++APE
Sbjct: 121 ---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEVLTET 176
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE 714
+ VD + GV++ E++ + EEE
Sbjct: 177 SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 4e-13
Identities = 62/224 (27%), Positives = 95/224 (42%), Gaps = 43/224 (19%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V+ V +G+ A+K L D + + + ++E + +V+L
Sbjct: 9 IGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY 67
Query: 570 -GFCDEALNRL-LVYEFMGNGTLANL--IFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
F DE L LV E+M G L NL + + R I+ E+ L +H +
Sbjct: 68 YSFQDE--EHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIA-ELVLALDSVH---KL 120
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSK-------------------------LLLSDQ 660
IH DIKP NIL+D K++DFGL K + D
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180
Query: 661 SRTHTMIR---GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+ GT Y+APE + P + D +S GV+L E++
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 4e-13
Identities = 65/211 (30%), Positives = 115/211 (54%), Gaps = 28/211 (13%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKL-D--RLAQEREREFKSEVSAIGR-THHKNL 565
++LG+G++GIV+K + + + + +A+KK+ D R A + +R F+ E+ + H N+
Sbjct: 12 LQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNI 69
Query: 566 VQLLGFCDEALNR--LLVYEFMGNGTLANLIFA-IPKPDWNLRVR-ISLEIARGLVYLHE 621
V+LL ++ LV+E+M L +I A I + ++ R I ++ + L Y+H
Sbjct: 70 VKLLNVIKAENDKDIYLVFEYM-ETDLHAVIRANILE---DVHKRYIMYQLLKALKYIHS 125
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
NV IH D+KP NILL++ K++DFGL++ LS+ T YVA W++
Sbjct: 126 G-NV--IHRDLKPSNILLNSDCRVKLADFGLAR-SLSELEENPENPVLTD-YVATRWYR- 179
Query: 682 AP---VSAK-----VDVYSFGVMLLEIICCR 704
AP + + VD++S G +L E++ +
Sbjct: 180 APEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 4e-13
Identities = 74/279 (26%), Positives = 122/279 (43%), Gaps = 45/279 (16%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
+LG+G FG V+ G + AI K + E F E + + H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE---AFLQEAQIMKKLRHDKLVPLYAV 69
Query: 572 CDEALNRLLVYEFMGNGTLANLI-------FAIPKPDWNLRVRISLEIARGLVYLHEECN 624
E +V EFMG G+L + + +P+ V ++ +IA G+ Y+ E N
Sbjct: 70 VSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ-----LVDMAAQIADGMAYI-ERMN 122
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
IH D++ NIL+ + KI+DFGL++L+ ++ + + APE
Sbjct: 123 Y--IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 180
Query: 685 SAKVDVYSFGVMLLEIICCRR-----SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
+ K DV+SFG++L E++ R V EV E+ + Y R+
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQ-----VERGY------RMPCPQGCP 229
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
E ++ + +L C ++DP +RPT + + LE
Sbjct: 230 E-SLHELMKL---------CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 60/200 (30%), Positives = 100/200 (50%), Gaps = 19/200 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-REFKSEVSAIGRTHH-KNLVQL 568
E+G G+ G VYK K +G +AVK++ R + E + ++ + ++H +V+
Sbjct: 21 GEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVP 626
G+ + + E M L L+ I P P+ ++ ++++ I + L YL E+ V
Sbjct: 80 YGYFITDSDVFICMELMST-CLDKLLKRIQGPIPE-DILGKMTVAIVKALHYLKEKHGV- 136
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE------WFK 680
IH D+KP NILLD + K+ DFG+S L+ S+ T G Y+APE
Sbjct: 137 -IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDPPDPNP 193
Query: 681 NAPVSAKVDVYSFGVMLLEI 700
+ A DV+S G+ L+E+
Sbjct: 194 KYDIRA--DVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 5e-13
Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 17/214 (7%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEV-SAIGRTHHKNLVQLLG 570
ELG G+ G+V K ++ I +KL L E + ++++ + H N ++G
Sbjct: 12 ELGAGNGGVVTK--VQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNSPYIVG 67
Query: 571 F-----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
F D ++ + E M G+L ++ + + ++S+ + RGL YL E+
Sbjct: 68 FYGAFYSDGEIS--ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ- 124
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
I+H D+KP NIL+++ K+ DFG+S L+ + + GTR Y++PE + S
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYS 180
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAIL 719
+ D++S G+ L+E+ R + +E AI
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 5e-13
Identities = 57/198 (28%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 567
LG+G+FG VY + +G+ +AVK++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 568 LLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
G + + R L E M G++ + + + N+ + + +I G+ YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM-- 126
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-QSRTHTM-IRGTRGYVAPEWFKNAP 683
I+H DIK NIL D+ + K+ DFG SK L + S T + GT +++PE
Sbjct: 127 -IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185
Query: 684 VSAKVDVYSFGVMLLEII 701
K D++S G ++E++
Sbjct: 186 YGRKADIWSVGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 13/208 (6%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT------HHKNLV 566
LG+GSFG V+ LK + + A+K L + + + E + + + H L
Sbjct: 3 LGKGSFGKVFLAELK-GTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLT 59
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
L N V E++ G L I + K D + EI GL +LH +
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---G 116
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
I++ D+K NILLD KI+DFG+ K + ++T T GT Y+APE +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFC-GTPDYIAPEILLGQKYNT 175
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD +SFGV+L E++ + EEE
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 8e-13
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 23/202 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLL 569
+G G+FG+V+ V GK +A+KK+ + Q +R F+ E+ + H N++ L
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNVLSAL 65
Query: 570 --------GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLH 620
+E +V E M L +I + P+P + V++ L +I RGL YLH
Sbjct: 66 DILQPPHIDPFEEIY---VVTELM-QSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLH 120
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
+ I+H DIKP N+L+++ KI DFGL+++ D+S+ T T+ Y APE
Sbjct: 121 ---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177
Query: 681 NAP-VSAKVDVYSFGVMLLEII 701
+ ++ VD++S G + E++
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELL 199
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 8e-13
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKA-IAVKKLDRLAQERE-REFKSEVSAIGRT-HHKNLVQLL 569
+G G+FG V K +K + A+K++ A + + R+F E+ + + HH N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 570 GFCDEALNRLLVYEFMGNGTLANLI-----------FAIPKPDWNLR-----VRISLEIA 613
G C+ L E+ +G L + + FAI + + + ++A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
RG+ YL ++ IH D+ +NIL+ + AKI+DFGLS+ + TM R +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 177
Query: 674 VAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+A E + + DV+S+GV+L EI+
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 23/211 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
+G+GSFG V K GK AVK L + L ++ ++ +E + + + + L
Sbjct: 3 IGKGSFGKVLLAKRK-LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEECN 624
+ + +L V +F+ G L F + + P+ R + EIA L YLH +
Sbjct: 62 HYSFQTTEKLYFVLDFVNGG---ELFFHLQRERSFPEPRARFYAA-EIASALGYLH---S 114
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
+ I++ D+KP+NILLD+ ++DFGL K ++ QS T T GT Y+APE + P
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPY 173
Query: 685 SAKVDVYSFGVMLLEII------CCRRSVEM 709
VD + G +L E++ CR EM
Sbjct: 174 DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 16/200 (8%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKNL 565
+G G FG VY+GV S + I AVK K RE+ F E + + H ++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHI 69
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRI----SLEIARGLVYLHE 621
V+L+G E V+ M L L + ++L + S +++ L YL
Sbjct: 70 VKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE- 124
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ +H DI +N+L+ + K+ DFGLS+ L + + + ++APE
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 682 APVSAKVDVYSFGVMLLEII 701
++ DV+ FGV + EI+
Sbjct: 183 RRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 67/208 (32%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 513 LGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 568
LG+GSFG V LK + AI K D + ++ + E + V A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 569 LGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
FC L V E++ G L I + + D + EI GL +LH++
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---G 116
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
II+ D+K N+LLD KI+DFG+ K ++ + + T GT Y+APE K +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQKYNE 175
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD +SFGV+L E++ + E E+E
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 23/200 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQ 567
LG+G FG V ++ A+GK A KKL++ +R ++ K E A+ + V
Sbjct: 8 LGKGGFGEVCACQVR-ATGKMYACKKLEK---KRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECN 624
L + E + L LV M G L I+ + P D + + E+ GL L E
Sbjct: 64 SLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPEWFKN 681
I++ D+KP+NILLD+ +ISD GL+ + ++ +R GT GY+APE N
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-----VRGRVGTVGYMAPEVINN 175
Query: 682 APVSAKVDVYSFGVMLLEII 701
+ D + G ++ E+I
Sbjct: 176 EKYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 32/207 (15%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNLVQLL 569
+G+G+FG VY+ V K + + A+K L + ++E E + + RT ++
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIV 59
Query: 570 G--FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL---------RVRISL-EIARGL 616
G F + + L LV ++M G L W+L R + + E+ L
Sbjct: 60 GLKFSFQTDSDLYLVTDYMSGGELF----------WHLQKEGRFSEDRAKFYIAELVLAL 109
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
+LH+ I++ D+KP+NILLD + DFGLSK L+D T+T GT Y+AP
Sbjct: 110 EHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC-GTTEYLAP 165
Query: 677 E-WFKNAPVSAKVDVYSFGVMLLEIIC 702
E + VD +S GV++ E+ C
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCC 192
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 90/331 (27%), Positives = 144/331 (43%), Gaps = 69/331 (20%)
Query: 513 LGRGSFGIVYK----GVLKSASGKA--IAVKKLDRLAQERE-REFKSEVSA---IGRTHH 562
LG G FG V G+ K K +AVK L A +++ + SE+ IG+ H
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK--H 77
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--------------IPKPDWNLR--V 606
KN++ LLG C + ++ E+ G L + A +P+ + V
Sbjct: 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 607 RISLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTH 664
+ ++ARG+ YL ++C IH D+ +N+L+ KI+DFGL++ + + D +
Sbjct: 138 SCAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT 193
Query: 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE--MEVEEEGRAILTDW 722
T R ++APE + + + DV+SFGV+L EI S + VEE
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--------- 244
Query: 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ EG D+PA + + MI C PS+RPT K +++ L+ +L
Sbjct: 245 LFKLLKEGH-----RMDKPA----NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295
Query: 783 VP---------------NPPCPSSFSIAVTG 798
V +P CP S S +G
Sbjct: 296 VTSTDEYLDLSVPFEQYSPGCPDSPSSCSSG 326
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT 560
E+ + +++LG G FG V+ + A+ K ++ E F +E + +
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTL 58
Query: 561 HHKNLVQLLGFCDEALNRLLVY---EFMGNGTLANLIFAIPKPDWNLRVRI------SLE 611
H LV+L + + +Y EFM G+L + + K D + + S +
Sbjct: 59 QHDKLVKL----HAVVTKEPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQ 110
Query: 612 IARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR 671
IA G+ ++ + IH D++ NIL+ KI+DFGL++++ ++ +
Sbjct: 111 IAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 167
Query: 672 GYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+ APE + K DV+SFG++L+EI+
Sbjct: 168 KWTAPEAINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 19/201 (9%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTH---HKNLV 566
E+G G++G VYK SG +A+K + E + EV+ + R H N+V
Sbjct: 7 EIGVGAYGTVYKA-RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 567 QLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYL 619
+L+ C D LV+E + + L + +P P L + RGL +L
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
H C I+H D+KP+NIL+ + K++DFGL+++ + T ++ T Y APE
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV--TLWYRAPEVL 179
Query: 680 KNAPVSAKVDVYSFGVMLLEI 700
+ + VD++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 34/203 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKNLV 566
+G G+FG+V +G+ +A+KK+ + LA+ RE K + H+N++
Sbjct: 18 VGMGAFGLVCSAR-DQLTGQNVAIKKIMKPFSTPVLAKRTYRELK----LLKHLRHENII 72
Query: 567 QLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
L D ++ L V E +G L L+ + P ++ +I RGL Y+H
Sbjct: 73 SL---SDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-FLYQILRGLKYVH-- 125
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE----W 678
+ ++H D+KP NIL++ KI DFGL+++ Q T TR Y APE W
Sbjct: 126 -SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTW 180
Query: 679 FKNAPVSAKVDVYSFGVMLLEII 701
K +VD++S G + E++
Sbjct: 181 QK---YDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 494 LRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-E 549
LR ELK + LG G+FG VYKG+ +A+K L+ + E
Sbjct: 1 LRILKETELKRV-----KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE 55
Query: 550 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRI 608
F E + H +LV+LLG C +L V + M +G L + + L +
Sbjct: 56 FMDEALIMASMDHPHLVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW 114
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668
++IA+G++YL E ++H D+ +N+L+ + KI+DFGL++LL D+ +
Sbjct: 115 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNA--D 169
Query: 669 GTR---GYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
G + ++A E + + DV+S+GV + E++
Sbjct: 170 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 60/216 (27%), Positives = 99/216 (45%), Gaps = 49/216 (22%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT----------HH 562
+G G++G V +G+ +A+KKL R F+S + A RT H
Sbjct: 23 VGSGAYGQVCSAFDTK-TGRKVAIKKLSR-------PFQSAIHA-KRTYRELRLLKHMDH 73
Query: 563 KNLVQLLG-FC-DEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGL 616
+N++ LL F +L LV MG L N++ D +++ + +I RGL
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQF-LVYQILRGL 131
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
Y+H + IIH D+KP NI ++ KI DFGL++ + + GYVA
Sbjct: 132 KYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT----------GYVAT 178
Query: 677 EWFKNAP--------VSAKVDVYSFGVMLLEIICCR 704
W++ AP + VD++S G ++ E++ +
Sbjct: 179 RWYR-APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 61/205 (29%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 512 ELGRGSFGIVYKGVLKSAS-GKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 564
ELG+G++GIV S + +A+KK+ LA+ RE K G HKN
Sbjct: 7 ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG---HKN 63
Query: 565 LVQLLGF---CDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLH 620
+ L N L +YE + L +I + P D + + I +I GL Y+H
Sbjct: 64 ITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI-YQILCGLKYIH 122
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG---TRGYVAPE 677
NV +H D+KP N+L++ KI DFGL++ + + TR Y APE
Sbjct: 123 S-ANV--LHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 678 -WFKNAPVSAKVDVYSFGVMLLEII 701
+ +DV+S G +L E++
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 27/207 (13%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKN 564
++G G++G VYK K +G+ +A+KK+ RL E+E RE K + + +H+N
Sbjct: 14 QIGEGTYGQVYKARDKD-TGELVALKKV-RLDNEKEGFPITAIREIK----ILRQLNHRN 67
Query: 565 LVQL----------LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 614
+V L L F + LV+E+M + + L + + ++
Sbjct: 68 IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLE 127
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
GL Y H +H DIK NILL+N K++DFGL++L S++SR +T T Y
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 675 APE-WFKNAPVSAKVDVYSFGVMLLEI 700
PE +DV+S G +L E+
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGEL 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 513 LGRGSFGIVYKGVL-KSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG G FG V +G L + S +AVK K+ + +F SE + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 570 GFCDEALNR------LLVYEFMGNGTLANLIFAIPKPDW------NLRVRISLEIARGLV 617
G C + + +++ FM +G L + + D + V+ +IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTHTMIRGTRGYVAP 676
YL + IH D+ +N +L+ + ++DFGLSK + + D R + + ++A
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEI 700
E + + K DV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 53/194 (27%), Positives = 96/194 (49%), Gaps = 15/194 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLD-----RLAQEREREFKSEVSAIGRTHHKNLVQ 567
+G G+FG V+ V S A+K + RL QE+ +E + H +++
Sbjct: 9 VGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQEQH--VHNEKRVLKEVSHPFIIR 65
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
L + ++ E++ G L + + + + + + EI L YLH + I
Sbjct: 66 LFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EI 122
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
++ D+KP+NILLD K++DFG +K L + RT T+ GT Y+APE ++ +
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKL---RDRTWTLC-GTPEYLAPEVIQSKGHNKA 178
Query: 688 VDVYSFGVMLLEII 701
VD ++ G+++ E++
Sbjct: 179 VDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 15/213 (7%)
Query: 495 RFFSYNELKEATGGFKEELGRGSFGIVYKGVL--KSASGK-AIAVKKL-DRLAQEREREF 550
R EL++ + LG G FG V+KG+ + S K +A+K + DR ++ +E
Sbjct: 2 RILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56
Query: 551 KSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRIS 609
+ A+G H +V+LLG C A + LV + G+L + + D +
Sbjct: 57 TDHMLAMGSLDHAYIVRLLGICPGA-SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC 115
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIR 668
++IA+G+ YL E ++H ++ +NILL + +I+DFG++ LL D + ++ +
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
++A E + + DV+S+GV + E++
Sbjct: 173 TPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 57/203 (28%), Positives = 96/203 (47%), Gaps = 16/203 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
+GRG FG V + V + A+G A+K + + LAQE F+ E + ++ + QL
Sbjct: 9 VGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISL-EIARGLVYLHEECNVPI 627
+ N LV E+ G L +L+ D ++ + L E+ + +H+ +
Sbjct: 68 YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-AQFYLAELVLAIHSVHQ---MGY 123
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H DIKP+N+L+D K++DFG + L +++ + GT Y+APE K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 688 ------VDVYSFGVMLLEIICCR 704
D +S GV+ E+I R
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 60/224 (26%), Positives = 108/224 (48%), Gaps = 15/224 (6%)
Query: 482 NNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR 541
+ +DS +++ R N++K F LG GSFG V K+ +A+K+ ++
Sbjct: 10 HKKKDSDSTKEPKR---KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEK 66
Query: 542 LAQEREREFK---SEVSAIGRTHHKNLVQLLG-FCDEALNRLLVYEFMGNGTLANLIFAI 597
++++ SE + +H V L G F DE+ LV EF+ G +
Sbjct: 67 SKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRN 125
Query: 598 PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657
+ ++ + +I YL ++ I++ D+KP+N+LLD K++DFG +K++
Sbjct: 126 KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV- 181
Query: 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+RT+T+ GT Y+APE N D ++ G+ + EI+
Sbjct: 182 --DTRTYTLC-GTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 5e-12
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK---SEVSA-IGRTHHKNLVQL 568
+G+GSFG V K+ GK AVK L + A +++E K +E + + H LV L
Sbjct: 3 IGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 569 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR---ISLEIARGLVYLHEECN 624
+ + ++L V +++ G L F + + R + EIA L YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGG---ELFFHLQRERSFPEPRARFYAAEIASALGYLHS--- 114
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
+ II+ D+KP+NILLD+ ++DFGL K + T T GT Y+APE + P
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPY 173
Query: 685 SAKVDVYSFGVMLLEIIC------CRRSVEM 709
VD + G +L E++ R + EM
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 33/265 (12%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+G GSFG VY S + + +AVKK+ + E+ ++ EV + + H N ++
Sbjct: 28 EIGHGSFGAVYFAT-NSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPI 627
G + LV E+ G+ ++L+ KP + + I+ +GL YLH +
Sbjct: 87 KGCYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---M 142
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE---WFKNAPV 684
IH DIK NILL K++DFG + S S ++ + GT ++APE
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSA----SKSSPANSFV-GTPYWMAPEVILAMDEGQY 197
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
KVDV+S G+ +E+ E + L ++ A L + +D P +
Sbjct: 198 DGKVDVWSLGITCIEL------------AERKPPL----FNMNAMSALYHIAQNDSPTLQ 241
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPT 769
+ +C+++ P +RP
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 513 LGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL 568
LG+GSFG V LK AI V K D + Q+ + + + + A+ H L L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTAL 61
Query: 569 LGFCDEALNRLL-VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
C + +RL V E++ G L I K D + E+ L++LH +
Sbjct: 62 HC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GV 117
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
I+ D+K NILLD K++DFG+ K + + T T GT Y+APE +
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFC-GTPDYIAPEILQELEYGPS 176
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD ++ GV++ E++ + E + E++
Sbjct: 177 VDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 60/197 (30%), Positives = 103/197 (52%), Gaps = 15/197 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 568
E+LG GS+ VYKG K +GK +A+K + RL +E F + E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGKSK-VNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNV 625
LV+E++ + L + P P+ N+++ + ++ RGL Y+H+
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPE-NVKLFL-FQLLRGLSYIHQRY-- 123
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WFKNAPV 684
I+H D+KPQN+L+ + K++DFGL++ S S T++ T Y P+ +
Sbjct: 124 -ILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVLLGSTEY 181
Query: 685 SAKVDVYSFGVMLLEII 701
S +D++ G + +E+I
Sbjct: 182 STCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 56/196 (28%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+G GSFG VY + + +A+KK+ + + E+ ++ EV + + H N ++
Sbjct: 22 EIGHGSFGAVYFAR-DVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPI 627
G LV E+ G+ ++++ KP + + I +GL YLH
Sbjct: 81 KGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER--- 136
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE---WFKNAPV 684
IH DIK NILL + K++DFG + L+ S GT ++APE
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMDEGQY 191
Query: 685 SAKVDVYSFGVMLLEI 700
KVDV+S G+ +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 6e-12
Identities = 62/199 (31%), Positives = 97/199 (48%), Gaps = 16/199 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG+G+FG V V + ASGK A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEECNV 625
+ + +RL V E++ G L F + + R EI L YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGG---ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG--- 114
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
I++ D+K +N++LD KI+DFGL K ++D + T GT Y+APE ++
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 686 AKVDVYSFGVMLLEIICCR 704
VD + GV++ E++C R
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 7e-12
Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG+G+FG V V + A+G+ A+K L + +A++ +E + T H L L
Sbjct: 3 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEECNV 625
+ + +RL V E+ G L F + + R EI L YLH
Sbjct: 61 KYAFQTHDRLCFVMEYANGG---ELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 114
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+++ DIK +N++LD KI+DFGL K +SD + T GT Y+APE ++
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYG 173
Query: 686 AKVDVYSFGVMLLEIICCR 704
VD + GV++ E++C R
Sbjct: 174 RAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 33/226 (14%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKG-VLKSASG---KAIAVKKL-DRLAQEREREFKSEVS 555
E+ +T F EELG FG VYKG + +A G +A+A+K L D+ EFK E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 556 AIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDW-----NLRVRIS 609
R H N+V LLG + +++ + + L L+ P D + V+ +
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 610 LE----------IARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
LE IA G+ +L ++H D+ +N+L+ + + KISD GL + + +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 660 Q-----SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
+ IR +++PE S D++S+GV+L E+
Sbjct: 178 DYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
++G GS+G+V+K + +G+ +A+KK + E + K E+ + + H NLV
Sbjct: 7 SKIGEGSYGVVFKCRNRE-TGQIVAIKKF--VESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 567 QLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHE 621
L+ E R LV+E+ + T+ N + P+ +L +I + + + + H+
Sbjct: 64 NLI----EVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 622 E-CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF- 679
C IH D+KP+NIL+ K+ DFG ++ +L+ +T TR Y APE
Sbjct: 119 HNC----IHRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELLV 173
Query: 680 KNAPVSAKVDVYSFGVMLLEIIC 702
+ VDV++ G + E++
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIG------RTHHKNL 565
E+G G++G V+K G+ +A+K++ R+ E S + + H N+
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 566 VQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVY 618
V+L C D LV+E + + L + +P+P + ++ RGL +
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
LH ++H D+KPQNIL+ + K++DFGL++ + S Q T + T Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMAL-TSVVVTLWYRAPEV 180
Query: 679 FKNAPVSAKVDVYSFGVMLLEI 700
+ + VD++S G + E+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEM 202
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 63/208 (30%), Positives = 101/208 (48%), Gaps = 29/208 (13%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLD-----RLAQEREREFKSEVSAIGRTHHKNLVQ 567
+G G++G+V K +G +A+KK+ Q RE K + R H+N++
Sbjct: 13 IGEGAYGMVCSATHK-PTGVKVAIKKISPFEHQTFCQRTLREIK----ILRRFKHENIIG 67
Query: 568 LLGFCD-------EALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 619
+L D E+ N + +V E M L LI + +++ + +I RGL Y+
Sbjct: 68 IL---DIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFL-YQILRGLKYI 122
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL--LLSDQSRTHTMIRGTRGYVAPE 677
H NV +H D+KP N+LL+ KI DFGL+++ D + T TR Y APE
Sbjct: 123 HS-ANV--LHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE 179
Query: 678 WFKNAPVSAK-VDVYSFGVMLLEIICCR 704
N+ K +D++S G +L E++ R
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 82/299 (27%), Positives = 133/299 (44%), Gaps = 54/299 (18%)
Query: 513 LGRGSFGIVYK----GVLKSASGKAI--AVKKLDRLAQERE-REFKSEVSA---IGRTHH 562
LG G FG V G+ K +A+ AVK L A E++ + SE+ IG+ H
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 80
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--------------IPKPDWNLR--V 606
KN++ LLG C + ++ E+ G L + A +P + V
Sbjct: 81 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140
Query: 607 RISLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTH 664
+ ++ARG+ YL ++C IH D+ +N+L+ KI+DFGL++ + + D +
Sbjct: 141 SCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196
Query: 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE--MEVEEEGRAILTDW 722
T R ++APE + + + DV+SFGV++ EI S + VEE
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--------- 247
Query: 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
+ EG D+PA + M+ C PS RPT K +++ L+ +L
Sbjct: 248 LFKLLKEGH-----RMDKPANCT----NELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 567
LG+G+FG VY +G+ +A K++ D + E +E + E+ + H+ +VQ
Sbjct: 10 LGQGAFGRVYL-CYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 568 LLG-FCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
G D A L ++ E+M G++ + + A ++ + + +I G+ YLH
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM-- 126
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPEWFKNA 682
I+H DIK NIL D+ + K+ DFG SK L + + T IR GT +++PE
Sbjct: 127 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQT-ICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 683 PVSAKVDVYSFGVMLLEII 701
K DV+S G ++E++
Sbjct: 185 GYGRKADVWSLGCTVVEML 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 62/202 (30%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAI-GRTHHKNLVQLL 569
E +G+G++G VYK V G AVK LD ++ E E ++E + + +H N+V+
Sbjct: 28 ETIGKGTYGKVYK-VTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFY 85
Query: 570 GFCDEALNRL-----LVYEFMGNGTLANLIFAIPKPDWNL-RVRISLEIARGLVYLHEEC 623
G +A + LV E G++ L+ + L IS + L+ L
Sbjct: 86 GMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK--- 680
N IIH D+K NILL K+ DFG+S L S + R +T + GT ++APE
Sbjct: 146 NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 204
Query: 681 --NAPVSAKVDVYSFGVMLLEI 700
+ A+ DV+S G+ +E+
Sbjct: 205 QYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAI-GRTHHKNLVQLL 569
E +G+G++G V+K VL +G AVK LD + + + E ++E + + + H N+V+
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFY 81
Query: 570 G--FCDEALN---RLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLH 620
G + + N LV E G++ +L+ K + I E GL +LH
Sbjct: 82 GMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH 141
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
IH D+K NILL K+ DFG+S L S + R +T + GT ++APE
Sbjct: 142 VN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197
Query: 681 -----NAPVSAKVDVYSFGVMLLEI 700
++ A+ DV+S G+ +E+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKA--IAVKKL-DRLAQEREREFKSEVSAI 557
EL + + LG G FG + +G LK S + +A+ L + ++ R F +E +
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTL 60
Query: 558 GRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE----IA 613
G+ H N+V+L G ++V E+M NG L + + K + L + +A
Sbjct: 61 GQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSF---LRKHEGQLVAGQLMGMLPGLA 117
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRG 672
G+ YL E + +H + +L+++ KIS F L D+S +T + G
Sbjct: 118 SGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSP 171
Query: 673 --YVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+ APE + S+ DV+SFG+++ E++
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 52/287 (18%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL----AQEREREFKSEVSAIGRTHHKNL 565
++++GRG F VY+ K +A+KK+ A+ R+ K E+ + + +H N+
Sbjct: 7 EKKIGRGQFSEVYRATCL-LDRKPVALKKVQIFEMMDAKARQDCVK-EIDLLKQLNHPNV 64
Query: 566 VQLLG--FCDEALNRLLVYEFMGNGTLANLIFAIPK-----PD---WNLRVRISLEIARG 615
++ L D LN +V E G L+ +I K P+ W V ++
Sbjct: 65 IKYLDSFIEDNELN--IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFV----QLCSA 118
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
+ ++H ++H DIKP N+ + K+ D GL + S + H+++ GT Y++
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735
PE + K D++S G +L E+ A L Y ++++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----------------AALQSPFYG----DKMNLF 214
Query: 736 V------DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
D P + +K + CI DP +RP + V Q+
Sbjct: 215 SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 65/247 (26%), Positives = 111/247 (44%), Gaps = 48/247 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSA-------------SGKA--IAVKKLDRLAQERER-EFKS 552
FKE+LG G FG V+ + + G+ +AVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLK 68
Query: 553 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---------------- 596
EV + R N+++LLG C + ++ E+M NG L + +
Sbjct: 69 EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128
Query: 597 ---IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653
+P ++ + ++L+IA G+ YL ++ +H D+ +N L+ + KI+DFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185
Query: 654 KLLLSD-----QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII-CCRRSV 707
+ L + Q R IR ++A E + DV++FGV L EI+ C+
Sbjct: 186 RNLYAGDYYRIQGRAVLPIR----WMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241
Query: 708 EMEVEEE 714
E+ +E
Sbjct: 242 YGELTDE 248
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 46/295 (15%)
Query: 512 ELGRGSFGIVY------KGVLKSASGKAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKN 564
+LG G FG V +G +G+ +AVK L + K E+ + +H+N
Sbjct: 11 DLGEGHFGKVELCRYDPEG---DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 565 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIP--KPDWNLR--VRISLEIARGLVY 618
+V+ G C E L+ EF+ +G+L + P K NL+ ++ +++I +G+ Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG----YV 674
L +H D+ +N+L+++ KI DFGL+K + +D+ + ++ +
Sbjct: 125 LGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE--YYTVKDDLDSPVFWY 179
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEII--CCRRSVEMEV------EEEGRAILTDWAYDC 726
APE + DV+SFGV L E++ C S M + G+ +T
Sbjct: 180 APECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL 239
Query: 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
RL P + LM W PSKR T + +++ E +L
Sbjct: 240 EEGKRL--------PRPPNCPEEVYQLMRKCW--EFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 59/196 (30%), Positives = 94/196 (47%), Gaps = 15/196 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
+G+GSFG V K+ K AVK L + L ++ E+ SE + + + + L
Sbjct: 3 IGKGSFGKVLLARHKAEE-KFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEECNV 625
F + ++L V +++ G L + + + L R EIA L YLH ++
Sbjct: 62 HFSFQTADKLYFVLDYINGG---ELFYHLQRERCFLEPRARFYAAEIASALGYLH---SL 115
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
I++ D+KP+NILLD+ ++DFGL K + T T GT Y+APE P
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC-GTPEYLAPEVLHKQPYD 174
Query: 686 AKVDVYSFGVMLLEII 701
VD + G +L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-11
Identities = 54/168 (32%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 515 RGSFGIVYKGVLKSASGKAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
RG+FG VY G K + K AVK K D + + + ++E A+ + +V L
Sbjct: 14 RGAFGKVYLG-RKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS 72
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCD 631
A N LV E++ G + +L+ D + V+ E+A L YLH IIH D
Sbjct: 73 LQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRD 129
Query: 632 IKPQNILLDNYFSAKISDFGLSK------LLLSDQSRTHTMIRGTRGY 673
+KP N+L+ N K++DFGLSK L + D T +M + Y
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDY 177
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 60/228 (26%), Positives = 102/228 (44%), Gaps = 32/228 (14%)
Query: 516 GSFGIVYKGVLKSASG---KAIAVKKL-DRLAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
G+FG ++ G+L + + VK + D ++ + E + H+N++ +L
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76
Query: 572 CDEALNRLLV-YEFMGNGTLANLIFAIPK--PDWNLR-------VRISLEIARGLVYLHE 621
C E V Y +M G L L + N + V ++++IA G+ YLH
Sbjct: 77 CIEDGEPPFVLYPYMNWGNL-KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL-------LSDQSRTHTMIRGTRGYV 674
+IH DI +N ++D KI+D LS+ L L D R + ++
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNEN-----RPVK-WM 186
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVE-EEGRAILTD 721
A E N S+ DV+SFGV+L E++ ++ +E++ E A L D
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKD 234
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG+G+FG V V + A+G+ A+K L + +A++ +E + + H L L
Sbjct: 3 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPD--WNLRVRI-SLEIARGLVYLHEECNV 625
+ + +RL V E+ G L F + + R R EI L YLH E NV
Sbjct: 61 KYSFQTHDRLCFVMEYANGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV 117
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
++ D+K +N++LD KI+DFGL K + D + T GT Y+APE ++
Sbjct: 118 --VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYG 174
Query: 686 AKVDVYSFGVMLLEIICCR 704
VD + GV++ E++C R
Sbjct: 175 RAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 53/196 (27%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+ +G G++G VYK +G+ AVK + + + E+ + H N+V G
Sbjct: 15 QRVGSGTYGDVYKA-RNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 571 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPI 627
E L + E+ G G+L + I+ + P L++ + E +GL YLH +
Sbjct: 74 SYLSREKL--WICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLHSKGK--- 127
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF---KNAPV 684
+H DIK NILL + K++DFG++ + + ++ + I GT ++APE KN
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGY 186
Query: 685 SAKVDVYSFGVMLLEI 700
+ D+++ G+ +E+
Sbjct: 187 NQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 57/202 (28%), Positives = 96/202 (47%), Gaps = 26/202 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 572
+GRG FG VY G K+ +GK A+K LD+ +R + + E A+ + + ++ L+
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLAL---NERIMLSLVSTG 54
Query: 573 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR------------ISLEIARGLVYLH 620
D + Y F L ++ + D + + + EI GL ++H
Sbjct: 55 DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMH 114
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF- 679
N +++ D+KP NILLD + +ISD GL+ + + H + GT GY+APE
Sbjct: 115 ---NRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASV-GTHGYMAPEVLQ 168
Query: 680 KNAPVSAKVDVYSFGVMLLEII 701
K + D +S G ML +++
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 7e-11
Identities = 74/289 (25%), Positives = 130/289 (44%), Gaps = 60/289 (20%)
Query: 510 KEELGRGSFGIVYKGVLKSASG-------KAIAVKKL---DRLAQEREREFKSEVS--AI 557
++ LG+GSFG VY K A K I V +L + + +E + S++ AI
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 558 GRTH-----HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRIS 609
+ H + +C+ + E G + + +W +++ +
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT------LSENQVCEWFIQLLL- 117
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS--DQSRTHTMI 667
G+ Y+H+ I+H D+K +NI L N KI DFG+S+LL+ D + T T
Sbjct: 118 -----GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFT-- 166
Query: 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCY 727
GT Y++PE K+ +K D++S G +L E +CC + EG+ L+
Sbjct: 167 -GTPYYMSPEALKHQGYDSKSDIWSLGCILYE-MCC-----LAHAFEGQNFLS------- 212
Query: 728 AEGRLDVLVDSDEPAMADR-SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ +V+ P++ + SR +M +M + +DPS RP+ +L+
Sbjct: 213 ---VVLRIVEGPTPSLPETYSRQLNSIMQSM--LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 9e-11
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 43/211 (20%)
Query: 513 LGRGSFGIV---YKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHK 563
+G G+ GIV Y V G+ +A+KKL R A+ RE + +HK
Sbjct: 24 IGSGAQGIVCAAYDTVT----GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHK 75
Query: 564 NLVQLLG-FC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV---RISLEIAR 614
N++ LL F +E + LV E M ANL I + + R+S + +
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVI-----QMDLDHERMSYLLYQ 126
Query: 615 ---GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR 671
G+ +LH + IIH D+KP NI++ + + KI DFGL++ + T ++ TR
Sbjct: 127 MLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TR 181
Query: 672 GYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC 702
Y APE VD++S G ++ E+I
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 9e-11
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAI----AVKKL-DRLAQEREREFKSEVSA 556
LKE + LG G+FG VYKG L G+ + A+K+L + + + +E E
Sbjct: 4 LKETEFKKIKVLGSGAFGTVYKG-LWIPEGEKVKIPVAIKELREATSPKANKEILDEAYV 62
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK---PDWNLRVRISLEIA 613
+ + ++ +LLG C + +L + + M G L + + + L ++IA
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLN--WCVQIA 119
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
+G+ YL E ++H D+ +N+L+ KI+DFGL+KLL +D+ H G
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYH----AEGGK 172
Query: 674 VAPEWFKNAPV-----SAKVDVYSFGVMLLEII 701
V +W + + + DV+S+GV + E++
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 1e-10
Identities = 57/196 (29%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+G GSFG VY + + +A+KK+ + + E+ ++ EV + R H N ++
Sbjct: 32 EIGHGSFGAVYFA-RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPI 627
G LV E+ G+ ++L+ KP + + I+ +GL YLH +
Sbjct: 91 KGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NM 146
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE---WFKNAPV 684
IH DIK NILL K++DFG + + S GT ++APE
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMDEGQY 201
Query: 685 SAKVDVYSFGVMLLEI 700
KVDV+S G+ +E+
Sbjct: 202 DGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 513 LGRGSFGIVYKGVLKSASG---------KAIAVKKLDRLAQERE-REFKSEVSA---IGR 559
LG G FG V V+ A G +AVK L A E++ + SE+ IG+
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 560 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA------------IPKPDWNLR-- 605
HKN++ LLG C + ++ E+ G L + A P+ L
Sbjct: 83 --HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140
Query: 606 --VRISLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQS 661
V + ++ARG+ YL ++C IH D+ +N+L+ KI+DFGL++ + D
Sbjct: 141 DLVSCAYQVARGMEYLASKKC----IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 196
Query: 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
+ T R ++APE + + + DV+SFGV+L EI
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 82/310 (26%), Positives = 138/310 (44%), Gaps = 62/310 (20%)
Query: 509 FKEELGRGSFGIVY----KGVLK--------SASGKA---IAVKKLDRLAQERER-EFKS 552
FKE+LG G FG V+ +G+ K SG +AVK L A + R +F
Sbjct: 9 FKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68
Query: 553 EVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL-----------ANLIFAIPKPD 601
E+ + R N+++LL C + ++ E+M NG L A +
Sbjct: 69 EIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTIS 128
Query: 602 WNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-- 659
++ + ++ +IA G+ YL ++ +H D+ +N L+ ++ KI+DFG+S+ L S
Sbjct: 129 YSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 660 ---QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRR------SVEM 709
Q R IR +++ E + DV++FGV L EI+ C+ S E
Sbjct: 186 YRIQGRAVLPIR----WMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241
Query: 710 EVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT 769
+E G D +GR L +PA+ S + LM++ W R + +RP+
Sbjct: 242 VIENTGE-FFRD-------QGRQVYLP---KPALCPDSLYK--LMLSCW--RRNAKERPS 286
Query: 770 MKVV-LQMLE 778
+ + +LE
Sbjct: 287 FQEIHATLLE 296
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 61/281 (21%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLV 566
++++GRG F VY+ G +A+KK+ D + + + E+ + + +H N++
Sbjct: 7 EKKIGRGQFSEVYRATC-LLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVI 65
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPK-----PD---WNLRVRISLEIARGLVY 618
+ E +V E G L+ +I K P+ W V ++ L +
Sbjct: 66 KYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFV----QLCSALEH 121
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
+H ++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRSV---EMEVEEEGRAILTDWAYDCYAEGRLDVL 735
+ K D++S G +L E+ + +M + + I
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI----------------- 220
Query: 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
D P + ++ + CI DP KRP + V +
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 15/196 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKNLVQL 568
+G+GSFG V KS G AVK L + L ++ + +E + + + H LV L
Sbjct: 3 IGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVYLHEECNV 625
A V +++ G L F + + L R E+A + YLH ++
Sbjct: 62 HYSFQTAEKLYFVLDYVNGG---ELFFHLQRERCFLEPRARFYAAEVASAIGYLH---SL 115
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+KP+NILLD+ ++DFGL K + + T T GT Y+APE + P
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC-GTPEYLAPEVLRKEPYD 174
Query: 686 AKVDVYSFGVMLLEII 701
VD + G +L E++
Sbjct: 175 RTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 57/195 (29%), Positives = 100/195 (51%), Gaps = 11/195 (5%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 568
E+LG GS+ VYKG+ + +G+ +A+K + + E F + E S + H N+V L
Sbjct: 11 EKLGEGSYATVYKGISR-INGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEECNVPI 627
V+E+M + LA + P VR+ + ++ RGL Y+H + I
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HI 124
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP-VSA 686
+H D+KPQN+L+ K++DFGL++ S S+T++ T Y P+ A S+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVVTLWYRPPDVLLGATDYSS 183
Query: 687 KVDVYSFGVMLLEII 701
+D++ G + +E++
Sbjct: 184 ALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 27/204 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQ 567
+++G G++G V L +G +A+KKL R Q +R ++ E+ + H+N++
Sbjct: 21 KQVGSGAYGTVCSA-LDRRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIG 78
Query: 568 LLGF--CDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISL---EIARGLVY 618
LL D +L+R LV FMG L L+ K + RI ++ +GL Y
Sbjct: 79 LLDVFTPDLSLDRFHDFYLVMPFMGT-DLGKLM----KHEKLSEDRIQFLVYQMLKGLKY 133
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
+H IIH D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE
Sbjct: 134 IHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVV--TRWYRAPEV 186
Query: 679 FKN-APVSAKVDVYSFGVMLLEII 701
N + VD++S G ++ E++
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 56/197 (28%), Positives = 87/197 (44%), Gaps = 44/197 (22%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FK----SEVSAIGRTHHKNL 565
+LG G+FG VYK +G+ +A+KK+ E++ F E+ + + H N+
Sbjct: 14 GKLGEGTFGEVYKARQI-KTGRVVALKKI---LMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 566 VQLLGFC----DEALNRL----LVYEFMG---NGTLANLIFAIPKPDWNLRVR----ISL 610
V L+ D++ + +V +M +G L N P L L
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN-------PSVKLTESQIKCYML 122
Query: 611 EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---------- 660
++ G+ YLHE I+H DIK NIL+DN KI+DFGL++
Sbjct: 123 QLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 661 SRTHTMIRGTRGYVAPE 677
+R +T + TR Y PE
Sbjct: 180 TRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 60/208 (28%), Positives = 100/208 (48%), Gaps = 33/208 (15%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLL 569
+G G++G V + +G +AVKKL R Q +R ++ E+ + H+N++ LL
Sbjct: 25 VGSGAYGSVCAA-FDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 82
Query: 570 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+E + LV MG L N++ D +++ I +I RGL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLI-YQILRGLKYIH--- 137
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
+ IIH D+KP N+ ++ KI DFGL++ HT T GYVA W++
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLAR---------HTDDEMT-GYVATRWYRAPE 187
Query: 684 V-------SAKVDVYSFGVMLLEIICCR 704
+ + VD++S G ++ E++ R
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 43/279 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+ +G G++G VYK +G+ A+K + E + E+ + H N+V G
Sbjct: 15 QRIGSGTYGDVYKA-RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPIIH 629
+ EF G G+L + I+ + P ++ +S E +GL YLH + +H
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK---MH 129
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK-- 687
DIK NILL + K++DFG+S + + ++ + I GT ++APE A V K
Sbjct: 130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEV---AAVERKGG 185
Query: 688 ----VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD--EP 741
D+++ G+ +E+ A L +D + L ++ S+ P
Sbjct: 186 YNQLCDIWAVGITAIEL----------------AELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 742 AMADRSRLQKWL-----MIAMWCIREDPSKRPTMKVVLQ 775
+ D+ KW + M + ++P KRPT + +LQ
Sbjct: 230 KLKDK---MKWSNSFHHFVKM-ALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 4e-10
Identities = 59/200 (29%), Positives = 98/200 (49%), Gaps = 20/200 (10%)
Query: 513 LGRGSFGIVY--KGVLKSASGKAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLV 566
LG+G +G V+ + V + +GK A+K L + Q+ K+E + + H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 567 QLLGFCDEALNRLLVYEFMGNGTL-ANL----IFAIPKPDWNLRVRISLEIARGLVYLHE 621
L+ L+ E++ G L +L IF + L EI+ L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISLALEHLHQ 118
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ II+ D+KP+NILLD K++DFGL K + + + THT GT Y+APE
Sbjct: 119 Q---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC-GTIEYMAPEILMR 174
Query: 682 APVSAKVDVYSFGVMLLEII 701
+ VD +S G ++ +++
Sbjct: 175 SGHGKAVDWWSLGALMYDML 194
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 4e-10
Identities = 55/200 (27%), Positives = 104/200 (52%), Gaps = 28/200 (14%)
Query: 516 GSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKNLVQL 568
G++G+VY+ K +G+ +A+KKL ++ +E+E RE + H N+V +
Sbjct: 16 GTYGVVYRARDKK-TGEIVALKKL-KMEKEKEGFPITSLREINILLKL----QHPNIVTV 69
Query: 569 ----LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEE 622
+G L+++ +V E++ + L +L+ + +P V+ + L++ G+ +LH+
Sbjct: 70 KEVVVG---SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I+H D+K N+LL+N KI DFGL++ + +T + T Y APE A
Sbjct: 126 W---ILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 683 PV-SAKVDVYSFGVMLLEII 701
S +D++S G + E++
Sbjct: 182 KEYSTAIDMWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 37/101 (36%), Positives = 58/101 (57%), Gaps = 8/101 (7%)
Query: 605 RVRISL-EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-R 662
VR+ + EI L +LH+ + II+ DIK +NILLD+ ++DFGLSK L+++ R
Sbjct: 106 EVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162
Query: 663 THTMIRGTRGYVAPEWFKNAPV--SAKVDVYSFGVMLLEII 701
++ GT Y+APE + VD +S GV+ E++
Sbjct: 163 AYSFC-GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 17/196 (8%)
Query: 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+G GSFG VY + + +A+KK+ + + E+ ++ EV + + H N +Q
Sbjct: 22 EIGHGSFGAVYFA-RDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPI 627
G LV E+ G+ ++L+ KP + + ++ +GL YLH + +
Sbjct: 81 RGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNM 136
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE---WFKNAPV 684
IH D+K NILL K+ DFG + ++ GT ++APE
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMDEGQY 191
Query: 685 SAKVDVYSFGVMLLEI 700
KVDV+S G+ +E+
Sbjct: 192 DGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 34/216 (15%)
Query: 513 LGRGSFGIVYK----GVLKSASGKA--IAVKKLDRLAQERE-REFKSEVS---AIGRTHH 562
LG G FG V + G+ KS + +AVK L A +++ + SE+ IG+ H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGK--H 77
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR--------------V 606
KN++ LLG C + ++ E+ G L + A P PD+ V
Sbjct: 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137
Query: 607 RISLEIARGLVYLH-EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTH 664
+ ++ARG+ YL C IH D+ +N+L+ KI+DFGL++ + D +
Sbjct: 138 SCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKT 193
Query: 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
+ R ++APE + + + DV+SFG+++ EI
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLL 569
+G G+ GIV + G +AVKKL R Q + +R ++ E+ + +HKN++ LL
Sbjct: 29 IGSGAQGIVC-AAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLL 86
Query: 570 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEE 622
+E + LV E M ANL I + R+ L ++ G+ +LH
Sbjct: 87 NVFTPQKSLEEFQDVYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
+ IIH D+KP NI++ + + KI DFGL++ ++ T ++ TR Y APE
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRYYRAPEVILGM 197
Query: 683 PVSAKVDVYSFGVMLLEII 701
VD++S G ++ E++
Sbjct: 198 GYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 35/160 (21%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 568
++LG GS+ VYKG K +G+ +A+K++ RL E F + E S + H N+V L
Sbjct: 11 DKLGEGSYATVYKGRSK-LTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTL 68
Query: 569 --LGFCDEALNRLLVYEFM-----------GNGTLANLIFAIPKPDWNLRVRISL-EIAR 614
+ + L LV+E++ G G + VR+ L ++ R
Sbjct: 69 HDIIHTKKTLT--LVFEYLDTDLKQYMDDCGGGLSMH------------NVRLFLFQLLR 114
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
GL Y H+ ++H D+KPQN+L+ K++DFGL++
Sbjct: 115 GLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 6e-10
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 34/206 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL---- 568
+GRG FG VY G K+ +GK A+K LD+ +R + + E A+ +LV
Sbjct: 2 IGRGGFGEVY-GCRKADTGKMYAMKCLDK---KRIKMKQGETLALNERIMLSLVSTGDCP 57
Query: 569 ----LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRISLEIARGLVY 618
+ + ++L + + M G L + +F+ + +R + EI GL +
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EAEMRFYAA-EIILGLEH 112
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT--HTMIRGTRGYVAP 676
+H N +++ D+KP NILLD + +ISD GL+ D S+ H + GT GY+AP
Sbjct: 113 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASV-GTHGYMAP 164
Query: 677 EWF-KNAPVSAKVDVYSFGVMLLEII 701
E K + D +S G ML +++
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 8e-10
Identities = 55/195 (28%), Positives = 97/195 (49%), Gaps = 16/195 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL-DRLAQEREREFK-SEVSAIGRTHHKNLVQLLG 570
+G G++G+V K K + + +A+KK D E +E E+ + +N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVEL-- 65
Query: 571 FCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEECNV 625
EA R LV+E++ L L+ +P +VR + ++ + + + H+
Sbjct: 66 --KEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN--- 119
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
I+H DIKP+N+L+ + K+ DFG ++ L + +T TR Y +PE AP
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179
Query: 686 AKVDVYSFGVMLLEI 700
VD++S G +L E+
Sbjct: 180 KAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 11/207 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE---FKSEVSAIGRTHHKNLVQ 567
LG+GSFG V LK G+ AVK L D + + + E + V A+ + L
Sbjct: 3 LGKGSFGKVLLAELK-GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALA-WENPFLTH 60
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
L + V EF+ G L I + D + EI GL +LH + I
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GI 117
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
I+ D+K N++LD KI+DFG+ K + +R T GT Y+APE + +
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLKYTFS 176
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEE 714
VD +SFGV+L E++ + + E+E
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 35/208 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK-----SEVSAIG--------- 558
+G GSFG+VY+ + S K +A+KK+ + Q + RE + ++ I
Sbjct: 74 IGNGSFGVVYEAICIDTSEK-VAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTEC 132
Query: 559 -RTHHKN--LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 615
+ + KN L ++ F + +++ + + N L + + S ++ R
Sbjct: 133 FKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL----------YSYQLCRA 182
Query: 616 LVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
L Y+H + I H D+KPQN+L+D N + K+ DFG +K LL+ Q R+ + I +R Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-RSVSYI-CSRFYR 237
Query: 675 APEWFKNAP-VSAKVDVYSFGVMLLEII 701
APE A + +D++S G ++ E+I
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 28/202 (13%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--------EVSAIGR-THHK 563
+G G+F V K +GK A+K + ++ FKS E+ A+ R + H
Sbjct: 7 IGEGTFSEVLK-AQSRKTGKYYAIKCM-------KKHFKSLEQVNNLREIQALRRLSPHP 58
Query: 564 NLVQLLGFC-DEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLH 620
N+++L+ D RL LV+E M + L LI +P RV+ + ++ + L ++H
Sbjct: 59 NILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WF 679
I H DIKP+NIL+ + K++DFG + + S +T TR Y APE
Sbjct: 118 RN---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPP--YTEYISTRWYRAPECLL 171
Query: 680 KNAPVSAKVDVYSFGVMLLEII 701
+ K+D+++ G + EI+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 1e-09
Identities = 55/193 (28%), Positives = 98/193 (50%), Gaps = 10/193 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
+G+GSFG V + V K + + A+K + + +++ +E + + + + +V L
Sbjct: 1 IGKGSFGKVMQ-VRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL- 58
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
F ++ +L LV F+ G L + + + D + + E+ L LH+ +I
Sbjct: 59 KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHK---FNVI 115
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
+ D+KP+NILLD + DFGL KL + D +T+T GT Y+APE + V
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTKAV 174
Query: 689 DVYSFGVMLLEII 701
D ++ GV+L E++
Sbjct: 175 DWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 59/225 (26%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 494 LRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKA---IAVKKL-DRLAQERERE 549
+R ELK+ + LG G+FG VYKG+ +A+K L + + + +E
Sbjct: 1 MRILKETELKKV-----KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKE 55
Query: 550 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS 609
E + + +LLG C + +L V + M G L + + + RI
Sbjct: 56 ILDEAYVMAGVGSPYVCRLLGICLTSTVQL-VTQLMPYGCLLDYV-------RENKDRIG 107
Query: 610 --------LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661
++IA+G+ YL E V ++H D+ +N+L+ + KI+DFGL++LL D++
Sbjct: 108 SQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
Query: 662 RTHTMIRGTRGYVAPEWFKNAPV-----SAKVDVYSFGVMLLEII 701
H G V +W + + + DV+S+GV + E++
Sbjct: 165 EYH----ADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 56/197 (28%), Positives = 94/197 (47%), Gaps = 14/197 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V + V +S K A+K L + + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
+ +V E+M G L NL+ P+ + + E+ L +H ++ +IH
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA-EVVLALDAIH---SMGLIH 165
Query: 630 CDIKPQNILLDNYFSAKISDFGLS-KLLLSDQSRTHTMIRGTRGYVAPEWFK----NAPV 684
D+KP N+LLD + K++DFG K+ + R T + GT Y++PE K +
Sbjct: 166 RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 685 SAKVDVYSFGVMLLEII 701
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 41/247 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V + V K +G A+K K D L +E+ ++E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMF 67
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
+ LN L+ EF+ G + L+ K D IA ++ + + IH
Sbjct: 68 YSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAIDSIHQLGFIH 124
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLL------------------------LSDQSRTHT 665
DIKP N+LLD+ K+SDFGL L ++ + + T
Sbjct: 125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAET 184
Query: 666 MIR----------GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG 715
R GT Y+APE F + D +S GV++ E++ E +E
Sbjct: 185 WKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQET 244
Query: 716 RAILTDW 722
+ +W
Sbjct: 245 YKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 40/160 (25%), Positives = 75/160 (46%), Gaps = 34/160 (21%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 567
E++G G++G V+K + + + +A+K++ RL + E S E+ + HKN+V+
Sbjct: 6 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 568 L-------------LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 614
L +CD+ L + Y NG D + ++ +
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKK---YFDSCNG----------DIDPEIVKSFMFQLLK 110
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
GL + H ++H D+KPQN+L++ K++DFGL++
Sbjct: 111 GLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 30/234 (12%)
Query: 479 KYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKK 538
+YE + + ++ +K +GRG+FG V + V +S + A+K
Sbjct: 27 RYEKAAEKITKLRMKAE--DFDVIKV--------IGRGAFGEV-QLVRHKSSKQVYAMKL 75
Query: 539 LDRLAQERERE---FKSEVSAIGRTHHKNLVQL-LGFCDEALNRLLVYEFMGNGTLANLI 594
L + + + F E + + + +VQL F D+ +V E+M G L NL+
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLM 134
Query: 595 --FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652
+ IP+ W + E+ L +H ++ IH D+KP N+LLD K++DFG
Sbjct: 135 SNYDIPE-KWA--RFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGT 188
Query: 653 SKLLLSD-QSRTHTMIRGTRGYVAPEWFKNAPVSA----KVDVYSFGVMLLEII 701
+ ++ R T + GT Y++PE K+ + D +S GV L E++
Sbjct: 189 CMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 27/203 (13%)
Query: 513 LGRGSFGIV---YKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLV 566
+G G+ GIV Y +L+ + +A+KKL R Q + +R ++ E+ + +HKN++
Sbjct: 32 IGSGAQGIVCAAYDAILE----RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 86
Query: 567 QLLGF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYL 619
LL +E + +V E M ANL I + R+ L ++ G+ +L
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 142
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
H + IIH D+KP NI++ + + KI DFGL++ + T ++ TR Y APE
Sbjct: 143 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 197
Query: 680 KNAPVSAKVDVYSFGVMLLEIIC 702
VD++S G ++ E+I
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIK 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 61/230 (26%), Positives = 97/230 (42%), Gaps = 46/230 (20%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V + V K +G A+KKL + L +E+ ++E + + +V+L
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLY 67
Query: 570 -GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
F DE L+ E++ G + L+ K D IA ++ + + I
Sbjct: 68 YSFQDE-NYLYLIMEYLPGGDMMTLLM---KKDTFTEEETRFYIAETILAIDSIHKLGYI 123
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLL---------------------------LSDQS 661
H DIKP N+LLD K+SDFGL L +S +
Sbjct: 124 HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKR 183
Query: 662 RTHTMIR----------GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+ T R GT Y+APE F + + D +S GV++ E++
Sbjct: 184 KAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 6e-09
Identities = 51/205 (24%), Positives = 98/205 (47%), Gaps = 29/205 (14%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK-SEVSAIGRTHHKNLVQLL 569
E+LG G++ VYKG +G+ +A+K++ A+E E+S + H+N+V+L
Sbjct: 6 EKLGEGTYATVYKG-RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH 64
Query: 570 GFCDEALNRLLVYEFMGNGTLANL-IFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
+LV+E+M + + D N + ++ +G+ + HE +
Sbjct: 65 DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RV 121
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLL------LSDQS-----RTHTMIRGTRGYVAP 676
+H D+KPQN+L++ K++DFGL++ S++ R ++ G+R Y
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY--- 178
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII 701
S +D++S G ++ E+I
Sbjct: 179 --------STSIDIWSVGCIMAEMI 195
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 44/169 (26%), Positives = 72/169 (42%), Gaps = 43/169 (25%)
Query: 514 GRGSFGIVYKGVLKSAS-GKAIAVKKLDRLAQEREREFKSEV--------SAIGRT---- 560
GRG++G VYK K+ GK A+KK FK + SA R
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK-----------FKGDKEQYTGISQSAC-REIALL 56
Query: 561 ---HHKNLVQLLGFCDEALNRL--LVYEFMGNGTLANLIF-----AIPKPDWNLRVRISL 610
H+N+V L+ E ++ L++++ + + F + P ++ +
Sbjct: 57 RELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLW 115
Query: 611 EIARGLVYLHEECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSKL 655
+I G+ YLH ++H D+KP NIL+ KI D GL++L
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-09
Identities = 44/151 (29%), Positives = 77/151 (50%), Gaps = 15/151 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKA-IAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQL 568
+E+G G FG V + + +G A + VK+L A +E+ EF + H N++Q
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------VRISLEIARGLVYLHE 621
LG C EA+ LLV+E+ G L + + + W+ R R++ EIA G+ ++H+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSY---LSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK 117
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652
+H D+ +N L + + K+ D+G+
Sbjct: 118 H---NFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 1e-08
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 27/202 (13%)
Query: 513 LGRGSFGIV---YKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLV 566
+G G+ GIV Y VL + +A+KKL R Q + +R ++ E+ + +HKN++
Sbjct: 25 IGSGAQGIVCAAYDAVLD----RNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNII 79
Query: 567 QLLGF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYL 619
LL +E + LV E M ANL I + R+ L ++ G+ +L
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
H + IIH D+KP NI++ + + KI DFGL++ + T ++ TR Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPEVI 190
Query: 680 KNAPVSAKVDVYSFGVMLLEII 701
VD++S G ++ E++
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 568
++LG G++ V+KG K + +A+K++ RL E + EVS + H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSK-LTENLVALKEI-RLEHEEGAPCTAIREVSLLKNLKHANIVTL 68
Query: 569 LGFCDEALNRLLVYEFMGN---------GTLANLIFAIPKPDWNLRVRISLEIARGLVYL 619
LV+E++ + G L ++ N+++ ++ RGL Y
Sbjct: 69 HDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSM--------HNVKI-FMFQLLRGLSYC 119
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-W 678
H+ I+H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+
Sbjct: 120 HKR---KILHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVL 175
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCR 704
+ S +D++ G +L E+ R
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 49/230 (21%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK---SEVSAIGRTHHKNLVQ 567
+ LG+G G V+ LK +GK A+K LD+ + + K +E + H L
Sbjct: 7 KLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPT 65
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYL 619
L LV ++ G L L+ P +S E+AR L YL
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQRQPGK------CLSEEVARFYAAEVLLALEYL 119
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL----------LSDQSRTHTMIR- 668
H + I++ D+KP+NILL +SDF LSK L SR ++
Sbjct: 120 H---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 669 -----------------GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
GT Y+APE + VD ++ G++L E++
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 55/203 (27%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 568
E+LG G++ V+KG K + +A+K++ RL E + EVS + H N+V L
Sbjct: 12 EKLGEGTYATVFKGRSK-LTENLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 569 LGFCDEALNRLLVYEFMGNGTLANL-----IFAIPKPDWNLRVRISL-EIARGLVYLHEE 622
+ LV+E++ + I ++ V+I L +I RGL Y H
Sbjct: 70 HDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN------VKIFLYQILRGLAYCHRR 123
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WFKN 681
++H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+ +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVVTLWYRPPDVLLGS 179
Query: 682 APVSAKVDVYSFGVMLLEIICCR 704
+ S ++D++ G + E+ R
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 27/203 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQERE-REFKSEVSAIGRTHHKNLVQ 567
++G+G +G V+ K +G+ +A+K++ + L + E R +E + T + LV+
Sbjct: 7 TQVGQGGYGQVFLA-KKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVK 65
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYL 619
LL + L E++ G L+ NL V +S + AR + L
Sbjct: 66 LLYAFQDDEYLYLAMEYVPGGDFRTLLN-------NLGV-LSEDHARFYMAEMFEAVDAL 117
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
HE + IH D+KP+N L+D K++DFGLSK ++ + ++++ G+ Y+APE
Sbjct: 118 HE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV---TYANSVV-GSPDYMAPEVL 170
Query: 680 KNAPVSAKVDVYSFGVMLLEIIC 702
+ VD +S G ML E +C
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLC 193
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 59/202 (29%), Positives = 101/202 (50%), Gaps = 24/202 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL-----DRLAQERE-REFKSEVSAIGRTHHKNLV 566
+GRG++GIV S + + +A+KK+ +R+ +R RE K + H+N++
Sbjct: 13 IGRGAYGIVCSAK-NSETNEKVAIKKIANAFDNRIDAKRTLREIK----LLRHLDHENVI 67
Query: 567 QLLGF----CDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLH 620
+ EA N + +VYE M T + I + + + L ++ RGL Y+H
Sbjct: 68 AIKDIMPPPHREAFNDVYIVYELMD--TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
+ ++H D+KP N+LL+ KI DFGL++ S++ T TR Y APE
Sbjct: 126 ---SANVLHRDLKPSNLLLNANCDLKICDFGLAR-TTSEKGDFMTEYVVTRWYRAPELLL 181
Query: 681 N-APVSAKVDVYSFGVMLLEII 701
N + + +DV+S G + E++
Sbjct: 182 NCSEYTTAIDVWSVGCIFAELL 203
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 53/227 (23%), Positives = 94/227 (41%), Gaps = 53/227 (23%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--------------EVSAIG 558
LG G++G V K + +GK +A+KK+ + + E+ +
Sbjct: 17 LGEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 559 RTHHKNLVQLLG-FCDEA-LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS------- 609
H+N++ L+ + + +N LV + M L ++ + ++R++
Sbjct: 76 EIKHENIMGLVDVYVEGDFIN--LVMDIM-ASDLKKVV--------DRKIRLTESQVKCI 124
Query: 610 -LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK-----LLLSDQSRT 663
L+I GL LH +H D+ P NI +++ KI+DFGL++ S+
Sbjct: 125 LLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKD 181
Query: 664 HTMIRG--------TRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEII 701
TM R T Y APE A VD++S G + E++
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
|
Length = 335 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 53/206 (25%), Positives = 98/206 (47%), Gaps = 27/206 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS--EVSAIGRTHHKNLVQL 568
++LG G++ VYKG K + +A+K++ RL E + EVS + H N+V L
Sbjct: 12 DKLGEGTYATVYKGRSK-LTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHANIVTL 69
Query: 569 LGFCDEALNRLLVYEFMGN---------GTLANLIFAIPKPDWNLRVRISLEIARGLVYL 619
+ LV+E++ G N+ N+++ + ++ RGL Y
Sbjct: 70 HDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINM--------HNVKLFL-FQLLRGLNYC 120
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-W 678
H ++H D+KPQN+L++ K++DFGL++ S ++T++ T Y P+
Sbjct: 121 HRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCR 704
+ S ++D++ G + E+ R
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 23/207 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE---REFKSEVSAIGRTHHKN-LV 566
E++G G++G VYK K+ +GK +A+KK RL + E E+S + +V
Sbjct: 7 EKIGEGTYGKVYKARDKN-TGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSESIYIV 64
Query: 567 QLLGF--CDEALNRL---LVYEFMGNGTLANLIFAIPKP----DWNLRVRISLEIARGLV 617
+LL +E + LV+E++ + + P ++ +G+
Sbjct: 65 RLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSA-KISDFGLSK-LLLSDQSRTHTMIRGTRGYVA 675
+ H+ ++H D+KPQN+L+D KI+D GL + + +S TH ++ T Y A
Sbjct: 125 HCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV--TLWYRA 179
Query: 676 PEWFKNAP-VSAKVDVYSFGVMLLEII 701
PE + S VD++S G + E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 33/205 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLG 570
+G G++G V + + +AVKKL R Q R E+ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 571 FCD-----EALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
E N + LV MG L N++ D +++ I ++ RGL Y+H +
Sbjct: 82 VFTPATSIENFNEVYLVTNLMG-ADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIH---S 136
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP- 683
IIH D+KP N+ ++ +I DFGL++ +D T GYVA W++ AP
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMT--------GYVATRWYR-APE 185
Query: 684 -------VSAKVDVYSFGVMLLEII 701
+ VD++S G ++ E++
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 2e-08
Identities = 32/91 (35%), Positives = 54/91 (59%), Gaps = 4/91 (4%)
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669
+++ G+ ++HE+ ++H DIK +NI L K+ DFG ++LL S + T + G
Sbjct: 107 VQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-G 162
Query: 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
T YV PE ++N P + K D++S G +L E+
Sbjct: 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 60/201 (29%), Positives = 98/201 (48%), Gaps = 19/201 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR-LAQERER--EFKSEVSAIGR-THHKNLVQL 568
+GRGS+ V LK + A+K + + L + E ++E ++H LV L
Sbjct: 3 IGRGSYAKVLLVELKKTR-RIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 569 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEEC 623
C + +RL V EF+ G +L+F + + P+ + R S EI+ L +LHE
Sbjct: 62 HS-CFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNFLHER- 115
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
II+ D+K N+LLD K++D+G+ K + T T GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC-GTPNYIAPEILRGED 172
Query: 684 VSAKVDVYSFGVMLLEIICCR 704
VD ++ GV++ E++ R
Sbjct: 173 YGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 74/295 (25%), Positives = 115/295 (38%), Gaps = 65/295 (22%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD--------RLAQEREREFKSEVSAIGRTHH 562
E LG+G+F +YKGVL+ S I + F S + + H
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYL 619
K+LV+L G C ++V E++ G L + W L V L A L YL
Sbjct: 61 KHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQL--ASALHYL 117
Query: 620 HEECNVPIIHCDIKPQNILLDNY-------FSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
++ ++H ++ +NIL+ Y K+SD G+ +LS + R +
Sbjct: 118 EDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI-----P 169
Query: 673 YVAPEWFKNAPVSAKV--DVYSFGVMLLEIICCR--------RSVEMEVEEEGRAILTDW 722
++APE +N S + D +SFG LLE IC S E E + + L
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGEEPLSTLSSSEKERFYQDQHRL--- 225
Query: 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
M D + L + C DP+KRP+ + +L+ L
Sbjct: 226 -------------------PMPDCAELANLINQ---CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 32/113 (28%), Positives = 51/113 (45%), Gaps = 20/113 (17%)
Query: 606 VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK--------LLL 657
+ I +I + Y+H + ++H D+KP NILL + I D+G + LL
Sbjct: 116 LSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLD 172
Query: 658 SDQSRTHTM---------IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
D + I GT Y+APE P S D+Y+ GV+L +++
Sbjct: 173 IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 19/159 (11%)
Query: 611 EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670
EI L +LH+ + II+ DIK +NILLD+ ++DFGLSK D+ GT
Sbjct: 113 EIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGT 169
Query: 671 RGYVAPEWFKNAPV--SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728
Y+AP+ + VD +S GV++ E++ ++ E+ +A ++
Sbjct: 170 IEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEIS-------- 221
Query: 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKR 767
++ S+ P + S L K ++ + + +DP KR
Sbjct: 222 ----RRILKSEPPYPQEMSALAKDIIQRL--LMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 50/165 (30%), Positives = 79/165 (47%), Gaps = 40/165 (24%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHKNL 565
+G+G+FG V+K K + + +A+KK+ + E+E RE K + H+N+
Sbjct: 20 IGQGTFGEVFKARHKK-TKQIVALKKV-LMENEKEGFPITALREIK----ILQLLKHENV 73
Query: 566 VQLLGFCD---EALNR-----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIAR-- 614
V L+ C NR LV+EF + LA L+ N V+ +L EI +
Sbjct: 74 VNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLS-------NKNVKFTLSEIKKVM 125
Query: 615 -----GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
GL Y+H I+H D+K NIL+ K++DFGL++
Sbjct: 126 KMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 513 LGRGSFGIVYKGVLKSASG-KAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLLG 570
+GRGS+ V LK A+ V K + + + + ++ ++E + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 571 FCDEALNRLL-VYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEECNV 625
C + +RL V E++ G +L+F + + P+ + R S EI+ L YLHE
Sbjct: 63 SCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARF-YSAEISLALNYLHER--- 115
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+K N+LLD+ K++D+G+ K L T T GT Y+APE +
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRGEDYG 174
Query: 686 AKVDVYSFGVMLLEIICCRRSVEM 709
VD ++ GV++ E++ R ++
Sbjct: 175 FSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 41/115 (35%), Positives = 65/115 (56%), Gaps = 7/115 (6%)
Query: 606 VRI-SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRT 663
VR S EI L +LH+ + I++ DIK +NILLD+ ++DFGLSK LS++ RT
Sbjct: 107 VRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERT 163
Query: 664 HTMIRGTRGYVAPEWFKNAPVSAK-VDVYSFGVMLLEIICCRRSVEMEVEEEGRA 717
++ GT Y+APE + K VD +S G+++ E++ +E E ++
Sbjct: 164 YSFC-GTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 55/214 (25%), Positives = 95/214 (44%), Gaps = 36/214 (16%)
Query: 511 EELGRGSFGIVYKGVLKSAS--GKA----IAVKKLDRLAQEREREFKSEVSAIGRTHHKN 564
E LG+G+F ++KG+ + G+ + +K LD+ + F S + + HK+
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTL-------ANLIFAIPKPDWNLRVRISLEIARGLV 617
LV G C ++V E++ G+L NLI W L V + ++A L
Sbjct: 61 LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINIS----WKLEV--AKQLAWALH 114
Query: 618 YLHEECNVPIIHCDIKPQNILL----DNYFSA----KISDFGLSKLLLSDQSRTHTMIRG 669
+L ++ + H ++ +N+LL D K+SD G+S +L + ++
Sbjct: 115 FLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE-----ILLE 166
Query: 670 TRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIIC 702
+V PE +N +S D +SFG L EI
Sbjct: 167 RIPWVPPECIENPQNLSLAADKWSFGTTLWEIFS 200
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667
I +I GL YLH + IIH D+K +NI +++ I D G ++ +
Sbjct: 162 IEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-----PAF 213
Query: 668 RGTRGYV---APEWFKNAPVSAKVDVYSFGVMLLEII 701
G G V APE ++K D++S G++L E++
Sbjct: 214 LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 44/143 (30%), Positives = 73/143 (51%), Gaps = 13/143 (9%)
Query: 572 CDEALNRL-LVYEFMGNGTLANLIFAIPK----PDWNLRVRISLEIARGLVYLHEECNVP 626
C + +RL LV E++ G +L+F + + P+ + R + EI L +LHE
Sbjct: 64 CFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARF-YAAEICIALNFLHER---G 116
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
II+ D+K N+LLD K++D+G+ K L T T GT Y+APE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC-GTPNYIAPEILRGEEYGF 175
Query: 687 KVDVYSFGVMLLEIICCRRSVEM 709
VD ++ GV++ E++ R ++
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 41/226 (18%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK---KLDRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V + V K +G A+K K D L +E+ ++E + +V++
Sbjct: 9 IGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMF 67
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
+ N L+ EF+ G + L+ K D IA ++ + + IH
Sbjct: 68 YSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAIDAIHQLGFIH 124
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLL------------------------LSDQSRTHT 665
DIKP N+LLD K+SDFGL L ++ + + T
Sbjct: 125 RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAET 184
Query: 666 MIR----------GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+ GT Y+APE F + D +S GV++ E++
Sbjct: 185 WKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 57/199 (28%), Positives = 99/199 (49%), Gaps = 22/199 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLL 569
+G G++G V + K +G+ +A+KKL R Q +R ++ E++ + H+N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLL 80
Query: 570 GF------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
DE + LV +M T I P + ++ + ++ GL Y+H
Sbjct: 81 DVFTSAVSGDEFQDFYLVMPYMQ--TDLQKIMGHPLSEDKVQYLV-YQMLCGLKYIHS-- 135
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN-A 682
IIH D+KP N+ ++ KI DFGL++ +D T ++ TR Y APE N
Sbjct: 136 -AGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV--TRWYRAPEVILNWM 190
Query: 683 PVSAKVDVYSFGVMLLEII 701
+ VD++S G ++ E++
Sbjct: 191 HYNQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 36/214 (16%)
Query: 511 EELGRGSFGIVYKGVLK---------SASGKAIAV--KKLDRLAQEREREFKSEVSAIGR 559
E LGRG+ +Y G+L + K I V K LD ++ F S + +
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60
Query: 560 THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPD-----WNLRVRISLEIAR 614
HK++V L G C + ++V EF+ G L +F K D W +V + ++A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKV--AKQLAS 116
Query: 615 GLVYLHEECNVPIIHCDIKPQNILL-----DNYFSA--KISDFGLSKLLLSDQSRTHTMI 667
L YL ++ ++H ++ +NILL D K+SD G+ +LS Q +
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI- 172
Query: 668 RGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEI 700
++APE +++ S D +SFG L EI
Sbjct: 173 ----PWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)
Query: 609 SLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT-M 666
S ++ARG+ +L +C IH D+ +NILL KI DFGL++ + D
Sbjct: 179 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
R ++APE + + + DV+SFGV+L EI
Sbjct: 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 14/197 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V + V ++ K A+K L + + + F E + + +VQL
Sbjct: 51 IGRGAFGEV-QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
+ +V E+M G L NL+ P+ R + E+ L +H ++ IH
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA-EVVLALDAIH---SMGFIH 165
Query: 630 CDIKPQNILLDNYFSAKISDFGLS-KLLLSDQSRTHTMIRGTRGYVAPEWFK----NAPV 684
D+KP N+LLD K++DFG K+ R T + GT Y++PE K +
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 685 SAKVDVYSFGVMLLEII 701
+ D +S GV L E++
Sbjct: 225 GRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 17/200 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL- 568
+GRG+FG V LK+A K A+K L++ + E F+ E + ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNAD-KVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
F DE N LV ++ G L L+ F P+ R ++ E+ + +H+ +
Sbjct: 68 YAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVIAIDSVHQ---LH 122
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK-----N 681
+H DIKP NIL+D +++DFG L+ D + ++ GT Y++PE +
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 682 APVSAKVDVYSFGVMLLEII 701
+ D +S GV + E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL---L 569
LG GS G+V+ V S K +AVKK+ + + E+ I R H N+V++ L
Sbjct: 13 LGCGSNGLVFSAV-DSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 570 GFCDEALNRLL-----------VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVY 618
G L + V E+M LAN++ P + + R+ ++ RGL Y
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARL-FMYQLLRGLKY 129
Query: 619 LHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRG--TRGYVA 675
+H NV +H D+KP N+ ++ KI DFGL++++ S + G T+ Y +
Sbjct: 130 IHS-ANV--LHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 676 PE 677
P
Sbjct: 187 PR 188
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 23/139 (16%)
Query: 580 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNIL 638
+V E++ G A L+ I P R+ + E L YLH N I+H D+KP N+L
Sbjct: 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLKPDNLL 133
Query: 639 LDNYFSAKISDFGLSKLLLSDQSRTHTM----------------IRGTRGYVAPEWFKNA 682
+ + K++DFGLSK+ L S T + + GT Y+APE
Sbjct: 134 ITSMGHIKLTDFGLSKIGL--MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191
Query: 683 PVSAKVDVYSFGVMLLEII 701
VD ++ G++L E +
Sbjct: 192 GYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 7e-07
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 40/224 (17%)
Query: 511 EELGRGSFGIVY----KGVLKSASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
+++G G FG V+ K + KAI+ + L +ERE+ + EV+ + HKN+
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL----KEREKSQLVIEVNVMRELKHKNI 74
Query: 566 VQLLG-FCDEALNRL-LVYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYL 619
V+ + F ++A +L ++ EF G L+ I K + + V I+ ++ L Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 620 HEECNVP----IIHCDIKPQNILLDNYFS-----------------AKISDFGLSKLLLS 658
H + P ++H D+KPQNI L AKI DFGLSK +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK-NIG 193
Query: 659 DQSRTHTMIRGTRGYVAPEWFKNAPVS--AKVDVYSFGVMLLEI 700
+S H+ + GT Y +PE + S K D+++ G ++ E+
Sbjct: 194 IESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236
|
Length = 1021 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 63/253 (24%), Positives = 96/253 (37%), Gaps = 81/253 (32%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--------DRLAQER-EREFKSEVSAIGRTHHK 563
+G+G+FG V + V K +GK A+K L D+LA + ER+ +E +
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE------SDSP 61
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+V L +A L+ EF+ G L ++ ++ S ++ R + EC
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLI-----KYDT---FSEDVTR---FYMAEC 110
Query: 624 NVPI--------IHCDIKPQNILLDNYFSAKISDFGLS-------------KLLLSDQSR 662
+ I IH DIKP NIL+D K+SDFGLS KLL ++
Sbjct: 111 VLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 663 THTMIR---------------------------------GTRGYVAPEWFKNAPVSAKVD 689
R GT Y+APE F + D
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 690 VYSFGVMLLEIIC 702
+S G ++ E +
Sbjct: 231 WWSLGAIMFECLI 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 48/192 (25%), Positives = 88/192 (45%), Gaps = 33/192 (17%)
Query: 600 PDWNLRV----RISLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
W L + R S ++A+G+ +L + C IH D+ +N+LL + AKI DFGL++
Sbjct: 205 DSWPLDLDDLLRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLAR 260
Query: 655 LLLSDQSRTHTMIRGTR----GYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEME 710
+++D ++ +++G ++APE + + + DV+S+G++L EI +S
Sbjct: 261 DIMND---SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS---- 313
Query: 711 VEEEGRAILTDWA-YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT 769
IL + Y G P A + I C +P++RPT
Sbjct: 314 ---PYPGILVNSKFYKMVKRG-----YQMSRPDFA----PPEIYSIMKMCWNLEPTERPT 361
Query: 770 MKVVLQMLEGLL 781
+ Q+++ L
Sbjct: 362 FSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 31/177 (17%)
Query: 609 SLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667
S ++A+G+ +L + C IH D+ +NILL + KI DFGL++ + +D ++ ++
Sbjct: 220 SYQVAKGMSFLASKNC----IHRDLAARNILLTHGRITKICDFGLARDIRND---SNYVV 272
Query: 668 RGTR----GYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTD 721
+G ++APE N + + DV+S+G++L EI S M V+ +
Sbjct: 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------- 325
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
Y EG + + M D I C DP KRPT K ++Q++E
Sbjct: 326 -FYKMIKEGYRMLSPECAPSEMYD---------IMKSCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 25/178 (14%)
Query: 609 SLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT-M 666
S ++ARG+ +L +C IH D+ +NILL KI DFGL++ + D
Sbjct: 180 SFQVARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE--MEVEEEGRAILTDWAY 724
R ++APE + + + DV+SFGV+L EI S +++ EE L D
Sbjct: 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--- 292
Query: 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ + E A + R +M+A W + DP +RPT ++++L LL+
Sbjct: 293 --------GTRMRAPENATPEIYR----IMLACW--QGDPKERPTFSALVEILGDLLQ 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 31/92 (33%), Positives = 44/92 (47%), Gaps = 4/92 (4%)
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS-KLLLSDQSRTHTMIRGTRGYV 674
L YLH IIH D+K +NI LD +A + DFG + KL + GT
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETN 254
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706
+PE P AK D++S G++L E+ +
Sbjct: 255 SPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 33/160 (20%), Positives = 72/160 (45%), Gaps = 12/160 (7%)
Query: 548 REFKSEVSAIGRTHHKNLVQLLGF----CDEALNRLLVYEFMGNGTLANLIFAIPKPDWN 603
++E+ + R N++++ GF D+ L+ E+ G L ++ +
Sbjct: 63 DITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFK 122
Query: 604 LRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663
++ ++++ +GL L++ N P + ++ + L+ + KI GL K+L S +
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKN 180
Query: 664 HTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEII 701
+ Y + + + + + K D+YS GV+L EI
Sbjct: 181 VNFM----VYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216
|
Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 3e-06
Identities = 39/160 (24%), Positives = 67/160 (41%), Gaps = 19/160 (11%)
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 620
+ N ++L +L+ +++ +G L +L+ K +I ++ L LH
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAK----ISDFGLSKLLLSDQSRTHT--MIRGTRGYV 674
IIH DIK +N+L Y AK + D+GL K T GT Y
Sbjct: 127 ---KHNIIHNDIKLENVL---YDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYF 173
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE 714
+PE K D ++ GV+ E++ + + + +EE
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 17/100 (17%)
Query: 611 EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670
++ R L Y+H NV H D+KP+NIL + KI DFGL+++ +D T T I T
Sbjct: 111 QLLRALKYIHT-ANV--FHRDLKPKNILANADCKLKICDFGLARVAFND---TPTAIFWT 164
Query: 671 RGYVAPEWFKNAP---------VSAKVDVYSFGVMLLEII 701
YVA W++ AP + +D++S G + E++
Sbjct: 165 -DYVATRWYR-APELCGSFFSKYTPAIDIWSIGCIFAEVL 202
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 3/100 (3%)
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667
I + R + YLHE IIH DIK +NI +++ + DFG + + + +
Sbjct: 187 IERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSV 707
GT APE P VD++S G++L E+ C S+
Sbjct: 244 AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 9e-06
Identities = 51/178 (28%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 609 SLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM- 666
S ++A+G+ +L +C IH D+ +NILL KI DFGL++ + D
Sbjct: 185 SFQVAKGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE--MEVEEEGRAILTDWAY 724
R ++APE + + + DV+SFGV+L EI S ++++EE L
Sbjct: 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---- 296
Query: 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
EG D P M M+ W +PS+RPT +++ L LL+
Sbjct: 297 ----EGTRMRAPDYTTPEMYQT-------MLDCW--HGEPSQRPTFSELVEHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 61/257 (23%), Positives = 105/257 (40%), Gaps = 28/257 (10%)
Query: 526 LKSASGKAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584
+ + K V K L ER+ + +SE+ + H +V+ LL+ E+
Sbjct: 87 TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146
Query: 585 MGNGTLANLIFA-----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639
G L I +P ++ + + + +I L +H ++H D+K NI L
Sbjct: 147 GSGGDLNKQIKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFL 202
Query: 640 DNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLL 698
K+ DFG SK S + GT Y+APE ++ S K D++S GV+L
Sbjct: 203 MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262
Query: 699 EIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMW 758
E++ R + + E I+ Y Y +P S K L+ +
Sbjct: 263 ELLTLHRPFKGPSQRE---IMQQVLYGKY------------DPFPCPVSSGMKALLDPL- 306
Query: 759 CIREDPSKRPTMKVVLQ 775
+ ++P+ RPT + +L
Sbjct: 307 -LSKNPALRPTTQQLLH 322
|
Length = 478 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 5e-05
Identities = 13/67 (19%), Positives = 24/67 (35%), Gaps = 3/67 (4%)
Query: 362 NNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYD--GNRCWKKKLPLSNGWLRDTGF 419
+V P + + EC +CL +C C Y+ C L+N +G
Sbjct: 18 PDVKLPDNAS-AITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGG 76
Query: 420 SKVLFKV 426
+ ++
Sbjct: 77 GTLYLRL 83
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 35/93 (37%), Positives = 49/93 (52%), Gaps = 11/93 (11%)
Query: 509 FKEELGRGSFGIVYK----GVLKSASGKAIAVKKLDRLAQERE-REFKSEVSA---IGRT 560
+ LGRG+FG V + G+ KSAS + +AVK L A E + +E+ IG
Sbjct: 11 LGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIG-- 68
Query: 561 HHKNLVQLLGFCDEALNRLLV-YEFMGNGTLAN 592
HH N+V LLG C + L+V E+ G L+N
Sbjct: 69 HHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSN 101
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 32/92 (34%), Positives = 46/92 (50%), Gaps = 6/92 (6%)
Query: 509 FKEELGRGSFGIVYK----GVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRT-HH 562
F + LG G+FG V + G+ KS + +AVK L A ERE SE+ + +H
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH 98
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 594
N+V LLG C L++ E+ G L N +
Sbjct: 99 INIVNLLGACTVGGPTLVITEYCCYGDLLNFL 130
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 34/124 (27%), Positives = 58/124 (46%), Gaps = 10/124 (8%)
Query: 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEECNVPIIHCDIKPQNILL 639
+ LI P + V S ++A G+ +L + C +H D+ +N+L+
Sbjct: 217 LPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNC----VHRDLAARNVLI 272
Query: 640 DNYFSAKISDFGLSKLLLSDQ---SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVM 696
KI DFGL++ ++ D S+ T + ++APE N + DV+SFG++
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGIL 330
Query: 697 LLEI 700
L EI
Sbjct: 331 LWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 12/171 (7%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL- 568
+GRG+FG V +K+ +G+ A+K L++ + E F+ E + + + L
Sbjct: 9 IGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
F DE N LV ++ G L L+ F P+ R ++ E+ + +H+ +
Sbjct: 68 YAFQDEN-NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA-EMVLAIDSVHQ---LG 122
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
+H DIKP N+LLD +++DFG LL+D + + GT Y++PE
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 19/201 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE---FKSEVSAIGRTHHKNLVQL- 568
+GRG+FG V +K + A+K L++ + E F+ E + + + + L
Sbjct: 9 IGRGAFGEVAVVKMKHTE-RIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 569 LGFCDEALNRL-LVYEFMGNGTLANLI--FAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
F DE N L LV ++ G L L+ F P+ R IA ++ +H +
Sbjct: 68 YAFQDE--NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR----FYIAEMVLAIHSIHQL 121
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN---- 681
+H DIKP N+LLD +++DFG + D + ++ GT Y++PE +
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDG 181
Query: 682 -APVSAKVDVYSFGVMLLEII 701
+ D +S GV + E++
Sbjct: 182 MGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 15/106 (14%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYK----GVLKSASGKAIAVKKLDRLAQERERE-FK 551
F + L+ F + LG G+FG V + G+ K + +AVK L A ERE
Sbjct: 35 FPRDNLQ-----FGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALM 89
Query: 552 SEV---SAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI 594
SE+ S +G HKN+V LLG C L++ E+ G L N +
Sbjct: 90 SELKILSHLG--QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 35/89 (39%), Positives = 48/89 (53%), Gaps = 7/89 (7%)
Query: 513 LGRGSFGIVYK----GVLKSASGKAIAVKKLDRLAQERE-REFKSEVSA-IGRTHHKNLV 566
LGRG+FG V + G+ K+A+ + +AVK L A E R SE+ I HH N+V
Sbjct: 15 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 74
Query: 567 QLLGFCDEALNRLLV-YEFMGNGTLANLI 594
LLG C + L+V EF G L+N +
Sbjct: 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYL 103
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 59/240 (24%), Positives = 93/240 (38%), Gaps = 61/240 (25%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL---DRLAQEREREFKSEVSAIGRTHHKNLVQLL 569
+G G+FG V V K + A+K L D L + + K+E + ++ +V+L
Sbjct: 9 IGIGAFGEVCL-VRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY 67
Query: 570 -GFCDEALNRLLVYEFMGNGTLANL-----IFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
F D+ N V +++ G + +L IF + R I+ E+ + +H
Sbjct: 68 YSFQDKD-NLYFVMDYIPGGDMMSLLIRLGIF----EEDLARFYIA-ELTCAIESVH--- 118
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLS------------------------------ 653
+ IH DIKP NIL+D K++DFGL
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 654 -------KLLLSDQSRTHTMIR-----GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
K L + R H GT Y+APE + D +S GV+L E++
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 29/96 (30%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 609 SLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---SRTH 664
+ ++ARG+ +L + C +H D+ +N+LL KI DFGL++ ++ D S+
Sbjct: 243 TYQVARGMEFLASKNC----VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
T + ++APE + + DV+S+G++L EI
Sbjct: 299 TFL--PVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 31/93 (33%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 612 IARGLV----YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL-SDQSRTHTM 666
+AR L+ Y+H E IIH DIK +N+L++ + DFG + S + H
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
I GT APE P + VD++S G+++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 23/179 (12%)
Query: 534 IAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANL 593
+ +K LD ++ F S + + H +L + G C ++V EF+ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC 106
Query: 594 I----FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL------DNYF 643
+ +P W + V + ++A L YL ++ ++H ++ +NILL +
Sbjct: 107 LRKEKGRVPV-AWKITV--AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTS 160
Query: 644 S-AKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEI 700
K+SD G+S LS + R + ++APE +S D +SFG LLEI
Sbjct: 161 PFIKLSDPGVSFTALSREERVERI-----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 799 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.98 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.91 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.9 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.63 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.52 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.5 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.27 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.15 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.15 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.14 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.02 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.97 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.94 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.92 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 98.88 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.65 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.48 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.41 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.32 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.24 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.03 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.01 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 97.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.9 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.83 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.81 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.78 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 97.73 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 97.64 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.49 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.46 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.36 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.35 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.3 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.29 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.25 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.15 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.14 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.1 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.04 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.8 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.7 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.27 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.25 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.01 | |
| PLN02236 | 344 | choline kinase | 95.8 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.79 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.78 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.38 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 95.33 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.62 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.11 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.03 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=459.25 Aligned_cols=287 Identities=46% Similarity=0.772 Sum_probs=251.6
Q ss_pred CccccChHHHHHHhhchh--hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceee
Q 038294 493 NLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570 (799)
Q Consensus 493 ~~~~~~~~~l~~~~~~~~--~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g 570 (799)
..+.|++.+|..+|.+|. +.||+|+||.||+|.+.+ ++.||||++.....+..++|.+|+.++.+++|||||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~--~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD--GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC--CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEE
Confidence 678899999999999999 589999999999999974 5899999987654331567999999999999999999999
Q ss_pred eeeccc-ceeeEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 038294 571 FCDEAL-NRLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKI 647 (799)
Q Consensus 571 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl 647 (799)
||.+.. +++||||||++|+|.++|+... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999999 4999999999999999999765 8899999999999999999999999889999999999999999999999
Q ss_pred ccccCcccccCCCCcceeee-ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH
Q 038294 648 SDFGLSKLLLSDQSRTHTMI-RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 648 ~DfGla~~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+..... ....+..|+...
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~-~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPR-GELSLVEWAKPL 296 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCc-ccccHHHHHHHH
Confidence 999999765431 1111112 7999999999999999999999999999999999999988765422 222367899999
Q ss_pred HhcCceeEeecCCCC-CccCH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 727 YAEGRLDVLVDSDEP-AMADR-SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+.++++.+++|+.+. ..... +++.++..++.+|++.+|.+||+|.||+++|+.+...
T Consensus 297 ~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 999999999999987 44443 7889999999999999999999999999999776554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=391.58 Aligned_cols=251 Identities=35% Similarity=0.548 Sum_probs=209.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeE-EEEEEccccchh--hHHHHHHHHHHhcccccccccceeeeeeccc-ceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKA-IAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLGFCDEAL-NRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~-vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~ 584 (799)
+.+.||+|+||+||+|.++ |+. ||||++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 45 ~~~~iG~G~~g~V~~~~~~---g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWR---GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhcccCCceeEEEEEeC---CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 3456999999999999996 444 999999753322 2569999999999999999999999999988 78999999
Q ss_pred cCCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeEEcCCC-ceEEccccCcccccCCC
Q 038294 585 MGNGTLANLIFA--IPKPDWNLRVRISLEIARGLVYLHEECNVP-IIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~ 660 (799)
|++|+|.++++. ...+++..+++|+.|||+||.|||++ + ||||||||+||||+.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 999999999988 57899999999999999999999998 5 99999999999999997 99999999998765432
Q ss_pred CcceeeeccCCccccccccc--CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 SRTHTMIRGTRGYVAPEWFK--NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~--~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||...... ..+......+..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~-------~~~~~v~~~~~R------ 264 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV-------QVASAVVVGGLR------ 264 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcCCC------
Confidence 2233357999999999999 669999999999999999999999999876542 112222222221
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
...+......+..++.+||+.||+.||++.+++..|+.+..
T Consensus 265 ---p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 ---PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred ---CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 11122245678889999999999999999999999987654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=384.43 Aligned_cols=263 Identities=27% Similarity=0.412 Sum_probs=218.1
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
++.+....+.++||+|.||.||+|.++. ...||+|.++.. ....++|.+|+++|++++|+|||+++|+|..+...+|
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~--~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNG--STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcC--CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 4455555678899999999999999973 458999999764 3445789999999999999999999999999889999
Q ss_pred EEeecCCCChhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 581 VYEFMGNGTLANLIFA--IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
|+|||+.|+|.++|.. ...+...+.+.++.|||+|++||+++ ++|||||.++||||+++..+||+|||||+....
T Consensus 279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999997 45788899999999999999999998 999999999999999999999999999996655
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
++........-+..|.|||.+....++.|+|||||||+||||+| |+.|+......+ +.+.+..|..
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--------v~~~le~GyR----- 422 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--------VLELLERGYR----- 422 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--------HHHHHhccCc-----
Confidence 55444443445789999999999999999999999999999999 566666554333 2233333321
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 786 (799)
-..+......+.+++..||+.+|++|||++.+...|+.+.....+
T Consensus 423 ----lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~~ 467 (468)
T KOG0197|consen 423 ----LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTEG 467 (468)
T ss_pred ----CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcccC
Confidence 112334556788899999999999999999999999987765443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.20 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=214.0
Q ss_pred cChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 497 ~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
.+..+|.. ...||+|..|+|||+.++. +++.+|+|.+... .....+++.+|++++++.+||+||+++|.|...
T Consensus 76 i~~~dle~-----~~~lG~G~gG~V~kv~Hk~-t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~ 149 (364)
T KOG0581|consen 76 ISLSDLER-----LGVLGSGNGGTVYKVRHKP-TGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN 149 (364)
T ss_pred cCHHHhhh-----hhhcccCCCcEEEEEEEcC-CCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence 34445543 4679999999999999985 7899999999543 344567899999999999999999999999888
Q ss_pred c-ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 576 L-NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 576 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
. ...|+||||.+|+|++++...+.+++...-+|+.+|++||.|||++ .+||||||||+||||+..|++||+|||.+.
T Consensus 150 ~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~ 227 (364)
T KOG0581|consen 150 GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSG 227 (364)
T ss_pred CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccH
Confidence 8 4999999999999999999888999999999999999999999974 289999999999999999999999999999
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
.+.+. .....+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+....+.. ....... ..
T Consensus 228 ~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--~~~~~Ll---------~~ 293 (364)
T KOG0581|consen 228 ILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--LDIFELL---------CA 293 (364)
T ss_pred Hhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--CCHHHHH---------HH
Confidence 87544 3345679999999999999999999999999999999999999987652111 1111111 11
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+++...+........+++..++..||++||.+||++.|+++
T Consensus 294 Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 294 IVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred HhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 23333333333357789999999999999999999999875
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=358.64 Aligned_cols=200 Identities=31% Similarity=0.484 Sum_probs=180.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.++||+|+||+||+|+++. ++.+||||.+... ..+..+-+..|+++|++++|||||++++++..++..+||||||.
T Consensus 14 ~~~~iG~GsfavVykg~h~~-~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~ 92 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKK-SGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCN 92 (429)
T ss_pred ehhhccCcceEEEEEeEecc-CCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCC
Confidence 45679999999999999986 5699999999664 45566678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC------CceEEccccCcccccCCC
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY------FSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~------~~~kl~DfGla~~~~~~~ 660 (799)
+|+|.++|+....+++.....++.|||.||++||++ +||||||||+||||+.. -.+||+|||+|+.+...
T Consensus 93 gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~- 168 (429)
T KOG0595|consen 93 GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG- 168 (429)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-
Confidence 999999999999999999999999999999999998 99999999999999864 46899999999988532
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhh
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE 714 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~ 714 (799)
......+|++-|||||++...+|+.|+|+||+|++|||+++|+.||+.....+
T Consensus 169 -~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 169 -SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred -hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 23345679999999999999999999999999999999999999999776554
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=389.92 Aligned_cols=267 Identities=27% Similarity=0.443 Sum_probs=223.5
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
++......+.++||+|+||+||+|.... .+...||||.++..+.. ...+|++|+++++.++|||||+|+|.|.++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG 561 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC
Confidence 4445555677899999999999998642 23468999999886665 678999999999999999999999999999
Q ss_pred cceeeEEeecCCCChhhhhhcC----------CC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 576 LNRLLVYEFMGNGTLANLIFAI----------PK----PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~----------~~----~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
+..++|+|||..|||.+||... .. ++..+.+.||.|||.|++||-++ .++||||..+|+||.+
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGE 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceecc
Confidence 9999999999999999999742 12 67788999999999999999998 8999999999999999
Q ss_pred CCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhH
Q 038294 642 YFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~ 719 (799)
+..+||+||||++...+... +......-+.+|||||.+..++||+++|||||||+|||++| |+.|+.....++
T Consensus 639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----- 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----- 713 (774)
T ss_pred ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----
Confidence 99999999999998754332 22223335789999999999999999999999999999998 788988776554
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPP 787 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 787 (799)
+.+.+.+|++-. .+.....++..|+..||+.+|.+||+++||-..|+...+..++.
T Consensus 714 ---VIe~i~~g~lL~---------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~~~ 769 (774)
T KOG1026|consen 714 ---VIECIRAGQLLS---------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASPKY 769 (774)
T ss_pred ---HHHHHHcCCccc---------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCccc
Confidence 455667776522 23334457889999999999999999999999999877655443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=357.38 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=209.3
Q ss_pred HHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh-------hHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 503 KEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-------REREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 503 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
.+..+-+.+.||+|+||.|-+|..+. +++.||||++++.... ......+|+++|++++|||||++.+++...
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~-tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKK-TGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcc-cCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 34455667899999999999999875 7999999999652111 123457999999999999999999999999
Q ss_pred cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEEccccC
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGL 652 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~---~~~kl~DfGl 652 (799)
+..|||+||++||+|.+.+-..+.+.+..-.-++.|++.|+.|||+. +|+||||||+|||+..+ ..+||+|||+
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999999999988888888889999999999999998 99999999999999765 7899999999
Q ss_pred cccccCCCCcceeeeccCCcccccccccCCCC---CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV---SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~---s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
|+... ....+...+||+.|.|||++.++.. ..++|+||+||+||-++||..||....... . ..+.+..
T Consensus 326 AK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---s----l~eQI~~ 396 (475)
T KOG0615|consen 326 AKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---S----LKEQILK 396 (475)
T ss_pred hhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc---c----HHHHHhc
Confidence 99865 3334556789999999999987643 348899999999999999999998653321 1 2333444
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
|+... ......+..++..+++.+||..||++|||+.|+++
T Consensus 397 G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 397 GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 44321 22334567788999999999999999999999874
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=378.12 Aligned_cols=268 Identities=25% Similarity=0.424 Sum_probs=221.6
Q ss_pred ccChHHHHHHhhch-----------hhhcCccccceEEEEEEeCCC--CeEEEEEEccccc-hhhHHHHHHHHHHhcccc
Q 038294 496 FFSYNELKEATGGF-----------KEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLA-QEREREFKSEVSAIGRTH 561 (799)
Q Consensus 496 ~~~~~~l~~~~~~~-----------~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~ 561 (799)
-++|++--++...| .++||.|.||.|++|.++... ...||||.|+... ++..++|+.|..+|++++
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 35676655555544 356999999999999998543 3579999998654 445579999999999999
Q ss_pred cccccceeeeeecccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 038294 562 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD 640 (799)
Q Consensus 562 h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~ 640 (799)
||||++|.|+.......+||.|||+||+|+.||+.. ..+++.+..-+..+||.|+.||.+. +++||||.++||||+
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVN 765 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVN 765 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhheeec
Confidence 999999999999999999999999999999999976 4688999999999999999999987 999999999999999
Q ss_pred CCCceEEccccCcccccCCCCcceeee--ccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 641 NYFSAKISDFGLSKLLLSDQSRTHTMI--RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 641 ~~~~~kl~DfGla~~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
.+..+|++|||+++.+..+.....+.. .-+.+|.|||.+..++++.++|||||||+|||.++ |.+|+-.....+
T Consensus 766 snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--- 842 (996)
T KOG0196|consen 766 SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--- 842 (996)
T ss_pred cceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH---
Confidence 999999999999998765543222222 23678999999999999999999999999999987 889987655433
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+...+++| .++| .+......|.+|+..|||+|..+||++.+|+.+|++++..
T Consensus 843 -----VIkaIe~g-------yRLP--pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 843 -----VIKAIEQG-------YRLP--PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----HHHHHHhc-------cCCC--CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 22233332 1222 3455667888999999999999999999999999998754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=337.18 Aligned_cols=256 Identities=26% Similarity=0.355 Sum_probs=211.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceee-eeecccc-eee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLG-FCDEALN-RLL 580 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g-~~~~~~~-~~l 580 (799)
+.+.+.++||+|.||+|||+.... +++.+|.|.+.- ...+...+...|+.+|++++|||||++++ -+.+... .+|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~-~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlni 97 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLL-DGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNI 97 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeecc-CcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHH
Confidence 344567899999999999998874 789999999863 33445567899999999999999999999 5566655 789
Q ss_pred EEeecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 581 VYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECN-VPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~-~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
||||+..|+|..+++. .+.++++.+++++.|++.||.++|.... .-|+||||||.||+|+.+|.+||+|||+++.
T Consensus 98 vmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 98 VMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999874 3578999999999999999999998432 2399999999999999999999999999999
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
+.+..... ...+|||.||+||.+.+.+|+.|+||||+||++|||...+.||.+.+-.+ +.+.+..|.
T Consensus 178 l~s~~tfA-~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~--------L~~KI~qgd---- 244 (375)
T KOG0591|consen 178 LSSKTTFA-HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS--------LCKKIEQGD---- 244 (375)
T ss_pred hcchhHHH-HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH--------HHHHHHcCC----
Confidence 86655433 34579999999999999999999999999999999999999998763211 334445542
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.+...+..+++.+..++..|+..||+.||+...+++.+.
T Consensus 245 ----~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 245 ----YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 233445788899999999999999999999655555444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=366.23 Aligned_cols=246 Identities=27% Similarity=0.397 Sum_probs=210.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+...+.||+|||+.||.++..+ +|+.||+|++.+. .....+...+|+++.+.++|||||+++++|++.+..|||.|
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~-tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLD-TGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcC-CCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 3445789999999999999854 6899999999652 22334568899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|++++|.++++..+.+++..++.+..||+.||.|||+. +|||||||..|++|+++.++||+|||||..+..+..+.
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk 175 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERK 175 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCccccc
Confidence 999999999999889999999999999999999999998 89999999999999999999999999999887664444
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
. ..+|||.|+|||++....++..+||||+||+||-||.|+.||+...-.+ .+..++... ...|.
T Consensus 176 ~-TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke--------ty~~Ik~~~------Y~~P~- 239 (592)
T KOG0575|consen 176 K-TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE--------TYNKIKLNE------YSMPS- 239 (592)
T ss_pred c-eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH--------HHHHHHhcC------ccccc-
Confidence 3 4579999999999999999999999999999999999999999764433 223333221 11222
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.......++|..+|+.+|.+|||+++|+.
T Consensus 240 ---~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 240 ---HLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33445678999999999999999999984
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.97 Aligned_cols=278 Identities=27% Similarity=0.295 Sum_probs=215.4
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 584 (799)
..++||+|+||.||||+... +|+.||+|+++... ++......+|+.+|++++||||++|.+...+. ...|||+||
T Consensus 121 ki~kIGeGTyg~VYkAr~~~-tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeY 199 (560)
T KOG0600|consen 121 KIEKIGEGTYGQVYKARDLE-TGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEY 199 (560)
T ss_pred HHHHhcCcchhheeEeeecc-cCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEec
Confidence 34689999999999999875 78999999987544 44456778999999999999999999999776 578999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|++ +|.-++... -.++..++..++.|++.||+|+|+. +|+|||||.+|||||++|.+||+|||||+++.......
T Consensus 200 Mdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~ 275 (560)
T KOG0600|consen 200 MDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP 275 (560)
T ss_pred ccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcc
Confidence 988 888888764 4789999999999999999999998 99999999999999999999999999999887776666
Q ss_pred eeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcCceeEeecC
Q 038294 664 HTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~d~ 738 (799)
.+..+.|..|+|||++.+. .|+.++|+||.||||.||+.|+..+.+..+-+....+..... ..|...++......
T Consensus 276 ~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~ 355 (560)
T KOG0600|consen 276 YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIF 355 (560)
T ss_pred cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccccc
Confidence 7777789999999999876 799999999999999999999999988776555443322111 11111111100000
Q ss_pred CCCCccCH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCce
Q 038294 739 DEPAMADR-------SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSF 792 (799)
Q Consensus 739 ~~~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~ 792 (799)
.....+.+ ...+..++|+..+|..||++|.|+.++++. +-..+.|.|..|+.+
T Consensus 356 kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s-eyF~t~p~~~~p~~L 415 (560)
T KOG0600|consen 356 KPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS-EYFTTEPLPCDPSSL 415 (560)
T ss_pred CCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC-cccccCCCCCCcccC
Confidence 11111111 223346789999999999999999988753 112344555555544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.66 Aligned_cols=260 Identities=21% Similarity=0.291 Sum_probs=204.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
.++|+|+||+|||++.++ +|+.||||++.... ....+-.++|+++|++++|+|+|.|+.+|.......||+||++..
T Consensus 8 gkvGEGSYGvV~KCrnk~-TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKD-TGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT 86 (396)
T ss_pred hccccCcceEEEEeccCC-cccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence 469999999999999986 79999999996533 233456789999999999999999999999999999999999886
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeec
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 668 (799)
-|.++-+.....+.+...+++.|+++|+.|+|++ ++|||||||+||||+.++.+||+|||+|+.+... ....+..+
T Consensus 87 vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd~YTDYV 162 (396)
T KOG0593|consen 87 VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GDNYTDYV 162 (396)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC-cchhhhhh
Confidence 5655555556788999999999999999999998 8999999999999999999999999999988642 23344556
Q ss_pred cCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHH--------HHhcCceeEeecCC
Q 038294 669 GTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD--------CYAEGRLDVLVDSD 739 (799)
Q Consensus 669 gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~d~~ 739 (799)
.|++|+|||.+.+ .+|...+||||+||++.||++|..-|-+..+-+....+..-+.. ...++.+..+.-+.
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~ 242 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE 242 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence 8999999999987 68999999999999999999999888766544332222211111 11222232222222
Q ss_pred CCCccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMAD-----RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+ ......+++++..||+.||++|++-+|++.
T Consensus 243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 221111 123346789999999999999999999873
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=343.70 Aligned_cols=266 Identities=27% Similarity=0.414 Sum_probs=215.2
Q ss_pred HHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhH-HHHHHHHHHhcccccccccceeeeeecccce
Q 038294 500 NELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-REFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 500 ~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
.|..+....|.++||+|.||.|.++... .+..||||+++..+.... ++|..|+++|.+++||||++|+|.|..++..
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeve--g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVE--GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEec--CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3445555567899999999999999986 368999999998777665 7999999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 579 LLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
++|+|||++|+|.+++... +...-....+|+.|||.|++||.+- +++||||.++|+|+|.++++||+|||+++.+
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccc
Confidence 9999999999999999876 3445566788999999999999997 9999999999999999999999999999976
Q ss_pred cCCC-CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHH--hCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 657 LSDQ-SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII--CCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 657 ~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ell--tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
.... .+.....+-+.+|||||.+..++++.++|||+||+.|||++ +...|++....+..... .......+...
T Consensus 688 ysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven----~~~~~~~~~~~ 763 (807)
T KOG1094|consen 688 YSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN----AGEFFRDQGRQ 763 (807)
T ss_pred ccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh----hhhhcCCCCcc
Confidence 5443 34444555688999999999999999999999999999986 46788876554432221 11122221111
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
..+ . .+.-....+.+++.+||..|-++||+++++...|+..
T Consensus 764 ~~l-~-----~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVL-S-----RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eec-c-----CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111 1 1223445778999999999999999999999998764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.54 Aligned_cols=239 Identities=28% Similarity=0.372 Sum_probs=202.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||+|++++.++ +++.+|+|++++.. ....+...+|..+|.+++||.||++.-.|++....++|+||
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~d-t~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKD-TGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeccCCceEEEEEEcc-cCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 345789999999999999884 78999999997532 23456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+.||.|.-+|.+...+++..+.-++.+|+.||.|||+. +||||||||+|||||++|+++|+|||+++........ .
T Consensus 107 ~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~-t 182 (357)
T KOG0598|consen 107 LNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA-T 182 (357)
T ss_pred cCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCc-c
Confidence 99999999999999999999999999999999999998 9999999999999999999999999999965444333 3
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+||+.|||||++.+..|+..+|-||+|+++|||++|..||....... .++.+..+++ ...
T Consensus 183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~--------~~~~I~~~k~---------~~~ 245 (357)
T KOG0598|consen 183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK--------MYDKILKGKL---------PLP 245 (357)
T ss_pred ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH--------HHHHHhcCcC---------CCC
Confidence 34689999999999999999999999999999999999999998765433 2233333331 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP 768 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP 768 (799)
+........+++...|+.||++|.
T Consensus 246 p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CccCCHHHHHHHHHHhccCHHHhc
Confidence 222345667889999999999996
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=375.67 Aligned_cols=258 Identities=28% Similarity=0.486 Sum_probs=212.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCe----EEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
..-.+.+.||+|+||.||+|...+..+. .||||.++.. +.+.+.+|++|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 3334557799999999999999876664 4899999764 4556679999999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccC
Q 038294 580 LVYEFMGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGl 652 (799)
|++|||++|+|..+|++. ..+.....+.|+.|||+|+.||++. ++|||||.++|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999865 3578889999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhC-CcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 653 SKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICC-RRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 653 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
|+.+...+. .......-+..|||||.+..+.|+.|+|||||||+|||++|. ..||......+ ......+.|
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~-------v~~~~~~gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE-------VLLDVLEGG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH-------HHHHHHhCC
Confidence 996543332 222222346799999999999999999999999999999994 55665444332 122233444
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+++. +....+.+.+|+..||+.+|++||++..|++.++.+..
T Consensus 922 RL~~----------P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 922 RLDP----------PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred ccCC----------CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 3322 44556788899999999999999999999999987654
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=354.50 Aligned_cols=259 Identities=29% Similarity=0.388 Sum_probs=211.3
Q ss_pred chhhhcCccccceEEEEEEeCCCC--eE-EEEEEccc---cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG--KA-IAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~--~~-vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
.+.++||+|+||.||+|.++..++ .. ||||..+. .......+|.+|.++|++++|||||+++|++......++|
T Consensus 160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv 239 (474)
T KOG0194|consen 160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV 239 (474)
T ss_pred cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence 345889999999999999986544 23 89999874 3456678999999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||+|.||+|.++|...+ .++..++++++.+.|.||+|||+. ++|||||.++|+|++.++.+||+|||+++......
T Consensus 240 mEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~ 316 (474)
T KOG0194|consen 240 MELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV 316 (474)
T ss_pred EEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCccee
Confidence 99999999999999887 599999999999999999999998 89999999999999999999999999988653111
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH-hcCceeEeecC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY-AEGRLDVLVDS 738 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~ 738 (799)
... ....-+..|+|||.+....|+.++|||||||++||+.+ |..|+......+ +...+ .++..
T Consensus 317 ~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~--------v~~kI~~~~~r------ 381 (474)
T KOG0194|consen 317 MKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE--------VKAKIVKNGYR------ 381 (474)
T ss_pred ecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH--------HHHHHHhcCcc------
Confidence 111 11235789999999999999999999999999999998 777887654332 22222 22211
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPP 787 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 787 (799)
...+......+..++..|++.+|++||+|.++.+.|+.+.....++
T Consensus 382 ---~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 382 ---MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ---CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 1111233456667888999999999999999999999887765553
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=343.93 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=202.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.||+|.||+||+|.+.. .||||++.. ...+..+.|++|+.++++-+|.||+-+.|+|..+.. .||..+|+
T Consensus 396 l~~rIGsGsFGtV~Rg~whG----dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCe 470 (678)
T KOG0193|consen 396 LGERIGSGSFGTVYRGRWHG----DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCE 470 (678)
T ss_pred ccceeccccccceeeccccc----ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhcc
Confidence 46789999999999999963 699999964 334566899999999999999999999999998877 99999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC-CCcce
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-QSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~-~~~~~ 664 (799)
|-+|..+|+.. .+++..+.++||.|||+|+.|||.+ +|||||||..||+|.+++++||+|||++.....- .....
T Consensus 471 GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 471 GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 99999999865 4788889999999999999999998 9999999999999999999999999999754321 11112
Q ss_pred eeeccCCcccccccccCC---CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 665 TMIRGTRGYVAPEWFKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~---~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
....|...|||||+++.. +|+.++||||||+++|||++|..|+.....+.... ++..|.+ ..|.
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIif--------mVGrG~l--~pd~--- 614 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIF--------MVGRGYL--MPDL--- 614 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEE--------Eeccccc--Cccc---
Confidence 223467889999999644 79999999999999999999999998433221100 0111110 0111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..........+.+|+..||.+++++||.+.+|+..|+.++.
T Consensus 615 s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 615 SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 11122334467789999999999999999999999888766
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.17 Aligned_cols=279 Identities=25% Similarity=0.309 Sum_probs=212.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.||+|.||.||+|++.. +|+.||||+++.. .........+|++.|+.++|+||+.|+++|...+..-||+|||+
T Consensus 6 ~~~~lGEG~~gvVyka~d~~-t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~ 84 (318)
T KOG0659|consen 6 KLEKLGEGTYGVVYKARDTE-TGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP 84 (318)
T ss_pred hhhhhcCcceEEEEEEEecC-CCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc
Confidence 35789999999999999875 7899999999643 22334678899999999999999999999999999999999997
Q ss_pred CCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
. +|+..++... .+.-.++..++.++++||+|||.+ .|+||||||.|+|++++|.+||+|||+|+.+.........
T Consensus 85 t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 85 T-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred c-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 6 9999998764 567778889999999999999998 8999999999999999999999999999998765443333
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHH----HHhcCceeEeecC--
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD----CYAEGRLDVLVDS-- 738 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~d~-- 738 (799)
. +.|+.|+|||.+.+. .|+..+||||.||++.||+-|..-|.+..+-++...+...... .|.+ +..+.|.
T Consensus 161 ~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~--~~~lpdY~~ 237 (318)
T KOG0659|consen 161 Q-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPE--MTSLPDYVK 237 (318)
T ss_pred c-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcc--ccccccHHH
Confidence 2 579999999998765 6899999999999999999877666555443332222211110 0000 0011110
Q ss_pred --CCC----CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCceeecc
Q 038294 739 --DEP----AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSFSIAV 796 (799)
Q Consensus 739 --~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~~~~~ 796 (799)
..+ ...-.......++++..++.+||.+|+|++|++++ +-....|.|..|+-+.+..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~-~yf~~~P~pt~~~~lp~p~ 300 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH-PYFKSLPLPTPPSKLPIPS 300 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc-hhhhcCCCCCChhhCcCCc
Confidence 000 00112344566899999999999999999999875 2345566666666655543
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=333.08 Aligned_cols=252 Identities=32% Similarity=0.448 Sum_probs=202.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc--ceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e~ 584 (799)
+...+.||+|+||.||++...+ +|+..|||..........+.+.+|+.+|.+++|||||+.+|...... ..+++|||
T Consensus 19 ~~~~~~lG~Gs~G~V~l~~~~~-~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 19 WSKGKLLGRGSFGSVYLATNKK-TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhccccCccceEEEEEEecC-CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 3446789999999999999875 48899999987653333667899999999999999999999855444 57899999
Q ss_pred cCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccC--CC
Q 038294 585 MGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLS--DQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~--~~ 660 (799)
+++|+|.+++.... .+++..+.++..||++||+|||++ +|+||||||+||||+. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999876 789999999999999999999998 9999999999999999 79999999999987753 22
Q ss_pred CcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
........||+.|||||++.++ ....++||||+||++.||+||+.|+... .+. ..+......+. .
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~~-----~~~~~~ig~~~--------~ 240 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FEE-----AEALLLIGRED--------S 240 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cch-----HHHHHHHhccC--------C
Confidence 2333456799999999999863 3345999999999999999999998753 000 01111111111 1
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.| ..+........+++..|++.+|++|||++++++..
T Consensus 241 ~P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 LP-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred CC-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 11 22333556778899999999999999999998765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=334.49 Aligned_cols=264 Identities=26% Similarity=0.316 Sum_probs=205.8
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh-hHHHHHHHHHHhcccc-cccccceeeeeeccc-ceeeE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTH-HKNLVQLLGFCDEAL-NRLLV 581 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~-~~~lv 581 (799)
..+...++||.|+||.||+|+-+. +++.||||+++..-.. .+-.=++|++.|.+++ |||||+|...+.+.+ .+++|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~-~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKE-TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecC-CCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 445667899999999999999875 6788999998653222 2223368999999998 999999999998888 88999
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||+. +|.++++.+ ..+++..+..|+.||++||+|+|.+ |++|||+||+|||+..+..+||+|||+||...+..
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCC
Confidence 999965 999999876 4679999999999999999999999 99999999999999999999999999999876554
Q ss_pred CcceeeeccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhc------
Q 038294 661 SRTHTMIRGTRGYVAPEWF-KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAE------ 729 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l-~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~------ 729 (799)
. .+..+.|+.|+|||++ +..-|+.+.|+||+||+++|+.+.+.-|-+..+-+....+-+.+. +.+.+
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 3445679999999987 566899999999999999999999988876654332111111000 00011
Q ss_pred ---CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 730 ---GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 730 ---~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
-++.+.....+....+ ....++.+++.+|++.||++|||+.|.+++
T Consensus 243 ~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111112222222 367788999999999999999999999875
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=345.35 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=201.1
Q ss_pred hhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeeccc-ce
Q 038294 506 TGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL-NR 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~~ 578 (799)
.+.+.+.||+|+||.||+|... ..+++.||||+++... ....+.+.+|+.++.++ +||||++++++|.... ..
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~ 87 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPL 87 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCce
Confidence 3456688999999999999752 2245689999997533 23346789999999999 8999999999987654 57
Q ss_pred eeEEeecCCCChhhhhhcC-------------------------------------------------------------
Q 038294 579 LLVYEFMGNGTLANLIFAI------------------------------------------------------------- 597 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 597 (799)
+++|||+++|+|.+++...
T Consensus 88 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (338)
T cd05102 88 MVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLW 167 (338)
T ss_pred EEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccc
Confidence 8999999999999988642
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-ceeeeccCCcccc
Q 038294 598 -PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVA 675 (799)
Q Consensus 598 -~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~a 675 (799)
..+++..+.+++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++........ ......+++.|+|
T Consensus 168 ~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 1366778899999999999999998 9999999999999999999999999999865432211 1122345678999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHH
Q 038294 676 PEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLM 754 (799)
Q Consensus 676 PE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 754 (799)
||.+.+..++.++|||||||+||||++ |..||......+ ........+... .. .....+.+.+
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-------~~~~~~~~~~~~-----~~----~~~~~~~l~~ 308 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-------EFCQRLKDGTRM-----RA----PENATPEIYR 308 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-------HHHHHHhcCCCC-----CC----CCCCCHHHHH
Confidence 999999999999999999999999997 899987543211 011122222111 11 1123456788
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 755 IAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 755 l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
++.+||+.||++|||+.||+++|+++++
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.13 Aligned_cols=265 Identities=29% Similarity=0.451 Sum_probs=201.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcc--cccccccceeeeeeccc----ceeeEE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEAL----NRLLVY 582 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~----~~~lv~ 582 (799)
+.+.||+|.||.||||.+. ++.||||++.. +....|++|-.+... ++|+||+++++.-..+. +.+||+
T Consensus 214 l~eli~~Grfg~V~KaqL~---~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD---NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hHHHhhcCccceeehhhcc---CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 4688999999999999995 58999999964 445577777777664 68999999999986665 789999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC------NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
||.+.|+|.++|.. ..++|....+|+..+++||+|||++. +++|+|||||++||||.+|+++.|+|||+|..+
T Consensus 288 ~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999999976 46899999999999999999999863 678999999999999999999999999999988
Q ss_pred cCCCCcce-eeeccCCcccccccccCC-CCC-----cchhHHHHHHHHHHHHhCCcCCch--------hhhhh-cc-hhH
Q 038294 657 LSDQSRTH-TMIRGTRGYVAPEWFKNA-PVS-----AKVDVYSFGVMLLEIICCRRSVEM--------EVEEE-GR-AIL 719 (799)
Q Consensus 657 ~~~~~~~~-~~~~gt~~y~aPE~l~~~-~~s-----~k~DVwS~Gvll~elltg~~p~~~--------~~~~~-~~-~~~ 719 (799)
........ ...+||.+|||||++.+. .+. .+.||||+|.+||||+++-.-.+. ..+.+ +. ..+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 65443222 236799999999999765 222 368999999999999987544321 11111 11 111
Q ss_pred HHHHHHHHhcCce-eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 038294 720 TDWAYDCYAEGRL-DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785 (799)
Q Consensus 720 ~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 785 (799)
.+ +...+-..+. ..+.+. ......+..+.+.+..||+.||+.|.|+.=|-+.+..+....+
T Consensus 447 e~-mq~~VV~kK~RP~~p~~----W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 447 EE-MQELVVRKKQRPKIPDA----WRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HH-HHHHHHhhccCCCChhh----hhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 11 1111111111 111111 1123556678899999999999999999999998887766554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=338.85 Aligned_cols=246 Identities=27% Similarity=0.365 Sum_probs=208.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.++||+|+.|.||.+.-.. +++.||||++........+-+.+|+.+|+..+|+|||+++..+..+++.|+|||||++|+
T Consensus 278 ~~kigqgaSG~vy~A~~~~-~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 278 FKKIGQGATGGVYVARKIS-TKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhhccccccceeeeeecc-CCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 3679999999999998764 678999999987666667778999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeecc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 669 (799)
|.+.+... .+++.++..|+.++++||+|||.+ +|+|||||.+|||++.++.+||+|||++..+...+.+.. ..+|
T Consensus 357 LTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~-TmVG 431 (550)
T KOG0578|consen 357 LTDVVTKT-RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS-TMVG 431 (550)
T ss_pred hhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc-cccC
Confidence 99998654 488999999999999999999998 999999999999999999999999999998866655443 3469
Q ss_pred CCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHH
Q 038294 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749 (799)
Q Consensus 670 t~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 749 (799)
|+.|||||+...+.|.+|+||||||++++||+-|..||-.+.+-. ..+-...+|.. .-.......
T Consensus 432 TPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-------AlyLIa~ng~P--------~lk~~~klS 496 (550)
T KOG0578|consen 432 TPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-------ALYLIATNGTP--------KLKNPEKLS 496 (550)
T ss_pred CCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-------HHHHHhhcCCC--------CcCCccccC
Confidence 999999999999999999999999999999999999998643321 12211222221 112233455
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 750 QKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 750 ~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+.+++.+||+.|+++||++.|+|+.
T Consensus 497 ~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 497 PELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred HHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 678889999999999999999999863
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=336.21 Aligned_cols=249 Identities=28% Similarity=0.372 Sum_probs=207.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..|.+.||+|+|++|++|+.+. +++++|||++.+. .+...+....|-.+|.+| .||.|++|+--|.+...+|.|+
T Consensus 75 F~Fg~~lGeGSYStV~~A~~~~-t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL 153 (604)
T KOG0592|consen 75 FKFGKILGEGSYSTVVLAREKA-TGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL 153 (604)
T ss_pred cchhheeccccceeEEEeeecC-CCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence 3578999999999999999886 7899999999653 223344567788899999 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.++|.+...+++.-...++.+|+.||+|||+. +||||||||+|||||+++++||+|||-|+.+...+..
T Consensus 154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~ 230 (604)
T KOG0592|consen 154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS 230 (604)
T ss_pred EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence 9999999999999999999999999999999999999998 9999999999999999999999999999988543211
Q ss_pred ----------ce--eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 663 ----------TH--TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 663 ----------~~--~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
.. ...+||..|.+||++.....+..+|+|+|||+||+|+.|+.||...++-. .+...+.
T Consensus 231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~~------ 301 (604)
T KOG0592|consen 231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQA------ 301 (604)
T ss_pred ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHHH------
Confidence 11 34789999999999999999999999999999999999999998765432 1111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
++...+... .+.+.+|+.+.|..||.+|+|.++|.+..
T Consensus 302 -----l~y~fp~~f----p~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 302 -----LDYEFPEGF----PEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -----hcccCCCCC----CHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111222222 25667789999999999999999987653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=322.58 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=206.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.++||.|..++||+|.... .++.||||++.-.... ..+++.+|+..+..++||||++++-.|..+...|+||.||
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p-~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIP-TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred eeEEEEEeccceeEeeeeeecc-cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 4567899999999999999874 5699999999643333 2578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
.+|++.++++.. ..+++..+.-|..++++||.|||++ +.||||||+.||||+++|.+||+|||.+-.+.....+.
T Consensus 107 a~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~ 183 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ 183 (516)
T ss_pred cCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence 999999999864 4688889999999999999999998 99999999999999999999999999887665433222
Q ss_pred e---eeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 664 H---TMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~---~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
. ...+||+.|||||++.. ..|+.|+||||||+...||.+|..||....+-. .....+. +....+...
T Consensus 184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmk-------vLl~tLq-n~pp~~~t~ 255 (516)
T KOG0582|consen 184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMK-------VLLLTLQ-NDPPTLLTS 255 (516)
T ss_pred eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHH-------HHHHHhc-CCCCCcccc
Confidence 1 34579999999999643 368999999999999999999999998553322 1111111 111111111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+..........+.+++..||++||.+|||++++++
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 2222233445557889999999999999999999885
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.06 Aligned_cols=257 Identities=22% Similarity=0.320 Sum_probs=205.3
Q ss_pred HHhhchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.....+.+.||+|+||.||+|.++. ..+..||+|.++... ....+.|.+|+.++.+++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 3455677899999999999998753 345789999987643 2334678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
||||+++|+|.+++... ..+++..+++++.||+.||+|||+. +++||||||+|||++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999764 4689999999999999999999998 8999999999999999999999999987654222
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+ ..+.+..+.. .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--------~~~~~~~~~~-----~ 227 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--------VIKAVEDGFR-----L 227 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCC-----C
Confidence 1111112234678999999999999999999999999999875 999987553322 1111222211 0
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
. ........+.+++..||+.+|++||++++|++.|+++
T Consensus 228 ~----~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 P----APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C----CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 1122345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=335.90 Aligned_cols=238 Identities=31% Similarity=0.466 Sum_probs=199.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCCh
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
+=||.|+-|.||+|+++ ++.||||+++... ..+++-|++|+|+||+++.|+|....-.+||||||+.|-|
T Consensus 130 eWlGSGaQGAVF~Grl~---netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 130 EWLGSGAQGAVFLGRLH---NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhccCcccceeeeecc---CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 34999999999999996 6899999986432 3478889999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccC
Q 038294 591 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670 (799)
Q Consensus 591 ~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 670 (799)
.++|+....+.-....++..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++..... .+.-.+.||
T Consensus 200 ~~VLka~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 200 YEVLKAGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HHHHhccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 99999999999999999999999999999998 8999999999999999999999999999876433 223346799
Q ss_pred CcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHH
Q 038294 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQ 750 (799)
Q Consensus 671 ~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 750 (799)
..|||||++++.+.++|+|||||||+|||||||..|+......- ++ .-+....+.. ..+....+
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA---II-----wGVGsNsL~L--------pvPstcP~ 338 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA---II-----WGVGSNSLHL--------PVPSTCPD 338 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe---eE-----EeccCCcccc--------cCcccCch
Confidence 99999999999999999999999999999999999987543211 00 0011111111 12333445
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 751 KWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 751 ~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.+.-|+.+||+-.|.+||++++|+..|+-
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 67779999999999999999999999863
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=331.74 Aligned_cols=246 Identities=19% Similarity=0.274 Sum_probs=199.7
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhh---HHHHHHHHHHhcccccccccceeeeeec----ccceeeEEe
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e 583 (799)
..||+|++|.||+|.+ +++.||||+++...... .+.|.+|+.++.+++||||++++|++.+ ....++|||
T Consensus 26 ~~i~~g~~~~v~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E 102 (283)
T PHA02988 26 VLIKENDQNSIYKGIF---NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102 (283)
T ss_pred eEEeeCCceEEEEEEE---CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence 4699999999999998 47899999997643322 4678899999999999999999999876 346789999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++....+++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999998888999999999999999999999742 67899999999999999999999999998653321
Q ss_pred eeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+ ....+..+... ...
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~--------~~~~i~~~~~~----~~~- 243 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE--------IYDLIINKNNS----LKL- 243 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhcCCC----CCC-
Confidence 12347889999999976 689999999999999999999999998553221 11111111110 011
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+....+.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 244 ---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 ---PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1123456888999999999999999999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=331.86 Aligned_cols=260 Identities=25% Similarity=0.369 Sum_probs=215.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|.||.||||+-+. +.+.||+|.+.+. .++..+.+.+|++++++++|||||.+++.|+...+.++|.||+
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~-t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKY-TIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hHHHHhcCCccceeeeccccc-ceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 356889999999999999875 7899999998653 3344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
.+ +|..+|.....++++.+..|+.++..||.|||+. +|+|||+||+|||++.++.+|++|||+|+.+... ....+
T Consensus 84 ~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~vlt 158 (808)
T KOG0597|consen 84 VG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TSVLT 158 (808)
T ss_pred hh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC-ceeee
Confidence 87 9999999999999999999999999999999998 9999999999999999999999999999987543 33456
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
.+.|||-|||||+..+.+|+..+|.||+||+|||+.+|+.||...... ..+..... |+. ..+
T Consensus 159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~-------~Lv~~I~~--------d~v---~~p 220 (808)
T KOG0597|consen 159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSIT-------QLVKSILK--------DPV---KPP 220 (808)
T ss_pred eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHH-------HHHHHHhc--------CCC---CCc
Confidence 678999999999999999999999999999999999999999865422 11211111 111 112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hhc-CcCCCCCCCCCc
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEG-LLEVPNPPCPSS 791 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~-~~~~~~p~~p~~ 791 (799)
......+..++...|++||..|.|..+++.. .++ +..+..|-+|..
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~ 269 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAF 269 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccc
Confidence 3566778889999999999999999998753 233 333444444433
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=334.09 Aligned_cols=263 Identities=27% Similarity=0.384 Sum_probs=220.8
Q ss_pred cChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc
Q 038294 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL 576 (799)
Q Consensus 497 ~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 576 (799)
.+.-|+.+....+.++||-|.||.||.|.++.. ...||||.++... ...++|+.|..+|+.++|||+|+|+|+|....
T Consensus 259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKky-slTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKY-SLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred cchhhccchheeeeeccCCCcccceeeeeeecc-ceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 344577777778889999999999999999863 5789999998754 45689999999999999999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
..|||.|||.+|+|.++|+... .++--..+.++.||+.|++||... .+|||||.++|+|+.++..+||+|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999998753 456667789999999999999998 89999999999999999999999999999
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
++..+.........-++.|.|||.+....++.|+|||+|||+||||.| |..|+-+..- ..++.+++.|-.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl--------SqVY~LLEkgyR- 484 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYGLLEKGYR- 484 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH--------HHHHHHHhcccc-
Confidence 997765444433345778999999999999999999999999999998 6667654322 224555554421
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
-..+....+++.++++.||+-.|.+||++.|+.+.+|.+.
T Consensus 485 --------M~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 485 --------MDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred --------ccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1123344568899999999999999999999999998765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=327.53 Aligned_cols=244 Identities=27% Similarity=0.405 Sum_probs=213.4
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
.+.||+|.||.||||.+.. +++.||+|++.-... ...+++.+|+.++..++|+||.+++|.+..+...+++|||+.+|
T Consensus 18 ~~~IgrGsfG~Vyk~~d~~-t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gG 96 (467)
T KOG0201|consen 18 LELIGRGSFGEVYKAIDNK-TKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGG 96 (467)
T ss_pred chhccccccceeeeeeecc-ccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCc
Confidence 4789999999999999875 689999999975433 34578899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeec
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 668 (799)
++.+.|.....+++....-|..+++.||.|||.+ +.+|||||+.|||+..+|.+|++|||++..+.....+. ...+
T Consensus 97 sv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr-~tfv 172 (467)
T KOG0201|consen 97 SVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR-KTFV 172 (467)
T ss_pred chhhhhccCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc-cccc
Confidence 9999998877777777888899999999999999 89999999999999999999999999999887666555 5567
Q ss_pred cCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHH
Q 038294 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR 748 (799)
Q Consensus 669 gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 748 (799)
||+.|||||++....|+.|+||||||++.+||.+|..|+....+. +...++....+...+...
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-----------------rvlflIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-----------------RVLFLIPKSAPPRLDGDF 235 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-----------------eEEEeccCCCCCcccccc
Confidence 999999999999889999999999999999999999998754321 233444555555556677
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 749 LQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 749 ~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+++..||++||++||++.++++
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 888999999999999999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=334.21 Aligned_cols=247 Identities=27% Similarity=0.397 Sum_probs=205.4
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc----ch-hhHHHHHHHHHHhcccc-cccccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL----AQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~ 579 (799)
.+.+.+.||+|.||+|++|.... +++.||+|.+... .. ...+.+.+|+.++++++ ||||++++.++......+
T Consensus 18 ~y~~~~~lG~GsfgkV~~a~~~~-t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 18 KYELGRTLGSGSFGKVKLAKHRL-TGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred ceeeeeeecCCCCeeEEEeeecc-CCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 34566889999999999998875 5799999977542 11 23456678999999998 999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEccccCcccccC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLS 658 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl~DfGla~~~~~ 658 (799)
+||||+.+|+|.+++.....+.+....+++.|++.|++|+|+. +|+||||||+|||++.+ +++||+|||++....
T Consensus 97 ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~- 172 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISP- 172 (370)
T ss_pred EEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccC-
Confidence 9999999999999999988899999999999999999999998 99999999999999999 999999999999874
Q ss_pred CCCcceeeeccCCcccccccccCCC-CC-cchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAP-VS-AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~-~s-~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
.........+||+.|+|||++.+.. |+ .++||||+||+||-|++|+.||+...... ....+..+...
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--------l~~ki~~~~~~--- 241 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--------LYRKIRKGEFK--- 241 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--------HHHHHhcCCcc---
Confidence 2223445567999999999999987 86 68999999999999999999998633211 22223333221
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
.+.... ...+..++.+|++.+|.+|+|+.+|+
T Consensus 242 ---~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 242 ---IPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---CCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 122111 56788899999999999999999998
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=376.14 Aligned_cols=258 Identities=26% Similarity=0.537 Sum_probs=207.7
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
..+.||+|+||.||+|..+. +++.||||+++..... ...|++.+++++|||||+++|+|.+....++||||+++|
T Consensus 694 ~~~~ig~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g 768 (968)
T PLN00113 694 EENVISRGKKGASYKGKSIK-NGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGK 768 (968)
T ss_pred cccEEccCCCeeEEEEEECC-CCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence 34579999999999999864 6789999998653322 234688899999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeec
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 668 (799)
+|.++++ .++|..+.+|+.|||+||+|||+.+..+|+||||||+||+++.++.+++. |+.+...... ....
T Consensus 769 ~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~-----~~~~ 839 (968)
T PLN00113 769 NLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD-----TKCF 839 (968)
T ss_pred cHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-----CCcc
Confidence 9999996 38899999999999999999997766799999999999999999888876 6655433221 1224
Q ss_pred cCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC--ccCH
Q 038294 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA--MADR 746 (799)
Q Consensus 669 gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~ 746 (799)
+++.|+|||++.+..++.++|||||||++|||++|+.|++..... ...+..|+............+++.... ....
T Consensus 840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 917 (968)
T PLN00113 840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV--HGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ 917 (968)
T ss_pred ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC--CCcHHHHHHHhcCccchhheeCccccCCCCccH
Confidence 788999999999999999999999999999999999998643221 122334554444444444455554432 2345
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
++..++.+++.+||+.+|++||||+||+++|+++..
T Consensus 918 ~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 667788999999999999999999999999998765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=339.45 Aligned_cols=258 Identities=28% Similarity=0.385 Sum_probs=202.1
Q ss_pred HHhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 577 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 577 (799)
.....+.+.||+|+||.||+|+.. ..++..||||+++... ....+.+.+|++++..+ +||||++++++|.+...
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 334566789999999999999742 2345689999996432 23345788999999999 89999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcCC-----------------------------------------------------------
Q 038294 578 RLLVYEFMGNGTLANLIFAIP----------------------------------------------------------- 598 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 598 (799)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999886421
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 599 ----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 599 ----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
.+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 367888999999999999999998 9999999999999999999999999999866433221
Q ss_pred c-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 663 T-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 663 ~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
. .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... . ..+.+..+... ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~---~----~~~~~~~~~~~-----~~ 338 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS---K----FYKMIKEGYRM-----LS 338 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH---H----HHHHHHhCccC-----CC
Confidence 1 112234668999999999999999999999999999998 777876432211 1 11222222110 01
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
+. .....+.+++.+||+.||++||+|.||+++|++.
T Consensus 339 ~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 339 PE----CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CC----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11 1234678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.21 Aligned_cols=261 Identities=25% Similarity=0.369 Sum_probs=216.0
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCC-CC--eEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccc
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSA-SG--KAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL 576 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~-~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 576 (799)
+|.+......+.||.|.||.||+|++.+. .| -.||||..+... ....+.|+.|..+|++++||||++|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 45555556778999999999999998643 22 368999987633 34467899999999999999999999999764
Q ss_pred ceeeEEeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
..+||||.++-|.|.++|...+ .++......++.||+.||+|||+. +.+||||..+|||+.....+||+|||+++.
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhh
Confidence 6799999999999999998764 788888899999999999999998 899999999999999999999999999999
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
+..+.....+...-+..|||||.+.-++++.++|||-|||.+|||++ |.+||.+....+. -.
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~ 603 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IG 603 (974)
T ss_pred ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EE
Confidence 87766555555556889999999999999999999999999999987 7889986543221 11
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+....+-..+......+..++.+||+++|.+||++.|+...|+.+++
T Consensus 604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 122222223344556688899999999999999999999988876554
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.81 Aligned_cols=249 Identities=33% Similarity=0.520 Sum_probs=194.7
Q ss_pred hhhhcCccccceEEEEEEe---CCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLK---SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.||.|.||.||+|.+. ...+..|+||.++... ....++|.+|++.+++++||||++++|+|......++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999998 2234789999996533 33467899999999999999999999999988889999999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS- 661 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 661 (799)
+++|+|.++|... ..+++..+.+|+.||++||+|||+. +++|++|+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987 6789999999999999999999998 899999999999999999999999999987632221
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
...........|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ....+.++...
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~--------~~~~~~~~~~~------- 224 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE--------IIEKLKQGQRL------- 224 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH--------HHHHHHTTEET-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccccc-------
Confidence 11222346778999999999889999999999999999999 678876442221 11222332210
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.........+.+++.+||+.+|++||||.+|++.|
T Consensus 225 --~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 225 --PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 01112345678899999999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=329.07 Aligned_cols=261 Identities=25% Similarity=0.358 Sum_probs=199.6
Q ss_pred hhchhhhcCccccceEEEEEEeC---------------CCCeEEEEEEccccc-hhhHHHHHHHHHHhccccccccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS---------------ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLL 569 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~---------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 569 (799)
.+.+.++||+|+||.||++.++. ..+..||+|.+.... .....+|.+|++++.+++||||++++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 85 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLL 85 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEE
Confidence 34567889999999999998642 133579999987543 33456799999999999999999999
Q ss_pred eeeecccceeeEEeecCCCChhhhhhcC-------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEec
Q 038294 570 GFCDEALNRLLVYEFMGNGTLANLIFAI-------------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHC 630 (799)
Q Consensus 570 g~~~~~~~~~lv~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~ 630 (799)
+++.+....++||||+++|+|.+++... ..+++....+++.||+.||+|||+. +|+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~ 162 (304)
T cd05096 86 GVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHR 162 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence 9999999999999999999999988642 2357888999999999999999998 89999
Q ss_pred CCCCCCeEEcCCCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh--CCcCC
Q 038294 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC--CRRSV 707 (799)
Q Consensus 631 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt--g~~p~ 707 (799)
||||+|||+++++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++|||++ +..|+
T Consensus 163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~ 242 (304)
T cd05096 163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY 242 (304)
T ss_pred CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999999999865433221 1122345788999999998899999999999999999987 45566
Q ss_pred chhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 708 EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 708 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
......+. + .............. .. .. .......+.+++.+||+.+|++||||.||++.|++
T Consensus 243 ~~~~~~~~---~-~~~~~~~~~~~~~~-~~-~~----~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 243 GELTDEQV---I-ENAGEFFRDQGRQV-YL-FR----PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CcCCHHHH---H-HHHHHHhhhccccc-cc-cC----CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 54332211 1 11111111111100 00 00 11223578889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=301.45 Aligned_cols=233 Identities=27% Similarity=0.319 Sum_probs=202.5
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+...||.|+||.|.+++.+. ++..+|+|+++...- +..+...+|..+|+.+.||.++++.+-+.+.+..+|||||+
T Consensus 48 ~~~tlGtGSFGrV~LVr~k~-~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 48 RLKTLGTGSFGRVHLVREKH-SGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred heeeeccCccceEEEEEEcc-CCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 34679999999999999986 589999999976432 33456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+||.|..+|++..+++.....-+|.||+.||+|||+. .|++|||||+|||||.+|.+||+|||.|+..... .-
T Consensus 127 ~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r----T~ 199 (355)
T KOG0616|consen 127 PGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR----TW 199 (355)
T ss_pred CCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc----EE
Confidence 9999999999999999999999999999999999998 9999999999999999999999999999976332 45
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..+|||.|+|||++..+.+..++|-|||||++|||+.|..||...... ..++.+.++++.- +
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~--------~iY~KI~~~~v~f----------P 261 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI--------QIYEKILEGKVKF----------P 261 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH--------HHHHHHHhCcccC----------C
Confidence 578999999999999999999999999999999999999999876542 2556666665421 3
Q ss_pred HHHHHHHHHHHHHhcccCCCCC
Q 038294 746 RSRLQKWLMIAMWCIREDPSKR 767 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~R 767 (799)
......+.+++...|+.|-.+|
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhh
Confidence 3344566778888889898888
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.43 Aligned_cols=253 Identities=28% Similarity=0.419 Sum_probs=204.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
...+.+.||+|+||.||+|..+. .++.||+|.++.. ....+++.+|++++++++|+||+++++++......+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HeEEeeecCCcccceEEEEEEec-CCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34566789999999999999875 5789999998753 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..++.++.|+++||+|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998754 3578999999999999999999998 89999999999999999999999999998764432221
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......+..|+|||.+.+..++.++||||||+++|||++ |..|+.....++ ..+....+. ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~-----~~~--- 225 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKGY-----RME--- 225 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCC-----CCC---
Confidence 112224568999999999999999999999999999998 888886543221 111111110 011
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
........+.+++.+||+.+|++||++.+++++|+.+
T Consensus 226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1122335788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=337.46 Aligned_cols=258 Identities=27% Similarity=0.399 Sum_probs=202.2
Q ss_pred HhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 578 (799)
....+.+.||+|+||.||+|.... .+++.||+|+++... ....+.+.+|+++++.+ +|+||++++++|......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 345567899999999999998632 234589999997533 33345788999999999 899999999999999999
Q ss_pred eeEEeecCCCChhhhhhcC-------------------------------------------------------------
Q 038294 579 LLVYEFMGNGTLANLIFAI------------------------------------------------------------- 597 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 597 (799)
++||||+++|+|.+++...
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 9999999999999988532
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce-eee
Q 038294 598 ---------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-TMI 667 (799)
Q Consensus 598 ---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 667 (799)
..+++....+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......... ...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1357788899999999999999998 999999999999999999999999999986543322111 122
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
.++..|+|||++.+..++.++|||||||++|||++ |+.||........ .......+. ....+.
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-------~~~~~~~~~-----~~~~~~---- 338 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-------FYKMVKRGY-----QMSRPD---- 338 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-------HHHHHHccc-----CccCCC----
Confidence 34668999999998899999999999999999997 9999875432211 111111111 011111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.....+.+++.+||+.||++|||+.+|+++|++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 12356788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=332.22 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=213.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+-||+|+-|.|-.|++.. +|+.+|||++.+.. ......+..|+.+|+.+.|||++++++++.+..+.|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~-TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAE-TGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhccc-ccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 3456789999999999999875 79999999996542 2223467889999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|-|.+++...+.+.+....+++.||+.|+.|+|.. +|+||||||+|+|||..+++||+|||||.+...+ +.
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--kl 167 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--KL 167 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC--cc
Confidence 999999999999999999999999999999999999998 9999999999999999999999999999875433 33
Q ss_pred eeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
....+|++.|.|||++.+.+| ..++||||.|||||.||+|+.||+..+. +-+..++..|..+. |
T Consensus 168 LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi--------r~LLlKV~~G~f~M------P- 232 (786)
T KOG0588|consen 168 LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI--------RVLLLKVQRGVFEM------P- 232 (786)
T ss_pred ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH--------HHHHHHHHcCcccC------C-
Confidence 445679999999999999998 4689999999999999999999984432 22445566665543 2
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLE 782 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~ 782 (799)
.....++.+++.+|+..||+.|.|++||++. |.+-..
T Consensus 233 ---s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 233 ---SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ---CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 2334567789999999999999999999974 444433
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=332.21 Aligned_cols=260 Identities=25% Similarity=0.380 Sum_probs=203.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+...+.||+|+||.||++..+. ++..+|+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 85 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKP-SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 85 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECC-CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecC
Confidence 3455789999999999999874 67899999986532 334567999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 86 ~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~ 160 (331)
T cd06649 86 DGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---AN 160 (331)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc---cc
Confidence 99999999988788899999999999999999999852 69999999999999999999999999987653221 22
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc--------------
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR-------------- 731 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 731 (799)
...|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ......+.
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF----GRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh----cccccccccCCccccCcccccc
Confidence 345899999999999999999999999999999999999999654322111000 00000000
Q ss_pred --------------------eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 732 --------------------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 732 --------------------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+.....+..........+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000001111111122345678899999999999999999999865
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.88 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=208.0
Q ss_pred chhhhcCccccceEEEEEEeCCCC---eEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.-.++||+|+||+||||.+.-..+ -+||+|++... ..+...++++|+.+|.+++||||+||+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 345789999999999999864322 37899998653 3455679999999999999999999999998776 789999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+.|+|.++++.. ..+.-+..+.|..|||+||.|||.+ +++||||.++||||..-..+||+|||+++.+..+...
T Consensus 778 ~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred hcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999865 4678888999999999999999998 8999999999999999999999999999998765433
Q ss_pred ce-eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 663 TH-TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 663 ~~-~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
-. ....-.+.|||-|.+....|+.++|||||||.+||++| |..|++....++.. +.++.|..
T Consensus 855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~--------dlle~geR-------- 918 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP--------DLLEKGER-------- 918 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh--------HHHhcccc--------
Confidence 22 22334678999999999999999999999999999998 78898876555432 23333321
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
-..+.-....+..++.+||..|++.||+++++...+.++..
T Consensus 919 -LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 919 -LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 11122334567889999999999999999999998876554
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=317.34 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=205.1
Q ss_pred HHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 503 KEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 503 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
......+.+.||+|++|.||+|... +++.||+|.++... ...+++.+|+.++++++|+||+++++++......+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWN--NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVT 80 (261)
T ss_pred chhheeeEEEecccCCccEEEEEec--CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeee
Confidence 3445567789999999999999875 35789999986533 34567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 583 EFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||+++++|.+++.... .+++..+.+++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999997654 689999999999999999999998 89999999999999999999999999998765322
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.........+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+.. .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~-----~- 223 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--------VLQQVDQGYR-----M- 223 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC-----C-
Confidence 211111223457999999999999999999999999999999 888886543221 1111111110 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.......+.+.+++.+|++.+|++||++.++++.|+.+
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 224 ---PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred ---CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 01122346788899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=331.43 Aligned_cols=242 Identities=26% Similarity=0.317 Sum_probs=199.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|+||.||++..+. +++.||+|+++... ......+.+|+.++++++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKA-TGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 368999999999999874 68899999987532 23345678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 99999998888899999999999999999999998 99999999999999999999999999987532221 122335
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..+.. ..+ ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--------~~~~~~~~~~------~~p----~~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--------LFELILMEEI------RFP----RT 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCCC------CCC----CC
Confidence 68999999999999999999999999999999999999997543221 1111111111 111 22
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 345678899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=319.29 Aligned_cols=254 Identities=28% Similarity=0.453 Sum_probs=204.6
Q ss_pred hchhhhcCccccceEEEEEEeCCC----CeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSAS----GKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.+.||+|+||.||+|...... .+.|++|.+.... .....+|.+|++++.+++||||+++++++......+++
T Consensus 7 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 7 VRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred cchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 345688999999999999876422 2679999986433 23346789999999999999999999999988899999
Q ss_pred EeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 038294 582 YEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~ 645 (799)
+||+++++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+||++++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcE
Confidence 9999999999998754 3467888999999999999999998 89999999999999999999
Q ss_pred EEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHH
Q 038294 646 KISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 646 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 723 (799)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ .
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~--------~ 235 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE--------V 235 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence 9999999986543221 12223346788999999998899999999999999999998 999987543322 1
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
...+..+... .........+.+++.+||+.+|++||++.||++.|+++
T Consensus 236 ~~~i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 236 IEMIRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1222222211 11223456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=315.26 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=199.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.+.||+|+||.||++.++ ++..+|+|.+... ....+++.+|+.++++++||||+++++++.+....++||||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~--~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 6 LTFMKELGSGQFGVVHLGKWR--AQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred cEEeeEecCCcCceEEEEEec--cCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 345678999999999999886 3568999988643 2335678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+|+|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999998754 4688999999999999999999998 8999999999999999999999999998865433222222
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+... ..
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~--------~~~i~~~~~~-----~~---- 222 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV--------VEMISRGFRL-----YR---- 222 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHHCCCCC-----CC----
Confidence 2234668999999998899999999999999999999 8888865432211 1111221100 00
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
+......+.+++.+||+.+|++||+|.++++.|.
T Consensus 223 ~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 223 PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112356789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=320.79 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=207.3
Q ss_pred hchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.||+|+||.||+|.... .++..+++|.++.......+.+.+|++++++++|+||+++++++......++||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 3456789999999999998642 234679999997766666678999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 038294 583 EFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAK 646 (799)
Q Consensus 583 e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~k 646 (799)
||+++++|.+++... ..+++..+++++.||+.||+|||+. +|+||||||+|||+++++.+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 999999999998643 2378999999999999999999998 899999999999999999999
Q ss_pred EccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHH
Q 038294 647 ISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAY 724 (799)
Q Consensus 647 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 724 (799)
|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ..
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--------~~ 235 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--------VI 235 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HH
Confidence 999999976543321 11222346778999999999999999999999999999999 899886543322 11
Q ss_pred HHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 725 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+....+.... ........+.+++.+||+.+|++|||+++|+++|+.+..
T Consensus 236 ~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 236 ECITQGRVLE---------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHhCCCCCC---------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1222222211 111234567899999999999999999999999998855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.31 Aligned_cols=247 Identities=26% Similarity=0.311 Sum_probs=198.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
..+.||+|+||.||++.... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++|+||+
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCEEEEEEEEec-CCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 45789999999999999875 67899999986432 223346789999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 83 ~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05631 83 NGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE--T 157 (285)
T ss_pred CCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--e
Confidence 999999888643 3578999999999999999999998 99999999999999999999999999998653222 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||........... ......... ..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~----------~~ 223 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE----VDRRVKEDQ----------EE 223 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH----HHHHhhccc----------cc
Confidence 2334689999999999999999999999999999999999999986533211111 111111111 01
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
......+.+.+++.+||+.||++||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 12223456788999999999999997 788886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.81 Aligned_cols=251 Identities=22% Similarity=0.278 Sum_probs=203.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+|..+. +++.||+|+++... ....+.+.+|++++..++||||+++++++.+....++||||
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKD-TGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred EEEEEEeecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 356789999999999999874 57899999997532 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++++|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..... ..
T Consensus 83 ~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~~ 155 (333)
T cd05600 83 VPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----YA 155 (333)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----cc
Confidence 99999999998878889999999999999999999998 999999999999999999999999999986533 22
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .... ...........
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i--------~~~~--~~~~~~~~~~~ 225 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL--------KYWK--ETLQRPVYDDP 225 (333)
T ss_pred CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH--------Hhcc--ccccCCCCCcc
Confidence 3345899999999999999999999999999999999999999765433211111 1100 00000001101
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.......+.+++.+||+.+|++||++.++++.
T Consensus 226 ~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 226 RFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 12335677889999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=315.38 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=202.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+.+....++++||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYN--NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred eEEeeecCCcCCceEEEEEec--CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 445688999999999999875 45689999986532 235688999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++...........
T Consensus 85 ~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 85 KGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred CCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 99999999753 4678899999999999999999997 899999999999999999999999999987643322222
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....++..|+|||.+....++.++||||||+++|||++ |+.||........ ...+..+.. . +
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~-----~--~-- 224 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV--------MSALQRGYR-----M--P-- 224 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH--------HHHHHcCCC-----C--C--
Confidence 22335678999999998899999999999999999998 8888865432221 111111110 0 0
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
........+.+++.+|++.+|++||+++++++.|+++
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 225 RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1112335678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=328.06 Aligned_cols=239 Identities=23% Similarity=0.292 Sum_probs=195.1
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|+||.||++..+. +++.||+|+++.. .......+..|+.++++++||||+++++++.+....++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRD-TQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 7999999999999874 5789999998643 22334578889999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeecc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 669 (799)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~g 155 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCG 155 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC-ccccccC
Confidence 999998877899999999999999999999998 999999999999999999999999999986432222 2233468
Q ss_pred CCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHH
Q 038294 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749 (799)
Q Consensus 670 t~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 749 (799)
|+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+..+.. .. +....
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--------~~~~~~~~~~------~~----~~~~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--------MYRKILQEPL------RF----PDGFD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcCCC------CC----CCcCC
Confidence 999999999999999999999999999999999999997543221 1111111111 11 12233
Q ss_pred HHHHHHHHHhcccCCCCCCC---HHHHH
Q 038294 750 QKWLMIAMWCIREDPSKRPT---MKVVL 774 (799)
Q Consensus 750 ~~l~~l~~~Cl~~dP~~RPt---~~evl 774 (799)
+.+.+++.+||+.||++||+ +.|++
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 56778999999999999986 45554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=320.11 Aligned_cols=267 Identities=22% Similarity=0.291 Sum_probs=214.2
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+||+|+||.||+++-++ +|+.+|+|++++... ...+..+.|-.+|...+++.||+|+..|.+...+||||||++
T Consensus 146 Lk~IgkGAfGeVrLarKk~-Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylP 224 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKD-TGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLP 224 (550)
T ss_pred heeeccccceeEEEEEEcc-CCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecC
Confidence 3679999999999999875 799999999976432 334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC--------
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-------- 658 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~-------- 658 (799)
||++..+|.....+++.....++.+++.|++-||+. ++|||||||+|+|||..|++||+||||+.-+..
T Consensus 225 GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~ 301 (550)
T KOG0605|consen 225 GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYR 301 (550)
T ss_pred CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhc
Confidence 999999999999999999999999999999999998 999999999999999999999999999854311
Q ss_pred ---------------CCCc----c-------------------eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHH
Q 038294 659 ---------------DQSR----T-------------------HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEI 700 (799)
Q Consensus 659 ---------------~~~~----~-------------------~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~el 700 (799)
+... . ....+|||.|||||++.++.|+..+|.||+|||+|||
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEm 381 (550)
T KOG0605|consen 302 LDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEM 381 (550)
T ss_pred chhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHH
Confidence 0000 0 0113599999999999999999999999999999999
Q ss_pred HhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 038294 701 ICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT---MKVVLQML 777 (799)
Q Consensus 701 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~L 777 (799)
|.|-.||....+.+.-..+..|...... | .......+..++|++|+. ||++|.- ++||-+.=
T Consensus 382 LvGyPPF~s~tp~~T~rkI~nwr~~l~f------------P--~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP 446 (550)
T KOG0605|consen 382 LVGYPPFCSETPQETYRKIVNWRETLKF------------P--EEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP 446 (550)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhhhccC------------C--CcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence 9999999988776654444444322111 1 111222677889999999 9999976 55554321
Q ss_pred -------hcCcCCCCCCCCCceeec
Q 038294 778 -------EGLLEVPNPPCPSSFSIA 795 (799)
Q Consensus 778 -------~~~~~~~~p~~p~~~~~~ 795 (799)
+.+.+.++|-.|..-++.
T Consensus 447 fF~~v~W~~l~~~~apfvP~v~~~~ 471 (550)
T KOG0605|consen 447 FFKGVDWDHLREMPAPFVPQVNSEL 471 (550)
T ss_pred ccccCCcchhhcCCCCCCCCCCCcc
Confidence 445566766666655443
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=314.99 Aligned_cols=255 Identities=25% Similarity=0.397 Sum_probs=204.7
Q ss_pred hchhhhcCccccceEEEEEEeCC--CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.+.||+|+||.||+|.++.. +...||+|.++... .....+|.+|+.++++++|+||+++++++.+....+++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 44678899999999999998643 24589999986543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 86 YMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999764 4689999999999999999999997 8999999999999999999999999999877522211
Q ss_pred -ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 663 -THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 663 -~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ ....+..+... +
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~----~-- 228 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--------VIKAVEDGYRL----P-- 228 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--------HHHHHHcCCCC----C--
Confidence 1112234678999999999999999999999999999998 888885433221 11112221100 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
......+.+.+++.+|++.+|++||++.||++.|++++
T Consensus 229 ---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~~ 266 (266)
T cd05033 229 ---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266 (266)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 11223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=323.76 Aligned_cols=243 Identities=22% Similarity=0.262 Sum_probs=200.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 356789999999999999874 57899999986432 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----~ 155 (291)
T cd05612 83 VPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----T 155 (291)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC----c
Confidence 99999999998888889999999999999999999998 9999999999999999999999999999865322 1
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+..+.. ..+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~------~~~--- 218 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--------IYEKILAGKL------EFP--- 218 (291)
T ss_pred ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCc------CCC---
Confidence 23458999999999999999999999999999999999999997643322 1122222221 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 776 (799)
......+.+++.+||+.||.+||+ ++|+++.
T Consensus 219 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 -RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112346778999999999999995 8887754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=319.60 Aligned_cols=264 Identities=21% Similarity=0.235 Sum_probs=201.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+++.+. +++.+|+|+++... ....+.+.+|++++++++|+||+++++++......++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKE-TKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred eEEEEecccCCEEEEEEEECC-CCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 456789999999999999874 67899999986432 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++.|..+......+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||++............
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 83 EKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9988776665556788999999999999999999998 9999999999999999999999999999876443332333
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH--------HHHHHHhcCceeEeec
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD--------WAYDCYAEGRLDVLVD 737 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~d 737 (799)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ................
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence 44689999999999998999999999999999999999999976433221111100 0000001111100000
Q ss_pred CCCCCc------cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAM------ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..... ........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 01113456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=327.32 Aligned_cols=242 Identities=26% Similarity=0.317 Sum_probs=197.9
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|+||.||++..+. +++.||+|+++... ......+.+|++++++++||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCC
Confidence 368999999999999864 68899999986532 23345678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 99999998877889999999999999999999998 99999999999999999999999999987532221 122234
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||........ ...+..+.. ..+ ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--------~~~~~~~~~------~~p----~~ 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL--------FELILMEEI------RFP----RT 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH--------HHHHhcCCC------CCC----CC
Confidence 689999999999999999999999999999999999999975433221 111111111 111 12
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
....+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 345677899999999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=327.52 Aligned_cols=243 Identities=26% Similarity=0.308 Sum_probs=199.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|+||.||++..+. +++.||+|++.... ......+.+|+++++.++||||+++.+++......++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKA-SGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999999864 67899999996532 23345788899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ......
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 99999998878899999999999999999999998 99999999999999999999999999987542221 122334
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+..+. ...+ ..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~--------~~~~~~~~------~~~p----~~ 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------FELILMED------IKFP----RT 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH--------HHHhccCC------ccCC----CC
Confidence 689999999999999999999999999999999999999975433221 11111111 1111 12
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRP-----TMKVVLQM 776 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 776 (799)
....+.+++.+||+.||++|| ++.|+++.
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 345677899999999999997 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.01 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=205.3
Q ss_pred HhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
.+..+.+.||+|+||.||+|.... .+++.||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 445667899999999999998753 23578999999765443 4578999999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 038294 580 LVYEFMGNGTLANLIFAI--------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~ 645 (799)
++|||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 999999999999999753 2467888999999999999999998 89999999999999999999
Q ss_pred EEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHH
Q 038294 646 KISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 646 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 723 (799)
||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....++.
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~-------- 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV-------- 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH--------
Confidence 9999999976533221 11122335678999999999999999999999999999999 9999865433221
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
...+..+.... ........+.+++.+||+.+|++||++.||++.|++
T Consensus 234 ~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11122222111 112234567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=328.88 Aligned_cols=243 Identities=26% Similarity=0.310 Sum_probs=201.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+. +++.||+|.++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 98 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKG-TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLE 98 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEc
Confidence 4456889999999999999875 67899999986532 2234578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--- 172 (329)
T PTZ00263 99 FVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--- 172 (329)
T ss_pred CCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc---
Confidence 999999999998888889999999999999999999998 99999999999999999999999999998653321
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+.++... .+.
T Consensus 173 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--------~~~~i~~~~~~------~p~- 236 (329)
T PTZ00263 173 -FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR--------IYEKILAGRLK------FPN- 236 (329)
T ss_pred -ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH--------HHHHHhcCCcC------CCC-
Confidence 23468999999999999999999999999999999999999997543221 12222333211 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
.....+.+++.+||+.||++||+ +.++++
T Consensus 237 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 237 ---WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ---CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 12346778999999999999997 677763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=310.31 Aligned_cols=246 Identities=22% Similarity=0.372 Sum_probs=207.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|.||.|-++.... .|+.||||.+++..- +..-.+.+|+++|..++||||+.++.+|+..+...|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~-sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHK-SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred HHHHHHHhcCCcccceeehhhcc-CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 45567899999999999998753 689999999976443 33446789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||..+|.|.+++.....+++.....++.||..|+.|+|.+ +++|||||.+|||||.|+++||+|||++.++... +
T Consensus 133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~--k 207 (668)
T KOG0611|consen 133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADK--K 207 (668)
T ss_pred EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccc--c
Confidence 9999999999999999999999999999999999999998 9999999999999999999999999999887433 3
Q ss_pred ceeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
-....+|++-|.+||++.+.+| .+.+|.||+||+||-|+-|..||++..... +...+..|...+ +.-+
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------lvrQIs~GaYrE---P~~P 276 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------LVRQISRGAYRE---PETP 276 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--------HHHHhhcccccC---CCCC
Confidence 3456789999999999999998 578999999999999999999998764321 122233333221 1111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....-+|+|||-.+|++|.|+.+|...
T Consensus 277 --------SdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 277 --------SDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred --------chHHHHHHHHHhcCcccchhHHHHhhh
Confidence 234469999999999999999998754
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=327.61 Aligned_cols=201 Identities=26% Similarity=0.392 Sum_probs=174.6
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
...+.+.+.||+|+||.||++..+. +++.+|+|.++.. .....+.+.+|++++++++|+||+++++++.+....++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP-SGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC-CCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3445567889999999999999874 6788999988653 2334467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++++|.+++.....+++.....++.|++.||.|||+. .+|+|+||||+|||+++++.+||+|||++......
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 83 EHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 9999999999998877889999999999999999999974 26999999999999999999999999998765322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchh
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEME 710 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~ 710 (799)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 112345889999999999989999999999999999999999998754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=318.38 Aligned_cols=258 Identities=25% Similarity=0.426 Sum_probs=207.5
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
...+.+.||+|+||.||++.... .++..+|+|.+........+.+.+|++++++++|+||+++++++......++|
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 85 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 85 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 34567889999999999998632 24567999999776555667899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 582 YEFMGNGTLANLIFAIP-------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~-------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
+||+++++|.+++.... .+++..+.+++.|++.||+|||+. +++||||||+||++++++.+||+
T Consensus 86 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 86 FEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEec
Confidence 99999999999986432 478999999999999999999998 89999999999999999999999
Q ss_pred cccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHH
Q 038294 649 DFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 649 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--------~~~~ 234 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIEC 234 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH
Confidence 9999986543221 11122335678999999999999999999999999999998 888876543221 1122
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+..+.... . .......+.+++.+||+.+|.+|||+.||++.|+++...
T Consensus 235 i~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQ-----R----PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCC-----C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222111 1 112235688999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=331.62 Aligned_cols=260 Identities=24% Similarity=0.343 Sum_probs=203.4
Q ss_pred HHhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccch-hhHHHHHHHHHHhcccc-cccccceeeeeecccc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEALN 577 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~ 577 (799)
.....+.+.||+|+||.||+|+... ..+..||||+++.... ...+.+.+|+++++++. ||||++++++|.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 3344566899999999999998642 1235799999975433 33457899999999996 9999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcC------------------------------------------------------------
Q 038294 578 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 597 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 597 (799)
.++||||+++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999887642
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 598 ------------------------------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 598 ------------------------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
..+++..+.+++.||++||+|||+. +|+|+||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeC
Confidence 1366778889999999999999998 8999999999999999
Q ss_pred CCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhH
Q 038294 642 YFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~ 719 (799)
++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+........
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~---- 348 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST---- 348 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence 999999999999865433221 1122346778999999999999999999999999999997 8888865422110
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.......+.. ..........+.+++.+||+.+|++||++.+|+++|+.+.+
T Consensus 349 ---~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 349 ---FYNKIKSGYR---------MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ---HHHHHhcCCC---------CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 1112222210 00112234578889999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.13 Aligned_cols=248 Identities=28% Similarity=0.391 Sum_probs=199.1
Q ss_pred hcCccccceEEEEEEe-CCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 512 ELGRGSFGIVYKGVLK-SASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~-~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+||+|+||.||+|.++ ..+++.+|+|+++... ....+++.+|+.++++++|+||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 6899999999999764 2356889999986432 2345689999999999999999999999854 5678999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce--ee
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH--TM 666 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~--~~ 666 (799)
+|.+++.....+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.......... ..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCC
Confidence 9999998777889999999999999999999998 899999999999999999999999999987644332111 11
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+..+.. ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~i~~~~~-----~~~~---- 220 (257)
T cd05116 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--------VTQMIESGER-----MECP---- 220 (257)
T ss_pred CCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCC-----CCCC----
Confidence 234578999999988889999999999999999998 899987543221 1112222211 0111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
......+.+++.+||+.||++||++.+|++.|++.
T Consensus 221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 12345678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.63 Aligned_cols=247 Identities=25% Similarity=0.398 Sum_probs=197.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.||+|+||.||+|..+. +++.+|+|.+... ..+....+.+|++++++++||||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA-DNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEec-CCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 469999999999999875 5789999987643 23445679999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc-eeee
Q 038294 590 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT-HTMI 667 (799)
Q Consensus 590 L~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~ 667 (799)
|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......... ....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99999754 4688999999999999999999998 89999999999999999999999999987653221111 1111
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..+..|+|||.+.+..++.++||||||+++|||++ |..|+......... .....+. +.....
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~--------~~~~~~~---------~~~~~~ 219 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR--------EAIEQGV---------RLPCPE 219 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH--------HHHHcCC---------CCCCcc
Confidence 23457999999999999999999999999999998 77787644322111 1111110 001112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.....+.+++.+|++.+|++|||+.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 23457888999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=328.65 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=203.0
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||+|..+..++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 45567889999999999999876555789999986432 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 111 Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--- 184 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--- 184 (340)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC---
Confidence 9999999999998888899999999999999999999998 9999999999999999999999999999865322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+..+... .+.
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~------~p~ 249 (340)
T PTZ00426 185 -TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--------IYQKILEGIIY------FPK 249 (340)
T ss_pred -cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCCC------CCC
Confidence 223468999999999999889999999999999999999999997543321 12222222211 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 776 (799)
.....+.+++.+|++.||++|+ +++++++.
T Consensus 250 ----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 250 ----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 1234567899999999999995 89988764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.86 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=206.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.++||+|+||.||+|..+. ++.+++|.+.........++..|+.+++.++|+||+++++++......++||||+
T Consensus 7 ~y~~~~~ig~g~~~~vy~~~~~~--~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 7 EFTLERKLGSGYFGEVWEGLWKN--RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHhhhhccCCCccEEEeEecC--CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 34567899999999999999874 7899999998765555678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+.+++.||+.||+|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~ 161 (261)
T cd05148 85 EKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS 161 (261)
T ss_pred ccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence 999999999864 4678999999999999999999998 89999999999999999999999999998764332211
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
....++..|+|||.+.+..++.++||||||+++|+|++ |+.|+......+. + .....+. ..
T Consensus 162 -~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~-----~~~~~~~---------~~ 223 (261)
T cd05148 162 -SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---Y-----DQITAGY---------RM 223 (261)
T ss_pred -cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---H-----HHHHhCC---------cC
Confidence 12335678999999998899999999999999999998 7888865432211 1 1111111 00
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.......+.+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 11223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=311.81 Aligned_cols=249 Identities=28% Similarity=0.421 Sum_probs=200.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.+.||+|+||.||+|..+ ++..+|+|.++... ...++|.+|+.++.+++||||+++++++.+....+++|||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~--~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred eEEeeEecCcccceEEEEEec--CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 346678999999999999875 34579999987432 335679999999999999999999999998888999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..+++..+++++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999764 4689999999999999999999998 9999999999999999999999999998866443222211
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ .......+... ..
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----~~---- 222 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--------TVEKVSQGLRL-----YR---- 222 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHhcCCCC-----CC----
Confidence 2235678999999998889999999999999999998 888886543321 11111121110 00
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.....+.+.+++.+||+.+|++||++.+|++.|+
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1123467888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=308.67 Aligned_cols=280 Identities=23% Similarity=0.316 Sum_probs=207.6
Q ss_pred CCccccChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcc--ccccccccee
Q 038294 492 TNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLL 569 (799)
Q Consensus 492 ~~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~ 569 (799)
.+++++-...+.+ +..+.+.||+|.||.||+|.++ |+.||||++... .++.+.+|.++.+. ++|+||+.++
T Consensus 199 SGlplLVQRTiar-qI~L~e~IGkGRyGEVwrG~wr---Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFI 271 (513)
T KOG2052|consen 199 SGLPLLVQRTIAR-QIVLQEIIGKGRFGEVWRGRWR---GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFI 271 (513)
T ss_pred CCchhHhHHhhhh-eeEEEEEecCccccceeecccc---CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhh
Confidence 3445444444433 2346688999999999999996 789999999653 34566777777664 6999999999
Q ss_pred eeeeccc----ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEecCCCCCCeEEc
Q 038294 570 GFCDEAL----NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE-----CNVPIIHCDIKPQNILLD 640 (799)
Q Consensus 570 g~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiH~dlk~~NILl~ 640 (799)
+.-..++ ..+||.+|.++|||.|+|.. ..++.+..++++..+|.||+|||.+ .++.|.|||||++||||.
T Consensus 272 aaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK 350 (513)
T KOG2052|consen 272 AADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 350 (513)
T ss_pred hccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence 9876544 46899999999999999987 6788899999999999999999975 478899999999999999
Q ss_pred CCCceEEccccCcccccCCCC---cceeeeccCCcccccccccCC----CC--CcchhHHHHHHHHHHHHhC--------
Q 038294 641 NYFSAKISDFGLSKLLLSDQS---RTHTMIRGTRGYVAPEWFKNA----PV--SAKVDVYSFGVMLLEIICC-------- 703 (799)
Q Consensus 641 ~~~~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~----~~--s~k~DVwS~Gvll~elltg-------- 703 (799)
.++.+.|+|+|||........ -.....+||.+|||||++... .+ -..+||||||.++||+..+
T Consensus 351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e 430 (513)
T KOG2052|consen 351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE 430 (513)
T ss_pred cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence 999999999999987755432 223446799999999999654 12 2359999999999999742
Q ss_pred --CcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 704 --RRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 704 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+.||....+.+. .+.+ ..+.+-..++ -........+.+.+..+.+++..||..+|..|.|+--|-+.|.++.
T Consensus 431 ey~~Pyyd~Vp~DP--s~ee-MrkVVCv~~~---RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 431 EYQLPYYDVVPSDP--SFEE-MRKVVCVQKL---RPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred hhcCCcccCCCCCC--CHHH-Hhcceeeccc---CCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 234443322211 1111 1110000111 1111122345678889999999999999999999999999998887
Q ss_pred CCCC
Q 038294 782 EVPN 785 (799)
Q Consensus 782 ~~~~ 785 (799)
+.++
T Consensus 505 ~~~e 508 (513)
T KOG2052|consen 505 NSDE 508 (513)
T ss_pred cChh
Confidence 6543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.12 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=201.9
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCC---eEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
...+...+.||+|+||.||+|.+..... ..||+|+++... ....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3444556789999999999999754221 248999986533 34456899999999999999999999999764 567
Q ss_pred eEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 580 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
+++||+++|+|.+++... ..+++...++++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999999875 4688999999999999999999998 999999999999999999999999999987654
Q ss_pred CCCcce-eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 659 DQSRTH-TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 659 ~~~~~~-~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
...... .....+..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. ......+..
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~--------~~~~~~~~~---- 229 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------SSILEKGER---- 229 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHhCCCC----
Confidence 332211 11224668999999999999999999999999999998 8999875432221 111111110
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+. .......+.+++.+||+.+|++||++.+++..|..+..
T Consensus 230 ---~~~--~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 230 ---LPQ--PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---CCC--CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000 11123467889999999999999999999999986654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=310.53 Aligned_cols=267 Identities=25% Similarity=0.315 Sum_probs=205.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------------hhHHHHHHHHHHhcccccccccceeeee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------------EREREFKSEVSAIGRTHHKNLVQLLGFC 572 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~ 572 (799)
+.+.++||+|.||.|-+|.... +++.||||++.+... ...+...+|+.+|++++|||||+|+.+.
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~-~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEV-DGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred eehhhhhcCCccceEEEEeecC-CCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 3456789999999999999874 789999999964211 1124688999999999999999999998
Q ss_pred ecc--cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 573 DEA--LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 573 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
.+. +..|||+|||..|.+...-.....+...+.++++.++..||+|||.+ +||||||||+|+||+++|++||+||
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDF 254 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDF 254 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeecc
Confidence 654 56899999999988765544444588999999999999999999999 9999999999999999999999999
Q ss_pred cCcccccCCC----CcceeeeccCCcccccccccCCC----CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH
Q 038294 651 GLSKLLLSDQ----SRTHTMIRGTRGYVAPEWFKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW 722 (799)
Q Consensus 651 Gla~~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~----~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~ 722 (799)
|.+....... ........|||.|+|||...++. .+.+.||||+||+||.|+-|+.||.....-+
T Consensus 255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~-------- 326 (576)
T KOG0585|consen 255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE-------- 326 (576)
T ss_pred ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--------
Confidence 9998663221 11122357999999999987643 3568999999999999999999998664432
Q ss_pred HHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh--cCcCCCCCCCCCcee
Q 038294 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE--GLLEVPNPPCPSSFS 793 (799)
Q Consensus 723 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~--~~~~~~~p~~p~~~~ 793 (799)
.++++.+..+. -....+..+.+.+|+.++|++||+.|.+..+|....= .-.+.+.+.+|...+
T Consensus 327 l~~KIvn~pL~--------fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c~ 391 (576)
T KOG0585|consen 327 LFDKIVNDPLE--------FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSCS 391 (576)
T ss_pred HHHHHhcCccc--------CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccce
Confidence 23333332221 1112245567888999999999999999999876552 233444555555443
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=314.28 Aligned_cols=254 Identities=25% Similarity=0.431 Sum_probs=199.8
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.+.||+|+||.||+|..+. ..+..||+|++.... .....++.+|+.+++.++|+||+++++++.++...++
T Consensus 7 ~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 7 KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred HceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 34566889999999999998642 245689999986432 2344578999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCC----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 581 VYEFMGNGTLANLIFAIP----------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~----------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
|+||+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+||++++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCC
Confidence 999999999999986532 357888999999999999999997 8999999999999999999999999
Q ss_pred cCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHh
Q 038294 651 GLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 651 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
|+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..|+.....++ ......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--------~~~~~~ 235 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--------VLRFVM 235 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHH
Confidence 9987654322111 112235678999999999999999999999999999999 677876543221 111112
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
++.... . .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 221111 1 11223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=297.46 Aligned_cols=276 Identities=24% Similarity=0.260 Sum_probs=207.9
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchh--hHHHHHHHHHHhcccccccccceeeeeec--ccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE--REREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 586 (799)
+.|++|+||.||+|+++. +++.||+|+++...+. -.-.-++|+.+|.+.+|||||.+-.+... -+..|||||||+
T Consensus 82 nrI~EGtyGiVYRakdk~-t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKK-TDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred hhcccCcceeEEEeccCC-cceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 579999999999999985 6799999999754321 12356889999999999999999888754 356899999998
Q ss_pred CCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
. +|..++...+ .+...+..-+..|+++|++|||++ .|+|||||++|+|+.+.|.+||+|||+|+.+.+. .+..+
T Consensus 161 h-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-~k~~T 235 (419)
T KOG0663|consen 161 H-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-LKPYT 235 (419)
T ss_pred h-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-cccCc
Confidence 7 8999998765 777888888999999999999998 8999999999999999999999999999987654 34456
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHH---HHhcC-ceeEeec-CC
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD---CYAEG-RLDVLVD-SD 739 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~d-~~ 739 (799)
..+.|..|+|||++.+. .|++.+|+||+|||+.||++++..|.+..+-.....+.+.... .+..| .....+. -.
T Consensus 236 ~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~ 315 (419)
T KOG0663|consen 236 PLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMT 315 (419)
T ss_pred ceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccc
Confidence 66789999999999876 5899999999999999999999988876654433332221110 00000 0000000 00
Q ss_pred CCC---------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCcee
Q 038294 740 EPA---------MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSFS 793 (799)
Q Consensus 740 ~~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~~ 793 (799)
.+. .......+.-++++...+..||.+|.|++|.++. +=..+.|.|-+|..+.
T Consensus 316 f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h-~~F~e~P~p~~P~~~P 377 (419)
T KOG0663|consen 316 FSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH-EYFRETPLPIDPSMFP 377 (419)
T ss_pred cCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc-cccccCCCCCChhhcC
Confidence 000 0000133566788899999999999999988754 1255667777776553
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=324.73 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=201.4
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccch-hhHHHHHHHHHHhccc-ccccccceeeeeecc-cce
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-LNR 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~~ 578 (799)
.+.+.+.||+|+||.||+|.... .+++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|... ...
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 45567899999999999997532 2347899999875332 3345678899999999 899999999988644 567
Q ss_pred eeEEeecCCCChhhhhhcC-------------------------------------------------------------
Q 038294 579 LLVYEFMGNGTLANLIFAI------------------------------------------------------------- 597 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~------------------------------------------------------------- 597 (799)
++++||+++++|.+++...
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999988532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-ceeeeccCCccccc
Q 038294 598 PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAP 676 (799)
Q Consensus 598 ~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aP 676 (799)
..++|..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.+...... ......++..|+||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 2568899999999999999999998 9999999999999999999999999999876432221 11223456789999
Q ss_pred ccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHH
Q 038294 677 EWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMI 755 (799)
Q Consensus 677 E~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 755 (799)
|++.+..++.++|||||||+||||++ |..||......+. .......+... ..+......+.++
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~~---------~~~~~~~~~~~~l 308 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-------FCRRLKEGTRM---------RAPEYATPEIYSI 308 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-------HHHHHhccCCC---------CCCccCCHHHHHH
Confidence 99999999999999999999999998 8888865322211 11111222110 0112234578889
Q ss_pred HHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 756 AMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 756 ~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+.+||+.+|++||++.||+++|+++++
T Consensus 309 ~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 309 MLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=290.64 Aligned_cols=260 Identities=25% Similarity=0.297 Sum_probs=209.3
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc-----cee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~ 579 (799)
..+.+.+.||+|||+-||.++.-. +++.+|+|++.....+..+..++|++..++++||||+++++++..+. +.|
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s-~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLS-TGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccC-cccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 345678899999999999998553 67899999998877777888999999999999999999999985433 479
Q ss_pred eEEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 580 LVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
|+++|...|+|.+.+... ..+++.+.++|+.+|++||++||+.. ++++||||||.|||+.+.+.++|.|||.+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999999998753 36789999999999999999999973 4699999999999999999999999999876
Q ss_pred ccCCCCc--------ceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH
Q 038294 656 LLSDQSR--------THTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY 724 (799)
Q Consensus 656 ~~~~~~~--------~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~ 724 (799)
..-.-.. .-.....|..|+|||.+. +..+++++|||||||+||+|+-|..||+......
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---------- 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---------- 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC----------
Confidence 5321100 001133688999999985 4567999999999999999999999998654322
Q ss_pred HHHhcCceeEeecC-CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 725 DCYAEGRLDVLVDS-DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 725 ~~~~~~~~~~~~d~-~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
|.+.-.+.. ......+..+.+.+.+++.+|++.||.+||++.+++..++.++
T Consensus 249 -----gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 249 -----GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 222222221 2222223347889999999999999999999999999998764
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=310.83 Aligned_cols=255 Identities=27% Similarity=0.427 Sum_probs=203.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCC--eEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
....+.||+|+||.||+|.++...+ ..+++|.++... ....+++.+|++++.+++|+|++++++++......++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 3456789999999999999874322 479999986542 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 87 YMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 99999999999764 5689999999999999999999998 8999999999999999999999999999866433222
Q ss_pred cee--eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 THT--MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~~~--~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
... ....+..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ....+..+. .
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~--------~~~~i~~~~-------~ 228 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE--------VMKAINDGF-------R 228 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH--------HHHHHhcCC-------C
Confidence 111 1123457999999998889999999999999999997 999986543321 111112211 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.+ ........+.+++.+|++.+|++||++.+|++.|++++
T Consensus 229 ~~--~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 229 LP--APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 00 11123456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=308.29 Aligned_cols=250 Identities=28% Similarity=0.380 Sum_probs=201.0
Q ss_pred hhcCccccceEEEEEEeCCC--CeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
++||+|+||.||+|.+...+ +..+|+|.++.... ...+++.+|++++++++|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999876443 36899999875443 34568999999999999999999999876 4567899999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce--e
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH--T 665 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~--~ 665 (799)
++|.+++.....+++..+.+++.|++.||+|||.. +++|+||||+|||++.++.+||+|||+++.......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~ 156 (257)
T cd05060 80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT 156 (257)
T ss_pred CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccccc
Confidence 99999998877899999999999999999999998 899999999999999999999999999987643322111 1
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+..+.. ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~---------~~~ 219 (257)
T cd05060 157 AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--------VIAMLESGER---------LPR 219 (257)
T ss_pred CccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCc---------CCC
Confidence 1223567999999999999999999999999999998 899986543221 1111122110 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.......+.+++.+|++.+|++||++.+|++.|+++.
T Consensus 220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1223357788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=337.47 Aligned_cols=249 Identities=21% Similarity=0.232 Sum_probs=201.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++......++.||+|.+..........+..|+.+++.++||||+++++++......+|||||++
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~ 148 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGS 148 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCC
Confidence 45678899999999999987654467888898755444555678899999999999999999999999999999999999
Q ss_pred CCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-
Q 038294 587 NGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS- 661 (799)
Q Consensus 587 ~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 661 (799)
+|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 149 gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 149 GGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999988764 23578888999999999999999998 999999999999999999999999999987643322
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+... + .
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~--------~~~~~~~~~~~----~-~- 291 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE--------IMQQVLYGKYD----P-F- 291 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCC----C-C-
Confidence 12234568999999999999999999999999999999999999997543221 11111122111 0 1
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.......+.+++.+||+.+|++||++.+++.
T Consensus 292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1123356788999999999999999998864
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=312.87 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=201.8
Q ss_pred chhhhcCccccceEEEEEEe----CCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.++||+|+||.||++... ..++..+++|.+..........+.+|++++++++|+||+++++++......++++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 87 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFE 87 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEe
Confidence 45688999999999999753 23456899999887666666789999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 584 FMGNGTLANLIFAIP---------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~---------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
|+++++|.+++.... .+++..++.++.|++.||+|||+. +++|+||||+|||+++++.+||+
T Consensus 88 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~ 164 (280)
T cd05092 88 YMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIG 164 (280)
T ss_pred cCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEEC
Confidence 999999999987542 478899999999999999999998 99999999999999999999999
Q ss_pred cccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHH
Q 038294 649 DFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 649 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+. ...
T Consensus 165 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------~~~ 236 (280)
T cd05092 165 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--------IEC 236 (280)
T ss_pred CCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--------HHH
Confidence 9999976543221 11112234678999999999999999999999999999998 8888764332221 111
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
...+.. ...+......+.+++.+||+.||++||++.||++.|++
T Consensus 237 ~~~~~~---------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQGRE---------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcCcc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111110 00111223567789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.40 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=199.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.+.||+|+||.||+|..+ ++..+|+|.+.... ....++.+|++++++++|+||+++++++......++|+||++
T Consensus 6 ~~~~~~lg~G~~~~v~~~~~~--~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 6 LTFLKELGSGQFGVVHLGKWR--GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred cchhhhhccCCCceEEEeEec--CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 346788999999999999876 45689999986432 234578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+||++++++.+||+|||+++...........
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 99999999764 4678999999999999999999998 8999999999999999999999999999865433222111
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+. ....
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~-----~~~~---- 222 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--------VESVSAGY-----RLYR---- 222 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--------HHHHHcCC-----cCCC----
Confidence 1223457999999999999999999999999999999 7888865433221 11111111 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.......+.+++.+||+.+|++||||.|+++.|
T Consensus 223 ~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 223 PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 122345788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=326.25 Aligned_cols=257 Identities=20% Similarity=0.227 Sum_probs=195.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++.... +++.||+|.... ..+.+|++++++++||||+++++++......++|+|++.
T Consensus 94 y~~~~~lg~G~~g~V~~~~d~~-~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~ 166 (391)
T PHA03212 94 FSILETFTPGAEGFAFACIDNK-TCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK 166 (391)
T ss_pred cEEEEEEcCCCCeEEEEEEECC-CCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC
Confidence 4456889999999999999874 678999997532 346789999999999999999999999889999999985
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
++|.+++.....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++............
T Consensus 167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 68999888777889999999999999999999998 99999999999999999999999999997543322223334
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc----hhHHHHHHHHHhc-------------
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR----AILTDWAYDCYAE------------- 729 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~------------- 729 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.|+.......+. ..+.. .......
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~-i~~~~g~~p~~~~~~~~~~~ 321 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL-IIRRSGTHPNEFPIDAQANL 321 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHH-HHHHhcCChhhcCcchhHHH
Confidence 56899999999999999999999999999999999999886533211100 00000 0000000
Q ss_pred -----Ccee-EeecCC-CCCc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 730 -----GRLD-VLVDSD-EPAM-ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 730 -----~~~~-~~~d~~-~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.... ....+. .+.. ........+.+++.+||+.||++|||++|+++
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 322 DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000 000000 0000 01123446788999999999999999999985
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=313.87 Aligned_cols=253 Identities=28% Similarity=0.428 Sum_probs=200.3
Q ss_pred hchhhhcCccccceEEEEEEeC---CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS---ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~---~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.++||+|+||.||+|.... ..++.|++|.+.... .+...++.+|++++++++||||+++++++..+...+++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 86 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLF 86 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEE
Confidence 4566889999999999998632 245789999997432 334467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 038294 583 EFMGNGTLANLIFAI-----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645 (799)
Q Consensus 583 e~~~~gsL~~~l~~~-----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~ 645 (799)
||+++++|.+++... ..+++...+.++.|++.||+|||+. +++|+||||+|||+++++.+
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (283)
T cd05090 87 EYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHV 163 (283)
T ss_pred EcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcE
Confidence 999999999998532 2467888999999999999999998 89999999999999999999
Q ss_pred EEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHH
Q 038294 646 KISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 646 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~ 723 (799)
||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~--------~ 235 (283)
T cd05090 164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE--------V 235 (283)
T ss_pred EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--------H
Confidence 9999999986543321 11222335678999999998889999999999999999998 888886433211 1
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.+....+... .. .......+.+++.+|++.+|++||++.+|++.|.+
T Consensus 236 ~~~~~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMVRKRQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHcCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1122221111 01 11223567889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=325.39 Aligned_cols=243 Identities=25% Similarity=0.312 Sum_probs=197.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|+||.||++..+. +++.||+|+++... ......+..|++++..++||||+++.+++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 368999999999998864 68899999986532 22345678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|+|..++.....+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 9999999887889999999999999999999997 5 899999999999999999999999999875432221 2223
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||++.+..++.++|||||||+||||++|+.||.....+.. ...+..+.. ..+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~--------~~~i~~~~~------~~p----~ 217 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------FELILMEEI------RFP----R 217 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH--------HHHHhcCCC------CCC----C
Confidence 4589999999999999999999999999999999999999975433221 111111111 111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRP-----TMKVVLQM 776 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 776 (799)
.....+.+++.+||+.||++|+ ++.++++.
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 2235677899999999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=311.52 Aligned_cols=253 Identities=25% Similarity=0.354 Sum_probs=199.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCe----EEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~----~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.||+|+||.||+|.+.. +++ .+++|.+..... ....++..|+..+++++||||+++++++.. ...++++|
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~-~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIP-EGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eccccCccCCcceEEEEEcC-CCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 45789999999999999864 233 478888754332 334678889999999999999999999864 45678999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS- 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 661 (799)
|+++|+|.+++... ..+++..+.+++.||+.||+|||+. +++|+||||+|||+++++.+||+|||+++.......
T Consensus 89 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T cd05111 89 LSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165 (279)
T ss_pred eCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcc
Confidence 99999999999764 5689999999999999999999998 899999999999999999999999999987643322
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....... ..+.+..+.... .
T Consensus 166 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~~-----~ 232 (279)
T cd05111 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--------VPDLLEKGERLA-----Q 232 (279)
T ss_pred cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCcCC-----C
Confidence 12223446778999999999999999999999999999998 888886543221 112222222111 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+. .....+.+++.+|++.+|++|||+.|+++.|+.+..-
T Consensus 233 ~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 233 PQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 11 1224567789999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.60 Aligned_cols=241 Identities=28% Similarity=0.356 Sum_probs=192.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcc-cccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|..+. +++.||+|.++... ....+.+..|..++.. .+||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG-TNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 369999999999999874 67899999986532 2223445566666665 489999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 999999998877889999999999999999999998 99999999999999999999999999998643322 22233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+.... +..+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~------~~~~----~ 217 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE--------LFDSILNDR------PHFP----R 217 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCC------CCCC----C
Confidence 468999999999999999999999999999999999999997654322 111111111 1111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMK-VVL 774 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 774 (799)
.....+.+++.+||+.+|++||++. +++
T Consensus 218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 218 WISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2334667899999999999999975 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=305.26 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=198.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.||+|+||.||+|..+ +++.+|+|.++.... .....+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~--~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK--DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec--CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46999999999999865 578899999875433 334578999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeec
Q 038294 590 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668 (799)
Q Consensus 590 L~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 668 (799)
|.+++... ..+++..+.+++.|++.||.|||+. +++|+||||+||++++++.+||+|||++...............
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99998754 4578999999999999999999988 9999999999999999999999999998764332222222223
Q ss_pred cCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 669 gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
++..|+|||++.+..++.++||||||+++||+++ |..||....... .......+.. ......
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--------~~~~~~~~~~---------~~~~~~ 218 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--------AREQVEKGYR---------MSCPQK 218 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHHcCCC---------CCCCCC
Confidence 4667999999998899999999999999999998 888986543221 1111111110 011112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
....+.+++.+|++.+|++||++.|++++|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 3467888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=332.78 Aligned_cols=259 Identities=21% Similarity=0.304 Sum_probs=210.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeee-eec------cccee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGF-CDE------ALNRL 579 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~-~~~------~~~~~ 579 (799)
.+.+.|.+|||+.||.+.+.. .+..+|+|++-...+...+.+++|+++|++|+ |+|||.+++. ... .-+.+
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~-~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVK-GGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEccCCcEEEEEEEecC-CCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 356789999999999999875 34899999987767888899999999999997 9999999993 211 23568
Q ss_pred eEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 580 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
|.||||.+|.|.+++..+ ..+++..+++|+.|+++|+++||.. .++|||||||-+||||..+++.||||||.+.-..
T Consensus 119 lLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~ 197 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI 197 (738)
T ss_pred eehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence 999999999999999854 4689999999999999999999985 6789999999999999999999999999987543
Q ss_pred CCCCcc--------eeeeccCCcccccccc---cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH
Q 038294 658 SDQSRT--------HTMIRGTRGYVAPEWF---KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 658 ~~~~~~--------~~~~~gt~~y~aPE~l---~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
..-... .-...-|+.|+|||.+ .+..+++|+|||||||+||-|+-...||+....
T Consensus 198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------------- 263 (738)
T KOG1989|consen 198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------------- 263 (738)
T ss_pred CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--------------
Confidence 221110 0112358999999976 577899999999999999999999999985321
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPC 788 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 788 (799)
..+++....-.....+...+..||..||+.||++||++-+|++.+-++...+.|-.
T Consensus 264 ------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~ 319 (738)
T KOG1989|consen 264 ------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIP 319 (738)
T ss_pred ------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCcc
Confidence 11222222222336788899999999999999999999999999988776655443
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=306.13 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=197.2
Q ss_pred hcCccccceEEEEEEeCC-CCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 512 ELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~-~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.||+|+||.||+|.++.. .+..||+|++..... ...++|.+|+.++++++|+||+++++++.. ...++|+||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence 489999999999987632 356799999875433 334679999999999999999999998854 56789999999999
Q ss_pred hhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce--ee
Q 038294 590 LANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH--TM 666 (799)
Q Consensus 590 L~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~--~~ 666 (799)
|.+++.. ...+++..+.+++.|++.||+|||+. +++|+||||+|||++.++.+||+|||++........... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999975 35689999999999999999999998 899999999999999999999999999986543322111 11
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..++..|+|||.+.+..++.++||||||+++||+++ |..||......+ +...+..+.. ...+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~---------~~~~ 220 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKR---------LDCP 220 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--------HHHHHHCCCC---------CCCC
Confidence 223568999999998889999999999999999996 999987543322 1112222211 1111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
....+.+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22346777899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.44 Aligned_cols=237 Identities=28% Similarity=0.381 Sum_probs=193.7
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++..+. +++.||+|+++... ....+.+..|..++..+ +||||+++++++......++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE-SGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC
Confidence 368999999999999874 67899999986432 23345677888888876 69999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 999999998888899999999999999999999998 99999999999999999999999999987542222 12233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ....+..+.. ..+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--------~~~~i~~~~~------~~~----~ 217 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEV------VYP----T 217 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCC------CCC----C
Confidence 468999999999999999999999999999999999999997654322 1112222211 011 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
.....+.+++.+||+.||++||++
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 218 WLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCC
Confidence 233567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=326.41 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=203.7
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccch-hhHHHHHHHHHHhcccc-cccccceeeeeec
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDE 574 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 574 (799)
++......+.+.||+|+||.||+|++.. ..++.||+|+++.... ...+.+..|++++.++. ||||++++++|..
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~ 112 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK 112 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence 3444445567899999999999998742 2346899999975432 23357889999999997 9999999999999
Q ss_pred ccceeeEEeecCCCChhhhhhcCC--------------------------------------------------------
Q 038294 575 ALNRLLVYEFMGNGTLANLIFAIP-------------------------------------------------------- 598 (799)
Q Consensus 575 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------------- 598 (799)
....++|+||+++|+|.++++...
T Consensus 113 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (401)
T cd05107 113 GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPM 192 (401)
T ss_pred CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccch
Confidence 999999999999999999986421
Q ss_pred ------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 038294 599 ------------------------------------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQN 636 (799)
Q Consensus 599 ------------------------------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~N 636 (799)
.+++...++++.||+.||+|||+. +++||||||+|
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~N 269 (401)
T cd05107 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARN 269 (401)
T ss_pred hcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcce
Confidence 246677889999999999999987 89999999999
Q ss_pred eEEcCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhh
Q 038294 637 ILLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEE 714 (799)
Q Consensus 637 ILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~ 714 (799)
||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 9999999999999999986533221 11122346788999999998889999999999999999998 888876432211
Q ss_pred cchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.....+..+.. ... +......+.+++.+||+.+|++||+++||++.|++++
T Consensus 350 -------~~~~~~~~~~~-----~~~----p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -------QFYNAIKRGYR-----MAK----PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------HHHHHHHcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111122110 001 1122457888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=314.34 Aligned_cols=268 Identities=25% Similarity=0.349 Sum_probs=200.3
Q ss_pred chhhhcCccccceEEEEEEe---CCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLK---SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 581 (799)
.+.+.||+|+||+||++..+ ..+++.||+|.++... ....+.|.+|++++++++||||+++++++... ...+++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 35678999999999887642 2356789999987543 23456788999999999999999999998654 357899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|||+++++|.+++... .+++..+..++.|+++||+|||+. +|+|+||||+|||+++++.+||+|||+++.......
T Consensus 87 ~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 87 MEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred ecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 9999999999999764 589999999999999999999998 899999999999999999999999999987643221
Q ss_pred cc--eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 662 RT--HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 662 ~~--~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.. .....++..|+|||.+.+..++.++||||||+++|||++|..|+......... .+ ...........+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 163 YYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MI-GPKQGQMTVVRLIELLERG 240 (283)
T ss_pred hhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh-hh-cccccccchhhhhhhhhcC
Confidence 11 11223466799999999888999999999999999999999997543211000 00 0000000000000111111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.....+......+.+++..||+.+|++|||+++|+++|+.+.
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111112233467888999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=321.22 Aligned_cols=250 Identities=25% Similarity=0.322 Sum_probs=198.9
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++..+. +++.||+|+++... ....+.+..|..++.++ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK-TRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC
Confidence 368999999999999875 67899999997532 22345678899999888 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 999999998878899999999999999999999998 99999999999999999999999999987532221 12233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhh-cchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE-GRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .......+..+.+..+... .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~------~p---- 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR------IP---- 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC------CC----
Confidence 568999999999999999999999999999999999999996432211 0111112233333332211 11
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPT------MKVVLQ 775 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt------~~evl~ 775 (799)
......+.+++.+||+.||++||+ +.++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 122356788999999999999997 667763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.02 Aligned_cols=243 Identities=25% Similarity=0.323 Sum_probs=197.1
Q ss_pred hhcCccccceEEEEEEeC--CCCeEEEEEEccccc----hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 511 EELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.||+|+||.||++.... ..++.||+|.++... ......+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 579999999999998642 357899999986532 12234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++++|.+++.....+.+.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VT 157 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-cc
Confidence 99999999998877888889999999999999999998 999999999999999999999999999875432222 22
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+.. ..+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--------~~~~~~~~~~------~~~~-- 221 (323)
T cd05584 158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--------TIDKILKGKL------NLPP-- 221 (323)
T ss_pred cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC------CCCC--
Confidence 23468999999999999889999999999999999999999997543321 1111122211 1111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
.....+.+++.+||+.+|++|| ++.++++
T Consensus 222 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 222 --YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 2235678899999999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.93 Aligned_cols=263 Identities=20% Similarity=0.239 Sum_probs=196.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|..+. +++.||+|+++... ......+.+|+.++++++||||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL 85 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECC-CCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCC
Confidence 3456789999999999999874 67899999986432 223456789999999999999999999999888899999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++ +|.+++... ..+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 86 ~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~~ 160 (288)
T cd07871 86 DS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-TY 160 (288)
T ss_pred Cc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-cc
Confidence 75 898888654 3578889999999999999999998 999999999999999999999999999976532221 12
Q ss_pred eeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhc----CceeEe
Q 038294 665 TMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAE----GRLDVL 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~----~~~~~~ 735 (799)
....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+..... ..+.. ......
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (288)
T cd07871 161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240 (288)
T ss_pred cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcc
Confidence 23357889999998865 5689999999999999999999999976543322111111000 00000 000000
Q ss_pred ecCCCCCc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAM----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+..... ........+.+++.+||+.||.+|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 241 LFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 10100000 00112345778999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.70 Aligned_cols=245 Identities=26% Similarity=0.338 Sum_probs=194.4
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++..+. +++.+|+|+++... ....+.+..|+.++.++ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK-TERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC
Confidence 469999999999999874 67899999987532 23345677888888776 89999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 999999998878899999999999999999999998 999999999999999999999999999875422221 2233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhc-chhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG-RAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+..+.+..... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~p---- 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RIP---- 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CCC----
Confidence 4689999999999999999999999999999999999999963221110 11111223333332221 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
......+.+++.+||+.||++||+.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 2233567789999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=306.33 Aligned_cols=255 Identities=25% Similarity=0.307 Sum_probs=192.5
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc---c--eeeEEee
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL---N--RLLVYEF 584 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~---~--~~lv~e~ 584 (799)
.+.+|.|+||.||+|++.. +++.||||+.-.... .--.|+++|++++|||||+|+-+|.... . ..+|+||
T Consensus 29 ~~liG~GsFg~Vyq~~~~e-~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 29 VRLIGSGSFGVVYQAKLRE-TEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred eEEEeecccceEEEEEEcC-CCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 3679999999999999986 478999998744322 1245899999999999999999885332 2 2489999
Q ss_pred cCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEccccCcccccCC
Q 038294 585 MGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLSD 659 (799)
Q Consensus 585 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl~DfGla~~~~~~ 659 (799)
||. +|.+.++. ...++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ +.+||+|||.|+.+...
T Consensus 104 mP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ 179 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG 179 (364)
T ss_pred chH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence 987 88888874 35666666677899999999999997 99999999999999965 99999999999998776
Q ss_pred CCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHh------
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYA------ 728 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~------ 728 (799)
+..... ..|+.|+|||.+.+. .|+.+.||||.||++.||+-|+.-|.+....+....+..... +.+.
T Consensus 180 epniSY--icSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y 257 (364)
T KOG0658|consen 180 EPNISY--ICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY 257 (364)
T ss_pred CCceeE--EEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence 655443 358899999998765 799999999999999999999999887654333222222111 1111
Q ss_pred -cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 729 -EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 729 -~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+-+..++.................++++.++++++|.+|.++.|++.
T Consensus 258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111111233345567889999999999999999999884
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.30 Aligned_cols=243 Identities=25% Similarity=0.326 Sum_probs=197.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|..+. +++.||+|+++... ....+.+..|.+++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG-TDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC
Confidence 469999999999999874 67899999986532 23335677888888865 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|...+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ ....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 999999998888899999999999999999999998 899999999999999999999999999875432221 2233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+.+..+.. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~--------~~~i~~~~~------~~p~---- 217 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL--------FESILHDDV------LYPV---- 217 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH--------HHHHHcCCC------CCCC----
Confidence 4589999999999999999999999999999999999999986543321 111112111 1111
Q ss_pred HHHHHHHHHHHHhcccCCCCCC-------CHHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRP-------TMKVVLQM 776 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RP-------t~~evl~~ 776 (799)
.....+.+++..||+.||++|| ++.++++.
T Consensus 218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 1235677899999999999999 77877643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=285.43 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=204.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|.||.||.|+.+. ++-.||+|++.+.. .+.+.++.+|+++-..++||||+++++++.+....||++||
T Consensus 25 eigr~LgkgkFG~vYlarekk-s~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKK-SLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred cccccccCCccccEeEeeecc-CCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 346789999999999999875 67899999986532 33457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIF--AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~--~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
.+.|.|...|. ....++......++.|+|.||.|+|.. +||||||||+|+|++.++..||+|||-+..-. ..
T Consensus 104 a~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~~ 177 (281)
T KOG0580|consen 104 APRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SN 177 (281)
T ss_pred cCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC---CC
Confidence 99999999999 456788888999999999999999998 89999999999999999999999999887543 22
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....+||..|.+||...+..++..+|+|++|++.||++.|..||+.....+. ++.+..-+ -..+
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et--------YkrI~k~~------~~~p- 242 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET--------YKRIRKVD------LKFP- 242 (281)
T ss_pred CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH--------HHHHHHcc------ccCC-
Confidence 33446799999999999999999999999999999999999999997764442 22222211 1112
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+.+++.+|+..+|.+|.+..||++.
T Consensus 243 ---~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 243 ---STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2233567789999999999999999998763
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=318.71 Aligned_cols=242 Identities=28% Similarity=0.350 Sum_probs=194.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcc-cccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|..+. +++.||+|+++... ....+.+..|..++.. ++||||+++++++.+....++||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC
Confidence 369999999999999874 57899999986532 2233456667777776 489999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 999999998877889999999999999999999998 999999999999999999999999999875322221 2233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+..+. +..+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~i~~~~------~~~~----~ 217 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--------LFQSIRMDN------PCYP----R 217 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC------CCCC----c
Confidence 468999999999999999999999999999999999999997543322 111111111 1111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMK-VVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 775 (799)
.....+.+++.+||+.+|++||++. ++.+
T Consensus 218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 218 WLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred cCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 2334677899999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=308.56 Aligned_cols=250 Identities=28% Similarity=0.428 Sum_probs=196.4
Q ss_pred hhcCccccceEEEEEEeCCCC-eEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASG-KAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|+||.||+|.+++... ..+++|.++... ....+.+.+|++++.++ +||||+++++++......+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999875322 357889887532 34456789999999999 899999999999999999999999999
Q ss_pred CChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcccc
Q 038294 588 GTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFG 651 (799)
Q Consensus 588 gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfG 651 (799)
|+|.+++.... .+++..+.+++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986532 467889999999999999999997 99999999999999999999999999
Q ss_pred CcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 652 LSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 652 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
++...... ........+..|+|||++....++.++||||||+++|||++ |..||......+ .......+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~--------~~~~~~~~ 227 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEKLPQG 227 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH--------HHHHHhCC
Confidence 98632211 11111223567999999988899999999999999999997 899986543221 11111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.. ..........+.+++.+|++.+|.+|||+.++++.|+++++
T Consensus 228 ~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~ 270 (270)
T cd05047 228 YR---------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 270 (270)
T ss_pred CC---------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence 00 00111223467899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=307.31 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=200.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.++||+|+||.||+|.+.. ...||+|+++... ...+++.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~--~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecC--CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 45677899999999999998763 3569999997532 234678999999999999999999998754 4578999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++|+|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999763 3578999999999999999999998 89999999999999999999999999998664332222
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ .......+. ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--------~~~~~~~~~---------~~ 222 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGY---------RM 222 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--------HHHHHhcCC---------CC
Confidence 222345678999999998899999999999999999999 777876543221 111111111 00
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.........+.+++.+|++.+|++||++.++++.|+...
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 112234467889999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=314.63 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=201.4
Q ss_pred chhhhcCccccceEEEEEEeCCCC-eEEEEEEcccc-chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG-KAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~-~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+|.++.... ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++++||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~ 84 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEY 84 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEe
Confidence 456789999999999999875322 35788888743 233456789999999999 799999999999999999999999
Q ss_pred cCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 585 MGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 585 ~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
+++++|.+++.... .+++..+.+++.|++.||+|||+. +|+||||||+|||+++++.+||+
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~ 161 (297)
T cd05089 85 APYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIA 161 (297)
T ss_pred cCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEEC
Confidence 99999999996532 477889999999999999999997 99999999999999999999999
Q ss_pred cccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 649 DFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 649 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
|||++....... .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+ .....
T Consensus 162 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--------~~~~~ 231 (297)
T cd05089 162 DFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--------LYEKL 231 (297)
T ss_pred CcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHH
Confidence 999986432111 1111123557999999998899999999999999999998 999986543221 11111
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 786 (799)
..+. ... ........+.+++.+||+.+|.+||++.++++.|+.+++...+
T Consensus 232 ~~~~-----~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 232 PQGY-----RME----KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred hcCC-----CCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111 001 1112335678899999999999999999999999988775544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=310.36 Aligned_cols=240 Identities=24% Similarity=0.385 Sum_probs=189.3
Q ss_pred hcCccccceEEEEEEeCC-----------------------CCeEEEEEEccccchhhHHHHHHHHHHhcccccccccce
Q 038294 512 ELGRGSFGIVYKGVLKSA-----------------------SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~-----------------------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l 568 (799)
.||+|+||.||+|.+... ....|++|++.........+|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 599999999999986421 123589999876555555678999999999999999999
Q ss_pred eeeeecccceeeEEeecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----
Q 038294 569 LGFCDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---- 643 (799)
Q Consensus 569 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---- 643 (799)
+++|.+....++||||+++|+|..++.. ...+++..+.+++.||++||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999875 45688999999999999999999998 899999999999997643
Q ss_pred ---ceEEccccCcccccCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHH-hCCcCCchhhhhhcchh
Q 038294 644 ---SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEII-CCRRSVEMEVEEEGRAI 718 (799)
Q Consensus 644 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~ell-tg~~p~~~~~~~~~~~~ 718 (799)
.+|++|||++....... ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+......+..
T Consensus 159 ~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-- 231 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-- 231 (274)
T ss_pred ccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH--
Confidence 38999999886542221 1236778999998865 56899999999999999995 688888654332211
Q ss_pred HHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.. .... ...+.. ....+.+++.+||+.+|++||||.+|++.|+
T Consensus 232 --~~----~~~~-------~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 232 --RF----YEKK-------HRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HH----HHhc-------cCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 10 1100 001111 1235788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=314.20 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=203.2
Q ss_pred hhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 579 (799)
...+.+.||+|+||.||++... ...+..||+|+++... ....+.+.+|+++++++ +|+||+++++++......+
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 3456688999999999999852 2245689999987543 33346789999999999 7999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 580 LVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
+++||+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||+++...
T Consensus 116 lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 192 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIM 192 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccccc
Confidence 9999999999999997643 379999999999999999999998 89999999999999999999999999998664
Q ss_pred CCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 658 SDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 658 ~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
...... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+. .......+..
T Consensus 193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~--- 262 (302)
T cd05055 193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-------FYKLIKEGYR--- 262 (302)
T ss_pred CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-------HHHHHHcCCc---
Confidence 332211 112235678999999999999999999999999999998 8888865432110 1111222210
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.. ......+.+.+++.+|++.+|++|||+.||++.|+++
T Consensus 263 --~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 263 --MA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --CC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 00 1112235788899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=308.05 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=199.6
Q ss_pred hhhhcCccccceEEEEEEeCCC--CeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccc------e
Q 038294 509 FKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------R 578 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 578 (799)
+.+.||+|+||.||+|.+.... +..||+|+++.. ......++.+|++.++.++|+||+++++++..... .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 4578999999999999986432 478999998643 23344678999999999999999999999866554 6
Q ss_pred eeEEeecCCCChhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccC
Q 038294 579 LLVYEFMGNGTLANLIFAI------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGl 652 (799)
++++||+++++|..++... ..+++.....++.|++.||+|||+. +++||||||+||++++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999988542 3578899999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 653 SKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 653 a~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......+ ..+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--------IYDYLRHG 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcC
Confidence 9876433221 1112234678999999998899999999999999999999 788876433221 11111222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
... .........+.+++.+||+.||++|||+.||++.|++++
T Consensus 232 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~~ 273 (273)
T cd05035 232 NRL---------KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273 (273)
T ss_pred CCC---------CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 110 112234457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=307.92 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=196.7
Q ss_pred hhhhcCccccceEEEEEEeCCCC-eEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc------ccee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASG-KAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRL 579 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~-~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 579 (799)
+.+.||+|+||.||+|.+..... ..+|+|.++.. .....+.+..|++++++++|+||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 45789999999999999864322 36899988643 234456789999999999999999999987432 2458
Q ss_pred eEEeecCCCChhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCc
Q 038294 580 LVYEFMGNGTLANLIFA------IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
+++||+++|+|.+++.. ...+++.....++.|++.||+|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999988742 13478999999999999999999997 9999999999999999999999999999
Q ss_pred ccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCc
Q 038294 654 KLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGR 731 (799)
Q Consensus 654 ~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (799)
+........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~ 231 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE--------IYDYLRQGN 231 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHcCC
Confidence 876433211 1122335678999999999999999999999999999999 788886432221 112222222
Q ss_pred eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 732 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
... ........+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 232 ~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 232 RLK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 1112345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=311.48 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=200.8
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
...+.++||+|+||.||+|.... ..++.||+|+++..... ..+.+.+|+.++.+++||||+++++++......++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 34567889999999999998753 23578999999754332 34578899999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 038294 581 VYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS 644 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~ 644 (799)
++||+++++|.+++... ..+++..+.+++.|++.||+|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998521 2467888899999999999999998 8999999999999999999
Q ss_pred eEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHH
Q 038294 645 AKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDW 722 (799)
Q Consensus 645 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~ 722 (799)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------- 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------- 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH--------
Confidence 999999998865432211 1122335778999999988889999999999999999998 777776433221
Q ss_pred HHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 723 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
....+..+.... ........+.+++..||+.+|++||++.+|++.|+.
T Consensus 235 ~~~~i~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 112222222110 112234567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.84 Aligned_cols=250 Identities=22% Similarity=0.262 Sum_probs=195.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|+||+||+|..+. +++.||+|++.... ....+.+.+|++++.+++|+||+++++++.+....++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~ 83 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVD-THALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (381)
T ss_pred EEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecC
Confidence 45789999999999999875 67899999996532 233457899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC----
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS---- 661 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 661 (799)
++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 84 PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999998888889999999999999999999998 999999999999999999999999999764311000
Q ss_pred ------------------------------------------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHH
Q 038294 662 ------------------------------------------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699 (799)
Q Consensus 662 ------------------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~e 699 (799)
.......||+.|+|||.+.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00112468999999999999999999999999999999
Q ss_pred HHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHH--hcccCCCCCCCHHHHHHH
Q 038294 700 IICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMW--CIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 700 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~evl~~ 776 (799)
|++|+.||......+....+.. ..... ..+. .......+.+++.+ |+..+|..||++.|+++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~------~~~~~------~~~~--~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVIN------WENTL------HIPP--QVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHc------ccccc------CCCC--CCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 9999999976543221111100 00000 0111 11123455566665 566777779999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=322.07 Aligned_cols=245 Identities=25% Similarity=0.400 Sum_probs=191.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.++||+|+||.||+|.... +++.||||++.... ....+.+.+|++++++++|+||+++++++......++||||+++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRP-TGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhhccCCCCeEEEEEEECC-CCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 35789999999999999864 67899999986433 23346789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
++|.+.. ..++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... .....
T Consensus 157 ~~L~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~~~ 228 (353)
T PLN00034 157 GSLEGTH----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-PCNSS 228 (353)
T ss_pred Ccccccc----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccc-ccccc
Confidence 9986532 345677888999999999999998 999999999999999999999999999987643221 12234
Q ss_pred ccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 668 RGTRGYVAPEWFKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 668 ~gt~~y~aPE~l~~-----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.||..|+|||.+.. ...+.++|||||||++|||++|+.||......+.... ... ..... ..
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~----~~~-~~~~~---------~~ 294 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL----MCA-ICMSQ---------PP 294 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHH----HHH-HhccC---------CC
Confidence 68999999998743 2345689999999999999999999974322211111 100 10000 01
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.........+.+++.+||+.||++|||+.||++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334578889999999999999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.52 Aligned_cols=254 Identities=21% Similarity=0.340 Sum_probs=203.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+|+.+. +++.||||.++.. .......+.+|+++++.++||||+++++++......++++||
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLL-DRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeC-CCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 456789999999999999875 6789999987532 233445789999999999999999999999998999999999
Q ss_pred cCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 585 MGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+++++|.+++.. ...++......++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 84 ADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999988853 23478889999999999999999998 99999999999999999999999999988764332
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.. .....+++.|+|||.+.+..++.++|+||||+++|||++|+.|+....... ..+. +.+.... .
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-----~~~~-~~~~~~~--------~ 225 (267)
T cd08228 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----FSLC-QKIEQCD--------Y 225 (267)
T ss_pred HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-----HHHH-HHHhcCC--------C
Confidence 21 122357889999999998889999999999999999999999986432211 0111 1111111 1
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
+..........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 226 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1112233446788999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=299.72 Aligned_cols=262 Identities=27% Similarity=0.340 Sum_probs=200.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhccccccc-ccceeeeeeccc------cee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKN-LVQLLGFCDEAL------NRL 579 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~------~~~ 579 (799)
..++||+|+||+||+|+.+. +|+.||+|+++-..+ .......+|+.++++++|+| |++|.+++...+ ..+
T Consensus 15 ~~eklGeGtyg~Vykar~~~-~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~ 93 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKR-TGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLY 93 (323)
T ss_pred HHHHhCCCCceEEEEEEEec-CCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEE
Confidence 34679999999999999985 679999999965433 23456789999999999999 999999998777 678
Q ss_pred eEEeecCCCChhhhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 580 LVYEFMGNGTLANLIFAIP----KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
+|+||+.. +|..++.... .++...+..++.||++||+|||++ +|+||||||+||||++.|.+||+|||+|+.
T Consensus 94 lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 94 LVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred EEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHH
Confidence 99999965 8999998754 466778899999999999999999 999999999999999999999999999996
Q ss_pred ccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC--ce
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG--RL 732 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~ 732 (799)
..-+ .+..+..++|..|+|||++.+. .|+...||||+||++.||++++.-|.+..+.+....+.+.+..--.+. .+
T Consensus 170 ~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 170 FSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV 248 (323)
T ss_pred hcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence 5422 2234556689999999999887 799999999999999999999888877765433322222111100000 00
Q ss_pred eEeecC--CCCCcc-CH-------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 733 DVLVDS--DEPAMA-DR-------SRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 733 ~~~~d~--~~~~~~-~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+.+. ..+... .. .......+++.+||+.+|.+|.|++.++++
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 000010 011111 11 111356789999999999999999999876
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=312.08 Aligned_cols=262 Identities=24% Similarity=0.356 Sum_probs=199.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCC-------------CCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSA-------------SGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLG 570 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~-------------~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g 570 (799)
..+.+.+.||+|+||.||++..... ....||+|.++.. .......|.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 3455678899999999999876421 1235899998653 2334457999999999999999999999
Q ss_pred eeecccceeeEEeecCCCChhhhhhcC------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 038294 571 FCDEALNRLLVYEFMGNGTLANLIFAI------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNIL 638 (799)
Q Consensus 571 ~~~~~~~~~lv~e~~~~gsL~~~l~~~------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NIL 638 (799)
++......++||||+++++|.+++... ..+++..+++++.|++.||+|||+. +++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 999999999999999999999998643 1367889999999999999999998 9999999999999
Q ss_pred EcCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh--CCcCCchhhhhhc
Q 038294 639 LDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMEVEEEG 715 (799)
Q Consensus 639 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt--g~~p~~~~~~~~~ 715 (799)
+++++.+||+|||++........ .......++..|+|||.+.+..++.++||||||++++||++ +..||......+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999986543221 11122235678999999998899999999999999999998 5556654332221
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
+.. ..+......... . ...+......+.+++.+|++.+|++||+|.+|++.|+.
T Consensus 242 ---~~~-~~~~~~~~~~~~-~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 242 ---IEN-TGEFFRNQGRQI-Y-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHH-HHHhhhhccccc-c-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 101 111111110000 0 00111223578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=306.08 Aligned_cols=250 Identities=25% Similarity=0.381 Sum_probs=198.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.++||+|+||.||+|..+ ++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++.+ ...+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~--~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWN--GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred HhhhhheeccccCceEEEEEec--CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 3456788999999999999876 456799999875332 34678999999999999999999998854 5678999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999764 3578999999999999999999998 89999999999999999999999999998764332222
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ... .+..+. ..
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~-~~~~~~---------~~ 222 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-------VLE-QVERGY---------RM 222 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-------HHH-HHHcCC---------CC
Confidence 122235668999999988899999999999999999999 888886543221 111 111110 00
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.........+.+++.+|++.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112334568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.49 Aligned_cols=242 Identities=28% Similarity=0.343 Sum_probs=196.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++..+. +++.||+|+++... ......+..|.+++..+ +||||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG-TDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 369999999999999874 57899999997532 23345677888888877 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 999999998887899999999999999999999998 999999999999999999999999999875322221 1223
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..|++.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..... .. +.
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--------~~~~i~~~~~------~~----~~ 217 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--------LFQSILEDEV------RY----PR 217 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCC------CC----CC
Confidence 458999999999999999999999999999999999999997543322 1111111111 11 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTM-----KVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 775 (799)
.....+.+++.+||+.||++||++ .++++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 233567889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=311.32 Aligned_cols=244 Identities=27% Similarity=0.329 Sum_probs=194.7
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|+||+||++..+. +++.+|+|++..... ...+.+..|++++++++|+||+++.+++......++||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRA-TGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEcc-CCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 7999999999999874 678999999864322 233567889999999999999999999999999999999999999
Q ss_pred hhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 590 LANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 590 L~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
|...+.. ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......... ..
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~ 155 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TK 155 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-cc
Confidence 9988753 24688999999999999999999998 9999999999999999999999999999765433222 22
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||.......... . .......+. ....
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~-~~~~~~~~~----------~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK---E-LKQRILNDS----------VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH---H-HHHhhcccC----------CCCc
Confidence 3458999999999999999999999999999999999999997543221110 0 111111110 0112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
......+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 23445778899999999999999 7788875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=314.40 Aligned_cols=263 Identities=22% Similarity=0.313 Sum_probs=191.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhccc---ccccccceeeeee-----ccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRT---HHKNLVQLLGFCD-----EAL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 576 (799)
+.+.+.||+|+||.||+|.....+++.||+|+++... ......+.+|+.+++.+ +||||++++++|. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 3456789999999999999865457889999886432 22233455666666554 6999999999985 234
Q ss_pred ceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 577 NRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
..++|+||++ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 5789999996 5899888754 3578999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhc-
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAE- 729 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~- 729 (799)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..... ..+..
T Consensus 159 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 65432 222334589999999999988999999999999999999999999986543322111111000 00000
Q ss_pred Cce-eEeecCCCCC---ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 730 GRL-DVLVDSDEPA---MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 730 ~~~-~~~~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+ .......... .......+.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 237 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000 001122345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=307.19 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=204.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.++||.+... ......++.+|+.+++.++|+||+++++++.++...+++|||
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhcccCCeEEEEEeecC-CCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 456789999999999999764 5789999987542 223345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 585 MGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+++++|.+++.. ...+++....+++.||++||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 84 ADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred cCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999998863 34578999999999999999999998 99999999999999999999999999988654332
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.. .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ . ..+.+... ..
T Consensus 161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~--------~~ 225 (267)
T cd08229 161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-----S-LCKKIEQC--------DY 225 (267)
T ss_pred cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-----H-HhhhhhcC--------CC
Confidence 21 1234578899999999998999999999999999999999999864322110 1 01111111 11
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+........+.+.+++.+||+.+|++||||.+|+++++++.
T Consensus 226 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 11112234567888999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.70 Aligned_cols=271 Identities=23% Similarity=0.345 Sum_probs=198.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc-----ceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 580 (799)
.+.+.||+|+||.||+|..+. +++.||||+++.. .......+.+|++++++++||||+++++++.... ..++
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTH-TGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred EEEEEEeecCCeEEEEEEECC-CCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 456789999999999999874 6789999998642 2233457889999999999999999999885432 4689
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||+. ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 v~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 82 VFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDT 157 (338)
T ss_pred EEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccccc
Confidence 999995 68999998877899999999999999999999998 99999999999999999999999999998653322
Q ss_pred Cc--ceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHHhc
Q 038294 661 SR--THTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCYAE 729 (799)
Q Consensus 661 ~~--~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~ 729 (799)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+... ....+..
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 11 1123468999999999876 67899999999999999999999998654321111000000 0000000
Q ss_pred CceeEee---cCCCCCc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCC
Q 038294 730 GRLDVLV---DSDEPAM---ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLEV 783 (799)
Q Consensus 730 ~~~~~~~---d~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~ 783 (799)
....... ....+.. .-......+.+++.+||+.||++|||++|+++. ++++...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKV 299 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCcc
Confidence 0000000 0000000 001123456789999999999999999999854 4444443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=306.29 Aligned_cols=241 Identities=24% Similarity=0.378 Sum_probs=190.6
Q ss_pred hhcCccccceEEEEEEeCCC-----------CeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 511 EELGRGSFGIVYKGVLKSAS-----------GKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~-----------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
+.||+|+||.||+|.....+ ...|++|.+..........|.+|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 46899999999999864321 2358999887655555568899999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-------eEEcccc
Q 038294 580 LVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS-------AKISDFG 651 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~-------~kl~DfG 651 (799)
+++||+++++|..++... ..+++..+.+++.||++||+|||+. +|+||||||+|||++.++. +|++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999988754 4689999999999999999999998 9999999999999987654 8999999
Q ss_pred CcccccCCCCcceeeeccCCccccccccc-CCCCCcchhHHHHHHHHHHHH-hCCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 652 LSKLLLSDQSRTHTMIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEII-CCRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 652 la~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ .|..|+......+.. .. ..
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~--------~~-~~ 223 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE--------RF-YE 223 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH--------HH-Hh
Confidence 98765322 1234678899999886 567899999999999999998 577776543222110 11 11
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
+... . .....+.+.+++.+||+.||++||++.+|++.|+
T Consensus 224 ~~~~------~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 224 GQCM------L----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCcc------C----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1100 0 1112356788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=311.59 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=201.2
Q ss_pred hhhhcCccccceEEEEEEeCC----CCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 509 FKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.||+|+||.||+|..... ....+++|.+..... ...+++.+|+.+++.++||||+++++.+......++++|
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVE 83 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEE
Confidence 457899999999999987531 235789998865432 334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 584 FMGNGTLANLIFAI------------------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 584 ~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +|+||||||+|||+
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill 160 (290)
T cd05045 84 YAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV 160 (290)
T ss_pred ecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEE
Confidence 99999999988642 2467888999999999999999987 99999999999999
Q ss_pred cCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 640 DNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..|+.....++
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--- 237 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--- 237 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 999999999999998653322211 122235678999999988889999999999999999999 888886543322
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+....+. .... .......+.+++.+|++.+|++||++.|+++.|++++.
T Consensus 238 -----~~~~~~~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -----LFNLLKTGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -----HHHHHhCCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111112111 0111 12233578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.54 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=203.1
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+...++.+.++||+|+||.||+|..+ +++.||+|.+.... ...+++.+|+.++++++|+|++++++++. ....+++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~--~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN--GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC--CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 34556677889999999999999876 46789999987533 23467899999999999999999999874 4568999
Q ss_pred EeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 582 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||+++++|.+++... ..+++.++..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999998754 3678999999999999999999987 8999999999999999999999999999876433
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.........++..|+|||.+....++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~------ 221 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV--------IQNLERGYR------ 221 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH--------HHHHHcCCC------
Confidence 2222222345678999999998889999999999999999999 9999875432211 111111110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
..........+.+++.+|++.+|++|||++++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 ---MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 01111233578899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.52 Aligned_cols=251 Identities=24% Similarity=0.287 Sum_probs=198.6
Q ss_pred chhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc----hhhHHHHHHHHHHhccc-ccccccceeeeeecccceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.||+|+||.||++.... .+++.||+|++.... ....+.+..|+.++.++ +|+||+++++++......++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 356789999999999988642 357899999986432 22335678899999999 59999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 83 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999998888899999999999999999999998 89999999999999999999999999998654433
Q ss_pred CcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...........+ ...+... ++.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~----~~~~~~~------~~~ 229 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV----SRRILKC------DPP 229 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH----HHHHhcC------CCC
Confidence 3333345689999999999875 4788999999999999999999999754322111111 1111111 111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
.+. .....+.+++.+||+.||++|| +++++++
T Consensus 230 ~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 230 FPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111 2334677899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=308.26 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=201.4
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.+.||+|+||.||+|+... +++.||+|+++.......+.+.+|+.++++++||||+++++.+......++|+||+
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLH-TGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hcchhheeecCCCeEEEEEEECC-CCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 34566889999999999999864 67899999987554445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++........ ...
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~~ 164 (267)
T cd06646 89 GGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-KRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccccc-ccC
Confidence 9999999998777889999999999999999999998 999999999999999999999999999986643221 112
Q ss_pred eeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 666 MIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
...+++.|+|||.+. ...++.++||||||+++|||++|+.|+......+.... ...... ..+...
T Consensus 165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~---~~~~~~- 232 (267)
T cd06646 165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSKSNF---QPPKLK- 232 (267)
T ss_pred ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eecCCC---CCCCCc-
Confidence 235788999999884 44578899999999999999999999864322111000 000000 001111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
........+.+++.+||+.+|++|||+++|++.|
T Consensus 233 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 -DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred -cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1122346788999999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.91 Aligned_cols=241 Identities=27% Similarity=0.331 Sum_probs=193.7
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcc-cccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|..+. +++.||+|.++... ....+.+..|..++.. .+||||+++++++.+.+..++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG-KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC
Confidence 469999999999999875 67899999986532 2233456677777765 489999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|..++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAST 155 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cceec
Confidence 999999998877889999999999999999999998 99999999999999999999999999987432211 22234
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+..+. +..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--------~~~~~~~~~------~~~~~---- 217 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--------LFESIRVDT------PHYPR---- 217 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCC------CCCCC----
Confidence 568999999999999999999999999999999999999997543321 111111111 11111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMK-VVL 774 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 774 (799)
.....+.+++.+||+.||++||++. +++
T Consensus 218 ~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 218 WITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 2334677899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=323.80 Aligned_cols=199 Identities=27% Similarity=0.348 Sum_probs=173.5
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|+||+||++..+. +++.||+|+++... ......+..|+.++.+++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKD-TGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred EeEEEEeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 45789999999999999874 67899999996532 223356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC----
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS---- 661 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 661 (799)
++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 84 PGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 662 ------------------------------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 662 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~ 240 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCC
Confidence 00123468999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=313.26 Aligned_cols=256 Identities=27% Similarity=0.377 Sum_probs=203.3
Q ss_pred hhchhhhcCccccceEEEEEEeCC----CCeEEEEEEcccc-chhhHHHHHHHHHHhccc-ccccccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 579 (799)
.+.+.+.||+|+||.||++..+.. ....+|+|.+... ..+...++.+|+.++.++ +|+||+++++++..+...+
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 344567899999999999987632 3368999998753 233445788999999999 7999999999999999999
Q ss_pred eEEeecCCCChhhhhhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 038294 580 LVYEFMGNGTLANLIFA----------------IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF 643 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~----------------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~ 643 (799)
++|||+++|+|.+++.. ...+++..+++++.|++.||+|||+. +|+|+||||+||++++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCC
Confidence 99999999999999853 23578899999999999999999987 999999999999999999
Q ss_pred ceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHH
Q 038294 644 SAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTD 721 (799)
Q Consensus 644 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~ 721 (799)
.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------- 242 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------- 242 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-------
Confidence 99999999998764332111 112234678999999999999999999999999999998 888876443221
Q ss_pred HHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 722 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
..+....+.. ...+......+.+++.+|++.+|++|||+.|+++.|++++
T Consensus 243 -~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 -LFKLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1122222211 0111223457888999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=306.25 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=202.9
Q ss_pred hchhhhcCccccceEEEEEEeCCC--CeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+..+ +..+|+|.++... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTE 85 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEE
Confidence 345688999999999999876332 3479999986533 3345688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+|||++.++.++|+|||++.........
T Consensus 86 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 86 YMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999765 4678999999999999999999998 8999999999999999999999999999876543222
Q ss_pred ceee--eccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 THTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~~~~--~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.... ..++..|+|||.+.+..++.++||||||+++||+++ |..|+......+. ...+.++..
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~--------~~~~~~~~~------- 227 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV--------IKAIEEGYR------- 227 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH--------HHHHhCCCc-------
Confidence 2111 123567999999999899999999999999999887 9999865432211 111111110
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.+ ......+.+.+++.+|++.+|++||+|.++++.|++++
T Consensus 228 ~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 267 (267)
T cd05066 228 LP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267 (267)
T ss_pred CC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhhC
Confidence 00 01123456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=326.56 Aligned_cols=250 Identities=24% Similarity=0.315 Sum_probs=202.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+|.... +++.||+|+++... ......+.+|++++..++|+||+++++++.++...++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKD-TGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECC-CCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 456789999999999999875 68899999986532 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC----
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---- 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 660 (799)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 83 MPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 99999999998888889999999999999999999997 99999999999999999999999999998764332
Q ss_pred ------------------------CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc
Q 038294 661 ------------------------SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR 716 (799)
Q Consensus 661 ------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~ 716 (799)
........||+.|+|||.+.+..++.++|||||||+||||++|+.||......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 11222345899999999999999999999999999999999999999765432211
Q ss_pred hhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 038294 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT-MKVVLQM 776 (799)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~~ 776 (799)
..+.... ... ..+. .....+.+.+++.+|++ +|++||+ ++|+++.
T Consensus 240 --------~~i~~~~-~~~---~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 240 --------NKIINWK-ESL---RFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --------HHHhccC-Ccc---cCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 1111100 000 0111 11134567789999998 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=316.64 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=208.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeecccc-eeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-RLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e 583 (799)
+...++||+|+||.++....+. +.+.+++|++.- ......+...+|+.++++++|||||.+.+.+.++.. .+|||+
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~-~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKS-DDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhcCccccchhhhhhhcc-CCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 3456889999999999988875 567899998853 233344578899999999999999999999999888 899999
Q ss_pred ecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 584 FMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|++||+|.+.+...+ .++++++.+++.|++.|+.|||++ .|+|||||+.||+++.++.+||.|||+|+.+.....
T Consensus 85 Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~ 161 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS 161 (426)
T ss_pred ecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence 999999999998754 578889999999999999999987 899999999999999999999999999999876553
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
. .....||+.||.||.+.+.+|..|+|||||||++|||++.+.+|...+...- +.+ +..+ ..
T Consensus 162 ~-a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L-------i~k-i~~~---------~~ 223 (426)
T KOG0589|consen 162 L-ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL-------ILK-INRG---------LY 223 (426)
T ss_pred h-hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH-------HHH-Hhhc---------cC
Confidence 2 3346799999999999999999999999999999999999999987654321 111 1111 12
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+..+...+..++..|++.+|+.||++.+++.+
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 23345667788889999999999999999999865
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.24 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=198.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.++||+|++|.||++.++. +..+|+|.+.... ...+.+.+|++++++++|+|++++++++.. ...+++|||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~--~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNG--TTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcC--CceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 35567889999999999998763 4569999886432 234678899999999999999999998854 5678999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999764 3478999999999999999999998 89999999999999999999999999998664332222
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. . .....+.. .
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~-~~~~~~~~-----~---- 222 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-------L-EQVERGYR-----M---- 222 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------H-HHHHcCCC-----C----
Confidence 222335678999999998899999999999999999999 8888875432221 1 11111100 0
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.........+.+++.+||+.+|++||++++|++.|+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1112234578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=312.97 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=200.0
Q ss_pred chhhhcCccccceEEEEEEe---CCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeec--ccceeeEE
Q 038294 508 GFKEELGRGSFGIVYKGVLK---SASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVY 582 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~---~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 582 (799)
.+.+.||+|+||.||++..+ ..+++.||+|+++.......+.+.+|++++++++||||+++++++.. ....++|+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 86 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEE
Confidence 45678999999999999853 33578999999977666666789999999999999999999998753 34578999
Q ss_pred eecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.......
T Consensus 87 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~ 163 (284)
T cd05081 87 EYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163 (284)
T ss_pred EecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCc
Confidence 999999999999764 4689999999999999999999998 999999999999999999999999999987643322
Q ss_pred cce--eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhc-------c-hhHHHHHHHHHhcCc
Q 038294 662 RTH--TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG-------R-AILTDWAYDCYAEGR 731 (799)
Q Consensus 662 ~~~--~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~-------~-~~~~~~~~~~~~~~~ 731 (799)
... ....++..|+|||.+.+..++.++||||||++++||++|..++........ . ........+....+.
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (284)
T cd05081 164 YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNG 243 (284)
T ss_pred ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCC
Confidence 111 112234469999999988999999999999999999998766532211100 0 000000111111110
Q ss_pred eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 732 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
...........+.+++.+||+.+|++||||.||++.|+.+
T Consensus 244 ---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 244 ---------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011122345688899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.36 Aligned_cols=258 Identities=23% Similarity=0.331 Sum_probs=202.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCC---eEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.||+|+||+||+|.....+. ..||+|+++.. .....+++.+|+.+++.++|+||+++++++... ..++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence 3456889999999999998764222 24899998653 333456789999999999999999999999754 567999
Q ss_pred eecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 88 ~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 88 QLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 999999999999874 4689999999999999999999998 899999999999999999999999999987643222
Q ss_pred cc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 662 RT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 662 ~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.. .....++..|+|||.+.+..++.++||||||+++|||++ |..|+....... ....+..+... .
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-----~ 231 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--------IPDLLEKGERL-----P 231 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHHHHCCCcC-----C
Confidence 11 111234678999999999999999999999999999998 888886433221 11112222110 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 785 (799)
........+.+++.+||+.||++||++.++++.|+.+...+.
T Consensus 232 ----~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 232 ----QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred ----CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 011233567889999999999999999999999988866653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=315.11 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=199.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCC--eEEEEEEcccc-chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.||+|+||.||+|.++. ++ ..+++|.++.. .....+++.+|++++.++ +|+||+++++++..+...++|+
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~ 87 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 87 (303)
T ss_pred ceeeeeecCCCCceEEEEEEcc-CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEE
Confidence 4566889999999999999864 34 35688877643 234456889999999999 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceE
Q 038294 583 EFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAK 646 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~k 646 (799)
||+++++|.+++.... .+++..++.++.||+.||+|||+. +++||||||+|||+++++.+|
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 88 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEE
Confidence 9999999999997432 467889999999999999999998 999999999999999999999
Q ss_pred EccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHH
Q 038294 647 ISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYD 725 (799)
Q Consensus 647 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 725 (799)
|+|||++....... ......++..|+|||.+.+..++.++|||||||++|||+| |..||......+. ..
T Consensus 165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~~ 234 (303)
T cd05088 165 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL--------YE 234 (303)
T ss_pred eCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH--------HH
Confidence 99999986432111 1111224567999999988889999999999999999998 9999864432211 11
Q ss_pred HHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 726 CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 726 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
....+. ...........+.+++.+|++.+|++||++.++++.|+.+++-
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 111110 0001112234678899999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.17 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=199.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+....++||||
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKA-TGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred eEEEEEEeccCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 456789999999999999874 67899999997532 23445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++... ..+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 83 QPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999876 5789999999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeeccCCccccccccc------CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 664 HTMIRGTRGYVAPEWFK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~------~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||........ . ..+.... ....
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~-~~i~~~~--~~~~ 229 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-------Y-NNIMNFQ--RFLK 229 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-------H-HHHHcCC--CccC
Confidence 33446899999999986 45678999999999999999999999975433221 1 1111110 0000
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+. .......+.+++..|++ +|++|||+.++++
T Consensus 230 --~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 230 --FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 011 11234567788899998 9999999999885
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=312.99 Aligned_cols=264 Identities=26% Similarity=0.360 Sum_probs=206.8
Q ss_pred HHHHhhchhhhcCccccceEEEEEEe------CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeee
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLK------SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCD 573 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~------~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 573 (799)
+....+.+.+.||+|+||.||++... ..++..||+|.+.... ....+++.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33445556789999999999999753 1234579999986532 34456789999999999 8999999999999
Q ss_pred cccceeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 038294 574 EALNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNI 637 (799)
Q Consensus 574 ~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NI 637 (799)
.....+++|||+++|+|.+++... ..+++..+.+++.||++||+|||+. +++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence 999999999999999999998753 2467888999999999999999998 999999999999
Q ss_pred EEcCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhc
Q 038294 638 LLDNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEG 715 (799)
Q Consensus 638 Ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~ 715 (799)
++++++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..|+......+
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~- 247 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 247 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-
Confidence 99999999999999998764332211 122335678999999998889999999999999999998 677775432221
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 785 (799)
....+..+... .........+.+++.+||+.+|++||||.||++.|++++....
T Consensus 248 -------~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~ 301 (304)
T cd05101 248 -------LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTT 301 (304)
T ss_pred -------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence 11122222110 0112234577889999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.93 Aligned_cols=249 Identities=27% Similarity=0.324 Sum_probs=199.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
...+.||+|+||.||++.... +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++||||
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcC-CCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345789999999999999764 57899999986432 12234678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++|+|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999888654 4588999999999999999999998 899999999999999999999999999986543221
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....|++.|+|||.+.+..++.++||||+|+++|||++|+.||........... ....+..+. .
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~----------~ 222 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE----VERRVKEDQ----------E 222 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH----HHHHhhhcc----------c
Confidence 1233588999999999999999999999999999999999999976433221111 111111111 1
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 776 (799)
.........+.+++..||+.||++|| +++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 11223445678899999999999999 88888653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=303.58 Aligned_cols=247 Identities=26% Similarity=0.376 Sum_probs=202.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|++|.||+++.+. +++.|++|.+... .....+++.+|++++++++|||++++++++.+....++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKA-DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcC-CCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 355789999999999999874 5789999988532 3344568899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+.+++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~- 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF- 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccch-
Confidence 999999999764 5678899999999999999999987 9999999999999999999999999998876443221
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....+++.|+|||++.+..++.++||||||++++||++|+.||....... .......+... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~---------~ 220 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA--------LILKIIRGVFP---------P 220 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCC---------C
Confidence 223457889999999999999999999999999999999999997554221 11111111111 1
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 111344678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=306.22 Aligned_cols=255 Identities=26% Similarity=0.408 Sum_probs=201.7
Q ss_pred hchhhhcCccccceEEEEEEeCCC--CeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.+.||+|+||.||+|.++... +..||+|.++.. .....++|..|+.++++++||||+++++++.++...++|+|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 456788999999999999987432 247999998754 33445689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~ 162 (269)
T cd05065 86 FMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162 (269)
T ss_pred cCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence 99999999999764 4678999999999999999999998 9999999999999999999999999998765432211
Q ss_pred c-eee-ec--cCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 663 T-HTM-IR--GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 663 ~-~~~-~~--gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
. ... .. .+..|+|||.+.+..++.++||||||+++||+++ |..||......+. ...+....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~--------~~~i~~~~------ 228 (269)
T cd05065 163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--------INAIEQDY------ 228 (269)
T ss_pred cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH--------HHHHHcCC------
Confidence 1 111 11 2457999999999999999999999999999886 8889865432211 11111110
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
..+ ........+.+++.+||+.+|++||++.+|+.+|++++
T Consensus 229 -~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 269 (269)
T cd05065 229 -RLP--PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269 (269)
T ss_pred -cCC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhhC
Confidence 000 01122346778999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.92 Aligned_cols=248 Identities=26% Similarity=0.367 Sum_probs=200.1
Q ss_pred hhcCccccceEEEEEEeCCCCe--EEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGK--AIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~--~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|++|.||+|.+....++ .||+|.++.... ...+.+.+|+.++++++|+||+++++.+.+ ...++++||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 4689999999999998653333 689999976555 556789999999999999999999999988 888999999999
Q ss_pred CChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc--c
Q 038294 588 GTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--T 663 (799)
Q Consensus 588 gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--~ 663 (799)
++|.+++.... .+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997754 688999999999999999999998 9999999999999999999999999999876442211 1
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+. .......+.. .
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~~~~~-------~-- 220 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-------LKKIDKEGER-------L-- 220 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHHHhcCCc-------C--
Confidence 112346788999999999999999999999999999999 9999864433221 1111111100 0
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.........+.+++.+|++.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011123457888999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=308.72 Aligned_cols=258 Identities=23% Similarity=0.335 Sum_probs=204.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCC---CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeec-cccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSA---SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~---~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~ 579 (799)
..+.+.+.||+|+||.||+|..... .++.|++|++.... ....+.+.+|+.++++++|+||+++++++.. +...+
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~ 85 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPF 85 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCE
Confidence 3445678899999999999998752 26789999987543 3345678999999999999999999998866 46788
Q ss_pred eEEeecCCCChhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcccc
Q 038294 580 LVYEFMGNGTLANLIFAI--------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFG 651 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfG 651 (799)
+++||+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 86 VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred EEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCC
Confidence 999999999999998653 3578999999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 652 LSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 652 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
+++.+...... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+ + ...+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----~----~~~~~~ 234 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----M----AAYLKD 234 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH----H----HHHHHc
Confidence 99866433221 1122335678999999998899999999999999999999 999987543221 1 111122
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+.. .. ......+.+.+++.+||+.+|++|||+.+|++.|+.+.+
T Consensus 235 ~~~-------~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GYR-------LA--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CCC-------CC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 110 00 011223567899999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=323.63 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=198.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc-----ceeeE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRLLV 581 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~lv 581 (799)
..+.||+|+||.||++.... +++.||+|++... .....+.+.+|+++++.++|+||+++++++.... ..++|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPR-DGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred ccceeeeCCCEEEEEEEECC-CCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 45789999999999999864 6789999998643 2234467889999999999999999999998766 78999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+||+. ++|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred eeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99996 58888887777899999999999999999999998 999999999999999999999999999987544333
Q ss_pred cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH---------------HHH
Q 038294 662 RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW---------------AYD 725 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~---------------~~~ 725 (799)
.......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........+... ...
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~ 238 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA 238 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence 333334578899999998874 4789999999999999999999999765433211111100 000
Q ss_pred HHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 726 CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 726 ~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+............ .........+.+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 239 HILRGPHKPPSLPV-LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHhCCCCCCchHH-hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 01000000000000 000111224567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=303.58 Aligned_cols=246 Identities=28% Similarity=0.406 Sum_probs=202.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.+.||+|+||.||+|... ++.||+|.++.... ..+++.+|+.++.+++|+||+++++++......++|+||++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~---~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR---GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred ccceeeeecCCCceEEEEEec---CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 345688999999999999874 68899999976544 46789999999999999999999999998889999999999
Q ss_pred CCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|.+++.... .+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||+++.......
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--- 157 (256)
T cd05039 84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--- 157 (256)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence 999999997665 689999999999999999999998 999999999999999999999999999987632211
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....+..|+|||.+....++.++||||||++++|+++ |..|+......+ .......+.. ..
T Consensus 158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~---------~~ 219 (256)
T cd05039 158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPHVEKGYR---------ME 219 (256)
T ss_pred -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhcCCC---------CC
Confidence 2234567999999998889999999999999999997 888886543221 1111111100 01
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
......+.+.+++.+|++.+|++|||++|++++|+.+
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 1112346788899999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=307.73 Aligned_cols=252 Identities=26% Similarity=0.390 Sum_probs=198.4
Q ss_pred hchhhhcCccccceEEEEEEeCC----CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.+.||+|+||.||+|.+... .+..|++|.+.... ...+..|..|+.++++++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 34557899999999999998742 35789999886433 33456799999999999999999999999998899999
Q ss_pred EeecCCCChhhhhhcCC-------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEcccc
Q 038294 582 YEFMGNGTLANLIFAIP-------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---SAKISDFG 651 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~-------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---~~kl~DfG 651 (799)
|||+++++|.+++.... .+++..+++++.||+.||+|||+. +++|+||||+||+++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999987542 478999999999999999999998 899999999999998654 69999999
Q ss_pred CcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 652 LSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 652 la~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
+++......... ......+..|+|||.+.+..++.++|||||||++|||++ |..||......+. ...+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~--------~~~~~~ 236 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV--------MEFVTG 236 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH--------HHHHHc
Confidence 998763222111 111223567999999999999999999999999999997 8888875443221 111111
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.. ....+......+.+++.+|++.+|++||++.+|++.|+
T Consensus 237 ~~---------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 237 GG---------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 10 00111223357788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=308.30 Aligned_cols=255 Identities=27% Similarity=0.441 Sum_probs=202.9
Q ss_pred HhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
....+.+.||+|+||.||+|..+. ..+..||+|.+.... .....++.+|+.+++.++|+||+++++++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 344556889999999999998863 234789999986543 234457889999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 580 LVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
+||||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~d 162 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGD 162 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECC
Confidence 999999999999998643 2367889999999999999999987 999999999999999999999999
Q ss_pred ccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 650 FGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 650 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
||+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |..|+......+. .+..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--------~~~~ 234 (277)
T cd05032 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--------LKFV 234 (277)
T ss_pred cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--------HHHH
Confidence 999986543321 11222346778999999998889999999999999999998 8888865433221 1111
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
..+... ..+ ......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 235 ~~~~~~-----~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 235 IDGGHL-----DLP----ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred hcCCCC-----CCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 121111 111 1224678899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.72 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=201.3
Q ss_pred HhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
..+.+.+.||+|+||.||+|..++ ..+..||+|.+.... ......+.+|+.++++++|+||+++++++.+....+
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 345567899999999999997652 234689999886433 223456889999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 580 LVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
+||||+++|+|.+++... ..+++..+.+++.|++.||.|||+. +|+||||||+||++++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999999642 2346778899999999999999998 999999999999999999999999
Q ss_pred ccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 650 FGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 650 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+.....++ ....+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--------~~~~~ 234 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--------VLKFV 234 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHH
Confidence 9999865432211 1112234678999999999899999999999999999999 677876443222 11111
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+.... . .....+.+.+++.+||+.+|++|||+.++++.|++.+.
T Consensus 235 ~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 280 (288)
T cd05061 235 MDGGYLD-----Q----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH 280 (288)
T ss_pred HcCCCCC-----C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence 1111100 0 11223578889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=311.25 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=202.4
Q ss_pred hhchhhhcCccccceEEEEEEeCCC---------------CeEEEEEEccccc-hhhHHHHHHHHHHhccccccccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSAS---------------GKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLL 569 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~---------------~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~ 569 (799)
.+.+.++||+|+||.||++...... +..||+|.+.... ....+++.+|++++++++|+||++++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 3456789999999999999875422 2468999987543 33456889999999999999999999
Q ss_pred eeeecccceeeEEeecCCCChhhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 038294 570 GFCDEALNRLLVYEFMGNGTLANLIFAIP-----------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNIL 638 (799)
Q Consensus 570 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NIL 638 (799)
+++..+...++++||+++++|.+++.... .+++..++.++.|++.||+|||+. +|+|+||||+||+
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 99999999999999999999999997654 688999999999999999999998 8999999999999
Q ss_pred EcCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh--CCcCCchhhhhhc
Q 038294 639 LDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMEVEEEG 715 (799)
Q Consensus 639 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt--g~~p~~~~~~~~~ 715 (799)
+++++.++|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ +..|+.......
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~- 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ- 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence 99999999999999986543321 11223345778999999998889999999999999999998 566765432221
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.+ ................ .........+.+++.+|++.+|++|||+.||++.|+.
T Consensus 242 --~~-~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 242 --VI-ENAGHFFRDDGRQIYL------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred --HH-HHHHhccccccccccC------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11 1111111111111100 0111233578899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.03 Aligned_cols=240 Identities=26% Similarity=0.320 Sum_probs=199.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+..+||+|.||+|+++.++. +++.+|||.+++.. ....+..+.|.+++... +||.|+.|+.++...++.+.||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~-~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvm 448 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKG-TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVM 448 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcC-CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEE
Confidence 3456889999999999999986 67899999997632 33456677888888777 5999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+.||++ -++.....+++..+.-++..|+.||.|||++ +||+||||.+|||||.+|.+||+||||++..-.. ..
T Consensus 449 ey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~-g~ 523 (694)
T KOG0694|consen 449 EYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ-GD 523 (694)
T ss_pred EecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCC-CC
Confidence 99999993 3333446788999999999999999999999 9999999999999999999999999999864322 33
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....+||+.|||||++.+..|+..+|-|||||+|||||.|..||.++++++.-..+ .. .+.
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI--------~~------d~~---- 585 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI--------VN------DEV---- 585 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--------hc------CCC----
Confidence 455678999999999999999999999999999999999999999988776632221 11 112
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
.++.....+.+.++.++|..+|++|.-+
T Consensus 586 ~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 586 RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 2344455677889999999999999876
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=325.25 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=197.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|+||.||++..+. +++.||||++.... ......+.+|+.++..++|+||+++++++.++...++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 5 SIKVIGRGAFGEVRLVQKKD-TGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred EEEEEEecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 45789999999999999875 57899999996532 233456788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc---
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--- 662 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--- 662 (799)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+......
T Consensus 84 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 84 PGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 9999999998888899999999999999999999998 9999999999999999999999999998765321100
Q ss_pred ----------------------------------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCc
Q 038294 663 ----------------------------------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 663 ----------------------------------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
......||+.|+|||++....++.++|||||||++|||++|..||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0112358999999999999999999999999999999999999997
Q ss_pred hhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038294 709 MEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT---MKVVLQ 775 (799)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~ 775 (799)
.....+. ...+....... ..+. .....+.+.+++.+|+. +|.+|++ +.|+++
T Consensus 241 ~~~~~~~--------~~~i~~~~~~~----~~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 241 SDNPQET--------YRKIINWKETL----QFPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCHHHH--------HHHHHcCCCcc----CCCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 5543221 11111111000 0011 11223466778888886 9999998 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=304.07 Aligned_cols=249 Identities=23% Similarity=0.303 Sum_probs=200.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-----hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
...+.||+|++|.||++.... +++.+++|.+.... ....+.+.+|++++++++||||+++++++.+....++++
T Consensus 5 ~~~~~lg~g~~~~vy~~~~~~-~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 5 RRGKLLGQGAFGRVYLCYDVD-TGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred cccceecCCCceEEEEEEEcC-CCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 346789999999999998764 57899999885421 122357889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++++|.+++.....+++....+++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||+++........
T Consensus 84 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 84 EYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999998877888999999999999999999998 9999999999999999999999999999765432211
Q ss_pred ce--eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 663 TH--TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 663 ~~--~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.. ....++..|+|||.+.+..++.++||||||+++|||++|+.||........ ........ .
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~---------~ 224 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA-------IFKIATQP---------T 224 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH-------HHHHhccC---------C
Confidence 11 234477899999999999999999999999999999999999865422111 01110110 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+......+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111122334567889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=317.28 Aligned_cols=240 Identities=28% Similarity=0.353 Sum_probs=194.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccccc-ccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.||+|+||.||+|..+. +++.||+|+++... ....+.+..|.+++..++| ++|+++.+++.+.+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 81 (324)
T ss_pred eEEEEEeeccCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEc
Confidence 356789999999999999874 57899999986532 2334567889999998865 568889999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 157 (324)
T cd05587 82 YVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG-KT 157 (324)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC-Cc
Confidence 999999999998888889999999999999999999998 99999999999999999999999999987532211 22
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+..... ..+.
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~--------~~~i~~~~~------~~~~- 222 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL--------FQSIMEHNV------SYPK- 222 (324)
T ss_pred eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH--------HHHHHcCCC------CCCC-
Confidence 3345689999999999999999999999999999999999999975543221 111122111 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
.....+.+++.+||+.||++||+.
T Consensus 223 ---~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 223 ---SLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCHHHHHHHHHHhhcCHHHcCCC
Confidence 233567889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.47 Aligned_cols=240 Identities=25% Similarity=0.277 Sum_probs=194.9
Q ss_pred hhcCccccceEEEEEEe--CCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLK--SASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~--~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++... ..+++.+|+|+++.... .....+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 56999999999998763 23578999999975332 223457789999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ....
T Consensus 82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 157 (318)
T cd05582 82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAYS 157 (318)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ceec
Confidence 999999998877889999999999999999999998 999999999999999999999999999886543322 2233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+..... ..+ .
T Consensus 158 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~--------~~~i~~~~~------~~p----~ 219 (318)
T cd05582 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET--------MTMILKAKL------GMP----Q 219 (318)
T ss_pred ccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH--------HHHHHcCCC------CCC----C
Confidence 5689999999999998899999999999999999999999975432211 111111111 111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKV 772 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~e 772 (799)
.....+.+++.+||+.||++||++.+
T Consensus 220 ~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 220 FLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 22346778999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.15 Aligned_cols=238 Identities=28% Similarity=0.320 Sum_probs=190.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHH-HhcccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||+||+|..+. +++.||+|++..... ...+++..|.. +++.++||||+++++.+.+....++||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA-DGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC
Confidence 368999999999999874 688999999864321 22234555544 5678899999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 999999998878889999999999999999999998 99999999999999999999999999987542221 22233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+..+.. .. ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~------~~----~~ 217 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE--------MYDNILNKPL------RL----KP 217 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH--------HHHHHHcCCC------CC----CC
Confidence 468999999999999999999999999999999999999997543221 1111111111 01 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMK 771 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~ 771 (799)
.....+.+++.+||+.||++||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 2245678899999999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=323.87 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=198.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKS-SKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 34456789999999999999875 67899999986422 223345788999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++... .++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~ 198 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence 999999999988654 567788888999999999999998 9999999999999999999999999999876433322
Q ss_pred ceeeeccCCcccccccccCC----CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 663 THTMIRGTRGYVAPEWFKNA----PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~----~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
......||+.|+|||.+.+. .++.++|||||||+||||++|+.||....... ....+...... .
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~~----~ 266 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMDHKNS----L 266 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--------HHHHHHcCCCc----C
Confidence 22345689999999998654 47889999999999999999999997654321 11111111100 0
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSK--RPTMKVVLQM 776 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 776 (799)
..+. .......+.+++..||+.+|++ ||++.|+++.
T Consensus 267 ~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 267 TFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111 1123457778999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.52 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=194.1
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|+||.||++..+. +++.+|+|++.... ....+.+..|++++++++||||+++.+++..+...++||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKN-TGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEcc-CCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 7999999999999875 68899999986422 1223456679999999999999999999999999999999999999
Q ss_pred hhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 590 LANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 590 L~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++....... .....
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 99888654 3578899999999999999999998 99999999999999999999999999988664322 22334
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.|+..|+|||++.+..++.++|||||||++|||++|+.||.......... ... ........ .. ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~---~~~-~~~~~~~~----~~-----~~~~ 221 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE---ELK-RRTLEDEV----KF-----EHQN 221 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH---HHH-HHhhcccc----cc-----cccc
Confidence 58899999999999899999999999999999999999986432211110 111 11111111 00 0112
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
....+.+++..||+.||++||++.|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 345678899999999999999997766444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=312.75 Aligned_cols=262 Identities=27% Similarity=0.360 Sum_probs=204.5
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCC------CCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeee
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSA------SGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFC 572 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 572 (799)
++....+.+.+.||+|+||.||++..... ....+|+|.++... .....++..|++++.++ +|+||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 33345566788999999999999986421 22469999997532 33456788999999999 799999999999
Q ss_pred ecccceeeEEeecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 038294 573 DEALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQN 636 (799)
Q Consensus 573 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~N 636 (799)
......++|+||+++|+|.+++.... .+++..+++++.|++.||+|||+. +++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHh
Confidence 99999999999999999999997532 478899999999999999999987 99999999999
Q ss_pred eEEcCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhh
Q 038294 637 ILLDNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEE 714 (799)
Q Consensus 637 ILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~ 714 (799)
|+++.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..|+.....++
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999987654322111 111224568999999999899999999999999999998 778876433221
Q ss_pred cchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.......+.. ..........+.+++.+|++.+|++||||.+|++.|+.++.
T Consensus 251 --------~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 251 --------LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred --------HHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 1111122110 01111234577789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.99 Aligned_cols=244 Identities=25% Similarity=0.319 Sum_probs=194.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++..+. +++.+|+|+++... ....+.+..|+.++.++ +|+||+++++++......++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK-NDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC
Confidence 369999999999999875 57899999997532 22345678899999888 69999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 999999998878899999999999999999999998 99999999999999999999999999987532221 12233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||++.+..++.++|||||||+||||++|+.||........... .....+....... ..+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~------~~p----~ 224 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT-EDYLFQVILEKPI------RIP----R 224 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc-HHHHHHHHHhCCC------CCC----C
Confidence 5689999999999999999999999999999999999999964332211111 1222222222211 111 1
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
.....+.+++.+||+.||++||++
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCC
Confidence 223566789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=315.68 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=192.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHH---hcccccccccceeeeeecccceeeEE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSA---IGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~---l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.||+|+||.||+|..+. +++.||||+++... ....+.+..|+++ ++.++||||+++++++......++||
T Consensus 3 i~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 3 CLAVLGRGHFGKVLLAEYKK-TGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred EEEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 45789999999999999874 67899999996432 2223456666555 45678999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++++|...+.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 156 (324)
T cd05589 82 EYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD- 156 (324)
T ss_pred cCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC-
Confidence 99999999888754 4689999999999999999999998 999999999999999999999999999875432221
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||......+. ...+..+.. ..+
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~--------~~~i~~~~~------~~p- 221 (324)
T cd05589 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV--------FDSIVNDEV------RYP- 221 (324)
T ss_pred cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCC------CCC-
Confidence 22335689999999999999999999999999999999999999976543221 111111111 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
......+.+++.+||+.||++|| ++.++++
T Consensus 222 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 222 ---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 12235677899999999999999 4666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.27 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=203.9
Q ss_pred HHhhchhhhcCccccceEEEEEEeCC--CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.....+.+.||+|+||.||+|...+. ....|++|...... ....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 33455678999999999999997643 23478999886544 4455689999999999999999999999875 45789
Q ss_pred EEeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++.....
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 999999999999997643 579999999999999999999997 8999999999999999999999999999876443
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.........++..|+|||.+....++.++||||||++++|+++ |..||......+. . ..+..+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~-~~~~~~~~~----- 227 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------I-GRIENGERL----- 227 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------H-HHHHcCCcC-----
Confidence 2222222234568999999988889999999999999999996 9999875543221 1 111121100
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.. .......+.+++.+|+..+|++|||+.++++.|+++..
T Consensus 228 ~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01 11223578889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=303.56 Aligned_cols=252 Identities=28% Similarity=0.453 Sum_probs=202.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
....+.++||+|+||.||++..+ +++.++||.++... ...+++.+|+.++++++|+||+++++++......+++|||
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~--~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWN--GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEc--CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 34456788999999999999976 45789999987532 3356799999999999999999999999988899999999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999765 3688999999999999999999998 8999999999999999999999999999876432221
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
.......+..|+|||.+.+..++.++||||||++++|+++ |+.||....... .+ +.+..+. ....+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~-----~~~~~~~-----~~~~~ 226 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VL-----EQVERGY-----RMPRP 226 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-----HHHHcCC-----CCCCC
Confidence 1122234568999999999899999999999999999999 888886543221 11 1111110 00011
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
......+.+++.+|++.+|++||+++++++.|+.
T Consensus 227 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ----PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1124568889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=303.92 Aligned_cols=252 Identities=28% Similarity=0.394 Sum_probs=191.2
Q ss_pred hhcCccccceEEEEEEeC-CCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.||+|+||.||+|...+ ..+..+++|+++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998753 2446799999865432 33457899999999999999999999999998999999999999
Q ss_pred ChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-
Q 038294 589 TLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR- 662 (799)
Q Consensus 589 sL~~~l~~~-----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 662 (799)
+|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999753 2456778889999999999999998 8999999999999999999999999998754332211
Q ss_pred ceeeeccCCcccccccccCC-------CCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 663 THTMIRGTRGYVAPEWFKNA-------PVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~-------~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
......++..|+|||++.+. .++.++||||||+++|||++ |+.||......+.. . ..+... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~----~---~~~~~~-~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL----T---YTVREQ-QLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH----H---HHhhcc-cCC
Confidence 11223467889999998642 35789999999999999996 99898654332211 0 011111 111
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
..++... ....+.+.+++..|+ .+|++|||++||++.|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 112345667888898 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=317.18 Aligned_cols=244 Identities=27% Similarity=0.297 Sum_probs=192.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHH-HhcccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||+||++..+. +++.+|+|++.... .....++..|.. +++.++|+||+++++.+...+..++||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA-EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECC-CCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC
Confidence 369999999999999875 57899999986432 122334444444 5677899999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|.+++.....+.......++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~-~~~~ 155 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG-TTST 155 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-Cccc
Confidence 999999998877788888889999999999999998 999999999999999999999999999975432221 2233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+. .+.+..... . ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------~~~i~~~~~------~----~~~ 217 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM--------YDNILNKPL------Q----LKP 217 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH--------HHHHHhCCc------C----CCC
Confidence 4689999999999999999999999999999999999999975433221 111111111 0 111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.....+.+++.+||+.+|.+||++.+.+..+
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 2335677899999999999999987544433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=305.88 Aligned_cols=241 Identities=23% Similarity=0.408 Sum_probs=190.5
Q ss_pred hhcCccccceEEEEEEeCCC------CeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 511 EELGRGSFGIVYKGVLKSAS------GKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.||+|+||.||+|..+... ...+++|.+........+++.+|+.+++.++|||++++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 46999999999999875321 235888888665555567889999999999999999999999998999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--------eEEccccCccc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS--------AKISDFGLSKL 655 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~--------~kl~DfGla~~ 655 (799)
+++|+|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999765 4679999999999999999999998 9999999999999987665 69999998875
Q ss_pred ccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCC-cCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCR-RSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
.... ....+++.|+|||.+.+. .++.++||||||+++|||++|. .|+......... ..... .
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~--------~~~~~-~-- 221 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL--------QFYED-R-- 221 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH--------HHHHc-c--
Confidence 4322 123467889999999864 5799999999999999999995 444432221100 01111 0
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
...+ ......+.+++.+||+.+|++|||++++++.|+
T Consensus 222 ----~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ----HQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----ccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0111 112246788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=298.90 Aligned_cols=267 Identities=24% Similarity=0.312 Sum_probs=200.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeec-----ccceeeEE
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-----ALNRLLVY 582 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~lv~ 582 (799)
.+.||+|+||.|.++..+. +++.||+|++.. ...-..++-.+|+++|+.++|+||+.+.+++.- -+..|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~-t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKR-TGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcC-CCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 4679999999999999885 679999999973 233344677899999999999999999998854 34579999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-C
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-S 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~ 661 (799)
|+| ..+|.+.++..+.++.....-+..||++||.|+|+. +|+||||||+|+|++.+...||+|||+|+...... .
T Consensus 106 elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred hHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999 459999999988899999999999999999999998 99999999999999999999999999999875431 1
Q ss_pred cceeeeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCcee
Q 038294 662 RTHTMIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGRLD 733 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~ 733 (799)
...+..+.|..|+|||++. ...|+...||||.||+|.||++|+.-|.+...-.....+.... ...+...+..
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 1224456799999999874 5689999999999999999999999887654322211111100 0111111100
Q ss_pred EeecC--CCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 038294 734 VLVDS--DEPA----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLL 781 (799)
Q Consensus 734 ~~~d~--~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 781 (799)
..+.. ..+. ..-.......++++.+||..||.+|+|++|.++. |+..-
T Consensus 262 ~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 262 PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 00000 0000 0001233466789999999999999999999863 44443
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=315.68 Aligned_cols=240 Identities=29% Similarity=0.362 Sum_probs=193.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.||+|+||.||+|..+. +++.||+|+++... ....+.+..|..++..+ +|++|+++++++...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVME 81 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEc
Confidence 356789999999999999874 67899999987532 22234567788887776 68999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ..
T Consensus 82 ~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-~~ 157 (323)
T cd05616 82 YVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-VT 157 (323)
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-Cc
Confidence 999999999998878889999999999999999999998 99999999999999999999999999987543221 12
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+.+..... ..+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~--------~~~i~~~~~------~~p-- 221 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL--------FQSIMEHNV------AYP-- 221 (323)
T ss_pred cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCC------CCC--
Confidence 2334689999999999999999999999999999999999999976543221 111222111 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
......+.+++.+|++.+|++|++.
T Consensus 222 --~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 --KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred --CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=325.06 Aligned_cols=248 Identities=21% Similarity=0.243 Sum_probs=192.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|+||.||+|..+. +++.+|+|++.... ....+.+.+|++++++++|+||+++++.+.++...++||||+
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVD-TKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYI 83 (382)
T ss_pred EEEEEEeCCCEEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCC
Confidence 45789999999999999874 67899999986532 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-----
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ----- 660 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~----- 660 (799)
++|+|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 84 PGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999998877788899999999999999999998 89999999999999999999999999975331100
Q ss_pred -----------------------------------------CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHH
Q 038294 661 -----------------------------------------SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699 (799)
Q Consensus 661 -----------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~e 699 (799)
........||+.|+|||++.+..++.++|||||||+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 000112458999999999999999999999999999999
Q ss_pred HHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 038294 700 IICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT---MKVVLQ 775 (799)
Q Consensus 700 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~ 775 (799)
|++|+.||......+.... . ...... ...+ ........+.+++.+++ .+|++|++ +.|+++
T Consensus 241 lltG~~Pf~~~~~~~~~~~-------i-~~~~~~----~~~p--~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMK-------V-INWQTS----LHIP--PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHhCCCCCCCCCHHHHHHH-------H-HccCCC----cCCC--CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 9999999976543221111 1 110000 0001 01112344556666655 49999997 777764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=302.70 Aligned_cols=252 Identities=24% Similarity=0.402 Sum_probs=201.3
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.....+.+.||+|+||.||++.+. .+..+++|.++.. ....+.+.+|++++++++|+|++++.+++.+ ...+++||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~--~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec--CCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345567789999999999999865 4567999988653 2345678999999999999999999999887 67899999
Q ss_pred ecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 584 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 99999999999763 3578899999999999999999987 899999999999999999999999999986643322
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.......++..|+|||.+....++.++|+||||+++||+++ |+.||....... ....+..+..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--------~~~~~~~~~~-------- 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--------VIRALERGYR-------- 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHhCCCC--------
Confidence 22222335677999999998889999999999999999999 888886543221 1111122110
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
..........+.+++.+|++.+|++||++.+++++|+.
T Consensus 222 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112334578889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=318.69 Aligned_cols=242 Identities=27% Similarity=0.301 Sum_probs=192.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHH-HhcccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||++..+. +++.+|+|++.... .....++..|.. +++.++||||+++++.+...+..++||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL-DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC
Confidence 469999999999999864 68899999986432 223345555554 4677899999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|..++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 999999998888899999999999999999999998 99999999999999999999999999987532221 22234
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||......+ ..+.+..+... . ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--------~~~~~~~~~~~------~----~~ 217 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--------MYDNILHKPLV------L----RP 217 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--------HHHHHHcCCcc------C----CC
Confidence 568999999999999999999999999999999999999997543221 11111111110 0 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+++.+|++.+|++||++.+.++
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 23356778999999999999998864433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.25 Aligned_cols=248 Identities=31% Similarity=0.487 Sum_probs=203.3
Q ss_pred hhcCccccceEEEEEEeC--CCCeEEEEEEccccchhh-HHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||+|+||.||++.... ..+..+++|.++...... .+.+.+|++.+..++|+|++++++++......++++||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999874 126789999997654433 67899999999999999999999999998899999999999
Q ss_pred CChhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 588 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 588 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++|.+++... ..+++..+.+++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999875 6789999999999999999999998 999999999999999999999999999987754
Q ss_pred CCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 659 DQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 659 ~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
... .......++..|+|||.+....++.++||||+|+++|||++ |..|+......+ ..+....+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~---- 225 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE--------VLEYLRKGYR---- 225 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC----
Confidence 321 11223446889999999998889999999999999999999 588887653221 1112221110
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
..........+.+++.+|++.+|++|||+.|+++.|+
T Consensus 226 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 -----LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0111222467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=301.22 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=193.7
Q ss_pred hhcCccccceEEEEEEeCC--CCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeee-cccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCD-EALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|.+.+. ....+|+|++... .....+.+.+|+.+++.++||||+++++++. .+...++++||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 4689999999999987532 3467999998543 2334568889999999999999999999875 4455789999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC---c
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS---R 662 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~---~ 662 (799)
+++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999764 3567888899999999999999997 899999999999999999999999999986543211 1
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCc-CCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......++..|+|||.+.+..++.++||||||+++|||++|+. |+......+ + . .....+.. ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~----~---~-~~~~~~~~-----~~~- 223 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD----I---T-VYLLQGRR-----LLQ- 223 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH----H---H-HHHhcCCC-----CCC-
Confidence 1112335678999999998899999999999999999999655 444322111 1 1 11111110 000
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+......+.+++..||+.+|++||++.||++.|+++.
T Consensus 224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 1122356788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=288.03 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=201.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcc--ccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.++||+|.|+.||++.... +|+.+|+|.+. .......+++.+|+++-+.++||||++|..-..+....+||+
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~-tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhcc-chHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 344567899999999999987764 78888888774 233345678899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~ 659 (799)
|+|.|++|..-+-..--.++...-..+.||+++|.|+|.+ +|||||+||+|+||-. .--+||+|||+|..+..
T Consensus 90 e~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred ecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 9999999977665554456667778999999999999998 9999999999999953 44589999999998862
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
........|||+|||||+++..+|+..+|||+.||+||-|+.|..||..+.... .++.+..|..+.
T Consensus 166 -g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--------lye~I~~g~yd~----- 231 (355)
T KOG0033|consen 166 -GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYEQIKAGAYDY----- 231 (355)
T ss_pred -ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--------HHHHHhccccCC-----
Confidence 223334569999999999999999999999999999999999999998754332 344444443321
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+...-....+...+++++||..||.+|.|+.|.+.
T Consensus 232 -~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 232 -PSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred -CCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 11112233456678999999999999999988763
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=311.52 Aligned_cols=262 Identities=24% Similarity=0.360 Sum_probs=200.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|+||.||++.... +++.+|+|.++.. .....+++.+|++++.+++||||+++++++..+...++|+||++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRP-SGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcC-CCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 345789999999999999874 5788999988643 23344578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|.+++.....+++.....++.|+++||.|||+. .+++|+||||+|||+++++.+||+|||++....... ...
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---~~~ 157 (308)
T cd06615 83 GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANS 157 (308)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc---ccc
Confidence 999999998878889999999999999999999973 279999999999999999999999999987653221 122
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC-c--------------
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG-R-------------- 731 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~-------------- 731 (799)
..++..|+|||.+.+..++.++||||||+++|||++|+.|+...........+... ....... .
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP-VSEGEAKESHRPVSGHPPDSPRP 236 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCc-cccccccCCcccccCCCCCccch
Confidence 45788999999998888999999999999999999999998644322111000000 0000000 0
Q ss_pred ------eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 732 ------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 732 ------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+.....+..........+.+++.+||+.+|++|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 237 MAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred hhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000001111111234568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=316.34 Aligned_cols=259 Identities=28% Similarity=0.397 Sum_probs=199.2
Q ss_pred HhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecc-cc
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-LN 577 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 577 (799)
..+.+.+.||+|+||.||+|... ..+++.||||+++... ......+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 34567789999999999999753 2356799999997533 23345788999999999 789999999988654 45
Q ss_pred eeeEEeecCCCChhhhhhcC------------------------------------------------------------
Q 038294 578 RLLVYEFMGNGTLANLIFAI------------------------------------------------------------ 597 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~------------------------------------------------------------ 597 (799)
.++++||+++|+|.+++...
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 68999999999999988642
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-ceeeecc
Q 038294 598 -------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRG 669 (799)
Q Consensus 598 -------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~g 669 (799)
..+++..+.+++.||++||+|||+. +|+||||||+|||+++++.+||+|||++......... ......+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1257788899999999999999998 9999999999999999999999999999865332211 1112235
Q ss_pred CCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHH
Q 038294 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR 748 (799)
Q Consensus 670 t~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 748 (799)
+..|+|||.+.+..++.++||||||+++|||++ |..|+....... . ......++... ..+. ..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~-~~~~~~~~~~~-----~~~~----~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------E-FCRRLKEGTRM-----RAPD----YT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------H-HHHHHhccCCC-----CCCC----CC
Confidence 678999999999999999999999999999997 888876432211 0 11112222110 1111 12
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 749 LQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 749 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
...+.+++..||+.+|++|||+.||++.|+.+++
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3467889999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.43 Aligned_cols=260 Identities=23% Similarity=0.330 Sum_probs=198.6
Q ss_pred hchhhhcCccccceEEEEEEeC---------------CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS---------------ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLG 570 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~---------------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g 570 (799)
+.+.+.||+|+||.||++.... .++..+|+|+++... .....+|.+|++++++++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4567889999999999985431 234578999997543 334568999999999999999999999
Q ss_pred eeecccceeeEEeecCCCChhhhhhcCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 571 FCDEALNRLLVYEFMGNGTLANLIFAIP-----------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 571 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
++......+++|||+++++|.+++.... .+++.....++.|++.||+|||+. +++|+||||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili 163 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLV 163 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEE
Confidence 9999999999999999999999987532 356788999999999999999998 89999999999999
Q ss_pred cCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh--CCcCCchhhhhhcc
Q 038294 640 DNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC--CRRSVEMEVEEEGR 716 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt--g~~p~~~~~~~~~~ 716 (799)
++++.++|+|||+++.+....... .....++..|+|||...+..++.++|||||||++|||++ |..|+......+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~ 243 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVI 243 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 999999999999998654332111 112234678999999888889999999999999999998 66777644322211
Q ss_pred hhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.. ............ ..+. .......+.+++.+||+.||++||+|.||++.|++
T Consensus 244 ~~----~~~~~~~~~~~~-~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 244 EN----TGEFFRDQGRQV-YLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH----HHHHHhhccccc-cCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 111111110000 0010 11223578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.70 Aligned_cols=260 Identities=23% Similarity=0.258 Sum_probs=193.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|..+. +++.||+|++..... .....+.+|+.+++.++||||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKV-NGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECC-CCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 3456789999999999999874 578999999864322 22346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+ ++|.+++... ..++...+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++...... ...
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 160 (303)
T cd07869 86 H-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTY 160 (303)
T ss_pred C-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-ccC
Confidence 6 5777777654 5678889999999999999999998 99999999999999999999999999987543221 122
Q ss_pred eeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc---------eeE
Q 038294 665 TMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR---------LDV 734 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 734 (799)
....+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ .+.. ......... ...
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~ 237 (303)
T cd07869 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLER-IFLVLGTPNEDTWPGVHSLPH 237 (303)
T ss_pred CCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHH-HHHHhCCCChhhccchhhccc
Confidence 23457899999999865 4578999999999999999999999975422111 0100 000000000 000
Q ss_pred eecCCC----CCc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVDSDE----PAM-----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d~~~----~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...... +.. ........+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 000 00012245678999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.98 Aligned_cols=253 Identities=24% Similarity=0.383 Sum_probs=200.5
Q ss_pred hchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.+.||+|+||.||++..+. .++..||+|.++... ....+++.+|+.++++++||||+++++++..+...+++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 3456789999999999998752 246789999987533 33456799999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 582 YEFMGNGTLANLIFAI----------------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
+||+++++|.+++... ..+++..++.++.|++.||+|||+. +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 9999999999999642 1367888899999999999999998 99999999999999
Q ss_pred cCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 640 DNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
++++.+||+|||++........ ........+..|+|||.+.+..++.++|||||||++|||++ |..|+......+
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~--- 240 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE--- 240 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999876533221 11112234667999999998999999999999999999998 777876443222
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
....+..+.... . .......+.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 -----~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -----VIYYVRDGNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHhcCCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111222222110 0 11233578889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=306.22 Aligned_cols=258 Identities=23% Similarity=0.315 Sum_probs=205.3
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.+.+.||+|+||+||++.... +++.+|+|++.... ....+.+.+|+++++.++||||+++++++......++|+|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP-TGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC-CCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 345567899999999999999864 57899999876432 3345689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++.....++.+++.||.|||+. .+++|+||+|+||++++++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--- 158 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--- 158 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc---
Confidence 999999999998877889999999999999999999973 279999999999999999999999999987543221
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc----hhHHHHHHHHHhcCceeEeecCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR----AILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..+.........+ .
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~ 229 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE---------P 229 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc---------c
Confidence 12345889999999998889999999999999999999999999855432110 1111111111111 1
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.+..........+.+++.+|++.||++|||+.||+++.
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 11111122345678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=301.62 Aligned_cols=256 Identities=22% Similarity=0.368 Sum_probs=205.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||+|.++.. .....+.+.+|++++++++|+|++++++++.+....+++||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 82 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLL-DGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE 82 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcC-CCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence 3466889999999999999874 6789999988532 22335678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 584 FMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 584 ~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|+++++|.+++... ..+++.++.+++.|+++||+|||+. +|+|+||+|+||+++.++.++|+|||++......
T Consensus 83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 99999999988642 3578899999999999999999998 9999999999999999999999999998765433
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ... ..+....+.
T Consensus 160 ~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~-------- 224 (267)
T cd08224 160 TTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-----LYS-LCKKIEKCD-------- 224 (267)
T ss_pred Ccc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-----HHH-HHhhhhcCC--------
Confidence 221 22335788999999999989999999999999999999999998643211 101 111111111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.+..........+.+++.+||+.+|++|||+.+|+++|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111112234457788999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.25 Aligned_cols=239 Identities=27% Similarity=0.454 Sum_probs=190.8
Q ss_pred hhcCccccceEEEEEEeCCCC---------eEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 511 EELGRGSFGIVYKGVLKSASG---------KAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~---------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.||+|+||.||+|.++.... ..+++|.+...... ...|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 469999999999999975321 35788887654333 6788999999999999999999999988 778999
Q ss_pred EeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-------ceEEccccCc
Q 038294 582 YEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-------SAKISDFGLS 653 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-------~~kl~DfGla 653 (799)
+||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+|||++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999998765 789999999999999999999997 999999999999999887 7999999999
Q ss_pred ccccCCCCcceeeeccCCcccccccccCC--CCCcchhHHHHHHHHHHHHhC-CcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 654 KLLLSDQSRTHTMIRGTRGYVAPEWFKNA--PVSAKVDVYSFGVMLLEIICC-RRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 654 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~s~k~DVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
..... .....++..|+|||.+.+. .++.++||||||+++|||++| ..|+......+.. ..+...
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~--------~~~~~~ 222 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE--------RFYQDQ 222 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--------HHHhcC
Confidence 86533 1123356789999999876 789999999999999999995 6666543221110 001100
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
. ..+. .....+.+++.+||+.+|++|||+.+|++.|+
T Consensus 223 ~-------~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H-------RLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C-------CCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 0010 01167888999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=315.22 Aligned_cols=238 Identities=26% Similarity=0.301 Sum_probs=190.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHH-HhcccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|+.+. +++.||+|++.... .....++..|.. +++.++||||+++++.+.+.+..++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS-DGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC
Confidence 469999999999999874 67899999986432 122334555554 5778999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|...+.....++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 999999988777888888999999999999999998 99999999999999999999999999987532222 12233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ....+..+.. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~i~~~~~----------~~~~ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKPL----------QLPG 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH--------HHHHHhcCCC----------CCCC
Confidence 468999999999999999999999999999999999999997643221 1111111111 1112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMK 771 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~ 771 (799)
.....+.+++.+||+.+|.+||+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 2345678899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.37 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=200.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.+.||+|+||.||+|.... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+++
T Consensus 23 ~~~~~lg~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~ 101 (296)
T cd06654 23 TRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101 (296)
T ss_pred eeEEEecCCCCeEEEEEEECC-CCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCC
Confidence 345779999999999998764 6789999998765555567789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
++|.+++.. ..+++.++..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++......... ....
T Consensus 102 ~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~ 176 (296)
T cd06654 102 GSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTM 176 (296)
T ss_pred CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccc-cCcc
Confidence 999999865 3578899999999999999999998 8999999999999999999999999998865332211 1223
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.+++.|+|||.+.+..++.++|||||||++|||++|+.||........ .......+. ........
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-------~~~~~~~~~--------~~~~~~~~ 241 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGT--------PELQNPEK 241 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-------HHHHhcCCC--------CCCCCccc
Confidence 578899999999988899999999999999999999999975433211 111111111 00011223
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+.+++.+||+.+|++|||+.||++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 34567889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=321.30 Aligned_cols=252 Identities=23% Similarity=0.267 Sum_probs=196.3
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||++..+. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKS-SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 34456789999999999999875 67899999986422 223456789999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++... .++......++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~ 198 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence 999999999998654 578888999999999999999998 9999999999999999999999999999876433222
Q ss_pred ceeeeccCCcccccccccCCC----CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 663 THTMIRGTRGYVAPEWFKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~----~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
......||+.|+|||++.+.. ++.++||||+||+||||++|+.||........ ...+...... .
T Consensus 199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------~~~i~~~~~~----~ 266 (370)
T cd05621 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------YSKIMDHKNS----L 266 (370)
T ss_pred ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCcc----c
Confidence 223456899999999997643 78899999999999999999999975533221 1111111100 0
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSK--RPTMKVVLQM 776 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 776 (799)
..+. .......+.+++..|++.++.+ ||++.|+++.
T Consensus 267 ~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111 1123445667888899755543 8999998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=323.13 Aligned_cols=250 Identities=24% Similarity=0.255 Sum_probs=195.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||||++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKD-TGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred eEeEEEeecCCEEEEEEEECC-CCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 345789999999999998875 67899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC---
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS--- 661 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~--- 661 (799)
+++|+|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 83 LPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999998878889999999999999999999998 999999999999999999999999999964321100
Q ss_pred ---------c----------------------------------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHH
Q 038294 662 ---------R----------------------------------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLL 698 (799)
Q Consensus 662 ---------~----------------------------------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ 698 (799)
. ......||+.|+|||++.+..++.++|||||||+||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 0 001235899999999999999999999999999999
Q ss_pred HHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 038294 699 EIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKR---PTMKVVLQ 775 (799)
Q Consensus 699 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~ 775 (799)
||++|+.||......+.. ..+..... .+ ..+. .......+.+++.+|++ +|.+| |++.|+++
T Consensus 240 elltG~~Pf~~~~~~~~~--------~~i~~~~~-~~---~~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 240 ECLIGWPPFCSENSHETY--------RKIINWRE-TL---YFPD--DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhcCCCCCCCCCHHHHH--------HHHHccCC-cc---CCCC--CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 999999999754432211 11111000 00 0011 11223466788899997 66665 59999886
Q ss_pred H
Q 038294 776 M 776 (799)
Q Consensus 776 ~ 776 (799)
.
T Consensus 305 h 305 (377)
T cd05629 305 H 305 (377)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=329.54 Aligned_cols=250 Identities=27% Similarity=0.319 Sum_probs=198.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc-------
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------- 576 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 576 (799)
.+.+.+.||+|+||+||++.... +++.||||++... .......+.+|+..+..++|+|++++...+....
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVS-DGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcC-CCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 44567889999999999999864 6789999998542 3344567889999999999999999988764332
Q ss_pred -ceeeEEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcccc
Q 038294 577 -NRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFG 651 (799)
Q Consensus 577 -~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfG 651 (799)
..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecc
Confidence 257999999999999998653 3578888999999999999999998 99999999999999999999999999
Q ss_pred CcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 652 LSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 652 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
+++....... .......||+.|+|||.+.+..++.++|||||||+||||++|+.||......+ .......+
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--------~~~~~~~~ 260 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--------VMHKTLAG 260 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHhcC
Confidence 9987643221 12233568999999999999999999999999999999999999997543221 11112222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.... .+......+.+++.+||+.+|++||++.++++.
T Consensus 261 ~~~~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 261 RYDP---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 112234568889999999999999999999863
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.36 Aligned_cols=264 Identities=28% Similarity=0.368 Sum_probs=205.8
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCC------CCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeee
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSA------SGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFC 572 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~------~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~ 572 (799)
++....+.+.+.||+|+||.||++..... ....||+|.++... ....+++.+|++++.++ +|+||++++++|
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 34445567788999999999999976421 12478999887532 33456899999999999 799999999999
Q ss_pred ecccceeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 038294 573 DEALNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQN 636 (799)
Q Consensus 573 ~~~~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~N 636 (799)
......++++||+++|+|.+++... ..+++..+++++.|++.||+|||+. +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 9999999999999999999998753 2467889999999999999999998 99999999999
Q ss_pred eEEcCCCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhh
Q 038294 637 ILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEE 714 (799)
Q Consensus 637 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~ 714 (799)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....++
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865432211 1112234567999999999999999999999999999998 778876443222
Q ss_pred cchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
....+..+... .........+.+++.+|++.+|++||++.|+++.|+++....
T Consensus 245 --------~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 245 --------LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred --------HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 11112221110 011123356788999999999999999999999999877443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=324.74 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=195.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||+|++.... ......+.+|++++++++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVD-TNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 356789999999999999875 58899999986532 12345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC----
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---- 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 660 (799)
+++|+|.+++.....++......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..+....
T Consensus 83 ~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 83 IPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999998888888899999999999999999998 99999999999999999999999999975321000
Q ss_pred --------------------------------------CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh
Q 038294 661 --------------------------------------SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC 702 (799)
Q Consensus 661 --------------------------------------~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt 702 (799)
........||+.|+|||++.+..++.++|||||||+||||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 000112468999999999999999999999999999999999
Q ss_pred CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 038294 703 CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRP---TMKVVLQM 776 (799)
Q Consensus 703 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~evl~~ 776 (799)
|+.||......+.... +....... . .+. .......+.+++.+|+ .+|++|+ ++.|+++.
T Consensus 240 G~~Pf~~~~~~~~~~~--------i~~~~~~~--~--~~~--~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 240 GQPPFLADTPAETQLK--------VINWETTL--H--IPS--QAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred CCCCCCCCCHHHHHHH--------HhccCccc--c--CCC--CCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 9999976543321111 11110000 0 000 1112334556666665 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=302.57 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=198.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.+.||+|+||.||+|.... ++..+++|.+........+.+.+|+++++.++|+|++++++++......++|+||+++
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKE-TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHhhcccCCCeEEEEEEECC-CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 345789999999999999874 5788999998765555667889999999999999999999999999999999999999
Q ss_pred CChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
++|..++.. ...+++..+..++.|+++||+|||+. +++|+||||+||+++.++.+||+|||++........ ....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccccc-cccc
Confidence 999998865 35689999999999999999999998 999999999999999999999999999876533221 1223
Q ss_pred eccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 667 IRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 667 ~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
..++..|+|||.+. +..++.++|||||||++|||++|+.||......+. ...... .... ..
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~-~~~~-----~~- 228 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-------LLKIAK-SEPP-----TL- 228 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-------HHHHhh-cCCC-----CC-
Confidence 45788999999984 44578899999999999999999999875432211 111111 1000 00
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111234577889999999999999999988754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.88 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=201.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhH--HHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||+||++.... +++.+|+|.+........ .....|+.++++++||||+++++++......++||||+
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKK-NGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETT-TTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECC-CCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 356789999999999999885 678999999976543332 23456999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.||++||++||+. +|+|+||||+||++++++.++|+|||.+.... .......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~~ 156 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENFN 156 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEBS
T ss_pred ccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999999778889999999999999999999998 99999999999999999999999999997641 2222333
Q ss_pred eeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...++..|+|||++. +...+.++||||+|+++++|++|..|+...........+.......... . ...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--------~---~~~ 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS--------S---SQQ 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH--------H---TTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc--------c---ccc
Confidence 455788999999998 8889999999999999999999999998652222111111111100000 0 000
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.......+.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011268889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.16 Aligned_cols=240 Identities=28% Similarity=0.367 Sum_probs=193.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+..|..++..+. |++|+++.+++...+..++|||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKG-TDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred eEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 456789999999999999874 67899999987532 223456778888888875 6778889999999899999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 y~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~-~ 157 (323)
T cd05615 82 YVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV-T 157 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCc-c
Confidence 999999999998888899999999999999999999998 999999999999999999999999999875432221 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.+..... ..+
T Consensus 158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--------~~~~i~~~~~------~~p-- 221 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--------LFQSIMEHNV------SYP-- 221 (323)
T ss_pred ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC------CCC--
Confidence 223458999999999999999999999999999999999999997654321 1111112111 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
......+.+++.+||+.+|.+|++.
T Consensus 222 --~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 --KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 1223467789999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=302.96 Aligned_cols=247 Identities=25% Similarity=0.379 Sum_probs=199.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+...+.||+|+||.||+|.+.. +++.||+|.++... ....+.+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNR-TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcC-CCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3345789999999999998864 57899999986433 344567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.. ..+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 85 ~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 85 GGGSALDLLKP-GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 99999998864 4678899999999999999999997 999999999999999999999999999986543221 112
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...++..|+|||.+.+..++.++||||||++++||++|+.|+........ . ..+..+ .+....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~-~~~~~~---------~~~~~~ 222 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------L-FLIPKN---------SPPTLE 222 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------H-hhhhcC---------CCCCCC
Confidence 23478899999999998999999999999999999999999864322211 0 011111 111112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+.+++.+||+.+|++||+|.+|++.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2334567889999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=301.49 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=200.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.+.||+|+||.||+|.... +++.||+|.++.........+.+|+.+++.++||||+++++.+......++++||+
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVN-TGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcC-CCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 34566889999999999998864 67899999987654445567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++.+...++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~~~ 164 (267)
T cd06645 89 GGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AKRK 164 (267)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cccc
Confidence 9999999998888899999999999999999999998 89999999999999999999999999987653321 1122
Q ss_pred eeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 666 MIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
...|+..|+|||.+. ...++.++|||||||++|||++|+.|+......... ... ...... .+....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-------~~~-~~~~~~---~~~~~~ 233 (267)
T cd06645 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-------FLM-TKSNFQ---PPKLKD 233 (267)
T ss_pred cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-------Hhh-hccCCC---CCcccc
Confidence 345889999999974 456889999999999999999999998643321110 000 011000 000000
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+.+++.+|++.+|++||++++|++
T Consensus 234 --~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 234 --KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 1122346788999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.77 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=201.6
Q ss_pred hchhhhcCccccceEEEEEEe---CCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc--cceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLK---SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 580 (799)
....+.||+|+||.||++.+. ..+++.||+|.++... ....+.+.+|++++++++|+|++++.+++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKL 85 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEE
Confidence 344578999999999999853 2356889999987543 33446799999999999999999999998765 56789
Q ss_pred EEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
||||+++++|.+++... ..+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred EEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 99999999999999764 4679999999999999999999998 9999999999999999999999999999876433
Q ss_pred CCc--ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhh--------hcchhHHHHHHHHHhc
Q 038294 660 QSR--THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE--------EGRAILTDWAYDCYAE 729 (799)
Q Consensus 660 ~~~--~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~ 729 (799)
... ......++..|+|||.+.+..++.++||||||+++|||++++.|....... ........ .......
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 241 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR-LVRVLEE 241 (284)
T ss_pred ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHH-HHHHHHc
Confidence 221 112234667899999999888999999999999999999987664322110 00001111 1111122
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+... .........+.+++.+||+.+|++|||+.++++.|++++
T Consensus 242 ~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~~ 284 (284)
T cd05079 242 GKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284 (284)
T ss_pred CccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhhC
Confidence 1110 011223467889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=301.35 Aligned_cols=252 Identities=28% Similarity=0.418 Sum_probs=189.3
Q ss_pred hhcCccccceEEEEEEeCC-CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
++||+|+||.||+|..... ....+++|.+.... .....+|.+|+..++.++|+||+++++.+......++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 3699999999999976532 34578999876433 334567899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC-----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-
Q 038294 589 TLANLIFAIP-----KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR- 662 (799)
Q Consensus 589 sL~~~l~~~~-----~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 662 (799)
+|.+++.... ..++....+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997643 246778899999999999999998 8999999999999999999999999998754322111
Q ss_pred ceeeeccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 663 THTMIRGTRGYVAPEWFKN-------APVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~-------~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
......++..|+|||++.. ..++.++|||||||++|||++ |..|+......+ .......++.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~~~~-~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-------VLKQVVREQDI-K 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHHhhccCc-c
Confidence 1122235678999998743 456889999999999999999 677776443221 11122222211 1
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
+..+.. .......+.+++..|+ .||++|||++||++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKPQL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCCcc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 1223345566788888 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.61 Aligned_cols=260 Identities=27% Similarity=0.427 Sum_probs=203.7
Q ss_pred chhhhcCccccceEEEEEEeC---CCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeec--ccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKS---ASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~---~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv 581 (799)
.+.+.||+|+||.||++.+.. ..++.+|||.++..... ..++|.+|++++++++|+||+++++++.. ....+++
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 86 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEE
Confidence 455789999999999998752 34689999999764443 46789999999999999999999999877 5578999
Q ss_pred EeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05038 87 MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163 (284)
T ss_pred EecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCC
Confidence 99999999999997654 689999999999999999999998 89999999999999999999999999998765322
Q ss_pred Cc--ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc--------hhHHHHHHHHHhcC
Q 038294 661 SR--THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR--------AILTDWAYDCYAEG 730 (799)
Q Consensus 661 ~~--~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~~~ 730 (799)
.. ......++..|+|||.+.+..++.++||||||++++||++|+.|+......... ..... .......+
T Consensus 164 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 242 (284)
T cd05038 164 DYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR-LLELLKEG 242 (284)
T ss_pred cceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH-HHHHHHcC
Confidence 11 111223456799999998889999999999999999999999987643221100 00111 11111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.. .........++.+++.+|++.+|++||||.||+++|+++
T Consensus 243 ~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 243 ER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred Cc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 10 001112235788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=302.94 Aligned_cols=248 Identities=25% Similarity=0.409 Sum_probs=196.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.+.||+|+||.||+|.... +++.||+|.+... .....+++.+|++++++++||||+++++++......++|+||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLL-TRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred heeeeccCCCeEEEEEEEcC-CCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 45789999999999998864 5788999998643 234456799999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
++|..+. .+++.....++.|++.||+|||+. +|+|+||||+|||++.++.+||+|||++....... ....
T Consensus 84 ~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---~~~~ 153 (279)
T cd06619 84 GSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---AKTY 153 (279)
T ss_pred CChHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---ccCC
Confidence 9986542 467888899999999999999998 99999999999999999999999999997653321 2224
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.++..|+|||.+.+..++.++||||||+++|||++|+.||................ +..... ..+......
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~~~~~ 224 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL-QCIVDE--------DPPVLPVGQ 224 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH-HHHhcc--------CCCCCCCCc
Confidence 58889999999999999999999999999999999999987543222111111111 111111 111111222
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+.+++.+|++.+|++||+++|+++.
T Consensus 225 ~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 34567889999999999999999998864
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=299.25 Aligned_cols=249 Identities=29% Similarity=0.487 Sum_probs=199.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.+.||+|+||.||++.+. .++.+|+|.++... ....+|.+|++++++++|||++++++++......++++||++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~--~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWL--EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eEEEeeecCcccceEEEEEEe--CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 345688999999999999886 35689999986432 234578999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..++++.+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999764 4578999999999999999999998 8999999999999999999999999998865433222222
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ .. +....+. ... .
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~-~~~~~~~--~~~---~---- 222 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE-------VV-ETINAGF--RLY---K---- 222 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH-------HH-HHHhCCC--CCC---C----
Confidence 2234678999999998899999999999999999998 888886543221 11 1111110 000 0
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
+....+.+.+++.+||+.+|++|||+.|+++.|.
T Consensus 223 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 223 PRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112367888999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=298.66 Aligned_cols=246 Identities=28% Similarity=0.377 Sum_probs=196.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee-cccceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD-EALNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e~ 584 (799)
...+.+.||+|+||.||++..+ ++.+++|.++... ..+.+.+|+.++++++|+|++++++++. ++...++++||
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~---~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 7 ELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred hCeeeeeecccCCCeEEEEEEc---CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 3445688999999999999764 6789999986532 3467899999999999999999999764 55668999999
Q ss_pred cCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++++|.+++.... .+++..+.+++.|++.||+|||+. +++||||||+||++++++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~- 157 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence 99999999997643 478999999999999999999998 899999999999999999999999999886533221
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
....+..|+|||++.+..++.++||||||+++|||++ |+.|+......+ ....+..+.. .
T Consensus 158 ---~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~-----~--- 218 (256)
T cd05082 158 ---TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYK-----M--- 218 (256)
T ss_pred ---CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCC-----C---
Confidence 2234568999999999899999999999999999998 888876432211 1111111110 0
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.........+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11122345778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=301.74 Aligned_cols=249 Identities=28% Similarity=0.435 Sum_probs=196.8
Q ss_pred hhcCccccceEEEEEEeCC-----CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 511 EELGRGSFGIVYKGVLKSA-----SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~-----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.||+|+||.||+|+.++. +++.+++|.+.... .....++.+|+.+++.++||||+++++++......++++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 3689999999999987531 23679999886533 23456889999999999999999999999998899999999
Q ss_pred cCCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-----ceEEccccC
Q 038294 585 MGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-----SAKISDFGL 652 (799)
Q Consensus 585 ~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-----~~kl~DfGl 652 (799)
+++++|.+++... ..+++..++.++.|++.||+|||+. +++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 3468899999999999999999987 899999999999999877 899999999
Q ss_pred cccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 653 SKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 653 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+. . ..+..+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-------~-~~~~~~ 229 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-------L-QHVTAG 229 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-------H-HHHhcC
Confidence 976543221 11112235678999999999999999999999999999998 8988864432211 1 111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
. ...........+.+++.+||+.+|++||++.+|++.|++
T Consensus 230 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 001122334677899999999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.67 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=198.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
++||+|+||.||++.+.. ++.|++|.++..... ..+.+.+|++++++++|+||+++++++......++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG--NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC--CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999999863 789999998754333 45689999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce-eee
Q 038294 590 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-TMI 667 (799)
Q Consensus 590 L~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~-~~~ 667 (799)
|.+++... ..+++.....++.+++.||+|||++ +++||||+|+||+++.++.+||+|||++........... ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99999654 4678899999999999999999998 899999999999999999999999999986542211111 112
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..+..|+|||.+.+..++.++|+||||+++|||++ |..|+........ ...+..+. ....+.
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~--------~~~~~~~~---------~~~~~~ 218 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT--------RERIESGY---------RMPAPQ 218 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH--------HHHHhcCC---------CCCCCc
Confidence 23567999999998899999999999999999999 7778765432211 11111110 000112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.....+.+++.+|++.+|++|||+.||++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 234578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=308.72 Aligned_cols=258 Identities=25% Similarity=0.368 Sum_probs=201.5
Q ss_pred HhhchhhhcCccccceEEEEEEeC------CCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeeccc
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS------ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 576 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 576 (799)
....+.+.||+|+||.||++.... .....+|+|.++... .....++.+|++++.++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 344567889999999999997531 234578999987532 33456788999999999 6999999999999888
Q ss_pred ceeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 038294 577 NRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD 640 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~ 640 (799)
..++++||+++|+|.+++... ..+++....+++.||+.||.|||+. +++|+||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEc
Confidence 899999999999999999653 2478889999999999999999998 999999999999999
Q ss_pred CCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchh
Q 038294 641 NYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAI 718 (799)
Q Consensus 641 ~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~ 718 (799)
+++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---- 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---- 244 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence 99999999999998664322111 111224567999999999899999999999999999999 788876443221
Q ss_pred HHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.......+... .........+.+++.+|++.+|++|||+.|+++.|+++..
T Consensus 245 ----~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 ----LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ----HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11122222110 0111223467789999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=302.44 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=200.7
Q ss_pred hhhhcCccccceEEEEEEeCC----CCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 509 FKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.||+|+||.||+|+.+.. ..+.|++|.+...... ..+++.+|++++++++|+||+++++++.+....++|||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 88 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILE 88 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEE
Confidence 456799999999999997532 3467999998654433 45689999999999999999999999999899999999
Q ss_pred ecCCCChhhhhhcCC---------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 584 FMGNGTLANLIFAIP---------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~---------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++.
T Consensus 89 ~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~ 165 (275)
T cd05046 89 YTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSK 165 (275)
T ss_pred ecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccccccc
Confidence 999999999998655 689999999999999999999998 89999999999999999999999999987
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
..............++..|+|||.+.+...+.++||||||+++|||++ |..||....... .......+...
T Consensus 166 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~--------~~~~~~~~~~~ 237 (275)
T cd05046 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE--------VLNRLQAGKLE 237 (275)
T ss_pred ccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH--------HHHHHHcCCcC
Confidence 553332222223345678999999988889999999999999999999 677875432211 11112222211
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.. ........+.+++.+||+.+|++||++.|+++.|.+
T Consensus 238 ~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 238 LP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred CC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 10 111233578889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=300.95 Aligned_cols=247 Identities=28% Similarity=0.392 Sum_probs=199.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---------hhHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
.+...||+|++|.||+|.... +++.+|+|.+..... +..+.+..|+.++++++||||+++++++.+....
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNAS-SGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred cccceeecCCCeEEEEEEecC-CCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 456789999999999999764 578999998854221 1235688999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++++||+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||+++....
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred EEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999998877889999999999999999999997 899999999999999999999999999987653
Q ss_pred CCCc-----ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 659 DQSR-----THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 659 ~~~~-----~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
.... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~-~~~~~--- 227 (267)
T cd06628 159 NSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-------IF-KIGEN--- 227 (267)
T ss_pred ccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-------HH-HHhcc---
Confidence 2111 11123478899999999998899999999999999999999999975432110 00 11111
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+. .+....+.+.+++.+||+.+|++||++.||++
T Consensus 228 --~~~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 --ASPE----IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --CCCc----CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111 12233467788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=282.01 Aligned_cols=247 Identities=28% Similarity=0.384 Sum_probs=203.5
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------hhHHHHHHHHHHhccc-ccccccceeeeeeccccee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 579 (799)
-+++||+|..++|.++..+. +++..|+|++..... ...++-..|+.+|+++ -||+|+++.++++.+...+
T Consensus 21 pkeilgrgvss~vrRci~k~-t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~F 99 (411)
T KOG0599|consen 21 PKEILGRGVSSVVRRCIHKE-TGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVF 99 (411)
T ss_pred hHHHhcccchhhhhhhhhcc-cccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhh
Confidence 35789999999999998875 678888888853221 1123456799999998 5999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+|+|.|+.|.|.++|.+.-.++++...+|+.|+..|+.|||.. .|+||||||+|||+|++.++||+|||++..+...
T Consensus 100 lVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 100 LVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 9999999999999999988999999999999999999999998 8999999999999999999999999999977543
Q ss_pred CCcceeeeccCCccccccccc------CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 660 QSRTHTMIRGTRGYVAPEWFK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~------~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
......+|||+|+|||.+. ...|+..+|+||+||++|.|+.|..||..... -....++.+|+.+
T Consensus 177 --ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--------mlMLR~ImeGkyq 246 (411)
T KOG0599|consen 177 --EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--------MLMLRMIMEGKYQ 246 (411)
T ss_pred --hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--------HHHHHHHHhcccc
Confidence 3445578999999999884 34688899999999999999999999975432 1233455666543
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
- .+..-........+++.+||+.||.+|.|++|+++
T Consensus 247 F------~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 247 F------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred c------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 2 11112234456678999999999999999999874
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=334.66 Aligned_cols=256 Identities=23% Similarity=0.334 Sum_probs=199.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.++||+|+||.||+|.... +++.||+|+++... ....++|.+|++++++++||||+++++++.+++..+++|||
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~-tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPV-CSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred EEEEEEecCCCEEEEEEEECC-CCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456789999999999999864 57899999986432 23346799999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCc
Q 038294 585 MGNGTLANLIFAI-----------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 585 ~~~gsL~~~l~~~-----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
+++++|.+++... ...++..+++++.||++||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999988642 2345677889999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-----------------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc
Q 038294 654 KLLLSDQS-----------------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR 716 (799)
Q Consensus 654 ~~~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~ 716 (799)
+....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki- 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI- 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh-
Confidence 87621110 011124589999999999999999999999999999999999999975322110
Q ss_pred hhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcC
Q 038294 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRP-TMKVVLQMLEGLLE 782 (799)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~ 782 (799)
.... . ...+... .........+.+++.+|++.||++|| +++++++.|+..++
T Consensus 240 ------~~~~----~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 ------SYRD----V---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ------hhhh----h---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0000 0 0000000 00112335677899999999999995 67888888877654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=299.30 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=200.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc----------chhhHHHHHHHHHHhcc-cccccccceeeeeeccc
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL----------AQEREREFKSEVSAIGR-THHKNLVQLLGFCDEAL 576 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~~~ 576 (799)
.+.+.||+|+||.||+|.++...++.+|+|.+... ......++..|+.++.+ ++|+||+++++++.++.
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 34678999999999999998655789999987531 22234567788888875 79999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccC
Q 038294 577 NRLLVYEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGl 652 (799)
..+++|||+++++|.+++.. ...+++..+++++.|++.||.|||+. .+++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccc
Confidence 99999999999999988753 34678889999999999999999963 2799999999999999999999999999
Q ss_pred cccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........ . ..+.++..
T Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-------~-~~~~~~~~ 230 (269)
T cd08528 161 AKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-------A-TKIVEAVY 230 (269)
T ss_pred eeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------H-HHHhhccC
Confidence 98754332 22344578899999999998899999999999999999999999865432211 1 11111111
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
. ..........+.+++.+||+.||++||++.||.++++.
T Consensus 231 ~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 231 E--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred C--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 1 00111234578889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.40 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=188.4
Q ss_pred hhcCccccceEEEEEEeCCC-CeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSAS-GKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~-~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
++||+|+||.||+|...... ...+++|.++... ....+.|.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 36999999999999865322 2456777765433 344568999999999999999999999999999999999999999
Q ss_pred ChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Ccc
Q 038294 589 TLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRT 663 (799)
Q Consensus 589 sL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 663 (799)
+|.+++... ...++.....++.||++||+|||+. +++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999753 2356667789999999999999997 89999999999999999999999999986432211 111
Q ss_pred eeeeccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHhC-CcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 664 HTMIRGTRGYVAPEWFKN-------APVSAKVDVYSFGVMLLEIICC-RRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~-------~~~s~k~DVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.....++..|+|||++.. ..++.++||||||+++|||+++ ..|+....+.+ .......+ ....+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~~~-~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-------VLNHVIKD-QQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHhh-ccccc
Confidence 223457889999998753 2457899999999999999975 55665432211 11111222 11222
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.++..... ..+.+.+++..|+ .+|++||++++|++.|.
T Consensus 230 ~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 23322222 3356677888899 57999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=297.11 Aligned_cols=247 Identities=25% Similarity=0.358 Sum_probs=201.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|..+. +++.+++|.++.... .+++.+|++++++++|+||+++++++......++++||++
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKE-TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcC-CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 3456789999999999999875 578999999875433 6789999999999999999999999999999999999999
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 82 ~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 157 (256)
T cd06612 82 AGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-KRN 157 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-ccc
Confidence 9999999975 35789999999999999999999998 899999999999999999999999999987643321 222
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+........... ..... ......+
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------~~~~~-------~~~~~~~ 222 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------IPNKP-------PPTLSDP 222 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------hccCC-------CCCCCch
Confidence 33478899999999999999999999999999999999999875433221100 00000 0000112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+.+++.+|++.+|++|||++||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 233457888999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=300.63 Aligned_cols=246 Identities=27% Similarity=0.366 Sum_probs=195.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCCh
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
..||+|+||.||+|.+.. +++.|++|.+........+.+.+|++++++++|+||+++++++..+...++++||+++++|
T Consensus 14 ~~lg~g~~g~v~~~~~~~-~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 92 (268)
T cd06624 14 VVLGKGTYGIVYAARDLS-TQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSL 92 (268)
T ss_pred EEEecCCceEEEEeEecC-CCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCH
Confidence 579999999999999864 5789999998766556667899999999999999999999999999999999999999999
Q ss_pred hhhhhcC-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCCcceee
Q 038294 591 ANLIFAI-PKP--DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 591 ~~~l~~~-~~~--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
.+++... ..+ ++..+..++.||+.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 93 ~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~-~~~~ 168 (268)
T cd06624 93 SALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-CTET 168 (268)
T ss_pred HHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC-cccc
Confidence 9999764 334 7788889999999999999998 9999999999999986 67999999999876543222 1222
Q ss_pred eccCCcccccccccCCC--CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 667 IRGTRGYVAPEWFKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~--~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
..++..|+|||.+.... ++.++||||||+++|||++|+.|+......... .+.... . . ..+. .
T Consensus 169 ~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~----~~~~~~--~-~----~~~~----~ 233 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA----MFKVGM--F-K----IHPE----I 233 (268)
T ss_pred CCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh----Hhhhhh--h-c----cCCC----C
Confidence 34788999999986643 788999999999999999999998643221110 000000 0 0 0011 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
+....+.+..++.+||+.+|++|||+.|+++.
T Consensus 234 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 234 PESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 22334567889999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=305.77 Aligned_cols=252 Identities=26% Similarity=0.404 Sum_probs=196.7
Q ss_pred hhhhcCccccceEEEEEEeCCCC---eEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
..+.||+|+||.||+|....... ..+|+|.+..... ....++.+|+.++++++||||++++++|... ..++++||
T Consensus 11 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 11 RVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred eccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 34689999999999999864322 2578898865432 3345789999999999999999999999754 46789999
Q ss_pred cCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++.... .+++..+.+++.|++.||+|||+. +|+|+||||+||++++++.+||+|||+++.........
T Consensus 90 ~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 166 (303)
T cd05110 90 MPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEY 166 (303)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCccccc
Confidence 99999999987654 678999999999999999999998 99999999999999999999999999998764332211
Q ss_pred -eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 664 -HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 664 -~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.|+......+ ..+....+.. .+
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~-------~~ 231 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--------IPDLLEKGER-------LP 231 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHCCCC-------CC
Confidence 112235678999999999999999999999999999998 888886543221 1111111111 00
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
. .......+.+++..|+..+|++||++.++++.|+.+.
T Consensus 232 ~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~ 269 (303)
T cd05110 232 Q--PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA 269 (303)
T ss_pred C--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0 1112346778999999999999999999999997654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=310.05 Aligned_cols=255 Identities=19% Similarity=0.247 Sum_probs=194.4
Q ss_pred hhhhcCcc--ccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 509 FKEELGRG--SFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G--~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.++||+| +|++||++..+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++..++..++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP-TGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecc-cCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 789999999874 68999999986532 23445678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++|+|.+++... ..+++..+.+++.|++.||+|||+. +|+||||||+|||++.++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999653 4588999999999999999999998 8999999999999999999999999865443211110
Q ss_pred ------ceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 663 ------THTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 663 ------~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... . .. ..+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~-----~~-~~~~~~~ 229 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--L-----EK-LNGTVPC 229 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--H-----HH-hcCCccc
Confidence 0111235678999999976 46899999999999999999999999743321100 0 00 0000000
Q ss_pred eec------------------------------------CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVD------------------------------------SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d------------------------------------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+ ..............+.+++.+||+.||++|||++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 00000112234457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=317.36 Aligned_cols=253 Identities=22% Similarity=0.260 Sum_probs=196.8
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.+.+.||+|+||.||++..+. +++.+|+|.+.... ....+.+.+|+.+++.++||||+++++.+.++...++|
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~-~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 121 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECC-CCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 344556889999999999999875 67899999986422 22334678899999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|||+++|+|.+++... .++...+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 122 ~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~ 197 (371)
T cd05622 122 MEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 197 (371)
T ss_pred EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc
Confidence 9999999999998654 477888889999999999999998 999999999999999999999999999987644333
Q ss_pred cceeeeccCCcccccccccCCC----CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~----~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ....+......
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~---- 265 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--------TYSKIMNHKNS---- 265 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCc----
Confidence 2333456899999999987543 7899999999999999999999997653321 11111111100
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSK--RPTMKVVLQM 776 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 776 (799)
...+ ........+.+++.+|++.++.+ ||++.|+++.
T Consensus 266 ~~~~--~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 266 LTFP--DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred ccCC--CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 0011 11223456778999999844443 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=319.10 Aligned_cols=259 Identities=20% Similarity=0.206 Sum_probs=192.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++.... .++.||||... ...+.+|++++++++|+||+++++++..+...++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~-~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPD-YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECC-CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 3456789999999999999875 57899999643 2345789999999999999999999999999999999995
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-ce
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-TH 664 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~~ 664 (799)
++|.+++... ..+++..+..|+.||++||.|||+. +|+||||||+||||+.++.+||+|||+++........ ..
T Consensus 244 -~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 244 -SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccc
Confidence 6888887654 4689999999999999999999998 9999999999999999999999999999875432221 12
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee--Eeec-----
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD--VLVD----- 737 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~d----- 737 (799)
....||+.|+|||++.+..++.++|||||||+||||++|..++...............+.+.+...... ....
T Consensus 320 ~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~ 399 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSR 399 (461)
T ss_pred cccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchH
Confidence 234689999999999999999999999999999999998876543221111110111111111111100 0000
Q ss_pred -----------CCCCCcc--C----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 738 -----------SDEPAMA--D----RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 738 -----------~~~~~~~--~----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+... . ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 400 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 400 LVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 0 0112356789999999999999999999874
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.94 Aligned_cols=281 Identities=20% Similarity=0.246 Sum_probs=202.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+...+.||+|+||.||+|..+. +++.||+|+++.... .....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKL-TENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred eEEEEEecccCCEEEEEEEecC-CCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 3456789999999999999874 578999999864332 23346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++....... ..
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 161 (309)
T cd07872 87 DK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-TY 161 (309)
T ss_pred CC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCcc-cc
Confidence 75 888877654 4578889999999999999999998 999999999999999999999999999976433221 12
Q ss_pred eeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcC-ceeEe
Q 038294 665 TMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEG-RLDVL 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~ 735 (799)
....+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... +..+... .....
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (309)
T cd07872 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY 241 (309)
T ss_pred ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence 22347889999998865 468999999999999999999999997554322111110000 0000000 00000
Q ss_pred ecCCCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCCCCCceee
Q 038294 736 VDSDEPA----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLLEVPNPPCPSSFSI 794 (799)
Q Consensus 736 ~d~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~p~~p~~~~~ 794 (799)
..+.... .........+.+++.+||+.||++|||+.|+++ .++.+. ....+.|...|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~-~~~~~~~~~~~~ 305 (309)
T cd07872 242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG-TRIHSLPESISI 305 (309)
T ss_pred hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc-cccccCCcceee
Confidence 0000000 000122345678999999999999999999987 444432 222334444444
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.43 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=199.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.+.||.|++|.||+|.... +++.|++|.+........+.+.+|+.+++.++|+|++++++++......++|+||++++
T Consensus 23 ~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 101 (296)
T cd06655 23 RYEKIGQGASGTVFTAIDVA-TGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGG 101 (296)
T ss_pred EEEEEecCCCeEEEEEEEcC-CCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCC
Confidence 45679999999999998764 67899999987655555678899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeec
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 668 (799)
+|.+++... .+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++......... .....
T Consensus 102 ~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~~~~~ 176 (296)
T cd06655 102 SLTDVVTET-CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-RSTMV 176 (296)
T ss_pred cHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccccc-CCCcC
Confidence 999988653 588999999999999999999998 9999999999999999999999999998865433221 12235
Q ss_pred cCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHH
Q 038294 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR 748 (799)
Q Consensus 669 gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 748 (799)
++..|+|||.+.+..++.++|||||||++|||++|+.||.......... .....+ ... .......
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-------~~~~~~-~~~-------~~~~~~~ 241 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-------LIATNG-TPE-------LQNPEKL 241 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHHhcC-Ccc-------cCCcccC
Confidence 7889999999999889999999999999999999999997654322111 111111 000 0011123
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 749 LQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 749 ~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+++.+||+.+|++||++.+|++
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 346778999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=304.63 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=200.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++.... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIA-TGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECC-CCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 3455789999999999999764 678999999976555555678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|.+++.. ..+++..+.+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......... ...
T Consensus 100 ~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-~~~ 174 (297)
T cd06656 100 GGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 174 (297)
T ss_pred CCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccC-cCc
Confidence 9999999865 4578889999999999999999998 9999999999999999999999999998765433221 122
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..+++.|+|||.+.+..++.++||||||+++|++++|+.||........... ... ..........
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-------~~~--------~~~~~~~~~~ 239 (297)
T cd06656 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IAT--------NGTPELQNPE 239 (297)
T ss_pred ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-------ecc--------CCCCCCCCcc
Confidence 3578899999999999999999999999999999999999975432211000 000 0011111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+++.+||+.+|++||++.+|++
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 23355778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=299.75 Aligned_cols=246 Identities=28% Similarity=0.419 Sum_probs=193.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecc------cceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA------LNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~------~~~~l 580 (799)
.+.+.||+|+||.||+|..+. +++.||+|.+.... ....++..|+.++.++ +|+||+++++++... ...++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 9 ELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred hHHHheeecCCeEEEEEEEcC-CCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 445789999999999999874 67899999986533 3456788999999998 799999999998653 35789
Q ss_pred EEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 581 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
+|||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~ 163 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 163 (272)
T ss_pred EEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence 99999999999999864 3578999999999999999999998 899999999999999999999999999986533
Q ss_pred CCCcceeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
... ......|+..|+|||++. +..++.++|||||||++|||++|+.|+......... .. .....
T Consensus 164 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-------~~-~~~~~-- 232 (272)
T cd06637 164 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FL-IPRNP-- 232 (272)
T ss_pred ccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-------HH-HhcCC--
Confidence 221 222345888999999986 345788999999999999999999998643221110 00 01100
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+..........+.+++.+||+.+|++|||+.|+++
T Consensus 233 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 233 ------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 011111223356788999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=296.30 Aligned_cols=249 Identities=33% Similarity=0.496 Sum_probs=201.3
Q ss_pred hhhhcCccccceEEEEEEeCCC---CeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSAS---GKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~---~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.||+|+||.||++...... +..||+|.++..... ..+.+..|+..+..++|+||+++++++.+....+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 4578999999999999987532 488999999765433 567899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++++|.+++..... +++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 83 MEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred cCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999986544 89999999999999999999998 9999999999999999999999999999876544222
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......+++.|+|||.+.+..++.++||||+|++++||++ |..|+....... ..+....+... .
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----~-- 224 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE--------VLEYLKKGYRL-----P-- 224 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHhcCCCC-----C--
Confidence 2212236789999999988889999999999999999998 677776432211 11111221110 0
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
........+.+++.+|++.+|++|||+.|+++.|
T Consensus 225 --~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 --KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1112345788899999999999999999999875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=307.17 Aligned_cols=250 Identities=30% Similarity=0.358 Sum_probs=210.3
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh---hHHHHHHHHHHhcccc-cccccceeeeeecccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE---REREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv 581 (799)
.+.+.++||+|.||.||+++.+. +|+.+|+|.+.+.... ..+.+.+|+++|+++. |||||.+.+.++.....++|
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~-tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKS-TGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecC-CCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 34556899999999999999885 5899999999654332 3458899999999998 99999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----CCceEEccccCccccc
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN----YFSAKISDFGLSKLLL 657 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~----~~~~kl~DfGla~~~~ 657 (799)
||++.||.|.+.+... ..++.....++.|++.++.|||+. +|+||||||+|+|+.. ++.+|++|||++....
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 9999999999999876 488999999999999999999997 9999999999999964 3579999999999876
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
. .......+||+.|+|||++....|+..+||||+||++|.|++|..||......+... .+..++.
T Consensus 191 ~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------~i~~~~~----- 255 (382)
T KOG0032|consen 191 P--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------AILRGDF----- 255 (382)
T ss_pred C--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------HHHcCCC-----
Confidence 5 445566789999999999999999999999999999999999999999776543211 2333333
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......-....+.+.+++..++..||..|+|+.++++.
T Consensus 256 -~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222223345677789999999999999999999983
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.94 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=203.3
Q ss_pred hhhhcCccccceEEEEEEeCCCCe--EEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGK--AIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~--~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.|+||+|.||.|++|.+....|+ .||||.++..... ...+|+.|+.+|.+|+|+|+++|+|+..+ ....||+|.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 468899999999999999876665 5799999765443 56799999999999999999999999987 7788999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+.|+|.+.|++. ..+-......++.|||.|+.||..+ ++|||||..+|+||-....+||+||||.+.+...+..-
T Consensus 193 plGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y 269 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY 269 (1039)
T ss_pred ccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcce
Confidence 999999999873 3456677788999999999999998 89999999999999999999999999999886543221
Q ss_pred -ee-eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 664 -HT-MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 664 -~~-~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.. ...-++.|.|||.++...|+.++|||+|||.||||+| |..|+-+..... +.+. +|...
T Consensus 270 vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q--------IL~~---------iD~~e 332 (1039)
T KOG0199|consen 270 VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ--------ILKN---------IDAGE 332 (1039)
T ss_pred EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH--------HHHh---------ccccc
Confidence 11 2234678999999999999999999999999999999 456766543221 1122 22222
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.-.......+.+.+++..||..+|++|||+..|.+.+
T Consensus 333 rLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 RLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 2333556778999999999999999999999997443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=300.58 Aligned_cols=249 Identities=23% Similarity=0.316 Sum_probs=198.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.++||+|+||.||+|.... +++.+++|.+........+.+.+|+.+++.++|+|++++++.+..+...++||||++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhheecCCCCeEEEEEEECC-CCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 3456789999999999999874 578999999977666666789999999999999999999999999899999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|..++.+. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 93 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~ 168 (292)
T cd06644 93 GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-RRD 168 (292)
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccccc-ccc
Confidence 99999887653 5689999999999999999999997 999999999999999999999999999875432211 122
Q ss_pred eeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 666 MIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
...+++.|+|||.+. ...++.++|||||||++|||++|+.|+........ .... ..... +
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-------~~~~-~~~~~-----~-- 233 (292)
T cd06644 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-------LLKI-AKSEP-----P-- 233 (292)
T ss_pred eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-------HHHH-hcCCC-----c--
Confidence 345788999999984 34578899999999999999999999865432111 1111 11110 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+......+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00112233456788999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.27 Aligned_cols=256 Identities=26% Similarity=0.372 Sum_probs=202.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCC---eEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
...+.+.||+|+||.||+|..+.... ..+|+|.+.... .....++.+|+.++++++|+||+++++++.. ...++|
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v 86 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLI 86 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEE
Confidence 34556889999999999999864221 368999886543 3345688999999999999999999999987 778899
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+||+++|+|.+++... ..+++....+++.||+.||+|||+. +++|+||||+||++++++.+||+|||+++......
T Consensus 87 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~ 163 (279)
T cd05057 87 TQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE 163 (279)
T ss_pred EecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence 9999999999999864 4688999999999999999999997 99999999999999999999999999998764332
Q ss_pred Ccce-eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 SRTH-TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~~~~-~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.... ....++..|+|||.+....++.++|+||||+++||+++ |+.|+......+ ..+.+..+...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--------~~~~~~~~~~~----- 230 (279)
T cd05057 164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--------IPDLLEKGERL----- 230 (279)
T ss_pred cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhCCCCC-----
Confidence 2111 11223567999999988889999999999999999999 999987543322 11122222110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+ ......+.+++.+||..+|++||++.++++.|+.+..
T Consensus 231 ~~~----~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 PQP----PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC----CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 011 1122457789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=296.39 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=203.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++.... +++.+++|.+........+.+.+|++++++++||||+++++++......+++|||++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIA-TGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred eEEEEEecCCCceEEEEeEecC-CCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 3456789999999999999874 567899999876555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..++...+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ ...
T Consensus 84 ~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~ 159 (262)
T cd06613 84 GGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KRK 159 (262)
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhh-ccc
Confidence 99999999876 6789999999999999999999998 899999999999999999999999999886543221 122
Q ss_pred eeccCCcccccccccCC---CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 666 MIRGTRGYVAPEWFKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~---~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
...++..|+|||.+.+. .++.++||||||+++|||++|+.|+........... ...... .... .
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~--------~~~~~~---~~~~--~ 226 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL--------ISKSNF---PPPK--L 226 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--------HHhccC---CCcc--c
Confidence 34578889999999776 889999999999999999999999875432221110 011100 0000 0
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+.+++.+||+.+|++|||+++|+.
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 227 KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 112344567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=296.95 Aligned_cols=245 Identities=25% Similarity=0.381 Sum_probs=200.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
..+.||+|+||.||+|..+. +++.||+|.++... ......+.+|++++++++|+||+++++++.++...++||||+++
T Consensus 8 ~~~~lg~g~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06640 8 KLERIGKGSFGEVFKGIDNR-TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGG 86 (277)
T ss_pred hhhhcccCCCeEEEEEEEcc-CCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCC
Confidence 45779999999999999874 57899999986432 34456789999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
++|.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 87 ~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~ 161 (277)
T cd06640 87 GSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRNTF 161 (277)
T ss_pred CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-ccccc
Confidence 999999865 4678888999999999999999998 999999999999999999999999999977643322 12223
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .... ...+......
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--------~~~~---------~~~~~~~~~~ 224 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL--------FLIP---------KNNPPTLTGE 224 (277)
T ss_pred cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh--------hhhh---------cCCCCCCchh
Confidence 4788899999999888999999999999999999999998754322110 0001 1111223344
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+.+++.+||+.+|++||++.++++.
T Consensus 225 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 225 FSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 56678899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=306.59 Aligned_cols=240 Identities=25% Similarity=0.353 Sum_probs=201.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
++||.|+||.||-+.+.. +.+.||||++.-. +.+...++..|++.|.+++|||.|.+-||+......|||||||-|
T Consensus 32 rEIGHGSFGAVYfArd~~-n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLG 110 (948)
T ss_pred HHhcCCccceeEEeeccC-ccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhc
Confidence 579999999999999874 6789999998642 334456899999999999999999999999999999999999954
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+-.|++.-. +++....+..|+.+.+.||+|||+. +.||||||+.||||.+.|.+||+|||.|..... ...
T Consensus 111 -SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-----Ans 181 (948)
T KOG0577|consen 111 -SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-----ANS 181 (948)
T ss_pred -cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-----hhc
Confidence 777777644 5677888899999999999999998 899999999999999999999999999987633 334
Q ss_pred eccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 667 IRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 667 ~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
++|||.|||||++. .+.|+-|+||||+|++..||.-.+.|....+.-. .++.. .....|..
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-------ALYHI---------AQNesPtL 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHI---------AQNESPTL 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-------HHHHH---------HhcCCCCC
Confidence 67999999999874 5689999999999999999999999976553222 12211 12234555
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+..+.+..++..||++-|.+|||..+++..
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 578899999999999999999999999987653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=304.62 Aligned_cols=245 Identities=27% Similarity=0.389 Sum_probs=198.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCCh
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
..||+|+||.||++.... +++.||+|++........+.+.+|+..+.+++|+||+++++.+..+...++||||+++++|
T Consensus 28 ~~lg~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 28 IKIGEGSTGIVCIATEKH-TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hcccCCCCeEEEEEEECC-CCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 569999999999998764 5789999998765555567789999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccC
Q 038294 591 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670 (799)
Q Consensus 591 ~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 670 (799)
.+++.. ..+++.....++.||+.||+|||+. +|+||||||+||++++++.+||+|||++......... .....++
T Consensus 107 ~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~~~~~~ 181 (292)
T cd06658 107 TDIVTH-TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGT 181 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-CceeecC
Confidence 998854 4578999999999999999999998 8999999999999999999999999998765332221 2234578
Q ss_pred CcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHH
Q 038294 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQ 750 (799)
Q Consensus 671 ~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 750 (799)
..|+|||.+.+..++.++||||||+++|||++|+.||........ + ..+... ....... ......
T Consensus 182 ~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~-----~~~~~~-----~~~~~~~--~~~~~~ 246 (292)
T cd06658 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---M-----RRIRDN-----LPPRVKD--SHKVSS 246 (292)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H-----HHHHhc-----CCCcccc--ccccCH
Confidence 899999999988899999999999999999999999875432211 0 111110 0111111 112334
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 751 KWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 751 ~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+..++.+|++.+|++|||++|+++.
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhC
Confidence 67789999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=311.10 Aligned_cols=189 Identities=20% Similarity=0.268 Sum_probs=161.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|.... +++.||+|..... ....|+.++++++|+||+++++++......++|+||+.
T Consensus 68 y~~~~~lg~G~~g~Vy~~~~~~-~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 140 (357)
T PHA03209 68 YTVIKTLTPGSEGRVFVATKPG-QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS 140 (357)
T ss_pred cEEEEEecCCCCeEEEEEEECC-CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC
Confidence 4556789999999999999874 5688999985432 23568999999999999999999999999999999995
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++|.+++.. ...+++..+.+|+.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 141 -~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--~~~ 214 (357)
T PHA03209 141 -SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFL 214 (357)
T ss_pred -CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCc--ccc
Confidence 588888765 35789999999999999999999998 89999999999999999999999999997532221 122
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
...||+.|+|||++.+..++.++|||||||++|||+++..++.
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 3458999999999999999999999999999999999766653
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=298.58 Aligned_cols=246 Identities=26% Similarity=0.377 Sum_probs=200.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||.|++|.||+|.... +++.||+|.+.... ......+.+|+.++++++|+|++++++++.++...++|+||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKR-TNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCG 82 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECC-CCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeC
Confidence 345789999999999999874 67899999986533 3445678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++....... ....
T Consensus 83 ~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (274)
T cd06609 83 GGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KRNT 157 (274)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeeccccc-cccc
Confidence 99999998765 788999999999999999999998 899999999999999999999999999987654321 2223
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..+.. +... ..
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--------~~~~~~~~~-----~~~~---~~ 221 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--------LFLIPKNNP-----PSLE---GN 221 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--------HHHhhhcCC-----CCCc---cc
Confidence 3578889999999998899999999999999999999999875432110 111111110 1111 11
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+++.+||+.+|++|||++++++
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 14456788999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.47 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=197.7
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc------hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.||+|+||.||+|... +++.+|+|.++... ......+.+|++++++++|+||+++++++.+....++++
T Consensus 4 ~~~~ig~g~~~~v~~~~~~--~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 4 KGEVLGKGAYGTVYCGLTN--QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccceEeccCCeEEEEEEEc--CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 4578999999999999864 57899999885321 222356889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC--
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-- 660 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-- 660 (799)
||+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 158 (265)
T cd06631 82 EFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH 158 (265)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence 9999999999998777788999999999999999999997 89999999999999999999999999987653211
Q ss_pred ---CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 661 ---SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 661 ---~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
........++..|+|||.+.+..++.++||||||+++|||++|+.||......+..... ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~~~------ 226 (265)
T cd06631 159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI------GAHRGL------ 226 (265)
T ss_pred ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh------hhccCC------
Confidence 11112345788999999999989999999999999999999999999754322111000 000000
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+.+.+++.+||+.+|++||++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ---MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 01112234467788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.47 Aligned_cols=252 Identities=21% Similarity=0.243 Sum_probs=193.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||+|++.... ....+.+.+|+.++..++|+||+++++++.++...++||||
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKN-TGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred eEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 456789999999999999875 57899999986421 22345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999976 35788899999999999999999998 99999999999999999999999999987654433322
Q ss_pred eeeeccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 664 HTMIRGTRGYVAPEWFKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~-----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. ............
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~-------~~~i~~~~~~~~---- 228 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET-------YGKIMNHKEHFQ---- 228 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH-------HHHHHcCCCccc----
Confidence 233458999999999863 4578899999999999999999999975432211 111111110000
Q ss_pred CCCCccCHHHHHHHHHHHHHhccc--CCCCCCCHHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIRE--DPSKRPTMKVVLQM 776 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~evl~~ 776 (799)
.+.. .....+.+.+++.+|+.. ++..||++.++++.
T Consensus 229 -~~~~-~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -FPPD-VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -CCCc-cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0100 111334566677776644 44448899988865
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=301.62 Aligned_cols=248 Identities=25% Similarity=0.306 Sum_probs=196.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
..+.||+|+||+||++.... +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+..++..++++||+
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRA-TGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred EEEEEecCCCeEEEEEEECC-CCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34679999999999999875 67899999986432 222345788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++....... .
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 157 (285)
T cd05632 83 NGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--S 157 (285)
T ss_pred cCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--c
Confidence 999999888653 3689999999999999999999998 89999999999999999999999999987653221 1
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|+..|+|||.+.+..++.++|+||||+++|||++|..||........... .......+.. .
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~----~~~~~~~~~~------~---- 223 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE----VDRRVLETEE------V---- 223 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHHhhhcccc------c----
Confidence 2234589999999999999999999999999999999999999975433221111 1111111110 0
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~~ 776 (799)
........+.+++..|++.+|++||+ +.++++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11122345678999999999999999 6676653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=303.22 Aligned_cols=247 Identities=26% Similarity=0.319 Sum_probs=196.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
..+.||+|+||.||++..+. +++.+|+|.+.... ....+.+.+|+.++++++|+|++++++.+...+..++||||+
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeEEeecCCCeEEEEEEEcC-CCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 34679999999999999875 67899999986432 222356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+..++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........
T Consensus 83 ~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 157 (285)
T cd05630 83 NGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-- 157 (285)
T ss_pred CCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc--
Confidence 999999988654 3588899999999999999999987 999999999999999999999999999876533221
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|+..|+|||.+.+..++.++||||||+++|||++|+.||............ ........ ..
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~----~~~~~~~~------~~---- 223 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV----ERLVKEVQ------EE---- 223 (285)
T ss_pred ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH----Hhhhhhhh------hh----
Confidence 12235899999999999999999999999999999999999999754321111111 11111000 00
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
........+.+++..||+.||++||| +.|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11122345778999999999999999 888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=302.89 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=197.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh-----hHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-----REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.||+|+||.||+|..+. +++.|++|+++..... ....+..|++++++++|+||+++++++.+....++||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKE-TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred eeeeeeeeccccEEEEEEECC-CCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345689999999999999864 5789999998654322 3456778999999999999999999999988999999
Q ss_pred eecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
||+ +++|.+++.... .+++..+.+++.||++||+|||+. +++|+||+|+||+++.++.+||+|||++........
T Consensus 82 e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 157 (298)
T cd07841 82 EFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR 157 (298)
T ss_pred ccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence 999 899999998765 789999999999999999999998 899999999999999999999999999987644322
Q ss_pred cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH----HHHHh-cCceeEe
Q 038294 662 RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA----YDCYA-EGRLDVL 735 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~-~~~~~~~ 735 (799)
......+++.|+|||.+.+ ..++.++|||||||+++||++|..+|......+......... ...+. .......
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T cd07841 158 -KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236 (298)
T ss_pred -cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccc
Confidence 1122245778999998865 467899999999999999999977766443221111100000 00000 0000000
Q ss_pred ecCCCC-----CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 736 VDSDEP-----AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 736 ~d~~~~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...... ..........+.+++.+||+.+|++|||+.||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 237 VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000000 00112235678899999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=313.28 Aligned_cols=241 Identities=26% Similarity=0.317 Sum_probs=189.2
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhccc---ccccccceeeeeecccceeeEEeecC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRT---HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
||+|+||+||+|..+. +++.||+|++..... .....+..|..++.+. +||||+++++.+.+....++||||++
T Consensus 1 lG~G~~g~Vy~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKD-TRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 7999999999999874 678999999864321 1223455566666654 69999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....... ....
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 999999998888899999999999999999999998 999999999999999999999999999875432221 2233
Q ss_pred eccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||......+ ....+..+... .+ .
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~------~~---~ 218 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVR------FP---K 218 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--------HHHHHHcCCCC------CC---C
Confidence 4689999999998765 48999999999999999999999997543221 11222222111 11 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCC----CHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRP----TMKVVLQ 775 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RP----t~~evl~ 775 (799)
......+.+++.+||+.||++|| ++.++++
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11234667899999999999998 4565554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.21 Aligned_cols=245 Identities=27% Similarity=0.377 Sum_probs=199.4
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-----hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.||+|+||.||+|..+. +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++..+...++++|
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLD-DGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred ccceeeecCCceEEEEEEcC-CCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 45789999999999999864 57899999885432 2345688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||++....... .
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~--~ 157 (258)
T cd06632 83 LVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--F 157 (258)
T ss_pred ecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc--c
Confidence 999999999998877789999999999999999999998 99999999999999999999999999988754332 1
Q ss_pred eeeeccCCcccccccccCCC-CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~-~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.... ++.++|+||||+++|||++|+.||....... ........... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~---------~ 221 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-------AVFKIGRSKEL---------P 221 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-------HHHHHHhcccC---------C
Confidence 22345788999999987776 8999999999999999999999986543211 01111110111 0
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+....+.+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 111223456778999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=311.06 Aligned_cols=252 Identities=19% Similarity=0.240 Sum_probs=195.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+++.+. +++.||+|.+.... ......+.+|..++..++|+||+++++++.+.+..++||||
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKH-TERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 456789999999999999874 57899999986422 22334578899999999999999999999999999999999
Q ss_pred cCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 83 YVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred CCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999987 35788899999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeeccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 664 HTMIRGTRGYVAPEWFKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~-----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.....||+.|+|||.+.+ ..++.++|||||||+||||++|+.||......+. ...+.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~--------~~~i~~~~~~~---- 227 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHEERF---- 227 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH--------HHHHHcCCCcc----
Confidence 333568999999999875 4678899999999999999999999975432211 11111111000
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSK--RPTMKVVLQM 776 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 776 (799)
..+.. .....+.+.+++.+|+..++++ |++++++++.
T Consensus 228 ~~p~~-~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 QFPSH-ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred cCCCc-cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00110 1122456777888888865544 4688888753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=306.21 Aligned_cols=194 Identities=23% Similarity=0.359 Sum_probs=158.9
Q ss_pred hhcCccccceEEEEEEeC-CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeec--ccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~ 587 (799)
.+||+|+||+||+|..++ .+++.+|+|.++.. .....+.+|++++++++||||+++++++.. +...++++||+.+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 579999999999999753 35678999998653 223457889999999999999999998854 4457899999864
Q ss_pred CChhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEccccCcc
Q 038294 588 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSK 654 (799)
Q Consensus 588 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl----~~~~~~kl~DfGla~ 654 (799)
+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 787776522 2477888999999999999999998 89999999999999 456789999999998
Q ss_pred cccCCCC--cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchh
Q 038294 655 LLLSDQS--RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME 710 (799)
Q Consensus 655 ~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~ 710 (799)
....... .......+|+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 7643321 122335689999999998774 5899999999999999999999998644
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.30 Aligned_cols=250 Identities=24% Similarity=0.311 Sum_probs=200.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++.... +++.+|+|.++.......+.|..|++++++++|+||+++++.+..+...++||||++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKE-TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcC-CCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 4456789999999999999874 678999999876555566789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..+++..+.+++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 86 ~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~ 161 (280)
T cd06611 86 GGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK-RD 161 (280)
T ss_pred CCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccc-cc
Confidence 99999998764 4689999999999999999999998 8999999999999999999999999998765332221 22
Q ss_pred eeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 666 MIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
...+++.|+|||.+. ...++.++||||||+++|||++|+.||........ .. .+..+... ..
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-------~~-~~~~~~~~-----~~ 228 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-------LL-KILKSEPP-----TL 228 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-------HH-HHhcCCCC-----Cc
Confidence 345788999999875 34577899999999999999999999875432211 11 11111100 00
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+......+.+++..||+.+|++||++.+|++.
T Consensus 229 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 --DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred --CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111233467789999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=295.18 Aligned_cols=247 Identities=21% Similarity=0.303 Sum_probs=199.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|+||.||++..+. +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+..+...++++||++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVN-SDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcC-CCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 356789999999999999875 5788999988542 23345678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|.+++... ..++......++.|++.||.|||+. +|+|+||||+||++++++.++|+|||++........ ..
T Consensus 82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (255)
T cd08219 82 GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-YA 157 (255)
T ss_pred CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc-cc
Confidence 99999988653 3578889999999999999999998 999999999999999999999999999976643221 12
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....+..+.... .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~---------~ 220 (255)
T cd08219 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--------LILKVCQGSYKP---------L 220 (255)
T ss_pred ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--------HHHHHhcCCCCC---------C
Confidence 23457889999999999899999999999999999999999997543221 111112222111 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.......+.+++.+||+.||++||++.||+..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 12233467789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=293.36 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=198.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecc-cceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-LNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 584 (799)
.+.+.||+|++|.||++..+. +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+... ...+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRT-DGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcC-CCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 456789999999999999875 57889999986432 33456788999999999999999999987644 457899999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++++|.+++... ..+++.++.+++.|++.||+|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~- 157 (257)
T cd08223 82 CEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD- 157 (257)
T ss_pred cCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence 9999999999763 4578999999999999999999998 899999999999999999999999999987643322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......+++.|+|||.+.+..++.++||||||++++||++|+.||....... .... +..+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~-------~~~~-~~~~~~~--------- 220 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS-------LVYR-IIEGKLP--------- 220 (257)
T ss_pred ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-------HHHH-HHhcCCC---------
Confidence 2223457889999999999999999999999999999999999987543221 1111 1122111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.........+.+++.+|++.+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1122344678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=321.38 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=186.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc--------cce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--------LNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~ 578 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ....+|+.++++++|+||+++++++... ...
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 142 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECC-CCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEE
Confidence 4456889999999999999874 67899999885422 2335699999999999999999876321 235
Q ss_pred eeEEeecCCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCc
Q 038294 579 LLVYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLS 653 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla 653 (799)
++||||+++ +|.+++. ....+++.....++.||+.||+|||+. +|+||||||+||||+.++ .+||+|||++
T Consensus 143 ~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla 218 (440)
T PTZ00036 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccc
Confidence 689999985 6766664 235688999999999999999999998 899999999999999654 7999999999
Q ss_pred ccccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHh
Q 038294 654 KLLLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYA 728 (799)
Q Consensus 654 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~ 728 (799)
+....... .....+|+.|+|||++.+. .++.++|||||||+||||++|..||......+....+..... +.+.
T Consensus 219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~ 296 (440)
T PTZ00036 219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK 296 (440)
T ss_pred hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 87643322 1224578999999998764 689999999999999999999999976543321111111000 0000
Q ss_pred --cCceeEe-----ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 729 --EGRLDVL-----VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 729 --~~~~~~~-----~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+ .........+......+.+++.+||+.||.+|||+.|+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 297 EMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000000 0000000111123357889999999999999999999983
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=314.36 Aligned_cols=249 Identities=23% Similarity=0.283 Sum_probs=194.5
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|+||.||++..+. +++.||+|+++... ......+.+|+.++..++|+||+++++.+.+....++||||+
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKD-TGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred EEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45789999999999999875 67899999986432 233457888999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC----
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS---- 661 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~---- 661 (799)
++|+|.+++.....+++.....++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 84 ~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 84 PGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred CCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 9999999998888899999999999999999999998 999999999999999999999999999875432110
Q ss_pred ------------------------------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 662 ------------------------------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 662 ------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00112458999999999999999999999999999999999999997654
Q ss_pred hhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHH
Q 038294 712 EEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT---MKVVLQM 776 (799)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~ 776 (799)
.... ...+........+.+. ....+.+.+++.+++. +|++|++ +.|+++.
T Consensus 241 ~~~~--------~~~i~~~~~~~~~p~~------~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 241 PQET--------YRKVMNWKETLVFPPE------VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred HHHH--------HHHHHcCCCceecCCC------CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 3221 1111111111111111 1123455667777664 9999985 5665543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=304.62 Aligned_cols=263 Identities=24% Similarity=0.328 Sum_probs=198.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.||+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|+||+
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKE-TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eEeeeeccCCCeEEEEEEECC-CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 456789999999999999874 578999998854322 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|..+......+++..+..++.||++||+|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07846 83 DHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VYT 158 (286)
T ss_pred CccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-ccC
Confidence 9999998887666789999999999999999999998 899999999999999999999999999987644332 222
Q ss_pred eeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH-------HHHhcCc-eeEee
Q 038294 666 MIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY-------DCYAEGR-LDVLV 736 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~~~ 736 (799)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+......+....+..... ....... .....
T Consensus 159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07846 159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR 238 (286)
T ss_pred cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence 3347889999999875 4578899999999999999999988865432221111110000 0000000 00000
Q ss_pred cCCCCCc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 DSDEPAM-----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 d~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+..... ........+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 239 LPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred cccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 01123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=302.15 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=198.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCCh
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
..||+|+||.||++.... +++.||+|.+........+.+.+|+.++..++||||+++++++..+...++++||+++++|
T Consensus 27 ~~ig~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 27 IKIGEGSTGIVCIAREKH-SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhcCCCCceeEEEEEEcC-CCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 469999999999998864 6789999998654444556788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccC
Q 038294 591 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670 (799)
Q Consensus 591 ~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 670 (799)
.+++.. ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ......++
T Consensus 106 ~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~ 180 (297)
T cd06659 106 TDIVSQ-TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGT 180 (297)
T ss_pred HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccceecC
Confidence 987754 5678999999999999999999998 899999999999999999999999999876543322 12234578
Q ss_pred CcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHH
Q 038294 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQ 750 (799)
Q Consensus 671 ~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 750 (799)
..|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..+...... .. ........
T Consensus 181 ~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--------~~~~~~~~~-----~~--~~~~~~~~ 245 (297)
T cd06659 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--------KRLRDSPPP-----KL--KNAHKISP 245 (297)
T ss_pred ccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------HHHhccCCC-----Cc--cccCCCCH
Confidence 9999999999889999999999999999999999998754322211 111111100 00 01112234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 751 KWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 751 ~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+.+++.+|++.+|++||+++++++.
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 67789999999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=301.84 Aligned_cols=261 Identities=24% Similarity=0.315 Sum_probs=189.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhccc---ccccccceeeeeec-----ccc
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCDE-----ALN 577 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~~ 577 (799)
.+.+.||+|+||+||+|..+. +++.||+|.++.... .....+.+|+.+++++ +||||+++++++.. ...
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred eEeeEEeecCCeEEEEEEECC-CCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345789999999999999875 678999998864321 2223455677666655 79999999998854 234
Q ss_pred eeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 578 RLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
.++++||+++ +|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 82 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 82 VTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARI 157 (288)
T ss_pred EEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCcccc
Confidence 6899999975 888888754 3578999999999999999999998 899999999999999999999999999986
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcC-
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEG- 730 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~- 730 (799)
..... ......++..|+|||.+.+..++.++|||||||++|||++|+.||...........+..... ..+...
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07863 158 YSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 235 (288)
T ss_pred ccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence 54322 12234578899999999999999999999999999999999999865433221111111000 000000
Q ss_pred ce-eEeecCCCC---CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RL-DVLVDSDEP---AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~-~~~~d~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. .....+..+ ........+.+.+++.+||+.||++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 236 TLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000000 0011123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=295.86 Aligned_cols=252 Identities=25% Similarity=0.399 Sum_probs=196.0
Q ss_pred hhhhcCccccceEEEEEEeC--CCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc------ce
Q 038294 509 FKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 578 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 578 (799)
+.+.||+|+||.||+|.++. ..++.||||+++.. .....+++.+|++++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 45789999999999998753 24688999998653 2344567899999999999999999999885432 23
Q ss_pred eeEEeecCCCChhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccC
Q 038294 579 LLVYEFMGNGTLANLIFAI------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGl 652 (799)
++++||+++|+|.+++... ..+++....+++.|++.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccc
Confidence 6889999999998887532 2468888999999999999999998 899999999999999999999999999
Q ss_pred cccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 653 SKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 653 a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
++....... .......+++.|++||.+....++.++||||||+++|||++ |+.|+......+ + ...+..+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~----~----~~~~~~~ 231 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----I----YNYLIKG 231 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH----H----HHHHHcC
Confidence 987643221 11122335678999999998889999999999999999999 778876443221 1 1111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.. .. ........+.+++.+|++.+|++||++.|+++.|+++
T Consensus 232 ~~-----~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 NR-----LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred Cc-----CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 00 1112345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=308.99 Aligned_cols=252 Identities=21% Similarity=0.271 Sum_probs=194.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.+|+|++.... ......+.+|+.++..++|+||+++++++.+....++||||
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECC-CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 456789999999999999875 57899999986422 22234588899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..........
T Consensus 83 ~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 83 YVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 9999999999863 5788999999999999999999998 99999999999999999999999999997654333323
Q ss_pred eeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 664 HTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.....||+.|+|||++. ...++.++|||||||+||||++|+.||......+. ...+.......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~--------~~~i~~~~~~~---- 227 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET--------YGKIMNHKERF---- 227 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH--------HHHHhCCCccc----
Confidence 33356899999999986 34688999999999999999999999975432221 11111111000
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCC--CCCCHHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPS--KRPTMKVVLQM 776 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPt~~evl~~ 776 (799)
..+. ........+.+++.+|+..+++ .||++.|+++.
T Consensus 228 ~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0011 0112234566788887755444 47899988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=293.01 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=201.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||.+.... +++.+++|++... .....+++.+|++++++++|+||+++++++.+....+++|||+
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTE-DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred eEeeEecccCCceEEEEEEcC-CCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 356789999999999988764 6788999987543 3444567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++... ..+++..+..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++........ .
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-~ 157 (256)
T cd08221 82 NGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-M 157 (256)
T ss_pred CCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-c
Confidence 999999999765 4578999999999999999999997 899999999999999999999999999987644332 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....+++.|+|||.+.+..++.++||||||++++||++|+.||......+ ... .+..+....
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~-~~~~~~~~~--------- 220 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN-------LVV-KIVQGNYTP--------- 220 (256)
T ss_pred ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH-------HHH-HHHcCCCCC---------
Confidence 223457899999999998889999999999999999999999987543221 111 111221111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 112334567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.00 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=199.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|+||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRE-TGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeecccCCeEEEEEEECC-CCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 345789999999999999874 57899999886432 223456889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++.|..++.....+++..+.+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........ ...
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~ 158 (286)
T cd07847 83 DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-DYT 158 (286)
T ss_pred CccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc-ccc
Confidence 9999988887777899999999999999999999997 999999999999999999999999999987644322 112
Q ss_pred eeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH-------HhcCce-eEee
Q 038294 666 MIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC-------YAEGRL-DVLV 736 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~~~~~-~~~~ 736 (799)
...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....... +..... ....
T Consensus 159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T cd07847 159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238 (286)
T ss_pred CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence 2346788999999876 567899999999999999999999997544322211111100000 000000 0000
Q ss_pred cCCCCCccC-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 DSDEPAMAD-----RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 d~~~~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+....... ......+.+++.+||+.+|++||++.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 011100000 112456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.25 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=191.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-----hhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 581 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 581 (799)
..+.||+|+||.||++.... +++.|++|+++... .+..+.+.+|+.++++++||||+++++++.+. ...+++
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~ 84 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVD-TGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIF 84 (266)
T ss_pred ccceecCCCCEEEEEEEEcC-CCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEE
Confidence 45789999999999998864 57899999885321 22345688999999999999999999988653 556899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+||+++++|.+++.....+++.....++.|++.||+|||+. +|+|+||+|+||+++.++.+||+|||+++.......
T Consensus 85 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 85 MEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999998877789999999999999999999987 899999999999999999999999999986543211
Q ss_pred --cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 662 --RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 662 --~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.......++..|+|||.+.+..++.++|||||||++|||++|+.||....... . ........ ..+.
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~-~~~~~~~~-----~~~~ 229 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------A-IFKIATQP-----TNPQ 229 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------H-HHHHhcCC-----CCCC
Confidence 11122447889999999999889999999999999999999999987442211 0 11111111 0111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. +....+.+..++ .||..+|++||+|+||++
T Consensus 230 ~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 230 L----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred C----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1 112223444455 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.07 Aligned_cols=244 Identities=28% Similarity=0.377 Sum_probs=200.6
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCChh
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLA 591 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 591 (799)
+||+|.||+||-|++.+ +...+|||.+.....+...-+.+|+.+.+.++|+|||+++|.|.++...-|.||.++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~-tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD-TQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeecccc-ceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 59999999999999885 56889999997766666667899999999999999999999999999889999999999999
Q ss_pred hhhhcC-CCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCCcceeee
Q 038294 592 NLIFAI-PKP--DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 592 ~~l~~~-~~~--~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
++|+.. .++ ++..+--+..||++||.|||++ .|+|||||-+||||+- .|.+||+|||-++++..-...+. ..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE-TF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE-TF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc-cc
Confidence 999865 444 5667777889999999999998 8999999999999974 78999999999998755443333 35
Q ss_pred ccCCcccccccccCC--CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 668 RGTRGYVAPEWFKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~--~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
.||..|||||++..+ .|..++|||||||.+.||.||+.||....... .++ ++-|... +.+ ..+
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-------AAM--FkVGmyK--vHP----~iP 801 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-------AAM--FKVGMYK--VHP----PIP 801 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-------Hhh--hhhccee--cCC----CCc
Confidence 699999999999866 48899999999999999999999997443221 111 1122111 111 234
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+...+...++.+|+.+||.+||+++++++
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 566677888999999999999999999875
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.55 Aligned_cols=262 Identities=20% Similarity=0.226 Sum_probs=198.4
Q ss_pred HhhchhhhcCccccceEEEEEEeC-CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.+.+.||+|+||.||++...+ ..++.||+|.+... +.+.+|++++++++||||+++++++......+++||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 345667889999999999997643 24578999988642 245679999999999999999999999899999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-c
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-R 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~ 662 (799)
++. ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~ 242 (392)
T PHA03207 167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTP 242 (392)
T ss_pred hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccc
Confidence 986 68888887677899999999999999999999998 999999999999999999999999999976543322 2
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee---------
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD--------- 733 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 733 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.... ........+
T Consensus 243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~~~~~~~~~ 321 (392)
T PHA03207 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEFPQNGSTNL 321 (392)
T ss_pred cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCccccCCccchhH
Confidence 2234568999999999999999999999999999999999999997543322111111111 100000000
Q ss_pred --------EeecCC--CCC-ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 734 --------VLVDSD--EPA-MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 734 --------~~~d~~--~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+. .+. .........+.+++.+||+.||++|||+.|++..
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000 000 0001123456779999999999999999999865
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=295.94 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=197.7
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch----------hhHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ----------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
..+.||+|+||.||+|.... +++.+|+|.++.... ...+.+..|+.++++++|+|++++++++......
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVT-TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYL 83 (272)
T ss_pred ecceecccCceEEEEEeecC-CCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCce
Confidence 45789999999999999764 578999998753211 1124678899999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++|+||+++++|.+++.....+++..+..++.||+.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 84 SIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred EEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 99999999999999998877889999999999999999999998 899999999999999999999999999986543
Q ss_pred CCCc-ceeeeccCCcccccccccCCC--CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 659 DQSR-THTMIRGTRGYVAPEWFKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 659 ~~~~-~~~~~~gt~~y~aPE~l~~~~--~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.... ......++..|+|||.+.... ++.++||||||++++|+++|..|+......+ . ....... ..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~-~~~~~~~-~~--- 229 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------A-MFKLGNK-RS--- 229 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------H-HHHhhcc-cc---
Confidence 2211 122345788999999987654 7899999999999999999999986432211 0 0111111 00
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+..........+.+++.+|++.+|++||++.+|++.
T Consensus 230 -~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 230 -APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0111111112234678889999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=301.56 Aligned_cols=264 Identities=23% Similarity=0.309 Sum_probs=201.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.|++|+++... ....+.+.+|++++++++|+||+++++++..++..++++||+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~-~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 4 EVLGVVGEGAYGVVLKCRNKA-TGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eEEEEecccCCeeEEEEEeCC-CCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 456789999999999999875 57899999986432 233467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++.|..+......+++..+..++.||+.||+|||+. +++|+||+|+||++++++.+||+|||++............
T Consensus 83 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 83 ERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9988877776667789999999999999999999998 8999999999999999999999999999876544332233
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH--------HHHhcCcee--E
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY--------DCYAEGRLD--V 734 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~--~ 734 (799)
...++..|+|||++.+. .++.++||||||+++|||++|+.|+......+.......... ......... .
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA 239 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence 34578899999999888 889999999999999999999998875432211100000000 000000000 0
Q ss_pred eecCCCC----CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVDSDEP----AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+.... ..........+.+++.+||+.+|++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 0011122567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=293.12 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=200.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
...+.||+|+||.||+|.... +++.|++|.++.... ...+++.+|+.++++++|+||+++++++......++|+||+
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLD-TGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81 (264)
T ss_pred eeeeEeecCCCcEEEEEEECC-CCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecC
Confidence 345789999999999999864 578999999865433 35678999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||++............
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 158 (264)
T cd06626 82 SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE 158 (264)
T ss_pred CCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc
Confidence 9999999998877788999999999999999999998 8999999999999999999999999999876543322211
Q ss_pred ---eeccCCcccccccccCCC---CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 666 ---MIRGTRGYVAPEWFKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 666 ---~~~gt~~y~aPE~l~~~~---~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
...++..|+|||.+.+.. ++.++||||||++++|+++|+.||....... ..... ...+. .+.
T Consensus 159 ~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~------~~~~~-~~~~~-----~~~ 226 (264)
T cd06626 159 EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF------QIMFH-VGAGH-----KPP 226 (264)
T ss_pred cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH------HHHHH-HhcCC-----CCC
Confidence 245788999999998766 8899999999999999999999996442111 00111 01110 111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+. .......+.+++.+||+.+|++|||+.|++.
T Consensus 227 ~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 227 IPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 1112456678999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=291.75 Aligned_cols=243 Identities=29% Similarity=0.441 Sum_probs=195.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|.. .++.+|+|.++... ..+.+.+|+.++.+++|||++++++++... ..+++|||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~---~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY---TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred ceeeeeeccCCCCceEeccc---CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 45668899999999999875 46789999986532 345789999999999999999999998654 4789999999
Q ss_pred CCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|.+++.... .+++..+.+++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 999999997643 578999999999999999999987 99999999999999999999999999987643221
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+.. ..
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~---------~~ 217 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV--------KECVEKGYR---------ME 217 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH--------HHHHhCCCC---------CC
Confidence 11223567999999998899999999999999999998 8888865433221 111122110 00
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
........+.+++.+||+.+|++||++.+|++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112234577889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=292.65 Aligned_cols=247 Identities=21% Similarity=0.299 Sum_probs=194.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-----hhhHHHHHHHHHHhcccccccccceeeeeecc--cceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 580 (799)
.+.+.||+|+||.||+|.... +++.||+|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...++
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDAD-TGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred eEeeEEecCCceEEEEEEEcC-CCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 345789999999999999864 67899999875321 22345788899999999999999999988664 45679
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
++||+++++|.+++.....+++....+++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 999999999999998777788899999999999999999998 89999999999999999999999999998653221
Q ss_pred C--cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 S--RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~--~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
. .......++..|+|||.+.+..++.++||||||+++|||++|+.||....... . ........
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~-~~~~~~~~-------- 225 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA------A-IFKIATQP-------- 225 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH------H-HHHHhcCC--------
Confidence 1 11223457889999999998889999999999999999999999986432111 0 01111110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 -~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 1111233445677788888885 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=296.70 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=196.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|+||.||++..+. +++.||+|.++.. .......+.+|+.++++++|+||+++++.+......++|+||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRP-TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcC-CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 456789999999999999864 6789999988643 23344678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|..++... ..+++..+.+++.|++.||.|||+. .+|+|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 158 (286)
T cd06622 83 AGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-- 158 (286)
T ss_pred CCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCcc--
Confidence 99999988763 3689999999999999999999964 2899999999999999999999999999876532221
Q ss_pred eeeeccCCcccccccccCC------CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 664 HTMIRGTRGYVAPEWFKNA------PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~------~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
....+++.|+|||.+.+. .++.++|||||||++|||++|+.||........... . .....+.
T Consensus 159 -~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~----~-~~~~~~~------ 226 (286)
T cd06622 159 -KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ----L-SAIVDGD------ 226 (286)
T ss_pred -ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH----H-HHHhhcC------
Confidence 223477899999998554 358899999999999999999999865322111100 0 1111111
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..........+.+++.+||+.+|++||++.++++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 ---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 11112235567788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=292.60 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=200.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||++..+. +++.+++|++... .....+++.+|+.++++++|+||+++++++.+....++|+||+
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKE-DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYC 81 (256)
T ss_pred eEEEEeccCCceEEEEEEEcC-CCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecC
Confidence 356789999999999999875 6789999998642 2334468899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++.... .+++..+++++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~- 157 (256)
T cd08218 82 EGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL- 157 (256)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh-
Confidence 9999999987643 578899999999999999999997 8999999999999999999999999999865432211
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....+++.|+|||.+.+...+.++||||||++++||++|+.|+......+ ..... ..+... .
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~-------~~~~~-~~~~~~---------~ 220 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN-------LVLKI-IRGSYP---------P 220 (256)
T ss_pred hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH-------HHHHH-hcCCCC---------C
Confidence 122347888999999999899999999999999999999999987543221 11111 111110 1
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.+|++||+|.+|++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 122334568889999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=294.33 Aligned_cols=250 Identities=23% Similarity=0.403 Sum_probs=199.7
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc------hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.||+|++|.||++.... +++.+|+|.++... ....+.+..|++++++++|+||+++++++.+....++|+
T Consensus 4 ~~~~lg~g~~~~v~~~~~~~-~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 4 KGQQLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred ccceecCcCceEEEEEEEcC-CCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 34679999999999998764 67899999986422 123467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 661 (799)
||+++++|.+++.....+++....+++.|++.||+|||+. +++|+||+|+||+++.++ .+||+|||++........
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 83 EWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred eccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999998877889999999999999999999998 999999999999998775 599999999987654321
Q ss_pred c---ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 662 R---THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 662 ~---~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
. ......++..|+|||.+.+..++.++||||+|++++||++|..|+........... ..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~--------- 226 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL----IFKIASA--------- 226 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH----HHHHhcc---------
Confidence 1 11224578899999999888899999999999999999999999864332111111 1111000
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+......+.+++.+|++.+|++||++.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 0111122344567888999999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=320.41 Aligned_cols=260 Identities=20% Similarity=0.252 Sum_probs=187.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc------cccccceeeeeecc-ccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH------HKNLVQLLGFCDEA-LNRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~g~~~~~-~~~~ 579 (799)
+.+.+.||+|+||+||+|.... .++.||||+++... ...+++..|++++++++ |.+++++++++... ...+
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~-~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~ 208 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRK-RKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMC 208 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcC-CCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEE
Confidence 4456789999999999999874 57899999986432 22334555666665554 45688999988654 4678
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----------------
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---------------- 643 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---------------- 643 (799)
+|||++ +++|.+++.....+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 209 iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 209 IVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 899987 678999888877899999999999999999999973 2899999999999998765
Q ss_pred ceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH--
Q 038294 644 SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD-- 721 (799)
Q Consensus 644 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~-- 721 (799)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+....+..
T Consensus 286 ~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence 49999999876432 122345689999999999999999999999999999999999999976543221111111
Q ss_pred ------HHH--------HHHhc-CceeEeecCCC-------CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 722 ------WAY--------DCYAE-GRLDVLVDSDE-------PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 722 ------~~~--------~~~~~-~~~~~~~d~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
|.. ..+.. +.+....++.. ...........+.+|+.+||+.||++|||++|+++
T Consensus 362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~ 437 (467)
T PTZ00284 362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTT 437 (467)
T ss_pred CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhc
Confidence 100 00000 00000000000 00001112345779999999999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=309.22 Aligned_cols=261 Identities=24% Similarity=0.271 Sum_probs=192.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc------ce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 578 (799)
+.+.+.||+|+||.||++.... +++.||+|++... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 101 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTV-LGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDV 101 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcC-CCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccccee
Confidence 3456789999999999998864 6789999998642 2334567889999999999999999999986443 46
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 102 YLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred EEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 899999975 56665533 477888899999999999999998 999999999999999999999999999976432
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhH---------------HHHH
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAIL---------------TDWA 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~---------------~~~~ 723 (799)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||............ ....
T Consensus 176 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (359)
T cd07876 176 NF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253 (359)
T ss_pred Cc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence 21 122345789999999999999999999999999999999999999754322110000 0000
Q ss_pred HHHHhcC-ce-----eEeecCC-C--CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEG-RL-----DVLVDSD-E--PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~-~~-----~~~~d~~-~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....... .. .+..... . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 00 0000000 0 000111223567889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.01 Aligned_cols=194 Identities=23% Similarity=0.360 Sum_probs=158.5
Q ss_pred hhcCccccceEEEEEEeC-CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeec--ccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~ 587 (799)
.+||+|+||.||+|..++ .+++.||+|.++... ....+.+|++++++++||||+++++++.. +...++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 479999999999999753 245789999986532 23467889999999999999999998843 4567899999875
Q ss_pred CChhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEccccCcc
Q 038294 588 GTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSK 654 (799)
Q Consensus 588 gsL~~~l~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl----~~~~~~kl~DfGla~ 654 (799)
+|.+++... ..+++..+.+++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 777766421 2467888999999999999999998 89999999999999 567799999999998
Q ss_pred cccCCCCc--ceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchh
Q 038294 655 LLLSDQSR--THTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEME 710 (799)
Q Consensus 655 ~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~ 710 (799)
........ ......+|+.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 76443221 22334578999999998764 5799999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.59 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=202.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEc--ccc--chhhHHHHHHHHHHhcccccccccceeeeeecccc--eeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKL--DRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN--RLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l--~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--~~lv 581 (799)
.|.++||+|+|-+||||.+.. +|.+||=-.+ ++. .....+.|..|+.+|+.|+|+||++++....+... ..+|
T Consensus 43 k~~evLGrGafKtVYka~De~-~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE-EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccc-cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 356889999999999999854 6777764322 221 23334789999999999999999999999976655 5689
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~ 660 (799)
.|.|..|+|..++++.+..+.+...+|+.||++||.|||++ .++|||||||-+||+|+. .|.+||+|+|||..+....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999999999999999999999999999999999997 689999999999999985 6899999999999875443
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
. ..+.|||.|||||... ..|.+.+||||||+.++||+|+.-|+..-... ..+++++..|.....+..
T Consensus 201 a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-------AQIYKKV~SGiKP~sl~k-- 267 (632)
T KOG0584|consen 201 A---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-------AQIYKKVTSGIKPAALSK-- 267 (632)
T ss_pred c---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-------HHHHHHHHcCCCHHHhhc--
Confidence 3 2367999999999987 77999999999999999999999998754321 236667766654332222
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
-....+.++|.+||.. .++|||+.|+++
T Consensus 268 ------V~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 ------VKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ------cCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 1124567799999999 999999999985
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.29 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=199.0
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.+.||+|++|.||++..+. +++.+++|+++.......+.+.+|+.+++.++|+||+++++++...+..++++||+++++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKS-TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred ceEeccCCCeEEEEEEECC-CCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 3589999999999998764 578999999865545556678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeecc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 669 (799)
|.+++.. ..+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........ ......+
T Consensus 103 L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~ 177 (285)
T cd06648 103 LTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKSLVG 177 (285)
T ss_pred HHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccccccC
Confidence 9999877 5688999999999999999999998 899999999999999999999999998876543222 1122457
Q ss_pred CCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHH
Q 038294 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749 (799)
Q Consensus 670 t~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 749 (799)
++.|+|||.+.+..++.++||||||+++|||++|+.||........ . .....+.. +... ......
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~-------~-~~~~~~~~-----~~~~--~~~~~~ 242 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA-------M-KRIRDNLP-----PKLK--NLHKVS 242 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH-------H-HHHHhcCC-----CCCc--ccccCC
Confidence 8899999999988899999999999999999999999865432111 1 11111110 0000 011234
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 750 QKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 750 ~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+.+++.+||+.+|++||++.++++
T Consensus 243 ~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 243 PRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHcc
Confidence 57889999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=297.34 Aligned_cols=261 Identities=25% Similarity=0.320 Sum_probs=193.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|++|.||+|..+. +++.||+|+++... ....+.+.+|+.++.+++||||+++++++.++...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKK-TGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred eEeeEecccCceEEEEEEECC-CCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 345789999999999999864 57899999986432 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 586 GNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 586 ~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+ ++|.+++... ..+++..+..++.||+.||+|||+. +++|+||||+||++++++.+||+|||++....... .
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (285)
T cd07861 82 S-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R 156 (285)
T ss_pred C-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence 7 6888887643 4578999999999999999999998 99999999999999999999999999987653221 1
Q ss_pred ceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH----HHHHhc--------
Q 038294 663 THTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA----YDCYAE-------- 729 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~~-------- 729 (799)
......+++.|+|||.+.+. .++.++||||||++++||++|+.||................ ...+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 12223467899999988654 57899999999999999999999987543221110000000 000000
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........... ..........+.+++.+||+.||++|||+.+|++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 237 NTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0001113456678999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=293.90 Aligned_cols=251 Identities=26% Similarity=0.434 Sum_probs=201.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|++|.||++..+. +++.+++|.+.... ....+++.+|++++++++||||+++++.+......++++||++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRP-TGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcC-CCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 356789999999999999874 67899999986543 3455688999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|.+++... ..++.....+++.|++.||+|||+ . +++|+||||+||++++++.+||+|||.+..........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~- 158 (265)
T cd06605 83 GGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT- 158 (265)
T ss_pred CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc-
Confidence 99999999876 678889999999999999999999 6 89999999999999999999999999987653322111
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
..++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ....... ....+ ..+...
T Consensus 159 --~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~-~~~~~--------~~~~~~ 225 (265)
T cd06605 159 --FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD--GIFELLQ-YIVNE--------PPPRLP 225 (265)
T ss_pred --ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc--cHHHHHH-HHhcC--------CCCCCC
Confidence 4578899999999999999999999999999999999999865421111 1111111 11111 111111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.......+.+++.+||+.+|++|||+.+++..
T Consensus 226 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 226 SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11245678899999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=299.62 Aligned_cols=253 Identities=21% Similarity=0.285 Sum_probs=200.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKE-TRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred eEeeEeecCCCeeEEEEEECC-CCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345789999999999999874 57899999986543 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC----
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---- 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~---- 660 (799)
+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 83 VEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999998877889999999999999999999998 89999999999999999999999999987421100
Q ss_pred ----------CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 661 ----------SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 661 ----------~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
........++..|+|||.+.+..++.++|+||||+++|||++|..||......+ .......+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--------~~~~~~~~ 231 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--------LFGQVISD 231 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhc
Confidence 001112346788999999998889999999999999999999999987543221 11111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
... .+.. .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus 232 ~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 232 DIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 110 0110 11234567889999999999999998777777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=328.42 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=194.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec--ccceee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLL 580 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~l 580 (799)
..+.+.+.||+|+||+||++.... +++.+|+|.+... .......|..|+.++++++||||+++++++.. ....+|
T Consensus 13 ~~YeIl~kLG~GgFGtVYLAkdk~-tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 13 NEYEVIKKIGNGRFGEVFLVKHKR-TQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred CCEEEEEEEecCCCeEEEEEEECC-CCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 345567889999999999999875 6789999988642 23345678999999999999999999998854 346789
Q ss_pred EEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEecCCCCCCeEEcC-----------
Q 038294 581 VYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECN----VPIIHCDIKPQNILLDN----------- 641 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~----~~iiH~dlk~~NILl~~----------- 641 (799)
||||+++|+|.++|... ..+++..++.|+.||+.||+|||+... .+||||||||+||||+.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998752 468999999999999999999998421 25999999999999964
Q ss_pred ------CCceEEccccCcccccCCCCcceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhh
Q 038294 642 ------YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEE 713 (799)
Q Consensus 642 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~ 713 (799)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||+||||++|+.||......
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~ 249 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF 249 (1021)
T ss_pred ccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence 3358999999998653322 1223468999999999854 45889999999999999999999999743221
Q ss_pred hcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 714 EGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. . ....+..+. ..+ .......+.+|+..||+.+|++||++.|++.
T Consensus 250 ~------q-li~~lk~~p-------~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 250 S------Q-LISELKRGP-------DLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred H------H-HHHHHhcCC-------CCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 1 111111111 111 1122356888999999999999999999983
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=303.76 Aligned_cols=250 Identities=24% Similarity=0.367 Sum_probs=204.2
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
..+.+...||-|+||.|||++.+. ++...|.|++.....+..++|+-|+++|+..+||+||+|++.|.-.+.++|+.||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke-t~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE-TKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc-chhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 345567789999999999999874 5556678888777777788999999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|.||-.+.++... ..+...++.-++.|++.||.|||++ .|||||||+.|||+.-+|.++|+|||++........ .
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q-k 186 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ-K 186 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHh-h
Confidence 9999999988765 5788999999999999999999998 999999999999999999999999999865432222 2
Q ss_pred eeeeccCCcccccccc-----cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 664 HTMIRGTRGYVAPEWF-----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l-----~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.....|||.|||||+. ...+|+.++||||||+.|.||..+..|.....+-. .+.. +.. .
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR-------VllK-iaK--------S 250 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-------VLLK-IAK--------S 250 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH-------HHHH-Hhh--------c
Confidence 2345699999999986 46789999999999999999999988865432211 1111 111 1
Q ss_pred CCCC-ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPA-MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..|. ..+......+.+++.+||..||+.||++.++++
T Consensus 251 ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 251 EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1111 124456677889999999999999999999875
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=309.10 Aligned_cols=261 Identities=23% Similarity=0.245 Sum_probs=193.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc------cce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 578 (799)
+.+.+.||+|+||.||++.... .++.||||++... .......+.+|+.+++.++||||+++++++... ...
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~ 104 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 104 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECC-CCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeE
Confidence 4456789999999999998764 5789999998653 223345788899999999999999999987543 346
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 105 YIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred EEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 899999975 67666643 477888999999999999999998 999999999999999999999999999986533
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH---------------HH
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD---------------WA 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~---------------~~ 723 (799)
.. ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.. ..
T Consensus 179 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (364)
T cd07875 179 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256 (364)
T ss_pred CC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence 21 22234589999999999999999999999999999999999999975433221110000 00
Q ss_pred HHHHhcCc-e-----eEeecCC---CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEGR-L-----DVLVDSD---EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~~-~-----~~~~d~~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........ . ....... ............+.+++.+||+.||.+|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000 0 0000000 0000111223567889999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=308.38 Aligned_cols=261 Identities=24% Similarity=0.270 Sum_probs=192.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc------cce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 578 (799)
+.+.+.||+|+||.||++.... .++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 97 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDV 97 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecC-CCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccccee
Confidence 3445789999999999998764 5789999998653 223345778899999999999999999988543 346
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+++ +|.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 98 ~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 98 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred EEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 899999975 66666543 478888899999999999999998 999999999999999999999999999986532
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHH---------------HHH
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT---------------DWA 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~---------------~~~ 723 (799)
.. ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+...... ...
T Consensus 172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (355)
T cd07874 172 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249 (355)
T ss_pred cc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence 21 2233458999999999999999999999999999999999999997543221100000 000
Q ss_pred HHHHhcC-ceeEee------cCCCC--CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEG-RLDVLV------DSDEP--AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~-~~~~~~------d~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....... ...... +...+ ..........+.+++.+||+.||++|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000 000000 00000 00112234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=300.17 Aligned_cols=263 Identities=20% Similarity=0.236 Sum_probs=195.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|..+. +++.||+|.++... ......+.+|+.++++++|+||+++++++......++|+||+
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~ 86 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKL-TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 86 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcC-CCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEecc
Confidence 3455789999999999999874 57899999986432 223346788999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+ ++|.+++... ..+++.....++.||++||+|||+. +|+|+||||+||++++++.+||+|||++........ ..
T Consensus 87 ~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-~~ 161 (301)
T cd07873 87 D-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TY 161 (301)
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-cc
Confidence 7 5888888654 4678899999999999999999998 999999999999999999999999999976432221 11
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHH-HhcCceeEe
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDC-YAEGRLDVL 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~-~~~~~~~~~ 735 (799)
....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+.... +.. .........
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (301)
T cd07873 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241 (301)
T ss_pred cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence 223468899999988654 57889999999999999999999997554322111110000 000 000000000
Q ss_pred ecCCCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPA----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+.... .........+.+++.+||+.||.+|||+.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 001122345778999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.95 Aligned_cols=264 Identities=23% Similarity=0.292 Sum_probs=199.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|.... +++.|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRE-TGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECC-CCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc
Confidence 456789999999999999864 57899999986533 334567899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|.+++... ..+++..+.+++.||++||+|||+. +++|+||||+||+++.++.++|+|||++...........
T Consensus 82 -~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (286)
T cd07832 82 -PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLY 157 (286)
T ss_pred -CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcc
Confidence 99999998654 5689999999999999999999998 899999999999999999999999999987654432223
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcC----ceeEe
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEG----RLDVL 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~----~~~~~ 735 (799)
....++..|+|||.+.+. .++.++||||+|++++||++|..++......+.......... ..+.+. ....+
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 334578899999998654 468999999999999999999777754432221111000000 000000 00000
Q ss_pred ecCCCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 736 VDSDEPA----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 736 ~d~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+.... .......+.+.+++.+||+.+|++|||++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 0011234678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=305.81 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=200.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-c-----ccccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-H-----KNLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~g~~~~~~~~~ 579 (799)
++.+.+.||+|+||.|-|+.+.. +++.||||++++. ..-.++-..|+++|..++ | -|+|+++++|.-.++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~-T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHK-TGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecC-CCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 55667899999999999999874 7899999999864 334566788999999986 4 37999999999999999
Q ss_pred eEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEccccCccc
Q 038294 580 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN--YFSAKISDFGLSKL 655 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~--~~~~kl~DfGla~~ 655 (799)
||+|.+.. +|.++|+.. ..++......|+.||+.||.+||+. +|||+||||+||||.+ ...+||+|||.+..
T Consensus 265 iVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999854 999999976 4688999999999999999999988 9999999999999975 44799999999986
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HH---
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YD--- 725 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~--- 725 (799)
... ......-++.|+|||++.+.+|+.+.||||||||++||++|..-|.+..+.+....+.+.. .+
T Consensus 341 ~~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~ 416 (586)
T KOG0667|consen 341 ESQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK 416 (586)
T ss_pred cCC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 422 1123345788999999999999999999999999999999987776665544332222211 11
Q ss_pred ----HHhc--CceeEe----------------------ecCCCC-C------ccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 726 ----CYAE--GRLDVL----------------------VDSDEP-A------MADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 726 ----~~~~--~~~~~~----------------------~d~~~~-~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
.+.. +..... .+...+ . ......-..+++++.+||+.||.+|+|.
T Consensus 417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp 496 (586)
T KOG0667|consen 417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP 496 (586)
T ss_pred ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence 0111 110000 000011 0 0111344567899999999999999999
Q ss_pred HHHHHH
Q 038294 771 KVVLQM 776 (799)
Q Consensus 771 ~evl~~ 776 (799)
.|+++.
T Consensus 497 ~qal~H 502 (586)
T KOG0667|consen 497 AQALNH 502 (586)
T ss_pred HHHhcC
Confidence 998853
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=290.58 Aligned_cols=250 Identities=27% Similarity=0.375 Sum_probs=199.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec--ccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~e 583 (799)
.+.+.||.|+||.||++.... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.. +...++++|
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKS-DGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred eeeeeeccCCCeEEEEeeecC-CCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 345789999999999998875 6788999988642 23445678899999999999999999998753 445789999
Q ss_pred ecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 584 FMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEEC--NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 584 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
|+++++|.+++.. ...+++...+.++.||+.||+|||..+ ..+++|+||+|+||++++++.+||+|||++....
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~ 161 (265)
T cd08217 82 YCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG 161 (265)
T ss_pred hccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccccc
Confidence 9999999999875 356889999999999999999999321 2389999999999999999999999999998765
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
..... .....++..|+|||.+.+..++.++||||||+++++|++|+.|+....... ..+.+..+..
T Consensus 162 ~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~----- 227 (265)
T cd08217 162 HDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--------LASKIKEGKF----- 227 (265)
T ss_pred CCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--------HHHHHhcCCC-----
Confidence 43321 223357889999999999889999999999999999999999987653221 1122222211
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..........+.+++.+|++.+|++||++.+|++.
T Consensus 228 ----~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ----RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ----CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=291.23 Aligned_cols=250 Identities=29% Similarity=0.406 Sum_probs=205.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|++|.||+++.+. +++.|++|++..... ...+++.+|+..+.+++|+|++++++++......++|+||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKP-TGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcC-CCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345789999999999999875 688999999876443 445789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++.....++...+.+++.|+++||+|||+ . +++|+||+|+||+++.++.++|+|||++.......... .
T Consensus 83 ~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~-~ 158 (264)
T cd06623 83 GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-N 158 (264)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc-c
Confidence 99999999887888999999999999999999999 7 99999999999999999999999999998765433222 2
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...++..|+|||.+.+..++.++||||||+++|||++|+.|+........ .+..... ..+. .+. ..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~----~~~~~~~-~~~~--------~~~-~~ 224 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF----FELMQAI-CDGP--------PPS-LP 224 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCH----HHHHHHH-hcCC--------CCC-CC
Confidence 33478899999999999999999999999999999999999876532111 1111111 1111 111 11
Q ss_pred HH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 746 RS-RLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 746 ~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.. ..+.+.+++.+||+.+|++||++.|+++.
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 12 45688899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=295.20 Aligned_cols=248 Identities=26% Similarity=0.347 Sum_probs=191.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeee-----cccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCD-----EALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~lv 581 (799)
.+.+.||+|+||.||++..+. +++.+|+|.++... ....++.+|+.++.++ +|+||+++++++. .+...++|
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKK-NGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeccCCCcEEEEEEECC-CCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 455789999999999999875 57899999886532 2345788899999999 6999999999884 34567999
Q ss_pred EeecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 582 YEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
|||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||++++++.+||+|||+++...
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 175 (286)
T cd06638 99 LELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT 175 (286)
T ss_pred EeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecc
Confidence 999999999988753 24678888999999999999999998 89999999999999999999999999988654
Q ss_pred CCCCcceeeeccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
.... ......|++.|+|||.+.. ..++.++|||||||++|||++|+.|+........ ... ...+..
T Consensus 176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-------~~~-~~~~~~ 246 (286)
T cd06638 176 STRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFK-IPRNPP 246 (286)
T ss_pred cCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-------Hhh-ccccCC
Confidence 3221 1223358899999999853 4578899999999999999999999875432110 000 000000
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.... ........+.+++.+||+.+|++|||+.||++.
T Consensus 247 ~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 247 PTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred Cccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0000 111123468889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=291.56 Aligned_cols=247 Identities=26% Similarity=0.385 Sum_probs=199.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|.... +++.+|+|.+.... ....+.+.+|+.++.+++|+||+++++++.++...++|+||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECC-CCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3456789999999999998764 57899999886432 334467899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.. ..+++.....++.|++.|+.|||+. +++|+||+|+||++++++.++|+|||++........ ...
T Consensus 85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 99999998864 4678999999999999999999998 999999999999999999999999999876543221 122
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...++..|+|||.+.+..++.++|||||||++|||++|..|+....... ....+..+. .....
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~---------~~~~~ 222 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--------VLFLIPKNN---------PPTLE 222 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--------HHHHHhcCC---------CCCCC
Confidence 2357888999999998889999999999999999999999986432211 111111111 11112
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 2234567789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-33 Score=292.32 Aligned_cols=245 Identities=23% Similarity=0.370 Sum_probs=196.5
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccc---cccccceeeeeecccceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.||+|+||.||+|.... +++.+++|.++.. ......++.+|+.++++++ |||++++++++.++...++||||
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVP-TGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhheeccCCceEEEEEEcC-CCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 45789999999999999864 6789999998643 2334567888999999886 99999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++++|.+++... .+++.....++.|++.||.|||+. +|+|+||+|+||++++++.++|+|||++......... .
T Consensus 84 ~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~ 158 (277)
T cd06917 84 AEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK-R 158 (277)
T ss_pred CCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-c
Confidence 9999999998664 788999999999999999999998 9999999999999999999999999999876543322 2
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....|+..|+|||.+.++ .++.++||||||+++|||++|..||........ .. ..... ..+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-------~~-~~~~~--------~~~~~ 222 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-------MM-LIPKS--------KPPRL 222 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-------hh-ccccC--------CCCCC
Confidence 233578899999988654 578999999999999999999999875432111 00 00000 01111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+++.+||+.||++||++.|+++
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11124457888999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.77 Aligned_cols=248 Identities=24% Similarity=0.283 Sum_probs=197.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++.... +++.+|+|.+..... ...+.+.+|++++..++|+||+++++.+......++||||
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKG-TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred EEeeeecCCccEEEEEEEEcC-CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 345789999999999999875 678999999865332 2445788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+.+++|.+++... ..+++..+..++.|+++||+|||+. +++|+||||+||+++.++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 83 CPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred cCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999998754 4678899999999999999999998 8999999999999999999999999998754321110
Q ss_pred ----------------------------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhh
Q 038294 663 ----------------------------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE 714 (799)
Q Consensus 663 ----------------------------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~ 714 (799)
......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 0112347889999999999889999999999999999999999997554322
Q ss_pred cchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 038294 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT----MKVVLQ 775 (799)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~evl~ 775 (799)
. + ... ..... ..+ ........+.+++.+||+.+|++||| +.|+++
T Consensus 240 ~---~----~~~-~~~~~------~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 240 T---F----SNI-LKKEV------TFP--GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H---H----HHH-hcCCc------cCC--CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 1 111 11110 011 11124567889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=287.69 Aligned_cols=246 Identities=26% Similarity=0.380 Sum_probs=197.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||++.... +++.+|+|.+... .....+.+.+|++++++++|+|++++++.+..+...++|+||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKA-DQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred eEEEEecccCceEEEEEEEcC-CCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 345789999999999999875 6789999998543 2334568899999999999999999999999889999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEccccCcccccCCCCc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~ 662 (799)
++++|.+++... ..+++..+.+++.|+++||+|||+. +++|+||+|+||+++++ ..+||+|||++........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (256)
T cd08220 82 PGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK- 157 (256)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-
Confidence 999999999764 3578999999999999999999998 99999999999999854 4689999999987643321
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.|+....... .... ...+....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-------~~~~-~~~~~~~~-------- 220 (256)
T cd08220 158 -AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-------LVLK-IMSGTFAP-------- 220 (256)
T ss_pred -ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-------HHHH-HHhcCCCC--------
Confidence 122457889999999998889999999999999999999999986543221 1111 11111110
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.+|++|||+.|+++.
T Consensus 221 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 221 -ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=322.68 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=208.2
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCCC------CeEEEEEEccccchh-hHHHHHHHHHHhccc-ccccccceeeee
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSAS------GKAIAVKKLDRLAQE-REREFKSEVSAIGRT-HHKNLVQLLGFC 572 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~------~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~g~~ 572 (799)
|+......+.+.||+|.||.|++|...... ...||||.++..... ..+.+..|+++|+.+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 444444456679999999999999875222 457999999865443 456899999999998 799999999999
Q ss_pred ecccceeeEEeecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 038294 573 DEALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQN 636 (799)
Q Consensus 573 ~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~N 636 (799)
.++...++|.||+..|+|.++|+..+ .+.....+.++.|||.|++||++. +++||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhhh
Confidence 99889999999999999999998655 377788999999999999999998 89999999999
Q ss_pred eEEcCCCceEEccccCcccccCCCCcceeeec--cCCcccccccccCCCCCcchhHHHHHHHHHHHHhCC-cCCchhhhh
Q 038294 637 ILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR--GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMEVEE 713 (799)
Q Consensus 637 ILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~-~p~~~~~~~ 713 (799)
||+.++..+||+|||+++.............. -+..|||||.+....|+.|+|||||||+||||+|.. .|+.....
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~- 527 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP- 527 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-
Confidence 99999999999999999976544333222111 356799999999999999999999999999999954 55543110
Q ss_pred hcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 714 EGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
..+ +.+.+++|... ..+.....++.+++..||+.+|++||++.++++.|+.+
T Consensus 528 -----~~~-l~~~l~~G~r~---------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 -----TEE-LLEFLKEGNRM---------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred -----HHH-HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 112 23455555421 12333356788999999999999999999999999884
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=290.79 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=206.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|.|..|-++++.- +|+.||||++.+..- -....+.+|++.|+.++|||||+|+.+.......|||+|.-
T Consensus 21 DLekTlG~GHFAVVKLArHVF-TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 21 DLEKTLGRGHFAVVKLARHVF-TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred hhhhhhcCCceehhhhhhhhc-ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 445779999999999998763 789999999976433 23457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-cCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL-DNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl-~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
.+|+|.++|.+. ..+.+....+++.||+.|+.|+|+. .++||||||+||.+ ..-|-+||+|||++..+...+ .
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~--k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK--K 174 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcc--h
Confidence 999999999765 5789999999999999999999997 89999999999866 567889999999998765433 3
Q ss_pred eeeeccCCcccccccccCCCCC-cchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVS-AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s-~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
....+|+..|-|||++.+..|+ +++||||+||+||-|++|+.||+..++.+....+ +| ..-
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI----------------mD--CKY 236 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI----------------MD--CKY 236 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh----------------hc--ccc
Confidence 4456799999999999999885 5799999999999999999999877665543332 11 223
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+.....++.++|..||..||.+|.+.+||+.
T Consensus 237 tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 237 TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 345677788999999999999999999999875
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=296.72 Aligned_cols=261 Identities=20% Similarity=0.247 Sum_probs=193.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.+|+|+++... ......+.+|++++++++|+||+++++++.+....++++||+
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~-~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC 81 (284)
T ss_pred eeEEEecccCCeEEEEEEECC-CCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecC
Confidence 345789999999999999875 57899999986422 223356788999999999999999999999999999999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+ ++|.+++.. ...+++..+..++.||++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ..
T Consensus 82 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 156 (284)
T cd07839 82 D-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-CY 156 (284)
T ss_pred C-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-Cc
Confidence 7 478777764 45689999999999999999999998 899999999999999999999999999986533221 12
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHHH-------HHHHHhcCceeEe
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTDW-------AYDCYAEGRLDVL 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~~-------~~~~~~~~~~~~~ 735 (799)
....++..|+|||.+.+. .++.++|||||||++|||++|+.|+......+.. ..+... .+.....- ....
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL-PDYK 235 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc-cccc
Confidence 223468899999998765 4789999999999999999999986533221110 000000 00000000 0000
Q ss_pred ecCCCCC-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPA-----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.-+..+. .......+.+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000000 011123456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=294.83 Aligned_cols=261 Identities=24% Similarity=0.275 Sum_probs=197.9
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 584 (799)
+.+.||+|+||.||+|+... +++.+|+|++.... ......+.+|++++++++|+|++++++++... ...++|+||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKK-TGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEECC-CCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 45789999999999999874 57899999997643 33446788999999999999999999999887 789999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++ +|.+++... ..+++..+..++.||++||+|||+. +++|+||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 82 MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCccc
Confidence 975 898888765 5789999999999999999999998 89999999999999999999999999998765443222
Q ss_pred eeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc---eeEe----
Q 038294 664 HTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR---LDVL---- 735 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---- 735 (799)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...........+...... ..... ...+
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGS-PTDENWPGVSKLPWFE 236 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC-Cchhhccccccchhhh
Confidence 333446788999998765 46789999999999999999999998765432211111110000 00000 0000
Q ss_pred -------ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 -------VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 -------~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
................+.+++.+||+.+|++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0000000001112567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=294.62 Aligned_cols=241 Identities=26% Similarity=0.314 Sum_probs=199.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++.... +++.+|+|.++... ....+.+.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKG-SGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 456789999999999999875 57899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++++|.+++.....++...+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++...... .
T Consensus 83 ~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----~ 155 (290)
T cd05580 83 VPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----T 155 (290)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----C
Confidence 99999999998888899999999999999999999997 9999999999999999999999999999876433 2
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
....+++.|+|||.+.+...+.++||||||+++|||++|+.||....... ..+....+.. ..+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~--- 218 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ--------IYEKILEGKV------RFP--- 218 (290)
T ss_pred CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHhcCCc------cCC---
Confidence 23357889999999988889999999999999999999999987543211 1111112211 111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP-----TMKVVL 774 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl 774 (799)
......+.+++.+||+.+|++|| +++|++
T Consensus 219 -~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 219 -SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred -ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 12245778899999999999999 677665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.22 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=200.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++.... +++.|++|.+........+.+.+|+.++++++|||++++++.+......++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVA-TGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcC-CCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 3456789999999999998764 578899999865444555678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|.+++... .+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++........ ....
T Consensus 100 ~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~~~~ 174 (293)
T cd06647 100 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 174 (293)
T ss_pred CCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-cccc
Confidence 99999998653 578889999999999999999998 999999999999999999999999999876543322 1222
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..+++.|+|||.+....++.++||||||+++||+++|+.||........... ....+ ........
T Consensus 175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~-------~~~~~--------~~~~~~~~ 239 (293)
T cd06647 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-------IATNG--------TPELQNPE 239 (293)
T ss_pred ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee-------hhcCC--------CCCCCCcc
Confidence 3578899999999888899999999999999999999999975432211100 00000 00111122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.....+.+++.+||+.+|++||++.+++..
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 234567789999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.71 Aligned_cols=244 Identities=25% Similarity=0.344 Sum_probs=194.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+...+.||+|+||.||+|.... +++.||+|++... ..+..+++.+|+++++.++||||+++.++|......++|+|
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcC-CCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3445789999999999999864 5789999988532 22334578899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|++ |+|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 96 ~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~-- 169 (307)
T cd06607 96 YCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN-- 169 (307)
T ss_pred hhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCCC--
Confidence 997 577666653 45689999999999999999999997 89999999999999999999999999987653221
Q ss_pred ceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 THTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
...+++.|+|||.+. ...++.++||||||+++|||++|+.|+........ ....... .
T Consensus 170 ---~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-------~~~~~~~---------~ 230 (307)
T cd06607 170 ---SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQN---------D 230 (307)
T ss_pred ---CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-------HHHHhcC---------C
Confidence 234678899999874 45688999999999999999999999865432211 1111110 1
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+..........+.+++.+||+.+|++||++.+|+..
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111223345678899999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=289.20 Aligned_cols=251 Identities=27% Similarity=0.394 Sum_probs=201.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||.|+||+||+|.... +++.+++|++.... ....+.+.+|++.++.++|+|++++++.+..+...++++|+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLP-NNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcC-CCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 456789999999999999765 67899999986432 2345789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-
Q 038294 587 NGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR- 662 (799)
Q Consensus 587 ~gsL~~~l~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~- 662 (799)
+++|.+++... ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 83 GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred CCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999764 4588999999999999999999988 9999999999999999999999999999876543322
Q ss_pred --ceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 --THTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 --~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
......++..|+|||.+... .++.++|+||||++++||++|+.|+......+ .. ...... . .+.
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~----~~~~~~-~-----~~~ 226 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK---VL----MLTLQN-D-----PPS 226 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh---hH----HHHhcC-C-----CCC
Confidence 12334578899999998777 78999999999999999999999987543221 01 111111 0 011
Q ss_pred CCCcc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMA-DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..... .....+.+.+++.+|++.||++||++.+|++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 227 LETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11111 1234467789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=291.44 Aligned_cols=246 Identities=27% Similarity=0.378 Sum_probs=200.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.+.||+|++|.||+|..+. +++.+++|+++.... ..+.+.+|++.+++++|+|++++++++......++++||++++
T Consensus 23 ~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 23 NLEKIGEGASGEVYKATDRA-TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred HhHhccCCCCeEEEEEEEcc-CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 44679999999999999874 578899999975443 4667899999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 589 TLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 589 sL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
+|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 101 ~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 176 (286)
T cd06614 101 SLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-KRNSV 176 (286)
T ss_pred cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-hhccc
Confidence 9999998876 889999999999999999999997 999999999999999999999999999876543221 11223
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.++..|+|||.+.+..++.++||||||+++|||++|+.|+.......... . ........ ......
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-------~-~~~~~~~~-------~~~~~~ 241 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-------L-ITTKGIPP-------LKNPEK 241 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-------H-HHhcCCCC-------Ccchhh
Confidence 46789999999998889999999999999999999999987543321110 1 11111000 001111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+.+++.+|++.+|.+||++.+|++
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 242 WSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 3456788999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=289.82 Aligned_cols=254 Identities=26% Similarity=0.336 Sum_probs=197.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~~ 585 (799)
+.+.||.|++|.||++.++. +++.+|+|.+..... ....++.+|++++++++||||+++++++.+. ...++||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKN-TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEeccCCceEEEEEEECC-CCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 45789999999999999875 578999999864322 3456789999999999999999999998543 4678999999
Q ss_pred CCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
++++|.+++.. ...++......++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (287)
T cd06621 84 EGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA 160 (287)
T ss_pred CCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence 99999988753 24578889999999999999999998 999999999999999999999999999876532221
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... .. ... ..........+.+.
T Consensus 161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~-~~~-~~~~~~~~~~~~~~--- 231 (287)
T cd06621 161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PI-ELL-SYIVNMPNPELKDE--- 231 (287)
T ss_pred ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hH-HHH-HHHhcCCchhhccC---
Confidence 1234678899999999999999999999999999999999999755321111 01 111 11111111111111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+.+++.+||+.+|++|||+.||++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0111234567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=294.28 Aligned_cols=250 Identities=25% Similarity=0.331 Sum_probs=196.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
...+.||+|+||.||+++... +++.+|+|++... ......++.+|++++++++|+|++++++++.++...++|+||
T Consensus 28 ~~~~~lg~G~~~~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 28 TDLREIGHGSFGAVYFARDVR-TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhheeccCCCeEEEEEEEcC-CCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 345789999999999999864 5789999998642 223345788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++ +|.+.+.. ...+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---- 178 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---- 178 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCCc----
Confidence 975 77777654 45689999999999999999999998 8999999999999999999999999998754321
Q ss_pred eeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 664 HTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
....+++.|+|||.+. .+.++.++|||||||++|||++|+.|+........ .......+.
T Consensus 179 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~~--------- 241 (317)
T cd06635 179 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNES--------- 241 (317)
T ss_pred -ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhccC---------
Confidence 2234788999999973 45689999999999999999999999865422111 111111111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+..........+.+++.+||+.+|.+||++.+|++.+--....
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 242 PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 1111223445678899999999999999999999866544433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=282.20 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=206.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.++||+|+||.|||+.++. +|+.+|+|++.-. ....++..|+.++++.+.|++|+++|.+.....+++|||||.-
T Consensus 36 Di~~KLGEGSYGSV~KAIH~E-sG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 36 DIVGKLGEGSYGSVHKAIHRE-SGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHhcCCcchHHHHHHHhc-cCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 456889999999999999985 7899999998643 3467889999999999999999999999999999999999999
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|+..+.++.. +.+.+..+..+..+-++||+|||.. .-||||||+.||||+-+|.+||+|||+|..+...-.+. ..
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR-NT 188 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR-NT 188 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhh-Cc
Confidence 9999999865 6788999999999999999999997 78999999999999999999999999998765433333 33
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc-cC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM-AD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~ 745 (799)
+.||+.|||||++..-.|..++||||+|+...||.-|+.|+...-+- ..+..+.....+.. .+
T Consensus 189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM----------------RAIFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM----------------RAIFMIPTKPPPTFKKP 252 (502)
T ss_pred cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc----------------ceeEeccCCCCCCCCCh
Confidence 56999999999999999999999999999999999999998643211 11122222222222 34
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+..+.+++..||-+.|++|.|+.++++.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5677889999999999999999999887653
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=293.36 Aligned_cols=260 Identities=25% Similarity=0.324 Sum_probs=195.3
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.||+|++|.||+|..+. +++.|++|++.... ....+.+.+|++++++++|+|++++++++.++...++++||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKL-TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcC-CCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 45789999999999999875 67899999986432 2234578899999999999999999999999999999999995
Q ss_pred CCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++|.+++.... .+++..+.+++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 82 -~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~~ 156 (283)
T cd07835 82 -LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-TY 156 (283)
T ss_pred -cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-cc
Confidence 68999987765 689999999999999999999997 899999999999999999999999999976532221 11
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHH---HhcC--c
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDC---YAEG--R 731 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~---~~~~--~ 731 (799)
....++..|+|||.+.+. .++.++||||||+++|||++|+.||.............+.. +.. ..+. .
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 222457889999988664 57899999999999999999999987543321111100000 000 0000 0
Q ss_pred eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..... ..............+.+++.+|++.+|++|||++|+++
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 237 FPKWA-RQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred ccccc-ccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00000111223357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=284.65 Aligned_cols=246 Identities=27% Similarity=0.420 Sum_probs=202.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
..+.||+|++|.||++.... +++.+++|++........+++.+|++.+++++|+|++++++++......++++||++++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~ 82 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKR-TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82 (253)
T ss_pred eeeeeccCCceEEEEEEECC-CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCC
Confidence 45789999999999999874 57899999997765556678999999999999999999999999999999999999999
Q ss_pred ChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 589 TLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 589 sL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
+|.+++... ..+++..+..++.|++.||+|||.. +++|+||+|+||++++++.++|+|||.+........ ....
T Consensus 83 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~ 157 (253)
T cd05122 83 SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RNTM 157 (253)
T ss_pred cHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--ccce
Confidence 999999876 5789999999999999999999997 999999999999999999999999999987654332 2334
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.++..|+|||.+.+..++.++||||||+++++|++|+.|+.......... . ....... ..+ ....
T Consensus 158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-------~-~~~~~~~-----~~~--~~~~ 222 (253)
T cd05122 158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-------K-IATNGPP-----GLR--NPEK 222 (253)
T ss_pred ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH-------H-HHhcCCC-----CcC--cccc
Confidence 57889999999998889999999999999999999999987543211110 0 0000000 000 0111
Q ss_pred HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+.+++.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 2457888999999999999999999976
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=290.11 Aligned_cols=246 Identities=28% Similarity=0.387 Sum_probs=199.6
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|+||.||++.... +++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++++||+++++
T Consensus 1 lg~g~~~~vy~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKS-TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECC-CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCc
Confidence 6899999999999874 578999999865332 345678899999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-------c
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-------R 662 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-------~ 662 (799)
|.+++.....+++..+.+++.||++||+|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 999998877889999999999999999999998 999999999999999999999999999886543321 1
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......++..|+|||.+.....+.++||||||++++||++|+.||......+. . .....+... .+.
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-------~-~~~~~~~~~------~~~ 222 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI-------F-QNILNGKIE------WPE 222 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-------H-HHHhcCCcC------CCc
Confidence 22234578899999999888899999999999999999999999875543221 1 111111111 011
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.......+..++.+|++.+|++|||+.++.+.|+
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred --cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1112467788999999999999999977777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.32 Aligned_cols=247 Identities=27% Similarity=0.370 Sum_probs=192.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecc-----cceeeEE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-----LNRLLVY 582 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-----~~~~lv~ 582 (799)
+.+.||+|+||.||++..+. +++.+|+|.+.... ....++.+|+.++.++ +|||++++++++... ...++|+
T Consensus 26 ~~~~l~~g~~~~vy~~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 103 (291)
T cd06639 26 IIETIGKGTYGKVYKVTNKK-DGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVL 103 (291)
T ss_pred EEEEeecCCCeEEEEEEECC-CCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEE
Confidence 45789999999999999874 67899999986532 2345678899999998 799999999998653 3578999
Q ss_pred eecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 583 EFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 583 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
||+++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.+||+|||++.....
T Consensus 104 ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~ 180 (291)
T cd06639 104 ELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS 180 (291)
T ss_pred EECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhccc
Confidence 99999999998863 35678999999999999999999998 999999999999999999999999999886543
Q ss_pred CCCcceeeeccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNA-----PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~-----~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
.... .....++..|+|||.+... .++.++|||||||++|||++|+.|+......+. + .. +..+...
T Consensus 181 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~----~~-~~~~~~~ 251 (291)
T cd06639 181 TRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---L----FK-IPRNPPP 251 (291)
T ss_pred cccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---H----HH-HhcCCCC
Confidence 2211 1223578899999998644 368899999999999999999999875432211 1 01 1111111
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+. ........+.+++.+|++.+|++||++.|+++.
T Consensus 252 ~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 252 TLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred CCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 100 112233568889999999999999999999863
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.65 Aligned_cols=260 Identities=24% Similarity=0.313 Sum_probs=192.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.||+|++|.||+|+.+. +++.||||+++... ......+.+|++++++++||||+++++++.+....++||||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeecCCCceEEEEEEECC-CCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45679999999999999864 67899999886432 2233578899999999999999999999999999999999996
Q ss_pred CCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++|.+++... ..+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++........ ..
T Consensus 83 -~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-~~ 157 (284)
T cd07860 83 -QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 157 (284)
T ss_pred -cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-cc
Confidence 6898888653 4678999999999999999999998 899999999999999999999999999876533221 12
Q ss_pred eeeccCCcccccccccCCC-CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHH---Hhc--Cc
Q 038294 665 TMIRGTRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDC---YAE--GR 731 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~-~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~---~~~--~~ 731 (799)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....+........... +.. ..+ ..
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd07860 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237 (284)
T ss_pred ccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhh
Confidence 2234678899999887654 6889999999999999999999987543322111100000 000 000 00
Q ss_pred eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.......... .........+.+++.+||+.||++|||++++++
T Consensus 238 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 238 FPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred cccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0000000000 000112345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=287.39 Aligned_cols=243 Identities=25% Similarity=0.295 Sum_probs=196.8
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|++|.||+++... +++.+++|.+.... ....+.+.+|+.++++++|+||+++++.+.++...++++||+++++
T Consensus 1 lg~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 7999999999999874 57899999986432 2344678999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeecc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 669 (799)
|.+++.....+++..+..++.||+.||+|||+. +++|+||+|+||+++.++.+||+|||++....... ......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 999998877789999999999999999999997 99999999999999999999999999998764432 1223357
Q ss_pred CCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHH
Q 038294 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749 (799)
Q Consensus 670 t~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 749 (799)
+..|+|||.+.+..++.++|+||||+++|||++|..|+........ . .......+.. .... +....
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~-~~~~~~~~~~----~~~~----~~~~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM-----E-IYNDILKGNG----KLEF----PNYID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH-----H-HHHHHhccCC----CCCC----CcccC
Confidence 8899999999888899999999999999999999999976542110 1 1111111100 0011 11124
Q ss_pred HHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 750 QKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 750 ~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
..+.+++.+||+.+|++||+ ++|+++
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 67889999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=280.02 Aligned_cols=264 Identities=23% Similarity=0.301 Sum_probs=208.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|.-|+||++.++. ++...|+|++.+..- +.....+.|-++|+.++||.+++|++.++.+...+++||||
T Consensus 81 llk~LG~GdiG~VyL~~l~~-t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyC 159 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRG-TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYC 159 (459)
T ss_pred HHHHcCCCCceeEEEEEecC-CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecC
Confidence 35679999999999999985 568999999976433 33456778999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC-----
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS----- 658 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~----- 658 (799)
+||+|..+++.. +.++...+.-++.+++-||+|||.. |||.|||||+||||.++|++-|+||.|+.....
T Consensus 160 pGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~ 236 (459)
T KOG0610|consen 160 PGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLV 236 (459)
T ss_pred CCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCCeee
Confidence 999999998865 3678888888999999999999998 999999999999999999999999998765410
Q ss_pred ---C--------------------C---C-c-----------------------ceeeeccCCcccccccccCCCCCcch
Q 038294 659 ---D--------------------Q---S-R-----------------------THTMIRGTRGYVAPEWFKNAPVSAKV 688 (799)
Q Consensus 659 ---~--------------------~---~-~-----------------------~~~~~~gt~~y~aPE~l~~~~~s~k~ 688 (799)
. . . + .....+||-.|+|||++.+...+.++
T Consensus 237 ~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAV 316 (459)
T KOG0610|consen 237 KSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAV 316 (459)
T ss_pred ccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchh
Confidence 0 0 0 0 00114589999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 038294 689 DVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRP 768 (799)
Q Consensus 689 DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 768 (799)
|-|+|||+|||||-|..||.+....+....+ +.+ +...+. ....+..+.++|++.|.+||.+|.
T Consensus 317 DWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI---v~~-----------~l~Fp~--~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 317 DWWTFGIFLYEMLYGTTPFKGSNNKETLRNI---VGQ-----------PLKFPE--EPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred hHHHHHHHHHHHHhCCCCcCCCCchhhHHHH---hcC-----------CCcCCC--CCcchhHHHHHHHHHhccChhhhh
Confidence 9999999999999999999987665432222 111 111111 124556788899999999999999
Q ss_pred C----HHHHHH--HHhcC----cCCCCCCC-CCce
Q 038294 769 T----MKVVLQ--MLEGL----LEVPNPPC-PSSF 792 (799)
Q Consensus 769 t----~~evl~--~L~~~----~~~~~p~~-p~~~ 792 (799)
- +.||-+ .++++ +....||. |...
T Consensus 381 g~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~ 415 (459)
T KOG0610|consen 381 GSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPV 415 (459)
T ss_pred ccccchHHhhcCccccCCChhheeccCCCcCCCcc
Confidence 8 777764 34543 34444443 5444
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=300.07 Aligned_cols=259 Identities=23% Similarity=0.266 Sum_probs=189.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecc------ccee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRL 579 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~ 579 (799)
...+.||+|+||.||+|.... +++.||||++.... ....+.+.+|++++++++|+||+++++++... ...+
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 18 QNLTPVGSGAYGSVCSAYDTR-LRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhheecccCCCeEEEEEEECC-CCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 345789999999999999864 57899999986532 22345678899999999999999999987533 3468
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+++|++ +++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.....
T Consensus 97 ~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 97 LVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred EEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 899987 7789887753 4688999999999999999999998 9999999999999999999999999999865332
Q ss_pred CCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCc
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGR 731 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~ 731 (799)
.....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+.... ...+....
T Consensus 172 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (343)
T cd07878 172 ----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247 (343)
T ss_pred ----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence 123357899999999876 568999999999999999999999986543211110000000 00000000
Q ss_pred eeEeec--CCCCCc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 732 LDVLVD--SDEPAM----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 732 ~~~~~d--~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...... +..+.. .-....+.+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 000000 000112346789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=291.06 Aligned_cols=246 Identities=27% Similarity=0.399 Sum_probs=192.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeec------ccceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE------ALNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~l 580 (799)
.+.+.||+|+||.||+|.... +++.+|+|.+.... ....++..|+.++.++ +|+||+++++++.. ....++
T Consensus 19 ~~~~~lg~g~~~~v~~~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 19 ELVEVVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hhheeeccCCCeEEEEEEEcC-CCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 345789999999999999874 67899999986532 3345788899999998 79999999999853 456789
Q ss_pred EEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 581 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
+|||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+|+||+|+||++++++.++|+|||++.....
T Consensus 97 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~ 173 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 173 (282)
T ss_pred EEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence 99999999999999754 3577888899999999999999998 899999999999999999999999999876532
Q ss_pred CCCcceeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
... ......+++.|+|||.+. ...++.++|||||||++|||++|+.||.......... .. ..
T Consensus 174 ~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-------~~-~~---- 240 (282)
T cd06636 174 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-------LI-PR---- 240 (282)
T ss_pred ccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-------hH-hh----
Confidence 211 122345788999999886 3467889999999999999999999986443211100 00 00
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+..........+.+++.+||+.||.+|||+.|+++
T Consensus 241 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 ----NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 01111112234467889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.94 Aligned_cols=245 Identities=24% Similarity=0.321 Sum_probs=192.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHh-cccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAI-GRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|.... +++.||+|.++... ......+..|..++ ...+|+|++++++++..++..++|+||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS-TGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecC-CCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence 468999999999999864 57899999986532 12223445555444 44589999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+++|.+++.....+++..+.+++.|++.||.|||+. +++|+||+|+||++++++.+||+|||+++.... ...
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 999999998877889999999999999999999998 899999999999999999999999999875432 122
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..++..|+|||.+.+..++.++||||||+++|||++|..||........ ......+... .+.....
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~------~~~~~~~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--------FDNILSRRIN------WPEEVKE 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhcccC------CCCcccc
Confidence 3478899999999888899999999999999999999999975433211 1111111111 0111111
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
.....+.+++.+||+.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 23457889999999999999998877666553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.42 Aligned_cols=263 Identities=21% Similarity=0.239 Sum_probs=195.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 582 (799)
+.+.+.||+|+||.||+|..+. +++.+++|.++.... .....+.+|+.++.+++||||+++++++... ...++|+
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKK-TGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECC-CCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 3446789999999999999874 578999999864322 2234677899999999999999999998777 7889999
Q ss_pred eecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
||+.+ +|.+++.... .+++....+++.||+.||+|||+. +++|+||||+||++++++.+||+|||++........
T Consensus 86 e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 86 EYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred hhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 99974 9988887643 589999999999999999999998 899999999999999999999999999987654321
Q ss_pred cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHH------
Q 038294 662 RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCY------ 727 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~------ 727 (799)
......+++.|+|||.+.+. .++.++|+||||+++|||++|+.||...........+.... +..+
T Consensus 162 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (293)
T cd07843 162 -PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA 240 (293)
T ss_pred -ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence 12223467889999998765 46899999999999999999999987543322111110000 0000
Q ss_pred hcCceeEeecCCCCCccCHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 728 AEGRLDVLVDSDEPAMADRS-RLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.................... ..+.+.+++..||+.+|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000000111111 3556788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.58 Aligned_cols=243 Identities=27% Similarity=0.338 Sum_probs=193.2
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|+||+||++..+. +++.+|+|.+.... ....+.+.+|++++++++||||+++++.+......++|+||+++++
T Consensus 1 lg~g~~g~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKA-TGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcC-CCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 6999999999998764 67899999986422 2234467789999999999999999999999999999999999999
Q ss_pred hhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 590 LANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 590 L~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
|.+++.... .+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++....... .....
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999997655 688999999999999999999998 99999999999999999999999999987654321 12223
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
.++..|+|||.+.+..++.++||||||+++++|++|+.||...........+ . ..... .+......
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~----~~~~~------~~~~~~~~ 220 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL----K----RRTLE------MAVEYPDK 220 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH----H----hcccc------ccccCCcc
Confidence 4678999999998888999999999999999999999998654332111111 0 00000 01111222
Q ss_pred HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 748 RLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
....+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 355778899999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=288.57 Aligned_cols=248 Identities=28% Similarity=0.401 Sum_probs=194.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeeccc------cee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL------NRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~------~~~ 579 (799)
+.+.+.||+|++|.||+|..+. +++.+++|.+..... ..+++.+|+.+++++ +|+||+++++++.... ..+
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKK-TGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eeheeeecCCCCeEEEEEEECC-CCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 3456889999999999999874 578999999865433 346789999999998 7999999999996644 478
Q ss_pred eEEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 580 LVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
+||||+++++|.+++... ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++..
T Consensus 86 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 999999999999988652 4688999999999999999999998 899999999999999999999999999876
Q ss_pred ccCCCCcceeeeccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
...... ......++..|+|||.+.. ..++.++||||||++|+||++|+.||....... . ..+ ...+
T Consensus 163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~----~~~-~~~~ 233 (275)
T cd06608 163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR---A----LFK-IPRN 233 (275)
T ss_pred cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH---H----HHH-hhcc
Confidence 543222 1222347889999998753 346789999999999999999999996432211 0 111 1111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. ..........+.+.+++.+||+.||++|||+.++++
T Consensus 234 ~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 PP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred CC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 10 011112234567889999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=286.80 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=198.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. ++..+|+|.+.... ....+.+.+|++++++++|+||+++++.+......++|+||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKS-DSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC 81 (257)
T ss_pred eEEEEecCCCcceEEEEEEcC-CCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecC
Confidence 345789999999999999875 57889999986432 234457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCCCc
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~ 662 (799)
++++|.+++.... .+++..+.+++.|+++||+|||+. +++|+||||+||++++++ .+||+|||.+........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~- 157 (257)
T cd08225 82 DGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME- 157 (257)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc-
Confidence 9999999987643 478999999999999999999998 899999999999999875 469999999987643222
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......|++.|+|||.+.+..++.++||||||++++||++|+.|+......+ ...... .+.. .+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~-~~~~----~~---- 221 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-------LVLKIC-QGYF----AP---- 221 (257)
T ss_pred cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHHHHh-cccC----CC----
Confidence 2223457889999999988889999999999999999999999987543211 111111 1111 11
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+|++.+|++|||+.||++.
T Consensus 222 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 222 -ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 111233568889999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-32 Score=290.20 Aligned_cols=244 Identities=26% Similarity=0.358 Sum_probs=197.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCCh
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
..||+|+||.||++..+. +++.||+|++........+.+.+|+.+++.++|+|++++++++...+..+++|||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcC-CCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 579999999999999874 6889999998655555566799999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccC
Q 038294 591 ANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670 (799)
Q Consensus 591 ~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 670 (799)
.+++.. ..+++.....++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ......++
T Consensus 105 ~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 105 TDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 998754 4578999999999999999999998 899999999999999999999999999876543221 12234578
Q ss_pred CcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHH
Q 038294 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQ 750 (799)
Q Consensus 671 ~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 750 (799)
+.|+|||.+.+..++.++|+||||+++|||++|..|+......+... ....+. ...... ......
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~--------~~~~~~-----~~~~~~--~~~~~~ 244 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK--------MIRDNL-----PPKLKN--LHKVSP 244 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--------HHHhhC-----CcccCC--cccCCH
Confidence 89999999988889999999999999999999999987543322111 111100 000100 112234
Q ss_pred HHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 751 KWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 751 ~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+.+++.+||+.+|.+||++.++++
T Consensus 245 ~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 245 SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 5778999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.61 Aligned_cols=246 Identities=26% Similarity=0.268 Sum_probs=200.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRD-TKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred eEEEEeccCCCceEEEEEEcc-CCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 356789999999999999864 57899999986432 23457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+.+++|.+++.....+++.....++.||++||.|||+. +++|+||+|+||++++++.++|+|||++....... ..
T Consensus 82 ~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 156 (258)
T cd05578 82 LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LT 156 (258)
T ss_pred CCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--cc
Confidence 99999999998777889999999999999999999998 89999999999999999999999999988764332 22
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
....++..|+|||.+.+..++.++|+||||+++|+|++|+.|+......... ......... ....
T Consensus 157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----~~~~~~~~~----------~~~~ 221 (258)
T cd05578 157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-----QIRAKQETA----------DVLY 221 (258)
T ss_pred cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-----HHHHHhccc----------cccC
Confidence 2345788999999999888999999999999999999999998865432111 111111100 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTM--KVVL 774 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~--~evl 774 (799)
+......+.+++.+||+.+|.+||++ +|++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12233678889999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=289.06 Aligned_cols=243 Identities=23% Similarity=0.251 Sum_probs=188.4
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHh---cccccccccceeeeeecccceeeEEeec
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAI---GRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.||+|+||.||++.... +++.+|+|.+.... ......+.+|..++ ...+|+|++++.+.+...+..++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECC-CCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecC
Confidence 48999999999999864 67899999885422 11223344444433 3347999999999999989999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++.....++.|++.||+|||+. +|+|+||||+|||+++++.++|+|||++....... ..
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 9999999998878899999999999999999999998 89999999999999999999999999987553221 12
Q ss_pred eeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...|+..|+|||.+. +..++.++|||||||++|||++|..||......... .+ ...... ... ..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~----~~~~~~------~~~----~~ 218 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI----DRMTLT------VNV----EL 218 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HH----HHHhhc------CCc----CC
Confidence 235889999999986 456899999999999999999999999754221110 11 110000 011 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 776 (799)
+......+.+++.+||+.||++|| +++|+++.
T Consensus 219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 223345778899999999999999 69999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=314.70 Aligned_cols=199 Identities=20% Similarity=0.329 Sum_probs=158.5
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcc-----------------ccchhhHHHHHHHHHHhcccccccccc
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLD-----------------RLAQEREREFKSEVSAIGRTHHKNLVQ 567 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~-----------------~~~~~~~~~~~~E~~~l~~l~h~niv~ 567 (799)
..+.+.++||+|+||+||++.++...++..+.|.+. .........+.+|+.++++++|+||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 345667899999999999998765443333333110 011223456889999999999999999
Q ss_pred eeeeeecccceeeEEeecCCCChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 038294 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 568 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~ 642 (799)
+++++...+..++|+|++. ++|.+++... .........+|+.||+.||+|||+. +|+||||||+|||++.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCC
Confidence 9999999999999999985 4677766532 1233556778999999999999998 99999999999999999
Q ss_pred CceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCC
Q 038294 643 FSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSV 707 (799)
Q Consensus 643 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~ 707 (799)
+.+||+|||+++.+............||+.|+|||++.+..++.++|||||||+||||++|..++
T Consensus 304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999876544333333456899999999999999999999999999999999987543
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=292.08 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=191.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|++|.||+|..+. +++.||+|.+..... .....+.+|++++++++|+||+++++++.+....++||||++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKL-TGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcC-CCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 345789999999999999864 578999999864322 223457789999999999999999999999999999999998
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+ +|.+++... ..+++.....++.|+++||.|||+. +|+|+||||+||+++.++.+||+|||+++....... ...
T Consensus 87 ~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~ 161 (291)
T cd07844 87 T-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-TYS 161 (291)
T ss_pred C-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-ccc
Confidence 5 899888754 4678899999999999999999998 899999999999999999999999999875432211 112
Q ss_pred eeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC------------ce
Q 038294 666 MIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG------------RL 732 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------------~~ 732 (799)
...++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......... + .......... ..
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--L-HKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--H-HHHHHhcCCCChhhhhhhhhcccc
Confidence 2235788999999875 45889999999999999999999998644311100 0 0000000000 00
Q ss_pred eEeecCCCC-C-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 DVLVDSDEP-A-----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 ~~~~d~~~~-~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......... . .........+.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000000000 0 000111256678999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-32 Score=294.26 Aligned_cols=261 Identities=20% Similarity=0.271 Sum_probs=192.7
Q ss_pred hhcCcc--ccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 511 EELGRG--SFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G--~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
++||+| +||+||++.... +++.||+|++... ..+..+.+.+|+.+++.++||||+++++++..+...++|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP-TGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcC-CCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 567777 899999998864 6899999998642 23344678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc-
Q 038294 587 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT- 663 (799)
Q Consensus 587 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~- 663 (799)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998764 3578888999999999999999987 89999999999999999999999998654332211110
Q ss_pred -----eeeeccCCcccccccccCC--CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH-------------HH
Q 038294 664 -----HTMIRGTRGYVAPEWFKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD-------------WA 723 (799)
Q Consensus 664 -----~~~~~gt~~y~aPE~l~~~--~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~-------------~~ 723 (799)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||.............. ..
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE 239 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence 0011245679999999764 478999999999999999999999975432211000000 00
Q ss_pred HH-------HHhcCc---------eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 724 YD-------CYAEGR---------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 724 ~~-------~~~~~~---------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. ....+. .....+..............+.+++.+||+.||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00 000000 00111111112223345678899999999999999999999974
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=289.74 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=189.1
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHH-hcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSA-IGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||++..+. +++.||+|+++... .....++..|+.. ++..+||||+++++++..+...++++||+
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVP-TGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred eEEEEecccCCeEEEEEEEcC-CCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 345789999999999999874 68999999986532 2334455566665 55678999999999999999999999999
Q ss_pred CCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+ ++|.+++.. ...+++..+.+++.||+.||+|||+++ +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 158 (283)
T cd06617 83 D-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV- 158 (283)
T ss_pred c-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeeccccccccccc-
Confidence 7 688877754 246789999999999999999999852 79999999999999999999999999998653322
Q ss_pred cceeeeccCCcccccccccC----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 662 RTHTMIRGTRGYVAPEWFKN----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.|+....... . . ...... +.
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~---~-~~~~~~-~~------ 224 (283)
T cd06617 159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--Q---Q-LKQVVE-EP------ 224 (283)
T ss_pred -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--H---H-HHHHHh-cC------
Confidence 1122357889999998865 456889999999999999999999986422110 0 0 111111 10
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+........+.+.+++.+||+.+|++||++.+|++
T Consensus 225 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 --SPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111123467888999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=281.27 Aligned_cols=248 Identities=29% Similarity=0.410 Sum_probs=202.9
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e~ 584 (799)
..+.||+|++|.||+|..+. +++.|++|++..... ...+.+.+|+..+++++|+||+++++.+... ...++++||
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKD-TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeEeeecCceEEEEEEECC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 34679999999999999874 678999999865432 4467889999999999999999999999888 788999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc-c
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-T 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~-~ 663 (799)
+++++|.+++.....+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.+......... .
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 83 VSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999998877899999999999999999999997 8999999999999999999999999999877544321 1
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....++..|+|||.+.....+.++||||||+++++|++|+.|+....... ...... .. ......
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~-~~--------~~~~~~ 224 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM------AALYKI-GS--------SGEPPE 224 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHhc-cc--------cCCCcC
Confidence 223457889999999998889999999999999999999999987544111 111111 00 001111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+......+.+++.+|++.+|++||++.++++
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 12223567888999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=297.76 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=193.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc------cce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 578 (799)
+...+.||+|+||.||++.... +++.||+|.+... ......++.+|+.++++++|+||+++++++... ...
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 96 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTV-TGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDV 96 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECC-CCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcE
Confidence 3345789999999999999875 6789999998642 233345678899999999999999999988543 346
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++|+||+. ++|.+.+... ++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 97 YLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred EEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 89999996 4888877643 78888999999999999999998 999999999999999999999999999987543
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHH--------HH-------H
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT--------DW-------A 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~--------~~-------~ 723 (799)
... .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+. .+ .
T Consensus 171 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (353)
T cd07850 171 SFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248 (353)
T ss_pred CCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence 221 222347889999999999999999999999999999999999987543211100000 00 0
Q ss_pred HHHHhcCc------eeEeec----CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEGR------LDVLVD----SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~~------~~~~~d----~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........ ...+.. +.............+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 000000 000011122345667899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=288.10 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=190.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|+||.||+|..+. +++.|++|++..... .....+.+|+.+++.++|+||+++.+++..+...++|+||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRI-NGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcC-CCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 345789999999999999874 578999999864332 223467889999999999999999999999989999999996
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++|.+.+... ..+.+..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++........ ..
T Consensus 87 -~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~ 161 (291)
T cd07870 87 -TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQT-YS 161 (291)
T ss_pred -CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCC-CC
Confidence 6776666543 4577888889999999999999998 8999999999999999999999999998764322211 12
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh-------------cCc
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA-------------EGR 731 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------------~~~ 731 (799)
...++..|+|||.+.+. .++.++||||||+++|||++|+.||........ .+... ..... ...
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE--QLEKI-WTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH--HHHHH-HHHcCCCChhhhhhhhhcccc
Confidence 23468899999998764 578899999999999999999999975432110 00000 00000 000
Q ss_pred eeEeecCCCCCc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 LDVLVDSDEPAM-----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ~~~~~d~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+.. ........+.+++.+|++.||++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000 00112346678999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=287.78 Aligned_cols=260 Identities=23% Similarity=0.262 Sum_probs=191.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccc-cccccceeeeeecc--cceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEA--LNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~--~~~~lv~e~ 584 (799)
+.++||+|+||.||+|..+. +++.+|+|+++... .........|+.++.++. |+|++++++++.+. ...++|+||
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 81 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRK-TGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81 (282)
T ss_pred eEeeccccccceEEEEEEcC-CCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEec
Confidence 45789999999999999874 67899999986532 222334557888888885 99999999999877 788999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++ ++|.+.+... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++. +.+||+|||+++........
T Consensus 82 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 82 MD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred CC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence 97 5787777653 5689999999999999999999998 8999999999999999 99999999999876433221
Q ss_pred eeeeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHHhcCceeEe
Q 038294 664 HTMIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCYAEGRLDVL 735 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 735 (799)
....++..|+|||.+. +..++.++|||||||++|||++|..||......+........ ..+..........
T Consensus 156 -~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07831 156 -TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234 (282)
T ss_pred -CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccc
Confidence 2234688999999764 456788999999999999999999999754332211111000 0011111110000
Q ss_pred ecCCCC----CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 736 VDSDEP----AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 736 ~d~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+... ..........+.+++.+||+.+|++||+++++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 235 NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000 00012345788999999999999999999999863
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-32 Score=281.06 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=201.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|++|.||++..+. +++.+++|.+..... ...+.+.+|++++.+++|+|++++++++.+....++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLE-TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYA 81 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcC-CCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecC
Confidence 346789999999999998864 578899999876443 34568999999999999999999999999989999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.|++.||.|||+. +|+|+||+|+||+++.++.++|+|||++......... ..
T Consensus 82 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~ 157 (254)
T cd06627 82 ENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-DA 157 (254)
T ss_pred CCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc-cc
Confidence 9999999998878899999999999999999999998 9999999999999999999999999999876543321 22
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...++..|+|||.+.+..++.++||||+|+++++|++|+.|+........ .... ..... ... +
T Consensus 158 ~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-------~~~~-~~~~~-----~~~----~ 220 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-------LFRI-VQDDH-----PPL----P 220 (254)
T ss_pred ccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-------HHHH-hccCC-----CCC----C
Confidence 34578899999999888889999999999999999999999874432110 1111 11100 111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+.+..++.+||+.+|++|||+.+++.
T Consensus 221 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 221 EGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 122457778999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=282.01 Aligned_cols=245 Identities=27% Similarity=0.333 Sum_probs=200.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||++..+. +++.+++|.+.... .....++.+|++++++++|+||+++++++.+....++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLS-DNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYA 81 (256)
T ss_pred eEeeeecCCCceeEEEEEECC-CCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhc
Confidence 345789999999999998764 67899999986432 333457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
++++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.+||+|||++......
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 82 PFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 99999999876 35678999999999999999999998 9999999999999999999999999999876543
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......++..|+|||.+.+..++.++|+||||++++||++|+.|+......+. ...+..+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~--------~~~~~~~~~--------- 218 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL--------RYKVQRGKY--------- 218 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHhcCCC---------
Confidence 12223478899999999999999999999999999999999999875433221 111112111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..........+.+++.+|++.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 11122455678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=287.88 Aligned_cols=250 Identities=27% Similarity=0.402 Sum_probs=191.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.||+|+||.||++.... +++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...++++||+.
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKP-SGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHHhCCCCceEEEEEEECC-CCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 35689999999999999874 67899999986432 234567889999999996 9999999999998889999999986
Q ss_pred CCChhhhh---h--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 587 NGTLANLI---F--AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 587 ~gsL~~~l---~--~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
. +|.++. . ....+++....+++.|++.||+|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 I-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred C-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4 554433 2 235688999999999999999999974 2799999999999999999999999999976543221
Q ss_pred cceeeeccCCcccccccccCC---CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNA---PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~---~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
. ....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... .. ....+.. .+. .+
T Consensus 164 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~-~~~~~~~-~~~-----~~ 229 (288)
T cd06616 164 K--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VF-DQLTQVV-KGD-----PP 229 (288)
T ss_pred c--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HH-HHHhhhc-CCC-----CC
Confidence 1 223478899999999776 689999999999999999999999864321 00 1111111 111 01
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.............+.+++.+||+.+|++|||+.+|++.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111122355678899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=288.78 Aligned_cols=258 Identities=18% Similarity=0.194 Sum_probs=183.4
Q ss_pred hhchhhhcCccccceEEEEEEeCCC--CeEEEEEEccccchhh--H---------HHHHHHHHHhcccccccccceeeee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLAQER--E---------REFKSEVSAIGRTHHKNLVQLLGFC 572 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~~~~--~---------~~~~~E~~~l~~l~h~niv~l~g~~ 572 (799)
.+.+.+.||+|+||.||+|...... +..+++|+........ + .....+...+..++|+|++++++++
T Consensus 13 ~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 92 (294)
T PHA02882 13 EWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCG 92 (294)
T ss_pred ceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEee
Confidence 4556788999999999999986421 3456666543211111 0 1123344556677899999999977
Q ss_pred eccc----ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 573 DEAL----NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 573 ~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
.... ..++++|++. .++.+.+......++..+..|+.|++.||+|||+. +|+||||||+|||++.++.++|+
T Consensus 93 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~l~ 168 (294)
T PHA02882 93 SFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYII 168 (294)
T ss_pred eEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEEEE
Confidence 5443 2356777664 36666666555567888899999999999999998 89999999999999999999999
Q ss_pred cccCcccccCCCC------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHH
Q 038294 649 DFGLSKLLLSDQS------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTD 721 (799)
Q Consensus 649 DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~ 721 (799)
|||+++....... .......||+.|+|||.+.+..++.++|||||||+|+||++|+.||......... .....
T Consensus 169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~ 248 (294)
T PHA02882 169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKC 248 (294)
T ss_pred EcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHH
Confidence 9999987643211 1112245899999999999999999999999999999999999999865322211 00000
Q ss_pred HHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 722 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
-....+..+++. .+ .....+.+++..|++.+|++||++.++++.|+
T Consensus 249 ~~~~~~~~~~~~------~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 249 DFIKRLHEGKIK------IK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhhhhhhc------cC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 011112222110 01 11356778999999999999999999998873
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=287.99 Aligned_cols=255 Identities=22% Similarity=0.269 Sum_probs=199.7
Q ss_pred chhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc----hhhHHHHHHHHHHhccc-ccccccceeeeeecccceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.||+|++|.||+++... .+++.+|||.++... ....+.+.+|++++.++ +|+||+++++.+..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 345789999999999998642 256789999986432 22335688999999999 69999999999999889999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||+++++|.+++.....+++.....++.|+++||.|||+. +++|+||+|+||+++.++.++|+|||+++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 83 ILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999998777788999999999999999999997 99999999999999999999999999988764433
Q ss_pred CcceeeeccCCcccccccccCCC--CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~--~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
........++..|+|||.+.+.. .+.++||||||+++|||++|..|+........ ........... ..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~-------~~ 229 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRILKS-------KP 229 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHHcc-------CC
Confidence 22223345788999999987665 78899999999999999999999864321110 11111111111 01
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
..+ ......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 230 ~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 PFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred CCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111 1123456789999999999999999999888765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=281.44 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=195.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-----chhhHHHHHHHHHHhcccccccccceeeeeecc--cceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~l 580 (799)
.+.+.||+|+||.||+|.... +++.+++|.+... ..+..+.+.+|++++++++|+||+++++++.+. ...++
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDAD-TGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcC-CCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 456789999999999999864 6789999987421 223446788999999999999999999998654 45779
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
++||+++++|.+++.....+++....+++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 999999999999998777788999999999999999999998 89999999999999999999999999998653211
Q ss_pred --CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 --SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 --~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
........++..|+|||.+.+..++.++|+||||++++||++|+.||....... . ..+....
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~~~~~~~--------- 224 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA------A-IFKIATQ--------- 224 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH------H-HHHHHcC---------
Confidence 111123457889999999998889999999999999999999999987432211 0 1111111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+....+.+.+++.+|++ +|..||+..+++.
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11112233445678889999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-32 Score=289.66 Aligned_cols=257 Identities=26% Similarity=0.338 Sum_probs=191.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|++|.||+|..+. +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|+||+
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRV-TNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred EEEEEecCCCCEEEEEEEecC-CCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 345789999999999999874 67899999986432 233467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCCc
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~ 662 (799)
+ ++|.+++.... ..++.....++.||+.||+|||+. +++|+||+|+||+++. ++.+||+|||++....... .
T Consensus 84 ~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~-~ 158 (294)
T PLN00009 84 D-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV-R 158 (294)
T ss_pred c-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc-c
Confidence 6 57887776543 347788889999999999999998 8999999999999985 5679999999997653321 1
Q ss_pred ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee-----
Q 038294 663 THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV----- 736 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 736 (799)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+..... . ....... ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~---~-~~~~~~~-~~~~~~~~~ 233 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI---F-RILGTPN-EETWPGVTS 233 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-HHhCCCC-hhhcccccc
Confidence 1122346789999998866 45789999999999999999999999754332211110 0 0000000 0000
Q ss_pred --c-----CCCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 --D-----SDEPA----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 --d-----~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+ +.... .......+.+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00000 011223456788999999999999999999986
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=292.67 Aligned_cols=264 Identities=25% Similarity=0.307 Sum_probs=194.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhccc-ccccccceeeeeecc--cceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA--LNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~--~~~~lv 581 (799)
+.+.+.||+|+||.||+|.... +++.+|+|++... .......+..|+.+++++ +|+||+++++++... ...++|
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv 87 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRR-TKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLV 87 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcC-CCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEE
Confidence 4456889999999999999864 5789999988542 223345677899999999 999999999998643 357899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||++........
T Consensus 88 ~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 88 FEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred ecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99997 5999888765 778999999999999999999997 999999999999999999999999999987644322
Q ss_pred ----cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-----------HH
Q 038294 662 ----RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-----------YD 725 (799)
Q Consensus 662 ----~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-----------~~ 725 (799)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||................ ..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS 242 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence 12223457889999998765 457889999999999999999999986443221110000000 00
Q ss_pred HHhcCceeEeecCCC--CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 726 CYAEGRLDVLVDSDE--PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 726 ~~~~~~~~~~~d~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+........ ...........+.+++.+||+.+|++|||+.++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000000000 000111134678899999999999999999999965
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-32 Score=293.09 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=193.6
Q ss_pred chhhhcCccccceEEEEEEeCC-CCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~-~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 581 (799)
.+.+.||+|+||.||+|..+.. .++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 3457899999999999998753 57899999997632 33346778899999999999999999999887 778999
Q ss_pred EeecCCCChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----CCceEEccccC
Q 038294 582 YEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN----YFSAKISDFGL 652 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~----~~~~kl~DfGl 652 (799)
|||+++ +|.+++... ..++......++.||+.||+|||+. +|+||||||+||+++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 666665422 2578888999999999999999998 8999999999999999 99999999999
Q ss_pred cccccCCCC--cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc------hhHHHHH
Q 038294 653 SKLLLSDQS--RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR------AILTDWA 723 (799)
Q Consensus 653 a~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~------~~~~~~~ 723 (799)
+........ .......+++.|+|||.+.+. .++.++||||||++++||++|+.||......... ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 987643322 112234578899999988764 5789999999999999999999998755432210 0000000
Q ss_pred HHH----------H-hcCceeE----eecCCCCCc-----cCH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 724 YDC----------Y-AEGRLDV----LVDSDEPAM-----ADR--SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 724 ~~~----------~-~~~~~~~----~~d~~~~~~-----~~~--~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+ . ....... ......+.. ... .....+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 0 0000000 000000000 000 23456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-32 Score=289.46 Aligned_cols=264 Identities=24% Similarity=0.280 Sum_probs=193.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeeccc-------
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------- 576 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------- 576 (799)
.+.+.+.||+|+||.||+|..+. +++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 8 ~~~~~~~lg~g~~g~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~ 86 (302)
T cd07864 8 KFDIIGQIGEGTYGQVYKARDKD-TGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKK 86 (302)
T ss_pred hhheeeeecccCCEEEEEEEECC-CCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccc
Confidence 34456789999999999999975 57899999986532 223356788999999999999999999987654
Q ss_pred ---ceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccC
Q 038294 577 ---NRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652 (799)
Q Consensus 577 ---~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGl 652 (799)
..++|+||+++ +|.+.+... ..+++..+..++.||+.||+|||+. +|+|+||||+||++++++.+||+|||+
T Consensus 87 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 87 DKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred cCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccc
Confidence 68899999986 676666653 4689999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR 731 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (799)
+...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+....+........ ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC-PAV 241 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-hhh
Confidence 98765433222222345778999998865 3578999999999999999999999875433221111111000000 000
Q ss_pred eeEe--------ecCCCC--C---ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 LDVL--------VDSDEP--A---MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ~~~~--------~d~~~~--~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+ .+.... . .........+.+++.+||+.+|++||+++++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 000000 0 000012356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=287.35 Aligned_cols=259 Identities=23% Similarity=0.318 Sum_probs=195.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+.+.||+|++|.||+|+.+. +++.||+|+++.... .....+.+|+.++++++|+||+++++++......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRT-TGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD 81 (284)
T ss_pred eEeeeeccCCceEEEEEEECC-CCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC
Confidence 345789999999999999874 678999999865432 234567889999999999999999999999999999999998
Q ss_pred CCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+ +|.+++... ..+++..+.+++.|++.||+|||+. +++|+||||+||++++++.+||+|||++........ .
T Consensus 82 ~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 156 (284)
T cd07836 82 K-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T 156 (284)
T ss_pred c-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence 5 888887653 3578999999999999999999988 899999999999999999999999999976533221 1
Q ss_pred eeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCceeEe
Q 038294 664 HTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGRLDVL 735 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~ 735 (799)
.....++..|++||.+.+. .++.++||||||+++|||++|+.||......+......... ++.+.. ...
T Consensus 157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~- 233 (284)
T cd07836 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ--LPE- 233 (284)
T ss_pred cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc--Cch-
Confidence 1223467889999988654 56889999999999999999999987654332211111100 000000 000
Q ss_pred ecCCCCCc-------cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAM-------ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.. ........+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000100 01122456778999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=272.06 Aligned_cols=282 Identities=23% Similarity=0.297 Sum_probs=200.3
Q ss_pred chhhhcCccccceEEEEEEeCCCC---eEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeec-ccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv 581 (799)
.....||+|.||.|||+.-++..+ +.+|+|+++.... .......+|+.+++.++||||+.|..++.+ +...+++
T Consensus 27 e~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~ 106 (438)
T KOG0666|consen 27 EGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLL 106 (438)
T ss_pred hccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEE
Confidence 345679999999999997654332 3789999976422 223456789999999999999999999977 6778999
Q ss_pred EeecCCCChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CceEEccccC
Q 038294 582 YEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY----FSAKISDFGL 652 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~----~~~kl~DfGl 652 (799)
+||.+. +|.++|+-. +.++-.....|..||+.|+.|||++ -|+||||||.||||..+ |.+||+|+|+
T Consensus 107 fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 107 FDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred ehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccH
Confidence 999987 888888632 3567778889999999999999998 89999999999999877 9999999999
Q ss_pred cccccCCCCc--ceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcch--hHHHHHHHHH
Q 038294 653 SKLLLSDQSR--THTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA--ILTDWAYDCY 727 (799)
Q Consensus 653 a~~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~--~~~~~~~~~~ 727 (799)
++++.+.-.. ....++.|..|+|||.+.+. .|+.+.||||.||++.||++.+..|....+..... .-.+.+...+
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 9998765332 23456679999999999876 58999999999999999999888776543221110 0001011100
Q ss_pred h-cCc-----eeEeec-CCC-------C-Ccc-C----------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 728 A-EGR-----LDVLVD-SDE-------P-AMA-D----------RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 728 ~-~~~-----~~~~~d-~~~-------~-~~~-~----------~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+ -|. ...+.. +.. + ... + .......++++..+|+.||.+|.|+++.++.. -..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~-yF~ 341 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP-YFT 341 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc-ccc
Confidence 0 000 000000 000 0 000 0 00112257889999999999999999876542 345
Q ss_pred CCCCCCCCCceee
Q 038294 782 EVPNPPCPSSFSI 794 (799)
Q Consensus 782 ~~~~p~~p~~~~~ 794 (799)
+.+.||.|..--+
T Consensus 342 ~d~lpp~pt~~~v 354 (438)
T KOG0666|consen 342 EDPLPPLPTSDNV 354 (438)
T ss_pred cCCCCCCccccee
Confidence 6677777755433
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.2e-33 Score=285.15 Aligned_cols=241 Identities=27% Similarity=0.309 Sum_probs=198.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
-++||+|+||.|+-+..+. +|+.+|.|++.+.. .+.+.-.++|-.+|.+++.+.||.+-..++..+.+++|+..|.
T Consensus 190 ~RvlGkGGFGEV~acqvra-TGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMN 268 (591)
T KOG0986|consen 190 YRVLGKGGFGEVCACQVRA-TGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMN 268 (591)
T ss_pred eEEEecccccceeEEEEec-chhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeec
Confidence 3689999999999998875 79999999985422 2344567899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
||+|.-+|.+.. .+++..++-++.+|+.||++||.+ +|+.|||||+|||||+.|+++|+|.|+|..+...+. .
T Consensus 269 GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~--~ 343 (591)
T KOG0986|consen 269 GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP--I 343 (591)
T ss_pred CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCc--c
Confidence 999999998764 788999999999999999999998 999999999999999999999999999998765543 3
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+||.+|||||++.++.|+...|-||+||+||||+-|+.||....+...... +.+.+.+ .+...
T Consensus 344 ~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE----vdrr~~~----------~~~ey 409 (591)
T KOG0986|consen 344 RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE----VDRRTLE----------DPEEY 409 (591)
T ss_pred ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH----HHHHHhc----------chhhc
Confidence 334799999999999999999999999999999999999999976543221111 1111111 12223
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
+...++++..+....|+.||++|.--
T Consensus 410 ~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 410 SDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred ccccCHHHHHHHHHHHccCHHHhccC
Confidence 45556677778888999999999643
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=279.46 Aligned_cols=246 Identities=28% Similarity=0.412 Sum_probs=201.3
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.||+|+||.||++.... +++.+++|++..... ...+++.+|++++++++|+|++++++.+......++++||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 4 IIKQIGKGSFGKVYLVRRKS-DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred EEeeeccCCCeEEEEEEEcC-CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 45789999999999999864 578999999865432 455678999999999999999999999999899999999999
Q ss_pred CCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 587 NGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 587 ~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++|.+++... ..+++..+..++.+++.||+|||+. +++|+||+|+||++++++.++|+|||++....... .
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 158 (258)
T cd08215 83 GGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D 158 (258)
T ss_pred CCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence 99999999764 6788999999999999999999998 99999999999999999999999999998764433 1
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......+++.|+|||.+.+..++.++||||+|+++++|++|+.|+......+ .... ....... ..+
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-------~~~~-~~~~~~~-----~~~- 224 (258)
T cd08215 159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE-------LALK-ILKGQYP-----PIP- 224 (258)
T ss_pred eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH-------HHHH-HhcCCCC-----CCC-
Confidence 2223457889999999999899999999999999999999999986543221 1111 1111111 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+.+++.+||+.+|++|||+.|+++.
T Consensus 225 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 ---SQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ---CCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1234567889999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=288.65 Aligned_cols=258 Identities=23% Similarity=0.256 Sum_probs=190.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhccc-ccccccceeeeeecccc-----ee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN-----RL 579 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~-----~~ 579 (799)
...+.||+|+||.||+|.... +++.||+|+++.... .....+.+|+.+++++ +|+||+++++++..... .+
T Consensus 4 ~~~~~lg~g~~g~vy~~~~~~-~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 4 EKLEKIGEGTYGKVYKARDKN-TGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred eEeeEecccCCeEEEEEEECC-CCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 345789999999999999874 678999998764322 2335788899999999 46999999999876655 78
Q ss_pred eEEeecCCCChhhhhhcC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCc
Q 038294 580 LVYEFMGNGTLANLIFAI-----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLS 653 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla 653 (799)
+||||+++ +|.+++... ..+++..+..++.||++||+|||+. +|+||||+|+||+++. ++.+||+|||++
T Consensus 83 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred EEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccc
Confidence 99999986 788887643 3468999999999999999999998 9999999999999998 899999999998
Q ss_pred ccccCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 654 KLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 654 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
+........ .....+++.|+|||++.+ ..++.++||||||+++|||++|..||......+....+ . ........
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~---~-~~~~~~~~ 233 (295)
T cd07837 159 RAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI---F-KLLGTPTE 233 (295)
T ss_pred eecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H-HHhCCCCh
Confidence 865332211 112245788999998865 45789999999999999999999998754332211111 0 00000000
Q ss_pred eE---e--------e---cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 DV---L--------V---DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 ~~---~--------~---d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. . . .+.............+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00 0 0 000000001123456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=283.13 Aligned_cols=243 Identities=22% Similarity=0.255 Sum_probs=188.6
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHH---HhcccccccccceeeeeecccceeeEEeec
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVS---AIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.||+|+||.||++.... +++.||+|.+.... ......+..|.. .++..+||||+++++++.+....++|+||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEec-CCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecC
Confidence 48999999999998764 57899999886422 122223444443 344457999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---~ 153 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---H 153 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---c
Confidence 9999999998777899999999999999999999997 899999999999999999999999999876533221 2
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.......... ....... .....+
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~~~------~~~~~~--- 219 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----IDRMTLT------MAVELP--- 219 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH-----HHHHhhc------cCCCCC---
Confidence 23588999999998754 68999999999999999999999997542211100 0111110 011111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQM 776 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~ 776 (799)
......+.+++.+|++.+|++|| ++.++++.
T Consensus 220 -~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 220 -DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12245788899999999999999 99999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=283.33 Aligned_cols=261 Identities=27% Similarity=0.362 Sum_probs=195.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.||+|++|+||+|+... +++.|++|++..... .......+|+..+.+++ |+|++++++++..+...++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKE-TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eheeeccCCceEEEEEEECC-CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 56789999999999999864 578999999865322 22334567899999998 999999999999999999999999
Q ss_pred CCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+|+|.+++.... .+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||++........ .
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 155 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--Y 155 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--c
Confidence 889999887654 789999999999999999999998 899999999999999999999999999986543221 1
Q ss_pred eeeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHH---------HHHHHHHhcCceeE
Q 038294 665 TMIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT---------DWAYDCYAEGRLDV 734 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~ 734 (799)
....++..|+|||.+. ...++.++|+||||++++||++|+.||......+...... .|............
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07830 156 TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGF 235 (283)
T ss_pred CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccc
Confidence 2234788999999885 4567899999999999999999999886543222110000 01100000111111
Q ss_pred eecCCCCCc---cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 735 LVDSDEPAM---ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 735 ~~d~~~~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+....... ........+.+++.+||+.+|++|||++|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 236 RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 111111000 001114578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=285.80 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=192.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
..+.||+|+||.||+|..+. +++.+++|.+... .....+++.+|+++++.++|+|++++++++......++|+||+
T Consensus 19 ~~~~lg~g~~g~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 97 (308)
T cd06634 19 DLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC 97 (308)
T ss_pred HHHheeeCCCEEEEEEEEcC-CCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEcc
Confidence 35679999999999999875 5788999988532 2233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
. |+|.+.+.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 98 ~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~----- 168 (308)
T cd06634 98 L-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168 (308)
T ss_pred C-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc-----
Confidence 6 578777654 34678899999999999999999998 8999999999999999999999999998765322
Q ss_pred eeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 665 TMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
....+++.|+|||.+. ...++.++|||||||++|||++|+.|+......+. ... +..+.. +
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~-~~~~~~--------~ 232 (308)
T cd06634 169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYH-IAQNES--------P 232 (308)
T ss_pred ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-------HHH-HhhcCC--------C
Confidence 2234788999999974 35678899999999999999999999864322111 111 111111 1
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
..........+.+++.+||+.+|++||++.++++..
T Consensus 233 ~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 233 ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 111223445678899999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=285.34 Aligned_cols=250 Identities=24% Similarity=0.267 Sum_probs=195.6
Q ss_pred hhhhcCccccceEEEEEEeC--CCCeEEEEEEccccch----hhHHHHHHHHHHhccc-ccccccceeeeeecccceeeE
Q 038294 509 FKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLAQ----EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.||+|+||.||++.... .+++.||+|++..... ...+.+.+|++++.++ +|+||+++.+++..+...++|
T Consensus 4 ~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (290)
T cd05613 4 LLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLI 83 (290)
T ss_pred eeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEE
Confidence 45789999999999998742 3578999999865322 2345788899999999 699999999999988889999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+||+++++|.+++.....+++.....++.|++.||.|||+. +++||||+|+|||+++++.+||+|||++........
T Consensus 84 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 84 LDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999998877888999999999999999999997 999999999999999999999999999987644332
Q ss_pred cceeeeccCCcccccccccCC--CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~--~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.......++..|+|||.+... .++.++||||||+++|||++|+.|+.......... .......... +.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~~~~~~~~~~-------~~ 230 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSE-------PP 230 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHH---HHHHHhhccC-------CC
Confidence 223334578899999998753 46789999999999999999999986432211111 1111111110 01
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
. +......+.+++.+|++.+|++|| ++.+++.
T Consensus 231 ~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 Y----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred C----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1 122345677899999999999997 6677665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=287.43 Aligned_cols=263 Identities=25% Similarity=0.296 Sum_probs=192.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~e 583 (799)
.+.+.||+|+||.||+|..+. +++.||+|+++.... .....+.+|+.++++++|+||+++++++.+. ...++|+|
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTT-SGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eEeeeeeecCCEEEEEEEECC-CCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 455789999999999999874 688999999864322 2233567899999999999999999998655 45789999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+.+ +|.+++... ..+++..+..++.||++||+|||+. +++|+||||+||++++++.+||+|||++....... .
T Consensus 89 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~-~ 163 (309)
T cd07845 89 YCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-K 163 (309)
T ss_pred cCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc-C
Confidence 9975 888887753 5689999999999999999999998 89999999999999999999999999998764332 1
Q ss_pred ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH-------HHHhcCce-e
Q 038294 663 THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY-------DCYAEGRL-D 733 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~ 733 (799)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ..+..... .
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence 2222335778999999865 4678999999999999999999999975543322111111000 00000000 0
Q ss_pred E--eecCCCCCc--cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 734 V--LVDSDEPAM--ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 734 ~--~~d~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
. ......... ......+.+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred cccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 000000000 001124566789999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-32 Score=285.66 Aligned_cols=257 Identities=25% Similarity=0.314 Sum_probs=197.7
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
..+.||+|++|.||++.... +++.+++|+++.... .....+..|++++++++|+||+++++++..+...++|+||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKL-TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCC-CCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 35679999999999999864 678999999865322 245678899999999999999999999999999999999997
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+ +|.+++... ..+++..+..++.|++.||.|||+. +|+|+||+|+||++++++.+||+|||.+....... ....
T Consensus 82 ~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~~ 156 (283)
T cd05118 82 T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYT 156 (283)
T ss_pred C-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cccc
Confidence 5 888887664 5789999999999999999999998 89999999999999999999999999998765443 1222
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC---ceeEee-----
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG---RLDVLV----- 736 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~----- 736 (799)
...++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+...... ...... ......
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF----RTLGTPDPEVWPKFTSLARN 232 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----HHcCCCchHhcccchhhhhh
Confidence 23467889999998876 78999999999999999999999986544322111110 000000 000000
Q ss_pred ------cCCC--CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 ------DSDE--PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 ------d~~~--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.... ...........+.+++.+||+.||.+||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 00111234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=286.25 Aligned_cols=241 Identities=25% Similarity=0.366 Sum_probs=190.5
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.++||+|+||+||+|+... +++.|++|++.... ....+.+.+|++++++++|+|++++++++.+....++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSH-TNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL 104 (313)
T ss_pred ceeeccCCCeEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC
Confidence 3569999999999999764 67899999986422 2334578899999999999999999999999999999999996
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++|.+++.. ...+++..+..++.||+.||.|||+. +++|+||+|+||++++++.+||+|||++..... ..
T Consensus 105 -~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-----~~ 175 (313)
T cd06633 105 -GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-----AN 175 (313)
T ss_pred -CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC-----CC
Confidence 577777754 35689999999999999999999998 899999999999999999999999999864321 12
Q ss_pred eeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 666 MIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
...++..|+|||.+. ...++.++||||||+++|||++|..|+........ ........ .+.
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~ 239 (313)
T cd06633 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQND---------SPT 239 (313)
T ss_pred CccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcC---------CCC
Confidence 345788999999984 45688899999999999999999999865432111 11111111 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.........+.+++.+||+.+|++||++.+++..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122233467789999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=263.95 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=197.7
Q ss_pred cChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccc-cccccceeeeeec
Q 038294 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNLVQLLGFCDE 574 (799)
Q Consensus 497 ~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~ 574 (799)
...+||+. ...||.|..|.|++...+. +|..+|||.+.... .+..+.++..+.++.+-+ +|.||+.+|+|..
T Consensus 89 ~dindl~~-----l~dlGsGtcG~V~k~~~rs-~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 89 ADINDLEN-----LGDLGSGTCGQVWKMRFRS-TGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred cChHHhhh-----HHhhcCCCccceEEEEEcc-cceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 34455543 4679999999999999985 68999999997643 344467888888877765 8999999999999
Q ss_pred ccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCc
Q 038294 575 ALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 575 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
+...++.||.|.. .++.+++.. ..+++...-++...+.+||.||.+.. +|||||+||+|||+|+.|++|++|||++
T Consensus 163 n~dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIs 239 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGIS 239 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccc
Confidence 9999999999854 566666654 45777778899999999999999864 9999999999999999999999999999
Q ss_pred ccccCCCCcceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 654 KLLLSDQSRTHTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 654 ~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
-.+.... ..+...|-+.|||||.+. ..+|+.++||||||+.|+||.||+-||.....+-. +...+.+.
T Consensus 240 GrlvdSk--AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------~ltkvln~ 310 (391)
T KOG0983|consen 240 GRLVDSK--AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------VLTKVLNE 310 (391)
T ss_pred ceeeccc--ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-------HHHHHHhc
Confidence 8775433 334445788999999995 34789999999999999999999999986432210 11111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. .+.++. ....+..+.+++..||++|+.+||...++++
T Consensus 311 e-----PP~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 311 E-----PPLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred C-----CCCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 0 012221 1126678899999999999999999988765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=287.83 Aligned_cols=264 Identities=22% Similarity=0.275 Sum_probs=191.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeeccc--------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-------- 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 576 (799)
+.+.++||+|+||.||++..+. +++.||||++.... ......+.+|++++++++||||+++++++....
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~-~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKK-TKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECC-CCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 3456789999999999999874 68899999885432 222345678999999999999999999986544
Q ss_pred ceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
..++|+||+.+ +|.+.+... ..+++....+++.||+.||+|||+. +++|+||||+||+++.++.+||+|||++..
T Consensus 93 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 93 SFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred eEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 34899999975 788777654 3689999999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCc---ceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHH
Q 038294 656 LLSDQSR---THTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCY 727 (799)
Q Consensus 656 ~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~ 727 (799)
....... ......++..|+|||.+.+. .++.++||||||+++|||++|..|+...........+..... ..+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW 248 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 6432211 11223467889999988665 478899999999999999999999875543222111111000 000
Q ss_pred hcCceeEeecC-CCCCc---------cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 728 AEGRLDVLVDS-DEPAM---------ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 728 ~~~~~~~~~d~-~~~~~---------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+. ..+.. ........+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000000 00000 00012345678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=292.86 Aligned_cols=258 Identities=22% Similarity=0.251 Sum_probs=195.0
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhh--------------HHHHHHHHHHhcccccccccceeeeeecc
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER--------------EREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
.+.||+|+||+||+|..+. +++.||+|+++...... ...+.+|++++.+++|+||+++++++...
T Consensus 14 ~~~ig~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTL-TGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhcccCCCceeEEEEEECC-CCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4679999999999999874 67899999886432211 12577899999999999999999999999
Q ss_pred cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
...+++|||+. ++|.+++.....+++.....++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++..
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceee
Confidence 99999999997 69999998777889999999999999999999997 999999999999999999999999999986
Q ss_pred ccCCC-------------CcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH
Q 038294 656 LLSDQ-------------SRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD 721 (799)
Q Consensus 656 ~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~ 721 (799)
..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~--- 245 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR--- 245 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Confidence 54111 1111122357789999998764 468999999999999999999999876543321111
Q ss_pred HHHHHHhcCcee---E--------eecCCCCC---ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 722 WAYDCYAEGRLD---V--------LVDSDEPA---MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 722 ~~~~~~~~~~~~---~--------~~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
+.......... . ......+. .........+.+++..||+.+|++|||+.|++..
T Consensus 246 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 246 -IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred -HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111100000 0 00000000 0011224567899999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-32 Score=295.65 Aligned_cols=269 Identities=25% Similarity=0.328 Sum_probs=194.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc-----cceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 580 (799)
+.+.+.||+|+||.||+|.... +++.||+|+++... ......+.+|+.++++++|+||+++++++... ...++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKP-TGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcC-CCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 3456789999999999999864 67899999986432 23345688899999999999999999987544 34789
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
++||+++ +|.+++.. ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 86 v~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 86 VQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred Eehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 9999975 78777743 4688999999999999999999998 99999999999999999999999999998654322
Q ss_pred Cc--ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcC
Q 038294 661 SR--THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEG 730 (799)
Q Consensus 661 ~~--~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~ 730 (799)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+.... ...+...
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL 240 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence 11 1123457889999998754 568999999999999999999999986543211100000000 0000000
Q ss_pred c----eeEeec-CCCC-CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 038294 731 R----LDVLVD-SDEP-AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLL 781 (799)
Q Consensus 731 ~----~~~~~d-~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 781 (799)
. +..... ...+ ..........+.+++.+||+.+|++|||+.|+++. ++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0 000000 0000 00011224568899999999999999999999986 65544
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=293.89 Aligned_cols=266 Identities=22% Similarity=0.295 Sum_probs=197.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc-----cceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 580 (799)
...+.||+|+||+||++.... +++.||||.++.. .......+.+|+.+++.++|+||+++++++... ...++
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSE-TNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eEEEEeccCCCeEEEEEEecC-CCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 345689999999999999864 6889999998642 223345677899999999999999999988644 34789
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
++||+. ++|.+++.....+++.....++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 87 v~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 999996 68999988777899999999999999999999998 89999999999999999999999999998764332
Q ss_pred CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCce
Q 038294 661 SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGRL 732 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 732 (799)
.......++..|+|||.+.. ..++.++||||||+++|||++|+.||...........+.... ...+..+..
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (337)
T cd07858 163 -DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKA 241 (337)
T ss_pred -ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhh
Confidence 11223347889999998865 468999999999999999999999986543221111110000 000000000
Q ss_pred eEee-------cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 038294 733 DVLV-------DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGL 780 (799)
Q Consensus 733 ~~~~-------d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 780 (799)
.... ..... .........+.+++.+||+.+|++|||++|+++. ++.+
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 242 RRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 00000 0011234567899999999999999999999976 6554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=284.05 Aligned_cols=246 Identities=26% Similarity=0.345 Sum_probs=200.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.||+|+||.||++..+. +++.+++|++... .....+.+..|++++++++ |+||+++++++......++|||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKE-TNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred eEeeeecCCCceEEEEEEEcC-CCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 355789999999999999875 6789999998642 2334467889999999998 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC--
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-- 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 661 (799)
|+++++|.+++.....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 83 YAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999998888899999999999999999999998 999999999999999999999999999987643221
Q ss_pred -----------------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH
Q 038294 662 -----------------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY 724 (799)
Q Consensus 662 -----------------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~ 724 (799)
.......++..|+|||.+.....+.++||||||++++|+++|+.|+....... .+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----- 231 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TF----- 231 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HH-----
Confidence 11223457889999999988889999999999999999999999988554211 01
Q ss_pred HHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 038294 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTM----KVVLQ 775 (799)
Q Consensus 725 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~evl~ 775 (799)
+...... .. .+....+.+.+++.+||+.+|++||++ +++++
T Consensus 232 ~~~~~~~------~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 232 QKILKLE------YS----FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHhcC------CC----CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111100 01 112224678899999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=293.55 Aligned_cols=264 Identities=21% Similarity=0.309 Sum_probs=195.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeec----ccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 581 (799)
.+.+.||+|+||.||+|..+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTR-SGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcC-CCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 345789999999999999875 57899999986532 2334567889999999999999999998753 3457899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+||+. ++|.+++.....+++....+++.||+.||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 87 ~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 87 MDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred Eehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99996 68999998777799999999999999999999998 899999999999999999999999999976543221
Q ss_pred c---ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHHhcC
Q 038294 662 R---THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCYAEG 730 (799)
Q Consensus 662 ~---~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~ 730 (799)
. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+... ..+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~ 242 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD 242 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence 1 1123457889999999865 46889999999999999999999999654322111000000 00000000
Q ss_pred ceeEeecC-CCCCc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 731 RLDVLVDS-DEPAM-----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 731 ~~~~~~d~-~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+....+. ..... ......+.+.+++.+||+.+|++||++.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000000 00000 012235678899999999999999999998863
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=293.57 Aligned_cols=269 Identities=23% Similarity=0.308 Sum_probs=203.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeeccc-----ceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-----NRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-----~~~l 580 (799)
.+.+.||+|++|.||+|.... +++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..++
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKR-TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCC-CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 456789999999999999864 57899999987543 334567899999999999999999999997765 7899
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
++||++ ++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 82 VTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157 (330)
T ss_pred Eecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccc
Confidence 999998 48999998777899999999999999999999998 89999999999999999999999999998765432
Q ss_pred C--cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HH---HhcC
Q 038294 661 S--RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DC---YAEG 730 (799)
Q Consensus 661 ~--~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~---~~~~ 730 (799)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+..... .. ....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 237 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSE 237 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcccc
Confidence 1 112234578899999999888 889999999999999999999999976543321111100000 00 0000
Q ss_pred ceeEeecC-CCCC-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCc
Q 038294 731 RLDVLVDS-DEPA-----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLL 781 (799)
Q Consensus 731 ~~~~~~d~-~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~ 781 (799)
.....+.. .... .........+.+++.+||+.+|++||++.++++. ++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 238 KARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred chhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000000 0000 0011234567889999999999999999999974 66543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=282.51 Aligned_cols=260 Identities=25% Similarity=0.299 Sum_probs=192.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhccc---ccccccceeeeeecccc-----e
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRT---HHKNLVQLLGFCDEALN-----R 578 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~~~~-----~ 578 (799)
+.+.||+|+||.||+|+.+. +++.+|+|+++... ......+.+|+.++.++ +|+|++++++++..... .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLN-TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEECC-CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 45789999999999999875 57899999986422 22234566777766655 69999999999987776 8
Q ss_pred eeEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 579 LLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
+++|||+.+ +|.+++.... .+++..+.+++.|+++||+|||+. +++|+||+|+||++++++.+||+|||++...
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY 157 (287)
T ss_pred EEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceec
Confidence 899999974 8988887643 589999999999999999999998 8999999999999999999999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcCce
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEGRL 732 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~ 732 (799)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......+....+.+... ..+.....
T Consensus 158 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (287)
T cd07838 158 SFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS 235 (287)
T ss_pred cCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence 43321 1223467889999999999999999999999999999999988876543322111100000 00000000
Q ss_pred --eEeecCCC---CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 --DVLVDSDE---PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 --~~~~d~~~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........ ...........+.+++.+||+.||++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 01111233466788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-31 Score=284.09 Aligned_cols=257 Identities=17% Similarity=0.183 Sum_probs=189.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.+|.|+++.||++.. +++.||||++... .....+.+..|++++++++|+||+++++++.+....+++|||++++
T Consensus 8 ~~~~~~~~v~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 8 KCFEDLMIVHLAKHKP---TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred HhhcCCceEEEEEecC---CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 3445555555555543 6789999998653 3445568999999999999999999999999999999999999999
Q ss_pred ChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc----
Q 038294 589 TLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR---- 662 (799)
Q Consensus 589 sL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~---- 662 (799)
+|.+++... ..+++.....++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||.+.........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999764 4578888899999999999999998 8999999999999999999999999988755322111
Q ss_pred --ceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH----H-------
Q 038294 663 --THTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC----Y------- 727 (799)
Q Consensus 663 --~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~------- 727 (799)
......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ .... .... +
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEK-VRGTVPCLLDKSTYPL 238 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH-HhccCccccccCchhh
Confidence 1122346778999999876 3588999999999999999999999975432110 0000 0000 0
Q ss_pred hcCceeE----e----ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 728 AEGRLDV----L----VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 728 ~~~~~~~----~----~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....... . ................+.+++.+||+.||++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000000 0 00011112233445678889999999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=283.49 Aligned_cols=261 Identities=26% Similarity=0.305 Sum_probs=197.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.||+|++|.||+|+... +++.+++|.+.... ....+.+..|+.++++++|+|++++++++.+....++|+||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKK-TGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeecC-CCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 34679999999999999874 57899999987643 3334678889999999999999999999999999999999998
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||+|+||++++++.+||+|||++........ ...
T Consensus 82 -~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~ 156 (282)
T cd07829 82 -MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYT 156 (282)
T ss_pred -cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-ccC
Confidence 5899999876 5789999999999999999999998 899999999999999999999999999987643321 122
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhc-Cce---eEee
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAE-GRL---DVLV 736 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~-~~~---~~~~ 736 (799)
...++..|+|||.+.+. .++.++||||||++++||++|+.||......+....+..... ..+.. ..+ ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 23356789999998776 789999999999999999999999876543221111110000 00000 000 0000
Q ss_pred cCC---CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 DSD---EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 d~~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
... ............+.+++..||+.+|++||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 000001112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-32 Score=274.27 Aligned_cols=252 Identities=21% Similarity=0.294 Sum_probs=201.3
Q ss_pred chhhhcCccccceEEEEEEeCCC----CeEEEEEEccccchhh-HHHHHHHHHHhcccccccccceeeeeecc-cceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSAS----GKAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEA-LNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~----~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv 581 (799)
..+..+-+|.||.||.|.+++.+ .+.|.||.++....+. ...|+.|...+..+.|||+..+.+++.+. ...+++
T Consensus 287 ~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~ 366 (563)
T KOG1024|consen 287 RLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVL 366 (563)
T ss_pred echhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEE
Confidence 34456889999999999886432 2567788887654443 35788999999999999999999999654 567899
Q ss_pred EeecCCCChhhhhhcC--------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCc
Q 038294 582 YEFMGNGTLANLIFAI--------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~--------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
|.++.-|+|..+|..- +.++-.+...++.|++.|++|||.+ +|||.||.++|++||+..++||+|-.++
T Consensus 367 y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 367 YPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred EeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhc
Confidence 9999999999999721 2455667788999999999999998 9999999999999999999999999999
Q ss_pred ccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCc
Q 038294 654 KLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGR 731 (799)
Q Consensus 654 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (799)
+.+..... ........+..||+||.+.+..|+..+|||||||+||||+| |+.|+...++.+ +...+++|.
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------m~~ylkdGy 515 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------MEHYLKDGY 515 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--------HHHHHhccc
Confidence 98754432 22233446789999999999999999999999999999998 677776555444 333444442
Q ss_pred eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 732 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
. -..+-+..++++.++.-||...|++||++++++.-|.+
T Consensus 516 R---------laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 516 R---------LAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred e---------ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 1 11233455788999999999999999999999998865
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=283.73 Aligned_cols=249 Identities=26% Similarity=0.411 Sum_probs=190.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.||||.++... .....++..|+.++.+.+ |+||+++++++.+....+++|||+
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKK-TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred eeeeEeeccCCeEEEEEEECC-CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 456889999999999999874 57899999986532 233456677777777665 999999999999999999999998
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++ +|.+++.. ...+++..+.+++.||++||+|||+. .+|+||||+|+||++++++.+||+|||++.........
T Consensus 97 ~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~-- 171 (296)
T cd06618 97 ST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK-- 171 (296)
T ss_pred Cc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc--
Confidence 54 77777655 34688999999999999999999973 28999999999999999999999999998765432221
Q ss_pred eeeccCCcccccccccCCC----CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 665 TMIRGTRGYVAPEWFKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~----~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
....++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... ......... ... ..
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~-~~~-----~~ 239 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF------EVLTKILQE-EPP-----SL 239 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH------HHHHHHhcC-CCC-----CC
Confidence 2234678899999987554 7889999999999999999999986432111 101111111 100 01
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
+. .....+.+.+++.+||+.+|++||++.++++.
T Consensus 240 ~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 PP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 10 11234578889999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=277.08 Aligned_cols=235 Identities=20% Similarity=0.227 Sum_probs=184.0
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecCCCChh
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNGTLA 591 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 591 (799)
||+|+||.||++..+. +++.+|+|.+....... . |+.....+ +|+|++++++.+...+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKP-TQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcC-CCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 5999999999999875 57889999986432111 1 22222212 6999999999999999999999999999999
Q ss_pred hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCCCcceeeeccC
Q 038294 592 NLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSRTHTMIRGT 670 (799)
Q Consensus 592 ~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~~~~~~~gt 670 (799)
+++.....+++..+..++.||++||.|||+. +++|+||||+||+++.++ .++|+|||++....... ...++
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-----~~~~~ 169 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-----CYDGT 169 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-----cCCCC
Confidence 9998877899999999999999999999998 899999999999999988 99999999987653221 23478
Q ss_pred CcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHH
Q 038294 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQ 750 (799)
Q Consensus 671 ~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~ 750 (799)
..|+|||.+.+..++.++||||||+++|||++|+.||.....+.. ....+... . .. . .........
T Consensus 170 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~-~-~~--------~--~~~~~~~~~ 235 (267)
T PHA03390 170 LDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL--DLESLLKR-Q-QK--------K--LPFIKNVSK 235 (267)
T ss_pred CcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh--hHHHHHHh-h-cc--------c--CCcccccCH
Confidence 899999999999999999999999999999999999974432221 11111111 0 00 0 011123456
Q ss_pred HHHHHHHHhcccCCCCCCC-HHHHHH
Q 038294 751 KWLMIAMWCIREDPSKRPT-MKVVLQ 775 (799)
Q Consensus 751 ~l~~l~~~Cl~~dP~~RPt-~~evl~ 775 (799)
.+.+++.+||+.+|.+||+ ++|+++
T Consensus 236 ~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 236 NANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred HHHHHHHHHhccChhhCCchHHHHhc
Confidence 7888999999999999996 688874
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=287.02 Aligned_cols=269 Identities=21% Similarity=0.280 Sum_probs=193.5
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeeccc------ceeeE
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NRLLV 581 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~lv 581 (799)
.+.||+|+||.||+|.... +++.||+|++.... ......+.+|+.++++++|+||+++++++.... ..++|
T Consensus 20 ~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 20 LKQVGSGAYGSVCSAIDKR-TGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEeeecCCeEEEEEEeCC-CCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 4679999999999999864 57899999986421 223356889999999999999999999986543 45899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+||+.. +|..++. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-- 170 (342)
T cd07879 99 MPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-- 170 (342)
T ss_pred eccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--
Confidence 999864 6766552 3678899999999999999999998 8999999999999999999999999998764321
Q ss_pred cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHHhcCcee
Q 038294 662 RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCYAEGRLD 733 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 733 (799)
.....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+... ..+.+......
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07879 171 --MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK 248 (342)
T ss_pred --CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence 122346788999999876 46889999999999999999999999754322111000000 00000000000
Q ss_pred Eeec--CCCCCcc----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCCCCCC
Q 038294 734 VLVD--SDEPAMA----DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLEVPNPPCP 789 (799)
Q Consensus 734 ~~~d--~~~~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~p~~p 789 (799)
.... +..+... .......+.+++.+||+.||++||++.|++.. +++..+.++.+.|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~~~~ 312 (342)
T cd07879 249 SYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQ 312 (342)
T ss_pred HHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccccCCC
Confidence 0000 0000000 01123467889999999999999999999944 7776655444443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=277.21 Aligned_cols=245 Identities=25% Similarity=0.342 Sum_probs=191.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-----chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.++||+|+||.||++.... .+..+++|.++.. ......++..|+.++++++||||+++++++.+....++|+
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKK-AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred eeeeeecCCCCceEEEEEecC-CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 456889999999999998764 2344555554421 1223346778999999999999999999999999999999
Q ss_pred eecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 583 EFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 583 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++ +.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 82 EYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred EeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecCC
Confidence 99999999998864 34689999999999999999999998 9999999999999986 5699999999887643
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+....... ... ....+.
T Consensus 158 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-------~~~-~~~~~~------- 221 (260)
T cd08222 158 SCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-------VVL-RIVEGP------- 221 (260)
T ss_pred Ccc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-------HHH-HHHcCC-------
Confidence 322 2223457889999999988889999999999999999999999986432211 111 111111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+......+.+++.+|++.+|++||++.|+++
T Consensus 222 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 --TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11112344567888999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=295.33 Aligned_cols=199 Identities=28% Similarity=0.438 Sum_probs=171.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhh-HHHHHHHHHHhcccccccccceeeeeeccc------cee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~ 579 (799)
+...+.||+|+||.||+|+.+. +|+.||||.+....... .+....|+++|++++|+|||+++++-++.. ...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnke-tG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKE-TGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccc-cccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4456889999999999999875 79999999997644333 345678999999999999999999876544 468
Q ss_pred eEEeecCCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCC--ceEEccccC
Q 038294 580 LVYEFMGNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD--NYF--SAKISDFGL 652 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~--~~~--~~kl~DfGl 652 (799)
+|||||.+|||+..|.+. ..+++...+.+..+++.||.|||++ +|+||||||.||++- +++ ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999999864 4789999999999999999999988 999999999999984 233 479999999
Q ss_pred cccccCCCCcceeeeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
|+.+..+. .....+||+.|++||... .+.|+..+|.|||||++||..||..||....
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99875443 566788999999999998 5889999999999999999999999997553
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=273.88 Aligned_cols=237 Identities=29% Similarity=0.319 Sum_probs=194.2
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
||+|+||.||++.... +++.+++|.+..... .....+..|+.++++++|+||+++++.+..+...+++|||+++++
T Consensus 1 lg~G~~~~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECC-CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6999999999999864 578999999865332 244578999999999999999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeecc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 669 (799)
|.+++.....+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 999998877889999999999999999999997 99999999999999999999999999998764332 12223457
Q ss_pred CCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHH
Q 038294 670 TRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749 (799)
Q Consensus 670 t~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 749 (799)
+..|+|||.+.+...+.++|+||||+++||+++|+.||....... .......+. ...+ ....
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--------~~~~~~~~~------~~~~----~~~~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE--------IYEKILKDP------LRFP----EFLS 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHhcCC------CCCC----CCCC
Confidence 889999999988889999999999999999999999996543211 111111111 1111 1124
Q ss_pred HHHHHHHHHhcccCCCCCCCHHH
Q 038294 750 QKWLMIAMWCIREDPSKRPTMKV 772 (799)
Q Consensus 750 ~~l~~l~~~Cl~~dP~~RPt~~e 772 (799)
..+.+++.+||+.||++||++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCccc
Confidence 56788999999999999999955
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=288.80 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=202.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+...||+|.|++|.+|+... ++..||+|.+++..- .....+.+|+++|..++|||||+++.+......+++||||
T Consensus 58 y~i~~tig~g~f~~V~La~~~~-t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ey 136 (596)
T KOG0586|consen 58 YVIIKTIGKGNFAKVKLARHIL-TGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEY 136 (596)
T ss_pred eeeeeeeccceeEEEEeeEecC-CCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEe
Confidence 3456789999999999999886 688999999976432 2234588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+.+|.+.+++.............++.|+.+|++|||++ .|+|||||++||||+.+.++||+|||++..+. .....
T Consensus 137 a~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~~~~l 211 (596)
T KOG0586|consen 137 ASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--YGLML 211 (596)
T ss_pred ccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--ccccc
Confidence 99999999999988887788899999999999999998 89999999999999999999999999998774 22334
Q ss_pred eeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
...+|++.|.|||++.+.+| .+++|+||+|++||-|++|..||++..-.+-+.. ...|++.
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------vl~gk~r---------- 273 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------VLRGKYR---------- 273 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch--------heeeeec----------
Confidence 45679999999999999877 6789999999999999999999986543221111 1111110
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+......+-++++++|-.+|.+|++++++.+.
T Consensus 274 Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 274 IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111222356679999999999999999998753
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=282.13 Aligned_cols=247 Identities=22% Similarity=0.363 Sum_probs=192.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 583 (799)
+...++||+||.+.|||+... +.+.+|+|++.. ...+...-|.+|+..|.+++ |.+||+|++|-..+...|||||
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s--~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNS--DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhHHHhhcCCCcceeeeeecC--CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 345578999999999998764 456788887643 44556678999999999995 9999999999999999999999
Q ss_pred ecCCCChhhhhhcCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 584 FMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|- ..+|..+|.+... +.| .+..+..||+.|+.++|++ +|||.||||.|+|+-. |.+||+|||+|..+..+..
T Consensus 441 ~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTT 514 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTT 514 (677)
T ss_pred cc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCcccc
Confidence 85 4599999987643 335 6667889999999999999 9999999999999875 4899999999999877654
Q ss_pred cce-eeeccCCcccccccccCC-----------CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 662 RTH-TMIRGTRGYVAPEWFKNA-----------PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 662 ~~~-~~~~gt~~y~aPE~l~~~-----------~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
... ...+||+.||+||.+... +.+.++||||+||+||+|+-|+.||..-.. .|+
T Consensus 515 sI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------~~a------ 580 (677)
T KOG0596|consen 515 SIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------QIA------ 580 (677)
T ss_pred ceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------HHH------
Confidence 433 345799999999998533 256789999999999999999999874321 111
Q ss_pred CceeEeecCCCCCcc-CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 730 GRLDVLVDSDEPAMA-DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
++..+.++....+. ....-..+++++..||+.||.+|||..|+++.
T Consensus 581 -Kl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 581 -KLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred -HHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 12223333221111 11111228899999999999999999999864
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=262.20 Aligned_cols=256 Identities=25% Similarity=0.320 Sum_probs=203.5
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
.+.||+|+++.|--++... ++.++|||++.+..........+|++++...+ |+||+.|+.+|+++...|||||-|.||
T Consensus 83 ~e~LGeGAyasVqtcv~i~-t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQ-TGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHHhcCccceeeeeeeeec-cchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 3789999999999887654 78999999998876666678889999999985 999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEccccCcccccCCC--C--
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS---AKISDFGLSKLLLSDQ--S-- 661 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~---~kl~DfGla~~~~~~~--~-- 661 (799)
+|..+|.+...+++....++..+||.||.|||.. +|.||||||+|||-..... +||+||.+..-+.... +
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 9999999999999999999999999999999998 9999999999999976544 7999998876543221 1
Q ss_pred --cceeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhh-------hcchhHHHHHHHHH
Q 038294 662 --RTHTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE-------EGRAILTDWAYDCY 727 (799)
Q Consensus 662 --~~~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~-------~~~~~~~~~~~~~~ 727 (799)
......+|+..|||||+.. ...|+.+.|.|||||+||-||+|..||.+.-.+ +.=....+.+-+.+
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesI 318 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 318 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHH
Confidence 1122346888999999763 335889999999999999999999999754221 11122333344455
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+|+.+- |...-...+....+++...+..++.+|.++.++++
T Consensus 319 QEGkYeF------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 319 QEGKYEF------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred hccCCcC------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 5665321 22222344455667888888999999999999887
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=285.57 Aligned_cols=264 Identities=25% Similarity=0.305 Sum_probs=190.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeeccc--------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-------- 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-------- 576 (799)
+.+.+.||+|+||.||+|..+. +++.+|+|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~-~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 88 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIK-TGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRG 88 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCc
Confidence 3456789999999999999874 578899998854322 22346788999999999999999999875443
Q ss_pred ceeeEEeecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 577 NRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
..++|+||+.. +|...+.. ...+++..+..++.|+++||+|||+. +|+|+||||+||++++++.+||+|||+++.
T Consensus 89 ~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 89 SVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred eEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 35899999875 67666654 35789999999999999999999998 899999999999999999999999999986
Q ss_pred ccCCCCc----------ceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-
Q 038294 656 LLSDQSR----------THTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA- 723 (799)
Q Consensus 656 ~~~~~~~----------~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~- 723 (799)
....... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||...........+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5432211 11223467889999987654 58899999999999999999999987544322111111000
Q ss_pred ------HHHHhc--CceeEeecCCCCCcc---CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 724 ------YDCYAE--GRLDVLVDSDEPAMA---DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 724 ------~~~~~~--~~~~~~~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..+.. ...........+... .....+.+.+++.+||+.+|++|||+.|++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 000000000011000 0122256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=302.83 Aligned_cols=246 Identities=31% Similarity=0.426 Sum_probs=184.4
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeec---------------
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--------------- 574 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------------- 574 (799)
+.||+||||.|||++.+- +|+.+|||++.-. +.+....+.+|++.+++++|||||+++....+
T Consensus 485 ~lLGkGGFG~VvkVRNKl-DGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~ 563 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKL-DGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDS 563 (1351)
T ss_pred HHhcCCCCceEEEEeecc-cchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccch
Confidence 469999999999999885 7999999999654 33344678899999999999999998763100
Q ss_pred --------------------------------------------------------------------------------
Q 038294 575 -------------------------------------------------------------------------------- 574 (799)
Q Consensus 575 -------------------------------------------------------------------------------- 574 (799)
T Consensus 564 ~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d 643 (1351)
T KOG1035|consen 564 ESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILD 643 (1351)
T ss_pred hhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccC
Confidence
Q ss_pred ----------------c--------cceeeEEeecCCCChhhhhhcCCCC-CHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 038294 575 ----------------A--------LNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPIIH 629 (799)
Q Consensus 575 ----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 629 (799)
. ...||-||||+...|.+++...... .-...++++.+|+.||+|+|+. +|||
T Consensus 644 ~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~---giIH 720 (1351)
T KOG1035|consen 644 DTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ---GIIH 720 (1351)
T ss_pred cchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC---ceee
Confidence 0 1136778899888888888765543 4566789999999999999998 8999
Q ss_pred cCCCCCCeEEcCCCceEEccccCccccc-----------------CCCCcceeeeccCCcccccccccCC---CCCcchh
Q 038294 630 CDIKPQNILLDNYFSAKISDFGLSKLLL-----------------SDQSRTHTMIRGTRGYVAPEWFKNA---PVSAKVD 689 (799)
Q Consensus 630 ~dlk~~NILl~~~~~~kl~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~l~~~---~~s~k~D 689 (799)
|||||.||+||++..+||+|||+|.... .......+...||.-|+|||++.+. +|+.|+|
T Consensus 721 RDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiD 800 (1351)
T KOG1035|consen 721 RDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKID 800 (1351)
T ss_pred ccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhh
Confidence 9999999999999999999999998731 0011133456799999999999765 4999999
Q ss_pred HHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC
Q 038294 690 VYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT 769 (799)
Q Consensus 690 VwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 769 (799)
+||+||+|+||+. ||....+. . -+...++.|.+..- ......+...-.+++.|+++.||++|||
T Consensus 801 mYSLGIVlFEM~y---PF~TsMER--a-----~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 801 MYSLGIVLFEMLY---PFGTSMER--A-----SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hHHHHHHHHHHhc---cCCchHHH--H-----HHHHhcccCCCCCC------cccccccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999984 45432211 0 11122334433221 1122333445567999999999999999
Q ss_pred HHHHHHH
Q 038294 770 MKVVLQM 776 (799)
Q Consensus 770 ~~evl~~ 776 (799)
+.|++.-
T Consensus 865 A~eLL~s 871 (1351)
T KOG1035|consen 865 ATELLNS 871 (1351)
T ss_pred HHHHhhc
Confidence 9998753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=265.14 Aligned_cols=262 Identities=26% Similarity=0.364 Sum_probs=200.8
Q ss_pred CccccChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhccc-ccccccceee
Q 038294 493 NLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLG 570 (799)
Q Consensus 493 ~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g 570 (799)
.+..|+..+|+.. .+||.|+||+|+|=.++. .|+.+|||+++.... ...++++.|.+...+- +.||||+++|
T Consensus 57 ~~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~-sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 57 HLHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKP-SGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred cccccccchHHHH-----HHhcCCcchhhhhhhcCc-cCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 3444665666553 579999999999988874 789999999976443 5567888888876665 7999999999
Q ss_pred eeecccceeeEEeecCCCChhhhhh-----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 038294 571 FCDEALNRLLVYEFMGNGTLANLIF-----AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645 (799)
Q Consensus 571 ~~~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~ 645 (799)
.+-.+...|+.||.|. -+|+.+.+ +...+++...-+|.....+||.||-.+ ..|||||+||+|||||..|.+
T Consensus 131 a~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCE
Confidence 9999999999999995 47766543 235778888889999999999999987 489999999999999999999
Q ss_pred EEccccCcccccCCCCcceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH
Q 038294 646 KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 646 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 723 (799)
||+|||++-.+...-.++ .-.|-..|||||.+.. ..|+.++||||||+.|||+.||+-|+..-.. .+ +.+
T Consensus 208 KLCDFGIcGqLv~SiAkT--~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vf-eql 279 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSIAKT--VDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VF-EQL 279 (361)
T ss_pred eeecccchHhHHHHHHhh--hccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HH-HHH
Confidence 999999998765433222 2347778999999953 3589999999999999999999999874322 11 111
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+ +..|....+.. .....+....+..++..|+-+|.++||...++.++
T Consensus 280 ~~-Vv~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 280 CQ-VVIGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HH-HHcCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 11 22232222211 11234566788999999999999999999987654
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=282.72 Aligned_cols=263 Identities=22% Similarity=0.253 Sum_probs=190.3
Q ss_pred chhhhcCccccceEEEEEEeCCC--CeEEEEEEccccc--hhhHHHHHHHHHHhccc-ccccccceeeeeecc----cce
Q 038294 508 GFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLA--QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA----LNR 578 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~----~~~ 578 (799)
.+.+.||+|+||.||++.... . ++.+|+|++.... ....+.+.+|+.+++++ +|+||+++++++... ...
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 81 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAE-TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81 (332)
T ss_pred eEEEEccccCCeEEEEEEeCC-CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcE
Confidence 356789999999999999864 4 6789999986422 22345678899999999 599999999975432 346
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++++||+. ++|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~ 157 (332)
T cd07857 82 YLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSE 157 (332)
T ss_pred EEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceeccc
Confidence 78888886 68999998778899999999999999999999998 899999999999999999999999999986543
Q ss_pred CCCc---ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHH
Q 038294 659 DQSR---THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCY 727 (799)
Q Consensus 659 ~~~~---~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~ 727 (799)
.... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||............... ....+
T Consensus 158 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 158 NPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred ccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 2211 1122458899999998765 46899999999999999999999998754322110000000 00000
Q ss_pred hcCce----eEe--ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 728 AEGRL----DVL--VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 728 ~~~~~----~~~--~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..... ... ................+.+++.+|++.+|++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 238 GSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000 000 0000000001112356788999999999999999999863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=284.31 Aligned_cols=263 Identities=21% Similarity=0.247 Sum_probs=190.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc-----------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA----------- 575 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 575 (799)
+.+.+.||+|+||.||+|.... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~-~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSD-CDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECC-CCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 3456789999999999999874 6789999998665555567789999999999999999999876543
Q ss_pred ---cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEcccc
Q 038294 576 ---LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFG 651 (799)
Q Consensus 576 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-~~~~~kl~DfG 651 (799)
...++|+||++ ++|.+++.. ..+++.....++.||+.||.|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcc
Confidence 34689999997 588888754 3578899999999999999999998 899999999999997 46678999999
Q ss_pred CcccccCCCCcc--eeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH------
Q 038294 652 LSKLLLSDQSRT--HTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW------ 722 (799)
Q Consensus 652 la~~~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~------ 722 (799)
+++......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.......-
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 998653321111 122346888999998754 56788999999999999999999999754322111000000
Q ss_pred -HHHHHhcCceeEeecCCCCCc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 723 -AYDCYAEGRLDVLVDSDEPAM-----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 723 -~~~~~~~~~~~~~~d~~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..................... ........+.+++.+||+.||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000000000000000 00123356778999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=263.72 Aligned_cols=238 Identities=26% Similarity=0.299 Sum_probs=196.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.|.+.||+|.||.|.+++-+. +++.+|+|++++.- ......-+.|-++|+..+||.+..|-..+...++.+.||||
T Consensus 171 dfLKvLGkGTFGKVIL~rEKa-t~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMey 249 (516)
T KOG0690|consen 171 DFLKVLGKGTFGKVILCREKA-TGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEY 249 (516)
T ss_pred hHHHHhcCCccceEEEEeecc-cCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEE
Confidence 456889999999999998874 78999999997632 23334557799999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
..||.|.-+|.....+++....-+-..|..||.|||++ +|+.||||.+|.|||.+|++||+|||+.+.-- ....+.
T Consensus 250 anGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g~t~ 325 (516)
T KOG0690|consen 250 ANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYGDTT 325 (516)
T ss_pred ccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccccee
Confidence 99999999998888888888888899999999999998 99999999999999999999999999998532 233455
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+|||.|+|||++....|...+|-|.+||++|||++|+.||.....+.-- +++..+. -..|
T Consensus 326 kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLF--------eLIl~ed------~kFP--- 388 (516)
T KOG0690|consen 326 KTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLF--------ELILMED------LKFP--- 388 (516)
T ss_pred ccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHH--------HHHHhhh------ccCC---
Confidence 6678999999999999999999999999999999999999999876554311 1111111 1112
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP 768 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP 768 (799)
+....+...++...|.+||.+|.
T Consensus 389 -r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 -RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred -ccCCHHHHHHHHHHhhcChHhhc
Confidence 22233455677888999999995
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=280.78 Aligned_cols=265 Identities=23% Similarity=0.258 Sum_probs=192.9
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc------ceee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NRLL 580 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~~l 580 (799)
+.+.||+|+||.||++.... +++.||||++... .....+.+.+|+.++++++|+||+++++++.... ..++
T Consensus 19 ~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 19 DLKQVGSGAYGTVCSALDRR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEeeecCCeEEEEEEECC-CCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 45679999999999998764 6789999998542 2223456889999999999999999999986543 3489
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|+||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 98 v~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 98 VMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 99998 6789888764 4688999999999999999999998 89999999999999999999999999998653221
Q ss_pred CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH-------HHHHHHhcCce
Q 038294 661 SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD-------WAYDCYAEGRL 732 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 732 (799)
....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.. .....+.....
T Consensus 173 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07880 173 ----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDA 248 (343)
T ss_pred ----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhH
Confidence 22346889999999876 4588999999999999999999999975432211000000 00000000000
Q ss_pred eEeecC--CC----CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH--HHHhcCcCC
Q 038294 733 DVLVDS--DE----PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL--QMLEGLLEV 783 (799)
Q Consensus 733 ~~~~d~--~~----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl--~~L~~~~~~ 783 (799)
...... .. ...........+.+++.+|++.||++|||+.+++ ..++...+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred HHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 000000 00 0000112234578899999999999999999998 455554443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-32 Score=311.04 Aligned_cols=246 Identities=26% Similarity=0.342 Sum_probs=198.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
..||.|.||.||-+...+ +|+-.|+|.++... ....+...+|+.++..++|||+|+++|+-...+..+|.||||++|
T Consensus 1241 ~~Ig~G~fG~VYtavN~~-tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1241 NFIGGGTFGKVYTAVNLD-TGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred cccCCcceeeeEEeecCC-ccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 569999999999999875 78899999875422 334467889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC---ccee
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS---RTHT 665 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~---~~~~ 665 (799)
+|.+++......++.....+..|++.|++|||++ +|+||||||.||+|+.+|.+|++|||.|..+..... ....
T Consensus 1320 sLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1320 SLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred cHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence 9999998877777777778889999999999999 999999999999999999999999999998865431 1122
Q ss_pred eeccCCcccccccccCCC---CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 666 MIRGTRGYVAPEWFKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~---~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
...||+.|||||++.+.. ..-+.||||+||++.||+||++|+.....+= . .+-.+..|...+
T Consensus 1397 ~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~------a-IMy~V~~gh~Pq-------- 1461 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW------A-IMYHVAAGHKPQ-------- 1461 (1509)
T ss_pred hhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh------H-HHhHHhccCCCC--------
Confidence 356999999999997643 5668999999999999999999997543210 1 112234444322
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+......-.+++..||+.||.+|=++.|+++.
T Consensus 1462 -~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 -IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred -CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 122244555679999999999999888777654
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=279.10 Aligned_cols=259 Identities=22% Similarity=0.289 Sum_probs=190.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec-ccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||+|++... .....+.+..|++++.+++||||+++.+++.. ....++++||
T Consensus 13 ~~~~~ig~g~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 13 VDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred EEEEeecccCCeEEEEEEECC-CCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 345789999999999999774 6789999987532 22334678899999999999999999998865 5578899999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+ +++|.+++.. ..+++.....++.|+++||+|||+. +|+|+||+|+||++++++.+||+|||++.......
T Consensus 92 ~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~---- 162 (328)
T cd07856 92 L-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQM---- 162 (328)
T ss_pred h-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCCCc----
Confidence 8 5688888764 3567888889999999999999998 89999999999999999999999999987543211
Q ss_pred eeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCceeEee
Q 038294 665 TMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGRLDVLV 736 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~ 736 (799)
....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.+.. .+.+..+......
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd07856 163 TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFV 242 (328)
T ss_pred CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHH
Confidence 22346788999998866 568999999999999999999999986543322111111100 0000000000000
Q ss_pred cC-CCCCc-----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 737 DS-DEPAM-----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 737 d~-~~~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.. ..... ......+.+.+++.+||+.+|++|||+.+++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 243 QSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000 001223678889999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=270.20 Aligned_cols=257 Identities=26% Similarity=0.319 Sum_probs=196.1
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--c-hhh----HHHHHHHHHHhcccccccccceeeeee-cc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--A-QER----EREFKSEVSAIGRTHHKNLVQLLGFCD-EA 575 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~-~~~----~~~~~~E~~~l~~l~h~niv~l~g~~~-~~ 575 (799)
+..+-+.+.||+|||+.|||+.+.. ..+.||||+-.-. . .+. .+...+|..+.+.++||.||++++++. +.
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~-EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLT-EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccc-hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 3444456789999999999998864 5789999986321 1 111 234678999999999999999999995 45
Q ss_pred cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccC
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGL 652 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGl 652 (799)
+..+-|+||++|.+|+-+|+..+.++++.+..|+.||+.||.||.+. +++|||.||||.||||-+ -|.+||+|||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 56789999999999999999999999999999999999999999985 689999999999999954 57899999999
Q ss_pred cccccCCCCc------ceeeeccCCcccccccccCC----CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH
Q 038294 653 SKLLLSDQSR------THTMIRGTRGYVAPEWFKNA----PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW 722 (799)
Q Consensus 653 a~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~----~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~ 722 (799)
++.+..+... ......||.+|++||.+--+ +++.|+||||.||++|+.+-|++||....... ..+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dIL--- 694 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DIL--- 694 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HHH---
Confidence 9998654322 22335699999999988533 57899999999999999999999998653321 111
Q ss_pred HHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 723 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
.+..+.....-..+. .+....+...+|++||++.-++|....++.
T Consensus 695 -----qeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 -----QENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred -----hhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111111111111111 112233556799999999999998877764
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=280.15 Aligned_cols=266 Identities=24% Similarity=0.279 Sum_probs=191.3
Q ss_pred HHHHHHhhch--hhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 500 NELKEATGGF--KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 500 ~~l~~~~~~~--~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
.++...+..+ .+.||+|+||.||+|.... +++.||+|+++... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcC-CCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3444444443 4679999999999998764 67899999986532 22345688899999999999999999988533
Q ss_pred ------cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 576 ------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 576 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEec
Confidence 3356777776 7899887764 4688999999999999999999998 899999999999999999999999
Q ss_pred ccCcccccCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH------
Q 038294 650 FGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW------ 722 (799)
Q Consensus 650 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~------ 722 (799)
||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+...
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998764321 223357889999999866 56889999999999999999999998644322111000000
Q ss_pred -HHHHHhcCc-------eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 723 -AYDCYAEGR-------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 723 -~~~~~~~~~-------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+.... +......... .........+.+++.+|++.||++||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 000000000 0000000000 0000123467889999999999999999998854
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=282.93 Aligned_cols=257 Identities=24% Similarity=0.296 Sum_probs=190.9
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccc------eee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------RLL 580 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l 580 (799)
+.+.||+|++|.||+|.... +++.||+|++... .....+.+.+|+.++++++|+|++++++++..... .++
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTK-TGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYL 97 (343)
T ss_pred EEEEeccCCceEEEEEEECC-CCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEE
Confidence 45789999999999999875 5789999998642 22334567889999999999999999998866554 789
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|+||+ +++|.+++.. ..+++..+.+++.|+++||+|||+. +|+|+||||+||++++++.+||+|||++......
T Consensus 98 v~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~- 171 (343)
T cd07851 98 VTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE- 171 (343)
T ss_pred EEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-
Confidence 99998 5699888865 4689999999999999999999998 8999999999999999999999999999865332
Q ss_pred CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCce
Q 038294 661 SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGRL 732 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~ 732 (799)
.....++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.... ...+.....
T Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESA 248 (343)
T ss_pred ---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhH
Confidence 222346888999999865 467899999999999999999999986543221111100000 000000000
Q ss_pred eEeecCCC----CC--ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 DVLVDSDE----PA--MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 ~~~~d~~~----~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........ .. .......+.+.+++.+||+.+|++|||+.||++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 249 RNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000000 00 000112567889999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-31 Score=258.43 Aligned_cols=266 Identities=22% Similarity=0.216 Sum_probs=201.7
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeec----ccceeeEEeec
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE----ALNRLLVYEFM 585 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~ 585 (799)
++||-|-.|.|..+..+. +++.+|+|++.... ..++|+++.-.. .|||||.+++++.. ...+++|||.|
T Consensus 68 qvLG~GinGkV~~C~~k~-T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m 141 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKR-TQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM 141 (400)
T ss_pred hhhccccCCceEEEEecc-chhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence 689999999999998875 78899999996532 236677776666 59999999999853 33457899999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCC
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 660 (799)
+||.|...+.+.. .++++++-+|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|||+|+.-...
T Consensus 142 eGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~- 217 (400)
T KOG0604|consen 142 EGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP- 217 (400)
T ss_pred cchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCC-
Confidence 9999999998775 488899999999999999999998 9999999999999964 667999999999865432
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
......+-|+.|.|||++...+|+...|+||+||++|-|++|-.||...-... +..-....++.|..+ .
T Consensus 218 -~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a----ispgMk~rI~~gqy~------F 286 (400)
T KOG0604|consen 218 -GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKRRIRTGQYE------F 286 (400)
T ss_pred -ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc----CChhHHhHhhccCcc------C
Confidence 22333456999999999999999999999999999999999999998543211 111233344444321 1
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCCCceeeccc
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSFSIAVT 797 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p~~~~~~~~ 797 (799)
+..--...++...++++.+|..+|.+|.|+.|++..==-.-....|..|...+.++.
T Consensus 287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t~~~l~ 343 (400)
T KOG0604|consen 287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLSTSRMLK 343 (400)
T ss_pred CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchhhhhcc
Confidence 222223445566779999999999999999998754211122334455555555544
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=266.49 Aligned_cols=222 Identities=20% Similarity=0.170 Sum_probs=177.8
Q ss_pred cccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCChhhhhh
Q 038294 516 GSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 595 (799)
Q Consensus 516 G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 595 (799)
|.+|.||++..+. +++.+|+|+++... .+..|...+....|||++++++++.+....+++|||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~-~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTR-TQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEcc-CCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 8899999999875 67899999996532 23345555556679999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccc
Q 038294 596 AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675 (799)
Q Consensus 596 ~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 675 (799)
....+++.....++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+....... ....++..|+|
T Consensus 78 ~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~a 150 (237)
T cd05576 78 KFLNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYCA 150 (237)
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccccC
Confidence 777789999999999999999999997 99999999999999999999999999876553221 12235677999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHH
Q 038294 676 PEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMI 755 (799)
Q Consensus 676 PE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 755 (799)
||.+.+..++.++||||+|+++|||++|+.|+....... .. ......+ ....+.+.++
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-------------~~-----~~~~~~~----~~~~~~~~~l 208 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-------------NT-----HTTLNIP----EWVSEEARSL 208 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-------------cc-----ccccCCc----ccCCHHHHHH
Confidence 999988889999999999999999999998764321100 00 0000111 1234567889
Q ss_pred HHHhcccCCCCCCCHHH
Q 038294 756 AMWCIREDPSKRPTMKV 772 (799)
Q Consensus 756 ~~~Cl~~dP~~RPt~~e 772 (799)
+.+|++.||++||++.+
T Consensus 209 i~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 209 LQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHccCCHHHhcCCCc
Confidence 99999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=301.80 Aligned_cols=143 Identities=33% Similarity=0.449 Sum_probs=128.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.++||+|+||.||+|.... +++.||||+++... ......+..|+.+++.++|+||+++++.+......++||||
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKN-NSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEecCCCeEEEEEEECC-CCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 356789999999999999874 67899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
+++++|.+++.....+++...++|+.||+.||+|||.. +|+||||||+||||+.++.+||+|||+++
T Consensus 86 ~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 86 LIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998777888999999999999999999997 89999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=282.60 Aligned_cols=237 Identities=23% Similarity=0.267 Sum_probs=193.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+...+|.|+|+.|-++.... +++..+||++... ..+-.+|+.++.+. +||||+++.+.+.++.+.++|||.+.
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~-t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~ 399 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSP-TDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLD 399 (612)
T ss_pred ccccccCCCCccceeeeeccc-cccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeeehhcc
Confidence 455679999999999999875 5788999999764 22335566666555 79999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-cCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL-DNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl-~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++-|.+.+...+... ..+.+|+.+|+.|+.|||.+ +++||||||+|||+ ++.++++|+|||.++..... ..
T Consensus 400 g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~----~~ 471 (612)
T KOG0603|consen 400 GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS----CD 471 (612)
T ss_pred ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh----hc
Confidence 998888877665555 67778999999999999998 99999999999999 58999999999999977554 11
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..+-|..|.|||++....|++++|+||||++||+||+|+.||.....+. -++..+..++..
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~-------ei~~~i~~~~~s------------ 532 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI-------EIHTRIQMPKFS------------ 532 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH-------HHHHhhcCCccc------------
Confidence 2234778999999999999999999999999999999999998654431 133333333221
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...++...+++.+||+.||.+||+|.++...
T Consensus 533 ~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 533 ECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 3445667789999999999999999998643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=295.19 Aligned_cols=267 Identities=22% Similarity=0.265 Sum_probs=211.6
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
...+.+.++||+|+||.|..++++. +++.+|+|++.+.. .....-|..|-.+|..-+.+-|+.+.-.|.+..++|+
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~-t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKS-TEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeec-cccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 3344566889999999999999985 68899999997632 2334568999999999899999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|||||+||+|..++.....++++.+.-++..|..||.-||+- |+|||||||+|||||..|++||+|||.+-.+..+.
T Consensus 153 VMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG 229 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG 229 (1317)
T ss_pred EEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence 999999999999999888899998889999999999999997 99999999999999999999999999998887666
Q ss_pred CcceeeeccCCccccccccc----C-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 661 SRTHTMIRGTRGYVAPEWFK----N-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~----~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.-.....+|||.|++||++. + +.|...+|-||+||++|||+.|..||+.+.-.+....+..+ . ..
T Consensus 230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~h------k----~~ 299 (1317)
T KOG0612|consen 230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNH------K----ES 299 (1317)
T ss_pred cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhch------h----hh
Confidence 65566678999999999995 3 57899999999999999999999999977544432222211 0 00
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC---HHHHHHHH-------hcCcCCCCCCCC
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT---MKVVLQML-------EGLLEVPNPPCP 789 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~evl~~L-------~~~~~~~~p~~p 789 (799)
+ ..|. ....++...++|+..+. +|+.|.. ++++-..- ++|-+..+|-.|
T Consensus 300 l--~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 300 L--SFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred c--CCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 1 1111 12244556667776664 7888888 77776432 334445555555
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=261.14 Aligned_cols=239 Identities=28% Similarity=0.363 Sum_probs=194.9
Q ss_pred ccceEEEEEEeCCCCeEEEEEEccccchhh-HHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCChhhhhh
Q 038294 517 SFGIVYKGVLKSASGKAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 595 (799)
Q Consensus 517 ~fG~Vykg~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 595 (799)
+||.||+|+... +++.+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~-~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKK-TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECC-CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999874 57899999997654443 6789999999999999999999999999999999999999999999998
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccc
Q 038294 596 AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675 (799)
Q Consensus 596 ~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 675 (799)
....+++..+..++.++++++.|||+. +++|+||+|+||++++++.++|+|||.+....... ......++..|++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 766689999999999999999999998 99999999999999999999999999998765432 2233457889999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHH
Q 038294 676 PEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMI 755 (799)
Q Consensus 676 PE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 755 (799)
||.+....++.++||||||+++++|++|..|+......+ . ..+....+.... ..........+.++
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~---~----~~~~~~~~~~~~-------~~~~~~~~~~~~~~ 220 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL---E----LFKKIGKPKPPF-------PPPEWKISPEAKDL 220 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH---H----HHHHHhccCCCC-------ccccccCCHHHHHH
Confidence 999998889999999999999999999999987532111 0 111111111110 00000034578889
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 038294 756 AMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 756 ~~~Cl~~dP~~RPt~~evl~ 775 (799)
+.+|+..+|++||++.++++
T Consensus 221 i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 221 IRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHccCCchhccCHHHHhh
Confidence 99999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=265.38 Aligned_cols=245 Identities=28% Similarity=0.329 Sum_probs=197.9
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhccc-ccccccceeeeeeccc
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 576 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 576 (799)
.++....+|..+||+|+||.|.++.-+. +.+.+|||++++.-- ...+--+.|-++|+.. +-|.++++..++..-+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkg-tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKG-TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccC-cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence 3455556888999999999999998774 568899999976321 1222235677777776 5788999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
.++.||||+.+|+|--++.+..++.+..+.-+|.+||-||-|||++ +||.||||.+|||||.+|++||+|||+.+.-
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeeccccccc
Confidence 9999999999999999999888888899999999999999999998 9999999999999999999999999999853
Q ss_pred cCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
-- ...+....+||+.|+|||++...+|..++|-|||||+||||+.|+.||+++.+++.-.. +.+-
T Consensus 501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~a--------I~eh------ 565 (683)
T KOG0696|consen 501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQA--------IMEH------ 565 (683)
T ss_pred cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--------HHHc------
Confidence 22 23344567899999999999999999999999999999999999999998876652211 1111
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCC
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRP 768 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP 768 (799)
...++...+.+...+....|.+.|.+|.
T Consensus 566 ----nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 ----NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ----cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 1122334445566677777888898884
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=274.88 Aligned_cols=241 Identities=24% Similarity=0.412 Sum_probs=192.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.||.|.||+||-|+.+. +|+.||||++.+ ...+.+.++++|+.+|++++||.||.+.-.|+..+..++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRk-tGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRK-TGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecc-cCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 679999999999999985 799999999975 3455668899999999999999999999999999999999999955
Q ss_pred Chhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCCCcc
Q 038294 589 TLANLIFA--IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 589 sL~~~l~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+..++|.. ...+++..-.-+..||+.||.|||.. +|+|+||||+||||.+ --++||+|||.|+.+....-
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 55555443 24677777777889999999999998 9999999999999964 45799999999999865432
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
...++||+.|+|||+++++.|...-|+||.||++|--|+|.-||....+-.++ + .+- . -..+..
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--I--------QNA---a---FMyPp~ 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--I--------QNA---A---FMYPPN 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--h--------hcc---c---cccCCC
Confidence 23467999999999999999999999999999999999999999754221110 1 110 0 011222
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
.-.+.....+++|...||..-++|-+...-+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 2334555677888888998888888876543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=266.83 Aligned_cols=276 Identities=20% Similarity=0.302 Sum_probs=211.1
Q ss_pred CCCCccccChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc--ccc---
Q 038294 490 SETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH--HKN--- 564 (799)
Q Consensus 490 ~~~~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~n--- 564 (799)
...+..+|...+.....+.+...+|+|+||.|-++.+... +..||||+++..... .+..+-|+++++++. .|+
T Consensus 74 D~dGH~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~-~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~ 151 (415)
T KOG0671|consen 74 DKDGHYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRET-KEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKF 151 (415)
T ss_pred CCCceEEEEeccccccceehhhhhcCCcccceEEEeecCC-CceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCce
Confidence 3445567777777777788889999999999999998864 889999999875433 345567899999983 222
Q ss_pred -ccceeeeeecccceeeEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 565 -LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 565 -iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
+|.+.+++.-..+.+||+|.+ |-|+.++|..+. ..+..++..|+.|++++++|||+. +++|.||||+|||+.+
T Consensus 152 rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvs 227 (415)
T KOG0671|consen 152 RCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVS 227 (415)
T ss_pred EEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEec
Confidence 677888899999999999988 559999998764 667889999999999999999998 9999999999999931
Q ss_pred --------------------CCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHH
Q 038294 642 --------------------YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701 (799)
Q Consensus 642 --------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ell 701 (799)
+..+||+|||.|....... ..++.|..|+|||++.+-.++.++||||+||||.|+.
T Consensus 228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Ely 303 (415)
T KOG0671|consen 228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELY 303 (415)
T ss_pred cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEee
Confidence 3458999999998653332 4566799999999999999999999999999999999
Q ss_pred hCCcCCchhhhhhcchhHHHHH-------------HHHHhcCcee-----------EeecCCCC----CccCHHHHHHHH
Q 038294 702 CCRRSVEMEVEEEGRAILTDWA-------------YDCYAEGRLD-----------VLVDSDEP----AMADRSRLQKWL 753 (799)
Q Consensus 702 tg~~p~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~-----------~~~d~~~~----~~~~~~~~~~l~ 753 (799)
+|..-|......+....+...+ .+....++++ ...++..+ -.....+..+++
T Consensus 304 tG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~Lf 383 (415)
T KOG0671|consen 304 TGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLF 383 (415)
T ss_pred ccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHH
Confidence 9999887665443322222111 1111122221 11111111 112345666799
Q ss_pred HHHHHhcccCCCCCCCHHHHHH
Q 038294 754 MIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 754 ~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+++..+|.+||.+|+|+.|+++
T Consensus 384 DLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 384 DLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHccCccccccHHHHhc
Confidence 9999999999999999999875
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-30 Score=232.89 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=192.4
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.|+||+|.||+||||+.++ +++.||+|+++- ..+.......+|+.+++.++|+|||++++....+....+|+|||..
T Consensus 7 mekigegtygtvfkarn~~-t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq 85 (292)
T KOG0662|consen 7 MEKIGEGTYGTVFKARNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ 85 (292)
T ss_pred HHhhcCCcceeeEecccCC-ccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH
Confidence 4789999999999999875 678999998753 3344456788999999999999999999999999999999999954
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|..+.... ..++.+....++.|+++||.|+|++ .+.||||||+|.||+.+|..|++|||+++.+.-.- +....
T Consensus 86 -dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-rcysa 160 (292)
T KOG0662|consen 86 -DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSA 160 (292)
T ss_pred -HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-Eeeec
Confidence 777777654 5788889999999999999999998 89999999999999999999999999999774332 22334
Q ss_pred eccCCcccccccccCCC-CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH--HhcCc---eeEeecCCC
Q 038294 667 IRGTRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC--YAEGR---LDVLVDSDE 740 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~-~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~~~d~~~ 740 (799)
.+.|..|++|.++.+.+ |+...|+||-||++.|+....+|.....+...+ +....+.+ ..+.. +..+.|...
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t~lpdyk~ 238 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMTKLPDYKP 238 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCccccCCCCcc
Confidence 45689999999998764 789999999999999999877776544332221 11111111 11111 111222111
Q ss_pred CCcc----CH-HHHH----HHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 741 PAMA----DR-SRLQ----KWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 741 ~~~~----~~-~~~~----~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
-... .. ..+. .=.++....+.-+|..|.++++.++.
T Consensus 239 yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 239 YPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred cCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111 11 1111 12456777788899999999987753
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-31 Score=252.85 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=192.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeecc--------cceee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--------LNRLL 580 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--------~~~~l 580 (799)
.+||+|.||.||++..+. +++.||+|+.-. ..+.--....+|+++|..++|+|++.++..|... ...++
T Consensus 23 ~kigqGtfgeVFkAr~~n-~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKN-TGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HhcCCchHHHHHHHhhcC-ccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 579999999999999875 577788887632 2233335678899999999999999999998432 23689
Q ss_pred EEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|+.+++. +|.-+|... ..++...+.+++.++..||.|+|.. .|+|||+||.|+||+.++.+||+|||+++.+...
T Consensus 102 Vf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~ 177 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTS 177 (376)
T ss_pred eHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecc
Confidence 9999987 888888765 5788889999999999999999998 8999999999999999999999999999876432
Q ss_pred C---CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHH----HHhcCc
Q 038294 660 Q---SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD----CYAEGR 731 (799)
Q Consensus 660 ~---~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~ 731 (799)
. ....+..+.|..|++||.+.+ +.|+++.|||+-||++.||.++...+....+......+...... .|.+-.
T Consensus 178 ~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 178 KNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred cccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 2 122334556999999998876 47899999999999999999999988877655443333221111 011100
Q ss_pred eeEeecCC----CCCcc---CHHH------HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 LDVLVDSD----EPAMA---DRSR------LQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ~~~~~d~~----~~~~~---~~~~------~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
-..+.... ++... -.+. ....++++..++..||.+||++++++.
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 00000000 00000 0111 125678899999999999999998864
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=278.50 Aligned_cols=249 Identities=28% Similarity=0.391 Sum_probs=202.1
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeee-----ccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCD-----EALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~-----~~~~~~ 579 (799)
++.|.+.||+|.+|.||+++.+. +++-.|+|++... ....+++..|.++++.. +|||++.++|++. .++.+|
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~-~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVK-TGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeee-cCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 44567899999999999999875 6788899988654 34456788899999987 6999999999984 456789
Q ss_pred eEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 580 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
||||||.+|+..|+++.. ..+.|..+.-|+..+++|+.+||.+ .+||||||-.|||++.++.+||.|||++..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 999999999999999865 4678999999999999999999998 89999999999999999999999999998875
Q ss_pred CCCCcceeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
....+..+ ..||+.|||||++. ...|+.++|+||||++..||--|..|+...-+.. .++
T Consensus 175 sT~grRnT-~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aLF------------- 238 (953)
T KOG0587|consen 175 STVGRRNT-FIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--ALF------------- 238 (953)
T ss_pred cccccccC-cCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hhc-------------
Confidence 54444333 45999999999985 3357889999999999999999999876432211 000
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...-.+.+.-..+....+++.++|..||.+|-++||++.++++
T Consensus 239 ~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0011122222346778899999999999999999999998775
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=275.01 Aligned_cols=256 Identities=21% Similarity=0.283 Sum_probs=175.4
Q ss_pred hchhhhcCccccceEEEEEEe---------------CCCCeEEEEEEccccchhhHHHH--------------HHHHHHh
Q 038294 507 GGFKEELGRGSFGIVYKGVLK---------------SASGKAIAVKKLDRLAQEREREF--------------KSEVSAI 557 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~---------------~~~~~~vavK~l~~~~~~~~~~~--------------~~E~~~l 557 (799)
+.+.++||+|+||+||+|.+. ...++.||||++........++| ..|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 345678999999999999752 12346899999865433333333 3466677
Q ss_pred cccccccc-----cceeeeeec--------ccceeeEEeecCCCChhhhhhcC------------------------CCC
Q 038294 558 GRTHHKNL-----VQLLGFCDE--------ALNRLLVYEFMGNGTLANLIFAI------------------------PKP 600 (799)
Q Consensus 558 ~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~------------------------~~~ 600 (799)
.+++|.++ ++++++|.. ....+|||||+++++|.++++.. ..+
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766554 678888753 34679999999999999988632 123
Q ss_pred CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCccccccccc
Q 038294 601 DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680 (799)
Q Consensus 601 ~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 680 (799)
+|..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+............+++.|+|||.+.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 5778889999999999999998 8999999999999999999999999999765433222222223478999999875
Q ss_pred CCCC----------------------CcchhHHHHHHHHHHHHhCCc-CCchhhhhhc-----chhHHHHHHHHHhcCce
Q 038294 681 NAPV----------------------SAKVDVYSFGVMLLEIICCRR-SVEMEVEEEG-----RAILTDWAYDCYAEGRL 732 (799)
Q Consensus 681 ~~~~----------------------s~k~DVwS~Gvll~elltg~~-p~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 732 (799)
.... ..+.||||+||+++||+++.. |+........ ......| ..+.....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~~~~~~ 461 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMYKGQKY 461 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--HhhcccCC
Confidence 4321 234799999999999999875 5542211000 0111111 11111111
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDP---SKRPTMKVVLQ 775 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~evl~ 775 (799)
+.. ......+...+++.++|..+| .+|+|++|+++
T Consensus 462 ----~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 ----DFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ----Ccc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111 111224567788999998766 68999999985
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=282.55 Aligned_cols=256 Identities=22% Similarity=0.235 Sum_probs=164.4
Q ss_pred hchhhhcCccccceEEEEEEeCCC----CeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeee------eeccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSAS----GKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGF------CDEAL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~----~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~------~~~~~ 576 (799)
+.+.+.||+|+||.||+|++.. + +..||+|++..... .+.+..| .+....+.+++.++.. +..+.
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~-~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVN-KQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcC-CccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 3456789999999999999875 4 67899999864221 1111111 1112222233222221 24566
Q ss_pred ceeeEEeecCCCChhhhhhcCCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 038294 577 NRLLVYEFMGNGTLANLIFAIPK--------------------PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQN 636 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~N 636 (799)
..++|+||+++++|.+++..... .....+..++.||+.||+|||+. +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 78999999999999998865321 11233557999999999999998 89999999999
Q ss_pred eEEcC-CCceEEccccCcccccCCCCcceeeeccCCcccccccccCC----------------------CCCcchhHHHH
Q 038294 637 ILLDN-YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA----------------------PVSAKVDVYSF 693 (799)
Q Consensus 637 ILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----------------------~~s~k~DVwS~ 693 (799)
||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++|||||
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99986 68999999999987644333333445689999999965322 23456799999
Q ss_pred HHHHHHHHhCCcCCchhhhhhc------chhHHHHHHHHHhcCceeEeecCCCCC--ccCHHHHHHHHHHHHHhcccCCC
Q 038294 694 GVMLLEIICCRRSVEMEVEEEG------RAILTDWAYDCYAEGRLDVLVDSDEPA--MADRSRLQKWLMIAMWCIREDPS 765 (799)
Q Consensus 694 Gvll~elltg~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~~l~~l~~~Cl~~dP~ 765 (799)
||+||||+++..+.......-. ...+..|... ... . ..+.... ...........+++.+||+.||+
T Consensus 366 GviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~-~----~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKL-VEP-R----ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHh-hcc-c----cchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 9999999997766443211000 0000011000 000 0 0000000 00000112345799999999999
Q ss_pred CCCCHHHHHHH
Q 038294 766 KRPTMKVVLQM 776 (799)
Q Consensus 766 ~RPt~~evl~~ 776 (799)
+|||+.|+++.
T Consensus 440 kR~ta~e~L~H 450 (566)
T PLN03225 440 QRISAKAALAH 450 (566)
T ss_pred cCCCHHHHhCC
Confidence 99999999874
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-30 Score=249.86 Aligned_cols=262 Identities=25% Similarity=0.345 Sum_probs=197.9
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecc-----cceeeEEe
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~lv~e 583 (799)
+.||.|+||.||..++.. +|+.||+|++...-. ..-+.+..|+++|..++|.|++..+++..-. .+.|++.|
T Consensus 59 RPIGYGAFGVVWsVTDPR-dgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPR-SGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CcccccceeEEEeccCCC-CccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 579999999999998874 789999999875432 2335788899999999999999988876433 24578888
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
.|.. +|.+++-....++-..+.-+..||++||.|||+. +|.||||||.|.|++.|..+||+|||+++....++...
T Consensus 138 LmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h 213 (449)
T KOG0664|consen 138 LMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN 213 (449)
T ss_pred HHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhh
Confidence 8854 8888888877888888888999999999999998 99999999999999999999999999999887777777
Q ss_pred eeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH-------HHHhcCceeEe
Q 038294 664 HTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY-------DCYAEGRLDVL 735 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 735 (799)
.+..+.|..|+|||++.+. .|+.+.||||.||++.||+-.+.-|....+-+....+.+... ..--+|....+
T Consensus 214 MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~ 293 (449)
T KOG0664|consen 214 MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHV 293 (449)
T ss_pred hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHh
Confidence 7777789999999999876 689999999999999999988888876554443333332211 11111111100
Q ss_pred e-----cCCCCCc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 736 V-----DSDEPAM----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 736 ~-----d~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
+ .+..+.. .....-.+.+.+.+.++..||+.|.+..+.+..+
T Consensus 294 LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 294 LRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0 0111110 0111222345677788999999999999887665
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=246.26 Aligned_cols=245 Identities=24% Similarity=0.319 Sum_probs=198.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+..+||+|+|..|..+.++. +.+.+|+|++++.- .+...-.+.|-.+.... +||.+|.|..++...+..+.|.||
T Consensus 254 ll~vigrgsyakvl~~~~~~-t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffviey 332 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKK-TDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEY 332 (593)
T ss_pred eeeeecCcchhhhhheehcc-cceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEE
Confidence 34789999999999999985 56889999987532 12223345666666665 799999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|+|--++.+..+++++.+.-+...|..||.|||+. +||.||||.+|||+|..|.+||+|+|+.+.--.+ ....
T Consensus 333 v~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~-gd~t 408 (593)
T KOG0695|consen 333 VNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP-GDTT 408 (593)
T ss_pred ecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCC-Cccc
Confidence 99999999998888999999999999999999999998 9999999999999999999999999999864333 3344
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+||+.|+|||++++..|...+|-|++||+++||+.|+.||+..........-.+++.+.+.+..+..
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri---------- 478 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI---------- 478 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc----------
Confidence 5678999999999999999999999999999999999999999865443333344455555555543321
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRP 768 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RP 768 (799)
++..+-+...++..-|.+||.+|.
T Consensus 479 prslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhc
Confidence 222233455677778899999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=259.34 Aligned_cols=237 Identities=24% Similarity=0.261 Sum_probs=196.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccc---cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
..||-|+||.|=+...+. ....+|+|.+++ .....++....|-.+|...+.|.||+++--|.+....|++||-|-|
T Consensus 426 aTLGvGgFGRVELV~~~~-~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClG 504 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNS-QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLG 504 (732)
T ss_pred hhcccCccceEEEEEecc-cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcC
Confidence 359999999999988864 223478887754 3455567788999999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~ 667 (799)
|.|...|+....++.....-++..+++|++|||.. +||.|||||+|.+||.+|-+||.|||+|+.+... ...-..
T Consensus 505 GElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~KTwTF 579 (732)
T KOG0614|consen 505 GELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RKTWTF 579 (732)
T ss_pred chhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC--Cceeee
Confidence 99999999999999888888999999999999998 9999999999999999999999999999987543 233456
Q ss_pred ccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHH
Q 038294 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747 (799)
Q Consensus 668 ~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 747 (799)
+||+.|.|||++.++.++.++|.||+|+++|||++|..||...++-... ..+..|. | ....++.
T Consensus 580 cGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY--------n~ILkGi-----d---~i~~Pr~ 643 (732)
T KOG0614|consen 580 CGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY--------NLILKGI-----D---KIEFPRR 643 (732)
T ss_pred cCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH--------HHHHhhh-----h---hhhcccc
Confidence 8999999999999999999999999999999999999999977654322 2222221 0 0111233
Q ss_pred HHHHHHHHHHHhcccCCCCCCC
Q 038294 748 RLQKWLMIAMWCIREDPSKRPT 769 (799)
Q Consensus 748 ~~~~l~~l~~~Cl~~dP~~RPt 769 (799)
......+++.+....+|.+|.-
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhc
Confidence 3445667888888999999976
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=226.30 Aligned_cols=195 Identities=29% Similarity=0.422 Sum_probs=163.9
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.||+|++|.|-+-++.. +|..+|+|++... ..+..+..+.|+.+..+. .+|.+|.++|........++.||.|.-
T Consensus 51 i~elGrGayG~vekmrh~~-sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 51 IEELGRGAYGVVEKMRHIQ-SGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhcCCccchhhheeecc-CCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 4679999999998888874 7899999999653 345567788899887765 799999999999888899999999954
Q ss_pred CChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 588 GTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 588 gsL~~~l~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+.+-. .....++...-+|+..+.+||.|||++ ..+||||+||+|||++.+|++||+|||++-.+.+.-..+
T Consensus 130 -Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt 206 (282)
T KOG0984|consen 130 -SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKT 206 (282)
T ss_pred -hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHH
Confidence 7776654 446788889999999999999999987 589999999999999999999999999998775443333
Q ss_pred eeeeccCCccccccccc----CCCCCcchhHHHHHHHHHHHHhCCcCCchh
Q 038294 664 HTMIRGTRGYVAPEWFK----NAPVSAKVDVYSFGVMLLEIICCRRSVEME 710 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~----~~~~s~k~DVwS~Gvll~elltg~~p~~~~ 710 (799)
. -.|-..|||||.+. .+.|+.|+||||||+.+.||.+++.|+..-
T Consensus 207 ~--daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 207 M--DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred H--hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 2 23566899999884 347899999999999999999999998743
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=266.85 Aligned_cols=238 Identities=29% Similarity=0.377 Sum_probs=182.0
Q ss_pred hhhcCccccce-EEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecCC
Q 038294 510 KEELGRGSFGI-VYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 510 ~~~lG~G~fG~-Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.+|.|+.|+ ||+|... +++||||++-. +...-..+|+..|+.- +|||||++++.-.+....||..|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye---~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~- 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE---GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA- 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC---CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-
Confidence 36789998874 7999984 78999999853 3334557899999887 69999999999889999999999995
Q ss_pred CChhhhhhcC-CCC---CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCceEEccccCcccccC
Q 038294 588 GTLANLIFAI-PKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-----YFSAKISDFGLSKLLLS 658 (799)
Q Consensus 588 gsL~~~l~~~-~~~---~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-----~~~~kl~DfGla~~~~~ 658 (799)
.+|.+++... ... .-...+.+..|++.||++||+- +||||||||+||||+. ...++|+|||+++.+..
T Consensus 587 ~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 587 CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 4999999874 111 1123467888999999999996 9999999999999975 35799999999999876
Q ss_pred CCCcc--eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhC-CcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 659 DQSRT--HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICC-RRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 659 ~~~~~--~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
+.... .....||-+|+|||.+....-+.++||||+||++|+.++| +.||....+.+. .+ ..+.....
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NI--------l~~~~~L~ 733 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NI--------LTGNYTLV 733 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hh--------hcCcccee
Confidence 54322 3345699999999999998888899999999999999997 788875432211 11 11111110
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
.-... .+. ...++|.+|++++|..||++.+|+
T Consensus 734 ~L~~~-----~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 734 HLEPL-----PDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred eeccC-----chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 00000 111 567799999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=253.94 Aligned_cols=208 Identities=23% Similarity=0.340 Sum_probs=176.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.||-|+||.|-++.-.+ +...+|+|.|++... ......+.|-.+|+.-+.+-||+|+-.|.+.+.+|.||+|++|
T Consensus 635 k~iGvGAFGeV~Lv~KvD-T~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPG 713 (1034)
T KOG0608|consen 635 KTIGVGAFGEVCLVRKVD-TRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPG 713 (1034)
T ss_pred eeecccccceeEEEeecc-hhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCC
Confidence 459999999999987554 567899999976332 2234678899999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc---------C
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL---------S 658 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~---------~ 658 (799)
|++-.+|.+..-+++....-++.++..|+++.|.. ++|||||||+|||||.+|++||+||||+.-+. .
T Consensus 714 GDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 714 GDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred ccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 99999999988899999999999999999999987 99999999999999999999999999986431 0
Q ss_pred CC-C-------------------------------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcC
Q 038294 659 DQ-S-------------------------------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706 (799)
Q Consensus 659 ~~-~-------------------------------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p 706 (799)
.. . ......+||+.|+|||++....++..+|-||.||+||||+-|+.|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 00 0 011124599999999999999999999999999999999999999
Q ss_pred CchhhhhhcchhHHHH
Q 038294 707 VEMEVEEEGRAILTDW 722 (799)
Q Consensus 707 ~~~~~~~~~~~~~~~~ 722 (799)
|-.....+.+..+..|
T Consensus 871 f~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 871 FLADTPGETQYKVINW 886 (1034)
T ss_pred ccCCCCCcceeeeeeh
Confidence 9988777666555444
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-26 Score=231.50 Aligned_cols=210 Identities=38% Similarity=0.578 Sum_probs=183.1
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCChh
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLA 591 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 591 (799)
||+|++|.||++.... +++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~-~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKK-TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecC-CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999864 5789999999764332 3467899999999999999999999999989999999999999999
Q ss_pred hhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCCcceeeecc
Q 038294 592 NLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRTHTMIRG 669 (799)
Q Consensus 592 ~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~~~g 669 (799)
+++... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 999876 5788999999999999999999998 9999999999999999 89999999999987643321 1222346
Q ss_pred CCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHH
Q 038294 670 TRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR 748 (799)
Q Consensus 670 t~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~ 748 (799)
...|++||.+... ..+.+.|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7789999999887 788999999999999998
Q ss_pred HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 749 LQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 749 ~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+.+++..|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 356679999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=216.11 Aligned_cols=256 Identities=18% Similarity=0.317 Sum_probs=187.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeeccc--ceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL--NRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~lv~e~ 584 (799)
.+.+++|+|.++.|+.|.... +.+.++||+++.. ..+.+.+|+++|+.+. ||||++|++...+.. ...||+||
T Consensus 41 eivrk~GRGKYSEVFeg~~~~-~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 41 EIVRKVGRGKYSEVFEGINIT-NNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHHcCccHhhHhcccccC-CCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 456789999999999998654 5688999999864 3457789999999997 999999999997654 45799999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+.+.+...+. +.++-..+.-.+.++++||.|+|+. ||+|||+||.|++||. ...++|+|+|+|...+......
T Consensus 117 v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYn 190 (338)
T KOG0668|consen 117 VNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYN 190 (338)
T ss_pred hccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceee
Confidence 9998766555 3455556677889999999999998 9999999999999995 5679999999999886554322
Q ss_pred eeeeccCCccccccccc-CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHHH-----HHHHHhc------C
Q 038294 664 HTMIRGTRGYVAPEWFK-NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTDW-----AYDCYAE------G 730 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~-~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~~-----~~~~~~~------~ 730 (799)
..+.+..|--||.+- ...|+..-|+|||||+|.+|+-.+.||.......++ ..+... ....+.. .
T Consensus 191 --VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 191 --VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred --eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 234577889999885 456889999999999999999999999755332221 111111 1111111 1
Q ss_pred ceeEeecCC--------CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSD--------EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~--------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+...++... .......-...+.++++...|..|-.+|||++|.+.
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111100 001111112356778899999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-27 Score=247.16 Aligned_cols=192 Identities=24% Similarity=0.356 Sum_probs=165.9
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------hhHHHHHHHHHHhcccc---cccccceeeeeecccce
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------EREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNR 578 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 578 (799)
.+++|+|+||.|+.++++. ....|+||.+.+..- ...-..-.|+++|+.++ |+||+|++++|++++..
T Consensus 566 lq~lG~GAyGkV~lai~K~-n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~y 644 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKE-NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYY 644 (772)
T ss_pred eeeccccccceEEEeeecc-cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCee
Confidence 3579999999999999986 467899998865211 11123456999999997 99999999999999999
Q ss_pred eeEEeec-CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 579 LLVYEFM-GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 579 ~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
+|++|-. ++-+|.+++...+.+++....-|+.||+.|+++||++ +|||||||-+||.++.+|-+||+|||.+....
T Consensus 645 yl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~k 721 (772)
T KOG1152|consen 645 YLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTK 721 (772)
T ss_pred EEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhc
Confidence 9999965 5679999999999999999999999999999999998 99999999999999999999999999998754
Q ss_pred CCCCcceeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCc
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
+. .....+||..|.|||++.+.+| ...-|||++|++||.++-...|+.
T Consensus 722 sg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 722 SG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 33 3445679999999999999987 456899999999999998888875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=233.52 Aligned_cols=130 Identities=28% Similarity=0.408 Sum_probs=109.9
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-----c---ccccceeeeee---
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----H---KNLVQLLGFCD--- 573 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~g~~~--- 573 (799)
..+-..++||.|.|++||++.+.. ..+.||+|+.+.. +.-.+..+.|+++|++++ | ..||+|++.|.
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq-~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQ-NKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred ceEEEEEeccccccceeEEEeecc-CCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 566678899999999999999874 5689999998752 333456788999999874 2 35999999994
Q ss_pred -cccceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 574 -EALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 574 -~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
.+.+.+||+|++ |.+|..+|... +.++...+.+|+.||+.||.|||.+| +|||.||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 567889999998 55888888754 68899999999999999999999997 99999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=227.67 Aligned_cols=197 Identities=30% Similarity=0.461 Sum_probs=173.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.+.||+|++|.||++.... +++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKG-TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEcC-CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 45789999999999999874 4689999999765444 567899999999999999999999999998999999999999
Q ss_pred CChhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~~~-~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
++|.+++..... +++.....++.+++.++.+||+. +++|+||+|+||+++.++.++|+|||.+.............
T Consensus 82 ~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 82 GDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999987666 89999999999999999999998 99999999999999999999999999998875443112233
Q ss_pred eccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHhCCcCCch
Q 038294 667 IRGTRGYVAPEWF-KNAPVSAKVDVYSFGVMLLEIICCRRSVEM 709 (799)
Q Consensus 667 ~~gt~~y~aPE~l-~~~~~s~k~DVwS~Gvll~elltg~~p~~~ 709 (799)
..++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 159 ~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 159 VKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4567889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-27 Score=210.75 Aligned_cols=100 Identities=39% Similarity=0.600 Sum_probs=71.6
Q ss_pred CCeEEEeecCCCCCC---CCceeEEcccc-eEEEcCCCCEEecc-CCC-C--ceeeEEeecCccEEEEecCCcccccccc
Q 038294 73 ERTIVWHANGDNPAP---RGSTLELTATG-LLLKDPGGKTIWDG-KPD-K--KVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 73 ~~t~VWvANr~~pv~---~~s~l~l~~~g-lvl~~~~~~~vWst-~~~-~--~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
++||||+|||++|+. ...+|.|+.|| |+|.|.+++++|++ ++. . ....|+|+|+|||||++. .+.+||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~--~~~~lW~S 78 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS--SGNVLWQS 78 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET--TSEEEEES
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee--cceEEEee
Confidence 479999999999993 23699999999 99999999999999 432 2 367899999999999874 67899999
Q ss_pred cccCCCccCCCcccCCC------ceEEeecCCCCCC
Q 038294 145 FKNPTDTILPTQILDLD------SVLISRLTETNFS 174 (799)
Q Consensus 145 FD~PTDtlLpg~kl~~~------~~L~S~~s~~dps 174 (799)
|||||||+||||+|+.+ ..|+||++.+|||
T Consensus 79 f~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 79 FDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred cCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999974 2499999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=225.81 Aligned_cols=268 Identities=26% Similarity=0.300 Sum_probs=190.9
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec------ccceeeEEe
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALNRLLVYE 583 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~lv~e 583 (799)
.+|.|.- .|-.+.+. -.+++||+|++... .....+....|..++..++|+|+++++.++.- -.+.++|||
T Consensus 24 p~~~g~~-~v~~a~D~-v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e 101 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQ-VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME 101 (369)
T ss_pred ccCCCCc-eEEecchh-hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence 4666665 44444433 25689999988532 23445677889999999999999999999842 345689999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|. .+|.+.+. -.++.+....|..|++.|+.|||+. +|+||||||+||++..+..+||.|||+|+....+ ..
T Consensus 102 ~m~-~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~--~~ 173 (369)
T KOG0665|consen 102 LMD-ANLCQVIL--MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD--FM 173 (369)
T ss_pred hhh-hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcc--cc
Confidence 995 48887776 4567788889999999999999998 9999999999999999999999999999864332 35
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc---------------hhHHHHHHHHHh
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR---------------AILTDWAYDCYA 728 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~---------------~~~~~~~~~~~~ 728 (799)
.+..+.|+.|.|||++.+..+.+.+||||.||++.||++|+.-|.+...-+.- ..+...+...++
T Consensus 174 mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~ 253 (369)
T KOG0665|consen 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVE 253 (369)
T ss_pred cCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhh
Confidence 56677899999999999999999999999999999999999877644321110 011111111111
Q ss_pred cCc------eeE-eecCCCCCc--cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--Hh---cCcCCCCCCCC
Q 038294 729 EGR------LDV-LVDSDEPAM--ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LE---GLLEVPNPPCP 789 (799)
Q Consensus 729 ~~~------~~~-~~d~~~~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~---~~~~~~~p~~p 789 (799)
... ..+ +.|...+.. .++.....+.+++.+||-.+|++|.+++++++. ++ .--++++|+++
T Consensus 254 ~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 254 NRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDPDEVEAPPPE 328 (369)
T ss_pred cChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeecccccccCCCCc
Confidence 100 001 111111111 122334456779999999999999999999864 33 33345555555
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=232.62 Aligned_cols=212 Identities=19% Similarity=0.237 Sum_probs=176.8
Q ss_pred CCCccccChHHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc------ccc
Q 038294 491 ETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH------HKN 564 (799)
Q Consensus 491 ~~~~~~~~~~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~------h~n 564 (799)
..+...+...|+....+.+....|+|-|++|-+|.+.. .+..||||++... +-..+.=+.|+++|++|+ .-|
T Consensus 418 aEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~-r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~H 495 (752)
T KOG0670|consen 418 AEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA-RGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFH 495 (752)
T ss_pred ccceEEEehhhhhcceeEEEeccccceeeeeeeccccC-CCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhH
Confidence 34455566778888888888889999999999999875 4679999999764 233445577999999986 347
Q ss_pred ccceeeeeecccceeeEEeecCCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 565 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
.++|+-.|...+++|||+|-+. .+|.++|+... .+....+..++.|+..||..|-.. +|+|.||||+|||+++
T Consensus 496 clrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 496 CLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEecc
Confidence 8999999999999999999774 58999998653 577888899999999999999986 9999999999999997
Q ss_pred -CCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 642 -YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 642 -~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
...+||+|||.|.....++ .++...+..|.|||++.+.+|+...|+||.||.||||.||+..|.+..
T Consensus 572 ~k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred CcceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 4568999999998764333 233345678999999999999999999999999999999999886554
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.9e-24 Score=195.40 Aligned_cols=109 Identities=35% Similarity=0.584 Sum_probs=95.8
Q ss_pred cCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEEcCCCCEEeccCC
Q 038294 36 SSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGKTIWDGKP 114 (799)
Q Consensus 36 ~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~~~~~~~vWst~~ 114 (799)
.++++|+|+++.|++|||.+.... .++.+|||.+++ +++||.||++.|....++|.|+.|| |+|.|.+|.+||++++
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q~-~dgnlv~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~~ 82 (116)
T cd00028 5 SSGQTLVSSGSLFELGFFKLIMQS-RDYNLILYKGSS-RTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGSGTVVWSSNT 82 (116)
T ss_pred CCCCEEEeCCCcEEEecccCCCCC-CeEEEEEEeCCC-CeEEEECCCCCCCCCCEEEEEecCCCeEEEcCCCcEEEEecc
Confidence 346899999999999999987654 389999999887 8999999999997667799999999 9999999999999876
Q ss_pred C--CceeeEEeecCccEEEEecCCcccccccccccC
Q 038294 115 D--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNP 148 (799)
Q Consensus 115 ~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~P 148 (799)
. ....+|+|+|+|||||++. ++.+||||||||
T Consensus 83 ~~~~~~~~~~L~ddGnlvl~~~--~~~~~W~Sf~~P 116 (116)
T cd00028 83 TRVNGNYVLVLLDDGNLVLYDS--DGNFLWQSFDYP 116 (116)
T ss_pred cCCCCceEEEEeCCCCEEEECC--CCCEEEcCCCCC
Confidence 4 4556899999999999865 467999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-25 Score=241.81 Aligned_cols=248 Identities=23% Similarity=0.320 Sum_probs=198.3
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+...+|.|.+|.|||++++. .++..|+|+++-.......-.++|+-+++..+|+||+.++|-+...+..++.|||+.+|
T Consensus 19 llqrvgsgTygdvyKaRd~~-s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 19 LLQRVGSGTYGDVYKARDKR-SGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred heeeecCCcccchhhhcccc-cCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 34679999999999999985 67899999998777777778889999999999999999999999999999999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeec
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 668 (799)
+|.+.-+-...+++.++...+....+||+|||+. +-+|||||-.|||+++.+.+|++|||.+..+...-.+ .....
T Consensus 98 slQdiy~~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~K-rksfi 173 (829)
T KOG0576|consen 98 SLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK-RKSFI 173 (829)
T ss_pred cccceeeecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhh-hhccc
Confidence 9999998888899999999999999999999998 7899999999999999999999999998766433222 23345
Q ss_pred cCCcccccccc---cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc-c
Q 038294 669 GTRGYVAPEWF---KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM-A 744 (799)
Q Consensus 669 gt~~y~aPE~l---~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~ 744 (799)
||+.|||||+. +.+.|..++|||+.|+...|+--.+.|....-+.. +..+... ...++ +.. .
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--------~l~LmTk----S~~qp--p~lkD 239 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--------ALFLMTK----SGFQP--PTLKD 239 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--------HHHHhhc----cCCCC--CcccC
Confidence 99999999986 45678999999999999999877666643221111 0001010 01111 111 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+-+-+++..|+-.+|.+|||++.+++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 2344556677999999999999999987653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=259.53 Aligned_cols=194 Identities=19% Similarity=0.218 Sum_probs=139.0
Q ss_pred cccc-ccccceeeee-------ecccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEe
Q 038294 559 RTHH-KNLVQLLGFC-------DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629 (799)
Q Consensus 559 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 629 (799)
.++| +||+++++.| .+....+.++|++ +++|.++|... ..+++..+..++.||++||+|||++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 4456 6888888887 2334556788887 55999999753 4689999999999999999999998 9999
Q ss_pred cCCCCCCeEEcC-------------------CCceEEccccCcccccCCCC---------------cceeeeccCCcccc
Q 038294 630 CDIKPQNILLDN-------------------YFSAKISDFGLSKLLLSDQS---------------RTHTMIRGTRGYVA 675 (799)
Q Consensus 630 ~dlk~~NILl~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~y~a 675 (799)
|||||+||||+. ++.+||+|||+++....... .......||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999954 45567777777764311000 00111347888999
Q ss_pred cccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHH
Q 038294 676 PEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMI 755 (799)
Q Consensus 676 PE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 755 (799)
||++.+..++.++|||||||+||||+++..|+..... .+...... . ..+.. .........+
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-----~~~~~~~~-----~----~~~~~-----~~~~~~~~~~ 244 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-----TMSSLRHR-----V----LPPQI-----LLNWPKEASF 244 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-----HHHHHHHh-----h----cChhh-----hhcCHHHHHH
Confidence 9999999999999999999999999998887543211 11111100 0 00000 1112345678
Q ss_pred HHHhcccCCCCCCCHHHHHH
Q 038294 756 AMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 756 ~~~Cl~~dP~~RPt~~evl~ 775 (799)
+.+||+.+|.+||+|.||++
T Consensus 245 ~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHhCCCChhhCcChHHHhh
Confidence 88999999999999999976
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=188.04 Aligned_cols=107 Identities=34% Similarity=0.578 Sum_probs=94.2
Q ss_pred cCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEEcCCCCEEeccCC
Q 038294 36 SSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGKTIWDGKP 114 (799)
Q Consensus 36 ~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~~~~~~~vWst~~ 114 (799)
..+++|+|+++.|++|||.+.... ++.+|||++.+ +++||+|||+.|+..+..|.|..|| |+|.|.+|.+||++++
T Consensus 5 ~~~~~l~s~~~~f~~G~~~~~~q~--dgnlV~~~~~~-~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~g~~vW~S~t 81 (114)
T smart00108 5 SSGQTLVSGNSLFELGFFTLIMQN--DYNLILYKSSS-RTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGDGRVVWSSNT 81 (114)
T ss_pred CCCCEEecCCCcEeeeccccCCCC--CEEEEEEECCC-CcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCCCCEEEEecc
Confidence 346899999999999999987653 89999999887 8999999999999777899999999 9999999999999876
Q ss_pred C--CceeeEEeecCccEEEEecCCccccccccccc
Q 038294 115 D--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKN 147 (799)
Q Consensus 115 ~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~ 147 (799)
. .+..+++|+|+|||||++. .+++|||||||
T Consensus 82 ~~~~~~~~~~L~ddGnlvl~~~--~~~~~W~Sf~~ 114 (114)
T smart00108 82 TGANGNYVLVLLDDGNLVIYDS--DGNFLWQSFDY 114 (114)
T ss_pred cCCCCceEEEEeCCCCEEEECC--CCCEEeCCCCC
Confidence 4 4556899999999999865 45699999997
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=204.10 Aligned_cols=251 Identities=18% Similarity=0.289 Sum_probs=182.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeee-eecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGF-CDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~-~~~~~~~~lv~e~ 584 (799)
+++.+.||+|.||.+.++.++. ++..+++|.+.... ...++|.+|...--.+ .|.||+.-++. |...+..+.++||
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~-s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~ 103 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQ-SKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEF 103 (378)
T ss_pred hhHHHHhcccceeeEEeeeccC-CceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeecc
Confidence 4566889999999999999985 67899999987643 3467898888765555 59999987654 5666677799999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD--NYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~ 662 (799)
++.|+|.+-+.. ..+.+.-..+++.|++.||.|||++ .++|||||.+||||- +...+||+|||+.+.....
T Consensus 104 aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--- 176 (378)
T KOG1345|consen 104 APRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--- 176 (378)
T ss_pred CccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence 999999988865 4566677788999999999999998 999999999999993 4458999999998754221
Q ss_pred ceeeeccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 663 THTMIRGTRGYVAPEWFKNA-----PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~-----~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.....-+..|.|||..... ...+.+|||.||++++.++||..|+....... .. .|.+..|..+...
T Consensus 177 -V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d-~~---Y~~~~~w~~rk~~---- 247 (378)
T KOG1345|consen 177 -VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD-KP---YWEWEQWLKRKNP---- 247 (378)
T ss_pred -ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC-ch---HHHHHHHhcccCc----
Confidence 1112234578999977433 24678999999999999999999998443221 11 2333344443322
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
..|... ....+++.++..+-+..+|++|=...++.++-
T Consensus 248 -~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 248 -ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred -cCchhh-cccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 111111 12345666777888899999995555554443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=202.08 Aligned_cols=166 Identities=23% Similarity=0.205 Sum_probs=125.7
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|+|.+++... ..+++..+..|+.||++||+|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 6899999864 4689999999999999999999997 3 999999999999999 99988654322
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..|++.|||||++.+..++.++|||||||++|||++|+.||....... ..+....... ... .+. ......
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~-~~~------~~~-~~~~~~ 133 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGM-PAD------DPR-DRSNLE 133 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHh-ccC------Ccc-ccccHH
Confidence 247899999999999999999999999999999999999986543211 1111111110 000 000 001112
Q ss_pred HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 747 SRLQ--KWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 747 ~~~~--~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
...+ .+.+++.+||+.+|++||++.|+++.+..+
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 2222 588999999999999999999999988643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.1e-24 Score=219.01 Aligned_cols=195 Identities=24% Similarity=0.342 Sum_probs=160.7
Q ss_pred hhhhcCccccceEEEEEEeCC--CCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
..++||+|.|++||++++... ..+.||+|.+... .......+|+++|..+ -+.||+++.+++..++...+|+||+
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~ 117 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYF 117 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEeccc
Confidence 346899999999999998642 4678999998653 3345689999999998 4999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCC----
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQ---- 660 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~---- 660 (799)
+.....+++.. ++...+..++..+.+||+++|++ +||||||||+|+|.+. .+.-.|.|||+|......+
T Consensus 118 ~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~ 191 (418)
T KOG1167|consen 118 EHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEH 191 (418)
T ss_pred CccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHHHHHhhhhhhh
Confidence 99998888865 45778888999999999999998 9999999999999985 5678999999998321000
Q ss_pred ---------C------------------------------cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHH
Q 038294 661 ---------S------------------------------RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEI 700 (799)
Q Consensus 661 ---------~------------------------------~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~el 700 (799)
. .......||++|+|||++.. ..-++++||||-||+++.+
T Consensus 192 s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lsl 271 (418)
T KOG1167|consen 192 SRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSL 271 (418)
T ss_pred hhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehh
Confidence 0 00111348999999999865 4568899999999999999
Q ss_pred HhCCcCCchhh
Q 038294 701 ICCRRSVEMEV 711 (799)
Q Consensus 701 ltg~~p~~~~~ 711 (799)
++++.||....
T Consensus 272 ls~~~PFf~a~ 282 (418)
T KOG1167|consen 272 LSRRYPFFKAK 282 (418)
T ss_pred hccccccccCc
Confidence 99999986543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=203.80 Aligned_cols=247 Identities=23% Similarity=0.382 Sum_probs=189.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccc--cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.++..+|.+...|..|+|+++ |..+++|++.- ......++|.+|.-.|+.+.||||+.++|.|....+..++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq---gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ---GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCccccccccc---CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 345667899999999999996 45677787743 3344557899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc--cccCcccccCCC
Q 038294 585 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS--DFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~--DfGla~~~~~~~ 660 (799)
|+.|+|..+|+... ..+-.+..+++.+||+|++|||+.. +-|..--|.++.|++|++.+++|+ |--++.
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf------ 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF------ 341 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee------
Confidence 99999999999765 3567789999999999999999964 224444689999999999988875 211111
Q ss_pred CcceeeeccCCcccccccccCCCCC---cchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVS---AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s---~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
......-.+.||+||.+..++-+ .++|+|||+++||||.|...||....+-+-...+ -.+
T Consensus 342 --qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-------ale-------- 404 (448)
T KOG0195|consen 342 --QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-------ALE-------- 404 (448)
T ss_pred --eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-------hhc--------
Confidence 11111135789999999877654 3689999999999999999999755433321111 011
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.+....++.....+.+++.-|+..||.+||.+..|+-+||++.
T Consensus 405 -glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 -GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1222334445567888999999999999999999999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=211.60 Aligned_cols=164 Identities=21% Similarity=0.126 Sum_probs=126.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-----chhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.+.||+|+||+||+|.++..+++.||||++... .....+.|.+|++++++++|+|+++.+... ...++
T Consensus 19 ~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~~~~L 95 (365)
T PRK09188 19 RFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---GKDGL 95 (365)
T ss_pred CceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---CCcEE
Confidence 3456788999999999999987556788899987532 122345789999999999999998533322 45799
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDI-KPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dl-k~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
||||+++++|... .... ...++.++++||.|||+. +|+|||| ||+|||++.++.+||+|||+++.+...
T Consensus 96 VmE~~~G~~L~~~-~~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~ 165 (365)
T PRK09188 96 VRGWTEGVPLHLA-RPHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRR 165 (365)
T ss_pred EEEccCCCCHHHh-Cccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccC
Confidence 9999999999632 1111 246788999999999998 9999999 999999999999999999999977543
Q ss_pred CCc-------ceeeeccCCcccccccccCC
Q 038294 660 QSR-------THTMIRGTRGYVAPEWFKNA 682 (799)
Q Consensus 660 ~~~-------~~~~~~gt~~y~aPE~l~~~ 682 (799)
... ......+++.|+|||.+.-.
T Consensus 166 ~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 166 GALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 211 11235578889999998543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-20 Score=199.10 Aligned_cols=261 Identities=20% Similarity=0.258 Sum_probs=190.2
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc----ccccceeeee-ecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH----KNLVQLLGFC-DEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~g~~-~~~~~~~l 580 (799)
.+.+.+.||+|+||.||++.......+.+|+|............+..|+.++..+.+ +++.++++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 455678999999999999998653345788888765433333367788888888863 5888999888 47777899
Q ss_pred EEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-----CceEEccccCc
Q 038294 581 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-----FSAKISDFGLS 653 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-----~~~kl~DfGla 653 (799)
||+.+ |.+|.++.... +.++-.+.++|+.|++.+|.+||+. +++||||||.|+++... ..+.|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 77999988654 4788999999999999999999998 99999999999999754 46999999999
Q ss_pred c--cccCCCC------cc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH
Q 038294 654 K--LLLSDQS------RT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY 724 (799)
Q Consensus 654 ~--~~~~~~~------~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~ 724 (799)
+ ....... +. ....+||..|+++....+...+.+.|+||++.++.|++.|..|+...........+.....
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 9 4322211 11 1234599999999999999999999999999999999999999865433221111111111
Q ss_pred HHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 725 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
.. .... . .......+.++...+-+.+..++|....+...|+.....
T Consensus 255 ~~--------~~~~--~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 255 KL--------LTDR--F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hh--------cccc--c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 00 0000 0 111122334444444557999999999999998765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=220.85 Aligned_cols=252 Identities=22% Similarity=0.266 Sum_probs=189.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEcc-----ccchhh-HHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLD-----RLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~-----~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+|.|++|.|+...... ..+..+.|... ...... ...+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~-~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRS-DLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred cceeeecccCceEEEEecC-CCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4679999999777766542 23333333322 111111 1226678888888999999998888877777666699
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC--
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-- 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-- 661 (799)
|+++ +|..++.....+.-..+..++.|+..|+.|||+. +|.|||+|++|+++..++.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 9999 9999998877788888999999999999999998 999999999999999999999999999988765443
Q ss_pred -cceeeeccCCcccccccccCCCCCcc-hhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 662 -RTHTMIRGTRGYVAPEWFKNAPVSAK-VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 662 -~~~~~~~gt~~y~aPE~l~~~~~s~k-~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.......|+-.|+|||.+.+..|.+. .||||.|+++..|++|+.||......+.... ............
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~---------~~~~~~~~~~~~ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK---------TNNYSDQRNIFE 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh---------hhcccccccccc
Confidence 33445678999999999999999875 8999999999999999999986654433210 000001111112
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+.........+...++.++|+.+|.+|.||++|++
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 222233445556678999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.2e-19 Score=191.37 Aligned_cols=256 Identities=29% Similarity=0.370 Sum_probs=194.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh---hHHHHHHHHHHhcccccc-cccceeeeeecccceeeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE---REREFKSEVSAIGRTHHK-NLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++..++......++++|+
T Consensus 4 ~~~~l~~g~~~~v~~~~~~----~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR----KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred eEEeecCCCCeEEEEEEec----cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 4567999999999999875 67899988654332 367899999999999888 799999999777777999999
Q ss_pred cCCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCC
Q 038294 585 MGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~ 660 (799)
+.+++|.+++.... .+.......+..|++.++.|+|.. +++|||+||+||+++... .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997777664 688889999999999999999998 899999999999999988 79999999998664433
Q ss_pred Cc-----ceeeeccCCcccccccccC---CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 661 SR-----THTMIRGTRGYVAPEWFKN---APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 661 ~~-----~~~~~~gt~~y~aPE~l~~---~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
.. ......++..|+|||.+.+ ...+...|+||+|+++++++++..|+......... ......+.....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~----~~~~~~~~~~~~ 232 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT----SQTLKIILELPT 232 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH----HHHHHHHHhcCC
Confidence 22 2345678999999999987 57889999999999999999999996544321000 111111111110
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
. .................+.+++..++..+|..|.++.+....
T Consensus 233 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 233 P-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000000002223567788999999999999999887764
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=196.88 Aligned_cols=217 Identities=25% Similarity=0.437 Sum_probs=164.6
Q ss_pred hcccccccccceeeeeecccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe-EecCCCC
Q 038294 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPI-IHCDIKP 634 (799)
Q Consensus 557 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~i-iH~dlk~ 634 (799)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|.+.+... ..++|.....+..+|++||+|||.. +| .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeecc
Confidence 45688999999999999999999999999999999999874 5889999999999999999999987 44 9999999
Q ss_pred CCeEEcCCCceEEccccCcccccCC-CCcceeeeccCCcccccccccCC-------CCCcchhHHHHHHHHHHHHhCCcC
Q 038294 635 QNILLDNYFSAKISDFGLSKLLLSD-QSRTHTMIRGTRGYVAPEWFKNA-------PVSAKVDVYSFGVMLLEIICCRRS 706 (799)
Q Consensus 635 ~NILl~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~-------~~s~k~DVwS~Gvll~elltg~~p 706 (799)
+|+++|....+||+|||+....... .........-..-|.|||.++.. ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999999876431 11111112234569999999764 146789999999999999999999
Q ss_pred CchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 707 VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
|......+....+ +.. ++.+. ...+-+.... ..+..+.+..++..||..+|++||++++|-..++.+...
T Consensus 158 ~~~~~~~~~~~ei---i~~-~~~~~-~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 158 FDLRNLVEDPDEI---ILR-VKKGG-SNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred cccccccCChHHH---HHH-HHhcC-CCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 9875443322111 222 22210 0011111111 113334688899999999999999999999998876554
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.2e-19 Score=175.67 Aligned_cols=139 Identities=17% Similarity=0.131 Sum_probs=108.1
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchh--h-------H-----------------HHHHHHHHHhcccccc
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE--R-------E-----------------REFKSEVSAIGRTHHK 563 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~--~-------~-----------------~~~~~E~~~l~~l~h~ 563 (799)
.+.||+|+||.||+|... +|+.||||+++..... . . .....|++.+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA--NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTA 79 (190)
T ss_pred CCccccccceEEEEEECC--CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHC
Confidence 357999999999999986 6899999998643211 0 0 1223499999999888
Q ss_pred cccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeEEcCC
Q 038294 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 564 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~dlk~~NILl~~~ 642 (799)
++.....+.. ...+|||||+++++|...+.....++.....+++.|++.+|.|+ |+. +|+||||||+|||++ +
T Consensus 80 ~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 80 GIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 7744333221 23489999999987766544445788899999999999999999 566 899999999999998 4
Q ss_pred CceEEccccCcccc
Q 038294 643 FSAKISDFGLSKLL 656 (799)
Q Consensus 643 ~~~kl~DfGla~~~ 656 (799)
+.++|+|||++...
T Consensus 154 ~~v~LiDFG~a~~~ 167 (190)
T cd05147 154 GKLYIIDVSQSVEH 167 (190)
T ss_pred CcEEEEEccccccC
Confidence 78999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-19 Score=158.79 Aligned_cols=87 Identities=31% Similarity=0.526 Sum_probs=69.4
Q ss_pred EEEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEEecCCCCCCcceeeEeecCccccccccccCCCCccCCCcc
Q 038294 228 VYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDICRRLFNEIGSGTCGFNSY 307 (799)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~~~~~~~~~~~W~~~~~~p~~~C~~y~~~~~~~~CG~~g~ 307 (799)
.+.+..+.+++++++ ...+.+.++|++||.+|++++|.| ....++|.+.|.+|.|+||+ |+.||+||+
T Consensus 24 ~~~fv~~~~e~~~t~---~~~~~s~~~r~~ld~~G~l~~~~w---~~~~~~W~~~~~~p~d~Cd~------y~~CG~~g~ 91 (110)
T PF00954_consen 24 NYSFVSNNEEVYYTY---SLSNSSVLSRLVLDSDGQLQRYIW---NESTQSWSVFWSAPKDQCDV------YGFCGPNGI 91 (110)
T ss_pred EEEEEECCCeEEEEE---ecCCCceEEEEEEeeeeEEEEEEE---ecCCCcEEEEEEecccCCCC------ccccCCccE
Confidence 344445544444443 234567799999999999999999 44567899999999999999 599999999
Q ss_pred cccCCCCCcccCCCCccccC
Q 038294 308 CLLQNGRPFCDCPPGYVLAD 327 (799)
Q Consensus 308 C~~~~~~~~C~Cl~GF~p~~ 327 (799)
|+. +..|.|+||+||+|++
T Consensus 92 C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 92 CNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred eCC-CCCCceECCCCcCCCc
Confidence 976 4578999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.2e-18 Score=172.75 Aligned_cols=198 Identities=20% Similarity=0.291 Sum_probs=166.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.++||+|.||.++.|+.-- .+++||||.-... ...-++..|.+..+.| ..++|..++-|-.++.+-.||+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~-nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLY-NNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ceeccccccCcceeeecccccc-cCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 4457899999999999998653 6899999986432 2234566777777766 5799999999999999999999988
Q ss_pred CCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCceEEccccCcccccCC
Q 038294 586 GNGTLANLIF-AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-----YFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 586 ~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-----~~~~kl~DfGla~~~~~~ 659 (799)
|-+|+|+.. ....++.++...||.|+..-++|+|++ .+|.|||||+|+||.. ...+.|+|||+|+.....
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 669988875 446889999999999999999999998 8999999999999963 456899999999988765
Q ss_pred CCcce------eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 660 QSRTH------TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 660 ~~~~~------~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
..+.. ....||.+||+---..+++-+.+.|+=|+|-++.+.|-|..|+.+..
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 54332 33569999999999999999999999999999999999999998653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=169.53 Aligned_cols=140 Identities=16% Similarity=0.103 Sum_probs=109.9
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchh--------------------------hHHHHHHHHHHhcccccc
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE--------------------------REREFKSEVSAIGRTHHK 563 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ 563 (799)
...||+|+||.||+|... +|+.||||+++..... ....+..|.+.+.++.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~--~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG--DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC--CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 357999999999999976 6899999998643210 011245789999999999
Q ss_pred cccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCC
Q 038294 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 564 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~~~ 642 (799)
++.....+... ..++||||++++++.........++.....+++.|++.++.+||+ . +|+||||||+|||++ +
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~ 153 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-D 153 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-C
Confidence 87554443322 248999999988654433333456778889999999999999999 7 999999999999999 7
Q ss_pred CceEEccccCccccc
Q 038294 643 FSAKISDFGLSKLLL 657 (799)
Q Consensus 643 ~~~kl~DfGla~~~~ 657 (799)
+.++|+|||++....
T Consensus 154 ~~~~liDFG~a~~~~ 168 (190)
T cd05145 154 GKPYIIDVSQAVELD 168 (190)
T ss_pred CCEEEEEcccceecC
Confidence 899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1e-18 Score=174.67 Aligned_cols=173 Identities=13% Similarity=0.078 Sum_probs=130.1
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHH---------HHHHHHHHhcccccccccceeee
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERER---------EFKSEVSAIGRTHHKNLVQLLGF 571 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~---------~~~~E~~~l~~l~h~niv~l~g~ 571 (799)
++.+..+...+.+|.|+||.||.... ++..+|+|.++......++ .+.+|+..+.+++|++|..+..+
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~---~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT---DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec---CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 34445555668899999999998544 3568999999753322222 26899999999999999999888
Q ss_pred eecc--------cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 038294 572 CDEA--------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF 643 (799)
Q Consensus 572 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~ 643 (799)
+... ...+|+|||++|.+|.++.. ++. ....+++.+|..+|.. +++|||++|+||++++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC
Confidence 6432 35789999999999988742 221 3456999999999998 999999999999999988
Q ss_pred ceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHH
Q 038294 644 SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701 (799)
Q Consensus 644 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ell 701 (799)
++|+|||.......+... ..+.....+..++|+|+||+.+.-+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654221111 11334455677999999999987654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.1e-18 Score=164.51 Aligned_cols=202 Identities=21% Similarity=0.265 Sum_probs=166.6
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc-ccccceeeeeecccceeeEEe
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.+.++||.|+||.+|.|.... +|+.||+|.-+... ...++.-|.++...++| ..|..+..+..+...-.+||+
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~-~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISIT-SGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred cceEEEEeecCCchhheeeeeecc-CCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 344567899999999999999874 78999999875432 23466778888888864 678888888899999999999
Q ss_pred ecCCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCC
Q 038294 584 FMGNGTLANLIF-AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 584 ~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~ 659 (799)
.+ |-+|+++.. ....++.++.+-++-|++.-++|+|.. ++|||||||+|+|..- ..++.++|||+++.....
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 88 668988775 346788899999999999999999998 8999999999999963 456899999999987544
Q ss_pred CCcc------eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhh
Q 038294 660 QSRT------HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE 713 (799)
Q Consensus 660 ~~~~------~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~ 713 (799)
.... .....||.+|.+--...+...+.+.|+=|+|.+|.++.-|..|+......
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 3322 23356899999998888888899999999999999999999999876443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=198.13 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=177.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHH--hcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSA--IGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||.+.|=+|.+++++ .|. |+||++-+.. .-..+.|.++++- ...++|||.+.+.-.-......|||-+|
T Consensus 26 ~~~~~LGstRFlKv~r~k~~--eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDR--EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeecccCchhhhhhhhccCC--Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 45678999999999999886 354 8899885432 3334555554444 4446899999998887777888999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc--cCCCCc
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL--LSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~--~~~~~~ 662 (799)
..+ +|.|.|..++-+......-|+.|++.||..+|.. +|+|||||.+||||+.-.=+.|+||.--+.. ..+...
T Consensus 103 vkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa 178 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA 178 (1431)
T ss_pred Hhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence 866 8999998888888888888999999999999998 9999999999999999999999999866543 222221
Q ss_pred ce----eeeccCCcccccccccCC----------C-CCcchhHHHHHHHHHHHHhC-CcCCchhhhhhcchhHHHHHHHH
Q 038294 663 TH----TMIRGTRGYVAPEWFKNA----------P-VSAKVDVYSFGVMLLEIICC-RRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 663 ~~----~~~~gt~~y~aPE~l~~~----------~-~s~k~DVwS~Gvll~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
.. .....-.+|+|||.+-.. . .+++-||||.||++.||++- +.+|+...- + +
T Consensus 179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL------~---a--- 246 (1431)
T KOG1240|consen 179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL------L---A--- 246 (1431)
T ss_pred cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH------H---h---
Confidence 11 112234479999987431 2 67889999999999999985 555543210 0 0
Q ss_pred HhcCc---eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 727 YAEGR---LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 727 ~~~~~---~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
++.+. .+.++.. -+...+..++..|++.||++|.++++.++.-.++
T Consensus 247 Yr~~~~~~~e~~Le~--------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEK--------IEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred HhccCccCHHHHHHh--------CcCccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 11110 0000000 0011456799999999999999999999885554
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-17 Score=161.68 Aligned_cols=187 Identities=16% Similarity=0.043 Sum_probs=138.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhh----HHHHHHHHHHhcccc-cccccceeeeeecccceeeEEee
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER----EREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~----~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
...|++|+||+||.+.- ++..++.+.++....-. ...|.+|+++|++++ |+++++++++ ...+++|||
T Consensus 7 ~~~l~~~~f~~v~~~~~---~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 7 NEPLKSDTFGRILLVRG---GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ceeecCCCcceEEEeec---CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 46799999999996543 56788877776543311 125789999999995 5889999886 346899999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC-CCCCeEEcCCCceEEccccCcccccCCCCc-
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDI-KPQNILLDNYFSAKISDFGLSKLLLSDQSR- 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dl-k~~NILl~~~~~~kl~DfGla~~~~~~~~~- 662 (799)
++|.+|...+.. ....++.|++++|.++|.. +|+|||| ||+|||++.++.++|+|||++.........
T Consensus 80 I~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 80 LAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999998654321 1245778999999999998 9999999 799999999999999999999865432210
Q ss_pred ---c--------eeeeccCCcccccccccCC-CCC-cchhHHHHHHHHHHHHhCCcCCchhhhh
Q 038294 663 ---T--------HTMIRGTRGYVAPEWFKNA-PVS-AKVDVYSFGVMLLEIICCRRSVEMEVEE 713 (799)
Q Consensus 663 ---~--------~~~~~gt~~y~aPE~l~~~-~~s-~k~DVwS~Gvll~elltg~~p~~~~~~~ 713 (799)
. ......++.|+.|+...-. ..+ ...+-++-|.-+|.++|++.+...+.+.
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~~ 213 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNEG 213 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCCC
Confidence 0 0012246677777754322 223 5678889999999999999987655443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=169.93 Aligned_cols=227 Identities=21% Similarity=0.292 Sum_probs=145.2
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccc---cchhhHHHHHHHHHHhccccc----------ccccceeeee----
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHH----------KNLVQLLGFC---- 572 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~~~l~~l~h----------~niv~l~g~~---- 572 (799)
.+.||.|+++.||.+++.. +++++|||+... ......+++++|.-.+..+.+ -.++.-++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~-t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~ 95 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVE-TGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPG 95 (288)
T ss_dssp EEEEEEETTEEEEEEEETT-TTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETT
T ss_pred ccccccCCceEEEEEEEcc-CCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcC
Confidence 4679999999999999875 689999998743 223345677877766666433 1222222211
Q ss_pred -----eccc--------ceeeEEeecCCCChhhhhhc---CCC----CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCC
Q 038294 573 -----DEAL--------NRLLVYEFMGNGTLANLIFA---IPK----PDWNLRVRISLEIARGLVYLHEECNVPIIHCDI 632 (799)
Q Consensus 573 -----~~~~--------~~~lv~e~~~~gsL~~~l~~---~~~----~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dl 632 (799)
.... ..+++|+-+ -++|.+++.. ... +...-++.+..|+.+.+++||+. +++|+||
T Consensus 96 ~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi 171 (288)
T PF14531_consen 96 KPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDI 171 (288)
T ss_dssp S-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-
T ss_pred CCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEeccc
Confidence 1111 225667766 4578777542 222 22334567778999999999998 9999999
Q ss_pred CCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccC--------CCCCcchhHHHHHHHHHHHHhCC
Q 038294 633 KPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN--------APVSAKVDVYSFGVMLLEIICCR 704 (799)
Q Consensus 633 k~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~k~DVwS~Gvll~elltg~ 704 (799)
+|+|++++.+|.+.|+||+.......... ....+..|.+||.... -.++.+.|.|++|+++|.|.++.
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~ 247 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR 247 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence 99999999999999999987765422111 1234578999997743 25788999999999999999999
Q ss_pred cCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCC
Q 038294 705 RSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKR 767 (799)
Q Consensus 705 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R 767 (799)
.||.....+..... .-.... +..+.+..++..+|+.+|++|
T Consensus 248 lPf~~~~~~~~~~~---------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 248 LPFGLSSPEADPEW---------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -STCCCGGGSTSGG---------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred CCCCCCCccccccc---------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99986644332211 001122 455677789999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=158.68 Aligned_cols=134 Identities=17% Similarity=0.240 Sum_probs=104.1
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-----ccccccceeeeeeccc---cee-e
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-----HHKNLVQLLGFCDEAL---NRL-L 580 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~g~~~~~~---~~~-l 580 (799)
.+.||+|+||.||. ++. ++.. +||++........+++.+|++++..+ +||||++++|++.++. ..+ +
T Consensus 7 ~~~LG~G~~~~Vy~--hp~-~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE-DAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred cceecCCCceEEEE--CCC-CcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 36799999999996 443 3333 68887654444567899999999999 5799999999998764 223 7
Q ss_pred EEee--cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEecCCCCCCeEEcC----CCceEEccccCc
Q 038294 581 VYEF--MGNGTLANLIFAIPKPDWNLRVRISLEIARGL-VYLHEECNVPIIHCDIKPQNILLDN----YFSAKISDFGLS 653 (799)
Q Consensus 581 v~e~--~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL-~yLH~~~~~~iiH~dlk~~NILl~~----~~~~kl~DfGla 653 (799)
|+|| +++++|.+++.+. .++.. ..++.+++.++ +|||++ +|+||||||+|||++. +.+++|+||+-+
T Consensus 83 I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 5579999999764 34444 35677888777 999998 9999999999999974 348999995433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.5e-18 Score=183.65 Aligned_cols=227 Identities=24% Similarity=0.216 Sum_probs=174.6
Q ss_pred hcCccccceEEEEEEe--CCCCeEEEEEEccccchh--hHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecC
Q 038294 512 ELGRGSFGIVYKGVLK--SASGKAIAVKKLDRLAQE--REREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~--~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
.+|+|.||.|+...-- ...+..+|+|.+.+.... .......|..++...+ ||.++++.-.+..+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999864321 113567788887643221 1114456777888886 9999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|.|...+......+..........++-+++++|+. +|+|||+|++||+++.+|.+++.|||+++........
T Consensus 81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---- 153 (612)
T ss_pred cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc----
Confidence 999999988877777777777888899999999998 9999999999999999999999999999876433222
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
+||..|||||++. .....+|-||||++++||+||..||..... ..+ . + ..-..+.
T Consensus 154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~----~~I---l----~-----------~~~~~p~ 208 (612)
T KOG0603|consen 154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTM----KRI---L----K-----------AELEMPR 208 (612)
T ss_pred -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHH----HHH---h----h-----------hccCCch
Confidence 7899999999998 568899999999999999999999986110 111 0 0 0111234
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
+.......++..++..+|.+|.-.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 444555667777888888888655
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=184.29 Aligned_cols=197 Identities=24% Similarity=0.252 Sum_probs=154.7
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc---cccccceeeeeecccc
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALN 577 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~ 577 (799)
++......+.++||+|+||+||+|+..+ ++.||+|+-+....- +|.--.+++.+|+ -+-|..+.....-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~--~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN--GKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC--CcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 3444445567889999999999999874 899999987653321 1111222333333 2334445555566677
Q ss_pred eeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-------CCCceEEccc
Q 038294 578 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-------NYFSAKISDF 650 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-------~~~~~kl~Df 650 (799)
-+||+||.+.|+|.+++...+.++|...+.++.|+++.+++||.. +|||+||||+|.||. +...++|+||
T Consensus 769 S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEec
Confidence 789999999999999999888999999999999999999999998 999999999999994 3566999999
Q ss_pred cCcccccCC-CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCc
Q 038294 651 GLSKLLLSD-QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR 705 (799)
Q Consensus 651 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~ 705 (799)
|.+..+.-- ........+.|-.+-.+|...+++++.++|.|.++-+++-||-|+-
T Consensus 846 G~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 846 GRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999766422 2234455678889999999999999999999999999999997753
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.2e-16 Score=160.41 Aligned_cols=140 Identities=22% Similarity=0.204 Sum_probs=108.4
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh------------------------hHHHHHHHHHHhcccccc-
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE------------------------REREFKSEVSAIGRTHHK- 563 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~------------------------~~~~~~~E~~~l~~l~h~- 563 (799)
+.+.||+|+||.||+|.+...+|+.||+|+++..... ....+..|++.+.++.+.
T Consensus 32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~ 111 (237)
T smart00090 32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG 111 (237)
T ss_pred hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 4578999999999999833346899999998642210 112356899999999753
Q ss_pred -cccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEecCCCCCCeEEcC
Q 038294 564 -NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP-IIHCDIKPQNILLDN 641 (799)
Q Consensus 564 -niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~-iiH~dlk~~NILl~~ 641 (799)
.+.+++++ ...++||||+++.+|.................++.||+.++++||+. + |+|+||||+||+++
T Consensus 112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~- 183 (237)
T smart00090 112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH- 183 (237)
T ss_pred CCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-
Confidence 34444543 23589999999988877654444455566788999999999999998 8 99999999999999
Q ss_pred CCceEEccccCcccc
Q 038294 642 YFSAKISDFGLSKLL 656 (799)
Q Consensus 642 ~~~~kl~DfGla~~~ 656 (799)
++.++|+|||.+...
T Consensus 184 ~~~i~LiDFg~a~~~ 198 (237)
T smart00090 184 DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCCEEEEEChhhhcc
Confidence 889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.65 E-value=7.8e-16 Score=155.85 Aligned_cols=134 Identities=23% Similarity=0.282 Sum_probs=112.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch--------hhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.||+|++|.||+|.. .+..+++|+...... .....+.+|++++..++|+++.....++......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~---~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF---LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee---CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence 4689999999999987 356788887643211 11245788999999999999988887777777889999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
||+++++|.+++..... .+..++.+++.+|.+||+. +++|+|++|+|||++ ++.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999999865332 7789999999999999998 899999999999999 78999999998874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.4e-15 Score=152.55 Aligned_cols=130 Identities=22% Similarity=0.320 Sum_probs=106.3
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccc--------hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.||+|+||.||+|.+ ++..+++|+..... ....+++.+|++++..++|+++.....++......++|||
T Consensus 1 ~ig~G~~~~vy~~~~---~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF---LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec---CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEE
Confidence 389999999999985 46788999854311 1123567889999999998877666556666667789999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
|+++++|.+++..... .++.+++.+|.+||.. +++|+|++|+||+++ ++.++++|||++..
T Consensus 78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999988754321 7899999999999998 999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.5e-15 Score=154.26 Aligned_cols=196 Identities=22% Similarity=0.288 Sum_probs=131.1
Q ss_pred ccccccceeeeeec---------------------------ccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHH
Q 038294 561 HHKNLVQLLGFCDE---------------------------ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIA 613 (799)
Q Consensus 561 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia 613 (799)
+|||||+++++|.+ +...|+||...+. +|.+++.....- .....-|+.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s-~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRS-YRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCc-hHHHHHHHHHHH
Confidence 58888888776532 3345778776543 888888765443 445556888999
Q ss_pred HHHHHHHhcCCCCeEecCCCCCCeEEc--CC--CceEEccccCcccccCC--C---CcceeeeccCCcccccccccCCC-
Q 038294 614 RGLVYLHEECNVPIIHCDIKPQNILLD--NY--FSAKISDFGLSKLLLSD--Q---SRTHTMIRGTRGYVAPEWFKNAP- 683 (799)
Q Consensus 614 ~gL~yLH~~~~~~iiH~dlk~~NILl~--~~--~~~kl~DfGla~~~~~~--~---~~~~~~~~gt~~y~aPE~l~~~~- 683 (799)
+|+.|||.+ +|.|||+|++||||. ++ -...|+|||.+-.-... + ..-....-|.-.-||||+....+
T Consensus 352 Eav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 352 EAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999 999999999999993 33 34789999977543221 1 11111223666799999986542
Q ss_pred -----CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHH
Q 038294 684 -----VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMW 758 (799)
Q Consensus 684 -----~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~ 758 (799)
--.|+|.|+.|.+.||++....||....+. .+..-. +.+.++ +.++.. ....+.+++..
T Consensus 429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem----~L~~r~---Yqe~qL-----Palp~~----vpp~~rqlV~~ 492 (598)
T KOG4158|consen 429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM----LLDTRT---YQESQL-----PALPSR----VPPVARQLVFD 492 (598)
T ss_pred CceeeccchhhhhhhhhhHHHHhccCCcccccchh----eechhh---hhhhhC-----CCCccc----CChHHHHHHHH
Confidence 135899999999999999999999863221 111101 111111 122222 22355678888
Q ss_pred hcccCCCCCCCHHHHHHHH
Q 038294 759 CIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 759 Cl~~dP~~RPt~~evl~~L 777 (799)
.|+.||.+||+..-....|
T Consensus 493 lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 493 LLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HhcCCccccCCccHHHhHH
Confidence 9999999999987655554
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.6e-15 Score=149.34 Aligned_cols=136 Identities=18% Similarity=0.155 Sum_probs=106.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch----------------------hhHHHHHHHHHHhccccccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ----------------------EREREFKSEVSAIGRTHHKN 564 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~----------------------~~~~~~~~E~~~l~~l~h~n 564 (799)
+.+.+.||+|+||.||++..+ +++.||||++..... .....+..|+.++.++.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP--DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC--CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 345678999999999999875 588999998653210 01123667888898888874
Q ss_pred --ccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 038294 565 --LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 565 --iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~ 642 (799)
+++.++. ...+++|||+++++|.++... ....+++.+++.++.++|+. +|+|+||||+||+++++
T Consensus 95 i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 95 FPVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCC
Confidence 4444442 345899999999998776431 33567889999999999997 99999999999999999
Q ss_pred CceEEccccCccccc
Q 038294 643 FSAKISDFGLSKLLL 657 (799)
Q Consensus 643 ~~~kl~DfGla~~~~ 657 (799)
+.++|+|||++....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.6e-16 Score=168.61 Aligned_cols=170 Identities=25% Similarity=0.358 Sum_probs=126.3
Q ss_pred ceeeEEeecCCCChhhhhhcC---CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCc
Q 038294 577 NRLLVYEFMGNGTLANLIFAI---PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
..++.|+++.-.+|.++|... ...++....+++.|++.|+.| + +.+|+|+||.||+...+.++||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 357899999999999999754 356788899999999999999 4 7999999999999999999999999998
Q ss_pred ccccCCC-----CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 654 KLLLSDQ-----SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 654 ~~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
....... ....+...||..||+||.+.+..|+.|+||||||++|+|++. -..+++... ...-+
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------t~~d~ 472 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------TLTDI 472 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------hhhhh
Confidence 8765443 223344569999999999999999999999999999999986 222222110 11112
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKV 772 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 772 (799)
+.|.+....-...+ .-..+..+++.+.|.+||++.+
T Consensus 473 r~g~ip~~~~~d~p---------~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 RDGIIPPEFLQDYP---------EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred hcCCCChHHhhcCc---------HHHHHHHHhcCCCcccCchHHH
Confidence 23332211111111 1235788899999999994443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-15 Score=170.69 Aligned_cols=132 Identities=17% Similarity=0.282 Sum_probs=108.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEc-cc-cc------hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKL-DR-LA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l-~~-~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
..+.||+|+||+||+|.+.. ..+++|+. .. .. ....+.+.+|++++.+++|++++....++......++
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~---~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLG---RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccceeccCCcEEEEEEeecC---ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 35789999999999998753 23333332 11 11 1123568899999999999999988888877778899
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
||||+++++|.+++. ...+++.+++++|.|||+. +++||||||+|||+ +++.++|+|||+++.
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999999885 4578999999999999998 99999999999999 677999999999875
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.2e-14 Score=166.33 Aligned_cols=204 Identities=24% Similarity=0.285 Sum_probs=139.4
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.+.|..|++|.||...++. ..+.+|+|+-+... +.+- ++.....|.+| |+
T Consensus 88 IklisngAygavylvrh~~-trqrfa~kiNkq~l------ilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKE-TRQRFAMKINKQNL------ILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred eEeeccCCCCceeeeeccc-cccchhhcccccch------hhhc--cccccCCccee---------------------ch
Confidence 3568999999999998874 45677774432210 0100 12222222222 44
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC--------
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-------- 661 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-------- 661 (799)
-...++..+.++. +++.+++|||+. +|+|||+||+|.+|+.-|.+|++|||+.+.......
T Consensus 138 c~tllk~~g~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I 206 (1205)
T KOG0606|consen 138 CATLLKNIGPLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHI 206 (1205)
T ss_pred hhhhcccCCCCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcch
Confidence 4455555444432 237899999998 999999999999999999999999999886532110
Q ss_pred ------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 662 ------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 662 ------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.....++||+.|+|||++....|...+|-|++|+++||.+-|..||..+..++-.. ..+...+.
T Consensus 207 ~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg---~visd~i~------- 276 (1205)
T KOG0606|consen 207 EKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---QVISDDIE------- 276 (1205)
T ss_pred HHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh---hhhhhhcc-------
Confidence 11223579999999999999999999999999999999999999999887665221 11111100
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCC
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPT 769 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 769 (799)
+ ++ .+.....+..+++.+.|+.+|.+|--
T Consensus 277 w----pE-~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 277 W----PE-EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred c----cc-cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 0 11 12233346667888999999999953
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=1e-13 Score=131.72 Aligned_cols=134 Identities=20% Similarity=0.167 Sum_probs=113.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc--ccccceeeeeecccceeeEEeecCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH--KNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.||+|.++.||++... +..+++|....... ...+..|+..+..++| .++++++++....+..++++||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~---~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTK---DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEec---CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 357999999999999975 36899999865433 4678899999999976 5899999998888889999999998
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
+.+..+ +......++.++++++++||.....+++|+|++|+||++++.+.+++.|||.+..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 877654 5566778899999999999986445799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.3e-14 Score=138.51 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=95.2
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchh--hHHH----------------------HHHHHHHhccccccc-
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE--RERE----------------------FKSEVSAIGRTHHKN- 564 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n- 564 (799)
.+.||+|+||.||+|... +++.||||++...... .... ...|...+.++.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~--~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 2 GGPIGTGKEADVYLALDG--DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CcccccccceeEEEEECC--CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 367999999999999876 5789999987642211 1111 124555555554332
Q ss_pred -ccceeeeeecccceeeEEeecCCCChhhh-hhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcC
Q 038294 565 -LVQLLGFCDEALNRLLVYEFMGNGTLANL-IFAIPKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 565 -iv~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~~ 641 (799)
+.+.+++ ...++||||++++.+... +.... .. ....+++.+++.++.++|. . +|+|+||||+||+++
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 3444443 245899999999554321 11111 11 5667899999999999998 6 899999999999999
Q ss_pred CCceEEccccCcccc
Q 038294 642 YFSAKISDFGLSKLL 656 (799)
Q Consensus 642 ~~~~kl~DfGla~~~ 656 (799)
++.++|+|||.+...
T Consensus 150 ~~~~~liDfg~a~~~ 164 (187)
T cd05119 150 DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCcEEEEECcccccc
Confidence 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=9e-15 Score=167.97 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=185.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+|+.|-...........+|+|.+.... ....+....|..+-..+. |+|++++++...+....+++.|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 3445669999999999887755455678888876543 222234445777777776 9999999999999999999999
Q ss_pred ecCCCChhhhh-hcCC-CCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccC-
Q 038294 584 FMGNGTLANLI-FAIP-KPDWNLRVRISLEIARGLVYLH-EECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLS- 658 (799)
Q Consensus 584 ~~~~gsL~~~l-~~~~-~~~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~- 658 (799)
|..++++.+.+ .... ..+.......+.|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|.....
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999888 4433 5556667788999999999999 65 899999999999999999 999999999998766
Q ss_pred -CCCcceeeecc-CCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 659 -DQSRTHTMIRG-TRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 659 -~~~~~~~~~~g-t~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
..........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........... .|. +.+ ..
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~--~~~-----~~~--~~ 249 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS--SWK-----SNK--GR 249 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce--eec-----ccc--cc
Confidence 23333444568 9999999999885 446789999999999999999999876544332111 000 000 00
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
.. .............+...++..+|+.|.+.+++.
T Consensus 250 ~~----~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 FT----QLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cc----cCccccCChhhhhcccccccCCchhcccccccc
Confidence 00 001112223445677778889999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.2e-13 Score=137.77 Aligned_cols=134 Identities=16% Similarity=0.123 Sum_probs=103.8
Q ss_pred hhcC-ccccceEEEEEEeCCCCeEEEEEEccccc-------------hhhHHHHHHHHHHhcccccccc--cceeeeeec
Q 038294 511 EELG-RGSFGIVYKGVLKSASGKAIAVKKLDRLA-------------QEREREFKSEVSAIGRTHHKNL--VQLLGFCDE 574 (799)
Q Consensus 511 ~~lG-~G~fG~Vykg~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~g~~~~ 574 (799)
..|| .|+.|+||+.... +..++||++.... ......+.+|++++.+++|+++ ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~---~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP---GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC---CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 4687 8999999998764 5788898874310 1223467889999999998885 677777543
Q ss_pred ccc----eeeEEeecCC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 575 ALN----RLLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 575 ~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
... .++|+|++++ .+|.+++... .++. ..+.+|+.+|.+||+. +|+|+||||+|||++.++.++|+|
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~----~~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-PLSE----EQWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-CCCH----HHHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 322 2599999997 6898887653 3333 2367899999999998 999999999999999988999999
Q ss_pred ccCccc
Q 038294 650 FGLSKL 655 (799)
Q Consensus 650 fGla~~ 655 (799)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998875
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.2e-11 Score=137.98 Aligned_cols=138 Identities=22% Similarity=0.230 Sum_probs=97.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhh----------------------------------------HHHH
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER----------------------------------------EREF 550 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~----------------------------------------~~~~ 550 (799)
+.||.|++|.||+|+++ +|+.||||+.+...... +-+|
T Consensus 123 ~plasaSigQVh~A~l~--~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV--DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred cceeeeehhheEEEEec--CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 45999999999999997 58899999985421110 0124
Q ss_pred HHHHHHhcccc----cccccceeeeee-cccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHH-HHHHHHhcC
Q 038294 551 KSEVSAIGRTH----HKNLVQLLGFCD-EALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIAR-GLVYLHEEC 623 (799)
Q Consensus 551 ~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~-gL~yLH~~~ 623 (799)
..|.+.+.+++ |.+-+.+-..+. .....+|||||++|++|.++.... ... .+.+++..++. .+..+|..
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 44555555542 333333333332 234578999999999998876532 122 23456776666 46788887
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
+++|+|++|.||+++++++++++|||++..+
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 9999999999999999999999999998765
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.2e-12 Score=126.81 Aligned_cols=196 Identities=20% Similarity=0.301 Sum_probs=132.7
Q ss_pred hcccccccccceeeeeecc-----cceeeEEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 038294 557 IGRTHHKNLVQLLGFCDEA-----LNRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPI 627 (799)
Q Consensus 557 l~~l~h~niv~l~g~~~~~-----~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~i 627 (799)
|-.+.|.|||++..|..+. .+...+.|||+.|+|..+|++. ..+......+++.||..||.|||+ |.++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCcc
Confidence 3445699999999988543 3457899999999999999864 345556667899999999999998 57899
Q ss_pred EecCCCCCCeEEcCCCceEEccccCcccccCC----CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhC
Q 038294 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSD----QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICC 703 (799)
Q Consensus 628 iH~dlk~~NILl~~~~~~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg 703 (799)
+|+++.-+.|++..++-+||.- +.....+.. .........+-++|.+||+=...+.+..+|||+||+..+||--+
T Consensus 200 ihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred ccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 9999999999999998888753 221111110 00111112356789999987777778899999999999999766
Q ss_pred CcCC-chhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 704 RRSV-EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 704 ~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..-. .....-+....+.. -+..+-+. .-..++..|++..|..||+|++++.
T Consensus 279 Eiq~tnseS~~~~ee~ia~---------~i~~len~------------lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVEVEENIAN---------VIIGLENG------------LQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceeehhhhhhh---------heeeccCc------------cccCcCcccccCCCCCCcchhhhhc
Confidence 5431 11111111111100 00000011 1123677899999999999998753
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-11 Score=98.73 Aligned_cols=57 Identities=25% Similarity=0.404 Sum_probs=49.6
Q ss_pred ccceeEeeccCCCCCCcccc-CCCChhhhhhhhcccccceeeeec----CCceeecccCCCC
Q 038294 355 LYEIREFNNVDWPFGDYERL-EPYNQTECEISCLHDCLCAVAIYD----GNRCWKKKLPLSN 411 (799)
Q Consensus 355 ~~~f~~~~~~~~~~~~~~~~-~~~~~~~C~~~Cl~nCsC~a~~~~----~~~C~~~~~~l~~ 411 (799)
.++|+++++|++|+++...+ .+.++++|+..||+||||+||+|. +++|++|...|.|
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~~L~d 65 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYGDLVD 65 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcCEeec
Confidence 36899999999999876665 679999999999999999999995 4789999887654
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.7e-10 Score=128.57 Aligned_cols=139 Identities=17% Similarity=0.203 Sum_probs=87.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchh----------------------------------hHH------HH
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE----------------------------------RER------EF 550 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~----------------------------------~~~------~~ 550 (799)
+.||.|++|.||+|++++ +|+.||||+++....+ ..+ +|
T Consensus 125 ~PlasaSiaQVh~A~l~~-~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~ 203 (537)
T PRK04750 125 KPLASASIAQVHFARLKD-NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDL 203 (537)
T ss_pred hhhcCCCccEEEEEEECC-CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCH
Confidence 469999999999999984 4899999998642110 011 23
Q ss_pred HHHHHHhcccc----cccccceeeeeec-ccceeeEEeecCCCChhhhhh-cCCCCCHHHHHHHHHHHHHH-HHHHHhcC
Q 038294 551 KSEVSAIGRTH----HKNLVQLLGFCDE-ALNRLLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIARG-LVYLHEEC 623 (799)
Q Consensus 551 ~~E~~~l~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~g-L~yLH~~~ 623 (799)
..|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+++.++-. .....+.+ .++...++. +..++..
T Consensus 204 ~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~---~la~~~v~~~~~Qif~~- 279 (537)
T PRK04750 204 MREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMK---LLAERGVEVFFTQVFRD- 279 (537)
T ss_pred HHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHH---HHHHHHHHHHHHHHHhC-
Confidence 34444444432 3333333333332 445789999999999987532 11122211 222222221 2223334
Q ss_pred CCCeEecCCCCCCeEEcCCC----ceEEccccCcccc
Q 038294 624 NVPIIHCDIKPQNILLDNYF----SAKISDFGLSKLL 656 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~----~~kl~DfGla~~~ 656 (799)
+++|+|+||.||+++.++ ++++.|||+...+
T Consensus 280 --GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 280 --GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred --CeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 899999999999999888 9999999998765
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.4e-10 Score=112.92 Aligned_cols=130 Identities=19% Similarity=0.125 Sum_probs=96.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccccc-ceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLV-QLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.|+.|.++.||++... ++.+++|....... ....+..|++++..+.+.+++ +++.+.. ...++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~---~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA---NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC---CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 46889999999998863 67899999765322 223567888888888665544 4555432 34579999999988
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC--NVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
+.+.. .....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 112345678999999999873 22369999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.14 E-value=5.8e-11 Score=130.44 Aligned_cols=252 Identities=22% Similarity=0.223 Sum_probs=178.2
Q ss_pred HHHHHhhchhhhcCc--cccceEEEEEE--eCCCCeEEEEEEccccch--hhHHHHHHHHHHhccc-ccccccceeeeee
Q 038294 501 ELKEATGGFKEELGR--GSFGIVYKGVL--KSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKNLVQLLGFCD 573 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~--G~fG~Vykg~~--~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 573 (799)
+.......+.+.+|. |.+|.||++.. .. ++..+|+|+-+.... .....=.+|+...+++ .|+|.++......
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~-s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSE-SPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCccc-CCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 445555667788999 99999999987 53 567889988432211 2222224566666666 4999999888889
Q ss_pred cccceeeEEeecCCCChhhhhhcCCC-CCHHHHHHHHHHHHH----HHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEE
Q 038294 574 EALNRLLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIAR----GLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKI 647 (799)
Q Consensus 574 ~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~ia~----gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl 647 (799)
+++..++-.|++. .+|..+...... ++....+.+..+... ||.++|.. .++|-|+||.||++..+ ..+++
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~ 264 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL 264 (524)
T ss_pred cCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence 9999999999885 677777766533 556666677777777 99999998 89999999999999999 89999
Q ss_pred ccccCcccccCCC-Ccc---eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH
Q 038294 648 SDFGLSKLLLSDQ-SRT---HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 648 ~DfGla~~~~~~~-~~~---~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 723 (799)
.|||+...+.... ... .....|...|++||.+.+. ++...|+|++|.+..|..++.......... .|
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~-------~W- 335 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNS-------SW- 335 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCC-------Cc-
Confidence 9999998886543 111 1222467789999998654 688999999999999999887665433111 01
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+. .+.+.-.....++..++..+++.+|-.|++.+.+..
T Consensus 336 -~~~r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 -SQLRQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -ccccccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0011111 111111122234445788899999999999887653
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=7e-10 Score=122.95 Aligned_cols=171 Identities=16% Similarity=0.227 Sum_probs=125.6
Q ss_pred EEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCH
Q 038294 523 KGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDW 602 (799)
Q Consensus 523 kg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~ 602 (799)
.|..+. ++.+|.|+..+...........+-++.|+.++||||++++....+....|||.|-+. .|..++.+.. .
T Consensus 30 ~~t~k~-~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~ 103 (690)
T KOG1243|consen 30 DGTRKA-DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---K 103 (690)
T ss_pred ccceec-cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---H
Confidence 455553 677888888876555444557788899999999999999999999999999999873 4666665433 2
Q ss_pred HHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCC
Q 038294 603 NLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682 (799)
Q Consensus 603 ~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 682 (799)
....-.+.||+.||.|||+.| +++|++|....|+|+..|..||.+|-+......... .......-..|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 334446789999999999876 899999999999999999999999988764322111 01111112245666654332
Q ss_pred CCCcchhHHHHHHHHHHHHhCC
Q 038294 683 PVSAKVDVYSFGVMLLEIICCR 704 (799)
Q Consensus 683 ~~s~k~DVwS~Gvll~elltg~ 704 (799)
. -..|.|-||++++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3569999999999999983
|
|
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.4e-10 Score=98.52 Aligned_cols=72 Identities=18% Similarity=0.318 Sum_probs=60.7
Q ss_pred ccceeEeeccCCCCCCccccCCCChhhhhhhhcccccceeeeec--CCceeecccCCCCCccccCCCCceEEEEe
Q 038294 355 LYEIREFNNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYD--GNRCWKKKLPLSNGWLRDTGFSKVLFKVR 427 (799)
Q Consensus 355 ~~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~~l~~g~~~~~~~~~~~lkv~ 427 (799)
.++|+++.++++|+..+.. .+.++++|++.||+||+|.||+|. +++|++|..++.+.+.........|+|++
T Consensus 11 ~~~f~~~~~~~~~~~~~~~-~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAI-TAISLEECREACLSNCSCTAYAYNNGSGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhh-ccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEeceecceEeecCCCcEEEEEeC
Confidence 3579999999999886655 788999999999999999999995 58999999988887765545578898874
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.9e-09 Score=104.48 Aligned_cols=138 Identities=14% Similarity=0.135 Sum_probs=97.0
Q ss_pred hhcCccccceEEEEEEeCC-----CCeEEEEEEccccc----------------------hhhHHHHH----HHHHHhcc
Q 038294 511 EELGRGSFGIVYKGVLKSA-----SGKAIAVKKLDRLA----------------------QEREREFK----SEVSAIGR 559 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~-----~~~~vavK~l~~~~----------------------~~~~~~~~----~E~~~l~~ 559 (799)
..||.|--+.||.|...+. .+..+|||+.+... ....+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 4689999999999975421 24789999764210 00012233 78999988
Q ss_pred ccc--ccccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCC
Q 038294 560 THH--KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEECNVPIIHCDIKPQN 636 (799)
Q Consensus 560 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~dlk~~N 636 (799)
+.. -++.+++++ ...+|||||+.+..+....-....++.+...++..+++.+|..| |.. +|+|+||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence 853 466677764 45689999997754422111112334455667889999999999 666 99999999999
Q ss_pred eEEcCCCceEEccccCcccc
Q 038294 637 ILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 637 ILl~~~~~~kl~DfGla~~~ 656 (799)
||+++ +.+.|+|||.+...
T Consensus 156 IL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-CcEEEEECCCceeC
Confidence 99974 67999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.2e-09 Score=107.24 Aligned_cols=142 Identities=17% Similarity=0.258 Sum_probs=109.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhccccc--ccccceeeeeeccc---ceeeEEee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHH--KNLVQLLGFCDEAL---NRLLVYEF 584 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~---~~~lv~e~ 584 (799)
+.|+.|..+.||++... +|+.+++|....... ....++..|+++++.+++ .++.+++.+..+.. ..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~--~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG--GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEec--CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 46899999999999875 357899999764322 134578899999999875 44677888876643 56899999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC----------------------------------------- 623 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~----------------------------------------- 623 (799)
+++.++.+.+.. ..++...+..++.+++++|..||+..
T Consensus 82 i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 82 VDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred eCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 999888776532 34566777788888888888888521
Q ss_pred ------------CCCeEecCCCCCCeEEcC--CCceEEccccCccc
Q 038294 624 ------------NVPIIHCDIKPQNILLDN--YFSAKISDFGLSKL 655 (799)
Q Consensus 624 ------------~~~iiH~dlk~~NILl~~--~~~~kl~DfGla~~ 655 (799)
...++|+|+++.||++++ ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.97 E-value=7.2e-10 Score=121.96 Aligned_cols=244 Identities=22% Similarity=0.251 Sum_probs=171.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHH--HHHHHHHhccc-ccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE--FKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
++...||.|.|+.|++...+..++..+++|.+.+.......+ -..|+.+...+ .|.++++....+......++=-||
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~ 347 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEF 347 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhh
Confidence 445679999999999988654567889999886543332222 13466665555 588889888888777788899999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++++...+.....++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.+..+.-...
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~-- 422 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG-- 422 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceecc--
Confidence 99999877765545667778889999999999999987 89999999999999886 8889999999864311111
Q ss_pred eeeeccCCcc-cccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGY-VAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y-~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....+..| .+++......+-.+.|++|||.-+.|.+++..-...... ...+.....+.
T Consensus 423 -~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-------------------~~~i~~~~~p~ 482 (524)
T KOG0601|consen 423 -VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-------------------SLTIRSGDTPN 482 (524)
T ss_pred -cccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------------ceeeecccccC
Confidence 111123334 366666777889999999999999999887653221110 00111111111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
... ..+.+..++..++..++..||.+.+.....+
T Consensus 483 ~~~--~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 LPG--LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CCc--hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111 1145555677788899999999988776554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.3e-09 Score=97.94 Aligned_cols=131 Identities=21% Similarity=0.314 Sum_probs=101.7
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEc-ccc------ch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL-DRL------AQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l-~~~------~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+++|+-+.+|.+.+. +..+++|.- ++. .. -..+...+|+.++.+++--.|....-+..+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~---g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL---GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeecc---CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEE
Confidence 35789999999998764 344555542 211 11 11235678999999988777766666777888889999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
||+++-.|.+.+... ...++..+-.-+.-||.. +|+|+||.++||++.... +.++||||+..
T Consensus 79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999999888765 356777788888899998 999999999999998875 99999999874
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.6e-08 Score=107.13 Aligned_cols=167 Identities=21% Similarity=0.277 Sum_probs=130.1
Q ss_pred cceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee----cccceeeEEeecCC-CChhh
Q 038294 518 FGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD----EALNRLLVYEFMGN-GTLAN 592 (799)
Q Consensus 518 fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv~e~~~~-gsL~~ 592 (799)
-.+.||+.... +|..+++|+++....+.......-+++++++.|.|+|++..++. .+...++||+|.++ ++|.+
T Consensus 289 ~~Ttyk~~s~~-DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNV-DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeecc-CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 35789998774 78999999996544443333455688899999999999999885 44567899999986 57776
Q ss_pred hhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 593 LIFAI---------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 593 ~l~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
+-+.. .+.+++..+.++.|+..||.++|+. |+.-+-|.+++||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 65432 2346788899999999999999998 89889999999999999999999999887765
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcC
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p 706 (799)
.+.... +. --.+-|.=.||.+++.|.||...
T Consensus 445 ~d~~~~---------------le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTEP---------------LE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCcc---------------hh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 443111 11 12467999999999999999654
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=98.88 E-value=2.1e-09 Score=88.76 Aligned_cols=64 Identities=9% Similarity=0.018 Sum_probs=53.7
Q ss_pred ceeEeeccCCCCCCccccCCCChhhhhhhhcc---cccceeeeec--CCceeecccCC-CCCccccCCCCceEEE
Q 038294 357 EIREFNNVDWPFGDYERLEPYNQTECEISCLH---DCLCAVAIYD--GNRCWKKKLPL-SNGWLRDTGFSKVLFK 425 (799)
Q Consensus 357 ~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~--~~~C~~~~~~l-~~g~~~~~~~~~~~lk 425 (799)
.|+++.++++|++.. .+++||+++|++ ||||+||+|. +.+|++|...+ .+.+....++.++|+|
T Consensus 10 ~fl~~~~~klpd~~~-----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 10 TTLIKIALKIKTTKA-----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPFNSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred eEEEeecccCCcccc-----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecCcchhhHHhccCCCceeEeE
Confidence 589999999998744 689999999999 9999999994 56899999988 7776665556677775
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.1e-08 Score=94.25 Aligned_cols=141 Identities=21% Similarity=0.278 Sum_probs=104.5
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEc-cc-------cchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKL-DR-------LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l-~~-------~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
.+.|-||+-+.|+++.+. |+..+||.- .+ ...-..+..++|++++.+++--.|.-..-++.+...-.|+
T Consensus 12 l~likQGAEArv~~~~~~---Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS---GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred ceeeeccceeeEeeeccC---CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 356889999999999884 667666642 21 1112235678899999998766666666666677777899
Q ss_pred EeecCC-CChhhhhhcC-CCCCHHHH-HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEccccCccc
Q 038294 582 YEFMGN-GTLANLIFAI-PKPDWNLR-VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---SAKISDFGLSKL 655 (799)
Q Consensus 582 ~e~~~~-gsL~~~l~~~-~~~~~~~~-~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---~~kl~DfGla~~ 655 (799)
|||+++ .++.+++... .....+.. ..++..|-+.+.-||.+ .|||+||..+||+|..++ .+.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999977 4778887654 22233333 67888999999999998 999999999999996543 358999999875
Q ss_pred c
Q 038294 656 L 656 (799)
Q Consensus 656 ~ 656 (799)
.
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.8e-07 Score=97.17 Aligned_cols=130 Identities=18% Similarity=0.149 Sum_probs=96.0
Q ss_pred eEEEEEEeCCCCeEEEEEEccccchh-hHH----------HHHHHHHHhcccccccc--cceeeeeec-----ccceeeE
Q 038294 520 IVYKGVLKSASGKAIAVKKLDRLAQE-RER----------EFKSEVSAIGRTHHKNL--VQLLGFCDE-----ALNRLLV 581 (799)
Q Consensus 520 ~Vykg~~~~~~~~~vavK~l~~~~~~-~~~----------~~~~E~~~l~~l~h~ni--v~l~g~~~~-----~~~~~lv 581 (799)
.|.+..+ +|+.+.||+....... ..+ .+.+|...+.++...+| ++++++... ....+||
T Consensus 37 rvvr~~~---~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LV 113 (268)
T PRK15123 37 RTLRFEL---AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFII 113 (268)
T ss_pred eEEEEEE---CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEE
Confidence 3666665 4678999977432211 111 37789999888864444 445666543 2346799
Q ss_pred EeecCCC-Chhhhhhc--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-------CCceEEcccc
Q 038294 582 YEFMGNG-TLANLIFA--IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-------YFSAKISDFG 651 (799)
Q Consensus 582 ~e~~~~g-sL~~~l~~--~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-------~~~~kl~DfG 651 (799)
+|++++- +|.+++.. ....+...+..++.+++..+.-||.. +|+|+|++++|||++. +..+.++||+
T Consensus 114 te~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~ 190 (268)
T PRK15123 114 TEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLH 190 (268)
T ss_pred EeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence 9999986 89998854 23445567788999999999999998 9999999999999975 5689999999
Q ss_pred Cccc
Q 038294 652 LSKL 655 (799)
Q Consensus 652 la~~ 655 (799)
.++.
T Consensus 191 r~~~ 194 (268)
T PRK15123 191 RAQI 194 (268)
T ss_pred cccc
Confidence 8763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.65 E-value=9.8e-09 Score=118.66 Aligned_cols=241 Identities=18% Similarity=0.156 Sum_probs=156.3
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
-+-+|.++.++.+.-. ..+...+.|..... .....+....+-.++-..+||-+++..--+.......|+++|..++
T Consensus 811 p~qS~sp~ss~p~~pa-~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPA-GSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred cccCCCCcccccCCcc-ccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 4667778877765432 13323333332211 1111112222222222233455554444445567778999999999
Q ss_pred ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc-----------
Q 038294 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL----------- 657 (799)
Q Consensus 589 sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~----------- 657 (799)
+|...|+.....+.+-.......+..+++|||.. .+.|+|++|.|+|...++..+++|||......
T Consensus 890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~ 966 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGP 966 (1205)
T ss_pred CchhhhhcCCCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCcccc
Confidence 9999998877666666666777788999999986 68999999999999999999999998433220
Q ss_pred ----------CC----C-----CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchh
Q 038294 658 ----------SD----Q-----SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718 (799)
Q Consensus 658 ----------~~----~-----~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~ 718 (799)
.. + ........+|+.|.+||.+.+......+|.|+.|++++|.++|..||.....+..-..
T Consensus 967 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~n 1046 (1205)
T KOG0606|consen 967 SSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFEN 1046 (1205)
T ss_pred cccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhc
Confidence 00 0 0112234589999999999999999999999999999999999999987665432211
Q ss_pred HHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038294 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 771 (799)
+ ..+.+ ...............++...+..+|.+|..|.
T Consensus 1047 i--------~~~~~-------~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1047 I--------LNRDI-------PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred c--------ccCCC-------CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 1 11110 01111223333445567777788888887765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.9e-07 Score=90.18 Aligned_cols=124 Identities=23% Similarity=0.250 Sum_probs=80.0
Q ss_pred EEEEEEeCCCCeEEEEEEccccc--------------------------hhhHHHHHHHHHHhcccccc--cccceeeee
Q 038294 521 VYKGVLKSASGKAIAVKKLDRLA--------------------------QEREREFKSEVSAIGRTHHK--NLVQLLGFC 572 (799)
Q Consensus 521 Vykg~~~~~~~~~vavK~l~~~~--------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~g~~ 572 (799)
||.|... ++..+|||..+... ........+|.+.|.++..- ++.+++.+-
T Consensus 2 Vy~~~~~--~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 2 VYHAIDP--DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEC--TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred EEEEECC--CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 8888875 57899999764210 00123467899999999755 566776552
Q ss_pred ecccceeeEEeecC--CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 573 DEALNRLLVYEFMG--NGTLANLIFAIPKPDWNLRVRISLEIARGLVYL-HEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 573 ~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yL-H~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
...|||||++ +..+..+.... ++.+....++.+++..+..+ |.. +|+|+||.+.|||++++ .+.|+|
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence 4579999998 65554433221 11234456777787866664 565 99999999999999988 999999
Q ss_pred ccCcccc
Q 038294 650 FGLSKLL 656 (799)
Q Consensus 650 fGla~~~ 656 (799)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=3.8e-06 Score=88.51 Aligned_cols=253 Identities=15% Similarity=0.173 Sum_probs=149.4
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeee----e---ecccceeeE
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGF----C---DEALNRLLV 581 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~----~---~~~~~~~lv 581 (799)
...||+|+.+.+|---- -..-+.|+.+........+. +..|... .||-+-.-+.+ . .++...-++
T Consensus 16 gr~LgqGgea~ly~l~e----~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLGE----VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecch----hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 46799999999995221 11234476665433333222 2333333 45543331111 0 111123356
Q ss_pred EeecCCCC-hhhhhh------cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 582 YEFMGNGT-LANLIF------AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 582 ~e~~~~gs-L~~~l~------~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
|..+++.- ...++. ..+..+|...++.+..+|.+.+.||.. +..-+|+.++|+|+.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence 66665542 222222 124568999999999999999999998 89999999999999999999999854433
Q ss_pred cccCCCCcceeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhC-CcCCchhhhhh--cchhHHHHHHHH
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICC-RRSVEMEVEEE--GRAILTDWAYDC 726 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg-~~p~~~~~~~~--~~~~~~~~~~~~ 726 (799)
.. .........+|...|++||.-. +-.-+...|.|.+|+++++++.| +.||.+..... ......+
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~----- 238 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD----- 238 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh-----
Confidence 22 1222233346888999999764 34557789999999999999987 88887542211 1111111
Q ss_pred HhcCceeEeecCCC-----CCccCH-HHHHHHHHHHHHhccc--CCCCCCCHHHHHHHHhc
Q 038294 727 YAEGRLDVLVDSDE-----PAMADR-SRLQKWLMIAMWCIRE--DPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 727 ~~~~~~~~~~d~~~-----~~~~~~-~~~~~l~~l~~~Cl~~--dP~~RPt~~evl~~L~~ 779 (799)
+..|......+... +...+. -....+..+..+|+.. .+.-|||++-.+..|..
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a 299 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA 299 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence 12222222222111 111111 1122344456667754 35689999988877743
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.9e-06 Score=83.52 Aligned_cols=136 Identities=18% Similarity=0.104 Sum_probs=102.9
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccc------hhhHHHHHHHHHHhcccccc--cccceeeeee-cc----ccee
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLA------QEREREFKSEVSAIGRTHHK--NLVQLLGFCD-EA----LNRL 579 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~-~~----~~~~ 579 (799)
-|+||-+-|++-.+. |+.+-+|+-.... .-....|.+|...|.++... .+.+++ ++. .. ...+
T Consensus 26 ~~rgG~SgV~r~~~~---g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 26 YRRNGMSGVQCVERN---GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred cCCCCcceEEEEEeC---CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 477999999997764 4578889865211 22467899999999998643 345555 332 21 2247
Q ss_pred eEEeecCC-CChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--eEEccccCcc
Q 038294 580 LVYEFMGN-GTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS--AKISDFGLSK 654 (799)
Q Consensus 580 lv~e~~~~-gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~--~kl~DfGla~ 654 (799)
||+|-+++ -+|.+++.+. ..++...+..+..++++.++-||+. ++.|+|+.+.||+++.++. ++++||--++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997764 5898888663 3557777889999999999999998 9999999999999986667 9999997665
Q ss_pred c
Q 038294 655 L 655 (799)
Q Consensus 655 ~ 655 (799)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.1e-06 Score=86.23 Aligned_cols=106 Identities=21% Similarity=0.240 Sum_probs=85.3
Q ss_pred HHHHHHHHHhcccccc--cccceeeeeeccc----ceeeEEeecCC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 038294 548 REFKSEVSAIGRTHHK--NLVQLLGFCDEAL----NRLLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 620 (799)
Q Consensus 548 ~~~~~E~~~l~~l~h~--niv~l~g~~~~~~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH 620 (799)
....+|...+.++... ..++.+++..... ..++|+|++++ .+|.+++.....++......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 4567788888777543 4556777765533 34799999988 489999987555667778899999999999999
Q ss_pred hcCCCCeEecCCCCCCeEEcCCC---ceEEccccCcccc
Q 038294 621 EECNVPIIHCDIKPQNILLDNYF---SAKISDFGLSKLL 656 (799)
Q Consensus 621 ~~~~~~iiH~dlk~~NILl~~~~---~~kl~DfGla~~~ 656 (799)
.. +|+|+|+++.|||++.+. .+.++||+.++..
T Consensus 136 ~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 136 DA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 98 999999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.6e-07 Score=104.94 Aligned_cols=150 Identities=17% Similarity=0.246 Sum_probs=99.7
Q ss_pred HHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc--------ceeeeccCCccccccccc
Q 038294 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--------THTMIRGTRGYVAPEWFK 680 (799)
Q Consensus 609 ~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~--------~~~~~~gt~~y~aPE~l~ 680 (799)
+.+++.|+.|+|.. .++||++|.|++|.++.++..||+.|+.+......... ..........|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34566999999987 48999999999999999999999999987654331110 001122456799999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCcCCc-hhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHh
Q 038294 681 NAPVSAKVDVYSFGVMLLEIICCRRSVE-MEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWC 759 (799)
Q Consensus 681 ~~~~s~k~DVwS~Gvll~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~C 759 (799)
+...+.++|+||+|+++|-+..+..+.. ........ .+ ....+.....-...+...++.+=+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~-~~-------------~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY-SF-------------SRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh-hh-------------hhcccccccccccccCcHHHHHHHHHH
Confidence 9888999999999999999995555432 22111100 00 000011001111123334566666778
Q ss_pred cccCCCCCCCHHHHH
Q 038294 760 IREDPSKRPTMKVVL 774 (799)
Q Consensus 760 l~~dP~~RPt~~evl 774 (799)
+..++..||++.++.
T Consensus 249 l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLL 263 (700)
T ss_pred hcCCcccCcchhhhh
Confidence 899999999887764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.6e-05 Score=89.66 Aligned_cols=138 Identities=23% Similarity=0.281 Sum_probs=88.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhh------------------------------HH----------HH
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER------------------------------ER----------EF 550 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~------------------------------~~----------~~ 550 (799)
+.|+.++-|.||+|+++ +|+.||||+.+..-.+. .+ ++
T Consensus 131 ~PiAsASIaQVH~A~L~--sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy 208 (517)
T COG0661 131 EPIASASIAQVHRAVLK--SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDY 208 (517)
T ss_pred CchhhhhHhhheeEEec--CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCH
Confidence 45889999999999998 48999999875311100 01 12
Q ss_pred HHHHHHhcccc----cccccceeeeee-cccceeeEEeecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHH-HHHHhcC
Q 038294 551 KSEVSAIGRTH----HKNLVQLLGFCD-EALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGL-VYLHEEC 623 (799)
Q Consensus 551 ~~E~~~l~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL-~yLH~~~ 623 (799)
..|...+.+++ +..-+++=..+. -.....|+|||++|-.+.+...- ....+- ..++..++++. ..+-..
T Consensus 209 ~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~d- 284 (517)
T COG0661 209 RREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLRD- 284 (517)
T ss_pred HHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhc-
Confidence 33444444332 222233333343 34567899999999988887432 134442 23333333332 222222
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
+++|.|..|.||+++.++++.+.|||+...+
T Consensus 285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred --CccccCCCccceEEecCCcEEEEcCcceecC
Confidence 8999999999999999999999999998755
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=7e-06 Score=82.66 Aligned_cols=134 Identities=19% Similarity=0.164 Sum_probs=90.4
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--------------------ch--hhHHHHHHHHHHhcccccc--
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--------------------AQ--EREREFKSEVSAIGRTHHK-- 563 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--------------------~~--~~~~~~~~E~~~l~~l~h~-- 563 (799)
.+.++||-|.-+.||.|..+ .+.++|||.-+.. +. -.....++|.++|.++.-.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~--~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP--KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred hhccccccCccceEEEEECC--CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 45678999999999999986 5789999954210 00 0112456788889888644
Q ss_pred cccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 038294 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF 643 (799)
Q Consensus 564 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~ 643 (799)
.+.+.++. +...+||||+++-.|...-- +-+..-.|+..|++-+.-+-.. +|||+|+++-||+++++|
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg 239 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDG 239 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecccC-----cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCC
Confidence 56666654 44579999999866654331 1112223333333333322233 899999999999999999
Q ss_pred ceEEccccCccc
Q 038294 644 SAKISDFGLSKL 655 (799)
Q Consensus 644 ~~kl~DfGla~~ 655 (799)
.+.++||--+..
T Consensus 240 ~~~vIDwPQ~v~ 251 (304)
T COG0478 240 DIVVIDWPQAVP 251 (304)
T ss_pred CEEEEeCccccc
Confidence 999999976553
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.03 E-value=1.6e-05 Score=78.19 Aligned_cols=102 Identities=23% Similarity=0.352 Sum_probs=83.5
Q ss_pred HHHHHHhccccc-ccccceeeeeecccceeeEEeecCCCChhhh---hhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 038294 551 KSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYEFMGNGTLANL---IFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626 (799)
Q Consensus 551 ~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~ 626 (799)
.+|.-+++.+++ +++++++|.| ..+++.||...+++... +.+.-..+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888876 6999999999 44789999987766432 223345789999999999999999999865456
Q ss_pred eEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 627 iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.7e-05 Score=76.92 Aligned_cols=136 Identities=14% Similarity=0.166 Sum_probs=84.2
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc--ccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.||+|..+.||+. .+..+++|..+... ......+|.+++..+..-. +.+.+++........+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~-----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH-----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe-----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 56899999999983 13456788876422 2345688999998886444 467788887777778999999986
Q ss_pred C-hhhhh---------------------hcC--CCCCHHHHH-HHHH----------HHHHH-HHHHHhc-CCCCeEecC
Q 038294 589 T-LANLI---------------------FAI--PKPDWNLRV-RISL----------EIARG-LVYLHEE-CNVPIIHCD 631 (799)
Q Consensus 589 s-L~~~l---------------------~~~--~~~~~~~~~-~i~~----------~ia~g-L~yLH~~-~~~~iiH~d 631 (799)
+ +...+ +.. ......... ++.. .+... ..+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 21111 111 111111100 0100 11111 2222211 123578999
Q ss_pred CCCCCeEEcCCCceEEccccCcc
Q 038294 632 IKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 632 lk~~NILl~~~~~~kl~DfGla~ 654 (799)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.1e-05 Score=66.97 Aligned_cols=58 Identities=19% Similarity=0.313 Sum_probs=46.6
Q ss_pred cceeEeeccCCCCCCccccCCCChhhhhhhhcc-cccceeeeec--CCceeecc-cCCCCCc
Q 038294 356 YEIREFNNVDWPFGDYERLEPYNQTECEISCLH-DCLCAVAIYD--GNRCWKKK-LPLSNGW 413 (799)
Q Consensus 356 ~~f~~~~~~~~~~~~~~~~~~~~~~~C~~~Cl~-nCsC~a~~~~--~~~C~~~~-~~l~~g~ 413 (799)
..|++++++.+++.........++++|++.|++ +|+|.|+.|. ++.|+++. .++.+..
T Consensus 4 ~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~~~~~~~ 65 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLGDAR 65 (78)
T ss_pred ceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCCccccce
Confidence 358899999998655443467899999999999 9999999996 68999998 5555544
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.90 E-value=8.3e-05 Score=73.66 Aligned_cols=129 Identities=17% Similarity=0.180 Sum_probs=79.1
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHH---------HHHHHHhccccccc---ccceeeeee-----c
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREF---------KSEVSAIGRTHHKN---LVQLLGFCD-----E 574 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~---------~~E~~~l~~l~h~n---iv~l~g~~~-----~ 574 (799)
.+-......|.+-.. +++.+++|..+......++.| .+++..+.+++... ...++.+.. -
T Consensus 38 v~k~~~r~~ValIei---~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~ 114 (229)
T PF06176_consen 38 VFKNTKRNYVALIEI---DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRY 114 (229)
T ss_pred eecCCCccEEEEEEE---CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccc
Confidence 344444444554443 467888888765332222222 23344344443222 222222222 2
Q ss_pred ccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 575 ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 575 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
....+++|||++|..|.++.. ++. .++..+++++.-||.. |++|+|..|.|+++++++ +++.||+..+
T Consensus 115 ~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 115 TSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred eeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 234468999999988776542 111 3456677889999998 999999999999999654 9999998765
Q ss_pred c
Q 038294 655 L 655 (799)
Q Consensus 655 ~ 655 (799)
.
T Consensus 183 ~ 183 (229)
T PF06176_consen 183 M 183 (229)
T ss_pred c
Confidence 3
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.83 E-value=0.00013 Score=75.41 Aligned_cols=136 Identities=15% Similarity=0.112 Sum_probs=83.0
Q ss_pred cCcccc-ceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecCCCCh
Q 038294 513 LGRGSF-GIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 513 lG~G~f-G~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
|..|.. ..||+.... +..+.||+..... ..+...|++++..+. +--+.+++++.......++|||+++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~---~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK---NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC---CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 445555 788987653 3578888876532 335667888887773 44466788877766677899999999877
Q ss_pred hhhh-------------------hcCCC--CC----HHHHHHHH-H-------------------HHHHHHHHHHhc---
Q 038294 591 ANLI-------------------FAIPK--PD----WNLRVRIS-L-------------------EIARGLVYLHEE--- 622 (799)
Q Consensus 591 ~~~l-------------------~~~~~--~~----~~~~~~i~-~-------------------~ia~gL~yLH~~--- 622 (799)
.... +..+. .. ........ . .+...+..|-..
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11110 00 00000000 0 011112222111
Q ss_pred -CCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 623 -CNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 623 -~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13468999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.81 E-value=9.4e-05 Score=83.15 Aligned_cols=140 Identities=21% Similarity=0.234 Sum_probs=87.9
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchh-------------------------------------hHHHHHHH
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-------------------------------------REREFKSE 553 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-------------------------------------~~~~~~~E 553 (799)
+.||.-+.|.||+|++++ |+.||||+-+..-+. .+-+|..|
T Consensus 167 ~piaaASlaQVhrA~L~~--G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN--GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC--CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 459999999999999984 899999986531100 01124455
Q ss_pred HHHhccc----ccccc---cceeeeee-cccceeeEEeecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038294 554 VSAIGRT----HHKNL---VQLLGFCD-EALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECN 624 (799)
Q Consensus 554 ~~~l~~l----~h~ni---v~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~ 624 (799)
.+-..++ .|-++ |++=.++. -...+.|+||||+|..+.+.-.- ...++-. .++..+.++. ++.-..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~---~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRGISPH---DILNKLVEAY--LEQIFK 319 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcCCCHH---HHHHHHHHHH--HHHHHh
Confidence 5544443 34441 12223332 23467999999999888776432 1233333 3333333332 221111
Q ss_pred CCeEecCCCCCCeEEc----CCCceEEccccCccccc
Q 038294 625 VPIIHCDIKPQNILLD----NYFSAKISDFGLSKLLL 657 (799)
Q Consensus 625 ~~iiH~dlk~~NILl~----~~~~~kl~DfGla~~~~ 657 (799)
.|++|+|=.|.||+++ .+..+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 2899999999999998 36789999999987653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00018 Score=72.09 Aligned_cols=136 Identities=21% Similarity=0.247 Sum_probs=86.2
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccchhhHH---------H---------------HHHHHHHhcccc--cccc
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERER---------E---------------FKSEVSAIGRTH--HKNL 565 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~---------~---------------~~~E~~~l~~l~--h~ni 565 (799)
.|+.|.-+.||+|.-. ++..+|||+.+.......+ . ...|+.-|.++. +-.+
T Consensus 55 ~istGKEA~Vy~a~~~--~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 55 CISTGKEANVYLAETG--DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eecCCcceEEEeeccC--CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 5788889999998864 5789999998642211110 1 123555555442 3334
Q ss_pred cceeeeeecccceeeEEeecCCCChh-hhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 038294 566 VQLLGFCDEALNRLLVYEFMGNGTLA-NLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS 644 (799)
Q Consensus 566 v~l~g~~~~~~~~~lv~e~~~~gsL~-~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~ 644 (799)
.+.+++. .-.|||||+....+. =.|... .+..+....+..++++.+.-|-..+ +++|+||+.=|||+. ++.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CCe
Confidence 4444443 236999999654211 111111 1122245666777777777776632 899999999999999 889
Q ss_pred eEEccccCccccc
Q 038294 645 AKISDFGLSKLLL 657 (799)
Q Consensus 645 ~kl~DfGla~~~~ 657 (799)
+.|+|++-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999887553
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3.8e-06 Score=92.98 Aligned_cols=182 Identities=16% Similarity=0.102 Sum_probs=125.8
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc-ccceeeeeecccceeeEEeecCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
-+.+++|++++++|.+.. ..+...++.+... .+..-++++|.+++||| .++.++-+..+...++.++++..+
T Consensus 247 fh~fvK~altknpKkRpt--aeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPT--AEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHhcCCCccCCC--hhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 356789999999986542 1233334444322 34456788999999999 777777777788888999999877
Q ss_pred -Chhhhh-hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 589 -TLANLI-FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 589 -sL~~~l-~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+-.... ...-.+...+...+...-+++++|||+. .-+|+| ||+..+ ...|..||+....+.... ....
T Consensus 320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~~~t 389 (829)
T KOG0576|consen 320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--KPRT 389 (829)
T ss_pred ccccccCChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCccc--cccc
Confidence 211111 1111122223344555667889999986 458888 777666 578999999988765433 2334
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCc
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
..+++.++|||+.....+..+.|+|+.|+--.++--|-.|..
T Consensus 390 ~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 390 AIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 458999999999999999999999999987666666655543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00017 Score=73.76 Aligned_cols=139 Identities=19% Similarity=0.170 Sum_probs=81.7
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccc--cccceeeeeecc---cceeeEEeec
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHK--NLVQLLGFCDEA---LNRLLVYEFM 585 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~g~~~~~---~~~~lv~e~~ 585 (799)
+.|+.|..+.||+.... +..+++|..... .....+..|..++..+... .+.+++.++... ...+++|+++
T Consensus 3 ~~l~~G~~n~~~~v~~~---~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTD---DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEET---TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEEC---CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 46888999999998875 258999997654 3456777888888887543 356777654322 2357999999
Q ss_pred CCCChhh----------------hhh---cC--C--CCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 038294 586 GNGTLAN----------------LIF---AI--P--KPDWNL---------RVRI------------SLEIAR-GLVYLH 620 (799)
Q Consensus 586 ~~gsL~~----------------~l~---~~--~--~~~~~~---------~~~i------------~~~ia~-gL~yLH 620 (799)
++..+.. .+. .. . ...+.. .... ...+.+ .+..++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987776 111 11 0 111100 0000 112222 233333
Q ss_pred hc----CCCCeEecCCCCCCeEEc-CCCceEEccccCcc
Q 038294 621 EE----CNVPIIHCDIKPQNILLD-NYFSAKISDFGLSK 654 (799)
Q Consensus 621 ~~----~~~~iiH~dlk~~NILl~-~~~~~kl~DfGla~ 654 (799)
.. ....++|+|+.|+|||++ +++.+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 21 234799999999999999 56666899998765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00014 Score=65.52 Aligned_cols=73 Identities=22% Similarity=0.440 Sum_probs=50.5
Q ss_pred eEEcccc-eEEEcCC-CCEEeccCCC---CceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEEe
Q 038294 92 LELTATG-LLLKDPG-GKTIWDGKPD---KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLIS 166 (799)
Q Consensus 92 l~l~~~g-lvl~~~~-~~~vWst~~~---~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S 166 (799)
+....+| +|+.+.. +.+||+++.. .....+.|.++|||||++. ++.++|+| +|- +
T Consensus 24 ~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~--~g~~vW~S-----~t~-~------------ 83 (114)
T smart00108 24 LIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG--DGRVVWSS-----NTT-G------------ 83 (114)
T ss_pred cCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC--CCCEEEEe-----ccc-C------------
Confidence 3444678 8887654 5899998753 2225788999999999764 35689997 111 1
Q ss_pred ecCCCCCCCcceEEEEe-CCceEEEe
Q 038294 167 RLTETNFSKGRFELRFS-NGSLKLIS 191 (799)
Q Consensus 167 ~~s~~dps~G~f~~~~~-~~~~~~~~ 191 (799)
..|.+.+.|+ +|+++++-
T Consensus 84 -------~~~~~~~~L~ddGnlvl~~ 102 (114)
T smart00108 84 -------ANGNYVLVLLDDGNLVIYD 102 (114)
T ss_pred -------CCCceEEEEeCCCCEEEEC
Confidence 2367888887 78887753
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00021 Score=64.43 Aligned_cols=72 Identities=19% Similarity=0.374 Sum_probs=50.6
Q ss_pred Ecc-cc-eEEEcCC-CCEEeccCCC---CceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEEee
Q 038294 94 LTA-TG-LLLKDPG-GKTIWDGKPD---KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISR 167 (799)
Q Consensus 94 l~~-~g-lvl~~~~-~~~vWst~~~---~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~ 167 (799)
... +| +|+.+.. +++||++++. .....+.|.++|||||.+. ++.++|||=-.
T Consensus 26 ~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~--~g~~vW~S~~~-------------------- 83 (116)
T cd00028 26 MQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG--SGTVVWSSNTT-------------------- 83 (116)
T ss_pred CCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC--CCcEEEEeccc--------------------
Confidence 344 78 8887654 5899998753 2445789999999999764 45689986421
Q ss_pred cCCCCCCCcceEEEEe-CCceEEEee
Q 038294 168 LTETNFSKGRFELRFS-NGSLKLISV 192 (799)
Q Consensus 168 ~s~~dps~G~f~~~~~-~~~~~~~~~ 192 (799)
.+.+.+.+.|+ +|+++++-.
T Consensus 84 -----~~~~~~~~~L~ddGnlvl~~~ 104 (116)
T cd00028 84 -----RVNGNYVLVLLDDGNLVLYDS 104 (116)
T ss_pred -----CCCCceEEEEeCCCCEEEECC
Confidence 02467888886 888877653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0007 Score=64.18 Aligned_cols=128 Identities=21% Similarity=0.306 Sum_probs=84.3
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.+.|++|.+|.||+|.+. +..+|+|+-+..+ ....+..|+++|..+.-.++.+=+-++-+. ++.|||+.|-.
T Consensus 27 ~~~L~KG~~s~Vyl~~~~---~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~---~i~me~i~G~~ 98 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR---GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED---FIRMEYIDGRP 98 (201)
T ss_pred hhhhhcccccEEEEeecc---CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh---hhhhhhhcCcc
Confidence 467999999999999985 5689999876533 346788999999998877765433333222 34599999877
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC-CCeEEcCCCceEEccccCccc
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKP-QNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~-~NILl~~~~~~kl~DfGla~~ 655 (799)
|.+.-... +-++ ...++.+ +|.-+. .+|-|+.|.- ...+|-++..+.|+||.-|..
T Consensus 99 L~~~~~~~---~rk~----l~~vlE~-a~~LD~--~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIGG---DRKH----LLRVLEK-AYKLDR--LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhcc---cHHH----HHHHHHH-HHHHHH--hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 76654322 1122 2233333 333332 2788888764 444444444899999998874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0011 Score=80.82 Aligned_cols=80 Identities=11% Similarity=0.238 Sum_probs=56.0
Q ss_pred hhcCccccceEEEEEEeCCCC-eEEEEEEccccc-hhhHHHHHHHHHHhcccc-cccc--cceeeeeecc---cceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASG-KAIAVKKLDRLA-QEREREFKSEVSAIGRTH-HKNL--VQLLGFCDEA---LNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~-~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~g~~~~~---~~~~lv~ 582 (799)
+.++.|.+..+|+........ ..+++|+..... ......+.+|+++++.+. |.++ .+++.+|.+. ...++||
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVM 123 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIM 123 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEE
Confidence 568899999999977653211 467777764322 122356889999999885 6665 7888888764 3568999
Q ss_pred eecCCCCh
Q 038294 583 EFMGNGTL 590 (799)
Q Consensus 583 e~~~~gsL 590 (799)
||+++..+
T Consensus 124 E~v~G~~~ 131 (822)
T PLN02876 124 EYLEGRIF 131 (822)
T ss_pred EecCCccc
Confidence 99988643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0012 Score=67.83 Aligned_cols=73 Identities=15% Similarity=0.188 Sum_probs=44.8
Q ss_pred hhcCccccc-eEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccc---cccceeeeeeccc---ceeeEEe
Q 038294 511 EELGRGSFG-IVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---NLVQLLGFCDEAL---NRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG-~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~~~~---~~~lv~e 583 (799)
+.|+.|+.. .||+. +..+++|..+.. .....+..|.+++..+... -+.++++...... ..+++||
T Consensus 3 ~~~~~gG~~n~vy~~------~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL------GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc------CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 456767666 48874 124667765542 2244788899888877532 3445555443322 3478999
Q ss_pred ecCCCChh
Q 038294 584 FMGNGTLA 591 (799)
Q Consensus 584 ~~~~gsL~ 591 (799)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99987664
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0021 Score=68.44 Aligned_cols=75 Identities=8% Similarity=0.051 Sum_probs=53.4
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc---ccccceeeeeecc---cceeeEEee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH---KNLVQLLGFCDEA---LNRLLVYEF 584 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~---~~~~lv~e~ 584 (799)
+.||.|..+.||+.... ++ .+.+|..+.. .....|..|.+.++.+.. -.+.++++.|... ...+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~~--~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDS--QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcC--CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 56999999999987543 23 4666664331 123478889998888743 4678899887543 557999999
Q ss_pred cCCCCh
Q 038294 585 MGNGTL 590 (799)
Q Consensus 585 ~~~gsL 590 (799)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0026 Score=62.93 Aligned_cols=130 Identities=18% Similarity=0.224 Sum_probs=86.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc----------------hhhHHHHHHHHHHhcccc------cccccce
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA----------------QEREREFKSEVSAIGRTH------HKNLVQL 568 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l 568 (799)
..||+|+.=.||. ++ +.....||+..... ....++...|+.....+. +.+|.++
T Consensus 7 ~~i~~G~~R~cy~--HP--~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 7 DLIAQGGERDCYQ--HP--DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred cccccCCCceEEE--CC--CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 5699999999995 33 34457778876544 122345555655554444 8899999
Q ss_pred eeeeecccceeeEEeecCC------CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 038294 569 LGFCDEALNRLLVYEFMGN------GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 569 ~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~ 642 (799)
+|+.+.+...-+|+|.+.+ -+|.+++... .++. ...+. +-+-..||-++ .|+.+|++|+||++..+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~-~~~~~---L~~f~~~l~~~---~Iv~~dl~~~NIv~~~~ 154 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE-ELRQA---LDEFKRYLLDH---HIVIRDLNPHNIVVQRR 154 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH-HHHHH---HHHHHHHHHHc---CCeecCCCcccEEEEec
Confidence 9999999999999998753 2577777543 3333 22222 23334566665 79999999999999642
Q ss_pred --C--ceEEcc-ccC
Q 038294 643 --F--SAKISD-FGL 652 (799)
Q Consensus 643 --~--~~kl~D-fGl 652 (799)
+ .+.|+| ||-
T Consensus 155 ~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 155 DSGEFRLVLIDGLGE 169 (199)
T ss_pred CCCceEEEEEeCCCC
Confidence 2 466666 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00087 Score=79.83 Aligned_cols=196 Identities=20% Similarity=0.191 Sum_probs=136.7
Q ss_pred HHHHHHHhcccccccccceeeeeecccce----eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 038294 550 FKSEVSAIGRTHHKNLVQLLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625 (799)
Q Consensus 550 ~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~ 625 (799)
..-|...+.++.|+|++.++.+-.+.... .+..|++..-++...+......+..+.+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~--- 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL--- 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh---
Confidence 44577788889999999999987654433 35567888888999998888889999999999999999999997
Q ss_pred CeEecCCCCC---CeEEcCCCceEEc--cccCcccccCCCCcceeeeccCCcccccccccCCCCCcc--hhHHHHHHHHH
Q 038294 626 PIIHCDIKPQ---NILLDNYFSAKIS--DFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK--VDVYSFGVMLL 698 (799)
Q Consensus 626 ~iiH~dlk~~---NILl~~~~~~kl~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k--~DVwS~Gvll~ 698 (799)
...|.-+..+ +...+.++...++ ||+..+.......... ..-+..+.+||......++.+ .|+|.+|.++.
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 4445444444 4555667777777 8888876543322111 123456778888776655544 79999999999
Q ss_pred HHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 038294 699 EIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777 (799)
Q Consensus 699 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L 777 (799)
.+..|..+........ ..+..... .........|+..++++|+.+.+++...
T Consensus 384 ~~~~~~~i~~~~~~~~-----------------------~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPV-----------------------SLLDVLST----SELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred hhhhcCcccccccchh-----------------------hhhccccc----hhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9998776533211000 00000000 0344567889999999999999998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0019 Score=63.35 Aligned_cols=135 Identities=30% Similarity=0.407 Sum_probs=92.7
Q ss_pred CCccccChHHHHHHhhchhhhcCcccc-ceEEEEEEeCCCCeEEEEEEcccc-----------ch----------hhHHH
Q 038294 492 TNLRFFSYNELKEATGGFKEELGRGSF-GIVYKGVLKSASGKAIAVKKLDRL-----------AQ----------ERERE 549 (799)
Q Consensus 492 ~~~~~~~~~~l~~~~~~~~~~lG~G~f-G~Vykg~~~~~~~~~vavK~l~~~-----------~~----------~~~~~ 549 (799)
..++.|+... ....|.+.||.|.- |.|||..+. |+.+|+|.++.. .. .....
T Consensus 27 PKL~~F~~h~---~~I~flefLg~g~~~~~V~kv~I~---g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~P 100 (207)
T PF13095_consen 27 PKLEPFTHHG---DDIEFLEFLGHGSHDGYVFKVEID---GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADP 100 (207)
T ss_pred CCcCCcCCCC---CcEeeeeecCCCCceeEEEEEEEC---CeEEEEEEeeccccCCCccccccccccccccchhhhhcCh
Confidence 3445555522 55567789999999 999999984 789999993210 00 11235
Q ss_pred HHHHHHHhcccc---cccc--cceeeeeecc------------------cceeeEEeecCCCChhhhhhcCCCCCHHHHH
Q 038294 550 FKSEVSAIGRTH---HKNL--VQLLGFCDEA------------------LNRLLVYEFMGNGTLANLIFAIPKPDWNLRV 606 (799)
Q Consensus 550 ~~~E~~~l~~l~---h~ni--v~l~g~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 606 (799)
|.+|++..++++ +.++ |+.+|+..-. ..+.||.||++... ....
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~ 167 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI 167 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch
Confidence 889999998885 4466 8888887211 11246777765532 1223
Q ss_pred HHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCc
Q 038294 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 607 ~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
+-+.+|.+-|..+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 168 ~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 168 RDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred hHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 4456777788889987 9999999999986 4588999864
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0033 Score=56.36 Aligned_cols=99 Identities=23% Similarity=0.431 Sum_probs=62.4
Q ss_pred CeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEee-cCCCCCCCCceeEEcccc-eEEEcCCCCEEeccCCCC
Q 038294 39 SSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHA-NGDNPAPRGSTLELTATG-LLLKDPGGKTIWDGKPDK 116 (799)
Q Consensus 39 ~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvA-Nr~~pv~~~s~l~l~~~g-lvl~~~~~~~vWst~~~~ 116 (799)
+++.+.+|.+.|-|-.-++ |-|. + ...++||.. +..........+.|..+| |||.|..+.++|++....
T Consensus 12 ~p~~~~s~~~~L~l~~dGn------Lvl~-~--~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~p 82 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN------LVLY-D--SNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSSGNVLWQSFDYP 82 (114)
T ss_dssp EEEEECETTEEEEEETTSE------EEEE-E--TTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETTSEEEEESTTSS
T ss_pred cccccccccccceECCCCe------EEEE-c--CCCCEEEEecccCCccccCeEEEEeCCCCEEEEeecceEEEeecCCC
Confidence 4565545777777754221 4443 2 225679999 434444356789999999 999999999999996545
Q ss_pred ceeeEEeec--CccEEEEecCCcccccccccccCC
Q 038294 117 KVSDAAMLD--TGNFVLRASGNNSDYAWQSFKNPT 149 (799)
Q Consensus 117 ~~~~a~Lld--sGNlVl~~~~~~~~~lWQSFD~PT 149 (799)
..+....++ .||++ .. +...+.|.|=+.|+
T Consensus 83 tdt~L~~q~l~~~~~~-~~--~~~~~sw~s~~dps 114 (114)
T PF01453_consen 83 TDTLLPGQKLGDGNVT-GK--NDSLTSWSSNTDPS 114 (114)
T ss_dssp S-EEEEEET--TSEEE-EE--STSSEEEESS----
T ss_pred ccEEEeccCcccCCCc-cc--cceEEeECCCCCCC
Confidence 555666666 89988 42 23457888866653
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00037 Score=57.01 Aligned_cols=46 Identities=26% Similarity=0.551 Sum_probs=36.7
Q ss_pred eccCCCCCCccccCCCChhhhhhhhcccccceeeeec--CCceeeccc
Q 038294 362 NNVDWPFGDYERLEPYNQTECEISCLHDCLCAVAIYD--GNRCWKKKL 407 (799)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~--~~~C~~~~~ 407 (799)
.+++++..++......+.++|++.|+.||+|.||.|. .+.|+++..
T Consensus 10 ~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 4566666656555567899999999999999999994 578998866
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0027 Score=66.12 Aligned_cols=135 Identities=12% Similarity=0.118 Sum_probs=77.0
Q ss_pred cCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccc-cceeeeeecccceeeEEeecCCCChh
Q 038294 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNGTLA 591 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~ 591 (799)
+..|-...+|+... +++.+++|..............+|.++++.+....+ .++++... ..+|+||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~---~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH---PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe---CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 55677889998763 466788887654322211234678888887754333 44555432 36899999986653
Q ss_pred hh--------------h---hcCC----CCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeEecCCCCC
Q 038294 592 NL--------------I---FAIP----KPDWNLR-VRISLE---------IARGLVYLHEE-----CNVPIIHCDIKPQ 635 (799)
Q Consensus 592 ~~--------------l---~~~~----~~~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiH~dlk~~ 635 (799)
.. + +..+ ..+.... .+...+ +.+.+..+... ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 1 1111 1111111 111111 11112222111 1235899999999
Q ss_pred CeEEcCCCceEEccccCccc
Q 038294 636 NILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 636 NILl~~~~~~kl~DfGla~~ 655 (799)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999876 78999987753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0043 Score=63.67 Aligned_cols=140 Identities=17% Similarity=0.203 Sum_probs=78.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc-ccceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.|..|-...+|+....+.+++.+++|+...... ....-..|+.++..+...+ .+++++.+. ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 3567787889998765421246788887754221 1122346777777775333 345554433 248999999876
Q ss_pred hhhh--------------h---hcCC-C----------C-CHHHHHHHHH----------------------HHHHHHHH
Q 038294 590 LANL--------------I---FAIP-K----------P-DWNLRVRISL----------------------EIARGLVY 618 (799)
Q Consensus 590 L~~~--------------l---~~~~-~----------~-~~~~~~~i~~----------------------~ia~gL~y 618 (799)
+... + +... . . -|+....+.. .+...+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 5311 1 1110 1 1 1222111111 11111111
Q ss_pred H----Hhc-CCCCeEecCCCCCCeEEcC-CCceEEccccCccc
Q 038294 619 L----HEE-CNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKL 655 (799)
Q Consensus 619 L----H~~-~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~ 655 (799)
| ... ....++|+|+.+.|||+++ ++.+.|+||..+..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1 111 2346999999999999998 57899999987753
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0045 Score=65.99 Aligned_cols=138 Identities=14% Similarity=0.160 Sum_probs=82.4
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc--ccceeeee------ecccceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFC------DEALNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~ 582 (799)
+.|..|....+|+.... +..+++|+... ........|++++..+++.+ +.+++... ......++++
T Consensus 20 ~~i~~G~~n~~y~v~~~---~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 20 EGISAGIENTNYFVTTD---SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred ecccCccccceEEEEeC---CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 45777877899987643 34688888764 22345666777777775333 44544421 2234557999
Q ss_pred eecCCCChhh----hh----------hc----CC-------CCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 038294 583 EFMGNGTLAN----LI----------FA----IP-------KPDWNLRV----------RISLEIARGLVYLHE----EC 623 (799)
Q Consensus 583 e~~~~gsL~~----~l----------~~----~~-------~~~~~~~~----------~i~~~ia~gL~yLH~----~~ 623 (799)
+|++|..+.. .. +. .. ...|.... .....+..++.++.. ..
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876532 00 10 00 01222211 011123344455543 12
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
...++|+|+.|.||+++++..+.|.||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 3469999999999999998778999998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.022 Score=62.64 Aligned_cols=75 Identities=16% Similarity=0.208 Sum_probs=51.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEcccc------c-hhhHHHHHHHHHHhcccc---cccccceeeeeecccceee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRL------A-QEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 580 (799)
+.||.|.+..||+....+ .++.++||.-... . .-..+.+..|.+.|..+. -.++++++.+.. ...++
T Consensus 32 ~elggGn~N~VyrV~~~~-g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE-GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCC-CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence 579999999999998853 2258999984311 0 113345666777777652 245777777743 45789
Q ss_pred EEeecCCC
Q 038294 581 VYEFMGNG 588 (799)
Q Consensus 581 v~e~~~~g 588 (799)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999864
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.031 Score=58.91 Aligned_cols=72 Identities=17% Similarity=0.268 Sum_probs=45.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc---cccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.|+.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.+. --.+++++++....+..+|++||++.
T Consensus 23 ~~v~GG~i~~a~~~~---~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD---TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE---TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE---CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 458889999999866 3678899998762 23346777777777763 45577889988777778999999987
Q ss_pred C
Q 038294 588 G 588 (799)
Q Consensus 588 g 588 (799)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.25 E-value=0.018 Score=61.55 Aligned_cols=139 Identities=23% Similarity=0.274 Sum_probs=80.2
Q ss_pred hcCccccceEEEEEEeCC-----CCeEEEEEEccccchhhHHHHHHHHHHhccccccc-ccceeeeeecccceeeEEeec
Q 038294 512 ELGRGSFGIVYKGVLKSA-----SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~-----~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+..|-...+|+...... .++.+++|+..... ........|.+++..+.... ..++++++.. .+|+||+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~i 79 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEFI 79 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhee
Confidence 455666678898775421 24688889875432 22234566777777774333 3456666542 3589999
Q ss_pred CCCChhhh--------------h---hcCC-CC--------C--HHHHHH--------------------------HHHH
Q 038294 586 GNGTLANL--------------I---FAIP-KP--------D--WNLRVR--------------------------ISLE 611 (799)
Q Consensus 586 ~~gsL~~~--------------l---~~~~-~~--------~--~~~~~~--------------------------i~~~ 611 (799)
+|..+... + +... .. + |....+ +...
T Consensus 80 ~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (302)
T cd05156 80 PSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLED 159 (302)
T ss_pred CCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHH
Confidence 88765321 1 1111 00 0 111111 0112
Q ss_pred HHHHHHHHHh------cCCCCeEecCCCCCCeEEcCC----CceEEccccCccc
Q 038294 612 IARGLVYLHE------ECNVPIIHCDIKPQNILLDNY----FSAKISDFGLSKL 655 (799)
Q Consensus 612 ia~gL~yLH~------~~~~~iiH~dlk~~NILl~~~----~~~kl~DfGla~~ 655 (799)
+...+..|.. .....++|+|+.+.|||++++ +.++++||..+..
T Consensus 160 ~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 160 EAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 2222334432 134578999999999999985 8899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.055 Score=57.43 Aligned_cols=126 Identities=19% Similarity=0.313 Sum_probs=74.7
Q ss_pred CeEEEEEEcc-ccchhhHHHHHHHHHHhcccc--cccccceeeeeeccc--ceeeEEeecCCCChh--------------
Q 038294 531 GKAIAVKKLD-RLAQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEAL--NRLLVYEFMGNGTLA-------------- 591 (799)
Q Consensus 531 ~~~vavK~l~-~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~--~~~lv~e~~~~gsL~-------------- 591 (799)
++.+++.+-. ...........+|+++|+.+. -.-+.+.+++|.++. ..+.||+|++|..+.
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 5677777221 122233455667777777764 234556788887777 678999999884322
Q ss_pred ----hhhhcC---C--------C---------CCHHHHHHHH--------HHHHHHHHHHHhcC-----CCCeEecCCCC
Q 038294 592 ----NLIFAI---P--------K---------PDWNLRVRIS--------LEIARGLVYLHEEC-----NVPIIHCDIKP 634 (799)
Q Consensus 592 ----~~l~~~---~--------~---------~~~~~~~~i~--------~~ia~gL~yLH~~~-----~~~iiH~dlk~ 634 (799)
++|... + . -.|....+.+ -....-..+|+.+. ...++|+|+++
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 222110 0 0 0111111101 01222344555432 34699999999
Q ss_pred CCeEEcCCCceEEccccCcccc
Q 038294 635 QNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 635 ~NILl~~~~~~kl~DfGla~~~ 656 (799)
.||++++..-+-|.||+++..-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999888999999998753
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.087 Score=56.76 Aligned_cols=31 Identities=23% Similarity=0.307 Sum_probs=26.6
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
..+++|+|+.+.||+++++...-|+||+.+.
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 3479999999999999977666899999875
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.056 Score=58.83 Aligned_cols=138 Identities=17% Similarity=0.206 Sum_probs=79.1
Q ss_pred cCccccceEEEEEEeCC---CCeEEEEEEccccchhhHHHHHHHHHHhccccccccc-ceeeeeecccceeeEEeecCCC
Q 038294 513 LGRGSFGIVYKGVLKSA---SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLV-QLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 513 lG~G~fG~Vykg~~~~~---~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~g 588 (799)
|-.|-.-.+|+...... .++.+++|+........ -.-.+|..++..+...++. ++++.+..+ .|+||+++.
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~ 118 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHAR 118 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCC
Confidence 44466678888765421 23678888876533222 1236688888877544443 566666443 579999876
Q ss_pred Chhhh-----------------hhcCC----C-C-CHHHHHHHHHH-----------------HHHHHHHHH----h-cC
Q 038294 589 TLANL-----------------IFAIP----K-P-DWNLRVRISLE-----------------IARGLVYLH----E-EC 623 (799)
Q Consensus 589 sL~~~-----------------l~~~~----~-~-~~~~~~~i~~~-----------------ia~gL~yLH----~-~~ 623 (799)
+|... +++.+ . . .|....++..+ +...+..|. . ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 65311 11111 0 1 13322222211 111222222 1 22
Q ss_pred CCCeEecCCCCCCeEEcC-CCceEEccccCccc
Q 038294 624 NVPIIHCDIKPQNILLDN-YFSAKISDFGLSKL 655 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~ 655 (799)
...++|+|+++.|||+++ ++.+.++||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346899999999999986 57899999988764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.071 Score=56.05 Aligned_cols=31 Identities=26% Similarity=0.497 Sum_probs=25.7
Q ss_pred CCeEecCCCCCCeEEcCCCc-eEEccccCccc
Q 038294 625 VPIIHCDIKPQNILLDNYFS-AKISDFGLSKL 655 (799)
Q Consensus 625 ~~iiH~dlk~~NILl~~~~~-~kl~DfGla~~ 655 (799)
..++|+|+++.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.0041 Score=75.90 Aligned_cols=157 Identities=13% Similarity=-0.012 Sum_probs=109.3
Q ss_pred HHHHHHHhcccccccccceeeee--ecccceeeEEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcC
Q 038294 550 FKSEVSAIGRTHHKNLVQLLGFC--DEALNRLLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEEC 623 (799)
Q Consensus 550 ~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~ 623 (799)
...|...+++..|+++.....=. .+..+.+..++|+.+|.+.+.|.+. +.++.........+...+..-.|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 34455556667888876654433 2445568899999999999988754 22232222323333344555555443
Q ss_pred C--CCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHH
Q 038294 624 N--VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701 (799)
Q Consensus 624 ~--~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ell 701 (799)
+ .-.+|+++|+-|.+|..+..+|+.++|+.+....... ......+++.|+.|+....-.++.++|+|..++.+|+.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2 2368999999999999999999999999994332222 223345788899999999889999999999999999987
Q ss_pred hCCcCC
Q 038294 702 CCRRSV 707 (799)
Q Consensus 702 tg~~p~ 707 (799)
-|..++
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 666554
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.22 Score=53.29 Aligned_cols=139 Identities=15% Similarity=0.235 Sum_probs=78.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc--ccceeeee------ecccceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFC------DEALNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~ 582 (799)
+.++.|.-..+|+.... ++ .+++|+.+... ..++...|++++..+.... +++++... ......++++
T Consensus 28 ~~~~~G~~n~~y~v~t~--~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTD--VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred cccCCccccceEEEEeC--CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 34677777889987542 33 57778765421 1234445566666653222 34444422 1234567999
Q ss_pred eecCCCChhh-----------h---hhcC-CC-----------CCHHHHH------------HHHHHHHHHHHHHHh---
Q 038294 583 EFMGNGTLAN-----------L---IFAI-PK-----------PDWNLRV------------RISLEIARGLVYLHE--- 621 (799)
Q Consensus 583 e~~~~gsL~~-----------~---l~~~-~~-----------~~~~~~~------------~i~~~ia~gL~yLH~--- 621 (799)
||++|..+.. . ++.. .. ..|.... .....+.+.++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998854321 1 1110 00 1122111 011123344555543
Q ss_pred -cCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 622 -ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 622 -~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
....+++|+|+++.||++++++...|.||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223589999999999999998777899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=95.33 E-value=0.022 Score=59.32 Aligned_cols=132 Identities=14% Similarity=0.112 Sum_probs=84.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccc-------c-------------chhh--HHHHHHHHHHhccccc--c
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR-------L-------------AQER--EREFKSEVSAIGRTHH--K 563 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~-------~-------------~~~~--~~~~~~E~~~l~~l~h--~ 563 (799)
.+.++||-|.-+-||.+... .|++.++|.-+- . +... .-....|+..|+.+.. -
T Consensus 95 svGnqIGVGKESDIY~v~d~--~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADE--EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhccccccccccceEEEecC--CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 45688999999999999876 577888874321 0 0000 0123457777777742 2
Q ss_pred cccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 038294 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF 643 (799)
Q Consensus 564 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~ 643 (799)
-+.+.+++ +..++|||++.+-.|...-+-... . .+...+..-+--|..+ ++||+|..-=||+++++.
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d~---~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVEDP---P---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCCh---H---HHHHHHHHHHHHHHHc---CceecccchheeEEecCC
Confidence 24444444 355799999988777655432221 1 2222222223334444 999999999999999999
Q ss_pred ceEEccccCcc
Q 038294 644 SAKISDFGLSK 654 (799)
Q Consensus 644 ~~kl~DfGla~ 654 (799)
.++++||--..
T Consensus 240 ~i~vIDFPQmv 250 (465)
T KOG2268|consen 240 KIVVIDFPQMV 250 (465)
T ss_pred CEEEeechHhh
Confidence 99999996543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.62 E-value=0.52 Score=51.86 Aligned_cols=73 Identities=15% Similarity=0.222 Sum_probs=47.0
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEcccc----ch---hhHHHHHHHHHHhcccc---cccccceeeeeeccccee
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL----AQ---EREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~ 579 (799)
.+.||-|..-.||+.... +..++||+-... .. -....-..|.+.|+.+. ..++.+++.++.+ ..+
T Consensus 37 ~~eiggGn~N~VyrV~~~---~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS---SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEcC---CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 357899999999997652 456889976411 00 01222233455555442 3578889998873 457
Q ss_pred eEEeecCC
Q 038294 580 LVYEFMGN 587 (799)
Q Consensus 580 lv~e~~~~ 587 (799)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999976
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.41 E-value=0.12 Score=51.94 Aligned_cols=31 Identities=29% Similarity=0.474 Sum_probs=21.8
Q ss_pred CCeEecCCCCCCeEE-cCCCceEEccccCccc
Q 038294 625 VPIIHCDIKPQNILL-DNYFSAKISDFGLSKL 655 (799)
Q Consensus 625 ~~iiH~dlk~~NILl-~~~~~~kl~DfGla~~ 655 (799)
..+.|+|+.+.|||+ +.++.++++||..+..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 368999999999999 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.27 E-value=0.22 Score=53.86 Aligned_cols=139 Identities=19% Similarity=0.281 Sum_probs=77.8
Q ss_pred hcCccccceEEEEEEeCCC--CeEEEEEEccccchhhHHHHHHHHHHhcccccccc-cceeeeeecccceeeEEeecCCC
Q 038294 512 ELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~g 588 (799)
.|..|=.-.+|+....... +..+++|+....... .-.-.+|..+++.+...++ .++++++..+ +|.+|+++.
T Consensus 21 ~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g~ 95 (330)
T PLN02421 21 RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINAR 95 (330)
T ss_pred EeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcCC
Confidence 3445666678887654321 237888887543221 2223567888887765555 4566666332 589998776
Q ss_pred Chhh-------hh----------hcCC-----CC-CHHHHHHHHHHH----------------------HHHHHHHHh--
Q 038294 589 TLAN-------LI----------FAIP-----KP-DWNLRVRISLEI----------------------ARGLVYLHE-- 621 (799)
Q Consensus 589 sL~~-------~l----------~~~~-----~~-~~~~~~~i~~~i----------------------a~gL~yLH~-- 621 (799)
.|.. .+ +..+ .+ -|....++..++ .+-+..+..
T Consensus 96 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~ 175 (330)
T PLN02421 96 TLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEIT 175 (330)
T ss_pred CCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHh
Confidence 5421 11 1111 01 133332222211 111222211
Q ss_pred ---cCCCCeEecCCCCCCeEEcC-CCceEEccccCccc
Q 038294 622 ---ECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKL 655 (799)
Q Consensus 622 ---~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~ 655 (799)
....-+.|+|+.+.|||+++ ++.++++||..|..
T Consensus 176 ~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 176 DSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred ccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11234799999999999974 57899999988764
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.11 E-value=0.35 Score=51.96 Aligned_cols=133 Identities=17% Similarity=0.251 Sum_probs=75.8
Q ss_pred ccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc------ccceee----eeecccceeeEEeecC
Q 038294 517 SFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN------LVQLLG----FCDEALNRLLVYEFMG 586 (799)
Q Consensus 517 ~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g----~~~~~~~~~lv~e~~~ 586 (799)
.--.+|+.... +++. ++|..+.. ....++..|...+..+.-.. |..+=| ....+...+-+++|++
T Consensus 37 ~eN~~f~~~~~--~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~ 111 (331)
T COG2334 37 EENSNFRVQTE--DGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLP 111 (331)
T ss_pred ccCceEEEEec--CCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecC
Confidence 34568887664 3444 88887654 33445566666666653221 111111 2222235678999999
Q ss_pred CCChhh-hh--------------h----cCC--------CCCHHH----H---------HHHHHHHHHHHHHHHhcC---
Q 038294 587 NGTLAN-LI--------------F----AIP--------KPDWNL----R---------VRISLEIARGLVYLHEEC--- 623 (799)
Q Consensus 587 ~gsL~~-~l--------------~----~~~--------~~~~~~----~---------~~i~~~ia~gL~yLH~~~--- 623 (799)
|..+.. .. + ..+ ...|.. . .....++...+..+++.-
T Consensus 112 G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~ 191 (331)
T COG2334 112 GRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAH 191 (331)
T ss_pred CcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhh
Confidence 987762 10 0 111 223431 0 112334444455544431
Q ss_pred -CC-C--eEecCCCCCCeEEcCCCc-eEEccccCcc
Q 038294 624 -NV-P--IIHCDIKPQNILLDNYFS-AKISDFGLSK 654 (799)
Q Consensus 624 -~~-~--iiH~dlk~~NILl~~~~~-~kl~DfGla~ 654 (799)
.. + +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus 192 lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 192 LPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred CCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 2 999999999999999875 8999999765
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.03 E-value=0.17 Score=49.99 Aligned_cols=139 Identities=19% Similarity=0.197 Sum_probs=86.6
Q ss_pred EEEEEEccccchh-hHHHHHHHHHHhcccccccccceeeeeecccc-eeeEEeecCCCChhhhhhcCCCCCHHHHHHHHH
Q 038294 533 AIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQLLGFCDEALN-RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL 610 (799)
Q Consensus 533 ~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~ 610 (799)
+..+|++....-. ...-|.++.+++++++ .|++|. .+..+ .-++.|+|..-. ... ..++.
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~~------------i~~-~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKIK------------INF-SNFIT 148 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCcc------------cch-hHHHH
Confidence 4566777654433 4556788899998875 456655 23333 348888874311 000 11222
Q ss_pred HHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhH
Q 038294 611 EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690 (799)
Q Consensus 611 ~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DV 690 (799)
.=.++|.-.|++ ..+.+|+|-.|+||+-|..|.+||.|=+.... . +..|.-- .....++++.+
T Consensus 149 agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~------~-------~V~~vN~---~Y~~lT~~aE~ 211 (308)
T PF07387_consen 149 AGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE------N-------QVNMVNI---EYESLTQEAEV 211 (308)
T ss_pred HhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh------h-------eeeEEee---eccccChHHHH
Confidence 224677888864 45899999999999999999999999653221 0 1122221 12345778888
Q ss_pred HHHHHHHHHHHhCCcC
Q 038294 691 YSFGVMLLEIICCRRS 706 (799)
Q Consensus 691 wS~Gvll~elltg~~p 706 (799)
-+|=.-++++....+.
T Consensus 212 ~~fv~s~l~~v~~~~~ 227 (308)
T PF07387_consen 212 KVFVKSCLKLVEKQRS 227 (308)
T ss_pred HHHHHHHHHHHHHHhc
Confidence 8888888888765443
|
The function of this family is unknown. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 799 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 9e-55 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-43 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-42 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-39 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-36 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 5e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 6e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 7e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 8e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-18 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-18 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-18 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-18 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-18 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-18 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-18 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-18 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-16 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-16 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-16 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-16 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-16 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 9e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-15 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 5e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 6e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 6e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 7e-15 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-15 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-15 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 8e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-15 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-14 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-14 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-14 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 7e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-13 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-13 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-13 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-13 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 3e-13 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-13 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-13 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-13 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 6e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-13 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-13 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-12 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-12 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 5e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 8e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-11 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-11 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-11 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-11 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-11 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 8e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 9e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-11 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-10 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-10 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-10 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-10 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-10 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-10 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-10 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-10 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-10 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-10 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-10 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-10 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-10 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-10 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-10 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-10 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-10 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-10 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-10 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-10 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-10 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-10 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-10 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-10 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-10 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-10 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-10 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-10 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-10 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-10 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-10 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-10 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-10 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-10 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-10 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-10 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-10 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-10 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-10 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 6e-10 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-10 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 7e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 8e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 8e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-10 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-10 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-10 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-10 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-09 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-09 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-09 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-09 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 6e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 7e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 7e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 7e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 7e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 7e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-08 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-08 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-08 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 9e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-07 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-07 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 6e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 7e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 8e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-06 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-06 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-06 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 8e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 8e-06 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 9e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 376 bits (967), Expect = e-125
Identities = 119/303 (39%), Positives = 172/303 (56%), Gaps = 10/303 (3%)
Query: 485 QDSSTSETNLRFFSYNELKEATGGFKEE--LGRGSFGIVYKGVLKSASGKAIAVKKLDR- 541
+D L+ FS EL+ A+ F + LGRG FG VYKG L G +AVK+L
Sbjct: 8 EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD--GTLVAVKRLKEE 65
Query: 542 LAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP- 600
Q E +F++EV I H+NL++L GFC RLLVY +M NG++A+ + P+
Sbjct: 66 RTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ 125
Query: 601 ---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657
DW R RI+L ARGL YLH+ C+ IIH D+K NILLD F A + DFGL+KL+
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEM-EVEEEGR 716
+ T +RGT G++APE+ S K DV+ +GVMLLE+I +R+ ++ + +
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
+L DW E +L+ LVD D +++ + +A+ C + P +RP M V++M
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 777 LEG 779
LEG
Sbjct: 306 LEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-114
Identities = 108/308 (35%), Positives = 162/308 (52%), Gaps = 15/308 (4%)
Query: 487 SSTSETNLRFFSYNELKEATGGFKEE--LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ 544
S +L+EAT F + +G G FG VYKGVL+ G +A+K+ +
Sbjct: 19 SYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD--GAKVALKRRTPESS 76
Query: 545 EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---- 600
+ EF++E+ + H +LV L+GFCDE +L+Y++M NG L ++ P
Sbjct: 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSM 136
Query: 601 DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660
W R+ I + ARGL YLH IIH D+K NILLD F KI+DFG+SK
Sbjct: 137 SWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL- 192
Query: 661 SRTH--TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718
+TH T+++GT GY+ PE+F ++ K DVYSFGV+L E++C R ++ + E
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE-MVN 251
Query: 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
L +WA + + G+L+ +VD + L+K+ A+ C+ RP+M VL LE
Sbjct: 252 LAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
Query: 779 GLLEVPNP 786
L +
Sbjct: 312 YALRLQES 319
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-110
Identities = 105/317 (33%), Positives = 163/317 (51%), Gaps = 34/317 (10%)
Query: 485 QDSSTSETNLRFFSYNELKEATGGFKEE--------LGRGSFGIVYKGVLKSASGKAIAV 536
+ S+T FS+ ELK T F E +G G FG+VYKG + +AV
Sbjct: 3 KSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN---NTTVAV 59
Query: 537 KKLDRLAQER----EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLAN 592
KKL + +++F E+ + + H+NLV+LLGF + + LVY +M NG+L +
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 593 LIFAIPKP---DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649
+ + W++R +I+ A G+ +LHE IH DIK NILLD F+AKISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 650 FGLSKLLLSDQSRTH--TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSV 707
FGL++ +T + I GT Y+APE + ++ K D+YSFGV+LLEII +V
Sbjct: 177 FGLARASEKFA-QTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAV 234
Query: 708 EMEVEEEGRAILTDWAYDCYAEGR-LDVLVDSDEPAMADRSR--LQKWLMIAMWCIREDP 764
+ E + +L D + E + ++ +D M D ++ +A C+ E
Sbjct: 235 DEHREPQ---LLLDIKEEIEDEEKTIEDYID---KKMNDADSTSVEAMYSVASQCLHEKK 288
Query: 765 SKRPTMKVVLQMLEGLL 781
+KRP +K V Q+L+ +
Sbjct: 289 NKRPDIKKVQQLLQEMT 305
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 4e-74
Identities = 74/329 (22%), Positives = 133/329 (40%), Gaps = 34/329 (10%)
Query: 482 NNVQDSSTSETNLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKL 539
+ +S + L + + E RG FG V+K L + +AVK
Sbjct: 2 GHHHHHHSSGVD---LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL---NEYVAVKIF 55
Query: 540 DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RLLVYEFMGNGTLANLIF 595
++ + + EV ++ H+N++Q +G + L+ F G+L++ +
Sbjct: 56 PI-QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 596 AIPKPDWNLRVRISLEIARGLVYLHEE-------CNVPIIHCDIKPQNILLDNYFSAKIS 648
A WN I+ +ARGL YLHE+ I H DIK +N+LL N +A I+
Sbjct: 115 A-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 649 DFGLSKLLLSDQSRTHTMIR-GTRGYVAPE-----WFKNAPVSAKVDVYSFGVMLLEIIC 702
DFGL+ + +S T + GTR Y+APE ++D+Y+ G++L E+
Sbjct: 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233
Query: 703 CRRSVEMEVEEEGRAILTD--WAYDCYAEGRLDVLVDSDEPAMADR----SRLQKWLMIA 756
+ + V +E + + + + V+ P + D + +
Sbjct: 234 RCTAADGPV-DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292
Query: 757 MWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
C D R + V + + + + N
Sbjct: 293 EECWDHDAEARLSAGCVGERITQMQRLTN 321
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 3e-68
Identities = 85/302 (28%), Positives = 146/302 (48%), Gaps = 47/302 (15%)
Query: 499 YNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSA 556
+ +L KE++G GSFG V++ G +AVK L ER EF EV+
Sbjct: 36 WCDLN-----IKEKIGAGSFGTVHRAEWH---GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIA 613
+ R H N+V +G + N +V E++ G+L L+ A + D R+ ++ ++A
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
+G+ YLH N PI+H ++K N+L+D ++ K+ DFGLS+ L + + GT +
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEW 205
Query: 674 VAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR--------SVEMEVEEEGRAILTDWAYD 725
+APE ++ P + K DVYSFGV+L E+ ++ V V + +
Sbjct: 206 MAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK--------- 256
Query: 726 CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
RL++ + + P +A ++ C +P KRP+ ++ +L L++
Sbjct: 257 -----RLEIPRNLN-PQVAA-------II--EGCWTNEPWKRPSFATIMDLLRPLIKSAV 301
Query: 786 PP 787
PP
Sbjct: 302 PP 303
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 8e-67
Identities = 79/310 (25%), Positives = 139/310 (44%), Gaps = 56/310 (18%)
Query: 499 YNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIG 558
Y E++ +E +GRG+FG+V K + K +A+K++ ++ + F E+ +
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR---AKDVAIKQI--ESESERKAFIVELRQLS 56
Query: 559 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRVRISLEIARG 615
R +H N+V+L G C + LV E+ G+L N++ +P + L+ ++G
Sbjct: 57 RVNHPNIVKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114
Query: 616 LVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
+ YLH +IH D+KP N+LL KI DFG + D T +G+ ++
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWM 170
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRR----------SVEMEVEEEGRAILTDWAY 724
APE F+ + S K DV+S+G++L E+I R+ + V R L
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIK--- 227
Query: 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE-V 783
+ + LM W +DPS+RP+M+ +++++ L+
Sbjct: 228 NL-------------PKPIES-------LMTRCW--SKDPSQRPSMEEIVKIMTHLMRYF 265
Query: 784 PNPPCPSSFS 793
P P +
Sbjct: 266 PGADEPLQYP 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-63
Identities = 78/322 (24%), Positives = 140/322 (43%), Gaps = 62/322 (19%)
Query: 484 VQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKL---- 539
+ S ++ L + NE++ +++++G+G FG+V+KG L +A+K L
Sbjct: 3 MGGSEFPKSRLPTLADNEIE-----YEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGD 56
Query: 540 ---DRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA 596
+ E+ +EF+ EV + +H N+V+L G +V EF+ G L + +
Sbjct: 57 SEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD 114
Query: 597 IPKP-DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-----FSAKISDF 650
P W++++R+ L+IA G+ Y+ N PI+H D++ NI L + AK++DF
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 651 GLSKLLLSDQSRTHTMIRGTRGYVAPEWF--KNAPVSAKVDVYSFGVMLLEIICCRR--- 705
GLS+ + + + G ++APE + + K D YSF ++L I+
Sbjct: 174 GLSQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 706 -------SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMW 758
+ EEG R + D P + + ++ W
Sbjct: 230 EYSYGKIKFINMIREEGL--------------RPTIPEDCP-PRLRN-------VIELCW 267
Query: 759 CIREDPSKRPTMKVVLQMLEGL 780
DP KRP +++ L L
Sbjct: 268 --SGDPKKRPHFSYIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 7e-63
Identities = 76/302 (25%), Positives = 119/302 (39%), Gaps = 56/302 (18%)
Query: 499 YNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKL----DRLAQEREREFKSEV 554
+ EL +E +G G FG VY+ G +AVK D + + E
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 555 SAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 614
H N++ L G C + N LV EF G L ++ + + ++ V +++IAR
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIAR 116
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFS--------AKISDFGLSKLLLSDQSRTHTM 666
G+ YLH+E VPIIH D+K NIL+ KI+DFGL++ +
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAA- 175
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR--------SVEMEVEEEGRAI 718
G ++APE + + S DV+S+GV+L E++ +V V
Sbjct: 176 --GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKL-- 231
Query: 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
L + EP + + C DP RP+ +L L
Sbjct: 232 ------------ALPIPSTCPEP----------FAKLMEDCWNPDPHSRPSFTNILDQLT 269
Query: 779 GL 780
+
Sbjct: 270 TI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 8e-61
Identities = 75/333 (22%), Positives = 126/333 (37%), Gaps = 45/333 (13%)
Query: 497 FSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSE- 553
+ +E K E +GRG +G VYKG L + +AVK + F +E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD---ERPVAVKVFS---FANRQNFINEK 56
Query: 554 -VSAIGRTHHKNLVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR 607
+ + H N+ + + D + LLV E+ NG+L + DW R
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCR 115
Query: 608 ISLEIARGLVYLHEE------CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-- 659
++ + RGL YLH E I H D+ +N+L+ N + ISDFGLS L +
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175
Query: 660 -----QSRTHTMIRGTRGYVAPEWFKNA-------PVSAKVDVYSFGVMLLEIIC-CRRS 706
+ GT Y+APE + A +VD+Y+ G++ EI C
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235
Query: 707 VEMEVEEEGRAILTDWAYD--CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMW-----C 759
E E + + + + ++ V + P + + + ++ C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295
Query: 760 IREDPSKRPTMKVVLQMLEGLL-EVPNPPCPSS 791
+D R T + + + L+ S
Sbjct: 296 WDQDAEARLTAQXAEERMAELMMIWERNKSVSP 328
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-60
Identities = 66/301 (21%), Positives = 120/301 (39%), Gaps = 56/301 (18%)
Query: 499 YNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSA 556
+ +L F +L G ++KG + G I VK L + + R+F E
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 557 IGRTHHKNLVQLLGFCDE--ALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEI 612
+ H N++ +LG C A + L+ +M G+L N++ D + V+ +L++
Sbjct: 61 LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
ARG+ +LH I + +++++D +A+IS + S
Sbjct: 121 ARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPA 173
Query: 673 YVAPEWFKNAPVSA---KVDVYSFGVMLLEIICCRR--------SVEMEVEEEGRAILTD 721
+VAPE + P D++SF V+L E++ + M+V EG
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL----- 228
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
R + P ++ LM EDP+KRP +++ +LE +
Sbjct: 229 ---------RPTIPPGIS-PHVSK-------LMKICM--NEDPAKRPKFDMIVPILEKMQ 269
Query: 782 E 782
+
Sbjct: 270 D 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 1e-59
Identities = 74/307 (24%), Positives = 130/307 (42%), Gaps = 38/307 (12%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSA 556
F ++L E LG+G FG K + +G+ + +K+L R +E +R F EV
Sbjct: 7 FRPSDLI-----HGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKV 60
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARG 615
+ H N+++ +G + + E++ GTL +I ++ W+ RV + +IA G
Sbjct: 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASG 120
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM--------- 666
+ YLH N IIH D+ N L+ + ++DFGL++L++ ++++ +
Sbjct: 121 MAYLH-SMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 667 ----IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW 722
+ G ++APE KVDV+SFG++L EII + + D+
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRV-----NADPDYLPRTMDF 232
Query: 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ + + I + C DP KRP+ + LE L
Sbjct: 233 GLNVRGFLDRYCPPNCPPS----------FFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282
Query: 783 VPNPPCP 789
P
Sbjct: 283 HLAGHLP 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 4e-58
Identities = 68/313 (21%), Positives = 127/313 (40%), Gaps = 48/313 (15%)
Query: 499 YNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSA 556
+ +L+ E +G+G FG VY G +A++ + +R +++ + FK EV A
Sbjct: 32 FEQLE-----IGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 557 IGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARG 615
+T H+N+V +G C + ++ TL +++ D N +I+ EI +G
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL----LLSDQSRTHTMIRGTR 671
+ YLH + I+H D+K +N+ DN I+DFGL + + + G
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 672 GYVAPEWFKNA---------PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW 722
++APE + P S DV++ G + E+ W
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHARE-----------------W 241
Query: 723 AYDCYAEGRLDVLVDSDE-PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
+ + + + P ++ ++ I ++C + +RPT ++ MLE L
Sbjct: 242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
Query: 782 EVPN-PPCPSSFS 793
+ P F
Sbjct: 302 KRNRRLSHPGHFW 314
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 73/288 (25%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLV 566
+ +G GSFG VYKG +AVK L ++ + FK+EV + +T H N++
Sbjct: 28 VGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 83
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLI-FAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
+G+ +V ++ +L + + + K + + I+ + ARG+ YLH +
Sbjct: 84 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK--- 139
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFKNA-- 682
IIH D+K NI L + KI DFGL+ S + G+ ++APE +
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199
Query: 683 -PVSAKVDVYSFGVMLLEIICCR------RSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735
P S + DVY+FG++L E++ + + + +E GR L D+
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL-----------SPDLS 248
Query: 736 VDSDE--PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
M LM C+++ +RP+ +L +E L
Sbjct: 249 KVRSNCPKRMKR-------LM--AECLKKKRDERPSFPRILAEIEELA 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 8e-54
Identities = 67/301 (22%), Positives = 126/301 (41%), Gaps = 31/301 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+++G+G +G V+ G + G+ +AVK +E ++E+ H+N++
Sbjct: 41 MVKQIGKGRYGEVWMGKWR---GEKVAVKVF-FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 569 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE-- 622
+ + L+ ++ NG+L + + D ++++ GL +LH E
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 623 ---CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH---TMIRGTRGYVAP 676
I H D+K +NIL+ + I+D GL+ +SD + GT+ Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 677 E------WFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD--WAYDCYA 728
E + D+YSFG++L E+ RR V + EE + D + Y
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 729 EGRLDVLVDSDEPAMADRSR----LQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
+ R V + P+ +R L++ + C +P+ R T V + L + E
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333
Query: 785 N 785
+
Sbjct: 334 D 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 7e-52
Identities = 66/321 (20%), Positives = 123/321 (38%), Gaps = 30/321 (9%)
Query: 485 QDSSTSETNLRFFSYNE-LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA 543
+S S + L + +E +G+G FG V++G + G+ +AVK
Sbjct: 23 MTTSGSGSGLPLLVQRTIARTIV--LQESIGKGRFGEVWRGKWR---GEEVAVKIF-SSR 76
Query: 544 QEREREFKSEVSAIGRTHHKNLVQLLGFC----DEALNRLLVYEFMGNGTLANLIFAIPK 599
+ER ++E+ H+N++ + LV ++ +G+L + +
Sbjct: 77 EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYT 135
Query: 600 PDWNLRVRISLEIARGLVYLHEE-----CNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
++++L A GL +LH E I H D+K +NIL+ + I+D GL+
Sbjct: 136 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 195
Query: 655 LLLSDQSRTHTMI---RGTRGYVAPE------WFKNAPVSAKVDVYSFGVMLLEIICCRR 705
S GT+ Y+APE K+ + D+Y+ G++ EI
Sbjct: 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 255
Query: 706 SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR----LQKWLMIAMWCIR 761
+ + + + E R V P + +R + L+ I C
Sbjct: 256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 315
Query: 762 EDPSKRPTMKVVLQMLEGLLE 782
+ + R T + + L L +
Sbjct: 316 ANGAARLTALRIKKTLSQLSQ 336
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-51
Identities = 71/298 (23%), Positives = 126/298 (42%), Gaps = 35/298 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E +G+G +G V++G + G+ +AVK E+ ++E+ H+N++
Sbjct: 12 LLECVGKGRYGEVWRGSWQ---GENVAVKIF-SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 569 LGFC----DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE-- 622
+ + L+ + G+L + + + D +RI L IA GL +LH E
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 623 ---CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI---RGTRGYVAP 676
I H D+K +NIL+ I+D GL+ + ++ GT+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 677 EWFKNAPVSA------KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD--CYA 728
E +VD+++FG++L E+ RR V + E+ + D + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 729 EGRLDVLVDSDEPAMADRSR----LQKW--LMIAMWCIREDPSKRPTMKVVLQMLEGL 780
+ R V VD P + +R L LM W ++PS R T + + L +
Sbjct: 245 DMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECW--YQNPSARLTALRIKKTLTKI 300
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-43
Identities = 67/271 (24%), Positives = 113/271 (41%), Gaps = 34/271 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLV 566
F E+GRGSF VYKG L + + +A + +L + + FK E + H N+V
Sbjct: 30 FDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 567 QLLGFC---DEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
+ + +++ E M +GTL + + +I +GL +LH
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 147
Query: 623 CNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
PIIH D+K NI + S KI D GL+ L + ++ + GT ++APE ++
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 204
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
VDVY+FG+ +LE+ ++ +C ++ V S
Sbjct: 205 K-YDESVDVYAFGMCMLEMATSEYP---------------YS-ECQNAAQIYRRVTSGVK 247
Query: 742 AMA---DRSRLQKWLMIAMWCIREDPSKRPT 769
+ K I CIR++ +R +
Sbjct: 248 PASFDKVAIPEVK--EIIEGCIRQNKDERYS 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 6e-41
Identities = 59/292 (20%), Positives = 113/292 (38%), Gaps = 50/292 (17%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
+ LGRG FG+V++ A+K++ +E RE EV A+ + H +V+
Sbjct: 11 QCLGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 69
Query: 570 GFCDEALN---------RLLVY---EFMGNGTLANLIFA---IPKPDWNLRVRISLEIAR 614
E ++ +Y + L + + I + + ++ + I L+IA
Sbjct: 70 NAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR------ 668
+ +LH + ++H D+KP NI K+ DFGL + D+ +
Sbjct: 130 AVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 669 -----GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA 723
GT+ Y++PE S KVD++S G++L E + S +ME +
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE-LLYPFSTQMERVRTLTDVR---- 241
Query: 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ P + + ++ + P +RP +++
Sbjct: 242 -----NLKFP-------PLFTQKYPCEYVMV--QDMLSPSPMERPEAINIIE 279
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-40
Identities = 65/285 (22%), Positives = 116/285 (40%), Gaps = 35/285 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 567
E++GRG+FG V+ G L++ + +AVK + +F E + + H N+V+
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTL-VAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 176
Query: 568 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
L+G C + +V E + G L + +++ + A G+ YL +
Sbjct: 177 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM-----IRGTRGYVAPEWFKN 681
IH D+ +N L+ KISDFG+S+ ++ T APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNY 289
Query: 682 APVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
S++ DV+SFG++L E S + ++ + GRL
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG--------GRL------P 335
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
P + + + LM W +P +RP+ + Q L+ + +
Sbjct: 336 CPELCP-DAVFR-LMEQCW--AYEPGQRPSFSTIYQELQSIRKRH 376
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 62/277 (22%), Positives = 114/277 (41%), Gaps = 34/277 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKK--LDRLAQEREREF-KSEVSAIGRTHHKNLVQ 567
+++GRG F VY+ G +A+KK + L + R E+ + + +H N+++
Sbjct: 38 KKIGRGQFSEVYR-AACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96
Query: 568 LLGFCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEE 622
E N L + E G L+ +I K + + +++ L ++H
Sbjct: 97 YYASFIED-NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR 155
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
++H DIKP N+ + K+ D GL + S + H+++ GT Y++PE
Sbjct: 156 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 211
Query: 683 PVSAKVDVYSFGVMLLEIICCRR---SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
+ K D++S G +L E+ + +M + + I Y S+
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC-DYPPLPSDHY-----SE 265
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
E L++ + CI DP KRP + V +
Sbjct: 266 E--------LRQLV---NMCINPDPEKRPDVTYVYDV 291
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-38
Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 12/205 (5%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREF-KSEVSAIGRTHHKNLVQL 568
+G GS+G K + + + GK + K+LD + E E++ SEV+ + H N+V+
Sbjct: 12 YTIGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 569 LG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEE 622
D L +V E+ G LA++I K L +R+ ++ L H
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 623 CNVP--IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
+ ++H D+KP N+ LD + K+ DFGL+++L D S T + GT Y++PE
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMN 189
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRR 705
+ K D++S G +L E+
Sbjct: 190 RMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 75/313 (23%), Positives = 126/313 (40%), Gaps = 60/313 (19%)
Query: 493 NLRFFS-YNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFK 551
+LR+ S + E+ LG+G+FG V K + A+KK+ +E+
Sbjct: 1 SLRYASDFEEIAV--------LGQGAFGQVVKARNAL-DSRYYAIKKIR-HTEEKLSTIL 50
Query: 552 SEVSAIGRTHHKNLVQLLGFCDEALNRL-------------LVYEFMGNGTLANLIFAIP 598
SEV + +H+ +V+ E N + + E+ NGTL +LI +
Sbjct: 51 SEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN 110
Query: 599 KP-DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL- 656
+ R+ +I L Y+H + IIH D+KP NI +D + KI DFGL+K +
Sbjct: 111 LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 657 -------------LSDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIIC 702
+ I GT YVA E + K+D+YS G++ E +
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE-MI 225
Query: 703 CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIRE 762
S ME + + ++ ++ +++K + I I
Sbjct: 226 YPFSTGMERVNILKKLR---------SVSIEF----PPDFDDNKMKVEKKI-IR-LLIDH 270
Query: 763 DPSKRPTMKVVLQ 775
DP+KRP + +L
Sbjct: 271 DPNKRPGARTLLN 283
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 67/273 (24%), Positives = 124/273 (45%), Gaps = 37/273 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
++G GS GIV K SG+ +AVK +D Q+R +EV + H N+V++
Sbjct: 51 VKIGEGSTGIVCLAREK-HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYK 109
Query: 571 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
E L ++ EF+ G L +++ + + + + + + L YLH + +I
Sbjct: 110 SYLVGEEL--WVLMEFLQGGALTDIVSQVRLNEEQIAT-VCEAVLQALAYLHAQ---GVI 163
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
H DIK +ILL K+SDFG + D + +++ GT ++APE + + +V
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRSLYATEV 222
Query: 689 DVYSFGVMLLEIICCRRSVEMEV----EEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
D++S G+M++E++ + E + +A+ L DS P +
Sbjct: 223 DIWSLGIMVIEMV------DGEPPYFSDSPVQAMK--------------RLRDSPPPKLK 262
Query: 745 DRSRLQKWLM--IAMWCIREDPSKRPTMKVVLQ 775
+ ++ L + + DP +R T + +L
Sbjct: 263 NSHKVSPVLRDFLE-RMLVRDPQERATAQELLD 294
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-37
Identities = 76/282 (26%), Positives = 123/282 (43%), Gaps = 27/282 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
K +LG G +G VY+GV K S +AVK L E E EF E + + H NLVQL
Sbjct: 224 MKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 281
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
LG C ++ EFM G L + + + + + + ++ +I+ + YL ++
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--- 338
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IH ++ +N L+ K++DFGLS+L+ D H + + APE S
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 687 KVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
K DV++FGV+L EI S +++ + + D R+
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRM--------ERPE 442
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
LM A W + +PS RP+ + Q E + + +
Sbjct: 443 GCPEKVYELMRACW--QWNPSDRPSFAEIHQAFETMFQESSI 482
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-37
Identities = 75/318 (23%), Positives = 116/318 (36%), Gaps = 55/318 (17%)
Query: 476 RRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFG-IVYKGVLKSASGKAI 534
E + D TS + S+ K+ LG G+ G IVY+G+ + +
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKISFC--------PKDVLGHGAEGTIVYRGMFD---NRDV 51
Query: 535 AVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANL 593
AVK R+ E EV + H N+++ + + + E TL
Sbjct: 52 AVK---RILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEY 107
Query: 594 IFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-----YFSAKI 647
+ L + + GL +LH N I+H D+KP NIL+ A I
Sbjct: 108 VEQKDFAHLGLEPITLLQQTTSGLAHLHS-LN--IVHRDLKPHNILISMPNAHGKIKAMI 164
Query: 648 SDFGLSKLLLSDQSRTHTM--IRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIIC 702
SDFGL K L + + GT G++APE + VD++S G + +I
Sbjct: 165 SDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224
Query: 703 CRR-----SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAM 757
S++ + A LD L + + L+
Sbjct: 225 EGSHPFGKSLQRQ------------ANILLGACSLDCLHPEK-----HEDVIARELI--E 265
Query: 758 WCIREDPSKRPTMKVVLQ 775
I DP KRP+ K VL+
Sbjct: 266 KMIAMDPQKRPSAKHVLK 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 9e-37
Identities = 68/273 (24%), Positives = 126/273 (46%), Gaps = 37/273 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E++G+G+ G VY + A+G+ +A+++++ Q ++ +E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDV-ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 571 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
+ L +V E++ G+L +++ + + + E + L +LH +I
Sbjct: 85 SYLVGDEL--WVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSN---QVI 138
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
H DIK NILL S K++DFG + +QS+ TM+ GT ++APE KV
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKV 197
Query: 689 DVYSFGVMLLEIICCRRSVEMEV----EEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
D++S G+M +E+I E E E RA+ ++ + P +
Sbjct: 198 DIWSLGIMAIEMI------EGEPPYLNENPLRALY--------------LIATNGTPELQ 237
Query: 745 DRSRLQKWLM--IAMWCIREDPSKRPTMKVVLQ 775
+ +L + C+ D KR + K +LQ
Sbjct: 238 NPEKLSAIFRDFLN-RCLEMDVEKRGSAKELLQ 269
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 71/290 (24%), Positives = 116/290 (40%), Gaps = 33/290 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 567
KE LG G FG V + + + +G+ +A+K+ + + RE + E+ + + +H N+V
Sbjct: 18 MKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 568 LLGFCDEALN------RLLVYEFMGNGTLANLIFAIPKPDWNLR---VRISL-EIARGLV 617
D LL E+ G L + + L+ +R L +I+ L
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSALR 135
Query: 618 YLHEECNVPIIHCDIKPQNILLD---NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
YLHE IIH D+KP+NI+L KI D G +K L + GT Y+
Sbjct: 136 YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-GTLQYL 190
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEIIC-------CRRSVEME--VEEEGRAILTDWAYD 725
APE + + VD +SFG + E I + V+ V E+ + +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL 250
Query: 726 CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
A VL + + +L++WL + +R T
Sbjct: 251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPN 297
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 3e-36
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 29/282 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +LG+G FG V+ G +A+K L E F E + + H+ LVQL
Sbjct: 188 LEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 244
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
E +V E+M G+L + + L V ++ +IA G+ Y+ E N
Sbjct: 245 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN-- 300
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
+H D++ NIL+ K++DFGL++L+ ++ + + APE +
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 687 KVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
K DV+SFG++L E+ R M E + R+ P
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRM--------PCPP 404
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
+ LM W R++P +RPT + + LE P
Sbjct: 405 ECPESLHDLMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 444
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-36
Identities = 60/194 (30%), Positives = 92/194 (47%), Gaps = 13/194 (6%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 572
LG+G++GIVY G ++ IA+K++ + E++ HKN+VQ LG
Sbjct: 30 LGKGTYGIVYAG-RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 573 DEALNRLLVYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
E + E + G+L+ L+ + + + + +I GL YLH+ I+
Sbjct: 89 SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF-YTKQILEGLKYLHDNQ---IV 144
Query: 629 HCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV--S 685
H DIK N+L++ Y KISDFG SK L T T GT Y+APE P
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGYG 203
Query: 686 AKVDVYSFGVMLLE 699
D++S G ++E
Sbjct: 204 KAADIWSLGCTIIE 217
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 72/316 (22%), Positives = 121/316 (38%), Gaps = 59/316 (18%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 565
+ +LG+G+FG V +AVK+L +++R+F+ E+ + H +
Sbjct: 27 YISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFI 86
Query: 566 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
V+ G + LV E++ +G L + L + D + + S +I +G+ YL
Sbjct: 87 VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL-GS 145
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ----SRTHTM--IRGTRGYVAP 676
+H D+ +NIL+++ KI+DFGL+KLL D+ R I AP
Sbjct: 146 RR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY----AP 199
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735
E + S + DV+SFGV+L E+ C +S C +
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS-------------------CSPSAEFLRM 240
Query: 736 VDSDEPAMADRS---------RLQK---------WLMIAMWCIREDPSKRPTMKVVLQML 777
+ + A RL LM W P RP+ + L
Sbjct: 241 MGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCW--APSPQDRPSFSALGPQL 298
Query: 778 EGLLEVPNPPCPSSFS 793
+ L +F+
Sbjct: 299 DMLWSGSRGCETHAFT 314
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-35
Identities = 62/232 (26%), Positives = 94/232 (40%), Gaps = 21/232 (9%)
Query: 476 RRRKYENNVQDSSTSETNLRFFSYNE-LKEATGGFKEELGRGSFGIVYKGVLKSASGKAI 534
+ E+N T + + Y E + T +GRGSFG V++ +G
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ--PRVGRGSFGEVHRM-KDKQTGFQC 86
Query: 535 AVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC--DEALNRLLVYEFMGNGTLAN 592
AVKK+ E E+ A +V L G +N + E + G+L
Sbjct: 87 AVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVN--IFMELLEGGSLGQ 139
Query: 593 LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFG 651
LI + + + + GL YLH I+H D+K N+LL + A + DFG
Sbjct: 140 LIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFG 196
Query: 652 LSKLLLSDQSRTHTM----IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
+ L D + I GT ++APE P AKVD++S M+L
Sbjct: 197 HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 70/289 (24%), Positives = 116/289 (40%), Gaps = 58/289 (20%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E +G G FG V+K + GK +K++ E+ + EV A+ + H N+V G
Sbjct: 17 ELIGSGGFGQVFKAKHRI-DGKTYVIKRVK---YNNEKA-EREVKALAKLDHVNIVHYNG 71
Query: 571 -FCDEALNRL---------------LVYEFMGNGTLANLI-----FAIPKPD-WNLRVRI 608
+ + + EF GTL I + K +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----EL 127
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR 668
+I +G+ Y+H + +I+ D+KP NI L + KI DFGL L +D RT +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK-- 182
Query: 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728
GT Y++PE + +VD+Y+ G++L E++ + E TD
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA-----FETSKFFTD-----LR 232
Query: 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
+G + + D E K L+ + + P RP +L+ L
Sbjct: 233 DGIISDIFDKKE----------KTLL--QKLLSKKPEDRPNTSEILRTL 269
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-35
Identities = 70/282 (24%), Positives = 115/282 (40%), Gaps = 29/282 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +LG+G FG V+ G +A+K L E F E + + H+ LVQL
Sbjct: 271 LEVKLGQGCFGEVWMGTWNGT--TRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 327
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
E +V E+M G+L + + L V ++ +IA G+ Y+ E N
Sbjct: 328 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV-ERMN-- 383
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
+H D++ NIL+ K++DFGL++L+ ++ + + APE +
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 687 KVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
K DV+SFG++L E+ R M E + R+ P
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--------YRM--------PCPP 487
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
+ LM W R++P +RPT + + LE P
Sbjct: 488 ECPESLHDLMCQCW--RKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 35/284 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +ELG G FG+V G + +A+K + + + EF E + H+ LVQL
Sbjct: 28 FLKELGTGQFGVVKYGKWRGQ--YDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQL 84
Query: 569 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G C + ++ E+M NG L N L + + + ++ + YL E
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-ESKQF-- 141
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHTM--IRGTRGYVAPEWFKNAP 683
+H D+ +N L+++ K+SDFGLS+ +L D+ S + +R + PE +
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSK 197
Query: 684 VSAKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
S+K D+++FGV++ EI + E I RL P
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--------LRL------YRP 243
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
+A +M + W E +RPT K++L + +++ +
Sbjct: 244 HLASEKVYT--IMYSCW--HEKADERPTFKILLSNILDVMDEES 283
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-35
Identities = 61/277 (22%), Positives = 120/277 (43%), Gaps = 40/277 (14%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREF-KSEVSAIGRTHHKNLVQL 568
+++G GSFG V + G+ +K+++ +ERE + EV+ + H N+VQ
Sbjct: 30 QKIGEGSFGKAIL-VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR------VRISLEIARGLVYLHEE 622
+E + +V ++ G L I + + ++I L ++H+
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRI----NAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I+H DIK QNI L + ++ DFG++++L S I GT Y++PE +N
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE-P 741
P + K D+++ G +L E+ + A++ + L + + S P
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKH-----------------AFEAGSMKNLVLKIISGSFP 243
Query: 742 AMADR--SRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
++ L+ + + +P RP++ +L+
Sbjct: 244 PVSLHYSYDLRSLV---SQLFKRNPRDRPSVNSILEK 277
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-35
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 43/307 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 567
+ LG+G+ V++G K +G A+K + ++ R + E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 568 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 621
L +E R L+ EF G+L ++ P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 622 ECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
I+H +IKP NI+ D K++DFG ++ L D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 678 WFKNAPV--------SAKVDVYSFGVMLLEIIC---------CRRSVEMEVEEEGRAILT 720
++ A + A VD++S GV R + + + +
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 721 DWAYDCYAEGRLDVLVDSDEPAMADRSR-----LQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ D P SR L L + D K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLAN---ILEADQEKCWGFDQFFA 302
Query: 776 MLEGLLE 782
+L
Sbjct: 303 ETSDILH 309
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 9e-35
Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 59/301 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
++ +G G G V G L+ + + A+K L ER+R +F SE S +G+ H N+
Sbjct: 53 IEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
++L G ++V E+M NG+L L + V + + G+ YL +
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDLG 171
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM------IRGTRGYVAPEW 678
+H D+ +N+L+D+ K+SDFGLS++L D +T IR T APE
Sbjct: 172 Y--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT----APEA 225
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRS---------VEMEVEEEGR----AILTDWAYD 725
S+ DV+SFGV++ E++ V VEE R +
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ 285
Query: 726 CYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
LM+ W +D ++RP ++ +L+ L+ P
Sbjct: 286 ---------------------------LMLDCW--HKDRAQRPRFSQIVSVLDALIRSPE 316
Query: 786 P 786
Sbjct: 317 S 317
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 60/302 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
++ +G G FG VYKG+LK++SGK +A+K L E++R +F E +G+ H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+++L G + +++ E+M NG L L + V + IA G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM 166
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM------IRGTRGYVAPE 677
N +H D+ +NIL+++ K+SDFGLS++L D T+T IR T APE
Sbjct: 167 N--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT----APE 220
Query: 678 WFKNAPVSAKVDVYSFGVMLLEIICCRRS---------VEMEVEEEGR----AILTDWAY 724
++ DV+SFG+++ E++ V + + R Y
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY 280
Query: 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
LM+ W +++ ++RP ++ +L+ L+ P
Sbjct: 281 Q---------------------------LMMQCW--QQERARRPKFADIVSILDKLIRAP 311
Query: 785 NP 786
+
Sbjct: 312 DS 313
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 65/289 (22%), Positives = 109/289 (37%), Gaps = 38/289 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
+G G FG V++G+ S A+ A+K + R +F E + + H ++
Sbjct: 19 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
V+L+G E ++ E G L + L D + + +++ L YL E
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL-ESKR 136
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHTM--IRGTRGYVAPEWFK 680
+H DI +N+L+ + K+ DFGLS+ + + I+ APE
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 190
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
++ DV+ FGV + EI+ ++ + I RL
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ERL------ 236
Query: 739 DEPAMAD-RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
P + L LM W DPS+RP + L +LE
Sbjct: 237 --PMPPNCPPTLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEEKA 280
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 67/307 (21%), Positives = 111/307 (36%), Gaps = 49/307 (15%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F ++LG G F V V G A+K++ Q+ E + E +H N+++L
Sbjct: 33 FIQKLGEGGFSYVDL-VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 569 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLH 620
+ +C L+ F GTL N I + L + + L I RGL +H
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH 151
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR--------GTRG 672
+ H D+KP NILL + + D G + + T
Sbjct: 152 AK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 673 YVAPEWF---KNAPVSAKVDVYSFGVMLLEIICCRRS----VEMEVEEEGRAILTDWAYD 725
Y APE F + + + DV+S G +L + V + + A+ +
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYA-MMFGEGPYDMVFQKGDSVALAVQNQLSI- 266
Query: 726 CYAEGRLDVLVDSDEPAMADRS-RLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
P S L + ++ + DP +RP + ++L LE L P
Sbjct: 267 ---------------PQSPRHSSALWQ--LLN-SMMTVDPHQRPHIPLLLSQLEALQP-P 307
Query: 785 NPPCPSS 791
P ++
Sbjct: 308 APGQHTT 314
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 70/300 (23%), Positives = 123/300 (41%), Gaps = 42/300 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 565
F ++LG+G+FG V +AVKKL +E R+F+ E+ + H N+
Sbjct: 14 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 73
Query: 566 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
V+ G C A R L+ E++ G+L + L + D ++ + +I +G+ YL
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-GT 132
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ----SRTHTM--IRGTRGYVAP 676
IH D+ +NIL++N KI DFGL+K+L D+ + I AP
Sbjct: 133 KR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY----AP 186
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII--CCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734
E + S DV+SFGV+L E+ + + L
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---HLIE 243
Query: 735 LVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
L+ ++ RL + +M W + ++RP+ + + ++ + +
Sbjct: 244 LLKNNG-------RLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 2e-34
Identities = 75/281 (26%), Positives = 123/281 (43%), Gaps = 35/281 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ELG G FG+V G K +AVK + + + EF E + + H LV+
Sbjct: 12 LLKELGSGQFGVVKLGKWKGQY--DVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKF 68
Query: 569 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G C + +V E++ NG L N L + + + + ++ G+ +L E
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL-ESHQF-- 125
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHTM--IRGTRGYVAPEWFKNAP 683
IH D+ +N L+D K+SDFG+++ +L DQ S T ++ + APE F
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181
Query: 684 VSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
S+K DV++FG+++ E+ + E + RL P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG--------HRL------YRP 227
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+A + Q +M + W E P KRPT + +L +E L E
Sbjct: 228 HLASDTIYQ--IMYSCW--HELPEKRPTFQQLLSSIEPLRE 264
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 56/201 (27%), Positives = 89/201 (44%), Gaps = 16/201 (7%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
LG G FG VY+GV + G+ I AVK + + +F SE + H ++
Sbjct: 16 LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
V+L+G +E ++ E G L + L V SL+I + + YL E N
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL-ESIN 133
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHTM--IRGTRGYVAPEWFK 680
+H DI +NIL+ + K+ DFGLS+ + + + T I+ +PE
Sbjct: 134 C--VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESIN 187
Query: 681 NAPVSAKVDVYSFGVMLLEII 701
+ DV+ F V + EI+
Sbjct: 188 FRRFTTASDVWMFAVCMWEIL 208
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 70/297 (23%), Positives = 123/297 (41%), Gaps = 42/297 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQEREREFKSEVSAIGRTHHKNL 565
F ++LG+G+FG V +AVKKL +E R+F+ E+ + H N+
Sbjct: 45 FLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNI 104
Query: 566 VQLLGFCDEALNR--LLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
V+ G C A R L+ E++ G+L + L + D ++ + +I +G+ YL
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL-GT 163
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ----SRTHTM--IRGTRGYVAP 676
IH D+ +NIL++N KI DFGL+K+L D+ + I AP
Sbjct: 164 KR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY----AP 217
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII--CCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734
E + S DV+SFGV+L E+ + + L
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF---HLIE 274
Query: 735 LVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
L+ ++ RL + +M W + ++RP+ + + ++ + +
Sbjct: 275 LLKNNG-------RLPRPDGCPDEIYMIMTECW--NNNVNQRPSFRDLALRVDQIRD 322
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 71/292 (24%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
F E +GRG FG VY G L GK I AVK L+R+ E +F +E + H N+
Sbjct: 29 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 566 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+ LLG C + L+V +M +G L N + P + L++A+G+ YL
Sbjct: 89 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL-ASK 147
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-----QSRTHTM--IRGTRGYVAP 676
+H D+ +N +LD F+ K++DFGL++ + ++T ++ A
Sbjct: 148 K--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----AL 201
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEIICCRRSV------EMEVEEEGRAILTDWAYDCYAEG 730
E + + K DV+SFGV+L E++ + ++ + +L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYLLQG--------R 249
Query: 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
RL L + +M+ W RP+ ++ + +
Sbjct: 250 RL-------LQPEYCPDPLYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 291
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-34
Identities = 71/301 (23%), Positives = 112/301 (37%), Gaps = 58/301 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQ 567
++ LG GS G V G+ +AVK++ + E+ + + H N+++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQ--GRPVAVKRMLI---DFCDIALMEIKLLTESDDHPNVIR 73
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE-------IARGLVYLH 620
+ E L +L+ + D NL+++ IA G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 621 EECNVPIIHCDIKPQNILLDN-------------YFSAKISDFGLSKLLLSDQSRTHTMI 667
IIH D+KPQNIL+ ISDFGL K L S QS T +
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 668 R---GTRGYVAPEWFKNA-------PVSAKVDVYSFGVMLLEIICCRR---SVEMEVEEE 714
GT G+ APE + + ++ +D++S G + I+ + + E
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES- 248
Query: 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
I+ G L + L+ M I DP KRPT VL
Sbjct: 249 --NII---------RGIFS-LDEMKCLHDRSLIAEATDLISQM--IDHDPLKRPTAMKVL 294
Query: 775 Q 775
+
Sbjct: 295 R 295
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 75/304 (24%), Positives = 122/304 (40%), Gaps = 42/304 (13%)
Query: 509 FKEELGRGSFGIVYKGVLK---SASGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
+LG G FG V +G+ +AVK L A + R +K E+ + +H++
Sbjct: 35 KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 565 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
+++ G C++A LV E++ G+L + + + + +I G+ YL
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYL-HA 152
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ----SRTHTM--IRGTRGYVAP 676
+ IH D+ +N+LLDN KI DFGL+K + R + AP
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY----AP 206
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735
E K DV+SFGV L E++ C S + + RL L
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIA---QGQMTVLRLTEL 263
Query: 736 VDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
++ E RL + LM W + S RPT + ++ +L+ + E
Sbjct: 264 LERGE-------RLPRPDKCPAEVYHLMKNCW--ETEASFRPTFENLIPILKTVHEKYQG 314
Query: 787 PCPS 790
PS
Sbjct: 315 QAPS 318
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-34
Identities = 68/285 (23%), Positives = 122/285 (42%), Gaps = 35/285 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+++LG G FG V+ +AVK + + E F +E + + H LV+L
Sbjct: 192 LEKKLGAGQFGEVWMATYNKH--TKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKL 248
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
+ ++ EFM G+L + + + L + S +IA G+ ++ E+ N
Sbjct: 249 HAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI-EQRN-- 304
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV---APEWFKNAP 683
IH D++ NIL+ KI+DFGL++++ ++ +T G + + APE
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS 361
Query: 684 VSAKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
+ K DV+SFG++L+EI+ R M E RA+ R+ P
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG--------YRM--------P 405
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
+ +M+ W + P +RPT + + +L+
Sbjct: 406 RPENCPEELYNIMMRCW--KNRPEERPTFEYIQSVLDDFYTATES 448
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 83/283 (29%), Positives = 126/283 (44%), Gaps = 35/283 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +E+G G FG+V+ G + +A+K + A E +F E + + H LVQL
Sbjct: 12 FVQEIGSGQFGLVHLGYWLNKD--KVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 68
Query: 569 LGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G C E LV EFM +G L++ L + + L++ G+ YL EE V
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-EEACV-- 125
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHTM--IRGTRGYVAPEWFKNAP 683
IH D+ +N L+ K+SDFG+++ +L DQ S T T ++ +PE F +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSR 181
Query: 684 VSAKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
S+K DV+SFGV++ E+ + E I T RL +P
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG--------FRL------YKP 227
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
+A Q +M W RE P RP +L+ L + E
Sbjct: 228 RLASTHVYQ--IMNHCW--RERPEDRPAFSRLLRQLAEIAESG 266
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-34
Identities = 78/290 (26%), Positives = 133/290 (45%), Gaps = 37/290 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
+ +G G FG V G LK S K I A+K L E++R +F E S +G+ H N+
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
++L G ++ ++V E+M NG+L + L + V + IA G+ YL +
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL-SDMG 167
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM------IRGTRGYVAPEW 678
+H D+ +NIL+++ K+SDFGL ++L D +T IR T +PE
Sbjct: 168 Y--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWT----SPEA 221
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736
++ DV+S+G++L E++ EM ++ +A+ RL
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD--------EGYRL---- 269
Query: 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
P D LM+ W ++D + RP + ++ +L+ L+ P
Sbjct: 270 ----PPPMDCPAALYQLMLDCW--QKDRNNRPKFEQIVSILDKLIRNPGS 313
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 37/307 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 567
+ LG+G+ V++G K +G A+K + ++ R + E + + +HKN+V+
Sbjct: 13 LSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 568 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 621
L +E R L+ EF G+L ++ P + L + + ++ G+ +L E
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 622 ECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
I+H +IKP NI+ D K++DFG ++ L D + ++ GT Y+ P+
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFVSLY-GTEEYLHPD 185
Query: 678 WFKNAPV--------SAKVDVYSFGVMLLEIIC----------CRRSVE-MEVEEEGRAI 718
++ A + A VD++S GV RR+ E M G+
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
G +D D R + + D K
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 779 GLLEVPN 785
+L N
Sbjct: 306 DILHRGN 312
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 6e-34
Identities = 67/313 (21%), Positives = 119/313 (38%), Gaps = 63/313 (20%)
Query: 494 LRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-E 549
LR E K + LG G+FG VYKG+ K +A+K+L + E
Sbjct: 9 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 550 FKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVR 607
E + + ++ +LLG C + L+ + M G L + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667
++IA+G+ YL E+ ++H D+ +N+L+ KI+DFGL+KLL +++ H
Sbjct: 122 WCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-- 176
Query: 668 RGTRGYV---APEWFKNAPVSAKVDVYSFGVMLLEII---------CCRRSVEMEVEEEG 715
G + + A E + + + DV+S+GV + E++ + +E+
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE 236
Query: 716 R----AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771
R I T Y +M W D RP +
Sbjct: 237 RLPQPPICTIDVYM---------------------------IMRKCW--MIDADSRPKFR 267
Query: 772 VVLQMLEGLLEVP 784
++ + P
Sbjct: 268 ELIIEFSKMARDP 280
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-34
Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 14/197 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR-LAQERERE-FKSEVSAIGR-THHKNLVQ 567
LG GS+G V+K V G+ AVK+ ++R +EV + + H V+
Sbjct: 63 SRLGHGSYGEVFK-VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEECNV 625
L +E L E G +L A P+ + + L +LH +
Sbjct: 122 LEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHSQ--- 176
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
++H D+KP NI L K+ DFGL L G Y+APE +
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQE-GDPRYMAPELLQG-SYG 233
Query: 686 AKVDVYSFGVMLLEIIC 702
DV+S G+ +LE+ C
Sbjct: 234 TAADVFSLGLTILEVAC 250
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 8e-34
Identities = 76/310 (24%), Positives = 127/310 (40%), Gaps = 50/310 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
LG G+FG VY+G + +AVK L + E++ +F E I + +H+
Sbjct: 34 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 93
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR------VRISLEIARGL 616
N+V+ +G ++L R ++ E M G L + L P+P + ++ +IA G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGLSKLLLSDQ---SRTHTM--IR 668
YL EE + IH DI +N LL AKI DFG+++ + M ++
Sbjct: 154 QYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDC 726
PE F ++K D +SFGV+L EI +E + +
Sbjct: 211 WM----PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG----- 261
Query: 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP-- 784
GR+ +P + + +M W + P RP ++L+ +E + P
Sbjct: 262 ---GRM-------DPPKNCPGPVYR-IMTQCW--QHQPEDRPNFAIILERIEYCTQDPDV 308
Query: 785 -NPPCPSSFS 793
N P +
Sbjct: 309 INTALPIEYG 318
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 63/293 (21%), Positives = 111/293 (37%), Gaps = 48/293 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA------IAVKKLDRLAQEREREFKSEVSAIGRTHH 562
F E LG+G+F ++KGV + + +K LD+ + F S + + H
Sbjct: 12 FNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHE 621
K+LV G C +LV EF+ G+L L + ++ ++ ++A + +L E
Sbjct: 72 KHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL-E 130
Query: 622 ECNVPIIHCDIKPQNILLDNYFS--------AKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
E + IH ++ +NILL K+SD G+S +L I
Sbjct: 131 ENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWV--- 184
Query: 674 VAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEG 730
PE +N + D +SFG L EI ++ + Y +
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR---------KLQFYEDR 234
Query: 731 -RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+L +A+ L+ +P RP+ + +++ L L
Sbjct: 235 HQLP---APKAAELAN-------LINNCM--DYEPDHRPSFRAIIRDLNSLFT 275
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 67/300 (22%), Positives = 117/300 (39%), Gaps = 48/300 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-EFKSEVSAIGRTHHKN 564
+LG G FG V +AVK L + + K E+ + +H+N
Sbjct: 25 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHEN 84
Query: 565 LVQLLGFCDEALNR--LLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVY 618
+V+ G C E L+ EF+ +G+L + +PK + ++ +++I +G+ Y
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSL--KEY-LPKNKNKINLKQQLKYAVQICKGMDY 141
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ----SRTHTM--IRGTRG 672
L +H D+ +N+L+++ KI DFGL+K + +D+ + +
Sbjct: 142 L-GSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY-- 196
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEII-CCRRSVEMEVEEEGRAILTDWAYDCYAEGR 731
APE + DV+SFGV L E++ C T + R
Sbjct: 197 --APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT---HGQMTVTR 251
Query: 732 LDVLVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
L + + RL LM W PS R + + +++ E LL+
Sbjct: 252 LVNTLKEGK-------RLPCPPNCPDEVYQLMRKCW--EFQPSNRTSFQNLIEGFEALLK 302
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 82/285 (28%), Positives = 128/285 (44%), Gaps = 35/285 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
K +LG G +G VY+GV K S +AVK L E E EF E + + H NLVQL
Sbjct: 17 MKHKLGGGQYGEVYEGVWKKYSLT-VAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 74
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
LG C ++ EFM G L + + + + + + ++ +I+ + YL E+ N
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL-EKKNF- 132
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM----IRGTRGYVAPEWFKNA 682
IH D+ +N L+ K++DFGLS+L+ D H I+ T APE
Sbjct: 133 -IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYN 187
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740
S K DV++FGV+L EI S +++ + + D R+ +
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD--------YRM------ER 233
Query: 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
P + LM A W + +PS RP+ + Q E + + +
Sbjct: 234 PEGCPEKVYE--LMRACW--QWNPSDRPSFAEIHQAFETMFQESS 274
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-33
Identities = 64/288 (22%), Positives = 107/288 (37%), Gaps = 36/288 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
+G G FG V++G+ S A+ A+K + R +F E + + H ++
Sbjct: 394 LGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 453
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
V+L+G E ++ E G L + L D + + +++ L YL E
Sbjct: 454 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL-ESKR 511
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHTM--IRGTRGYVAPEWFK 680
+H DI +N+L+ + K+ DFGLS+ + + I+ APE
Sbjct: 512 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESIN 565
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
++ DV+ FGV + EI+ ++ + I RL
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG--------ERL------ 611
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
L LM W DPS+RP + L +LE
Sbjct: 612 -PMPPNCPPTLYS-LMTKCW--AYDPSRRPRFTELKAQLSTILEEEKL 655
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 64/294 (21%), Positives = 121/294 (41%), Gaps = 37/294 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
ELG G+ G+V+K K SG +A K + + R E+ + + +V
Sbjct: 39 SELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFY 97
Query: 570 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G + D ++ + E M G+L ++ + + ++S+ + +GL YL E+ I
Sbjct: 98 GAFYSDGEIS--ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 153
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D+KP NIL+++ K+ DFG+S L+ + + GTR Y++PE + S +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 210
Query: 688 VDVYSFGVMLLEI---------ICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
D++S G+ L+E+ + M + L+
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
Query: 739 DEPAMADRSRLQK-------WLMIAMW----------CIREDPSKRPTMKVVLQ 775
P MA L L ++ C+ ++P++R +K ++
Sbjct: 271 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-33
Identities = 70/292 (23%), Positives = 122/292 (41%), Gaps = 47/292 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
F E +GRG FG VY G L GK I AVK L+R+ E +F +E + H N+
Sbjct: 93 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 566 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+ LLG C + L+V +M +G L N + P + L++A+G+ +L
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL-ASK 211
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-----QSRTHTM--IRGTRGYVAP 676
+H D+ +N +LD F+ K++DFGL++ + ++T ++ A
Sbjct: 212 K--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----AL 265
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEIICCRRSV------EMEVEEEGRAILTDWAYDCYAEG 730
E + + K DV+SFGV+L E++ + ++ + +L
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELM----TRGAPPYPDVNTFDITVYLLQG--------R 313
Query: 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
RL L + +M+ W RP+ ++ + +
Sbjct: 314 RL-------LQPEYCPDPLYE-VMLKCW--HPKAEMRPSFSELVSRISAIFS 355
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 3e-33
Identities = 54/199 (27%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
ELG G+FG VYK K +G A K ++ ++E ++ E+ + H +V+LLG
Sbjct: 25 GELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 571 --FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPI 627
+ D L ++ EF G + ++ + + +++ + ++ L +LH + I
Sbjct: 84 AYYHDGKL--WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RI 138
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-----WFKNA 682
IH D+K N+L+ +++DFG+S L + + I GT ++APE K+
Sbjct: 139 IHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDT 197
Query: 683 PVSAKVDVYSFGVMLLEII 701
P K D++S G+ L+E+
Sbjct: 198 PYDYKADIWSLGITLIEMA 216
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-33
Identities = 73/279 (26%), Positives = 120/279 (43%), Gaps = 35/279 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +G+G FG V G + G +AVK + A + F +E S + + H NLVQL
Sbjct: 197 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 251
Query: 569 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNV 625
LG E L +V E+M G+L + + + + ++ SL++ + YL E N
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNN- 309
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+H D+ +N+L+ AK+SDFGL+K S Q ++ T APE + S
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 364
Query: 686 AKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743
K DV+SFG++L EI R + +++ + ++ A
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKM--------DAP 408
Query: 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+M W D + RPT + + LE +
Sbjct: 409 DGCPPAVYDVMKNCW--HLDAATRPTFLQLREQLEHIRT 445
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-33
Identities = 40/216 (18%), Positives = 71/216 (32%), Gaps = 26/216 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLD-RLAQEREREFKSEVSAIGRTHHK 563
LG G+F VY+ + + +K E + + + +
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ-LMERLKPSMQH 127
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDW-----NLRVRISLEIARGLVY 618
++ +LV E GTL N I L + ++ + +
Sbjct: 128 MFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSA-----------KISDFGLSK-LLLSDQSRTHTM 666
+H+ IIH DIKP N +L N F + D G S + L + T
Sbjct: 188 VHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC 702
T G+ E N P + ++D + + ++
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 41/210 (19%), Positives = 85/210 (40%), Gaps = 23/210 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNL--V 566
+++G G V++ + + A+K L+ + +++E++ + + + +
Sbjct: 34 KQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 91
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+L + +V E GN L + + D R + + +H+
Sbjct: 92 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 147
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-TMIRGTRGYVAPEWFKNAP-- 683
I+H D+KP N L+ + K+ DFG++ + D + GT Y+ PE K+
Sbjct: 148 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 684 ---------VSAKVDVYSFGVMLLEIICCR 704
+S K DV+S G +L + +
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 78/310 (25%), Positives = 128/310 (41%), Gaps = 50/310 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
LG G+FG VY+G + +AVK L + E++ +F E I + +H+
Sbjct: 75 LIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQ 134
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR------VRISLEIARGL 616
N+V+ +G ++L R ++ E M G L + L P+P + ++ +IA G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
YL EE + IH DI +N LL AKI DFG+++ D R +G
Sbjct: 195 QYL-EENH--FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247
Query: 674 V-----APEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDC 726
+ PE F ++K D +SFGV+L EI +E + +
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG----- 302
Query: 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP-- 784
GR+ +P + + +M W + P RP ++L+ +E + P
Sbjct: 303 ---GRM-------DPPKNCPGPVYR-IMTQCW--QHQPEDRPNFAIILERIEYCTQDPDV 349
Query: 785 -NPPCPSSFS 793
N P +
Sbjct: 350 INTALPIEYG 359
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 16/211 (7%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKAI--AVK--KLDRLAQERER-EFKSEVS 555
+ E E+LG GSFG+V +G + SGK + AVK K D L+Q +F EV+
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 73
Query: 556 AIGRTHHKNLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIA 613
A+ H+NL++L G + +V E G+L + L R ++++A
Sbjct: 74 AMHSLDHRNLIRLYGVVLTPPM--KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
G+ YL E IH D+ +N+LL KI DFGL + L + + M +
Sbjct: 132 EGMGYL-ESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVP 187
Query: 674 V---APEWFKNAPVSAKVDVYSFGVMLLEII 701
APE K S D + FGV L E+
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 8e-33
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 17/201 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHK 563
E +G+G F +V + + + +G+ AVK K + K E S H
Sbjct: 28 LCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHP 86
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR----GLVYL 619
++V+LL +V+EFM L I + ++ R L Y
Sbjct: 87 HIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 620 HEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
H+ IIH D+KP +LL +N K+ FG++ L + GT ++AP
Sbjct: 147 HDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAP 202
Query: 677 EWFKNAPVSAKVDVYSFGVML 697
E K P VDV+ GV+L
Sbjct: 203 EVVKREPYGKPVDVWGCGVIL 223
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-33
Identities = 46/248 (18%), Positives = 95/248 (38%), Gaps = 26/248 (10%)
Query: 476 RRRKYENNVQDSSTSETNLRFFSYNELKEATGG---FKEELGRGSFGIVYKGVLKSASGK 532
+ + + D T + + S NE G +++G G V++ + +
Sbjct: 24 KFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV--LNEKKQ 81
Query: 533 AIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNL--VQLLGFCDEALNRLLVYEFMGNG 588
A+K L+ + +++E++ + + + ++L + +V E GN
Sbjct: 82 IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNI 140
Query: 589 TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648
L + + D R + + +H+ I+H D+KP N L+ + K+
Sbjct: 141 DLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI 196
Query: 649 DFGLSKLLLSDQSRTH-TMIRGTRGYVAPEWFKNAP-----------VSAKVDVYSFGVM 696
DFG++ + D + G Y+ PE K+ +S K DV+S G +
Sbjct: 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256
Query: 697 LLEIICCR 704
L + +
Sbjct: 257 LYYMTYGK 264
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 10/193 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG+G FG VY K + +A+K L + + E + + E+ H N++++
Sbjct: 22 LGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
+ + L+ EF G L + + D E+A L Y HE +IH
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIH 137
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIKP+N+L+ KI+DFG S + R TM GT Y+ PE + KVD
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV--HAPSLRRRTMC-GTLDYLPPEMIEGKTHDEKVD 194
Query: 690 VYSFGVMLLEIIC 702
++ GV+ E +
Sbjct: 195 LWCAGVLCYEFLV 207
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 41/288 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E LG G FG V+ G + +AVK L + + + F +E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNGHT--KVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 569 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNV 625
E + ++ E+M NG+L + + + + ++ +IA G+ ++ EE N
Sbjct: 74 YAVVTQEPI--YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI-EERNY 130
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--SRTHT--MIRGTRGYVAPEWFKN 681
IH D++ NIL+ + S KI+DFGL++L+ ++ +R I+ T APE
Sbjct: 131 --IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT----APEAINY 184
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
+ K DV+SFG++L EI+ R M E + + R+
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--------YRM------- 229
Query: 740 EPAMAD-RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
+ L + LM W +E P RPT + +LE
Sbjct: 230 -VRPDNCPEELYQ-LMRLCW--KERPEDRPTFDYLRSVLEDFFTATEG 273
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGR-THHKNLV 566
+ELGRG F +V + + KS +G+ A K K R Q+ E E++ + ++
Sbjct: 34 SKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEE 622
L + +L+ E+ G + +L +P+ + +R+ +I G+ YLH+
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLC--LPELAEMVSENDVIRLIKQILEGVYYLHQN 150
Query: 623 CNVPIIHCDIKPQNILLDNYFSA---KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
I+H D+KPQNILL + + KI DFG+S+ + M GT Y+APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM--GTPEYLAPEIL 205
Query: 680 KNAPVSAKVDVYSFGVML 697
P++ D+++ G++
Sbjct: 206 NYDPITTATDMWNIGIIA 223
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 60/193 (31%), Positives = 91/193 (47%), Gaps = 10/193 (5%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG+G FG VY K S +A+K L + E + + EV H N+++L
Sbjct: 17 LGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIH 629
G+ +A L+ E+ GT+ + + K D E+A L Y H + +IH
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIH 132
Query: 630 CDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVD 689
DIKP+N+LL + KI+DFG S + SR + GT Y+ PE + KVD
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV--HAPSSRRTDLC-GTLDYLPPEMIEGRMHDEKVD 189
Query: 690 VYSFGVMLLEIIC 702
++S GV+ E +
Sbjct: 190 LWSLGVLCYEFLV 202
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 69/297 (23%), Positives = 123/297 (41%), Gaps = 57/297 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVKKLDRLAQERER-EFKSEVSAIGRTHHKNL 565
+G+G FG+VY G + I A+K L R+ + ++ F E + +H N+
Sbjct: 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 566 VQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
+ L+G ++ +M +G L + P + L++ARG+ YL E
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL-AEQ 143
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD-----QSRTHTM--IRGTRGYVAP 676
+H D+ +N +LD F+ K++DFGL++ +L Q H ++ T A
Sbjct: 144 K--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDV 734
E + + K DV+SFGV+L E++ ++ + A+GR
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD---------LTHFLAQGR--- 245
Query: 735 LVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
RL + +M W DP+ RPT +V++ +E ++
Sbjct: 246 -------------RLPQPEYCPDSLYQVMQQCW--EADPAVRPTFRVLVGEVEQIVS 287
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 42/210 (20%), Positives = 86/210 (40%), Gaps = 23/210 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIG--RTHHKNLV 566
+++G G V++ + + A+K L+ + +++E++ + + H ++
Sbjct: 15 KQIGSGGSSKVFQV--LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII 72
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+L + +V E GN L + + D R + + +H+
Sbjct: 73 RLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG--- 128
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-TMIRGTRGYVAPEWFKNAP-- 683
I+H D+KP N L+ + K+ DFG++ + D + GT Y+ PE K+
Sbjct: 129 IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 684 ---------VSAKVDVYSFGVMLLEIICCR 704
+S K DV+S G +L + +
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 73/310 (23%), Positives = 122/310 (39%), Gaps = 66/310 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKN 564
LG+G FG V + LK G + AVK K D +A EF E + + H +
Sbjct: 27 LGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPH 86
Query: 565 LVQLLGFC------DEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR----VRISLEI 612
+ +L+G +++ FM +G L + A I + +NL VR ++I
Sbjct: 87 VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTM--I 667
A G+ YL N IH D+ +N +L + ++DFGLS+ + S + + +
Sbjct: 147 ACGMEYL-SSRN--FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203
Query: 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYD 725
+ A E + + DV++FGV + EI+ ++ +E E Y+
Sbjct: 204 KWL----ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---------IYN 250
Query: 726 CYAEGRLDVLVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQM 776
G RL++ LM W DP +RP+ +
Sbjct: 251 YLIGGN----------------RLKQPPECMEEVYDLMYQCW--SADPKQRPSFTCLRME 292
Query: 777 LEGLLEVPNP 786
LE +L +
Sbjct: 293 LENILGHLSV 302
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 512 ELGRGSFGIVYKGVLKSASGK-AIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
ELG G+FG V KG + +AVK K + + E +E + + + + +V++
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
+G C+ + +LV E G L + + + +++ G+ YL EE N +
Sbjct: 84 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL-EESN--FV 139
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV---APEWFKNAPVS 685
H D+ +N+LL AKISDFGLSK L +D++ + + V APE S
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 686 AKVDVYSFGVMLLEII 701
+K DV+SFGV++ E
Sbjct: 199 SKSDVWSFGVLMWEAF 214
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 510 KEELGRGSFGIVYKGVLKSASGK-AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 567
ELG G+FG V +GV + + +A+K L + ++ + E E + + + +V+
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 568 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
L+G C +LV E G G L L+ + + + +++ G+ YL EE N
Sbjct: 75 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 130
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV---APEWFKNAP 683
+H D+ +N+LL N AKISDFGLSK L +D S +T + + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 189
Query: 684 VSAKVDVYSFGVMLLEII 701
S++ DV+S+GV + E +
Sbjct: 190 FSSRSDVWSYGVTMWEAL 207
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-32
Identities = 52/194 (26%), Positives = 94/194 (48%), Gaps = 9/194 (4%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKNLVQLL 569
LG+GSF VY+ +G +A+K +D+ + + + ++EV + H ++++L
Sbjct: 19 LGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEECNVPII 628
+ +++ LV E NG + + KP R +I G++YLH I+
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---IL 134
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
H D+ N+LL + KI+DFGL+ L + +T+ GT Y++PE + +
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC-GTPNYISPEIATRSAHGLES 193
Query: 689 DVYSFGVMLLEIIC 702
DV+S G M ++
Sbjct: 194 DVWSLGCMFYTLLI 207
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 71/312 (22%), Positives = 124/312 (39%), Gaps = 70/312 (22%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQEREREFKSEVSAIGRTHHKN 564
K ELG G+FG V+ + S +AVK L ++F+ E + H++
Sbjct: 19 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 78
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----VRI 608
+V+ G C + ++V+E+M +G L + + L + I
Sbjct: 79 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---SRTHT 665
+ +IA G+VYL + +H D+ +N L+ KI DFG+S+ + S HT
Sbjct: 139 ASQIASGMVYL-ASQH--FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 195
Query: 666 M--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTD 721
M IR PE + + DV+SFGV+L EI + ++ E
Sbjct: 196 MLPIRWM----PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------- 243
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKV 772
+C +GR L++ +M+ W + +P +R +K
Sbjct: 244 -VIECITQGR----------------VLERPRVCPKEVYDVMLGCW--QREPQQRLNIKE 284
Query: 773 VLQMLEGLLEVP 784
+ ++L L +
Sbjct: 285 IYKILHALGKAT 296
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 51/196 (26%), Positives = 88/196 (44%), Gaps = 18/196 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+LGRG FGIV++ V S S K K + ++ K E+S + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHL 66
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLR----VRISLEIARGLVYLHEEC 623
+ ++++EF+ + F I + L V ++ L +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSH- 121
Query: 624 NVPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
I H DI+P+NI+ S+ KI +FG ++ L ++ Y APE ++
Sbjct: 122 --NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQH 177
Query: 682 APVSAKVDVYSFGVML 697
VS D++S G ++
Sbjct: 178 DVVSTATDMWSLGTLV 193
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 74/307 (24%), Positives = 125/307 (40%), Gaps = 65/307 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
ELG+GSFG+VY+GV K +A+K ++ A RER EF +E S + +
Sbjct: 29 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR---------VRISLEIA 613
++V+LLG + L++ E M G L + L P N ++++ EIA
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTM--IR 668
G+ YL+ +H D+ +N ++ F+ KI DFG+++ + + + +R
Sbjct: 149 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDC 726
+PE K+ + DV+SFGV+L EI + E+
Sbjct: 206 WM----SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---------VLRF 252
Query: 727 YAEGRLDVLVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQML 777
EG L K LM W + +P RP+ ++ +
Sbjct: 253 VMEGG----------------LLDKPDNCPDMLFELMRMCW--QYNPKMRPSFLEIISSI 294
Query: 778 EGLLEVP 784
+ +E
Sbjct: 295 KEEMEPG 301
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 33/324 (10%), Positives = 74/324 (22%), Gaps = 56/324 (17%)
Query: 490 SETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE 549
S E E L G +V+ + A+K A+ E
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSE 105
Query: 550 ---FKSEVSAIGRTHHKNLVQLLGFC--------------------------DEALNRLL 580
A R ++ + N LL
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165
Query: 581 VYEFMGNGTLANLIFAIPK-------PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIK 633
+ L L + ++ ++ R L + ++H
Sbjct: 166 LMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFT 221
Query: 634 PQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF--KNAPVSAKVDVY 691
P N+ + + D +R Y E+ A + ++ +
Sbjct: 222 PDNLFIMPDGRLMLGDVSALW---KVGTRGPASS-VPVTYAPREFLNASTATFTHALNAW 277
Query: 692 SFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQK 751
G+ + + C + + + L + P ++ + +
Sbjct: 278 QLGLSIYRVWCLFLPFGLV-TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV-KTLIGR 335
Query: 752 WLMIAMWCIREDPSKRPTMKVVLQ 775
+ D +R ++
Sbjct: 336 -------FLNFDRRRRLLPLEAME 352
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 78/305 (25%), Positives = 126/305 (41%), Gaps = 65/305 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAI--AVK--KLDRLAQEREREFKSEVSAIGRTHHKN 564
+ LG G FG V +G LK G ++ AVK KLD +Q EF SE + + H N
Sbjct: 38 LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 565 LVQLLGFC-----DEALNRLLVYEFMGNGTLANLIFA--IPKPDWNLR----VRISLEIA 613
+++LLG C +++ FM G L + + ++ ++ ++IA
Sbjct: 98 VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTM--IR 668
G+ YL N +H D+ +N +L + + ++DFGLSK + S + ++
Sbjct: 158 LGMEYL-SNRN--FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDC 726
A E + ++K DV++FGV + EI + ++ E YD
Sbjct: 215 WI----AIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---------MYDY 261
Query: 727 YAEGRLDVLVDSDEPAMADRSRLQK---------WLMIAMWCIREDPSKRPTMKVVLQML 777
G RL++ +M + W R DP RPT V+ L
Sbjct: 262 LLHGH----------------RLKQPEDCLDELYEIMYSCW--RTDPLDRPTFSVLRLQL 303
Query: 778 EGLLE 782
E LLE
Sbjct: 304 EKLLE 308
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 77/288 (26%), Positives = 125/288 (43%), Gaps = 50/288 (17%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRT-HHKNLVQL 568
E+GRG++G V K V K SG+ +AVK++ E+E++ ++ + R+ +VQ
Sbjct: 28 GEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 569 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV----RISLEIARGLVYLHEE 622
G F + + E M + D + +I+L + L +L E
Sbjct: 87 YGALFREGDCW--ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
IIH DIKP NILLD + K+ DFG+S L+ ++T G R Y+APE +
Sbjct: 145 LK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPS 200
Query: 683 PV----SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL--- 735
+ DV+S G+ L E+ GR W D L
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELA------------TGRFPYPKW------NSVFDQLTQV 242
Query: 736 VDSDEPAMADRSRLQKW-----LMIAMWCIREDPSKRPTMKVVLQMLE 778
V D P +++ S +++ + + C+ +D SKRP K ++L+
Sbjct: 243 VKGDPPQLSN-SEEREFSPSFINFVNL-CLTKDESKRPKYK---ELLK 285
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 39/279 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 567
KE++G GS+ + + + K+ + AVK +D+ +R+ E+ + R H N++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIIT 80
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNV 625
L D+ +V E M G L + I + ++ R + I + + YLH
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHA-QG- 136
Query: 626 PIIHCDIKPQNILL----DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
++H D+KP NIL N S +I DFG +K L ++ T T +VAPE +
Sbjct: 137 -VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLER 194
Query: 682 APVSAKVDVYSFGVMLLEIICC-----RRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736
A D++S GV+L + + EE I G+ +
Sbjct: 195 QGYDAACDIWSLGVLLY-TMLTGYTPFANGPDDTPEEILARIG---------SGKFSL-- 242
Query: 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
S K L+ M + DP +R T +VL+
Sbjct: 243 --SGGYWNSVSDTAKDLVSKMLHV--DPHQRLTAALVLR 277
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 27/202 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
KEELG+G+F +V + V K+ +G A K ++ +L+ ++ + E + H N+V
Sbjct: 10 VKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 68
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--------Y 618
+L E LV++ + G L I A R S A + Y
Sbjct: 69 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAY 120
Query: 619 LHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
H I+H ++KP+N+LL + K++DFGL+ + +D H GT GY++
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPGYLS 175
Query: 676 PEWFKNAPVSAKVDVYSFGVML 697
PE K P S VD+++ GV+L
Sbjct: 176 PEVLKKDPYSKPVDIWACGVIL 197
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 9e-32
Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
EELG G+FG+V++ V K+ +G+ K ++ + K+E+S + + HH L+ L
Sbjct: 55 ILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 113
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIAR----GLVYLHEEC 623
++ +L+ EF+ G L F I D+ + + R GL ++HE
Sbjct: 114 HDAFEDKYEMVLILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH- 168
Query: 624 NVPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
I+H DIKP+NI+ + ++ KI DFGL+ L + + T + APE
Sbjct: 169 --SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDR 224
Query: 682 APVSAKVDVYSFGVML 697
PV D+++ GV+
Sbjct: 225 EPVGFYTDMWAIGVLG 240
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKNLVQLL 569
LG+G F ++ + + A K + + L + +RE E+S H+++V
Sbjct: 49 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 621
GF ++ +V E +L L R ++ AR G YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHR 159
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+IH D+K N+ L+ KI DFGL+ + D R + GT Y+APE
Sbjct: 160 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSK 215
Query: 682 APVSAKVDVYSFGVMLLEIIC 702
S +VDV+S G ++ ++
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLV 236
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 52/201 (25%), Positives = 85/201 (42%), Gaps = 24/201 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQERERE-FKSEVSAIGRTHHKNLVQLL 569
LG+G F ++ + + A K + + L + +RE E+S H+++V
Sbjct: 23 LGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 621
GF ++ +V E +L L R ++ AR G YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHKR--------RKALTEPEARYYLRQIVLGCQYLHR 133
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+IH D+K N+ L+ KI DFGL+ + D R + GT Y+APE
Sbjct: 134 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIAPEVLSK 189
Query: 682 APVSAKVDVYSFGVMLLEIIC 702
S +VDV+S G ++ ++
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLV 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 58/194 (29%), Positives = 105/194 (54%), Gaps = 11/194 (5%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQLL 569
E++G+GSFG V+KG+ + K +A+K +D A++ + + E++ + + + +
Sbjct: 28 EKIGKGSFGEVFKGIDN-RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 570 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G D L ++ E++G G+ +L+ P + + I EI +GL YLH E
Sbjct: 87 GSYLKDTKL--WIIMEYLGGGSALDLLEPGPLDETQIAT-ILREILKGLDYLHSE---KK 140
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH DIK N+LL + K++DFG++ L Q + +T + GT ++APE K + +K
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 199
Query: 688 VDVYSFGVMLLEII 701
D++S G+ +E+
Sbjct: 200 ADIWSLGITAIELA 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 53/303 (17%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
K ELG G+FG V+ + + +AVK L + A E R +F+ E + H+
Sbjct: 45 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL-KEASESARQDFQREAELLTMLQHQ 103
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR--------------VRI 608
++V+ G C E L+V+E+M +G L L P + +
Sbjct: 104 HIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ---SRTHT 665
+ ++A G+VYL + +H D+ +N L+ KI DFG+S+ + S T
Sbjct: 164 ASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 666 M--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTD 721
M IR PE + + DV+SFGV+L EI + ++ E I
Sbjct: 221 MLPIRWM----PPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781
L E A + +M W + +P +R ++K V L+ L
Sbjct: 277 --------REL-------ERPRACPPEVYA-IMRGCW--QREPQQRHSIKDVHARLQALA 318
Query: 782 EVP 784
+ P
Sbjct: 319 QAP 321
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 58/194 (29%), Positives = 103/194 (53%), Gaps = 12/194 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E+LG GS+G VYK + K +G+ +A+K++ + +E E+S + + ++V+ G
Sbjct: 35 EKLGEGSYGSVYKAIHKE-TGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPHVVKYYG 91
Query: 571 --FCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
F + L +V E+ G G+++++I K + I +GL YLH
Sbjct: 92 SYFKNTDL--WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RK 146
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH DIK NILL+ AK++DFG++ L ++ +T+I GT ++APE + +
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCV 205
Query: 688 VDVYSFGVMLLEII 701
D++S G+ +E+
Sbjct: 206 ADIWSLGITAIEMA 219
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 55/296 (18%), Positives = 104/296 (35%), Gaps = 64/296 (21%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR-LAQEREREFK-SEVSAIGR-THHKNLVQ 567
E++G G FG V+K +K G A+K+ + LA + + EV A H ++V+
Sbjct: 17 EKIGSGEFGSVFK-CVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 568 LLG-FCDEALNRLLVY-EFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHE 621
+ ++ + +L+ E+ G+LA+ I + + + L++ RGL Y+H
Sbjct: 76 YFSAWAED--DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 622 ECNVPIIHCDIKPQNILLDN-------------------YFSAKISDFGLSKLLLSDQSR 662
++H DIKP NI + KI D G + S
Sbjct: 134 M---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----SS 186
Query: 663 THTMIRGTRGYVAPE-WFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD 721
G ++A E +N K D+++ + ++
Sbjct: 187 PQVEE-GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEP---------------- 229
Query: 722 WAYDCYAEGRLDVLVDSDEPAMADR--SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + P + + L I DP +RP+ +++
Sbjct: 230 -LPRNGDQ--WHEIRQGRLPRIPQVLSQEFTELL---KVMIHPDPERRPSAMALVK 279
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 43/287 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +G+G FG V G + G +AVK + A + F +E S + + H NLVQL
Sbjct: 25 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQL 79
Query: 569 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNV 625
LG +E +V E+M G+L + + + + ++ SL++ + YL E N
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL-EGNNF 138
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM----IRGTRGYVAPEWFKN 681
+H D+ +N+L+ AK+SDFGL+K + S T ++ T APE +
Sbjct: 139 --VHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWT----APEALRE 188
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSV--EMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
S K DV+SFG++L EI R + +++ + ++ D
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------YKM------D 234
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786
P + + +M W D + RP+ + + LE +
Sbjct: 235 APDGCPPAVYE--VMKNCW--HLDAAMRPSFLQLREQLEHIKTHELH 277
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 52/210 (24%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 501 ELKEATGGFKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-EFKSEVSA 556
KE + LG G FG V+KGV + +K ++ + + + A
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLA 68
Query: 557 IGRTHHKNLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIAR 614
IG H ++V+LLG C +L LV +++ G+L + + L + ++IA+
Sbjct: 69 IGSLDHAHIVRLLGLCPGSSL--QLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
G+ YL EE ++H ++ +N+LL + +++DFG++ LL D + + +
Sbjct: 127 GMYYL-EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPI 181
Query: 675 ---APEWFKNAPVSAKVDVYSFGVMLLEII 701
A E + + DV+S+GV + E++
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-31
Identities = 66/302 (21%), Positives = 120/302 (39%), Gaps = 41/302 (13%)
Query: 494 LRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKA---IAVKKLDRLAQERER-E 549
LR E K + LG G+FG VYKG+ K +A+K+L + E
Sbjct: 9 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 63
Query: 550 FKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVR 607
E + + ++ +LLG C + L+ + M G L + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGICLTSTV--QLITQLMPFGCLLDYVREHKDNIGSQYLLN 121
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI 667
++IA+G+ YL E+ ++H D+ +N+L+ KI+DFGL+KLL +++ H
Sbjct: 122 WCVQIAKGMNYL-EDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-- 176
Query: 668 RGTRGYV---APEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDW 722
G + + A E + + + DV+S+GV + E++ + E +
Sbjct: 177 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG- 235
Query: 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
RL +P + +M+ W D RP + ++ +
Sbjct: 236 -------ERL------PQPPICTIDVYM--IMVKCW--MIDADSRPKFRELIIEFSKMAR 278
Query: 783 VP 784
P
Sbjct: 279 DP 280
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-31
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 20/201 (9%)
Query: 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQ 567
E LG G FG V+K + +G +A K + + + E K+E+S + + H NL+Q
Sbjct: 92 SKTEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLR----VRISLEIARGLVYLHEE 622
L + + +LV E++ G L F I +NL + +I G+ ++H+
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205
Query: 623 CNVPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
I+H D+KP+NIL N + KI DFGL++ + GT ++APE
Sbjct: 206 MY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAPEVVN 261
Query: 681 NAPVSAKVDVYSFGV---MLL 698
VS D++S GV MLL
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLL 282
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 28/209 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLL 569
E +G G++G VYKG +G+ A+K +D + + E E K E++ + + HH+N+
Sbjct: 30 ELVGNGTYGQVYKGRHVK-TGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 570 G-----FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR------ISLEIARGLV 617
G ++L LV EF G G++ +LI K ++ I EI RGL
Sbjct: 88 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI----KNTKGNTLKEEWIAYICREILRGLS 143
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
+LH+ +IH DIK QN+LL K+ DFG+S L R +T I GT ++APE
Sbjct: 144 HLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE 199
Query: 678 -----WFKNAPVSAKVDVYSFGVMLLEII 701
+A K D++S G+ +E+
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-31
Identities = 50/202 (24%), Positives = 91/202 (45%), Gaps = 26/202 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLV 566
EELG+G+F +V + V +G+ A ++ L+ ++ + E H N+V
Sbjct: 15 LFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--------Y 618
+L E + L+++ + G L I A R S A + +
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGELFEDIVA--------REYYSEADASHCIQQILEAVLH 125
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSA---KISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
H+ ++H ++KP+N+LL + K++DFGL+ + +Q GT GY++
Sbjct: 126 CHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLS 181
Query: 676 PEWFKNAPVSAKVDVYSFGVML 697
PE + P VD+++ GV+L
Sbjct: 182 PEVLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-31
Identities = 59/202 (29%), Positives = 96/202 (47%), Gaps = 27/202 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
KEELG+G+F +V + V K+ +G A K ++ +L+ ++ + E + H N+V
Sbjct: 33 VKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--------Y 618
+L E LV++ + G L I A R S A + Y
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGELFEDIVA--------REFYSEADASHCIQQILESIAY 143
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSA---KISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
H I+H ++KP+N+LL + K++DFGL+ + +D H GT GY++
Sbjct: 144 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFA-GTPGYLS 198
Query: 676 PEWFKNAPVSAKVDVYSFGVML 697
PE K P S VD+++ GV+L
Sbjct: 199 PEVLKKDPYSKPVDIWACGVIL 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 64/310 (20%), Positives = 119/310 (38%), Gaps = 49/310 (15%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 568
+ L G F VY+ SG+ A+K+L +E+ R EV + + + H N+VQ
Sbjct: 33 RRVLAEGGFAFVYE-AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 569 LGFCDEALNR--------LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVY 618
LL+ E + L + + ++I + R + +
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQH 151
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMI----------- 667
+H PIIH D+K +N+LL N + K+ DFG + + + +
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210
Query: 668 RGTRGYVAPE---WFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG-RAILTDWA 723
T Y PE + N P+ K D+++ G +L +C R+ E+ I+
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL-LCFRQH---PFEDGAKLRIV---- 262
Query: 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783
G+ + P + + L+ AM ++ +P +R ++ V+ L+ +
Sbjct: 263 -----NGKYSI------PPHDTQYTVFHSLIRAM--LQVNPEERLSIAEVVHQLQEIAAA 309
Query: 784 PNPPCPSSFS 793
N S +
Sbjct: 310 RNVNPKSPIT 319
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 26/200 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F E LG G+F V+ + +GK A+K + + R+ ++E++ + + H+N+V L
Sbjct: 13 FMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--------VRISLEIARGLVYLH 620
+ + LV + + G L + I R + ++ + YLH
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILE--------RGVYTEKDASLVIQQVLSAVKYLH 123
Query: 621 EECNVPIIHCDIKPQNILLDNYF---SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
E I+H D+KP+N+L I+DFGLSK+ T GT GYVAPE
Sbjct: 124 ENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKME--QNGIMSTAC-GTPGYVAPE 177
Query: 678 WFKNAPVSAKVDVYSFGVML 697
P S VD +S GV+
Sbjct: 178 VLAQKPYSKAVDCWSIGVIT 197
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 511 EELGRGSFGIVYKG---VLKSASGKAIAVKKLD-RLAQERE--REFKSEVSAIGRTHHKN 564
++LG G VY +L +A+K + ++ E + F+ EV + H+N
Sbjct: 17 DKLGGGGMSTVYLAEDTIL----NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
+V ++ +E LV E++ TL+ I + + + + +I G+ + H+
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM-- 130
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT-MIRGTRGYVAPEWFKNAP 683
I+H DIKPQNIL+D+ + KI DFG++K LS+ S T T + GT Y +PE K
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 684 VSAKVDVYSFGVMLLEII 701
D+YS G++L E++
Sbjct: 189 TDECTDIYSIGIVLYEML 206
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 67/273 (24%), Positives = 117/273 (42%), Gaps = 28/273 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
++LG G++G V K + A+K + ++ + EV+ + H N++
Sbjct: 41 RVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+L F ++ N LV E G L + I K + I ++ G+ YLH+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN--- 156
Query: 627 IIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
I+H D+KP+N+LL++ KI DFGLS + + + GT Y+APE +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERLGTAYYIAPEVLRK-K 213
Query: 684 VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG-RAILTDWAYDCYAEGRLDVLVDSDEPA 742
K DV+S GV+L ++ + ++E R + +G+ D P
Sbjct: 214 YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE---------KGKY----TFDSPE 260
Query: 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ S K L+ M D +R + + L+
Sbjct: 261 WKNVSEGAKDLIKQMLQF--DSQRRISAQQALE 291
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 38/213 (17%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---------LAQEREREFKSEVSAIGR 559
KE LGRG +V + + K + K AVK +D QE EV + +
Sbjct: 21 PKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 79
Query: 560 -THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV- 617
+ H N++QL + LV++ M G L + + +V +S + R ++
Sbjct: 80 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--------KVTLSEKETRKIMR 131
Query: 618 -------YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670
LH+ I+H D+KP+NILLD+ + K++DFG S L + + GT
Sbjct: 132 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKLREVC-GT 186
Query: 671 RGYVAPEWFKNAPVSA------KVDVYSFGVML 697
Y+APE + + +VD++S GV++
Sbjct: 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 66/283 (23%), Positives = 119/283 (42%), Gaps = 45/283 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTH-HKNLVQL 568
E+G G+ G V+K + +G IAVK++ R + E + ++ + ++H +VQ
Sbjct: 31 GEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 569 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNV 625
G + + + E MG L + P + ++++ I + L YL E+
Sbjct: 90 FGTFITNTDVF--IAMELMGTCAEK-LKKRMQGPIPERILGKMTVAIVKALYYLKEKHG- 145
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-----WFK 680
+IH D+KP NILLD K+ DFG+S L+ D+++ + G Y+APE
Sbjct: 146 -VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPT 202
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL---VD 737
+ DV+S G+ L+E+ G+ + + +VL +
Sbjct: 203 KPDYDIRADVWSLGISLVELA------------TGQFPYKNC------KTDFEVLTKVLQ 244
Query: 738 SDEPAMADRSRLQKWL--MIAMWCIREDPSKRPTMKVVLQMLE 778
+ P + + C+ +D KRP ++LE
Sbjct: 245 EEPPLLPGHMGFSGDFQSFVKD-CLTKDHRKRPKYN---KLLE 283
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 2e-30
Identities = 58/201 (28%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASG-----KAIAVKKLDRLAQERERE-FKSEVSAIGRTHH 562
EELG G F IV K KS +G K I ++ + RE + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISL--EIARGLVYLH 620
N++ L + + +L+ E + G L + + K + S +I G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFL--AQKESLSEEEATSFIKQILDGVNYLH 132
Query: 621 EECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
+ I H D+KP+NI+L K+ DFGL+ + + I GT +VAP
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAP 187
Query: 677 EWFKNAPVSAKVDVYSFGVML 697
E P+ + D++S GV+
Sbjct: 188 EIVNYEPLGLEADMWSIGVIT 208
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 510 KEELGRGSFGIVYKGVLKSASGK-AIAVKKLDRLAQERER-EFKSEVSAIGRTHHKNLVQ 567
ELG G+FG V +GV + + +A+K L + ++ + E E + + + +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 568 LLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
L+G C +LV E G G L L+ + + + +++ G+ YL EE N
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL-EEKN-- 456
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV---APEWFKNAP 683
+H ++ +N+LL N AKISDFGLSK L +D S +T + + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK 515
Query: 684 VSAKVDVYSFGVMLLEII 701
S++ DV+S+GV + E +
Sbjct: 516 FSSRSDVWSYGVTMWEAL 533
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 17/196 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
EELG G+FG+V++ + A+G A K + + + + E+ + H LV L
Sbjct: 161 IHEELGTGAFGVVHRVTER-ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 219
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIAR----GLVYLHEEC 623
++ +++YEFM G L F + + ++E R GL ++H E
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-EN 274
Query: 624 NVPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
N +H D+KP+NI+ S K+ DFGL+ L D ++ + GT + APE +
Sbjct: 275 N--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEG 330
Query: 682 APVSAKVDVYSFGVML 697
PV D++S GV+
Sbjct: 331 KPVGYYTDMWSVGVLS 346
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 74/304 (24%), Positives = 117/304 (38%), Gaps = 65/304 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
F EELG FG VYKG L + A+A+K L A+ R EF+ E R H
Sbjct: 13 FMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHP 72
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----VR 607
N+V LLG + +++ + +G L L V
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTH 664
+ +IA G+ YL + ++H D+ +N+L+ + + KISD GL + + + + +
Sbjct: 133 LVAQIAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGN 189
Query: 665 TM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC------CRRSVE--MEVEEE 714
++ IR APE S D++S+GV+L E+ C S + +E+
Sbjct: 190 SLLPIRWM----APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245
Query: 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
L + + LMI W E PS+RP K +
Sbjct: 246 R--------------QVL-------PCPDDCPAWVYA-LMIECW--NEFPSRRPRFKDIH 281
Query: 775 QMLE 778
L
Sbjct: 282 SRLR 285
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 77/318 (24%), Positives = 130/318 (40%), Gaps = 62/318 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA------IAVKKLDRLAQERER-EFKSEVS---AIG 558
+ LG G+FG V +AVK L A E++ + SE+ IG
Sbjct: 73 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 559 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 605
+ HKN++ LLG C + ++ E+ G L P+ L
Sbjct: 133 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190
Query: 606 ---VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD--- 659
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ +
Sbjct: 191 KDLVSCAYQVARGMEYL-ASKK--CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 660 QSRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEG 715
+ T+ ++ APE + + + DV+SFGV+L EI S + VEE
Sbjct: 248 KKTTNGRLPVKWM----APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301
Query: 716 RAILTDWAYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
+ EG R+ D+P+ + L +M W PS+RPT K ++
Sbjct: 302 -------LFKLLKEGHRM------DKPSNCT-NELYM-MMRDCW--HAVPSQRPTFKQLV 344
Query: 775 QMLEGLLEVPNPPCPSSF 792
+ L+ ++ + + +
Sbjct: 345 EDLDRIVALTSNQEMGYY 362
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 67/283 (23%), Positives = 114/283 (40%), Gaps = 39/283 (13%)
Query: 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNL 565
+ LG GSF I K V K S +A AVK + + + ++ E++A+ H N+
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKK-SNQAFAVKIISKRMEANTQK---EITALKLCEGHPNI 68
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEEC 623
V+L + L+ LV E + G L I K ++ I ++ + ++H+
Sbjct: 69 VKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVG 126
Query: 624 NVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
++H D+KP+N+L ++ KI DFG ++L D T T Y APE
Sbjct: 127 ---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLN 182
Query: 681 NAPVSAKVDVYSFGVMLLEIIC--------CRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732
D++S GV+L ++ R E + I +G
Sbjct: 183 QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---------KGDF 233
Query: 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ A + S+ K L+ + + DP+KR M +
Sbjct: 234 SF----EGEAWKNVSQEAKDLIQGLLTV--DPNKRLKMSGLRY 270
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-30
Identities = 81/345 (23%), Positives = 143/345 (41%), Gaps = 67/345 (19%)
Query: 473 LKWRRRKYENNVQDSSTSETNLRF-----FSYNELKEATGGFKEELGRGSFGIVYKG--- 524
++W+ + + T L + F N L+ F + LG G+FG V +
Sbjct: 14 VRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQ-----FGKTLGAGAFGKVVEATAF 68
Query: 525 -VLKSASGKAIAVKKLDRLAQERER-EFKSEV---SAIGRTHHKNLVQLLGFCDEALNRL 579
+ K + +AVK L A E+ SE+ S +G H+N+V LLG C L
Sbjct: 69 GLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG--QHENIVNLLGACTHGGPVL 126
Query: 580 LVYEFMGNGTLAN----------LIFAIPKPDWNLR----VRISLEIARGLVYLHEECNV 625
++ E+ G L N A + + S ++A+G+ +L N
Sbjct: 127 VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL-ASKN- 184
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTM--IRGTRGYVAPEWFK 680
IH D+ +N+LL N AKI DFGL++ +++D + + ++ APE
Sbjct: 185 -CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWM----APESIF 239
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEG-RLDVLVD 737
+ + + DV+S+G++L EI + + V + Y +G ++
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--------FYKLVKDGYQM----- 286
Query: 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+PA A + +M A W +P+ RPT + + L+ +
Sbjct: 287 -AQPAFAP-KNIYS-IMQACW--ALEPTHRPTFQQICSFLQEQAQ 326
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-30
Identities = 68/323 (21%), Positives = 117/323 (36%), Gaps = 79/323 (24%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
+ ++G G+FG V++ +AVK L A + +F+ E + + +
Sbjct: 51 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 110
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLAN-LIFAIPKPDWNLR----------------- 605
N+V+LLG C L++E+M G L L P +L
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 606 ------VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
+ I+ ++A G+ YL E +H D+ +N L+ KI+DFGLS+ + S
Sbjct: 171 LSCAEQLCIARQVAAGMAYL-SERK--FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 660 ---QSRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVE 712
++ + IR PE + + DV+++GV+L EI M E
Sbjct: 228 DYYKADGNDAIPIRWM----PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283
Query: 713 EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQK---------WLMIAMWCIRED 763
E +G L LM W +
Sbjct: 284 E---------VIYYVRDGN----------------ILACPENCPLELYNLMRLCW--SKL 316
Query: 764 PSKRPTMKVVLQMLEGLLEVPNP 786
P+ RP+ + ++L+ + E
Sbjct: 317 PADRPSFCSIHRILQRMCERAEG 339
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 20/201 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQERERE-FKSEVSAIGRTHH 562
EELG G F IV K K +GK A K +L + RE + EV+ + H
Sbjct: 9 MGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLH 620
N++ L + + +L+ E + G L + + K + +I G+ YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL--AEKESLTEDEATQFLKQILDGVHYLH 125
Query: 621 EECNVPIIHCDIKPQNILLDNYFSA----KISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
+ I H D+KP+NI+L + K+ DFG++ + + I GT +VAP
Sbjct: 126 SKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIFGTPEFVAP 180
Query: 677 EWFKNAPVSAKVDVYSFGVML 697
E P+ + D++S GV+
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 58/252 (23%), Positives = 105/252 (41%), Gaps = 39/252 (15%)
Query: 482 NNVQDSSTSETNLRFFSYNELKEAT--GGFK--EELGRGSFGIVYKGVLKSASGKAIAVK 537
+++D ++ +NL + + ++ ++ L +G F + L K A+K
Sbjct: 4 GSMKDILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALK 60
Query: 538 KLDRLAQEREREF-----------------KSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580
K ++ E++R+F K+E+ I ++ + G +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYI 120
Query: 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEECNVPIIHCDI 632
+YE+M N ++ D N I +++ + Y+H E N I H D+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDV 178
Query: 633 KPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV--SAKVDV 690
KP NIL+D K+SDFG S+ + RGT ++ PE+F N AKVD+
Sbjct: 179 KPSNILMDKNGRVKLSDFGESE--YMVDKKIKGS-RGTYEFMPPEFFSNESSYNGAKVDI 235
Query: 691 YSFGVMLLEIIC 702
+S G+ L +
Sbjct: 236 WSLGICLYVMFY 247
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 79/363 (21%), Positives = 140/363 (38%), Gaps = 78/363 (21%)
Query: 474 KWRR-RKYEN---NVQDSSTSETNLRFFSYNELKEATG--------GFKEELGRGSFGIV 521
K+++ +YE+ VQ + +S+ + + E + F + LG G+FG V
Sbjct: 2 KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61
Query: 522 YKGVLKSASGKA----IAVKKLDRLAQERER-EFKSEV---SAIGRTHHKNLVQLLGFCD 573
S +AVK L A ER SE+ + +G H+N+V LLG C
Sbjct: 62 MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS--HENIVNLLGACT 119
Query: 574 EALNRLLVYEFMGNGTL-------------------ANLIFAIPKPDWNLR----VRISL 610
+ L++E+ G L + L + +
Sbjct: 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAY 179
Query: 611 EIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---QSRTHTM- 666
++A+G+ +L E + +H D+ +N+L+ + KI DFGL++ ++SD R +
Sbjct: 180 QVAKGMEFL-EFKS--CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 667 -IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWA 723
++ APE + K DV+S+G++L EI + + V+
Sbjct: 237 PVKWM----APESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN--------F 284
Query: 724 YDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
Y G ++ D+P A + +M + W D KRP+ + L L
Sbjct: 285 YKLIQNGFKM------DQPFYATEE-IYI-IMQSCW--AFDSRKRPSFPNLTSFLGCQLA 334
Query: 783 VPN 785
Sbjct: 335 DAE 337
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRT-HHKNLVQL 568
ELGRG++G+V K SG+ +AVK++ +E++ ++ RT V
Sbjct: 13 MELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 569 LG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV----RISLEIARGLVYLHEE 622
G F + + + E M +L + + +I++ I + L +LH +
Sbjct: 72 YGALFREGDV--WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK 128
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE----W 678
+ +IH D+KP N+L++ K+ DFG+S L+ D ++ G + Y+APE
Sbjct: 129 LS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD-IDA-GCKPYMAPERINPE 184
Query: 679 FKNAPVSAKVDVYSFGVMLLEI 700
S K D++S G+ ++E+
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 79/308 (25%), Positives = 124/308 (40%), Gaps = 61/308 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERER-EFKSEV---SAIGRT 560
F + LG G+FG V + +AVK L A ER SE+ S +G
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN- 85
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGTL--------------ANLIFAIPKPDWNLR- 605
H N+V LLG C L++ E+ G L + + L
Sbjct: 86 -HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 606 ---VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD--- 659
+ S ++A+G+ +L N IH D+ +NILL + KI DFGL++ + +D
Sbjct: 145 EDLLSFSYQVAKGMAFL-ASKN--CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 660 QSRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEG 715
+ + ++ APE N + + DV+S+G+ L E+ S M V+ +
Sbjct: 202 VVKGNARLPVKWM----APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256
Query: 716 RAILTDWAYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
Y EG R+ P A + +M W DP KRPT K ++
Sbjct: 257 -------FYKMIKEGFRM------LSPEHAPA-EMYD-IMKTCW--DADPLKRPTFKQIV 299
Query: 775 QMLEGLLE 782
Q++E +
Sbjct: 300 QLIEKQIS 307
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 24/203 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASG-----KAIAVKKLDRLAQERERE-FKSEVSAIGRTHH 562
EELG G F IV K KS +G K I ++ + RE + EVS + + H
Sbjct: 16 IGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVY 618
N++ L + + +L+ E + G L + + +L +I G+ Y
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNY 130
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSA----KISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
LH + I H D+KP+NI+L + K+ DFGL+ + + I GT +V
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFV 185
Query: 675 APEWFKNAPVSAKVDVYSFGVML 697
APE P+ + D++S GV+
Sbjct: 186 APEIVNYEPLGLEADMWSIGVIT 208
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 77/313 (24%), Positives = 129/313 (41%), Gaps = 62/313 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA------IAVKKLDRLAQERER-EFKSEVS---AIG 558
+ LG G+FG V +AVK L A E++ + SE+ IG
Sbjct: 39 LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98
Query: 559 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 605
+ HKN++ LLG C + ++ E+ G L P+ +
Sbjct: 99 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 606 ---VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD--- 659
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ + +
Sbjct: 157 KDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 213
Query: 660 QSRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEG 715
+ T+ ++ APE + + + DV+SFGV++ EI S + VEE
Sbjct: 214 KKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267
Query: 716 RAILTDWAYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
+ EG R+ D+PA + L +M W PS+RPT K ++
Sbjct: 268 -------LFKLLKEGHRM------DKPANCT-NELYM-MMRDCW--HAVPSQRPTFKQLV 310
Query: 775 QMLEGLLEVPNPP 787
+ L+ +L +
Sbjct: 311 EDLDRILTLTTNE 323
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 76/308 (24%), Positives = 126/308 (40%), Gaps = 62/308 (20%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK------AIAVKKLDRLAQERER-EFKSEV---SAIG 558
+ LG G FG V +AVK L A E++ + SE+ IG
Sbjct: 85 LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144
Query: 559 RTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR- 605
+ HKN++ LLG C + ++ E+ G L P+ +
Sbjct: 145 K--HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 606 ---VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD--- 659
V + ++ARG+ YL IH D+ +N+L+ KI+DFGL++ + +
Sbjct: 203 KDLVSCTYQLARGMEYL-ASQK--CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259
Query: 660 QSRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEG 715
+ T+ ++ APE + + + DV+SFGV++ EI S + VEE
Sbjct: 260 KKTTNGRLPVKWM----APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 313
Query: 716 RAILTDWAYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774
+ EG R+ D+PA + M+ C PS+RPT K ++
Sbjct: 314 -------LFKLLKEGHRM------DKPANCT----NELYMMMRDCWHAVPSQRPTFKQLV 356
Query: 775 QMLEGLLE 782
+ L+ +L
Sbjct: 357 EDLDRILT 364
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 15/197 (7%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQ 567
FK +LG G+FG V+ +S SG +K ++ +Q + ++E+ + H N+++
Sbjct: 26 FKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR----VRISLEIARGLVYLHEEC 623
+ ++ N +V E G L I + L + ++ L Y H +
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ- 143
Query: 624 NVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
++H D+KP+NIL + + KI DFGL++L SD+ T GT Y+APE FK
Sbjct: 144 --HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALYMAPEVFK 199
Query: 681 NAPVSAKVDVYSFGVML 697
V+ K D++S GV++
Sbjct: 200 R-DVTFKCDIWSAGVVM 215
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 68/274 (24%), Positives = 114/274 (41%), Gaps = 29/274 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 565
+ LG+GSFG V K +G+ AVK + + + + EV + + H N+
Sbjct: 30 GQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
++L F ++ LV E G L + I + + RI ++ G+ Y+H+
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-- 146
Query: 626 PIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I+H D+KP+N+LL++ + +I DFGLS + S+ GT Y+APE
Sbjct: 147 -IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG- 202
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG-RAILTDWAYDCYAEGRLDVLVDSDEP 741
K DV+S GV+L ++ E + + + G+ + P
Sbjct: 203 TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK---------GKY----TFELP 249
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
S K L+ M PS R + + L
Sbjct: 250 QWKKVSESAKDLIRKMLTY--VPSMRISARDALD 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 37/260 (14%), Positives = 82/260 (31%), Gaps = 56/260 (21%)
Query: 490 SETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVK---KLDRLAQER 546
+ R S + T LG+ + +G++ V +R
Sbjct: 58 TGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNA 116
Query: 547 EREFKSEVSAIGR-------------------------THHKNLVQLLGFCD--EALNRL 579
++ K EV + K ++++ L+R
Sbjct: 117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRF 176
Query: 580 LVYEFMGN------GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIK 633
+Y M + L + + R++++L++ R L LH ++H ++
Sbjct: 177 FLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLR 233
Query: 634 PQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK-----------NA 682
P +I+LD ++ F + + +RG+ PE
Sbjct: 234 PVDIVLDQRGGVFLTGFEHLV-----RDGARVVSSVSRGFEPPELEARRATISYHRDRRT 288
Query: 683 PVSAKVDVYSFGVMLLEIIC 702
++ D ++ G+++ I C
Sbjct: 289 LMTFSFDAWALGLVIYWIWC 308
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 43/208 (20%), Positives = 81/208 (38%), Gaps = 36/208 (17%)
Query: 583 EFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639
+ L + + ++ + + + I ++IA + +LH + ++H D+KP NI
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFF 197
Query: 640 DNYFSAKISDFGLSKLLLSDQSR-----------THTMIRGTRGYVAPEWFKNAPVSAKV 688
K+ DFGL + D+ THT GT+ Y++PE S KV
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 689 DVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR 748
D++S G++L E + S +ME + + +L P
Sbjct: 258 DIFSLGLILFE-LLYSFSTQMERVRIITDVR---------NLKFPLLFTQKYPQEHM--- 304
Query: 749 LQKWLMIAMWCIREDPSKRPTMKVVLQM 776
M+ + P++RP +++
Sbjct: 305 -----MVQ-DMLSPSPTERPEATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 16/58 (27%), Positives = 29/58 (50%), Gaps = 2/58 (3%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 567
+ +GRG FG+V++ A+K++ +E RE EV A+ + H +V+
Sbjct: 12 QCMGRGGFGVVFE-AKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVR 68
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 3e-29
Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 12/194 (6%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
LG+GSFG V K + + + AVK ++ + EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+L +++ + +V E G L + I + + RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 627 IIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
I+H D+KP+NILL + KI DFGLS + + I GT Y+APE +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRI-GTAYYIAPEVLRG-T 198
Query: 684 VSAKVDVYSFGVML 697
K DV+S GV+L
Sbjct: 199 YDEKCDVWSAGVIL 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 78/307 (25%), Positives = 121/307 (39%), Gaps = 60/307 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERER-EFKSEVS---AIGRT 560
+ LGRG+FG V + A +AVK L A E SE+ IG
Sbjct: 31 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH- 89
Query: 561 HHKNLVQLLGFC-DEALNRLLVYEFMGNGTL--------------ANLIFAIPKPDWNLR 605
H N+V LLG C +++ EF G L + K L
Sbjct: 90 -HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 606 --VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD---Q 660
+ S ++A+G+ +L IH D+ +NILL KI DFGL++ + D
Sbjct: 149 HLICYSFQVAKGMEFL-ASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 205
Query: 661 SRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGR 716
+ ++ APE + + + DV+SFGV+L EI S ++++EE
Sbjct: 206 RKGDARLPLKWM----APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-- 259
Query: 717 AILTDWAYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
EG R+ P + + M+ W +PS+RPT +++
Sbjct: 260 ------FCRRLKEGTRM------RAPDYTTP-EMYQ-TMLDCW--HGEPSQRPTFSELVE 303
Query: 776 MLEGLLE 782
L LL+
Sbjct: 304 HLGNLLQ 310
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-29
Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 36/277 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
LG+GSFG V K + + + AVK ++ + EV + + H N++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP 626
+L +++ + +V E G L + I + + RI ++ G+ Y+H+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN--- 141
Query: 627 IIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
I+H D+KP+NILL++ KI DFGLS + + I GT Y+APE +
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRI-GTAYYIAPEVLRG-T 198
Query: 684 VSAKVDVYSFGVMLLEIIC-----CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
K DV+S GV+L ++ ++ E ++ + + T G+
Sbjct: 199 YDEKCDVWSAGVILYILLSGTPPFYGKN-EYDILK---RVET---------GKY----AF 241
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
D P S K L+ M PS R T L+
Sbjct: 242 DLPQWRTISDDAKDLIRKMLTF--HPSLRITATQCLE 276
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 71/311 (22%), Positives = 127/311 (40%), Gaps = 63/311 (20%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKA----IAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
+ LG G FG V K G+A +AVK L A E + SE + + + +H
Sbjct: 27 LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHP 86
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTL--------------------ANLIFAIPKPDWN 603
++++L G C + LL+ E+ G+L N +
Sbjct: 87 HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 604 LR----VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
L + + +I++G+ YL E ++H D+ +NIL+ KISDFGLS+ + +
Sbjct: 147 LTMGDLISFAWQISQGMQYL-AEMK--LVHRDLAARNILVAEGRKMKISDFGLSRDVYEE 203
Query: 660 ---QSRTHTM--IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVE 712
R+ ++ A E + + + DV+SFGV+L EI+ + + E
Sbjct: 204 DSYVKRSQGRIPVKWM----AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259
Query: 713 EEGRAILTDWAYDCYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771
++ G R+ + P + + LM+ W +++P KRP
Sbjct: 260 R---------LFNLLKTGHRM------ERPDNCSE-EMYR-LMLQCW--KQEPDKRPVFA 300
Query: 772 VVLQMLEGLLE 782
+ + LE ++
Sbjct: 301 DISKDLEKMMV 311
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 60/202 (29%), Positives = 88/202 (43%), Gaps = 22/202 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK-------KLDRLAQEREREFKSEVSAIGRTH 561
EELG G F +V K KS +G A K K R RE + + EVS +
Sbjct: 15 TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSRE-DIEREVSILKEIQ 72
Query: 562 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYL 619
H N++ L + + +L+ E + G L + + K +I G+ YL
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFL--AEKESLTEEEATEFLKQILNGVYYL 130
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSA----KISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
H I H D+KP+NI+L + KI DFGL+ + D I GT +VA
Sbjct: 131 HSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVA 185
Query: 676 PEWFKNAPVSAKVDVYSFGVML 697
PE P+ + D++S GV+
Sbjct: 186 PEIVNYEPLGLEADMWSIGVIT 207
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 39/213 (18%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--------LAQEREREFKSEVSAIGR- 559
K+ +GRG +V + V ++ +G AVK ++ +E + E I R
Sbjct: 98 PKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRET-HILRQ 155
Query: 560 -THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV- 617
H +++ L+ + + LV++ M G L + + +V +S + R ++
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--------KVALSEKETRSIMR 207
Query: 618 -------YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGT 670
+LH I+H D+KP+NILLD+ ++SDFG S L + + GT
Sbjct: 208 SLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSC-HLEPGEKLRELC-GT 262
Query: 671 RGYVAPEWFKNAPVSA------KVDVYSFGVML 697
GY+APE K + +VD+++ GV+L
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 71/305 (23%), Positives = 119/305 (39%), Gaps = 78/305 (25%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQLL 569
E +G G+ +V + +A+K+++ Q E E+ A+ + HH N+V
Sbjct: 21 EVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 570 G--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR--------ISLEIARGLVYL 619
+ L LV + + G++ ++I I + I E+ GL YL
Sbjct: 80 TSFVVKDEL--WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL-----LSDQSRTHTMIRGTRGYV 674
H+ IH D+K NILL S +I+DFG+S L ++ T + GT ++
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWM 193
Query: 675 APEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733
APE + K D++SFG+ +E+ G A
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELA------------TGAAPY-------------- 227
Query: 734 VLVDSDEPAM------------------ADRSRLQKW-----LMIAMWCIREDPSKRPTM 770
P M D+ L+K+ MI++ C+++DP KRPT
Sbjct: 228 ----HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISL-CLQKDPEKRPTA 282
Query: 771 KVVLQ 775
+L+
Sbjct: 283 AELLR 287
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 37/211 (17%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--------LAQEREREFKSEVSAIGRT 560
+ LG G+ G V + + K +A++ + + + ++E+ + +
Sbjct: 139 MSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL 197
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS--------LEI 612
+H ++++ F D + +V E M G L + + R+ ++
Sbjct: 198 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQM 248
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRG 669
+ YLHE IIH D+KP+N+LL + KI+DFG SK +L + S T+ G
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-G 303
Query: 670 TRGYVAPE---WFKNAPVSAKVDVYSFGVML 697
T Y+APE A + VD +S GV+L
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 76/302 (25%), Positives = 125/302 (41%), Gaps = 50/302 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK-AIAVKKLDRLAQERER-EFKSEVSAIGR-THHKNL 565
F++ +G G+FG V K +K + A+K++ A + + +F E+ + + HH N+
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTL------------ANLIFAIPKPDWNLR----VRIS 609
+ LLG C+ L E+ +G L L + +
Sbjct: 89 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 148
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM--I 667
++ARG+ YL + IH D+ +NIL+ + AKI+DFGLS+ +T +
Sbjct: 149 ADVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 205
Query: 668 RGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYD 725
R A E + + DV+S+GV+L EI+ + M E Y+
Sbjct: 206 RWM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---------LYE 252
Query: 726 CYAEG-RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
+G RL ++P D LM W RE P +RP+ +L L +LE
Sbjct: 253 KLPQGYRL------EKPLNCDDEVYD--LMRQCW--REKPYERPSFAQILVSLNRMLEER 302
Query: 785 NP 786
Sbjct: 303 KT 304
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 27/200 (13%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ ELGRG+ IVY+ K + K A+K L + ++ ++E+ + R H N+++L
Sbjct: 57 VESELGRGATSIVYRCKQKG-TQKPYALKVLKK--TVDKKIVRTEIGVLLRLSHPNIIKL 113
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS--------LEIARGLVYLH 620
+ LV E + G L + I + S +I + YLH
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVE--------KGYYSERDAADAVKQILEAVAYLH 165
Query: 621 EECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
E I+H D+KP+N+L KI+DFGLSK++ Q T+ GT GY APE
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVC-GTPGYCAPE 220
Query: 678 WFKNAPVSAKVDVYSFGVML 697
+ +VD++S G++
Sbjct: 221 ILRGCAYGPEVDMWSVGIIT 240
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 50/310 (16%), Positives = 98/310 (31%), Gaps = 52/310 (16%)
Query: 511 EELGRG--SFGIVYKGVLKSASGKAIAVKK--LDRLAQEREREFKSEVSAIGRTHHKNLV 566
+G+G V K +G+ + V++ L+ + E + E+ +H N+V
Sbjct: 31 TVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89
Query: 567 QLLG--FCDEALNRLLVYEFMGNGTLANLI-FAIPKP-DWNLRVRISLEIARGLVYLHEE 622
D L +V FM G+ +LI + I + + L Y+H
Sbjct: 90 PYRATFIADNELW--VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM 147
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV------AP 676
+H +K +IL+ +S + ++S R + + V +P
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 677 EWFK--NAPVSAKVDVYSFGVMLLEII------------------------CCRRSVEME 710
E + AK D+YS G+ E+ C + +
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 711 VEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKW-----LMIAMWCIREDPS 765
EE + A ++ + + + C++ +P
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ-CLQRNPD 323
Query: 766 KRPTMKVVLQ 775
RP+ +L
Sbjct: 324 ARPSASTLLN 333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 73/287 (25%), Positives = 117/287 (40%), Gaps = 45/287 (15%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR-------------LAQEREREFKSEVS 555
+LG G++G V K+ A+K + + ++ E +E+S
Sbjct: 40 KVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEIS 98
Query: 556 AIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 615
+ H N+++L ++ LV EF G L I K D I +I G
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSG 158
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
+ YLH+ I+H DIKP+NILL+N + KI DFGLS D + + GT
Sbjct: 159 ICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRL-GTAY 213
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEIIC----CRRSVEMEVEEEGRAILTDWAYDCYA 728
Y+APE K + K DV+S GV++ ++C + ++ + +
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK---KVE--------- 260
Query: 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+G+ D + S K L+ M D +KR T + L
Sbjct: 261 KGKY----YFDFNDWKNISDEAKELIKLMLTY--DYNKRCTAEEALN 301
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS---EVSAIGRTHHKNLVQ 567
E+G GSFG VY + + +A+KK+ ++ +++ EV + + H N +Q
Sbjct: 60 REIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 568 LLG--FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR----ISLEIARGLVYLHE 621
G + LV E+ G+ ++L+ KP L+ ++ +GL YLH
Sbjct: 119 YRGCYLREHTA--WLVMEYCL-GSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS 172
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE---W 678
+IH D+K NILL K+ DFG + ++ + ++ + GT ++APE
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAPEVILA 224
Query: 679 FKNAPVSAKVDVYSFGVMLLEII 701
KVDV+S G+ +E+
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELA 247
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 51/203 (25%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 511 EELGRGSFGIVYKG---VLKSASGKAIAVKKLD-RLAQERE--REFKSEVSAIGRTHHKN 564
E LG G V+ + +AVK L LA++ F+ E +H
Sbjct: 18 EILGFGGMSEVHLARDLRD----HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 565 LVQLL--GFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 620
+V + G + L +V E++ TL +++ + + + + L + H
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH 133
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR-THT-MIRGTRGYVAPEW 678
+ IIH D+KP NI++ + K+ DFG+++ + + T T + GT Y++PE
Sbjct: 134 QN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 679 FKNAPVSAKVDVYSFGVMLLEII 701
+ V A+ DVYS G +L E++
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVL 213
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 54/246 (21%), Positives = 88/246 (35%), Gaps = 56/246 (22%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHK 563
K +G+GS+G+V + + A+K K+ ++ + K+EV + + HH
Sbjct: 30 LKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE------------ 611
N+ +L ++ LV E G L + + ++
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 612 ----------------------------IARGLVYLHEECNVPIIHCDIKPQNILL--DN 641
I L YLH + I H DIKP+N L +
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK 205
Query: 642 YFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPEWFKNA--PVSAKVDVYSFGVM 696
F K+ DFGLSK + + + GT +VAPE K D +S GV+
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265
Query: 697 LLEIIC 702
L ++
Sbjct: 266 LHLLLM 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 9e-28
Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 37/211 (17%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--------LAQEREREFKSEVSAIGRT 560
+ LG G+ G V + + K +A+K + + + ++E+ + +
Sbjct: 14 MSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL 72
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV--- 617
+H ++++ F D + +V E M G L + + R+ +
Sbjct: 73 NHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVG--------NKRLKEATCKLYFYQM 123
Query: 618 -----YLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGLSKLLLSDQSRTHTMIRG 669
YLHE IIH D+KP+N+LL + KI+DFG SK +L + S T+ G
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMRTLC-G 178
Query: 670 TRGYVAPE---WFKNAPVSAKVDVYSFGVML 697
T Y+APE A + VD +S GV+L
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 48/197 (24%), Positives = 81/197 (41%), Gaps = 17/197 (8%)
Query: 511 EELGRGSFGIVYKG---VLKSASGKAIAVKKLD-RLAQE---REREFKSEVSAIGRTHHK 563
+GRG G VY+ V + +A+K + L+ + R R + E GR
Sbjct: 40 RLVGRGGMGDVYEAEDTVR----ERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEP 94
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
++V + F + + + LA ++ V I +I L H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA- 153
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT-MIRGTRGYVAPEWFKNA 682
H D+KP+NIL+ A + DFG++ +D+ T GT Y+APE F +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSES 210
Query: 683 PVSAKVDVYSFGVMLLE 699
+ + D+Y+ +L E
Sbjct: 211 HATYRADIYALTCVLYE 227
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 10/192 (5%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +GRGS+G V V K + A KK+ + E FK E+ + H N+++L
Sbjct: 13 LENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
++ + LV E G L + + RI ++ + Y H+ +
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVA 128
Query: 629 HCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
H D+KP+N L K+ DFGL+ + GT YV+P+ +
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVLEG-LYG 185
Query: 686 AKVDVYSFGVML 697
+ D +S GVM+
Sbjct: 186 PECDEWSAGVMM 197
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-27
Identities = 68/222 (30%), Positives = 108/222 (48%), Gaps = 19/222 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
LGRG FG V+ A+GK A KKL RL + + + E + + H + +V L
Sbjct: 193 LGRGGFGEVF-ACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL---RVRI-SLEIARGLVYLHEECN 624
+ E L LV M G + I+ + + + R + +I GL +LH+
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN- 309
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
II+ D+KP+N+LLD+ + +ISD GL+ L + Q++T GT G++APE
Sbjct: 310 --IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEEY 366
Query: 685 SAKVDVYSFGVMLLEIICCR-----RSVEMEVEEEGRAILTD 721
VD ++ GV L E+I R R ++E +E + +L
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ 408
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-26
Identities = 32/233 (13%), Positives = 69/233 (29%), Gaps = 45/233 (19%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK---KLDRLAQEREREFKSEVSAIGRTHH----- 562
LG+ + +G++ V +R ++ K EV +
Sbjct: 84 TVLGQEDPYAYLEAT-DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQK 142
Query: 563 -----------KNLVQLLGFCD-----------EALNRLLVYEFMGN------GTLANLI 594
+LV+ L+R +Y M + L +
Sbjct: 143 QAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 595 FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
+ R++++L++ R L LH ++H ++P +I+LD ++ F
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAP-----VSAKVDVYSFGVMLLEIIC 702
+ A ++ D ++ G+ + I C
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 22/198 (11%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 568
K+ LG G G V + + +G+ A+K L + R+ EV + + ++V +
Sbjct: 34 KQVLGLGVNGKVLECFHRR-TGQKCALKLLYDSPKARQ-----EVDHHWQASGGPHIVCI 87
Query: 569 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEE 622
L + + L++ E M G L + I + R I +I + +LH
Sbjct: 88 LDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH 147
Query: 623 CNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
I H D+KP+N+L + K++DFG +K Q+ T T YVAPE
Sbjct: 148 N---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPC-YTPYYVAPEVL 201
Query: 680 KNAPVSAKVDVYSFGVML 697
D++S GV++
Sbjct: 202 GPEKYDKSCDMWSLGVIM 219
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 568
++ LG G+ V + + + AVK +++ EV + + H+N+++L
Sbjct: 18 EDVLGEGAHARVQTCINLI-TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
+ F +E LV+E M G++ + I + +N + ++A L +LH +
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHI--HKRRHFNELEASVVVQDVASALDFLHNKG--- 131
Query: 627 IIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIR------GTRGYVAPE 677
I H D+KP+NIL + KI DF L + + + G+ Y+APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 678 WFKNAPVSAK-----VDVYSFGVML 697
+ A D++S GV+L
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 26/205 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL----DRLAQEREREFKSEVSAIGRTHHKNLV 566
+ G G +Y + ++ +G+ + +K L D AQ +E + H ++V
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM---AMAERQFLAEVVHPSIV 142
Query: 567 QLLGFCDEALNRL-----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
Q+ F + +V E++G +L K + LEI L YLH
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS 200
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT-MIRGTRGYVAPEWFK 680
+ +++ D+KP+NI+L K+ D G + + GT G+ APE +
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI------NSFGYLYGTPGFQAPEIVR 250
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRR 705
P A D+Y+ G L +
Sbjct: 251 TGPTVAT-DIYTVGRTLAALTLDLP 274
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 7e-25
Identities = 51/199 (25%), Positives = 80/199 (40%), Gaps = 21/199 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 567
+ LG G G V + K + + A+K L + R EV R + ++V+
Sbjct: 66 TSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 119
Query: 568 LLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHE 621
++ + L+V E + G L + I + R I I + YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 622 ECNVPIIHCDIKPQNILLDNYFSA---KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
N I H D+KP+N+L + K++DFG +K S T T YVAPE
Sbjct: 180 -IN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTPC-YTPYYVAPEV 234
Query: 679 FKNAPVSAKVDVYSFGVML 697
D++S GV++
Sbjct: 235 LGPEKYDKSCDMWSLGVIM 253
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 65/220 (29%), Positives = 105/220 (47%), Gaps = 18/220 (8%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
LG+G FG V A+GK A KKL R+ + + +E + + + + +V L
Sbjct: 192 LGKGGFGEVC-ACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 249
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNL-RVRI-SLEIARGLVYLHEECNVP 626
+ E + L LV M G L I+ + + + R + EI GL LH E
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--- 306
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
I++ D+KP+NILLD++ +ISD GL+ + + + GT GY+APE KN +
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAV-HVPEGQTIKGRV-GTVGYMAPEVVKNERYTF 364
Query: 687 KVDVYSFGVMLLEIICCR-----RSVEMEVEEEGRAILTD 721
D ++ G +L E+I + R +++ EE R +
Sbjct: 365 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV 404
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 35/212 (16%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+ +G GSFG+VY+ L SG+ +A+KK+ Q++ + + E+ + + H N+V+L
Sbjct: 60 KVIGNGSFGVVYQAKLC-DSGELVAIKKV---LQDKRFKNR-ELQIMRKLDHCNIVRLRY 114
Query: 571 F--------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLE--------IAR 614
F + LN LV +++ T+ + + + + + + R
Sbjct: 115 FFYSSGEKKDEVYLN--LVLDYVPE-TVYRVA----RHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY 673
L Y+H + I H DIKPQN+LLD + K+ DFG +K L+ + + +R Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYY 222
Query: 674 VAPEWFKNAPV-SAKVDVYSFGVMLLEIICCR 704
APE A ++ +DV+S G +L E++ +
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 60/222 (27%), Positives = 99/222 (44%), Gaps = 22/222 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSE---VSAIGRTHHKNLV 566
+GRG FG VY G K+ +GK A+K L R+ ++ +E +S + +V
Sbjct: 197 IGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 567 QLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRI-SLEIARGLVYLHEECN 624
+ + ++L + + M G L + +R + EI GL ++H
Sbjct: 256 CM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEHMHNRF- 312
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WFKNAP 683
+++ D+KP NILLD + +ISD GL+ + H + GT GY+APE K
Sbjct: 313 --VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASV-GTHGYMAPEVLQKGVA 367
Query: 684 VSAKVDVYSFGVMLLEIIC----CRRSVEMEVEEEGRAILTD 721
+ D +S G ML +++ R+ + E R LT
Sbjct: 368 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 39/240 (16%)
Query: 486 DSSTSETNLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKK--LDR 541
S N + ++ F+ G+G+FG V G KS +G ++A+KK D
Sbjct: 2 PGSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDP 60
Query: 542 LAQERE-REFKSEVSAIGRTHHKNLVQLL---------GFCDEALNRLLVYEFMGNGTLA 591
+ RE + + + HH N+VQL D LN +V E++ + TL
Sbjct: 61 RFRNRELQIMQD----LAVLHHPNIVQLQSYFYTLGERDRRDIYLN--VVMEYVPD-TLH 113
Query: 592 NLIFAIPKPDWNLRVRISLE--------IARGLVYLHEECNVPIIHCDIKPQNILLDNYF 643
+ + +V + R + LH V + H DIKP N+L++
Sbjct: 114 RCC----RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEAD 168
Query: 644 SA-KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
K+ DFG +K L + + +R Y APE + VD++S G + E++
Sbjct: 169 GTLKLCDFGSAKKLSPSEPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 16/202 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR--------LAQEREREFKSEVSAIGRTHH 562
LG G+FG V+ V K K + VK + + + + + E++ + R H
Sbjct: 30 SPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH 88
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGT-LANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
N++++L + LV E G+G L I P+ D L I ++ + YL
Sbjct: 89 ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ IIH DIK +NI++ F+ K+ DFG + L +T GT Y APE
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAA-YLERGKLFYTFC-GTIEYCAPEVLMG 203
Query: 682 AP-VSAKVDVYSFGVMLLEIIC 702
P +++++S GV L ++
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVF 225
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 61/299 (20%), Positives = 104/299 (34%), Gaps = 59/299 (19%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVS----AIGRT 560
LG+G FG V+ G + +A+K + R EV+
Sbjct: 37 PLLGKGGFGTVFAGH-RLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGG 95
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGT-LANLIFAIPKPDWNLRVRISLEIARGLVYL 619
H +++LL + + +LV E L + I ++ + +
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 620 HEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
H ++H DIK +NIL+D AK+ DFG LL + GTR Y PEW
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEW 209
Query: 679 FKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737
+ V+S G++L +++C G + +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVC---------------------------GDIP--FE 240
Query: 738 SDEPAMADRSRLQKWL------MIAMWCIREDPSKRPTMKVVLQ---MLEGLLEVPNPP 787
D+ + + +I C+ PS RP+++ +L M +VP P
Sbjct: 241 RDQEILEAELHFPAHVSPDCCALIR-RCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNP 298
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-22
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 32/210 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+ +G GSFG+V++ L S + +A+KK+ Q++ + + E+ + H N+V L
Sbjct: 46 KVIGNGSFGVVFQAKLV-ESDE-VAIKKV---LQDKRFKNR-ELQIMRIVKHPNVVDLKA 99
Query: 571 FCDEALNRL------LVYEFMGNGTLANLIFAIPKPDWNLRVRISLE--------IARGL 616
F ++ LV E++ T+ + L+ + + + R L
Sbjct: 100 FFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 617 VYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
Y+H ++ I H DIKPQN+LLD K+ DFG +K+L++ + + +R Y A
Sbjct: 155 AYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC--SRYYRA 209
Query: 676 PEWFKNAPV-SAKVDVYSFGVMLLEIICCR 704
PE A + +D++S G ++ E++ +
Sbjct: 210 PELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREF-KSEVSAIGRTHHKNL 565
F + LG GSF V + A+ + A+K L+ + +E + + E + R H
Sbjct: 34 FGKILGEGSFSTVVL-ARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 566 VQLLG-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLV 617
V+L F D+ +L + NG L I F R + EI L
Sbjct: 93 VKLYFTFQDD--EKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVSALE 144
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL--LSDQSRTHTMIRGTRGYVA 675
YLH + IIH D+KP+NILL+ +I+DFG +K+L S Q+R ++ + GT YV+
Sbjct: 145 YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQYVS 200
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEIIC 702
PE D+++ G ++ +++
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVA 227
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 61/297 (20%), Positives = 108/297 (36%), Gaps = 57/297 (19%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHK- 563
LG G FG VY G+ + + +A+K +++ EV + +
Sbjct: 49 PLLGSGGFGSVYSGI-RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 107
Query: 564 -NLVQLLGFCDEALNRLLVYEF-MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
+++LL + + + +L+ E L + I L ++ + + H
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN 167
Query: 622 ECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
++H DIK +NIL+D N K+ DFG LL GTR Y PEW +
Sbjct: 168 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD---GTRVYSPPEWIR 221
Query: 681 NAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
V+S G++L +++C G + + D
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVC---------------------------GDIP--FEHD 252
Query: 740 EPAMADRSRLQKWL------MIAMWCIREDPSKRPTMKVVLQ---MLEGLLEVPNPP 787
E + + ++ + +I WC+ PS RPT + + M + LL
Sbjct: 253 EEIIRGQVFFRQRVSSECQHLIR-WCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 53/205 (25%), Positives = 98/205 (47%), Gaps = 22/205 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
E+G G++G V+K G+ +A+K++ R+ E RE + + H
Sbjct: 17 AEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAV-LRHLETFEHP 74
Query: 564 NLVQLL----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGL 616
N+V+L + +L LV+E + + L + +P+P + ++ RGL
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
+LH ++H D+KPQNIL+ + K++DFGL+++ + T ++ T Y AP
Sbjct: 134 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAP 188
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEII 701
E + + VD++S G + E+
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF 213
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 21/202 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
LG+G+FG V V + A+G+ A+K L + + + E +E + + H L L
Sbjct: 156 LGKGTFGKVIL-VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHEE 622
+ + +RL V E+ G L + F+ R R EI L YLH E
Sbjct: 215 -YSFQTHDRLCFVMEYANGGELFFHLSRERVFSED------RARFYGAEIVSALDYLHSE 267
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
N +++ D+K +N++LD KI+DFGL K + D + T GT Y+APE ++
Sbjct: 268 KN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDN 324
Query: 683 PVSAKVDVYSFGVMLLEIICCR 704
VD + GV++ E++C R
Sbjct: 325 DYGRAVDWWGLGVVMYEMMCGR 346
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 9/195 (4%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +G+G+F V +G+ +A+K +D+ L ++ EV + +H N+V+L
Sbjct: 21 KTIGKGNFAKVKLAR-HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
+ L+ E+ G + + + A + +I + Y H++ I+
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IV 136
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP-VSAK 687
H D+K +N+LLD + KI+DFG S + + G Y APE F+ +
Sbjct: 137 HRDLKAENLLLDADMNIKIADFGFSN-EFTVGGKLDAFC-GAPPYAAPELFQGKKYDGPE 194
Query: 688 VDVYSFGVMLLEIIC 702
VDV+S GV+L ++
Sbjct: 195 VDVWSLGVILYTLVS 209
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 7e-22
Identities = 55/232 (23%), Positives = 90/232 (38%), Gaps = 53/232 (22%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREF------------------- 550
K+E+G+GS+G+V A+K L + R+ F
Sbjct: 18 KDEIGKGSYGVVKLAY-NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQP 76
Query: 551 -------KSEVSAIGRTHHKNLVQLLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKPD 601
E++ + + H N+V+L+ D+ L V+E + G + +P
Sbjct: 77 RGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPT-- 130
Query: 602 WNLRVRISLEIAR--------GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLS 653
+S + AR G+ YLH + IIH DIKP N+L+ KI+DFG+S
Sbjct: 131 ---LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVS 184
Query: 654 KLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS---AKVDVYSFGVMLLEIIC 702
+ GT ++APE +DV++ GV L +
Sbjct: 185 NEFKGSDALLSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 9e-22
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAI---------GRTH 561
E+G G++G VYK SG +A+K + R+ +S +
Sbjct: 15 AEIGVGAYGTVYKARDPH-SGHFVALKSV-RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 562 HKNLVQLL----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR 614
H N+V+L+ + ++ LV+E + + L + P P + + R
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
GL +LH C I+H D+KP+NIL+ + + K++DFGL+++ + T ++ T Y
Sbjct: 132 GLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV--TLWYR 186
Query: 675 APEWFKNAPVSAKVDVYSFGVMLLEII 701
APE + + VD++S G + E+
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMF 213
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 1e-21
Identities = 56/197 (28%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
+G GS+G+V K K +G+ +A+KK + + + K E+ + + H+NLV
Sbjct: 31 GLVGEGSYGMVMKCRNK-DTGRIVAIKKF-LESDDDK-MVKKIAMREIKLLKQLRHENLV 87
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNV 625
LL C + LV+EF+ + T+ + + P D+ + + +I G+ + H
Sbjct: 88 NLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN-- 144
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV- 684
IIH DIKP+NIL+ K+ DFG ++ L+ + TR Y APE
Sbjct: 145 -IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVATRWYRAPELLVGDVKY 202
Query: 685 SAKVDVYSFGVMLLEII 701
VDV++ G ++ E+
Sbjct: 203 GKAVDVWAIGCLVTEMF 219
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
++G GS+G+V+K + +G+ +A+KK +++ K E+ + + H NLV
Sbjct: 9 GKIGEGSYGVVFKCRNRD-TGQIVAIKKF-LESEDDP-VIKKIALREIRMLKQLKHPNLV 65
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNV 625
LL LV+E+ + T+ + + + +L I+ + + + + H+
Sbjct: 66 NLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN-- 122
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV- 684
IH D+KP+NIL+ + K+ DFG ++ LL+ S + TR Y +PE
Sbjct: 123 -CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVATRWYRSPELLVGDTQY 180
Query: 685 SAKVDVYSFGVMLLEII 701
VDV++ G + E++
Sbjct: 181 GPPVDVWAIGCVFAELL 197
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-21
Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 29/204 (14%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQLLG 570
LG G++G V V + +A+AVK +D E K E+ +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPEN-IKKEICINKMLNHENVVKFYG 72
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEE 622
E + L E+ G L + I + + A+ G+VYLH
Sbjct: 73 HRREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPEWF 679
I H DIKP+N+LLD + KISDFGL+ + + ++ GT YVAPE
Sbjct: 125 G---ITHRDIKPENLLLDERDNLKISDFGLAT--VFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 680 KNAP-VSAKVDVYSFGVMLLEIIC 702
K + VDV+S G++L ++
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLA 203
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
E++G G++G V+K + + + +A+K++ RL + E RE + + HK
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRV-RLDDDDEGVPSSALRE----ICLLKELKHK 61
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEE 622
N+V+L LV+EF + L + V+ ++ +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--THTMIRGTRGYVAPEWFK 680
++H D+KPQN+L++ K+++FGL++ R + ++ T Y P+
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV--TLWYRPPDVLF 174
Query: 681 NAPV-SAKVDVYSFGVMLLEIICCRR 705
A + S +D++S G + E+ R
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 4e-21
Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGRTHHKNLVQLL 569
LG+G+FG V V + A+G+ A+K L + + + E +E + T H L L
Sbjct: 13 LGKGTFGKVIL-VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHEE 622
+ + +RL V E+ G L + F R R EI L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEE------RARFYGAEIVSALEYLHSR 124
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
+++ DIK +N++LD KI+DFGL K +SD + T GT Y+APE ++
Sbjct: 125 ---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDN 180
Query: 683 PVSAKVDVYSFGVMLLEIICCR 704
VD + GV++ E++C R
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGR 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 6e-21
Identities = 55/200 (27%), Positives = 100/200 (50%), Gaps = 21/200 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
E++G G++G+VYK ++ G+ A+KK+ RL +E E RE +S + H
Sbjct: 8 EKIGEGTYGVVYKA--QNNYGETFALKKI-RLEKEDEGIPSTTIRE----ISILKELKHS 60
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEE 622
N+V+L +LV+E + + L L+ ++ + L++ G+ Y H+
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
++H D+KPQN+L++ KI+DFGL++ R +T T Y AP+ +
Sbjct: 120 R---VLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 683 PV-SAKVDVYSFGVMLLEII 701
S +D++S G + E++
Sbjct: 176 KKYSTTIDIWSVGCIFAEMV 195
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 7e-21
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 22/203 (10%)
Query: 513 LGRGSFGIVY--KGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 568
LG+GSFG V+ K + S + + A+K L L K E + +H +V+L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 569 LGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHE 621
+ + +L L+ +F+ G L + F V+ E+A L +LH
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE------DVKFYLAELALALDHLHS 144
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
II+ D+KP+NILLD K++DFGLSK + + + ++ GT Y+APE
Sbjct: 145 LG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC-GTVEYMAPEVVNR 200
Query: 682 APVSAKVDVYSFGVMLLEIICCR 704
+ D +SFGV++ E++
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGT 223
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 27/203 (13%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLVQLLGF 571
LG G++G V V + +A+AVK +D A + K E+ +H+N+V+ G
Sbjct: 15 LGEGAYGEVQLAV-NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 572 CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEEC 623
E + L E+ G L + I + + A+ G+VYLH
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP--------DIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPEWFK 680
I H DIKP+N+LLD + KISDFGL+ + + ++ GT YVAPE K
Sbjct: 126 ---ITHRDIKPENLLLDERDNLKISDFGLAT--VFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 681 NAP-VSAKVDVYSFGVMLLEIIC 702
+ VDV+S G++L ++
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLA 203
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 59/202 (29%), Positives = 105/202 (51%), Gaps = 25/202 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
E++G G++G+VYK K + G+ +A+K++ RL E E RE +S + HH
Sbjct: 27 EKVGEGTYGVVYKA--KDSQGRIVALKRI-RLDAEDEGIPSTAIRE----ISLLKELHHP 79
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEE 622
N+V L+ LV+EFM L ++ + +++ ++ RG+ + H+
Sbjct: 80 NIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--THTMIRGTRGYVAPEWFK 680
I+H D+KPQN+L+++ + K++DFGL++ R TH ++ T Y AP+
Sbjct: 139 R---ILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV--TLWYRAPDVLM 192
Query: 681 NAPV-SAKVDVYSFGVMLLEII 701
+ S VD++S G + E+I
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMI 214
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 32/209 (15%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR----LAQEREREFKSEVSAIGRTHHKNLVQL 568
LG GS+G V + + S + AVK L + E K E+ + R HKN++QL
Sbjct: 13 LGEGSYGKVKEVL-DSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 569 LG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVY 618
+ +E ++ +V E+ G + D R + A GL Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--ML-----DSVPEKRFPVCQAHGYFCQLIDGLEY 124
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVA 675
LH + I+H DIKP N+LL + KIS G+++ L R G+ +
Sbjct: 125 LHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL--HPFAADDTCRTSQGSPAFQP 179
Query: 676 PEWFKNAPV--SAKVDVYSFGVMLLEIIC 702
PE KVD++S GV L I
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITT 208
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 7e-20
Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE-------REFKSEVSAIGRTHHK 563
+LG G++G VYK + + + +A+K++ RL E E RE VS + H+
Sbjct: 40 TKLGEGTYGEVYKAIDTV-TNETVAIKRI-RLEHEEEGVPGTAIRE----VSLLKELQHR 93
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
N+++L L++E+ L + P + ++ G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152
Query: 624 NVPIIHCDIKPQNILLDNYFSA-----KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
+H D+KPQN+LL ++ KI DFGL++ R T T Y PE
Sbjct: 153 ---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEIITLWYRPPEI 208
Query: 679 FKNAPV-SAKVDVYSFGVMLLEII 701
+ S VD++S + E++
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEML 232
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 7e-20
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 19/202 (9%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
+GRG+FG V V + K A+K L + + E F+ E + K + L
Sbjct: 82 IGRGAFGEVAV-VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 570 G-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEECNVP 626
F D+ N L LV ++ G L L+ R L E+ + +H+
Sbjct: 141 YAFQDD--NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH--- 195
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVS 685
+H DIKP NIL+D +++DFG L+ D + ++ + GT Y++PE +
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGG 254
Query: 686 AK-----VDVYSFGVMLLEIIC 702
D +S GV + E++
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLY 276
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 26/202 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG G+FG V G +G +AVK L+R + + + K E+ + H ++++L
Sbjct: 19 LGVGTFGKVKIGE-HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 621
+ +V E++ G L + I R+ AR + Y H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICK--------HGRVEEMEARRLFQQILSAVDYCHR 129
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
++H D+KP+N+LLD + +AKI+DFGLS ++SD T G+ Y APE
Sbjct: 130 HM---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISG 184
Query: 682 AP-VSAKVDVYSFGVMLLEIIC 702
+VD++S GV+L ++C
Sbjct: 185 RLYAGPEVDIWSCGVILYALLC 206
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 55/206 (26%), Positives = 99/206 (48%), Gaps = 26/206 (12%)
Query: 513 LGRGSFGIVY---KGVLKSASGKAIAVK---KLDRLAQEREREF-KSEVSAIGRTHHKNL 565
LG+G +G V+ K + +GK A+K K + ++ K+E + + H +
Sbjct: 25 LGKGGYGKVFQVRKVTGAN-TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFI 83
Query: 566 VQLLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVY 618
V L+ + + +L L+ E++ G L + F EI+ L +
Sbjct: 84 VDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMED------TACFYLAEISMALGH 136
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
LH++ II+ D+KP+NI+L++ K++DFGL K + D + THT GT Y+APE
Sbjct: 137 LHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC-GTIEYMAPEI 192
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCR 704
+ + VD +S G ++ +++
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 28/207 (13%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
+G+GSFG V V K+ + K A+K +++ + + R E+ + H LV L
Sbjct: 23 IGKGSFGKVCI-VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 570 G-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRISL-EIARGLVYLHE 621
F DE + +V + + G L + F V++ + E+ L YL
Sbjct: 82 YSFQDE--EDMFMVVDLLLGGDLRYHLQQNVHFKEE------TVKLFICELVMALDYLQN 133
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ IIH D+KP NILLD + I+DF ++ +L +++ TM GT+ Y+APE F +
Sbjct: 134 Q---RIIHRDMKPDNILLDEHGHVHITDFNIAA-MLPRETQITTMA-GTKPYMAPEMFSS 188
Query: 682 APV---SAKVDVYSFGVMLLEIICCRR 705
S VD +S GV E++ RR
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 568
LG+GSFG V + + + AVK L D + Q+ + E E + L QL
Sbjct: 28 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 569 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 621
C + ++RL V E++ G L F P + EIA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQS 139
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ II+ D+K N++LD+ KI+DFG+ K + D T T GT Y+APE
Sbjct: 140 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 195
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE-GRAILTD 721
P VD ++FGV+L E++ + E E E+E ++I+
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 236
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 53/203 (26%), Positives = 82/203 (40%), Gaps = 26/203 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC 572
+G G+FG+ + + +AVK ++R A E + E+ H N+V+
Sbjct: 28 IGSGNFGVARLMR-DKLTKELVAVKYIERGAAIDEN-VQREIINHRSLRHPNIVRFKEVI 85
Query: 573 DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHEECN 624
+ ++ E+ G L I R S + AR G+ Y H
Sbjct: 86 LTPTHLAIIMEYASGGELYERICN--------AGRFSEDEARFFFQQLLSGVSYCHSMQ- 136
Query: 625 VPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
I H D+K +N LLD + KI DFG SK + S+ + + GT Y+APE
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQ 192
Query: 683 P-VSAKVDVYSFGVMLLEIICCR 704
DV+S GV L ++
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGA 215
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 2e-19
Identities = 68/221 (30%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 568
LG+GSFG V + + + AVK L D + Q+ + E E + L QL
Sbjct: 349 LGKGSFGKVML-SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 569 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 621
C + ++RL V E++ G L F P + EIA GL +L
Sbjct: 408 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP------HAVFYAAEIAIGLFFLQS 460
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ II+ D+K N++LD+ KI+DFG+ K + D T T GT Y+APE
Sbjct: 461 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEIIAY 516
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEE-GRAILTD 721
P VD ++FGV+L E++ + E E E+E ++I+
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 52/239 (21%), Positives = 96/239 (40%), Gaps = 63/239 (26%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
+ LG GSFGIV + SGK A+KK+ + + + RE + H N+++L+
Sbjct: 13 KTLGTGSFGIVCEVFDI-ESGKRFALKKVLQDPRYKNRELD----IMKVLDHVNIIKLVD 67
Query: 571 FCDEALNRL--------------------------------------LVYEFMGNGTLAN 592
+ + ++ E++ + TL
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHK 126
Query: 593 LIFAIPKPDWNLRVRISLE--------IARGLVYLHEECNVPIIHCDIKPQNILLD-NYF 643
++ K I + + R + ++H ++ I H DIKPQN+L++
Sbjct: 127 VL----KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDN 179
Query: 644 SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
+ K+ DFG +K L+ + + +R Y APE A + +D++S G + E+I
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYIC--SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 39/287 (13%), Positives = 77/287 (26%), Gaps = 56/287 (19%)
Query: 511 EELGRGSFGIVYKG---VLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKN 564
G ++ L + +A+ +D L + +E S + R
Sbjct: 37 IFHGGVPPLQFWQALDTAL----DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
+ ++L L+V E++ G+L + P P +R +A H
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAHRA-- 148
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
+ P + +S G L +
Sbjct: 149 -GVALSIDHPSRVR--------VSIDGDVVL-------------AYPATM-------PDA 179
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
+ + D+ G L ++ R + G A E +D D P
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPA---DIDRDIPFQI 236
Query: 745 DRSRLQKWLMIAMWCIREDPSKRP--TMKVVLQMLEGLLEVPNPPCP 789
+A ++ D R T+ ++Q + + P
Sbjct: 237 SA--------VAARSVQGDGGIRSASTLLNLMQQATAVADRTEVLGP 275
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 3e-19
Identities = 47/199 (23%), Positives = 88/199 (44%), Gaps = 23/199 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER-EREFKSEVSAIGR--THHKNLVQ 567
+LGRG + V++ + + + + VK L + +++ +RE K I N++
Sbjct: 42 RKLGRGKYSEVFEAI-NITNNEKVVVKILKPVKKKKIKREIK-----ILENLRGGPNIIT 95
Query: 568 LLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLVYLHEECN 624
L D LV+E + N L + D +R + EI + L Y H
Sbjct: 96 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD----IRFYMYEILKALDYCHSMG- 150
Query: 625 VPIIHCDIKPQNILLDNYFSA-KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
I+H D+KP N+++D+ ++ D+GL++ Q + +R + PE +
Sbjct: 151 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV--ASRYFKGPELLVDYQ 206
Query: 684 V-SAKVDVYSFGVMLLEII 701
+ +D++S G ML +I
Sbjct: 207 MYDYSLDMWSLGCMLASMI 225
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 44/199 (22%), Positives = 73/199 (36%), Gaps = 42/199 (21%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 567
+ LG G G V + K + + A+K L + R EV R + ++V+
Sbjct: 22 TSQVLGLGINGKVLQIFNKR-TQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVR 75
Query: 568 LLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHE 621
++ + L+V E + G L + I + R I I + YLH
Sbjct: 76 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 134
Query: 622 ECNVPIIHCDIKPQNILLDNYFSA---KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
N I H D+KP+N+L + K++DFG +K Y
Sbjct: 135 SIN--IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG------------EKY----- 175
Query: 679 FKNAPVSAKVDVYSFGVML 697
D++S GV++
Sbjct: 176 ------DKSCDMWSLGVIM 188
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 568
+GRGS+ V V + + A+K + + + + + ++ ++E + ++H LV L
Sbjct: 17 IGRGSYAKVLL-VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 569 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 621
C + +RL V E++ G L R S EI+ L YLHE
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE 128
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
II+ D+K N+LLD+ K++D+G+ K L T T GT Y+APE +
Sbjct: 129 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 184
Query: 682 APVSAKVDVYSFGVMLLEIICCR 704
VD ++ GV++ E++ R
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGR 207
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-19
Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 568
+GRGS+ V V + + A++ + + + + + ++ ++E + ++H LV L
Sbjct: 60 IGRGSYAKVLL-VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 118
Query: 569 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 621
C + +RL V E++ G L R S EI+ L YLHE
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE------HARFYSAEISLALNYLHE 171
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
II+ D+K N+LLD+ K++D+G+ K L T T GT Y+APE +
Sbjct: 172 R---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC-GTPNYIAPEILRG 227
Query: 682 APVSAKVDVYSFGVMLLEIICCR 704
VD ++ GV++ E++ R
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGR 250
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-19
Identities = 63/203 (31%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSEVSAIGR-THHKNLVQL 568
+G+GSFG V A AVK L + +++E + SE + + + H LV L
Sbjct: 46 IGKGSFGKVLL-ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 569 LGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLHE 621
F + ++L V +++ G L F P R R + EIA L YLH
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEP------RARFYAAEIASALGYLHS 157
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
I++ D+KP+NILLD+ ++DFGL K + S T T GT Y+APE
Sbjct: 158 L---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFC-GTPEYLAPEVLHK 213
Query: 682 APVSAKVDVYSFGVMLLEIICCR 704
P VD + G +L E++
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 25/204 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREF-KSE--VSAIGRTHHKNLVQ 567
LG+GSFG V +G AVK L D + Q+ + E +E + ++ +H L Q
Sbjct: 31 LGKGSFGKVML-ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA-RNHPFLTQ 88
Query: 568 LLGFCDEALNRL-LVYEFMGNGTL-----ANLIFAIPKPDWNLRVRI-SLEIARGLVYLH 620
L C + +RL V EF+ G L + F R R + EI L++LH
Sbjct: 89 LF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA------RARFYAAEIISALMFLH 141
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
++ II+ D+K N+LLD+ K++DFG+ K + + T T GT Y+APE +
Sbjct: 142 DK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC-GTPDYIAPEILQ 197
Query: 681 NAPVSAKVDVYSFGVMLLEIICCR 704
VD ++ GV+L E++C
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 53/202 (26%), Positives = 94/202 (46%), Gaps = 27/202 (13%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG GSFG V + + +A+K + R + + E+S + H ++++L
Sbjct: 17 LGEGSFGKVKLAT-HYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 621
+ ++V E+ G G L + I + R++ + R + Y H
Sbjct: 76 DVITTPTDIVMVIEYAG-GELFDYIVE--------KKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
I+H D+KP+N+LLD+ + KI+DFGLS +++D + T G+ Y APE
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSN-IMTDGNFLKTSC-GSPNYAAPEVING 181
Query: 682 AP-VSAKVDVYSFGVMLLEIIC 702
+VDV+S G++L ++
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLV 203
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 19/201 (9%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE--FKS----EVSAIGRTHHKN 564
+ LG G F VYK K+ + + +A+KK+ +L E + E+ + H N
Sbjct: 16 DFLGEGQFATVYKARDKN-TNQIVAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-ISLEIARGLVYLHEEC 623
++ LL N LV++FM L +I ++ L +GL YLH+
Sbjct: 74 IIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 132
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--THTMIRGTRGYVAPEWFKN 681
I+H D+KP N+LLD K++DFGL+K +R TH ++ TR Y APE
Sbjct: 133 ---ILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV--TRWYRAPELLFG 186
Query: 682 APV-SAKVDVYSFGVMLLEII 701
A + VD+++ G +L E++
Sbjct: 187 ARMYGVGVDMWAVGCILAELL 207
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 35/206 (16%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT----------HH 562
+G G+ GIV + + +A+KKL R F+++ A R +H
Sbjct: 33 IGSGAQGIVCA-AYDAILERNVAIKKLSRP-------FQNQTHAK-RAYRELVLMKCVNH 83
Query: 563 KNLVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARG 615
KN++ LL E + +V E M ANL I + R+ L ++ G
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCG 139
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVA 675
+ +LH + IIH D+KP NI++ + + KI DFGL++ + T ++ TR Y A
Sbjct: 140 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRA 194
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLEII 701
PE VD++S G ++ E+I
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMI 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 3e-18
Identities = 59/239 (24%), Positives = 99/239 (41%), Gaps = 34/239 (14%)
Query: 477 RRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAV 536
+Y++ + + + +GRG+FG V V ++ K A+
Sbjct: 51 LSRYKDTINKIRDLRMKAEDYE----------VVKVIGRGAFGEVQL-VRHKSTRKVYAM 99
Query: 537 KKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLLG-FCDEALNRL-LVYEFMGNGTLA 591
K L + + + F E + + +VQL F D+ L +V E+M G L
Sbjct: 100 KLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD--RYLYMVMEYMPGGDLV 157
Query: 592 NLI--FAIPKPDWNLRVRI-SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648
NL+ + +P+ R + E+ L +H + IH D+KP N+LLD K++
Sbjct: 158 NLMSNYDVPEK----WARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLA 210
Query: 649 DFGLSK-LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK----VDVYSFGVMLLEIIC 702
DFG + R T + GT Y++PE K+ D +S GV L E++
Sbjct: 211 DFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 28/210 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE--REFKSEVSAIGRT-------- 560
+ GS+G V GV G +A+K++ + R
Sbjct: 28 RFISSGSYGAVCAGVDSE--GIPVAIKRVFNTVSDGRTVNILSDSFLCK-RVLREIRLLN 84
Query: 561 --HHKNLVQLLG----FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EI 612
HH N++ L F + A+++L LV E M LA +I ++ + I
Sbjct: 85 HFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRG 672
GL LHE V +H D+ P NILL + I DF L++ +D ++TH + R
Sbjct: 144 LLGLHVLHE-AGV--VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRW 198
Query: 673 YVAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
Y APE + VD++S G ++ E+
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE-FKSE--VSAIGRTHHKNLVQ 567
LG+GSFG V+ + + A+K L D + + + E E V ++ H L
Sbjct: 25 LGKGSFGKVFL-AEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 82
Query: 568 LLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLH 620
+ + L V E++ G L I F + R + EI GL +LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS------RATFYAAEIILGLQFLH 135
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680
+ I++ D+K NILLD KI+DFG+ K + ++T+T GT Y+APE
Sbjct: 136 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 191
Query: 681 NAPVSAKVDVYSFGVMLLEIICCR 704
+ VD +SFGV+L E++ +
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQLL 569
LG G+FG V G +G +AVK L+R + + + + E+ + H ++++L
Sbjct: 24 LGVGTFGKVKVGK-HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLHE 621
+ +V E++ G L + I R+ + +R G+ Y H
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICK--------NGRLDEKESRRLFQQILSGVDYCHR 134
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
++H D+KP+N+LLD + +AKI+DFGLS ++SD T G+ Y APE
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFLRTSC-GSPNYAAPEVISG 189
Query: 682 AP-VSAKVDVYSFGVMLLEIIC 702
+VD++S GV+L ++C
Sbjct: 190 RLYAGPEVDIWSSGVILYALLC 211
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 3e-18
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 24/204 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
E+LG G++ VYKG+ K+ +G +A+K++ +L + E S E+S + H+N+V
Sbjct: 11 EKLGNGTYATVYKGLNKT-TGVYVALKEV-KL--DSEEGTPSTAIREISLMKELKHENIV 66
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS------LEIARGLVYLH 620
+L LV+EFM + L + + + + ++ ++ +GL + H
Sbjct: 67 RLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--THTMIRGTRGYVAPEW 678
E I+H D+KPQN+L++ K+ DFGL++ + ++ T Y AP+
Sbjct: 126 ENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV--TLWYRAPDV 179
Query: 679 FKNAPV-SAKVDVYSFGVMLLEII 701
+ S +D++S G +L E+I
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMI 203
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 33/210 (15%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
+GRG+F V V +G+ A+K + + + E F+ E + + + QL
Sbjct: 69 IGRGAFSEVAV-VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127
Query: 570 GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR--------GLVYLH 620
F + N L LV E+ G L L+ RI E+AR + +H
Sbjct: 128 -FAFQDENYLYLVMEYYVGGDLLTLLS-------KFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWF 679
+H DIKP NILLD +++DFG L +D + R+ + GT Y++PE
Sbjct: 180 RLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEIL 235
Query: 680 KNAPVSAKVDVY-------SFGVMLLEIIC 702
+ Y + GV E+
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 55/219 (25%), Positives = 87/219 (39%), Gaps = 42/219 (19%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHH--- 562
+LG G F V+ + +A+K K+ A E E + V+ T
Sbjct: 25 RKLGWGHFSTVWL-AKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 563 --KNLVQLLG---FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR-- 614
++++LL + +V+E +G NL+ I K I L +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVLG----ENLLALIKK---YEHRGIPLIYVKQI 136
Query: 615 ------GLVYLHEECNVPIIHCDIKPQNILLD------NYFSAKISDFGLSKLLLSDQSR 662
GL Y+H C IIH DIKP+N+L++ N KI+D G +
Sbjct: 137 SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDE 190
Query: 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEII 701
+T TR Y +PE AP D++S ++ E+I
Sbjct: 191 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 229
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-18
Identities = 51/197 (25%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
++LG G++ VYKG K + +A+K++ RL E E EVS + H N+V
Sbjct: 8 DKLGEGTYATVYKGKSKL-TDNLVALKEI-RL--EHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNV 625
L + LV+E++ + L + + + ++ RGL Y H +
Sbjct: 64 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-- 120
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV- 684
++H D+KPQN+L++ K++DFGL++ S ++T+ T Y P+ +
Sbjct: 121 -VLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGSTDY 178
Query: 685 SAKVDVYSFGVMLLEII 701
S ++D++ G + E+
Sbjct: 179 STQIDMWGVGCIFYEMA 195
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 57/201 (28%), Positives = 101/201 (50%), Gaps = 27/201 (13%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
LG GSFG V+ + +G+ A+K L + + + ++ E E + H ++++
Sbjct: 14 LGTGSFGRVHL-IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 72
Query: 570 G-FCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHE 621
G F D ++ ++ +++ G L +L+ F P + + E+ L YLH
Sbjct: 73 GTFQDA--QQIFMIMDYIEGGELFSLLRKSQRFPNP------VAKFYAAEVCLALEYLHS 124
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
+ II+ D+KP+NILLD KI+DFG +K T+T+ GT Y+APE
Sbjct: 125 -KD--IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTLC-GTPDYIAPEVVST 177
Query: 682 APVSAKVDVYSFGVMLLEIIC 702
P + +D +SFG+++ E++
Sbjct: 178 KPYNKSIDWWSFGILIYEMLA 198
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 23/199 (11%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
LG GSFG V V SG A+K L ++ + ++ E +E + + LV+L
Sbjct: 49 LGTGSFGRVML-VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 570 GFCDEALNRLLVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIARGLVYLHEEC 623
+ N +V E++ G + + + F+ P R + +I YLH
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEP------HARFYAAQIVLTFEYLHSLD 161
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP 683
+I+ D+KP+N+L+D +++DFG +K + RT T+ GT +APE +
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTL-CGTPEALAPEIILSKG 214
Query: 684 VSAKVDVYSFGVMLLEIIC 702
+ VD ++ GV++ E+
Sbjct: 215 YNKAVDWWALGVLIYEMAA 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 49/213 (23%), Positives = 98/213 (46%), Gaps = 34/213 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKS----EVSAIGRTHHKNLV 566
++G+G+FG V+K + +G+ +A+KK+ + E+E F E+ + H+N+V
Sbjct: 23 AKIGQGTFGEVFKARHRK-TGQKVALKKV-LMENEKE-GFPITALREIKILQLLKHENVV 79
Query: 567 QLLGFCDEALNRL--------LVYEFMGN---GTLANLIFAIPKPDWNLRVR-ISLEIAR 614
L+ C + LV++F + G L+N++ + ++ + +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE----IKRVMQMLLN 135
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL---LSDQSR--THTMIRG 669
GL Y+H I+H D+K N+L+ K++DFGL++ + Q T+ ++
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV-- 190
Query: 670 TRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
T Y PE +D++ G ++ E+
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 1e-16
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 27/204 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 564
+ +G G+ GIV + + +A+KKL R A+ RE + +HKN
Sbjct: 68 KPIGSGAQGIVCA-AYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKN 122
Query: 565 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLV 617
++ LL E + LV E M ANL I + R+ L ++ G+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIK 178
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
+LH + IIH D+KP NI++ + + KI DFGL++ + T ++ TR Y APE
Sbjct: 179 HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV--TRYYRAPE 233
Query: 678 WFKNAPVSAKVDVYSFGVMLLEII 701
VD++S G ++ E++
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMV 257
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 513 LGRGSFGIVY--KGVLKSASGKAIAVKKL--DRLAQER--------EREFKSEVSAIGRT 560
LG G++G V+ + + +GK A+K L + Q+ ER+ +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR----- 116
Query: 561 HHKNLVQLLGFCDEALNRL-LVYEFMGNGTLANLI-----FAIPKPDWNLRVRI-SLEIA 613
LV L + + +L L+ +++ G L + F V+I EI
Sbjct: 117 QSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEH------EVQIYVGEIV 169
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRTHTMIRGTRG 672
L +LH+ II+ DIK +NILLD+ ++DFGLSK ++D+ R + GT
Sbjct: 170 LALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIE 225
Query: 673 YVAPE--WFKNAPVSAKVDVYSFGVMLLEIICCR 704
Y+AP+ ++ VD +S GV++ E++
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-15
Identities = 51/209 (24%), Positives = 92/209 (44%), Gaps = 33/209 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT---------- 560
+G G++G+V + +A+KK+ F+ + RT
Sbjct: 33 SYIGEGAYGMVCSAYDNL-NKVRVAIKKISP--------FEHQTYCQ-RTLREIKILLRF 82
Query: 561 HHKNLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 615
H+N++ + + ++ +V + M L L+ + ++ +I RG
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICY-FLYQILRG 140
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR--GTRGY 673
L Y+H NV +H D+KP N+LL+ KI DFGL+++ D T + TR Y
Sbjct: 141 LKYIHS-ANV--LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 674 VAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
APE N+ + +D++S G +L E++
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEML 226
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 34/217 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL----DRLAQEREREFKSEVSAIGRTHHKNLV 566
+ LG G G+V+ V + K +A+KK+ + + RE K I R H N+V
Sbjct: 17 KPLGCGGNGLVFSAV-DNDCDKRVAIKKIVLTDPQSVKHALREIK----IIRRLDHDNIV 71
Query: 567 QLL-------------GFCDEALNRL-LVYEFMGNGT-LANLIFAIPKPDWNLRVRISLE 611
++ LN + +V E+M T LAN++ P + + R+ +
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME--TDLANVLEQGPLLEEHARL-FMYQ 128
Query: 612 IARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSRTHTMIR-- 668
+ RGL Y+H NV +H D+KP N+ ++ KI DFGL++++ S +
Sbjct: 129 LLRGLKYIHS-ANV--LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 669 GTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCR 704
T+ Y +P + + +D+++ G + E++ +
Sbjct: 186 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 30/205 (14%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 564
+G G++G V + K SG+ +A+KKL R A+ RE + H+N
Sbjct: 30 THVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELL----LLKHMQHEN 84
Query: 565 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISL-EIARGLV 617
++ LL LV FM L ++ + +++ + ++ +GL
Sbjct: 85 VIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEE---KIQYLVYQMLKGLK 140
Query: 618 YLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE 677
Y+H V +H D+KP N+ ++ KI DFGL++ ++ T TR Y APE
Sbjct: 141 YIHS-AGV--VHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPE 193
Query: 678 WFKNAPV-SAKVDVYSFGVMLLEII 701
+ + VD++S G ++ E++
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEML 218
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 50/208 (24%), Positives = 82/208 (39%), Gaps = 36/208 (17%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 565
+ +G+GSFG V K + +A+K K E + + + N+
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161
Query: 566 VQLLGFCD---------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR 614
+ +L E L+ L YE + +L + + + I +
Sbjct: 162 IHMLENFTFRNHICMTFELLSMNL-YELIKKNKFQGF---------SLPLVRKFAHSILQ 211
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRG 672
L LH+ IIHCD+KP+NILL + K+ DFG S + + +R
Sbjct: 212 CLDALHK-NR--IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRF 264
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEI 700
Y APE A +D++S G +L E+
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAEL 292
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 5e-15
Identities = 53/241 (21%), Positives = 92/241 (38%), Gaps = 74/241 (30%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT--------- 560
K +GRGS+G VY K+ + K +A+KK++R+ F+ + R
Sbjct: 31 KHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRM-------FEDLIDCK-RILREITILNR 81
Query: 561 -HHKNLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLE--- 611
+++L + L + +V E + L L + I L
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLF----------KTPIFLTEEH 130
Query: 612 -------IARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664
+ G ++HE + IH D+KP N LL+ S K+ DFGL++ + S++
Sbjct: 131 IKTILYNLLLGENFIHE-SGI--IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 665 TMIRG---------------------TRGYVAPE---WFKNAPVSAKVDVYSFGVMLLEI 700
TR Y APE +N + +D++S G + E+
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAEL 245
Query: 701 I 701
+
Sbjct: 246 L 246
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 48/218 (22%), Positives = 89/218 (40%), Gaps = 39/218 (17%)
Query: 510 KEELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQEREREFKSEVSAIGRT------HH 562
++GRG++G VYK K K A+K++ +SA H
Sbjct: 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMSACREIALLRELKH 77
Query: 563 KNLVQLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVR---------ISLE 611
N++ L F A ++ L++++ + L ++I N + + +
Sbjct: 78 PNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 612 IARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA----KISDFGLSKLLLSDQSRTHTMI 667
I G+ YLH ++H D+KP NIL+ KI+D G ++ L + + +
Sbjct: 137 ILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADL 192
Query: 668 RG---TRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEII 701
T Y APE A + +D+++ G + E++
Sbjct: 193 DPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 51/209 (24%), Positives = 82/209 (39%), Gaps = 38/209 (18%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 565
+G+GSFG V K + +A+K K + E ++ +
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 566 VQLLGF-------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWN----LRVR-ISLEIA 613
V L C LV+E + NL + ++ R + ++
Sbjct: 119 VHLKRHFMFRNHLC-------LVFEMLS----YNLYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 614 RGLVYLH-EECNVPIIHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGT 670
L++L E + IIHCD+KP+NILL N + KI DFG S + +
Sbjct: 168 TALLFLATPELS--IIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQS 221
Query: 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
R Y +PE P +D++S G +L+E
Sbjct: 222 RFYRSPEVLLGMPYDLAIDMWSLGCILVE 250
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 49/247 (19%), Positives = 90/247 (36%), Gaps = 81/247 (32%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT--------- 560
+ +G GS+G V + K + +A+KK+ R F+ + R
Sbjct: 58 RHLIGTGSYGHVCEAYDKL-EKRVVAIKKILR-------VFEDLIDCK-RILREIAILNR 108
Query: 561 -HHKNLVQLLGFC----DEALNRL-LVYEFMGNGT-LANLIFAIPKPDWNLRVRISLE-- 611
+H ++V++L E + L +V E + L R + L
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--SDFKKLF----------RTPVYLTEL 156
Query: 612 --------IARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663
+ G+ Y+H + +H D+KP N L++ S K+ DFGL++ + ++
Sbjct: 157 HIKTLLYNLLVGVKYVHS-AGI--LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213
Query: 664 HTMIRG--------------------------TRGYVAPE---WFKNAPVSAKVDVYSFG 694
+ TR Y APE +N + +DV+S G
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQEN--YTEAIDVWSIG 271
Query: 695 VMLLEII 701
+ E++
Sbjct: 272 CIFAELL 278
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 51/219 (23%), Positives = 93/219 (42%), Gaps = 42/219 (19%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-------- 560
K LG G++G+V K +G+ +A+KK+ F + A+ RT
Sbjct: 15 LKSLLGEGAYGVVCSATHKP-TGEIVAIKKI--------EPFDKPLFAL-RTLREIKILK 64
Query: 561 --HHKNLVQLLG-FCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIA 613
H+N++ + ++ ++ E M L +I D +++ +
Sbjct: 65 HFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQY-FIYQTL 122
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR-- 671
R + LH NV IH D+KP N+L+++ K+ DFGL++++ +
Sbjct: 123 RAVKVLHG-SNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 672 -GYVAPEWFKNAP--------VSAKVDVYSFGVMLLEII 701
+VA W++ AP S +DV+S G +L E+
Sbjct: 180 VEFVATRWYR-APEVMLTSAKYSRAMDVWSCGCILAELF 217
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 52/232 (22%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQE--RE----REFKSEVSA 556
++LG+G++GIV+K + +G+ +AVKK+ AQ RE E
Sbjct: 13 LVKKLGKGAYGIVWK-SIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS----- 66
Query: 557 IGRTHHKNLVQLLG-FCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 614
H+N+V LL + + LV+++M L +I A + + + ++ +
Sbjct: 67 ----GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQY-VVYQLIK 120
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTR--- 671
+ YLH + +H D+KP NILL+ K++DFGLS+ ++ + T+ +
Sbjct: 121 VIKYLHS-GGL--LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177
Query: 672 -----------GYVAPEWFKNAP--------VSAKVDVYSFGVMLLEIICCR 704
YVA W++ AP + +D++S G +L EI+C +
Sbjct: 178 ENFDDDQPILTDYVATRWYR-APEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-14
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 27/204 (13%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR------LAQEREREFKSEVSAIGRTHHKN 564
+ +G G++G V + +G +A+KKL R A+ RE + + H+N
Sbjct: 31 QPVGSGAYGAVCS-AVDGRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKHMRHEN 85
Query: 565 LVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVY 618
++ LL + LV FMG L L+ + ++ + ++ +GL Y
Sbjct: 86 VIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQF-LVYQMLKGLRY 143
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
+H + IH D+KP N+ ++ KI DFGL++ S+ T TR Y APE
Sbjct: 144 IHA-AGI--IHRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEV 196
Query: 679 FKNAPV-SAKVDVYSFGVMLLEII 701
N + VD++S G ++ E+I
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMI 220
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 8e-14
Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 35/208 (16%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT---------- 560
+G G++G V + +G +AVKKL R F+S + A RT
Sbjct: 35 SPVGSGAYGSVCA-AFDTKTGLRVAVKKLSRP-------FQSIIHAK-RTYRELRLLKHM 85
Query: 561 HHKNLVQLL-----GFCDEALNRL-LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIAR 614
H+N++ LL E N + LV MG L N++ D +++ + +I R
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQF-LIYQILR 143
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYV 674
GL Y+H + IIH D+KP N+ ++ KI DFGL++ + + TR Y
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA----TRWYR 196
Query: 675 APEWFKNAPV-SAKVDVYSFGVMLLEII 701
APE N + VD++S G ++ E++
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELL 224
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 3e-13
Identities = 48/184 (26%), Positives = 79/184 (42%), Gaps = 31/184 (16%)
Query: 606 VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665
+ S ++A+G+ +L IH D+ +NILL KI DFGL++ + D
Sbjct: 196 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP----D 248
Query: 666 MIRGTRGYV-----APEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAI 718
+R + APE + + + DV+SFGV+L EI S ++++EE
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 308
Query: 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
L + R+ P Q M+ W +PS+RPT +++ L
Sbjct: 309 LKE-------GTRM------RAPDYTTPEMYQ--TMLDCW--HGEPSQRPTFSELVEHLG 351
Query: 779 GLLE 782
LL+
Sbjct: 352 NLLQ 355
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 42/153 (27%), Positives = 64/153 (41%), Gaps = 14/153 (9%)
Query: 509 FKEELGRGSFGIVYKGVL----KSASGKAIAVKKLDRLAQERER-EFKSEVS-AIGRTHH 562
+ LGRG+FG V + K+A+ + +AVK L A E SE+ I HH
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 85
Query: 563 KNLVQLLGFCDEALNRLLV-YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
N+V LLG C + L+V EF G L+ + + R +G +
Sbjct: 86 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-------RSKRNEFVPYKTKGARFRQG 138
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654
+ V I D+K + + + S+ S F K
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 1e-10
Identities = 26/190 (13%), Positives = 48/190 (25%), Gaps = 51/190 (26%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL--------DRLAQEREREFKSEV-------- 554
E++G G FG V++ + +A+K + + Q+ E E+
Sbjct: 26 EKIGEGVFGEVFQTIAD---HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSL 82
Query: 555 -SAIGRTHHKNLVQLL------GFCDEAL-----------------------NRLLVYEF 584
S + + L G L ++L +
Sbjct: 83 LSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLE 142
Query: 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS 644
G + I ++ L H D+ N+LL
Sbjct: 143 FEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSL 200
Query: 645 AKISDFGLSK 654
K+ K
Sbjct: 201 KKLHYTLNGK 210
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 53/251 (21%), Positives = 79/251 (31%), Gaps = 70/251 (27%)
Query: 513 LGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTH--HKNL 565
LG G F V+ K +A+K + E V + +
Sbjct: 45 LGWGHFSTVWL-SWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 566 VQLLG-FCDEALN---RLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIARGLVYL 619
VQLL F +N +V+E +G+ L I L +I ++ +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYL 162
Query: 620 HEECNVPIIHCDIKPQNILL---------------------------------------- 639
H +C IIH DIKP+NILL
Sbjct: 163 HTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 640 ---------DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690
KI+D G + + T TR Y + E + + D+
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADI 276
Query: 691 YSFGVMLLEII 701
+S M E+
Sbjct: 277 WSTACMAFELA 287
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 8e-10
Identities = 46/224 (20%), Positives = 78/224 (34%), Gaps = 52/224 (23%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 565
LG G+FG V + + + +A+K R A E ++ + +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 566 VQLLGFCD---------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRV--RISLEIAR 614
V + + + E L + +EF+ L ++ ++
Sbjct: 85 VLMSDWFNFHGHMCIAFELLGKNT-FEFLKENNFQPY---------PLPHVRHMAYQLCH 134
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSA-------------------KISDFGLSKL 655
L +LHE + H D+KP+NIL N +++DFG +
Sbjct: 135 ALRFLHE-NQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA-- 189
Query: 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
+ HT I TR Y PE + DV+S G +L E
Sbjct: 190 --TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 2e-09
Identities = 53/236 (22%), Positives = 86/236 (36%), Gaps = 72/236 (30%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK-----------------KLDRLAQEREREFKSE 553
++G G+FG V + K AVK L ++ Q + +
Sbjct: 41 RKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKI-QNDDINNNNI 98
Query: 554 VSAIGRTHHKN---LV-QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVR-I 608
V G+ + + L+ + LG +YE + N ++
Sbjct: 99 VKYHGKFMYYDHMCLIFEPLGPS--------LYEIITR----NNYNGFHIE----DIKLY 142
Query: 609 SLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA----------------------- 645
+EI + L YL + + + H D+KP+NILLD+ +
Sbjct: 143 CIEILKALNYLRK-MS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 646 --KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
K+ DFG + + +S H I TR Y APE N D++SFG +L E
Sbjct: 200 GIKLIDFGCA----TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 53/224 (23%), Positives = 86/224 (38%), Gaps = 52/224 (23%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK-----KLDRLAQEREREFKSEVSAIGRTHHKNL 565
+ LG G+FG V + + A G+ +AVK A E + ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 566 VQLLGFCD---------EALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRVR-ISLEIAR 614
VQ+L + + E L Y+F+ NG L F + +R ++ +I +
Sbjct: 80 VQMLEWFEHHGHICIVFELLGLST-YDFIKENGFLP---FRLD------HIRKMAYQICK 129
Query: 615 GLVYLHEECNVPIIHCDIKPQNILLDNYFSA-------------------KISDFGLSKL 655
+ +LH + H D+KP+NIL K+ DFG +
Sbjct: 130 SVNFLHS-NK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA-- 184
Query: 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLE 699
+ H+ + TR Y APE S DV+S G +L+E
Sbjct: 185 --TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 41/204 (20%), Positives = 88/204 (43%), Gaps = 24/204 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+G GSFG++++G + + +A+K A + E+++ G T + +
Sbjct: 16 RRIGEGSFGVIFEGT-NLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTG---IPNV 71
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
F E L+ +LV + +G +L +L + ++++ + ++ + +HE+
Sbjct: 72 YYFGQEGLHNVLVIDLLGP-SLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIHEKS--- 126
Query: 627 IIHCDIKPQNILLDNYFSAK-----ISDFGLSKLLLSDQSRTHTMIR------GTRGYVA 675
+++ DIKP N L+ S + DFG+ K ++ H R GT Y++
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 186
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLE 699
S + D+ + G + +
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMY 210
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 55.8 bits (133), Expect = 2e-08
Identities = 35/279 (12%), Positives = 77/279 (27%), Gaps = 36/279 (12%)
Query: 21 SAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLF--LLAIWFNKIPERTIVW 78
+ + +LS+ LSP++ F Q + N + +W +
Sbjct: 12 VGTSVLPAYQTLSA---GQYLLSPNQRFKLLL-QGDGNLVIQDNGATVWVANEQQPFSST 67
Query: 79 HANGDNPAPRGSTLELTATGLLLKDPGGK-------TIWDGKPDKKVSDAAMLDTGNFVL 131
+ AP G L D + + + + + D GN VL
Sbjct: 68 IPLRNKKAP---LAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVL 124
Query: 132 RASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFSNGSLKLIS 191
+ + + + + +L S L+ + + G+ KL+
Sbjct: 125 VD--SLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV------------YGAGASKLVF 170
Query: 192 VAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSPRVD 251
+ Y + + + VF ++ + ++ W +
Sbjct: 171 QGDGNLVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVL----WHSHTGGHA 226
Query: 252 HYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDDIC 290
+ L +G +A + + PT I
Sbjct: 227 SA-VLRLQANGSIAILDEKPVWARF-GFQPTYRHIRKIN 263
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 33/163 (20%), Positives = 75/163 (46%), Gaps = 18/163 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK--KLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+++G G+FG + G + + +A+K + A + E++ + Q+
Sbjct: 15 KKIGCGNFGELRLGK-NLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDG---IPQV 70
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECNVP 626
F +V E +G +L +L F + ++L+ + I++++ + Y+H +
Sbjct: 71 YYFGPCGKYNAMVLELLGP-SLEDL-FDLCDRTFSLKTVLMIAIQLISRMEYVHSKN--- 125
Query: 627 IIHCDIKPQNILLDNYFSAK-----ISDFGLSKLLLSDQSRTH 664
+I+ D+KP+N L+ + I DF L+K + +++ H
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 45/204 (22%), Positives = 83/204 (40%), Gaps = 26/204 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKNLV 566
++G GSFG +Y G A+G+ +A+K + E + + +
Sbjct: 15 RKIGSGSFGDIYLGT-DIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGG-----VGIP 68
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECN 624
+ E ++V E +G +L +L F ++L+ + ++ ++ + Y+H +
Sbjct: 69 TIRWCGAEGDYNVMVMELLGP-SLEDL-FNFCSRKFSLKTVLLLADQMISRIEYIHSKN- 125
Query: 625 VPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSRTHTMIR------GTRGYVA 675
IH D+KP N L+ I DFGL+K ++ H R GT Y +
Sbjct: 126 --FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLE 699
S + D+ S G +L+
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMY 207
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 33/171 (19%), Positives = 61/171 (35%), Gaps = 23/171 (13%)
Query: 513 LGRGSFGIVYKGV-LKSASGKAIAVKKLDRLAQER-EREFK-----SEVSAIGRTHHKNL 565
+G G FG++Y A V K++ E K ++ I + +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 566 VQLLGF----------CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARG 615
+ LG R +V E +G L + + +++ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDV 163
Query: 616 LVYLHEECNVPIIHCDIKPQNILLDNYFSAKI--SDFGLSKLLLSDQSRTH 664
L Y+HE +H DIK N+LL ++ +D+GLS + +
Sbjct: 164 LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 43/204 (21%), Positives = 82/204 (40%), Gaps = 26/204 (12%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKNLV 566
++G GSFG +Y G + + +A+K + + E + + +
Sbjct: 13 RKIGSGSFGEIYLGT-NIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGG-----TGIP 66
Query: 567 QLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEIARGLVYLHEECN 624
+ F E +LV + +G +L +L + +L+ + ++ ++ + ++H +
Sbjct: 67 NVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRK-LSLKTVLMLADQMINRVEFVHSKS- 123
Query: 625 VPIIHCDIKPQNILLDNYFSAK---ISDFGLSKLLLSDQSRTHTMIR------GTRGYVA 675
+H DIKP N L+ A I DFGL+K + H R GT Y +
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181
Query: 676 PEWFKNAPVSAKVDVYSFGVMLLE 699
S + D+ S G +L+
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMY 205
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 40/224 (17%), Positives = 78/224 (34%), Gaps = 44/224 (19%)
Query: 513 LGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQEREREFK-----SEVSAIGRTHHK 563
+G+G FG +Y + S S VK E K ++ I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 564 NLVQLLGFC----------DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR-------V 606
++ LG + R ++ + G+ L + + N + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIY------EANAKRFSRKTVL 155
Query: 607 RISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKI--SDFGLSKLLLSDQSRTH 664
++SL I L Y+HE +H DIK N+LL+ ++ D+GL+ +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 665 ------TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC 702
GT + + + S + D+ G +++ +
Sbjct: 213 YAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLT 256
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 7e-07
Identities = 33/164 (20%), Positives = 65/164 (39%), Gaps = 26/164 (15%)
Query: 513 LGRGSFGIVYKGV------LKSASGKAIAVKKLD----RLAQER---EREFKSEVSAIGR 559
R + GI+Y+ S K KLD RL E+ +R K +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 560 THHKNLV----QLLGF-CDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLR--VRISLEI 612
+ + +GF + R LV +G +L + + PK + R ++++ +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACRL 168
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKI--SDFGLSK 654
L +LHE +H ++ +NI +D +++ + +G +
Sbjct: 169 LDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 1e-04
Identities = 55/366 (15%), Positives = 104/366 (28%), Gaps = 112/366 (30%)
Query: 2 DSLALPCLILLCFPLLQFLSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDL 61
++ L C ILL TT + +++ ++ +S + + S
Sbjct: 260 NAFNLSCKILL-----------TTRFKQVTDFLSAATTTHIS-LDHHSMTLTPDEVKS-- 305
Query: 62 FLLAIWFNKIPERTIVWHANGDNP--APRGSTLELTATGLLLKDPGGKTIWDGKPDKKVS 119
LL + + P+ D P + L+ ++D G WD K V+
Sbjct: 306 -LLLKYLDCRPQ---------DLPREVLTTNPRRLSIIAESIRD--GLATWDNW--KHVN 351
Query: 120 DAAMLDTGNFVLRASGNN--SDYAWQSFKN----PTDTILPTQILDLDSVLISRLTETNF 173
+ + +S N + F P +PT +L S++ + +++
Sbjct: 352 CDKLTTI----IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL---SLIWFDVIKSD- 403
Query: 174 SKGRFELRFSNGSL--KLISVAWPSRFQYKSY--YTSNTGSANSTGSGHQLVFNESADVY 229
+ SL K P Y + + H+ + + Y
Sbjct: 404 -VMVVVNKLHKYSLVEK-----QPKESTISIPSIYLELKVKLENEYALHRSIVDH----Y 453
Query: 230 IVKDNGQIVQLPQWAKLSPRVDHYF---------------------RVTLDFDGVLAEYA 268
+ + P +D YF V LDF + +
Sbjct: 454 NIPKT-----FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 269 HPKNSSTNQSWFPTRTLPDD----------ICR------RLFNEIGS--GTCGFNSY--- 307
H + +W + ++ + IC RL N I N
Sbjct: 509 H-----DSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
Query: 308 --CLLQ 311
LL+
Sbjct: 564 YTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 5e-04
Identities = 62/435 (14%), Positives = 111/435 (25%), Gaps = 131/435 (30%)
Query: 266 EYAHPKNSSTNQSWFPTRTLPDDICR-RLFNEI-------------------GSG-TCGF 304
+ + NQ F ++ R + + ++ GSG T
Sbjct: 113 IEQRDRLYNDNQV-FA----KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVA 167
Query: 305 NSYCL---LQNGRPF---------CDCPPGYVLADPNNRFRGCKPNFWQGCGPDDGSRNA 352
CL +Q F C+ P VL PN+ D S N
Sbjct: 168 LDVCLSYKVQCKMDFKIFWLNLKNCNSP-ETVLEMLQKLLYQIDPNWTSRS---DHSSN- 222
Query: 353 QELYEIREFNNVDWPFGDYERLEPYNQTECEISCLH--DCLCAVAIYD--GNRCWKKKLP 408
+++ + +PY CL + ++ C K L
Sbjct: 223 ----IKLRIHSIQAELRRLLKSKPYEN------CLLVLLNVQNAKAWNAFNLSC--KILL 270
Query: 409 LSNGWLRDTGFSKVLFKVRKGNFPGYSDNSG-SKKERGPLFLLGAFLLGGSIF------C 461
+ R + L + + + E L L L
Sbjct: 271 TT----RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK---YLDCRPQDLPREVL 323
Query: 462 NAFLLLAILI--FLK-----WRRRKYENNVQDSSTSETNLRFFSYNELKEATGGFKEELG 514
+I ++ W K+ N + ++ E++L E ++ F
Sbjct: 324 TTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKM---FDR--- 377
Query: 515 RGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE 574
+ I L + + + +V + ++
Sbjct: 378 ---LSVFPPSAH-------IPTILLSLIWFDVIKS---DVMVV--------------VNK 410
Query: 575 ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC----NVPIIHC 630
LV +I P L +++ LE LH N+P
Sbjct: 411 LHKYSLV-----EKQPKESTISI--PSIYLELKVKLE---NEYALHRSIVDHYNIPKTFD 460
Query: 631 --DIKPQNILLDNYF 643
D+ P LD YF
Sbjct: 461 SDDLIPPY--LDQYF 473
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 22/124 (17%), Positives = 43/124 (34%), Gaps = 23/124 (18%)
Query: 25 TINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDN 84
+ G L + S E + F Q + N L ++ + W +N
Sbjct: 3 LLTNGEGLYAGQSLDV-----EPYHFIM-QEDCN-----LVLYDHSTSV----WASNTGI 47
Query: 85 PAPRGSTLELTATG-LLLKDPGGKTIWDGKPDKKVSD--AAMLDTGNFVLRASGNNSDYA 141
+G L + G ++ D G+++W + + + + GN V+ SD
Sbjct: 48 LGKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY----GSDI- 102
Query: 142 WQSF 145
W +
Sbjct: 103 WSTG 106
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 799 | |||
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 99.98 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.98 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.94 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.83 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.74 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.72 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.71 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.7 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.62 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.57 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.43 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.4 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.39 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.37 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.32 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.3 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.04 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 98.95 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.87 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 98.83 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 98.82 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 98.66 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.63 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.53 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.52 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 98.37 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.24 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 98.16 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.13 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.03 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.95 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.9 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.63 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.4 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.36 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.2 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.13 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.6 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.28 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.22 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.2 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.09 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.82 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.68 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.97 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.8 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.79 | |
| 3no2_A | 276 | Uncharacterized protein; six-bladed beta-propeller | 87.57 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.27 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.97 |
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=443.33 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=207.3
Q ss_pred chhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.++||+|+||+||+|.++. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+....+||||
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~E 123 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 456889999999999998752 3578999999987766777899999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 584 FMGNGTLANLIFAI---------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 584 ~~~~gsL~~~l~~~---------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
||++|+|.++++.. ..++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+
T Consensus 124 y~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~ 200 (329)
T 4aoj_A 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIG 200 (329)
T ss_dssp CCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEEC
T ss_pred cCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEc
Confidence 99999999999753 2488999999999999999999998 89999999999999999999999
Q ss_pred cccCcccccCCC-CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHH
Q 038294 649 DFGLSKLLLSDQ-SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 649 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......+ +...
T Consensus 201 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--------~~~~ 272 (329)
T 4aoj_A 201 DFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--------AIDC 272 (329)
T ss_dssp CCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--------HHHH
T ss_pred ccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--------HHHH
Confidence 999999764433 223344569999999999999999999999999999999999 899997654322 1222
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+..+... ..+ ....+.+.+++.+||+.||++||||+||++.|+.+.+.
T Consensus 273 i~~g~~~-----~~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 273 ITQGREL-----ERP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHTCCC-----CCC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHcCCCC-----CCc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 3333211 111 22335788899999999999999999999999998775
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=442.13 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=212.9
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
...+.++||+|+||+||+|.+.. .+++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..+||
T Consensus 14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV 93 (299)
T 4asz_A 14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMV 93 (299)
T ss_dssp GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEE
T ss_pred HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 34567899999999999998752 35688999999877667778999999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 582 YEFMGNGTLANLIFAI-------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
||||++|+|.++|... ..++|.++++|+.|||+||+|||++ +||||||||+||||++++.+||+
T Consensus 94 ~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 94 FEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999753 3689999999999999999999998 89999999999999999999999
Q ss_pred cccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHH
Q 038294 649 DFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 649 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
|||+++........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||......+ +...
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--------~~~~ 242 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--------VIEC 242 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--------HHHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--------HHHH
Confidence 99999876443322 2223458999999999999999999999999999999999 899997654322 2223
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+..+.... .+ ....+.+.+++.+||+.||++||||+||++.|+++.+
T Consensus 243 i~~~~~~~-----~p----~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 243 ITQGRVLQ-----RP----RTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCCC-----CC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33333211 11 2234578889999999999999999999999998765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=437.90 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=214.0
Q ss_pred HHHHHhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 501 ELKEATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 501 ~l~~~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
|+...+..|.++||+|+||+||+|.+.. .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 3444556788999999999999999742 356899999997543 33457899999999999999999999999999
Q ss_pred cceeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 576 LNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
...+||||||++|+|.++|... ..++|..+++|+.|||+||+|||+. +||||||||+||||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl 178 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLV 178 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEE
Confidence 9999999999999999999642 3578999999999999999999998 89999999999999
Q ss_pred cCCCceEEccccCcccccCCC-CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 640 DNYFSAKISDFGLSKLLLSDQ-SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
++++.+||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||......+
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~--- 255 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD--- 255 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998764432 223344568999999999999999999999999999999999 889997654322
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+...+..+.... . +......+.+++.+||+.||++||||+||++.|+....
T Consensus 256 -----~~~~i~~~~~~~-----~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 256 -----VVEMIRNRQVLP-----C----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -----HHHHHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -----HHHHHHcCCCCC-----C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 223334433211 1 12234568889999999999999999999999987543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-50 Score=427.03 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=200.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
..+.++||+|+||+||+|+++ ..||||+++.. ..+..++|.+|++++++++|||||+++|+|.+ +..+|||||
T Consensus 38 l~l~~~iG~G~fG~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 38 VMLSTRIGSGSFGTVYKGKWH----GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp CCEEEECCCCSSSEEEEEESS----SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred eEEeeEEeeCCCcEEEEEEEC----CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 346788999999999999875 25999998643 33455789999999999999999999999865 468999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Cc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~ 662 (799)
|++|+|.++|... ..++|.++++|+.|||+||+|||+. +||||||||+||||++++.+||+|||+|+...... ..
T Consensus 113 ~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 113 CEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp CSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred CCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 9999999999765 5799999999999999999999998 89999999999999999999999999998764332 22
Q ss_pred ceeeeccCCcccccccccC---CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 THTMIRGTRGYVAPEWFKN---APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~---~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
......||+.|||||++.+ .+|+.++|||||||+||||+||+.||....... .....+..+... +.
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~-------~~~~~~~~~~~~----p~ 258 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD-------QIIFMVGRGYAS----PD 258 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHHHHHTTCCC----CC
T ss_pred eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcCCCC----CC
Confidence 3344679999999999964 468999999999999999999999997543221 112222222211 11
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.+ .......+.+.+++.+||+.||++||||.||++.|+.+
T Consensus 259 ~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 259 LS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp ST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11 11223346788899999999999999999999999764
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=417.73 Aligned_cols=248 Identities=25% Similarity=0.335 Sum_probs=207.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.++||+|+||+||+|..+. +|+.||||+++.......+.+.+|+++|++++|||||++++++.+++..+|||||++
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~ 154 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 154 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred cEEeEEeecCcCeEEEEEEECC-CCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCC
Confidence 3445789999999999999875 689999999976555556678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.. ..+++..+..++.||+.||+|||++ +||||||||+||||+.++.+||+|||+++.+..... ....
T Consensus 155 gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 229 (346)
T 4fih_A 155 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 229 (346)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cccc
Confidence 9999999976 4689999999999999999999998 999999999999999999999999999987654332 2334
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||......+. ...+..+.. +..+ ...
T Consensus 230 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~--------~~~i~~~~~-----~~~~--~~~ 294 (346)
T 4fih_A 230 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA--------MKMIRDNLP-----PRLK--NLH 294 (346)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--------HHHHHHSSC-----CCCS--CGG
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------HHHHHcCCC-----CCCC--ccc
Confidence 5799999999999999999999999999999999999999976543221 112222110 1111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33467888999999999999999999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-48 Score=407.69 Aligned_cols=246 Identities=29% Similarity=0.432 Sum_probs=199.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec----ccceeeEE
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLVY 582 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~ 582 (799)
+.++||+|+||+||+|.++. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....+|||
T Consensus 30 ~~~~iG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 30 FDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred eeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55789999999999999875 6889999998643 23345679999999999999999999999864 34578999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~ 661 (799)
|||++|+|.+++.....+++..+..++.||+.||+|||++ .++||||||||+||||+. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~-- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-- 185 (290)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT--
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC--
Confidence 9999999999999888899999999999999999999997 123999999999999984 799999999999864322
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......||+.|||||++.+ +|+.++|||||||+||||+||+.||....... .+...+..+.. +
T Consensus 186 -~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-------~~~~~i~~~~~--------~ 248 (290)
T 3fpq_A 186 -FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVK--------P 248 (290)
T ss_dssp -SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCC--------C
T ss_pred -ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-------HHHHHHHcCCC--------C
Confidence 2344679999999999875 69999999999999999999999996432211 12222333221 1
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+....+.+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 249 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1112222346788999999999999999999975
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=416.98 Aligned_cols=249 Identities=25% Similarity=0.233 Sum_probs=203.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.++||+|+||+||+|+.+. +++.||||+++... ...+|+.++++++|||||++++++.++...+|||||+++
T Consensus 61 ~~~~~lG~G~fG~Vy~a~~~~-~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~g 134 (336)
T 4g3f_A 61 THQPRVGRGSFGEVHRMKDKQ-TGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEG 134 (336)
T ss_dssp EEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred EeCcEeccCCCeEEEEEEECC-CCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCC
Confidence 345679999999999999875 68999999996432 224699999999999999999999999999999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCCCc----
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSR---- 662 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~---- 662 (799)
|+|.++|.....+++..+..++.||+.||+|||++ +||||||||+||||+.++ .+||+|||+|+.+......
T Consensus 135 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~ 211 (336)
T 4g3f_A 135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLL 211 (336)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----------
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccccee
Confidence 99999999888899999999999999999999998 999999999999999987 6999999999977543221
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|||||++.+..|+.++|||||||+||||++|+.||......+. +.. +..+.. ...
T Consensus 212 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~-----i~~~~~-------~~~ 276 (336)
T 4g3f_A 212 TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK-----IASEPP-------PIR 276 (336)
T ss_dssp --CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH-----HHHSCC-------GGG
T ss_pred cCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH-----HHcCCC-------Cch
Confidence 12235799999999999999999999999999999999999999976543321 111 111110 001
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
..+....+.+.+++.+||+.||++|||+.|+++.|+..
T Consensus 277 ~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~ 314 (336)
T 4g3f_A 277 EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314 (336)
T ss_dssp GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 11223345778899999999999999999999887653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=413.19 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=202.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc----ceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL----NRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 583 (799)
.+.++||+|+||+||+|++ .|+.||||+++.... ....+..|+..+.+++|||||+++|+|.++. ..+||||
T Consensus 6 ~L~~~iG~G~fG~Vy~~~~---~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 6 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEEECSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 4568899999999999997 478999999975322 2233456777788899999999999997654 4689999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC-----NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
||++|+|.++|+. ..++|+.+.+|+.|+|+||+|||+++ .++||||||||+||||+.++++||+|||+++....
T Consensus 82 y~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 160 (303)
T 3hmm_A 82 YHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred CCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence 9999999999976 46899999999999999999999862 45899999999999999999999999999987654
Q ss_pred CCCc---ceeeeccCCcccccccccCC------CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhc--------chhHHH
Q 038294 659 DQSR---THTMIRGTRGYVAPEWFKNA------PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG--------RAILTD 721 (799)
Q Consensus 659 ~~~~---~~~~~~gt~~y~aPE~l~~~------~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~ 721 (799)
.... ......||+.|||||++.+. .++.++|||||||+||||+||+.|+........ .... .
T Consensus 161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~-~ 239 (303)
T 3hmm_A 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-E 239 (303)
T ss_dssp TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-H
T ss_pred CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH-H
Confidence 3322 12235699999999999764 467899999999999999999877643321110 0011 1
Q ss_pred HHHHHHhcCceeEeecCCCCCc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 722 WAYDCYAEGRLDVLVDSDEPAM-ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 722 ~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.....+.++. ..+..+.. .+.+..+.+.+++.+||+.||++||||.||++.|+++.+
T Consensus 240 ~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 240 EMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 1222222222 12222222 234566788899999999999999999999999987654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-48 Score=415.90 Aligned_cols=247 Identities=22% Similarity=0.321 Sum_probs=199.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.++||+|+||+||+|+.+. +++.||||+++.. .....+.|.+|++++++++|||||++++++.++...+|||||
T Consensus 26 Y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy 104 (350)
T 4b9d_A 26 YVRLQKIGEGSFGKAILVKSTE-DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDY 104 (350)
T ss_dssp EEEEEEC------CEEEEEETT-TCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 4566889999999999999875 6899999998643 334456899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++|+|.++|...+ .+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+...... .
T Consensus 105 ~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 180 (350)
T 4b9d_A 105 CEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-E 180 (350)
T ss_dssp CTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-H
T ss_pred CCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCc-c
Confidence 99999999997543 568889999999999999999998 99999999999999999999999999998764321 1
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|||||++.+..|+.++|||||||+||||++|+.||......+ ....+..+... .
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~~-----~--- 244 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN--------LVLKIISGSFP-----P--- 244 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCC-----C---
T ss_pred cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCCC-----C---
Confidence 2234569999999999999999999999999999999999999998654322 11122222211 1
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+|+.+||+.||++|||+.|+++
T Consensus 245 -~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 -VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223457888999999999999999999985
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=421.48 Aligned_cols=263 Identities=27% Similarity=0.364 Sum_probs=212.2
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCC----CCeEEEEEEccccch-hhHHHHHHHHHHhcccc-cccccceeeeeecc
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTH-HKNLVQLLGFCDEA 575 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~ 575 (799)
+......+.++||+|+||+||+|.+... .++.||||+++.... ...++|.+|+++|.+++ |||||+++|+|.+.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 3344556678999999999999998642 236899999976433 34568999999999995 59999999999764
Q ss_pred -cceeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 038294 576 -LNRLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNIL 638 (799)
Q Consensus 576 -~~~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NIL 638 (799)
...+||||||++|+|.++|+.. ..++|..++.|+.|||+||+|||++ +||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCcccee
Confidence 5689999999999999999753 2478999999999999999999998 8999999999999
Q ss_pred EcCCCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcc
Q 038294 639 LDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGR 716 (799)
Q Consensus 639 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~ 716 (799)
|++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||+||||+| |+.||......+
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-- 295 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-- 295 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH--
Confidence 999999999999999977554332 2334568999999999999999999999999999999998 899997543221
Q ss_pred hhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
.+...+.++... ..+. ...+.+.+++.+||+.||++||||.||++.|+.+++.
T Consensus 296 -----~~~~~i~~g~~~-----~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 296 -----EFCRRLKEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp -----HHHHHHHHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHcCCCC-----CCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 122233333211 1111 2235778899999999999999999999999987754
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=406.12 Aligned_cols=246 Identities=24% Similarity=0.305 Sum_probs=208.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||+||+|+.+. +++.||||+++.. .....+.+.+|++++++++|||||++++++.+.+..+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE 112 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 112 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEecccCeEEEEEEECC-CCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 5567899999999999999875 6899999999653 22345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-c
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-R 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~ 662 (799)
|+++|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+|+.+..... .
T Consensus 113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 999999999999888899999999999999999999998 999999999999999999999999999998754332 2
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....+||+.|||||++.+..|+.++||||+||+||||++|+.||......+ ....+..+.. ..+.
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~------~~p~ 255 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL--------IFAKIIKLEY------DFPE 255 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCC------CCCT
T ss_pred cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCC------CCCc
Confidence 3345679999999999999999999999999999999999999998654332 1222233322 1122
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
...+.+.+++.+||+.||++|||++|++
T Consensus 256 ----~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 256 ----KFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ----TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ----ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 2235678899999999999999999863
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=418.48 Aligned_cols=248 Identities=25% Similarity=0.338 Sum_probs=207.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.++||+|+||.||+|..+. +|+.||||++........+.+.+|+.+|++++|||||++++++.+++..+||||||+
T Consensus 153 y~~~~~iG~G~fG~V~~a~~~~-tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~ 231 (423)
T 4fie_A 153 LDNFIKIGEGSTGIVCIATVRS-SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 231 (423)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEeeeEeccCcCcEEEEEEECC-CCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCC
Confidence 3456789999999999999875 689999999976555555678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.. ..+++..+..|+.||+.||+|||++ +||||||||+||||+.++.+||+|||+|+.+..... ....
T Consensus 232 gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~~~ 306 (423)
T 4fie_A 232 GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 306 (423)
T ss_dssp TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-CBCC
T ss_pred CCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-cccc
Confidence 9999999875 4689999999999999999999998 999999999999999999999999999987654332 2334
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||......+ +...+..+.. +... ...
T Consensus 307 ~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--------~~~~i~~~~~-----~~~~--~~~ 371 (423)
T 4fie_A 307 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--------AMKMIRDNLP-----PRLK--NLH 371 (423)
T ss_dssp CEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHSCC-----CCCS--CTT
T ss_pred cccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--------HHHHHHcCCC-----CCCc--ccc
Confidence 579999999999999999999999999999999999999997654322 1122222111 1111 112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+|+.+||+.||++|||+.|+++
T Consensus 372 ~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 372 KVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 23457788999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=393.17 Aligned_cols=244 Identities=24% Similarity=0.374 Sum_probs=192.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||+||+|..+. +++.||||+++... ....+.+.+|++++++++|||||++++++.+.+..++|||
T Consensus 15 Y~i~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 15 YQIVKTLGEGSFGKVKLAYHTT-TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CEEEEEEEC---CCEEEEECTT-TCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 4567899999999999999874 68999999986432 2334679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+ +|+|.+++.....+++.....++.||+.||+|||++ +|+||||||+||||++++++||+|||+|+...... .
T Consensus 94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--~ 167 (275)
T 3hyh_A 94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN--F 167 (275)
T ss_dssp CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCC--c
Confidence 99 689999999888999999999999999999999998 99999999999999999999999999998754322 2
Q ss_pred eeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....||+.|||||++.+..+ +.++||||+||+||||++|+.||......+ ..+.+..+... .+.
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~--------~~~~i~~~~~~------~p~ 233 (275)
T 3hyh_A 168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV--------LFKNISNGVYT------LPK 233 (275)
T ss_dssp -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCC------CCT
T ss_pred cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCC------CCC
Confidence 334579999999999998886 579999999999999999999997643322 12223333211 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+.+++.+||+.||++|||++|+++
T Consensus 234 ----~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 234 ----FLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22356788999999999999999999986
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=398.53 Aligned_cols=247 Identities=24% Similarity=0.262 Sum_probs=197.6
Q ss_pred hchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||+||+|+... .+++.||||+++... ......+.+|++++++++|||||++++++.++...++||
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 105 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLIL 105 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5567899999999999998742 356899999986432 223346889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+.......
T Consensus 106 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 181 (304)
T 3ubd_A 106 DFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 181 (304)
T ss_dssp CCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C-
T ss_pred EcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc-
Confidence 9999999999999888899999999999999999999998 999999999999999999999999999986543322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|||||++.+..|+.++||||+||+||||++|+.||......+ ....+..+.. ..+.
T Consensus 182 ~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~------~~p~ 247 (304)
T 3ubd_A 182 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE--------TMTMILKAKL------GMPQ 247 (304)
T ss_dssp CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCCT
T ss_pred cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH--------HHHHHHcCCC------CCCC
Confidence 2334579999999999999999999999999999999999999998654332 1122222221 1122
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
...+.+.+++.+||+.||++||| ++|+++
T Consensus 248 ----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 248 ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 23356788999999999999998 467764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=387.51 Aligned_cols=246 Identities=22% Similarity=0.350 Sum_probs=186.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccc--------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-------- 577 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------- 577 (799)
+.+.+.||+|+||+||+|..+. +++.||||+++.... ...+.+.+|++++++++|||||++++++.+.+.
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~ 85 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS 85 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETT-TCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred CEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence 4456889999999999999874 689999999865333 344679999999999999999999999865443
Q ss_pred ----eeeEEeecCCCChhhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 578 ----RLLVYEFMGNGTLANLIFAIPK---PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 578 ----~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
.++||||+++|+|.+++..... .++..++.|+.||++||+|||++ +|+||||||+||||+.++.+||+||
T Consensus 86 ~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 86 PKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp -CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC
T ss_pred CCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccC
Confidence 5899999999999999987543 45667889999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCc-----------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhH
Q 038294 651 GLSKLLLSDQSR-----------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 651 Gla~~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~ 719 (799)
|+|+.+...... .....+||+.|||||++.+..|+.++|||||||+||||++ ||....+..
T Consensus 163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~----- 234 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERV----- 234 (299)
T ss_dssp CCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH-----
T ss_pred ccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHH-----
Confidence 999877543221 1223469999999999999999999999999999999996 775432111
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. ....+..... +. ........+.+++.+||+.||++|||+.|+++
T Consensus 235 -~-~~~~~~~~~~--------p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 235 -R-TLTDVRNLKF--------PP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp -H-HHHHHHTTCC--------CH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -H-HHHHHhcCCC--------CC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 1111122211 11 11223345677999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=382.92 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=200.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeec------ccce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 578 (799)
+.+.+.||+|+||+||+|..+. +|+.||||+++... ....+.+.+|+++|++++|||||++++++.. ....
T Consensus 56 Y~~~~~lG~G~fG~V~~a~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~ 134 (398)
T 4b99_A 56 YEIIETIGNGAYGVVSSARRRL-TGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134 (398)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCE
T ss_pred eEEEEEEecccCeEEEEEEECC-CCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEE
Confidence 4556889999999999999875 68999999996532 2344678899999999999999999998753 3567
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
+|||||++ |+|.+++.....+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++.+..
T Consensus 135 ~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 135 YVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp EEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 99999996 68999999888999999999999999999999998 999999999999999999999999999987643
Q ss_pred CC---CcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH-------H
Q 038294 659 DQ---SRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC-------Y 727 (799)
Q Consensus 659 ~~---~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~ 727 (799)
.. .......+||+.|||||++.+. .++.++||||+||++|||++|+.||......+....+....... .
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~ 290 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC--
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhh
Confidence 22 2223446799999999998875 56999999999999999999999998665433221111100000 0
Q ss_pred hcCceeEe---ecCCCCC---ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 728 AEGRLDVL---VDSDEPA---MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 728 ~~~~~~~~---~d~~~~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........ ..+..+. .......+.+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp ---CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000 0000000 000112356788999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=372.54 Aligned_cols=289 Identities=40% Similarity=0.693 Sum_probs=243.3
Q ss_pred CCccccChHHHHHHhhchh--hhcCccccceEEEEEEeCCCCeEEEEEEccccchh-hHHHHHHHHHHhcccccccccce
Q 038294 492 TNLRFFSYNELKEATGGFK--EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-REREFKSEVSAIGRTHHKNLVQL 568 (799)
Q Consensus 492 ~~~~~~~~~~l~~~~~~~~--~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~niv~l 568 (799)
...+.+++.++......+. +.||+|+||.||+|..+ +++.||||++...... ....+.+|++++++++||||+++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 92 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA--DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL 92 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS--SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEec--CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence 3456788888888777664 68999999999999865 5789999999754322 23478999999999999999999
Q ss_pred eeeeecccceeeEEeecCCCChhhhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc
Q 038294 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIP----KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS 644 (799)
Q Consensus 569 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~ 644 (799)
++++......++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+..+|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 999999999999999999999999998653 4899999999999999999999986668999999999999999999
Q ss_pred eEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhh-hcchhHHHHH
Q 038294 645 AKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE-EGRAILTDWA 723 (799)
Q Consensus 645 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~-~~~~~~~~~~ 723 (799)
+||+|||+++..............||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ........+.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 999999999887655544455566999999999999889999999999999999999999999754322 2233344555
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+....+............+.+.+++.+||+.||++|||+.||+++|++...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 55556666677777777777788899999999999999999999999999999987443
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=368.95 Aligned_cols=272 Identities=37% Similarity=0.655 Sum_probs=232.3
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.+.||+|+||.||+|.++ +++.||||++........+.+.+|++++++++||||+++++++.+....++||||+++|
T Consensus 43 ~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 120 (321)
T 2qkw_B 43 HKFLIGHGVFGKVYKGVLR--DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120 (321)
T ss_dssp CCCCSCBCSSSEEEEEECT--TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTC
T ss_pred ccceeecCCCeeEEEEEEC--CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCC
Confidence 3568999999999999975 57899999997766666778999999999999999999999999999999999999999
Q ss_pred ChhhhhhcCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Ccc
Q 038294 589 TLANLIFAIP----KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRT 663 (799)
Q Consensus 589 sL~~~l~~~~----~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~ 663 (799)
+|.+++.... .+++..+.+++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 121 ~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 197 (321)
T 2qkw_B 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197 (321)
T ss_dssp BTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCC
T ss_pred cHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 9999997643 588999999999999999999998 99999999999999999999999999998654322 222
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+... ...+.......+.+...+++.....
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T 2qkw_B 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN-LAEWAVESHNNGQLEQIVDPNLADK 276 (321)
T ss_dssp BCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCC-HHHHTHHHHTTTCCCSSSSSSCTTC
T ss_pred ccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHH-HHHHhhhccccccHHHhcChhhccc
Confidence 233458999999999999999999999999999999999999997654433322 2344555556667777777777777
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 786 (799)
......+.+.+++.+||+.||++|||+.||++.|+.++.+..+
T Consensus 277 ~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~ 319 (321)
T 2qkw_B 277 IRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQES 319 (321)
T ss_dssp SCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCC
T ss_pred cCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccC
Confidence 7788899999999999999999999999999999988766543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=371.72 Aligned_cols=197 Identities=19% Similarity=0.314 Sum_probs=167.6
Q ss_pred hchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.++||+|+||+||+|+.+. .+++.||+|++... .....+.+|+++|..+ +||||+++++++.+.+..++|||
T Consensus 23 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE 100 (361)
T 4f9c_A 23 FKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMP 100 (361)
T ss_dssp CEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEE
T ss_pred EEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEe
Confidence 4566889999999999998752 35689999998653 2345678999999988 69999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEccccCcccccCCCC-
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKLLLSDQS- 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl~DfGla~~~~~~~~- 661 (799)
|+++|+|.+++. .+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 101 ~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~ 174 (361)
T 4f9c_A 101 YLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE 174 (361)
T ss_dssp CCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred CCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence 999999999984 588999999999999999999998 99999999999999876 7999999999986543211
Q ss_pred --------------------------cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 662 --------------------------RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 662 --------------------------~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
......+||+.|||||++.+. .++.++||||+||++|||++|+.||....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 112234699999999999875 58999999999999999999999996543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=394.14 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=208.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||+|..+. +|+.||+|++........+.+.+|+++|+.++|||||++++++.+....+||||||+
T Consensus 159 Y~i~~~lG~G~fg~V~~~~~~~-tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~ 237 (573)
T 3uto_A 159 YDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 237 (573)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred cEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecC
Confidence 4567899999999999999875 789999999976555556788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC--CceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY--FSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~--~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+|.++|... ..+++..+..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+++.+.... .
T Consensus 238 gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~--~ 312 (573)
T 3uto_A 238 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 312 (573)
T ss_dssp CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS--E
T ss_pred CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC--c
Confidence 99999998754 5789999999999999999999998 99999999999999854 899999999999874332 3
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|||||++.+..|+.++||||+||+||||++|+.||......+. ...+..+.. ..+..
T Consensus 313 ~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~--------~~~i~~~~~------~~~~~ 378 (573)
T 3uto_A 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--------LRNVKSCDW------NMDDS 378 (573)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------HHHHHTTCC------CCCSG
T ss_pred eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH--------HHHHHhCCC------CCCcc
Confidence 3445799999999999999999999999999999999999999986544321 122222211 11111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+.+.+|+.+||+.||++|||+.|+++
T Consensus 379 ~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 379 AFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11223456788999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=387.38 Aligned_cols=246 Identities=22% Similarity=0.257 Sum_probs=199.2
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHH---HHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QERER---EFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~---~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
.+.+.||+|+||+||+|+.+. +++.||||+++... ..... +...++.+++.++|||||++++++.+.+..+||
T Consensus 192 ~i~k~LG~G~fG~V~la~~~~-tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 192 SVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred EEEEEEecccCeEEEEEEECC-CCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 456889999999999999875 78999999996422 11222 234456777888999999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|||++||+|.++|.....+++..+..++.||+.||+|||+. +||||||||+||||+.++.+||+|||+|+.+....
T Consensus 271 mEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~- 346 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 346 (689)
T ss_dssp ECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC-
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCC-
Confidence 99999999999999888899999999999999999999998 99999999999999999999999999998765433
Q ss_pred cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
....+||+.|||||++.. ..|+.++|+||+||+||||++|+.||.......... ....+..... ..
T Consensus 347 --~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~-----i~~~i~~~~~------~~ 413 (689)
T 3v5w_A 347 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----IDRMTLTMAV------EL 413 (689)
T ss_dssp --CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH-----HHHHHHHCCC------CC
T ss_pred --CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHHhhcCCCC------CC
Confidence 233579999999999964 579999999999999999999999997654322111 1112222111 11
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
+ ......+.+++.+||+.||++|++ ++||++
T Consensus 414 p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 414 P----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp C----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred C----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 2 223456788999999999999998 677764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=358.48 Aligned_cols=261 Identities=30% Similarity=0.472 Sum_probs=200.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.+.||+|+||+||+|.. .++.||||++.... ....+++.+|++++++++||||+++++++.+....++|||
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW---HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE---TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred HceeeeEeecCCCeEEEEEEE---CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 345568899999999999986 47899999986532 3445689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCC---CCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 584 FMGNGTLANLIFAIPK---PDWNLRVRISLEIARGLVYLHEECNVP--IIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~---~~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
|+++|+|.+++..... +++..+..++.||+.||+|||+. + |+||||||+|||++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 191 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence 9999999999987643 89999999999999999999998 7 99999999999999999999999999986533
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ......... .
T Consensus 192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~~-----~ 258 (309)
T 3p86_A 192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-------AAVGFKCKR-----L 258 (309)
T ss_dssp -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------HHHHHSCCC-----C
T ss_pred cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHhcCCC-----C
Confidence 22 1223346899999999999999999999999999999999999999765432211 111001100 1
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCP 789 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 789 (799)
. .+......+.+++.+||+.||++|||+.||++.|+.+++-..||.+
T Consensus 259 ~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~~ 305 (309)
T 3p86_A 259 E----IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPPN 305 (309)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-------
T ss_pred C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCCC
Confidence 1 1122335688899999999999999999999999998876555544
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=355.03 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=209.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||+|.... +++.||+|++........+.|.+|++++++++||||+++++++.++...++||||++
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 90 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRE-TGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIK 90 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETT-TCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeccceecCCCCEEEEEEEECC-CCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecC
Confidence 3456789999999999999874 688999999877666777889999999999999999999999999999999999999
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc--
Q 038294 587 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT-- 663 (799)
Q Consensus 587 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~-- 663 (799)
+++|.+++.. ...+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 91 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 91 GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999987 46789999999999999999999998 89999999999999999999999999998764332211
Q ss_pred -----------eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc--hhHHHHHHHHHhcC
Q 038294 664 -----------HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR--AILTDWAYDCYAEG 730 (799)
Q Consensus 664 -----------~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~ 730 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|..|+......... .........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----- 242 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----- 242 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-----
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-----
Confidence 11346899999999999999999999999999999999999988654322211 111111100
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+ ....+.+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 243 --------~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 --------YCP----PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --------TCC----TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------cCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 001 1112357789999999999999999999999987654
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=346.61 Aligned_cols=226 Identities=18% Similarity=0.255 Sum_probs=180.2
Q ss_pred hhcccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCC-----CceeEE
Q 038294 20 LSAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPR-----GSTLEL 94 (799)
Q Consensus 20 ~~~~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~-----~s~l~l 94 (799)
+++.++|.+|++|++ +++|+|++|+|+||||++ + + +|| |+ +++ |||+|||++|+.+ +++|+|
T Consensus 11 ~~~~~~l~~g~~l~~---~~~l~S~~g~F~lgf~~~-~--~-~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l 77 (276)
T 3m7h_A 11 GVGTSVLPAYQTLSA---GQYLLSPNQRFKLLLQGD-G--N-LVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPL 77 (276)
T ss_dssp CTTSSEECTTEEBCT---TCEEECTTSSEEEEECTT-S--C-EEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCS
T ss_pred cccCCEecCCCEecC---CCEEEcCCCcEEEEEECC-C--C-eEE---EC--CCC-eEEECCCCCCcCCcccccceEEEE
Confidence 456799999999985 689999999999999943 2 3 778 87 778 9999999999976 569999
Q ss_pred cccc-eEE--EcCCCCEEeccCCCC-------ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcc----cCC
Q 038294 95 TATG-LLL--KDPGGKTIWDGKPDK-------KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQI----LDL 160 (799)
Q Consensus 95 ~~~g-lvl--~~~~~~~vWst~~~~-------~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~k----l~~ 160 (799)
+.|| |+| .|++|++||||+... .++.|+|+|+|||||++ +.+|||| ||||||||||| |..
T Consensus 78 ~~~G~Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~----~~~lWqS--~ptdtlLpg~~~~~~l~~ 151 (276)
T 3m7h_A 78 AFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD----SLALWNG--TPAIPLVPGAIDSLLLAP 151 (276)
T ss_dssp EEEESSSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE----EEEEEES--CTTSCCCCSCTTCEEECS
T ss_pred eCCCcEEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC----CceeeCc--cccccccccccccccccc
Confidence 9999 998 788899999997532 35689999999999986 5699999 99999999999 667
Q ss_pred CceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEecccccEEEEecCceEEE
Q 038294 161 DSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQ 239 (799)
Q Consensus 161 ~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (799)
+++| ++..||++|.|+++|+ +|.++++ ... ...||+++++... . ..+.++..+.+.+++.++..+.
T Consensus 152 g~~L---~S~~dps~G~fsl~l~~dGnlvLy--~~~----~~~yW~Sgt~~~~---~-~~l~l~~dGnLvl~d~~~~~vW 218 (276)
T 3m7h_A 152 GSEL---VQGVVYGAGASKLVFQGDGNLVAY--GPN----GAATWNAGTQGKG---A-VRAVFQGDGNLVVYGAGNAVLW 218 (276)
T ss_dssp SEEE---CTTCEEEETTEEEEECTTSCEEEE--CTT----SSEEEECCCTTTT---C-CEEEECTTSCEEEECTTSCEEE
T ss_pred Cccc---ccCCCCCCceEEEeecCCceEEEE--eCC----CeEEEECCCCCCc---c-EEEEEcCCCeEEEEeCCCcEEE
Confidence 7888 6688999999999999 6655442 221 2689999887542 2 5677888888888877665555
Q ss_pred ecccccCCCCcceEEEEEEccCCcEEEEEecCCCCCCcceeeEeecCcc
Q 038294 240 LPQWAKLSPRVDHYFRVTLDFDGVLAEYAHPKNSSTNQSWFPTRTLPDD 288 (799)
Q Consensus 240 ~~~~~~~~~~~~~~~r~~L~~dG~l~~~~~~~~~~~~~~W~~~~~~p~~ 288 (799)
.+... . ...+|++|+.||++++|.| ...|..++..|+.
T Consensus 219 sS~t~---~--~~~~rl~Ld~dGnLvly~~------~~~Wqsf~~~P~~ 256 (276)
T 3m7h_A 219 HSHTG---G--HASAVLRLQANGSIAILDE------KPVWARFGFQPTY 256 (276)
T ss_dssp ECSCT---T--CTTCEEEECTTSCEEEEEE------EEEEESSSCCTTS
T ss_pred EecCC---C--CCCEEEEEcCCccEEEEcC------CCeEEccCccCCc
Confidence 44311 1 1237999999999999998 2458888888765
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=349.06 Aligned_cols=248 Identities=25% Similarity=0.349 Sum_probs=205.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||+|.... +++.||||++........+.+.+|+.++++++||||+++++++..+...++||||++
T Consensus 22 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 100 (297)
T 3fxz_A 22 YTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (297)
T ss_dssp BCCCEEEEEETTEEEEEEEBTT-TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eeeeeeeccCCCeEEEEEEECC-CCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCC
Confidence 3445789999999999999764 688999999976555566788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......... ...
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~ 175 (297)
T 3fxz_A 101 GGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RST 175 (297)
T ss_dssp TCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC-BCC
T ss_pred CCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccc-cCC
Confidence 99999999764 588999999999999999999998 9999999999999999999999999999876543332 234
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......+.. ......
T Consensus 176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~~~~~~~~--------~~~~~~ 240 (297)
T 3fxz_A 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTP--------ELQNPE 240 (297)
T ss_dssp CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHHCSC--------CCSCGG
T ss_pred ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC--------CCCCcc
Confidence 5689999999999999999999999999999999999999975543221 1111111110 011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 33456788999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=357.06 Aligned_cols=265 Identities=25% Similarity=0.382 Sum_probs=210.7
Q ss_pred HhhchhhhcCccccceEEEEEEeCC--CCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.+.+.||+|+||.||+|.+... .+..||||+++.. .....+.|.+|+.++++++||||+++++++.++...++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 3445568899999999999998632 2456999999754 334456899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 205 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205 (325)
T ss_dssp EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence 9999999999999765 5789999999999999999999998 99999999999999999999999999998765433
Q ss_pred Ccc--eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 661 SRT--HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 661 ~~~--~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+..
T Consensus 206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--------~~~~~~~~~~----- 272 (325)
T 3kul_A 206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD--------VISSVEEGYR----- 272 (325)
T ss_dssp -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCC-----
T ss_pred cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHcCCC-----
Confidence 222 222345778999999999999999999999999999999 999987554322 1112222211
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCP 789 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 789 (799)
..........+.+++.+||+.||++|||+.||++.|+.++..+....+
T Consensus 273 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~~~ 320 (325)
T 3kul_A 273 ----LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESLRA 320 (325)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC----
T ss_pred ----CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccccc
Confidence 011223345788899999999999999999999999998876554433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=359.15 Aligned_cols=257 Identities=26% Similarity=0.372 Sum_probs=209.2
Q ss_pred hhchhhhcCccccceEEEEEEeC------CCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccc
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS------ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 577 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 577 (799)
.+.+.+.||+|+||.||+|.... .++..||||+++... ....+++.+|+.+++++ +||||+++++++.+...
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 161 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGP 161 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCC
Confidence 34566889999999999998742 245689999997543 34456899999999999 89999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 578 RLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
.++||||+++|+|.+++.... .+++..+++++.||+.||+|||+. +|+||||||+|||++.
T Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~ 238 (370)
T 2psq_A 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTE 238 (370)
T ss_dssp CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECC
Confidence 999999999999999997643 478899999999999999999998 9999999999999999
Q ss_pred CCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhH
Q 038294 642 YFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~ 719 (799)
++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~----- 313 (370)
T 2psq_A 239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE----- 313 (370)
T ss_dssp TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----
T ss_pred CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence 99999999999987644322 12223446789999999999999999999999999999999 999987543322
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
....+..+... ..+......+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 314 ---~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 ---LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ---HHHHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122222211 1112234578889999999999999999999999998764
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.78 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=212.9
Q ss_pred cccChHHHHHHhhc------------hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc
Q 038294 495 RFFSYNELKEATGG------------FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH 562 (799)
Q Consensus 495 ~~~~~~~l~~~~~~------------~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h 562 (799)
+.+++++++.++.. ..+.||+|+||.||+|..+. +++.||||++........+.+.+|+.++++++|
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKH-SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECC-CCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 45778888877753 23579999999999999864 688999999976555566789999999999999
Q ss_pred ccccceeeeeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 038294 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 563 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~ 642 (799)
|||+++++++......++||||+++++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~ 177 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLD 177 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTT
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCC
Confidence 9999999999999999999999999999998865 4689999999999999999999998 99999999999999999
Q ss_pred CceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH
Q 038294 643 FSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW 722 (799)
Q Consensus 643 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~ 722 (799)
+.+||+|||++........ ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus 178 ~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~------- 249 (321)
T 2c30_A 178 GRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------- 249 (321)
T ss_dssp CCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------
T ss_pred CcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------
Confidence 9999999999987654322 22345689999999999999999999999999999999999999975433221
Q ss_pred HHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 723 AYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 723 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+..... +... ........+.+++.+||+.||++|||+.|+++.
T Consensus 250 -~~~~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 250 -MKRLRDSPP-----PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp -HHHHHHSSC-----CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -HHHHhcCCC-----CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111110 0111 112234567889999999999999999999863
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=348.68 Aligned_cols=266 Identities=23% Similarity=0.301 Sum_probs=210.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+.++.+++||||+++++++.+....++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 91 (294)
T 4eqm_A 13 YKIVDKLGGGGMSTVYLAEDTI-LNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVME 91 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECC-CCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEe
Confidence 4456889999999999999864 6789999998432 23445688999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 92 ~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 92 YIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 999999999998888899999999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ........ ... ....
T Consensus 169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~-~~~-----~~~~ 235 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-------AIKHIQDS-VPN-----VTTD 235 (294)
T ss_dssp ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-------HHHHHSSC-CCC-----HHHH
T ss_pred cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhhcc-CCC-----cchh
Confidence 4445689999999999999999999999999999999999999976543221 11111111 100 0011
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCCCCC
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRP-TMKVVLQMLEGLLEVPNPPCP 789 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~p~~p 789 (799)
......+.+.+++.+||+.||++|| +++++.+.|+.++.-......
T Consensus 236 ~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~~~ 282 (294)
T 4eqm_A 236 VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRANED 282 (294)
T ss_dssp SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTTCC
T ss_pred cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCCcc
Confidence 1122345788899999999999998 999999999998765544433
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=343.57 Aligned_cols=278 Identities=37% Similarity=0.623 Sum_probs=224.4
Q ss_pred CccccChHHHHHHhhchhh--------hcCccccceEEEEEEeCCCCeEEEEEEcccc----chhhHHHHHHHHHHhccc
Q 038294 493 NLRFFSYNELKEATGGFKE--------ELGRGSFGIVYKGVLKSASGKAIAVKKLDRL----AQEREREFKSEVSAIGRT 560 (799)
Q Consensus 493 ~~~~~~~~~l~~~~~~~~~--------~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l 560 (799)
....|++.++..++.+|.+ .||+|+||.||+|.. +++.||||++... .....+.+.+|+.+++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l 87 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV---NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC 87 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES---SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE---CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc
Confidence 4677999999999998874 499999999999986 4689999998642 233456899999999999
Q ss_pred ccccccceeeeeecccceeeEEeecCCCChhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 038294 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFA---IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNI 637 (799)
Q Consensus 561 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NI 637 (799)
+||||+++++++.+....++||||+++++|.+++.. ...+++..+.+++.||+.||+|||+. +|+||||||+||
T Consensus 88 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Ni 164 (307)
T 2nru_A 88 QHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANI 164 (307)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGE
T ss_pred CCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHE
Confidence 999999999999999999999999999999999874 34689999999999999999999998 999999999999
Q ss_pred EEcCCCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc
Q 038294 638 LLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR 716 (799)
Q Consensus 638 Ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~ 716 (799)
+++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 9999999999999999876443222 2223468999999998875 4889999999999999999999999865433221
Q ss_pred hhHHHHHHHHHh-cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 717 AILTDWAYDCYA-EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 717 ~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
. .+...... ...+...++... ........+.+.+++.+||+.||++|||+.+|++.|+++.
T Consensus 244 ~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 L---DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp T---HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred H---HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 1 11111111 111222223222 2345667788999999999999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=343.37 Aligned_cols=257 Identities=26% Similarity=0.413 Sum_probs=210.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
..+.+.+.||+|+||.||+|..+ ++..||+|+++... ...+++.+|++++.+++||||+++++++.+....++||||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK--GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hheeeeeeeccCCCceEEEEEec--CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 34556788999999999999876 56789999997543 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999865 3589999999999999999999998 99999999999999999999999999998765544333
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ......+.. ...
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--------~~~~~~~~~-----~~~-- 226 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV--------VLKVSQGHR-----LYR-- 226 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCC-----CCC--
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH--------HHHHHcCCC-----CCC--
Confidence 333446778999999999899999999999999999999 9999875543221 111122111 011
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
+....+.+.+++.+||+.||++|||+.|+++.|+.+.+..
T Consensus 227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 1112356888999999999999999999999999887643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=363.11 Aligned_cols=257 Identities=24% Similarity=0.392 Sum_probs=198.0
Q ss_pred hhchhhhcCccccceEEEEEEeC--CCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||+|.++. ..+..||||+++.. .....++|.+|+.++++++||||+++++++.+....++||
T Consensus 46 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 125 (373)
T 2qol_A 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVT 125 (373)
T ss_dssp GCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEE
Confidence 44566889999999999998762 24678999999754 3344568999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
||+++|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 126 e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 202 (373)
T 2qol_A 126 EYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE 202 (373)
T ss_dssp ECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred eCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence 9999999999998754 689999999999999999999998 999999999999999999999999999987654322
Q ss_pred cce--eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 662 RTH--TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 662 ~~~--~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+...
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~--------~~~~i~~~~~~----- 269 (373)
T 2qol_A 203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD--------VIKAVDEGYRL----- 269 (373)
T ss_dssp -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH--------HHHHHHTTEEC-----
T ss_pred cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-----
Confidence 211 12235778999999999999999999999999999998 999987543322 11222222110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
. ........+.+++.+||+.||++||++.||+++|++++.
T Consensus 270 ~----~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 270 P----PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp C----CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 0 112234578889999999999999999999999988754
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=350.39 Aligned_cols=246 Identities=22% Similarity=0.339 Sum_probs=205.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+++++.++||||+++++++......++||||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHIL-TGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 3456789999999999999864 6889999998653 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 96 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~ 170 (328)
T 3fe3_A 96 ASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KL 170 (328)
T ss_dssp CTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC--GG
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC--cc
Confidence 99999999998888899999999999999999999998 99999999999999999999999999998664332 22
Q ss_pred eeeccCCcccccccccCCCCC-cchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVS-AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s-~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....||+.|+|||.+.+..++ .++|||||||++|||++|+.||......+ ....+..+.. ..+.
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~------~~p~- 235 (328)
T 3fe3_A 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE--------LRERVLRGKY------RIPF- 235 (328)
T ss_dssp GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCCT-
T ss_pred ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC------CCCC-
Confidence 345689999999999988875 79999999999999999999997654322 1122222221 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.....+.+++.+||+.||++|||++|+++.
T Consensus 236 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 236 ---YMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---TSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 223567789999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=348.81 Aligned_cols=266 Identities=25% Similarity=0.387 Sum_probs=207.4
Q ss_pred HhhchhhhcCccccceEEEEEE---eCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc--ccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVL---KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 579 (799)
..+.+.+.||+|+||+||+|.+ ...+++.||||++........+.+.+|++++++++||||+++++++... ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 3455678899999999999985 2346789999999876666678899999999999999999999998554 4578
Q ss_pred eEEeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 580 LVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
+||||+++|+|.+++.... .+++..+.+++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166 (295)
T ss_dssp EEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred EEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence 9999999999999998754 589999999999999999999998 999999999999999999999999999987644
Q ss_pred CCC--cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhc--------chhHHHHHHHHHh
Q 038294 659 DQS--RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG--------RAILTDWAYDCYA 728 (799)
Q Consensus 659 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~ 728 (799)
... .......++..|+|||.+.+..++.++||||||+++|||++|..|+........ .............
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (295)
T 3ugc_A 167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 246 (295)
T ss_dssp ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence 322 122233467789999999999999999999999999999999999865432210 0111111222222
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+.. ...+....+.+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 247 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 247 NNGR---------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCc---------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 2211 11122334678889999999999999999999999987653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=373.59 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=213.0
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+......+.+.||+|+||.||+|.++. +++.||||+++... ...++|.+|+.++++++||||++++++|......++|
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGG-GTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcC-CCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 334445667899999999999999874 57899999997543 3457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 582 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|||+++|+|.+++... ..+++..++.|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999864 4588999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.........+++.|+|||.+.+..++.++|||||||+||||++ |+.||......+ +.+.+..+..
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--------~~~~~~~~~~------ 437 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--------VYELLEKDYR------ 437 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--------HHHHHHTTCC------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCC------
Confidence 3222223346788999999999999999999999999999999 888987554322 1112222110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
...+....+.+.+++.+||+.||++|||+.+|++.|+.+++
T Consensus 438 ---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 438 ---MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred ---CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 11112234578889999999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=369.33 Aligned_cols=258 Identities=23% Similarity=0.392 Sum_probs=209.4
Q ss_pred HHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 503 KEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 503 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
......+.+.||+|+||.||+|.++ .+..||||+++... ...++|.+|++++++++||||+++++++. ....++||
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN--KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC--CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 3344556789999999999999986 46789999997543 34678999999999999999999999986 56789999
Q ss_pred eecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 583 EFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 583 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||+++|+|.+++... ..+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999754 3688899999999999999999998 89999999999999999999999999998764322
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
........+|+.|+|||.+....++.++|||||||+||||++ |+.||......+. ...+..+.. ..
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~-----~~ 405 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV--------IRALERGYR-----MP 405 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH--------HHHHHHTCC-----CC
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCC-----CC
Confidence 222222346778999999999999999999999999999999 9999975433221 111222211 00
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
. +....+.+.+++.+||+.||++||||++|++.|+.+....
T Consensus 406 ~----~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 406 R----PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred C----CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 1 1223457888999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=342.65 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=207.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|... +++.||+|++.... ...+++.+|++++++++||||+++++++.+....++||||++
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 12 LTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred ceeeheecCCCccEEEEEEec--CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 445688999999999999986 46789999997543 234679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999764 4689999999999999999999998 8999999999999999999999999999876433222223
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+. ....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--------~~~~~~~~~---------~~~~ 228 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGF---------RLYK 228 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTC---------CCCC
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--------HHHHHhcCc---------cCCC
Confidence 3446778999999999999999999999999999999 899987654322 111122211 0111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 12224568889999999999999999999999988754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.40 Aligned_cols=266 Identities=26% Similarity=0.362 Sum_probs=205.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccc----eeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~lv~ 582 (799)
+.+.+.||+|+||+||+|... ++.||||++.... .....+..|+.++++++||||+++++++..... .++||
T Consensus 26 y~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~ 101 (322)
T 3soc_A 26 LQLLEVKARGRFGCVWKAQLL---NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT 101 (322)
T ss_dssp EEEEEEEECSTTCEEEEEEET---TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred chhhheecccCceEEEEEEEC---CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence 445688999999999999874 6899999997543 334456679999999999999999999987543 58999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-------CCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC-------NVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-------~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
||+++|+|.+++... .+++..+.+++.||+.||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 102 e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~ 180 (322)
T 3soc_A 102 AFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180 (322)
T ss_dssp ECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccc
Confidence 999999999999764 5899999999999999999999751 23799999999999999999999999999987
Q ss_pred ccCCCCc-ceeeeccCCcccccccccCC-----CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcch---------hHH
Q 038294 656 LLSDQSR-THTMIRGTRGYVAPEWFKNA-----PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA---------ILT 720 (799)
Q Consensus 656 ~~~~~~~-~~~~~~gt~~y~aPE~l~~~-----~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~---------~~~ 720 (799)
....... ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ...
T Consensus 181 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (322)
T 3soc_A 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260 (322)
T ss_dssp ECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHH
T ss_pred cccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchh
Confidence 6543322 22234689999999999863 45678899999999999999999987543322111 111
Q ss_pred HHHHHHHhcCceeEeecCCCCC-ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 721 DWAYDCYAEGRLDVLVDSDEPA-MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 721 ~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
. ........... +..+. .......+.+.+++.+||+.||++|||+.||++.|+++.+
T Consensus 261 ~-~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 261 D-MQEVVVHKKKR----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp H-HHHHHTTSCCC----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h-hhhhhhcccCC----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1 11111111111 11111 1233456778999999999999999999999999987653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=346.15 Aligned_cols=246 Identities=26% Similarity=0.319 Sum_probs=204.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++..+. +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++......++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E 85 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEe
Confidence 3456789999999999999874 6889999999653 22345678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 86 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~-~ 161 (337)
T 1o6l_A 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-c
Confidence 999999999998888899999999999999999999998 999999999999999999999999999986433222 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+.. ..+
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~------~~p-- 225 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEI------RFP-- 225 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCC--
T ss_pred ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC------CCC--
Confidence 334568999999999999999999999999999999999999997654322 1111222211 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
......+.+++.+||+.||++|| +++||++
T Consensus 226 --~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 12335678899999999999999 8999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=352.98 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=200.2
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCe----EEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.+.||+|+||+||+|.+.. +++ .||+|.++... ....++|.+|+.++++++||||++++++|.++. .++
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HcccceEEeeCCCeEEEEEEEcC-CCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 34566889999999999999764 333 46888885432 345578999999999999999999999998754 779
Q ss_pred EEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|+||+++|+|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 170 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 170 (327)
T ss_dssp EEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred EEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence 99999999999999874 5789999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 660 QSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 660 ~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+. ...+..+..
T Consensus 171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--------~~~~~~~~~----- 237 (327)
T 3poz_A 171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------SSILEKGER----- 237 (327)
T ss_dssp CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCC-----
T ss_pred cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH--------HHHHHcCCC-----
Confidence 322 2223446889999999999999999999999999999999 9999976543321 111222211
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
..........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 238 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp ----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0112223457888999999999999999999999998754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=360.33 Aligned_cols=255 Identities=23% Similarity=0.361 Sum_probs=206.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
...+.+.||+|+||.||+|.++. +++.||||+++... ....++|.+|++++++++||||+++++++......++||||
T Consensus 115 ~~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 115 DLVLGEQIGRGNFGEVFSGRLRA-DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp GEEEEEEEEEETTEEEEEEEETT-TCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HeEEeeEeccCCCCeEEEEEEec-CCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 44566889999999999999874 57899999987543 23345789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 194 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 9999999999865 3689999999999999999999998 89999999999999999999999999998653321111
Q ss_pred e-eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 664 H-TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 664 ~-~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
. ....+++.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....+..+... ..+
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--------~~~~~~~~~~~-----~~~ 337 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--------TREFVEKGGRL-----PCP 337 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--------HHHHHHTTCCC-----CCC
T ss_pred cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-----CCC
Confidence 1 11235678999999998899999999999999999998 899987654322 11222222110 111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
....+.+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 338 ----~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 373 (377)
T 3cbl_A 338 ----ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373 (377)
T ss_dssp ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 122356788999999999999999999999998764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=350.56 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=209.9
Q ss_pred hchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.+.||+|+||.||+|.... .+++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 49 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 128 (343)
T 1luf_A 49 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 128 (343)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred CeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEE
Confidence 4456789999999999999874 345899999997543 34456899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 038294 582 YEFMGNGTLANLIFAI------------------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNI 637 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~------------------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NI 637 (799)
|||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||
T Consensus 129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NI 205 (343)
T 1luf_A 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 205 (343)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceE
Confidence 9999999999999763 4688999999999999999999998 999999999999
Q ss_pred EEcCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhc
Q 038294 638 LLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEG 715 (799)
Q Consensus 638 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~ 715 (799)
|++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 284 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 284 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHH-
Confidence 999999999999999986643221 22233457889999999999999999999999999999999 999987554322
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
....+..+.... . +......+.+++.+||+.||++|||+.+|++.|+++.+-.
T Consensus 285 -------~~~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 285 -------VIYYVRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp -------HHHHHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred -------HHHHHhCCCcCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 112223332211 1 1123357888999999999999999999999999987643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=356.40 Aligned_cols=268 Identities=26% Similarity=0.351 Sum_probs=215.1
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeC------CCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeee
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKS------ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCD 573 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~ 573 (799)
+....+.+.+.||+|+||.||+|.... ..+..||||+++... ....+++.+|+++++++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 334455667899999999999999753 233689999997543 33456899999999999 9999999999999
Q ss_pred cccceeeEEeecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 038294 574 EALNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNI 637 (799)
Q Consensus 574 ~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NI 637 (799)
.....++||||+++|+|.+++.... .+++..+.+++.||+.||+|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 9999999999999999999998643 488999999999999999999998 999999999999
Q ss_pred EEcCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhc
Q 038294 638 LLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEG 715 (799)
Q Consensus 638 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~ 715 (799)
||+.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~- 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE- 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence 999999999999999987644322 22233457889999999999999999999999999999999 999987543322
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCP 789 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 789 (799)
....+..+... .. .......+.+++.+||+.||++|||+.||++.|++++........
T Consensus 302 -------~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~ 359 (382)
T 3tt0_A 302 -------LFKLLKEGHRM-----DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEM 359 (382)
T ss_dssp -------HHHHHHTTCCC-----CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC-
T ss_pred -------HHHHHHcCCCC-----CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCC
Confidence 12222222211 11 112335788899999999999999999999999998765444433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=350.14 Aligned_cols=249 Identities=24% Similarity=0.315 Sum_probs=205.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh------hHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
+.+.+.||+|+||.||++..+. +++.||+|.++..... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 14 y~~~~~LG~G~fg~V~~~~~~~-~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 92 (361)
T 2yab_A 14 YDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVL 92 (361)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred eEEeeEEeeCcCEEEEEEEECC-CCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEE
Confidence 4566889999999999999874 6889999998653321 24678999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEccccCcccc
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF----SAKISDFGLSKLL 656 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~----~~kl~DfGla~~~ 656 (799)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++ .+||+|||++...
T Consensus 93 v~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 93 ILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999998888899999999999999999999998 999999999999998876 7999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
.... ......||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...+..+...
T Consensus 170 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~--------~~~i~~~~~~--- 236 (361)
T 2yab_A 170 EDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------LANITAVSYD--- 236 (361)
T ss_dssp CTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------HHHHHTTCCC---
T ss_pred CCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhcCCC---
Confidence 4432 22345699999999999999999999999999999999999999976543321 1112222110
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+........+.+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 237 ---FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 010001122356788999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=345.23 Aligned_cols=251 Identities=25% Similarity=0.316 Sum_probs=205.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh------hHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
..+.+.+.||+|+||.||++..+. +++.||+|+++..... ..+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECC-CCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 345667889999999999999874 6889999998653221 356799999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEccccCcc
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF----SAKISDFGLSK 654 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~----~~kl~DfGla~ 654 (799)
++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~ 166 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 166 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCe
Confidence 99999999999999998888899999999999999999999998 999999999999999877 89999999998
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+... .+.....
T Consensus 167 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--------~~~~~~~-- 234 (326)
T 2y0a_A 167 KIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA--------NVSAVNY-- 234 (326)
T ss_dssp ECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH--------HHHHTCC--
T ss_pred ECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--------HHHhcCC--
Confidence 764332 2233468999999999999999999999999999999999999997654322111 1111110
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+..........+.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 235 ----EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp ----CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0111001122356778999999999999999999986
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-39 Score=342.02 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=205.2
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.+.||+|+||.||++..+ ++..||+|+++... ...+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 101 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101 (283)
T ss_dssp GEEEEEECC---CEEEEEEEET--TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred HHHhHhhcCCCCCceEEEEEEc--CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence 4456688999999999999876 57789999997543 23467999999999999999999999999999999999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 178 (283)
T 3gen_A 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS 178 (283)
T ss_dssp TTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHST
T ss_pred CCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccc
Confidence 99999999987 45789999999999999999999998 999999999999999999999999999987643322222
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.. ...
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~-----~~~--- 242 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLR-----LYR--- 242 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--------HHHHHTTCC-----CCC---
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--------HHHHhcccC-----CCC---
Confidence 23346778999999999999999999999999999998 9999876543221 111222210 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+....+.+.+++.+||+.+|++|||+.|+++.|++++
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 1122357888999999999999999999999998765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=339.47 Aligned_cols=267 Identities=20% Similarity=0.276 Sum_probs=209.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccc--ceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+. +++.||||+++... ....+.+.+|++++++++||||+++++++.... ..++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 89 (319)
T 4euu_A 11 WLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (319)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEE
T ss_pred EEEEEEecCCCCeEEEEEEECC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEe
Confidence 4456889999999999999875 67899999997543 233567889999999999999999999997665 6789999
Q ss_pred ecCCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEccccCcccc
Q 038294 584 FMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSKLL 656 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl----~~~~~~kl~DfGla~~~ 656 (799)
|+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~ 166 (319)
T 4euu_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (319)
T ss_dssp CCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred CCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence 999999999998653 389999999999999999999998 99999999999999 78888999999999876
Q ss_pred cCCCCcceeeeccCCccccccccc--------CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHHHHHHHH
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFK--------NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTDWAYDCY 727 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~ 727 (799)
..... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ..+..... ..
T Consensus 167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~ 243 (319)
T 4euu_A 167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT-GK 243 (319)
T ss_dssp CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH-HC
T ss_pred CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc-CC
Confidence 44332 22345899999999986 577899999999999999999999999754332222 11111111 11
Q ss_pred hcCceeEee-----------cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 728 AEGRLDVLV-----------DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 728 ~~~~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.......+. ...............+.+++.+||+.||++|||++|+++...+.
T Consensus 244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 111111111 11112234567777888999999999999999999999988753
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=342.20 Aligned_cols=257 Identities=21% Similarity=0.315 Sum_probs=196.5
Q ss_pred HhhchhhhcCccccceEEEEEEeCC--CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.+.+.||+|+||.||+|..... .+..||+|+++... ....+.+.+|+.++++++||||+++++++. .+..++|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv 93 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII 93 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEE
Confidence 3455678899999999999998642 34679999987533 334567999999999999999999999985 4567899
Q ss_pred EeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|||+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (281)
T 1mp8_A 94 MELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170 (281)
T ss_dssp EECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCccc
Confidence 99999999999998654 689999999999999999999998 99999999999999999999999999998765443
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
........+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+..+... .
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--------~~~i~~~~~~-----~ 237 (281)
T 1mp8_A 171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------IGRIENGERL-----P 237 (281)
T ss_dssp --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCCC-----C
T ss_pred ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--------HHHHHcCCCC-----C
Confidence 333333456789999999999999999999999999999997 8889876543321 1112222111 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+.+++.+||+.||++|||+.|+++.|+.+++
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 238 ----MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 112234577889999999999999999999999987653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=364.89 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=204.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
....+.+.||+|+||.||+|.++ .+..||||+++... ...++|.+|++++++++||||+++++++.+ ...++||||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~ 259 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 259 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hHceeeeeecCCCCeEEEEEEEC--CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence 34456788999999999999986 35789999997543 235689999999999999999999999976 678999999
Q ss_pred cCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++|+|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 336 (452)
T 1fmk_A 260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 336 (452)
T ss_dssp CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence 9999999999753 4689999999999999999999998 9999999999999999999999999999876543322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......+++.|+|||.+.+..++.++||||||++||||++ |+.||......+ ....+..+... .
T Consensus 337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~-----~-- 401 (452)
T 1fmk_A 337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRM-----P-- 401 (452)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCC-----C--
T ss_pred cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-----C--
Confidence 2333446789999999999999999999999999999999 899987543322 11222222110 0
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 786 (799)
.+....+.+.+++.+||+.||++|||+++|++.|+.+.....|
T Consensus 402 --~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 402 --CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred --CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 1122345788899999999999999999999999998764433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=354.79 Aligned_cols=259 Identities=27% Similarity=0.384 Sum_probs=207.2
Q ss_pred HhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccc-
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN- 577 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~- 577 (799)
..+.+.+.||+|+||.||+|.+. ..+++.||||+++... ....+.+.+|++++.++ +||||+++++++.+...
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~ 101 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 101 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCc
Confidence 34456688999999999999863 2356899999997643 33456799999999999 79999999999987654
Q ss_pred eeeEEeecCCCChhhhhhcCCC----------------------------------------------------------
Q 038294 578 RLLVYEFMGNGTLANLIFAIPK---------------------------------------------------------- 599 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------- 599 (799)
.++||||+++|+|.+++.....
T Consensus 102 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (359)
T 3vhe_A 102 LMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181 (359)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------------
T ss_pred eEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhccc
Confidence 8899999999999999976532
Q ss_pred --------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-cceeeeccC
Q 038294 600 --------PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGT 670 (799)
Q Consensus 600 --------~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt 670 (799)
+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......+|
T Consensus 182 ~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t 258 (359)
T 3vhe_A 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258 (359)
T ss_dssp --CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred ccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence 78899999999999999999998 999999999999999999999999999987644332 223345578
Q ss_pred CcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHH
Q 038294 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRL 749 (799)
Q Consensus 671 ~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 749 (799)
+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ....+..+... .. .....
T Consensus 259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~~~~~~~~~~~-----~~----~~~~~ 322 (359)
T 3vhe_A 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-------FCRRLKEGTRM-----RA----PDYTT 322 (359)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-------HHHHHHHTCCC-----CC----CTTCC
T ss_pred ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH-------HHHHHHcCCCC-----CC----CCCCC
Confidence 89999999999999999999999999999998 9999875432221 11222222111 11 11233
Q ss_pred HHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 750 QKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 750 ~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 323 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 323 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 568889999999999999999999999998754
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=342.98 Aligned_cols=259 Identities=23% Similarity=0.320 Sum_probs=197.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcc--cccccccceeeeeec----cccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDE----ALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~----~~~~~ 579 (799)
.+.+.+.||+|+||+||+|.. +++.||||++... ..+.+..|.+++.. ++||||+++++++.. ....+
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 9 DITLLECVGKGRYGEVWRGSW---QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GCEEEEEEEECSSEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cEEEEEeeccCCCcEEEEEEE---CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 345568899999999999987 4789999998653 23455556666555 799999999999754 34578
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeEEcCCCceEEcccc
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH--------EECNVPIIHCDIKPQNILLDNYFSAKISDFG 651 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~dlk~~NILl~~~~~~kl~DfG 651 (799)
+||||+++|+|.+++.. ..+++..+.+++.||+.||+||| +. +|+||||||+|||++.++.+||+|||
T Consensus 83 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg 158 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLG 158 (301)
T ss_dssp EEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCC
Confidence 99999999999999954 56899999999999999999999 65 99999999999999999999999999
Q ss_pred CcccccCCCCcc---eeeeccCCcccccccccCC------CCCcchhHHHHHHHHHHHHhC----------CcCCchhhh
Q 038294 652 LSKLLLSDQSRT---HTMIRGTRGYVAPEWFKNA------PVSAKVDVYSFGVMLLEIICC----------RRSVEMEVE 712 (799)
Q Consensus 652 la~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~------~~s~k~DVwS~Gvll~elltg----------~~p~~~~~~ 712 (799)
+++......... .....||+.|+|||.+.+. .++.++||||||+++|||++| +.||.....
T Consensus 159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 998764433221 2234689999999999876 455799999999999999999 777754432
Q ss_pred hhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 713 EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
..... .. .......... ................+.+++.+||+.||++|||+.||++.|+++
T Consensus 239 ~~~~~--~~-~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 239 NDPSF--ED-MRKVVCVDQQ---RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp SSCCH--HH-HHHHHTTSCC---CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcch--hh-hhHHHhccCC---CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 22111 11 1111111110 001111122345677899999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=344.70 Aligned_cols=257 Identities=24% Similarity=0.409 Sum_probs=204.2
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCC------eEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASG------KAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~------~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
..+.+.+.||+|+||.||+|..+.... +.||+|++........+.+.+|++++++++||||+++++++.++...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 445567889999999999999874321 57999999876666678899999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCCC-CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--------eEEcc
Q 038294 579 LLVYEFMGNGTLANLIFAIPK-PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS--------AKISD 649 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~--------~kl~D 649 (799)
++||||+++++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|
T Consensus 88 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D 164 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSD 164 (289)
T ss_dssp EEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred EEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeecc
Confidence 999999999999999987654 89999999999999999999998 8999999999999998887 99999
Q ss_pred ccCcccccCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh
Q 038294 650 FGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 650 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
||++...... ....+++.|+|||.+.+ ..++.++||||||+++|||++|..|+........ ......
T Consensus 165 fg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-------~~~~~~ 232 (289)
T 4fvq_A 165 PGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQFYE 232 (289)
T ss_dssp CCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHH
T ss_pred CcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-------HHHHhh
Confidence 9998754221 22347889999999987 7799999999999999999997665543322111 011111
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCC
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPP 787 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~ 787 (799)
... ..+. .....+.+++.+||+.||++|||+.|+++.|+.++.-..++
T Consensus 233 ~~~-------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~ 280 (289)
T 4fvq_A 233 DRH-------QLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280 (289)
T ss_dssp TTC-------CCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC------
T ss_pred ccC-------CCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCC
Confidence 110 0111 11235678999999999999999999999999988744443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=341.80 Aligned_cols=258 Identities=27% Similarity=0.402 Sum_probs=212.8
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+....+.+.+.||+|+||.||+|..+. +++.||+|++... ....+.+.+|++++++++||||+++++++.+....++|
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGG-GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecC-CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 344455667899999999999999875 5789999999753 33457899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 582 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 9999999999999864 4588999999999999999999998 9999999999999999999999999999877554
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |..||........ ...+....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~--------~~~~~~~~------- 229 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--------YELLEKDY------- 229 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------HHHHHTTC-------
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHhccC-------
Confidence 4433444557889999999999999999999999999999999 8888875433221 11111111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.........+.+.+++.+||+.||++|||+.|+++.|+.+.
T Consensus 230 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 230 --RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 01111223357889999999999999999999999998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=352.65 Aligned_cols=259 Identities=26% Similarity=0.392 Sum_probs=207.4
Q ss_pred HHhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
...+.+.+.||+|+||.||+|.+.. .+++.||||+++.. ......++.+|+.++++++||||+++++++......
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3445567889999999999999642 35678999999653 344556789999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEc
Q 038294 579 LLVYEFMGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---SAKIS 648 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---~~kl~ 648 (799)
++||||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999754 3578999999999999999999998 999999999999999544 59999
Q ss_pred cccCcccccCCC-CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHH
Q 038294 649 DFGLSKLLLSDQ-SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 649 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++ |..||......+ ....
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------~~~~ 298 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VLEF 298 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHH
Confidence 999998653221 222233457889999999999999999999999999999998 999987654322 1122
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+..+... .........+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 299 i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 299 VTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 2222110 0112233567889999999999999999999999977553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=350.89 Aligned_cols=251 Identities=27% Similarity=0.356 Sum_probs=201.8
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhccc-ccccccceeeeeecccc
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 577 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 577 (799)
+.-..+.+.+.||+|+||.||++..+. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+...
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~-~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKE-TGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcC-CCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 333445567899999999999999874 6889999999753 223445688899999988 79999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 578 RLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
.++||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 999999999999999998888899999999999999999999998 99999999999999999999999999998643
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+..
T Consensus 176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~----- 241 (353)
T 3txo_A 176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--------LFEAILNDEV----- 241 (353)
T ss_dssp C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC-----
T ss_pred cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCC-----
Confidence 222 22334569999999999999999999999999999999999999998654432 1122222221
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTM------KVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~evl~ 775 (799)
..+ ......+.+++.+||+.||++||++ .|+++
T Consensus 242 -~~p----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -VYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -CCC----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -CCC----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 111 1233567889999999999999998 67764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=353.65 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=205.5
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.+.||+|+||.||++..+. +++.+|+|++... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~-~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVL-AGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETT-TTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECC-CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 345567899999999999999874 6899999998643 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEccccCcccccCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD---NYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~---~~~~~kl~DfGla~~~~~~ 659 (799)
||+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~ 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence 9999999999999888899999999999999999999998 999999999999998 5688999999999876543
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.. ......||+.|+|||++.+..++.++||||+||++|||++|..||......+ ....+..+....
T Consensus 167 ~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~~~----- 232 (444)
T 3soa_A 167 QQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--------LYQQIKAGAYDF----- 232 (444)
T ss_dssp CC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCC-----
T ss_pred Cc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--------HHHHHHhCCCCC-----
Confidence 32 2233569999999999999999999999999999999999999997654322 122223332211
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+........+.+.+++.+||+.||++|||+.|+++
T Consensus 233 -~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 -PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111123456788999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=343.07 Aligned_cols=248 Identities=22% Similarity=0.282 Sum_probs=204.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++..+. +++.+|+|.+... ......+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 7 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 84 (321)
T 1tki_A 7 YMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEeeeEEecCCCeEEEEEEECC-CCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCC
Confidence 3456789999999999999874 6899999998753 3345678999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN--YFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 85 g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~--~ 159 (321)
T 1tki_A 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC--c
Confidence 999999997654 789999999999999999999998 9999999999999987 7899999999998764332 3
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|..||......+. ...+..+... .+..
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--------~~~i~~~~~~------~~~~ 225 (321)
T 1tki_A 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--------IENIMNAEYT------FDEE 225 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHHTCCC------CCHH
T ss_pred cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH--------HHHHHcCCCC------CChh
Confidence 3445689999999999998899999999999999999999999976543321 1111111110 0100
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01123456788999999999999999999987
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=343.71 Aligned_cols=267 Identities=20% Similarity=0.295 Sum_probs=202.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccce----e
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR----L 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~----~ 579 (799)
+.+.+.||+|+||.||++.... +++.||||+++... ......+.+|++++++++||||+++++++...... +
T Consensus 14 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 92 (311)
T 3ork_A 14 YELGEILGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 92 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEEEEEEccCCCEEEEEEEECC-CCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccE
Confidence 4456889999999999999864 68999999996532 23345789999999999999999999998766544 8
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+++++|.+++.....+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 93 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 9999999999999998888899999999999999999999998 9999999999999999999999999999876443
Q ss_pred CC--cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 660 QS--RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 660 ~~--~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.. .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ..........
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-------~~~~~~~~~~----- 237 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-------AYQHVREDPI----- 237 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHCCCC-----
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHhcCCCC-----
Confidence 22 122334689999999999999999999999999999999999999976543221 1111222111
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHH-HHHHHhcCcCCCCCCCCCc
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKV-VLQMLEGLLEVPNPPCPSS 791 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e-vl~~L~~~~~~~~p~~p~~ 791 (799)
.+..........+.+++.+||+.||++||++.+ +...|..+.....|..|..
T Consensus 238 --~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~~~~~~~~ 290 (311)
T 3ork_A 238 --PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKV 290 (311)
T ss_dssp --CHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTTCCCSSCCC
T ss_pred --CcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 111111223456788999999999999996554 5566666555444444443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=341.43 Aligned_cols=257 Identities=26% Similarity=0.370 Sum_probs=209.4
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.+.||+|+||.||+|.... .+++.||||+++... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 103 (314)
T 2ivs_A 24 NLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLL 103 (314)
T ss_dssp GEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred heeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEE
Confidence 34556889999999999998742 245799999997533 3445689999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCC
Q 038294 581 VYEFMGNGTLANLIFAIPK------------------------PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQN 636 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~------------------------~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~N 636 (799)
||||+++++|.+++..... +++..+.+++.||++||+|||+. +|+||||||+|
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~N 180 (314)
T 2ivs_A 104 IVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARN 180 (314)
T ss_dssp EEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred EEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchhe
Confidence 9999999999999986533 78899999999999999999998 99999999999
Q ss_pred eEEcCCCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhh
Q 038294 637 ILLDNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEE 714 (799)
Q Consensus 637 ILl~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~ 714 (799)
||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 181 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 260 (314)
T 2ivs_A 181 ILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER 260 (314)
T ss_dssp EEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred EEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999876443322 1223346788999999999899999999999999999999 999987654332
Q ss_pred cchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 715 GRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 715 ~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
. ...+..+... .......+.+.+++.+||+.||++|||+.||++.|++++.
T Consensus 261 ~--------~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 261 L--------FNLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp H--------HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--------HHHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1 1222222111 1112234578889999999999999999999999998754
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=358.67 Aligned_cols=247 Identities=28% Similarity=0.380 Sum_probs=202.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc-ceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL-NRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~-~~~lv~e~~ 585 (799)
..+.+.||+|+||.||+|.++ ++.||||+++... ..+.|.+|++++++++||||+++++++.+.. ..++||||+
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~ 269 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 269 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET---TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECC
T ss_pred eEEEeeecCcCCeeEEEEEec---CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEec
Confidence 345678999999999999874 6799999997643 4578999999999999999999999987665 689999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++|+|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 270 ~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--- 343 (450)
T 1k9a_A 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 343 (450)
T ss_dssp TTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc---
Confidence 9999999998654 368999999999999999999998 99999999999999999999999999998543221
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
....+++.|+|||.+.+..++.++||||||++||||++ |+.||......+. ...+..+... .
T Consensus 344 -~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--------~~~i~~~~~~-----~--- 406 (450)
T 1k9a_A 344 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYKM-----D--- 406 (450)
T ss_dssp ----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--------HHHHHTTCCC-----C---
T ss_pred -cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHHcCCCC-----C---
Confidence 12246889999999999999999999999999999999 9999875543221 1222222110 1
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+......+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 407 -~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 407 -APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 112234578889999999999999999999999988654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=346.05 Aligned_cols=252 Identities=25% Similarity=0.357 Sum_probs=206.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.+.||+|+||.||+|..+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECC-CCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 445667899999999999999874 6889999998643 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEEccccCcccccCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGLSKLLLSD 659 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~---~~~kl~DfGla~~~~~~ 659 (799)
||+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ +.+||+|||++......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999998888899999999999999999999998 99999999999999865 45999999999876433
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+...
T Consensus 185 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--------~~~~i~~~~~~------ 248 (362)
T 2bdw_A 185 E--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--------LYAQIKAGAYD------ 248 (362)
T ss_dssp C--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCC------
T ss_pred c--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhCCCC------
Confidence 2 2233568999999999999999999999999999999999999997653322 11222222211
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+..........+.+++.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1111112234567889999999999999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.04 Aligned_cols=250 Identities=26% Similarity=0.344 Sum_probs=205.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|..+. +++.||+|++..........+.+|++++++++||||+++++++.+....++||||++
T Consensus 53 y~i~~~LG~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 131 (387)
T 1kob_A 53 YDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131 (387)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCEEEEEEEECC-CCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCC
Confidence 4566889999999999999874 678999999976555556689999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN--YFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 206 (387)
T 1kob_A 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 206 (387)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCc--c
Confidence 999999997654 689999999999999999999998 9999999999999974 5789999999998764432 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+...... .+..
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~--------~~~i~~~~~~------~~~~ 272 (387)
T 1kob_A 207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--------LQNVKRCDWE------FDED 272 (387)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------HHHHHHCCCC------CCSS
T ss_pred eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCCC------CCcc
Confidence 3344689999999999999999999999999999999999999976543221 1111111110 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 273 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 112234578889999999999999999999863
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=343.22 Aligned_cols=260 Identities=28% Similarity=0.398 Sum_probs=210.7
Q ss_pred HHhhchhhhcCccccceEEEEEE----eCCCCeEEEEEEccccch-hhHHHHHHHHHHhccc-ccccccceeeeeecccc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVL----KSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 577 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~----~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 577 (799)
...+.+.+.||+|+||.||+|.. ...+++.||||+++.... ...+.+.+|+++++++ +||||+++++++.....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 34456678899999999999986 334668999999975433 3456799999999999 99999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 578 RLLVYEFMGNGTLANLIFAIP------------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
.++||||+++|+|.+++.... .+++..+.+++.||+.||+|||+. +|+||||||+|||+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 999999999999999997653 378999999999999999999998 99999999999999
Q ss_pred cCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 640 DNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
+.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-- 256 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence 999999999999998765443322 223346788999999999999999999999999999999 9999875432221
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.......+.. . .........+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 257 -----~~~~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 257 -----FYKMIKEGFR-----M----LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp -----HHHHHHHTCC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHhccCCC-----C----CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 1111122110 0 1112234578889999999999999999999999988654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.64 Aligned_cols=257 Identities=16% Similarity=0.187 Sum_probs=205.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ..+.+..|+++++++ +||||+++++++......++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (330)
T 2izr_A 11 FRVGKKIGCGNFGELRLGKNLY-TNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL 87 (330)
T ss_dssp EEEEEECCC-CTTSEEEEEETT-TTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEeeccCCceEEEEEECC-CCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC
Confidence 3456789999999999999764 68999999986432 234688999999999 9999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----eEEccccCcccccCC
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS-----AKISDFGLSKLLLSD 659 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~-----~kl~DfGla~~~~~~ 659 (799)
+++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 88 -GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 99999999864 6789999999999999999999998 9999999999999998887 999999999876443
Q ss_pred CCc------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 660 QSR------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 660 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......................
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~--- 240 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP--- 240 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC---
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC---
Confidence 321 12345699999999999999999999999999999999999999986533322211111111111100
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
......... .+.+++..||+.||.+||++.+|++.|+.+.
T Consensus 241 -------~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 241 -------IEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp -------HHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred -------HHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 000000112 7888999999999999999999999997654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=347.02 Aligned_cols=246 Identities=24% Similarity=0.282 Sum_probs=197.9
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.+.||+|+||.||+|.... +++.||+|+++.......+++.+|++++++++||||+++++++.+....++||||+++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETA-TGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEECC-----CEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred ceEEecCcCEEEEEEEEcC-CCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 4579999999999999864 688999999977555666789999999999999999999999999999999999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE--cCCCceEEccccCcccccCCCCcceee
Q 038294 590 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL--DNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 590 L~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl--~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 99988754 4689999999999999999999998 89999999999999 5678999999999987644322 223
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ... ..... ..+.....
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-------~~i-~~~~~------~~~~~~~~ 313 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL-------NNI-LACRW------DLEDEEFQ 313 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHH-HHTCC------CSCSGGGT
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHH-HhccC------CCChhhhc
Confidence 45899999999999999999999999999999999999999765433211 111 11110 00111112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 23457888999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=348.81 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=199.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||+++.+. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+....++||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~-~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~ 132 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKK-TDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 132 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEE
Confidence 4456889999999999999875 68899999997532 22234678899999887 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 133 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~-~ 208 (396)
T 4dc2_A 133 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 208 (396)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred EcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCC-C
Confidence 9999999999999888899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ........+.+..+.+. .+
T Consensus 209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~p 282 (396)
T 4dc2_A 209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------IP 282 (396)
T ss_dssp CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCC------CC
T ss_pred ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccC------CC
Confidence 233456999999999999999999999999999999999999999754221110 11112223333332221 11
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
......+.+++.+||+.||++||++
T Consensus 283 ----~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 283 ----RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1234567889999999999999995
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.99 Aligned_cols=261 Identities=25% Similarity=0.353 Sum_probs=207.9
Q ss_pred HHhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 577 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 577 (799)
...+.+.+.||+|+||.||+|... ..+++.||||++.... ....+.+.+|+.++.++ +||||+++++++.....
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 344556788999999999999973 2356789999997532 23446899999999999 89999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCC
Q 038294 578 RLLVYEFMGNGTLANLIFAIP-----------------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKP 634 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~ 634 (799)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp 200 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 200 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCh
Confidence 999999999999999997643 268999999999999999999998 999999999
Q ss_pred CCeEEcCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhh
Q 038294 635 QNILLDNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVE 712 (799)
Q Consensus 635 ~NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~ 712 (799)
+|||++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 99999999999999999998765443222 223457889999999999999999999999999999998 9999875532
Q ss_pred hhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 713 EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
... .......+.. ... +....+.+.+++.+||+.||++|||+.||++.|+.++..
T Consensus 281 ~~~-------~~~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 281 DAN-------FYKLIQNGFK-----MDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp SHH-------HHHHHHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred HHH-------HHHHHhcCCC-----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 211 1122222211 111 122345788899999999999999999999999986653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=337.40 Aligned_cols=259 Identities=16% Similarity=0.211 Sum_probs=207.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ..+.+.+|+.++.++ +|+|++++++++.+....++||||+
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 88 (298)
T 1csn_A 12 YKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 88 (298)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec
Confidence 4456789999999999999764 68999999986432 334678899999999 7999999999999999999999999
Q ss_pred CCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-----eEEccccCcccccCC
Q 038294 586 GNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS-----AKISDFGLSKLLLSD 659 (799)
Q Consensus 586 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~-----~kl~DfGla~~~~~~ 659 (799)
+++|.+++.... .+++..+.+++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++.....
T Consensus 89 -~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 89 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999999998754 589999999999999999999998 9999999999999987766 999999999877543
Q ss_pred CCc------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 660 QSR------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 660 ~~~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...................... ..
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~- 242 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-PL- 242 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-CH-
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-cH-
Confidence 321 2234568999999999999999999999999999999999999998643322211111111111100 00
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+.+.+++.+||+.||++|||+++|++.|+++++
T Consensus 243 --------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 243 --------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp --------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred --------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 00011223578889999999999999999999999998765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=338.59 Aligned_cols=262 Identities=18% Similarity=0.208 Sum_probs=200.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||+|++..... ...+.+.+|+.++++++||||+++++++......++|+|
T Consensus 36 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 36 YRLRRLVGRGGMGDVYEAEDTV-RERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEcCCCCeeEEEEEEcC-CCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 4456889999999999999864 678999999965422 234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||++..........
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 115 LINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp CCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999998878899999999999999999999998 99999999999999999999999999998765443333
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..... .+..
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~~~~~~~-------~~~~ 256 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV--------MGAHINQAIP-------RPST 256 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH--------HHHHHHSCCC-------CGGG
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH--------HHHHhccCCC-------Cccc
Confidence 334568999999999999999999999999999999999999997654321 1111111110 0111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcCcCCCCCC
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRP-TMKVVLQMLEGLLEVPNPP 787 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~~~~~~p~ 787 (799)
........+.+++.+||+.||++|| +++++++.|+..+....+.
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~~ 301 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQD 301 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-----
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhccc
Confidence 1222334678899999999999999 9999999999877655443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=346.04 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=210.6
Q ss_pred HHhhchhhhcCccccceEEEEEEeC------CCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKS------ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA 575 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~------~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~ 575 (799)
...+.+.+.||+|+||.||+|.... .+++.||||+++... ....+.+.+|+++++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 3455667899999999999998742 246789999997543 33456789999999999 899999999999999
Q ss_pred cceeeEEeecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
...++||||+++|+|.+++.... .+++..+++++.||+.||+|||+. +|+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 99999999999999999998643 378999999999999999999998 99999999999999
Q ss_pred cCCCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 640 DNYFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 267 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 267 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence 99999999999999876543321 1223346788999999998889999999999999999999 999987543322
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 786 (799)
....+..+... .. .......+.+++.+||+.||++|||+.||++.|++++.....
T Consensus 268 -----~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 268 -----LFKLLKEGHRM-----DK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp -----HHHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred -----HHHHHhcCCCC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 11122222111 11 122335688899999999999999999999999998765443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.00 Aligned_cols=251 Identities=27% Similarity=0.330 Sum_probs=201.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|..+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.++...++||||+
T Consensus 9 y~i~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 87 (323)
T 3tki_A 9 WDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 87 (323)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred ceeeeEEecCCCEEEEEEEECC-CCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcC
Confidence 3456789999999999999874 67899999986432 223457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Ccce
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 664 (799)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ....
T Consensus 88 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 88 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 9999999998888899999999999999999999998 99999999999999999999999999998764322 2222
Q ss_pred eeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... . ..+.... ....
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~-----~~~~~~~--------~~~~ 229 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y-----SDWKEKK--------TYLN 229 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--H-----HHHHTTC--------TTST
T ss_pred CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--H-----HHHhccc--------ccCC
Confidence 34568999999999988775 77899999999999999999999754332111 1 1111110 0001
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.||++|||+.|+++.
T Consensus 230 ~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 112334567789999999999999999999864
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=332.27 Aligned_cols=251 Identities=27% Similarity=0.459 Sum_probs=199.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhh-------HHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER-------EREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
.+.+.+.||+|+||.||+|.+.. +++.||+|++....... .+.+.+|++++++++||||+++++++.+..
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVK-DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETT-TCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred cceehhccccCCceeEEEEEEcC-CceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 34556889999999999999874 67899999985432211 167899999999999999999999997654
Q ss_pred eeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCc-----eEEccc
Q 038294 579 LLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVP--IIHCDIKPQNILLDNYFS-----AKISDF 650 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~dlk~~NILl~~~~~-----~kl~Df 650 (799)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999998888765 4789999999999999999999998 7 999999999999988776 999999
Q ss_pred cCcccccCCCCcceeeeccCCccccccccc--CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh
Q 038294 651 GLSKLLLSDQSRTHTMIRGTRGYVAPEWFK--NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 651 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
|+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||......... .......
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~~~~~ 244 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-----FINMIRE 244 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-----HHHHHHH
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-----HHHHHhc
Confidence 99975422 233456899999999984 456789999999999999999999999754332211 1111111
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
.+ . .........+.+.+++.+||+.||++|||+.||++.|+++
T Consensus 245 ~~-~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 245 EG-L--------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp SC-C--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cC-C--------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 1 1111223345788999999999999999999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=332.46 Aligned_cols=251 Identities=29% Similarity=0.434 Sum_probs=192.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch----hhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ----EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||+|.+. ++.||||+++.... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 9 ~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 9 LTLEEIIGIGGFGKVYRAFWI---GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEET---TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred eeeeeeeccCCCeEEEEEEEc---CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 445688999999999999974 78999999865322 23467899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--------CCceEEccccCcc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN--------YFSAKISDFGLSK 654 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~--------~~~~kl~DfGla~ 654 (799)
||+++++|.+++.. ..+++..+..++.|++.||+|||+....+|+||||||+|||++. ++.+||+|||++.
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~ 164 (271)
T 3dtc_A 86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164 (271)
T ss_dssp ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence 99999999999864 57889999999999999999999983223999999999999986 7789999999998
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .... ......
T Consensus 165 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~-~~~~~~- 232 (271)
T 3dtc_A 165 EWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-------AYGV-AMNKLA- 232 (271)
T ss_dssp --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-------HHHH-HTSCCC-
T ss_pred ccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHhh-hcCCCC-
Confidence 6543222 234589999999999999999999999999999999999999975433221 1111 111111
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
........+.+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 233 -------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 233 -------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 111222345788899999999999999999999999864
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.91 Aligned_cols=258 Identities=25% Similarity=0.382 Sum_probs=194.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCC--eEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccce---
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR--- 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~--- 578 (799)
.+.+.+.||+|+||.||+|.++...+ ..||||+++.. .....+.+.+|++++++++||||+++++++......
T Consensus 24 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (323)
T 3qup_A 24 QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRL 103 (323)
T ss_dssp -CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC------
T ss_pred HeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCC
Confidence 45567889999999999999864322 37999999653 334567899999999999999999999999877655
Q ss_pred ---eeEEeecCCCChhhhhhcCC------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 579 ---LLVYEFMGNGTLANLIFAIP------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 579 ---~lv~e~~~~gsL~~~l~~~~------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
++|+||+++|+|.+++.... .+++..+.+++.||+.||+|||+. +|+||||||+|||+++++.+||+|
T Consensus 104 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~D 180 (323)
T 3qup_A 104 PIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVAD 180 (323)
T ss_dssp -CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECC
T ss_pred CccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEee
Confidence 89999999999999996432 588999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 650 FGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 650 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+
T Consensus 181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------~~~~ 252 (323)
T 3qup_A 181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI--------YNYL 252 (323)
T ss_dssp CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHH
T ss_pred ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH--------HHHH
Confidence 999987644322 22223446788999999999999999999999999999999 8999876543321 1111
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
..+.. ........+.+.+++.+||+.||++|||+.++++.|++++..
T Consensus 253 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IGGNR---------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HTTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hcCCC---------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111 011122345788999999999999999999999999987754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=346.76 Aligned_cols=265 Identities=25% Similarity=0.346 Sum_probs=210.9
Q ss_pred hhchhhhcCccccceEEEEEE---eCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee--cccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVL---KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~l 580 (799)
.+.+.+.||+|+||.||++.+ ...+++.||||++........+.+.+|++++++++||||+++++++. +....++
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 103 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRL 103 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEE
Confidence 345668899999999999985 23467899999998766666778999999999999999999999886 4556789
Q ss_pred EEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 104 VMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 99999999999999863 4689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc--ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-------hhHHHHHHHHHhcC
Q 038294 660 QSR--THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-------AILTDWAYDCYAEG 730 (799)
Q Consensus 660 ~~~--~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~ 730 (799)
... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+......... .............+
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG 260 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence 321 122345788899999999988999999999999999999999998755432110 00001111222222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
. .........+.+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 261 ~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 261 Q---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp C---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred c---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1 111123344678899999999999999999999999998764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=358.36 Aligned_cols=251 Identities=21% Similarity=0.268 Sum_probs=202.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||+||+|+.+. +++.||+|+++.... ...+.+.+|+.++..++||||+++++++.+....++||||
T Consensus 77 ~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey 155 (437)
T 4aw2_A 77 EILKVIGRGAFGEVAVVKLKN-ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155 (437)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeCCCEEEEEEEEcC-CCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEec
Confidence 345789999999999999875 678999999965322 1223488999999999999999999999999999999999
Q ss_pred cCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.........
T Consensus 156 ~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 232 (437)
T 4aw2_A 156 YVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232 (437)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence 999999999987 46789999999999999999999998 99999999999999999999999999998765544444
Q ss_pred eeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 664 HTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+.... ..+
T Consensus 233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~------~~~------ 300 (437)
T 4aw2_A 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK------ERF------ 300 (437)
T ss_dssp CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH------HHC------
T ss_pred cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc------ccc------
Confidence 44467999999999997 5678999999999999999999999998654433211111000 000
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSK--RPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~ 775 (799)
..+.. .....+.+.+++.+||+.+|++ ||+++|+++
T Consensus 301 ~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 301 QFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp CCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred cCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 01110 0112356778999999888888 999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.78 Aligned_cols=263 Identities=24% Similarity=0.374 Sum_probs=206.0
Q ss_pred hhchhhhcCccccceEEEEEE---eCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc--ccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVL---KSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~---~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~ 579 (799)
.+.+.+.||+|+||.||+|.+ ...+++.||+|+++... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 22 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 101 (302)
T 4e5w_A 22 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 101 (302)
T ss_dssp GEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEE
T ss_pred hhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEE
Confidence 345668899999999999985 23367899999997533 23446889999999999999999999999876 5678
Q ss_pred eEEeecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 580 LVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 102 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 178 (302)
T 4e5w_A 102 LIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178 (302)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccC
Confidence 99999999999999954 45789999999999999999999998 999999999999999999999999999987654
Q ss_pred CCC--cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhh--------hcchhHHHHHHHHHh
Q 038294 659 DQS--RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE--------EGRAILTDWAYDCYA 728 (799)
Q Consensus 659 ~~~--~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~ 728 (799)
... .......+|..|+|||.+.+..++.++||||||+++|||++|..|+...... ...... ........
T Consensus 179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 257 (302)
T 4e5w_A 179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV-TRLVNTLK 257 (302)
T ss_dssp TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH-HHHHHHHH
T ss_pred CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH-HHHHHHHh
Confidence 432 1222345788899999999999999999999999999999999886533211 001111 11112222
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.+.. ...+....+.+.+++.+||+.||++|||+.|+++.|+.++
T Consensus 258 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 258 EGKR---------LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp TTCC---------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCC---------CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 2211 1112233467889999999999999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-38 Score=337.05 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=203.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e 86 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 86 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEe
Confidence 3456789999999999999874 68999999996532 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~---- 159 (318)
T 1fot_A 87 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 159 (318)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCCc----
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999875332
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+.. ..+.
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------~~~~i~~~~~------~~p~- 224 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAEL------RFPP- 224 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCC------CCCT-
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC------CCCC-
Confidence 223568999999999999999999999999999999999999997653322 1111222211 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
.....+.+++.+||+.||++|| +++||++
T Consensus 225 ---~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 225 ---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 2235678899999999999999 8898884
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=346.16 Aligned_cols=252 Identities=24% Similarity=0.292 Sum_probs=202.4
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-----hhHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-----EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
...+.+.+.||+|+||.||+|..+. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRE-TGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECC-CCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 4456677899999999999999874 688999999864221 1356799999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEcccc
Q 038294 579 LLVYEFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS---AKISDFG 651 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~---~kl~DfG 651 (799)
++||||+++++|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 9999999999998887643 3578999999999999999999998 9999999999999986554 9999999
Q ss_pred CcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc
Q 038294 652 LSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR 731 (799)
Q Consensus 652 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 731 (799)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+..+.
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---------~~~~i~~~~ 248 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER---------LFEGIIKGK 248 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH---------HHHHHHHTC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH---------HHHHHHcCC
Confidence 9987654322 223346899999999999999999999999999999999999999764321 111112221
Q ss_pred eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
... .........+.+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 249 YKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCC------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 110 00000122356788999999999999999999985
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.48 Aligned_cols=250 Identities=24% Similarity=0.305 Sum_probs=183.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.||+|+||.||++..+. +++.||||++... ....+.+|+.++.+++ ||||+++++++.+....++||||+++|+
T Consensus 17 ~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKK-SNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp CCSEEETTEEEEEEEETT-TCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CccccCCCeEEEEEEECC-CCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 579999999999999874 6889999998642 3457788999999997 9999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEccccCcccccCCCCcceee
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---SAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 93 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 168 (325)
T 3kn6_A 93 LFERIKKKKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLKT 168 (325)
T ss_dssp HHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cccc
Confidence 999999888899999999999999999999998 999999999999998665 899999999986543322 2233
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||.+.+..++.++||||||+++|||++|+.||.............. ....+..+... .+.....
T Consensus 169 ~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~-~~~~i~~~~~~------~~~~~~~ 241 (325)
T 3kn6_A 169 PCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE-IMKKIKKGDFS------FEGEAWK 241 (325)
T ss_dssp ---------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHH-HHHHHTTTCCC------CCSHHHH
T ss_pred cCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHH-HHHHHHcCCCC------CCccccc
Confidence 4579999999999999999999999999999999999999986543221111111 22333333221 1111112
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+.+++.+||+.||++|||++|+++
T Consensus 242 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp TSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred CCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 23467888999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=333.73 Aligned_cols=253 Identities=29% Similarity=0.442 Sum_probs=207.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||++... +++.||+|++..... ..+++.+|++++++++||||+++++++.+....++||||++
T Consensus 10 y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 10 LTFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp EEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred eeeeeEecCCCceeEEEEEec--CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 445678999999999999986 467899999976432 34679999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++... ..+++..+.+++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++............
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999875 4689999999999999999999998 8999999999999999999999999999876432222222
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.. ...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~i~~~~~-----~~~---- 226 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFR-----LYK---- 226 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCC-----CCC----
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH--------HHHHHhcCCc-----CCC----
Confidence 3346778999999998999999999999999999999 888987543322 1112222211 011
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+......+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11234567889999999999999999999999988654
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=343.10 Aligned_cols=244 Identities=25% Similarity=0.338 Sum_probs=200.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||+|++.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus 11 Y~i~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 11 YIIRETLGEGSFGKVKLATHYK-TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 3456889999999999999864 68899999986432 1223578999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+ +|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||++....... .
T Consensus 90 ~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~--~ 163 (336)
T 3h4j_B 90 YA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN--F 163 (336)
T ss_dssp CC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB--T
T ss_pred CC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCc--c
Confidence 99 789999998888899999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred eeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........... +.... .
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-----------------i~~~~-~ 225 (336)
T 3h4j_B 164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-----------------VNSCV-Y 225 (336)
T ss_dssp TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-----------------CCSSC-C
T ss_pred cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-----------------HHcCC-C
Confidence 233468999999999988876 7899999999999999999999975432221100 00000 0
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+......+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 226 VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111223456788999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=335.75 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=205.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.+.||+|+||.||+|... +++.||+|+++... ...+.+.+|++++++++||||+++++++.+ ...++||||+
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 89 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred hhhheeeecCCCCeEEEEEEEc--CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence 4456788999999999999975 46789999997533 235689999999999999999999999864 4688999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++++|.+++.... .+++..+.+++.|++.||+|||+. +|+||||||+||++++++.+||+|||++..........
T Consensus 90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (279)
T 1qpc_A 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (279)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCccccc
Confidence 9999999997643 689999999999999999999998 99999999999999999999999999998765433222
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+.. ..
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~~~~~~-----~~--- 230 (279)
T 1qpc_A 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--------VIQNLERGYR-----MV--- 230 (279)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCC-----CC---
T ss_pred ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH--------HHHHHhcccC-----CC---
Confidence 223346788999999998889999999999999999999 888987543322 1112222211 01
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
......+.+.+++.+||+.||++|||+.++++.|+.+..
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 112233578889999999999999999999999998654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=337.50 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=195.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|... ++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKWR---AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEET---TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred eeeeeEeecCCCceEEEEEEC---CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 345678999999999999874 688999999643 345689999999999999999999999874 4789999999
Q ss_pred CCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc-eEEccccCcccccCCCCc
Q 038294 587 NGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS-AKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 587 ~gsL~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~-~kl~DfGla~~~~~~~~~ 662 (799)
+++|.+++.... .+++..+++++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999998654 4678899999999999999999943238999999999999998876 799999999765322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ... .....+.... .
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~-~~~~~~~~~~-----~-- 225 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-----RIM-WAVHNGTRPP-----L-- 225 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-----HHH-HHHHTTCCCC-----C--
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-----HHH-HHHhcCCCCC-----c--
Confidence 1233589999999999999999999999999999999999999975422211 111 1111221111 1
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 226 --~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 226 --IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp --BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred --ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 11223567889999999999999999999999987654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=333.54 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=202.4
Q ss_pred hchhhhcCccccceEEEEEEeCCC--CeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|...... +..||+|.++.. .....+.+.+|+.++++++||||+++++++.++ ..++|||
T Consensus 14 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e 92 (281)
T 3cc6_A 14 VVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIME 92 (281)
T ss_dssp EEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEE
T ss_pred eEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEe
Confidence 445688999999999999976432 356999999754 334457899999999999999999999998654 5689999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.........
T Consensus 93 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 93 LYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp CCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred cCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999765 4589999999999999999999998 9999999999999999999999999999876544333
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+.. ..+..+... ..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~--------~~~~~~~~~-----~~- 235 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI--------GVLEKGDRL-----PK- 235 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH--------HHHHHTCCC-----CC-
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH--------HHHhcCCCC-----CC-
Confidence 3334457889999999999999999999999999999998 99999754332211 111111110 01
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.....+.+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 236 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 236 ---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 11223568889999999999999999999999987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=334.50 Aligned_cols=247 Identities=21% Similarity=0.317 Sum_probs=193.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------------------------hhHHHHHHHHHHhccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------------------------EREREFKSEVSAIGRT 560 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------------------------~~~~~~~~E~~~l~~l 560 (799)
+.+.+.||+|+||.||+|..+. +++.||||++..... ...+.+.+|+++++++
T Consensus 15 y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 15 YTLKDEIGKGSYGVVKLAYNEN-DNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp EEEEEEEEC--CCEEEEEEETT-TTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred eEEEeEEeecCCEEEEEEEECC-CCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 3456889999999999999864 689999999864321 1134688999999999
Q ss_pred ccccccceeeeeec--ccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeE
Q 038294 561 HHKNLVQLLGFCDE--ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNIL 638 (799)
Q Consensus 561 ~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NIL 638 (799)
+||||+++++++.+ ....++||||+++++|.+++. ...+++..+..++.||++||+|||+. +|+||||||+|||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil 169 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLL 169 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEE
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEE
Confidence 99999999999976 567899999999999988764 35789999999999999999999998 9999999999999
Q ss_pred EcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCC---CCcchhHHHHHHHHHHHHhCCcCCchhhhhhc
Q 038294 639 LDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG 715 (799)
Q Consensus 639 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~ 715 (799)
++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||.......
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~- 247 (298)
T 2zv2_A 170 VGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC- 247 (298)
T ss_dssp ECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-
T ss_pred ECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH-
Confidence 99999999999999987644322 223356899999999998765 3778999999999999999999997543221
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+....... + ......+.+.+++.+||+.||++|||+.|+++
T Consensus 248 -------~~~~~~~~~~~~------~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 248 -------LHSKIKSQALEF------P--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp -------HHHHHHHCCCCC------C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------HHHHHhcccCCC------C--CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 111122221110 0 01123356888999999999999999999874
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=346.49 Aligned_cols=266 Identities=18% Similarity=0.167 Sum_probs=202.1
Q ss_pred hhchhhhcCccccceEEEEEEeCC----CCeEEEEEEccccchhhH-----------HHHHHHHHHhcccccccccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLAQERE-----------REFKSEVSAIGRTHHKNLVQLLG 570 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~g 570 (799)
.+.+.+.||+|+||.||+|.++.. .++.||||++........ ..+..|+..+..++|+||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 445678899999999999998753 257899999865332111 23445666778889999999999
Q ss_pred eeecc----cceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCC
Q 038294 571 FCDEA----LNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD--NYF 643 (799)
Q Consensus 571 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~--~~~ 643 (799)
++... ...++||||+ +++|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTT
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCC
Confidence 99765 4478999999 99999999876 5789999999999999999999998 999999999999999 899
Q ss_pred ceEEccccCcccccCCCCc------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcch
Q 038294 644 SAKISDFGLSKLLLSDQSR------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA 717 (799)
Q Consensus 644 ~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~ 717 (799)
.+||+|||+++.+...... ......||+.|+|||.+.+..++.++|||||||+||||++|+.||..........
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 9999999999876433211 1123458999999999999999999999999999999999999998543222111
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
......... .+..+++...+ .......+.+++..||+.+|++||++.+|++.|+.+++
T Consensus 272 ---~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 272 ---RDSKIRYRE-NIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp ---HHHHHHHHH-CHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHhhh-hHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111111111 11111111111 01123567889999999999999999999999988765
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-38 Score=344.42 Aligned_cols=248 Identities=24% Similarity=0.330 Sum_probs=203.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++..+. +++.||+|++.... ....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 17 y~i~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 17 FEILRAIGKGSFGKVCIVQKND-TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp EEEEEEEECCTTCCEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 4556889999999999999874 68899999986432 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 96 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~ 170 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--Q 170 (384)
T ss_dssp CCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC--C
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCC--c
Confidence 999999999999888899999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred eeeeccCCcccccccccC---CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 664 HTMIRGTRGYVAPEWFKN---APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~---~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.....||+.|+|||++.. ..++.++|||||||++|||++|+.||............ ..+..... ..
T Consensus 171 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~-----~~~~~~~~------~~ 239 (384)
T 4fr4_A 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-----HTFETTVV------TY 239 (384)
T ss_dssp BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH-----HHHHHCCC------CC
T ss_pred eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH-----HHHhhccc------CC
Confidence 334569999999999964 45899999999999999999999999754332211111 11111111 11
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPT-MKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~evl~ 775 (799)
+......+.+++.+||+.||++||+ +++|++
T Consensus 240 ----p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 240 ----PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1223457888999999999999998 777764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=345.10 Aligned_cols=269 Identities=24% Similarity=0.332 Sum_probs=208.3
Q ss_pred chhhhcCccccceEEEEEEe---CCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLK---SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~---~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv 581 (799)
.+.+.||+|+||.||++.++ ..+++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 113 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLV 113 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEE
Confidence 45688999999999988753 2257899999997543 34456799999999999999999999999764 567899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|||+++++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 114 ~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 189 (318)
T 3lxp_A 114 MEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189 (318)
T ss_dssp ECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS
T ss_pred EecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccccccccccc
Confidence 9999999999999765 488999999999999999999998 999999999999999999999999999987754332
Q ss_pred c--ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-------hhHHHHHHHHHhcCce
Q 038294 662 R--THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-------AILTDWAYDCYAEGRL 732 (799)
Q Consensus 662 ~--~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~ 732 (799)
. ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......... .............+.
T Consensus 190 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 268 (318)
T 3lxp_A 190 YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGE- 268 (318)
T ss_dssp EEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTC-
T ss_pred ccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhccc-
Confidence 1 222345788899999999989999999999999999999999998754322100 000001111222221
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCCC
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCP 789 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~p 789 (799)
...........+.+++.+||+.||++|||+.|+++.|+.+.+.-.++.|
T Consensus 269 --------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~p 317 (318)
T 3lxp_A 269 --------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317 (318)
T ss_dssp --------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC---
T ss_pred --------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccCCC
Confidence 1111223346788999999999999999999999999987664444443
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.03 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=202.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||+|..+. +++.||+|+++... ....+.+..|..++..+ +||||+++++++.+....++||
T Consensus 19 y~~~~~lG~G~fg~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 19 FILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 4456889999999999999874 68999999997532 23345678899999876 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 98 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 173 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 173 (345)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC-
Confidence 9999999999998878899999999999999999999998 999999999999999999999999999986432222
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+.. ..+.
T Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~------~~p~ 239 (345)
T 1xjd_A 174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNP------FYPR 239 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCCT
T ss_pred cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHhCCC------CCCc
Confidence 2334569999999999999999999999999999999999999997654322 1112222211 1111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMK-VVL 774 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl 774 (799)
.....+.+++.+||+.||++||++. ||+
T Consensus 240 ----~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 240 ----WLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----ccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 2335678899999999999999997 664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.68 Aligned_cols=248 Identities=24% Similarity=0.384 Sum_probs=201.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc--cceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA--LNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~--~~~~lv~ 582 (799)
+.+.+.||+|+||.||+|+++ ++.||||+++.. .....+.|.+|+.++++++||||+++++++.+. ...++||
T Consensus 12 y~~~~~lg~G~~g~V~~~~~~---~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 12 LNFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp CEEEEEEEEETTEEEEEEEET---TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred hHHHHHhcCCCcceEEEEEEC---CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 445688999999999999984 788999998653 234456899999999999999999999999877 6789999
Q ss_pred eecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 583 EFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVP--IIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
||+++|+|.+++.... .+++..+..++.||+.||+|||+. + |+||||||+|||++.++.++|.|||++.....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 9999999999998765 489999999999999999999997 6 99999999999999999999999988764322
Q ss_pred CCCcceeeeccCCcccccccccCCCCCc---chhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSA---KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~---k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
. ...+|+.|+|||.+.+..++. ++||||||+++|||++|+.||......+. .......+..
T Consensus 166 ~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-------~~~~~~~~~~--- 229 (271)
T 3kmu_A 166 P------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-------GMKVALEGLR--- 229 (271)
T ss_dssp T------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH-------HHHHHHSCCC---
T ss_pred c------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH-------HHHHHhcCCC---
Confidence 1 235789999999998765544 89999999999999999999975433221 1111122111
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+.. +......+.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 230 --~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 230 --PTI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp --CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred --CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111 12234568889999999999999999999999988653
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=329.66 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=205.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.+.||+|+||.||+|..+. +++.+|+|++........+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 10 YYTLENTIGRGSWGEVKIAVQKG-TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hEEeeeEEeecCCEEEEEEEeCC-CCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 35566889999999999999874 57899999997765566778999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCcccccCCCCc
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
++++|.+++.....+++..+.+++.|++.||+|||+. +|+|+||||+|||+ +.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-- 163 (277)
T 3f3z_A 89 TGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-- 163 (277)
T ss_dssp CSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS--
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc--
Confidence 9999999998888899999999999999999999998 99999999999999 788999999999998764332
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||.+.+. ++.++||||||+++|||++|+.||......+. ...+..+... .+.
T Consensus 164 ~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~~------~~~ 228 (277)
T 3f3z_A 164 MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV--------MLKIREGTFT------FPE 228 (277)
T ss_dssp CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCCC------CCH
T ss_pred chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhCCCC------CCc
Confidence 22334589999999998765 89999999999999999999999976543221 1112222111 011
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 229 KDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000123457888999999999999999999985
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=337.49 Aligned_cols=258 Identities=22% Similarity=0.290 Sum_probs=197.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||+||+|..+ +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 23 y~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 23 YQKLEKVGEGTYGVVYKAKDS--QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEEECSSCEEEEEEET--TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hHhhhhccCCCCeEEEEEEEC--CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 345678999999999999985 58899999986432 22346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 101 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~ 175 (311)
T 3niz_A 101 MEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RS 175 (311)
T ss_dssp CSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-C-
T ss_pred CCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-cc
Confidence 985 787777654 4589999999999999999999998 99999999999999999999999999998764332 22
Q ss_pred eeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc-----------
Q 038294 664 HTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR----------- 731 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------- 731 (799)
.....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+ ........
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKI----FSILGTPNPREWPQVQELP 251 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHH----HHHHCCCCTTTSGGGTTSH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HHHHCCCChHHhhhhhccc
Confidence 233458999999999876 56899999999999999999999999765443321111 11110000
Q ss_pred -----eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 -----LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 -----~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..................+.+.+++.+||+.||++|||++|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 00000000000011123356788999999999999999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-38 Score=340.30 Aligned_cols=249 Identities=25% Similarity=0.325 Sum_probs=200.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+..|..++.++ +||||+++++++.+....++||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 89 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKK-TDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 89 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEEecCCeEEEEEEECC-CCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEE
Confidence 3456789999999999999874 68999999996532 23345688999999887 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 90 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~-~ 165 (345)
T 3a8x_A 90 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-D 165 (345)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT-C
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCC-C
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......... ........+.+..+... .+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~------~p 239 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR------IP 239 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCC------CC
T ss_pred cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCC------CC
Confidence 233456999999999999999999999999999999999999999753211100 00111222333332211 11
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
......+.+++.+||+.||++||++
T Consensus 240 ----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 ----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 1234567889999999999999995
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=367.97 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=209.5
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.....+.++||+|+||.||+|.++ .+..||||+++... ...++|.+|++++++++|+||+++++++.+ ...+||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEEC--CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 344556788999999999999986 35789999997543 235689999999999999999999999976 67899999
Q ss_pred ecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 584 FMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|+++|+|.+++... ..+++..+++|+.||+.||+|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 99999999999753 4689999999999999999999998 999999999999999999999999999987643221
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.......++..|+|||.+.+..++.++|||||||+||||++ |+.||......+ +...+..+... .
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~--------~~~~i~~~~~~-----~- 484 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--------VLDQVERGYRM-----P- 484 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH--------HHHHHHTTCCC-----C-
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-----C-
Confidence 11222346788999999999999999999999999999999 899987543322 11222222110 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNP 786 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p 786 (799)
......+.+.+++.+||+.||++|||+++|+++|+.+.....|
T Consensus 485 ---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 485 ---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 1122345788899999999999999999999999998764443
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.02 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=200.2
Q ss_pred chhhhcCccccceEEEEEEeCCC---CeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSAS---GKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~---~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.||+|+||.||+|..+..+ +..||||+++... ......+.+|++++++++||||+++++++.+....++|||
T Consensus 47 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 126 (333)
T 1mqb_A 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 126 (333)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEe
Confidence 34578999999999999987433 3469999997543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 127 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 203 (333)
T 1mqb_A 127 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 203 (333)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred CCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcccccc
Confidence 99999999999865 5789999999999999999999998 8999999999999999999999999999876543221
Q ss_pred c--eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 T--HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~--~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
. .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+... .
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~~-----~ 270 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--------VMKAINDGFRL-----P 270 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHHHHTTCCC-----C
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHHCCCcC-----C
Confidence 1 122345778999999999999999999999999999999 999987543322 11222222110 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+.+++.+||+.||++||++.+|++.|++++.
T Consensus 271 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 271 ----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp ----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 112234578889999999999999999999999987653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=340.79 Aligned_cols=243 Identities=22% Similarity=0.248 Sum_probs=204.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 121 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEc
Confidence 3456789999999999999874 68899999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 122 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---- 194 (350)
T 1rdq_E 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC----
Confidence 999999999999878899999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+..+... .+
T Consensus 195 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--------~~~~i~~~~~~------~p-- 258 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVR------FP-- 258 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCC------CC--
T ss_pred cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH--------HHHHHHcCCCC------CC--
Confidence 223468999999999999999999999999999999999999997654322 12222233211 11
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
......+.+++.+||+.||++||+ ++||++
T Consensus 259 --~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 --SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 123456788999999999999998 888874
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-38 Score=333.51 Aligned_cols=261 Identities=19% Similarity=0.241 Sum_probs=197.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||+||+|..+. +++.||+|+++... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceeeeEecCCCCeEEEEEEECC-CCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 3456789999999999999874 67899999986432 33346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 158 (292)
T 3o0g_A 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CY 158 (292)
T ss_dssp CSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-CC
T ss_pred CCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccc-cc
Confidence 98644444444457899999999999999999999998 999999999999999999999999999987643322 22
Q ss_pred eeeccCCcccccccccCCC-CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc---e---eEeec
Q 038294 665 TMIRGTRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR---L---DVLVD 737 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~-~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~---~~~~d 737 (799)
....+|+.|+|||.+.+.. ++.++|||||||++|||++|+.|+........ .+.. ......... . ....+
T Consensus 159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~~~ 235 (292)
T 3o0g_A 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKR-IFRLLGTPTEEQWPSMTKLPD 235 (292)
T ss_dssp CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHH-HHHHHCCCCTTTCTTGGGSTT
T ss_pred cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHH-HHHHhCCCChhhhhhhccccc
Confidence 3345899999999998765 79999999999999999999988653322211 1111 111110000 0 00000
Q ss_pred ---------CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 ---------SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..............+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00000111234457788999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=335.86 Aligned_cols=249 Identities=23% Similarity=0.260 Sum_probs=195.4
Q ss_pred HHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhccc-ccccccceeeeeeccc
Q 038294 500 NELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 576 (799)
Q Consensus 500 ~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 576 (799)
.++....+.+.++||+|+||+||+|.++. +++.||||++.... .....++..|+..+.++ +||||++++++|.++.
T Consensus 52 ~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~ 130 (311)
T 3p1a_A 52 ESFFQQSFQRLSRLGHGSYGEVFKVRSKE-DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGG 130 (311)
T ss_dssp SCHHHHHEEEEEEEEEETTEEEEEEEETT-TSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred cchhhhheeeeheeccCCCeEEEEEEECC-CCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCC
Confidence 34555566777899999999999999874 68999999985422 23334555666666555 8999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
..++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~ 206 (311)
T 3p1a_A 131 ILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206 (311)
T ss_dssp EEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred EEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeee
Confidence 999999999 67898888764 4689999999999999999999998 899999999999999999999999999987
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
..... ......||+.|+|||++.+ .++.++|||||||++|||++|..++...... ..+..+..
T Consensus 207 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----------~~~~~~~~--- 269 (311)
T 3p1a_A 207 LGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----------QQLRQGYL--- 269 (311)
T ss_dssp CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----------HHHTTTCC---
T ss_pred cccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----------HHHhccCC---
Confidence 64322 2233458999999999876 7999999999999999999998776543211 11111111
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+........+.+.+++.+||+.||++|||+.|+++
T Consensus 270 -----~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 270 -----PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp -----CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 11111223457888999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=336.86 Aligned_cols=259 Identities=24% Similarity=0.295 Sum_probs=203.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee----cccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD----EALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~----~~~~~~lv 581 (799)
.+.+.+.||+|+||.||++.... +++.||||++........+.+.+|++++++++||||+++++++. .....++|
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 108 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLL 108 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecC-CCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEE
Confidence 34567889999999999999864 68899999987655666778999999999999999999999986 34567899
Q ss_pred EeecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 582 YEFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
+||+++|+|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 185 (317)
T 2buj_A 109 LPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQAC 185 (317)
T ss_dssp EECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESC
T ss_pred EEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcc
Confidence 999999999999875 35789999999999999999999998 99999999999999999999999999987653
Q ss_pred CCCCc--------ceeeeccCCcccccccccCCC---CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH
Q 038294 658 SDQSR--------THTMIRGTRGYVAPEWFKNAP---VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 658 ~~~~~--------~~~~~~gt~~y~aPE~l~~~~---~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~ 726 (799)
..... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........... ..
T Consensus 186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~ 259 (317)
T 2buj_A 186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------LA 259 (317)
T ss_dssp EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH------HH
T ss_pred cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh------HH
Confidence 21110 011234689999999987654 68999999999999999999999975432221110 01
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
.... .. .+ ........+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 260 ~~~~-~~------~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~ 307 (317)
T 2buj_A 260 VQNQ-LS------IP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307 (317)
T ss_dssp HHCC---------CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred hhcc-CC------CC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence 1110 00 00 1122335788899999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=345.55 Aligned_cols=255 Identities=25% Similarity=0.415 Sum_probs=193.8
Q ss_pred chhhhcCccccceEEEEEEeCCCC--eEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeec-ccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 583 (799)
.+.+.||+|+||.||+|.+...++ ..||||.++... ....++|.+|+.++++++||||+++++++.+ ....++|||
T Consensus 92 ~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e 171 (373)
T 3c1x_A 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 171 (373)
T ss_dssp EEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEE
T ss_pred ecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEE
Confidence 345789999999999999864443 468999986533 3455789999999999999999999998754 457789999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 172 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 172 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred CCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999865 4688999999999999999999998 9999999999999999999999999999876433211
Q ss_pred ---ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 663 ---THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 663 ---~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+..+...
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--------~~~~~~~~~~----- 315 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVYLLQGRRL----- 315 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--------HHHHHTTCCC-----
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--------HHHHHcCCCC-----
Confidence 1223446788999999999999999999999999999999 5556654332221 1111222110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.. +......+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 316 ~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~ 355 (373)
T 3c1x_A 316 LQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355 (373)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01 11223568889999999999999999999999988654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=337.43 Aligned_cols=246 Identities=22% Similarity=0.332 Sum_probs=194.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccc--------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-------- 577 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------- 577 (799)
+.+.+.||+|+||.||+|+.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+...
T Consensus 8 y~~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~ 86 (332)
T 3qd2_B 8 FEPIQCMGRGGFGVVFEAKNKV-DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMD 86 (332)
T ss_dssp EEEEEEEECC-CSEEEEEEETT-TCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHH
T ss_pred CceeeEecCCCCeEEEEEEEcC-CCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhh
Confidence 4456889999999999999874 68899999986433 3345789999999999999999999999865432
Q ss_pred -------------------------------------------------eeeEEeecCCCChhhhhhcCC---CCCHHHH
Q 038294 578 -------------------------------------------------RLLVYEFMGNGTLANLIFAIP---KPDWNLR 605 (799)
Q Consensus 578 -------------------------------------------------~~lv~e~~~~gsL~~~l~~~~---~~~~~~~ 605 (799)
.++||||+++++|.+++.... ..++..+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 166 (332)
T 3qd2_B 87 EIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC 166 (332)
T ss_dssp C--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHH
T ss_pred hhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHH
Confidence 689999999999999998754 3456678
Q ss_pred HHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-----------cceeeeccCCccc
Q 038294 606 VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-----------RTHTMIRGTRGYV 674 (799)
Q Consensus 606 ~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~y~ 674 (799)
.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... .......||+.|+
T Consensus 167 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 99999999999999998 999999999999999999999999999987754321 1122346899999
Q ss_pred ccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHH
Q 038294 675 APEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLM 754 (799)
Q Consensus 675 aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~ 754 (799)
|||.+.+..++.++||||||+++|||++|..|+..... ......... ...........+.+
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~----------~~~~~~~~~---------~~~~~~~~~~~~~~ 304 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR----------IITDVRNLK---------FPLLFTQKYPQEHM 304 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH----------HHHHHHTTC---------CCHHHHHHCHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH----------HHHHhhccC---------CCcccccCChhHHH
Confidence 99999999999999999999999999998776432211 111111111 11112334456788
Q ss_pred HHHHhcccCCCCCCCHHHHHH
Q 038294 755 IAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 755 l~~~Cl~~dP~~RPt~~evl~ 775 (799)
++.+||+.||++|||+.|+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCCCcCCCHHHHhh
Confidence 999999999999999999986
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=340.70 Aligned_cols=246 Identities=28% Similarity=0.343 Sum_probs=202.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+..|..++..+ +||||+++++++......++||
T Consensus 22 y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 22 FNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-EEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred cEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 4556889999999999999874 57899999997532 23346788999999987 8999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 101 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~-~ 176 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG-V 176 (353)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT-C
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC-c
Confidence 9999999999998878899999999999999999999998 99999999999999999999999999998643222 2
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+.+..+.. ..+
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~------~~p- 241 (353)
T 2i0e_A 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHNV------AYP- 241 (353)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCC-
T ss_pred ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhCCC------CCC-
Confidence 2334569999999999999999999999999999999999999998654322 1122222221 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
......+.+++.+||+.||++||+ ++||++
T Consensus 242 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 242 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 123457788999999999999995 566664
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-38 Score=369.14 Aligned_cols=249 Identities=27% Similarity=0.378 Sum_probs=202.0
Q ss_pred hhcCccccceEEEEEEeC-CCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
++||+|+||.||+|.+.. ..++.||||+++.... ...+++.+|++++++++||||+++++++.. ...++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 479999999999997753 2457899999975432 345789999999999999999999999964 457899999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC--ccee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS--RTHT 665 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~--~~~~ 665 (799)
|+|.+++.....+++..+..|+.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++....... ....
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~ 530 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 530 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccccc
Confidence 99999999888899999999999999999999998 999999999999999999999999999987654332 2222
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+|+.|+|||++.+..++.++|||||||+||||++ |+.||......+ +...+..+... ..
T Consensus 531 ~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~-----~~---- 593 (635)
T 4fl3_A 531 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERM-----GC---- 593 (635)
T ss_dssp ----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCC-----CC----
T ss_pred CCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCC-----CC----
Confidence 3346788999999999999999999999999999998 999997654432 12222332211 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
+......+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122346788899999999999999999999999875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=350.83 Aligned_cols=250 Identities=22% Similarity=0.248 Sum_probs=201.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+|..+. +++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 72 ~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 72 EVVKVIGRGAFGEVQLVRHKS-TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEcCCCEEEEEEEECC-CCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 345789999999999999875 678999999965221 2234588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..........
T Consensus 151 ~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 226 (410)
T 3v8s_A 151 MPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRC 226 (410)
T ss_dssp CTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEEC
T ss_pred CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccc
Confidence 999999999876 4688999999999999999999998 999999999999999999999999999987654433333
Q ss_pred eeeccCCcccccccccCCC----CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 665 TMIRGTRGYVAPEWFKNAP----VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~----~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
....||+.|+|||++.+.. ++.++|||||||+||||++|+.||......+... .+..+... ...
T Consensus 227 ~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--------~i~~~~~~----~~~ 294 (410)
T 3v8s_A 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--------KIMNHKNS----LTF 294 (410)
T ss_dssp CSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--------HHHTHHHH----CCC
T ss_pred cCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH--------HHHhcccc----ccC
Confidence 4567999999999998765 7899999999999999999999998654332111 11111000 001
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSK--RPTMKVVLQM 776 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~evl~~ 776 (799)
+. .......+.+++.+||+.+|.+ ||+++||++.
T Consensus 295 p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 295 PD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 10 1122356788999999999988 9999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-38 Score=354.54 Aligned_cols=246 Identities=25% Similarity=0.304 Sum_probs=194.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++..+. +++.||||+++.. .......+.+|+.++++++||||+++++++......++|||
T Consensus 150 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 150 FEYLKLLGKGTFGKVILVKEKA-TGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred cEEeEEEeeCcCEEEEEEEEcC-CCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 4456789999999999999874 6899999999653 22334567899999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+ . +|+||||||+||||+.++.+||+|||+++...... .
T Consensus 229 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~ 304 (446)
T 4ejn_A 229 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-A 304 (446)
T ss_dssp CCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC----
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCC-c
Confidence 99999999999888889999999999999999999998 6 89999999999999999999999999998643322 2
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||+||||++|+.||........ ...+..+.. ..+
T Consensus 305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--------~~~i~~~~~------~~p- 369 (446)
T 4ejn_A 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL--------FELILMEEI------RFP- 369 (446)
T ss_dssp --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHCCC------CCC-
T ss_pred ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH--------HHHHHhCCC------CCC-
Confidence 23345699999999999999999999999999999999999999976543221 111111111 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
......+.+++.+||+.||++|| +++|+++
T Consensus 370 ---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 ---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp ---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 12235678899999999999999 9999985
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.30 Aligned_cols=254 Identities=24% Similarity=0.359 Sum_probs=200.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCe----EEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~----~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.+.||+|+||.||+|.+.. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++. +...++|
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v 92 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIP-EGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLV 92 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECC-TTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEE
T ss_pred ceeeeeeeecCCceEEEEEEcC-CCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEE
Confidence 3456789999999999999864 343 37888875432 233356788999999999999999999986 4568899
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 169 (325)
T 3kex_A 93 TQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169 (325)
T ss_dssp EECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred EEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence 9999999999999875 4788999999999999999999998 99999999999999999999999999999875443
Q ss_pred C-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 S-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
. .......+|..|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+....
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--------~~~~~~~~~~~---- 237 (325)
T 3kex_A 170 KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV--------PDLLEKGERLA---- 237 (325)
T ss_dssp TCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH--------HHHHHTTCBCC----
T ss_pred ccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH--------HHHHHcCCCCC----
Confidence 2 22334557889999999999999999999999999999999 9999976543221 12222221111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+ ......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 238 -~~----~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 238 -QP----QICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -CC----TTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -CC----CcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01 1112346679999999999999999999999987653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=336.05 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=205.6
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh------hHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE------REREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
..+.+.+.||+|+||.||++..+. +++.||+|+++..... ..+++.+|+.++++++||||+++++++.+....
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKS-TGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECC-CCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 345667899999999999999874 6889999998653221 356799999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEccccCcc
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF----SAKISDFGLSK 654 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~----~~kl~DfGla~ 654 (799)
++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||++.
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 99999999999999998888889999999999999999999998 999999999999999887 79999999998
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 168 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~i~~~~~-- 235 (321)
T 2a2a_A 168 EIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------LANITSVSY-- 235 (321)
T ss_dssp ECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH--------HHHHHTTCC--
T ss_pred ecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhccc--
Confidence 764432 22334589999999999999999999999999999999999999976543221 111111111
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+........+.+.+++.+||+.||++|||+.|+++
T Consensus 236 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 236 ----DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp ----CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred ----ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0010001122356788999999999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=343.94 Aligned_cols=251 Identities=23% Similarity=0.265 Sum_probs=193.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||++..+. +++.||||++.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus 22 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 99 (361)
T 3uc3_A 22 YDFVKDIGSGNFGVARLMRDKL-TKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYAS 99 (361)
T ss_dssp EEEEEEESSSTTSSEEEEEETT-TCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EEEEEEeccCCCEEEEEEEECC-CCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCC
Confidence 4567889999999999999874 68899999996532 234678899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--eEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS--AKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~--~kl~DfGla~~~~~~~~~~~ 664 (799)
+|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+++...... ..
T Consensus 100 ~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~--~~ 174 (361)
T 3uc3_A 100 GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QP 174 (361)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccC--CC
Confidence 999999998878899999999999999999999998 9999999999999987765 9999999997532221 22
Q ss_pred eeeccCCcccccccccCCCCCcc-hhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAK-VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k-~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....||+.|+|||++.+..++.+ +|||||||++|||++|+.||.......... ..... +..... ..+
T Consensus 175 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~~~~~-~~~~~~------~~~-- 242 (361)
T 3uc3_A 175 KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR---KTIQR-ILSVKY------SIP-- 242 (361)
T ss_dssp ------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH---HHHHH-HHTTCC------CCC--
T ss_pred CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH---HHHHH-HhcCCC------CCC--
Confidence 33458999999999988888766 899999999999999999998654332211 11111 111111 001
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........+.+++.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 111223577889999999999999999999863
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=364.64 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=200.9
Q ss_pred hcCccccceEEEEEEeCC-CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCC
Q 038294 512 ELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+||+|+||.||+|.++.. ++..||||+++... ....++|.+|++++++++||||++++++|.. ...++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 699999999999988632 45689999997643 3356789999999999999999999999976 56899999999999
Q ss_pred hhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc--eee
Q 038294 590 LANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT--HTM 666 (799)
Q Consensus 590 L~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~~ 666 (799)
|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||++++.+||+|||+++......... ...
T Consensus 422 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 498 (613)
T 2ozo_A 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSA 498 (613)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-----------
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccC
Confidence 99999754 4689999999999999999999998 99999999999999999999999999998764332211 122
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..+++.|+|||++.+..++.++|||||||+||||++ |+.||......+ +...+..+... ..+
T Consensus 499 ~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--------~~~~i~~~~~~---------~~p 561 (613)
T 2ozo_A 499 GKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRM---------ECP 561 (613)
T ss_dssp ---CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--------HHHHHHTTCCC---------CCC
T ss_pred CCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCC---------CCC
Confidence 335689999999999999999999999999999998 999997654332 22223333211 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
......+.+++.+||+.||++||++.+|++.|+.+.
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 223467888999999999999999999999998854
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=332.19 Aligned_cols=255 Identities=25% Similarity=0.431 Sum_probs=202.8
Q ss_pred hhhhcCccccceEEEEEEeCC--CCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccce-eeEEee
Q 038294 509 FKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR-LLVYEF 584 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~-~lv~e~ 584 (799)
..+.||+|+||+||+|.+... .+..+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.... ++|+||
T Consensus 25 ~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~ 104 (298)
T 3pls_A 25 SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104 (298)
T ss_dssp EEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECC
T ss_pred cCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEec
Confidence 347899999999999997542 234799999875433 3456899999999999999999999999876665 899999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC---
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--- 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 660 (799)
+.+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 181 (298)
T 3pls_A 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYS 181 (298)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGC
T ss_pred ccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccc
Confidence 9999999999874 5789999999999999999999998 99999999999999999999999999998654322
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
........+++.|+|||.+.+..++.++||||||+++|||++|..|+........ ....+..+..
T Consensus 182 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-------~~~~~~~~~~-------- 246 (298)
T 3pls_A 182 VQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-------LTHFLAQGRR-------- 246 (298)
T ss_dssp SCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-------HHHHHHTTCC--------
T ss_pred cccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH-------HHHHhhcCCC--------
Confidence 1122234578899999999999999999999999999999997766543322111 1111122211
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+.+.+++.+||+.||++|||+.++++.|+++++
T Consensus 247 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 247 -LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 01112233578889999999999999999999999988654
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=344.61 Aligned_cols=266 Identities=17% Similarity=0.173 Sum_probs=200.8
Q ss_pred hchhhhcCcc--ccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRG--SFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G--~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+| +||.||+|..+. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 27 y~~~~~lG~G~~~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 105 (389)
T 3gni_B 27 YELLTVIGKGFEDLMTVNLARYKP-TGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 105 (389)
T ss_dssp EEEEEEEEEETTTTEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEecccCCcCCceEEEEEEEcC-CCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEE
Confidence 4456889999 999999999874 68999999996533 344567889999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 583 EFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 583 e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||.+.......
T Consensus 106 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 182 (389)
T 3gni_B 106 SFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG 182 (389)
T ss_dssp ECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred EccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence 999999999999875 6789999999999999999999998 99999999999999999999999999987553221
Q ss_pred C------cceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH-HHHHHHh---
Q 038294 661 S------RTHTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD-WAYDCYA--- 728 (799)
Q Consensus 661 ~------~~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~--- 728 (799)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.............. .......
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (389)
T 3gni_B 183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262 (389)
T ss_dssp EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence 1 11122358899999999987 6799999999999999999999999975433221100000 0000000
Q ss_pred --cC-------------ceeEeec---------CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 729 --EG-------------RLDVLVD---------SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 729 --~~-------------~~~~~~d---------~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.. ....... ..............+.+++.+||+.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 0000000 000001122334568889999999999999999999854
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=340.92 Aligned_cols=248 Identities=26% Similarity=0.343 Sum_probs=189.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|..+. +++.||||+++... ..+.+.+|++++++++||||+++++++.+....++||||++
T Consensus 55 y~~~~~lG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 131 (349)
T 2w4o_A 55 FEVESELGRGATSIVYRCKQKG-TQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVT 131 (349)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EEEeeEEeeCCCEEEEEEEECC-CCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCC
Confidence 4456789999999999999874 57899999997532 34578899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++...... .
T Consensus 132 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~ 206 (349)
T 2w4o_A 132 GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--L 206 (349)
T ss_dssp SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCccc--c
Confidence 999999998888899999999999999999999998 9999999999999975 8899999999998654322 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+..+.... ...
T Consensus 207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------~~~~~i~~~~~~~------~~~ 273 (349)
T 2w4o_A 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-------FMFRRILNCEYYF------ISP 273 (349)
T ss_dssp ------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-------HHHHHHHTTCCCC------CTT
T ss_pred cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-------HHHHHHHhCCCcc------CCc
Confidence 233568999999999999999999999999999999999999997543221 1112222221110 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+++.+||+.||++|||+.|+++
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11223457788999999999999999999986
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-38 Score=332.12 Aligned_cols=254 Identities=27% Similarity=0.371 Sum_probs=204.7
Q ss_pred chhh-hcCccccceEEEEEEeC-CCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 508 GFKE-ELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~-~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+ .||+|+||.||+|.+.. ..++.||||+++... ....+++.+|++++++++||||+++++++ +....++|||
T Consensus 19 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e 97 (291)
T 1xbb_A 19 TLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVME 97 (291)
T ss_dssp EEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEE
T ss_pred hhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEE
Confidence 3445 89999999999997642 346899999997543 23356899999999999999999999999 5567889999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++..........
T Consensus 98 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 98 MAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp CCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred eCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 999999999999888899999999999999999999998 99999999999999999999999999998765443222
Q ss_pred --eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 664 --HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 664 --~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+... .
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--------~~~~~~~~~~~-----~- 240 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERM-----G- 240 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCC-----C-
T ss_pred cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCC-----C-
Confidence 122346788999999998889999999999999999999 999997654322 11222222211 1
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+....+.+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 241 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 241 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112334578889999999999999999999999988653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=339.12 Aligned_cols=253 Identities=23% Similarity=0.266 Sum_probs=197.3
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-----chhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-----AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
..+.+.+.||+|+||.||+|..+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+....+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQ-TRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECC-CCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 345567899999999999999864 6789999998643 2344568999999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 038294 580 LVYEFMGNGTLANLIFAI----------------------------------------PKPDWNLRVRISLEIARGLVYL 619 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~----------------------------------------~~~~~~~~~~i~~~ia~gL~yL 619 (799)
+||||+++|+|.+++... ..+++..+..++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999988521 0124667788999999999999
Q ss_pred HhcCCCCeEecCCCCCCeEEcCCC--ceEEccccCcccccCCCC---cceeeeccCCcccccccccC--CCCCcchhHHH
Q 038294 620 HEECNVPIIHCDIKPQNILLDNYF--SAKISDFGLSKLLLSDQS---RTHTMIRGTRGYVAPEWFKN--APVSAKVDVYS 692 (799)
Q Consensus 620 H~~~~~~iiH~dlk~~NILl~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS 692 (799)
|+. +|+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++||||
T Consensus 185 H~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 185 HNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 998 999999999999998766 899999999987643221 12334568999999999975 67899999999
Q ss_pred HHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038294 693 FGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKV 772 (799)
Q Consensus 693 ~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 772 (799)
||+++|||++|+.||......+.. ...... .. ..+..........+.+++.+||+.||++|||+.|
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~-------~~~~~~-~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTI-------SQVLNK-KL------CFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHH-------HHHHHC-CC------CTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHCCCCCCCCChHHHH-------HHHHhc-cc------ccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 999999999999999765433211 111111 10 0111111223457888999999999999999999
Q ss_pred HHH
Q 038294 773 VLQ 775 (799)
Q Consensus 773 vl~ 775 (799)
+++
T Consensus 328 ~l~ 330 (345)
T 3hko_A 328 ALQ 330 (345)
T ss_dssp HHH
T ss_pred Hhc
Confidence 986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=336.90 Aligned_cols=258 Identities=26% Similarity=0.438 Sum_probs=208.0
Q ss_pred HhhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
..+.+.+.||+|+||.||+|..+. .+++.||+|++..... .....+.+|++++++++||||+++++++.+....+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 104 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 104 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccE
Confidence 345567889999999999998752 2467899999975432 34457899999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 580 LVYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
+||||+++|+|.+++... ..+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|
T Consensus 105 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~D 181 (322)
T 1p4o_A 105 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 181 (322)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECc
Confidence 999999999999998752 3568999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 650 FGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 650 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--------~~~~~ 253 (322)
T 1p4o_A 182 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRFV 253 (322)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------HHHHH
T ss_pred CccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--------HHHHH
Confidence 999986543221 11122346888999999999999999999999999999999 788887543322 11222
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+.... ........+.+++.+||+.||++|||+.|+++.|+++++
T Consensus 254 ~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 MEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 2222111 112233567889999999999999999999999988754
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=337.14 Aligned_cols=269 Identities=22% Similarity=0.279 Sum_probs=198.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.||+|+||.||+|.... +++.||||+++.......+.+.+|++++.++ +||||+++++++.+....++||||+++++
T Consensus 19 ~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 97 (316)
T 2ac3_A 19 DVLGEGAHARVQTCINLI-TSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97 (316)
T ss_dssp CCCCCCSSEEEEEEECSS-SCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCB
T ss_pred ceecCCceEEEEEEEEcC-CCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCc
Confidence 579999999999999764 6789999999765555567899999999885 79999999999999999999999999999
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEccccCcccccCCCC-----
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS---AKISDFGLSKLLLSDQS----- 661 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~---~kl~DfGla~~~~~~~~----- 661 (799)
|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++. +||+|||++........
T Consensus 98 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 174 (316)
T 2ac3_A 98 ILSHIHKRRHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPIS 174 (316)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------------
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccc
Confidence 999998888899999999999999999999998 9999999999999998766 99999999986542211
Q ss_pred -cceeeeccCCcccccccccC-----CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-------hhHHHHHHHHHh
Q 038294 662 -RTHTMIRGTRGYVAPEWFKN-----APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-------AILTDWAYDCYA 728 (799)
Q Consensus 662 -~~~~~~~gt~~y~aPE~l~~-----~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~ 728 (799)
.......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ..........+.
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 254 (316)
T 2ac3_A 175 TPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQ 254 (316)
T ss_dssp -------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHH
T ss_pred ccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHh
Confidence 11223458999999999875 56889999999999999999999999754322100 000111222222
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCCCC
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLLEVPNPPCP 789 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~p~~p 789 (799)
.+... .+..........+.+++.+||+.||++|||+.|+++ .+++.......|.|
T Consensus 255 ~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~~ 311 (316)
T 2ac3_A 255 EGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTP 311 (316)
T ss_dssp HCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----------
T ss_pred ccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCCCc
Confidence 22211 110000122356888999999999999999999987 34444333333333
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=335.42 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=190.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|..+. +++.||+|+++.... ...+.+.+|++++++++||||+++++++......++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 85 (317)
T 2pmi_A 7 FKQLEKLGNGTYATVYKGLNKT-TGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85 (317)
T ss_dssp ------------CEEEEEECSS-SCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECC
T ss_pred eeEeeEECCCCCEEEEEEEECC-CCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEec
Confidence 3456789999999999999874 678999999865332 23467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 586 GNGTLANLIFAI------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 586 ~~gsL~~~l~~~------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+ ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 86 D-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp C-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred C-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 8 5999988643 3588999999999999999999998 9999999999999999999999999999876432
Q ss_pred CCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHH----Hhc----C
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDC----YAE----G 730 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~----~ 730 (799)
.. ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....... +.. .
T Consensus 162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 240 (317)
T 2pmi_A 162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLP 240 (317)
T ss_dssp CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCT
T ss_pred cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhh
Confidence 21 2233458999999999976 468999999999999999999999998654433221111100000 000 0
Q ss_pred ceeEeecCCCCC--------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPA--------MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+....+. .........+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 241 KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 000000000000 001123357889999999999999999999985
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=327.75 Aligned_cols=245 Identities=28% Similarity=0.387 Sum_probs=200.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 89 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred EEEeeEEecCCCeEEEEEEEcc-CCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEe
Confidence 3456789999999999999874 67899999986432 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||++...... .
T Consensus 90 ~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~---~ 163 (279)
T 3fdn_A 90 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 163 (279)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcc---c
Confidence 999999999998888899999999999999999999998 9999999999999999999999999998654322 1
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+.. ..+..... ..+
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~------~~~-- 227 (279)
T 3fdn_A 164 RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY--------KRISRVEF------TFP-- 227 (279)
T ss_dssp ----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--------HHHHHTCC------CCC--
T ss_pred ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH--------HHHHhCCC------CCC--
Confidence 23346899999999999999999999999999999999999999755432211 11111111 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+.+.+++.+||+.||++|||+.|+++.
T Consensus 228 --~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 228 --DFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp --TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred --CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1223567789999999999999999999964
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.90 Aligned_cols=249 Identities=26% Similarity=0.356 Sum_probs=203.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||.||+|..+. +++.||+|++... .....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 86 (284)
T 3kk8_A 8 YDVKEELGKGAFSVVRRCVHKT-TGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 86 (284)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hhhhhhhcCcCCeEEEEEEEcC-CCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEec
Confidence 3456789999999999999874 6789999998643 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEccccCcccccCCCC
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS---AKISDFGLSKLLLSDQS 661 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~---~kl~DfGla~~~~~~~~ 661 (799)
+++++|.+.+.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||++........
T Consensus 87 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 87 VTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99999999998888899999999999999999999998 9999999999999986655 99999999987643322
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ...+..+.... +
T Consensus 164 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~~------~ 227 (284)
T 3kk8_A 164 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL--------YAQIKAGAYDY------P 227 (284)
T ss_dssp --CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHTCCCC------C
T ss_pred --ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH--------HHHHHhccccC------C
Confidence 2334689999999999999999999999999999999999999976543221 11122222111 1
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+.+++.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 1111123356788999999999999999999986
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.90 Aligned_cols=268 Identities=21% Similarity=0.289 Sum_probs=210.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccc--ceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.++. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.. ..++|||
T Consensus 11 y~i~~~LG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e 89 (396)
T 4eut_A 11 WLLSDILGQGATANVFRGRHKK-TGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIME 89 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEC
T ss_pred eEEEEEEEcCCCeEEEEEEECC-CCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEe
Confidence 4456889999999999999874 68899999997543 233567889999999999999999999997655 6789999
Q ss_pred ecCCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEccccCcccc
Q 038294 584 FMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL----DNYFSAKISDFGLSKLL 656 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl----~~~~~~kl~DfGla~~~ 656 (799)
|+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++..
T Consensus 90 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~ 166 (396)
T 4eut_A 90 FCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166 (396)
T ss_dssp CCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred cCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence 999999999998643 389999999999999999999998 99999999999999 77888999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccC--------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKN--------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
.... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.......... ........
T Consensus 167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~---~~~~~~~~ 241 (396)
T 4eut_A 167 EDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK---EVMYKIIT 241 (396)
T ss_dssp CCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH---HHHHHHHH
T ss_pred cCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH---HHHHHHhc
Confidence 4332 2233468999999999865 567889999999999999999999997543322111 11112111
Q ss_pred c---CceeEee-----------cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 729 E---GRLDVLV-----------DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 729 ~---~~~~~~~-----------d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
. ..+.... +..............+.+++.+||+.||++||++.|+++.++.+++.
T Consensus 242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 1 1111110 11112233466777888999999999999999999999999887664
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=331.12 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=198.0
Q ss_pred HHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccc
Q 038294 500 NELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 577 (799)
Q Consensus 500 ~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 577 (799)
.|+....+.+.+.||+|+||.||+|... ..||+|+++.. .....+.|.+|++++++++||||+++++++ ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESS----SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEc----CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCc
Confidence 3444555667789999999999999864 35999998643 334456899999999999999999999976 4556
Q ss_pred eeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 578 RLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
.++||||+++++|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceecccc
Confidence 78999999999999999654 5689999999999999999999998 9999999999999999999999999999865
Q ss_pred cCCC-CcceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 657 LSDQ-SRTHTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 657 ~~~~-~~~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
.... ........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ ........+..
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-------~~~~~~~~~~~ 243 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------QIIEMVGRGSL 243 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH-------HHHHHHHHTSC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH-------HHHHHhccccc
Confidence 4322 22223456899999999986 6678899999999999999999999997543322 11222222222
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.... ..........+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 244 ~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 244 SPDL-----SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCT-----TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred Ccch-----hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1111 11122334678899999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=348.24 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=206.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+. +++.||||++..... ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus 18 Y~l~~~LG~G~fg~V~~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 18 YILGDTLGVGTFGKVKVGKHEL-TGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp EEEEEEEECCSSSCEEEEEETT-TCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3456789999999999999874 689999999965322 234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++....... .
T Consensus 97 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~--~ 171 (476)
T 2y94_A 97 YVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 171 (476)
T ss_dssp CCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC--C
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc--c
Confidence 999999999998888899999999999999999999998 99999999999999999999999999998764332 2
Q ss_pred eeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....||+.|+|||++.+..+ +.++|||||||++|||++|+.||....... ....+..+... .+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--------~~~~i~~~~~~------~p~ 237 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--------LFKKICDGIFY------TPQ 237 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--------HHHHHHTTCCC------CCT
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--------HHHHHhcCCcC------CCc
Confidence 233468999999999988765 689999999999999999999997543221 12222333211 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhc
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEG 779 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 779 (799)
.....+.+++.+||+.||++|||+.|+++ .+.+
T Consensus 238 ----~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~ 272 (476)
T 2y94_A 238 ----YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ 272 (476)
T ss_dssp ----TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred ----cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence 12346788999999999999999999996 4554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.61 Aligned_cols=260 Identities=20% Similarity=0.316 Sum_probs=198.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||+|+++.. .....+++.+|+.++++++||||+++++++.+....++|||
T Consensus 34 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 34 FRIEKKIGRGQFSEVYRAACLL-DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp EEEEEEEECC--CEEEEEEETT-TCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eEEEEeecCCCCceEEEEEEcC-CCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 4566889999999999999864 6789999998642 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 584 FMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 584 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|+++++|.+++.. ...+++..+.+++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp CCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred cCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999864 35688999999999999999999998 9999999999999999999999999999866433
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .. ....+..+...
T Consensus 190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~~~------ 256 (310)
T 2wqm_A 190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-----YS-LCKKIEQCDYP------ 256 (310)
T ss_dssp ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-----HH-HHHHHHTTCSC------
T ss_pred Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-----HH-HHHHhhcccCC------
Confidence 22 2223458999999999999999999999999999999999999987543211 01 11222222211
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~ 785 (799)
........+.+.+++.+||+.||++|||+.+|++.|+++.....
T Consensus 257 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~ 300 (310)
T 2wqm_A 257 --PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300 (310)
T ss_dssp --CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred --CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence 11112234578889999999999999999999999998765433
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.02 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=199.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 5 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (311)
T 4agu_A 5 YEKIGKIGEGSYGVVFKCRNRD-TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEY 83 (311)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEeeEEeecCCeEEEEEEeCC-CCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEe
Confidence 3456789999999999999874 68899999885432 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........ ..
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 159 (311)
T 4agu_A 84 CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-YY 159 (311)
T ss_dssp CSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred CCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-cc
Confidence 99999999998888899999999999999999999998 999999999999999999999999999987643322 22
Q ss_pred eeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHHhcCce-eEe
Q 038294 665 TMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCYAEGRL-DVL 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~ 735 (799)
....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.... ...+..... ...
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (311)
T 4agu_A 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGV 239 (311)
T ss_dssp ------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTC
T ss_pred CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccC
Confidence 33458999999999976 678999999999999999999999997654433221111100 000111000 000
Q ss_pred ecCCCCCcc-----CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 736 VDSDEPAMA-----DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 736 ~d~~~~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+...... .......+.+++.+||+.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp CCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 01234567889999999999999999999853
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=331.50 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=199.1
Q ss_pred chhhhcCccccceEEEEEEeCCC--CeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeee-cccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCD-EALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-~~~~~~lv~e 583 (799)
.+.+.||+|+||.||+|.+...+ ...+|+|.+.... ....+.+.+|+.++++++||||+++++++. .+...++|||
T Consensus 28 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e 107 (298)
T 3f66_A 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 107 (298)
T ss_dssp EEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEE
T ss_pred hhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEe
Confidence 45678999999999999975332 3468999987533 334568999999999999999999999864 4557789999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS- 661 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~- 661 (799)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 184 (298)
T 3f66_A 108 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY 184 (298)
T ss_dssp CCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred CCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence 99999999999764 4688999999999999999999998 999999999999999999999999999987643321
Q ss_pred --cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCc-CCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 662 --RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 662 --~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.......+|+.|+|||.+.+..++.++||||||+++|||++|.. |+......+. ......+...
T Consensus 185 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--------~~~~~~~~~~----- 251 (298)
T 3f66_A 185 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--------TVYLLQGRRL----- 251 (298)
T ss_dssp BC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--------HHHHHTTCCC-----
T ss_pred ccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--------HHHHhcCCCC-----
Confidence 12223457789999999999999999999999999999999555 4443322211 1111111110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+......+.+++.+||+.||++|||+.|+++.|++++.
T Consensus 252 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 ----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111223568889999999999999999999999998765
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.54 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=195.9
Q ss_pred HhhchhhhcCccccceEEEEEEeCC--CCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccc---
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN--- 577 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~--- 577 (799)
..+.+.+.||+|+||.||+|..... .++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+...
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 3445667899999999999988643 3468999998643 23445679999999999999999999999976553
Q ss_pred --eeeEEeecCCCChhhhhhc------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEcc
Q 038294 578 --RLLVYEFMGNGTLANLIFA------IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISD 649 (799)
Q Consensus 578 --~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~D 649 (799)
.++|+||+++++|.+++.. ...+++..+++++.||++||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~D 190 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVAD 190 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECS
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEee
Confidence 4899999999999999842 35689999999999999999999998 999999999999999999999999
Q ss_pred ccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHH
Q 038294 650 FGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCY 727 (799)
Q Consensus 650 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 727 (799)
||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+. ....
T Consensus 191 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--------~~~~ 262 (313)
T 3brb_A 191 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM--------YDYL 262 (313)
T ss_dssp CSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH--------HHHH
T ss_pred cCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--------HHHH
Confidence 999987643321 22233457889999999999999999999999999999999 8888875433221 1111
Q ss_pred hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 728 AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 728 ~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+... .........+.+++.+||+.||++|||+.++++.|+++++
T Consensus 263 ~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 263 LHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 222110 1112233578889999999999999999999999998654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=337.93 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=198.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCe----EEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.+.||+|+||.||+|.+.. +++ .|++|.+... .....+++.+|+.++++++||||+++++++.... .++|
T Consensus 17 y~~~~~lG~G~~g~Vy~~~~~~-~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v 94 (327)
T 3lzb_A 17 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLI 94 (327)
T ss_dssp EEEEEEEEECSSEEEEEEEECC-TTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEE
T ss_pred ceEEEEeeeCCCeEEEEEEEcC-CCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEE
Confidence 4456889999999999999864 333 4688877543 3345678999999999999999999999998754 7899
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 95 ~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~ 171 (327)
T 3lzb_A 95 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 171 (327)
T ss_dssp ECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--------
T ss_pred EEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCcc
Confidence 9999999999999874 5689999999999999999999998 99999999999999999999999999998764332
Q ss_pred Cc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 SR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.. ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+..
T Consensus 172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~--------~~~~~~~~~------ 237 (327)
T 3lzb_A 172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------SSILEKGER------ 237 (327)
T ss_dssp --------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--------HHHHHTTCC------
T ss_pred ccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH--------HHHHHcCCC------
Confidence 21 2223346788999999999999999999999999999999 9999976543321 111122111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..........+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 238 ---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 ---LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 01112233468889999999999999999999999988764
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.99 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=195.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~~~~~lg~G~~g~V~~~~~~--~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 5 HGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred hhhhhcccCCCEEEEEEEcC--CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 45678999999999999874 57899999986432 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++ +|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 157 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KY 157 (288)
T ss_dssp SE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred CC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-cc
Confidence 86 999988764 5789999999999999999999998 999999999999999999999999999987643221 22
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc------eeE--e
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR------LDV--L 735 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~--~ 735 (799)
....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+ . ....... ... .
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~ 233 (288)
T 1ob3_A 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI---F-RILGTPNSKNWPNVTELPK 233 (288)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H-HHHCCCCTTTSTTGGGSTT
T ss_pred ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-HHHCCCChhhchhhhcccc
Confidence 334589999999999764 5899999999999999999999999765433211111 1 1100000 000 0
Q ss_pred ecCCC-------CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDE-------PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~-------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.++.. .........+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00111223457788999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=342.26 Aligned_cols=247 Identities=27% Similarity=0.287 Sum_probs=193.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHH-hcccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSA-IGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||+++.+. +++.||+|+++... ....+.+..|..+ ++.++||||+++++++.+....++||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~ 118 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKA-EEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 118 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETT-TCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcC-CCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEE
Confidence 4567899999999999999874 67899999996533 2233456777776 56789999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 119 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~- 194 (373)
T 2r5t_A 119 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS- 194 (373)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC-
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCC-
Confidence 9999999999998878889999999999999999999998 999999999999999999999999999986433222
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ..+.+..+... .+.
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~--------~~~~i~~~~~~------~~~ 260 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--------MYDNILNKPLQ------LKP 260 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH--------HHHHHHHSCCC------CCS
T ss_pred ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhcccC------CCC
Confidence 2334569999999999999999999999999999999999999997654332 11122222111 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.....+.+++.+||+.||++||++.+.++.
T Consensus 261 ----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ 290 (373)
T 2r5t_A 261 ----NITNSARHLLEGLLQKDRTKRLGAKDDFME 290 (373)
T ss_dssp ----SSCHHHHHHHHHHTCSSGGGSTTTTTTHHH
T ss_pred ----CCCHHHHHHHHHHcccCHHhCCCCCCCHHH
Confidence 223567889999999999999998544333
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=329.57 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=203.7
Q ss_pred hhcCccccceEEEEEEe-CCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCC
Q 038294 511 EELGRGSFGIVYKGVLK-SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~-~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
+.||+|+||.||+|.+. ..+++.||||+++... ....+++.+|++++++++||||+++++++ +....++||||++++
T Consensus 16 ~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~ 94 (287)
T 1u59_A 16 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGG 94 (287)
T ss_dssp EEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred ccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCC
Confidence 38999999999999864 2356889999997643 34457899999999999999999999999 455689999999999
Q ss_pred ChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc--ee
Q 038294 589 TLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT--HT 665 (799)
Q Consensus 589 sL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~ 665 (799)
+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.......... ..
T Consensus 95 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 171 (287)
T 1u59_A 95 PLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS 171 (287)
T ss_dssp EHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCC
T ss_pred CHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccc
Confidence 999999754 4689999999999999999999998 99999999999999999999999999998765433221 12
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+... . .
T Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~~~i~~~~~~-----~----~ 234 (287)
T 1u59_A 172 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRM-----E----C 234 (287)
T ss_dssp SSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCC-----C----C
T ss_pred cccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--------HHHHHhcCCcC-----C----C
Confidence 2346789999999998889999999999999999999 999997544322 11222222211 1 1
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+....+.+.+++.+||+.||++||++.++++.|+.+..
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 12334578889999999999999999999999987653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=335.54 Aligned_cols=248 Identities=23% Similarity=0.274 Sum_probs=194.0
Q ss_pred hhchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc----hhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
.+.+.+.||+|+||.||++.... .+++.||+|+++... ......+.+|+.++++++||||+++++++......+
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 34567889999999999998742 367899999997532 223456788999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 174 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD 174 (327)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence 9999999999999998878889999999999999999999998 9999999999999999999999999999764322
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+..+.. .
T Consensus 175 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------~~~i~~~~~------~ 239 (327)
T 3a62_A 175 GT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT--------IDKILKCKL------N 239 (327)
T ss_dssp -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--------HHHHHHTCC------C
T ss_pred Cc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH--------HHHHHhCCC------C
Confidence 21 22334689999999999999999999999999999999999999976543221 111111111 1
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
.+ ......+.+++.+||+.||++|| ++.|+++
T Consensus 240 ~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 240 LP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 11 12235678899999999999999 7778775
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=337.06 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=200.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------hhHHHHHHHHHHhcccccccccceeeeeecccc
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALN 577 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~ 577 (799)
.+.+.+.||+|+||.||+|..+. +++.||||+++.... ...+.+.+|+.++++++||||+++++++.+...
T Consensus 25 ~y~~~~~lG~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 25 KYSTMSPLGSGAFGFVWTAVDKE-KNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HEEEEEECSSSSSCSEEEEEETT-TTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceEEEeEEEecCCEEEEEEEECC-CCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 34456789999999999999874 689999999865321 123467789999999999999999999999999
Q ss_pred eeeEEeecCCC-ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 578 RLLVYEFMGNG-TLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 578 ~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
.++||||+.+| +|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~ 180 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence 99999999777 9999999888899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.... ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ...
T Consensus 181 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------~~~--- 241 (335)
T 3dls_A 181 ERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------AAI--- 241 (335)
T ss_dssp CTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------TCC---
T ss_pred CCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------hcc---
Confidence 4432 2234568999999999988876 7899999999999999999999975322110 000
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+. ...+.+.+++.+||+.||++|||+.|+++.
T Consensus 242 ---~~~~----~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 ---HPPY----LVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---CCCc----ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111 123567889999999999999999999875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=346.92 Aligned_cols=250 Identities=20% Similarity=0.256 Sum_probs=200.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||++..+. +++.||+|+++... ....+.+.+|..++.+++||||+++++++.+....++||||
T Consensus 64 ~~~~~lG~G~fG~V~~~~~~~-~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~ 142 (412)
T 2vd5_A 64 EILKVIGRGAFSEVAVVKMKQ-TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEY 142 (412)
T ss_dssp EEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcC
Confidence 345789999999999999874 68999999996532 22234588999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.........
T Consensus 143 ~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~ 219 (412)
T 2vd5_A 143 YVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR 219 (412)
T ss_dssp CCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence 9999999999875 4789999999999999999999998 99999999999999999999999999998765444333
Q ss_pred eeeeccCCccccccccc-------CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 664 HTMIRGTRGYVAPEWFK-------NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~-------~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||......+....+.... ..-..
T Consensus 220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~----~~~~~---- 291 (412)
T 2vd5_A 220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK----EHLSL---- 291 (412)
T ss_dssp CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH----HHCCC----
T ss_pred cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc----cCcCC----
Confidence 33457999999999997 4578999999999999999999999998654433211111000 00000
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKR---PTMKVVLQ 775 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~evl~ 775 (799)
+. ........+.+++.+||+ +|++| |+++||++
T Consensus 292 -p~----~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 292 -PL----VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp -C--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred -Cc----cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 00 011233577889999999 99998 68999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=341.49 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=207.3
Q ss_pred HHHhhchhhhcCccccceEEEEEEeCCC----CeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeeccc
Q 038294 503 KEATGGFKEELGRGSFGIVYKGVLKSAS----GKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 576 (799)
Q Consensus 503 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 576 (799)
....+.+.+.||+|+||.||+|...... .+.||+|.+.... ....+.+.+|+.+++++ +||||+++++++....
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 3344556688999999999999986422 2489999997543 33456799999999999 8999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC
Q 038294 577 NRLLVYEFMGNGTLANLIFAI--------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY 642 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~ 642 (799)
..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCC
Confidence 999999999999999998742 3578999999999999999999998 99999999999999999
Q ss_pred CceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHH
Q 038294 643 FSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILT 720 (799)
Q Consensus 643 ~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~ 720 (799)
+.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~----- 275 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-----
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-----
Confidence 999999999998764433221 223446789999999999999999999999999999999 8889875432221
Q ss_pred HHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 721 DWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 721 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.......+.. ...+ ....+.+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 276 --~~~~~~~~~~-----~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~ 325 (333)
T 2i1m_A 276 --FYKLVKDGYQ-----MAQP----AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325 (333)
T ss_dssp --HHHHHHHTCC-----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --HHHHHhcCCC-----CCCC----CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence 1111222110 0111 112356788999999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.60 Aligned_cols=259 Identities=27% Similarity=0.382 Sum_probs=207.4
Q ss_pred HhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeeccc-c
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL-N 577 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~-~ 577 (799)
..+.+.+.||+|+||.||+|... ..+++.||||+++... ....+.+.+|++++.++ +||||+++++++.... .
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 106 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 106 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSC
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCc
Confidence 34456688999999999999864 2356899999997543 33456789999999999 7999999999987655 4
Q ss_pred eeeEEeecCCCChhhhhhcCCC----------------CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 578 RLLVYEFMGNGTLANLIFAIPK----------------PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
.++|+||+++++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+||+++.
T Consensus 107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 107 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 183 (316)
T ss_dssp CEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred eEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECC
Confidence 8899999999999999986543 78999999999999999999998 9999999999999999
Q ss_pred CCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhH
Q 038294 642 YFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~ 719 (799)
++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 184 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---- 259 (316)
T 2xir_A 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---- 259 (316)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred CCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH----
Confidence 999999999999876543322 2223457889999999999999999999999999999998 9999875432211
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
....+..+... .. .......+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 260 ---~~~~~~~~~~~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 260 ---FCRRLKEGTRM-----RA----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp ---HHHHHHHTCCC-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHhccCccC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11122222111 11 11233568889999999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=337.17 Aligned_cols=267 Identities=16% Similarity=0.178 Sum_probs=198.7
Q ss_pred HhhchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccchh-----------hHHHHHHHHHHhcccccccccceeee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLAQE-----------REREFKSEVSAIGRTHHKNLVQLLGF 571 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~g~ 571 (799)
..+.+.+.||+|+||.||+|.... ..++.+|+|++...... ..+.+.+|+..+..++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 345567899999999999999863 14578999998653221 12346678889999999999999999
Q ss_pred eec----ccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC--ce
Q 038294 572 CDE----ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF--SA 645 (799)
Q Consensus 572 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~--~~ 645 (799)
+.. ....++||||+ +++|.+++.....+++..+.+++.||+.||+|||+. +|+||||||+|||++.++ .+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcE
Confidence 977 67789999999 999999998877899999999999999999999998 999999999999999877 99
Q ss_pred EEccccCcccccCCCC------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhH
Q 038294 646 KISDFGLSKLLLSDQS------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 646 kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~ 719 (799)
||+|||+++.+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .
T Consensus 193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~ 270 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--V 270 (345)
T ss_dssp EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--H
T ss_pred EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--H
Confidence 9999999987643221 1113346899999999999999999999999999999999999999653222111 0
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.. ............+.. ..+ .....+.+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 271 ~~-~~~~~~~~~~~~~~~-~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QT-AKTNLLDELPQSVLK-WAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HH-HHHHHHHTTTHHHHH-HSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HH-HHHhhcccccHHHHh-hcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 01 111111100000000 000 01233578889999999999999999999999987644
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=334.01 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=207.8
Q ss_pred hchhhhcCccccceEEEEEE---eCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc--ceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVL---KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL--NRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~---~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~--~~~lv 581 (799)
+.+.+.||+|+||.||++.+ ...+++.||||++........+.+.+|++++++++||||+++++++.... ..++|
T Consensus 43 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 122 (326)
T 2w1i_A 43 LKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLI 122 (326)
T ss_dssp EEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEE
T ss_pred ceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEE
Confidence 45668899999999999985 23468899999998766666778999999999999999999999986654 67899
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+||+++++|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 123 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~ 199 (326)
T 2w1i_A 123 MEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK 199 (326)
T ss_dssp ECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred EECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence 9999999999999876 4689999999999999999999998 99999999999999999999999999998765433
Q ss_pred Ccc--eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhc--------chhHHHHHHHHHhcC
Q 038294 661 SRT--HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG--------RAILTDWAYDCYAEG 730 (799)
Q Consensus 661 ~~~--~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~ 730 (799)
... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......-. .........+.+..+
T Consensus 200 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (326)
T 2w1i_A 200 EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNN 279 (326)
T ss_dssp SEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTT
T ss_pred cccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcC
Confidence 211 1223467789999999988899999999999999999999998764321100 001111111222222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
... .........+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 280 ~~~---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 280 GRL---------PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp CCC---------CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC---------CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 110 111223457888999999999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=333.61 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=201.0
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcc--cccccccceeeeeecc----
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEA---- 575 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~---- 575 (799)
.....+.+.+.||+|+||.||+|... ++.||||++.... ...+..|.+++.. ++||||+++++++...
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR---GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET---TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC---CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 33455667889999999999999874 7899999986432 2334444444444 5899999999999776
Q ss_pred cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC-----NVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
...++||||+++|+|.+++... .+++..+.+++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df 186 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence 6789999999999999999664 6889999999999999999999752 338999999999999999999999999
Q ss_pred cCcccccCCCCcc---eeeeccCCcccccccccCCCCCcc------hhHHHHHHHHHHHHhC----------CcCCchhh
Q 038294 651 GLSKLLLSDQSRT---HTMIRGTRGYVAPEWFKNAPVSAK------VDVYSFGVMLLEIICC----------RRSVEMEV 711 (799)
Q Consensus 651 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~s~k------~DVwS~Gvll~elltg----------~~p~~~~~ 711 (799)
|+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||++| +.|+....
T Consensus 187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~ 266 (337)
T 3mdy_A 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV 266 (337)
T ss_dssp TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence 9998764433221 123468999999999988776665 9999999999999999 55554332
Q ss_pred hhhcchhHHHHHHHHHhcCceeEeecCCCC-CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 712 EEEGRAILTDWAYDCYAEGRLDVLVDSDEP-AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 712 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
...... ............ .+..+ ........+.+.+++.+||+.||++|||+.||++.|+++.+-.
T Consensus 267 ~~~~~~---~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 267 PSDPSY---EDMREIVCIKKL----RPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp CSSCCH---HHHHHHHTTSCC----CCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred CCCCch---hhhHHHHhhhcc----CccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence 221111 111111111111 11111 1123367778999999999999999999999999999877644
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=329.80 Aligned_cols=256 Identities=26% Similarity=0.377 Sum_probs=206.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
..+.+.+.||+|+||.||++..+. +++.||+|+++.......+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccceeeeeccCCCCceEEEEEECC-CCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 345567889999999999999874 6789999999765544556789999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCcccccCCCC
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||++ ++++.+||+|||++......
T Consensus 88 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-- 162 (304)
T 2jam_A 88 VSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-- 162 (304)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--
T ss_pred CCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--
Confidence 99999999998878899999999999999999999998 99999999999999 78899999999999764322
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+..+... .+
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~~i~~~~~~------~~ 227 (304)
T 2jam_A 163 -IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--------LFEKIKEGYYE------FE 227 (304)
T ss_dssp -TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--------HHHHHHHCCCC------CC
T ss_pred -ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCC------CC
Confidence 1223458999999999999999999999999999999999999997543322 11222222211 01
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCc
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLL 781 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~ 781 (799)
..........+.+++.+||+.||++|||+.|+++ .+++..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 1111223457888999999999999999999986 455543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=325.77 Aligned_cols=248 Identities=26% Similarity=0.360 Sum_probs=195.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.+.||+|+||.||++..+. +++.+|+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 23 LFIFKRKLGSGAFGDVHLVEERS-SGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HEEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred heeecceeccCCCeEEEEEEEcc-CCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 45667899999999999999864 67899999986543 23457899999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCccccc
Q 038294 585 MGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 585 ~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~ 657 (799)
+++|+|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999988643 6789999999999999999999998 99999999999999 456889999999998654
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
... ......||+.|+|||.+. ..++.++||||||+++|||++|+.||......+.. ..........
T Consensus 179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~--------~~~~~~~~~~--- 244 (285)
T 3is5_A 179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ--------QKATYKEPNY--- 244 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--------HHHHHCCCCC---
T ss_pred Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH--------hhhccCCccc---
Confidence 332 223345899999999986 56899999999999999999999999765432211 1111111000
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. ......+.+.+++.+||+.||++|||+.||++
T Consensus 245 ---~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 ---AV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ---cc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00112356778999999999999999999985
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=338.16 Aligned_cols=248 Identities=18% Similarity=0.275 Sum_probs=193.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhccccc--ccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHH--KNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||++... +++.||||++... .....+.+.+|+.++.+++| +||+++++++......++||
T Consensus 11 y~i~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 11 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEESCCSSEEEEEEECT--TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEecCCCeEEEEEEeC--CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 345688999999999999875 5789999998642 33445789999999999976 99999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
| +.+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 89 e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 163 (343)
T 3dbq_A 89 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 163 (343)
T ss_dssp C-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred e-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence 9 56889999999988899999999999999999999998 999999999999997 578999999999876543322
Q ss_pred -ceeeeccCCcccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 663 -THTMIRGTRGYVAPEWFKN-----------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 663 -~~~~~~gt~~y~aPE~l~~-----------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .........
T Consensus 164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~- 236 (343)
T 3dbq_A 164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDP- 236 (343)
T ss_dssp ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHCT-
T ss_pred ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH------HHHHHHhcC-
Confidence 2234569999999999865 678999999999999999999999997432211 111111111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+......+.+++.+||+.||++|||+.|+++.
T Consensus 237 --------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 237 --------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp --------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 11111111123467889999999999999999999854
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=327.12 Aligned_cols=251 Identities=24% Similarity=0.337 Sum_probs=202.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch------hhHHHHHHHHHHhcccccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ------EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~ 578 (799)
..+.+.+.||+|+||.||++..+. +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKG-TGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcC-CCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 345667899999999999999874 678999999864321 1356899999999999999999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEccccCcc
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF----SAKISDFGLSK 654 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~----~~kl~DfGla~ 654 (799)
++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++ .+||+|||++.
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 99999999999999998878899999999999999999999998 999999999999998877 89999999998
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
...... ......+++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------~~~~~~~~~-- 228 (283)
T 3bhy_A 161 KIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--------LTNISAVNY-- 228 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHTTCC--
T ss_pred eccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--------HHHhHhccc--
Confidence 764332 22334589999999999999999999999999999999999999976543221 111111111
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+........+.+.+++.+||+.||++|||+.|+++
T Consensus 229 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 229 ----DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp ----CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 0011011122356788999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=327.38 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=204.1
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeec-------
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------- 574 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------- 574 (799)
.....+.+.+.||+|+||.||+|.... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRI-DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETT-TCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred hhccccceeeeeccCCceEEEEEEEcC-CCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence 344455667889999999999999864 67899999986533 356789999999999999999998854
Q ss_pred ---------ccceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC
Q 038294 575 ---------ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF 643 (799)
Q Consensus 575 ---------~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~ 643 (799)
....++||||+++++|.+++... ..+++..+.+++.||+.||.|||+. +|+|+||||+|||+++++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK 159 (284)
T ss_dssp ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence 44578999999999999999754 5789999999999999999999998 999999999999999999
Q ss_pred ceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH
Q 038294 644 SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 644 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 723 (799)
.+||+|||++........ .....+++.|+|||.+.+..++.++||||||+++|||++|..|+..... .
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----------~ 227 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK----------F 227 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH----------H
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH----------H
Confidence 999999999987654322 2234589999999999999999999999999999999999988753211 1
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPC 788 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 788 (799)
......+.+ +.. ....+.+++.+||+.||++|||+.|+++.|+.+...+....
T Consensus 228 ~~~~~~~~~--------~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~~~ 280 (284)
T 2a19_B 228 FTDLRDGII--------SDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNE 280 (284)
T ss_dssp HHHHHTTCC--------CTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC------
T ss_pred HHHhhcccc--------ccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCccc
Confidence 111222211 111 22457789999999999999999999999988776555443
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=336.45 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=197.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+...+.||+|+||.||+|.... +++.||||++... .....+++.+|++++++++||||+++++++......++|||
T Consensus 56 y~~~~~lG~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 134 (348)
T 1u5q_A 56 FSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134 (348)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeeeeEEccCCCEEEEEEEEcc-CCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEe
Confidence 4456789999999999999764 6899999998643 23334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+. |+|.+++.. ...+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 135 ~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~--- 207 (348)
T 1u5q_A 135 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 207 (348)
T ss_dssp CCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred cCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---
Confidence 997 688887753 46789999999999999999999998 8999999999999999999999999999865322
Q ss_pred ceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 THTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
....||+.|+|||++. ...++.++|||||||++|||++|+.||........ .........
T Consensus 208 --~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-------~~~~~~~~~-------- 270 (348)
T 1u5q_A 208 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------LYHIAQNES-------- 270 (348)
T ss_dssp --CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSCC--------
T ss_pred --CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-------HHHHHhcCC--------
Confidence 2346899999999984 56789999999999999999999999875432221 111111111
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
+........+.+.+++.+||+.||++|||+.++++.
T Consensus 271 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 271 -PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111122234567889999999999999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=325.83 Aligned_cols=245 Identities=29% Similarity=0.427 Sum_probs=197.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec----ccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 581 (799)
.+.+.||+|+||.||+|.... +++.||+|++... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus 29 ~~~~~lg~G~~g~Vy~~~~~~-~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 107 (290)
T 1t4h_A 29 KFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeeccCCCCeEEEEeEecC-CceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEE
Confidence 345689999999999999874 6789999998643 23445678999999999999999999998864 3557899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEc-CCCceEEccccCcccccC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVP--IIHCDIKPQNILLD-NYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~dlk~~NILl~-~~~~~kl~DfGla~~~~~ 658 (799)
|||+++++|.+++.....+++..+..++.||+.||+|||+. + |+|+||||+|||++ +++.+||+|||++.....
T Consensus 108 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~ 184 (290)
T 1t4h_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence 99999999999998878899999999999999999999997 6 99999999999998 789999999999975433
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
. ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... . .......+..
T Consensus 185 ~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~-~~~~~~~~~~------ 247 (290)
T 1t4h_A 185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------Q-IYRRVTSGVK------ 247 (290)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------H-HHHHHTTTCC------
T ss_pred c---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH------H-HHHHHhccCC------
Confidence 2 2233468999999998874 58999999999999999999999997543221 1 1112222211
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..........+.+++.+||+.||++|||+.|+++
T Consensus 248 --~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 --PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp --CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 11112222356888999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=329.39 Aligned_cols=260 Identities=18% Similarity=0.233 Sum_probs=203.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeee-ecccceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~ 584 (799)
.+.+.+.||+|+||.||+|.... +++.||||++.... ...++..|++++.+++|++++..++.+ ......++||||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 86 (296)
T 4hgt_A 10 RYRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 86 (296)
T ss_dssp -CEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred ceEEeeeecCCCCeEEEEEEEcC-CCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEc
Confidence 34567889999999999999764 68999999865422 234578899999999988877777766 566677899999
Q ss_pred cCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCcccccCCC
Q 038294 585 MGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~~~~ 660 (799)
+ +++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++......
T Consensus 87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 87 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp C-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9 9999999985 45789999999999999999999998 99999999999999 789999999999998765433
Q ss_pred Cc------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 661 SR------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 661 ~~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......................
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---- 238 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP---- 238 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC----
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch----
Confidence 21 22345689999999999999999999999999999999999999986544332222222111111110
Q ss_pred eecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 735 LVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 735 ~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.........+.+.+++.+||+.||++|||+++|++.|+++.+
T Consensus 239 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 239 ------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 000011123578889999999999999999999999988664
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.66 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=180.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+....++|+|
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLE 91 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceeeeeecCCCceEEEEEEEcc-CCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEe
Confidence 3456789999999999999864 678999999964321 224678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++... ..+++..+..++.|+++||+|||+. +|+|+||||+||+++.++.+||+|||++.........
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 168 (278)
T 3cok_A 92 MCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK 168 (278)
T ss_dssp CCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred cCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence 99999999999875 5789999999999999999999998 9999999999999999999999999999876433221
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... .+...+
T Consensus 169 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~------~~~~~~- 232 (278)
T 3cok_A 169 -HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL--------NKVVL------ADYEMP- 232 (278)
T ss_dssp ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-------------CCS------SCCCCC-
T ss_pred -ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH--------HHHhh------cccCCc-
Confidence 22345899999999999999999999999999999999999999754322110 00000 011111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+.+++.+||+.||++|||++++++
T Consensus 233 ---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 233 ---SFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp ---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 223356788999999999999999999876
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.58 Aligned_cols=261 Identities=18% Similarity=0.236 Sum_probs=204.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeee-ecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFC-DEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~-~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ..+++.+|+.++.+++|++++..+..+ .+....++||||+
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~ 87 (296)
T 3uzp_A 11 YRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 87 (296)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEccCCCeEEEEEEEcC-CCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec
Confidence 3456789999999999999864 68999999986432 234688999999999988877776666 5566678999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+++|.+++.. ...+++..+..++.||+.||+|||+. +|+||||||+|||+ ++++.+||+|||+++.......
T Consensus 88 -~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 88 -GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 9999999974 45789999999999999999999998 99999999999999 4889999999999987654432
Q ss_pred c------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 662 R------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 662 ~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...........+........... .
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~--- 239 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-I--- 239 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC-H---
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc-h---
Confidence 1 12345689999999999999999999999999999999999999986543322222222111111110 0
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
........+.+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 240 ------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 240 ------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 0001122356888999999999999999999999999876533
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.10 Aligned_cols=256 Identities=28% Similarity=0.439 Sum_probs=203.4
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeE--EEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKA--IAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~--vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv 581 (799)
.+.+.+.||+|+||.||+|..+. +++. +|+|.++... ....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HccceeeeecCCCceEEEEEEcc-CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 34567889999999999999875 4554 5999886532 33445789999999999 899999999999999999999
Q ss_pred EeecCCCChhhhhhcCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCce
Q 038294 582 YEFMGNGTLANLIFAIP----------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSA 645 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~----------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~ 645 (799)
|||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997653 688999999999999999999998 99999999999999999999
Q ss_pred EEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHH
Q 038294 646 KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAY 724 (799)
Q Consensus 646 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 724 (799)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~--------~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LY 251 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH--------HH
Confidence 99999998743221 11223346889999999998889999999999999999998 999997554322 11
Q ss_pred HHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 725 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
..+..+.. ... .....+.+.+++.+||+.||++|||+.|+++.|+.+++-.
T Consensus 252 ~~~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 252 EKLPQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHGGGTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHhhcCCC-----CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 22222211 011 1123357888999999999999999999999998876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.36 Aligned_cols=261 Identities=23% Similarity=0.288 Sum_probs=197.2
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-----hhHHHHHHHHHHhcccc---cccccceeeeeecc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-----EREREFKSEVSAIGRTH---HKNLVQLLGFCDEA 575 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~ 575 (799)
...+.+.+.||+|+||+||+|..+. +++.||||+++.... .....+.+|++++++++ ||||+++++++...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 8 TSRYEPVAEIGVGAYGTVYKARDPH-SGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp --CCEEEEEECCSSSCCEEEEECTT-TCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3455667899999999999999764 688999999864221 12345667777777664 99999999999765
Q ss_pred c-----ceeeEEeecCCCChhhhhhcCCC--CCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEc
Q 038294 576 L-----NRLLVYEFMGNGTLANLIFAIPK--PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKIS 648 (799)
Q Consensus 576 ~-----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~ 648 (799)
. ..++||||+. ++|.+++..... +++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 4 4689999997 599999987643 89999999999999999999998 89999999999999999999999
Q ss_pred cccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh
Q 038294 649 DFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 649 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
|||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+ .....
T Consensus 163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i----~~~~~ 236 (308)
T 3g33_A 163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKI----FDLIG 236 (308)
T ss_dssp SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHH----HHHHC
T ss_pred eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHHhC
Confidence 999998664322 223456899999999999999999999999999999999999999765443321111 11110
Q ss_pred cCc---eeEe-------ecCCCC---CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 729 EGR---LDVL-------VDSDEP---AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 729 ~~~---~~~~-------~d~~~~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
... .... ..+..+ ........+.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 000 0000 000000 0011123457788999999999999999999885
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-37 Score=334.71 Aligned_cols=269 Identities=23% Similarity=0.324 Sum_probs=194.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee-----cccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD-----EALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~-----~~~~~~lv 581 (799)
+.+.+.||+|+||.||+|.. +++.||||+++..... ......|+..+..++|+||+++++.+. .....++|
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv 90 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL---DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLV 90 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE---TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEE
T ss_pred hheeeecccCCCeEEEEEEE---CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEE
Confidence 34567899999999999976 4789999999643221 112234455566689999999998543 33356899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC------CCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC------NVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~------~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
|||+++|+|.+++.... .++..+.+++.||++||+|||+.. ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~ 169 (336)
T 3g2f_A 91 MEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169 (336)
T ss_dssp ECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceee
Confidence 99999999999997644 488999999999999999999862 23899999999999999999999999999987
Q ss_pred ccCCCC-------cceeeeccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhc-chhH-
Q 038294 656 LLSDQS-------RTHTMIRGTRGYVAPEWFKN-------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG-RAIL- 719 (799)
Q Consensus 656 ~~~~~~-------~~~~~~~gt~~y~aPE~l~~-------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~-~~~~- 719 (799)
...... .......||+.|+|||.+.+ ..++.++|||||||++|||++|..|+........ ...+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 249 (336)
T 3g2f_A 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249 (336)
T ss_dssp CSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTH
T ss_pred cccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhh
Confidence 643221 11223458999999999987 4567789999999999999999887654322111 0000
Q ss_pred --------HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 --------TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 --------~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
................+.... .........+.+++.+||+.||++|||+.||++.|++++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 011111111111111111111 1233466789999999999999999999999999998764
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-38 Score=342.44 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=202.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||++.... +++.||+|++... .....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus 35 y~~~~~lg~G~~g~V~~~~~~~-~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 113 (360)
T 3eqc_A 35 FEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM 113 (360)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred ceeeeeecCCCCeEEEEEEECC-CCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECC
Confidence 4456789999999999999874 6789999998654 3344568999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.....+++..+..++.|++.||+|||+.. +|+||||||+|||++.++.+||+|||++...... ...
T Consensus 114 ~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~ 188 (360)
T 3eqc_A 114 DGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MAN 188 (360)
T ss_dssp TTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---C--
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---ccc
Confidence 99999999988888999999999999999999999831 7999999999999999999999999999765322 122
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHH--------HHhcCc------
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD--------CYAEGR------ 731 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~------ 731 (799)
...||+.|+|||.+.+..++.++||||||+++|||++|+.||......+........... ....+.
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (360)
T 3eqc_A 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFG 268 (360)
T ss_dssp --CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------------
T ss_pred CCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccc
Confidence 346899999999999999999999999999999999999999754332211100000000 000000
Q ss_pred ------------eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 ------------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 ------------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..+.....+..........+.+++.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 269 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000011111112223457889999999999999999999885
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=337.57 Aligned_cols=252 Identities=22% Similarity=0.327 Sum_probs=186.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeee--------ccc
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCD--------EAL 576 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~--------~~~ 576 (799)
.+.+.+.||+|+||.||+|.... +++.||||++........+.+.+|+.++.++. ||||+++++++. ...
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~ 107 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVG-SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA 107 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETT-TCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred eEEEEEEEccCCceEEEEEEECC-CCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence 45567899999999999999864 67899999987666666778999999999996 999999999983 344
Q ss_pred ceeeEEeecCCCChhhhhhc---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC--eEecCCCCCCeEEcCCCceEEcccc
Q 038294 577 NRLLVYEFMGNGTLANLIFA---IPKPDWNLRVRISLEIARGLVYLHEECNVP--IIHCDIKPQNILLDNYFSAKISDFG 651 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~--iiH~dlk~~NILl~~~~~~kl~DfG 651 (799)
..++|+||+. |+|.+++.. ...+++..+.+++.||+.||+|||+. + |+||||||+|||++.++.+||+|||
T Consensus 108 ~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 108 EFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred eEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCc
Confidence 5789999996 799988865 35689999999999999999999997 6 9999999999999999999999999
Q ss_pred CcccccCCCCcc-----------eeeeccCCcccccccc---cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcch
Q 038294 652 LSKLLLSDQSRT-----------HTMIRGTRGYVAPEWF---KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA 717 (799)
Q Consensus 652 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~l---~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~ 717 (799)
+++......... .....+|+.|+|||.+ .+..++.++||||||+++|||++|+.||........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-- 261 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI-- 261 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence 998765432211 1134589999999998 567789999999999999999999999964322110
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+.. .... .......+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 262 ----------~~~~~----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 262 ----------VNGKY----SIPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp --------------C----CCCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------hcCcc----cCCc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 00000 0001 11112346789999999999999999999999988765
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-37 Score=333.71 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=207.3
Q ss_pred HHHHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcc--cccccccceeeeeeccc-
Q 038294 500 NELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR--THHKNLVQLLGFCDEAL- 576 (799)
Q Consensus 500 ~~l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~g~~~~~~- 576 (799)
.+.....+.+.+.||+|+||.||+|.. +++.||||++... ..+.+..|.+++.. ++||||+++++++....
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~ 110 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE---TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE---cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC
Confidence 344455677889999999999999987 4789999999643 34567788888876 78999999999998776
Q ss_pred ---ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEecCCCCCCeEEcCCCce
Q 038294 577 ---NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH--------EECNVPIIHCDIKPQNILLDNYFSA 645 (799)
Q Consensus 577 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiH~dlk~~NILl~~~~~~ 645 (799)
..++||||+++|+|.+++.. ..+++..+.+++.|++.||+||| +. +|+||||||+|||++.++.+
T Consensus 111 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~ 186 (342)
T 1b6c_B 111 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTC 186 (342)
T ss_dssp SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCE
T ss_pred ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCE
Confidence 78999999999999999976 46889999999999999999999 55 89999999999999999999
Q ss_pred EEccccCcccccCCCCc---ceeeeccCCcccccccccCCC------CCcchhHHHHHHHHHHHHhC----------CcC
Q 038294 646 KISDFGLSKLLLSDQSR---THTMIRGTRGYVAPEWFKNAP------VSAKVDVYSFGVMLLEIICC----------RRS 706 (799)
Q Consensus 646 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~------~s~k~DVwS~Gvll~elltg----------~~p 706 (799)
||+|||++......... ......||+.|+|||.+.+.. ++.++||||||+++|||++| ..|
T Consensus 187 kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 187 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp EECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 99999999876544322 123346899999999997762 34689999999999999999 667
Q ss_pred CchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC-ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 707 VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA-MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 707 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
|......... ... ....+..... .+..+. .......+.+.+++.+||+.||++|||+.||++.|+.+.+
T Consensus 267 ~~~~~~~~~~--~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 267 YYDLVPSDPS--VEE-MRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TTTTSCSSCC--HHH-HHHHHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCcCccc--HHH-HHHHHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 7544322111 111 1122222211 111111 1234667789999999999999999999999999998754
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-37 Score=331.20 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=205.0
Q ss_pred CccccChHHHHHHhhchh-hhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhccc-ccccccce
Q 038294 493 NLRFFSYNELKEATGGFK-EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRT-HHKNLVQL 568 (799)
Q Consensus 493 ~~~~~~~~~l~~~~~~~~-~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l 568 (799)
++.+-..+++. ..+.+. +.||+|+||.||+|..+. +++.||+|+++.... ....++.+|+.++.++ +||||+++
T Consensus 17 n~~~~~~~~~~-~~y~~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~ 94 (327)
T 3lm5_A 17 NLYFQSMENFN-NFYILTSKELGRGKFAVVRQCISKS-TGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94 (327)
T ss_dssp CCCSBCHHHHH-HHEEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred hhHHHHHHhhh-hEEeeccceeCCCCCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEE
Confidence 33333444443 344444 789999999999999874 688999999865332 3356889999999998 57999999
Q ss_pred eeeeecccceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CC
Q 038294 569 LGFCDEALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YF 643 (799)
Q Consensus 569 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~ 643 (799)
++++.+....++||||+++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++. ++
T Consensus 95 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~ 171 (327)
T 3lm5_A 95 HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLG 171 (327)
T ss_dssp EEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBC
T ss_pred EEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCC
Confidence 99999999999999999999999998654 5789999999999999999999998 9999999999999997 78
Q ss_pred ceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH
Q 038294 644 SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA 723 (799)
Q Consensus 644 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~ 723 (799)
.+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...
T Consensus 172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------ 243 (327)
T 3lm5_A 172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL------ 243 (327)
T ss_dssp CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH------
Confidence 99999999998764322 2233468999999999999999999999999999999999999997654332111
Q ss_pred HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+..... ..+........+.+.+++.+||+.||++|||++|+++.
T Consensus 244 --~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 244 --NISQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp --HHHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred --HHHhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 1111111 11111112334567889999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=322.77 Aligned_cols=251 Identities=27% Similarity=0.328 Sum_probs=203.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.+.||+|+||.||+|..+. +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 8 DWDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceEEEEEeecCCCcEEEEEEECC-CCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 34566889999999999999864 67899999986433 33456889999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC-cc
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS-RT 663 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~-~~ 663 (799)
+++++|.+++.....+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++........ ..
T Consensus 87 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 163 (276)
T 2yex_A 87 CSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (276)
T ss_dssp CTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred cCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence 99999999998877899999999999999999999998 999999999999999999999999999986543221 12
Q ss_pred eeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ .. ..+..... ..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~-----~~~~~~~~--------~~ 228 (276)
T 2yex_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EY-----SDWKEKKT--------YL 228 (276)
T ss_dssp BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HH-----HHHHTTCT--------TS
T ss_pred ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HH-----HHhhhccc--------cc
Confidence 233568999999999987765 7799999999999999999999976433211 11 11111110 00
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+.+++.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 011223456788999999999999999999876
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=353.04 Aligned_cols=248 Identities=27% Similarity=0.300 Sum_probs=203.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.||+|+||.||+|..+. +++.||+|++.... ......+.+|++++++++||||+++++++.+....++||||
T Consensus 187 ~~~~~LG~G~fG~Vy~a~~~~-tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 187 RQYRVLGKGGFGEVCACQVRA-TGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 445789999999999999874 68999999996532 23346788999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 266 ~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-- 340 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 340 (576)
T ss_dssp CCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC--
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCc--
Confidence 99999999998654 489999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||........... ....+..... ..
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~----i~~~i~~~~~------~~-- 408 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE----VERLVKEVPE------EY-- 408 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH----HHHHHHHCCC------CC--
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH----HHHHhhcccc------cC--
Confidence 23335799999999999999999999999999999999999999986533221111 1122222111 11
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
+......+.+++.+||+.||++|| ++.||++
T Consensus 409 --p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 409 --SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 122345778899999999999999 7888874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.14 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=204.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++..+. +++.+|+|++... .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 17 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 17 YVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeecCCEEEEEEEECC-CCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 3456789999999999999874 6789999998643 22345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||++||+|||+. +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 96 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 171 (294)
T 2rku_A 96 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 171 (294)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCcc-c
Confidence 999999999998878899999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+..+.. ..+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------~~~~~~~~~------~~~~- 236 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRIKKNEY------SIPK- 236 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHTTCC------CCCT-
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--------HHHHhhccC------CCcc-
Confidence 2334589999999999999999999999999999999999999976533221 111122111 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+++.+||+.||++|||+.|+++
T Consensus 237 ---~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 237 ---HINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 22356788999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=338.24 Aligned_cols=261 Identities=15% Similarity=0.160 Sum_probs=202.6
Q ss_pred hhchhhhcCccccceEEEEEEeCC-------CCeEEEEEEccccchhhHHHHHHHHHHhcccccccccc-----------
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSA-------SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQ----------- 567 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~----------- 567 (799)
.+.+.+.||+|+||.||+|..... .++.||+|++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 117 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLL 117 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCcc
Confidence 345668899999999999998743 3789999998643 46788999999999999988
Q ss_pred ----eeeeeec-ccceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 038294 568 ----LLGFCDE-ALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD 640 (799)
Q Consensus 568 ----l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~ 640 (799)
+++++.. +...++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++
T Consensus 118 ~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 118 AIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVD 193 (352)
T ss_dssp SCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEE
T ss_pred CccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEc
Confidence 5666665 67789999999 99999999876 6799999999999999999999998 999999999999999
Q ss_pred CCC--ceEEccccCcccccCCCCc------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhh
Q 038294 641 NYF--SAKISDFGLSKLLLSDQSR------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVE 712 (799)
Q Consensus 641 ~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~ 712 (799)
.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++||||||++||||++|+.||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 9999999999876432211 11234689999999999999999999999999999999999999986542
Q ss_pred hhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 713 EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 713 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
... .+...... +... ...+.+.... .....+.+.+++.+||+.||++|||+++|++.|+++++
T Consensus 274 ~~~--~~~~~~~~-~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 274 NTE--DIMKQKQK-FVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp CHH--HHHHHHHH-HHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred CHH--HHHHHHHh-ccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 211 11111111 1111 1111111111 01123578889999999999999999999999998764
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.73 Aligned_cols=264 Identities=25% Similarity=0.353 Sum_probs=199.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 105 (331)
T 4aaa_A 27 YENLGLVGEGSYGMVMKCRNKD-TGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF 105 (331)
T ss_dssp EEEEEEGGGGTTSSEEEEEETT-TCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred heeeeEEeecCCEEEEEEEECC-CCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEec
Confidence 4456789999999999999874 68899999985432 23345688999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....... ..
T Consensus 106 ~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 181 (331)
T 4aaa_A 106 VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-VY 181 (331)
T ss_dssp CSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred CCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-cc
Confidence 99999999888778899999999999999999999998 999999999999999999999999999986543322 22
Q ss_pred eeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHHhc------C
Q 038294 665 TMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCYAE------G 730 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~~------~ 730 (799)
....+|+.|+|||.+.+. .++.++||||||+++|||++|+.||......+....+... ....+.. .
T Consensus 182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (331)
T 4aaa_A 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV 261 (331)
T ss_dssp --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence 334589999999999875 7899999999999999999999999765443221111000 0000000 0
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...................+.+.+++.+||+.||++|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111111111111111123567889999999999999999998875
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=323.52 Aligned_cols=248 Identities=25% Similarity=0.319 Sum_probs=205.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 16 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 16 FDIGRPLGKGKFGNVYLAREKQ-NKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceeeheecCCCCeEEEEEEEcC-CCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 4456789999999999999864 67899999986432 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 95 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 168 (284)
T 2vgo_A 95 FAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--- 168 (284)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC---
T ss_pred eCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccc---
Confidence 999999999998878899999999999999999999998 99999999999999999999999999987654322
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+..... ..+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~------~~~-- 232 (284)
T 2vgo_A 169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET--------HRRIVNVDL------KFP-- 232 (284)
T ss_dssp BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHTTCC------CCC--
T ss_pred cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH--------HHHHhcccc------CCC--
Confidence 2234589999999999999999999999999999999999999976543221 111122111 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhc
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEG 779 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~ 779 (799)
......+.+++.+||+.||++|||+.|+++ .++.
T Consensus 233 --~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~ 268 (284)
T 2vgo_A 233 --PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA 268 (284)
T ss_dssp --TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred --CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence 122356788999999999999999999986 4444
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=336.38 Aligned_cols=250 Identities=18% Similarity=0.203 Sum_probs=200.4
Q ss_pred hhchhhhcCccccceEEEEEE----eCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc---cccccceeeeeecccce
Q 038294 506 TGGFKEELGRGSFGIVYKGVL----KSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNR 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~----~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~ 578 (799)
.+.+.+.||+|+||+||+|.. ...+++.||||+++... ..++..|++++.+++ |+||+++++++...+..
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~ 142 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS 142 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence 344567899999999999953 22367899999997543 345666666666665 99999999999999999
Q ss_pred eeEEeecCCCChhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----------C
Q 038294 579 LLVYEFMGNGTLANLIFA-----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-----------Y 642 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~-----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-----------~ 642 (799)
++||||+++|+|.+++.. ...+++..+..|+.||++||+|||+. +|+||||||+||||+. +
T Consensus 143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------C
T ss_pred EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccccccc
Confidence 999999999999999974 45789999999999999999999998 8999999999999998 8
Q ss_pred CceEEccccCcccccCC-CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHH
Q 038294 643 FSAKISDFGLSKLLLSD-QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTD 721 (799)
Q Consensus 643 ~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~ 721 (799)
+.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------ 293 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC------ 293 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE------
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce------
Confidence 99999999999765422 22333445699999999999999999999999999999999999999865432110
Q ss_pred HHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhcCcCC
Q 038294 722 WAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKR-PTMKVVLQMLEGLLEV 783 (799)
Q Consensus 722 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~evl~~L~~~~~~ 783 (799)
......... ...+.+.+++..|++.+|.+| |++.++.+.|++.++.
T Consensus 294 -------------~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 294 -------------KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp -------------EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred -------------eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 011111111 124566678899999999999 7899999998876653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=325.76 Aligned_cols=248 Identities=28% Similarity=0.375 Sum_probs=195.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc-cceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-LNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~ 584 (799)
.+.+.+.||+|+||.||++... ++.||||+++... ..+.+.+|++++++++||||+++++++.+. ...++|+||
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~~---~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEET---TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hceEEeEEecCCCceEEEEEEc---CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 3456688999999999999873 7899999997532 456789999999999999999999997554 468999999
Q ss_pred cCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 585 MGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
+++++|.+++.... .+++..+.+++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999997653 378899999999999999999998 99999999999999999999999999988653321
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. ...+..+.. ..
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~--------~~~~~~~~~-----~~-- 234 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--------VPRVEKGYK-----MD-- 234 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH--------HHHHTTTCC-----CC--
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH--------HHHHhcCCC-----CC--
Confidence 22346889999999999999999999999999999998 9999875433221 111222211 11
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+.+++.+||+.||++|||+.|+++.|+.+..
T Consensus 235 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 235 --APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 112234578889999999999999999999999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=333.11 Aligned_cols=246 Identities=23% Similarity=0.305 Sum_probs=204.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||++.... +++.+|+|++... .....+.+.+|+.++++++|+||+++++++.+....++|||
T Consensus 43 y~~~~~lg~G~~g~Vy~~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 43 YVRGRFLGKGGFAKCFEISDAD-TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3456789999999999999874 6789999998643 22345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 122 ~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~ 197 (335)
T 2owb_A 122 LCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-R 197 (335)
T ss_dssp CCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred cCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcc-c
Confidence 999999999998878899999999999999999999998 999999999999999999999999999987643322 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...+..+.. ..+.
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~------~~~~- 262 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET--------YLRIKKNEY------SIPK- 262 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHHTCC------CCCT-
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH--------HHHHhcCCC------CCCc-
Confidence 2334589999999999999999999999999999999999999975433221 111111111 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+.+++.+||+.||++|||+.|+++
T Consensus 263 ---~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 263 ---HINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22346778999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.76 Aligned_cols=254 Identities=23% Similarity=0.263 Sum_probs=202.8
Q ss_pred hchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc----hhhHHHHHHHHHHhccc-ccccccceeeeeeccccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA----QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~ 579 (799)
+.+.+.||+|+||.||++.... .+++.||||+++... ....+.+.+|++++.++ +||||+++++++......+
T Consensus 56 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 135 (355)
T 1vzo_A 56 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 135 (355)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEE
Confidence 4556889999999999999842 367899999986532 22345677899999999 6999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 136 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred EEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 9999999999999998878899999999999999999999998 8999999999999999999999999999876544
Q ss_pred CCcceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.........||+.|+|||++.+ ..++.++|||||||+||||++|+.||...........+ ....... .
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~-~------ 282 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILKS-E------ 282 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHHC-C------
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH---HHHHhcc-C------
Confidence 3333344569999999999986 35789999999999999999999999754432221111 1111111 0
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQML 777 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~~L 777 (799)
+.. .......+.+++.+||+.||++|| ++.|+++..
T Consensus 283 ~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred CCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 111 122335677899999999999999 999998654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=334.32 Aligned_cols=250 Identities=24% Similarity=0.330 Sum_probs=199.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
.+.+.+.||+|+||.||++..+. +++.||||+++.... .+.+|++++.++ +||||+++++++.++...++||||
T Consensus 23 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 23 GYEVKEDIGVGSYSVCKRCIHKA-TNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEeeCCCEEEEEEEECC-CCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 45566889999999999999874 689999999965332 235678888877 799999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC----CceEEccccCcccccCCC
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY----FSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~----~~~kl~DfGla~~~~~~~ 660 (799)
+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+.++ +.+||+|||+++......
T Consensus 98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 99999999998888899999999999999999999998 99999999999998543 359999999998764433
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.......... ....+..+....
T Consensus 175 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~-----~~~~i~~~~~~~------ 242 (342)
T 2qr7_A 175 G-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE-----ILARIGSGKFSL------ 242 (342)
T ss_dssp C-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH-----HHHHHHHCCCCC------
T ss_pred C-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH-----HHHHHccCCccc------
Confidence 2 2233468999999999988889999999999999999999999997542221111 222233332211
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+........+.+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 243 SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11111233457788999999999999999999885
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-38 Score=345.60 Aligned_cols=235 Identities=15% Similarity=0.193 Sum_probs=183.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccc---cchhhHHHHHHHH---HHhccccccccccee-------eeeecc
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEV---SAIGRTHHKNLVQLL-------GFCDEA 575 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~---~~~~~~~~~~~E~---~~l~~l~h~niv~l~-------g~~~~~ 575 (799)
+.+.||+|+||.||+|..+. +++.||||++.. ......+.+.+|+ +.+++++||||++++ +++...
T Consensus 77 ~~~~lG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~ 155 (377)
T 3byv_A 77 RGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 155 (377)
T ss_dssp EEEEEEEETTEEEEEEEC-C-CCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECT
T ss_pred EcceeecCCCEEEEEEEECC-CCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhcc
Confidence 45789999999999999864 688999999863 2334557889999 566667899999998 555444
Q ss_pred c-----------------ceeeEEeecCCCChhhhhhcCCCCC-------HHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 038294 576 L-----------------NRLLVYEFMGNGTLANLIFAIPKPD-------WNLRVRISLEIARGLVYLHEECNVPIIHCD 631 (799)
Q Consensus 576 ~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~-------~~~~~~i~~~ia~gL~yLH~~~~~~iiH~d 631 (799)
+ ..++||||+ +|+|.+++.....++ +..+.+|+.||+.||+|||+. +|+|||
T Consensus 156 ~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrD 231 (377)
T 3byv_A 156 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 231 (377)
T ss_dssp TSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence 2 268999999 689999998643333 578889999999999999998 999999
Q ss_pred CCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCC-----------CCCcchhHHHHHHHHHHH
Q 038294 632 IKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA-----------PVSAKVDVYSFGVMLLEI 700 (799)
Q Consensus 632 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----------~~s~k~DVwS~Gvll~el 700 (799)
|||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+||||
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el 306 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred CCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence 999999999999999999999985321 2334457 999999999887 899999999999999999
Q ss_pred HhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 701 ICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 701 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
++|+.||...........+ .. .. ....+.+.+++.+||+.||++|||+.|+++
T Consensus 307 ltg~~Pf~~~~~~~~~~~~----------------~~-~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 307 WCADLPITKDAALGGSEWI----------------FR-SC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHSSCCC------CCSGGG----------------GS-SC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHCCCCCcccccccchhhh----------------hh-hc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 9999999754332211111 00 00 112356788999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.25 Aligned_cols=261 Identities=26% Similarity=0.403 Sum_probs=203.7
Q ss_pred HHHHhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeeccc
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL 576 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~ 576 (799)
+....+.+.+.||+|+||.||+|.+. ..+++.||||++... ......++.+|+.++++++||||+++++++.+..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL 106 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence 33445567789999999999999853 235678999999643 3345568999999999999999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcC-------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceE
Q 038294 577 NRLLVYEFMGNGTLANLIFAI-------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAK 646 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~k 646 (799)
..++||||+++++|.+++... ..+++..+++++.||+.||.|||+. +|+||||||+|||++. +..+|
T Consensus 107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999865 2478999999999999999999998 9999999999999984 55699
Q ss_pred EccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHH
Q 038294 647 ISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAY 724 (799)
Q Consensus 647 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~ 724 (799)
|+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------VL 255 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------HH
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------HH
Confidence 999999986543321 12223457889999999999999999999999999999998 888987543322 11
Q ss_pred HHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 725 ~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
..+..+... . ........+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 256 ~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 EFVTSGGRM-----D----PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHHHTTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhcCCCC-----C----CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 222222111 1 112233577889999999999999999999999987653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=340.90 Aligned_cols=248 Identities=18% Similarity=0.286 Sum_probs=194.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccc--cccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||++... .++.||||++... .....+.+.+|+.++.+++ ||||+++++++......++||
T Consensus 58 y~~~~~LG~G~fg~Vy~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 58 YSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEEEEEccCCCeEEEEEEcC--CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 455688999999999999875 4789999998542 3345578999999999996 599999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
| +.+++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||+++........
T Consensus 136 E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~ 210 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS 210 (390)
T ss_dssp E-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred e-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence 9 56889999999888889999999999999999999998 999999999999996 578999999999876543322
Q ss_pred -ceeeeccCCcccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 663 -THTMIRGTRGYVAPEWFKN-----------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 663 -~~~~~~gt~~y~aPE~l~~-----------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||....... ...... ..+
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~~~-~~~ 283 (390)
T 2zmd_A 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAI-IDP 283 (390)
T ss_dssp ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHH-HCT
T ss_pred ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH------HHHHHH-hCc
Confidence 2234569999999999865 468999999999999999999999997532211 111111 111
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
... ...+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 284 ~~~----~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 284 NHE----IEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp TSC----CCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccc----CCCCc----cchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 110 01111 113467889999999999999999999853
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.57 Aligned_cols=257 Identities=26% Similarity=0.330 Sum_probs=197.1
Q ss_pred hhchhhhcCccccceEEEEEEeCCCC--eEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
.+.+.+.||+|+||.||+|.+...++ ..||||+++.. .....+.+.+|++++++++||||+++++++.... .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 34566889999999999999764444 36899998653 2344578999999999999999999999998765 789
Q ss_pred EEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|+||+++++|.+++... ..+++..+.+++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 98 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 174 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN 174 (291)
T ss_dssp EEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred eEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence 99999999999999764 5688999999999999999999998 9999999999999999999999999999876543
Q ss_pred CCc--ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 660 QSR--THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 660 ~~~--~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ........+..
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~~---- 243 (291)
T 1u46_A 175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ-------ILHKIDKEGER---- 243 (291)
T ss_dssp CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHTSCCC----
T ss_pred ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH-------HHHHHHccCCC----
Confidence 321 1223457788999999998889999999999999999999 999987553322 11111111110
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
........+.+.+++.+||+.||++|||+.++++.|+++..
T Consensus 244 -----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 244 -----LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp -----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -----CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 01112234678889999999999999999999999987654
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=338.79 Aligned_cols=245 Identities=22% Similarity=0.259 Sum_probs=189.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcc-cccccccceeeeeec----ccceeeEEeec
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQLLGFCDE----ALNRLLVYEFM 585 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~g~~~~----~~~~~lv~e~~ 585 (799)
+.||+|+||+||++..+. +++.||||+++.. ..+.+|+.++.+ .+||||+++++++.. ....++||||+
T Consensus 68 ~~LG~G~~g~V~~~~~~~-~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~ 141 (400)
T 1nxk_A 68 QVLGLGINGKVLQIFNKR-TQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141 (400)
T ss_dssp EEEEEETTEEEEEEEETT-TCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred ceeeeccCeEEEEEEECC-CCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeC
Confidence 679999999999999874 6889999998642 346678887744 589999999998865 56789999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCC
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 660 (799)
++|+|.+++.... .+++..+..|+.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++......
T Consensus 142 ~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~ 218 (400)
T 1nxk_A 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218 (400)
T ss_dssp CSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC---
T ss_pred CCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCC
Confidence 9999999998753 589999999999999999999998 9999999999999997 7899999999998654322
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
......||+.|+|||++.+..++.++|||||||+||||++|+.||............ ...+..+... .
T Consensus 219 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~----~~~i~~~~~~------~ 286 (400)
T 1nxk_A 219 --SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----KTRIRMGQYE------F 286 (400)
T ss_dssp ----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSH----HHHHHHTCCC------C
T ss_pred --ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHH----HHHHHcCccc------C
Confidence 223456899999999999999999999999999999999999999765432211111 1112222211 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
+........+.+.+++.+||+.||++|||+.|+++.
T Consensus 287 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 111112234578889999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=335.73 Aligned_cols=259 Identities=21% Similarity=0.251 Sum_probs=192.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||+||+|.... +++.||||+++.... ...+.+.+|++++++++||||+++++++.+....++||||
T Consensus 36 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 114 (329)
T 3gbz_A 36 YRRITKLGEGTYGEVYKAIDTV-TNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114 (329)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEEecCCeEEEEEEECC-CCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEec
Confidence 4456889999999999998764 689999999965332 2345678999999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-----CCCceEEccccCcccccCC
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-----NYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-----~~~~~kl~DfGla~~~~~~ 659 (799)
+++ +|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++.....
T Consensus 115 ~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 115 AEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp CSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred CCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 984 9999999888899999999999999999999998 999999999999994 5556999999999876432
Q ss_pred CCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC---ceeEe
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG---RLDVL 735 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 735 (799)
.. ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+ ... .... .....
T Consensus 191 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~-~~~~~~~~~~~~ 265 (329)
T 3gbz_A 191 IR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI---FEV-LGLPDDTTWPGV 265 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHH-HCCCCTTTSTTG
T ss_pred cc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH---HHH-hCCCchhhhhhh
Confidence 22 22334579999999999875 4899999999999999999999999765433211111 110 0000 00000
Q ss_pred -----ecCCCCC--------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 -----VDSDEPA--------MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 -----~d~~~~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....+. .......+.+.+++.+||+.||++|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 266 TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 0000000 001113356789999999999999999999986
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.39 Aligned_cols=261 Identities=23% Similarity=0.283 Sum_probs=199.5
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-----cccccceeeeeeccccee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----HKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~g~~~~~~~~~ 579 (799)
..+.+.++||+|+||.||+|.... +++.||||+++.. ....+.+..|+.++.+++ ||||+++++++......+
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~ 112 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHID-NKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMC 112 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECC-CCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeE
Confidence 345566899999999999999874 6789999999753 334456778898888886 999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----------------
Q 038294 580 LVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---------------- 641 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---------------- 641 (799)
+||||+ +++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.
T Consensus 113 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 113 LIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhccccc
Confidence 999999 999999998654 588999999999999999999998 9999999999999975
Q ss_pred ---------CCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhh
Q 038294 642 ---------YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVE 712 (799)
Q Consensus 642 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~ 712 (799)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 189 ~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 189 KKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp CEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 789999999999864332 2234689999999999999999999999999999999999999976543
Q ss_pred hhcchhHHH--------HHHHHHhcCceeEeecCC----CCC-ccC---------------HHHHHHHHHHHHHhcccCC
Q 038294 713 EEGRAILTD--------WAYDCYAEGRLDVLVDSD----EPA-MAD---------------RSRLQKWLMIAMWCIREDP 764 (799)
Q Consensus 713 ~~~~~~~~~--------~~~~~~~~~~~~~~~d~~----~~~-~~~---------------~~~~~~l~~l~~~Cl~~dP 764 (799)
.+....+.. +................. .+. ... ....+.+.+++.+||+.||
T Consensus 265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 344 (360)
T 3llt_A 265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344 (360)
T ss_dssp HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence 322111110 000000000000000000 000 000 0111567799999999999
Q ss_pred CCCCCHHHHHH
Q 038294 765 SKRPTMKVVLQ 775 (799)
Q Consensus 765 ~~RPt~~evl~ 775 (799)
++|||+.|+++
T Consensus 345 ~~Rpta~elL~ 355 (360)
T 3llt_A 345 TLRPSPAELLK 355 (360)
T ss_dssp GGSCCHHHHTT
T ss_pred hhCCCHHHHhc
Confidence 99999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=326.79 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=199.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeee--cccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||++..+. +++.||+|++... .....+.+.+|++++++++||||+++++++. .....++||
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 86 (279)
T 2w5a_A 8 YEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 86 (279)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEE
T ss_pred eeeehhccCCCCcEEEEEEECC-CCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEE
Confidence 3456789999999999999874 6789999998643 2344567999999999999999999999874 456789999
Q ss_pred eecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCC-----eEecCCCCCCeEEcCCCceEEccccCc
Q 038294 583 EFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVP-----IIHCDIKPQNILLDNYFSAKISDFGLS 653 (799)
Q Consensus 583 e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~-----iiH~dlk~~NILl~~~~~~kl~DfGla 653 (799)
||+++++|.+++... ..+++..+.+++.|++.||+|||+. + |+|+||||+||+++.++.+||+|||++
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 87 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp ECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred eCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999753 3489999999999999999999998 6 999999999999999999999999999
Q ss_pred ccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 654 KLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 654 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
+....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ....+..+...
T Consensus 164 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~~ 234 (279)
T 2w5a_A 164 RILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFR 234 (279)
T ss_dssp HHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCC
T ss_pred eeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--------HHHHHhhcccc
Confidence 87643321 1223458999999999999999999999999999999999999997653321 11222333221
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
. . +......+.+++.+||+.||++|||+.||++.+.
T Consensus 235 ~-----~----~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 235 R-----I----PYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp C-----C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred c-----C----CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1 1 1123457888999999999999999999998653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-37 Score=342.94 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=192.4
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--------hhhHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
...+.+.+.||+|+||.||+|..+. +++.||||++.... ......+.+|++++++++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECC-CCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 3445667889999999999999875 67899999986432 1112358899999999999999999999854
Q ss_pred cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEEccccC
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGL 652 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~---~~~kl~DfGl 652 (799)
...++||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.+ ..+||+|||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeeccc
Confidence 45789999999999999998888899999999999999999999998 89999999999999754 4599999999
Q ss_pred cccccCCCCcceeeeccCCcccccccccC---CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFKN---APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....+..
T Consensus 289 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~~i~~ 359 (419)
T 3i6u_A 289 SKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-------LKDQITS 359 (419)
T ss_dssp TTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC-------HHHHHHT
T ss_pred ceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH-------HHHHHhc
Confidence 9876432 22334568999999999863 5788899999999999999999999975432211 1111222
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+.... .........+.+.+++.+||+.||++|||+.|+++
T Consensus 360 ~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 360 GKYNF------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCC------CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 22110 00001123457888999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=358.29 Aligned_cols=246 Identities=28% Similarity=0.346 Sum_probs=204.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||.||+|..+. +++.||||+++.. .....+.+..|..++..+ +|+||+++++++.+....++||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~-~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~ 421 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKG-TDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 421 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESS-SCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECC-CCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEE
Confidence 4556789999999999999875 6789999999753 223446788899999987 7999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 422 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~- 497 (674)
T 3pfq_A 422 EYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV- 497 (674)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC-
T ss_pred eCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCc-
Confidence 9999999999999888899999999999999999999998 999999999999999999999999999986433222
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||+||||++|+.||......+ ..+.+..+.. ..+
T Consensus 498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~------~~p- 562 (674)
T 3pfq_A 498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--------LFQSIMEHNV------AYP- 562 (674)
T ss_dssp CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHSSCC------CCC-
T ss_pred ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH--------HHHHHHhCCC------CCC-
Confidence 2344579999999999999999999999999999999999999998654332 2222233221 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTM-----KVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl~ 775 (799)
......+.+++.+||+.||++||++ +||++
T Consensus 563 ---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 563 ---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp ---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred ---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 2234578889999999999999997 66663
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.88 Aligned_cols=247 Identities=25% Similarity=0.364 Sum_probs=202.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+...+.||+|+||.||+|.... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 24 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 102 (303)
T 3a7i_A 24 FTKLEKIGKGSFGEVFKGIDNR-TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 102 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HHHhhhhcccCCeEEEEEEECC-CCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeC
Confidence 3456789999999999998764 67899999986433 334578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
++++|.+++.. ..+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++........ ...
T Consensus 103 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~ 177 (303)
T 3a7i_A 103 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 177 (303)
T ss_dssp TTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-CBC
T ss_pred CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcccc-ccC
Confidence 99999999865 5688999999999999999999998 999999999999999999999999999987644322 223
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
...|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..+..+.. +.. .
T Consensus 178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--------~~~~~~~~-----~~~----~ 240 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL--------FLIPKNNP-----PTL----E 240 (303)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--------HHHHHSCC-----CCC----C
T ss_pred ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH--------HHhhcCCC-----CCC----c
Confidence 345899999999999999999999999999999999999998754332211 11111111 111 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 241 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 1223567889999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=342.45 Aligned_cols=261 Identities=23% Similarity=0.262 Sum_probs=192.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc------cce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 578 (799)
+.+.+.||+|+||+||+|.... +++.||||++... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 64 y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 142 (464)
T 3ttj_A 64 YQNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 142 (464)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCCCeEEEEEEECC-CCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeE
Confidence 3456789999999999999874 6899999999653 334456788999999999999999999999654 346
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+++ +|.+.+.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 143 ~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 143 YLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred EEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 999999976 46666543 488999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH---------------H
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW---------------A 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~---------------~ 723 (799)
. .......||+.|+|||++.+..++.++|||||||+||||++|+.||......+....+... .
T Consensus 217 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~ 294 (464)
T 3ttj_A 217 S--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294 (464)
T ss_dssp C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred C--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence 2 2233456899999999999999999999999999999999999999765433221111110 0
Q ss_pred HHHHhcCc-ee-----EeecCC---CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEGR-LD-----VLVDSD---EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~~-~~-----~~~d~~---~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
........ .. ...... ............+.+++.+||+.||++|||++|+++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000 00 000000 0000112235678899999999999999999999863
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=332.43 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=201.1
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--------hhhHHHHHHHHHHhccc-ccccccceeeeeeccc
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--------QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEAL 576 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~ 576 (799)
.+.+.+.||+|+||.||+|.++. +|+.||||+++... ....+.+.+|+.++.++ +||||+++++++....
T Consensus 95 ~y~~~~~lg~G~~g~Vy~a~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 95 KYDPKDVIGRGVSSVVRRCVHRA-TGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hcccceEEecCCCEEEEEEEECC-CCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 34455789999999999999864 68899999985432 12235678999999999 7999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
..++||||+++++|.+++.....+++..+..++.||+.||.|||+. +|+|+||||+|||++.++.+||+|||++...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~ 250 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL 250 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence 9999999999999999998878899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccC------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKN------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+..+
T Consensus 251 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--------~~~~i~~~ 320 (365)
T 2y7j_A 251 EPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--------MLRMIMEG 320 (365)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred CCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHhC
Confidence 4332 2233568999999999863 358899999999999999999999997543221 11112222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.... ...........+.+++.+||+.||++|||+.|+++
T Consensus 321 ~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 321 QYQF------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp CCCC------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1110 00000112346788999999999999999999986
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=341.59 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=188.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccc-cccccceeeeeeccc--ceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL--NRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~--~~~l 580 (799)
.+.+.+.||+|+||.||+|..+. +++.||||++... .....+.+.+|+.++.++. ||||+++++++...+ ..++
T Consensus 10 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l 88 (388)
T 3oz6_A 10 KYELVKKLGKGAYGIVWKSIDRR-TGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88 (388)
T ss_dssp TEEEEEC-------CEEEEEETT-TCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred ceEEEEEeeeCCCeEEEEEEECC-CCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence 34566889999999999999874 6889999998542 2334567889999999997 999999999997544 6799
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||++ ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 163 (388)
T 3oz6_A 89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163 (388)
T ss_dssp EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence 999998 589998876 4688899999999999999999998 99999999999999999999999999998753211
Q ss_pred --------------------CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhH
Q 038294 661 --------------------SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 661 --------------------~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~ 719 (799)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i 243 (388)
T 3oz6_A 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243 (388)
T ss_dssp CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 111233568999999999976 67899999999999999999999999765433221111
Q ss_pred HHHH--------------------HHHHhcCce-eEeecCCCCC--------ccCHHHHHHHHHHHHHhcccCCCCCCCH
Q 038294 720 TDWA--------------------YDCYAEGRL-DVLVDSDEPA--------MADRSRLQKWLMIAMWCIREDPSKRPTM 770 (799)
Q Consensus 720 ~~~~--------------------~~~~~~~~~-~~~~d~~~~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~ 770 (799)
.... ......... ........+. .......+.+.+++.+||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 1000 000000000 0000000000 0000123567899999999999999999
Q ss_pred HHHHHH
Q 038294 771 KVVLQM 776 (799)
Q Consensus 771 ~evl~~ 776 (799)
+|+++.
T Consensus 324 ~e~l~H 329 (388)
T 3oz6_A 324 NDALKH 329 (388)
T ss_dssp HHHTTS
T ss_pred HHHhCC
Confidence 999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.23 Aligned_cols=245 Identities=28% Similarity=0.379 Sum_probs=195.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCCCCh
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTL 590 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 590 (799)
..||+|+||.||+|.... +++.||||.+........+.+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 28 ~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 106 (295)
T 2clq_A 28 VVLGKGTYGIVYAGRDLS-NQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106 (295)
T ss_dssp CEEEECSSSEEEEEEETT-TCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEH
T ss_pred EEEeecCcEEEEEEEECC-CCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCH
Confidence 479999999999999864 6789999999766555667899999999999999999999999999999999999999999
Q ss_pred hhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccccCCCCcceee
Q 038294 591 ANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 591 ~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
.+++.... ..++..+..++.||+.||+|||+. +|+|+||||+||+++. ++.+||+|||++........ ....
T Consensus 107 ~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 182 (295)
T 2clq_A 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CTET 182 (295)
T ss_dssp HHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------CC
T ss_pred HHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cccc
Confidence 99998652 456888899999999999999998 9999999999999987 89999999999987643221 1223
Q ss_pred eccCCcccccccccCCC--CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 667 IRGTRGYVAPEWFKNAP--VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~--~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
..|++.|+|||.+.+.. ++.++||||||+++|||++|+.||......... ........ ..+..+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~-----~~~~~~--- 248 (295)
T 2clq_A 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA------MFKVGMFK-----VHPEIP--- 248 (295)
T ss_dssp CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH------HHHHHHHC-----CCCCCC---
T ss_pred cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH------HHhhcccc-----cccccc---
Confidence 45899999999997653 889999999999999999999999754322110 00000000 011111
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+.+++.+||+.||++|||+.|+++
T Consensus 249 -~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 249 -ESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp -TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred -ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 223457788999999999999999999985
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=328.27 Aligned_cols=257 Identities=24% Similarity=0.323 Sum_probs=182.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ....+++.+|+.++++++||||+++++++......++||||+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 95 (303)
T 2vwi_A 17 YELQEVIGSGATAVVQAAYCAP-KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLL 95 (303)
T ss_dssp CEEEEECC---CCCEEEEEC-----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECC
T ss_pred hhhhheeccccceEEEEEEECC-CCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhc
Confidence 4456889999999999998764 57899999986533 234567889999999999999999999999999999999999
Q ss_pred CCCChhhhhhc--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccccc
Q 038294 586 GNGTLANLIFA--------IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 586 ~~gsL~~~l~~--------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~ 657 (799)
++++|.+++.. ...+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++....
T Consensus 96 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 172 (303)
T 2vwi_A 96 SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLA 172 (303)
T ss_dssp TTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC
T ss_pred cCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheec
Confidence 99999999874 34588999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCC----cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce
Q 038294 658 SDQS----RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732 (799)
Q Consensus 658 ~~~~----~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 732 (799)
.... .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......... ...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-------~~~~~~-~~ 244 (303)
T 2vwi_A 173 TGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-------MLTLQN-DP 244 (303)
T ss_dssp ---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-------HHHHTS-SC
T ss_pred cCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-------HHHhcc-CC
Confidence 3221 11223468999999999876 56899999999999999999999999765432211 111111 10
Q ss_pred eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 ~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...................+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0000000000111122356788999999999999999999986
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=344.92 Aligned_cols=251 Identities=25% Similarity=0.321 Sum_probs=204.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.+.||+|+||+||++..+. +++.||||++.... ......+.+|++++++++||||+++++++.+....++|+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETT-TCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECC-CCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 456677899999999999999874 68899999986432 234567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEccccCcccccCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD---NYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~---~~~~~kl~DfGla~~~~~~ 659 (799)
||+++|+|.+.+.....+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 9999999999998888899999999999999999999998 999999999999995 4667999999999866433
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
. ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......+ ....+..+....
T Consensus 178 ~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~----- 241 (486)
T 3mwu_A 178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAF----- 241 (486)
T ss_dssp ------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCS-----
T ss_pred C--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCC-----
Confidence 2 2233468999999999976 59999999999999999999999997654332 112222222110
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.........+.+.+++.+||+.||++|||+.|+++.
T Consensus 242 -~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 -DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp -CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred -CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 111112334577899999999999999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=345.80 Aligned_cols=250 Identities=24% Similarity=0.320 Sum_probs=199.7
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
..+.+.+.||+|+||+||+|..+. +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKV-THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETT-TCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECC-CCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 345667899999999999999874 67899999986532 233567899999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~ 659 (799)
||+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 9999999999998888899999999999999999999998 9999999999999976 455999999999876543
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
. ......||+.|+|||++. ..++.++||||+||++|||++|..||......+ ....+..+....
T Consensus 193 ~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~----- 256 (494)
T 3lij_A 193 K--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--------ILRKVEKGKYTF----- 256 (494)
T ss_dssp B--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHTCCCC-----
T ss_pred c--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCCCC-----
Confidence 2 223346899999999986 469999999999999999999999998654332 112222222110
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+........+.+.+++.+||+.||++|||+.|+++
T Consensus 257 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 257 -DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp -CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred -CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 01111123456788999999999999999999884
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=319.36 Aligned_cols=246 Identities=26% Similarity=0.400 Sum_probs=195.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+. +++.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus 13 y~i~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 13 YVLGDTLGVGTFGKVKIGEHQL-TGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEeeecCCCCeEEEEEEECC-CCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 3456789999999999999874 67899999986532 2234678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++....... .
T Consensus 92 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~ 166 (276)
T 2h6d_A 92 YVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE--F 166 (276)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred ccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCc--c
Confidence 999999999998878899999999999999999999998 89999999999999999999999999998764332 1
Q ss_pred eeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 664 HTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
.....+++.|+|||.+.+..+ +.++||||||+++|||++|+.||....... ..+.+..+.. ..+.
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~------~~~~ 232 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--------LFKKIRGGVF------YIPE 232 (276)
T ss_dssp ----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCCT
T ss_pred eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--------HHHHhhcCcc------cCch
Confidence 223458899999999988765 689999999999999999999997543221 1122222211 1111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 233 ----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 233 ----YLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----hcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 123567889999999999999999999873
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=323.54 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=198.9
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
..+.+.+.||+|+||.||+|..+. +++.||+|++... ...+++.+|+.++++++||||+++++++......++||||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 105 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKE-TGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY 105 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETT-TCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhhhhheeeccCCCeEEEEEEECC-CCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence 344566889999999999999864 6889999998653 2346789999999999999999999999999999999999
Q ss_pred cCCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 585 MGNGTLANLIF-AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 585 ~~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+++++|.+++. ....+++..+..++.||+.||.|||+. +|+|+||||+||+++.++.+||+|||++........ .
T Consensus 106 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-~ 181 (314)
T 3com_A 106 CGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA-K 181 (314)
T ss_dssp CTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-C
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-c
Confidence 99999999997 356789999999999999999999998 999999999999999999999999999987644322 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ... ...... +.. .
T Consensus 182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~-----~~~--~ 246 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-------IFM-IPTNPP-----PTF--R 246 (314)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHH-HHHSCC-----CCC--S
T ss_pred cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH-------HHH-HhcCCC-----ccc--C
Confidence 2234589999999999999999999999999999999999999975432211 111 111110 000 1
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+++.+||+.||++|||+.++++
T Consensus 247 ~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 247 KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12223457888999999999999999999985
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=346.08 Aligned_cols=247 Identities=27% Similarity=0.350 Sum_probs=200.6
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.||+|+||.||++..+. +++.||+|++.... ....+.+..|+.++++++||||+++++++......++||||+
T Consensus 189 ~~~~LG~G~fG~Vy~a~~~~-tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~ 267 (543)
T 3c4z_A 189 DFRVLGRGGFGEVFACQMKA-TGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIM 267 (543)
T ss_dssp EEEEEEECSSSEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred EEEEEeeCCCeEEEEEEECC-CCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEec
Confidence 34679999999999999874 68999999996532 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
++|+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.......
T Consensus 268 ~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 268 NGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp TTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred cCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 999999998764 3688999999999999999999998 999999999999999999999999999987654332
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||........... ..+.+..+.. ..+
T Consensus 345 ~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~----~~~~i~~~~~------~~p 413 (543)
T 3c4z_A 345 K-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE----LKQRVLEQAV------TYP 413 (543)
T ss_dssp C-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH----HHHHHHHCCC------CCC
T ss_pred c-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH----HHHHHhhccc------CCC
Confidence 2 2334699999999999999999999999999999999999999986532211111 1112222211 111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCH-----HHHH
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTM-----KVVL 774 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~evl 774 (799)
......+.+++.+||+.||++||++ .+|+
T Consensus 414 ----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~ 447 (543)
T 3c4z_A 414 ----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR 447 (543)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred ----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence 2234577889999999999999975 5665
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=341.30 Aligned_cols=192 Identities=24% Similarity=0.346 Sum_probs=153.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec-----cccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-----ALNRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-----~~~~~ 579 (799)
+.+.+.||+|+||+||+|..+. +++.||||++... .....+.+.+|++++++++||||+++++++.. ....+
T Consensus 55 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~ 133 (458)
T 3rp9_A 55 YEIRHLIGTGSYGHVCEAYDKL-EKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELY 133 (458)
T ss_dssp EEECCC-------CEEEEEECC---CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred eEEeeEeeecCCeEEEEEEECC-CCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEE
Confidence 4567889999999999999874 6889999998653 23345678999999999999999999999943 35679
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+ +++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 134 lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 209 (458)
T 3rp9_A 134 VVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209 (458)
T ss_dssp EEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred EEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence 999998 479999998888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred CC--------------------------cceeeeccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHhC
Q 038294 660 QS--------------------------RTHTMIRGTRGYVAPEWF-KNAPVSAKVDVYSFGVMLLEIICC 703 (799)
Q Consensus 660 ~~--------------------------~~~~~~~gt~~y~aPE~l-~~~~~s~k~DVwS~Gvll~elltg 703 (799)
.. .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 21 122335689999999976 566799999999999999999994
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=326.02 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=196.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||.||+|..+. +++.||+|++........+.+.+|++++++++||||+++++++......++||||++
T Consensus 21 y~i~~~lg~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (302)
T 2j7t_A 21 WEIVGELGDGAFGKVYKAKNKE-TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCP 99 (302)
T ss_dssp EEEEEEEECSTTCCEEEEEETT-TCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCT
T ss_pred eeecceeccCCCeEEEEEEEcC-CCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCC
Confidence 4456789999999999999874 678999999976655666789999999999999999999999999999999999999
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+++|.+++.. ...+++..+..++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++....... ....
T Consensus 100 ~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 175 (302)
T 2j7t_A 100 GGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-QKRD 175 (302)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-HC--
T ss_pred CCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccc-cccc
Confidence 9999999876 45789999999999999999999998 99999999999999999999999999876432111 1112
Q ss_pred eeccCCcccccccc-----cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 666 MIRGTRGYVAPEWF-----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 666 ~~~gt~~y~aPE~l-----~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
...|++.|+|||.+ .+..++.++||||||+++|||++|+.|+........ ....... ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~-~~~------- 240 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-------LLKIAKS-DPP------- 240 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHS-CCC-------
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-------HHHHhcc-CCc-------
Confidence 34589999999998 467789999999999999999999999875433221 1111111 100
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...........+.+++.+||+.||++|||+.++++
T Consensus 241 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 01112233457888999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=358.02 Aligned_cols=257 Identities=21% Similarity=0.314 Sum_probs=204.1
Q ss_pred HHhhchhhhcCccccceEEEEEEeCC--CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~--~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
...+.+.+.||+|+||.||+|.+... .+..||+|+++... ....+.|.+|+.++++++||||+++++++.+ ...++
T Consensus 389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~l 467 (656)
T 2j0j_A 389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI 467 (656)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceEE
Confidence 34456678899999999999998632 34689999987533 3345689999999999999999999999854 56899
Q ss_pred EEeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 581 VYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~ 544 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 544 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence 999999999999998654 689999999999999999999998 9999999999999999999999999999876544
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
.........+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+. ...+..+...
T Consensus 545 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~--------~~~i~~~~~~----- 611 (656)
T 2j0j_A 545 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--------IGRIENGERL----- 611 (656)
T ss_dssp ---------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH--------HHHHHHTCCC-----
T ss_pred cceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH--------HHHHHcCCCC-----
Confidence 3333334457789999999999999999999999999999997 8889875433221 1112222111
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.. +......+.+++.+||+.||++|||+.||++.|+.++
T Consensus 612 ~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 612 PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01 1223357888999999999999999999999998765
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=346.67 Aligned_cols=251 Identities=25% Similarity=0.303 Sum_probs=206.3
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
...+.+.+.||+|+||.||++..+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECC-CCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3456677899999999999999874 68899999985422 3345789999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCccccc
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLL 657 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~ 657 (799)
|+||+.+|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||+ +.++.+||+|||+++...
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 999999999999998888899999999999999999999998 99999999999999 567899999999998764
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
... ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......+ ....+..+....
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~~~~~--- 246 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--------ILKKVEKGKYTF--- 246 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCC---
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--------HHHHHHcCCCCC---
Confidence 332 2233468999999999876 69999999999999999999999998654332 112222222111
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+........+.+.+++.+||+.||++|||+.|+++
T Consensus 247 ---~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ---ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ---CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 11111233467888999999999999999999985
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-36 Score=328.24 Aligned_cols=263 Identities=25% Similarity=0.279 Sum_probs=194.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc------ce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 578 (799)
+.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|++++++++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~ 105 (367)
T 1cm8_A 27 YRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 105 (367)
T ss_dssp EEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEeEEeeecCCeEEEEEEECC-CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceE
Confidence 3456789999999999999864 6889999998542 2334567899999999999999999999997653 45
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 106 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 8999999 7899999876 5688999999999999999999998 999999999999999999999999999987533
Q ss_pred CCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH--------------
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------------- 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------------- 723 (799)
. .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||......+....+....
T Consensus 181 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~ 256 (367)
T 1cm8_A 181 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 256 (367)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhH
Confidence 2 233468999999999877 689999999999999999999999997654322111110000
Q ss_pred --HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcC
Q 038294 724 --YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLLE 782 (799)
Q Consensus 724 --~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~ 782 (799)
...... +........ ..........+.+++.+||+.||++|||+.|+++ .++.+.+
T Consensus 257 ~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 257 EAKNYMKG--LPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHHH--SCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred HHHHHHHh--CCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence 000000 000000000 0111123457888999999999999999999987 4555544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.98 Aligned_cols=241 Identities=24% Similarity=0.339 Sum_probs=196.1
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||+|..+. +++.||+|+++.. ......++.+|+..+.++ +||||+++++++.+....++||
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 12 EFHELEKIGSGEFGSVFKCVKRL-DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhhhhhhcCCCceEEEEEEEcC-CCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 44566889999999999999874 6789999998653 233456788999999998 9999999999999999999999
Q ss_pred eecCCCChhhhhhcC----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----------------
Q 038294 583 EFMGNGTLANLIFAI----PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN----------------- 641 (799)
Q Consensus 583 e~~~~gsL~~~l~~~----~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~----------------- 641 (799)
||+++++|.+++... ..+++..+.+++.||+.||+|||+. +|+||||||+|||++.
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~ 167 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA 167 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC------------------
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence 999999999999764 5689999999999999999999998 9999999999999984
Q ss_pred --CCceEEccccCcccccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchh
Q 038294 642 --YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718 (799)
Q Consensus 642 --~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~ 718 (799)
...+||+|||++........ ..||+.|+|||.+.+. .++.++||||||+++|||++|..++.....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------ 236 (289)
T 1x8b_A 168 SNKVMFKIGDLGHVTRISSPQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------ 236 (289)
T ss_dssp --CCCEEECCCTTCEETTCSCC-----CCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------
T ss_pred CCceEEEEcccccccccCCccc-----cCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------
Confidence 44799999999987643322 2489999999999776 567899999999999999999877643211
Q ss_pred HHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+..+... ..+ ......+.+++.+||+.||++|||+.|+++
T Consensus 237 -----~~~~~~~~~~-----~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 -----WHEIRQGRLP-----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -----HHHHHTTCCC-----CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----HHHHHcCCCC-----CCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1112222221 111 122357788999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=320.93 Aligned_cols=249 Identities=25% Similarity=0.299 Sum_probs=202.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---------hhhHHHHHHHHHHhcccc-cccccceeeeeeccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---------QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 576 (799)
+.+.+.||+|+||.||+|..+. +++.||||+++... ....+.+.+|++++++++ ||||+++++++....
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 19 YEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cceeeeecCCCceEEEEEEEcC-cCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 3456789999999999999874 68999999986432 123457889999999995 999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
..++||||+++++|.+++.....+++..+..++.||+.||+|||+. +|+|+||||+||+++.++.+||+|||++...
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999998878899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCcceeeeccCCccccccccc------CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFK------NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~------~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
.... ......+++.|+|||.+. ...++.++||||||+++|||++|+.||....... ....+..+
T Consensus 175 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~ 244 (298)
T 1phk_A 175 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMIMSG 244 (298)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred CCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--------HHHHHhcC
Confidence 4332 223345899999999985 4568899999999999999999999997543322 11112222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
... .+..........+.+++.+||+.||++|||+.|+++
T Consensus 245 ~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111 111111234467889999999999999999999985
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=330.50 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=194.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhh-HHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER-EREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||+||+|..+. +++.||+|++....... ...+.+|++++++++||||+++++++......++||||+
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKL-TDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eEEEEEEcCCCCEEEEEEEECC-CCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEeccc
Confidence 3456789999999999999874 67899999986533221 224567999999999999999999999999999999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+ |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~~~ 157 (324)
T 3mtl_A 83 D-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY 157 (324)
T ss_dssp S-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred c-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc-ccc
Confidence 7 5898888765 4588999999999999999999998 99999999999999999999999999998654322 222
Q ss_pred eeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCc---eeEeec---
Q 038294 665 TMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGR---LDVLVD--- 737 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~d--- 737 (799)
....+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+ ........ ......
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~ 233 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFI----FRILGTPTEETWPGILSNEE 233 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHHHCCCCTTTSTTGGGCHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HHHhCCCChHhchhhhcchh
Confidence 33457999999999876 56899999999999999999999999865443322111 11110000 000000
Q ss_pred ---CCCCC-------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 038294 738 ---SDEPA-------MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGL 780 (799)
Q Consensus 738 ---~~~~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 780 (799)
...+. .........+.+++.+||+.||++|||++|+++ .+.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 00000 001123356788999999999999999999987 44443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=337.02 Aligned_cols=197 Identities=27% Similarity=0.367 Sum_probs=166.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc-----ccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 579 (799)
+.+.+.||+|+||.||+|..+. +++.||||++... .....+.+.+|++++++++||||+++++++... ...+
T Consensus 28 y~~~~~lG~G~~g~V~~a~~~~-~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~ 106 (432)
T 3n9x_A 28 YIIKHLIGRGSYGYVYLAYDKN-TEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELY 106 (432)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEE
T ss_pred EEEEEEEeecCCEEEEEEEECC-CCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEE
Confidence 4456889999999999999874 6899999999653 233456789999999999999999999999766 5689
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+. ++|.+++.....+++..+..++.||++||+|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 107 lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 107 IVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999986 59999998888899999999999999999999998 9999999999999999999999999999876433
Q ss_pred CC---------------------cceeeeccCCcccccccc-cCCCCCcchhHHHHHHHHHHHHhCCcCCc
Q 038294 660 QS---------------------RTHTMIRGTRGYVAPEWF-KNAPVSAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 660 ~~---------------------~~~~~~~gt~~y~aPE~l-~~~~~s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
.. .......||+.|+|||++ ....++.++|||||||+||||++|..|+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 21 112445689999999986 56679999999999999999998655543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.42 Aligned_cols=266 Identities=21% Similarity=0.266 Sum_probs=196.9
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeec--------c
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDE--------A 575 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~ 575 (799)
.+.+.+.||+|+||.||+|..+. +++.||+|++.... ......+.+|++++++++||||+++++++.. .
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETT-TCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred ceeEEEEEecCCCcEEEEEEECC-CCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 34556889999999999999864 68899999985432 2234578899999999999999999999976 3
Q ss_pred cceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 576 LNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
...++||||+++ +|.+.+... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999985 777766654 5789999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCC---CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHH---
Q 038294 655 LLLSDQ---SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCY--- 727 (799)
Q Consensus 655 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--- 727 (799)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 764322 122233568999999999876 4589999999999999999999999986544332211111000000
Q ss_pred ----hcCceeEeecCCCCCcc-CHH------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 728 ----AEGRLDVLVDSDEPAMA-DRS------RLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 728 ----~~~~~~~~~d~~~~~~~-~~~------~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
................. ... ....+.+++.+||+.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00000000000000000 001 12457889999999999999999998863
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-36 Score=344.83 Aligned_cols=248 Identities=27% Similarity=0.335 Sum_probs=200.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-------------hhHHHHHHHHHHhcccccccccceeeeee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-------------EREREFKSEVSAIGRTHHKNLVQLLGFCD 573 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 573 (799)
+.+.+.||+|+||+||+|..+. +++.||+|++..... ...+.+.+|+.++++++||||+++++++.
T Consensus 38 Y~~~~~lG~G~~g~V~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 116 (504)
T 3q5i_A 38 YFKVRKLGSGAYGEVLLCKEKN-GHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFE 116 (504)
T ss_dssp EEEEEEEEC--CEEEEEEEETT-TCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred eEEEeEecccCCeEEEEEEECC-CCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 4456889999999999999874 678999999864321 23467899999999999999999999999
Q ss_pred cccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC---ceEEccc
Q 038294 574 EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---SAKISDF 650 (799)
Q Consensus 574 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---~~kl~Df 650 (799)
+....++||||+++|+|.+.+.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+||
T Consensus 117 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 117 DKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999998888899999999999999999999998 999999999999998765 6999999
Q ss_pred cCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 651 GLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 651 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
|++....... ......||+.|+|||++. ..++.++||||+||++|||++|..||......+ ....+..+
T Consensus 194 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------~~~~i~~~ 262 (504)
T 3q5i_A 194 GLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--------IIKKVEKG 262 (504)
T ss_dssp TTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHC
T ss_pred CCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcC
Confidence 9998764432 223346899999999987 468999999999999999999999998654332 11222222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.... +..........+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~~~------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 263 KYYF------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp CCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCC------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2110 00000122356888999999999999999999985
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-36 Score=342.00 Aligned_cols=258 Identities=17% Similarity=0.238 Sum_probs=202.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc-ccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.++||+|+||.||+|.... +++.||||++.... ...++..|++++..++| +++..+..++.+....+|||||+
T Consensus 9 y~i~~~LG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~ 85 (483)
T 3sv0_A 9 FRLGRKIGSGSFGEIYLGTNIQ-TNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL 85 (483)
T ss_dssp EECCCCCEECSSCEEEEEEETT-TCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECC-CCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC
Confidence 4456889999999999999864 67899999875432 23457889999999976 55666666667778889999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE---cCCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL---DNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl---~~~~~~kl~DfGla~~~~~~~~ 661 (799)
+++|.+++.. ...+++..++.|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||+++.......
T Consensus 86 -g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 86 -GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred -CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 9999999985 45799999999999999999999998 99999999999999 6889999999999987754332
Q ss_pred c------ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 662 R------THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 662 ~------~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
. ......||+.|+|||.+.+..++.++|||||||+||||++|+.||...........+.......... .+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~-~~~~l 240 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT-SIEAL 240 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS-CHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc-cHHHH
Confidence 1 1224568999999999999999999999999999999999999998654332222222211111111 00000
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.....+.+.+++..||+.+|++||++.+|+++|+.++
T Consensus 241 ---------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 241 ---------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp ---------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred ---------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0112357889999999999999999999999998764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=316.43 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=197.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc----hhhHHHHHHHHHHhcccccccccceeeee--ecccceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA----QEREREFKSEVSAIGRTHHKNLVQLLGFC--DEALNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~g~~--~~~~~~~l 580 (799)
+.+.+.||+|+||.||++.... +++.||+|+++... ....+.+.+|++++++++||||+++++++ .+....++
T Consensus 7 y~i~~~lg~G~~g~V~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 7 YLMGDLLGEGSYGKVKEVLDSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp BCCCCEEEECSSCEEEEEEBTT-TCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred eeEeeEEecCCCeEEEEEEECC-CCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4456889999999999999864 67899999997532 23456899999999999999999999998 45567899
Q ss_pred EEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 581 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
||||++++ |.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 86 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 161 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHP 161 (305)
T ss_dssp EEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence 99999876 77777653 4688999999999999999999998 999999999999999999999999999987643
Q ss_pred CC-CcceeeeccCCcccccccccCCCC--CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 659 DQ-SRTHTMIRGTRGYVAPEWFKNAPV--SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 659 ~~-~~~~~~~~gt~~y~aPE~l~~~~~--s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.. ........|++.|+|||.+.+... +.++||||||+++|||++|+.||......+ ....+..+..
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------~~~~i~~~~~--- 230 (305)
T 2wtk_C 162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK--------LFENIGKGSY--- 230 (305)
T ss_dssp TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHCCC---
T ss_pred cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH--------HHHHHhcCCC---
Confidence 22 222334568999999999986543 779999999999999999999997643322 1122222221
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGL 780 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 780 (799)
..+. .....+.+++.+||+.||++|||+.|+++ .+++.
T Consensus 231 ---~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 270 (305)
T 2wtk_C 231 ---AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270 (305)
T ss_dssp ---CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred ---CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence 1111 22356778999999999999999999996 35543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=329.75 Aligned_cols=260 Identities=26% Similarity=0.279 Sum_probs=196.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh-----hHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-----REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.+.||+|+||.||+|..+. +++.||||++...... ..+.+.+|++++++++||||+++++++.+....++|
T Consensus 12 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 90 (346)
T 1ua2_A 12 YEKLDFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 90 (346)
T ss_dssp -CEEEEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred cEEEeEEeecCCEEEEEEEECC-CCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEE
Confidence 4456789999999999999874 6789999998643221 124688999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|||+++ +|.+++... ..+++..+..++.|+++||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 91 FDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999986 888888765 3688899999999999999999998 89999999999999999999999999998764332
Q ss_pred CcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE-----
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV----- 734 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 734 (799)
. ......+|+.|+|||.+.+. .++.++|||||||++|||++|..||......+... ..... ........
T Consensus 167 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~---~i~~~-~~~~~~~~~~~~~ 241 (346)
T 1ua2_A 167 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFET-LGTPTEEQWPDMC 241 (346)
T ss_dssp C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHH-HCCCCTTTSSSTT
T ss_pred c-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHHH-cCCCChhhhhhhc
Confidence 2 22334689999999999764 58999999999999999999999987654332111 11111 00000000
Q ss_pred -eec----CCCCCc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 735 -LVD----SDEPAM----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 735 -~~d----~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
..+ ...+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 000 000000 012234678899999999999999999999874
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=321.33 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=184.5
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.+.||+|+||.||++.... +++.||+|+++.... ...+.+.++...++.++||||+++++++.+....++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVP-SGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred hhhhHHhcCCCCCeEEEEEEecC-CCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 34566889999999999999864 689999999965322 223345556666888999999999999999999999999
Q ss_pred ecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 584 FMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 584 ~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|++ |+|.+++.. ...+++..+..++.||+.||+|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 87 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 163 (290)
T 3fme_A 87 LMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD 163 (290)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred hhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence 997 488777654 467899999999999999999999852 7999999999999999999999999999876433
Q ss_pred CCcceeeeccCCcccccccc----cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 660 QSRTHTMIRGTRGYVAPEWF----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l----~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||....... ...........
T Consensus 164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~---- 231 (290)
T 3fme_A 164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF------QQLKQVVEEPS---- 231 (290)
T ss_dssp --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH------HHHHHHHHSCC----
T ss_pred cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH------HHHHHHhccCC----
Confidence 22 2223589999999996 56678999999999999999999999997432211 11111222211
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..........+.+++.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 -----PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp -----CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -----CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11112233457888999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=327.36 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=196.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||.||+|..+. .+|+|+++... ....+.+.+|+.++++++||||+++++++.+....++|+||
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~----~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~ 110 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG----EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL 110 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS----SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred eEEeeEeccCCceEEEEEEEcC----eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence 4456889999999999998752 48999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC---
Q 038294 585 MGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ--- 660 (799)
Q Consensus 585 ~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~--- 660 (799)
+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++ ++.+||+|||++.......
T Consensus 111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~ 186 (319)
T 2y4i_B 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR 186 (319)
T ss_dssp CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence 99999999998754 689999999999999999999998 999999999999998 6799999999987653211
Q ss_pred -CcceeeeccCCcccccccccC---------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 661 -SRTHTMIRGTRGYVAPEWFKN---------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 661 -~~~~~~~~gt~~y~aPE~l~~---------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .......+
T Consensus 187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~~ 258 (319)
T 2y4i_B 187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQMGTG 258 (319)
T ss_dssp -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH--------HHHHHHTT
T ss_pred cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHhccC
Confidence 112223458899999999864 457899999999999999999999997654322 11112222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
...... .......+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 259 ~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 259 MKPNLS--------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCC--------CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCC--------cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 111111 111224577899999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.72 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=197.1
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------hhHHHHHHHHHHhcccccccccceeeeeecc
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------EREREFKSEVSAIGRTHHKNLVQLLGFCDEA 575 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~ 575 (799)
...+.+.+.||+|+||.||+|..+. +++.||||++..... .....+.+|++++++++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERK-TCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcC-CCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 3456677899999999999999874 679999999864321 1224588999999999999999999998765
Q ss_pred cceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEccccC
Q 038294 576 LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS---AKISDFGL 652 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~---~kl~DfGl 652 (799)
. .++||||+++++|.+++.....+++.....++.||+.||+|||+. +|+||||||+|||++.++. +||+|||+
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 4 899999999999999998888899999999999999999999998 9999999999999987654 99999999
Q ss_pred cccccCCCCcceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
++...... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ + ...+..
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~----~~~~~~ 234 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS---L----KDQITS 234 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC---H----HHHHHH
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH---H----HHHHHh
Confidence 98764321 122345899999999974 56789999999999999999999999975433211 1 111112
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+.... .........+.+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 GKYNF------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TCCCC------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred Ccccc------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 21110 00001123457888999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.62 Aligned_cols=251 Identities=12% Similarity=0.035 Sum_probs=178.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhccc--cccccccee-------eeeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRT--HHKNLVQLL-------GFCDE 574 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~-------g~~~~ 574 (799)
+.+.+.||+|+||.||+|.+.. +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVE-RLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECC-CCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 3456789999999999999874 68999999997633 23345677885544444 699988755 33322
Q ss_pred c-----------------cceeeEEeecCCCChhhhhhcC-CCCCHHHH------HHHHHHHHHHHHHHHhcCCCCeEec
Q 038294 575 A-----------------LNRLLVYEFMGNGTLANLIFAI-PKPDWNLR------VRISLEIARGLVYLHEECNVPIIHC 630 (799)
Q Consensus 575 ~-----------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~------~~i~~~ia~gL~yLH~~~~~~iiH~ 630 (799)
. ...++||||++ |+|.+++... ..+++..+ ..++.||++||+|||+. +|+||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHr 218 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHG 218 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccC
Confidence 2 33789999999 8999999863 34455556 78889999999999998 99999
Q ss_pred CCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCCc
Q 038294 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 631 dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
||||+||||+.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||+||||++|+.||.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999986532 1113456799999999987 689999999999999999999999998
Q ss_pred hhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 709 MEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 709 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.......... ......................+.+.+++.+||+.||++|||+.|+++
T Consensus 295 ~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 295 LVTPGIKGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp BCCTTCTTCC---------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CcCcccccch---------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 6533211100 000000000001111111233467888999999999999999999874
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-36 Score=325.82 Aligned_cols=253 Identities=21% Similarity=0.338 Sum_probs=200.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhh-----------------HHHHHHHHHHhccccccccccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER-----------------EREFKSEVSAIGRTHHKNLVQLL 569 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l~ 569 (799)
+.+.+.||+|+||.||+|.. +++.||||++....... .+.+.+|+.++++++||||++++
T Consensus 33 y~~~~~lg~G~~g~V~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 109 (348)
T 2pml_X 33 YRIIRTLNQGKFNKIILCEK---DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE 109 (348)
T ss_dssp EEEEEEEECCSSCCEEEEEE---TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred eEEEEEEcCCCCeEEEEEEc---CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence 44567899999999999998 58999999986532211 17899999999999999999999
Q ss_pred eeeecccceeeEEeecCCCChhhh------hhc--CCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecCCCCCCeEEc
Q 038294 570 GFCDEALNRLLVYEFMGNGTLANL------IFA--IPKPDWNLRVRISLEIARGLVYLHE-ECNVPIIHCDIKPQNILLD 640 (799)
Q Consensus 570 g~~~~~~~~~lv~e~~~~gsL~~~------l~~--~~~~~~~~~~~i~~~ia~gL~yLH~-~~~~~iiH~dlk~~NILl~ 640 (799)
+++.+....++||||+++++|.++ +.. ...+++..+..++.||+.||+|||+ . +|+|+||||+||+++
T Consensus 110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMD 186 (348)
T ss_dssp EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEEC
T ss_pred EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEc
Confidence 999999999999999999999999 665 4678999999999999999999998 7 999999999999999
Q ss_pred CCCceEEccccCcccccCCCCcceeeeccCCcccccccccCC-CCCc-chhHHHHHHHHHHHHhCCcCCchhhhhhcchh
Q 038294 641 NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSA-KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718 (799)
Q Consensus 641 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~-k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~ 718 (799)
.++.+||+|||++...... ......+++.|+|||.+.+. .++. ++||||||+++|||++|+.||.......
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---- 259 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---- 259 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH----
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH----
Confidence 9999999999999876433 23345689999999999887 6666 9999999999999999999997654311
Q ss_pred HHHHHHHHHhcCceeEeecCC------C---CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 719 LTDWAYDCYAEGRLDVLVDSD------E---PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~------~---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. ....+..+......+.. . ...........+.+++.+||+.||++|||+.|+++
T Consensus 260 --~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 260 --E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp --H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11222222211110000 0 00001233457888999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=331.89 Aligned_cols=197 Identities=26% Similarity=0.309 Sum_probs=169.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc------ccccccceeeeeecccceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT------HHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~g~~~~~~~~~l 580 (799)
+.+.+.||+|+||.||+|.... +++.||||+++.. ....+++.+|+++++.+ +|+||+++++++......++
T Consensus 99 y~~~~~LG~G~fg~V~~a~~~~-~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~l 176 (429)
T 3kvw_A 99 YEVLKVIGKGSFGQVVKAYDHK-VHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICM 176 (429)
T ss_dssp EEEEEEEEESSSEEEEEEEETT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEE
T ss_pred EEEEEEcccCccEEEEEEEECC-CCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEE
Confidence 4566889999999999999874 6899999999753 23345677777777766 57799999999999999999
Q ss_pred EEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc--eEEccccCcccc
Q 038294 581 VYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS--AKISDFGLSKLL 656 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~--~kl~DfGla~~~ 656 (799)
||||+. ++|.+++.... .+++..+.+++.||+.||+|||+. +|+||||||+||||+.++. +||+|||++...
T Consensus 177 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 177 TFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 999996 69999987653 589999999999999999999998 9999999999999999887 999999999764
Q ss_pred cCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhh
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEE 713 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~ 713 (799)
... .....||+.|+|||++.+..++.++|||||||+||||++|+.||......
T Consensus 253 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 253 HQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp TCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 322 22346899999999999999999999999999999999999999766443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-36 Score=323.93 Aligned_cols=257 Identities=19% Similarity=0.276 Sum_probs=196.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeec--ccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDE--ALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|.... +++.||||+++.. ..+.+.+|++++++++ ||||+++++++.+ ....++|||
T Consensus 38 y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 38 YQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred eEEEEEecccCCeEEEEEEECC-CCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 4456889999999999999864 6789999999743 3467899999999997 9999999999987 566789999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~~ 662 (799)
|+++++|.+++.. +++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 114 ~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~- 186 (330)
T 3nsz_A 114 HVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE- 186 (330)
T ss_dssp CCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC-
T ss_pred ccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc-
Confidence 9999999998854 78889999999999999999998 999999999999999766 899999999987643322
Q ss_pred ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHH-----HHHHHHhcCce---
Q 038294 663 THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTD-----WAYDCYAEGRL--- 732 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~-----~~~~~~~~~~~--- 732 (799)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+.. .....+.....
T Consensus 187 -~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 187 -YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp -CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred -cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 233458899999999977 67899999999999999999999999543221110 00000 00011111000
Q ss_pred -----------eEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 733 -----------DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 733 -----------~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...................+.+++.+||+.||++|||++|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000111111224567889999999999999999999986
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-36 Score=327.62 Aligned_cols=260 Identities=25% Similarity=0.292 Sum_probs=180.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecc------cce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~ 578 (799)
+.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+++++.++||||+++++++... ...
T Consensus 31 y~~~~~lG~G~~g~V~~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~ 109 (367)
T 2fst_X 31 YQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 109 (367)
T ss_dssp EEEEEECC----CCEEEEEETT-TTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred eEEeeEEeecCCeEEEEEEECC-CCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeE
Confidence 3456789999999999999764 6899999999653 233456788999999999999999999998654 456
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++|+|++ +++|.+++.. ..+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 110 YLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp EEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred EEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 8999998 6899998865 5789999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHh---cC
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYA---EG 730 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~---~~ 730 (799)
. .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..... ..+. ..
T Consensus 185 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 260 (367)
T 2fst_X 185 E----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260 (367)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred c----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence 2 233468999999999877 6789999999999999999999999976543322111111000 0000 00
Q ss_pred ceeEeecC--CCCCc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 731 RLDVLVDS--DEPAM----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 731 ~~~~~~d~--~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.....+.. ..+.. ........+.+++.+||+.||++|||+.|+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 00000000 00000 001123567889999999999999999999863
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.34 Aligned_cols=248 Identities=29% Similarity=0.389 Sum_probs=190.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeec------------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------------ 574 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------------ 574 (799)
+.+.+.||+|+||.||+|.... +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 8 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (303)
T 1zy4_A 8 FEEIAVLGQGAFGQVVKARNAL-DSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVK 85 (303)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------
T ss_pred chhhheeccCCcEEEEEEEEcC-CCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccc
Confidence 4556889999999999999864 6789999999653 3445789999999999999999999998754
Q ss_pred -ccceeeEEeecCCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccC
Q 038294 575 -ALNRLLVYEFMGNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652 (799)
Q Consensus 575 -~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGl 652 (799)
....++||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 456789999999999999998643 567889999999999999999998 999999999999999999999999999
Q ss_pred cccccCCC-------------CcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchh
Q 038294 653 SKLLLSDQ-------------SRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718 (799)
Q Consensus 653 a~~~~~~~-------------~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~ 718 (799)
+....... ........|++.|+|||.+.+. .++.++||||||+++|||++ |+.......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~---- 235 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV---- 235 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH----
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH----
Confidence 98764321 1122334589999999999865 78999999999999999998 544321111
Q ss_pred HHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. ....+.... ...+..........+.+++.+||+.||++|||+.|+++
T Consensus 236 --~-~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 --N-ILKKLRSVS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --H-HHHHHHSTT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --H-HHHhccccc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 1 111122211 11122223344456788999999999999999999986
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=321.18 Aligned_cols=261 Identities=22% Similarity=0.307 Sum_probs=201.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc------ccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN------LVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~~ 579 (799)
.+.+.+.||+|+||.||+|.....+++.||||+++.. ....+.+.+|+++++.++|++ ++++++++......+
T Consensus 15 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~ 93 (339)
T 1z57_A 15 RYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHIC 93 (339)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEE
T ss_pred ceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEE
Confidence 4556788999999999999985557899999999753 234567889999999988765 999999999999999
Q ss_pred eEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC----------------
Q 038294 580 LVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---------------- 641 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---------------- 641 (799)
+||||+ +++|.+++.... .+++..+.+++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 94 IVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred EEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999 889999998764 678999999999999999999998 9999999999999987
Q ss_pred ---CCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchh
Q 038294 642 ---YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718 (799)
Q Consensus 642 ---~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~ 718 (799)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+....
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 245 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAM 245 (339)
T ss_dssp EESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHH
T ss_pred cccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 678999999999864322 2234589999999999999999999999999999999999999976543332111
Q ss_pred HHHHH-------HHHHhcCceeE--ee--cC---------------CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038294 719 LTDWA-------YDCYAEGRLDV--LV--DS---------------DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKV 772 (799)
Q Consensus 719 ~~~~~-------~~~~~~~~~~~--~~--d~---------------~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 772 (799)
+.... ........... .. .. ...........+.+.+++.+||+.||++|||+.|
T Consensus 246 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e 325 (339)
T 1z57_A 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLRE 325 (339)
T ss_dssp HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHH
T ss_pred HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHH
Confidence 11100 00000000000 00 00 0001112345678899999999999999999999
Q ss_pred HHH
Q 038294 773 VLQ 775 (799)
Q Consensus 773 vl~ 775 (799)
+++
T Consensus 326 ll~ 328 (339)
T 1z57_A 326 ALK 328 (339)
T ss_dssp HTT
T ss_pred Hhc
Confidence 975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-36 Score=322.15 Aligned_cols=246 Identities=28% Similarity=0.416 Sum_probs=191.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeec------ccceee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE------ALNRLL 580 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~------~~~~~l 580 (799)
.+.+.||+|+||.||+|.... +++.||||++.... ...+.+.+|+.+++++ +||||+++++++.. ....++
T Consensus 27 ~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~l 104 (326)
T 2x7f_A 27 ELVELVGNGTYGQVYKGRHVK-TGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 104 (326)
T ss_dssp EEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEE
T ss_pred EEEEEeccCCCEEEEEEEECC-CCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEE
Confidence 456789999999999999864 67899999986432 3456789999999998 89999999999976 457899
Q ss_pred EEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 581 VYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
||||+++++|.+++... ..+++..+..++.||+.||+|||+. +|+|+||||+|||++.++.+||+|||++.....
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 105 VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC----
T ss_pred EEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCc
Confidence 99999999999999865 4688999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCcceeeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
... ......|++.|+|||.+. +..++.++||||||+++|||++|+.||........ ... +.....
T Consensus 182 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~-~~~~~~- 251 (326)
T 2x7f_A 182 TVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFL-IPRNPA- 251 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHH-HHHSCC-
T ss_pred Ccc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHH-hhcCcc-
Confidence 221 122345899999999987 56789999999999999999999999975432211 111 111111
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+..........+.+++.+||+.||++|||+.++++
T Consensus 252 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 252 -------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11111223457888999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.49 Aligned_cols=260 Identities=23% Similarity=0.243 Sum_probs=189.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc------ce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 578 (799)
+.+.+.||+|+||.||+|.... +++.||||++... .....+.+.+|+.+++.++||||+++++++.... ..
T Consensus 27 y~~~~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 105 (371)
T 2xrw_A 27 YQNLKPIGSGAQGIVCAAYDAI-LERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDV 105 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEE
T ss_pred eeEeeeeEecCCEEEEEEEECC-CCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccce
Confidence 3456789999999999999864 6889999998642 2334567889999999999999999999997654 67
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+++ +|.+.+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 106 ~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 106 YIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred EEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 999999975 7888875 3588999999999999999999998 999999999999999999999999999986533
Q ss_pred CCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHH---------------HHH
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT---------------DWA 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~---------------~~~ 723 (799)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+. ...
T Consensus 180 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 257 (371)
T 2xrw_A 180 SF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257 (371)
T ss_dssp ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred cc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence 21 2233568999999999999999999999999999999999999997654322110000 000
Q ss_pred HHHHhcCc-e-----eEeecC---CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 724 YDCYAEGR-L-----DVLVDS---DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 724 ~~~~~~~~-~-----~~~~d~---~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........ . ...... .............+.+++.+||+.||++|||++|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 00000000 0 000000 0000011233567889999999999999999999986
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-36 Score=332.25 Aligned_cols=258 Identities=22% Similarity=0.258 Sum_probs=190.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc-----------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA----------- 575 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~----------- 575 (799)
+.+.+.||+|+||.||+|.... +++.||||++..... ...+|+++++.++||||+++++++...
T Consensus 9 y~~~~~lG~G~fg~V~~a~~~~-~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~ 83 (383)
T 3eb0_A 9 YSLGKTLGTGSFGIVCEVFDIE-SGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPP 83 (383)
T ss_dssp EEEEEEEECC-CEEEEEEEETT-TCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----------
T ss_pred EEEEEEEEeccCEEEEEEEECC-CCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccccccc
Confidence 4556889999999999999864 689999999864322 234699999999999999999998432
Q ss_pred ---------------------------cceeeEEeecCCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 038294 576 ---------------------------LNRLLVYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEECN 624 (799)
Q Consensus 576 ---------------------------~~~~lv~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~ 624 (799)
...++||||++ ++|.+.+. ....+++..+..++.||++||+|||+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-- 160 (383)
T 3eb0_A 84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-- 160 (383)
T ss_dssp --------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT--
T ss_pred cccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence 33779999998 47776665 346789999999999999999999998
Q ss_pred CCeEecCCCCCCeEEc-CCCceEEccccCcccccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHh
Q 038294 625 VPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIIC 702 (799)
Q Consensus 625 ~~iiH~dlk~~NILl~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~ellt 702 (799)
+|+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||+||++|||++
T Consensus 161 -gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 237 (383)
T 3eb0_A 161 -GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237 (383)
T ss_dssp -TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred -cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence 999999999999998 688999999999987644332 2234579999999998775 58999999999999999999
Q ss_pred CCcCCchhhhhhcchhHHHHHH-----HHH-hcCceeEee-----cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038294 703 CRRSVEMEVEEEGRAILTDWAY-----DCY-AEGRLDVLV-----DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771 (799)
Q Consensus 703 g~~p~~~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~~-----d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 771 (799)
|+.||......+....+..... ... ......... ...............+.+++.+||+.||++|||+.
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (383)
T 3eb0_A 238 GKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPY 317 (383)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHH
Confidence 9999986544332111111000 000 000000000 00000011222345688999999999999999999
Q ss_pred HHHH
Q 038294 772 VVLQ 775 (799)
Q Consensus 772 evl~ 775 (799)
|+++
T Consensus 318 e~l~ 321 (383)
T 3eb0_A 318 EAMA 321 (383)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 9984
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=313.38 Aligned_cols=252 Identities=26% Similarity=0.337 Sum_probs=203.1
Q ss_pred HHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 503 KEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 503 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
....+.+.+.||+|+||.||+|..+. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~-~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRI-TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcC-CCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 33455677899999999999999864 67899999986432 2345688999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC---CceEEccccCccccc
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY---FSAKISDFGLSKLLL 657 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~---~~~kl~DfGla~~~~ 657 (799)
|+||+++++|.+.+.....+++..+.+++.||+.||+|||+. +|+|+||||+||+++.+ +.+||+|||++....
T Consensus 99 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 999999999999998777899999999999999999999998 99999999999999754 479999999998764
Q ss_pred CCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 658 SDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 658 ~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.... .....+++.|+|||.+.+. ++.++||||||+++|||++|+.||......+ ....+..+....
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~--- 241 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD--------ILKRVETGKYAF--- 241 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCCCC---
T ss_pred CCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCCCC---
Confidence 3322 2223478899999998764 8999999999999999999999997654322 112222222110
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+ ........+.+++.+||+.||++|||+.|+++
T Consensus 242 -~~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 -DLP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -CSG--GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -Cch--hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 000 01123456888999999999999999999987
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.11 Aligned_cols=263 Identities=22% Similarity=0.240 Sum_probs=199.0
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc--------cccccceeeeee--
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH--------HKNLVQLLGFCD-- 573 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~g~~~-- 573 (799)
...+.+.+.||+|+||+||+|.... +++.||||+++.. ....+.+.+|++++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQ-GKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecC-CCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 3445667889999999999998864 6899999999753 334567889999999886 788999999987
Q ss_pred --cccceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC------
Q 038294 574 --EALNRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF------ 643 (799)
Q Consensus 574 --~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~------ 643 (799)
.....++||||+ +++|.+.+... ..+++..+..++.||+.||+|||+++ +|+||||||+||||+.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 566789999999 55666665543 46899999999999999999999853 799999999999999775
Q ss_pred -------------------------------------------ceEEccccCcccccCCCCcceeeeccCCccccccccc
Q 038294 644 -------------------------------------------SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680 (799)
Q Consensus 644 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 680 (799)
.+||+|||++...... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999876432 22345899999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHH--HHHHHHH--------hcCc-----------eeEeecCC
Q 038294 681 NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT--DWAYDCY--------AEGR-----------LDVLVDSD 739 (799)
Q Consensus 681 ~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~--~~~~~~~--------~~~~-----------~~~~~d~~ 739 (799)
+..++.++|||||||+||||++|+.||......+...... ....... ..+. ...+.+..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 9999999999999999999999999997543222110000 0011100 0000 00000000
Q ss_pred C---------CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 E---------PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. ...........+.+++.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 00124566778899999999999999999999985
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-35 Score=320.79 Aligned_cols=263 Identities=22% Similarity=0.263 Sum_probs=197.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc-----cceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 580 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|++++.+++||||+++++++... ...++
T Consensus 29 y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~i 107 (364)
T 3qyz_A 29 YTNLSYIGEGAYGMVCSAYDNL-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107 (364)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred EEEEEEeecCCCeEEEEEEECC-CCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEE
Confidence 4456889999999999999864 68899999997533 33346789999999999999999999998654 35789
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|+||+. ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 108 v~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 108 VQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 999997 599998865 4688999999999999999999998 99999999999999999999999999998764332
Q ss_pred Cc--ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcC---
Q 038294 661 SR--THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEG--- 730 (799)
Q Consensus 661 ~~--~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~--- 730 (799)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+..... ..+...
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 262 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence 21 1233468999999998754 4589999999999999999999999976543332111110000 000000
Q ss_pred c----eeEeecCCCC--CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 R----LDVLVDSDEP--AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~----~~~~~d~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. .......... ..........+.+++.+||+.||++|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000000000 0001122356789999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-36 Score=334.44 Aligned_cols=258 Identities=24% Similarity=0.261 Sum_probs=189.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc------cceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 580 (799)
+.+.+.||+|+||.||+|.++. +++.||||++.... +.+.+|++++++++||||+++++++... ...++
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~-~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~l 130 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECC-CCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEe
Confidence 3456789999999999999874 67899999986432 2234699999999999999999998432 23568
Q ss_pred EEeecCCCChhhhhh----cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-CceEEccccCccc
Q 038294 581 VYEFMGNGTLANLIF----AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-FSAKISDFGLSKL 655 (799)
Q Consensus 581 v~e~~~~gsL~~~l~----~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-~~~kl~DfGla~~ 655 (799)
||||+++ +|.+.+. ....+++..+..++.||++||+|||+. +|+||||||+||||+.+ +.+||+|||+++.
T Consensus 131 v~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 131 VLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred ehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 9999986 6655554 346789999999999999999999998 99999999999999955 6789999999987
Q ss_pred ccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH----HHHHh--
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA----YDCYA-- 728 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~----~~~~~-- 728 (799)
...... .....+|+.|+|||++.+. .++.++|||||||+||||++|+.||......+....+.... .+.+.
T Consensus 207 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~ 284 (420)
T 1j1b_A 207 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 284 (420)
T ss_dssp CCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred cccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 643322 2234689999999999765 79999999999999999999999998654332211111100 00000
Q ss_pred cCceeEeecCCCCC-----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 729 EGRLDVLVDSDEPA-----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 729 ~~~~~~~~d~~~~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+.... .........+.+|+.+||+.||++|||+.|+++
T Consensus 285 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 285 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00111100011000 011123457889999999999999999999985
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.47 Aligned_cols=262 Identities=20% Similarity=0.260 Sum_probs=190.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee-------------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD------------- 573 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~------------- 573 (799)
+.+.+.||+|+||.||+|..+. +++.||+|++........+++.+|++++++++||||+++++++.
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 91 (320)
T 2i6l_A 13 YMDLKPLGCGGNGLVFSAVDND-CDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91 (320)
T ss_dssp EEEEEECC-----CEEEEEETT-TTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----C
T ss_pred eeEEEEeccCCCeEEEEEEECC-CCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccc
Confidence 3456789999999999999874 68999999997666666778999999999999999999999873
Q ss_pred -cccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEcccc
Q 038294 574 -EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFG 651 (799)
Q Consensus 574 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-~~~~~kl~DfG 651 (799)
+....++||||++ |+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||
T Consensus 92 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 92 TELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp CSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred cccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 3456789999998 699999865 5688999999999999999999998 999999999999997 57799999999
Q ss_pred CcccccCCCC--cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH------
Q 038294 652 LSKLLLSDQS--RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW------ 722 (799)
Q Consensus 652 la~~~~~~~~--~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~------ 722 (799)
+++....... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+...
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 9987643221 11223457889999998865 67899999999999999999999999765432211111000
Q ss_pred -HHHHHhcCceeEe-----ecCCC-CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 723 -AYDCYAEGRLDVL-----VDSDE-PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 723 -~~~~~~~~~~~~~-----~d~~~-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+.... .+... ..+.. ...........+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 247 EDRQELLS-VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHHHT-TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhh-cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000 00000 00000 00001123457889999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=333.80 Aligned_cols=196 Identities=23% Similarity=0.351 Sum_probs=153.0
Q ss_pred hhhcCccccceEEEEEEeC-CCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeee--cccceeeEEeecC
Q 038294 510 KEELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCD--EALNRLLVYEFMG 586 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~--~~~~~~lv~e~~~ 586 (799)
.++||+|+||+||+|..++ .+++.||||++... .....+.+|+.++++++||||+++++++. .....++||||++
T Consensus 26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~ 103 (405)
T 3rgf_A 26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103 (405)
T ss_dssp SCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS
T ss_pred CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC
Confidence 3579999999999999763 25789999999753 22356889999999999999999999994 4667899999997
Q ss_pred CCChhhhhhcC---------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE----cCCCceEEccccCc
Q 038294 587 NGTLANLIFAI---------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL----DNYFSAKISDFGLS 653 (799)
Q Consensus 587 ~gsL~~~l~~~---------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl----~~~~~~kl~DfGla 653 (799)
+ +|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||| +.++.+||+|||++
T Consensus 104 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 179 (405)
T 3rgf_A 104 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 179 (405)
T ss_dssp E-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCC
T ss_pred C-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCc
Confidence 4 887777532 2488999999999999999999998 89999999999999 77899999999999
Q ss_pred ccccCCCC--cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhh
Q 038294 654 KLLLSDQS--RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEV 711 (799)
Q Consensus 654 ~~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~ 711 (799)
+....... .......||+.|+|||++.+. .++.++|||||||+||||++|+.||....
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 180 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp C----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred eecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 87643321 222345689999999999874 58999999999999999999999997543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-36 Score=321.24 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=196.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhccc---ccccccceeeeee-----ccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCD-----EAL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~-----~~~ 576 (799)
+.+.+.||+|+||.||+|.....+++.||+|+++.... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 92 (326)
T 1blx_A 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 92 (326)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred eeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCc
Confidence 34567899999999999998645689999999864322 1223566777776665 8999999999987 566
Q ss_pred ceeeEEeecCCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
..++|+||++ |+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 93 KLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp EEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred eEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 7889999998 69999998653 489999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeE
Q 038294 655 LLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734 (799)
Q Consensus 655 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 734 (799)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++|+.||......+....+ . ..........
T Consensus 169 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i---~-~~~~~~~~~~ 242 (326)
T 1blx_A 169 IYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---L-DVIGLPGEED 242 (326)
T ss_dssp CCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H-HHHCCCCGGG
T ss_pred cccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H-HHcCCCCccc
Confidence 654222 223346899999999999999999999999999999999999999865433211111 1 1100000000
Q ss_pred ----------ee---cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 735 ----------LV---DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 735 ----------~~---d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. .............+.+.+++.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000001111233456788999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.78 Aligned_cols=259 Identities=22% Similarity=0.257 Sum_probs=193.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccce------
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNR------ 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~------ 578 (799)
+.+.+.||+|+||.||+|..+. +++.||||++... .....+.+.+|+.++++++||||+++++++......
T Consensus 44 y~~~~~lG~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 122 (371)
T 4exu_A 44 YVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 122 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCC
T ss_pred EEEEeEEecCCCeEEEEEEECC-CCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeE
Confidence 3456789999999999999874 6899999999653 233356789999999999999999999999877655
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 123 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 123 YLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp EEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred EEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 89999997 588887743 488999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhc---C
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAE---G 730 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~---~ 730 (799)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+..... ..... .
T Consensus 197 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 272 (371)
T 4exu_A 197 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 272 (371)
T ss_dssp -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred C----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence 2 223457999999999987 7899999999999999999999999976543221111100000 00000 0
Q ss_pred ----ceeEeecCCCC--CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 731 ----RLDVLVDSDEP--AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 731 ----~~~~~~d~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....+...... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00000000000 00011234678899999999999999999999864
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-35 Score=316.70 Aligned_cols=249 Identities=18% Similarity=0.294 Sum_probs=192.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccc--cccccceeeeeecccceeeE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv 581 (799)
.+.+.+.||+|+||.||++..+ +++.||||++... .....+.+.+|++++.+++ |+||+++++++......++|
T Consensus 29 ~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 29 IYSILKQIGSGGSSKVFQVLNE--KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEECCSSEEEEEEECT--TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecCCCCEEEEEEEcC--CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 3455688999999999999875 4789999998542 3345578899999999997 59999999999999999999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|| +.+++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||+++ +.+||+|||+++.......
T Consensus 107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~ 181 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTT 181 (313)
T ss_dssp EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC------
T ss_pred Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccc
Confidence 99 56889999999888899999999999999999999998 9999999999999975 7999999999987644322
Q ss_pred c-ceeeeccCCcccccccccC-----------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhc
Q 038294 662 R-THTMIRGTRGYVAPEWFKN-----------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAE 729 (799)
Q Consensus 662 ~-~~~~~~gt~~y~aPE~l~~-----------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 729 (799)
. ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .........
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~~~~~~ 255 (313)
T 3cek_A 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------SKLHAIIDP 255 (313)
T ss_dssp --------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHCT
T ss_pred cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------HHHHHHHhc
Confidence 1 1223458999999999875 468889999999999999999999997542211 111111111
Q ss_pred CceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 730 GRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 730 ~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.. . ...+. ...+.+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~-~----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 256 NH-E----IEFPD----IPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TS-C----CCCCC----CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cc-c----cCCcc----cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11 0 01111 113567889999999999999999999863
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=324.55 Aligned_cols=271 Identities=22% Similarity=0.289 Sum_probs=201.0
Q ss_pred HHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-----------cccccceeeee
Q 038294 504 EATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----------HKNLVQLLGFC 572 (799)
Q Consensus 504 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~ 572 (799)
...+.+.+.||+|+||.||+|.... +++.||||++... ....+.+.+|++++++++ |+||+++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC-CCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 3455677899999999999999864 6899999999753 234567888999998876 89999999999
Q ss_pred eccc----ceeeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc------
Q 038294 573 DEAL----NRLLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD------ 640 (799)
Q Consensus 573 ~~~~----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~------ 640 (799)
.... ..++||||+ +++|.+++... ..+++..+.+++.||+.||+|||+++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCc
Confidence 7654 678999999 88999999864 45899999999999999999999852 799999999999994
Q ss_pred CCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc---h
Q 038294 641 NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR---A 717 (799)
Q Consensus 641 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~---~ 717 (799)
..+.+||+|||++...... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .
T Consensus 173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 248 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 248 (373)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence 4458999999999876432 22345899999999999999999999999999999999999999755322111 0
Q ss_pred hHHHHHHHHHh--------cCc-----------eeEeecCCC---------CCccCHHHHHHHHHHHHHhcccCCCCCCC
Q 038294 718 ILTDWAYDCYA--------EGR-----------LDVLVDSDE---------PAMADRSRLQKWLMIAMWCIREDPSKRPT 769 (799)
Q Consensus 718 ~~~~~~~~~~~--------~~~-----------~~~~~d~~~---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt 769 (799)
.+.... .... .++ ...+..... ....+....+.+.+++.+||+.||++|||
T Consensus 249 ~~~~~~-~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 249 HIAQII-ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHH-HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHH-HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 110100 0000 000 000000000 01123566778899999999999999999
Q ss_pred HHHHHH--HHhcCcCCC
Q 038294 770 MKVVLQ--MLEGLLEVP 784 (799)
Q Consensus 770 ~~evl~--~L~~~~~~~ 784 (799)
+.|+++ .+.+.....
T Consensus 328 ~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 328 AGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHHTCGGGTTCTTCT
T ss_pred HHHHhhChhhhcccCcc
Confidence 999997 455554433
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=323.15 Aligned_cols=264 Identities=22% Similarity=0.283 Sum_probs=197.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecc-----cceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~l 580 (799)
+.+.+.||+|+||.||+|.... +++.||||++.... ......+.+|++++++++||||+++++++... ...++
T Consensus 13 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~l 91 (353)
T 2b9h_A 13 FQLKSLLGEGAYGVVCSATHKP-TGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEE
T ss_pred eEEeeEEcCCCCeEEEEEEECC-CCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEE
Confidence 3456789999999999999864 68999999996433 33446788999999999999999999988654 56799
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|+||+. ++|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 92 v~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 92 IQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 999997 589998876 4688999999999999999999998 99999999999999999999999999998764322
Q ss_pred Cc---------ceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 661 SR---------THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 661 ~~---------~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
.. ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........+. ......
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~~ 242 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF----GIIGTP 242 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HHHCCC
T ss_pred ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH----HHhCCC
Confidence 11 1122458999999998764 678999999999999999999999997654322111110 000000
Q ss_pred ce------------eEeec--CCCC----CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcC
Q 038294 731 RL------------DVLVD--SDEP----AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGL 780 (799)
Q Consensus 731 ~~------------~~~~d--~~~~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~ 780 (799)
.. ..... +..+ ..........+.+++.+||+.||++|||+.|+++ .++..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (353)
T 2b9h_A 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTY 312 (353)
T ss_dssp CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 00000 0000 0001123456788999999999999999999987 44443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=321.64 Aligned_cols=263 Identities=21% Similarity=0.208 Sum_probs=183.1
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccc-------e
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-------R 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-------~ 578 (799)
.+.+.+.||+|+||.||+|..+. +++.||||++.... .....+.+|++.+..++||||+++++++..... .
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 24 RFQVERMAGQGTFGTVQLGKEKS-TGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp TEEEC----------CEEEEETT-TCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 34456889999999999999874 67899999985432 223456778888888999999999999965433 6
Q ss_pred eeEEeecCCCChhhhh----hcCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEecCCCCCCeEEcC-CCceEEcccc
Q 038294 579 LLVYEFMGNGTLANLI----FAIPKPDWNLRVRISLEIARGLVYLH--EECNVPIIHCDIKPQNILLDN-YFSAKISDFG 651 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l----~~~~~~~~~~~~~i~~~ia~gL~yLH--~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfG 651 (799)
++||||++++ |.+.+ .....+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg 177 (360)
T 3e3p_A 102 NVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFG 177 (360)
T ss_dssp EEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred EEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence 8999999874 44333 34567889999999999999999999 66 9999999999999996 8999999999
Q ss_pred CcccccCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------H
Q 038294 652 LSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------A 723 (799)
Q Consensus 652 la~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~ 723 (799)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+... .
T Consensus 178 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 255 (360)
T 3e3p_A 178 SAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255 (360)
T ss_dssp TCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHH
Confidence 9987654332 2234589999999998665 4899999999999999999999999865443221111110 0
Q ss_pred HHHHhcCcee-EeecCC-C-----CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 YDCYAEGRLD-VLVDSD-E-----PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ~~~~~~~~~~-~~~d~~-~-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...+...... ...+.. . ...........+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0000000000 000000 0 000111245678899999999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.77 Aligned_cols=199 Identities=26% Similarity=0.343 Sum_probs=167.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cc-----cccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HK-----NLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~g~~~~~~~~~ 579 (799)
.+.+.+.||+|+||+||+|..+. +++.||||+++.. ....+++..|+.+++.++ |+ +++++++++......+
T Consensus 55 ~y~~~~~lG~G~~g~V~~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~ 132 (382)
T 2vx3_A 55 RYEIDSLIGKGSFGQVVKAYDRV-EQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132 (382)
T ss_dssp TEEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEE
T ss_pred eEEEEEEEeecCCEEEEEEEEcC-CCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceE
Confidence 34556889999999999999874 6789999999753 233456778888888774 44 4999999999999999
Q ss_pred eEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEccccCccc
Q 038294 580 LVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD--NYFSAKISDFGLSKL 655 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~--~~~~~kl~DfGla~~ 655 (799)
+||||++ ++|.+++... ..+++..+..++.||+.||.|||.+ ..+|+||||||+|||++ .++.+||+|||+++.
T Consensus 133 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~ 210 (382)
T 2vx3_A 133 LVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ 210 (382)
T ss_dssp EEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCcee
Confidence 9999996 5999999865 4689999999999999999999952 23899999999999994 578899999999987
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhh
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVE 712 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~ 712 (799)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 211 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 211 LGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp TTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 6432 2234689999999999999999999999999999999999999986544
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=326.59 Aligned_cols=259 Identities=22% Similarity=0.233 Sum_probs=188.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch-----------hhHHHHHHHHHHhcccccccccceeeeeec--
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-----------EREREFKSEVSAIGRTHHKNLVQLLGFCDE-- 574 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-- 574 (799)
.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|++++++++||||+++++++..
T Consensus 25 ~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 102 (362)
T 3pg1_A 25 TVQRFISSGSYGAVCAGVDS--EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102 (362)
T ss_dssp EEEEEEEEETTEEEEEEECT--TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECC
T ss_pred EEeEEeccCCCEEEEEEECC--CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEecc
Confidence 34578999999999999875 488999999854221 123678999999999999999999999843
Q ss_pred ---ccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 575 ---ALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 575 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
....++||||++ |+|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+||
T Consensus 103 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 103 EPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp TTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCT
T ss_pred CCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEec
Confidence 335789999998 5888887754 4689999999999999999999998 9999999999999999999999999
Q ss_pred cCcccccCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH------
Q 038294 651 GLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA------ 723 (799)
Q Consensus 651 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~------ 723 (799)
|+++...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+....
T Consensus 179 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 256 (362)
T 3pg1_A 179 NLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIE 256 (362)
T ss_dssp TC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHH
T ss_pred Cccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChH
Confidence 9998543322 2233458899999999877 678999999999999999999999998654332111110000
Q ss_pred ----------HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 724 ----------YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 724 ----------~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
...... .... ................+.+++.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 257 DVVMFSSPSARDYLRN-SLSN-VPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHTSCHHHHHHTTT-CCCC-CCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HhhhccchhhhHHHHh-hccc-CChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 000000 0000 00000001112234568889999999999999999999863
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=327.82 Aligned_cols=259 Identities=22% Similarity=0.245 Sum_probs=189.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccc------eee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------RLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~~l 580 (799)
+.+.+.||+|+||+||+|.... +..+|+|++..... ...+|+++++.++||||+++++++..... .++
T Consensus 42 Y~~~~~lG~G~~g~V~~a~~~~--~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 42 YTNCKVIGNGSFGVVFQAKLVE--SDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEETTEEEEEEEETT--TEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred EEEeEEEeeCCCeEEEEEEECC--CCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 4566889999999999999863 44588888754322 22468999999999999999999954433 679
Q ss_pred EEeecCCCChhhhhh---cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEccccCcccc
Q 038294 581 VYEFMGNGTLANLIF---AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLL 656 (799)
Q Consensus 581 v~e~~~~gsL~~~l~---~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-~~~~~kl~DfGla~~~ 656 (799)
||||++++.+..... ....+++..+..++.||++||+|||+. +|+||||||+|||++ .++.+||+|||+++..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999998754433332 346789999999999999999999998 999999999999999 7999999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH-------HHHH-
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------YDCY- 727 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------~~~~- 727 (799)
..... .....+|+.|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.... ....
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 44332 2234579999999998765 58999999999999999999999998654332211111100 0000
Q ss_pred ---hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 728 ---AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 728 ---~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
.+......................+.+++.+||+.||++|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 0000000000000001111234578899999999999999999999863
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=318.25 Aligned_cols=254 Identities=21% Similarity=0.253 Sum_probs=172.3
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeec----ccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv~e~~~ 586 (799)
+.||+|+||.||+|..+. +++.||||++.... ...++ ....+..++||||+++++++.. ....++||||++
T Consensus 35 ~~lG~G~~g~V~~~~~~~-~~~~vavK~~~~~~-~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~ 109 (336)
T 3fhr_A 35 QVLGLGVNGKVLECFHRR-TGQKCALKLLYDSP-KARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECME 109 (336)
T ss_dssp EEEEEETTEEEEEEEETT-TCCEEEEEEEESSH-HHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCT
T ss_pred eeeeeCCCeEEEEEEECC-CCCEEEEEEecCcH-HHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccC
Confidence 469999999999999874 68899999986532 12222 2233456689999999999865 445789999999
Q ss_pred CCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCCC
Q 038294 587 NGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 587 ~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~~ 661 (799)
+|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 110 gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-- 184 (336)
T 3fhr_A 110 GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-- 184 (336)
T ss_dssp TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceecccc--
Confidence 999999998753 689999999999999999999998 9999999999999986 455999999999865422
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
......+|+.|+|||.+.+..++.++||||||+++|||++|+.||............ ......+. ...+
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~~------~~~~ 253 (336)
T 3fhr_A 185 -ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM----KRRIRLGQ------YGFP 253 (336)
T ss_dssp --------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------CCC
T ss_pred -ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH----HHhhhccc------cccC
Confidence 222345799999999999888999999999999999999999999755432211000 00001100 0111
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLLEVPN 785 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~ 785 (799)
..........+.+++.+||+.||++|||+.|+++ .+.+....+.
T Consensus 254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~ 299 (336)
T 3fhr_A 254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299 (336)
T ss_dssp TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCC
T ss_pred chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCC
Confidence 1111234457888999999999999999999997 5555444433
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=317.00 Aligned_cols=262 Identities=19% Similarity=0.269 Sum_probs=199.3
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc------ccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN------LVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~g~~~~~~~~ 578 (799)
..+.+.+.||+|+||.||+|.....+++.||+|+++.. ....+.+..|+.++++++|++ ++.+.+++......
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 97 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHM 97 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEE
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeE
Confidence 34556788999999999999987655589999999753 334567888999999998776 89999999999999
Q ss_pred eeEEeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE-----------------
Q 038294 579 LLVYEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL----------------- 639 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl----------------- 639 (799)
++||||+ +++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+|||+
T Consensus 98 ~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~ 173 (355)
T 2eu9_A 98 CIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEE 173 (355)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred EEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccc
Confidence 9999999 56777776654 3689999999999999999999998 99999999999999
Q ss_pred --cCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcch
Q 038294 640 --DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA 717 (799)
Q Consensus 640 --~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~ 717 (799)
+.++.+||+|||+++..... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......+...
T Consensus 174 ~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 249 (355)
T 2eu9_A 174 KSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLV 249 (355)
T ss_dssp EEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 66889999999999864332 223468999999999999999999999999999999999999998654332211
Q ss_pred hHHHHH-------HHHHhcCcee----EeecCC---------------CCCccCHHHHHHHHHHHHHhcccCCCCCCCHH
Q 038294 718 ILTDWA-------YDCYAEGRLD----VLVDSD---------------EPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771 (799)
Q Consensus 718 ~~~~~~-------~~~~~~~~~~----~~~d~~---------------~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~ 771 (799)
.+.... .......... ...+.. ............+.+++.+||+.||++|||+.
T Consensus 250 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ 329 (355)
T 2eu9_A 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329 (355)
T ss_dssp HHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHH
Confidence 111100 0000000000 000000 00011234456788999999999999999999
Q ss_pred HHHH
Q 038294 772 VVLQ 775 (799)
Q Consensus 772 evl~ 775 (799)
|+++
T Consensus 330 e~l~ 333 (355)
T 2eu9_A 330 EALL 333 (355)
T ss_dssp HHTT
T ss_pred HHhc
Confidence 9984
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-36 Score=321.06 Aligned_cols=238 Identities=25% Similarity=0.386 Sum_probs=196.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh------hHHHHHHHHHHhcccc--cccccceeeeeecccce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE------REREFKSEVSAIGRTH--HKNLVQLLGFCDEALNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 578 (799)
+.+.+.||+|+||.||+|.... +++.||||+++..... ..+.+..|+.++++++ |+||+++++++......
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~ 123 (320)
T 3a99_A 45 YQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 123 (320)
T ss_dssp EEEEEECSSSSSCEEEEEEETT-TTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred eEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcE
Confidence 4566889999999999999864 6899999998653221 2245678999999986 59999999999999999
Q ss_pred eeEEeecCC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEccccCcccc
Q 038294 579 LLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLL 656 (799)
Q Consensus 579 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-~~~~~kl~DfGla~~~ 656 (799)
++|+|++.+ ++|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++ +++.+||+|||+++..
T Consensus 124 ~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~ 200 (320)
T 3a99_A 124 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 200 (320)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCcccccc
Confidence 999999976 89999998888899999999999999999999998 999999999999999 7899999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....... .+..
T Consensus 201 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--------------~~~~--- 260 (320)
T 3a99_A 201 KDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII--------------RGQV--- 260 (320)
T ss_dssp CSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH--------------HCCC---
T ss_pred cccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh--------------cccc---
Confidence 4322 223458999999999987765 678999999999999999999997542110 0110
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+ ....+.+.+++.+||+.||++|||+.||++
T Consensus 261 ---~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 261 ---FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011 112356788999999999999999999987
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=317.81 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=191.6
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchh------hHHHHHHHHHHhccc----ccccccceeee
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE------REREFKSEVSAIGRT----HHKNLVQLLGF 571 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~g~ 571 (799)
.....+.+.+.||+|+||.||+|.... +++.||||+++..... ....+.+|+.++.++ +|+||++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT-DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT-TCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc-CCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 334456677899999999999998764 6789999999653221 223456788888888 89999999999
Q ss_pred eecccceeeEEee-cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEcc
Q 038294 572 CDEALNRLLVYEF-MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISD 649 (799)
Q Consensus 572 ~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-~~~~~kl~D 649 (799)
+......++|+|| +.+++|.+++.....+++..+.+++.||+.||+|||+. +|+||||||+||+++ +++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEE
Confidence 9999999999999 78999999998878899999999999999999999998 999999999999999 889999999
Q ss_pred ccCcccccCCCCcceeeeccCCcccccccccCCCCC-cchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh
Q 038294 650 FGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS-AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 650 fGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s-~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
||++....... .....|++.|+|||++.+..+. .++||||||+++|||++|+.||...... .
T Consensus 184 fg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------------~ 246 (312)
T 2iwi_A 184 FGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------------L 246 (312)
T ss_dssp CSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------H
T ss_pred cchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------------h
Confidence 99998764332 2334589999999999877664 5899999999999999999999753210 0
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.... .. .......+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~~------~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 247 EAEL------HF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HTCC------CC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhcc------CC----cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000 01 1123356788999999999999999999997
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=316.17 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=175.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHH-HhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVS-AIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.||||+++... .....++..|+. +++.++||||+++++++......++||||+
T Consensus 25 ~~~~~lg~G~~g~Vy~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~ 103 (327)
T 3aln_A 25 KDLGEIGRGAYGSVNKMVHKP-SGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM 103 (327)
T ss_dssp EC-CEEEECSSEEEEEEEETT-TTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred hehheeccCCCEEEEEEEEcC-CCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeec
Confidence 345789999999999999864 68999999996532 233445566665 777889999999999999999999999999
Q ss_pred CCCChhhhhhc-----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 586 GNGTLANLIFA-----IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 586 ~~gsL~~~l~~-----~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
++ +|.+++.. ...+++..+.+++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++......
T Consensus 104 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~ 180 (327)
T 3aln_A 104 ST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI 180 (327)
T ss_dssp SE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----
T ss_pred CC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc
Confidence 85 88877763 46788999999999999999999985 279999999999999999999999999998764332
Q ss_pred CcceeeeccCCcccccccc----cCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 661 SRTHTMIRGTRGYVAPEWF----KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l----~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
. .....||+.|+|||.+ .+..++.++||||||+++|||++|+.||......... .. ....+.
T Consensus 181 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~-~~~~~~----- 246 (327)
T 3aln_A 181 A--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ------LT-QVVKGD----- 246 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------C-CCCCSC-----
T ss_pred c--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH------HH-HHhcCC-----
Confidence 1 2233589999999998 4667899999999999999999999999753211000 00 000010
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+..+..........+.+++.+||+.||++|||+.||++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 011111111233457889999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-35 Score=326.85 Aligned_cols=244 Identities=27% Similarity=0.327 Sum_probs=184.0
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeecCCC
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
.+.||+|+||+||.+... +++.||||++... ..+.+.+|++++.++ +||||+++++++.+....++||||+. |
T Consensus 20 ~~~LG~G~~g~V~~~~~~--~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-g 93 (434)
T 2rio_A 20 EKILGYGSSGTVVFQGSF--QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-L 93 (434)
T ss_dssp EEEEEECSTTCEEEEEES--SSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-E
T ss_pred cCeEeeCCCeEEEEEEEE--CCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-C
Confidence 467999999999865443 5889999998643 235678899999876 89999999999999999999999996 6
Q ss_pred ChhhhhhcCCCC-------CHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCC-------------CceEEc
Q 038294 589 TLANLIFAIPKP-------DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNY-------------FSAKIS 648 (799)
Q Consensus 589 sL~~~l~~~~~~-------~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~-------------~~~kl~ 648 (799)
+|.+++...... .+..+.+++.||+.||+|||+. +|+||||||+|||++.+ +.+||+
T Consensus 94 sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~ 170 (434)
T 2rio_A 94 NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILIS 170 (434)
T ss_dssp EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEEC
T ss_pred CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEc
Confidence 999999865422 2334578999999999999998 99999999999999754 489999
Q ss_pred cccCcccccCCCCc---ceeeeccCCcccccccccC-------CCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcch
Q 038294 649 DFGLSKLLLSDQSR---THTMIRGTRGYVAPEWFKN-------APVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRA 717 (799)
Q Consensus 649 DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~l~~-------~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~ 717 (799)
|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......+.
T Consensus 171 DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-- 248 (434)
T 2rio_A 171 DFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES-- 248 (434)
T ss_dssp CCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH--
T ss_pred ccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH--
Confidence 99999977543321 1223568999999999976 678999999999999999999 8999864432210
Q ss_pred hHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 718 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. ..+... .+.............+.+++.+||+.||++|||+.||++
T Consensus 249 ---~i-----~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 249 ---NI-----IRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---HH-----HHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HH-----hcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 10 111110 011122234566778899999999999999999999985
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.55 Aligned_cols=255 Identities=23% Similarity=0.257 Sum_probs=192.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccc------e
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN------R 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~------~ 578 (799)
+.+.+.||+|+||.||+|..+. +++.||||++... .....+.+.+|+.++++++||||+++++++..... .
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 104 (353)
T 3coi_A 26 YVSPTHVGSGAYGSVCSAIDKR-SGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDF 104 (353)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCC
T ss_pred EEEeeeEecCCCeEEEEEEECC-CCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeE
Confidence 3455789999999999999874 6899999998653 23335678999999999999999999999977654 3
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+. ++|.+++.. .+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 105 ~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 105 YLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp EEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred EEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 89999997 588888753 588999999999999999999998 999999999999999999999999999986532
Q ss_pred CCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHH--------------
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA-------------- 723 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~-------------- 723 (799)
. .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+....
T Consensus 179 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 254 (353)
T 3coi_A 179 E----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK 254 (353)
T ss_dssp ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred C----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence 2 223458999999999877 678999999999999999999999998654322111110000
Q ss_pred --HHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 724 --YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 724 --~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...... +........ ..........+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 255 AAKSYIQS--LPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHHHHT--SCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHh--CcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000000000 0111234567889999999999999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-34 Score=306.09 Aligned_cols=248 Identities=25% Similarity=0.348 Sum_probs=175.7
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.+.||+|+||.||+|..+. +++.||||++..... ...+.+.++..+++.++||||+++++++.+....++||||+
T Consensus 28 ~~~~~lg~G~~g~V~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 106 (318)
T 2dyl_A 28 ENLGEMGSGTCGQVWKMRFRK-TGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM 106 (318)
T ss_dssp EEEEEC------CEEEEEETT-TCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC
T ss_pred cccceeeecCCeeEEEEEEec-CCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc
Confidence 445789999999999999874 678999999865322 22234555566788889999999999999999999999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
++.+..+... ...+++..+..++.||++||+|||+.. +|+|+||||+||+++.++.+||+|||++....... ..
T Consensus 107 -~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~--~~ 181 (318)
T 2dyl_A 107 -GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK--AK 181 (318)
T ss_dssp -SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH--CCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred -CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC--CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc--cc
Confidence 4455555543 457899999999999999999999831 79999999999999999999999999997654332 22
Q ss_pred eeeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 665 TMIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
....+++.|+|||.+. ...++.++||||||+++|||++|+.||....... ........... . .
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-~-----~ 249 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF------EVLTKVLQEEP-P-----L 249 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH------HHHHHHHHSCC-C-----C
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH------HHHHHHhccCC-C-----C
Confidence 2345899999999994 5578899999999999999999999997532211 11111111111 0 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+. .......+.+++.+||+.||++|||+.|+++
T Consensus 250 ~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 250 LPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 110 1122356788999999999999999999875
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-35 Score=335.68 Aligned_cols=261 Identities=24% Similarity=0.274 Sum_probs=197.6
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeec------ccce
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALNR 578 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~ 578 (799)
.+.+.+.||+|+||.||+|..+. +++.||||+++.. .....+.+.+|++++++++||||+++++++.. ....
T Consensus 15 rY~i~~~LG~G~fG~Vyla~~~~-tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 15 PWEMKERLGTGGFGYVLRWIHQD-TGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp --CCCCCCCBCSSSBCCCCCCTT-TTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CeEEEEEEeeCCCeEEEEEEECC-CCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 45567899999999999999864 6789999998653 34445679999999999999999999999765 6677
Q ss_pred eeEEeecCCCChhhhhhcCC---CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCc---eEEccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIP---KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFS---AKISDFGL 652 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~---~kl~DfGl 652 (799)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999998653 588999999999999999999998 9999999999999997665 99999999
Q ss_pred cccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc-hhHHH-HHHHHH---
Q 038294 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR-AILTD-WAYDCY--- 727 (799)
Q Consensus 653 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~-~~~~~-~~~~~~--- 727 (799)
+....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......... ..... ......
T Consensus 171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 248 (676)
T 3qa8_A 171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248 (676)
T ss_dssp CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCC
T ss_pred cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhh
Confidence 98764432 223356899999999999999999999999999999999999999754221100 00000 000000
Q ss_pred -hcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 038294 728 -AEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKV 772 (799)
Q Consensus 728 -~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e 772 (799)
..+..........+........+.+.+++.+||+.||++|||+.|
T Consensus 249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 001000000011122334556788999999999999999999976
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=339.97 Aligned_cols=239 Identities=22% Similarity=0.310 Sum_probs=192.0
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccc-----ee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN-----RL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~-----~~ 579 (799)
.+.+.+.||+|+||.||+|.++..+++.||||++... .....+.+.+|++++++++||||+++++++..... .+
T Consensus 81 ~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~ 160 (681)
T 2pzi_A 81 QYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGY 160 (681)
T ss_dssp TEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred ceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeE
Confidence 3456688999999999999987546899999998643 23445678999999999999999999999987665 69
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|||||+++++|.+++.. .+++..++.|+.||+.||.|||+. +|+||||||+|||++.+ .+||+|||+++.....
T Consensus 161 lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred EEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 99999999999988765 789999999999999999999998 89999999999999986 8999999999876432
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
....||+.|+|||++.+.. +.++|||||||+||||++|..|+....... .
T Consensus 235 -----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------------~ 284 (681)
T 2pzi_A 235 -----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------------L 284 (681)
T ss_dssp -----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------------C
T ss_pred -----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------------c
Confidence 3346899999999987654 889999999999999999988865421110 0
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRP-TMKVVLQMLEGL 780 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 780 (799)
............+.+++.+||+.||++|| +++++.+.|.++
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00111122335678899999999999999 566677766654
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=319.41 Aligned_cols=245 Identities=24% Similarity=0.296 Sum_probs=181.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+...+.||+|+||+|+..... +++.||||++..... ..+.+|+++++++ +||||+++++++.+....++||||+
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~--~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEES--SSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EecCCeeecCcCEEEEEEEEe--CCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 344578999999996543332 578999999864322 2356799999998 7999999999999999999999999
Q ss_pred CCCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCceEEccccCcccccCC
Q 038294 586 GNGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-----YFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 586 ~~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-----~~~~kl~DfGla~~~~~~ 659 (799)
. |+|.+++.... ...+..+..++.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++.....
T Consensus 101 ~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 101 A-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp S-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred C-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 6 59999997654 345556678999999999999998 8999999999999953 346889999999876533
Q ss_pred CC--cceeeeccCCccccccccc---CCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 660 QS--RTHTMIRGTRGYVAPEWFK---NAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 660 ~~--~~~~~~~gt~~y~aPE~l~---~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
.. .......||+.|+|||++. ...++.++|||||||++|||++ |..||....... ..........
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--------~~~~~~~~~~- 247 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--------ANILLGACSL- 247 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH--------HHHHTTCCCC-
T ss_pred CcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH--------HHHHhccCCc-
Confidence 21 2223456999999999997 4567889999999999999999 888885432221 1111111110
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+ ...........+.+++.+||+.||++|||+.||++
T Consensus 248 ---~---~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 248 ---D---CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ---T---TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---c---ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 01112334556788999999999999999999983
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=298.49 Aligned_cols=229 Identities=14% Similarity=0.115 Sum_probs=182.2
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||+|.... +++.||||++.... ....+.+.+|+..+.+++||||+++++++.+.+..++||
T Consensus 32 ~y~i~~~lg~G~~g~Vy~a~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 32 RYRLLIFHGGVPPLQFWQALDTA-LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TEEEEEEEEBSTTCEEEEEEETT-TTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEcccCCeEEEEEEecC-CCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 45567899999999999999864 68999999997532 233468999999999999999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++++|.+++... .......+|+.||+.||+|||+. +|+||||||+|||++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 999999999999653 35557888999999999999998 99999999999999999999998543
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC--C
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD--E 740 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~--~ 740 (799)
|++| ++.++|||||||+||||++|+.||......+..... ....... .
T Consensus 175 ----------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~-------------~~~~~~~~~~ 224 (286)
T 3uqc_A 175 ----------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA-------------ERDTAGQPIE 224 (286)
T ss_dssp ----------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC-------------CBCTTSCBCC
T ss_pred ----------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH-------------HHHhccCCCC
Confidence 3333 688999999999999999999999865432211000 0000000 0
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+........+.+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 001112234568889999999999999 99999999987554
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=292.11 Aligned_cols=233 Identities=21% Similarity=0.268 Sum_probs=179.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHh-cccccccccceeeeeec----ccceeeEEeec
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAI-GRTHHKNLVQLLGFCDE----ALNRLLVYEFM 585 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~g~~~~----~~~~~lv~e~~ 585 (799)
+.||+|+||.||++..+. +++.||+|+++. ...+.+|+.++ +..+||||+++++++.. ....++||||+
T Consensus 24 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~ 97 (299)
T 3m2w_A 24 QVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97 (299)
T ss_dssp EEEEEETTEEEEEEEETT-TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred cccccCCCeEEEEEEEcC-CCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeec
Confidence 679999999999999864 688999999864 23567788887 55689999999999876 67789999999
Q ss_pred CCCChhhhhhcCC--CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCC
Q 038294 586 GNGTLANLIFAIP--KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 586 ~~gsL~~~l~~~~--~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 660 (799)
++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--- 171 (299)
T 3m2w_A 98 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--- 171 (299)
T ss_dssp CSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc---
Confidence 9999999998754 689999999999999999999998 9999999999999998 7899999999987532
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
+..++.++|||||||++|||++|+.||......... ............
T Consensus 172 --------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~------------~~~~~~~~~~~~ 219 (299)
T 3m2w_A 172 --------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------------PGMKTRIRMGQY 219 (299)
T ss_dssp --------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCSCCSSCTTCC
T ss_pred --------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh------------HHHHHHHhhccc
Confidence 234678999999999999999999999754322110 000000000000
Q ss_pred --CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCCCCCC
Q 038294 741 --PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLLEVPNPP 787 (799)
Q Consensus 741 --~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~~~p~ 787 (799)
+..........+.+++.+||+.||++|||+.|+++ .+.+....+.+|
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~ 270 (299)
T 3m2w_A 220 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270 (299)
T ss_dssp SSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred cCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence 10000123467888999999999999999999997 455554444433
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=314.48 Aligned_cols=234 Identities=18% Similarity=0.167 Sum_probs=173.7
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch---hhHHHHHHHHHHhccccc-cccccee---------------
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ---EREREFKSEVSAIGRTHH-KNLVQLL--------------- 569 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~--------------- 569 (799)
..+.||+|+||+||+|.+.. +++.||||++..... ...+.|.+|+.+++.++| +|...+.
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~-~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQE-TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDP 160 (413)
T ss_dssp EEEEEEEETTEEEEEEEETT-TCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECC
T ss_pred EecccccCCCEEEEEEEecC-CCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccC
Confidence 34689999999999999874 688999999873222 235679999999999977 3221111
Q ss_pred ------eeeec-----ccceeeEEeecCCCChhhhhhc-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecC
Q 038294 570 ------GFCDE-----ALNRLLVYEFMGNGTLANLIFA-------IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCD 631 (799)
Q Consensus 570 ------g~~~~-----~~~~~lv~e~~~~gsL~~~l~~-------~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~d 631 (799)
.++.. ....+++|+++ +++|.+++.. ...+++..++.|+.||++||+|||+. +|+|||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrD 236 (413)
T 3dzo_A 161 QKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTY 236 (413)
T ss_dssp C---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred CCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCC
Confidence 11111 12345666654 6899988842 22467888999999999999999998 999999
Q ss_pred CCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccc----------cCCCCCcchhHHHHHHHHHHHH
Q 038294 632 IKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF----------KNAPVSAKVDVYSFGVMLLEII 701 (799)
Q Consensus 632 lk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l----------~~~~~s~k~DVwS~Gvll~ell 701 (799)
|||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||++|||+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell 311 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999998865322 333457 999999999 5566889999999999999999
Q ss_pred hCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 702 CCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 702 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
+|+.||......+....+ +.. .. ...+.+.+++.+||+.||++|||+.+++
T Consensus 312 tg~~Pf~~~~~~~~~~~~----------------~~~-~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l 362 (413)
T 3dzo_A 312 CADLPNTDDAALGGSEWI----------------FRS-CK-----NIPQPVRALLEGFLRYPKEDRLLPLQAM 362 (413)
T ss_dssp HSSCCCCTTGGGSCSGGG----------------GSS-CC-----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred HCCCCCCCcchhhhHHHH----------------Hhh-cc-----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999999765433221111 000 00 1125688899999999999999976654
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=99.98 E-value=7.4e-32 Score=275.42 Aligned_cols=209 Identities=16% Similarity=0.228 Sum_probs=154.7
Q ss_pred hcccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-e
Q 038294 21 SAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-L 99 (799)
Q Consensus 21 ~~~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-l 99 (799)
++.++|.+|++|++ +++| ++|.|+|||+.+++ +.+ |.. +|+||+|||+.| .++.|+|+.|| |
T Consensus 6 ~~~~~i~~g~~L~~---g~~l--~~g~f~l~f~~~gn------l~l-y~~---~~~vW~an~~~~--~~~~l~l~~dGnL 68 (236)
T 1dlp_A 6 GLSHEGSHPQTLHA---AQSL--ELSSFRFTMQSDCN------LVL-FDS---DVRVWASNTAGA--TGCRAVLQSDGLL 68 (236)
T ss_dssp CSSSSSCSCSCCCT---TCEE--CSTTEEEEECTTSC------EEE-EES---SSEEECCCCCSC--SCCBCCBCSSSCB
T ss_pred eccceeCCCCEECC---CCEE--EcCCEEEEECCCCc------EEE-EEC---CEEEEECCCCCC--CCeEEEEcCCCcE
Confidence 56799999999985 5678 59999999985442 233 432 799999999998 66799999999 9
Q ss_pred EEEcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccccccCCCcc----------CCCcccCCC-ceEEe
Q 038294 100 LLKDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTI----------LPTQILDLD-SVLIS 166 (799)
Q Consensus 100 vl~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtl----------Lpg~kl~~~-~~L~S 166 (799)
||.|++|++||++++. .+...|+|+|+|||||++ .++||||||||||+ +||||++.+ ++|+|
T Consensus 69 vl~d~~~~~vW~s~~~~~~~~~~~~l~d~Gnlvl~~-----~~~W~S~~~p~~t~~lp~~g~d~L~~gq~~~~~~~~L~s 143 (236)
T 1dlp_A 69 VILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIYG-----PGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHA 143 (236)
T ss_dssp CCBCTTTCCSCCCCCCCCSSCCEEEECSSSCEEEEC-----SEEEECSCCCSSCCCCSSCCCEECCCC--CCCCCCEECS
T ss_pred EEEcCCCcEEEeCCccccCCcEEEEEeCCCCEEEec-----CCEEECCCCCCcccccCCccceEEecCCcCCCccceEEc
Confidence 9999999999999753 234579999999999973 18999999998655 778777765 46764
Q ss_pred ecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEecccccEEEEecCceEEEeccccc
Q 038294 167 RLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAK 245 (799)
Q Consensus 167 ~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (799)
..||++|.|+|+++ +|.+.+ +... ..||+++++... ......++..+.+++++.+++++..+...
T Consensus 144 ---~~d~s~G~~~l~l~~dG~LvL--~~~~-----~~~W~s~~~~~~---~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~- 209 (236)
T 1dlp_A 144 ---TQSLQLSPYRLSMETDCNLVL--FDRD-----DRVWSTNTAGKG---TGCRAVLQPNGRMDVLTNQNIAVWTSGNS- 209 (236)
T ss_dssp ---SCCCBCSSCEEEEETTTEEEE--EBTT-----BCCSCCCCCSSC---SSCEEEEETTTEEEEEETTTEEEEECCCC-
T ss_pred ---CcEeecCcEEEEECCCCcEEE--EcCC-----EeEEeCCCcCCC---CceEEEECCCCcEEEEeCCCcEEEEeCCC-
Confidence 78999999999999 554433 3332 478988876432 23345566777766776666655443211
Q ss_pred CCCCcceEEEEEEccCCcEEEEE
Q 038294 246 LSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 246 ~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
.. ...+|++|++||++++|.
T Consensus 210 --~~-~~~~rl~Ld~dG~l~ly~ 229 (236)
T 1dlp_A 210 --RS-AGRYVFVLQPDRNLAIYG 229 (236)
T ss_dssp --CS-SSCCEEEECSSSCEEEEC
T ss_pred --CC-CCCEEEEEcCCCcEEEeC
Confidence 11 235799999999999994
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6e-33 Score=301.00 Aligned_cols=241 Identities=14% Similarity=0.085 Sum_probs=180.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--------hhhHHHHHHHHHHhcccc---------cccccc
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--------QEREREFKSEVSAIGRTH---------HKNLVQ 567 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~ 567 (799)
..+.+.+.||+|+||+||+|+. +++.||||+++... ....+.+.+|+.++++++ ||||++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA---DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE---TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccchheeeecccCceEEEEEEe---CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4455678999999999999987 47999999996532 223367888888888876 555555
Q ss_pred e-----------------eeeeec-------------ccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHH
Q 038294 568 L-----------------LGFCDE-------------ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLV 617 (799)
Q Consensus 568 l-----------------~g~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~ 617 (799)
+ ++++.+ ....++||||+++|++.+.+.. ..+++..+..++.||+.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence 4 444443 6788999999999977666644 56789999999999999999
Q ss_pred HHH-hcCCCCeEecCCCCCCeEEcCCC--------------------ceEEccccCcccccCCCCcceeeeccCCccccc
Q 038294 618 YLH-EECNVPIIHCDIKPQNILLDNYF--------------------SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676 (799)
Q Consensus 618 yLH-~~~~~~iiH~dlk~~NILl~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 676 (799)
||| +. +|+||||||+||||+.++ .+||+|||+++..... ...||+.|+||
T Consensus 176 ~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 77 899999999999999887 8999999999876432 34689999999
Q ss_pred ccccCCCCCcchhHHHHHHH-HHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHH
Q 038294 677 EWFKNAPVSAKVDVYSFGVM-LLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMI 755 (799)
Q Consensus 677 E~l~~~~~s~k~DVwS~Gvl-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l 755 (799)
|++.+.. +.++||||++++ .+++++|..||....... ........... ..............+.+.++
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~------~~~~~~~~~~~----~~~~~~~~~~~~~s~~~~dl 315 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLH------YLTDKMLKQMT----FKTKCNTPAMKQIKRKIQEF 315 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHH------HHHHHHHHTCC----CSSCCCSHHHHHHHHHHHHH
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhh------HHHHhhhhhhc----cCcccchhhhhhcCHHHHHH
Confidence 9998776 889999998776 788899999885321100 00111111100 11111222234567789999
Q ss_pred HHHhcccCCCCCCCHHHHH
Q 038294 756 AMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 756 ~~~Cl~~dP~~RPt~~evl 774 (799)
+.+||+.| |+.|++
T Consensus 316 i~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 316 HRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHGGGSS-----SHHHHH
T ss_pred HHHHhccC-----CHHHHH
Confidence 99999976 899887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-28 Score=278.60 Aligned_cols=186 Identities=19% Similarity=0.107 Sum_probs=131.8
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEcccc----------chhhHHHHHHHHHHhccc-ccccccceeeeeecccceee
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRL----------AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~l 580 (799)
..+.|++|.+.++... ..|+.+++|.+... .+...++|.+|+++|+++ +|+||++++++++++...||
T Consensus 241 ~~~~~~~~~h~~~rr~-~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRY-FFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp C-C--------CCEEE-EECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred ccccCCcccccccccc-cccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 4667777766655433 24778999998542 123346799999999999 79999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||++|++|.++|.....++.. +|+.||+.||+|+|++ +||||||||+||||++++.+||+|||+|+......
T Consensus 320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999999988777654 5889999999999998 99999999999999999999999999998765443
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p 706 (799)
.. .....||+.|||||++.+. +..++|+||+|++++++.++..+
T Consensus 394 ~~-~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 SW-PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred cc-ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 32 2335699999999999764 67789999999999988765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=248.68 Aligned_cols=182 Identities=16% Similarity=0.210 Sum_probs=144.3
Q ss_pred hhhcCccccceEEEEEEeCCCCeEEEEEEccccc--------hhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 510 ~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
.+.||+|+||.||+|.. .++.+++|+..... ....+.+.+|++++++++||||+++..++......++|
T Consensus 341 ~~~LG~G~fg~Vy~~~~---~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSY---LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp -------CCEEEEEEEC---SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCEEeeCCCEEEEEEEE---CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 46899999999999954 46788888763211 11234689999999999999999777777777788999
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
|||+++++|.+++.. +.+++.|+++||+|||+. +|+||||||+|||+++ .+||+|||+++.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 999999999999976 568999999999999998 9999999999999999 999999999998754322
Q ss_pred cc------eeeeccCCcccccccccC--CCCCcchhHHHHHHHHHHHHhCCcCC
Q 038294 662 RT------HTMIRGTRGYVAPEWFKN--APVSAKVDVYSFGVMLLEIICCRRSV 707 (799)
Q Consensus 662 ~~------~~~~~gt~~y~aPE~l~~--~~~s~k~DVwS~Gvll~elltg~~p~ 707 (799)
.. .....||+.|||||++.. ..|+...|+|+..+-..+-+.++.++
T Consensus 485 ~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 485 KAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 11 124569999999999986 56788899999988888877766554
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.6e-21 Score=203.36 Aligned_cols=141 Identities=15% Similarity=0.070 Sum_probs=115.1
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccch------------------hhHHHHHHHHHHhcccccccccceee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ------------------EREREFKSEVSAIGRTHHKNLVQLLG 570 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~g 570 (799)
+.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.++++++ | +++.+
T Consensus 94 ~~~~iG~G~~g~Vy~~~~--~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~ 168 (282)
T 1zar_A 94 IGKLMGEGKESAVFNCYS--EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPK 168 (282)
T ss_dssp EEEEEEECSSEEEEEEEE--TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCC
T ss_pred ecCEeccCCCceEEEEEe--CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCe
Confidence 347899999999999998 3689999999864221 13457899999999998 5 67777
Q ss_pred eeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 571 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+. +|+||||||+|||++ ++.+||+||
T Consensus 169 ~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 169 VYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp EEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCC
T ss_pred EEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 554 356799999999999988 421 23457999999999999998 999999999999999 999999999
Q ss_pred cCcccccCCCCcceeeeccCCccccccccc
Q 038294 651 GLSKLLLSDQSRTHTMIRGTRGYVAPEWFK 680 (799)
Q Consensus 651 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~ 680 (799)
|+++. +..++|||++.
T Consensus 237 G~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE--------------TTSTTHHHHHH
T ss_pred CCCeE--------------CCCCCHHHHHH
Confidence 99873 34578999874
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.74 E-value=9.2e-18 Score=150.64 Aligned_cols=105 Identities=17% Similarity=0.262 Sum_probs=88.1
Q ss_pred hcccccccCCCcccccCCCeec--cCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc
Q 038294 21 SAATTINLGSSLSSTSSNSSWL--SPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG 98 (799)
Q Consensus 21 ~~~~~~~~~~~l~~~~~~~~~~--S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g 98 (799)
++.++|.+|++|.+ +++|+ |++|.|+|+|+.+++ . +||++ +++||+|||+.| ..++.|+|..||
T Consensus 6 ~~~~~l~~g~~L~~---g~~l~~~S~~g~~~L~~~~dgn----l---vly~~---~~~vW~sn~~~~-~~~~~l~l~~dG 71 (119)
T 1b2p_A 6 SKQPDDNHPQILHA---TESLEILFGTHVYRFIMQTDCN----L---VLYDN---NNPIWATNTGGL-GNGCRAVLQPDG 71 (119)
T ss_dssp CSCSSSCCCCEEET---TCEEEEEETTEEEEEEECTTSC----E---EEEET---TEEEEECCCTTS-CSSCEEEECTTS
T ss_pred ecCcccCCCCEEcC---CCEEEEeCCCCCEEEEEecCCC----E---EEEEC---CEEEEeCCCccC-CCceEEEEccCC
Confidence 56889999999975 57899 999999999997553 2 57875 799999999977 345689999999
Q ss_pred -eEEEcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccc
Q 038294 99 -LLLKDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 99 -lvl~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
|||.|.++++||++.+. .+...++|+|+|||||++ .++|||
T Consensus 72 NLVl~d~~~~~lW~S~~~~~~g~~~l~l~~~Gnlvl~~-----~~~W~S 115 (119)
T 1b2p_A 72 VLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-----DALWAT 115 (119)
T ss_dssp CEEEECTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-----SEEEEC
T ss_pred EEEEEeCCCcEEEcCCCCCCCCCEEEEEECCCcEEEEC-----ccEeCC
Confidence 99999999999998653 345679999999999975 279998
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.72 E-value=3e-17 Score=143.74 Aligned_cols=101 Identities=18% Similarity=0.359 Sum_probs=82.3
Q ss_pred cccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEE
Q 038294 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 102 (799)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~ 102 (799)
++|.+|+.|.+ |++|+| |.|.|.|...+ .|.++. ..++||+|||+.|...++.|+|+.|| |||.
T Consensus 2 n~L~~g~~L~~---g~~L~s--g~y~l~~q~Dg------NLvly~----~~~~vW~ant~~~~~~~~~L~l~~dGnLvL~ 66 (105)
T 4h3o_A 2 NILDNNEGLYA---GQSLDV--EPYHFIMQDDC------NLVLYD----HSTSTWASNTEIGGKSGCSAVLQSDGNFVVY 66 (105)
T ss_dssp CEECTTEEECT---TCEEEE--TTEEEEECTTS------CEEEEE----TTEEEEECCCCCTTCCSCEEEECTTSCEEEE
T ss_pred CCcCCCCEEcC---CCEEEE--CCEEEEECCCC------eEEEEE----CCEEEEEecCCCCCCccEEEEEeCCccEEEE
Confidence 56788888864 578987 78999886432 266654 36899999999999888899999999 9999
Q ss_pred cCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccc
Q 038294 103 DPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 103 ~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
|+++++||+|++. .....|+|+|+|||||++ ..||||
T Consensus 67 d~~~~~vWss~t~~~~~~~~l~L~ddGNlVly~-----~~~W~S 105 (105)
T 4h3o_A 67 DSSGRSLWASHSTRGSGNYILILQDDGNVIIYG-----SDIWST 105 (105)
T ss_dssp CTTCCEEEECCCCCCSSCEEEEECTTSCEEEEE-----SEEEEC
T ss_pred CCCcEEEEEecCCCCCCCEEEEEeCCCeEEEEC-----CcEecC
Confidence 9999999998753 344579999999999974 259998
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.71 E-value=2.6e-17 Score=145.87 Aligned_cols=107 Identities=20% Similarity=0.378 Sum_probs=86.7
Q ss_pred ccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEE
Q 038294 23 ATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 101 (799)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl 101 (799)
+++|.+|+.|.+ +++|+ ++|.|+|+|+..++ . |+|+ ..++||.||++.|. .++.++|..|| |||
T Consensus 1 ~d~l~~g~~L~~---g~~l~-~~~~~~l~~~~dGn----l---vl~~---~~~~vW~sn~~~~~-~~~~l~l~~dGNLVl 65 (110)
T 3a0c_A 1 VNSLSSPNSLFT---GHSLE-VGPSYRLIMQGDCN----F---VLYD---SGKPVWASNTGGLG-SGCRLTLHNNGNLVI 65 (110)
T ss_dssp CCEEETTCEECT---TCEEE-ETTTEEEEECTTSC----E---EEEE---TTEEEEECCCTTSC-SSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECC---CCEEE-ECCCEEEEEcCCCc----E---EEEE---CCEEEEECCCCCCC-CcEEEEEeCCCCEEE
Confidence 368889998874 57899 99999999976543 2 6776 37999999999773 45689999999 999
Q ss_pred EcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccccccCC
Q 038294 102 KDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPT 149 (799)
Q Consensus 102 ~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PT 149 (799)
.|.+|.+||++.+. .+...++|+|+|||||++. ++||||+||.
T Consensus 66 ~~~~~~~~W~S~t~~~~g~~~l~l~~dGnlvl~~~-----~~W~S~~~~~ 110 (110)
T 3a0c_A 66 YDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIYGP-----VVWATGSGPA 110 (110)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-----EEEECSCCC-
T ss_pred ECCCCcEEEecCCCCCCCCEEEEEeCCccEEEECC-----CEecCCCcCC
Confidence 99999999998653 2345799999999999742 7999999983
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.7e-17 Score=170.57 Aligned_cols=135 Identities=20% Similarity=0.194 Sum_probs=104.2
Q ss_pred hhhhcCccccceEEEEEEeCCCCeE--EEEEEccccch------------------------hhHHHHHHHHHHhccccc
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKA--IAVKKLDRLAQ------------------------EREREFKSEVSAIGRTHH 562 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~--vavK~l~~~~~------------------------~~~~~~~~E~~~l~~l~h 562 (799)
+.+.||+|+||.||+|.... +|+. ||||+++.... .....+..|+..+.+++|
T Consensus 51 i~~~ig~G~~g~Vy~a~~~~-~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 51 MGGVISTGKEANVFYADGVF-DGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEECSSEEEEEEEEEE-TTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hCCEEeecceEEEEEEEEcC-CCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 45789999999999999842 5778 99998643211 112367899999999998
Q ss_pred ccc--cceeeeeecccceeeEEeecCC-C----ChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEecCCCC
Q 038294 563 KNL--VQLLGFCDEALNRLLVYEFMGN-G----TLANLIFAIPKPDWNLRVRISLEIARGLVYLH-EECNVPIIHCDIKP 634 (799)
Q Consensus 563 ~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH-~~~~~~iiH~dlk~ 634 (799)
+++ +.++.+ ...+|||||+.+ | +|.++... .++.....++.|++.||.||| +. +|+||||||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~---givHrDlkp 199 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEA---ELVHADLSE 199 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTS---CEECSSCST
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCH
Confidence 864 444432 366899999942 4 66665433 234567889999999999999 76 999999999
Q ss_pred CCeEEcCCCceEEccccCcccc
Q 038294 635 QNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 635 ~NILl~~~~~~kl~DfGla~~~ 656 (799)
+|||+++ .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999998 9999999999754
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.69 E-value=7.8e-17 Score=144.17 Aligned_cols=107 Identities=18% Similarity=0.357 Sum_probs=86.6
Q ss_pred ccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEE
Q 038294 23 ATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 101 (799)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl 101 (799)
.+||.+||+|.. +++|+ +|.|+|+|+..++ .. +|+ ..++||+||++.|. .++.|+|..+| |||
T Consensus 2 ~dtl~~gq~L~~---g~~L~--~g~~~L~~~~dgn----lv---ly~---~~~~vW~sn~~~~~-~~~~l~l~~~GnLvl 65 (115)
T 2dpf_A 2 DNVLLSGQTLHA---DHSLQ--AGAYTLTIQNKCN----LV---KYQ---NGRQIWASNTDRRG-SGCRLTLLSDGNLVI 65 (115)
T ss_dssp CCEEETTCEEET---TEEEE--ETTEEEEECTTSC----EE---EEE---TTEEEEECSCTTSC-SSCEEEECTTSCEEE
T ss_pred CCEeCCCCEECC---CCEEE--CCCEEEEEcCCCc----EE---EEe---CCEEEEeCCCCCCC-CceEEEECCCCcEEE
Confidence 478999999975 57798 8999999975442 32 365 47999999999884 45689999999 999
Q ss_pred EcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccccccCCC
Q 038294 102 KDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTD 150 (799)
Q Consensus 102 ~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTD 150 (799)
.|.++.+||+++.. .+...++|+|+|||||++. ++||||.+++.
T Consensus 66 ~d~~~~~vW~S~~~~~~g~~~l~l~~dGnlvl~~~-----~~W~S~~~~~~ 111 (115)
T 2dpf_A 66 YDHNNNDVWGSACWGDNGKYALVLQKDGRFVIYGP-----VLWSLGPNGCR 111 (115)
T ss_dssp ECTTCCEEEECCCCCSSSCCEEEECTTSCEEEECS-----EEECSSTTCBC
T ss_pred ECCCceEEEEcCCCCCCCCEEEEEeCCCeEEEECC-----CEEECCCCCCc
Confidence 99999999998753 3345799999999999732 79999998765
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.62 E-value=8.7e-16 Score=136.74 Aligned_cols=107 Identities=18% Similarity=0.427 Sum_probs=85.0
Q ss_pred ccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEE
Q 038294 23 ATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 101 (799)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl 101 (799)
.|||.+||+|.+ +++| ++|.|+|+|+.+++ . +||++ +++||+||++.+ ..++.|+|..+| |||
T Consensus 1 tdtl~~gq~L~~---g~~L--~~~~~~L~~~~dgn----l---vl~~~---~~~vW~sn~~~~-~~~~~l~l~~~GNLvl 64 (112)
T 1xd5_A 1 SDRLNSGHQLDT---GGSL--AEGGYLFIIQNDCN----L---VLYDN---NRAVWASGTNGK-ASGCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECT---TCEE--EETTEEEEECTTSC----E---EEEET---TEEEEECCCTTS-CSSEEEEECTTSCEEE
T ss_pred CCCCCCCCEECC---CCEE--eCCCEEEEEcCCCc----E---EEEEC---CEEEEeCCCcCC-CCCEEEEEeCCCCEEE
Confidence 378999999874 5778 58999999987653 2 35764 689999999864 234689999999 999
Q ss_pred EcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccccccC
Q 038294 102 KDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNP 148 (799)
Q Consensus 102 ~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~P 148 (799)
.| ++.++|++... .+...++|+++|||||++. .+.++||||+|.
T Consensus 65 ~d-~~~~~W~S~~~~~~g~~~l~l~~dGnlvl~~~--~~~~~W~S~~~~ 110 (112)
T 1xd5_A 65 YS-GSRAIWASNTNRQNGNYYLILQRDRNVVIYDN--SNNAIWATHTNV 110 (112)
T ss_dssp EE-TTEEEEECCCCCSCCCCEEEECTTSCEEEECT--TSCEEEECCCCC
T ss_pred Ec-CCEEEEECCccCCCCCEEEEEeCCCcEEEECC--CCceEEECCCcc
Confidence 99 88899998653 3345799999999999753 456999999985
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=8.6e-15 Score=129.40 Aligned_cols=100 Identities=18% Similarity=0.385 Sum_probs=79.5
Q ss_pred cccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEE
Q 038294 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 102 (799)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~ 102 (799)
.||.+||.|.+ +++|+ +|.|+|+|...++ .+| |.. .++||+||++.+ ..+..|.|..|| |||.
T Consensus 2 ntL~~gq~L~~---g~~L~--~g~~~L~~q~dGn----Lvl---y~~---~~~vW~snt~~~-~~~~~l~l~~dGNLvl~ 65 (109)
T 3dzw_A 2 NILYSGETLSP---GEFLN--NGRYVFIMQEDCN----LVL---YDV---DKPIWATNTGGL-DRRCHLSMQSDGNLVVY 65 (109)
T ss_dssp CEEETTEEECT---TCEEE--ETTEEEEECTTSC----EEE---EET---TEEEEECCCTTS-SSSCEEEECTTSCEEEE
T ss_pred CCcCCCCEeCC---CCEEE--CCCEEEEEcCCCc----EEE---EeC---CEEEEECCcccC-CCCEEEEEeCCCCEEEE
Confidence 57889998864 57786 7999999976543 433 654 589999999976 335689999999 9999
Q ss_pred cCCCCEEeccCCC-C-ceeeEEeecCccEEEEecCCcccccccc
Q 038294 103 DPGGKTIWDGKPD-K-KVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 103 ~~~~~~vWst~~~-~-~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
|.++.++|++++. . ....|+|+|+|||||++. ++|||
T Consensus 66 ~~~~~~~W~S~t~~~~~~~~~~L~ddGNlvly~~-----~~W~s 104 (109)
T 3dzw_A 66 SPRNNPIWASNTGGENGNYVCVLQKDRNVVIYGT-----ARWAT 104 (109)
T ss_dssp CTTSCEEEECCCCCSSSCEEEEECTTSCEEEEES-----CCCCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEEeCCCEEEEECC-----CEEeC
Confidence 9999999998753 2 235799999999999752 79998
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=5.6e-15 Score=159.17 Aligned_cols=138 Identities=12% Similarity=0.033 Sum_probs=94.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--------------hhHHHHHHHHHHhcccccccccceeeeee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--------------EREREFKSEVSAIGRTHHKNLVQLLGFCD 573 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~g~~~ 573 (799)
.+.+.||+|+||.||+|... +|+.||||+++.... ........++++.+...|+|+.++.....
T Consensus 98 ~I~~~IG~Gk~a~VY~a~d~--~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 98 SVGSRIGVGKESDIMIVADE--KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp EEEEEEEECSSEEEEEEECT--TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EecCEeeeCCceEEEEEECC--CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 45678999999999999875 589999998753110 00112222333333333444444432211
Q ss_pred ------cccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----
Q 038294 574 ------EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF---- 643 (799)
Q Consensus 574 ------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~---- 643 (799)
.....+|||||+++++|..+... +....++.||+.+|.|||.. +||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSC
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCccc
Confidence 11234799999999888765432 23356889999999999998 899999999999998776
Q ss_pred ------ceEEccccCcccc
Q 038294 644 ------SAKISDFGLSKLL 656 (799)
Q Consensus 644 ------~~kl~DfGla~~~ 656 (799)
.+.|+||+-+...
T Consensus 247 ~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECCCTTCEET
T ss_pred ccccccceEEEEeCCcccC
Confidence 3899999977654
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.43 E-value=2.8e-13 Score=119.67 Aligned_cols=102 Identities=19% Similarity=0.292 Sum_probs=78.1
Q ss_pred hcccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-e
Q 038294 21 SAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-L 99 (799)
Q Consensus 21 ~~~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-l 99 (799)
.+.+||.+||.|.. +++|+| |.|.|-| +..+ + |.+ |.. ++||.+|++.. ..+..|.|..+| |
T Consensus 4 ~~~dtL~~gq~L~~---g~~L~s--g~~~L~~-q~dG--n---Lvl-~~~----~~vW~snt~~~-~~~~~l~l~~dGNL 66 (110)
T 3r0e_B 4 FTNNLLFSGQVLYG---DGRLTA--KNHQLVM-QGDC--N---LVL-YGG----KYGWQSNTHGN-GEHCFLRLNHKGEL 66 (110)
T ss_dssp CBTTEEETTCEEET---TEEEEC--SSCEEEE-CTTS--C---EEE-ECS----SSCEECCCTTS-SSSCEEEECTTSCE
T ss_pred cccCEECCCCEecC---CCEEEe--CCEEEEE-cCCC--e---EEE-ECC----eEEEECCCcCC-CcCEEEEEeCCCcE
Confidence 47899999999874 577998 4588855 3322 2 444 654 47999999863 234689999999 9
Q ss_pred EEEcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccc
Q 038294 100 LLKDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 100 vl~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
||.|.++.++|++++. .+...|+|+|+|||||++ ..+|+|
T Consensus 67 vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGNlvly~-----~~~W~t 108 (110)
T 3r0e_B 67 IIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVIYG-----PAIFET 108 (110)
T ss_dssp EEECTTCCEEEECCCCCSSSCCEEEECTTSCEEEEC-----SEEEES
T ss_pred EEEeCCCCEEEEcCCcCCCCCEEEEEcCCccEEEec-----CCEecC
Confidence 9999999999998753 233579999999999974 379987
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.40 E-value=1.3e-12 Score=116.06 Aligned_cols=105 Identities=14% Similarity=0.225 Sum_probs=80.8
Q ss_pred hcccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-e
Q 038294 21 SAATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-L 99 (799)
Q Consensus 21 ~~~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-l 99 (799)
.+.++|.+||.|.+ ++.|.+ |.|.|-|...+ + |.++..+ ..++||.+|+..+- .+..|.|..+| |
T Consensus 4 ~~~~tL~~gq~L~~---g~~L~~--g~~~L~~q~dG---N---LvL~~~~--~~~~vWssnt~~~~-~~~~l~l~~dGNL 69 (113)
T 3mez_B 4 RVRNVLFSSQVMYD---NAQLAT--RDYSLVMRDDC---N---LVLTKGS--KTNIVWESGTSGRG-QHCFMRLGHSGEL 69 (113)
T ss_dssp CCSSEEETTCEEET---TCEEEE--TTEEEEECTTS---C---EEEEETT--TTEEEEECCCTTSC-SSCEEEECTTSCE
T ss_pred ccCCEeCCCCEECC---CCEeEc--CCEEEEEcCCC---E---EEEEECC--CCEEEEECCcccCC-cCEEEEEeCCCcE
Confidence 36789999999874 466864 78888885332 1 5664321 47899999998763 34689999999 9
Q ss_pred EEEcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccc
Q 038294 100 LLKDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 100 vl~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
||.|.+++++|++++. .+...|+|+|+|||||++ ..+|+|
T Consensus 70 Vl~d~~~~~iW~S~t~~~~~~~~~~L~~dGnlvly~-----~~~W~s 111 (113)
T 3mez_B 70 DITDDRLNTVFVSNTVGQEGDYVLILQINGQAVVYG-----PAVWST 111 (113)
T ss_dssp EEECTTSCEEEECSCCCSSSCCEEEECTTSCEEEEC-----SEEEES
T ss_pred EEECCCCCEEEECCCcCCCCCEEEEEcCCceEEEec-----CCEecC
Confidence 9999999999998763 234579999999999974 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=3.8e-13 Score=118.92 Aligned_cols=85 Identities=19% Similarity=0.411 Sum_probs=66.0
Q ss_pred CCceeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceE
Q 038294 88 RGSTLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVL 164 (799)
Q Consensus 88 ~~s~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L 164 (799)
...+|.|..|| |||.| .+++||+++... ....++|+|+|||||++. ++.++||||
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~~~~~~l~l~~dGNLVl~~~--~~~~~W~S~------------------- 77 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGLGSGCRLTLHNNGNLVIYDQ--SNRVIWQTK------------------- 77 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSCEEEECTTSCEEEECT--TCCEEEECC-------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCCCCcEEEEEeCCCCEEEECC--CCcEEEecC-------------------
Confidence 45689999999 99998 588999998632 235799999999999864 467999999
Q ss_pred EeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccC
Q 038294 165 ISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTG 209 (799)
Q Consensus 165 ~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~ 209 (799)
+++++|.|+++++ +|+++++ . . .||++.+.
T Consensus 78 ------t~~~~g~~~l~l~~dGnlvl~--~-~------~~W~S~~~ 108 (110)
T 3a0c_A 78 ------TNGKEDHYVLVLQQDRNVVIY--G-P------VVWATGSG 108 (110)
T ss_dssp ------CCCSSSCCEEEECTTSCEEEE--C-S------EEEECSCC
T ss_pred ------CCCCCCCEEEEEeCCccEEEE--C-C------CEecCCCc
Confidence 3567799999998 6666553 2 1 58887754
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.37 E-value=1.2e-12 Score=116.31 Aligned_cols=88 Identities=18% Similarity=0.340 Sum_probs=67.7
Q ss_pred CceeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEE
Q 038294 89 GSTLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLI 165 (799)
Q Consensus 89 ~s~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~ 165 (799)
..+|.|..|| |+|.+. +++||+++... ....|+|+|+|||||++ ++.++||||+
T Consensus 20 ~~~L~~~~dgnlvl~~~-~~~vW~sn~~~~~~~~~l~l~~~GNLvl~d---~~~~~W~S~~------------------- 76 (112)
T 1xd5_A 20 GYLFIIQNDCNLVLYDN-NRAVWASGTNGKASGCVLKMQNDGNLVIYS---GSRAIWASNT------------------- 76 (112)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSCSSEEEEECTTSCEEEEE---TTEEEEECCC-------------------
T ss_pred CEEEEEcCCCcEEEEEC-CEEEEeCCCcCCCCCEEEEEeCCCCEEEEc---CCEEEEECCc-------------------
Confidence 3589999999 999987 78999998532 23679999999999987 3569999994
Q ss_pred eecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCC
Q 038294 166 SRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSA 211 (799)
Q Consensus 166 S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~ 211 (799)
+|++|.|++.++ +|+++++. .. ...||++.++.+
T Consensus 77 ------~~~~g~~~l~l~~dGnlvl~~--~~----~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ------NRQNGNYYLILQRDRNVVIYD--NS----NNAIWATHTNVG 111 (112)
T ss_dssp ------CCSCCCCEEEECTTSCEEEEC--TT----SCEEEECCCCCC
T ss_pred ------cCCCCCEEEEEeCCCcEEEEC--CC----CceEEECCCccC
Confidence 456789999998 66665542 11 157899887653
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.8e-12 Score=113.95 Aligned_cols=82 Identities=17% Similarity=0.310 Sum_probs=64.5
Q ss_pred ceeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEEe
Q 038294 90 STLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLIS 166 (799)
Q Consensus 90 s~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S 166 (799)
.+|.|..|| |+|.+. +++||+++... ....++|+|+|||||++. +++++||||
T Consensus 32 ~~L~~~~dgnlvly~~-~~~vW~sn~~~~~~~~~l~l~~dGNLVl~d~--~~~~lW~S~--------------------- 87 (119)
T 1b2p_A 32 YRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITN--ENVTVWQSP--------------------- 87 (119)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECT--TCCEEEECS---------------------
T ss_pred EEEEEecCCCEEEEEC-CEEEEeCCCccCCCceEEEEccCCEEEEEeC--CCcEEEcCC---------------------
Confidence 378888898 999987 89999998532 235799999999999864 567999999
Q ss_pred ecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceeccc
Q 038294 167 RLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNT 208 (799)
Q Consensus 167 ~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~ 208 (799)
++|++|.|+++++ +|+++++. ..||++++
T Consensus 88 ----~~~~~g~~~l~l~~~Gnlvl~~---------~~~W~Sg~ 117 (119)
T 1b2p_A 88 ----VAGKAGHYVLVLQPDRNVVIYG---------DALWATQT 117 (119)
T ss_dssp ----CCCCSSCEEEEECTTSCEEEEE---------SEEEECCC
T ss_pred ----CCCCCCCEEEEEECCCcEEEEC---------ccEeCCCC
Confidence 4567899999998 66655542 26888875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.30 E-value=7e-12 Score=110.41 Aligned_cols=105 Identities=24% Similarity=0.415 Sum_probs=80.0
Q ss_pred cccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eE
Q 038294 22 AATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LL 100 (799)
Q Consensus 22 ~~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lv 100 (799)
+.+||.+||.|.. +++| .+|.|.|.|...++ |-+ |.. +|.+|+..+ ..+..|+|..|| ||
T Consensus 2 ~~dtL~~gq~L~~---g~~L--~~g~~~L~~q~dGN------Lvl-~~~------~Wssnt~~~-~~~~~l~l~~dGnLv 62 (109)
T 3r0e_A 2 GTNYLLSGQTLDT---EGHL--KNGDFDLVMQDDCN------LVL-YNG------NWQSNTANN-GRDCKLTLTDYGELV 62 (109)
T ss_dssp CCSEEETTCEECT---TCEE--EETTEEEEECTTSC------EEE-ETT------TEECCCTTS-CSSCEEEECTTSCEE
T ss_pred ccCCcCCCCCcCC---CCEe--ECCCEEEEEecCCe------EEE-EeC------eEEcCCCCC-CCcEEEEEcCCCeEE
Confidence 5789999999874 5668 57999998854332 222 432 699999875 335689999999 99
Q ss_pred EEcCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccccccCCCccCCC
Q 038294 101 LKDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPT 155 (799)
Q Consensus 101 l~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg 155 (799)
|.|.+++++|++++. .....|+|+|+|||||++ ..+|+| +|.+||
T Consensus 63 l~d~~~~~vWss~t~~~~~~~~~~L~~dGNlvly~-----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 63 IKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVFG-----PSVFKI-----DPWVRG 109 (109)
T ss_dssp EECTTSCEEEECCCCCSSSCCEEEEETTTEEEEEC-----SEEEEE-----CTTSCC
T ss_pred EEeCCCCEEEcCCCcCCCcCEEEEEcCCCeEEEEe-----cCEECC-----CCccCC
Confidence 999999999998753 234579999999999974 479998 555554
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.21 E-value=2.7e-11 Score=108.07 Aligned_cols=86 Identities=20% Similarity=0.407 Sum_probs=66.5
Q ss_pred CceeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEE
Q 038294 89 GSTLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLI 165 (799)
Q Consensus 89 ~s~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~ 165 (799)
...|.|..|| |+|.+ .+++||+++... ....++|+++|||||++. ++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~~~~~~l~l~~~GnLvl~d~--~~~~vW~S~~~------------------ 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRRGSGCRLTLLSDGNLVIYDH--NNNDVWGSACW------------------ 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTSCSSCEEEECTTSCEEEECT--TCCEEEECCCC------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCCCCceEEEECCCCcEEEECC--CceEEEEcCCC------------------
Confidence 4578888898 99988 588999998532 235799999999999864 46799999997
Q ss_pred eecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCC
Q 038294 166 SRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSA 211 (799)
Q Consensus 166 S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~ 211 (799)
+++|.|++.++ +|+++++ . ..||++.++..
T Consensus 80 -------~~~g~~~l~l~~dGnlvl~--~-------~~~W~S~~~~~ 110 (115)
T 2dpf_A 80 -------GDNGKYALVLQKDGRFVIY--G-------PVLWSLGPNGC 110 (115)
T ss_dssp -------CSSSCCEEEECTTSCEEEE--C-------SEEECSSTTCB
T ss_pred -------CCCCCEEEEEeCCCeEEEE--C-------CCEEECCCCCC
Confidence 35688999998 6766553 2 15899888754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=3.3e-10 Score=117.19 Aligned_cols=138 Identities=15% Similarity=0.032 Sum_probs=106.8
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecCC
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+...++.|+.+.||+... .++.+++|+...........+..|+++++.+. |..+.++++++......++||||++|
T Consensus 18 ~~~~~~g~s~~~v~~~~~---~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 94 (263)
T 3tm0_A 18 CVKDTEGMSPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADG 94 (263)
T ss_dssp EEECCSCCSSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSS
T ss_pred eEeeccCCCCCeEEEEEC---CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCC
Confidence 345678888899999864 35789999986532222346888999998884 67788999999888888999999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc---------------------------------------------
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE--------------------------------------------- 622 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 622 (799)
.+|.+.+.. ......++.+++++|+.||+.
T Consensus 95 ~~l~~~~~~-----~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T 3tm0_A 95 VLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE 169 (263)
T ss_dssp EEHHHHCCT-----TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred eehhhccCC-----cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence 999876321 123457888999999999981
Q ss_pred -----------CCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 623 -----------CNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 623 -----------~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
....++|+|++|.|||++++..+.|+||+.+.
T Consensus 170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 01358999999999999876667799999765
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.04 E-value=3.6e-10 Score=99.75 Aligned_cols=99 Identities=16% Similarity=0.275 Sum_probs=73.6
Q ss_pred cccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEE
Q 038294 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 102 (799)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~ 102 (799)
++|.+||.|.+ ++.| .+|.|.|-|...++ |-+ |.. .. ||.+|+..+ ..+..|.|..+| |||.
T Consensus 3 ~~l~~gq~L~~---g~~L--~~g~~~L~~q~dGn------Lvl-~~~---~~-vW~snt~~~-~~~~~l~l~~dGNLVl~ 65 (111)
T 3mez_A 3 NVLLTGDVIHT---DNQL--SYESAAFVMQGDCN------LVL-YNE---AG-GFQSNTHGR-GVDCTLRLNNRGQLEIH 65 (111)
T ss_dssp TEEETTCEECT---TCEE--EETTEEEEECTTSC------EEE-ECS---SC-CEECCCTTS-CSSCEEEECTTSCEEEE
T ss_pred CEeCCCCEeCC---CCEE--ecCCEEEEEccCCe------EEE-ECC---CC-EEECCcccC-CcCEEEEEcCCCcEEEE
Confidence 67888998874 5668 47899998854322 333 543 23 999999876 335689999999 9999
Q ss_pred cCCCC-EEeccCCC----CceeeEEeecCccEEEEecCCcccccccc
Q 038294 103 DPGGK-TIWDGKPD----KKVSDAAMLDTGNFVLRASGNNSDYAWQS 144 (799)
Q Consensus 103 ~~~~~-~vWst~~~----~~~~~a~LldsGNlVl~~~~~~~~~lWQS 144 (799)
|.++. ++|++++. .....++|+|+|||||++ ..+|+|
T Consensus 66 ~~~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~-----~~~W~s 107 (111)
T 3mez_A 66 SANSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG-----PAIWST 107 (111)
T ss_dssp CSSCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC-----SEEEEC
T ss_pred eCCCCEEEEEeccccCCCCcCEEEEECCCCeEEEec-----cCEEcc
Confidence 99876 59998731 234579999999999974 479987
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=98.95 E-value=1.8e-09 Score=111.61 Aligned_cols=114 Identities=13% Similarity=0.270 Sum_probs=82.0
Q ss_pred cccccccCCCccc-ccCCCeeccCCCeeeeeeeecC-CCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-
Q 038294 22 AATTINLGSSLSS-TSSNSSWLSPSEDFAFGFRQLN-NNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG- 98 (799)
Q Consensus 22 ~~~~~~~~~~l~~-~~~~~~~~S~~g~F~lGF~~~~-~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g- 98 (799)
-.||+-+|+.+.. ...+++|+|+ ..++.|+|... ......+| |++ ..+++|.+++..+-. ..|.+..+|
T Consensus 135 ptdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlvL---y~~--~~~~yW~Sgt~~~~~--~~l~l~~dGn 206 (276)
T 3m7h_A 135 PAIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLVA---YGP--NGAATWNAGTQGKGA--VRAVFQGDGN 206 (276)
T ss_dssp TTSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEEE---ECT--TSSEEEECCCTTTTC--CEEEECTTSC
T ss_pred cccccccccccccccccCcccccC-CCCCCceEEEeecCCceEEE---EeC--CCeEEEECCCCCCcc--EEEEEcCCCe
Confidence 4578888887321 1235678664 57788877653 11222443 432 258899999988732 688999999
Q ss_pred eEEEcCCCCEEeccCCC-CceeeEEeecCccEEEEecCCccccccccccc
Q 038294 99 LLLKDPGGKTIWDGKPD-KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKN 147 (799)
Q Consensus 99 lvl~~~~~~~vWst~~~-~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~ 147 (799)
|++.|.++.++|++++. .....|+|+++|||||++. +++||||||
T Consensus 207 Lvl~d~~~~~vWsS~t~~~~~~rl~Ld~dGnLvly~~----~~~Wqsf~~ 252 (276)
T 3m7h_A 207 LVVYGAGNAVLWHSHTGGHASAVLRLQANGSIAILDE----KPVWARFGF 252 (276)
T ss_dssp EEEECTTSCEEEECSCTTCTTCEEEECTTSCEEEEEE----EEEEESSSC
T ss_pred EEEEeCCCcEEEEecCCCCCCEEEEEcCCccEEEEcC----CCeEEccCc
Confidence 99999988999998753 3346899999999999853 589999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.87 E-value=4.7e-09 Score=108.09 Aligned_cols=130 Identities=16% Similarity=0.060 Sum_probs=96.2
Q ss_pred cC-ccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc--ccceeeeeecccceeeEEeecCCCC
Q 038294 513 LG-RGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 513 lG-~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
++ .|..+.||+.... +++.+++|..... ....+..|+.+++.+.+.+ +.+++++...+...++||||++|.+
T Consensus 27 ~~~gg~~~~v~~~~~~--~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~ 101 (264)
T 1nd4_A 27 QTIGCSDAAVFRLSAQ--GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 101 (264)
T ss_dssp CSCTTSSCEEEEEECT--TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred cccCCCCceEEEEecC--CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcc
Confidence 44 5556999998653 4678999997643 2245778888888886544 5668888887778899999999988
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC----------------------------------------------
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC---------------------------------------------- 623 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------------- 623 (799)
|. ... .+ ...++.++++.|..||+..
T Consensus 102 l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 102 LL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 84 211 11 2367778888888888642
Q ss_pred ---------CCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 624 ---------NVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 624 ---------~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
...++|+|++|.|||++++..+.|+||+.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=9e-09 Score=111.68 Aligned_cols=140 Identities=17% Similarity=0.260 Sum_probs=104.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEcc--ccc-hhhHHHHHHHHHHhcccc--cccccceeeeeecc---cceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLA-QEREREFKSEVSAIGRTH--HKNLVQLLGFCDEA---LNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~---~~~~lv~ 582 (799)
+.|+.|.++.||+.... +..+++|+.. ... ......+..|+.+++.+. +..+++++.++.+. ...++||
T Consensus 44 ~~l~~G~sn~~y~v~~~---~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTP---GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECS---SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEEC---CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 56899999999998764 4578888875 321 122346788999998886 45688999998776 3478999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC--------------------------------------- 623 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------- 623 (799)
||++|..+.+.. ...++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 999998775422 134667888899999999999999721
Q ss_pred ----------------CCCeEecCCCCCCeEEcCCCc--eEEccccCccc
Q 038294 624 ----------------NVPIIHCDIKPQNILLDNYFS--AKISDFGLSKL 655 (799)
Q Consensus 624 ----------------~~~iiH~dlk~~NILl~~~~~--~kl~DfGla~~ 655 (799)
...++|+|+++.|||++.++. +.|.||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997653 68999998864
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.83 E-value=7.1e-09 Score=91.78 Aligned_cols=81 Identities=12% Similarity=0.215 Sum_probs=59.8
Q ss_pred CCCCCC-CceeEEcccc-eEEEcC-CCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcc
Q 038294 83 DNPAPR-GSTLELTATG-LLLKDP-GGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQI 157 (799)
Q Consensus 83 ~~pv~~-~s~l~l~~~g-lvl~~~-~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~k 157 (799)
+.|+.+ ..+|.+..|| |||.+. .++++|++++.. ....++|+|+|||||++. ++.++|||=.+ +
T Consensus 18 g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~~~~~~l~l~~dGNLVl~d~--~~~~iW~S~t~-------~-- 86 (113)
T 3mez_B 18 NAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGRGQHCFMRLGHSGELDITDD--RLNTVFVSNTV-------G-- 86 (113)
T ss_dssp TCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTSCSSCEEEECTTSCEEEECT--TSCEEEECSCC-------C--
T ss_pred CCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccCCcCEEEEEeCCCcEEEECC--CCCEEEECCCc-------C--
Confidence 444433 3489999999 999998 589999997632 235799999999999864 45689998331 0
Q ss_pred cCCCceEEeecCCCCCCCcceEEEEe-CCceEEE
Q 038294 158 LDLDSVLISRLTETNFSKGRFELRFS-NGSLKLI 190 (799)
Q Consensus 158 l~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~ 190 (799)
..|.|.+.++ +|+++++
T Consensus 87 ----------------~~~~~~~~L~~dGnlvly 104 (113)
T 3mez_B 87 ----------------QEGDYVLILQINGQAVVY 104 (113)
T ss_dssp ----------------SSSCCEEEECTTSCEEEE
T ss_pred ----------------CCCCEEEEEcCCceEEEe
Confidence 1255888887 8888876
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=98.82 E-value=8.5e-09 Score=90.94 Aligned_cols=84 Identities=8% Similarity=0.267 Sum_probs=62.1
Q ss_pred ceeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEEe
Q 038294 90 STLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLIS 166 (799)
Q Consensus 90 s~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S 166 (799)
..|.+..|| |||.+.++ +|++++.. ....++|+|+|||||++.+ ...++|||.-+
T Consensus 22 ~~L~~q~dGnLvl~~~~~--vW~snt~~~~~~~~l~l~~dGNLVl~~~~-~~~~vW~S~t~------------------- 79 (111)
T 3mez_A 22 AAFVMQGDCNLVLYNEAG--GFQSNTHGRGVDCTLRLNNRGQLEIHSAN-SNTPVWVYPRS------------------- 79 (111)
T ss_dssp EEEEECTTSCEEEECSSC--CEECCCTTSCSSCEEEECTTSCEEEECSS-CSSCSEEESSS-------------------
T ss_pred EEEEEccCCeEEEECCCC--EEECCcccCCcCEEEEEcCCCcEEEEeCC-CCEEEEEeccc-------------------
Confidence 489999999 99999877 99987632 2357999999999998642 23359999731
Q ss_pred ecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceeccc
Q 038294 167 RLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNT 208 (799)
Q Consensus 167 ~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~ 208 (799)
.....|.|.+.++ +|+++++. .++|.+++
T Consensus 80 ----~~~~~~~~~l~Lq~dGNlvly~---------~~~W~s~t 109 (111)
T 3mez_A 80 ----VNTVRGNYAATLGPDQHVTIYG---------PAIWSTPA 109 (111)
T ss_dssp ----CCCCSSCCEEEECTTSCEEEEC---------SEEEECCC
T ss_pred ----cCCCCcCEEEEECCCCeEEEec---------cCEEccCC
Confidence 1113478999998 88888873 35787764
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=7.4e-08 Score=84.68 Aligned_cols=75 Identities=17% Similarity=0.337 Sum_probs=56.9
Q ss_pred CceeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEE
Q 038294 89 GSTLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLI 165 (799)
Q Consensus 89 ~s~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~ 165 (799)
...|.|..|| |+|.+. ++++|+++... ....++|+|+|||||++. ++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~~~~~~l~l~~dGNLvl~~~--~~~~~W~S~t~~----------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGLDRRCHLSMQSDGNLVVYSP--RNNPIWASNTGG----------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTSSSSCEEEECTTSCEEEECT--TSCEEEECCCCC-----------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccCCCCEEEEEeCCCCEEEECC--CCCEEEECCCCC-----------------
Confidence 3588999999 999987 78999997632 235799999999999864 456899986421
Q ss_pred eecCCCCCCCcceEEEEe-CCceEEEe
Q 038294 166 SRLTETNFSKGRFELRFS-NGSLKLIS 191 (799)
Q Consensus 166 S~~s~~dps~G~f~~~~~-~~~~~~~~ 191 (799)
..+.|.+.++ +|+++++-
T Consensus 80 --------~~~~~~~~L~ddGNlvly~ 98 (109)
T 3dzw_A 80 --------ENGNYVCVLQKDRNVVIYG 98 (109)
T ss_dssp --------SSSCEEEEECTTSCEEEEE
T ss_pred --------CCCCEEEEEeCCCEEEEEC
Confidence 1256888887 88888763
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-08 Score=106.55 Aligned_cols=183 Identities=17% Similarity=0.112 Sum_probs=119.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-cccc--ccceeeeeeccc---ceeeEEee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKN--LVQLLGFCDEAL---NRLLVYEF 584 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~g~~~~~~---~~~lv~e~ 584 (799)
+.++.|....||+.. ..+++|+.... .....+..|+++++.+ .+.. +.+++....... ..++|||+
T Consensus 26 ~~~~~G~~n~v~~v~------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CEEEECSSEEEEEST------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred EecCCCCcceEEEEC------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 458899999999752 35888886532 3346788899999887 3333 445655544333 34789999
Q ss_pred cCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 038294 585 MGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE------------------------------------------ 622 (799)
Q Consensus 585 ~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~------------------------------------------ 622 (799)
++|.+|.+... ..++..++..++.++++.|+.||..
T Consensus 98 i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 98 IKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred cCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 99988865433 2456667778888888888888851
Q ss_pred -------------CCCCeEecCCCCCCeEEcC--CCceEEccccCcccccCCCCcceeeeccCCcc---ccccccc----
Q 038294 623 -------------CNVPIIHCDIKPQNILLDN--YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGY---VAPEWFK---- 680 (799)
Q Consensus 623 -------------~~~~iiH~dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~l~---- 680 (799)
....++|+|++|.||++++ ...+.|+||+.+........ .. ..... ..|+...
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-l~----~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-FI----SLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-HH----TTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-HH----HHHhhccccCHHHHHHHHH
Confidence 1135899999999999998 56688999998865321100 00 00000 1222110
Q ss_pred -CCCC---------CcchhHHHHHHHHHHHHhCCcCCc
Q 038294 681 -NAPV---------SAKVDVYSFGVMLLEIICCRRSVE 708 (799)
Q Consensus 681 -~~~~---------s~k~DVwS~Gvll~elltg~~p~~ 708 (799)
.+.. ....+.|+++.++|++.+|..++.
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 0111 123689999999999999987754
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.53 E-value=5.1e-07 Score=91.37 Aligned_cols=73 Identities=16% Similarity=0.316 Sum_probs=53.5
Q ss_pred ceeEEcccc-eEEEcCCCCEEeccCCC-CceeeEEeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEEee
Q 038294 90 STLELTATG-LLLKDPGGKTIWDGKPD-KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISR 167 (799)
Q Consensus 90 s~l~l~~~g-lvl~~~~~~~vWst~~~-~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~ 167 (799)
..|.|..+| ++|.+. +++||++|.. .....++|+++|||||.+. +++++|+|+++
T Consensus 28 f~l~f~~~gnl~ly~~-~~~vW~an~~~~~~~~l~l~~dGnLvl~d~--~~~~vW~s~~~-------------------- 84 (236)
T 1dlp_A 28 FRFTMQSDCNLVLFDS-DVRVWASNTAGATGCRAVLQSDGLLVILTA--QNTIRWSSGTK-------------------- 84 (236)
T ss_dssp EEEEECTTSCEEEEES-SSEEECCCCCSCSCCBCCBCSSSCBCCBCT--TTCCSCCCCCC--------------------
T ss_pred EEEEECCCCcEEEEEC-CEEEEECCCCCCCCeEEEEcCCCcEEEEcC--CCcEEEeCCcc--------------------
Confidence 356666666 777775 7899998853 2345789999999999764 56799999975
Q ss_pred cCCCCCCCcceEEEEe-CCceEEE
Q 038294 168 LTETNFSKGRFELRFS-NGSLKLI 190 (799)
Q Consensus 168 ~s~~dps~G~f~~~~~-~~~~~~~ 190 (799)
.++|.|.+.++ +|+++++
T Consensus 85 -----~~~~~~~~~l~d~Gnlvl~ 103 (236)
T 1dlp_A 85 -----GSIGNYVLVLQPDRTVTIY 103 (236)
T ss_dssp -----CCSSCCEEEECSSSCEEEE
T ss_pred -----ccCCcEEEEEeCCCCEEEe
Confidence 12356778886 7777775
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.52 E-value=3.5e-07 Score=80.20 Aligned_cols=94 Identities=24% Similarity=0.405 Sum_probs=69.6
Q ss_pred CCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEeccccc
Q 038294 149 TDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESAD 227 (799)
Q Consensus 149 TDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 227 (799)
+|||+|||.|..+..| +.|.|.|.|+ +|+++++. .||.+.+... +.+..+.++..|.
T Consensus 3 ~dtL~~gq~L~~g~~L---------~~g~~~L~~q~dGNLvl~~----------~~Wssnt~~~---~~~~~l~l~~dGn 60 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL---------KNGDFDLVMQDDCNLVLYN----------GNWQSNTANN---GRDCKLTLTDYGE 60 (109)
T ss_dssp CSEEETTCEECTTCEE---------EETTEEEEECTTSCEEEET----------TTEECCCTTS---CSSCEEEECTTSC
T ss_pred cCCcCCCCCcCCCCEe---------ECCCEEEEEecCCeEEEEe----------CeEEcCCCCC---CCcEEEEEcCCCe
Confidence 6999999999999999 3499999998 88887752 3788765432 3456778888888
Q ss_pred EEEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 228 VYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
+.+++.++..+..+. .......++++|+.||++++|.
T Consensus 61 Lvl~d~~~~~vWss~----t~~~~~~~~~~L~~dGNlvly~ 97 (109)
T 3r0e_A 61 LVIKNGDGSTVWKSG----AQSVKGNYAAVVHPDGRLVVFG 97 (109)
T ss_dssp EEEECTTSCEEEECC----CCCSSSCCEEEEETTTEEEEEC
T ss_pred EEEEeCCCCEEEcCC----CcCCCcCEEEEEcCCCeEEEEe
Confidence 888877666554332 1112335689999999999994
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=98.37 E-value=1.4e-06 Score=76.49 Aligned_cols=96 Identities=22% Similarity=0.235 Sum_probs=69.9
Q ss_pred CCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEeccccc
Q 038294 149 TDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESAD 227 (799)
Q Consensus 149 TDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 227 (799)
+|||+|||.|..++.|+| |.|.|.|+ +|+++++. . ..||.+.+.. .+.+..+.+...|.
T Consensus 6 ~dtL~~gq~L~~g~~L~s---------g~~~L~~q~dGnLvl~~---~-----~~vW~snt~~---~~~~~~l~l~~dGN 65 (110)
T 3r0e_B 6 NNLLFSGQVLYGDGRLTA---------KNHQLVMQGDCNLVLYG---G-----KYGWQSNTHG---NGEHCFLRLNHKGE 65 (110)
T ss_dssp TTEEETTCEEETTEEEEC---------SSCEEEECTTSCEEEEC---S-----SSCEECCCTT---SSSSCEEEECTTSC
T ss_pred cCEECCCCEecCCCEEEe---------CCEEEEEcCCCeEEEEC---C-----eEEEECCCcC---CCcCEEEEEeCCCc
Confidence 799999999999999986 78999998 78877742 1 3688876543 13445778888888
Q ss_pred EEEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 228 VYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
+.+++.++..+..+. .. .....++++|+.||++++|.
T Consensus 66 Lvl~d~~~~~iW~S~---t~-~~~~~~~~~L~~dGNlvly~ 102 (110)
T 3r0e_B 66 LIIKDDDFKTIWSSR---SS-SKQGEYVLILQDDGFGVIYG 102 (110)
T ss_dssp EEEECTTCCEEEECC---CC-CSSSCCEEEECTTSCEEEEC
T ss_pred EEEEeCCCCEEEEcC---Cc-CCCCCEEEEEcCCccEEEec
Confidence 888877666554432 11 11123689999999999994
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=98.16 E-value=1.6e-05 Score=69.01 Aligned_cols=97 Identities=18% Similarity=0.201 Sum_probs=71.0
Q ss_pred CccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEecccccE
Q 038294 150 DTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADV 228 (799)
Q Consensus 150 DtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (799)
|||+|||.|..++.|+| |.|+|.|+ +++++++.. . ...|.+.+.... ..+..+.+...|.+
T Consensus 2 n~L~~g~~L~~g~~L~s---------g~y~l~~q~DgNLvly~~--~-----~~vW~ant~~~~--~~~~~L~l~~dGnL 63 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV---------EPYHFIMQDDCNLVLYDH--S-----TSTWASNTEIGG--KSGCSAVLQSDGNF 63 (105)
T ss_dssp CEECTTEEECTTCEEEE---------TTEEEEECTTSCEEEEET--T-----EEEEECCCCCTT--CCSCEEEECTTSCE
T ss_pred CCcCCCCEEcCCCEEEE---------CCEEEEECCCCeEEEEEC--C-----EEEEEecCCCCC--CccEEEEEeCCccE
Confidence 89999999999999987 89999999 888887642 2 457877654332 23456778888888
Q ss_pred EEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 229 YIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
.+++.++..+-.+.. .....-.+++|..||++.+|.
T Consensus 64 vL~d~~~~~vWss~t----~~~~~~~~l~L~ddGNlVly~ 99 (105)
T 4h3o_A 64 VVYDSSGRSLWASHS----TRGSGNYILILQDDGNVIIYG 99 (105)
T ss_dssp EEECTTCCEEEECCC----CCCSSCEEEEECTTSCEEEEE
T ss_pred EEECCCcEEEEEecC----CCCCCCEEEEEeCCCeEEEEC
Confidence 888888776644421 112223578999999999983
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=1.2e-05 Score=83.14 Aligned_cols=136 Identities=15% Similarity=0.100 Sum_probs=95.0
Q ss_pred hcCccccc-eEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecCCCC
Q 038294 512 ELGRGSFG-IVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 512 ~lG~G~fG-~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
.+..|..+ .||+..... ++..+++|+-.. ....++..|...|+.+. +--+.++++++.+....++|||++++.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~-~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKP-NAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCT-TCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecC-CCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 34455555 589866543 456788888643 23456788888888774 4447789999988888999999999988
Q ss_pred hhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 038294 590 LANLIFAIPKPDWNLRVRISLEIARGLVYLHEE----------------------------------------------- 622 (799)
Q Consensus 590 L~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------- 622 (799)
+.+..... ......+..+++..|+-||..
T Consensus 107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 77654321 122334555666666666642
Q ss_pred --------CCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 623 --------CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 623 --------~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
....++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 012379999999999999887778999998753
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.2e-05 Score=82.73 Aligned_cols=135 Identities=19% Similarity=0.163 Sum_probs=90.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccc---cccceeeeee-cccceeeEEeecC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHK---NLVQLLGFCD-EALNRLLVYEFMG 586 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~ 586 (799)
+.++.|....||+. +..+++|+-.. ......+..|.++|..+.+. .+.+++.++. .....++|||+++
T Consensus 25 ~~l~~G~~n~v~~v------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 25 ESLGEGFRNYAILV------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEECSSEEEEEE------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eecCCCcceeEEEE------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 34778888889986 34577887532 23346788999999998642 3567777764 4455789999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE-------------------------------------------- 622 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------- 622 (799)
|.+|.+... ..++...+..++.++++.|+.||+.
T Consensus 97 G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 97 GQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp SEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred CeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 988765321 1223344444555555555555431
Q ss_pred -------------CCCCeEecCCCCCCeEEcC---CCc-eEEccccCccc
Q 038294 623 -------------CNVPIIHCDIKPQNILLDN---YFS-AKISDFGLSKL 655 (799)
Q Consensus 623 -------------~~~~iiH~dlk~~NILl~~---~~~-~kl~DfGla~~ 655 (799)
....++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2235799999999999997 455 48999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=2.2e-05 Score=84.63 Aligned_cols=82 Identities=2% Similarity=-0.042 Sum_probs=55.1
Q ss_pred hhc-CccccceEEEEEEe---CC--CCeEEEEEEccccc---hhhHHHHHHHHHHhcccc-c--ccccceeeeeecc---
Q 038294 511 EEL-GRGSFGIVYKGVLK---SA--SGKAIAVKKLDRLA---QEREREFKSEVSAIGRTH-H--KNLVQLLGFCDEA--- 575 (799)
Q Consensus 511 ~~l-G~G~fG~Vykg~~~---~~--~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~g~~~~~--- 575 (799)
+.| +.|....+|+.... ++ +++.+++|+..... ......+..|+.+++.+. + ..+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 88889999987653 10 15678888865432 101245678888888874 3 3577888887665
Q ss_pred cceeeEEeecCCCChhh
Q 038294 576 LNRLLVYEFMGNGTLAN 592 (799)
Q Consensus 576 ~~~~lv~e~~~~gsL~~ 592 (799)
...++||||++|..+.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 34689999999876653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=0.00013 Score=79.78 Aligned_cols=75 Identities=17% Similarity=0.136 Sum_probs=47.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccch-------hhHHHHHHHHHHhccccc--c-cccceeeeeecccceee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ-------EREREFKSEVSAIGRTHH--K-NLVQLLGFCDEALNRLL 580 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~g~~~~~~~~~l 580 (799)
+.||.|..+.||++.... +++.++||....... .....+..|.++++.+.+ + .+.+++.+. ....++
T Consensus 36 ~~lg~G~~n~vyrv~~~~-~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EECCCCceEEEEEEEECC-CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 568999999999997653 357899997643211 122346678888877642 3 344566543 345689
Q ss_pred EEeecCCC
Q 038294 581 VYEFMGNG 588 (799)
Q Consensus 581 v~e~~~~g 588 (799)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00062 Score=71.49 Aligned_cols=134 Identities=16% Similarity=0.154 Sum_probs=89.1
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc---cccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.|+.|....+|+... ++..+++|+.... ....+..|.+.|+.+. ...+++++.++......++||||+++
T Consensus 42 ~~l~gG~~n~~y~v~~---~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND---EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEECCSSSSEEEEEES---SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred EEeCCccceeeeEEEE---CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 4689999999999764 3567888887532 3456888988888874 35688899988877788999999998
Q ss_pred CChhh-----------hhhcCCC----------------------CCHHHHH---HHH----------------HHHHHH
Q 038294 588 GTLAN-----------LIFAIPK----------------------PDWNLRV---RIS----------------LEIARG 615 (799)
Q Consensus 588 gsL~~-----------~l~~~~~----------------------~~~~~~~---~i~----------------~~ia~g 615 (799)
..+.. .|+.... -+|.... ++. ..+...
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76421 1121110 1354221 111 111111
Q ss_pred H-HHHHh-cCCCCeEecCCCCCCeEEcCCCceEEcccc
Q 038294 616 L-VYLHE-ECNVPIIHCDIKPQNILLDNYFSAKISDFG 651 (799)
Q Consensus 616 L-~yLH~-~~~~~iiH~dlk~~NILl~~~~~~kl~DfG 651 (799)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23421 2246799999999999999887 8899974
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0014 Score=69.59 Aligned_cols=136 Identities=15% Similarity=0.142 Sum_probs=76.8
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc--ccccceeee------eecccceeeEEe
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH--KNLVQLLGF------CDEALNRLLVYE 583 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~g~------~~~~~~~~lv~e 583 (799)
.|+.|....||+.... +..+++|+..... .++..|+.++..+.. -.+.+++.. .......++++|
T Consensus 39 ~l~gG~~n~~~~v~~~---~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 39 VIQGNQMALVWKVHTD---SGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp ECC----CEEEEEEET---TEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eccccccCcEEEEEeC---CCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 4666778899998753 3458899886521 233344555554431 123444431 123456789999
Q ss_pred ecCCCChh-----------hh---hhc----C--C--------CCCHHHHH-----------------------------
Q 038294 584 FMGNGTLA-----------NL---IFA----I--P--------KPDWNLRV----------------------------- 606 (799)
Q Consensus 584 ~~~~gsL~-----------~~---l~~----~--~--------~~~~~~~~----------------------------- 606 (799)
|++|..+. .. ++. . + ...|....
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 01 111 0 0 01232210
Q ss_pred --HHHHHHHHHHHHHHh----------cCCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 607 --RISLEIARGLVYLHE----------ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 607 --~i~~~ia~gL~yLH~----------~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
.+...+..++++|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 011123445666663 124589999999999999888899999999765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0013 Score=72.51 Aligned_cols=79 Identities=9% Similarity=-0.040 Sum_probs=47.3
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCC---CCcchhHHHHHHHHHHH
Q 038294 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAP---VSAKVDVYSFGVMLLEI 700 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~s~k~DVwS~Gvll~el 700 (799)
...++|+|+++.|||++.++ ++|+||+.+..-.....-......-...|.+|+...... -....++.+....+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34799999999999999876 999999988753211000000000013466666553211 12235566778888877
Q ss_pred HhC
Q 038294 701 ICC 703 (799)
Q Consensus 701 ltg 703 (799)
+++
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0013 Score=68.26 Aligned_cols=74 Identities=22% Similarity=0.271 Sum_probs=52.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc---ccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH---KNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
+.+|.|..+.||+.++. +|+.+++|+...........|..|++.|+.+.. --++++++.. ..++||||+++
T Consensus 21 ~~~g~G~~~~vyrv~l~--DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~~ 94 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELA--DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVDE 94 (288)
T ss_dssp EEEEEETTEEEEEEEET--TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCCC
T ss_pred EecCCCCCeEEEEEEEC--CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeecc
Confidence 56899999999999885 578999998765433334567888888887742 2345555542 34789999987
Q ss_pred CCh
Q 038294 588 GTL 590 (799)
Q Consensus 588 gsL 590 (799)
+..
T Consensus 95 ~~~ 97 (288)
T 3f7w_A 95 RPP 97 (288)
T ss_dssp CCC
T ss_pred cCC
Confidence 643
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0033 Score=69.29 Aligned_cols=74 Identities=14% Similarity=0.201 Sum_probs=49.6
Q ss_pred hhcCccccceEEEEEEeCC------CCeEEEEEEccccchhhHHHHHHHHHHhcccccccc-cceeeeeecccceeeEEe
Q 038294 511 EELGRGSFGIVYKGVLKSA------SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 583 (799)
+.|+.|....+|+....+. +++.+++|+.... .....+..|..+++.+...++ .++++.+.++ +|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~g----~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSGG----RLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETTE----EEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCCC----EEEE
Confidence 4578888889999886521 2468889987432 112455678888888754444 6777766542 8999
Q ss_pred ecCCCCh
Q 038294 584 FMGNGTL 590 (799)
Q Consensus 584 ~~~~gsL 590 (799)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0069 Score=65.29 Aligned_cols=140 Identities=17% Similarity=0.200 Sum_probs=82.4
Q ss_pred hhcCccccceEEEEEEeC------CCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEe
Q 038294 511 EELGRGSFGIVYKGVLKS------ASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~------~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.|..|-...+|+....+ .+++.+++|+.... ......+.+|.++++.+. +.-..++++++.++ +|+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEE
Confidence 356677788899987642 13468888886432 223455668888888874 33346777777653 8999
Q ss_pred ecCCCChhh--------------hh---hcC-----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 038294 584 FMGNGTLAN--------------LI---FAI-----PKPD--WNLRVRISLEIAR-------------------GLVYLH 620 (799)
Q Consensus 584 ~~~~gsL~~--------------~l---~~~-----~~~~--~~~~~~i~~~ia~-------------------gL~yLH 620 (799)
|++|.+|.. .| +.. +... |.+..++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865531 11 111 1122 4444444443321 233332
Q ss_pred h----c-CCCCeEecCCCCCCeEEcCC----CceEEccccCccc
Q 038294 621 E----E-CNVPIIHCDIKPQNILLDNY----FSAKISDFGLSKL 655 (799)
Q Consensus 621 ~----~-~~~~iiH~dlk~~NILl~~~----~~~kl~DfGla~~ 655 (799)
. . ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 1 23468999999999999876 7899999998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.28 E-value=0.03 Score=54.45 Aligned_cols=102 Identities=10% Similarity=0.009 Sum_probs=66.5
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
-+|.++|... .++++++++.++.|.+.+|.-+-.... + ..+=+.|..|+|..+|.+.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence 4789999865 589999999999999999877622111 1 1223456899999999998764 1110
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS 706 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p 706 (799)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122466888763 3457889999999999998854433
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.22 E-value=0.0076 Score=63.40 Aligned_cols=139 Identities=12% Similarity=0.105 Sum_probs=76.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc--ccceeeee------ecccceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGFC------DEALNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~~------~~~~~~~lv~ 582 (799)
+.|+.|....+|+.... ++ .+++|..... ....++..|+.++..+...+ +.+++... ......++++
T Consensus 28 ~~i~~G~~n~~~~v~~~--~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTT--KD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEECC---EEEEEEEES--SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eccCCCcccceEEEEeC--Cc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 34677888899988764 23 6788887642 11234556777766664222 33444221 1224468899
Q ss_pred eecCCCChhh-----------h---hhc----CCC--------CCHHHHHH------------HHHHHHHHHHHHHhc--
Q 038294 583 EFMGNGTLAN-----------L---IFA----IPK--------PDWNLRVR------------ISLEIARGLVYLHEE-- 622 (799)
Q Consensus 583 e~~~~gsL~~-----------~---l~~----~~~--------~~~~~~~~------------i~~~ia~gL~yLH~~-- 622 (799)
+|++|..+.. . ++. ... ..|..... +...+...++.++..
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998865321 0 111 000 11332111 011244455555532
Q ss_pred --CCCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 623 --CNVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 623 --~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 13479999999999999987666899998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.20 E-value=0.0082 Score=62.61 Aligned_cols=134 Identities=16% Similarity=0.152 Sum_probs=72.5
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccc-cceeeeeecccceeeEEeec-CCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFM-GNG 588 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~g 588 (799)
+.|+.|....+|+. +.+++|+....... ......|+.+++.+...++ .++++++. ..-++++||+ ++.
T Consensus 24 ~~l~gG~tN~~~~~-------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQ 93 (301)
T ss_dssp EEEESCSSEEEEEE-------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCE
T ss_pred eEcCCcccccccee-------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCc
Confidence 56888988999987 24778877542211 1123457777776643333 46666543 3457899999 654
Q ss_pred Chhh--------hh----------hcCC-CC----C-HHHHHHHHH--------------HHHHHHH----HHHh-cCCC
Q 038294 589 TLAN--------LI----------FAIP-KP----D-WNLRVRISL--------------EIARGLV----YLHE-ECNV 625 (799)
Q Consensus 589 sL~~--------~l----------~~~~-~~----~-~~~~~~i~~--------------~ia~gL~----yLH~-~~~~ 625 (799)
+|.. .. +..+ .. . +....++.. .+.+.+. .+.. ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 00 1111 00 1 111111110 0111111 1111 1234
Q ss_pred CeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 626 ~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 5899999999999 5666789999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.10 E-value=0.015 Score=64.30 Aligned_cols=74 Identities=18% Similarity=0.087 Sum_probs=46.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccc-cceeeeeecccceeeEEeecCCCC
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYEFMGNGT 589 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 589 (799)
+.|+.|-...+|+....+ .++.+++|+....... .-.-..|..++..+...++ .++++.+.. .+|+||+++.+
T Consensus 114 ~~lsgG~tN~~y~v~~~~-~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMS-KQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEECC--CEEEEEEEETT-TTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEcCCCeEeEEEEEEECC-CCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 467888889999987642 2478888887432211 1112567888887754444 577777743 25999998754
Q ss_pred h
Q 038294 590 L 590 (799)
Q Consensus 590 L 590 (799)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.09 E-value=0.022 Score=60.27 Aligned_cols=32 Identities=28% Similarity=0.359 Sum_probs=27.6
Q ss_pred CCCeEecCCCCCCeEEcCC----CceEEccccCccc
Q 038294 624 NVPIIHCDIKPQNILLDNY----FSAKISDFGLSKL 655 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~----~~~kl~DfGla~~ 655 (799)
...++|+|+.+.||+++.+ ..+.|+||+.+..
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3479999999999999874 6899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.024 Score=60.87 Aligned_cols=75 Identities=15% Similarity=0.096 Sum_probs=43.2
Q ss_pred hhcCccccceEEEEEEeCC-------CCeEEEEEEccccchhhHHHHHHHHHHhccccccc-ccceeeeeecccceeeEE
Q 038294 511 EELGRGSFGIVYKGVLKSA-------SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~-------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~ 582 (799)
+.|+.|..-.+|+...... .++.+++|+....... ..+...|.++++.+...+ ..++++... -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEEE
Confidence 4577788889999876421 1257888887543221 112356777777775334 346665542 36899
Q ss_pred eecCCCCh
Q 038294 583 EFMGNGTL 590 (799)
Q Consensus 583 e~~~~gsL 590 (799)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.68 E-value=0.027 Score=59.21 Aligned_cols=138 Identities=13% Similarity=0.071 Sum_probs=76.0
Q ss_pred hcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccc--ccceeee-----eecccceeeEEee
Q 038294 512 ELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN--LVQLLGF-----CDEALNRLLVYEF 584 (799)
Q Consensus 512 ~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~g~-----~~~~~~~~lv~e~ 584 (799)
.++ |....||+.... +|+.+++|...... .....+..|..++..+.... +++++.. .......++++|+
T Consensus 33 ~l~-g~~n~~y~v~~~--~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE--DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCT--TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcC--CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 355 777889986543 45678999985321 12345666777777664222 3445443 1112345789999
Q ss_pred cCCCChhh-----------h---hhc----C-----CCCCHHHH----HHH---------------HHHHHHHHHHHHhc
Q 038294 585 MGNGTLAN-----------L---IFA----I-----PKPDWNLR----VRI---------------SLEIARGLVYLHEE 622 (799)
Q Consensus 585 ~~~gsL~~-----------~---l~~----~-----~~~~~~~~----~~i---------------~~~ia~gL~yLH~~ 622 (799)
++|..+.. . ++. . ...++... ..+ ...+...++.+...
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 98754321 1 110 0 11122111 001 01111223333221
Q ss_pred ----CCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 623 ----CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 623 ----~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999987653
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.97 E-value=0.12 Score=54.73 Aligned_cols=31 Identities=32% Similarity=0.363 Sum_probs=27.5
Q ss_pred CCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 625 ~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987654
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.79 E-value=0.19 Score=54.72 Aligned_cols=75 Identities=12% Similarity=0.095 Sum_probs=46.0
Q ss_pred hhcCccccceEEEEEEeCCC------CeEEEEEEccccchhhHHHHHHHHHHhccccccc-ccceeeeeecccceeeEEe
Q 038294 511 EELGRGSFGIVYKGVLKSAS------GKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKN-LVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~------~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~g~~~~~~~~~lv~e 583 (799)
+.|..|-...+|+......+ ++.+++|+..... .......+|..+++.+...+ ..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 35677878889998775211 4678888864422 11112356777777764333 355665442 368999
Q ss_pred ecCCCCh
Q 038294 584 FMGNGTL 590 (799)
Q Consensus 584 ~~~~gsL 590 (799)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998654
|
| >3no2_A Uncharacterized protein; six-bladed beta-propeller, structural genomics, joint center structural genomics, JCSG, protein structure initiative; HET: MSE CIT PEG; 1.35A {Bacteroides caccae} | Back alignment and structure |
|---|
Probab=87.57 E-value=24 Score=35.32 Aligned_cols=84 Identities=17% Similarity=0.253 Sum_probs=51.1
Q ss_pred EEEEEeccCCCCeEEEeecCCCC-------CCCCceeEEcccc-eEEEcCCCCEEeccCCC--CceeeEEeecCccEEEE
Q 038294 63 LLAIWFNKIPERTIVWHANGDNP-------APRGSTLELTATG-LLLKDPGGKTIWDGKPD--KKVSDAAMLDTGNFVLR 132 (799)
Q Consensus 63 ylgiw~~~~~~~t~VWvANr~~p-------v~~~s~l~l~~~g-lvl~~~~~~~vWst~~~--~~~~~a~LldsGNlVl~ 132 (799)
.+.||= .....++|...+..+ +..+..+-++.++ +..+|++|..+|..... .....++.+.+||+++-
T Consensus 16 ~v~~~d--~~tG~~~w~~~~~~~~~~~~~~~~pdG~ilvs~~~~V~~~d~~G~~~W~~~~~~~~~~~~~~~~~dG~~lv~ 93 (276)
T 3no2_A 16 KIAIIN--KDTKEIVWEYPLEKGWECNSVAATKAGEILFSYSKGAKMITRDGRELWNIAAPAGCEMQTARILPDGNALVA 93 (276)
T ss_dssp EEEEEE--TTTTEEEEEEECCTTCCCCEEEECTTSCEEEECBSEEEEECTTSCEEEEEECCTTCEEEEEEECTTSCEEEE
T ss_pred EEEEEE--CCCCeEEEEeCCCccCCCcCeEECCCCCEEEeCCCCEEEECCCCCEEEEEcCCCCccccccEECCCCCEEEE
Confidence 356662 335678898887642 1122334445554 77788899999996542 23445777888888876
Q ss_pred ecC---------CcccccccccccCC
Q 038294 133 ASG---------NNSDYAWQSFKNPT 149 (799)
Q Consensus 133 ~~~---------~~~~~lWQSFD~PT 149 (799)
+.. .+++.+|+ |..++
T Consensus 94 ~~~~~~~v~~vd~~Gk~l~~-~~~~~ 118 (276)
T 3no2_A 94 WCGHPSTILEVNMKGEVLSK-TEFET 118 (276)
T ss_dssp EESTTEEEEEECTTSCEEEE-EEECC
T ss_pred ecCCCCEEEEEeCCCCEEEE-EeccC
Confidence 432 24556666 44433
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.27 E-value=1.2 Score=48.22 Aligned_cols=30 Identities=30% Similarity=0.336 Sum_probs=25.2
Q ss_pred CeEecCCCCCCeEE------cCCCceEEccccCccc
Q 038294 626 PIIHCDIKPQNILL------DNYFSAKISDFGLSKL 655 (799)
Q Consensus 626 ~iiH~dlk~~NILl------~~~~~~kl~DfGla~~ 655 (799)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567899999988764
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.72 E-value=1.5 Score=30.53 Aligned_cols=6 Identities=33% Similarity=0.512 Sum_probs=2.3
Q ss_pred HHHhhc
Q 038294 473 LKWRRR 478 (799)
Q Consensus 473 ~~~rr~ 478 (799)
+++|||
T Consensus 32 ~~~RRR 37 (44)
T 2l2t_A 32 VYVRRK 37 (44)
T ss_dssp HHHHTT
T ss_pred HHhhhh
Confidence 333333
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.97 E-value=4.2 Score=39.29 Aligned_cols=117 Identities=15% Similarity=0.145 Sum_probs=79.0
Q ss_pred ccccccceeeeeecccceeeEEeecCC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEE
Q 038294 561 HHKNLVQLLGFCDEALNRLLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILL 639 (799)
Q Consensus 561 ~h~niv~l~g~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl 639 (799)
.||+++.. .+-.+.+...+.|+.-+. -++.. ....+...+++++.+|+....+++. -+|--|.|+|+++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f 112 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF 112 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence 57877765 455555565566665432 22222 2356778899999999988866664 3788899999999
Q ss_pred cCCCceEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchh
Q 038294 640 DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEME 710 (799)
Q Consensus 640 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~ 710 (799)
+.++.+++.-.|+...+ +|. ..++..=.-.+=+++..+++++..|+.-
T Consensus 113 ~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~l 160 (215)
T 4ann_A 113 TRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDAL 160 (215)
T ss_dssp CTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHHH
T ss_pred cCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHHH
Confidence 99999999887764432 222 1122233445778889999998887643
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 799 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-66 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-64 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-60 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-59 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 7e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-52 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-48 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-42 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 9e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-40 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-39 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-33 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-20 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 3e-10 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 2e-08 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 6e-04 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 3e-06 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 5e-06 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 0.004 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 4e-05 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 3e-69
Identities = 66/279 (23%), Positives = 120/279 (43%), Gaps = 23/279 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +G GSFG VYKG A+ + + ++ + FK+EV + +T H N++
Sbjct: 12 VGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
+G+ +V ++ +L + + I + + I+ + A+G+ YLH + I
Sbjct: 70 MGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SI 125
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRTHTMIRGTRGYVAPEWFK---NAP 683
IH D+K NI L + KI DFGL+ + S + G+ ++APE + P
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 684 VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743
S + DVY+FG++L E++ + R + Y L + + AM
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQLPYS---NINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242
Query: 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ C+++ +RP +L +E L
Sbjct: 243 KR---------LMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (559), Expect = 6e-66
Identities = 70/308 (22%), Positives = 130/308 (42%), Gaps = 38/308 (12%)
Query: 497 FSYNELKEATGGFKEE-----------LGRGSFGIVYKGVLKSASGK--AIAVKKLDR-L 542
F++ + EA F +E +G G FG V G LK + +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 543 AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-D 601
+++ R+F SE S +G+ H N++ L G ++ +++ EFM NG+L + +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126
Query: 602 WNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661
V + IA G+ YL + +H D+ +NIL+++ K+SDFGLS+ L D S
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183
Query: 662 RTHTM----IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA 717
+ + APE + ++ DV+S+G+++ E++
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------------ 231
Query: 718 ILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQML 777
Y + ++ D + + C ++D + RP ++ L
Sbjct: 232 ----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL 287
Query: 778 EGLLEVPN 785
+ ++ PN
Sbjct: 288 DKMIRNPN 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 1e-64
Identities = 72/275 (26%), Positives = 122/275 (44%), Gaps = 23/275 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +E+G G FG+V+ G + +A+K + A E +F E + + H LVQL
Sbjct: 9 FVQEIGSGQFGLVHLGYWLN--KDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQL 65
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G C E LV+EFM +G L++ + + + L++ G+ YL E C +
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---V 122
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
IH D+ +N L+ K+SDFG+++ +L DQ + T + + +PE F + S+K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747
DV+SFGV++ E+ + Y+ + + + + R
Sbjct: 183 SDVWSFGVLMWEVFSEGKIP----------------YENRSNSEVVEDISTGFRLYKPRL 226
Query: 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
I C +E P RP +L+ L + E
Sbjct: 227 ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 3e-64
Identities = 64/272 (23%), Positives = 117/272 (43%), Gaps = 25/272 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E LG G FG V+ G +AVK L + + + F +E + + + H+ LV+L
Sbjct: 17 LVERLGAGQFGEVWMGYYNG--HTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRL 73
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNVP 626
+ ++ E+M NG+L + + N + ++ +IA G+ ++ E
Sbjct: 74 YAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--- 129
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IH D++ NIL+ + S KI+DFGL++L+ ++ + + APE +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746
K DV+SFG++L EI+ R Y + ++ +
Sbjct: 190 KSDVWSFGILLTEIVTHGR----------------IPYPGMTNPEVIQNLERGYRMVRPD 233
Query: 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
+ ++ + C +E P RPT + +LE
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-63
Identities = 63/271 (23%), Positives = 112/271 (41%), Gaps = 23/271 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
F +ELG G FG+V G + +A+K + E EF E + H+ LVQL
Sbjct: 8 FLKELGTGQFGVVKYGKWRG--QYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
G C + ++ E+M NG L N + + + + ++ + YL +
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---F 121
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D+ +N L+++ K+SDFGLS+ +L D+ + + + PE + S+K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747
D+++FGV++ EI + Y+ + +
Sbjct: 182 SDIWAFGVLMWEIYSLGK----------------MPYERFTNSETAEHIAQGLRLYRPHL 225
Query: 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
+K I C E +RPT K++L +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-62
Identities = 60/296 (20%), Positives = 119/296 (40%), Gaps = 27/296 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+E +G+G FG V++G + G+ +AVK +ER ++E+ H+N++
Sbjct: 7 LQESIGKGRFGEVWRGKWR---GEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGF 62
Query: 569 LGFCDE----ALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC- 623
+ ++ LV ++ +G+L + + ++++L A GL +LH E
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 624 ----NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH---TMIRGTRGYVAP 676
I H D+K +NIL+ + I+D GL+ S GT+ Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 677 EWF------KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI---LTDWAYDCY 727
E K+ + D+Y+ G++ EI + + + +D + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 728 AEGRLDVLVDSDEPA-MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ + + + P L+ I C + + R T + + L L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 4e-62
Identities = 62/294 (21%), Positives = 118/294 (40%), Gaps = 33/294 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQ 567
ELG G+ G+V+K K SG +A K + + R E+ + + +V
Sbjct: 10 KISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G + E M G+L ++ + + ++S+ + +GL YL E+ I
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--I 126
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D+KP NIL+++ K+ DFG+S L+ + + GTR Y++PE + S +
Sbjct: 127 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV---GTRSYMSPERLQGTHYSVQ 183
Query: 688 VDVYSFGVMLLEIICCRR--------SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
D++S G+ L+E+ R +E+ + + GR D
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243
Query: 740 EPAMADRSRLQKWLMIAMW------------------CIREDPSKRPTMKVVLQ 775
L +++ C+ ++P++R +K ++
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 3e-61
Identities = 70/275 (25%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +G+G FG V G + G +AVK + + F +E S + + H NLVQL
Sbjct: 11 LLQTIGKGEFGDVMLGDYR---GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQL 65
Query: 569 LGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNV 625
LG E L +V E+M G+L + + + + + ++ SL++ + YL
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN--- 122
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+H D+ +N+L+ AK+SDFGL+K S T + + APE + S
Sbjct: 123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFS 178
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
K DV+SFG++L EI R + + +G D PA+ +
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKMDAPDGCPPAVYE 231
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780
+ C D + RP+ + + LE +
Sbjct: 232 ---------VMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-60
Identities = 71/274 (25%), Positives = 119/274 (43%), Gaps = 28/274 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD--RLAQEREREFKSEVSAIGRTHHKNLV 566
F E+GRGSF VYKG+ + +A +L +L + + FK E + H N+V
Sbjct: 13 FDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 71
Query: 567 QLLGFCDEALNR----LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
+ + + +LV E M +GTL + + +I +GL +LH
Sbjct: 72 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH-T 130
Query: 623 CNVPIIHCDIKPQNILL-DNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKN 681
PIIH D+K NI + S KI D GL+ L + ++ + GT ++APE ++
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEMYEE 187
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
VDVY+FG+ +LE+ ++ A + +P
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEY---------------PYSECQNAAQIYRRVTSGVKP 231
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
A D+ + + I CIR++ +R ++K +L
Sbjct: 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (518), Expect = 3e-60
Identities = 74/276 (26%), Positives = 118/276 (42%), Gaps = 23/276 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
K +LG G +G VY+GV K +AVK L E E EF E + + H NLVQL
Sbjct: 21 MKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQL 78
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNVP 626
LG C ++ EFM G L + + + + + ++ +I+ + YL ++
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---N 135
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
IH D+ +N L+ K++DFGLS+L+ D H + + APE S
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746
K DV++FGV+L EI Y ++ L++ D
Sbjct: 196 KSDVWAFGVLLWEIATYGM----------------SPYPGIDLSQVYELLEKDYRMERPE 239
Query: 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+K + C + +PS RP+ + Q E + +
Sbjct: 240 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 3e-60
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 25/281 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +LG+G FG V+ G +A+K L E F E + + H+ LVQL
Sbjct: 21 LEVKLGQGCFGEVWMGTWNG--TTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL 77
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEECNVP 626
E +V E+M G+L + + V ++ +IA G+ Y+
Sbjct: 78 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--- 133
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSA 686
+H D++ NIL+ K++DFGL++L+ ++ + + APE +
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746
K DV+SFG++L E+ R + D G ++ D
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYRMPCPPECPESLHD- 245
Query: 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPP 787
+ C R++P +RPT + + LE P
Sbjct: 246 --------LMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-60
Identities = 67/282 (23%), Positives = 119/282 (42%), Gaps = 27/282 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK--AIAVKKLDRLAQERE-REFKSEVSAIGRTHHKNL 565
F E +GRG FG VY G L GK AVK L+R+ E +F +E + H N+
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 566 VQLLGFCDEALNR-LLVYEFMGNGTLANLIF-AIPKPDWNLRVRISLEIARGLVYLHEEC 623
+ LLG C + L+V +M +G L N I P + L++A+G+
Sbjct: 91 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM---KFLA 147
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH---TMIRGTRGYVAPEWFK 680
+ +H D+ +N +LD F+ K++DFGL++ + + + T + ++A E +
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740
+ K DV+SFGV+L E++ +V +GR + +
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-------DITVYLLQGRRLLQPEYCP 260
Query: 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ + + + C RP+ ++ + +
Sbjct: 261 DPLYE---------VMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 5e-60
Identities = 67/272 (24%), Positives = 112/272 (41%), Gaps = 25/272 (9%)
Query: 512 ELGRGSFGIVYKGVLK-SASGKAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLVQL 568
ELG G+FG V KG + K +AVK L A + E +E + + + + +V++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
+G C+ + +LV E G L + + + +++ G+ YL E +
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FV 129
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS--RTHTMIRGTRGYVAPEWFKNAPVSA 686
H D+ +N+LL AKISDFGLSK L +D++ + T + + APE S+
Sbjct: 130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 189
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746
K DV+SFGV++ E + Y + +++ E
Sbjct: 190 KSDVWSFGVLMWEAFSYGQ----------------KPYRGMKGSEVTAMLEKGERMGCPA 233
Query: 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
++ + C D RP V L
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 1e-59
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 24/278 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNL 565
+G G FG V++G+ S A+A+K + RE F E + + H ++
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHI 70
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECN 624
V+L+G E ++ E G L + + D + + +++ L YL +
Sbjct: 71 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR- 128
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
+H DI +N+L+ + K+ DFGLS+ + + + ++APE
Sbjct: 129 --FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
++ DV+ FGV + EI+ V+ G + + P +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERLPMPPNCPPTLY 239
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ C DPS+RP + L +LE
Sbjct: 240 S---------LMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-59
Identities = 65/272 (23%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 512 ELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
ELG G+FG V +GV + +A+K L + ++ + E E + + + +V+L+
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 75
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPII 628
G C +A +LV E G G L + + + + +++ G+ YL E+ +
Sbjct: 76 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH--TMIRGTRGYVAPEWFKNAPVSA 686
H D+ +N+LL N AKISDFGLSK L +D S + + + APE S+
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 687 KVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746
+ DV+S+GV + E + + +++ +G+ P +
Sbjct: 192 RSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKRMECPPECPPELYA- 243
Query: 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
+ C RP V Q +
Sbjct: 244 --------LMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-59
Identities = 69/286 (24%), Positives = 128/286 (44%), Gaps = 28/286 (9%)
Query: 509 FKEE--LGRGSFGIVYKGVLKSASGK---AIAVKKLDRLAQERER-EFKSEVSAIGRTHH 562
+ +G G FG VYKG+LK++SGK +A+K L E++R +F E +G+ H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHE 621
N+++L G + +++ E+M NG L + V + IA G+ YL
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM--IRGTRGYVAPEWF 679
+H D+ +NIL+++ K+SDFGLS++L D T+T + + APE
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
++ DV+SFG+++ E++ E+ + ++
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EVMKAINDG 229
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPN 785
+ M C +++ ++RP ++ +L+ L+ P+
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 1e-58
Identities = 63/277 (22%), Positives = 113/277 (40%), Gaps = 29/277 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLV 566
+G GS+G K KS GK + K+LD + + ++ SEV+ + H N+V
Sbjct: 8 VLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 567 QLLGFCDEALNRLL--VYEFMGNGTLANLIFAIPKP----DWNLRVRISLEIARGLVYLH 620
+ + N L V E+ G LA++I K D +R+ ++ L H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 621 E--ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
+ ++H D+KP N+ LD + K+ DFGL+++L D S + T Y++PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG-TPYYMSPEQ 185
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
+ K D++S G +L E+ ++E EG+ +
Sbjct: 186 MNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRRIPYR 237
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + I + RP+++ +L+
Sbjct: 238 YSDELNE---------IITRMLNLKDYHRPSVEEILE 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 1e-58
Identities = 59/304 (19%), Positives = 118/304 (38%), Gaps = 49/304 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDR-LAQEREREFKSEVSAIGRTHHK 563
+ ++G G+FG V++ +AVK L + + + +F+ E + + +
Sbjct: 17 YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNP 76
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIF------------------------AIPK 599
N+V+LLG C L++E+M G L + P
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 600 PDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS- 658
++ I+ ++A G+ YL E +H D+ +N L+ KI+DFGLS+ + S
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 659 DQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAI 718
D + ++ PE + + DV+++GV+L EI + E
Sbjct: 194 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE---- 249
Query: 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
+G + ++ + + + C + P+ RP+ + ++L+
Sbjct: 250 ---EVIYYVRDGNILACPENCPLELYN---------LMRLCWSKLPADRPSFCSIHRILQ 297
Query: 779 GLLE 782
+ E
Sbjct: 298 RMCE 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-58
Identities = 76/311 (24%), Positives = 124/311 (39%), Gaps = 48/311 (15%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVL----KSASGKAIAVKKLDRLAQERERE-FK 551
F N L F + LG G+FG V + KS + +AVK L A ERE
Sbjct: 20 FPRNRLS-----FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALM 74
Query: 552 SEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF--------------- 595
SE+ + +H N+V LLG C L++ E+ G L N +
Sbjct: 75 SELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 596 ---AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652
D + S ++A+G+ +L + IH D+ +NILL + KI DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGL 191
Query: 653 SKLLLSDQSRTH-TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEV 711
++ + +D + R ++APE N + + DV+S+G+ L E+ S
Sbjct: 192 ARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS----- 246
Query: 712 EEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMK 771
+ + ++ ++ + I C DP KRPT K
Sbjct: 247 ----------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK 296
Query: 772 VVLQMLEGLLE 782
++Q++E +
Sbjct: 297 QIVQLIEKQIS 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-57
Identities = 73/321 (22%), Positives = 134/321 (41%), Gaps = 45/321 (14%)
Query: 492 TNLRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGK-AIAVKKLDRLA-QERERE 549
T +N++K F++ +G G+FG V K +K + A+K++ A ++ R+
Sbjct: 2 TIYPVLDWNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD 56
Query: 550 FKSEVSAIGR-THHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-------- 600
F E+ + + HH N++ LLG C+ L E+ +G L + +
Sbjct: 57 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAI 116
Query: 601 --------DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGL 652
+ + ++ARG+ YL ++ IH D+ +NIL+ + AKI+DFGL
Sbjct: 117 ANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 173
Query: 653 SKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVE 712
S+ + TM R ++A E + + DV+S+GV+L EI+ + +
Sbjct: 174 SR--GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231
Query: 713 EEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKV 772
Y+ +G + + + D + C RE P +RP+
Sbjct: 232 CA-------ELYEKLPQGYRLEKPLNCDDEVYD---------LMRQCWREKPYERPSFAQ 275
Query: 773 VLQMLEGLLEVPNPPCPSSFS 793
+L L +LE ++
Sbjct: 276 ILVSLNRMLEERKTYVNTTLY 296
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 5e-57
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 28/270 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQER---EREFKSEVSAIGRTHHKNL 565
LG+G FG VY K S +A+K L + E+ E + + EV H N+
Sbjct: 10 IGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNI 68
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
++L G+ +A L+ E+ GT+ + + K D E+A L Y H +
Sbjct: 69 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK--- 125
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+IH DIKP+N+LL + KI+DFG S S + T + GT Y+ PE +
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHD 182
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
KVD++S GV+ E + + E +E Y + E A
Sbjct: 183 EKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEFTFPDFVTEGARD- 233
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ ++ +PS+RP ++ VL+
Sbjct: 234 ---------LISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-57
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 28/274 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
ELG G+FG VYK K + A K +D ++E ++ E+ + H N+V+L
Sbjct: 16 IIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
L N ++ EF G + ++ + +P + + + L YLH+ I
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KI 131
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF-----KNA 682
IH D+K NIL K++DFG+S R + I GT ++APE K+
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742
P K DV+S G+ L+E+ ++ L + S+ P
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEP----------------PHHELNPMRVLLKIAKSEPPT 234
Query: 743 MADRSRLQKWLM-IAMWCIREDPSKRPTMKVVLQ 775
+A SR C+ ++ R T +LQ
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-56
Identities = 67/302 (22%), Positives = 121/302 (40%), Gaps = 52/302 (17%)
Query: 509 FKEELGRGSFGIVYKGVL----KSASGKAIAVKKLDRLAQERERE-FKSEVSAIGR-THH 562
F + LG G+FG V K+ +AVK L A ERE SE+ + + H
Sbjct: 41 FGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 100
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP---------------------- 600
+N+V LLG C + L++E+ G L N + + +
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 601 -DWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659
+ + + ++A+G+ +L + +H D+ +N+L+ + KI DFGL++ ++SD
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 660 QSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGR 716
+ R ++APE + K DV+S+G++L EI + + V+
Sbjct: 218 SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277
Query: 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776
++ + ++D + E I C D KRP+ +
Sbjct: 278 KLIQN-------GFKMDQPFYATEEIYI----------IMQSCWAFDSRKRPSFPNLTSF 320
Query: 777 LE 778
L
Sbjct: 321 LG 322
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 5e-56
Identities = 64/266 (24%), Positives = 118/266 (44%), Gaps = 23/266 (8%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLG 570
E++G+G+ G VY + + +G+ +A+++++ Q ++ +E+ + + N+V L
Sbjct: 26 EKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHC 630
+V E++ G+L +++ D + E + L +LH +IH
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHR 140
Query: 631 DIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDV 690
DIK NILL S K++DFG + +QS+ TM+ GT ++APE KVD+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 691 YSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQ 750
+S G+M +E+I E L ++ + P + + +L
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLR----------------ALYLIATNGTPELQNPEKLS 243
Query: 751 KWLM-IAMWCIREDPSKRPTMKVVLQ 775
C+ D KR + K +LQ
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-55
Identities = 61/296 (20%), Positives = 115/296 (38%), Gaps = 29/296 (9%)
Query: 494 LRFFSYNELKEATGGFKEELGRGSFGIVYKGVLKS---ASGKAIAVKKLDRLAQER-ERE 549
LR E K + LG G+FG VYKG+ +A+K+L + +E
Sbjct: 3 LRILKETEFK-----KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKE 57
Query: 550 FKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRIS 609
E + + ++ +LLG C + +L+ L + +
Sbjct: 58 ILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 117
Query: 610 LEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM-IR 668
++IA+G+ YL + ++H D+ +N+L+ KI+DFGL+KLL +++ H +
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 669 GTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA 728
++A E + + + DV+S+GV + E++ YD
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS----------------KPYDGIP 218
Query: 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784
+ +++ E MI + C D RP + ++ + P
Sbjct: 219 ASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 72/270 (26%), Positives = 119/270 (44%), Gaps = 22/270 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD-RLAQEREREFKSEVSAIGRTHHKNLVQ 567
+ LG G++G V V + + +A+AVK +D + A + K E+ +H+N+V+
Sbjct: 9 LVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G E + L E+ G L + I R ++ G+VYLH I
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---I 124
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLL-LSDQSRTHTMIRGTRGYVAPEWFKNAPV-S 685
H DIKP+N+LLD + KISDFGL+ + +++ R + GT YVAPE K +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
VDV+S G++L ++ + + +DW L+ D +A
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKT---YLNPWKKIDSAPLA- 238
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + E+PS R T+ + +
Sbjct: 239 ---------LLHKILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 7e-55
Identities = 70/280 (25%), Positives = 109/280 (38%), Gaps = 31/280 (11%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGK--AIAVKKLDRLA---QEREREFKSEVSAIGRTHHK 563
E+LG GSFG+V +G + SGK ++AVK L E +F EV+A+ H+
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEE 622
NL++L G +V E G+L + + R ++++A G+ YL +
Sbjct: 72 NLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK 130
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS--DQSRTHTMIRGTRGYVAPEWFK 680
IH D+ +N+LL KI DFGL + L D + + APE K
Sbjct: 131 R---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 681 NAPVSAKVDVYSFGVMLLEIICCRRS--VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
S D + FGV L E+ + + + + I + RL D
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE-------GERLPRPEDC 240
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778
+ + + C P RPT + L
Sbjct: 241 PQDIYN----------VMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 9e-55
Identities = 63/271 (23%), Positives = 108/271 (39%), Gaps = 31/271 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLD---RLAQEREREFKSEVSAIGRTHHKNLVQ 567
E+G GSFG VY + + +A+KK+ + + E+ ++ EV + + H N +Q
Sbjct: 21 REIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
G LV E+ L ++ +GL YLH +
Sbjct: 80 YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NM 136
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF---KNAPV 684
IH D+K NILL K+ DFG + ++ S GT ++APE
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQY 191
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
KVDV+S G+ +E+ + ++ A L + ++ PA+
Sbjct: 192 DGKVDVWSLGITCIELAERKP----------------PLFNMNAMSALYHIAQNESPALQ 235
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + C+++ P RPT +V+L+
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 1e-53
Identities = 73/300 (24%), Positives = 130/300 (43%), Gaps = 36/300 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLAQERER-EFKSEVSAIGRTHHK 563
ELG+GSFG+VY+GV K +A+K ++ A RER EF +E S + +
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 83
Query: 564 NLVQLLGFCDEALNRLLVYEFMGNGTLANLIF----------AIPKPDWNLRVRISLEIA 613
++V+LLG + L++ E M G L + + + P + ++++ EIA
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 614 RGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS-DQSRTHTMIRGTRG 672
G+ YL+ +H D+ +N ++ F+ KI DFG+++ + D R
Sbjct: 144 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 673 YVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732
+++PE K+ + DV+SFGV+L EI + E EG L
Sbjct: 201 WMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE-------QVLRFVMEGGL 253
Query: 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPCPSSF 792
D+ + + + C + +P RP+ ++ ++ +E P S +
Sbjct: 254 LDKPDNCPDMLFE---------LMRMCWQYNPKMRPSFLEIISSIKEEME-PGFREVSFY 303
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-52
Identities = 76/298 (25%), Positives = 120/298 (40%), Gaps = 42/298 (14%)
Query: 509 FKEELGRGSFGIVYKGVL----KSASGKAIAVKKLDR-LAQEREREFKSEVSAIGRT-HH 562
+ LGRG+FG V + K+A+ + +AVK L R SE+ + HH
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH 76
Query: 563 KNLVQLLGFCDEALNRL-LVYEFMGNGTLANLIFAIPKP----------------DWNLR 605
N+V LLG C + L ++ EF G L+ + +
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 606 VRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH- 664
+ S ++A+G+ +L IH D+ +NILL KI DFGL++ + D
Sbjct: 137 ICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY 724
R ++APE + + + DV+SFGV+L EI S V+ + +
Sbjct: 194 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFC 247
Query: 725 DCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
EG D P M + C +PS+RPT +++ L LL+
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQ---------TMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 70/300 (23%), Positives = 117/300 (39%), Gaps = 44/300 (14%)
Query: 509 FKEELGRGSFGIVYKGVLKS------ASGKAIAVKKLDRLAQERE-REFKSEVSAIGR-T 560
+ LG G+FG V +AVK L A E++ + SE+ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKP----------------DWNL 604
HKN++ LLG C + ++ E+ G L + A P
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 605 RVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664
V + ++ARG+ YL + IH D+ +N+L+ KI+DFGL++ +
Sbjct: 137 LVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 665 TM-IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWA 723
T R ++APE + + + DV+SFGV+L EI S V E
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-------EL 246
Query: 724 YDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783
+ EG + + + C PS+RPT K +++ L+ ++ +
Sbjct: 247 FKLLKEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 178 bits (453), Expect = 2e-50
Identities = 67/294 (22%), Positives = 122/294 (41%), Gaps = 26/294 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
EELG G+FG+V++ ++ +G A K + + + + E+ + H LV L
Sbjct: 30 IHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNL 88
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
++ +++YEFM G L + + V ++ +GL ++HE
Sbjct: 89 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---Y 145
Query: 628 IHCDIKPQNILLDNYFS--AKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+H D+KP+NI+ S K+ DFGL+ L D ++ + GT + APE + PV
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVG 203
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
D++S GV+ ++ E ++E ++ D+ A +
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDE--------TLRNVKSCDWNM----DDSAFSG 251
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ---MLEGLLEVPNPPCPSSFSIAV 796
S K + + DP+ R T+ L+ + G + PSS +
Sbjct: 252 ISEDGKDFIRKLLLA--DPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKI 303
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (442), Expect = 6e-49
Identities = 70/288 (24%), Positives = 121/288 (42%), Gaps = 25/288 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
EELG G+FG+V++ V K+ +G+ K ++ + K+E+S + + HH L+ L
Sbjct: 33 ILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
++ +L+ EF+ G L + I A + + GL ++HE I
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SI 148
Query: 628 IHCDIKPQNILLDNYFSA--KISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+H DIKP+NI+ + ++ KI DFGL+ L + + T + APE PV
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
D+++ GV+ ++ G + + + DE A +
Sbjct: 207 FYTDMWAIGVLGYVLLS------------GLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 254
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLEVPNPPCPSS 791
S K + + +P KR T+ L+ L+G PSS
Sbjct: 255 VSPEAKDFIKNLLQK--EPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 300
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (437), Expect = 1e-48
Identities = 68/268 (25%), Positives = 106/268 (39%), Gaps = 18/268 (6%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR-LAQEREREFKSEVSAIGRTHHKNLVQ 567
F++ LG G+F V K + K +A+K + + + +E ++E++ + + H N+V
Sbjct: 13 FRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
L + + L+ + + G L + I R+ ++ + YLH+ V
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHR 131
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
LD ISDFGLSK+ D + GT GYVAPE P S
Sbjct: 132 DLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747
VD +S GV+ ++C G D E L + D P D S
Sbjct: 190 VDCWSIGVIAYILLC------------GYPPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 748 RLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
K + + DP KR T + LQ
Sbjct: 238 DSAKDFIRHLMEK--DPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-48
Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 26/276 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 565
F + LG GSF V + + + A+K L++ + + + E + R H
Sbjct: 12 FGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
V+L + + NG L I I D + EI L YLH +
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH-TMIRGTRGYVAPEWFKNAPV 684
IIH D+KP+NILL+ +I+DFG +K+L + + GT YV+PE
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
D+++ G ++ +++ E + + D A
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEYDFPEKFFPKA-- 237
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780
+ L+ + + D +KR + +
Sbjct: 238 ------RDLVEKLLVL--DATKRLGCEEMEGYGPLK 265
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-46
Identities = 58/270 (21%), Positives = 103/270 (38%), Gaps = 24/270 (8%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E+LGRG FGIV++ V S S K K + ++ K E+S + H+N++ L
Sbjct: 9 IAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHL 66
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
+ ++++EF+ + I + V ++ L +LH I
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NI 123
Query: 628 IHCDIKPQNILLDN--YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
H DI+P+NI+ + KI +FG ++ L ++ Y APE ++ VS
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
D++S G ++ ++ G E ++ DE A +
Sbjct: 182 TATDMWSLGTLVYVLLS------------GINPFLAETNQQIIENIMNAEYTFDEEAFKE 229
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
S + + + R T LQ
Sbjct: 230 ISIEAMDFVDRLLVK--ERKSRMTASEALQ 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (411), Expect = 1e-45
Identities = 54/281 (19%), Positives = 101/281 (35%), Gaps = 30/281 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 565
E LG G V+ + +AVK L F+ E +H +
Sbjct: 11 LGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 566 VQLLGFCDEALNRL----LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
V + + +V E++ TL +++ + + + + L + H+
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ 129
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM--IRGTRGYVAPEWF 679
IIH D+KP NI++ + K+ DFG+++ + + + GT Y++PE
Sbjct: 130 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
+ V A+ DVYS G +L E++ + D + +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPP---------------FTGDSPVSVAYQHVREDP 231
Query: 740 EPAMADRSRLQKWLM-IAMWCIREDPSKRP-TMKVVLQMLE 778
P A L L + + + ++P R T + L
Sbjct: 232 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (410), Expect = 2e-45
Identities = 68/283 (24%), Positives = 110/283 (38%), Gaps = 36/283 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD---------RLAQEREREFKSEVSAIGR 559
KE LGRG +V + + K + K AVK +D QE EV + +
Sbjct: 7 PKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 560 TH-HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVY 618
H N++QL + LV++ M G L + + +I + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICA 125
Query: 619 LHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
LH+ I+H D+KP+NILLD+ + K++DFG S L D + GT Y+APE
Sbjct: 126 LHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEI 180
Query: 679 FKNAPV------SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL 732
+ + +VD++S GV++ ++ + ++ Y
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF------ 234
Query: 733 DVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
P D S K L+ + P KR T + L
Sbjct: 235 ------GSPEWDDYSDTVKDLVSRFLVV--QPQKRYTAEEALA 269
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 3e-44
Identities = 66/267 (24%), Positives = 109/267 (40%), Gaps = 27/267 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRT-HHKN 564
+ LG+GSFG V+ K + + A+K L + L + E + H
Sbjct: 6 LHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 565 LVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECN 624
L + N V E++ G L I + K D + + EI GL +LH +
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG- 123
Query: 625 VPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPV 684
I++ D+K NILLD KI+DFG+ K + ++ GT Y+APE
Sbjct: 124 --IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKY 180
Query: 685 SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744
+ VD +SFGV+L E++ + + EEE + ++ A
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNPFYPRWLEKEA-- 230
Query: 745 DRSRLQKWLMIAMWCIREDPSKRPTMK 771
K L++ ++ +P KR ++
Sbjct: 231 ------KDLLVKLFVR--EPEKRLGVR 249
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 4e-44
Identities = 70/282 (24%), Positives = 106/282 (37%), Gaps = 21/282 (7%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR-----LAQEREREFKSEVSAIGRTHHKNL 565
+ LG G F VYK K+ + + +A+KK+ R E+ + H N+
Sbjct: 4 DFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
+ LL N LV++FM + + L +GL YLH+
Sbjct: 63 IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 120
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WFKNAPV 684
I+H D+KP N+LLD K++DFGL+K S R +T TR Y APE F
Sbjct: 121 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMY 178
Query: 685 SAKVDVYSFGVMLLEIICCR---------RSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735
VD+++ G +L E++ + E G W C +
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 736 VDSDEPAMADRSRLQKWLM-IAMWCIREDPSKRPTMKVVLQM 776
P S L+ + +P R T L+M
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (404), Expect = 1e-43
Identities = 56/269 (20%), Positives = 94/269 (34%), Gaps = 29/269 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLD------RLAQEREREFKSEVSAIGRTHH 562
+GRG FG VY +GK A+K LD + + + +S +
Sbjct: 8 VHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
+V + + + M G L + + EI GL ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR 126
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF-KN 681
+++ D+KP NILLD + +ISD GL+ + GT GY+APE K
Sbjct: 127 F---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYMAPEVLQKG 180
Query: 682 APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741
+ D +S G ML +++ ++ I L DS P
Sbjct: 181 VAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------LPDSFSP 234
Query: 742 AMADRSRLQKWLMIAMWCIREDPSKRPTM 770
+ + ++ D ++R
Sbjct: 235 ELRS---------LLEGLLQRDVNRRLGC 254
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 156 bits (396), Expect = 2e-43
Identities = 53/278 (19%), Positives = 103/278 (37%), Gaps = 18/278 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E++G G++G+VYK G+ A+KK+ ++ + E+S + H N+V+L
Sbjct: 8 EKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL 65
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
+LV+E + L + L++ G+ Y H+ ++
Sbjct: 66 YDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD---RRVL 122
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
H D+KPQN+L++ KI+DFGL++ + I + S +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 689 DVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSR 748
D++S G + E++ E + + ++ +V
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 749 LQKWLMIA-----------MWCIREDPSKRPTMKVVLQ 775
W ++ DP++R T K L+
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 156 bits (396), Expect = 2e-43
Identities = 50/284 (17%), Positives = 93/284 (32%), Gaps = 26/284 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
++G GSFG +Y G + +G+ +A+K + + + E +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 569 LGFC-DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
+ +C E ++V E +G F K + ++ ++ + Y+H +
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 628 IHCDIKPQNIL---LDNYFSAKISDFGLSKLLLSDQSRTH------TMIRGTRGYVAPEW 678
IH D+KP N L I DFGL+K ++ H + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
S + D+ S G +L+ + R + ++VL
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-STPIEVLCKG 243
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
A +C +P + Q+ L
Sbjct: 244 YPSEFAT---------YLNFCRSLRFDDKPDYSYLRQLFRNLFH 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-43
Identities = 69/277 (24%), Positives = 116/277 (41%), Gaps = 30/277 (10%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERER------EFKSEVSAIGRTHH 562
EELG G F +V K KS +G A K + + + R + + EVS + H
Sbjct: 14 TGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
N++ L + + +L+ E + G L + + +I G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 132
Query: 623 CNVPIIHCDIKPQNILLDNY----FSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
I H D+KP+NI+L + KI DFGL+ + D I GT +VAPE
Sbjct: 133 Q---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEI 187
Query: 679 FKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
P+ + D++S GV+ ++ + ++E A ++ Y +
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY------------EF 235
Query: 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
++ ++ S L K + + DP KR T++ LQ
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVK--DPKKRMTIQDSLQ 270
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 2e-42
Identities = 60/285 (21%), Positives = 109/285 (38%), Gaps = 25/285 (8%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEV---SAIGRTHHKNL 565
E+G G++G V+K G+ +A+K++ + EV + H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 566 VQLLGFC-----DEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYL 619
V+L C D LV+E + L P + ++ RGL +L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 620 HEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
H ++H D+KPQNIL+ + K++DFGL+++ T + T Y APE
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVL 187
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRR---------SVEMEVEEEGRAILTDWAYDCYAEG 730
+ + VD++S G + E+ + + ++ G DW D
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247
Query: 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + + + + C+ +P+KR + L
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 62/294 (21%), Positives = 110/294 (37%), Gaps = 33/294 (11%)
Query: 510 KEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQL 568
+ LG G G V + K + + A+K L + + EV R + ++V++
Sbjct: 17 SQVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRI 70
Query: 569 LGFCDEALNR----LLVYEFMGNGTLANLIFAIPKP--DWNLRVRISLEIARGLVYLHEE 622
+ + L+V E + G L + I I I + YLH
Sbjct: 71 VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 130
Query: 623 CNVPIIHCDIKPQNILLDNYF---SAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF 679
I H D+KP+N+L + K++DFG +K S S T T YVAPE
Sbjct: 131 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
D++S GV++ ++C ++ G+ +
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA----ISPGMKTRIRMGQYEF----P 237
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLEVPNPPCPSS 791
P ++ S K L+ ++ +P++R T+ + + +VP P +S
Sbjct: 238 NPEWSEVSEEVKMLI--RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 9e-42
Identities = 57/307 (18%), Positives = 112/307 (36%), Gaps = 27/307 (8%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERERE-FKSEVSAIGRTHHKNLVQLL 569
+G G++G+V + +A+KK+ + + E+ + R H+N++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 570 GFCDEALNRLLVYEFMGNGTLANLIFAIPKP---DWNLRVRISLEIARGLVYLHEECNVP 626
+ ++ + ++ + K + +I RGL Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSA---N 129
Query: 627 IIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR--THTMIRGTRGYVAPEWFKN-AP 683
++H D+KP N+LL+ KI DFGL+++ D T TR Y APE N
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189
Query: 684 VSAKVDVYSFGVMLLEIICCR---------RSVEMEVEEEGRAILTDWAYDCYAEGRLDV 734
+ +D++S G +L E++ R + + G D + R +
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249
Query: 735 LVDSDEPAMADRSRLQKW----LMIAMWCIREDPSKRPTMKVVLQ---MLEGLLEVPNPP 787
L + + L + + +P KR ++ L + + P
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309
Query: 788 CPSSFSI 794
+ F
Sbjct: 310 AEAPFKF 316
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 152 bits (384), Expect = 1e-41
Identities = 43/286 (15%), Positives = 92/286 (32%), Gaps = 28/286 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 567
+G GSFG++++G + + +A+K R + + + E +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
+ F E L+ +LV + +G L K + ++ + +HE+ +
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---L 122
Query: 628 IHCDIKPQNILLDNYFS-----AKISDFGLSKLLLSDQSRTHTM------IRGTRGYVAP 676
++ DIKP N L+ S + DFG+ K ++ H + GT Y++
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182
Query: 677 EWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736
S + D+ + G + + + + + + + L L
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLRELC 241
Query: 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782
+ P + + +LE
Sbjct: 242 AGFPEEFYK---------YMHYARNLAFDATPDYDYLQGLFSKVLE 278
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 152 bits (385), Expect = 1e-41
Identities = 51/200 (25%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 565
LG GSFG V+ + +G+ A+K L + + ++ E + H +
Sbjct: 8 ILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFI 66
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
+++ G +A ++ +++ G L +L+ + + + E+ L YLH +
Sbjct: 67 IRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD-- 124
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
II+ D+KP+NILLD KI+DFG +K + + GT Y+APE P +
Sbjct: 125 -IIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYN 179
Query: 686 AKVDVYSFGVMLLEIICCRR 705
+D +SFG+++ E++
Sbjct: 180 KSIDWWSFGILIYEMLAGYT 199
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 55/279 (19%), Positives = 103/279 (36%), Gaps = 18/279 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E++G G++G+VYK K +G+ +A+KK+ D + E+S + +H N+V+L
Sbjct: 8 EKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKP-DWNLRVRISLEIARGLVYLHEECNVPI 627
L LV+EF+ + + L ++ +GL + H +
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---V 123
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
+H D+KPQN+L++ + K++DFGL++ + S
Sbjct: 124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183
Query: 688 VDVYSFGVMLLEIICCRR---------SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738
VD++S G + E++ R + G W
Sbjct: 184 VDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243
Query: 739 DEPAMADRSRL--QKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + + + DP+KR + K L
Sbjct: 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-39
Identities = 61/278 (21%), Positives = 101/278 (36%), Gaps = 42/278 (15%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKL------DRLAQEREREFKSEVSAIGR--T 560
LG G FG VY G+ S +A+K + D EV + + +
Sbjct: 8 VGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 561 HHKNLVQLLGFCDEALNRLLVYEFM-GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYL 619
+++LL + + + +L+ E L + I L ++ + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 620 HEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEW 678
H ++H DIK +NIL+D N K+ DFG LL + +T GTR Y PEW
Sbjct: 127 HNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEW 180
Query: 679 FKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737
+ V+S G++L +++C E + E R V
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----------------RGQVFFR 224
Query: 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + WC+ PS RPT + +
Sbjct: 225 QRVSSECQH--------LIRWCLALRPSDRPTFEEIQN 254
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 4e-39
Identities = 65/326 (19%), Positives = 120/326 (36%), Gaps = 45/326 (13%)
Query: 497 FSYNELKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSA 556
SY + K +G GSFG+VY+ L SG+ +A+KK+ + +R E+
Sbjct: 20 VSYTDTKV--------IGNGSFGVVYQAKLCD-SGELVAIKKVLQ----DKRFKNRELQI 66
Query: 557 IGRTHHKNLVQLLGFCDEALNR------LLVYEFMGNGTLANLIFAIPKP---DWNLRVR 607
+ + H N+V+L F + + LV +++
Sbjct: 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 608 ISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTM 666
++ R L Y+H I H DIKPQN+LLD + K+ DFG +K L +
Sbjct: 127 YMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSY 182
Query: 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR----SVEMEVEEEGRAILTDW 722
I F ++ +DV+S G +L E++ + ++ E +L
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242
Query: 723 AYDC-------YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ Y E + + + + + + + P+ R T
Sbjct: 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
Query: 776 ------MLEGLLEVPN-PPCPSSFSI 794
+ + +++PN P+ F+
Sbjct: 303 HSFFDELRDPNVKLPNGRDTPALFNF 328
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 48/279 (17%), Positives = 102/279 (36%), Gaps = 18/279 (6%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 568
E++G G++G V+K + + + +A+K++ D + E+ + HKN+V+L
Sbjct: 8 EKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 569 LGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPII 628
LV+EF D + ++ +GL + H ++
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VL 123
Query: 629 HCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKV 688
H D+KPQN+L++ K+++FGL++ + F S +
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 689 DVYSFGVMLLEIICCRR-----SVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743
D++S G + E+ R + + + +L + +
Sbjct: 184 DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYP 243
Query: 744 ADRSRLQKWLMIA-------MWCIREDPSKRPTMKVVLQ 775
A S + + ++ +P +R + + LQ
Sbjct: 244 ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 3e-38
Identities = 53/293 (18%), Positives = 112/293 (38%), Gaps = 32/293 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKL--DRLAQEREREFKSEVSAIGRTHHKNLVQL 568
++G+G+FG V+K + +G+ +A+KK+ + + E+ + H+N+V L
Sbjct: 16 AKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNL 74
Query: 569 LGFCDEALNR--------LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLH 620
+ C + LV++F + L + K + R+ + GL +
Sbjct: 75 IEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL---Y 131
Query: 621 EECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIR---GTRGYVAPE 677
I+H D+K N+L+ K++DFGL++ ++ T Y PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 678 WFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDV-- 734
+D++ G ++ E+ ++ E+ A+++ E +V
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251
Query: 735 --LVDSDEPAMADRSRLQKWLMIAMW----------CIREDPSKRPTMKVVLQ 775
L + E + +++ L + + DP++R L
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 2e-37
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 26/266 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNL 565
+ + LG+G+FG V K+ +G+ A+K L + +A++ +E + T H L
Sbjct: 9 YLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 566 VQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
L V E+ G L + EI L YLH
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR--- 124
Query: 626 PIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVS 685
+++ DIK +N++LD KI+DFGL K +SD + GT Y+APE ++
Sbjct: 125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYG 183
Query: 686 AKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745
VD + GV++ E++C R + E ++ + A
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEIRFPRTLSPEA--- 232
Query: 746 RSRLQKWLMIAMWCIREDPSKRPTMK 771
K L+ + DP +R
Sbjct: 233 -----KSLLAGLLKK--DPKQRLGGG 251
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 72/328 (21%), Positives = 121/328 (36%), Gaps = 44/328 (13%)
Query: 497 FSYNELKEATGGFK------EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE--R 548
F E+ + + + +G G++G V V +G +A+KKL R Q +
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAK 62
Query: 549 EFKSEVSAIGRTHHKNLVQLLGFC------DEALNRLLVYEFMGNGTLANLIFAIPKPDW 602
E+ + H+N++ LL D+ + LV FMG + K
Sbjct: 63 RAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKHEKLGE 120
Query: 603 NLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662
+ + ++ +GL Y+H IH D+KP N+ ++ KI DFGL++
Sbjct: 121 DRIQFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLARQA----DS 173
Query: 663 THTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCR---------------RS 706
T TR Y APE N + VD++S G ++ E+I +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 707 VEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSK 766
V E L Y +G ++ + + S L L+ M + D +
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL--DAEQ 291
Query: 767 RPTMKVVLQM--LEGLLEVPNPPCPSSF 792
R T L E L + + P +
Sbjct: 292 RVTAGEALAHPYFESLHDTEDEPQVQKY 319
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 134 bits (338), Expect = 4e-35
Identities = 53/261 (20%), Positives = 101/261 (38%), Gaps = 29/261 (11%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR---LAQEREREFKSEVSAIGRTHHKNLVQ 567
+ LG GSFG V K SG A+K LD+ + ++ +E + + LV+
Sbjct: 47 KTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVK 105
Query: 568 LLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPI 627
L + N +V E++ G + + + I + + +I YLH +
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---L 162
Query: 628 IHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAK 687
I+ D+KP+N+L+D +++DFG +K + GT +APE + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKA 218
Query: 688 VDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRS 747
VD ++ GV++ E+ + + Y+ G++
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKVRFPSHFSSDLK---- 266
Query: 748 RLQKWLMIAMWCIREDPSKRP 768
+ ++ D +KR
Sbjct: 267 ------DLLRNLLQVDLTKRF 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (333), Expect = 1e-34
Identities = 54/292 (18%), Positives = 117/292 (40%), Gaps = 37/292 (12%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGR-THHKNLVQ 567
+LGRG + V++ + + + + + VK L ++++ K E+ + N++
Sbjct: 39 LVRKLGRGKYSEVFEAINIT-NNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIIT 94
Query: 568 LLGFCDEALNRL--LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNV 625
L + ++R LV+E + N L + D EI + L Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMG-- 149
Query: 626 PIIHCDIKPQNILLDN-YFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPE-WFKNAP 683
I+H D+KP N+++D+ + ++ D+GL++ Q + + +R + PE
Sbjct: 150 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ--EYNVRVASRYFKGPELLVDYQM 206
Query: 684 VSAKVDVYSFGVMLLEIICCR------RSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737
+D++S G ML +I + ++ + + T+ YD + +++
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266
Query: 738 -SDEPAMADRSRLQKWLMIAMW-------------CIREDPSKRPTMKVVLQ 775
+D R R ++++ +R D R T + ++
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-33
Identities = 63/271 (23%), Positives = 114/271 (42%), Gaps = 26/271 (9%)
Query: 509 FKEELGRGSFGIVYKGVLKSA--SGKAIAVKKLDRLAQERE----REFKSEVSAIGR-TH 561
+ LG G++G V+ S +GK A+K L + ++ ++E +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 562 HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHE 621
LV L L+ +++ G L + + + EI L +LH+
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 147
Query: 622 ECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWF-- 679
+ II+ DIK +NILLD+ ++DFGLSK ++D++ GT Y+AP+
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 680 KNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739
++ VD +S GV++ E++ ++ E+ +A + ++ S+
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI------------SRRILKSE 252
Query: 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTM 770
P + S L K L+ + DP KR
Sbjct: 253 PPYPQEMSALAKDLIQRLLMK--DPKKRLGC 281
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 2e-33
Identities = 66/299 (22%), Positives = 114/299 (38%), Gaps = 45/299 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDR--LAQEREREFKSEVSAIGRTHHKNLVQL 568
+ +G G+ GIV + +A+KKL R Q + E+ + +HKN++ L
Sbjct: 23 KPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 569 LGFC------DEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEE 622
L +E + LV E M + + D + ++ G+ +LH
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 623 CNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA 682
IH D+KP NI++ + + KI DFGL++ + S T TR Y APE
Sbjct: 139 GI---IHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGM 193
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEME---------VEEEGRAILTDWAYDC------- 726
VD++S G ++ E++ + +E+ G
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253
Query: 727 ----------YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775
+ + D L +D ++ + L+ M I DP+KR ++ LQ
Sbjct: 254 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI--DPAKRISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 65/306 (21%), Positives = 111/306 (36%), Gaps = 32/306 (10%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQERE--REFKSEVSAIGRTHHKNLVQL 568
+G G++G V +G +AVKKL R Q + E+ + H+N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 569 LGFCDEA-----LNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC 623
L A N + + + G N I K + + +I RGL Y+H
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHL-MGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNA- 682
IH D+KP N+ ++ KI DFGL++ T TR Y APE N
Sbjct: 142 I---IHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWM 194
Query: 683 PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742
+ VD++S G ++ E++ R + ++ AE + +S
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNY 254
Query: 743 MADRSRLQKWLMIAMW-------------CIREDPSKRPTMKVVLQM--LEGLLEVPNPP 787
+ +++ K ++ + D KR T L + + P
Sbjct: 255 IQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEP 314
Query: 788 CPSSFS 793
+
Sbjct: 315 VADPYD 320
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 113 bits (283), Expect = 8e-28
Identities = 55/315 (17%), Positives = 100/315 (31%), Gaps = 52/315 (16%)
Query: 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQL 568
+LG G F V+ + +A+K + R + + E+ + R + + +
Sbjct: 17 LVRKLGWGHFSTVWLAKDMV-NNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 569 LGFCDEALNRLLVY--EFMGNGTLANLIFAI--------------PKPDWNLRVRISLEI 612
+ +LL + NG ++F + +IS ++
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 613 ARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQSRTHTM-IRGT 670
GL Y+H C IIH DIKP+N+L++ + ++ L + H T
Sbjct: 135 LLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192
Query: 671 RGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730
R Y +PE AP D++S ++ E+I E + A G
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252
Query: 731 RLDVLV----DSDEPAMADRSRLQKWLMIAMW--------------------------CI 760
L + R L+ + W +
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312
Query: 761 REDPSKRPTMKVVLQ 775
+ DP KR ++
Sbjct: 313 QLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 6e-20
Identities = 26/203 (12%), Positives = 56/203 (27%), Gaps = 31/203 (15%)
Query: 511 EELGRGSFGIVYKGVLKSASGKAIAVK----------KLDRLAQEREREFKSEVSAIGRT 560
+ +G G V+ + VK K+ + F R
Sbjct: 6 KLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 561 HHKNLVQLLGFCD----EALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGL 616
+ L +L G ++ E + + + + I +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNAVLMELIDAKE-------LYRVRVENPDEVLDMILEEV 116
Query: 617 VYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTMIRGTRGYVAP 676
+ I+H D+ N+L+ I DF S + + ++ +
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDFPQSVEV--GEEGWREILERDVRNII- 169
Query: 677 EWFKNAPVSAKVDVYSFGVMLLE 699
+F + D+ S +L+
Sbjct: 170 TYFSR-TYRTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 56.1 bits (135), Expect = 3e-10
Identities = 19/112 (16%), Positives = 36/112 (32%), Gaps = 13/112 (11%)
Query: 37 SNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTA 96
+N L + D L ++ + T VW +N +G L +
Sbjct: 5 TNGEGLYAGQSLDVEPYHFIMQED-CNLVLYDHS----TSVWASNTGILGKKGCKAVLQS 59
Query: 97 TG-LLLKDPGGKTIW--DGKPDKKVSDAAMLDTGNFVLRASGNNSDYAWQSF 145
G ++ D G+++W + + GN V+ S W +
Sbjct: 60 DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGSD-----IWSTG 106
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 51.5 bits (123), Expect = 2e-08
Identities = 14/111 (12%), Positives = 30/111 (27%), Gaps = 11/111 (9%)
Query: 51 GFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGS-TLELTATGLLLKDPGGKTI 109
G + NN + I ++ + L + L+ +
Sbjct: 1 GSVVVANNGNS----ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRV 56
Query: 110 WDGKPDKKVSD--AAMLDTGNFVLRASGNNSDYAWQSF--KNPTDTILPTQ 156
W K + A + G + + N + W S ++ + Q
Sbjct: 57 WSTNTAGKGTGCRAVLQPNGRMDVLTNQNIA--VWTSGNSRSAGRYVFVLQ 105
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 38.0 bits (88), Expect = 6e-04
Identities = 26/149 (17%), Positives = 49/149 (32%), Gaps = 30/149 (20%)
Query: 127 GNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NG 185
G+ V+ +GN+ Y+ Q N T+ TQ L L + L +
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQL---------------SPYRLSMETDC 45
Query: 186 SLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAK 245
+L L + + + G+G + V + + ++ + V W
Sbjct: 46 NLVL----------FDRDDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQNIAV----WTS 91
Query: 246 LSPRVDHYFRVTLDFDGVLAEYAHPKNSS 274
+ R + L D LA Y ++
Sbjct: 92 GNSRSAGRYVFVLQPDRNLAIYGGALWTT 120
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 44.4 bits (104), Expect = 3e-06
Identities = 24/128 (18%), Positives = 47/128 (36%), Gaps = 20/128 (15%)
Query: 25 TINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDN 84
+N G L + L+ + F + N L ++ N VW + +
Sbjct: 3 RLNSGHQLDT----GGSLA-EGGYLFIIQNDCN------LVLYDNNRA----VWASGTNG 47
Query: 85 PAPRGSTLELTATGLLLKDPGGKTIWDGKPDKKVSD--AAMLDTGNFVLRASGNNSDYAW 142
A G L++ G L+ G + IW +++ + + N V+ + NN+ W
Sbjct: 48 KA-SGCVLKMQNDGNLVIYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYDNSNNA--IW 104
Query: 143 QSFKNPTD 150
+ N +
Sbjct: 105 ATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 44.2 bits (104), Expect = 5e-06
Identities = 21/144 (14%), Positives = 43/144 (29%), Gaps = 27/144 (18%)
Query: 136 NNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRF-SNGSLKLISVAW 194
NN ++ Q N + T+ L E F + ++ +L L
Sbjct: 1 NNIIFSKQPDDNHPQILHATESL-----------EILFGTHVYRFIMQTDCNLVLYD--- 46
Query: 195 PSRFQYKSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSPRVDHYF 254
+ +NT G+G + V + ++ + V W ++
Sbjct: 47 ----NNNPIWATNT---GGLGNGCRAVLQPDGVLVVITNENVTV----WQSPVAGKAGHY 95
Query: 255 RVTLDFDGVLAEYAHPK-NSSTNQ 277
+ L D + Y + T +
Sbjct: 96 VLVLQPDRNVVIYGDALWATQTVR 119
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 35.8 bits (82), Expect = 0.004
Identities = 11/76 (14%), Positives = 18/76 (23%), Gaps = 9/76 (11%)
Query: 75 TIVWHANGDNPAPRGSTLELTATG-LLLKDPGGKTIW--DGKPDKKVSDAAMLDTGNFVL 131
+W N G L G L++ T+W + N V+
Sbjct: 49 NPIWATNTGGL-GNGCRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVVI 107
Query: 132 RASGNNSDYAWQSFKN 147
W +
Sbjct: 108 YGDA-----LWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 41.5 bits (97), Expect = 4e-05
Identities = 13/84 (15%), Positives = 22/84 (26%), Gaps = 4/84 (4%)
Query: 66 IWFNKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGKTIWDGKPDKKVSDAAM 123
I F E + + S + + L+L D + A +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 124 LDTGNFVLRASGNNSDYAWQSFKN 147
G V+ + N W S
Sbjct: 63 QSDGLLVILTAQNT--IRWSSGTK 84
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 799 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.68 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.66 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.65 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.58 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.4 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.29 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 98.9 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.8 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.7 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 98.41 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.28 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.21 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.96 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.54 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.11 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.21 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 94.43 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 89.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 89.36 | |
| d1lmja2 | 42 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 89.01 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 87.85 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 86.45 | |
| d1uzka2 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.39 | |
| d2vj3a2 | 39 | Neurogenic locus notch homolog protein 1, Notch1 { | 85.99 | |
| d1edmb_ | 39 | Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606 | 82.19 | |
| d1lmja1 | 44 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 82.12 | |
| d2vj3a3 | 35 | Neurogenic locus notch homolog protein 1, Notch1 { | 82.11 | |
| d1i0ua2 | 41 | Low density lipoprotein (LDL) receptor, different | 81.71 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.2e-49 Score=414.00 Aligned_cols=267 Identities=25% Similarity=0.404 Sum_probs=206.3
Q ss_pred cChHHHHHHhhchh-----------hhcCccccceEEEEEEeCCC--CeEEEEEEcccc-chhhHHHHHHHHHHhccccc
Q 038294 497 FSYNELKEATGGFK-----------EELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRL-AQEREREFKSEVSAIGRTHH 562 (799)
Q Consensus 497 ~~~~~l~~~~~~~~-----------~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h 562 (799)
++++++.+++..|. +.||+|+||+||+|.++..+ ...||||++... .....++|.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence 55666766666553 56999999999999986432 236899998653 34445689999999999999
Q ss_pred ccccceeeeeecccceeeEEeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 563 KNLVQLLGFCDEALNRLLVYEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 563 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
||||+++|+|.++...++||||+++|+|.+++... ..++|..+++++.|||+||+|||+. +|+||||||+||||+.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~ 163 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNS 163 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECT
T ss_pred CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECC
Confidence 99999999999999999999999999999988874 5689999999999999999999998 9999999999999999
Q ss_pred CCceEEccccCcccccCCCCcc----eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcc
Q 038294 642 YFSAKISDFGLSKLLLSDQSRT----HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGR 716 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~ 716 (799)
++.+||+|||+++......... .....||+.|||||.+.++.++.++|||||||+||||+| |+.||......+
T Consensus 164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~-- 241 (299)
T d1jpaa_ 164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD-- 241 (299)
T ss_dssp TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999998775433221 122357899999999999999999999999999999998 889987554322
Q ss_pred hhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 717 AILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 717 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+...+..+.. ...+....+.+.+++.+||+.||++||||.||++.|+++++.
T Consensus 242 ------~~~~i~~~~~---------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 242 ------VINAIEQDYR---------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------HHHHHHcCCC---------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 1122222211 011223345788899999999999999999999999988764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-49 Score=406.83 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=197.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.++||+|+||+||+|.++ +++.||||+++.. ....++|.+|++++++++|||||+++|+|.+.+..++||||+++
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWL--NKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEECCSSCCEEEEEET--TTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred EEEEEEeeCCCeEEEEEEEC--CCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCC
Confidence 45678999999999999986 4678999999753 33457899999999999999999999999999999999999999
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|+|.+++... ..+++..+++|+.|||+||+|||+. +|+||||||+||||++++.+||+|||+++............
T Consensus 85 g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~ 161 (263)
T d1sm2a_ 85 GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 161 (263)
T ss_dssp CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC---------------
T ss_pred CcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecc
Confidence 9999998765 5688999999999999999999998 89999999999999999999999999998775554444444
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCc-hhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE-MEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..||+.|+|||++.+..++.++|||||||+||||+|++.|+. .....+ ..+.+..+.. ... +
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~--------~~~~i~~~~~-----~~~----p 224 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--------VVEDISTGFR-----LYK----P 224 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH--------HHHHHHHTCC-----CCC----C
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHhcCC-----CCC----c
Confidence 568999999999999999999999999999999999655543 322211 1122222211 011 1
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
....+.+.+++.+||+.||++||||+||++.|+++.+
T Consensus 225 ~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1223577889999999999999999999999998754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-48 Score=410.29 Aligned_cols=260 Identities=27% Similarity=0.418 Sum_probs=215.2
Q ss_pred HHHHhhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 502 LKEATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 502 l~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+......+.++||+|+||+||+|.++. +++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKK-YSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGG-GTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECC-CCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 334445667899999999999999874 67899999997543 3456899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 582 YEFMGNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
|||+++|+|.+++... ..+++..++.|+.|||+||+|||++ +|+||||||+||||++++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred eecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 9999999999999754 5789999999999999999999998 9999999999999999999999999999987655
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.........|++.|+|||++.+..++.++|||||||++|||++|+.|+....... ...+.+..+.. ..
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-------~~~~~i~~~~~-----~~ 236 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYELLEKDYR-----ME 236 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-------HHHHHHHTTCC-----CC
T ss_pred CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-------HHHHHHhcCCC-----CC
Confidence 4444444568899999999999999999999999999999999887765432211 12222222211 11
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+....+.+.+++.+||+.||++||||.||++.|+.+.+
T Consensus 237 ----~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 ----RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112234578899999999999999999999999998754
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-48 Score=403.15 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=206.0
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
...+.+.||+|+||.||+|.++ +++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 14 ~~~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 14 TLKLVERLGAGQFGEVWMGYYN--GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GEEEEEEEEEETTEEEEEEEET--TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HeEEeEEEecCCCcEEEEEEEC--CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3456788999999999999986 46889999997543 345689999999999999999999998865 5678999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++|+|.+++... ..++|..+++|+.|||+||+|||+. +|+||||||+||||++++.+||+|||+++.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 999999987654 3689999999999999999999998 99999999999999999999999999999876544434
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||+||||+||+.|+....... . ..+.+..+.. ...
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~------~-~~~~i~~~~~-----~~~--- 231 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------E-VIQNLERGYR-----MVR--- 231 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCC-----CCC---
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHhcCC-----CCC---
Confidence 444568999999999999999999999999999999999777654332211 1 1222233211 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+....+.+.+++.+||+.||++||||+||+++|+.+.
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 1223356888999999999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-48 Score=402.51 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=201.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEF 584 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~ 584 (799)
+.+.+.||+|+||+||+|+++ ..||||+++.. .....++|.+|++++++++|||||+++|++.+ ...++||||
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~----~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey 84 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH----GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQW 84 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS----SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred EEEEEEEeeCCCcEEEEEEEC----CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEec
Confidence 345688999999999999864 35999998643 34456789999999999999999999999865 467899999
Q ss_pred cCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Cc
Q 038294 585 MGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SR 662 (799)
Q Consensus 585 ~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~ 662 (799)
+++|+|.+++... ..+++..+.+|+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++...... ..
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 9999999999765 5689999999999999999999998 99999999999999999999999999998765432 22
Q ss_pred ceeeeccCCcccccccccC---CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 THTMIRGTRGYVAPEWFKN---APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~---~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
......||+.|||||++.+ ..++.++|||||||+||||+||+.||....... .....+..+.....
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~-------~~~~~~~~~~~~p~---- 230 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD-------QIIFMVGRGYLSPD---- 230 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-------HHHHHHHHTSCCCC----
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH-------HHHHHHhcCCCCCc----
Confidence 3344579999999999864 358999999999999999999999997543221 11122222221110
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.........+.+.+++.+||+.||++||||+||++.|+.+.+
T Consensus 231 -~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 -LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp -GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011122334578889999999999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-47 Score=397.38 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=202.6
Q ss_pred hhcCccccceEEEEEEeC-CCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 511 EELGRGSFGIVYKGVLKS-ASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~-~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
++||+|+||+||+|.++. ..++.||||+++.. .....++|.+|++++++++|||||+++|+|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999999864 24578999999643 23345689999999999999999999999965 457899999999
Q ss_pred CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc--ee
Q 038294 588 GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT--HT 665 (799)
Q Consensus 588 gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~--~~ 665 (799)
|+|.+++.....+++..+++|+.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++......... ..
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~ 168 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC--
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccccc
Confidence 99999999988999999999999999999999998 89999999999999999999999999999775443322 23
Q ss_pred eeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCcc
Q 038294 666 MIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMA 744 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 744 (799)
...||+.|||||.+.+..++.++|||||||++|||+| |+.||......+ +...+..+... ..
T Consensus 169 ~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--------~~~~i~~~~~~-----~~---- 231 (277)
T d1xbba_ 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--------VTAMLEKGERM-----GC---- 231 (277)
T ss_dssp --CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--------HHHHHHTTCCC-----CC----
T ss_pred ccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--------HHHHHHcCCCC-----CC----
Confidence 3568999999999999999999999999999999998 899997543322 22233333211 11
Q ss_pred CHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 745 DRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 745 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
+....+.+.+++.+||+.||++||||++|++.|+.
T Consensus 232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 12233577889999999999999999999998875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=391.85 Aligned_cols=250 Identities=27% Similarity=0.435 Sum_probs=210.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecCC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMGN 587 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 587 (799)
.+.++||+|+||+||+|+++ +++.||||+++... ...++|++|++++++++||||++++|+|.+....++||||+++
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCEETTEEEEEEEET--TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred EEeEEEecCCCeEEEEEEEC--CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCC
Confidence 46689999999999999986 57899999997643 3457899999999999999999999999999999999999999
Q ss_pred CChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 588 GTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 588 gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
|+|.+++... ..+++..+.+++.|||+||+|||+. +|+||||||+|||+++++.+||+|||+++............
T Consensus 84 g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (258)
T d1k2pa_ 84 GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 160 (258)
T ss_dssp EEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCC
T ss_pred CcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecc
Confidence 9999997654 5788999999999999999999998 99999999999999999999999999998776554444444
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccC
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMAD 745 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 745 (799)
..+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+..+... ..+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--------~~~~i~~~~~~-----~~p---- 223 (258)
T d1k2pa_ 161 SKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--------TAEHIAQGLRL-----YRP---- 223 (258)
T ss_dssp SCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--------HHHHHHTTCCC-----CCC----
T ss_pred cCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--------HHHHHHhCCCC-----CCc----
Confidence 568999999999999999999999999999999998 788987654432 12223333211 111
Q ss_pred HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 746 RSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 746 ~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
....+.+.+++.+||+.||++|||++||++.|.++
T Consensus 224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 12235788999999999999999999999999764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-47 Score=393.23 Aligned_cols=244 Identities=29% Similarity=0.409 Sum_probs=206.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||+||+|+.+. +++.||+|++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE 86 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQ-SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE 86 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEecCCCcEEEEEEECC-CCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence 4566889999999999999874 68899999986432 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~ 160 (263)
T d2j4za1 87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R 160 (263)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999865432 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+.. ..+.
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~--------~~~~i~~~~~------~~p~- 225 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--------TYKRISRVEF------TFPD- 225 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHTTCC------CCCT-
T ss_pred ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCC------CCCc-
Confidence 234569999999999999999999999999999999999999997654322 1122222221 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+.+++.+||+.||++|||++|+++
T Consensus 226 ---~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 226 ---FVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 23356788999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=395.34 Aligned_cols=250 Identities=27% Similarity=0.336 Sum_probs=202.5
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||+||+|+.+. +++.||||+++... .+..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEecc
Confidence 3456889999999999999875 68999999986432 233457899999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Ccce
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~~~ 664 (799)
++|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||+++++.+||+|||+|+...... ....
T Consensus 86 ~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 86 SGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp TTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred CCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999998888899999999999999999999998 99999999999999999999999999999765433 2233
Q ss_pred eeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....||+.|||||++.+..+ +.++|||||||+||||++|+.||......... . ....... ....
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~--~-----~~~~~~~--------~~~~ 227 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--Y-----SDWKEKK--------TYLN 227 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH--H-----HHHHTTC--------TTST
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH--H-----HHHhcCC--------CCCC
Confidence 45679999999999988876 57899999999999999999999754432211 0 1111111 0011
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
......+.+.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223456778999999999999999999865
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-46 Score=395.02 Aligned_cols=248 Identities=25% Similarity=0.345 Sum_probs=206.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.++||+|+||+||+|..+. +++.||||+++.......+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~-~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVA-TGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTT-TCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred cEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecC
Confidence 3456789999999999999874 689999999976555556789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcceee
Q 038294 587 NGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHTM 666 (799)
Q Consensus 587 ~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~~ 666 (799)
+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++++||+|||+++....... ....
T Consensus 101 gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~~~ 175 (293)
T d1yhwa1 101 GGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KRST 175 (293)
T ss_dssp TCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CBCC
T ss_pred CCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccc-cccc
Confidence 9999998865 4689999999999999999999998 999999999999999999999999999987654332 2334
Q ss_pred eccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCccCH
Q 038294 667 IRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAMADR 746 (799)
Q Consensus 667 ~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 746 (799)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......+.. ....+.
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~~~~~~~~--------~~~~~~ 240 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-------LYLIATNGTP--------ELQNPE 240 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHHCSC--------CCSSGG
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-------HHHHHhCCCC--------CCCCcc
Confidence 5699999999999999999999999999999999999999975433221 1111222111 011122
Q ss_pred HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 747 SRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 747 ~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...+.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33467888999999999999999999875
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-47 Score=398.96 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=202.1
Q ss_pred chhhhcCccccceEEEEEEeCCCC---eEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG---KAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~---~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.+.||+|+||+||+|.++..++ ..||||+++... .....+|.+|++++++++|||||+++|++.+....++|||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e 89 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITE 89 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred EeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEE
Confidence 345789999999999999875332 479999986533 3345679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+.+++|.+++... ..++|..+.+++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++........
T Consensus 90 ~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 166 (283)
T d1mqba_ 90 YMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 166 (283)
T ss_dssp CCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----------
T ss_pred ecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCcc
Confidence 99999999988765 5789999999999999999999998 8999999999999999999999999999876543322
Q ss_pred --ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 663 --THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 663 --~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
......||+.|||||++.+..++.++|||||||+||||++++.|+....... .+...+..+...
T Consensus 167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-------~~~~~i~~~~~~------- 232 (283)
T d1mqba_ 167 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-------EVMKAINDGFRL------- 232 (283)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-------HHHHHHHTTCCC-------
T ss_pred ceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-------HHHHHHhccCCC-------
Confidence 2233458999999999999999999999999999999999877765432211 122233333211
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVP 784 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~ 784 (799)
..+......+.+++.+||+.||++||||.||+++|+++++.|
T Consensus 233 --~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 233 --PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp --CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred --CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence 111223457888999999999999999999999999887653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-47 Score=397.20 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=204.7
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
...+.+.||+|+||+||+|+++ +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus 18 ~~~i~~~iG~G~fg~Vy~~~~~--~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 18 SLRLEVKLGQGCFGEVWMGTWN--GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GEEEEEEEEECSSCEEEEEEET--TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HEEEeeEEeeCCCeEEEEEEEC--CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4566788999999999999986 4568999999754 3345789999999999999999999999965 5678999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
++|+|.+++... ..++|..+++|+.|||.||+|||+. +|+||||||+||||+.++++||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999988753 5789999999999999999999998 89999999999999999999999999998775554444
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++..+.++.++|||||||+||||++|+.|+....... . ....+..+.. ..
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~------~-~~~~i~~~~~-----~~---- 234 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------E-VLDQVERGYR-----MP---- 234 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTTCC-----CC----
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHhcCC-----CC----
Confidence 445668999999999999999999999999999999999877765443221 1 1122222211 11
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCCCCCCC
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEVPNPPC 788 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~~~p~~ 788 (799)
.+....+++.+++.+||+.||++||||++|+++|+.......|+.
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~ 279 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQY 279 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCC
Confidence 122234578899999999999999999999999999776555443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=390.04 Aligned_cols=247 Identities=29% Similarity=0.427 Sum_probs=198.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec----ccceeeE
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE----ALNRLLV 581 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~----~~~~~lv 581 (799)
.+.++||+|+||+||+|.++. +++.||+|++... .....+.|.+|++++++++|||||++++++.+ ....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~-~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTE-TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECC-CCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 355689999999999999874 6789999998643 23345679999999999999999999999864 3456899
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc-CCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD-NYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~-~~~~~kl~DfGla~~~~~~~ 660 (799)
|||+++|+|.+++.....+++..+..++.||++||+|||++ +.+|+||||||+||||+ +++.+||+|||+++.....
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 99999999999999888899999999999999999999987 12399999999999996 5789999999999864332
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
......||+.|||||++.+ +++.++|||||||+||||++|+.||....... ...+.+..+..
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-------~~~~~i~~~~~-------- 230 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-------QIYRRVTSGVK-------- 230 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-------HHHHHHTTTCC--------
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-------HHHHHHHcCCC--------
Confidence 2234579999999999876 59999999999999999999999996432221 12222222211
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+...+....+.+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 11112223346788999999999999999999976
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-47 Score=406.69 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=205.4
Q ss_pred HhhchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
..+.+.++||+|+||+||+|..+. +++.||+|+++.. .....+++.+|+.+|++++|||||+++++|.+....++|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKP-SGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETT-TTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 344566889999999999999874 6899999998653 23445689999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.+...+++..+..++.||+.||.|||+.. +|+||||||+||||++++.+||+|||+|+......
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~--- 159 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 159 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT---
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEEEeeCCCccccCCCc---
Confidence 9999999999998888999999999999999999999731 79999999999999999999999999998764322
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHH--------hcCc----
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCY--------AEGR---- 731 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~---- 731 (799)
.....||+.|+|||++.+.+++.++||||+||++|||++|+.||......+............. ..+.
T Consensus 160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (322)
T d1s9ja_ 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239 (322)
T ss_dssp C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence 2345799999999999999999999999999999999999999976543221110000000000 0000
Q ss_pred --------------eeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 732 --------------LDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 732 --------------~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.........+..........+.+++.+||+.||++|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00000011111111223456788999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=390.23 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=192.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec--ccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--ALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--~~~~~lv~ 582 (799)
+.+.+.||+|+||+||+|+.+. +++.||||+++.. .....+.+.+|++++++++|||||++++++.+ ....++||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKS-DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 3456889999999999999875 6889999998653 23345678999999999999999999999864 45578999
Q ss_pred eecCCCChhhhhhc----CCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 583 EFMGNGTLANLIFA----IPKPDWNLRVRISLEIARGLVYLHEEC--NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 583 e~~~~gsL~~~l~~----~~~~~~~~~~~i~~~ia~gL~yLH~~~--~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
||+++|+|.+++.. ...+++..++.++.||+.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++..
T Consensus 85 Ey~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 85 EYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp ECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred ecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeec
Confidence 99999999999864 357899999999999999999999862 124999999999999999999999999999986
Q ss_pred cCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV 736 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 736 (799)
..... ......||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+....
T Consensus 165 ~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~--------~~~~i~~~~~~~-- 233 (269)
T d2java1 165 NHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREGKFRR-- 233 (269)
T ss_dssp ------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHHTCCCC--
T ss_pred ccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH--------HHHHHHcCCCCC--
Confidence 54332 2234568999999999999999999999999999999999999997654322 222233333221
Q ss_pred cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
. +....+.+.+++.+||+.||++|||+.|+++
T Consensus 234 ---~----~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 ---I----PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---C----CcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1 1223457888999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-46 Score=391.49 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=204.3
Q ss_pred hhh-hcCccccceEEEEEEeCC-CCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 509 FKE-ELGRGSFGIVYKGVLKSA-SGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 509 ~~~-~lG~G~fG~Vykg~~~~~-~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+ +||+|+||+||+|.++.. ++..||||+++... ....++|.+|++++++++|||||+++|+|.. +..++||||+
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~ 90 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA 90 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred ECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeC
Confidence 345 499999999999987532 35689999997543 3445789999999999999999999999865 4678999999
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc-
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT- 663 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~- 663 (799)
++|+|.+++... ..+++..+.+++.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 91 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (285)
T d1u59a_ 91 GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167 (285)
T ss_dssp TTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence 999999998654 5789999999999999999999998 99999999999999999999999999999875443221
Q ss_pred -eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCC
Q 038294 664 -HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEP 741 (799)
Q Consensus 664 -~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~ 741 (799)
.....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...+..+.... .+
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--------~~~~i~~~~~~~-----~p 234 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------VMAFIEQGKRME-----CP 234 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--------HHHHHHTTCCCC-----CC
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--------HHHHHHcCCCCC-----CC
Confidence 223458899999999999999999999999999999998 899997543322 223334433211 11
Q ss_pred CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 742 AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 742 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
....+.+.+++.+||+.||++||||.+|++.|+..
T Consensus 235 ----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 235 ----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22335778899999999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=393.92 Aligned_cols=246 Identities=24% Similarity=0.304 Sum_probs=204.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||+||+|..+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE 88 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELA-TSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS 88 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence 4567899999999999999874 68899999986432 2344679999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC-Cc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ-SR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~-~~ 662 (799)
|+++|+|.+++.....+++..+..++.|++.||+|||+. +|+||||||+|||+++++.+||+|||+++.+.... ..
T Consensus 89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999999888999999999999999999999998 99999999999999999999999999999775432 22
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||+||||++|+.||......+ ....+..+.. ..+.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~------~~p~ 231 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL--------IFQKIIKLEY------DFPE 231 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHTTCC------CCCT
T ss_pred ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH--------HHHHHHcCCC------CCCc
Confidence 2334569999999999999999999999999999999999999998654322 1222223221 1111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
...+.+.+++.+||+.||++|||++|++
T Consensus 232 ----~~s~~~~~li~~~L~~dP~~R~t~~e~~ 259 (288)
T d1uu3a_ 232 ----KFFPKARDLVEKLLVLDATKRLGCEEME 259 (288)
T ss_dssp ----TCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred ----cCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence 2235678899999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.37 Aligned_cols=249 Identities=24% Similarity=0.304 Sum_probs=204.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||+|..+. +++.||||+++.......+.|.+|++++++++|||||++++++.+.+..++||||++
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~ 92 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKE-TSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred eEEeEEEeeCCCcEEEEEEECC-CCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCC
Confidence 3456789999999999999875 688999999976655666789999999999999999999999999999999999999
Q ss_pred CCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 587 NGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 587 ~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
+|+|.+++.. ...+++..+..++.||++||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 93 ~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-~~~ 168 (288)
T d2jfla1 93 GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD 168 (288)
T ss_dssp TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-HHT
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcc-ccc
Confidence 9999999765 45689999999999999999999998 999999999999999999999999999976532211 122
Q ss_pred eeccCCccccccccc-----CCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 666 MIRGTRGYVAPEWFK-----NAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~-----~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
...||+.|+|||++. +..++.++|||||||+||||++|+.||......+. + .. +..+...
T Consensus 169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~----~~-i~~~~~~------- 233 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---L----LK-IAKSEPP------- 233 (288)
T ss_dssp CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---H----HH-HHHSCCC-------
T ss_pred ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---H----HH-HHcCCCC-------
Confidence 356999999999984 55689999999999999999999999976543321 1 11 1111110
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+....+.+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11112234467888999999999999999999876
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=399.97 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=205.1
Q ss_pred HhhchhhhcCccccceEEEEEEeCCC----CeEEEEEEcccc-chhhHHHHHHHHHHhccc-ccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSAS----GKAIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~~----~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 578 (799)
....+.++||+|+||+||+|+++..+ ...||+|++... .......+.+|+.++.++ +|||||++++++.+....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 34556789999999999999986432 247999998653 233446789999999998 899999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCC
Q 038294 579 LLVYEFMGNGTLANLIFAIP-----------------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQ 635 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~ 635 (799)
++||||+++|+|.++|.... .+++..++.++.||++||+|||+. +|+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 99999999999999997542 478999999999999999999998 9999999999
Q ss_pred CeEEcCCCceEEccccCcccccCCCCcc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhh
Q 038294 636 NILLDNYFSAKISDFGLSKLLLSDQSRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEE 713 (799)
Q Consensus 636 NILl~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~ 713 (799)
|||++.++.+||+|||+|+......... .....||+.|||||.+.+..++.++|||||||+||||+| |+.||......
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998765544322 234568999999999999999999999999999999998 89998754332
Q ss_pred hcchhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 038294 714 EGRAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLE 778 (799)
Q Consensus 714 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~ 778 (799)
. . ....+..+.. ... +....+.+.+++.+||+.||++||||+||++.|.
T Consensus 274 ~---~----~~~~~~~~~~-----~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 A---N----FYKLIQNGFK-----MDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp H---H----HHHHHHTTCC-----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred H---H----HHHHHhcCCC-----CCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 1 1 1222233211 111 1223357888999999999999999999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-45 Score=391.47 Aligned_cols=249 Identities=26% Similarity=0.353 Sum_probs=191.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||+||+|..+. +++.||||++.... ....+.+.+|++++++++|||||++++++.++...++||||+
T Consensus 11 Y~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~ 89 (307)
T d1a06a_ 11 YDFRDVLGTGAFSEVILAEDKR-TQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLV 89 (307)
T ss_dssp EEEEEESBSGGGGGEEEEEETT-TCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred eEEEEEEeeccCeEEEEEEECC-CCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 5567899999999999999874 68899999986533 233457889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEccccCcccccCCCCc
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD---NYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~---~~~~~kl~DfGla~~~~~~~~~ 662 (799)
++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+. +++.+||+|||+++......
T Consensus 90 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-- 164 (307)
T d1a06a_ 90 SGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-- 164 (307)
T ss_dssp CSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred CCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCC--
Confidence 9999999999888899999999999999999999998 999999999999994 57899999999998654322
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+... .+.
T Consensus 165 ~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--------~~~~i~~~~~~------~~~ 230 (307)
T d1a06a_ 165 VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--------LFEQILKAEYE------FDS 230 (307)
T ss_dssp --------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--------HHHHHHTTCCC------CCT
T ss_pred eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHhccCCC------CCC
Confidence 2234569999999999999999999999999999999999999997654322 11222222211 111
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.......+.+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 231 PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 112233457888999999999999999999987
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-45 Score=390.82 Aligned_cols=244 Identities=25% Similarity=0.320 Sum_probs=202.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+...++||+|+||+||+|+.+. +++.||||+++... ....+.+.+|++++++++|||||++++++.++...++|||
T Consensus 17 y~~l~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 17 FSDLREIGHGSFGAVYFARDVR-NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEeeEEEecCCCeEEEEEEECC-CCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4456789999999999999874 68999999986432 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|..++.....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB----
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCCC----
Confidence 999999988888778899999999999999999999998 9999999999999999999999999999865332
Q ss_pred eeeeccCCcccccccccC---CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 664 HTMIRGTRGYVAPEWFKN---APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~---~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||......+ ....... +..
T Consensus 169 -~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-------~~~~i~~-~~~-------- 231 (309)
T d1u5ra_ 169 -NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-------ALYHIAQ-NES-------- 231 (309)
T ss_dssp -CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHH-SCC--------
T ss_pred -CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHh-CCC--------
Confidence 23469999999999864 468999999999999999999999997543322 1111111 111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
+...+....+.+.+++.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11112233467888999999999999999999975
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-45 Score=388.23 Aligned_cols=256 Identities=23% Similarity=0.386 Sum_probs=208.7
Q ss_pred hchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
..+.++||+|+||+||+|+.+. .+++.||||+++.... +..++|.+|++++++++||||++++++|......+++
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v 94 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLL 94 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEE
Confidence 3456889999999999999863 3457899999975433 3456899999999999999999999999999999999
Q ss_pred EeecCCCChhhhhhcCC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCe
Q 038294 582 YEFMGNGTLANLIFAIP------------------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNI 637 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~------------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NI 637 (799)
+||+++|+|.+++.... .+++..+++|+.|||.||+|||+. +|+||||||+||
T Consensus 95 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NI 171 (301)
T d1lufa_ 95 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNC 171 (301)
T ss_dssp EECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred EEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccce
Confidence 99999999999996432 378899999999999999999998 999999999999
Q ss_pred EEcCCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCc-CCchhhhhhc
Q 038294 638 LLDNYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMEVEEEG 715 (799)
Q Consensus 638 Ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~-p~~~~~~~~~ 715 (799)
||+.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||+||||++|.. ||......+
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e- 250 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE- 250 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHH-
Confidence 999999999999999987644322 22334568899999999999999999999999999999999975 565443322
Q ss_pred chhHHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 716 RAILTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 716 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
....+.++.... . +......+.+|+.+||+.+|++||||.||+++|+++.+
T Consensus 251 -------~~~~v~~~~~~~-----~----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 251 -------VIYYVRDGNILA-----C----PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp -------HHHHHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -------HHHHHHcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222334443211 1 11223468889999999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.8e-45 Score=392.43 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=208.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||+|..+. +|+.||||++........+.+.+|++++++++|||||++++++.+.+..++||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~-~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERA-TGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 5567899999999999999874 689999999977666666789999999999999999999999999999999999999
Q ss_pred CCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD--NYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||++ .++.+||+|||+++...... .
T Consensus 107 gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~--~ 181 (350)
T d1koaa2 107 GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ--S 181 (350)
T ss_dssp SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS--C
T ss_pred CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccccc--c
Confidence 99999998654 5789999999999999999999998 999999999999996 46889999999998764332 3
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|||||++.+..++.++|||||||++|||++|+.||......+. ...+..+.. ..+..
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~--------~~~i~~~~~------~~~~~ 247 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--------LRNVKSCDW------NMDDS 247 (350)
T ss_dssp EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHHTCC------CSCCG
T ss_pred cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCC------CCCcc
Confidence 3445799999999999999999999999999999999999999976543321 111122111 11111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......+.+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122334577889999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=385.62 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=197.2
Q ss_pred hhchhhhcCccccceEEEEEEeCCC--CeEEEEEEccccch-hhHHHHHHHHHHhcccccccccceeeeeecccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSAS--GKAIAVKKLDRLAQ-EREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~--~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
.+.+.+.||+|+||.||+|++.... +..||||+++.... ...+.|.+|++++++++||||++++|++.+ +..++||
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~ 86 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIM 86 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEE
Confidence 4556789999999999999986432 35789999865433 345679999999999999999999999964 5789999
Q ss_pred eecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
||+++|+|.+++... ..+++..++.++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 87 E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~ 163 (273)
T d1mp8a_ 87 ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163 (273)
T ss_dssp ECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred EeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence 999999999987754 4689999999999999999999998 999999999999999999999999999987655444
Q ss_pred cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 662 RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
.......||+.|+|||.+.+..++.++|||||||+||||++ |..|+......+ +...+..+.... .
T Consensus 164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--------~~~~i~~~~~~~-----~ 230 (273)
T d1mp8a_ 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--------VIGRIENGERLP-----M 230 (273)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--------HHHHHHTTCCCC-----C
T ss_pred eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--------HHHHHHcCCCCC-----C
Confidence 44445668999999999999999999999999999999998 788887654432 122233332111 1
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+....+.+.+++.+||+.||++|||+.||++.|+.+++
T Consensus 231 ----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 231 ----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 12233578899999999999999999999999987653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-45 Score=387.22 Aligned_cols=256 Identities=27% Similarity=0.443 Sum_probs=204.8
Q ss_pred chhhhcCccccceEEEEEEeCCCC--eEEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeec-ccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE-ALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~-~~~~~lv~e 583 (799)
.|.++||+|+||+||+|++...++ ..||||+++.. .....++|.+|++++++++||||++++|++.+ +...++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 456789999999999999865433 36899999753 34455789999999999999999999999875 457899999
Q ss_pred ecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 584 FMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 584 ~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
|+++|+|.+++... ...++..+++++.|+|+||.|||+. +|+||||||+||||++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999998865 4678889999999999999999998 8999999999999999999999999999977544322
Q ss_pred c---eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 663 T---HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 663 ~---~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
. .....||+.|+|||.+....++.++||||||++||||+||+.|+....... + ....+..+... .
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~------~-~~~~i~~g~~~-----~ 254 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF------D-ITVYLLQGRRL-----L 254 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHTTCCC-----C
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH------H-HHHHHHcCCCC-----C
Confidence 2 223468999999999999999999999999999999999988876543221 1 11222333211 1
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+ ....+.+.+++.+||+.||++||+|.||++.|+++..
T Consensus 255 ~p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 255 QP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cc----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 11 1223567889999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-44 Score=389.86 Aligned_cols=249 Identities=27% Similarity=0.350 Sum_probs=207.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.+.||+|+||+||+|..+. +++.||||+++.......+.+.+|++++++++|||||++++++.++...++||||++
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 109 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKA-TGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 109 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCC
T ss_pred eEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 4567899999999999999874 689999999976555556788999999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc--CCCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD--NYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~--~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+|.+.+.... .+++..+..|+.||+.||+|||+. +|+||||||+||||+ .++.+||+|||+++...... .
T Consensus 110 gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~--~ 184 (352)
T d1koba_ 110 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE--I 184 (352)
T ss_dssp CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS--C
T ss_pred CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC--c
Confidence 999998876654 689999999999999999999998 999999999999998 67899999999999875432 3
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||......+ ....+..+.. ..+..
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--------~~~~i~~~~~------~~~~~ 250 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--------TLQNVKRCDW------EFDED 250 (352)
T ss_dssp EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--------HHHHHHHCCC------CCCSS
T ss_pred eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--------HHHHHHhCCC------CCCcc
Confidence 344568999999999999999999999999999999999999997654332 1112222211 11111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+++.+||+.||++|||+.|+++
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred cccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12233457788999999999999999999987
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-45 Score=383.02 Aligned_cols=250 Identities=25% Similarity=0.311 Sum_probs=205.8
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc------hhhHHHHHHHHHHhcccccccccceeeeeeccccee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA------QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRL 579 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~ 579 (799)
.+.+.+.||+|+||+||+|..+. +|+.||||+++... ....+.|.+|++++++++|||||++++++.+....+
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKS-TGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CEEEeEEEecCCCeEEEEEEECC-CCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34567899999999999999874 68999999985422 123568999999999999999999999999999999
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC----ceEEccccCccc
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF----SAKISDFGLSKL 655 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~----~~kl~DfGla~~ 655 (799)
|||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~ 166 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhh
Confidence 9999999999999998888899999999999999999999998 999999999999998766 599999999987
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
..... ......||+.|+|||++.+..++.++|||||||+||||++|+.||......+. ...+..+...
T Consensus 167 ~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~--------~~~i~~~~~~-- 234 (293)
T d1jksa_ 167 IDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--------LANVSAVNYE-- 234 (293)
T ss_dssp CTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--------HHHHHTTCCC--
T ss_pred cCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH--------HHHHHhcCCC--
Confidence 64332 22334689999999999999999999999999999999999999986543321 1112222111
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.+..........+.+++.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 ----FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111111123456788999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-45 Score=378.96 Aligned_cols=245 Identities=27% Similarity=0.372 Sum_probs=194.6
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc-cceeeEEeecC
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-LNRLLVYEFMG 586 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-~~~~lv~e~~~ 586 (799)
.+.+.||+|+||.||+|.++ ++.||||+++.. ...++|.+|++++++++||||++++|+|.+. ...++||||++
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~~---~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDYR---GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEEEEECSSCEEEEEEET---TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EEeEEEecCCCeEEEEEEEC---CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccC
Confidence 45688999999999999984 678999999753 3456899999999999999999999998654 56789999999
Q ss_pred CCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 587 NGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 587 ~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
+|+|.+++... ..++|..+++|+.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..... .
T Consensus 85 ~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~----~ 157 (262)
T d1byga_ 85 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----Q 157 (262)
T ss_dssp TEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred CCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC----C
Confidence 99999999764 3589999999999999999999998 9999999999999999999999999999865332 2
Q ss_pred eeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 665 TMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
....+|..|+|||++.+..++.++|||||||++|||+| |+.|+......+ +...+..+.... .
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--------~~~~i~~~~~~~-----~--- 221 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--------VVPRVEKGYKMD-----A--- 221 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--------HHHHHTTTCCCC-----C---
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCCC-----C---
Confidence 23357889999999999999999999999999999999 566665443222 112223332111 1
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+....+.+.+++.+||+.||++||||.||+++|+.+.
T Consensus 222 -~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 222 -PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1222357788999999999999999999999998764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=376.93 Aligned_cols=253 Identities=26% Similarity=0.332 Sum_probs=195.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCC--eEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASG--KAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~--~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.+.||+|+||.||+|++...++ ..||||+++.. ..+..++|.+|++++++++||||++++|+|.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 3456789999999999999865444 47899998643 23445689999999999999999999999976 467899
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
|||+++|+|.+++... ..+++..+++++.|||+||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred eeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 9999999999887654 4689999999999999999999998 89999999999999999999999999999875443
Q ss_pred Ccc--eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 661 SRT--HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 661 ~~~--~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
... .....+|..|+|||.+.+..++.++|||||||++|||+| |+.||......+. .......+...
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-------~~~i~~~~~~~---- 234 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKIDKEGERL---- 234 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHHHTSCCCC----
T ss_pred CcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-------HHHHHhCCCCC----
Confidence 222 233457889999999999999999999999999999998 8999875543321 12222222111
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhc
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEG 779 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~ 779 (799)
.. .......+.+++.+||+.||++||||.||++.|++
T Consensus 235 -~~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 235 -PR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp -CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred -CC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11 11223568889999999999999999999999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-43 Score=380.21 Aligned_cols=246 Identities=26% Similarity=0.310 Sum_probs=207.2
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc---chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL---AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|+.+. +++.||||+++.. .....+.+.+|+.+|++++||||+++++++.+....++|||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~-~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKA-TGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence 4456889999999999999875 6899999999653 22345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+|+....... .
T Consensus 86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~-~ 161 (337)
T d1o6la_ 86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 161 (337)
T ss_dssp CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-C
T ss_pred ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCc-c
Confidence 999999999999888899999999999999999999998 999999999999999999999999999987643332 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|+|||++.+..++.++||||+||+||||++|+.||......+ ..+.+..+.+ ..+.
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--------~~~~i~~~~~------~~p~- 226 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--------LFELILMEEI------RFPR- 226 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCCT-
T ss_pred cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--------HHHHHhcCCC------CCCc-
Confidence 334579999999999999999999999999999999999999998765432 1222222221 1122
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
.....+.+++.+||+.||++||+ ++|+++
T Consensus 227 ---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 227 ---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ---cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 23356788999999999999995 788875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-44 Score=383.08 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=199.7
Q ss_pred hchhhhcCccccceEEEEEEeCCCCe----EEEEEEcccc-chhhHHHHHHHHHHhcccccccccceeeeeecccceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGK----AIAVKKLDRL-AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~----~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv 581 (799)
+.+.+.||+|+||+||+|.+.. +++ .||+|+++.. ..+..++|.+|++++++++|||||+++|+|.++ ..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIP-EGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcC-CCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEE
Confidence 4456899999999999999864 333 6899998643 344567899999999999999999999999875 56788
Q ss_pred EeecCCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 582 YEFMGNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
+||+.+|+|.+++... ..+++..+++++.|||+||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 89 ~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred EEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 8999999999888765 5789999999999999999999998 99999999999999999999999999999875443
Q ss_pred Ccc-eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecC
Q 038294 661 SRT-HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDS 738 (799)
Q Consensus 661 ~~~-~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 738 (799)
... .....||+.|+|||.+.++.++.++|||||||+||||+| |+.||......+ +...+..+...
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--------~~~~i~~~~~~----- 232 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--------ISSILEKGERL----- 232 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--------HHHHHHHTCCC-----
T ss_pred ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--------HHHHHHcCCCC-----
Confidence 322 233468999999999999999999999999999999999 677876544332 11222222110
Q ss_pred CCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcC
Q 038294 739 DEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGL 780 (799)
Q Consensus 739 ~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~ 780 (799)
. .+....+.+.+++.+||+.||++||||.||++.|+.+
T Consensus 233 ~----~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 P----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp C----CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1 1122335788899999999999999999999998764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=381.77 Aligned_cols=259 Identities=27% Similarity=0.378 Sum_probs=197.3
Q ss_pred HhhchhhhcCccccceEEEEEEeCC----CCeEEEEEEccccc-hhhHHHHHHHHHHhccc-ccccccceeeeeecc-cc
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLKSA----SGKAIAVKKLDRLA-QEREREFKSEVSAIGRT-HHKNLVQLLGFCDEA-LN 577 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~~~----~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~-~~ 577 (799)
..+.+.++||+|+||.||+|.+... +++.||||+++... ....+++..|...+.++ +|+||+++++++.+. ..
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~ 92 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 92 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence 3455678999999999999998632 34789999997533 33456788888888877 799999999998665 45
Q ss_pred eeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 578 RLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
.++||||+++|+|.+++... ..+++..+..++.||++||+|||+. +|+||||||+||||++
T Consensus 93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSE 169 (299)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECG
T ss_pred EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECC
Confidence 78999999999999999743 2478999999999999999999998 9999999999999999
Q ss_pred CCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCc-CCchhhhhhcchhH
Q 038294 642 YFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMEVEEEGRAIL 719 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~-p~~~~~~~~~~~~~ 719 (799)
++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+++.. ||......+
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~----- 244 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE----- 244 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-----
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 999999999999876544332 2234568999999999999999999999999999999999765 665432221
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.....+..+... ..+ ....+.+.+++.+||+.||++||||.||++.|+++++
T Consensus 245 --~~~~~~~~~~~~-----~~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 245 --EFCRRLKEGTRM-----RAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp --HHHHHHHHTCCC-----CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHhcCCCC-----CCC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 122223333211 111 1223567889999999999999999999999998764
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=382.42 Aligned_cols=253 Identities=28% Similarity=0.452 Sum_probs=202.5
Q ss_pred chhhhcCccccceEEEEEEeCCCCe--EEEEEEcccc-chhhHHHHHHHHHHhccc-ccccccceeeeeecccceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGK--AIAVKKLDRL-AQEREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~--~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~~lv~e 583 (799)
.+.++||+|+||+||+|+++. ++. .||||+++.. ..+..++|.+|+++++++ +|||||+++|+|.+....++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKK-DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEE-TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEeeCCCcEEEEEEECC-CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEE
Confidence 456889999999999999975 343 5788887543 333456899999999998 79999999999999999999999
Q ss_pred ecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEE
Q 038294 584 FMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKI 647 (799)
Q Consensus 584 ~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl 647 (799)
|+++|+|.++|... ..+++..+.+++.|||+||.|||+. +|+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEE
Confidence 99999999999643 4689999999999999999999998 9999999999999999999999
Q ss_pred ccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCc-CCchhhhhhcchhHHHHHHHH
Q 038294 648 SDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRR-SVEMEVEEEGRAILTDWAYDC 726 (799)
Q Consensus 648 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~-p~~~~~~~~~~~~~~~~~~~~ 726 (799)
+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|.. ||......+ +...
T Consensus 169 ~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~--------~~~~ 238 (309)
T d1fvra_ 169 ADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--------LYEK 238 (309)
T ss_dssp CCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--------HHHH
T ss_pred ccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH--------HHHH
Confidence 9999998653222 1223458999999999999999999999999999999999875 555433222 2223
Q ss_pred HhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcCC
Q 038294 727 YAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLEV 783 (799)
Q Consensus 727 ~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~~ 783 (799)
+..+.. +.. +....+.+.+++.+||+.||++||||+||++.|+++++-
T Consensus 239 i~~~~~-----~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 239 LPQGYR-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp GGGTCC-----CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcCC-----CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 333321 111 122345788999999999999999999999999987753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.6e-44 Score=373.91 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=202.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccc----ee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALN----RL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~----~~ 579 (799)
+.+.+.||+|+||+||+|.... +++.||||+++... ....+.|.+|++++++++||||+++++++..... .+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLR-LHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 4567889999999999999874 68999999996532 3344679999999999999999999999876543 68
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+++++|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++..+|+|||.+......
T Consensus 88 lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccc
Confidence 9999999999999998888899999999999999999999998 9999999999999999999999999998765433
Q ss_pred CC--cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 660 QS--RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 660 ~~--~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.. .......||+.|+|||++.+..++.++|||||||+||||+||+.||......+ ........+.
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-------~~~~~~~~~~------ 231 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS-------VAYQHVREDP------ 231 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHHHHHCCC------
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH-------HHHHHHhcCC------
Confidence 22 22334569999999999999999999999999999999999999997654322 1222222221
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhcC
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRP-TMKVVLQMLEGL 780 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~evl~~L~~~ 780 (799)
..+........+.+.+++.+||+.||++|| |++++++.|.++
T Consensus 232 -~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 232 -IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp -CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 111122223346788899999999999999 899999988764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-43 Score=377.32 Aligned_cols=243 Identities=24% Similarity=0.326 Sum_probs=205.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||+||+|+.+. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+....++|||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~-~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 84 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD 84 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence 3456889999999999999874 68999999996432 2345678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+++|+|..++.....+++.....++.||+.||+|||++ +|+||||||+||||+.++.+||+|||+++.....
T Consensus 85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred ecCCccccccccccccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 999999999999988999999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|||||++.+..++.++|||||||+||||++|+.||......+ ....+..+.. ..+.
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~------~~p~- 222 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--------TYEKILNAEL------RFPP- 222 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--------HHHHHHHCCC------CCCT-
T ss_pred cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--------HHHHHHcCCC------CCCC-
Confidence 234579999999999999999999999999999999999999998654332 1122222221 1111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
...+.+.+++.+||+.||++|| |++|+++
T Consensus 223 ---~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 223 ---FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ---TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ---CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 2234678899999999999996 8999985
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-44 Score=376.35 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=200.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeeccc----ceeeEEe
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL----NRLLVYE 583 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv~e 583 (799)
.+.++||+|+||.||+|++ +|+.||||+++.... ....+..|+..+.+++||||++++++|.+.. ..++|||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~---~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~E 81 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKW---RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp EEEEEEECCSSSEEEEEEE---TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEeeCCCeEEEEEEE---CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEe
Confidence 4567899999999999997 478999999965322 2223345666777889999999999997654 4689999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEEC-----NVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
|+++|+|.++|++. .++|..+++++.|+|.||+|||+.. ..+|+||||||+||||+.++.+||+|||+++....
T Consensus 82 y~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~ 160 (303)
T d1vjya_ 82 YHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160 (303)
T ss_dssp CCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred cccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence 99999999999764 6899999999999999999999742 24899999999999999999999999999998754
Q ss_pred CCCc---ceeeeccCCcccccccccCCC------CCcchhHHHHHHHHHHHHhCCcCCchhhhhhc--------chhHHH
Q 038294 659 DQSR---THTMIRGTRGYVAPEWFKNAP------VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEG--------RAILTD 721 (799)
Q Consensus 659 ~~~~---~~~~~~gt~~y~aPE~l~~~~------~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~--------~~~~~~ 721 (799)
.... ......||+.|+|||++.+.. ++.++|||||||+||||+||..|+........ .... .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (303)
T d1vjya_ 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV-E 239 (303)
T ss_dssp TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH-H
T ss_pred CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH-H
Confidence 4322 223456999999999987653 57789999999999999999887653321110 0111 1
Q ss_pred HHHHHHhcCceeEeecCCCCCc-cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 722 WAYDCYAEGRLDVLVDSDEPAM-ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 722 ~~~~~~~~~~~~~~~d~~~~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
........+.. .+..+.. ...+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 240 ~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 240 EMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 12222222221 2222222 23345667889999999999999999999999998764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-44 Score=381.46 Aligned_cols=258 Identities=28% Similarity=0.391 Sum_probs=208.6
Q ss_pred HhhchhhhcCccccceEEEEEEe----CCCCeEEEEEEccccch-hhHHHHHHHHHHhccc-ccccccceeeeeecccce
Q 038294 505 ATGGFKEELGRGSFGIVYKGVLK----SASGKAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALNR 578 (799)
Q Consensus 505 ~~~~~~~~lG~G~fG~Vykg~~~----~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~~ 578 (799)
....+.+.||+|+||.||+|+++ ..+++.||||+++.... ....+|.+|+.+++++ +|||||+++|+|.+....
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 44556789999999999999874 23567999999975433 3445799999999999 699999999999999999
Q ss_pred eeEEeecCCCChhhhhhcCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc
Q 038294 579 LLVYEFMGNGTLANLIFAIP------------------KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD 640 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~------------------~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~ 640 (799)
++||||+++|+|.++++... .+++..+.+++.||++||+|||++ +|+||||||+|||++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 99999999999999997542 578999999999999999999998 899999999999999
Q ss_pred CCCceEEccccCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCc-hhhhhhcchh
Q 038294 641 NYFSAKISDFGLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVE-MEVEEEGRAI 718 (799)
Q Consensus 641 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~-~~~~~~~~~~ 718 (799)
.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+|++.|+. .....+ .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~---~ 256 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS---K 256 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH---H
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999999999997754432 22334568999999999999999999999999999999999655544 322211 1
Q ss_pred HHHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 719 LTDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 719 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
+...+..+.. ...+....+.+.+++.+||+.||++||||+||+++|++++
T Consensus 257 ----~~~~i~~~~~---------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 257 ----FYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ----HHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHhcCCC---------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 1222222211 1111223457889999999999999999999999998754
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-44 Score=377.22 Aligned_cols=257 Identities=27% Similarity=0.358 Sum_probs=204.1
Q ss_pred hhchhhhcCccccceEEEEEEeCCC------CeEEEEEEccccch-hhHHHHHHHHHHhccc-ccccccceeeeeecccc
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSAS------GKAIAVKKLDRLAQ-EREREFKSEVSAIGRT-HHKNLVQLLGFCDEALN 577 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~------~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~~~~ 577 (799)
.+.+.+.||+|+||.||+|+....+ +..||||+++.... ....++.+|+..+.++ +|||||+++++|.++..
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~ 93 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGP 93 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCe
Confidence 3445688999999999999875322 24799999976443 3457889999999888 89999999999999999
Q ss_pred eeeEEeecCCCChhhhhhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC
Q 038294 578 RLLVYEFMGNGTLANLIFAI----------------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN 641 (799)
Q Consensus 578 ~~lv~e~~~~gsL~~~l~~~----------------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~ 641 (799)
.++||||+++|+|.++|... ..+++..+++++.||+.||+|||+. +|+||||||+|||++.
T Consensus 94 ~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~ 170 (299)
T d1fgka_ 94 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTE 170 (299)
T ss_dssp CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecC
Confidence 99999999999999999754 2478999999999999999999998 9999999999999999
Q ss_pred CCceEEccccCcccccCCCCc-ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHh-CCcCCchhhhhhcchhH
Q 038294 642 YFSAKISDFGLSKLLLSDQSR-THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIIC-CRRSVEMEVEEEGRAIL 719 (799)
Q Consensus 642 ~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~ellt-g~~p~~~~~~~~~~~~~ 719 (799)
++.+||+|||+++........ ......+|+.|+|||.+.++.++.++|||||||++|||++ |..||.......
T Consensus 171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~----- 245 (299)
T d1fgka_ 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245 (299)
T ss_dssp TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-----
Confidence 999999999999977544322 2334568999999999999999999999999999999998 577776443321
Q ss_pred HHHHHHHHhcCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 720 TDWAYDCYAEGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 720 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+...+..+... .. +....+.+.+++.+||+.||++||||.||++.|++++.
T Consensus 246 ---~~~~i~~~~~~-----~~----p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 ---LFKLLKEGHRM-----DK----PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ---HHHHHHTTCCC-----CC----CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCCC-----CC----CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 22333333211 11 11233568899999999999999999999999998764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-43 Score=368.24 Aligned_cols=249 Identities=25% Similarity=0.295 Sum_probs=204.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---------hhhHHHHHHHHHHhcccc-cccccceeeeeeccc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---------QEREREFKSEVSAIGRTH-HKNLVQLLGFCDEAL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~ 576 (799)
+.+.+.||+|+||+||+|+.+. +++.||||+++... ....+.+.+|+.++++++ ||||+++++++.+++
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~-~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKP-TCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CEEceEEecCcCeEEEEEEECC-CCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 3456889999999999999864 68999999985422 112346889999999997 999999999999999
Q ss_pred ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
..+|||||+++|+|.+++.....+++..+..++.||++||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999888899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccC------CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKN------APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG 730 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~------~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 730 (799)
.... ......||+.|+|||++.+ ..++.++||||+||+||||++|+.||....... ....+..+
T Consensus 161 ~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--------~~~~i~~~ 230 (277)
T d1phka_ 161 DPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--------MLRMIMSG 230 (277)
T ss_dssp CTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHT
T ss_pred cCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--------HHHHHHhC
Confidence 5432 2234569999999999853 356889999999999999999999998654332 12222222
Q ss_pred ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 ~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
... .+........+.+.+++.+||+.||++|||+.||++
T Consensus 231 ~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 231 NYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp CCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 221 111122234567889999999999999999999875
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-44 Score=378.51 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=207.7
Q ss_pred hhchhhhcCccccceEEEEEEeC----CCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeecccceee
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKS----ASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~----~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
...+.+.||+|+||+||+|.++. .+++.||||+++... .+....|.+|++++++++||||++++|+|......++
T Consensus 21 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 100 (308)
T d1p4oa_ 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 100 (308)
T ss_dssp GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEE
T ss_pred HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeE
Confidence 34466889999999999998752 235789999997533 3344579999999999999999999999999999999
Q ss_pred EEeecCCCChhhhhhcC----------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 581 VYEFMGNGTLANLIFAI----------PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~----------~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
||||+++|+|.+++... ..+++..+.+++.|+|+||.|||+. +|+||||||+||||++++++||+||
T Consensus 101 v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DF 177 (308)
T d1p4oa_ 101 IMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDF 177 (308)
T ss_dssp EEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCT
T ss_pred EEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeec
Confidence 99999999999988632 3468999999999999999999998 8999999999999999999999999
Q ss_pred cCcccccCCCC-cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCC-cCCchhhhhhcchhHHHHHHHHHh
Q 038294 651 GLSKLLLSDQS-RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCR-RSVEMEVEEEGRAILTDWAYDCYA 728 (799)
Q Consensus 651 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~ 728 (799)
|+++....... .......+|+.|+|||.+.+..++.++||||||++||||+||+ .|+......+ ....+.
T Consensus 178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~--------~~~~i~ 249 (308)
T d1p4oa_ 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--------VLRFVM 249 (308)
T ss_dssp TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--------HHHHHH
T ss_pred ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH--------HHHHHH
Confidence 99987644322 2223345899999999999999999999999999999999996 5554433222 122233
Q ss_pred cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 729 EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 729 ~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
.+.... . +....+.+.+++.+||+.+|++||||++|+++|++.++
T Consensus 250 ~~~~~~-----~----p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 250 EGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp TTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred hCCCCC-----C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 332211 1 11223578899999999999999999999999998765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=376.00 Aligned_cols=246 Identities=26% Similarity=0.324 Sum_probs=203.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhc-ccccccccceeeeeecccceeeEE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIG-RTHHKNLVQLLGFCDEALNRLLVY 582 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~g~~~~~~~~~lv~ 582 (799)
+.+.+.||+|+||+||+|+.+. +++.||||+++... ....+.+..|..++. .++|||||++++++.++...++||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~-t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm 82 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKK-TNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 82 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECC-CCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence 3467899999999999999875 68999999996432 233445667777665 689999999999999999999999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCc
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSR 662 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~ 662 (799)
||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~- 158 (320)
T d1xjda_ 83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA- 158 (320)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC-
T ss_pred eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccc-
Confidence 9999999999999888899999999999999999999998 999999999999999999999999999986543332
Q ss_pred ceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCC
Q 038294 663 THTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPA 742 (799)
Q Consensus 663 ~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~ 742 (799)
......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ +...+..+.. ..+.
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--------~~~~i~~~~~------~~p~ 224 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--------LFHSIRMDNP------FYPR 224 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCCT
T ss_pred cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--------HHHHHHcCCC------CCCc
Confidence 2334569999999999999999999999999999999999999998654432 1222222221 1121
Q ss_pred ccCHHHHHHHHHHHHHhcccCCCCCCCHH-HHHH
Q 038294 743 MADRSRLQKWLMIAMWCIREDPSKRPTMK-VVLQ 775 (799)
Q Consensus 743 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-evl~ 775 (799)
.....+.+++.+||+.||++|||+. |+++
T Consensus 225 ----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 225 ----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----cCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 2235678899999999999999995 6753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-43 Score=373.21 Aligned_cols=256 Identities=24% Similarity=0.259 Sum_probs=197.6
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchh-----hHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQE-----REREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.||+|+||+||+|..+. +++.||||+++..... ..+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus 4 ~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKN-TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEETTEEEEEEECSS-CCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred eEeccCcCeEEEEEEECC-CCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 579999999999999875 6889999998643221 1346889999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
.++++..++.....+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....... ...
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-~~~ 158 (299)
T d1ua2a_ 83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-AYT 158 (299)
T ss_dssp SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-CCC
T ss_pred cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcc-ccc
Confidence 9988887777777889999999999999999999998 999999999999999999999999999987644332 223
Q ss_pred eeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEee--------
Q 038294 666 MIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLV-------- 736 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 736 (799)
...||+.|+|||++.. ..++.++|||||||++|||++|+.||....+.+....+ . +...........
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i---~-~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI---F-ETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HHHCCCCTTTSSSTTSSTTC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHH---H-HhcCCCChhhccchhccchh
Confidence 3468999999999865 46799999999999999999999999765443321111 1 111000000000
Q ss_pred --cCCCCCc----cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 737 --DSDEPAM----ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 737 --d~~~~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
....+.. ......+.+.+++.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 01122457889999999999999999999986
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-42 Score=371.03 Aligned_cols=248 Identities=22% Similarity=0.284 Sum_probs=204.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeecC
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFMG 586 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 586 (799)
+.+.++||+|+||+||+|..+. +++.||||+++... .....+.+|+++|++++|||||++++++.+....++||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~-~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETS-SKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred eEEEEEEecCCCeEEEEEEECC-CCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCC
Confidence 3456889999999999999875 68999999997643 334568899999999999999999999999999999999999
Q ss_pred CCChhhhhhcCC-CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC--CCceEEccccCcccccCCCCcc
Q 038294 587 NGTLANLIFAIP-KPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN--YFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 587 ~gsL~~~l~~~~-~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~--~~~~kl~DfGla~~~~~~~~~~ 663 (799)
+|+|.+++.... .+++.++..|+.||+.||+|||+. +|+||||||+|||++. ...+||+|||+++...... .
T Consensus 85 gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~--~ 159 (321)
T d1tkia_ 85 GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD--N 159 (321)
T ss_dssp CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC--E
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCC--c
Confidence 999999998765 689999999999999999999998 9999999999999985 4589999999998764332 2
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....+|+.|+|||.+.+..++.++||||+||++|||++|+.||......+. ...+..+.. ..+..
T Consensus 160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~--------~~~i~~~~~------~~~~~ 225 (321)
T d1tkia_ 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI--------IENIMNAEY------TFDEE 225 (321)
T ss_dssp EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--------HHHHHHTCC------CCCHH
T ss_pred ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH--------HHHHHhCCC------CCChh
Confidence 3445689999999999999999999999999999999999999986544321 111222211 01111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
........+.+++.+||+.||++|||+.|+++
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122356788999999999999999999987
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-43 Score=375.58 Aligned_cols=243 Identities=22% Similarity=0.248 Sum_probs=204.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEe
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 583 (799)
+.+.+.||+|+||.||+|..+. +++.||||+++... ....+.+.+|+++++.++|||||++++++......++|+|
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~-~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e 121 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKE-SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME 121 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEeecCcCcEEEEEEECC-CCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence 4456889999999999999874 68999999986422 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcc
Q 038294 584 FMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRT 663 (799)
Q Consensus 584 ~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~ 663 (799)
|+.+|+|.+++.....+++..+..++.||+.||.|||+. +||||||||+||||+.++.+||+|||+++.....
T Consensus 122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---- 194 (350)
T d1rdqe_ 122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---- 194 (350)
T ss_dssp CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence 999999999999888899999999999999999999998 9999999999999999999999999999876432
Q ss_pred eeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCCCCc
Q 038294 664 HTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDEPAM 743 (799)
Q Consensus 664 ~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~ 743 (799)
.....||+.|||||++.+..++.++|||||||+||||++|+.||....... ....+..+.. ..+
T Consensus 195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~--------~~~~i~~~~~------~~p-- 258 (350)
T d1rdqe_ 195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ--------IYEKIVSGKV------RFP-- 258 (350)
T ss_dssp BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------HHHHHHHCCC------CCC--
T ss_pred cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH--------HHHHHhcCCC------CCC--
Confidence 223569999999999999999999999999999999999999997653322 1122222221 111
Q ss_pred cCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 744 ADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 744 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
......+.+++.+||+.||.+|+ |++|+++
T Consensus 259 --~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 --SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 12335678899999999999994 8999985
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-42 Score=376.82 Aligned_cols=247 Identities=22% Similarity=0.236 Sum_probs=197.9
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc---hhhHHHHH---HHHHHhcccccccccceeeeeecccceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA---QEREREFK---SEVSAIGRTHHKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~---~~~~~~~~---~E~~~l~~l~h~niv~l~g~~~~~~~~~l 580 (799)
+.+.+.||+|+||.||+|+.+. +|+.||||++.... ......+. .|+++++.++|||||++++++.+.+..++
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~-t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKAD-TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECC-CCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence 3456889999999999999874 68999999986421 12223333 45777888899999999999999999999
Q ss_pred EEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCC
Q 038294 581 VYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 581 v~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~ 660 (799)
||||+++|+|.+++.....+++..+..++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~ 161 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161 (364)
T ss_dssp EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCc
Confidence 999999999999999888899999999999999999999998 99999999999999999999999999998765432
Q ss_pred CcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSD 739 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 739 (799)
.....||+.|+|||++.. ..++.++|||||||+||||++|+.||.......... ......... ..
T Consensus 162 ---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----~~~~~~~~~------~~ 227 (364)
T d1omwa3 162 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-----IDRMTLTMA------VE 227 (364)
T ss_dssp ---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH-----HHHHSSSCC------CC
T ss_pred ---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcccCC------CC
Confidence 233469999999999864 568999999999999999999999997653322111 111111111 11
Q ss_pred CCCccCHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 038294 740 EPAMADRSRLQKWLMIAMWCIREDPSKRPT-----MKVVLQ 775 (799)
Q Consensus 740 ~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~evl~ 775 (799)
.+ ....+.+.+++.+||+.||++||| ++|+++
T Consensus 228 ~~----~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 228 LP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CC----SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CC----CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 11 123356788999999999999999 688874
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-42 Score=372.31 Aligned_cols=253 Identities=23% Similarity=0.255 Sum_probs=197.8
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccc-ccccccceeeeeec----ccceeeEEeec
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRT-HHKNLVQLLGFCDE----ALNRLLVYEFM 585 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~g~~~~----~~~~~lv~e~~ 585 (799)
+.||+|+||+||+|..+. +++.||||+++. ...+.+|++++.++ +|||||++++++.+ ....++||||+
T Consensus 18 ~~lG~G~fg~Vy~a~~~~-~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~ 91 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKR-TQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 91 (335)
T ss_dssp EEEEECSSCEEEEEEETT-TCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred EEeeeccCeEEEEEEECC-CCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECC
Confidence 469999999999999875 689999999864 23567788887655 89999999999864 45679999999
Q ss_pred CCCChhhhhhcC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC---CCceEEccccCcccccCCC
Q 038294 586 GNGTLANLIFAI--PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN---YFSAKISDFGLSKLLLSDQ 660 (799)
Q Consensus 586 ~~gsL~~~l~~~--~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~---~~~~kl~DfGla~~~~~~~ 660 (799)
++|+|.+++... ..+++..+..|+.||+.||+|||+. +|+||||||+|||+++ ++.+||+|||+++......
T Consensus 92 ~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~ 168 (335)
T d2ozaa1 92 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168 (335)
T ss_dssp CSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred CCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCC
Confidence 999999999864 4689999999999999999999998 9999999999999985 5679999999998765433
Q ss_pred CcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeecCCC
Q 038294 661 SRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVDSDE 740 (799)
Q Consensus 661 ~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 740 (799)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||........... ....+..+. ...
T Consensus 169 ~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~----~~~~i~~~~------~~~ 236 (335)
T d2ozaa1 169 S--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG----MKTRIRMGQ------YEF 236 (335)
T ss_dssp C--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------CCCSCS------SSC
T ss_pred c--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH----HHHHHhcCC------CCC
Confidence 2 2345699999999999999999999999999999999999999976543221111 011111111 111
Q ss_pred CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCC
Q 038294 741 PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLEVP 784 (799)
Q Consensus 741 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~ 784 (799)
+........+.+.+++.+||+.||++|||+.|+++. +.+....+
T Consensus 237 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 237 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp CTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCC
Confidence 111122345678899999999999999999999873 54444433
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-41 Score=360.40 Aligned_cols=265 Identities=23% Similarity=0.310 Sum_probs=198.0
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.++||+|+||+||+|.... +++.||||+++... ....+++.+|++++++++|||||++++++.++...++||||+
T Consensus 5 ~~~~~lG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 5 QKVEKIGEGTYGVVYKARNKL-TGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEECSSSEEEEEEETT-TCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EeccEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeec
Confidence 345789999999999999874 67899999996432 223568899999999999999999999999999999999999
Q ss_pred CCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCcce
Q 038294 586 GNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTH 664 (799)
Q Consensus 586 ~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~ 664 (799)
.++.+...... ...+++..+..++.||+.||+|||+. +||||||||+|||++.++.+||+|||+++....... ..
T Consensus 84 ~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~-~~ 159 (298)
T d1gz8a_ 84 HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TY 159 (298)
T ss_dssp SEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-CT
T ss_pred CCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcc-cc
Confidence 76544444333 35789999999999999999999998 899999999999999999999999999987644332 23
Q ss_pred eeeccCCcccccccccCCC-CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh-cC----ceeEeec-
Q 038294 665 TMIRGTRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA-EG----RLDVLVD- 737 (799)
Q Consensus 665 ~~~~gt~~y~aPE~l~~~~-~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~----~~~~~~d- 737 (799)
....||+.|+|||.+.... ++.++||||+||++|||++|+.||......+....+ ...... .. ......+
T Consensus 160 ~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~~~~~ 236 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI---FRTLGTPDEVVWPGVTSMPDY 236 (298)
T ss_dssp TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCTTTSTTGGGSTTC
T ss_pred eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH---HHhcCCCchhhcccccccccc
Confidence 3346899999999887665 578999999999999999999999765433211111 100000 00 0000000
Q ss_pred -CCCCC-------ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcC
Q 038294 738 -SDEPA-------MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGL 780 (799)
Q Consensus 738 -~~~~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~ 780 (799)
...+. .......+.+.+++.+||+.||++|||++|+++. |+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence 00000 0011233567889999999999999999999874 5443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=360.27 Aligned_cols=238 Identities=24% Similarity=0.378 Sum_probs=195.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch------hhHHHHHHHHHHhcccc--cccccceeeeeecccce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ------EREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~ 578 (799)
+.+.+.||+|+||+||+|+.+. +++.||||+++.... .....+.+|+.++++++ |||||++++++.+.+..
T Consensus 6 Y~i~~~lG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 6 YQVGPLLGSGGFGSVYSGIRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEeEEEeeCCCeEEEEEEECC-CCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeE
Confidence 4566889999999999999874 689999999864221 11234678999999986 99999999999999999
Q ss_pred eeEEeecCC-CChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-CCceEEccccCcccc
Q 038294 579 LLVYEFMGN-GTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-YFSAKISDFGLSKLL 656 (799)
Q Consensus 579 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-~~~~kl~DfGla~~~ 656 (799)
++||||+.+ +++.+++.....+++..+..++.||+.||+|||+. +|+||||||+|||++. ++.+||+|||+++..
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceec
Confidence 999999976 68888888888899999999999999999999998 9999999999999985 579999999999865
Q ss_pred cCCCCcceeeeccCCcccccccccCCCC-CcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKNAPV-SAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~-s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
... ......||+.|+|||++.+..+ +.++||||+||+||||++|+.||.....- ..+..
T Consensus 162 ~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--------------~~~~~--- 221 (273)
T d1xwsa_ 162 KDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------------IRGQV--- 221 (273)
T ss_dssp CSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------------HHCCC---
T ss_pred ccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--------------hhccc---
Confidence 332 2234569999999999987765 56789999999999999999999753210 11111
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..+. ...+.+.+++.+||+.||++|||++|+++
T Consensus 222 ---~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 ---FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111 12356788999999999999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2e-41 Score=356.34 Aligned_cols=262 Identities=21% Similarity=0.259 Sum_probs=198.8
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
...++||+|+||+||+|..+ +++.||||+++... ....+.+.+|+.++++++||||+++++++...+..++++||+
T Consensus 5 ~~~~~iG~G~fg~Vy~~~~~--~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 5 HGLEKIGEGTYGVVYKAQNN--YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp EEEEEEEEETTEEEEEEEET--TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred eeccEEecCCCcEEEEEEeC--CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 34578999999999999885 57899999986532 233578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
.++.+..+......+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......... ..
T Consensus 83 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~ 158 (286)
T d1ob3a_ 83 DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YT 158 (286)
T ss_dssp SEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred hhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccc-cc
Confidence 9888888877778899999999999999999999998 9999999999999999999999999999876443322 22
Q ss_pred eeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHH--------HHhcCcee---
Q 038294 666 MIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYD--------CYAEGRLD--- 733 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~~--- 733 (799)
...+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+........... .....+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (286)
T d1ob3a_ 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (286)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccc
Confidence 33588999999998754 5689999999999999999999999765433211111000000 00000000
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
..................+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000001111111223457789999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-41 Score=359.21 Aligned_cols=261 Identities=22% Similarity=0.278 Sum_probs=194.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccch--hhHHHHHHHHHHhccc---ccccccceeeeeec-----cc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQ--EREREFKSEVSAIGRT---HHKNLVQLLGFCDE-----AL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~g~~~~-----~~ 576 (799)
+.+.++||+|+||+||+|.+...+++.||||+++.... .....+.+|+.+++.+ +||||++++++|.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCc
Confidence 44567899999999999998655578899999864322 2223456677776655 79999999999853 34
Q ss_pred ceeeEEeecCCCChhhhhhc-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 577 NRLLVYEFMGNGTLANLIFA-IPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
..++++||++++.+...... ...+++..+..++.||+.||+|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred eEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 67899999998877655443 35788999999999999999999998 999999999999999999999999999886
Q ss_pred ccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee--
Q 038294 656 LLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD-- 733 (799)
Q Consensus 656 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 733 (799)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+....+ ...........
T Consensus 166 ~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 166 YSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI---LDVIGLPGEEDWP 240 (305)
T ss_dssp CCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCCCCGGGSC
T ss_pred hccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhhCCCchhccc
Confidence 5332 2334456999999999999999999999999999999999999999866443321111 11000000000
Q ss_pred -------Ee---ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 -------VL---VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 -------~~---~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.. ..............+.+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 0000000111223456778999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=348.24 Aligned_cols=266 Identities=20% Similarity=0.250 Sum_probs=195.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec--------cc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE--------AL 576 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~--------~~ 576 (799)
+.+.++||+|+||+||+|+.+. +++.||||++... .....+++.+|+++|++++|||++++++++.. ..
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~ 90 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRK-TGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKG 90 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------
T ss_pred EEEEEEEecCcCeEEEEEEECC-CCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCc
Confidence 3456789999999999999874 6899999998543 23345678999999999999999999999855 34
Q ss_pred ceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccc
Q 038294 577 NRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLL 656 (799)
Q Consensus 577 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~ 656 (799)
..++||||+.++.+..........+......++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 91 SIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred eEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeec
Confidence 5789999999888777666667888999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCC---cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHh----
Q 038294 657 LSDQS---RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYA---- 728 (799)
Q Consensus 657 ~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---- 728 (799)
..... .......||+.|+|||.+.+. .++.++||||+||++|||++|+.||......+....+.........
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence 53321 112234689999999998765 6899999999999999999999999765443322221111100000
Q ss_pred ---cCceeEeecCCCCCccC-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 729 ---EGRLDVLVDSDEPAMAD-R------SRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 729 ---~~~~~~~~d~~~~~~~~-~------~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
................. . .....+.+++.+||+.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000000000000001 1 113356789999999999999999998854
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-40 Score=348.63 Aligned_cols=258 Identities=18% Similarity=0.225 Sum_probs=195.0
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccccccee-eeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLL-GFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~-g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||+||+|++.. +++.||||++.... ...++..|++++++++|+|++..+ ++..+....++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIA-AGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETT-TTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEeEEEeeCCCcEEEEEEECC-CCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc
Confidence 4567899999999999999864 68999999876532 234678899999999877766555 4556777788999999
Q ss_pred CCCChhhhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEc---CCCceEEccccCcccccCCCC
Q 038294 586 GNGTLANLIF-AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLD---NYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 586 ~~gsL~~~l~-~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~---~~~~~kl~DfGla~~~~~~~~ 661 (799)
. ++|.+.+. ....+++..+..++.|++.||+|||+. +|+||||||+|||++ .+..+||+|||+++.......
T Consensus 86 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 86 G-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp C-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred C-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 5 46655554 456899999999999999999999998 999999999999986 456799999999998754322
Q ss_pred ------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEe
Q 038294 662 ------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVL 735 (799)
Q Consensus 662 ------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 735 (799)
.......||+.|||||.+.+..++.++|||||||++|||++|+.||...................... .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-~---- 236 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-P---- 236 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-C----
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-C----
Confidence 12234569999999999999999999999999999999999999997654333222211111111110 0
Q ss_pred ecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCc
Q 038294 736 VDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLL 781 (799)
Q Consensus 736 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~ 781 (799)
.........+.+.+++..||+.+|++||+++++.+.|+.+.
T Consensus 237 -----~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 237 -----IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -----HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred -----hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 00011122356788999999999999999999999988754
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-40 Score=349.98 Aligned_cols=252 Identities=23% Similarity=0.263 Sum_probs=203.6
Q ss_pred hchhhhcCccccceEEEEEEeC--CCCeEEEEEEccccc----hhhHHHHHHHHHHhccccc-ccccceeeeeeccccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKS--ASGKAIAVKKLDRLA----QEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~--~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~ 579 (799)
+.+.++||+|+||+||+|.... .+++.||||+++... ....+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 5567899999999999998742 357899999986422 2234568899999999966 89999999999999999
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+++||+.+|+|.+++.....+.......++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++.+...
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 9999999999999999888888899999999999999999998 8999999999999999999999999999877554
Q ss_pred CCcceeeeccCCcccccccccCC--CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCceeEeec
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNA--PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLDVLVD 737 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~--~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 737 (799)
.........|++.|+|||.+.+. .++.++|||||||+||||++|+.||......+....+ . .......
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~-~~~~~~~------ 252 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---S-RRILKSE------ 252 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---H-HHHHHCC------
T ss_pred ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-HhcccCC------
Confidence 44444455689999999999765 4688999999999999999999999876544322221 1 1111111
Q ss_pred CCCCCccCHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 038294 738 SDEPAMADRSRLQKWLMIAMWCIREDPSKRP-----TMKVVLQ 775 (799)
Q Consensus 738 ~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~evl~ 775 (799)
... +....+.+.+++.+||+.||++|| |++|+++
T Consensus 253 ~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111 123456788899999999999999 5888886
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-40 Score=353.12 Aligned_cols=259 Identities=22% Similarity=0.242 Sum_probs=191.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccccccccceeeeeecc------cceee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLVQLLGFCDEA------LNRLL 580 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~------~~~~l 580 (799)
+...++||+|+||+||+|+++. +++.||||++..... .+.+|+++|++++||||+++++++... ...++
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCD-SGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-TCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cEeeeEEeeCcCeEEEEEEECC-CCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 3445789999999999999875 689999999965332 234699999999999999999998432 34689
Q ss_pred EEeecCCCChhhhh---hcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccc
Q 038294 581 VYEFMGNGTLANLI---FAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLL 656 (799)
Q Consensus 581 v~e~~~~gsL~~~l---~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~ 656 (799)
||||++++.+..+. .....+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 99999876444333 3456789999999999999999999998 999999999999999765 8999999999876
Q ss_pred cCCCCcceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHH-------HHHHHh
Q 038294 657 LSDQSRTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDW-------AYDCYA 728 (799)
Q Consensus 657 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~-------~~~~~~ 728 (799)
..... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+... ......
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 44332 223468999999998765 57899999999999999999999999765433211111000 000000
Q ss_pred ----cCceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 729 ----EGRLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 729 ----~~~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
.....................+.+.+|+.+||+.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111100001111112234456888999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-39 Score=341.37 Aligned_cols=260 Identities=18% Similarity=0.244 Sum_probs=202.3
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeecccceeeEEeec
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
.+.++||+|+||+||+|+++. +++.||||+++.. .....+++.+|+.+++.++||||+++++++.+....++++|++
T Consensus 5 ~~i~~LG~G~fg~V~~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 5 EKLEKIGEGTYGTVFKAKNRE-THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEECSSSEEEEEEETT-TCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred EeeeEEecCcCeEEEEEEECC-CCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeec
Confidence 455789999999999999874 6889999998543 2344578999999999999999999999999999999999999
Q ss_pred CCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCCccee
Q 038294 586 GNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQSRTHT 665 (799)
Q Consensus 586 ~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~~~~~ 665 (799)
.+++|..++.....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++....... ...
T Consensus 84 ~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-~~~ 159 (292)
T d1unla_ 84 DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-CYS 159 (292)
T ss_dssp SEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-CCC
T ss_pred cccccccccccccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc-cce
Confidence 9999999988888899999999999999999999998 999999999999999999999999999987654332 222
Q ss_pred eeccCCcccccccccCCC-CCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcC--------------
Q 038294 666 MIRGTRGYVAPEWFKNAP-VSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEG-------------- 730 (799)
Q Consensus 666 ~~~gt~~y~aPE~l~~~~-~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------- 730 (799)
...+++.|+|||.+.... ++.++|||||||++|||++|+.||......... +.. ........
T Consensus 160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKR-IFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHH-HHHHHCCCCTTTCTTGGGSTTC
T ss_pred eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHH-HHhhcCCCChhhhhhhhhcccc
Confidence 334678899999987665 689999999999999999999997543322111 101 11110000
Q ss_pred -ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 731 -RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 731 -~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
...................+.+.+++.+||+.||.+|||++||++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000000111112233456788999999999999999999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.4e-39 Score=340.93 Aligned_cols=259 Identities=16% Similarity=0.210 Sum_probs=202.6
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccc-ccccceeeeeecccceeeEEeec
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHH-KNLVQLLGFCDEALNRLLVYEFM 585 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~g~~~~~~~~~lv~e~~ 585 (799)
+.+.+.||+|+||+||+|+... +++.||||+++... ...++.+|++.++.++| +|++.+++++.++...++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~-~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLL-NNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETT-TTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred eEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec
Confidence 4567889999999999999874 68999999885432 23457788888888864 89999999999999999999998
Q ss_pred CCCChhhhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcC-----CCceEEccccCcccccCC
Q 038294 586 GNGTLANLIFAI-PKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDN-----YFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 586 ~~gsL~~~l~~~-~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~-----~~~~kl~DfGla~~~~~~ 659 (799)
+++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+|||++. ++.+||+|||+++.....
T Consensus 84 -~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 84 -GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp -CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred -CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 68999998765 4689999999999999999999998 9999999999999974 578999999999986543
Q ss_pred CC------cceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCcee
Q 038294 660 QS------RTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRLD 733 (799)
Q Consensus 660 ~~------~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 733 (799)
.. .......||+.|||||.+.+..++.++|||||||++|||++|+.||.................... .....
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-~~~~~ 238 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-STPLR 238 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-HSCHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-CCChH
Confidence 21 122345699999999999999999999999999999999999999975543322211111111110 00000
Q ss_pred EeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhcCcC
Q 038294 734 VLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQMLEGLLE 782 (799)
Q Consensus 734 ~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~L~~~~~ 782 (799)
+ ......+++.+++..|++.+|++||+++.+.+.|+++++
T Consensus 239 ~---------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 239 E---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp H---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred H---------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 0 001122467789999999999999999999998887653
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-39 Score=348.42 Aligned_cols=268 Identities=24% Similarity=0.263 Sum_probs=192.4
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeeccc------ce
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL------NR 578 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~------~~ 578 (799)
+.+.++||+|+||+||+|..+. +++.||||+++.. .....+.+.+|+++|++++|||||+++++|.... ..
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp EEEEEEC------CEEEEEETT-TCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred EEEEEEEecCCCeEEEEEEECC-CCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceE
Confidence 3455789999999999999874 6899999999643 2334567899999999999999999999997654 46
Q ss_pred eeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccC
Q 038294 579 LLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLS 658 (799)
Q Consensus 579 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~ 658 (799)
++||||+ +.+|..++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 ~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp EEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCC
Confidence 8999999 5577776644 5789999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcC---
Q 038294 659 DQSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEG--- 730 (799)
Q Consensus 659 ~~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~--- 730 (799)
. .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||................. +.+...
T Consensus 174 ~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (346)
T d1cm8a_ 174 E----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249 (346)
T ss_dssp S----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred c----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence 2 2334689999999998764 578999999999999999999999976543221111000000 000000
Q ss_pred -------ceeEeecCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhcCcCCCC
Q 038294 731 -------RLDVLVDSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM--LEGLLEVPN 785 (799)
Q Consensus 731 -------~~~~~~d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~--L~~~~~~~~ 785 (799)
.+....... ...........+.+|+.+||+.||++|||+.|+++. |+.+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~~~ 312 (346)
T d1cm8a_ 250 EAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTED 312 (346)
T ss_dssp HHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC----
T ss_pred hhhhhhccCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCccc
Confidence 000000000 001111233467789999999999999999999974 666654433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-39 Score=346.50 Aligned_cols=261 Identities=21% Similarity=0.259 Sum_probs=193.3
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc-hhhHHHHHHHHHHhcccccccccceeeeeeccc----ceeeE
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-QEREREFKSEVSAIGRTHHKNLVQLLGFCDEAL----NRLLV 581 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~~----~~~lv 581 (799)
+.+.++||+|+||+||+|..+. +++.||||+++... ....+.+++|+++|++++||||+++++++.... ..+++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNV-NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEETT-TCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred eEEEEEEeeccCeEEEEEEECC-CCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEE
Confidence 3455889999999999999764 68999999996533 334567899999999999999999999996553 23556
Q ss_pred EeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCCCC
Q 038294 582 YEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 582 ~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~~~ 661 (799)
++|+.+|+|.+++.. ..+++..+..++.||+.||+|||++ +|+||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 89 VTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 677789999999965 4689999999999999999999998 999999999999999999999999999987644322
Q ss_pred --cceeeeccCCcccccccccC-CCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHHHHHhcCce------
Q 038294 662 --RTHTMIRGTRGYVAPEWFKN-APVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAYDCYAEGRL------ 732 (799)
Q Consensus 662 --~~~~~~~gt~~y~aPE~l~~-~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 732 (799)
.......||+.|+|||.+.. ..++.++||||+||++|||++|+.||......+....... .......
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~ 240 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG----ILGSPSQEDLNCI 240 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----HHCSCCHHHHHTC
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh----hccCCChhhhhhh
Confidence 12234568999999999854 4678999999999999999999999976543221111000 0000000
Q ss_pred ---------eEeecCCCC--CccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 733 ---------DVLVDSDEP--AMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 733 ---------~~~~d~~~~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
......... .........++.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000000000 00011123467889999999999999999999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-38 Score=338.91 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=194.3
Q ss_pred hhchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeec--ccceeeEE
Q 038294 506 TGGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDE--ALNRLLVY 582 (799)
Q Consensus 506 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~--~~~~~lv~ 582 (799)
.+.+.++||+|+||+||+|+.+. +++.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~-~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINIT-NNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECC-CCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 34566889999999999999874 6899999998753 3457889999999995 9999999999874 34578999
Q ss_pred eecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC-ceEEccccCcccccCCCC
Q 038294 583 EFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF-SAKISDFGLSKLLLSDQS 661 (799)
Q Consensus 583 e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~-~~kl~DfGla~~~~~~~~ 661 (799)
||+++++|..+. +.+++..+..++.||+.||+|||+. +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 112 e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~ 185 (328)
T d3bqca1 112 EHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185 (328)
T ss_dssp ECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC
T ss_pred eecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCc
Confidence 999999998764 4688999999999999999999998 999999999999998654 699999999987654332
Q ss_pred cceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcch-hHHHH-----HHHHHhcCcee-
Q 038294 662 RTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRA-ILTDW-----AYDCYAEGRLD- 733 (799)
Q Consensus 662 ~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~-~~~~~-----~~~~~~~~~~~- 733 (799)
.....+|+.|+|||.+.+. .++.++||||+||+++||++|+.||.......... .+... ...........
T Consensus 186 --~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 263 (328)
T d3bqca1 186 --YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263 (328)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred --ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccccc
Confidence 2334589999999998765 47999999999999999999999997543321110 00000 00011100000
Q ss_pred -----Eee--------cCCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 038294 734 -----VLV--------DSDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ 775 (799)
Q Consensus 734 -----~~~--------d~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~ 775 (799)
... .............+.+.+|+.+||+.||++|||++|+++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000111111233456788999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-38 Score=341.29 Aligned_cols=260 Identities=23% Similarity=0.242 Sum_probs=186.9
Q ss_pred chhhhcCccccceEEEEEEeCCCCeEEEEEEcccc--chhhHHHHHHHHHHhcccccccccceeeeeec------cccee
Q 038294 508 GFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRL--AQEREREFKSEVSAIGRTHHKNLVQLLGFCDE------ALNRL 579 (799)
Q Consensus 508 ~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~------~~~~~ 579 (799)
.+.++||+|+||+||+|.++. +++.||||++... .......+.+|+.++++++||||+++++++.. ....+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~-t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAV-LDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEECSCC--CEEEEEEETT-TTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEEEEeecCcCeEEEEEEECC-CCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeE
Confidence 345789999999999999874 6899999999643 23344578999999999999999999999853 36779
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+||||+.++.+. .+. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||+++.....
T Consensus 99 iv~Ey~~~~l~~-~~~--~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 99 LVMELMDANLCQ-VIQ--MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEECCSEEHHH-HHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEeccchHHHH-hhh--cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccc
Confidence 999999765554 433 4578999999999999999999998 9999999999999999999999999998865432
Q ss_pred CCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHH---------------HHHH
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILT---------------DWAY 724 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~---------------~~~~ 724 (799)
. ......+|+.|+|||.+.+..+++++||||+||+++||++|+.||...........+. ....
T Consensus 173 ~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 250 (355)
T d2b1pa1 173 F--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250 (355)
T ss_dssp ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred c--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence 2 2334468999999999999999999999999999999999999997543221111000 0000
Q ss_pred HHHhcCc-ee-----Eeec---CCCCCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 038294 725 DCYAEGR-LD-----VLVD---SDEPAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQM 776 (799)
Q Consensus 725 ~~~~~~~-~~-----~~~d---~~~~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~~ 776 (799)
....... .. .... ..............+.+|+.+||+.||++|||++|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 1111100 00 0000 000111223456678899999999999999999999853
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=335.57 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=194.8
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccc--hhhHHHHHHHHHHhcccccccccceeeeeecc-----ccee
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA--QEREREFKSEVSAIGRTHHKNLVQLLGFCDEA-----LNRL 579 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~g~~~~~-----~~~~ 579 (799)
+...+.||+|+||+||+|+.+. +++.||||+++... ....+.+.+|+++|++++|||+|++++++... ...+
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~ 98 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTK-TGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDV 98 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETT-TTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCC
T ss_pred eEEEEEEecCCCeEEEEEEECC-CCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceE
Confidence 3445789999999999999864 68999999997532 23445788999999999999999999998533 3446
Q ss_pred eEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccccCcccccCC
Q 038294 580 LVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDFGLSKLLLSD 659 (799)
Q Consensus 580 lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~DfGla~~~~~~ 659 (799)
+++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+|++|||++.....
T Consensus 99 ~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~- 173 (348)
T d2gfsa1 99 YLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173 (348)
T ss_dssp EEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred EEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc-
Confidence 77888899999999865 5689999999999999999999998 999999999999999999999999999875432
Q ss_pred CCcceeeeccCCcccccccccCC-CCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcchhHHHHHH----HHHhcCce--
Q 038294 660 QSRTHTMIRGTRGYVAPEWFKNA-PVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGRAILTDWAY----DCYAEGRL-- 732 (799)
Q Consensus 660 ~~~~~~~~~gt~~y~aPE~l~~~-~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~~~~~-- 732 (799)
......|++.|+|||.+.+. .++.++||||+||++|||++|+.||...........+..... +.......
T Consensus 174 ---~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (348)
T d2gfsa1 174 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250 (348)
T ss_dssp ---GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred ---ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence 22334588999999987665 468899999999999999999999976543322111100000 00000000
Q ss_pred -eEeec--CCCCC----ccCHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhcCcCC
Q 038294 733 -DVLVD--SDEPA----MADRSRLQKWLMIAMWCIREDPSKRPTMKVVLQ--MLEGLLEV 783 (799)
Q Consensus 733 -~~~~d--~~~~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl~--~L~~~~~~ 783 (799)
..... ...+. .......+.+.+++.+||+.||++|||+.|+++ .+.+....
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 00000 00000 000122356788999999999999999999997 56655443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-33 Score=307.02 Aligned_cols=277 Identities=21% Similarity=0.200 Sum_probs=192.1
Q ss_pred hchhhhcCccccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-----------cccccceeeeeecc
Q 038294 507 GGFKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-----------HKNLVQLLGFCDEA 575 (799)
Q Consensus 507 ~~~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~g~~~~~ 575 (799)
+.+.++||+|+||+||+|+.+. +++.||||+++... ...+.+.+|++++++++ |+||+++++++...
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~-~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMV-NNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETT-TTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEECC-CCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5667899999999999999874 68999999997543 23456788888888775 57899999888644
Q ss_pred --cceeeEEeecCCCCh-hhhhh--cCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCC------c
Q 038294 576 --LNRLLVYEFMGNGTL-ANLIF--AIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYF------S 644 (799)
Q Consensus 576 --~~~~lv~e~~~~gsL-~~~l~--~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~------~ 644 (799)
...+++++++..+.. ..... .....++..+..++.||++||+|||+. .+|+||||||+||||+.++ .
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~~~~ 170 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQ 170 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccccce
Confidence 344566666655432 22222 335778889999999999999999983 1899999999999998654 3
Q ss_pred eEEccccCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHHHHHHHHhCCcCCchhhhhhcc---hhHHH
Q 038294 645 AKISDFGLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGVMLLEIICCRRSVEMEVEEEGR---AILTD 721 (799)
Q Consensus 645 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gvll~elltg~~p~~~~~~~~~~---~~~~~ 721 (799)
++++|||.+...... .....||+.|+|||.+....++.++||||+||+++||++|+.||......... ..+..
T Consensus 171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~ 246 (362)
T d1q8ya_ 171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246 (362)
T ss_dssp EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence 999999999865322 23346899999999999999999999999999999999999998754321111 01111
Q ss_pred HHHH-------HHhcCc----------eeEeecCCC----------CCccCHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 038294 722 WAYD-------CYAEGR----------LDVLVDSDE----------PAMADRSRLQKWLMIAMWCIREDPSKRPTMKVVL 774 (799)
Q Consensus 722 ~~~~-------~~~~~~----------~~~~~d~~~----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~evl 774 (799)
.... ....+. ....+.... ...........+.+++.+||+.||++|||++|++
T Consensus 247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L 326 (362)
T d1q8ya_ 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV 326 (362)
T ss_dssp HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 1000 000000 000000000 1112356677899999999999999999999998
Q ss_pred HH--HhcC---cCCCCCCCCCc
Q 038294 775 QM--LEGL---LEVPNPPCPSS 791 (799)
Q Consensus 775 ~~--L~~~---~~~~~p~~p~~ 791 (799)
+. +++. -++..|+.|.+
T Consensus 327 ~Hp~f~~~~~~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 327 NHPWLKDTLGMEEIRVPDRELY 348 (362)
T ss_dssp TCGGGTTCTTCTTCCCTTSCTT
T ss_pred cCcccCCCCCcccCCCCCcccC
Confidence 74 5543 33455555433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=4.7e-21 Score=187.05 Aligned_cols=166 Identities=14% Similarity=0.080 Sum_probs=118.0
Q ss_pred hhhhcCccccceEEEEEEeCCCCeEEEEEEccccc------------------hhhHHHHHHHHHHhcccccccccceee
Q 038294 509 FKEELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA------------------QEREREFKSEVSAIGRTHHKNLVQLLG 570 (799)
Q Consensus 509 ~~~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~------------------~~~~~~~~~E~~~l~~l~h~niv~l~g 570 (799)
+.++||+|+||+||+|.+. +|+.||||+++... ......+..|...+.++.|.+++..++
T Consensus 4 vg~~IG~G~~g~Vy~a~~~--~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSE--KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEECSSEEEEEEEET--TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hCCEeeeCcceEEEEEECC--CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 4578999999999999875 58899999865211 011234556888899999999998876
Q ss_pred eeecccceeeEEeecCCCChhhhhhcCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecCCCCCCeEEcCCCceEEccc
Q 038294 571 FCDEALNRLLVYEFMGNGTLANLIFAIPKPDWNLRVRISLEIARGLVYLHEECNVPIIHCDIKPQNILLDNYFSAKISDF 650 (799)
Q Consensus 571 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~i~~~ia~gL~yLH~~~~~~iiH~dlk~~NILl~~~~~~kl~Df 650 (799)
+. ..+++|||+++..+.+ ++.....+++.|++++|+|||+. +|+||||||+|||++++ .++|+||
T Consensus 82 ~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCC
T ss_pred ec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEEC
Confidence 53 2379999998866543 23344568999999999999998 99999999999999965 5899999
Q ss_pred cCcccccCCCCcceeeeccCCcccccccccCCCCCcchhHHHHHH
Q 038294 651 GLSKLLLSDQSRTHTMIRGTRGYVAPEWFKNAPVSAKVDVYSFGV 695 (799)
Q Consensus 651 Gla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~s~k~DVwS~Gv 695 (799)
|+|.....+.....-. ..... -.|.+ .+.|+.++|+||..-
T Consensus 147 G~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 147 PQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAID 187 (191)
T ss_dssp TTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHH
T ss_pred CCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHH
Confidence 9997654322111000 00000 01111 356788999999653
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.68 E-value=4.4e-17 Score=142.86 Aligned_cols=109 Identities=18% Similarity=0.381 Sum_probs=85.2
Q ss_pred ccccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEE
Q 038294 23 ATTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLL 101 (799)
Q Consensus 23 ~~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl 101 (799)
+|||.+||.|.+ +++|+ +|.|.|.|...++ |.|+. ..++||.||++.|.. ++.|.|..|| |+|
T Consensus 1 tDtL~~gq~L~~---g~~l~--~g~~~l~~q~DGN------Lvly~----~~~~vW~s~~~~~~~-~~~l~l~~dGnLvl 64 (112)
T d1xd5a_ 1 SDRLNSGHQLDT---GGSLA--EGGYLFIIQNDCN------LVLYD----NNRAVWASGTNGKAS-GCVLKMQNDGNLVI 64 (112)
T ss_dssp CCEEETTEEECT---TCEEE--ETTEEEEECTTSC------EEEEE----TTEEEEECCCTTSCS-SEEEEECTTSCEEE
T ss_pred CCEecCCCEecC---CCEEE--ECCEEEEEcCCCC------EEEEc----CCcEEEEccCccCCC-CcEEEEeccccEEE
Confidence 478999999875 57787 4999999976543 55654 368899999998843 4689999999 999
Q ss_pred EcCCCCEEeccCC--CCceeeEEeecCccEEEEecCCcccccccccccCCC
Q 038294 102 KDPGGKTIWDGKP--DKKVSDAAMLDTGNFVLRASGNNSDYAWQSFKNPTD 150 (799)
Q Consensus 102 ~~~~~~~vWst~~--~~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~PTD 150 (799)
.|.+ ..+|++++ ..+...|+|+|+|||||++. +++++|||+.+|+|
T Consensus 65 ~~~~-~~~w~s~t~~~~~~~~l~L~ddGNlvly~~--~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 65 YSGS-RAIWASNTNRQNGNYYLILQRDRNVVIYDN--SNNAIWATHTNVGN 112 (112)
T ss_dssp EETT-EEEEECCCCCSCCCCEEEECTTSCEEEECT--TSCEEEECCCCCCC
T ss_pred EecC-CeEEEEeeccCCCceEEEEcCCCCEEEECC--CCcEEecCCCccCC
Confidence 9975 55666543 23445799999999999864 56789999999986
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.66 E-value=1.5e-16 Score=137.92 Aligned_cols=104 Identities=20% Similarity=0.358 Sum_probs=83.7
Q ss_pred cccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEE
Q 038294 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 102 (799)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~ 102 (799)
++|.+|+.|.+ +++|. +|.|.|+|...++ |.++. ..++||+||++.|....+.|.|..|| |+|.
T Consensus 2 ~~L~~g~~L~~---g~~l~--~g~~~l~~q~dgn------Lvl~~----~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~ 66 (109)
T d1kj1a_ 2 NLLTNGEGLYA---GQSLD--VEPYHFIMQEDCN------LVLYD----HSTSVWASNTGILGKKGCKAVLQSDGNFVVY 66 (109)
T ss_dssp CEEETTCEEET---TCEEE--ETTEEEEECTTSC------EEEEE----TTEEEEECCCCCTTCCCCEEEECTTSCEEEE
T ss_pred CCccCCCEEeC---CCEEE--eCCEEEEecCCCe------EEEEe----CCEEEEEeCCCCCCceeEEEEEcCCceEEEE
Confidence 57888998874 57786 5889999964332 55543 35789999999999888899999999 9999
Q ss_pred cCCCCEEeccCCC--CceeeEEeecCccEEEEecCCccccccccccc
Q 038294 103 DPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKN 147 (799)
Q Consensus 103 ~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~ 147 (799)
|++|++||++++. .+...|+|+|+|||||++ ..+|||+-|
T Consensus 67 ~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~-----~~~W~S~t~ 108 (109)
T d1kj1a_ 67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYG-----SDIWSTGTY 108 (109)
T ss_dssp CSSSCEEEECCCCCCSSCCEEEECTTSCEEEEC-----CEEEECCCC
T ss_pred eCCCcEEEEEeeECCCCCEEEEEeCCCcEEEEC-----CCEecCCCc
Confidence 9999999998753 345579999999999974 259999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.65 E-value=1.7e-16 Score=137.64 Aligned_cols=103 Identities=19% Similarity=0.345 Sum_probs=81.8
Q ss_pred cccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEE
Q 038294 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 102 (799)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~ 102 (799)
++|.+|+.|.+ +++|. +|.|.|.|...++ |.|+.. .++||.||++.|. ..+.|.|..+| |+|.
T Consensus 2 ~~L~~g~~L~~---G~~l~--ng~~~l~~q~DGN------Lvly~~----~~~vW~s~~~~~~-~~~~l~l~~~Gnlvl~ 65 (108)
T d1jpca_ 2 NILYSGETLST---GEFLN--YGSFVFIMQEDCN------LVLYDV----DKPIWATNTGGLS-RSCFLSMQTDGNLVVY 65 (108)
T ss_dssp CEEETTEEECT---TCEEE--ETTEEEEECTTSC------EEEEET----TEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred CCccCCCEecC---CCEEE--cCCEEEEECCCCe------EEEEeC----CceeeEeCCCCCC-CccEEEEeccceEEEE
Confidence 57778888764 56784 6999999986553 667653 5789999999884 34579999999 9999
Q ss_pred cCCCCEEeccCCC--CceeeEEeecCccEEEEecCCccccccccccc
Q 038294 103 DPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFKN 147 (799)
Q Consensus 103 ~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD~ 147 (799)
|++|++||++++. .....|+|+|+|||||++ ..+||||+|
T Consensus 66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~-----~~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYG-----TDRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEE-----CCCCCCCCC
T ss_pred CCCccceEEccccCCCCcEEEEEcCCCCEEEeC-----CCcccCCCC
Confidence 9999999998752 234468999999999974 259999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.58 E-value=1.4e-15 Score=134.02 Aligned_cols=98 Identities=14% Similarity=0.242 Sum_probs=80.4
Q ss_pred EEEeccCCCCeEEEeecCCCCCCCCc-eeEEcccc-eEEEcCCCCEEeccCCCC--ceeeEEeecCccEEEEecCCcccc
Q 038294 65 AIWFNKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGKTIWDGKPDK--KVSDAAMLDTGNFVLRASGNNSDY 140 (799)
Q Consensus 65 giw~~~~~~~t~VWvANr~~pv~~~s-~l~l~~~g-lvl~~~~~~~vWst~~~~--~~~~a~LldsGNlVl~~~~~~~~~ 140 (799)
-|||.++++++.+|++|++.|+..+. +|.+..|| |+|.+. +.++|++++.. ....|+|+|+|||||++. ++++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~--~~~~ 87 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTN--QNIA 87 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEET--TTEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEccccCCCcEEEEEeCCeeEEEEcC--CCCE
Confidence 59999999999999999999997665 99999999 999986 67899987532 345799999999999875 4679
Q ss_pred cccccccCCCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEE
Q 038294 141 AWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLI 190 (799)
Q Consensus 141 lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~ 190 (799)
+||||. +.++|.|.+.|+ +|++++|
T Consensus 88 lW~S~t-------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 88 VWTSGN-------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp EEECCC-------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred EEEeCC-------------------------CCCCCcEEEEECCCCcEEEe
Confidence 999983 346788999998 7888776
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.40 E-value=9.1e-14 Score=120.86 Aligned_cols=107 Identities=17% Similarity=0.252 Sum_probs=86.3
Q ss_pred EEeccCCCCeEEEeecCCCCCCCCc-eeEEcccc-eEEEcCCCCEEeccCC-CCceeeEEeecCccEEEEecCCcccccc
Q 038294 66 IWFNKIPERTIVWHANGDNPAPRGS-TLELTATG-LLLKDPGGKTIWDGKP-DKKVSDAAMLDTGNFVLRASGNNSDYAW 142 (799)
Q Consensus 66 iw~~~~~~~t~VWvANr~~pv~~~s-~l~l~~~g-lvl~~~~~~~vWst~~-~~~~~~a~LldsGNlVl~~~~~~~~~lW 142 (799)
|||.-.++.+..|+.+.+.++.++. +|.+..|| |||.+ ++.++|++++ ...++.+.|+|+|||||++. ++.+||
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~-~~~~vW~s~t~~~~~~~l~l~~dGNLvl~d~--~~~~vW 79 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFD-SDVRVWASNTAGATGCRAVLQSDGLLVILTA--QNTIRW 79 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEE-SSSEEECCCCCSCSCCBCCBCSSSCBCCBCT--TTCCSC
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEc-CCeeEEEcccCCCCceEEEEeccCCEEEEcc--CCCEEE
Confidence 7887777888899999999997665 89999999 99988 5678999875 34567899999999999754 567999
Q ss_pred cccccCCCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccC
Q 038294 143 QSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTG 209 (799)
Q Consensus 143 QSFD~PTDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~ 209 (799)
||+- +.++|.|.+.|+ +|+++++ . .++|.+++.
T Consensus 80 sS~t-------------------------~~~~g~y~l~Lq~DGNlvlY---~------~~~Wssgt~ 113 (115)
T d1dlpa1 80 SSGT-------------------------KGSIGNYVLVLQPDRTVTIY---G------PGLWDSGTS 113 (115)
T ss_dssp CCCC-------------------------CCCSSCCEEEECSSSCEEEE---C------SEEEECSCC
T ss_pred EcCC-------------------------CCCCCCEEEEECCCCcEEEe---C------CCeecCCCC
Confidence 9873 346799999998 7887765 1 357887754
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.29 E-value=4.8e-12 Score=110.62 Aligned_cols=100 Identities=18% Similarity=0.312 Sum_probs=75.6
Q ss_pred cccccCCCcccccCCCeeccCCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEE
Q 038294 24 TTINLGSSLSSTSSNSSWLSPSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLK 102 (799)
Q Consensus 24 ~~~~~~~~l~~~~~~~~~~S~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~ 102 (799)
.++.++|+|. ..+..|.|.|.|...++ |-+ |. ..++||.||+..|. ....|.|..+| |+|.
T Consensus 15 ~~l~~~q~l~-------~~~~~~~y~l~mQ~DGN------LVL-y~---~~~~vWssnt~~~~-~~~~l~l~~dGnLvL~ 76 (119)
T d1b2pa_ 15 QILHATESLE-------ILFGTHVYRFIMQTDCN------LVL-YD---NNNPIWATNTGGLG-NGCRAVLQPDGVLVVI 76 (119)
T ss_dssp CEEETTCEEE-------EEETTEEEEEEECTTSC------EEE-EE---TTEEEEECCCTTSC-SSCEEEECTTSCEEEE
T ss_pred CEEeCCCeEE-------EecCCceEEEEECCCCc------EEE-EE---CCeEEEEecCCCCC-cceEEEEEeCCCEEEE
Confidence 4555555543 46679999999876543 433 43 36789999998774 34689999999 9999
Q ss_pred cCCCCEEeccCCC--CceeeEEeecCccEEEEecCCcccccccccc
Q 038294 103 DPGGKTIWDGKPD--KKVSDAAMLDTGNFVLRASGNNSDYAWQSFK 146 (799)
Q Consensus 103 ~~~~~~vWst~~~--~~~~~a~LldsGNlVl~~~~~~~~~lWQSFD 146 (799)
|++|.+||++++. .+...++|+|+|||||.+ ..+|||-.
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-----~~~W~S~T 117 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-----DALWATQT 117 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-----SEEEECCC
T ss_pred CCCCcEEEECCCcCCCCceEEEEcCCCCEEEEC-----CCEeccCC
Confidence 9999999998653 334568999999999963 36999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.90 E-value=1.4e-09 Score=93.87 Aligned_cols=86 Identities=16% Similarity=0.256 Sum_probs=65.3
Q ss_pred CCCeeeeeeeecCCCCCceEEEEEeccCCCCeEEEeecCCCCCCCCceeEEcccc-eEEEcCCCCEEeccCCC--Cceee
Q 038294 44 PSEDFAFGFRQLNNNSDLFLLAIWFNKIPERTIVWHANGDNPAPRGSTLELTATG-LLLKDPGGKTIWDGKPD--KKVSD 120 (799)
Q Consensus 44 ~~g~F~lGF~~~~~~~~~~ylgiw~~~~~~~t~VWvANr~~pv~~~s~l~l~~~g-lvl~~~~~~~vWst~~~--~~~~~ 120 (799)
.+|.|.|.|...++ |.|+. ...+||.+|... ...+++.|..+| |||.|.++++||++.+. .+...
T Consensus 24 ~~g~~~l~~q~DGN------LvL~~----~~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~~~~~vWsS~t~~~~g~y~ 91 (115)
T d1dlpa1 24 ELSSFRFTMQSDCN------LVLFD----SDVRVWASNTAG--ATGCRAVLQSDGLLVILTAQNTIRWSSGTKGSIGNYV 91 (115)
T ss_dssp CSTTEEEEECTTSC------EEEEE----SSSEEECCCCCS--CSCCBCCBCSSSCBCCBCTTTCCSCCCCCCCCSSCCE
T ss_pred EcCCEEEEECCCCe------EEEEc----CCeeEEEcccCC--CCceEEEEeccCCEEEEccCCCEEEEcCCCCCCCCEE
Confidence 36779998875443 56654 256799999764 345689999999 99999999999998653 34456
Q ss_pred EEeecCccEEEEecCCcccccccccc
Q 038294 121 AAMLDTGNFVLRASGNNSDYAWQSFK 146 (799)
Q Consensus 121 a~LldsGNlVl~~~~~~~~~lWQSFD 146 (799)
++|+++|||||++ ..+|+|-.
T Consensus 92 l~Lq~DGNlvlY~-----~~~Wssgt 112 (115)
T d1dlpa1 92 LVLQPDRTVTIYG-----PGLWDSGT 112 (115)
T ss_dssp EEECSSSCEEEEC-----SEEEECSC
T ss_pred EEECCCCcEEEeC-----CCeecCCC
Confidence 9999999999962 36999853
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.80 E-value=9.1e-09 Score=89.67 Aligned_cols=110 Identities=22% Similarity=0.298 Sum_probs=74.4
Q ss_pred EeecCccEEEEecCCcccccccccccCCCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCccccc
Q 038294 122 AMLDTGNFVLRASGNNSDYAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQY 200 (799)
Q Consensus 122 ~LldsGNlVl~~~~~~~~~lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~ 200 (799)
+++|+||+||.+. +|+|.|+++|.++|.| ..|.|+|.|+ +|+++++-. .
T Consensus 4 v~~~~~n~il~~~--------~~~~~~~~~l~~~q~l---------------~~g~y~L~~q~DGNLvL~~~--~----- 53 (120)
T d1dlpa2 4 VVANNGNSILYST--------QGNDNHPQTLHATQSL---------------QLSPYRLSMETDCNLVLFDR--D----- 53 (120)
T ss_dssp CCSSCCCEECCCC----------CCCCCCEECSSCCC---------------BCSSCEEEEETTTEEEEEBT--T-----
T ss_pred EEEeCCCeEEEcC--------CCCCCcccEEcCCCee---------------EcCCEEEEEcCCCcEEEecC--C-----
Confidence 4566666666321 6789999999999998 3588999998 888877632 2
Q ss_pred ccceecccCCCCCCCCCceeEecccccEEEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 201 KSYYTSNTGSANSTGSGHQLVFNESADVYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 201 ~~y~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
..+|.+.+.. .+....+.+...|.+.+++.++..+..+. ... ....++++|++||++++|.
T Consensus 54 ~~vW~s~t~~---~~~~~~~~l~~~GnLvl~d~~~~~lW~S~---t~~-~~~~~~l~Lq~DGnlvlY~ 114 (120)
T d1dlpa2 54 DRVWSTNTAG---KGTGCRAVLQPNGRMDVLTNQNIAVWTSG---NSR-SAGRYVFVLQPDRNLAIYG 114 (120)
T ss_dssp BCCSCCCCCS---SCSSCEEEEETTTEEEEEETTTEEEEECC---CCC-SSSCCEEEECSSSCEEEEC
T ss_pred cEEEEEcccc---CCCcEEEEEeCCeeEEEEcCCCCEEEEeC---CCC-CCCcEEEEECCCCcEEEeC
Confidence 4567665432 23445677888888888887776654332 111 1123589999999999994
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.70 E-value=5.6e-08 Score=83.80 Aligned_cols=96 Identities=19% Similarity=0.259 Sum_probs=70.0
Q ss_pred CCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEeccccc
Q 038294 149 TDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESAD 227 (799)
Q Consensus 149 TDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~ 227 (799)
||||+|||.|..++.|++ |.|+|.|+ +|+++++... ..+|.+.+... ..+..+.+...|.
T Consensus 1 tDtL~~gq~L~~g~~l~~---------g~~~l~~q~DGNLvly~~~-------~~vW~s~~~~~---~~~~~l~l~~dGn 61 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE---------GGYLFIIQNDCNLVLYDNN-------RAVWASGTNGK---ASGCVLKMQNDGN 61 (112)
T ss_dssp CCEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEETT-------EEEEECCCTTS---CSSEEEEECTTSC
T ss_pred CCEecCCCEecCCCEEEE---------CCEEEEEcCCCCEEEEcCC-------cEEEEccCccC---CCCcEEEEecccc
Confidence 899999999999999976 99999998 8888876421 46787765432 3445678888888
Q ss_pred EEEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 228 VYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
+.+++.++....... ......++++|..||++++|.
T Consensus 62 Lvl~~~~~~~w~s~t-----~~~~~~~~l~L~ddGNlvly~ 97 (112)
T d1xd5a_ 62 LVIYSGSRAIWASNT-----NRQNGNYYLILQRDRNVVIYD 97 (112)
T ss_dssp EEEEETTEEEEECCC-----CCSCCCCEEEECTTSCEEEEC
T ss_pred EEEEecCCeEEEEee-----ccCCCceEEEEcCCCCEEEEC
Confidence 877776544433221 112234689999999999994
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.41 E-value=8e-07 Score=76.77 Aligned_cols=104 Identities=16% Similarity=0.257 Sum_probs=76.2
Q ss_pred ccccccccCCCccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCc
Q 038294 140 YAWQSFKNPTDTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGH 218 (799)
Q Consensus 140 ~lWQSFD~PTDtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~ 218 (799)
+-||++|.|.+||-++|.|.. ..+.|+|+|.|+ +|+++++- .. ..+|.+.+... +...
T Consensus 5 ~s~~~~~~~~~~l~~~q~l~~-----------~~~~~~y~l~mQ~DGNLVLy~--~~-----~~vWssnt~~~---~~~~ 63 (119)
T d1b2pa_ 5 FSKQPDDNHPQILHATESLEI-----------LFGTHVYRFIMQTDCNLVLYD--NN-----NPIWATNTGGL---GNGC 63 (119)
T ss_dssp ECSCSSSCCCCEEETTCEEEE-----------EETTEEEEEEECTTSCEEEEE--TT-----EEEEECCCTTS---CSSC
T ss_pred EeeecCCCCCCEEeCCCeEEE-----------ecCCceEEEEECCCCcEEEEE--CC-----eEEEEecCCCC---Ccce
Confidence 358999999999999998732 225899999999 99988763 22 56788765422 3456
Q ss_pred eeEecccccEEEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 219 QLVFNESADVYIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
.+.+...|.+.+++.++..+..+. .......++++|+.||++++|.
T Consensus 64 ~l~l~~dGnLvL~d~~g~~vWsS~----t~~~~~~~~l~Lq~DGNlvlYg 109 (119)
T d1b2pa_ 64 RAVLQPDGVLVVITNENVTVWQSP----VAGKAGHYVLVLQPDRNVVIYG 109 (119)
T ss_dssp EEEECTTSCEEEECTTCCEEEECS----CCCCSSCEEEEECTTSCEEEEE
T ss_pred EEEEEeCCCEEEECCCCcEEEECC----CcCCCCceEEEEcCCCCEEEEC
Confidence 788889998888888887665432 1112234589999999999984
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.28 E-value=3.9e-06 Score=71.20 Aligned_cols=96 Identities=15% Similarity=0.224 Sum_probs=70.3
Q ss_pred CccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEecccccE
Q 038294 150 DTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADV 228 (799)
Q Consensus 150 DtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (799)
|||+|||.|..++.|.+ |+|+|.|+ +|+++++. .. ..+|.+.+... +....+.+...+.+
T Consensus 2 ~~L~~g~~L~~G~~l~n---------g~~~l~~q~DGNLvly~--~~-----~~vW~s~~~~~---~~~~~l~l~~~Gnl 62 (108)
T d1jpca_ 2 NILYSGETLSTGEFLNY---------GSFVFIMQEDCNLVLYD--VD-----KPIWATNTGGL---SRSCFLSMQTDGNL 62 (108)
T ss_dssp CEEETTEEECTTCEEEE---------TTEEEEECTTSCEEEEE--TT-----EEEEECCCTTS---CSSCEEEECTTSCE
T ss_pred CCccCCCEecCCCEEEc---------CCEEEEECCCCeEEEEe--CC-----ceeeEeCCCCC---CCccEEEEeccceE
Confidence 89999999999999954 99999998 89988764 22 56787665432 34456778888888
Q ss_pred EEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 229 YIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
.+++.++..+..+. .......++++|..||++++|.
T Consensus 63 vl~~~~g~~vWsS~----t~~~~~~~~l~L~ddGNlVly~ 98 (108)
T d1jpca_ 63 VVYNPSNKPIWASN----TGGQNGNYVCILQKDRNVVIYG 98 (108)
T ss_dssp EEECTTCCEEEECC----CCCSCSCEEEEECTTSCEEEEE
T ss_pred EEECCCccceEEcc----ccCCCCcEEEEEcCCCCEEEeC
Confidence 77887777665442 1112234578999999999995
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.21 E-value=3.5e-06 Score=71.57 Aligned_cols=97 Identities=18% Similarity=0.236 Sum_probs=70.5
Q ss_pred CccCCCcccCCCceEEeecCCCCCCCcceEEEEe-CCceEEEeecCCcccccccceecccCCCCCCCCCceeEecccccE
Q 038294 150 DTILPTQILDLDSVLISRLTETNFSKGRFELRFS-NGSLKLISVAWPSRFQYKSYYTSNTGSANSTGSGHQLVFNESADV 228 (799)
Q Consensus 150 DtlLpg~kl~~~~~L~S~~s~~dps~G~f~~~~~-~~~~~~~~~~~~~~~~~~~y~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (799)
|||.|||.|..++.|++ |.|+|.|+ +|+++++... ..+|.+.+.... ..+..+.+...|.+
T Consensus 2 ~~L~~g~~L~~g~~l~~---------g~~~l~~q~dgnLvl~~~~-------~~vW~ant~~~~--~~~~~l~l~~dGnL 63 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV---------EPYHFIMQEDCNLVLYDHS-------TSVWASNTGILG--KKGCKAVLQSDGNF 63 (109)
T ss_dssp CEEETTCEEETTCEEEE---------TTEEEEECTTSCEEEEETT-------EEEEECCCCCTT--CCCCEEEECTTSCE
T ss_pred CCccCCCEEeCCCEEEe---------CCEEEEecCCCeEEEEeCC-------EEEEEeCCCCCC--ceeEEEEEcCCceE
Confidence 89999999999999976 99999999 8888776421 467877554321 23456788888888
Q ss_pred EEEecCceEEEecccccCCCCcceEEEEEEccCCcEEEEE
Q 038294 229 YIVKDNGQIVQLPQWAKLSPRVDHYFRVTLDFDGVLAEYA 268 (799)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~L~~dG~l~~~~ 268 (799)
.+++.++..+-.+... .....++++|..||++++|.
T Consensus 64 vl~~~~g~~vW~s~t~----~~~~~~~l~L~ddGNlvly~ 99 (109)
T d1kj1a_ 64 VVYDAEGRSLWASHSV----RGNGNYVLVLQEDGNVVIYG 99 (109)
T ss_dssp EEECSSSCEEEECCCC----CCSSCCEEEECTTSCEEEEC
T ss_pred EEEeCCCcEEEEEeeE----CCCCCEEEEEeCCCcEEEEC
Confidence 8888787776544211 11223588999999999983
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.96 E-value=1.1e-05 Score=80.20 Aligned_cols=130 Identities=16% Similarity=0.050 Sum_probs=88.5
Q ss_pred ccceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc-cccccceeeeeecccceeeEEeecCCCChhhhhh
Q 038294 517 SFGIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH-HKNLVQLLGFCDEALNRLLVYEFMGNGTLANLIF 595 (799)
Q Consensus 517 ~fG~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~ 595 (799)
+.+.||+... +++.+++|+...........+..|...+..+. +--+.+++.+...+...++||+++++.++.+...
T Consensus 26 s~~~v~rv~~---~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~ 102 (263)
T d1j7la_ 26 SPAKVYKLVG---ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE 102 (263)
T ss_dssp SSSEEEEEEC---SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTT
T ss_pred CCCcEEEEEe---CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccc
Confidence 3468998653 45677888886544444445677877776663 4446788888888888899999999988765442
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------------
Q 038294 596 AIPKPDWNLRVRISLEIARGLVYLHEE----------------------------------------------------- 622 (799)
Q Consensus 596 ~~~~~~~~~~~~i~~~ia~gL~yLH~~----------------------------------------------------- 622 (799)
... ...+++.++++.++.||+.
T Consensus 103 ~~~-----~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 177 (263)
T d1j7la_ 103 DEQ-----SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTE 177 (263)
T ss_dssp TCS-----CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHS
T ss_pred ccc-----cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhc
Confidence 211 1223444555555555531
Q ss_pred C---CCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 623 C---NVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 623 ~---~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
. ...++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 178 ~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 178 KPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 0 1237999999999999987767799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.54 E-value=0.00012 Score=72.20 Aligned_cols=138 Identities=17% Similarity=0.092 Sum_probs=80.7
Q ss_pred hcCcccc-ceEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhcccc--cccccceeeeeecccceeeEEeecCCC
Q 038294 512 ELGRGSF-GIVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTH--HKNLVQLLGFCDEALNRLLVYEFMGNG 588 (799)
Q Consensus 512 ~lG~G~f-G~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g 588 (799)
.+..|.. +.||+.... ++..+++|.-.... ...+..|...++.+. .-.+.+++.+..++...++|||++++.
T Consensus 17 ~~~~G~s~~~v~r~~~~--~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ--GRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECT--TSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeC--CCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 3445543 578987654 46678888765432 224566677666653 233677888888888889999999886
Q ss_pred Chhhhh--------------hcCC-------CCC--HHHHHHHH--------------------HHHHHHHHHHHhcC--
Q 038294 589 TLANLI--------------FAIP-------KPD--WNLRVRIS--------------------LEIARGLVYLHEEC-- 623 (799)
Q Consensus 589 sL~~~l--------------~~~~-------~~~--~~~~~~i~--------------------~~ia~gL~yLH~~~-- 623 (799)
++.+.. .... ... +.....-. ......+..+....
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 653311 0000 000 00000000 00111222222211
Q ss_pred --CCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 624 --NVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 624 --~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
...++|+|+.|.|||++++..+-|+||+.+.
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1248999999999999988778899999765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.21 E-value=0.00053 Score=72.14 Aligned_cols=76 Identities=17% Similarity=0.126 Sum_probs=46.0
Q ss_pred hhcCccccceEEEEEEeCCCCeEEEEEEccccc-------hhhHHHHHHHHHHhcccc---cccccceeeeeecccceee
Q 038294 511 EELGRGSFGIVYKGVLKSASGKAIAVKKLDRLA-------QEREREFKSEVSAIGRTH---HKNLVQLLGFCDEALNRLL 580 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~~~~~vavK~l~~~~-------~~~~~~~~~E~~~l~~l~---h~niv~l~g~~~~~~~~~l 580 (799)
+.||.|..-.||+..... +++.++||.-.... .........|.+.|+.+. ...+++++.+. ....++
T Consensus 32 ~eig~G~~N~vfrV~~~~-~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE-HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EECCSSSSEEEEEEEC-----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEeCCCceEeEEEEEeCC-CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 568999999999988754 46789999643210 111223445676666552 23456666553 445679
Q ss_pred EEeecCCCC
Q 038294 581 VYEFMGNGT 589 (799)
Q Consensus 581 v~e~~~~gs 589 (799)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.11 E-value=0.0064 Score=61.70 Aligned_cols=131 Identities=13% Similarity=0.089 Sum_probs=71.6
Q ss_pred eEEEEEEeCCCCeEEEEEEccccchhhHHHHHHHHHHhccccccccc--ceee-----eeecccceeeEEeecCCCChhh
Q 038294 520 IVYKGVLKSASGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNLV--QLLG-----FCDEALNRLLVYEFMGNGTLAN 592 (799)
Q Consensus 520 ~Vykg~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~niv--~l~g-----~~~~~~~~~lv~e~~~~gsL~~ 592 (799)
.||+...+ +|+.+++|..+... ...+++..|...+..+....+. ..+. ........+.++++++|..+..
T Consensus 37 ~vy~v~~~--dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 37 RVYQFQDE--DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp EEEEECCT--TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred eeEEEEcC--CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 69998775 57889999876432 2345677788777776533322 1111 1123344678899887643210
Q ss_pred -----------hh---h----cC-----CCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCC
Q 038294 593 -----------LI---F----AI-----PKPDWN-------------------LRVRISLEIARGLVYLHE----ECNVP 626 (799)
Q Consensus 593 -----------~l---~----~~-----~~~~~~-------------------~~~~i~~~ia~gL~yLH~----~~~~~ 626 (799)
.+ + .. ...++. .+..+...+.+.++.+.. ....+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 00 0 00 111111 011111122222333322 22457
Q ss_pred eEecCCCCCCeEEcCCCceEEccccCccc
Q 038294 627 IIHCDIKPQNILLDNYFSAKISDFGLSKL 655 (799)
Q Consensus 627 iiH~dlk~~NILl~~~~~~kl~DfGla~~ 655 (799)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 45899997763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.21 E-value=0.028 Score=58.41 Aligned_cols=74 Identities=14% Similarity=0.179 Sum_probs=48.3
Q ss_pred hhcCccccceEEEEEEeCC------CCeEEEEEEccccchhhHHHHHHHHHHhcccccccc-cceeeeeecccceeeEEe
Q 038294 511 EELGRGSFGIVYKGVLKSA------SGKAIAVKKLDRLAQEREREFKSEVSAIGRTHHKNL-VQLLGFCDEALNRLLVYE 583 (799)
Q Consensus 511 ~~lG~G~fG~Vykg~~~~~------~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~g~~~~~~~~~lv~e 583 (799)
+.|+.|-.=.+|+...... ..+.|.+++.... .......+|..+++.+.-.++ .++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 4577777788999887532 2346777766432 223345678888888753344 578888754 58899
Q ss_pred ecCCCCh
Q 038294 584 FMGNGTL 590 (799)
Q Consensus 584 ~~~~gsL 590 (799)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.43 E-value=0.0095 Score=36.92 Aligned_cols=33 Identities=30% Similarity=0.626 Sum_probs=25.9
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCccccC
Q 038294 288 DICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLAD 327 (799)
Q Consensus 288 ~~C~~y~~~~~~~~CG~~g~C~~~~~~~~C~Cl~GF~p~~ 327 (799)
|+|.+ -..|| +|.|+.--..-.|.|-+||+|..
T Consensus 2 dECsi------gnpCG-nGTCtNviGgFec~C~~GFepgp 34 (39)
T d1emoa2 2 DECSV------GNPCG-NGTCKNVIGGFECTCEEGFEPGP 34 (39)
T ss_dssp CGGGT------TCSSS-SSCEEECSSSEEECCSSSSCCCS
T ss_pred Ccccc------CCccC-CceeeecccceEEeecCCcCCCc
Confidence 67888 57888 68897555567899999999753
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.57 E-value=0.061 Score=35.74 Aligned_cols=26 Identities=27% Similarity=0.680 Sum_probs=22.4
Q ss_pred CCccCCCcccccCCCCCcccCCCCcc
Q 038294 299 SGTCGFNSYCLLQNGRPFCDCPPGYV 324 (799)
Q Consensus 299 ~~~CG~~g~C~~~~~~~~C~Cl~GF~ 324 (799)
...|...|.|.....+-.|.|++||+
T Consensus 10 ~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 10 ANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp SCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred CCCCCCCcEeECCCCCEEeECCCCCc
Confidence 47899999998766678999999996
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=89.36 E-value=0.6 Score=45.93 Aligned_cols=31 Identities=19% Similarity=0.255 Sum_probs=27.5
Q ss_pred CCCeEecCCCCCCeEEcCCCceEEccccCcc
Q 038294 624 NVPIIHCDIKPQNILLDNYFSAKISDFGLSK 654 (799)
Q Consensus 624 ~~~iiH~dlk~~NILl~~~~~~kl~DfGla~ 654 (799)
..++||+|+.++||+++++...-|.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 3479999999999999998877899999875
|
| >d1lmja2 g.3.11.1 (A:47-88) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=89.01 E-value=0.045 Score=36.42 Aligned_cols=33 Identities=36% Similarity=0.779 Sum_probs=25.8
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCcccc
Q 038294 288 DICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLA 326 (799)
Q Consensus 288 ~~C~~y~~~~~~~~CG~~g~C~~~~~~~~C~Cl~GF~p~ 326 (799)
|+|... ++.|. ++.|.....+-.|.|++||.+.
T Consensus 3 dEC~~~-----~~~C~-~~~C~Nt~Gsy~C~C~~Gy~l~ 35 (42)
T d1lmja2 3 DECQRD-----PLLCR-GGVCHNTEGSYRCECPPGHQLS 35 (42)
T ss_dssp CHHHHC-----SSTTT-TSEEEEETTEEEEESCTTSCCC
T ss_pred cccCCC-----CCCCC-CCEeECCCCCeEEeCCCCCeEC
Confidence 566653 67885 7899877778899999999854
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.85 E-value=0.13 Score=34.26 Aligned_cols=31 Identities=32% Similarity=0.798 Sum_probs=24.8
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCccc
Q 038294 288 DICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVL 325 (799)
Q Consensus 288 ~~C~~y~~~~~~~~CG~~g~C~~~~~~~~C~Cl~GF~p 325 (799)
|+|.. +.|+..+.|....++-.|.|++||+.
T Consensus 6 dEC~~-------~~~~~~~~C~Nt~Gsy~C~C~~Gy~~ 36 (43)
T d1emoa1 6 DECKE-------PDVCKHGQCINTDGSYRCECPFGYIL 36 (43)
T ss_dssp CSSSS-------TTSCSSSCCCCCSSCCCCCCCTTEEE
T ss_pred eccCC-------cCCCCCCEeECCCCCeEeECCCCccc
Confidence 67865 45667899987777889999999975
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.45 E-value=0.16 Score=33.01 Aligned_cols=25 Identities=24% Similarity=0.534 Sum_probs=21.5
Q ss_pred CccCCCcccccCCCCCcccCCCCcc
Q 038294 300 GTCGFNSYCLLQNGRPFCDCPPGYV 324 (799)
Q Consensus 300 ~~CG~~g~C~~~~~~~~C~Cl~GF~ 324 (799)
..|...|.|........|.|++||+
T Consensus 6 ~PC~ngg~C~~~~~~y~C~C~~G~~ 30 (39)
T d1xkba1 6 SPCQNQGKCKDGLGEYTCTCLEGFE 30 (39)
T ss_dssp CCCCSSCEECCCSSSCCEECCTTEE
T ss_pred CCCCCCcEEECCCCCEEEECCCCCC
Confidence 7899999997665678999999996
|
| >d1uzka2 g.3.11.1 (A:1605-1647) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.39 E-value=0.1 Score=34.78 Aligned_cols=34 Identities=38% Similarity=0.907 Sum_probs=26.3
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCccccC
Q 038294 288 DICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLAD 327 (799)
Q Consensus 288 ~~C~~y~~~~~~~~CG~~g~C~~~~~~~~C~Cl~GF~p~~ 327 (799)
|+|... ++.|. .+.|....++-.|.|++||.+..
T Consensus 4 nEC~~~-----~~~c~-~~~C~Nt~Gsy~C~C~~Gy~l~~ 37 (43)
T d1uzka2 4 DECQEL-----PGLCQ-GGKCINTFGSFQCRCPTGYYLNE 37 (43)
T ss_dssp CHHHHC-----GGGGB-TSEEEECSSCEEEECCTTCCBCT
T ss_pred ccccCC-----CCCcC-CCEEECCCCCeEeECCCCCeECc
Confidence 567653 57785 68998777788999999998653
|
| >d2vj3a2 g.3.11.1 (A:453-491) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.99 E-value=0.12 Score=33.54 Aligned_cols=25 Identities=40% Similarity=0.776 Sum_probs=21.6
Q ss_pred CccCCCcccccCCCCCcccCCCCcc
Q 038294 300 GTCGFNSYCLLQNGRPFCDCPPGYV 324 (799)
Q Consensus 300 ~~CG~~g~C~~~~~~~~C~Cl~GF~ 324 (799)
..|...|.|.....+-.|.|++||+
T Consensus 7 ~PC~n~g~C~~~~~~y~C~C~~G~~ 31 (39)
T d2vj3a2 7 NPCQNDATCLDQIGEFQCICMPGYE 31 (39)
T ss_dssp CCCCSSCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCCEEECCCCCEEEeCCCCCc
Confidence 7899999997665678899999996
|
| >d1edmb_ g.3.11.1 (B:) Factor IX (IXa) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor IX (IXa) species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.19 E-value=0.21 Score=32.36 Aligned_cols=31 Identities=26% Similarity=0.497 Sum_probs=25.3
Q ss_pred ccccccccccCCCCccCCCcccccCCCCCcccCCCCcc
Q 038294 287 DDICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYV 324 (799)
Q Consensus 287 ~~~C~~y~~~~~~~~CG~~g~C~~~~~~~~C~Cl~GF~ 324 (799)
.|+|.- ..|-..|.|.....+..|.|++||+
T Consensus 3 ~d~C~~-------~PC~ngg~C~~~~~~y~C~C~~g~~ 33 (39)
T d1edmb_ 3 GDQCES-------NPCLNGGSCKDDINSYECWCPFGFE 33 (39)
T ss_dssp CCTTTT-------CCCCTTCEEEEETTEEEEECCTTCC
T ss_pred cccCCC-------CCCCCCcEEEcCCCCEEEECCCCCC
Confidence 366765 7899999997655678999999995
|
| >d1lmja1 g.3.11.1 (A:3-46) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.12 E-value=0.19 Score=33.53 Aligned_cols=33 Identities=33% Similarity=0.719 Sum_probs=24.9
Q ss_pred cccccccccCCCCccCCCcccccCCCCCcccCCCCcccc
Q 038294 288 DICRRLFNEIGSGTCGFNSYCLLQNGRPFCDCPPGYVLA 326 (799)
Q Consensus 288 ~~C~~y~~~~~~~~CG~~g~C~~~~~~~~C~Cl~GF~p~ 326 (799)
|+|..- +..|. ++.|.+..++-.|.|++||+..
T Consensus 4 dEC~~~-----~~~C~-~~~C~Nt~Gsy~C~C~~Gy~~~ 36 (44)
T d1lmja1 4 DECRIS-----PDLCG-RGQCVNTPGDFECKCDEGYESG 36 (44)
T ss_dssp CTTTTC-----SSTTT-TSCEEEETTEEEECCCSSEEEC
T ss_pred cccCCC-----CCCCC-CCEeEcCCCCeEEeCCCCCccC
Confidence 567652 45675 7899877778899999999754
|
| >d2vj3a3 g.3.11.1 (A:492-526) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.11 E-value=0.23 Score=31.27 Aligned_cols=25 Identities=32% Similarity=0.794 Sum_probs=21.3
Q ss_pred CccCCCcccccCCCCCcccCCCCcc
Q 038294 300 GTCGFNSYCLLQNGRPFCDCPPGYV 324 (799)
Q Consensus 300 ~~CG~~g~C~~~~~~~~C~Cl~GF~ 324 (799)
..|-..|.|.....+-.|.|++||+
T Consensus 6 ~PC~ngg~C~~~~~~y~C~C~~g~~ 30 (35)
T d2vj3a3 6 SPCLHNGRCLDKINEFQCECPTGFT 30 (35)
T ss_dssp CCSTTTCEEEECSSCEEEECCTTEE
T ss_pred CCCCCCcEEECCCCCeEEECCCCCC
Confidence 7899999997655578899999996
|
| >d1i0ua2 g.3.11.1 (A:42-82) Low density lipoprotein (LDL) receptor, different EGF domains {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Low density lipoprotein (LDL) receptor, different EGF domains species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.71 E-value=0.36 Score=31.60 Aligned_cols=26 Identities=31% Similarity=0.784 Sum_probs=20.2
Q ss_pred CCccCCCcccccCCCCCcccCCCCcccc
Q 038294 299 SGTCGFNSYCLLQNGRPFCDCPPGYVLA 326 (799)
Q Consensus 299 ~~~CG~~g~C~~~~~~~~C~Cl~GF~p~ 326 (799)
.+.| ..+|....++-.|.|++||...
T Consensus 7 ~~~C--~~~C~n~~Gsy~C~C~~Gy~L~ 32 (41)
T d1i0ua2 7 PDTC--SQLCVNLEGGYKCQCEEGFQLD 32 (41)
T ss_dssp TTSC--SSCEECSSSCCEECCCTTEEEC
T ss_pred CCCC--CCEeECCCCCEEeECCCCCeEC
Confidence 4566 4589776778899999999864
|